id,team_id,treatment,region,organization,job_family,performance_rating,gender,age,tenure_months,is_new_manager,num_direct_reports,tot_span_of_control,baseline_manager_efficacy,baseline_workload,baseline_turnover_intention,propensity_score,retention_3month,retention_6month,retention_9month,retention_12month,manager_efficacy_index,workload_index_mgr,turnover_intention_index_mgr
1,367,0,Latin America,Manufacturing,Market Access,Meets,Male,38,9,0,5,12,1.7,4.0,3.2,0.0348,1,1,1,1,2.1,5.0,2.5
2,262,0,Middle East & Africa,Commercial,Regulatory Affairs,Exceeds,Male,43,5,1,9,13,0.0,2.1,4.0,0.0743,1,1,1,1,3.5,2.7,4.3
3,433,0,Asia Pacific,Manufacturing,Market Access,Exceeds,Male,38,7,0,6,10,2.3,2.9,2.8,0.0616,0,0,0,0,3.2,4.8,3.2
4,326,0,Middle East & Africa,Commercial,Pharmacovigilance,Exceeds,Male,28,16,0,11,39,4.6,1.0,3.4,0.0743,1,1,1,1,4.7,1.7,3.5
5,786,0,Middle East & Africa,HR,IT & Digital,Meets,Male,45,10,0,11,20,3.1,3.1,2.5,0.0383,1,1,1,1,2.8,3.6,2.2
6,615,0,Europe,Digital,Quality Assurance,Meets,Male,39,32,0,7,21,4.1,3.5,2.7,0.0853,1,1,1,1,3.2,3.6,2.4
7,908,0,Asia Pacific,Finance,Data Science,Below,Female,28,14,0,7,11,5.0,3.8,2.2,0.0,1,0,0,0,4.1,3.2,1.8
8,291,1,Asia Pacific,Commercial,Clinical Operations,Exceeds,Female,47,15,0,5,6,2.0,3.2,2.4,0.0743,1,1,1,1,1.8,2.8,2.8
9,691,0,Asia Pacific,Digital,Medical Affairs,Meets,Male,47,9,0,12,24,3.3,3.1,2.7,0.0853,1,1,1,1,3.5,3.7,2.3
10,524,0,Middle East & Africa,Digital,Quality Assurance,Below,Female,32,14,0,7,13,2.6,3.1,2.6,0.0,1,1,1,1,2.9,3.4,2.3
11,207,0,Latin America,Commercial,Data Science,Meets,Female,29,9,0,11,23,3.1,2.5,2.4,0.0422,1,1,1,1,3.0,1.5,2.3
12,797,0,Asia Pacific,HR,Market Access,Meets,Male,45,12,1,12,22,0.0,3.3,1.3,0.0383,1,1,1,1,3.8,4.2,2.0
13,56,0,Middle East & Africa,R&D,IT & Digital,Meets,Female,45,17,1,10,13,0.0,4.7,3.0,0.0977,1,1,1,1,1.8,4.2,3.8
14,666,0,Europe,Digital,Regulatory Affairs,Below,Male,41,5,0,8,21,3.9,3.9,2.4,0.0,1,1,1,1,2.9,3.7,4.3
15,687,0,Latin America,Digital,Supply Chain,Meets,Male,35,14,0,6,14,4.3,3.5,2.5,0.0853,1,1,1,1,4.2,3.5,2.1
16,820,0,Europe,HR,Medical Affairs,Below,Female,33,12,0,7,22,3.7,3.0,2.8,0.0,0,0,0,0,4.0,3.4,3.0
17,824,0,Latin America,HR,Marketing,Meets,Male,42,29,0,9,38,3.8,3.1,3.5,0.0383,1,1,1,1,4.2,1.8,3.0
18,357,0,Middle East & Africa,Manufacturing,Sales,Exceeds,Male,34,6,0,11,13,3.1,4.1,1.8,0.0616,1,1,1,1,3.4,3.2,2.2
19,830,0,North America,HR,Regulatory Affairs,Meets,Female,34,10,1,7,14,0.0,3.9,2.5,0.0383,1,1,1,1,1.7,5.0,2.0
20,584,0,Latin America,Digital,Market Access,Meets,Female,43,8,0,11,17,3.2,4.0,1.0,0.0853,1,1,1,1,2.6,3.5,1.5
21,274,0,Europe,Commercial,Regulatory Affairs,Meets,Female,44,5,0,11,16,3.3,4.8,3.2,0.0422,1,1,1,1,4.0,3.7,4.4
22,128,0,Middle East & Africa,R&D,Legal & Compliance,Meets,Female,47,13,0,10,17,3.1,3.7,4.2,0.0977,1,1,1,1,4.0,3.7,4.6
23,355,0,Latin America,Manufacturing,Pharmacovigilance,Meets,Female,28,2,1,10,11,0.0,4.7,3.6,0.0348,1,1,1,1,2.4,3.5,1.9
24,209,0,North America,Commercial,Human Resources,Far Exceeds,Female,35,9,1,12,16,0.0,5.0,1.7,0.1275,1,1,1,1,2.5,4.3,2.7
25,20,0,North America,R&D,Market Access,Meets,Male,36,9,0,10,18,4.1,1.6,2.2,0.0977,1,0,0,0,3.7,4.3,3.3
26,106,0,Asia Pacific,R&D,Regulatory Affairs,Meets,Female,38,8,0,9,33,3.2,3.1,2.8,0.0977,1,1,1,1,4.2,2.9,3.2
27,140,0,Asia Pacific,R&D,Quality Assurance,Meets,Female,30,7,0,12,23,4.7,2.4,1.0,0.0977,1,1,1,1,4.2,3.9,1.0
28,900,0,Europe,Finance,Quality Assurance,Exceeds,Male,41,4,1,8,10,0.0,3.0,2.2,0.0588,1,1,1,1,2.9,2.5,2.6
29,344,0,Latin America,Commercial,Clinical Operations,Below,Female,49,9,1,10,24,0.0,4.9,2.7,0.0,1,1,1,1,2.9,2.5,3.2
30,521,0,Latin America,Manufacturing,Clinical Operations,Meets,Female,31,21,0,9,22,2.9,4.6,2.1,0.0348,1,1,1,1,3.3,4.2,3.5
31,487,0,Asia Pacific,Manufacturing,Finance & Accounting,Exceeds,Male,39,14,0,5,20,3.0,3.4,3.8,0.0616,1,1,1,1,2.6,2.5,2.0
32,15,0,Latin America,R&D,Medical Affairs,Exceeds,Male,46,14,0,11,24,3.2,3.5,1.7,0.1648,1,1,0,0,2.8,3.9,1.9
33,224,0,Latin America,Commercial,Regulatory Affairs,Meets,Male,37,15,0,6,14,3.6,2.5,2.0,0.0422,1,1,1,1,1.8,2.9,2.3
34,1023,0,North America,Finance,IT & Digital,Meets,Female,34,11,0,5,38,3.7,4.3,4.4,0.0331,1,1,1,1,2.9,4.9,2.9
35,152,0,Asia Pacific,R&D,Communications,Meets,Male,39,7,0,7,12,3.0,2.6,4.3,0.0977,1,1,1,1,4.6,4.1,4.0
36,760,0,Middle East & Africa,HR,Clinical Operations,Meets,Male,42,26,0,11,14,5.0,3.7,4.5,0.0383,1,1,0,0,4.3,2.8,3.3
37,444,0,Asia Pacific,Manufacturing,Pharmacovigilance,Exceeds,Male,30,8,0,6,28,2.9,2.5,2.0,0.0616,1,1,1,1,2.6,3.3,1.9
38,546,0,Middle East & Africa,Digital,Finance & Accounting,Below,Female,44,19,0,7,11,1.1,2.5,2.5,0.0,1,1,1,1,2.8,2.8,2.3
39,88,1,North America,R&D,Data Science,Meets,Female,37,27,0,6,10,2.6,4.1,1.0,0.0977,1,1,1,1,2.1,4.4,1.0
40,711,0,Europe,HR,Legal & Compliance,Exceeds,Female,34,9,0,7,15,3.4,2.8,2.0,0.0677,1,1,1,1,2.0,3.8,1.0
41,432,0,Latin America,Manufacturing,Legal & Compliance,Meets,Male,29,6,0,11,27,3.0,3.3,3.2,0.0348,1,1,1,1,3.0,4.5,4.1
42,964,0,North America,Finance,Legal & Compliance,Meets,Female,34,22,0,9,20,3.7,2.7,2.3,0.0331,0,0,0,0,4.5,1.7,3.0
43,187,0,Latin America,Commercial,Clinical Operations,Meets,Female,34,8,1,12,33,0.0,3.4,3.9,0.0422,1,1,1,1,3.1,2.2,4.6
44,450,0,Europe,Manufacturing,Regulatory Affairs,Exceeds,Female,31,19,1,7,30,0.0,3.1,2.8,0.0616,1,1,1,1,3.0,2.5,4.7
45,197,0,Europe,Commercial,Quality Assurance,Far Exceeds,Female,41,15,0,11,19,2.5,3.3,2.7,0.1275,1,1,1,1,3.6,3.4,1.8
46,300,0,North America,Commercial,Sales,Meets,Male,39,10,0,10,13,4.0,3.4,1.8,0.0422,1,1,1,1,4.6,2.3,3.0
47,990,0,Europe,Finance,Human Resources,Exceeds,Male,44,3,0,7,19,2.3,4.5,3.5,0.0588,1,1,1,1,3.2,2.6,1.7
48,1042,0,Middle East & Africa,Finance,Supply Chain,Far Exceeds,Male,42,13,0,9,23,2.6,2.6,1.8,0.1022,1,1,1,1,2.6,4.2,1.7
49,175,0,Europe,R&D,Marketing,Far Exceeds,Female,34,12,0,11,27,4.6,5.0,3.1,0.2644,1,1,1,1,4.9,3.9,3.2
50,5,0,Latin America,R&D,Finance & Accounting,Meets,Female,36,16,0,8,13,3.0,2.7,2.7,0.0977,1,1,1,1,3.5,3.3,3.6
51,417,0,Latin America,Manufacturing,Clinical Operations,Meets,Female,34,22,0,9,19,1.4,2.5,3.1,0.0348,1,1,1,1,1.7,3.9,3.1
52,905,0,Latin America,Finance,Marketing,Meets,Female,28,28,0,11,23,4.0,2.9,4.2,0.0331,1,1,1,1,5.0,4.4,3.4
53,823,0,Latin America,HR,Human Resources,Meets,Female,40,14,0,8,30,4.7,3.7,4.0,0.0383,1,1,1,1,3.9,2.3,3.9
54,441,0,Middle East & Africa,Manufacturing,Supply Chain,Meets,Male,39,7,1,12,38,0.0,2.2,2.7,0.0348,1,1,1,1,2.5,2.2,2.7
55,528,0,Asia Pacific,Digital,Medical Affairs,Meets,Male,34,19,0,11,12,3.2,4.1,3.1,0.0853,1,1,1,1,3.1,3.3,3.0
56,307,0,North America,Commercial,Quality Assurance,Meets,Female,43,8,0,8,16,5.0,3.0,4.0,0.0422,1,1,1,1,4.8,3.8,3.4
57,309,0,Latin America,Commercial,Quality Assurance,Meets,Non-Binary/Other,36,3,1,11,21,0.0,1.0,1.7,0.0422,1,1,1,1,3.5,1.4,3.3
58,61,0,Europe,R&D,Supply Chain,Exceeds,Female,45,9,1,11,31,0.0,4.1,3.3,0.1648,1,1,1,1,4.2,3.2,4.3
59,731,1,Latin America,HR,Human Resources,Exceeds,Female,37,8,1,8,16,0.0,2.8,3.7,0.0677,1,1,1,1,3.6,3.8,3.7
60,1019,0,Europe,Finance,Communications,Meets,Male,30,14,0,7,28,3.0,2.6,3.6,0.0331,1,1,1,1,3.4,3.3,2.9
61,916,0,Europe,Finance,Regulatory Affairs,Meets,Male,47,31,0,9,17,4.4,3.8,3.8,0.0331,0,0,0,0,3.5,4.4,2.1
62,107,0,Latin America,R&D,Marketing,Meets,Female,40,23,0,9,16,3.5,3.0,3.1,0.0977,1,1,1,1,3.7,3.5,3.3
63,679,0,Middle East & Africa,Digital,Marketing,Below,Female,32,26,0,6,11,4.4,2.3,2.2,0.0,1,1,1,1,5.0,2.5,3.2
64,468,0,Europe,Manufacturing,IT & Digital,Far Below,Female,36,5,1,7,15,0.0,2.6,1.3,0.0,1,1,1,1,3.6,3.2,2.9
65,378,0,Europe,Manufacturing,Communications,Exceeds,Female,33,30,0,5,12,4.1,1.9,4.3,0.0616,1,1,1,1,3.9,2.7,5.0
66,734,0,Latin America,HR,IT & Digital,Below,Male,44,13,0,10,19,2.9,3.2,3.6,0.0,1,1,1,1,2.9,3.1,1.3
67,176,0,Europe,R&D,Supply Chain,Exceeds,Male,28,16,0,11,48,2.4,3.8,3.1,0.1648,1,1,1,1,1.8,4.6,5.0
68,92,0,Europe,R&D,Marketing,Exceeds,Female,40,6,0,5,12,3.5,4.8,2.3,0.1648,1,1,1,1,4.5,4.0,2.3
69,595,0,Latin America,Digital,Regulatory Affairs,Meets,Male,28,22,0,10,29,2.7,1.7,3.6,0.0853,1,1,1,1,2.6,2.0,2.5
70,402,0,Latin America,Manufacturing,Quality Assurance,Exceeds,Female,28,10,1,7,17,0.0,3.3,2.4,0.0616,1,1,1,1,1.2,2.9,3.1
71,106,0,North America,R&D,Communications,Meets,Female,40,7,1,9,11,0.0,2.7,2.3,0.0977,1,1,1,1,2.6,3.2,2.6
72,897,0,Middle East & Africa,Finance,Medical Affairs,Exceeds,Female,31,8,0,7,28,3.8,3.5,3.1,0.0588,1,1,1,1,3.6,4.0,2.0
73,857,0,Middle East & Africa,HR,Pharmacovigilance,Exceeds,Non-Binary/Other,42,8,1,5,16,0.0,3.2,5.0,0.0677,1,1,1,1,2.4,4.0,3.4
74,488,0,Europe,Manufacturing,Quality Assurance,Below,Male,44,15,0,11,14,2.5,1.9,1.0,0.0,1,1,1,1,3.0,2.6,1.9
75,595,0,Middle East & Africa,Digital,Legal & Compliance,Meets,Female,35,5,0,8,23,3.4,2.7,2.6,0.0853,1,1,1,0,4.1,2.1,2.4
76,771,0,Europe,HR,Data Science,Meets,Male,41,6,1,8,15,0.0,3.4,2.5,0.0383,1,1,1,1,3.8,3.3,3.2
77,350,0,North America,Commercial,Data Science,Far Below,Male,47,9,0,10,14,3.7,2.8,2.2,0.0,1,0,0,0,3.4,1.0,1.5
78,964,0,Latin America,Finance,Quality Assurance,Far Exceeds,Female,32,4,0,11,33,3.7,1.4,3.7,0.1022,1,1,1,1,4.1,2.3,4.9
79,693,1,Latin America,Digital,Regulatory Affairs,Meets,Male,43,19,0,9,18,3.7,2.8,4.2,0.0853,1,1,1,1,4.2,2.9,5.0
80,874,0,Latin America,HR,Pharmacovigilance,Meets,Female,33,17,0,11,28,2.8,3.8,3.6,0.0383,1,1,1,1,2.9,4.5,4.8
81,60,0,Middle East & Africa,R&D,Medical Affairs,Below,Female,38,8,0,12,16,3.8,3.9,1.9,0.0,1,1,1,1,3.4,5.0,2.0
82,242,0,North America,Commercial,Communications,Meets,Male,34,11,0,11,24,2.3,4.0,3.3,0.0422,0,0,0,0,2.1,4.4,4.2
83,637,0,Middle East & Africa,Digital,Marketing,Exceeds,Male,34,16,0,10,14,3.6,3.0,3.3,0.1452,1,1,1,1,2.2,3.8,3.6
84,145,0,Middle East & Africa,R&D,Data Science,Meets,Male,36,8,1,12,18,0.0,2.6,2.4,0.0977,0,0,0,0,3.3,2.9,2.1
85,983,0,North America,Finance,Data Science,Meets,Female,34,12,0,6,23,1.8,3.5,2.7,0.0331,1,1,1,1,3.4,3.2,3.1
86,181,0,North America,Commercial,Data Science,Meets,Female,37,13,0,10,25,1.8,3.0,4.2,0.0422,1,0,0,0,2.1,3.2,4.2
87,398,0,North America,Manufacturing,Human Resources,Meets,Female,45,22,0,8,15,1.7,1.8,1.0,0.0348,1,1,1,0,2.5,2.8,2.6
88,69,0,North America,R&D,Finance & Accounting,Meets,Male,30,19,1,8,20,0.0,2.2,4.5,0.0977,1,1,1,1,3.6,2.6,2.9
89,764,0,Latin America,HR,Market Access,Below,Male,41,14,1,8,13,0.0,3.7,2.1,0.0,1,1,1,1,3.8,4.2,2.6
90,605,0,Asia Pacific,Digital,IT & Digital,Far Below,Male,32,12,0,9,12,4.4,2.9,2.6,0.0,1,1,1,1,4.7,3.5,1.0
91,281,0,Asia Pacific,Commercial,Legal & Compliance,Below,Female,32,5,1,9,12,0.0,2.1,2.6,0.0,1,1,1,1,2.7,2.6,2.3
92,169,0,North America,R&D,Legal & Compliance,Exceeds,Male,28,22,0,11,17,3.2,2.3,2.2,0.1648,1,1,1,1,4.8,4.5,2.0
93,402,0,Asia Pacific,Manufacturing,Legal & Compliance,Far Exceeds,Male,44,14,0,7,12,2.1,3.5,1.9,0.1069,1,1,1,1,2.4,5.0,2.9
94,642,0,Asia Pacific,Digital,IT & Digital,Below,Male,37,30,0,5,12,3.7,1.3,2.8,0.0,1,0,0,0,4.1,4.1,4.2
95,688,0,North America,Digital,Regulatory Affairs,Meets,Female,33,17,0,8,19,4.0,3.0,1.1,0.0853,1,1,1,1,3.6,2.1,4.3
96,84,0,Asia Pacific,R&D,Quality Assurance,Below,Female,39,13,0,10,19,3.2,3.5,2.4,0.0,1,1,1,1,3.4,3.8,2.7
97,362,0,Middle East & Africa,Manufacturing,Pharmacovigilance,Exceeds,Female,36,10,0,5,21,4.2,4.0,3.5,0.0616,0,0,0,0,3.1,2.3,2.7
98,996,0,Europe,Finance,Communications,Meets,Female,45,5,0,6,17,2.6,3.1,2.7,0.0331,1,1,1,1,3.3,3.5,4.5
99,1012,0,Europe,Finance,Quality Assurance,Meets,Female,32,14,0,8,19,4.0,1.3,2.3,0.0331,1,1,1,1,4.2,3.4,2.5
100,200,0,North America,Commercial,Communications,Meets,Male,37,6,1,8,16,0.0,3.6,3.0,0.0422,1,1,1,1,3.3,2.3,3.2
101,60,0,Latin America,R&D,Market Access,Meets,Male,43,34,0,6,9,3.9,3.5,4.0,0.0977,1,0,0,0,2.5,4.4,3.6
102,260,0,North America,Commercial,Data Science,Meets,Female,32,7,0,11,20,4.4,4.5,3.8,0.0422,1,1,0,0,3.4,5.0,3.1
103,933,0,Latin America,Finance,Supply Chain,Below,Male,35,9,0,11,15,2.5,4.5,1.2,0.0,1,1,1,1,1.7,3.4,1.8
104,528,0,Europe,Digital,Human Resources,Far Below,Male,30,12,1,9,12,0.0,3.1,3.6,0.0,1,1,1,1,2.6,2.8,4.0
105,335,0,North America,Commercial,Market Access,Meets,Male,33,11,0,7,19,2.8,2.2,2.8,0.0422,1,1,1,1,2.2,1.0,4.3
106,494,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Exceeds,Male,29,7,1,12,22,0.0,3.6,1.8,0.0616,0,0,0,0,4.8,5.0,3.4
107,866,0,Asia Pacific,HR,Medical Affairs,Meets,Male,32,11,1,9,14,0.0,4.0,2.5,0.0383,1,1,1,1,4.4,3.2,1.8
108,966,0,Latin America,Finance,IT & Digital,Below,Female,30,27,0,10,15,3.0,3.2,2.6,0.0,1,1,1,1,5.0,2.4,3.9
109,901,0,Asia Pacific,Finance,Finance & Accounting,Exceeds,Male,34,14,0,11,17,3.8,2.9,2.0,0.0588,1,1,1,1,4.4,2.8,2.7
110,359,0,Asia Pacific,Manufacturing,Legal & Compliance,Below,Male,44,12,1,5,14,0.0,4.7,3.7,0.0,1,1,1,1,1.8,4.1,2.1
111,244,0,North America,Commercial,Finance & Accounting,Below,Male,40,3,0,10,15,2.6,2.3,4.4,0.0,1,1,1,1,2.8,3.9,3.5
112,84,0,Asia Pacific,R&D,Marketing,Exceeds,Female,46,13,0,6,14,3.7,2.7,2.1,0.1648,1,1,1,1,2.2,2.3,2.1
113,637,0,Middle East & Africa,Digital,Human Resources,Meets,Female,36,27,0,11,16,3.8,3.5,1.8,0.0853,1,1,1,1,4.3,3.5,1.7
114,820,0,Asia Pacific,HR,Sales,Meets,Male,33,5,0,12,21,2.5,2.9,2.7,0.0383,1,1,1,1,3.7,3.7,2.7
115,61,0,North America,R&D,Finance & Accounting,Meets,Female,37,10,1,11,14,0.0,3.4,3.7,0.0977,1,1,1,1,3.2,2.5,3.1
116,58,0,Middle East & Africa,R&D,Pharmacovigilance,Meets,Male,34,10,0,8,34,3.1,4.0,1.0,0.0977,0,0,0,0,3.1,3.8,2.6
117,431,0,Europe,Manufacturing,Market Access,Far Below,Female,40,25,0,8,31,1.7,2.0,2.8,0.0,1,1,1,1,3.0,2.8,1.5
118,248,0,Asia Pacific,Commercial,Medical Affairs,Meets,Female,29,7,0,5,14,2.9,2.6,3.4,0.0422,1,1,1,1,4.0,3.3,3.5
119,970,0,North America,Finance,Sales,Meets,Female,38,7,0,10,13,3.4,4.7,2.3,0.0331,1,1,1,1,3.3,2.0,3.5
120,1005,0,Europe,Finance,Medical Affairs,Far Exceeds,Female,47,5,0,8,19,2.7,3.3,3.2,0.1022,1,1,0,0,1.9,3.6,2.8
121,511,0,Europe,Manufacturing,Legal & Compliance,Far Exceeds,Male,32,12,0,11,19,2.6,3.0,2.6,0.1069,1,1,1,1,1.7,3.2,3.6
122,336,0,Latin America,Commercial,Finance & Accounting,Meets,Female,35,25,0,9,14,3.3,2.7,3.4,0.0422,1,1,1,1,2.5,2.9,2.8
123,517,0,Middle East & Africa,Manufacturing,Legal & Compliance,Meets,Male,28,10,1,10,16,0.0,3.9,3.9,0.0348,1,1,1,1,3.6,2.1,3.2
124,970,0,Asia Pacific,Finance,Quality Assurance,Below,Non-Binary/Other,45,8,0,10,14,3.5,2.3,3.0,0.0,1,1,1,1,4.3,3.0,1.0
125,167,0,North America,R&D,Finance & Accounting,Below,Male,37,28,0,11,16,3.3,4.0,3.5,0.0,1,1,1,1,3.9,2.6,3.7
126,559,0,Latin America,Digital,Quality Assurance,Meets,Male,35,9,0,6,8,3.9,2.6,1.0,0.0853,1,1,1,1,3.7,2.4,2.2
127,202,0,Middle East & Africa,Commercial,Communications,Meets,Male,38,13,0,11,20,3.9,2.3,1.6,0.0422,1,1,1,1,4.0,3.3,2.0
128,829,0,Latin America,HR,Data Science,Meets,Male,38,9,0,9,18,4.0,2.0,2.6,0.0383,1,1,1,1,3.0,2.0,3.5
129,825,0,Middle East & Africa,HR,Clinical Operations,Meets,Female,34,19,0,9,11,4.3,3.0,1.6,0.0383,0,0,0,0,3.3,1.1,2.2
130,29,0,Middle East & Africa,R&D,Marketing,Exceeds,Female,30,15,0,11,19,4.1,3.1,2.3,0.1648,1,1,1,1,3.4,4.4,2.1
131,447,1,Asia Pacific,Manufacturing,Regulatory Affairs,Meets,Male,39,7,0,7,16,2.7,2.2,3.0,0.0348,1,1,0,0,1.8,3.9,3.2
132,518,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Meets,Male,38,31,0,6,13,2.3,2.4,2.6,0.0348,0,0,0,0,2.8,2.4,3.6
133,987,0,Latin America,Finance,Data Science,Below,Female,36,18,1,10,18,0.0,1.2,3.3,0.0,1,1,1,1,3.7,2.4,3.3
134,60,0,Middle East & Africa,R&D,Quality Assurance,Meets,Male,36,11,0,7,11,4.4,2.7,3.8,0.0977,1,1,1,1,3.3,2.6,1.5
135,901,0,Asia Pacific,Finance,Data Science,Exceeds,Male,44,23,0,7,37,2.7,5.0,3.3,0.0588,1,0,0,0,3.4,4.1,3.0
136,894,0,Asia Pacific,Finance,Supply Chain,Below,Female,40,13,0,8,10,4.0,1.0,2.8,0.0,1,1,1,1,3.4,2.7,1.0
137,745,0,Latin America,HR,Market Access,Meets,Male,30,8,0,5,27,4.8,3.4,2.2,0.0383,1,1,1,1,3.1,4.0,3.5
138,938,0,Europe,Finance,Legal & Compliance,Far Exceeds,Male,46,11,0,10,18,3.2,3.5,4.1,0.1022,1,1,1,1,3.3,5.0,2.4
139,972,0,Europe,Finance,Market Access,Meets,Female,42,9,1,7,18,0.0,2.7,2.8,0.0331,1,1,1,1,3.6,1.5,3.6
140,819,0,Middle East & Africa,HR,Pharmacovigilance,Meets,Male,42,17,0,12,20,4.5,3.2,1.0,0.0383,1,1,1,1,3.0,4.5,2.1
141,414,0,North America,Manufacturing,Finance & Accounting,Below,Male,33,5,0,11,15,3.8,2.4,3.6,0.0,1,1,1,1,3.3,2.4,3.5
142,253,0,Middle East & Africa,Commercial,Quality Assurance,Meets,Female,43,11,1,8,12,0.0,2.4,3.3,0.0422,1,1,1,1,2.0,1.9,3.9
143,543,0,Latin America,Digital,Clinical Operations,Meets,Male,39,4,1,8,21,0.0,3.7,2.8,0.0853,1,1,1,1,3.3,3.3,2.3
144,898,0,Latin America,Finance,Supply Chain,Below,Male,31,13,0,6,26,3.1,1.0,3.0,0.0,1,1,1,1,4.6,2.7,3.2
145,331,0,Latin America,Commercial,Supply Chain,Meets,Female,40,18,0,7,14,4.6,2.7,1.9,0.0422,0,0,0,0,3.9,1.5,2.4
146,859,0,Latin America,HR,Quality Assurance,Below,Female,44,9,1,9,12,0.0,3.4,2.2,0.0,1,1,1,1,2.4,3.4,1.8
147,218,0,Latin America,Commercial,Market Access,Meets,Female,41,10,1,10,27,0.0,2.9,2.2,0.0422,1,1,1,1,1.9,2.8,2.9
148,627,0,Asia Pacific,Digital,Sales,Far Exceeds,Male,28,15,0,11,17,3.0,4.2,4.1,0.2363,1,1,1,1,2.8,2.8,3.8
149,232,0,Europe,Commercial,Market Access,Meets,Male,40,8,0,12,16,1.7,3.2,2.2,0.0422,1,1,1,1,1.6,2.7,3.1
150,223,0,Latin America,Commercial,Pharmacovigilance,Meets,Female,36,9,0,5,7,3.4,3.3,1.7,0.0422,0,0,0,0,4.0,2.9,2.5
151,203,0,North America,Commercial,Pharmacovigilance,Meets,Male,28,6,0,10,18,5.0,3.4,3.1,0.0422,1,1,1,1,5.0,5.0,3.4
152,342,0,North America,Commercial,Quality Assurance,Below,Male,42,9,0,9,19,2.3,2.2,1.1,0.0,1,1,1,1,2.4,1.3,1.9
153,132,0,North America,R&D,Marketing,Far Exceeds,Female,42,25,0,7,19,2.9,3.6,2.3,0.2644,1,1,1,1,2.9,2.8,2.0
154,910,0,North America,Finance,Marketing,Below,Male,38,23,0,9,30,2.1,4.7,3.3,0.0,1,1,1,1,3.7,2.8,2.5
155,845,0,Asia Pacific,HR,Clinical Operations,Below,Male,32,8,0,7,29,3.2,1.3,2.4,0.0,0,0,0,0,3.2,1.8,1.5
156,547,0,North America,Digital,Finance & Accounting,Meets,Male,46,11,0,9,29,3.5,2.2,2.0,0.0853,1,1,1,1,4.9,3.4,2.7
157,801,0,Latin America,HR,Communications,Meets,Female,41,18,0,10,12,1.6,3.5,1.3,0.0383,1,1,1,1,2.8,1.9,2.0
158,63,0,Middle East & Africa,R&D,Marketing,Meets,Male,42,10,0,11,27,3.9,2.8,1.9,0.0977,1,1,1,1,3.9,2.3,2.1
159,97,0,North America,R&D,Legal & Compliance,Below,Male,44,7,1,7,10,0.0,3.0,2.7,0.0,1,1,1,1,3.7,2.8,1.9
160,74,0,Asia Pacific,R&D,Medical Affairs,Exceeds,Male,45,18,0,6,24,3.1,3.3,2.6,0.1648,1,1,1,1,3.1,3.6,3.2
161,919,0,Asia Pacific,Finance,Medical Affairs,Meets,Female,40,9,0,8,15,2.4,1.9,3.7,0.0331,1,1,1,1,2.4,2.5,2.7
162,164,0,North America,R&D,Legal & Compliance,Below,Female,31,11,0,8,24,3.4,2.4,2.3,0.0,1,1,1,1,3.0,3.5,2.3
163,199,0,Middle East & Africa,Commercial,Regulatory Affairs,Meets,Male,34,10,1,10,15,0.0,3.4,1.0,0.0422,1,1,1,1,3.8,4.1,1.9
164,807,0,North America,HR,Finance & Accounting,Meets,Female,35,6,1,6,16,0.0,2.6,3.7,0.0383,1,1,1,1,2.8,2.8,1.0
165,396,0,Asia Pacific,Manufacturing,Human Resources,Meets,Male,45,9,1,8,28,0.0,1.8,4.3,0.0348,1,1,1,1,3.4,2.2,3.3
166,556,0,Europe,Digital,Legal & Compliance,Meets,Male,39,5,1,11,16,0.0,2.6,1.0,0.0853,1,1,1,1,2.1,3.8,1.2
167,105,0,Latin America,R&D,Medical Affairs,Meets,Female,34,11,0,10,12,5.0,3.3,3.4,0.0977,1,1,1,1,2.6,3.5,4.0
168,795,0,Asia Pacific,HR,Sales,Meets,Female,37,10,1,7,15,0.0,4.7,4.5,0.0383,1,1,1,1,4.2,4.0,2.8
169,59,0,North America,R&D,Finance & Accounting,Below,Male,46,2,0,10,21,3.8,2.8,2.1,0.0,1,1,1,1,3.2,1.3,3.2
170,884,0,Latin America,Finance,IT & Digital,Far Below,Female,42,5,1,9,25,0.0,3.2,3.1,0.0,0,0,0,0,3.2,2.3,3.4
171,75,0,North America,R&D,Sales,Meets,Male,44,5,0,12,26,3.4,2.0,3.2,0.0977,1,1,1,1,3.0,3.1,2.4
172,120,0,North America,R&D,Sales,Far Below,Non-Binary/Other,31,9,0,12,14,4.1,1.1,2.5,0.0,1,1,1,1,4.2,4.3,2.2
173,46,0,Europe,R&D,Medical Affairs,Meets,Female,37,28,0,5,10,4.2,2.0,4.4,0.0977,1,1,1,1,3.8,2.1,1.8
174,47,0,Latin America,R&D,Clinical Operations,Below,Non-Binary/Other,34,6,0,5,8,2.0,3.0,1.8,0.0,1,1,1,1,3.0,2.9,3.4
175,685,0,Latin America,Digital,Legal & Compliance,Meets,Male,47,13,0,6,23,2.1,3.7,5.0,0.0853,1,1,1,1,3.1,3.2,4.3
176,837,0,Europe,HR,Market Access,Meets,Male,37,21,0,8,22,3.2,2.4,5.0,0.0383,1,1,1,1,2.7,3.1,3.7
177,882,0,Asia Pacific,Finance,Quality Assurance,Below,Female,35,6,0,10,21,3.7,3.0,2.9,0.0,1,1,0,0,3.2,2.5,2.4
178,72,0,North America,R&D,Data Science,Meets,Female,28,1,0,11,25,3.3,3.5,5.0,0.0977,1,1,1,1,2.9,3.1,2.1
179,100,0,Middle East & Africa,R&D,Regulatory Affairs,Meets,Female,46,4,0,9,14,2.5,1.0,2.3,0.0977,1,1,1,1,2.1,3.2,3.1
180,57,0,North America,R&D,Pharmacovigilance,Meets,Male,47,4,0,5,16,4.0,3.9,1.5,0.0977,0,0,0,0,3.5,4.1,2.2
181,140,0,North America,R&D,Supply Chain,Meets,Female,28,24,0,9,19,4.6,2.3,3.6,0.0977,1,1,1,1,3.6,2.9,4.0
182,267,0,Asia Pacific,Commercial,Pharmacovigilance,Below,Female,39,8,1,11,20,0.0,3.7,3.5,0.0,1,1,1,1,4.2,3.6,3.6
183,217,0,North America,Commercial,Finance & Accounting,Meets,Female,44,20,0,5,9,3.7,3.7,2.6,0.0422,1,1,1,1,4.8,3.9,1.9
184,500,0,Europe,Manufacturing,Regulatory Affairs,Meets,Male,41,6,0,9,16,2.0,4.2,4.4,0.0348,1,1,1,1,1.8,4.2,4.7
185,40,0,Europe,R&D,Pharmacovigilance,Meets,Female,35,13,0,8,16,3.0,3.3,2.1,0.0977,1,1,1,1,2.0,5.0,2.2
186,406,0,Latin America,Manufacturing,Market Access,Far Exceeds,Female,32,7,0,7,35,3.9,3.5,4.3,0.1069,1,1,1,1,4.5,2.4,3.9
187,541,0,Middle East & Africa,Digital,Pharmacovigilance,Far Below,Male,45,8,0,7,10,3.4,4.3,3.1,0.0,1,1,1,1,4.5,3.2,3.4
188,478,0,North America,Manufacturing,Human Resources,Meets,Female,43,24,0,9,22,2.6,2.2,3.1,0.0348,1,1,1,1,2.3,3.2,2.9
189,735,0,North America,HR,Pharmacovigilance,Meets,Male,42,12,0,8,15,3.0,3.3,2.5,0.0383,1,1,1,1,2.7,3.2,4.1
190,185,0,Asia Pacific,Commercial,Market Access,Below,Female,45,21,0,7,10,4.0,3.1,3.5,0.0,0,0,0,0,3.1,1.1,2.8
191,279,0,Europe,Commercial,Finance & Accounting,Far Below,Female,51,7,1,7,19,0.0,4.5,2.0,0.0,1,1,1,1,3.5,3.7,3.8
192,60,0,Middle East & Africa,R&D,Market Access,Exceeds,Male,36,15,0,11,17,2.8,2.6,1.9,0.1648,1,1,1,1,3.8,3.9,1.7
193,49,1,Latin America,R&D,Medical Affairs,Meets,Female,36,6,1,7,15,0.0,4.0,2.7,0.0977,1,1,1,1,3.1,5.0,2.8
194,579,1,Europe,Digital,Market Access,Far Exceeds,Female,36,8,0,9,28,3.2,3.1,2.7,0.2363,1,1,1,1,3.2,5.0,3.9
195,922,0,Latin America,Finance,Data Science,Meets,Female,32,11,0,11,13,4.2,2.5,2.2,0.0331,1,1,1,1,3.1,2.1,4.4
196,669,0,Asia Pacific,Digital,Marketing,Below,Female,45,7,1,12,23,0.0,4.2,2.6,0.0,1,1,1,1,1.9,4.7,2.0
197,781,0,Asia Pacific,HR,Data Science,Meets,Male,46,3,0,11,15,3.6,2.8,1.4,0.0383,1,1,1,1,2.2,3.7,1.4
198,155,0,North America,R&D,Human Resources,Exceeds,Female,44,1,0,5,19,2.2,2.4,3.2,0.1648,1,1,1,1,3.8,2.4,2.4
199,159,0,Middle East & Africa,R&D,Pharmacovigilance,Exceeds,Male,48,11,0,5,36,3.4,2.3,1.0,0.1648,1,1,1,1,3.1,2.7,2.2
200,560,0,Latin America,Digital,Data Science,Meets,Male,39,5,1,12,18,0.0,4.0,3.1,0.0853,1,1,1,0,3.9,3.5,3.1
201,621,1,Europe,Digital,Regulatory Affairs,Meets,Male,40,17,0,11,19,1.4,3.4,2.4,0.0853,1,1,1,1,2.6,3.6,3.4
202,640,0,Asia Pacific,Digital,Quality Assurance,Below,Female,42,8,1,6,11,0.0,2.2,2.7,0.0,1,1,1,1,3.2,4.7,2.0
203,296,0,North America,Commercial,Marketing,Meets,Female,35,17,0,11,19,3.0,3.3,2.5,0.0422,1,1,1,1,3.6,4.4,2.8
204,393,0,North America,Manufacturing,Quality Assurance,Meets,Female,32,15,0,10,27,3.3,3.2,1.5,0.0348,1,1,1,1,4.2,3.5,2.0
205,447,0,Latin America,Manufacturing,Communications,Far Exceeds,Female,39,5,0,6,41,3.0,3.8,2.1,0.1069,0,0,0,0,2.9,3.1,2.1
206,171,0,Asia Pacific,R&D,Finance & Accounting,Meets,Female,35,9,0,8,29,3.3,4.3,2.1,0.0977,1,1,1,1,2.7,4.2,2.8
207,300,0,Middle East & Africa,Commercial,Supply Chain,Exceeds,Female,51,3,1,11,14,0.0,2.4,2.2,0.0743,1,1,1,1,4.1,2.3,2.9
208,618,0,Asia Pacific,Digital,Data Science,Meets,Male,29,16,0,5,11,2.1,2.0,3.6,0.0853,1,1,1,1,3.5,2.2,4.7
209,45,0,Latin America,R&D,Quality Assurance,Meets,Female,38,9,0,7,14,3.8,4.1,2.9,0.0977,0,0,0,0,2.6,2.8,3.3
210,288,0,Latin America,Commercial,Market Access,Exceeds,Male,40,12,0,9,22,4.7,3.2,1.6,0.0743,1,1,1,1,4.6,4.0,2.9
211,729,0,Asia Pacific,HR,Clinical Operations,Meets,Female,33,15,0,5,8,3.1,3.6,2.4,0.0383,1,1,1,0,4.6,3.1,3.8
212,1026,0,Latin America,Finance,Clinical Operations,Meets,Male,35,9,0,10,23,2.8,2.8,3.4,0.0331,1,1,1,1,3.0,3.5,3.6
213,255,0,Asia Pacific,Commercial,Finance & Accounting,Meets,Male,38,36,0,11,18,3.1,2.8,1.8,0.0422,1,1,1,1,3.7,2.1,1.6
214,71,0,Europe,R&D,Finance & Accounting,Meets,Male,31,30,0,11,24,3.5,2.0,4.9,0.0977,1,1,1,1,3.3,1.3,4.3
215,472,0,Asia Pacific,Manufacturing,Market Access,Far Exceeds,Male,40,8,1,7,37,0.0,4.0,3.2,0.1069,1,1,1,1,3.3,3.1,2.0
216,605,0,Asia Pacific,Digital,Finance & Accounting,Meets,Male,47,14,1,10,15,0.0,3.2,3.3,0.0853,1,1,1,1,4.5,2.2,1.0
217,928,0,Latin America,Finance,Quality Assurance,Below,Male,36,14,0,5,16,5.0,3.8,2.8,0.0,1,1,1,1,4.3,3.4,3.6
218,834,0,Latin America,HR,Finance & Accounting,Meets,Male,43,20,0,5,9,4.7,3.6,3.0,0.0383,0,0,0,0,4.0,3.5,1.0
219,902,0,North America,Finance,Pharmacovigilance,Meets,Male,48,11,0,10,16,4.1,2.7,2.0,0.0331,1,1,1,1,3.8,2.4,1.3
220,1033,0,North America,Finance,Market Access,Meets,Male,44,5,0,8,32,4.1,3.8,2.5,0.0331,1,1,1,1,3.9,4.3,1.8
221,290,0,Europe,Commercial,Marketing,Below,Male,34,11,0,12,14,4.3,3.5,2.5,0.0,1,1,1,1,4.3,1.6,2.1
222,120,0,North America,R&D,Sales,Exceeds,Female,29,15,0,12,25,3.3,3.6,3.7,0.1648,1,1,1,1,3.9,3.9,3.3
223,5,0,Asia Pacific,R&D,Regulatory Affairs,Exceeds,Female,36,3,0,12,22,2.1,1.7,4.2,0.1648,1,1,1,1,2.2,3.3,2.3
224,883,0,Latin America,Finance,Human Resources,Below,Female,38,11,0,7,16,4.1,1.1,4.3,0.0,1,1,1,1,3.7,1.9,3.6
225,626,0,North America,Digital,Pharmacovigilance,Below,Female,28,10,0,10,16,2.0,1.5,2.6,0.0,1,1,1,1,2.7,2.9,4.0
226,62,0,North America,R&D,Marketing,Meets,Female,38,21,0,5,10,2.8,4.9,2.3,0.0977,1,1,1,1,3.1,4.8,3.1
227,1024,0,Europe,Finance,Quality Assurance,Meets,Female,33,6,0,5,14,3.8,2.6,2.9,0.0331,1,1,1,1,2.9,3.1,3.3
228,108,0,Europe,R&D,Pharmacovigilance,Meets,Male,37,4,0,5,11,2.6,2.1,1.5,0.0977,1,1,1,1,3.1,2.7,2.6
229,523,0,Asia Pacific,Digital,Pharmacovigilance,Below,Female,36,10,0,9,21,4.9,4.5,4.3,0.0,1,1,1,1,4.6,3.7,4.0
230,875,0,Latin America,HR,Quality Assurance,Meets,Male,37,13,0,12,18,2.9,3.6,4.7,0.0383,1,1,1,1,3.8,3.6,3.5
231,894,0,Europe,Finance,IT & Digital,Meets,Female,43,12,0,8,29,2.2,2.3,1.0,0.0331,1,1,1,1,2.3,2.6,1.0
232,461,1,North America,Manufacturing,Market Access,Meets,Female,32,10,0,9,18,3.6,1.4,2.1,0.0348,1,1,1,1,4.3,2.6,3.1
233,365,0,Latin America,Manufacturing,Quality Assurance,Meets,Female,28,16,0,5,12,2.7,3.2,1.0,0.0348,1,1,1,1,4.0,3.1,1.0
234,1008,0,Latin America,Finance,Data Science,Far Exceeds,Male,43,5,0,9,25,2.9,2.5,2.0,0.1022,1,1,1,1,2.3,3.6,3.4
235,301,0,North America,Commercial,Finance & Accounting,Below,Female,42,16,1,10,16,0.0,3.7,2.8,0.0,1,1,1,1,2.3,4.2,2.1
236,783,0,Europe,HR,Data Science,Meets,Non-Binary/Other,41,4,0,5,12,4.0,4.2,1.0,0.0383,1,1,1,1,3.1,5.0,2.1
237,212,0,North America,Commercial,Regulatory Affairs,Below,Female,33,15,0,10,16,3.8,3.9,3.6,0.0,1,1,0,0,4.0,4.2,3.3
238,380,0,Latin America,Manufacturing,Clinical Operations,Meets,Female,42,12,1,12,17,0.0,2.7,1.1,0.0348,1,1,1,1,3.1,2.0,2.5
239,696,0,Middle East & Africa,Digital,Medical Affairs,Below,Male,30,7,1,9,21,0.0,3.0,4.8,0.0,1,1,1,0,2.4,3.5,3.0
240,994,0,Middle East & Africa,Finance,Regulatory Affairs,Meets,Male,36,17,0,9,21,3.7,4.1,2.4,0.0331,1,0,0,0,2.6,2.6,3.0
241,23,1,Asia Pacific,R&D,Legal & Compliance,Exceeds,Male,47,14,0,8,28,3.4,2.5,3.7,0.1648,1,1,1,1,5.0,1.9,3.5
242,505,0,North America,Manufacturing,Legal & Compliance,Meets,Female,42,4,0,10,25,3.4,2.9,2.0,0.0348,1,1,1,1,3.7,4.8,1.6
243,730,0,North America,HR,Regulatory Affairs,Meets,Male,38,3,0,12,25,2.8,5.0,2.9,0.0383,1,1,0,0,2.3,2.8,2.9
244,469,0,Asia Pacific,Manufacturing,Finance & Accounting,Far Below,Male,37,36,0,7,15,3.5,2.2,4.3,0.0,1,1,1,1,4.8,2.8,4.2
245,728,0,Asia Pacific,HR,Human Resources,Meets,Male,31,6,1,9,11,0.0,3.8,2.0,0.0383,1,1,1,1,2.8,2.8,3.0
246,790,0,Asia Pacific,HR,Human Resources,Below,Male,48,34,0,12,24,3.5,3.1,2.8,0.0,1,1,1,1,3.7,5.0,3.7
247,1011,0,Latin America,Finance,Sales,Meets,Male,44,28,0,12,21,1.8,3.0,3.2,0.0331,0,0,0,0,2.8,3.8,2.5
248,752,0,North America,HR,Medical Affairs,Meets,Male,43,24,0,8,22,4.6,3.1,1.6,0.0383,0,0,0,0,4.9,5.0,1.0
249,198,0,Latin America,Commercial,Clinical Operations,Exceeds,Female,37,4,0,5,11,3.5,1.4,1.0,0.0743,0,0,0,0,4.3,1.7,1.6
250,593,0,Asia Pacific,Digital,Communications,Below,Male,36,8,0,11,29,3.0,3.7,2.5,0.0,1,1,1,1,3.9,2.1,2.5
251,458,0,North America,Manufacturing,Communications,Meets,Male,33,34,0,6,8,3.0,2.3,2.7,0.0348,1,1,1,1,4.0,3.0,2.1
252,642,0,Latin America,Digital,Pharmacovigilance,Far Below,Female,47,9,0,7,19,4.4,3.2,3.6,0.0,1,1,1,1,3.4,3.2,4.0
253,149,0,Latin America,R&D,Legal & Compliance,Meets,Non-Binary/Other,28,12,0,5,14,2.4,2.5,4.0,0.0977,1,1,1,1,2.5,2.7,4.2
254,424,0,Asia Pacific,Manufacturing,Medical Affairs,Meets,Male,41,6,0,10,18,2.8,2.8,1.3,0.0348,1,1,1,1,2.7,4.2,4.6
255,632,0,North America,Digital,Sales,Exceeds,Male,29,16,0,7,15,2.3,2.5,1.8,0.1452,1,1,1,1,2.5,2.8,1.4
256,672,0,Asia Pacific,Digital,Supply Chain,Meets,Female,37,6,0,11,16,3.4,2.8,2.1,0.0853,1,1,1,1,3.5,1.9,3.3
257,978,0,North America,Finance,Regulatory Affairs,Meets,Female,38,2,0,11,19,3.8,1.8,1.0,0.0331,1,1,1,1,3.5,2.4,3.7
258,904,0,Middle East & Africa,Finance,Quality Assurance,Meets,Female,30,12,0,6,11,3.5,5.0,3.7,0.0331,1,1,1,1,3.0,4.6,3.1
259,1,0,Europe,R&D,Human Resources,Below,Male,33,9,0,7,12,3.7,2.9,3.9,0.0,1,1,1,1,3.6,3.9,3.5
260,704,0,Europe,HR,Regulatory Affairs,Meets,Male,42,17,0,5,12,4.2,4.7,4.5,0.0383,1,1,1,1,3.4,2.7,2.8
261,420,0,Europe,Manufacturing,Human Resources,Exceeds,Female,47,16,0,5,9,3.2,2.7,1.4,0.0616,1,1,1,1,3.4,2.0,1.4
262,896,0,Asia Pacific,Finance,Market Access,Meets,Female,40,8,0,8,27,2.6,2.9,1.8,0.0331,0,0,0,0,4.1,2.2,1.6
263,508,0,Middle East & Africa,Manufacturing,Sales,Meets,Male,34,9,0,7,14,2.5,2.2,2.6,0.0348,1,1,1,1,3.8,2.7,2.6
264,172,0,North America,R&D,Finance & Accounting,Meets,Male,32,24,0,6,18,2.6,3.9,4.2,0.0977,1,1,1,1,3.1,3.7,3.2
265,891,0,Latin America,Finance,IT & Digital,Meets,Female,34,9,1,11,16,0.0,2.2,1.8,0.0331,1,1,1,1,5.0,4.6,3.1
266,937,0,North America,Finance,Regulatory Affairs,Meets,Male,38,4,0,5,10,3.9,2.1,2.9,0.0331,1,1,1,1,4.5,2.3,3.6
267,805,0,Latin America,HR,Regulatory Affairs,Below,Female,40,7,0,9,17,1.2,3.1,2.5,0.0,1,1,1,1,3.2,3.9,3.4
268,452,0,North America,Manufacturing,Medical Affairs,Meets,Male,45,13,1,9,30,0.0,3.1,2.2,0.0348,0,0,0,0,3.9,1.9,2.5
269,513,0,Middle East & Africa,Manufacturing,Medical Affairs,Meets,Male,38,16,1,5,14,0.0,2.4,2.9,0.0348,1,1,1,1,4.3,2.2,3.6
270,369,0,Latin America,Manufacturing,Finance & Accounting,Meets,Male,34,8,0,5,14,2.7,3.5,2.4,0.0348,1,1,1,1,2.2,3.5,2.1
271,699,0,Asia Pacific,HR,Quality Assurance,Meets,Female,31,6,0,9,18,3.0,1.1,2.3,0.0383,1,1,1,1,2.9,1.0,2.3
272,969,0,North America,Finance,Finance & Accounting,Meets,Male,37,13,0,10,41,2.5,2.5,3.2,0.0331,1,1,1,1,2.3,4.1,4.6
273,149,0,North America,R&D,Marketing,Meets,Female,28,13,0,6,11,2.2,1.8,2.9,0.0977,0,0,0,0,3.6,1.4,4.6
274,514,0,Latin America,Manufacturing,Market Access,Meets,Male,34,13,0,9,17,2.9,2.9,3.4,0.0348,1,1,1,1,1.7,2.9,4.1
275,627,0,Asia Pacific,Digital,Quality Assurance,Meets,Non-Binary/Other,30,11,0,7,11,4.7,4.4,2.3,0.0853,1,1,1,1,4.3,4.8,2.9
276,743,0,Asia Pacific,HR,Finance & Accounting,Meets,Non-Binary/Other,36,13,0,8,21,2.7,1.2,2.5,0.0383,1,1,1,1,4.0,2.2,2.9
277,297,0,Middle East & Africa,Commercial,Supply Chain,Meets,Female,41,16,0,10,24,3.1,3.5,1.8,0.0422,1,1,1,1,4.2,1.7,2.2
278,14,0,Asia Pacific,R&D,Finance & Accounting,Below,Non-Binary/Other,40,13,0,10,16,2.5,2.7,3.0,0.0,1,1,1,1,3.1,3.8,2.3
279,621,0,Asia Pacific,Digital,Market Access,Meets,Male,42,7,0,11,22,1.6,2.5,3.0,0.0853,1,1,1,1,2.8,4.1,2.5
280,357,0,Asia Pacific,Manufacturing,Medical Affairs,Exceeds,Non-Binary/Other,32,26,0,8,15,3.1,3.9,2.3,0.0616,1,1,1,1,3.7,3.4,4.2
281,214,0,Europe,Commercial,Regulatory Affairs,Meets,Male,47,16,0,12,15,4.1,1.2,3.4,0.0422,1,1,1,1,4.4,2.1,3.8
282,118,0,Middle East & Africa,R&D,Communications,Below,Male,42,13,1,11,35,0.0,2.2,1.6,0.0,1,1,1,1,2.6,3.7,2.6
283,800,0,North America,HR,Pharmacovigilance,Meets,Male,42,14,0,5,8,2.9,2.0,3.3,0.0383,1,1,1,1,3.5,1.2,1.5
284,267,0,Latin America,Commercial,Regulatory Affairs,Meets,Female,45,15,0,12,30,3.7,1.4,3.9,0.0422,1,1,1,1,2.3,3.4,3.2
285,898,0,North America,Finance,Clinical Operations,Meets,Female,39,14,0,9,16,3.0,3.5,2.7,0.0331,1,1,1,1,4.3,4.2,5.0
286,340,0,Middle East & Africa,Commercial,Quality Assurance,Meets,Female,37,8,0,12,22,2.2,3.1,1.8,0.0422,1,1,1,1,1.0,2.0,2.4
287,634,0,Latin America,Digital,Market Access,Meets,Non-Binary/Other,46,5,1,5,25,0.0,3.5,2.5,0.0853,1,1,1,1,2.9,2.7,1.9
288,165,0,Middle East & Africa,R&D,Communications,Meets,Female,33,7,0,11,17,3.1,3.7,2.5,0.0977,1,1,1,1,2.7,1.5,2.8
289,644,0,Asia Pacific,Digital,Pharmacovigilance,Far Exceeds,Female,37,15,1,9,13,0.0,4.1,2.4,0.2363,1,1,1,1,3.1,2.3,3.0
290,659,0,Latin America,Digital,Clinical Operations,Meets,Male,45,36,0,12,41,2.3,3.4,1.9,0.0853,1,1,1,0,3.0,4.9,1.9
291,391,0,Asia Pacific,Manufacturing,Supply Chain,Far Exceeds,Female,37,5,1,7,14,0.0,2.7,3.3,0.1069,1,1,1,1,2.7,3.2,4.1
292,828,0,North America,HR,Regulatory Affairs,Meets,Non-Binary/Other,34,17,0,10,11,4.1,3.5,2.4,0.0383,1,1,1,1,3.6,3.6,2.0
293,347,0,North America,Commercial,Marketing,Below,Non-Binary/Other,32,16,0,11,25,2.4,2.8,3.1,0.0,1,1,1,1,2.2,3.6,3.8
294,131,0,Latin America,R&D,Finance & Accounting,Meets,Male,39,23,0,10,28,3.4,4.0,3.6,0.0977,1,1,1,0,1.1,3.5,2.4
295,935,1,Latin America,Finance,Human Resources,Meets,Male,35,22,0,6,15,2.5,4.0,2.4,0.0331,1,1,1,1,2.7,2.3,3.4
296,846,0,Middle East & Africa,HR,Sales,Exceeds,Male,41,19,0,11,16,2.0,2.3,3.7,0.0677,1,1,1,1,2.7,2.9,3.2
297,781,0,Middle East & Africa,HR,Clinical Operations,Meets,Male,48,25,0,11,35,2.2,1.6,1.0,0.0383,1,1,1,1,2.7,3.6,3.5
298,33,0,Asia Pacific,R&D,Regulatory Affairs,Exceeds,Male,44,18,0,7,13,3.3,2.3,2.5,0.1648,0,0,0,0,3.5,1.4,3.0
299,715,0,Latin America,HR,Regulatory Affairs,Below,Female,28,9,0,8,24,4.9,4.4,1.0,0.0,1,1,1,1,4.6,2.2,1.9
300,508,0,North America,Manufacturing,Market Access,Far Below,Female,42,13,0,9,17,3.2,5.0,1.0,0.0,1,1,1,1,4.5,4.1,1.1
301,712,0,Middle East & Africa,HR,Market Access,Meets,Female,43,14,0,7,13,4.1,1.5,1.0,0.0383,0,0,0,0,3.0,2.1,1.7
302,425,0,Middle East & Africa,Manufacturing,Marketing,Meets,Male,36,10,0,9,18,2.6,4.1,4.1,0.0348,1,1,1,1,3.9,3.4,3.4
303,291,1,North America,Commercial,Human Resources,Meets,Male,45,13,0,9,16,3.3,2.4,1.9,0.0422,1,1,1,1,3.3,3.0,2.1
304,297,0,Middle East & Africa,Commercial,IT & Digital,Meets,Male,40,8,1,6,12,0.0,2.6,1.8,0.0422,1,1,1,1,4.0,2.7,2.7
305,605,0,Asia Pacific,Digital,Clinical Operations,Meets,Male,28,5,0,9,21,3.1,4.3,2.3,0.0853,1,1,0,0,3.1,4.6,1.9
306,367,0,Latin America,Manufacturing,Human Resources,Below,Male,39,10,0,10,13,2.9,3.5,1.1,0.0,1,1,1,1,2.7,2.6,2.2
307,1048,0,North America,Finance,Finance & Accounting,Meets,Male,36,11,0,10,11,4.3,4.1,3.4,0.0331,1,1,1,1,4.8,3.1,2.3
308,333,0,Latin America,Commercial,Medical Affairs,Meets,Female,34,13,1,5,8,0.0,2.7,3.2,0.0422,1,0,0,0,3.1,3.7,1.7
309,779,1,Middle East & Africa,HR,IT & Digital,Meets,Male,40,6,0,12,31,3.2,4.2,2.7,0.0383,1,1,1,1,2.0,4.0,3.2
310,71,0,Middle East & Africa,R&D,Market Access,Meets,Female,42,13,0,11,14,4.3,2.8,2.5,0.0977,1,1,1,1,4.3,3.7,1.0
311,153,0,North America,R&D,Human Resources,Exceeds,Female,42,6,0,8,22,3.9,3.1,2.1,0.1648,1,1,1,1,3.8,2.3,2.6
312,422,0,Asia Pacific,Manufacturing,Sales,Below,Female,42,29,0,9,13,3.9,3.6,2.8,0.0,1,1,1,1,2.8,2.9,2.3
313,952,0,Europe,Finance,Regulatory Affairs,Meets,Female,31,12,1,8,33,0.0,2.8,2.3,0.0331,1,1,1,1,3.7,3.7,2.0
314,640,0,North America,Digital,Regulatory Affairs,Meets,Female,32,23,1,5,9,0.0,5.0,1.0,0.0853,1,1,1,1,3.2,4.3,2.1
315,871,0,Europe,HR,Communications,Meets,Female,40,28,0,6,12,4.5,2.3,3.3,0.0383,1,0,0,0,4.4,2.8,2.3
316,456,0,Europe,Manufacturing,Supply Chain,Meets,Female,44,10,0,9,10,4.1,3.8,2.8,0.0348,1,1,1,1,4.3,4.3,3.8
317,93,0,Asia Pacific,R&D,Supply Chain,Exceeds,Male,40,8,0,6,16,3.9,2.7,1.0,0.1648,1,0,0,0,5.0,3.2,2.6
318,514,0,Europe,Manufacturing,Marketing,Meets,Male,28,5,1,8,9,0.0,3.9,1.7,0.0348,1,1,1,1,3.6,2.4,2.5
319,764,0,Europe,HR,Clinical Operations,Far Below,Female,41,8,0,12,15,4.6,3.3,1.6,0.0,1,1,1,1,3.2,2.8,2.1
320,891,0,Asia Pacific,Finance,IT & Digital,Below,Male,29,18,0,9,11,3.3,3.9,1.2,0.0,1,1,1,1,3.4,4.0,2.0
321,1016,0,Europe,Finance,Finance & Accounting,Meets,Female,42,8,0,7,9,4.1,2.2,3.1,0.0331,1,1,1,1,5.0,3.8,3.8
322,241,0,Europe,Commercial,IT & Digital,Meets,Female,35,6,0,5,19,3.9,3.2,3.2,0.0422,1,1,1,1,5.0,2.4,1.6
323,833,0,Europe,HR,Data Science,Below,Male,40,22,0,12,27,3.7,2.8,2.4,0.0,1,1,1,1,2.8,1.1,1.9
324,289,0,North America,Commercial,Pharmacovigilance,Below,Female,51,19,0,12,26,4.2,2.4,2.7,0.0,1,1,1,1,2.2,3.7,3.8
325,317,0,North America,Commercial,Market Access,Meets,Female,36,4,1,12,15,0.0,2.7,4.5,0.0422,1,1,1,1,3.4,4.1,2.1
326,309,0,North America,Commercial,Clinical Operations,Meets,Female,33,25,0,7,19,4.1,2.8,2.2,0.0422,0,0,0,0,3.2,5.0,2.5
327,414,0,Asia Pacific,Manufacturing,Regulatory Affairs,Below,Female,35,26,0,6,14,4.0,3.2,4.5,0.0,1,1,1,1,3.7,2.9,4.4
328,74,0,Middle East & Africa,R&D,Quality Assurance,Meets,Female,29,11,0,5,19,3.1,2.7,2.2,0.0977,1,1,1,1,2.9,3.2,2.1
329,902,0,Europe,Finance,Supply Chain,Meets,Female,32,10,0,6,24,3.8,2.1,2.1,0.0331,1,1,1,1,4.5,2.4,2.3
330,427,0,Europe,Manufacturing,Pharmacovigilance,Exceeds,Female,44,20,0,5,15,2.0,3.9,2.7,0.0616,1,1,1,1,3.5,3.4,3.6
331,33,0,Asia Pacific,R&D,Market Access,Meets,Male,28,4,0,7,24,3.8,3.0,3.8,0.0977,1,1,1,1,5.0,3.1,2.8
332,929,1,Europe,Finance,IT & Digital,Meets,Male,34,4,1,12,23,0.0,2.7,3.2,0.0331,1,1,1,1,2.3,4.2,2.9
333,702,0,North America,HR,Communications,Meets,Male,39,15,0,11,15,4.4,3.0,2.3,0.0383,1,1,1,1,3.1,4.1,2.1
334,884,0,Middle East & Africa,Finance,Communications,Far Below,Male,36,31,0,10,12,2.1,3.2,2.5,0.0,1,1,1,1,3.5,5.0,3.4
335,941,0,Latin America,Finance,Communications,Meets,Male,46,8,0,7,12,3.1,1.6,2.3,0.0331,1,1,1,1,3.1,3.4,2.9
336,941,0,Europe,Finance,IT & Digital,Below,Female,37,15,1,9,24,0.0,1.0,3.9,0.0,1,1,1,1,4.8,2.4,4.0
337,637,0,North America,Digital,Medical Affairs,Meets,Female,36,15,0,12,18,3.7,4.7,2.2,0.0853,1,1,1,1,3.8,2.9,3.0
338,791,0,Latin America,HR,Medical Affairs,Meets,Female,39,7,0,6,10,2.8,3.0,3.3,0.0383,1,1,1,1,3.7,4.2,3.5
339,398,0,Middle East & Africa,Manufacturing,Supply Chain,Far Below,Female,40,14,0,9,22,3.0,3.2,3.8,0.0,1,1,1,1,3.3,3.0,4.6
340,479,0,Latin America,Manufacturing,Clinical Operations,Meets,Male,38,18,0,10,20,4.0,4.0,2.9,0.0348,1,1,1,1,3.3,3.9,2.0
341,69,0,North America,R&D,Market Access,Meets,Male,38,14,0,7,12,2.6,2.2,3.9,0.0977,1,1,1,1,4.5,3.8,2.1
342,505,0,Latin America,Manufacturing,IT & Digital,Meets,Female,28,5,1,11,23,0.0,2.1,3.9,0.0348,1,0,0,0,3.7,2.5,3.5
343,269,0,Asia Pacific,Commercial,Pharmacovigilance,Meets,Male,31,5,0,5,10,2.8,3.4,1.5,0.0422,1,1,1,1,2.8,2.4,1.6
344,1005,1,Latin America,Finance,Regulatory Affairs,Meets,Female,41,12,0,5,44,3.7,3.4,3.6,0.0331,1,1,1,1,2.9,3.9,3.7
345,510,0,Europe,Manufacturing,Communications,Exceeds,Male,44,7,0,10,12,3.7,2.9,4.5,0.0616,1,1,1,1,3.6,4.3,3.0
346,152,0,Europe,R&D,Clinical Operations,Meets,Male,46,13,0,11,14,3.0,3.2,3.7,0.0977,1,0,0,0,2.5,3.1,2.0
347,74,1,Asia Pacific,R&D,Supply Chain,Meets,Male,29,15,0,11,28,2.5,3.6,4.6,0.0977,1,1,1,1,3.2,2.3,4.3
348,231,0,North America,Commercial,Marketing,Below,Female,33,14,0,10,28,2.8,1.0,2.6,0.0,1,1,1,1,4.4,1.8,2.9
349,132,0,Europe,R&D,IT & Digital,Far Below,Female,47,11,1,5,12,0.0,2.7,2.6,0.0,0,0,0,0,3.9,1.1,2.9
350,549,0,Middle East & Africa,Digital,Data Science,Meets,Female,36,5,1,6,13,0.0,3.0,1.0,0.0853,1,1,1,1,2.0,2.5,1.9
351,976,0,Europe,Finance,Clinical Operations,Meets,Female,42,11,0,9,18,4.1,1.0,2.5,0.0331,1,1,1,1,3.1,2.2,2.4
352,972,0,Europe,Finance,IT & Digital,Meets,Female,55,13,0,8,14,3.6,2.7,2.6,0.0331,1,1,0,0,4.2,4.0,3.2
353,1011,0,North America,Finance,Sales,Meets,Female,44,17,0,10,18,2.7,2.8,4.3,0.0331,1,0,0,0,1.8,3.1,5.0
354,748,0,Latin America,HR,Market Access,Meets,Female,37,10,1,7,10,0.0,1.5,3.0,0.0383,1,1,1,1,4.4,2.1,3.2
355,431,0,Europe,Manufacturing,Legal & Compliance,Meets,Male,37,5,1,11,17,0.0,5.0,3.6,0.0348,1,1,1,1,3.0,4.7,3.2
356,679,0,Asia Pacific,Digital,Medical Affairs,Below,Female,41,12,0,12,17,3.7,3.0,1.3,0.0,1,1,1,1,3.0,2.8,3.1
357,413,0,Latin America,Manufacturing,Sales,Below,Female,28,12,0,11,34,4.2,5.0,3.2,0.0,1,1,1,1,4.1,5.0,2.7
358,540,0,Middle East & Africa,Digital,Clinical Operations,Exceeds,Male,41,4,1,11,19,0.0,1.6,3.2,0.1452,0,0,0,0,3.3,3.1,4.4
359,501,0,North America,Manufacturing,Clinical Operations,Meets,Male,36,10,0,5,21,3.9,2.0,2.9,0.0348,0,0,0,0,2.4,3.1,3.2
360,178,0,Middle East & Africa,Commercial,Sales,Meets,Male,38,11,0,10,20,3.2,1.5,3.6,0.0422,1,1,1,1,3.7,1.0,2.2
361,18,0,Latin America,R&D,Marketing,Meets,Male,39,8,0,8,12,3.3,3.6,2.2,0.0977,1,1,1,1,2.6,4.9,1.6
362,112,0,Latin America,R&D,Sales,Meets,Female,47,10,1,12,19,0.0,3.6,3.2,0.0977,1,1,1,1,1.8,3.6,2.7
363,228,0,Latin America,Commercial,Regulatory Affairs,Below,Female,40,5,0,12,27,3.6,3.6,2.6,0.0,1,1,1,1,3.9,4.1,3.5
364,609,0,Middle East & Africa,Digital,Pharmacovigilance,Exceeds,Female,39,6,0,10,27,3.8,1.9,4.1,0.1452,1,1,1,1,2.8,4.1,3.4
365,849,0,Latin America,HR,Sales,Meets,Female,42,17,0,12,16,3.3,4.6,2.2,0.0383,1,1,1,1,2.8,4.0,1.0
366,685,0,Middle East & Africa,Digital,Human Resources,Below,Female,38,9,0,5,12,1.5,4.7,3.3,0.0,1,1,1,1,1.9,1.8,3.5
367,41,0,Latin America,R&D,Human Resources,Exceeds,Male,42,9,1,12,18,0.0,4.4,3.6,0.1648,1,1,1,1,3.2,3.6,2.5
368,805,0,Asia Pacific,HR,Sales,Meets,Female,37,11,0,11,12,1.4,2.1,1.6,0.0383,1,1,1,1,2.5,2.9,1.5
369,406,1,Latin America,Manufacturing,Market Access,Meets,Female,45,6,0,8,15,2.0,4.6,2.3,0.0348,1,1,1,0,3.1,3.5,3.4
370,739,0,Middle East & Africa,HR,Pharmacovigilance,Far Below,Female,46,26,0,10,21,3.4,3.9,2.1,0.0,1,1,1,1,3.3,4.1,1.3
371,561,0,Europe,Digital,Data Science,Far Below,Female,42,11,0,10,13,3.3,2.9,4.0,0.0,1,1,1,1,2.7,2.2,4.4
372,207,0,Latin America,Commercial,Sales,Below,Female,28,14,0,12,17,3.3,2.1,1.5,0.0,1,0,0,0,2.9,3.2,3.1
373,414,0,Europe,Manufacturing,Communications,Meets,Male,39,8,0,10,21,3.0,3.0,2.2,0.0348,1,1,1,1,3.2,2.4,1.9
374,648,0,Asia Pacific,Digital,Finance & Accounting,Meets,Female,28,2,1,8,32,0.0,4.3,2.2,0.0853,1,1,1,1,1.9,3.7,1.4
375,441,0,North America,Manufacturing,IT & Digital,Meets,Female,40,7,0,7,22,2.8,3.7,1.4,0.0348,1,1,1,1,2.6,4.2,1.1
376,777,0,Asia Pacific,HR,Sales,Meets,Female,48,7,0,10,19,3.1,2.5,3.3,0.0383,1,1,1,1,2.3,3.0,2.4
377,106,0,Latin America,R&D,Regulatory Affairs,Exceeds,Male,45,5,1,12,24,0.0,3.1,1.5,0.1648,1,1,1,1,5.0,2.1,2.7
378,638,0,Europe,Digital,Human Resources,Meets,Male,36,11,0,8,12,3.9,2.0,3.1,0.0853,1,1,1,1,3.7,2.7,3.9
379,281,0,Europe,Commercial,Medical Affairs,Exceeds,Male,37,11,0,6,14,3.4,3.1,3.6,0.0743,1,1,0,0,4.7,2.4,3.4
380,715,0,Middle East & Africa,HR,Human Resources,Exceeds,Female,28,31,0,5,7,1.7,1.5,1.7,0.0677,1,1,1,1,2.3,1.1,1.4
381,614,0,Europe,Digital,Human Resources,Meets,Male,38,22,0,10,19,3.1,2.6,1.5,0.0853,1,1,1,1,2.4,2.7,1.6
382,291,0,Middle East & Africa,Commercial,Regulatory Affairs,Below,Female,37,8,1,12,13,0.0,4.4,4.2,0.0,1,1,1,1,4.2,3.5,3.4
383,654,0,North America,Digital,Sales,Meets,Male,30,12,0,7,13,2.6,4.9,4.2,0.0853,1,1,1,1,2.7,4.3,5.0
384,878,0,Latin America,HR,Market Access,Meets,Male,32,9,0,6,30,5.0,2.7,2.0,0.0383,1,1,1,1,4.0,3.5,3.9
385,523,0,Middle East & Africa,Digital,Finance & Accounting,Meets,Female,31,6,0,8,21,2.8,3.7,1.7,0.0853,1,1,1,1,3.4,2.6,1.2
386,511,0,North America,Manufacturing,IT & Digital,Below,Female,51,9,0,11,15,3.0,5.0,2.1,0.0,1,1,1,1,3.5,3.9,1.8
387,743,0,Europe,HR,Regulatory Affairs,Meets,Female,39,3,1,7,10,0.0,5.0,3.1,0.0383,1,1,1,1,4.1,5.0,4.0
388,597,0,Europe,Digital,Market Access,Meets,Male,43,7,0,6,23,2.2,2.7,1.9,0.0853,1,0,0,0,2.9,2.4,1.3
389,13,0,North America,R&D,Communications,Below,Male,43,8,0,7,9,1.8,2.0,2.0,0.0,1,1,1,1,2.6,2.8,1.3
390,652,0,Europe,Digital,Legal & Compliance,Meets,Male,48,13,0,10,12,2.8,3.1,3.4,0.0853,1,1,1,1,4.1,4.1,3.2
391,428,0,North America,Manufacturing,Pharmacovigilance,Below,Male,47,12,0,12,21,1.0,5.0,1.7,0.0,1,1,1,1,1.8,5.0,2.4
392,262,0,Middle East & Africa,Commercial,Market Access,Meets,Female,44,5,1,9,11,0.0,2.1,3.1,0.0422,1,1,1,1,4.3,2.9,4.0
393,196,0,Middle East & Africa,Commercial,Marketing,Exceeds,Male,29,14,0,7,24,2.9,1.2,2.4,0.0743,0,0,0,0,3.7,1.0,2.6
394,246,0,North America,Commercial,Quality Assurance,Meets,Non-Binary/Other,44,17,1,10,11,0.0,3.7,3.5,0.0422,1,1,1,1,3.1,4.1,4.3
395,165,0,Middle East & Africa,R&D,Pharmacovigilance,Meets,Female,36,14,0,6,21,3.7,3.3,5.0,0.0977,1,1,1,1,3.6,3.4,3.9
396,364,0,Middle East & Africa,Manufacturing,Communications,Below,Female,30,16,0,10,15,2.7,3.3,1.3,0.0,1,1,1,0,2.5,3.3,2.5
397,754,0,Middle East & Africa,HR,Finance & Accounting,Meets,Non-Binary/Other,36,16,0,5,11,2.5,3.1,2.1,0.0383,0,0,0,0,3.4,2.8,1.7
398,216,0,Asia Pacific,Commercial,Quality Assurance,Exceeds,Male,39,21,0,8,13,1.8,3.0,2.3,0.0743,1,1,1,1,2.0,2.4,2.9
399,482,0,Latin America,Manufacturing,Sales,Meets,Male,28,14,1,5,12,0.0,1.9,2.2,0.0348,0,0,0,0,3.6,2.2,1.3
400,578,0,Europe,Digital,Sales,Exceeds,Female,40,17,0,10,21,4.1,3.5,2.9,0.1452,0,0,0,0,2.5,2.6,2.6
401,176,0,Asia Pacific,R&D,Marketing,Meets,Male,45,12,0,12,40,2.7,3.1,3.3,0.0977,1,1,1,1,4.1,3.4,3.9
402,362,0,Middle East & Africa,Manufacturing,Legal & Compliance,Meets,Non-Binary/Other,39,16,0,12,13,3.2,5.0,2.2,0.0348,1,1,1,1,4.6,4.8,1.5
403,386,0,North America,Manufacturing,Clinical Operations,Exceeds,Non-Binary/Other,32,8,0,6,21,2.8,2.8,2.7,0.0616,1,0,0,0,4.2,3.3,2.1
404,788,0,Middle East & Africa,HR,Finance & Accounting,Far Below,Female,42,12,0,10,11,3.8,3.2,2.3,0.0,0,0,0,0,4.2,2.0,3.5
405,416,0,Latin America,Manufacturing,Human Resources,Far Below,Female,38,12,1,9,31,0.0,1.6,1.4,0.0,1,1,1,1,2.9,2.9,1.1
406,862,0,Middle East & Africa,HR,Quality Assurance,Meets,Female,48,10,0,11,38,2.4,2.0,1.6,0.0383,1,1,1,1,2.5,2.1,1.7
407,34,0,North America,R&D,Regulatory Affairs,Meets,Female,28,7,0,9,23,1.9,3.7,3.1,0.0977,1,1,1,1,3.0,1.4,2.4
408,51,0,Latin America,R&D,Marketing,Meets,Male,28,7,0,9,17,3.5,5.0,4.6,0.0977,1,1,1,1,3.7,4.3,3.8
409,596,0,Middle East & Africa,Digital,Legal & Compliance,Below,Female,37,13,0,5,14,3.9,3.4,2.6,0.0,1,1,1,1,4.2,2.9,2.7
410,707,0,Latin America,HR,Legal & Compliance,Far Exceeds,Male,35,7,0,7,20,3.8,2.8,2.3,0.1168,1,1,1,1,3.9,2.8,2.4
411,796,0,Europe,HR,Pharmacovigilance,Meets,Female,40,14,0,11,32,4.1,1.4,2.1,0.0383,1,1,1,1,3.3,2.4,1.9
412,236,0,Europe,Commercial,Finance & Accounting,Exceeds,Non-Binary/Other,41,14,0,11,32,3.4,3.3,4.6,0.0743,1,1,0,0,4.0,2.6,3.5
413,236,0,Middle East & Africa,Commercial,Data Science,Meets,Male,47,5,0,7,12,3.7,4.4,2.6,0.0422,0,0,0,0,3.4,4.7,2.5
414,682,0,Latin America,Digital,Regulatory Affairs,Meets,Male,37,14,0,7,17,4.0,2.5,1.3,0.0853,1,1,1,1,4.4,1.6,1.0
415,131,1,North America,R&D,Market Access,Exceeds,Female,41,9,1,12,16,0.0,2.5,3.0,0.1648,1,1,1,1,4.7,1.9,3.2
416,1015,0,Middle East & Africa,Finance,Sales,Meets,Female,30,13,1,7,20,0.0,2.1,2.8,0.0331,1,1,1,1,4.3,3.0,2.6
417,353,0,Europe,Commercial,Human Resources,Far Exceeds,Female,53,34,0,11,17,3.7,4.0,4.0,0.1275,1,1,0,0,3.3,4.2,1.3
418,356,0,Europe,Manufacturing,Pharmacovigilance,Meets,Female,45,29,0,10,40,4.1,3.1,2.4,0.0348,0,0,0,0,4.0,2.4,2.4
419,66,0,Middle East & Africa,R&D,Marketing,Meets,Female,43,12,0,9,25,3.9,2.8,2.3,0.0977,1,1,1,0,4.2,2.6,3.5
420,918,0,Latin America,Finance,Legal & Compliance,Exceeds,Male,33,8,1,10,21,0.0,3.8,1.5,0.0588,1,1,1,1,1.9,3.5,1.9
421,401,0,Europe,Manufacturing,Quality Assurance,Far Exceeds,Female,46,12,1,12,20,0.0,2.4,1.9,0.1069,1,1,1,1,3.7,3.1,1.1
422,713,0,Latin America,HR,Quality Assurance,Meets,Female,44,3,0,7,15,3.5,1.9,1.5,0.0383,1,1,1,1,3.1,3.3,2.9
423,51,0,Europe,R&D,Supply Chain,Below,Male,42,10,0,8,18,2.9,3.3,2.6,0.0,1,1,1,1,4.4,2.5,1.2
424,612,0,Europe,Digital,Sales,Meets,Male,37,18,0,9,32,3.7,2.9,3.5,0.0853,1,1,1,1,2.9,3.5,3.1
425,861,0,Asia Pacific,HR,Regulatory Affairs,Exceeds,Female,32,18,0,5,8,3.8,3.2,1.7,0.0677,1,1,1,1,3.7,3.6,1.9
426,870,0,Europe,HR,Legal & Compliance,Meets,Non-Binary/Other,38,13,0,5,24,4.5,4.5,4.3,0.0383,1,1,1,1,4.6,3.6,4.0
427,434,0,North America,Manufacturing,Communications,Meets,Female,33,14,0,6,14,4.8,3.7,4.3,0.0348,1,1,1,1,3.9,3.1,3.7
428,720,0,Middle East & Africa,HR,Market Access,Meets,Female,40,11,0,11,20,3.7,2.0,4.0,0.0383,1,1,1,1,2.8,3.1,3.0
429,310,0,Middle East & Africa,Commercial,Market Access,Below,Male,31,6,0,11,31,3.7,3.0,2.2,0.0,1,0,0,0,3.7,3.8,2.6
430,118,1,Latin America,R&D,Sales,Far Exceeds,Non-Binary/Other,34,17,0,6,18,3.9,2.7,1.5,0.2644,1,1,1,1,4.7,3.9,4.3
431,281,0,Europe,Commercial,IT & Digital,Meets,Male,28,14,1,8,20,0.0,2.8,2.7,0.0422,1,1,1,1,4.3,4.4,2.7
432,384,0,North America,Manufacturing,Supply Chain,Meets,Female,41,6,1,5,9,0.0,2.0,4.0,0.0348,1,1,1,1,3.9,2.4,3.3
433,976,0,Latin America,Finance,IT & Digital,Meets,Male,41,2,1,12,16,0.0,2.8,4.4,0.0331,1,1,1,1,2.9,3.8,4.3
434,414,0,Asia Pacific,Manufacturing,IT & Digital,Meets,Female,35,9,0,5,14,3.1,2.4,4.0,0.0348,1,1,1,1,3.2,2.3,5.0
435,148,0,Latin America,R&D,Supply Chain,Meets,Male,28,14,0,12,16,2.8,2.7,4.6,0.0977,1,1,1,1,3.6,4.1,2.5
436,879,1,Latin America,HR,Human Resources,Far Exceeds,Male,28,7,1,10,23,0.0,3.1,3.8,0.1168,1,1,1,1,4.1,2.8,4.2
437,609,0,Europe,Digital,Finance & Accounting,Meets,Male,39,14,1,8,13,0.0,2.8,2.0,0.0853,0,0,0,0,4.4,3.4,1.1
438,393,0,Asia Pacific,Manufacturing,Communications,Meets,Male,44,8,0,8,12,3.4,1.5,4.2,0.0348,1,1,1,1,3.1,1.3,3.7
439,133,0,Latin America,R&D,Regulatory Affairs,Far Below,Male,32,9,0,10,29,3.7,2.6,1.5,0.0,1,1,1,1,4.6,3.6,2.4
440,556,0,North America,Digital,Supply Chain,Exceeds,Female,45,8,0,8,19,3.7,2.5,4.0,0.1452,1,1,1,1,3.1,3.2,3.3
441,803,1,North America,HR,Marketing,Meets,Male,48,6,1,5,11,0.0,3.7,2.2,0.0383,1,1,1,1,3.6,4.0,2.1
442,927,0,Middle East & Africa,Finance,Supply Chain,Below,Male,41,5,1,11,21,0.0,3.4,3.0,0.0,1,1,1,1,2.3,3.6,3.7
443,491,0,Asia Pacific,Manufacturing,Human Resources,Below,Male,44,8,0,8,13,4.8,3.8,1.7,0.0,1,1,0,0,3.3,3.9,1.6
444,952,0,Asia Pacific,Finance,Quality Assurance,Meets,Male,31,18,0,9,19,2.7,3.3,3.0,0.0331,1,1,1,1,3.6,4.7,3.3
445,142,0,Middle East & Africa,R&D,Medical Affairs,Far Exceeds,Female,28,6,0,8,16,3.6,3.2,3.7,0.2644,1,1,1,1,4.4,2.6,2.8
446,1034,0,Latin America,Finance,Clinical Operations,Meets,Female,49,9,0,7,12,3.2,3.1,3.1,0.0331,1,1,1,1,1.9,3.4,1.3
447,981,0,Asia Pacific,Finance,Quality Assurance,Meets,Male,32,7,0,10,15,3.2,4.2,3.3,0.0331,1,1,0,0,2.2,3.2,3.3
448,19,1,North America,R&D,Quality Assurance,Meets,Male,45,9,0,6,24,3.9,4.5,3.3,0.0977,1,1,1,0,5.0,4.1,3.1
449,110,0,North America,R&D,Data Science,Meets,Female,41,26,1,5,35,0.0,3.5,2.6,0.0977,1,0,0,0,1.3,1.9,2.8
450,399,0,Europe,Manufacturing,Data Science,Below,Female,49,6,0,5,15,3.0,3.6,3.0,0.0,1,1,1,1,2.9,3.8,3.7
451,971,0,Asia Pacific,Finance,Sales,Meets,Male,43,15,1,9,18,0.0,2.0,1.5,0.0331,1,1,1,1,5.0,1.8,2.2
452,584,0,Latin America,Digital,Legal & Compliance,Meets,Male,31,26,0,10,20,3.3,2.8,3.5,0.0853,1,1,1,1,2.3,2.9,4.5
453,30,1,Middle East & Africa,R&D,Data Science,Far Exceeds,Male,36,10,0,11,23,4.4,3.0,2.9,0.2644,1,1,1,1,4.9,1.5,3.1
454,737,0,Middle East & Africa,HR,Communications,Meets,Male,42,7,0,8,14,3.8,2.6,2.3,0.0383,1,1,1,1,3.9,2.8,3.2
455,896,0,Latin America,Finance,Legal & Compliance,Meets,Male,35,12,0,6,27,3.9,4.8,1.6,0.0331,1,1,1,1,3.7,3.6,2.7
456,53,1,Europe,R&D,Sales,Exceeds,Male,44,10,1,7,11,0.0,3.3,2.5,0.1648,1,1,1,1,3.6,3.8,2.5
457,527,0,Middle East & Africa,Digital,Communications,Meets,Male,39,9,0,10,13,5.0,2.9,1.2,0.0853,1,1,1,1,4.1,3.3,1.8
458,357,0,Asia Pacific,Manufacturing,Quality Assurance,Exceeds,Female,44,8,0,5,13,2.7,1.8,2.5,0.0616,1,0,0,0,3.4,1.2,2.2
459,1018,0,Europe,Finance,Clinical Operations,Meets,Female,45,15,0,11,19,1.9,3.8,3.7,0.0331,1,1,1,0,3.3,5.0,4.0
460,15,0,Asia Pacific,R&D,Regulatory Affairs,Meets,Female,40,9,1,5,24,0.0,3.6,3.1,0.0977,1,1,1,1,2.7,3.5,2.4
461,125,0,North America,R&D,Regulatory Affairs,Far Exceeds,Female,37,5,0,8,19,3.1,2.4,1.6,0.2644,1,1,1,1,3.8,4.1,1.3
462,720,0,Europe,HR,IT & Digital,Below,Male,35,16,0,7,11,5.0,2.6,3.1,0.0,1,1,1,1,4.1,3.3,4.1
463,744,0,Middle East & Africa,HR,Medical Affairs,Meets,Male,31,12,0,7,13,4.0,2.5,2.7,0.0383,1,1,1,1,3.6,3.6,2.7
464,942,0,Europe,Finance,Pharmacovigilance,Meets,Male,48,13,0,8,21,4.3,3.3,2.5,0.0331,1,1,1,1,4.1,3.4,1.6
465,131,1,Europe,R&D,Regulatory Affairs,Meets,Female,38,9,0,5,22,1.5,2.7,2.0,0.0977,1,1,1,1,3.3,2.6,2.9
466,887,1,Europe,Finance,IT & Digital,Exceeds,Female,37,6,0,7,23,2.9,2.1,2.3,0.0588,1,1,1,1,4.9,3.0,2.7
467,105,0,Europe,R&D,Legal & Compliance,Meets,Female,37,21,0,12,17,3.9,4.9,2.4,0.0977,1,1,1,1,2.6,1.7,1.8
468,700,0,Asia Pacific,HR,Human Resources,Exceeds,Male,38,12,0,12,27,3.5,3.3,2.5,0.0677,1,1,1,1,4.4,4.3,2.4
469,635,0,North America,Digital,Finance & Accounting,Meets,Male,35,16,0,8,31,2.0,1.9,2.8,0.0853,1,1,1,1,3.9,3.1,2.2
470,233,0,Latin America,Commercial,Communications,Far Exceeds,Female,35,6,0,12,19,3.6,1.9,4.5,0.1275,1,1,1,1,4.5,2.2,3.2
471,338,0,Europe,Commercial,IT & Digital,Meets,Female,30,6,0,6,20,2.7,3.8,3.9,0.0422,1,1,1,1,3.3,2.4,4.1
472,42,0,Middle East & Africa,R&D,Pharmacovigilance,Below,Male,38,11,1,7,12,0.0,2.1,2.9,0.0,1,1,1,0,2.5,2.8,3.2
473,734,0,Europe,HR,Supply Chain,Meets,Female,46,20,0,5,18,2.2,2.5,3.6,0.0383,1,1,1,1,1.9,2.0,2.1
474,495,0,Middle East & Africa,Manufacturing,Market Access,Meets,Male,34,8,0,7,10,3.3,1.9,2.1,0.0348,1,1,1,1,2.4,2.1,2.3
475,497,0,Asia Pacific,Manufacturing,Quality Assurance,Exceeds,Female,41,16,0,6,9,4.4,2.4,1.5,0.0616,0,0,0,0,3.3,3.0,2.5
476,189,0,Middle East & Africa,Commercial,Clinical Operations,Meets,Male,41,7,1,11,21,0.0,3.8,4.6,0.0422,1,1,1,0,4.0,2.2,4.6
477,676,0,Latin America,Digital,Finance & Accounting,Meets,Female,40,6,0,8,21,4.5,3.1,2.6,0.0853,1,0,0,0,4.9,2.9,2.2
478,208,0,North America,Commercial,Sales,Exceeds,Female,49,7,1,10,26,0.0,2.5,3.4,0.0743,1,1,1,1,3.5,4.9,2.5
479,6,0,Middle East & Africa,R&D,Pharmacovigilance,Exceeds,Non-Binary/Other,42,2,1,7,20,0.0,1.6,2.6,0.1648,1,1,1,1,4.2,3.2,2.9
480,552,0,Middle East & Africa,Digital,IT & Digital,Meets,Female,38,8,0,6,17,3.7,2.0,3.7,0.0853,1,1,1,1,3.9,2.5,3.1
481,355,0,North America,Manufacturing,Medical Affairs,Exceeds,Female,40,10,1,6,10,0.0,2.6,5.0,0.0616,1,1,1,1,3.0,1.0,4.2
482,840,0,Latin America,HR,Regulatory Affairs,Meets,Female,43,5,0,6,11,3.0,3.1,2.0,0.0383,1,1,1,1,3.1,2.9,4.0
483,782,0,Europe,HR,Marketing,Far Below,Male,48,8,0,7,23,2.3,3.5,3.3,0.0,1,1,1,1,3.2,3.6,3.5
484,4,0,Middle East & Africa,R&D,Regulatory Affairs,Far Below,Male,37,7,1,9,12,0.0,2.0,2.3,0.0,1,1,1,1,1.6,2.5,3.5
485,192,0,North America,Commercial,Data Science,Far Exceeds,Male,39,6,0,8,18,3.6,3.5,2.7,0.1275,1,1,1,1,3.7,3.0,2.2
486,131,0,Asia Pacific,R&D,Legal & Compliance,Below,Male,55,17,0,12,32,3.0,3.4,1.5,0.0,1,1,1,1,2.2,2.8,4.5
487,743,0,North America,HR,Quality Assurance,Meets,Female,38,5,0,6,20,4.3,3.3,2.5,0.0383,1,1,1,1,4.1,3.2,3.5
488,486,0,Asia Pacific,Manufacturing,Communications,Exceeds,Male,37,7,0,12,30,2.3,1.2,2.2,0.0616,1,0,0,0,2.2,2.5,3.3
489,720,0,Latin America,HR,Data Science,Below,Male,33,2,1,8,14,0.0,3.2,3.9,0.0,0,0,0,0,3.4,3.1,2.2
490,643,1,Europe,Digital,Regulatory Affairs,Exceeds,Female,39,5,1,12,21,0.0,2.8,2.2,0.1452,1,1,1,1,4.5,3.9,1.9
491,927,0,North America,Finance,Marketing,Exceeds,Female,38,8,0,10,18,2.5,2.9,2.7,0.0588,0,0,0,0,2.5,3.1,3.8
492,737,0,Middle East & Africa,HR,Legal & Compliance,Far Exceeds,Female,40,13,0,6,10,4.4,4.8,3.7,0.1168,1,1,1,1,4.4,3.4,2.8
493,718,0,Latin America,HR,Data Science,Meets,Female,40,18,0,10,17,2.5,1.5,3.5,0.0383,1,1,1,1,3.0,3.0,2.6
494,991,0,North America,Finance,Clinical Operations,Meets,Male,28,14,0,10,17,3.3,5.0,4.1,0.0331,1,1,1,0,4.0,3.8,5.0
495,662,0,Middle East & Africa,Digital,IT & Digital,Exceeds,Male,30,2,1,12,17,0.0,1.0,3.7,0.1452,1,1,1,1,3.3,3.5,2.4
496,330,0,North America,Commercial,Legal & Compliance,Meets,Female,37,10,1,5,22,0.0,2.8,3.1,0.0422,1,1,1,1,3.5,2.0,2.8
497,786,0,Asia Pacific,HR,Communications,Meets,Male,35,12,0,11,22,4.0,3.6,2.6,0.0383,1,1,1,1,4.4,1.9,2.4
498,165,0,North America,R&D,Communications,Meets,Female,32,18,0,10,17,2.3,2.0,2.5,0.0977,1,1,1,1,3.1,3.9,3.5
499,729,0,North America,HR,Legal & Compliance,Meets,Female,28,2,0,11,23,4.3,3.4,2.7,0.0383,1,1,1,1,1.2,2.4,3.6
500,101,1,North America,R&D,Data Science,Exceeds,Female,48,15,1,5,14,0.0,2.4,1.8,0.1648,1,1,1,1,4.1,2.8,2.9
501,667,0,Latin America,Digital,Marketing,Meets,Female,48,17,0,5,20,3.7,3.3,2.3,0.0853,1,1,1,1,3.4,3.8,3.1
502,827,0,North America,HR,Data Science,Far Below,Female,43,8,0,8,17,5.0,2.9,3.1,0.0,1,1,1,1,3.9,4.0,3.9
503,555,0,Middle East & Africa,Digital,Pharmacovigilance,Below,Male,34,36,0,6,20,4.2,2.9,1.2,0.0,1,1,1,0,2.8,3.4,3.0
504,535,0,Asia Pacific,Digital,Supply Chain,Below,Female,47,5,0,5,19,2.2,4.5,1.0,0.0,1,1,1,1,1.6,3.1,1.9
505,236,0,Asia Pacific,Commercial,Legal & Compliance,Meets,Female,34,16,0,8,29,1.1,4.1,1.0,0.0422,1,1,1,1,2.7,3.2,3.5
506,714,0,North America,HR,Sales,Meets,Male,41,13,0,5,13,4.5,2.5,1.3,0.0383,0,0,0,0,3.4,3.9,2.3
507,152,0,Latin America,R&D,Regulatory Affairs,Below,Female,33,4,0,6,12,3.5,3.7,2.4,0.0,1,1,1,1,2.4,2.4,2.3
508,22,0,Latin America,R&D,Communications,Meets,Male,38,28,0,5,8,4.6,3.3,2.5,0.0977,1,1,1,1,3.8,1.8,1.8
509,814,0,Middle East & Africa,HR,Pharmacovigilance,Exceeds,Male,41,23,0,7,20,4.0,2.3,1.8,0.0677,1,1,1,1,3.9,3.1,3.4
510,898,0,North America,Finance,Sales,Meets,Male,29,13,0,10,12,3.3,2.8,1.8,0.0331,1,1,1,1,3.6,3.2,2.3
511,324,0,Asia Pacific,Commercial,Supply Chain,Meets,Female,35,16,0,5,12,4.4,3.9,1.6,0.0422,1,1,1,1,4.0,4.6,3.2
512,261,0,Latin America,Commercial,Pharmacovigilance,Far Exceeds,Female,40,21,0,7,10,3.0,2.2,2.9,0.1275,0,0,0,0,2.8,4.3,3.4
513,316,0,North America,Commercial,Medical Affairs,Meets,Female,30,6,0,9,23,4.8,2.7,2.4,0.0422,1,1,1,1,5.0,3.1,2.8
514,162,0,Latin America,R&D,Pharmacovigilance,Exceeds,Female,32,5,0,9,19,2.9,3.9,2.9,0.1648,0,0,0,0,2.5,4.6,4.0
515,535,0,Latin America,Digital,Clinical Operations,Meets,Female,40,10,1,11,28,0.0,4.0,2.4,0.0853,1,1,1,1,3.4,3.3,3.1
516,999,0,Asia Pacific,Finance,IT & Digital,Meets,Male,35,21,0,5,11,3.8,3.3,2.3,0.0331,1,1,1,1,2.9,3.2,2.5
517,243,0,Europe,Commercial,Marketing,Meets,Male,31,6,0,11,26,3.0,2.4,2.8,0.0422,1,1,1,1,3.1,2.8,4.3
518,129,0,Middle East & Africa,R&D,Regulatory Affairs,Meets,Male,38,11,1,11,20,0.0,3.6,3.0,0.0977,1,1,1,1,3.0,2.3,1.5
519,55,0,Middle East & Africa,R&D,Quality Assurance,Exceeds,Male,41,5,0,11,17,3.1,1.5,3.9,0.1648,1,1,0,0,2.2,3.7,3.1
520,630,0,Asia Pacific,Digital,Sales,Exceeds,Female,51,21,0,10,30,3.7,2.1,3.3,0.1452,1,1,1,1,3.5,3.1,2.3
521,717,0,Latin America,HR,Communications,Meets,Female,39,10,0,8,18,4.4,4.4,4.3,0.0383,1,1,1,1,5.0,3.2,3.4
522,860,0,North America,HR,Data Science,Meets,Male,38,8,1,8,18,0.0,4.3,1.9,0.0383,1,1,1,1,4.1,3.7,1.3
523,187,0,Latin America,Commercial,Regulatory Affairs,Exceeds,Male,36,12,0,11,15,3.1,2.4,1.7,0.0743,1,1,1,1,2.2,2.7,2.9
524,266,0,Asia Pacific,Commercial,Quality Assurance,Meets,Female,45,10,0,8,22,3.1,1.8,2.2,0.0422,0,0,0,0,2.5,1.6,1.9
525,990,0,Middle East & Africa,Finance,Supply Chain,Exceeds,Male,40,17,0,8,17,4.0,1.9,3.4,0.0588,1,1,1,1,4.9,2.7,2.7
526,524,0,Latin America,Digital,Pharmacovigilance,Meets,Female,43,6,1,8,16,0.0,2.4,2.1,0.0853,0,0,0,0,4.7,3.3,2.4
527,224,0,Middle East & Africa,Commercial,Quality Assurance,Meets,Male,39,12,0,12,18,1.8,3.3,3.9,0.0422,1,1,1,1,2.3,5.0,2.4
528,643,0,North America,Digital,Human Resources,Far Below,Female,43,21,0,7,20,3.9,2.3,1.5,0.0,1,1,1,1,5.0,3.9,2.0
529,167,0,Middle East & Africa,R&D,Medical Affairs,Meets,Female,40,9,0,5,35,2.4,2.7,1.6,0.0977,1,1,1,1,2.9,3.0,1.8
530,261,0,Middle East & Africa,Commercial,Regulatory Affairs,Meets,Female,30,7,0,11,14,2.9,2.8,2.8,0.0422,1,1,1,1,3.1,4.4,1.0
531,99,0,Europe,R&D,Legal & Compliance,Meets,Female,36,5,0,11,35,3.3,3.8,4.7,0.0977,1,1,1,1,2.6,1.0,3.5
532,477,0,Europe,Manufacturing,Finance & Accounting,Meets,Female,36,32,0,5,7,3.3,2.3,3.3,0.0348,1,1,1,1,2.6,2.1,1.8
533,618,0,Europe,Digital,Regulatory Affairs,Meets,Female,41,30,0,5,9,3.2,3.0,3.3,0.0853,1,0,0,0,4.0,2.2,4.2
534,394,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Meets,Male,39,4,0,8,8,3.6,5.0,1.8,0.0348,1,1,0,0,2.2,3.2,3.1
535,318,0,Asia Pacific,Commercial,Legal & Compliance,Exceeds,Male,46,11,0,10,22,2.8,3.0,2.3,0.0743,1,1,1,1,3.7,3.3,2.6
536,96,0,Middle East & Africa,R&D,Human Resources,Meets,Non-Binary/Other,40,7,0,11,25,3.8,3.0,3.1,0.0977,1,1,1,1,3.9,2.6,1.0
537,242,0,Asia Pacific,Commercial,IT & Digital,Meets,Male,41,13,0,8,9,3.1,2.8,1.0,0.0422,1,1,1,1,3.7,2.8,2.1
538,501,0,Asia Pacific,Manufacturing,Marketing,Below,Male,32,15,0,9,12,3.6,3.2,2.5,0.0,1,1,1,1,2.5,3.4,1.7
539,250,0,Europe,Commercial,Supply Chain,Meets,Female,39,8,0,10,37,2.9,3.1,4.1,0.0422,1,1,1,1,2.4,4.1,3.4
540,883,0,Latin America,Finance,IT & Digital,Meets,Non-Binary/Other,37,7,1,7,11,0.0,3.5,3.9,0.0331,1,1,1,1,2.7,4.9,4.1
541,727,0,North America,HR,Marketing,Meets,Female,28,25,0,10,10,2.4,4.5,4.9,0.0383,1,1,1,1,2.1,4.0,3.5
542,397,0,Europe,Manufacturing,Regulatory Affairs,Meets,Female,30,10,0,10,19,3.0,2.7,2.4,0.0348,0,0,0,0,4.6,2.6,2.3
543,240,0,Europe,Commercial,Medical Affairs,Below,Female,42,11,1,5,13,0.0,2.7,1.3,0.0,1,1,1,1,2.8,2.2,1.0
544,18,0,Latin America,R&D,Data Science,Meets,Female,42,11,0,5,21,4.1,4.6,2.3,0.0977,1,1,1,1,3.3,3.9,2.7
545,231,0,North America,Commercial,Human Resources,Far Exceeds,Female,34,17,0,10,12,3.7,2.6,2.8,0.1275,0,0,0,0,4.4,2.0,1.6
546,63,0,Middle East & Africa,R&D,Finance & Accounting,Meets,Female,35,7,0,6,10,2.3,2.9,3.6,0.0977,1,1,1,1,3.8,2.6,3.4
547,814,0,Middle East & Africa,HR,Medical Affairs,Meets,Female,31,23,0,9,14,1.8,3.2,2.9,0.0383,1,1,1,1,1.0,2.8,2.1
548,352,0,Europe,Commercial,Sales,Meets,Male,44,15,0,11,18,4.0,2.6,3.2,0.0422,1,1,1,1,2.3,3.3,1.9
549,759,0,North America,HR,Supply Chain,Meets,Female,33,12,0,12,17,3.8,3.3,2.3,0.0383,1,1,1,1,3.3,1.8,3.2
550,505,0,Europe,Manufacturing,Legal & Compliance,Below,Female,35,24,0,5,19,2.2,2.0,2.4,0.0,1,0,0,0,1.8,2.0,3.3
551,33,0,Asia Pacific,R&D,Pharmacovigilance,Meets,Male,44,4,0,5,7,2.8,1.4,2.0,0.0977,1,1,1,1,3.1,2.3,2.1
552,1042,0,Europe,Finance,Communications,Meets,Male,44,4,1,12,32,0.0,1.8,1.4,0.0331,1,1,1,1,4.7,1.0,1.0
553,466,0,Europe,Manufacturing,Human Resources,Meets,Female,37,8,1,12,18,0.0,4.2,2.2,0.0348,1,1,1,1,2.8,3.2,1.8
554,148,0,Middle East & Africa,R&D,Regulatory Affairs,Below,Male,38,8,0,8,25,2.4,5.0,3.1,0.0,1,1,1,1,3.4,3.3,4.7
555,828,0,Middle East & Africa,HR,Quality Assurance,Meets,Female,41,7,0,6,15,2.8,1.6,3.3,0.0383,1,1,1,1,4.6,2.3,3.5
556,655,0,Middle East & Africa,Digital,Data Science,Meets,Male,36,26,0,11,20,4.0,3.2,3.1,0.0853,1,1,1,1,3.3,3.4,3.9
557,200,0,Asia Pacific,Commercial,Pharmacovigilance,Meets,Female,37,13,0,11,20,3.0,3.8,2.9,0.0422,1,1,1,1,2.6,3.0,3.6
558,804,0,Middle East & Africa,HR,Market Access,Meets,Female,37,28,0,7,26,4.0,2.2,2.3,0.0383,1,1,1,1,3.6,2.9,2.1
559,161,1,North America,R&D,IT & Digital,Meets,Female,42,15,0,6,26,2.7,3.7,4.2,0.0977,1,1,1,1,3.5,3.2,2.6
560,4,0,Latin America,R&D,Medical Affairs,Meets,Male,47,9,0,8,12,3.6,3.7,2.9,0.0977,1,1,1,1,3.7,4.2,2.9
561,111,0,North America,R&D,Communications,Far Below,Male,45,5,0,12,16,3.4,3.2,2.5,0.0,1,1,1,1,2.6,3.4,3.4
562,14,0,North America,R&D,Data Science,Meets,Female,44,10,0,8,34,2.6,4.0,3.5,0.0977,1,1,1,0,3.5,3.6,3.0
563,335,0,Middle East & Africa,Commercial,Market Access,Meets,Female,31,4,0,11,36,2.9,3.0,4.2,0.0422,1,1,1,1,2.4,3.6,3.1
564,458,0,Latin America,Manufacturing,Marketing,Meets,Female,46,17,0,7,15,3.6,4.1,3.5,0.0348,1,1,1,1,4.1,5.0,3.2
565,1049,0,Latin America,Finance,Market Access,Meets,Female,34,14,1,7,22,0.0,3.4,3.5,0.0331,1,1,1,1,3.4,2.5,2.5
566,664,0,Latin America,Digital,Finance & Accounting,Meets,Female,28,12,1,6,12,0.0,3.7,2.4,0.0853,1,1,1,1,4.6,2.8,2.9
567,279,0,Asia Pacific,Commercial,Pharmacovigilance,Meets,Female,33,18,0,6,13,4.0,4.6,4.4,0.0422,1,1,1,1,4.1,4.8,3.8
568,138,0,Middle East & Africa,R&D,Supply Chain,Meets,Female,37,3,1,12,25,0.0,2.8,4.1,0.0977,1,1,1,1,2.7,3.6,3.2
569,334,0,Latin America,Commercial,Medical Affairs,Meets,Female,28,13,1,12,16,0.0,2.5,2.9,0.0422,1,1,1,1,2.9,3.3,3.1
570,791,0,Asia Pacific,HR,Data Science,Meets,Male,42,6,1,8,23,0.0,3.2,2.7,0.0383,1,1,1,1,1.9,1.0,3.3
571,897,0,Europe,Finance,Market Access,Below,Male,43,10,0,10,18,2.0,2.1,3.5,0.0,1,1,1,1,2.1,2.6,3.5
572,71,0,Europe,R&D,Medical Affairs,Exceeds,Female,36,3,1,9,11,0.0,1.3,2.8,0.1648,1,1,1,1,2.7,3.0,1.7
573,596,0,Asia Pacific,Digital,Data Science,Meets,Male,31,2,0,8,12,3.2,1.5,4.6,0.0853,1,1,1,1,5.0,2.0,4.4
574,115,0,Asia Pacific,R&D,IT & Digital,Meets,Female,44,11,0,9,17,3.7,3.9,4.1,0.0977,1,1,1,1,3.4,4.7,2.9
575,898,0,Middle East & Africa,Finance,Data Science,Meets,Female,32,11,0,12,21,2.2,2.6,2.3,0.0331,1,1,1,1,3.2,2.6,2.0
576,673,0,Middle East & Africa,Digital,IT & Digital,Far Below,Male,28,12,0,8,12,3.9,1.5,2.5,0.0,1,1,1,1,3.4,2.6,2.9
577,940,0,Europe,Finance,Legal & Compliance,Meets,Female,38,12,0,6,18,4.0,2.6,1.6,0.0331,1,1,1,1,4.0,3.9,2.0
578,538,0,Latin America,Digital,Finance & Accounting,Meets,Male,38,9,0,10,22,5.0,2.3,4.3,0.0853,1,1,1,1,4.3,3.5,4.2
579,453,0,Europe,Manufacturing,Pharmacovigilance,Below,Female,40,36,0,6,9,4.1,2.1,3.4,0.0,1,1,1,1,2.2,3.1,2.7
580,509,0,Latin America,Manufacturing,Medical Affairs,Exceeds,Male,43,10,0,12,19,4.2,2.7,1.3,0.0616,1,1,1,1,4.5,2.7,2.9
581,212,0,Latin America,Commercial,Pharmacovigilance,Meets,Female,43,10,0,11,25,3.4,4.1,2.3,0.0422,1,1,1,1,2.9,4.5,3.9
582,275,0,Middle East & Africa,Commercial,IT & Digital,Below,Male,30,7,0,6,13,2.5,3.5,1.3,0.0,1,1,1,1,3.5,2.7,2.7
583,676,0,North America,Digital,Communications,Meets,Female,28,7,0,6,11,3.1,2.8,2.9,0.0853,1,1,1,1,3.6,2.3,3.4
584,161,0,North America,R&D,Market Access,Below,Female,41,6,0,5,9,4.2,3.4,2.2,0.0,1,1,1,1,2.4,2.0,3.3
585,842,0,Asia Pacific,HR,Sales,Exceeds,Male,38,10,1,11,22,0.0,3.7,2.4,0.0677,1,0,0,0,4.8,3.9,2.7
586,742,0,Middle East & Africa,HR,Supply Chain,Meets,Female,35,20,0,9,18,3.5,3.5,4.1,0.0383,1,1,1,1,3.8,2.7,3.0
587,163,0,Latin America,R&D,Legal & Compliance,Meets,Female,37,7,1,6,23,0.0,3.5,3.0,0.0977,1,1,1,1,3.3,2.3,3.2
588,37,0,North America,R&D,Sales,Meets,Male,33,5,1,8,10,0.0,2.8,3.0,0.0977,0,0,0,0,3.1,2.1,3.8
589,372,0,Latin America,Manufacturing,Clinical Operations,Meets,Male,48,6,0,11,17,3.1,4.9,2.4,0.0348,1,1,1,1,3.4,5.0,1.4
590,769,0,North America,HR,Regulatory Affairs,Meets,Male,28,3,0,6,23,2.8,3.0,2.7,0.0383,1,1,0,0,2.8,2.7,2.2
591,621,0,North America,Digital,Human Resources,Meets,Male,41,4,0,6,7,5.0,3.5,3.2,0.0853,1,1,1,1,3.8,4.8,3.5
592,882,0,North America,Finance,Communications,Meets,Female,30,10,1,6,9,0.0,2.5,4.3,0.0331,1,1,1,1,3.9,2.8,3.3
593,326,0,Middle East & Africa,Commercial,Sales,Meets,Male,34,11,0,8,12,2.3,3.8,2.9,0.0422,1,1,1,0,3.4,4.8,3.6
594,974,1,Europe,Finance,Marketing,Meets,Female,35,11,0,9,10,2.7,4.1,2.2,0.0331,1,1,1,1,2.9,4.0,2.5
595,438,0,Latin America,Manufacturing,Supply Chain,Far Below,Male,32,19,0,6,17,3.3,3.5,3.0,0.0,1,0,0,0,2.0,3.7,4.9
596,782,0,Middle East & Africa,HR,Regulatory Affairs,Below,Male,37,19,0,6,28,3.8,4.0,2.8,0.0,1,1,1,1,3.7,3.8,2.2
597,28,0,Middle East & Africa,R&D,Market Access,Meets,Male,28,2,0,8,16,3.2,4.1,5.0,0.0977,1,1,1,1,4.3,5.0,5.0
598,812,0,Middle East & Africa,HR,Pharmacovigilance,Meets,Male,29,16,0,12,30,2.0,4.0,2.5,0.0383,1,0,0,0,3.0,3.5,1.0
599,544,0,Middle East & Africa,Digital,Marketing,Exceeds,Female,28,28,1,8,14,0.0,3.0,2.9,0.1452,1,1,1,1,3.5,3.2,2.5
600,507,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Far Below,Male,31,19,1,10,10,0.0,3.7,3.5,0.0,1,1,1,1,1.0,2.8,3.6
601,112,0,Asia Pacific,R&D,Regulatory Affairs,Meets,Female,33,36,0,7,23,3.7,2.8,3.0,0.0977,1,1,1,1,3.1,1.7,4.0
602,939,0,Latin America,Finance,Data Science,Meets,Female,38,12,0,5,10,3.4,3.2,3.8,0.0331,1,1,1,1,2.7,2.5,3.4
603,569,0,Middle East & Africa,Digital,Clinical Operations,Exceeds,Male,34,9,0,7,24,2.7,2.7,2.9,0.1452,1,1,1,1,2.3,2.5,2.1
604,1041,0,Latin America,Finance,Pharmacovigilance,Exceeds,Male,33,16,0,11,25,5.0,1.8,2.4,0.0588,1,1,1,1,3.3,1.5,3.0
605,305,0,Asia Pacific,Commercial,Legal & Compliance,Meets,Male,35,21,0,11,16,3.3,3.8,3.2,0.0422,1,1,1,1,2.6,2.7,4.2
606,418,0,Asia Pacific,Manufacturing,Market Access,Meets,Male,34,8,0,7,24,1.9,2.4,3.1,0.0348,1,1,1,1,2.9,1.3,1.9
607,567,0,Latin America,Digital,Human Resources,Meets,Female,36,8,0,7,15,3.2,3.7,3.4,0.0853,0,0,0,0,3.7,2.7,2.3
608,640,0,North America,Digital,Medical Affairs,Below,Female,36,6,0,5,22,3.7,3.9,2.3,0.0,1,1,1,1,2.5,4.3,2.2
609,991,0,Europe,Finance,Sales,Meets,Female,33,6,0,9,14,2.9,2.9,3.3,0.0331,1,1,1,1,4.7,4.3,2.7
610,174,0,North America,R&D,Supply Chain,Meets,Female,29,6,0,9,25,3.1,4.2,4.1,0.0977,1,1,0,0,4.0,1.7,2.5
611,349,0,North America,Commercial,Clinical Operations,Far Below,Male,38,17,0,11,16,3.8,2.7,1.1,0.0,1,1,1,1,4.8,3.1,2.6
612,887,0,North America,Finance,Data Science,Meets,Male,43,11,0,5,7,3.5,2.7,2.8,0.0331,1,1,1,1,3.1,3.2,2.7
613,552,0,Middle East & Africa,Digital,Legal & Compliance,Below,Non-Binary/Other,32,8,0,7,9,3.8,2.7,1.9,0.0,1,1,1,1,3.0,2.5,1.8
614,409,0,Asia Pacific,Manufacturing,Data Science,Meets,Female,37,5,0,7,16,3.9,2.8,3.6,0.0348,1,1,1,1,3.6,2.3,3.1
615,589,0,North America,Digital,Regulatory Affairs,Exceeds,Male,35,10,0,5,9,2.0,2.8,2.8,0.1452,1,1,1,1,2.6,2.3,2.2
616,843,0,Asia Pacific,HR,Quality Assurance,Meets,Male,41,17,0,8,14,3.8,2.9,2.1,0.0383,1,1,1,1,3.7,2.4,2.4
617,440,0,Latin America,Manufacturing,Sales,Far Below,Male,33,12,0,8,10,3.8,5.0,2.2,0.0,1,1,1,1,3.9,5.0,3.4
618,477,0,Europe,Manufacturing,Clinical Operations,Far Below,Female,37,23,0,6,10,3.5,2.2,4.5,0.0,1,1,1,1,4.4,3.6,1.8
619,574,0,Latin America,Digital,IT & Digital,Meets,Female,37,5,0,5,6,3.6,4.3,2.6,0.0853,1,1,1,1,3.9,4.5,3.8
620,111,0,Latin America,R&D,Regulatory Affairs,Meets,Male,40,11,1,12,49,0.0,3.0,2.8,0.0977,1,1,1,1,3.0,2.7,2.2
621,423,0,Middle East & Africa,Manufacturing,Clinical Operations,Meets,Male,31,12,1,10,22,0.0,2.8,3.1,0.0348,1,1,1,1,4.9,2.4,2.2
622,818,0,Europe,HR,Communications,Below,Male,40,20,0,6,14,3.8,3.7,1.8,0.0,1,1,1,1,4.3,3.8,2.1
623,893,0,Latin America,Finance,Marketing,Meets,Male,35,2,0,12,18,3.9,3.6,3.7,0.0331,1,1,1,1,4.1,3.5,3.4
624,150,0,Latin America,R&D,Pharmacovigilance,Exceeds,Female,41,18,0,12,33,4.5,2.4,1.6,0.1648,1,1,1,1,3.3,3.7,1.8
625,14,0,Europe,R&D,Human Resources,Exceeds,Female,36,9,0,8,25,4.0,4.6,3.5,0.1648,1,1,1,1,3.3,3.5,3.7
626,30,0,Europe,R&D,Supply Chain,Meets,Male,46,7,1,6,18,0.0,2.1,2.1,0.0977,1,1,1,1,2.8,2.4,1.6
627,492,0,Latin America,Manufacturing,Sales,Meets,Female,28,1,1,6,15,0.0,3.4,2.7,0.0348,1,1,1,1,1.0,4.1,1.7
628,156,1,Europe,R&D,IT & Digital,Meets,Male,41,13,0,6,11,1.0,2.3,3.8,0.0977,1,1,1,1,2.8,3.0,3.9
629,673,0,Latin America,Digital,Finance & Accounting,Meets,Female,40,8,1,12,27,0.0,2.3,2.0,0.0853,0,0,0,0,3.4,1.3,2.5
630,53,0,Latin America,R&D,Data Science,Below,Female,41,20,0,7,16,3.5,4.1,2.5,0.0,1,1,1,1,2.8,4.7,3.0
631,705,0,Middle East & Africa,HR,IT & Digital,Meets,Male,44,8,0,5,18,3.6,2.9,2.2,0.0383,1,1,1,1,2.8,4.7,3.6
632,186,0,North America,Commercial,IT & Digital,Meets,Female,28,7,1,9,26,0.0,3.8,3.1,0.0422,1,1,1,1,3.3,4.1,4.2
633,823,0,Latin America,HR,Quality Assurance,Exceeds,Male,51,11,0,5,10,3.5,2.4,1.6,0.0677,1,1,1,1,3.7,3.2,1.9
634,490,0,Asia Pacific,Manufacturing,Market Access,Meets,Male,41,6,0,11,23,3.4,1.5,2.2,0.0348,1,1,1,1,3.3,3.3,2.2
635,42,0,North America,R&D,Medical Affairs,Meets,Male,50,7,1,5,23,0.0,3.6,3.0,0.0977,1,1,1,1,3.5,4.0,2.4
636,19,0,North America,R&D,Pharmacovigilance,Exceeds,Male,49,11,0,7,13,2.1,3.6,4.7,0.1648,1,1,1,1,2.3,4.2,4.1
637,609,0,North America,Digital,Sales,Meets,Female,41,20,0,7,16,3.2,2.7,3.0,0.0853,0,0,0,0,3.4,2.5,3.3
638,892,1,Middle East & Africa,Finance,Legal & Compliance,Far Exceeds,Male,40,16,0,10,17,2.8,3.5,2.6,0.1022,1,1,1,1,4.6,1.0,4.8
639,114,0,Latin America,R&D,Marketing,Meets,Female,42,16,0,6,24,2.9,2.7,2.5,0.0977,1,1,1,1,4.6,3.1,2.2
640,877,0,Middle East & Africa,HR,Sales,Far Exceeds,Female,28,13,1,7,12,0.0,4.5,4.7,0.1168,1,1,1,1,2.3,3.0,2.7
641,395,0,Latin America,Manufacturing,Market Access,Below,Male,37,36,0,6,18,3.1,4.2,3.6,0.0,1,1,1,1,3.4,3.2,1.0
642,289,0,Middle East & Africa,Commercial,IT & Digital,Meets,Male,44,7,0,7,35,3.5,2.6,1.6,0.0422,1,1,1,1,3.5,4.4,1.9
643,7,0,Middle East & Africa,R&D,Human Resources,Meets,Male,47,10,0,7,15,2.1,3.0,1.0,0.0977,1,1,1,1,3.2,2.6,2.3
644,350,1,Asia Pacific,Commercial,Supply Chain,Exceeds,Male,36,5,1,8,22,0.0,4.8,1.5,0.0743,1,1,1,1,4.2,3.6,2.7
645,81,0,Middle East & Africa,R&D,Supply Chain,Far Below,Male,40,17,0,11,19,2.1,3.5,2.9,0.0,1,1,1,1,4.3,4.3,1.8
646,506,0,Europe,Manufacturing,Clinical Operations,Far Below,Female,41,8,1,11,20,0.0,3.4,2.8,0.0,1,1,1,1,3.1,3.7,2.3
647,937,0,Asia Pacific,Finance,Regulatory Affairs,Meets,Male,38,20,0,6,12,2.6,3.7,2.9,0.0331,1,1,1,1,3.5,3.2,3.1
648,804,0,Middle East & Africa,HR,Supply Chain,Exceeds,Female,32,10,0,7,19,4.2,4.5,4.4,0.0677,1,1,1,1,4.8,3.1,2.8
649,401,0,North America,Manufacturing,Quality Assurance,Meets,Male,34,4,0,10,23,2.6,2.5,2.9,0.0348,1,1,1,1,4.2,2.9,2.8
650,351,0,Europe,Commercial,Medical Affairs,Meets,Male,32,16,0,9,13,2.4,4.0,2.8,0.0422,1,1,1,1,3.9,3.4,3.9
651,164,0,Europe,R&D,Marketing,Far Below,Male,29,8,1,9,25,0.0,3.1,2.5,0.0,1,1,1,1,4.4,2.5,1.3
652,283,0,Europe,Commercial,Human Resources,Meets,Male,37,11,0,11,15,3.6,4.0,3.0,0.0422,1,1,1,1,3.6,3.2,2.9
653,835,0,Asia Pacific,HR,IT & Digital,Meets,Male,51,15,0,10,30,4.1,2.6,3.4,0.0383,1,1,1,1,3.5,3.3,3.7
654,480,0,Middle East & Africa,Manufacturing,Market Access,Meets,Female,39,19,0,5,16,3.8,4.1,2.8,0.0348,1,1,1,1,3.8,2.4,3.5
655,280,0,Middle East & Africa,Commercial,Data Science,Meets,Female,36,4,1,11,14,0.0,2.1,1.5,0.0422,0,0,0,0,3.9,2.4,1.6
656,340,0,North America,Commercial,Supply Chain,Meets,Male,40,4,1,7,18,0.0,1.6,1.7,0.0422,1,1,1,1,1.9,2.9,2.6
657,781,0,North America,HR,Human Resources,Exceeds,Female,33,11,1,6,13,0.0,3.6,3.3,0.0677,1,0,0,0,2.8,2.8,2.9
658,84,0,Europe,R&D,Data Science,Meets,Male,28,20,0,8,35,4.1,4.0,1.8,0.0977,1,1,1,1,3.2,4.1,2.5
659,296,0,North America,Commercial,Human Resources,Meets,Male,34,11,1,5,7,0.0,3.3,2.4,0.0422,1,1,1,1,3.1,3.8,1.3
660,818,0,Asia Pacific,HR,Supply Chain,Meets,Female,31,5,0,12,31,3.4,4.9,1.0,0.0383,1,1,0,0,3.1,3.2,1.0
661,92,0,Middle East & Africa,R&D,IT & Digital,Meets,Female,28,8,0,7,11,3.0,2.8,3.6,0.0977,1,1,1,0,3.4,3.8,2.7
662,935,0,Europe,Finance,Human Resources,Exceeds,Female,35,5,0,11,27,4.6,4.3,2.1,0.0588,1,1,1,1,4.3,3.2,2.6
663,10,0,North America,R&D,IT & Digital,Below,Male,41,13,0,11,19,4.4,2.2,1.0,0.0,0,0,0,0,4.5,2.2,2.3
664,999,0,Asia Pacific,Finance,Human Resources,Exceeds,Non-Binary/Other,40,13,0,11,19,1.6,3.3,3.4,0.0588,0,0,0,0,3.4,2.3,4.1
665,382,0,Asia Pacific,Manufacturing,Quality Assurance,Below,Female,40,9,0,9,12,3.7,4.1,1.3,0.0,1,1,1,1,5.0,3.7,1.0
666,858,0,North America,HR,Data Science,Below,Female,48,15,0,8,22,3.1,4.4,1.5,0.0,0,0,0,0,3.1,4.6,2.1
667,112,0,Middle East & Africa,R&D,Regulatory Affairs,Meets,Female,35,9,1,11,42,0.0,2.5,3.5,0.0977,1,1,1,1,3.3,3.5,3.0
668,1009,0,North America,Finance,IT & Digital,Far Exceeds,Female,41,18,0,8,21,4.6,1.8,2.1,0.1022,1,1,1,1,4.6,4.1,1.9
669,1041,0,Europe,Finance,Marketing,Far Exceeds,Female,36,18,0,8,21,2.5,3.2,4.5,0.1022,1,1,1,1,2.1,3.9,2.7
670,462,0,North America,Manufacturing,Medical Affairs,Meets,Female,47,9,1,11,18,0.0,3.9,1.3,0.0348,0,0,0,0,4.5,3.4,1.0
671,650,0,Asia Pacific,Digital,Quality Assurance,Below,Male,33,5,1,6,20,0.0,1.8,4.3,0.0,1,1,1,1,3.1,1.4,3.5
672,802,0,North America,HR,Finance & Accounting,Meets,Female,42,15,0,8,18,2.2,3.9,1.7,0.0383,1,1,1,1,3.0,4.0,3.4
673,641,0,Middle East & Africa,Digital,Communications,Meets,Male,39,20,0,5,16,3.3,5.0,2.4,0.0853,1,1,1,1,3.0,5.0,2.8
674,26,0,Latin America,R&D,Legal & Compliance,Meets,Non-Binary/Other,45,16,0,12,17,1.9,1.6,1.7,0.0977,0,0,0,0,2.4,1.9,2.9
675,786,0,North America,HR,Regulatory Affairs,Meets,Female,38,10,0,10,18,5.0,1.0,3.8,0.0383,1,1,1,1,4.7,1.8,3.2
676,491,0,Middle East & Africa,Manufacturing,Medical Affairs,Meets,Female,37,3,1,5,24,0.0,1.5,4.2,0.0348,1,1,1,1,3.9,2.7,2.9
677,119,0,Middle East & Africa,R&D,Regulatory Affairs,Meets,Male,36,5,1,7,22,0.0,4.5,2.3,0.0977,1,1,1,1,4.1,3.5,2.7
678,732,0,Asia Pacific,HR,Legal & Compliance,Meets,Female,37,23,0,12,13,3.1,2.6,2.4,0.0383,1,1,1,1,3.2,2.8,2.6
679,818,0,Middle East & Africa,HR,Regulatory Affairs,Exceeds,Male,28,12,0,7,16,2.5,2.4,1.2,0.0677,1,1,1,1,3.6,1.8,1.0
680,565,0,Middle East & Africa,Digital,Regulatory Affairs,Below,Female,35,9,0,10,19,3.5,2.5,3.9,0.0,1,1,1,1,4.2,4.6,2.7
681,44,0,Middle East & Africa,R&D,Clinical Operations,Below,Female,35,10,1,10,15,0.0,3.6,1.7,0.0,1,1,1,1,2.1,3.8,1.0
682,374,0,Middle East & Africa,Manufacturing,Medical Affairs,Meets,Male,31,11,0,6,25,1.9,4.2,1.4,0.0348,1,1,1,1,1.8,4.7,2.9
683,441,0,Europe,Manufacturing,Regulatory Affairs,Meets,Male,35,11,0,8,24,3.5,4.2,2.7,0.0348,1,1,1,1,3.0,4.7,3.3
684,27,0,Europe,R&D,Pharmacovigilance,Far Below,Female,33,10,0,10,22,4.6,4.0,2.2,0.0,1,1,1,1,4.7,4.5,3.2
685,78,0,Asia Pacific,R&D,Pharmacovigilance,Exceeds,Male,35,9,0,10,22,2.5,2.9,2.0,0.1648,1,1,1,1,3.4,3.6,1.4
686,974,0,North America,Finance,Human Resources,Meets,Male,42,14,0,5,24,2.6,3.0,2.5,0.0331,0,0,0,0,3.0,2.5,2.3
687,240,0,Middle East & Africa,Commercial,Human Resources,Meets,Male,42,24,0,12,15,2.9,2.1,2.0,0.0422,1,1,1,1,3.4,2.9,1.9
688,665,0,North America,Digital,Supply Chain,Meets,Male,47,9,0,10,17,2.8,4.5,2.9,0.0853,1,1,1,1,2.1,2.5,3.2
689,92,0,North America,R&D,Marketing,Meets,Female,40,16,0,5,17,3.0,3.6,3.9,0.0977,1,1,1,1,3.2,2.5,2.9
690,134,1,Asia Pacific,R&D,IT & Digital,Far Exceeds,Female,29,7,0,10,17,3.6,3.2,1.0,0.2644,1,1,1,1,4.8,3.3,2.5
691,214,0,Middle East & Africa,Commercial,Data Science,Below,Female,36,6,0,6,14,3.0,2.0,3.0,0.0,1,1,1,1,3.4,2.6,2.0
692,277,0,Middle East & Africa,Commercial,Legal & Compliance,Meets,Male,34,5,1,9,15,0.0,1.0,4.0,0.0422,1,1,1,1,2.3,2.2,4.0
693,784,0,Latin America,HR,IT & Digital,Meets,Female,32,13,1,11,16,0.0,1.9,3.0,0.0383,1,1,1,1,3.4,1.4,3.9
694,369,0,North America,Manufacturing,Legal & Compliance,Meets,Female,44,21,1,10,21,0.0,3.6,3.9,0.0348,1,1,1,1,2.9,3.3,5.0
695,624,0,North America,Digital,Communications,Meets,Female,41,9,0,11,29,2.6,2.5,3.4,0.0853,1,1,1,1,2.8,3.3,3.4
696,784,0,Europe,HR,Supply Chain,Exceeds,Male,38,15,0,5,26,3.7,4.5,3.0,0.0677,1,1,1,1,3.7,4.2,2.4
697,37,0,Latin America,R&D,Clinical Operations,Meets,Male,29,6,0,8,33,4.1,1.9,1.3,0.0977,1,1,1,1,3.3,2.3,4.1
698,277,0,Europe,Commercial,Pharmacovigilance,Meets,Female,38,1,1,12,30,0.0,3.1,1.2,0.0422,1,1,1,1,2.8,2.4,3.6
699,883,0,Europe,Finance,Medical Affairs,Meets,Male,52,3,1,11,22,0.0,3.4,1.6,0.0331,1,1,1,1,3.7,5.0,2.2
700,387,0,Europe,Manufacturing,Marketing,Exceeds,Female,33,11,0,9,14,4.5,1.1,3.7,0.0616,1,1,1,1,3.8,1.7,5.0
701,869,0,Asia Pacific,HR,Marketing,Meets,Female,37,12,0,11,16,4.2,4.0,2.5,0.0383,0,0,0,0,2.8,3.6,4.0
702,1003,0,Asia Pacific,Finance,Human Resources,Meets,Male,46,11,1,10,35,0.0,2.8,2.9,0.0331,1,1,1,1,3.2,4.5,4.1
703,447,0,Europe,Manufacturing,Data Science,Meets,Female,35,10,1,8,18,0.0,1.0,3.0,0.0348,1,1,1,0,3.6,1.8,3.9
704,883,0,Latin America,Finance,Medical Affairs,Below,Female,35,12,0,12,14,4.1,2.8,2.4,0.0,1,1,1,1,2.3,2.9,1.3
705,255,0,North America,Commercial,Finance & Accounting,Below,Male,37,8,0,12,27,3.5,4.1,2.6,0.0,0,0,0,0,3.6,3.7,2.7
706,706,0,Latin America,HR,Human Resources,Far Exceeds,Male,40,16,0,11,24,4.1,2.2,3.8,0.1168,1,1,1,1,3.2,3.3,3.7
707,794,0,Middle East & Africa,HR,Market Access,Meets,Male,32,12,0,11,13,3.0,1.6,2.3,0.0383,1,1,1,1,3.4,2.4,3.2
708,469,0,Asia Pacific,Manufacturing,Data Science,Below,Male,44,19,0,8,11,2.9,1.6,3.0,0.0,1,1,1,1,2.6,2.3,2.4
709,1046,0,North America,Finance,Finance & Accounting,Exceeds,Male,36,20,0,10,14,1.8,2.7,2.0,0.0588,1,1,1,1,2.7,3.5,2.0
710,330,0,North America,Commercial,Marketing,Meets,Male,39,13,0,5,8,4.6,3.8,2.6,0.0422,1,1,1,1,4.6,5.0,3.0
711,148,0,Middle East & Africa,R&D,Clinical Operations,Meets,Male,35,19,0,8,16,4.4,3.4,3.8,0.0977,1,1,1,1,4.1,3.7,1.5
712,810,0,Middle East & Africa,HR,Quality Assurance,Below,Female,30,4,1,6,16,0.0,1.2,2.7,0.0,1,1,1,1,1.8,3.5,1.5
713,73,0,Europe,R&D,Quality Assurance,Exceeds,Male,28,6,0,5,11,3.4,2.5,2.1,0.1648,1,1,1,1,4.0,3.5,2.1
714,180,0,Asia Pacific,Commercial,Pharmacovigilance,Meets,Male,39,6,1,8,11,0.0,3.7,3.8,0.0422,1,1,1,1,4.1,3.1,2.7
715,804,0,Asia Pacific,HR,Marketing,Meets,Male,28,18,0,6,13,3.8,2.0,4.0,0.0383,0,0,0,0,3.4,1.7,5.0
716,753,0,Latin America,HR,Clinical Operations,Far Below,Male,43,8,1,9,19,0.0,2.7,5.0,0.0,1,1,1,1,2.1,2.7,5.0
717,904,0,Europe,Finance,Data Science,Meets,Non-Binary/Other,39,27,0,6,16,2.9,1.6,3.0,0.0331,1,1,1,1,2.6,2.6,1.9
718,19,0,Europe,R&D,Communications,Meets,Female,50,7,0,10,35,3.0,3.0,1.8,0.0977,1,1,1,1,3.7,3.3,1.2
719,978,0,Europe,Finance,Clinical Operations,Exceeds,Female,34,13,0,11,26,3.3,3.3,2.0,0.0588,0,0,0,0,3.1,1.0,3.0
720,630,0,Europe,Digital,Communications,Below,Female,48,7,0,12,33,3.0,4.7,2.4,0.0,1,1,1,1,3.1,5.0,3.9
721,21,0,Asia Pacific,R&D,Finance & Accounting,Meets,Female,36,5,0,5,7,4.9,3.2,3.3,0.0977,1,1,1,1,4.3,2.9,3.4
722,130,0,Asia Pacific,R&D,Communications,Far Below,Non-Binary/Other,44,2,1,8,18,0.0,3.4,1.8,0.0,1,1,1,1,4.2,4.2,1.0
723,553,0,Europe,Digital,Sales,Below,Male,41,4,1,5,11,0.0,3.3,3.3,0.0,1,1,1,1,3.0,4.5,2.9
724,198,0,Latin America,Commercial,Data Science,Meets,Female,28,13,0,12,15,3.0,2.6,1.6,0.0422,1,1,1,1,4.0,4.6,2.2
725,219,0,North America,Commercial,Legal & Compliance,Meets,Female,55,10,0,10,37,2.3,3.2,2.5,0.0422,0,0,0,0,3.3,3.3,3.4
726,865,0,North America,HR,Regulatory Affairs,Meets,Non-Binary/Other,48,16,1,10,18,0.0,4.8,1.8,0.0383,1,1,1,1,4.9,3.9,3.5
727,488,0,Latin America,Manufacturing,Data Science,Far Exceeds,Male,40,16,0,8,15,1.8,2.7,2.1,0.1069,1,1,1,1,1.8,3.4,2.7
728,900,0,Europe,Finance,Pharmacovigilance,Exceeds,Female,46,1,0,11,15,3.6,2.0,3.9,0.0588,1,1,1,1,3.6,2.8,2.4
729,461,0,Asia Pacific,Manufacturing,Human Resources,Below,Male,40,17,0,8,13,2.2,3.6,1.2,0.0,1,1,1,1,4.1,2.4,2.0
730,872,0,North America,HR,Quality Assurance,Exceeds,Female,43,8,1,12,19,0.0,1.9,3.4,0.0677,1,1,1,1,3.8,1.6,2.3
731,473,0,Middle East & Africa,Manufacturing,Finance & Accounting,Meets,Female,39,2,0,7,11,4.2,3.9,2.9,0.0348,1,1,1,0,3.7,2.4,3.2
732,119,0,Middle East & Africa,R&D,Data Science,Exceeds,Female,32,12,0,9,14,3.8,1.9,2.8,0.1648,1,1,1,1,3.2,1.7,2.2
733,35,0,Latin America,R&D,Human Resources,Below,Female,37,3,0,8,11,2.7,4.7,3.3,0.0,1,1,1,1,3.7,3.8,2.8
734,598,0,Europe,Digital,Regulatory Affairs,Exceeds,Female,35,6,1,10,18,0.0,3.4,2.7,0.1452,1,0,0,0,3.3,3.5,3.2
735,619,0,North America,Digital,Sales,Below,Female,42,23,0,10,17,3.2,2.6,1.7,0.0,1,1,1,1,2.9,2.4,2.3
736,717,0,Europe,HR,IT & Digital,Meets,Female,32,8,1,7,9,0.0,3.6,5.0,0.0383,1,0,0,0,3.7,4.3,4.9
737,702,0,North America,HR,IT & Digital,Far Below,Male,39,18,0,6,8,2.6,3.6,1.7,0.0,1,1,1,1,4.4,2.5,1.4
738,773,0,Latin America,HR,Finance & Accounting,Below,Male,30,9,0,11,16,2.9,3.5,4.0,0.0,1,1,1,1,3.1,4.4,2.0
739,48,0,Latin America,R&D,IT & Digital,Meets,Male,43,23,0,5,18,3.8,3.1,1.5,0.0977,1,1,1,0,3.9,3.8,2.5
740,478,0,Middle East & Africa,Manufacturing,Clinical Operations,Exceeds,Male,31,6,0,8,15,5.0,2.8,5.0,0.0616,1,1,0,0,4.1,3.0,3.6
741,994,0,Europe,Finance,Medical Affairs,Meets,Non-Binary/Other,42,7,0,5,9,3.4,4.4,1.5,0.0331,1,1,1,1,3.2,3.5,2.0
742,732,0,Middle East & Africa,HR,Quality Assurance,Meets,Male,39,14,0,11,26,2.8,2.9,2.2,0.0383,1,1,1,1,3.5,3.4,2.2
743,738,0,Europe,HR,Clinical Operations,Below,Female,44,13,0,12,15,4.3,2.7,1.0,0.0,1,1,1,1,4.1,2.8,3.0
744,145,0,Middle East & Africa,R&D,Sales,Meets,Male,37,18,0,11,16,4.2,3.5,2.1,0.0977,1,1,1,1,3.2,2.0,1.9
745,1039,0,Asia Pacific,Finance,IT & Digital,Exceeds,Male,43,7,1,10,24,0.0,3.4,3.0,0.0588,1,1,1,1,4.1,3.8,2.8
746,31,0,Asia Pacific,R&D,Medical Affairs,Below,Male,39,11,1,12,38,0.0,2.1,2.4,0.0,0,0,0,0,3.1,3.8,1.4
747,966,0,Asia Pacific,Finance,Marketing,Meets,Male,41,2,0,5,12,4.9,4.6,4.0,0.0331,0,0,0,0,5.0,4.4,2.3
748,155,0,Asia Pacific,R&D,Supply Chain,Below,Male,28,11,0,10,14,1.2,1.8,2.7,0.0,1,1,1,1,3.7,2.8,3.1
749,476,0,North America,Manufacturing,Pharmacovigilance,Meets,Female,34,9,0,12,17,3.2,1.8,3.1,0.0348,1,1,1,1,2.4,2.9,2.4
750,715,0,Asia Pacific,HR,Clinical Operations,Below,Female,37,8,1,7,27,0.0,4.8,2.7,0.0,1,1,1,1,3.3,2.8,3.1
751,247,0,Latin America,Commercial,Human Resources,Below,Female,46,12,0,10,16,3.7,3.0,2.0,0.0,1,1,1,1,3.5,3.8,2.7
752,283,0,Latin America,Commercial,Market Access,Below,Female,40,13,0,8,20,3.6,3.3,4.8,0.0,1,1,1,1,3.7,3.3,3.2
753,824,0,North America,HR,Medical Affairs,Meets,Female,28,7,0,10,15,3.6,2.6,3.1,0.0383,1,0,0,0,4.7,3.1,2.6
754,853,0,Asia Pacific,HR,Marketing,Meets,Female,41,10,0,8,28,2.9,2.8,2.6,0.0383,0,0,0,0,1.7,1.7,2.5
755,747,0,Asia Pacific,HR,Market Access,Meets,Male,33,2,0,11,22,3.6,4.1,1.4,0.0383,1,1,1,1,3.0,2.6,2.8
756,702,0,Asia Pacific,HR,Supply Chain,Below,Male,33,5,0,7,11,3.7,3.7,3.4,0.0,1,1,1,1,4.5,3.4,2.4
757,1027,0,Middle East & Africa,Finance,Supply Chain,Below,Male,38,8,1,11,28,0.0,3.6,2.5,0.0,1,1,1,1,2.1,5.0,3.5
758,382,0,Europe,Manufacturing,Quality Assurance,Below,Male,40,13,0,5,16,2.4,2.0,3.3,0.0,1,1,1,1,2.6,2.1,1.9
759,294,0,Middle East & Africa,Commercial,Legal & Compliance,Exceeds,Female,33,11,0,11,13,4.6,2.9,2.7,0.0743,1,1,1,1,4.4,2.7,2.3
760,540,0,Europe,Digital,Market Access,Meets,Female,28,17,0,9,10,4.0,3.8,3.9,0.0853,1,1,1,1,3.6,2.6,3.0
761,333,0,Asia Pacific,Commercial,Quality Assurance,Meets,Female,37,9,0,8,10,1.0,1.2,4.4,0.0422,1,1,1,1,2.6,3.3,3.6
762,286,0,Asia Pacific,Commercial,Quality Assurance,Meets,Female,37,13,0,12,27,2.3,2.3,2.4,0.0422,1,1,1,1,3.7,2.0,2.1
763,163,0,Middle East & Africa,R&D,Quality Assurance,Meets,Male,47,13,0,8,9,2.9,3.8,3.0,0.0977,1,1,1,1,3.8,4.6,2.7
764,718,0,Middle East & Africa,HR,IT & Digital,Far Below,Male,38,7,1,12,19,0.0,2.1,1.5,0.0,1,1,1,1,3.4,3.3,1.5
765,856,0,Europe,HR,Communications,Meets,Female,45,16,0,7,31,1.6,2.5,2.1,0.0383,1,1,1,1,3.5,3.6,2.7
766,731,0,Latin America,HR,Quality Assurance,Meets,Male,51,10,0,6,12,2.2,4.1,2.1,0.0383,1,1,1,1,4.2,4.4,3.9
767,148,0,Europe,R&D,Marketing,Exceeds,Female,31,5,1,12,23,0.0,3.6,2.6,0.1648,1,1,1,1,2.6,2.2,2.7
768,435,0,Middle East & Africa,Manufacturing,Pharmacovigilance,Exceeds,Male,47,6,0,10,24,3.4,3.8,1.6,0.0616,1,1,1,0,2.9,2.2,1.5
769,393,0,Middle East & Africa,Manufacturing,Data Science,Meets,Female,44,14,0,8,21,2.7,3.5,2.4,0.0348,1,1,1,1,3.6,2.0,1.6
770,676,1,North America,Digital,Marketing,Meets,Female,28,8,0,9,20,3.6,3.6,2.3,0.0853,1,1,1,0,4.8,4.6,1.9
771,454,0,Middle East & Africa,Manufacturing,Sales,Below,Female,37,20,0,7,13,2.8,3.2,5.0,0.0,1,1,1,1,3.6,1.0,4.2
772,367,0,North America,Manufacturing,Communications,Meets,Female,42,23,0,9,19,2.0,1.9,2.0,0.0348,1,1,1,1,2.8,2.5,3.1
773,731,0,Latin America,HR,Communications,Exceeds,Male,40,15,0,8,14,3.6,2.7,4.6,0.0677,1,1,1,1,3.8,5.0,3.4
774,925,0,Europe,Finance,Quality Assurance,Below,Male,48,6,0,5,9,3.9,2.9,1.9,0.0,1,1,1,1,3.9,2.3,1.8
775,283,0,Europe,Commercial,Medical Affairs,Far Exceeds,Male,42,23,0,7,14,4.1,1.6,3.0,0.1275,1,1,1,1,3.8,2.9,3.6
776,408,0,North America,Manufacturing,Medical Affairs,Meets,Male,29,10,0,9,28,2.2,2.6,2.9,0.0348,1,1,1,0,2.6,2.2,2.2
777,480,0,Europe,Manufacturing,Finance & Accounting,Meets,Male,43,11,0,12,50,3.8,2.7,3.9,0.0348,1,1,1,1,4.5,2.1,3.8
778,34,0,Middle East & Africa,R&D,Communications,Below,Female,31,20,0,10,21,3.6,4.5,3.8,0.0,1,1,1,1,3.6,3.9,2.4
779,630,0,Asia Pacific,Digital,Market Access,Meets,Male,35,20,0,7,22,4.9,1.4,4.5,0.0853,1,1,1,1,4.1,1.8,3.5
780,967,0,North America,Finance,Human Resources,Meets,Female,45,8,1,9,29,0.0,3.2,2.9,0.0331,1,1,1,1,3.0,1.8,2.3
781,86,1,Europe,R&D,Market Access,Meets,Female,44,10,0,7,21,3.4,3.4,3.7,0.0977,1,1,1,1,3.7,2.2,3.5
782,777,0,North America,HR,Finance & Accounting,Meets,Female,38,21,0,8,15,3.3,3.8,2.0,0.0383,0,0,0,0,2.9,3.6,2.8
783,338,0,North America,Commercial,Sales,Below,Female,34,11,0,7,26,1.9,4.1,2.0,0.0,1,1,1,1,2.3,3.6,3.1
784,541,0,Asia Pacific,Digital,Human Resources,Meets,Female,37,20,0,12,35,4.5,2.0,3.4,0.0853,1,1,1,1,4.7,2.5,2.0
785,35,0,Middle East & Africa,R&D,Finance & Accounting,Meets,Female,37,5,1,7,26,0.0,2.7,3.2,0.0977,1,1,1,1,3.1,3.1,1.7
786,392,0,North America,Manufacturing,Finance & Accounting,Meets,Female,35,17,0,6,17,2.6,3.7,4.1,0.0348,1,1,1,1,3.7,3.6,3.3
787,361,0,Europe,Manufacturing,Communications,Meets,Female,45,8,0,12,19,3.1,2.7,2.6,0.0348,1,1,1,1,4.1,1.9,4.4
788,585,0,Latin America,Digital,Marketing,Meets,Male,36,10,1,10,11,0.0,3.2,2.8,0.0853,1,1,1,1,2.4,1.9,1.2
789,381,0,North America,Manufacturing,Communications,Meets,Male,36,9,0,11,33,3.8,4.2,1.5,0.0348,0,0,0,0,3.5,4.9,3.4
790,142,0,North America,R&D,Human Resources,Meets,Female,37,18,1,5,10,0.0,4.0,4.0,0.0977,1,1,1,1,4.6,3.9,3.5
791,170,0,Asia Pacific,R&D,Medical Affairs,Meets,Male,42,7,0,9,25,1.6,3.6,2.6,0.0977,1,1,1,1,2.6,3.4,1.7
792,473,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Far Below,Non-Binary/Other,40,5,1,8,19,0.0,4.3,1.0,0.0,1,1,1,1,3.0,2.6,1.6
793,371,0,Latin America,Manufacturing,IT & Digital,Below,Female,39,3,1,7,7,0.0,2.4,4.4,0.0,1,1,1,1,3.4,2.1,4.1
794,866,0,Europe,HR,IT & Digital,Meets,Male,32,17,0,6,18,2.7,2.9,4.0,0.0383,1,1,1,1,4.4,1.7,1.8
795,316,0,Latin America,Commercial,Legal & Compliance,Meets,Male,39,18,1,7,19,0.0,3.2,2.6,0.0422,1,1,1,1,3.0,4.6,2.5
796,537,0,Europe,Digital,Regulatory Affairs,Below,Male,42,14,0,11,18,3.6,2.2,2.8,0.0,1,1,1,1,3.3,3.6,2.7
797,69,0,Middle East & Africa,R&D,IT & Digital,Below,Male,36,4,1,8,10,0.0,4.3,4.8,0.0,1,1,0,0,3.1,3.5,5.0
798,535,0,Europe,Digital,Data Science,Meets,Male,39,4,0,8,25,2.2,3.7,3.8,0.0853,1,1,1,1,3.0,3.0,3.5
799,775,0,Asia Pacific,HR,Regulatory Affairs,Far Below,Non-Binary/Other,44,8,0,7,24,3.8,3.5,2.9,0.0,1,1,1,1,3.3,4.9,3.1
800,8,0,Asia Pacific,R&D,Clinical Operations,Meets,Male,33,30,0,12,23,3.0,1.8,2.2,0.0977,1,1,1,1,4.0,1.1,2.9
801,801,0,Asia Pacific,HR,Legal & Compliance,Meets,Female,33,25,0,5,9,4.3,2.0,3.7,0.0383,1,1,1,1,4.7,1.4,3.0
802,856,0,Asia Pacific,HR,Quality Assurance,Exceeds,Male,37,16,0,9,21,3.8,2.1,2.8,0.0677,1,1,1,1,3.1,2.8,3.7
803,985,0,Latin America,Finance,IT & Digital,Far Below,Female,43,9,0,11,13,3.6,1.0,2.7,0.0,1,1,1,1,3.2,2.5,2.8
804,416,0,Middle East & Africa,Manufacturing,Sales,Meets,Female,28,4,1,8,25,0.0,3.2,2.6,0.0348,1,1,1,1,3.9,2.7,2.1
805,977,0,Europe,Finance,Market Access,Meets,Female,37,9,0,12,16,2.8,1.0,5.0,0.0331,1,1,1,1,2.7,3.1,5.0
806,577,0,Europe,Digital,Clinical Operations,Meets,Female,34,10,0,5,14,2.9,2.9,3.5,0.0853,1,1,1,1,3.9,4.0,4.8
807,627,0,Asia Pacific,Digital,Finance & Accounting,Meets,Female,40,5,1,10,14,0.0,4.4,1.6,0.0853,1,1,1,1,3.5,4.7,1.8
808,356,0,Asia Pacific,Manufacturing,Pharmacovigilance,Meets,Male,37,14,1,9,13,0.0,3.3,1.9,0.0348,1,1,1,1,3.4,3.2,2.6
809,1041,0,North America,Finance,Quality Assurance,Meets,Male,45,6,0,7,11,2.7,2.5,3.5,0.0331,1,1,1,1,2.9,5.0,4.3
810,546,0,Middle East & Africa,Digital,Medical Affairs,Far Below,Male,42,13,0,7,21,2.7,2.9,1.3,0.0,1,0,0,0,3.6,2.8,1.4
811,891,0,Latin America,Finance,Quality Assurance,Meets,Female,37,9,0,5,8,2.2,4.0,3.1,0.0331,1,1,1,1,1.0,4.1,3.4
812,510,0,Europe,Manufacturing,Finance & Accounting,Meets,Male,32,5,1,12,23,0.0,3.3,1.8,0.0348,1,1,1,1,5.0,3.8,3.5
813,43,0,North America,R&D,IT & Digital,Exceeds,Female,40,26,0,9,14,3.9,2.2,2.0,0.1648,0,0,0,0,3.8,2.7,2.4
814,725,0,North America,HR,Finance & Accounting,Meets,Male,36,7,1,12,17,0.0,3.2,2.9,0.0383,1,1,1,1,3.4,3.1,3.3
815,791,0,Europe,HR,Market Access,Far Below,Male,37,4,0,9,18,4.0,3.0,2.4,0.0,0,0,0,0,2.6,3.0,3.3
816,954,0,Latin America,Finance,Supply Chain,Meets,Female,31,5,0,6,27,3.3,1.9,1.0,0.0331,1,1,1,1,4.8,1.0,2.1
817,544,0,North America,Digital,Human Resources,Far Exceeds,Female,39,16,0,8,27,3.1,4.1,2.5,0.2363,1,1,1,1,2.5,2.0,1.7
818,1009,0,North America,Finance,Communications,Meets,Non-Binary/Other,35,4,1,9,16,0.0,1.0,3.4,0.0331,1,1,1,1,5.0,1.0,2.7
819,888,0,Middle East & Africa,Finance,Human Resources,Meets,Female,36,11,0,9,16,3.1,3.1,3.1,0.0331,1,1,1,1,3.0,3.9,2.1
820,177,0,Latin America,Commercial,Supply Chain,Meets,Male,28,8,0,5,11,3.2,2.9,4.0,0.0422,1,1,1,1,4.0,4.4,4.3
821,846,0,North America,HR,Clinical Operations,Meets,Female,38,18,0,12,19,3.2,2.4,1.6,0.0383,1,1,0,0,2.6,3.0,2.9
822,434,0,Latin America,Manufacturing,Marketing,Far Below,Male,32,23,0,12,14,2.2,2.3,3.3,0.0,0,0,0,0,4.1,2.2,1.3
823,995,0,Europe,Finance,Finance & Accounting,Below,Male,41,17,0,5,16,3.5,5.0,2.6,0.0,1,1,1,1,2.9,4.0,1.1
824,239,0,Asia Pacific,Commercial,Medical Affairs,Meets,Male,38,8,1,11,30,0.0,2.5,2.5,0.0422,1,1,1,1,2.4,2.3,3.3
825,232,0,North America,Commercial,Legal & Compliance,Meets,Female,29,3,1,8,13,0.0,2.7,3.1,0.0422,1,1,1,1,2.6,2.6,1.0
826,786,0,Middle East & Africa,HR,Market Access,Below,Male,37,13,0,5,22,5.0,3.3,2.2,0.0,1,1,1,1,4.9,4.3,2.2
827,857,0,Europe,HR,Market Access,Meets,Female,39,13,0,11,13,4.2,2.6,2.1,0.0383,1,1,1,1,3.5,2.1,2.0
828,845,0,Latin America,HR,Market Access,Meets,Male,51,34,0,8,21,2.7,2.4,1.9,0.0383,1,1,1,1,3.7,3.0,2.4
829,469,0,Europe,Manufacturing,Human Resources,Meets,Male,42,23,0,12,16,2.5,2.4,2.8,0.0348,1,1,1,1,2.4,3.7,3.3
830,200,0,North America,Commercial,IT & Digital,Below,Male,30,11,0,12,23,3.0,2.8,2.8,0.0,1,1,1,1,3.9,3.4,2.3
831,582,0,Latin America,Digital,Regulatory Affairs,Meets,Male,50,9,1,12,23,0.0,4.1,2.3,0.0853,1,1,1,1,4.0,3.3,2.9
832,413,0,Asia Pacific,Manufacturing,Market Access,Meets,Non-Binary/Other,36,25,0,7,10,1.8,3.2,3.6,0.0348,1,1,1,1,2.7,2.4,2.8
833,148,0,Europe,R&D,Supply Chain,Meets,Non-Binary/Other,36,14,0,11,33,3.0,4.6,2.6,0.0977,1,1,1,1,4.2,3.5,2.9
834,927,0,North America,Finance,Pharmacovigilance,Meets,Male,50,10,0,8,18,4.3,4.2,4.8,0.0331,1,1,1,1,4.4,3.4,3.6
835,782,0,Middle East & Africa,HR,Finance & Accounting,Meets,Female,34,13,0,8,10,3.0,4.2,4.2,0.0383,1,0,0,0,2.8,5.0,4.9
836,269,0,Latin America,Commercial,Sales,Exceeds,Female,37,15,1,6,8,0.0,3.4,1.0,0.0743,0,0,0,0,4.2,2.0,1.6
837,962,0,Europe,Finance,Quality Assurance,Meets,Male,28,7,0,6,10,2.3,3.3,1.7,0.0331,1,1,1,1,3.8,3.9,3.7
838,379,0,Europe,Manufacturing,Sales,Meets,Female,38,6,0,6,9,2.3,3.7,2.3,0.0348,1,1,1,1,3.5,3.4,2.1
839,146,0,Asia Pacific,R&D,Legal & Compliance,Meets,Female,37,4,0,10,16,4.4,4.0,4.1,0.0977,1,1,1,1,3.8,3.2,3.4
840,472,0,Asia Pacific,Manufacturing,Supply Chain,Below,Male,36,7,1,9,11,0.0,1.9,1.0,0.0,0,0,0,0,3.4,2.7,2.1
841,399,0,Middle East & Africa,Manufacturing,Supply Chain,Meets,Male,39,14,1,5,13,0.0,3.6,1.1,0.0348,1,1,1,1,2.3,4.3,2.1
842,685,0,Middle East & Africa,Digital,Pharmacovigilance,Below,Male,33,25,0,6,26,4.0,2.7,3.3,0.0,0,0,0,0,2.7,3.8,3.2
843,900,0,North America,Finance,Data Science,Meets,Male,47,6,1,5,9,0.0,2.9,3.8,0.0331,1,1,0,0,4.5,4.0,4.0
844,647,1,North America,Digital,Legal & Compliance,Meets,Male,38,24,0,8,20,3.2,3.4,2.0,0.0853,1,1,1,1,2.9,3.9,4.2
845,450,0,Middle East & Africa,Manufacturing,Clinical Operations,Below,Female,33,8,1,8,24,0.0,1.5,2.6,0.0,1,1,1,1,3.4,2.4,4.4
846,63,0,Middle East & Africa,R&D,Regulatory Affairs,Exceeds,Female,30,23,0,11,14,2.2,4.6,2.3,0.1648,1,1,1,1,3.5,3.7,2.2
847,294,0,Latin America,Commercial,IT & Digital,Meets,Male,38,4,0,11,24,3.2,2.8,4.3,0.0422,1,1,1,1,2.1,5.0,5.0
848,185,0,Asia Pacific,Commercial,Marketing,Meets,Male,44,5,1,7,22,0.0,2.5,4.2,0.0422,1,1,1,1,3.5,4.0,4.3
849,931,0,North America,Finance,Legal & Compliance,Meets,Female,40,9,0,11,23,2.1,3.6,1.1,0.0331,1,1,0,0,3.2,3.6,1.3
850,865,0,Asia Pacific,HR,Market Access,Meets,Male,50,11,0,6,11,3.0,3.5,2.2,0.0383,1,1,1,1,3.0,3.1,1.0
851,702,0,Asia Pacific,HR,Market Access,Meets,Female,50,10,1,10,14,0.0,2.0,2.3,0.0383,1,1,1,1,3.5,3.2,1.8
852,272,0,Middle East & Africa,Commercial,IT & Digital,Meets,Non-Binary/Other,30,7,0,8,14,3.7,4.6,3.4,0.0422,1,1,1,1,2.9,3.4,2.4
853,409,0,Latin America,Manufacturing,Finance & Accounting,Exceeds,Non-Binary/Other,29,3,0,8,14,3.2,2.0,4.7,0.0616,1,1,1,1,4.0,3.9,3.4
854,481,1,Europe,Manufacturing,Legal & Compliance,Meets,Female,33,10,1,8,28,0.0,2.9,2.4,0.0348,1,1,1,1,2.9,3.7,2.7
855,614,0,Latin America,Digital,Pharmacovigilance,Meets,Male,42,25,0,9,13,4.8,1.5,3.5,0.0853,1,1,1,1,3.4,4.3,2.7
856,1012,0,Latin America,Finance,Data Science,Meets,Male,40,17,0,9,14,4.2,5.0,1.6,0.0331,1,1,1,1,3.8,4.0,2.8
857,528,1,Asia Pacific,Digital,Market Access,Meets,Female,44,2,1,11,25,0.0,3.6,2.7,0.0853,1,1,1,1,3.9,1.4,4.6
858,832,0,Latin America,HR,Regulatory Affairs,Below,Non-Binary/Other,32,14,0,11,27,2.9,2.7,3.5,0.0,1,1,1,1,3.9,3.8,3.3
859,256,0,North America,Commercial,Human Resources,Below,Male,28,20,0,6,22,1.4,3.0,2.9,0.0,1,1,1,1,3.6,3.6,3.7
860,394,0,Asia Pacific,Manufacturing,Clinical Operations,Exceeds,Male,34,15,0,5,28,4.4,2.0,3.2,0.0616,1,1,1,1,2.6,2.5,2.3
861,303,0,North America,Commercial,Regulatory Affairs,Meets,Female,42,4,0,6,8,4.5,4.0,4.3,0.0422,1,1,1,1,3.8,4.3,4.6
862,171,0,Europe,R&D,Data Science,Exceeds,Male,39,4,0,8,35,3.3,1.6,5.0,0.1648,1,1,1,1,4.5,2.7,4.2
863,235,1,Asia Pacific,Commercial,Supply Chain,Meets,Male,45,16,1,5,46,0.0,3.7,3.2,0.0422,1,1,1,1,2.6,2.7,3.8
864,163,0,Europe,R&D,Regulatory Affairs,Meets,Female,34,16,0,5,21,3.6,2.2,4.1,0.0977,1,1,1,1,3.5,3.2,3.2
865,637,0,Asia Pacific,Digital,Finance & Accounting,Meets,Male,44,13,1,9,13,0.0,4.4,4.3,0.0853,1,1,1,1,4.6,3.5,4.0
866,541,0,Middle East & Africa,Digital,Sales,Below,Male,34,24,0,12,20,4.6,2.5,4.9,0.0,1,1,1,1,3.5,2.5,4.6
867,720,0,Latin America,HR,Regulatory Affairs,Meets,Female,43,7,0,5,8,3.3,3.2,2.1,0.0383,1,1,1,1,3.9,4.2,2.5
868,237,0,Middle East & Africa,Commercial,Supply Chain,Meets,Female,43,3,0,11,12,3.2,4.7,1.0,0.0422,0,0,0,0,3.3,4.0,2.6
869,246,0,Europe,Commercial,Market Access,Meets,Male,47,18,1,7,16,0.0,3.5,3.4,0.0422,1,1,0,0,4.0,3.0,2.1
870,58,0,Latin America,R&D,Quality Assurance,Meets,Male,30,14,1,12,16,0.0,3.6,4.0,0.0977,1,1,1,1,3.8,3.9,2.2
871,560,0,Asia Pacific,Digital,Quality Assurance,Below,Female,46,10,1,6,15,0.0,3.1,2.8,0.0,1,1,1,1,2.4,4.4,2.4
872,119,1,Latin America,R&D,Finance & Accounting,Meets,Female,41,11,1,11,32,0.0,2.7,2.9,0.0977,1,1,1,1,3.3,2.7,3.8
873,647,0,North America,Digital,Communications,Below,Male,38,12,0,10,20,2.2,3.4,3.4,0.0,1,1,1,1,2.4,3.7,3.2
874,81,0,Latin America,R&D,Quality Assurance,Meets,Male,37,20,0,9,24,3.2,3.2,2.3,0.0977,1,1,1,1,2.6,1.9,3.0
875,644,0,North America,Digital,Market Access,Exceeds,Female,38,9,0,7,9,3.6,3.7,1.4,0.1452,0,0,0,0,3.7,4.0,2.3
876,98,1,Latin America,R&D,Communications,Meets,Female,38,11,0,5,10,1.9,4.5,1.0,0.0977,1,1,1,1,2.1,3.4,2.3
877,529,0,North America,Digital,Pharmacovigilance,Meets,Female,28,7,0,12,18,2.8,2.9,1.0,0.0853,1,1,1,1,2.2,3.4,1.0
878,944,0,Europe,Finance,Clinical Operations,Meets,Female,39,17,0,12,35,3.4,2.6,2.4,0.0331,1,1,1,1,2.5,3.8,1.4
879,83,0,Middle East & Africa,R&D,IT & Digital,Below,Female,39,8,0,10,29,3.2,2.3,2.7,0.0,1,1,1,1,1.7,2.0,3.0
880,200,0,Asia Pacific,Commercial,Clinical Operations,Meets,Male,34,7,0,6,20,3.3,3.3,2.3,0.0422,1,1,1,1,3.0,3.2,3.3
881,718,0,Latin America,HR,Legal & Compliance,Meets,Female,38,14,0,12,15,2.1,3.9,1.3,0.0383,0,0,0,0,2.9,3.4,2.0
882,975,0,Middle East & Africa,Finance,Communications,Below,Female,45,9,0,8,21,2.2,2.8,2.4,0.0,1,1,1,1,2.7,2.7,2.3
883,910,0,Asia Pacific,Finance,Legal & Compliance,Exceeds,Female,34,10,1,8,25,0.0,3.5,2.4,0.0588,1,1,1,1,1.1,2.7,1.4
884,87,1,Asia Pacific,R&D,Legal & Compliance,Meets,Male,31,9,1,6,9,0.0,2.6,3.7,0.0977,1,1,1,1,5.0,3.0,3.9
885,751,0,North America,HR,Market Access,Far Below,Female,34,8,1,7,9,0.0,3.6,3.0,0.0,1,0,0,0,3.3,4.3,3.0
886,208,0,Europe,Commercial,Regulatory Affairs,Meets,Female,28,4,1,12,17,0.0,2.5,2.6,0.0422,1,1,1,1,3.5,2.6,1.0
887,940,0,Europe,Finance,Human Resources,Meets,Male,49,14,0,5,8,3.8,3.5,2.7,0.0331,1,1,1,1,5.0,3.6,3.6
888,198,0,Middle East & Africa,Commercial,Communications,Meets,Female,33,5,1,10,15,0.0,2.8,1.5,0.0422,1,1,1,1,3.9,1.0,2.3
889,526,0,Europe,Digital,Marketing,Meets,Female,46,18,0,9,24,2.2,1.1,3.0,0.0853,1,1,1,1,2.0,2.0,1.8
890,861,0,Latin America,HR,Legal & Compliance,Exceeds,Female,31,26,0,6,11,3.0,3.3,3.6,0.0677,0,0,0,0,3.1,3.5,2.7
891,389,0,Europe,Manufacturing,Clinical Operations,Meets,Male,34,20,0,5,17,3.2,3.4,2.9,0.0348,1,1,1,1,5.0,3.2,3.9
892,573,0,Middle East & Africa,Digital,Sales,Exceeds,Male,38,12,0,11,16,2.9,2.7,1.9,0.1452,1,1,1,1,2.3,3.2,2.3
893,761,0,Europe,HR,Communications,Exceeds,Female,42,5,1,9,16,0.0,1.4,3.6,0.0677,0,0,0,0,2.8,1.3,4.4
894,13,0,Latin America,R&D,Sales,Exceeds,Female,38,12,1,5,22,0.0,3.6,3.3,0.1648,1,1,1,1,2.4,2.9,2.1
895,137,0,North America,R&D,Communications,Below,Female,29,18,0,7,20,2.8,2.9,3.6,0.0,1,1,1,1,1.2,3.1,4.6
896,190,0,Middle East & Africa,Commercial,Communications,Meets,Female,38,20,0,6,15,2.1,3.0,2.9,0.0422,1,1,0,0,3.2,2.8,3.4
897,906,0,North America,Finance,Medical Affairs,Far Below,Male,46,14,0,6,10,4.3,3.2,3.3,0.0,1,1,1,1,4.0,4.3,3.2
898,481,0,North America,Manufacturing,Human Resources,Meets,Female,40,5,0,7,10,2.4,4.0,2.7,0.0348,1,1,1,1,3.9,5.0,3.7
899,122,1,North America,R&D,Sales,Exceeds,Non-Binary/Other,51,4,0,8,35,3.9,2.1,3.1,0.1648,1,1,1,1,3.8,2.1,3.0
900,798,0,Asia Pacific,HR,IT & Digital,Below,Female,39,6,1,7,17,0.0,2.2,2.3,0.0,1,1,1,1,3.2,2.3,1.8
901,882,0,Asia Pacific,Finance,Clinical Operations,Meets,Female,44,9,1,6,11,0.0,3.8,2.7,0.0331,1,1,1,1,4.3,4.2,2.4
902,941,1,North America,Finance,Human Resources,Meets,Female,41,8,0,5,8,3.3,4.5,2.6,0.0331,1,1,1,1,4.5,3.8,3.1
903,876,0,Middle East & Africa,HR,Human Resources,Below,Female,34,10,0,12,18,2.9,4.1,3.4,0.0,1,1,1,1,3.0,3.5,4.3
904,1045,0,Latin America,Finance,Marketing,Meets,Male,38,8,0,6,7,2.9,2.9,2.4,0.0331,1,1,1,1,3.2,3.7,3.1
905,36,0,Latin America,R&D,Supply Chain,Meets,Male,45,11,0,5,14,4.1,2.5,3.7,0.0977,1,1,1,1,3.0,2.0,4.1
906,841,0,Europe,HR,Quality Assurance,Below,Male,36,31,0,7,9,2.7,4.3,1.5,0.0,1,1,1,1,4.2,5.0,1.8
907,811,0,Middle East & Africa,HR,Communications,Meets,Female,40,9,0,12,16,3.1,4.3,1.0,0.0383,0,0,0,0,4.2,4.1,1.5
908,192,0,Asia Pacific,Commercial,Regulatory Affairs,Meets,Male,34,10,1,12,13,0.0,2.7,1.5,0.0422,0,0,0,0,4.8,4.4,2.4
909,374,0,North America,Manufacturing,Communications,Meets,Female,44,12,0,10,45,3.0,4.0,2.6,0.0348,1,1,1,1,2.7,5.0,3.1
910,260,0,Europe,Commercial,Communications,Below,Female,38,13,0,10,29,3.3,4.2,3.6,0.0,1,1,1,1,3.4,3.1,4.7
911,374,0,Latin America,Manufacturing,Supply Chain,Meets,Female,43,11,0,5,10,1.8,2.0,1.9,0.0348,0,0,0,0,2.9,1.7,2.4
912,789,0,Asia Pacific,HR,Marketing,Far Below,Male,45,20,0,5,30,3.1,2.0,1.4,0.0,1,1,1,1,3.1,2.0,1.8
913,1050,0,Asia Pacific,Finance,Pharmacovigilance,Exceeds,Female,42,14,1,12,17,0.0,3.1,1.9,0.0588,1,1,1,1,3.2,1.6,2.4
914,359,0,North America,Manufacturing,Communications,Meets,Female,37,1,0,7,12,3.1,1.6,3.4,0.0348,1,1,1,1,2.9,3.2,2.1
915,832,0,Latin America,HR,Quality Assurance,Exceeds,Female,37,4,0,5,13,3.7,2.6,2.4,0.0677,1,1,1,1,2.9,2.3,1.7
916,836,0,Middle East & Africa,HR,Legal & Compliance,Meets,Female,28,6,0,6,19,3.2,3.1,2.5,0.0383,1,1,1,1,2.4,3.7,3.0
917,286,0,Asia Pacific,Commercial,Human Resources,Meets,Non-Binary/Other,41,11,1,12,19,0.0,2.9,3.7,0.0422,0,0,0,0,3.9,2.6,3.2
918,286,0,North America,Commercial,Legal & Compliance,Meets,Female,44,13,0,7,16,2.9,1.4,2.3,0.0422,1,1,1,1,2.8,1.1,1.9
919,943,0,Middle East & Africa,Finance,Communications,Meets,Female,31,9,0,8,12,3.7,3.7,3.7,0.0331,1,1,1,1,3.6,5.0,2.3
920,625,0,Latin America,Digital,Medical Affairs,Meets,Female,37,30,0,5,25,2.2,2.7,2.6,0.0853,1,1,1,1,3.0,2.3,3.7
921,126,0,Asia Pacific,R&D,Legal & Compliance,Far Below,Female,37,17,0,9,14,3.1,1.4,1.9,0.0,1,1,1,1,3.8,2.1,1.8
922,569,0,Middle East & Africa,Digital,Finance & Accounting,Exceeds,Female,41,9,1,9,14,0.0,3.4,3.4,0.1452,1,0,0,0,4.7,3.3,4.0
923,604,0,Middle East & Africa,Digital,Pharmacovigilance,Meets,Female,39,6,1,9,19,0.0,3.2,3.3,0.0853,1,1,1,1,4.2,4.5,3.4
924,924,0,Middle East & Africa,Finance,Clinical Operations,Far Exceeds,Male,33,8,0,10,20,4.6,3.8,3.1,0.1022,1,1,1,1,4.2,3.1,3.3
925,461,0,Asia Pacific,Manufacturing,Human Resources,Meets,Female,48,25,0,10,24,3.7,3.1,4.8,0.0348,1,1,0,0,4.0,2.2,3.0
926,1049,0,Asia Pacific,Finance,Marketing,Below,Male,28,26,0,8,12,3.2,3.2,3.5,0.0,1,1,1,1,2.4,2.4,3.6
927,1031,0,Europe,Finance,Quality Assurance,Meets,Female,34,9,0,7,21,4.3,3.4,1.6,0.0331,0,0,0,0,4.6,2.9,2.7
928,827,0,Latin America,HR,Human Resources,Meets,Female,30,24,0,11,22,4.1,2.5,2.9,0.0383,1,1,1,1,4.2,2.7,3.9
929,869,0,North America,HR,Human Resources,Meets,Female,40,6,1,10,18,0.0,3.2,3.4,0.0383,0,0,0,0,4.0,3.3,2.6
930,805,0,Middle East & Africa,HR,Medical Affairs,Meets,Male,41,14,1,9,13,0.0,3.9,3.0,0.0383,1,1,1,1,3.4,4.0,4.1
931,124,0,Europe,R&D,Regulatory Affairs,Exceeds,Female,37,6,0,12,21,3.0,4.2,1.9,0.1648,0,0,0,0,2.9,4.5,1.6
932,375,0,North America,Manufacturing,Human Resources,Meets,Female,31,13,0,12,28,2.1,4.8,1.9,0.0348,1,1,1,1,3.1,4.6,1.9
933,451,0,Europe,Manufacturing,Regulatory Affairs,Meets,Female,32,14,0,5,9,4.0,3.7,1.5,0.0348,1,1,1,1,3.6,3.0,1.0
934,787,0,Asia Pacific,HR,Market Access,Meets,Female,43,13,1,11,22,0.0,2.1,3.0,0.0383,1,1,1,1,3.8,3.0,3.1
935,598,0,Middle East & Africa,Digital,Clinical Operations,Meets,Male,38,22,0,11,23,3.3,3.8,2.2,0.0853,1,1,1,1,3.5,4.0,2.3
936,160,0,North America,R&D,Sales,Meets,Female,35,8,0,10,18,3.4,2.9,1.9,0.0977,1,1,1,1,3.5,3.1,1.8
937,636,0,North America,Digital,Finance & Accounting,Meets,Female,34,14,0,5,8,4.1,4.5,2.2,0.0853,1,1,1,1,3.2,3.3,3.3
938,194,0,North America,Commercial,Marketing,Meets,Male,37,18,0,5,8,2.7,2.2,1.8,0.0422,1,1,1,1,1.0,2.9,2.0
939,415,0,North America,Manufacturing,Medical Affairs,Meets,Male,41,6,1,6,18,0.0,4.4,3.0,0.0348,1,1,1,1,3.0,3.7,4.4
940,482,0,North America,Manufacturing,Medical Affairs,Meets,Female,37,11,0,12,30,3.5,4.6,2.6,0.0348,1,1,0,0,3.5,4.9,3.8
941,616,1,Europe,Digital,Sales,Meets,Male,41,10,1,11,21,0.0,3.6,3.3,0.0853,1,1,1,1,4.5,3.1,3.1
942,87,0,Middle East & Africa,R&D,Legal & Compliance,Far Exceeds,Female,29,27,0,9,17,2.1,4.6,2.1,0.2644,0,0,0,0,3.3,3.6,3.7
943,407,0,Asia Pacific,Manufacturing,Communications,Below,Male,45,15,0,7,11,3.4,4.4,2.8,0.0,1,1,0,0,2.5,4.5,1.7
944,543,0,Asia Pacific,Digital,Sales,Meets,Female,38,11,1,7,17,0.0,3.1,2.9,0.0853,1,1,1,1,3.1,3.4,2.8
945,1041,0,Asia Pacific,Finance,Legal & Compliance,Below,Female,32,11,0,11,19,4.8,1.8,3.1,0.0,1,1,1,1,3.9,3.4,2.2
946,996,0,Asia Pacific,Finance,Legal & Compliance,Far Below,Female,41,17,0,12,22,3.8,2.3,2.8,0.0,1,1,1,1,4.9,3.1,2.9
947,148,0,Europe,R&D,Legal & Compliance,Exceeds,Female,39,13,0,6,12,2.4,1.8,1.6,0.1648,1,1,1,0,3.4,2.2,1.5
948,602,0,Latin America,Digital,Legal & Compliance,Exceeds,Female,31,17,0,5,11,3.7,3.9,3.2,0.1452,1,1,1,1,2.1,5.0,4.4
949,998,0,Middle East & Africa,Finance,Pharmacovigilance,Meets,Female,37,5,1,6,31,0.0,2.5,3.4,0.0331,1,1,1,1,3.0,1.8,3.5
950,44,0,North America,R&D,Quality Assurance,Exceeds,Female,35,4,0,5,21,3.6,2.7,2.8,0.1648,1,1,1,1,3.8,3.4,3.9
951,711,0,Latin America,HR,Pharmacovigilance,Exceeds,Female,30,6,0,10,18,1.9,3.6,2.4,0.0677,1,1,1,1,2.4,3.4,2.1
952,107,0,Asia Pacific,R&D,Finance & Accounting,Meets,Male,35,19,1,8,15,0.0,3.5,4.0,0.0977,1,1,1,0,2.7,2.5,4.6
953,317,0,Latin America,Commercial,Legal & Compliance,Exceeds,Female,32,25,0,9,24,2.4,2.6,3.2,0.0743,1,1,1,1,3.3,3.6,4.7
954,742,0,Middle East & Africa,HR,Data Science,Meets,Male,31,5,1,6,9,0.0,3.6,3.1,0.0383,1,1,1,1,2.8,4.0,2.6
955,535,0,North America,Digital,Legal & Compliance,Meets,Female,41,6,0,10,25,3.3,4.7,2.9,0.0853,1,1,1,1,2.9,4.9,3.8
956,740,0,North America,HR,Data Science,Meets,Male,40,29,0,5,19,2.5,4.1,2.3,0.0383,1,1,1,1,2.8,4.2,1.7
957,879,0,Middle East & Africa,HR,Clinical Operations,Below,Male,36,9,1,9,10,0.0,3.0,3.4,0.0,1,1,1,1,3.1,3.2,2.9
958,542,0,Middle East & Africa,Digital,Legal & Compliance,Exceeds,Male,28,27,0,8,10,3.5,3.9,2.3,0.1452,1,1,1,1,2.8,5.0,3.3
959,549,0,Asia Pacific,Digital,Market Access,Below,Male,38,3,0,9,11,3.7,1.8,3.3,0.0,1,1,1,1,4.5,1.5,1.9
960,895,0,North America,Finance,Finance & Accounting,Exceeds,Male,43,14,1,7,8,0.0,2.9,1.5,0.0588,1,1,1,1,2.6,3.7,2.0
961,208,0,Latin America,Commercial,Marketing,Meets,Female,45,13,0,7,12,3.5,2.9,3.5,0.0422,1,1,1,1,5.0,3.6,4.5
962,638,0,Europe,Digital,Medical Affairs,Meets,Female,44,20,1,10,16,0.0,3.6,2.9,0.0853,0,0,0,0,3.7,4.6,3.1
963,456,0,Europe,Manufacturing,Human Resources,Below,Male,31,18,0,11,19,2.7,1.6,3.0,0.0,1,1,1,1,1.7,3.2,3.2
964,373,0,Middle East & Africa,Manufacturing,Communications,Exceeds,Male,33,6,0,5,8,4.4,3.7,4.1,0.0616,1,1,1,1,4.4,3.9,3.5
965,202,0,Asia Pacific,Commercial,Communications,Below,Female,37,7,0,7,14,4.4,1.3,2.6,0.0,1,1,1,1,2.9,2.7,2.6
966,52,0,Europe,R&D,Legal & Compliance,Meets,Male,38,14,0,8,20,3.5,5.0,2.8,0.0977,1,1,1,1,4.2,4.7,2.3
967,143,1,North America,R&D,Quality Assurance,Meets,Female,38,9,0,11,15,2.8,1.6,2.5,0.0977,1,1,1,1,3.5,4.0,1.0
968,501,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Meets,Male,45,18,0,9,22,3.4,2.8,3.8,0.0348,1,1,1,1,4.0,2.2,4.5
969,649,0,Latin America,Digital,Human Resources,Far Exceeds,Female,39,8,1,12,20,0.0,5.0,1.9,0.2363,0,0,0,0,2.1,3.1,3.9
970,178,0,Middle East & Africa,Commercial,Regulatory Affairs,Below,Male,45,3,0,5,14,4.6,4.0,2.5,0.0,1,1,1,1,2.9,3.1,2.4
971,96,0,Latin America,R&D,Supply Chain,Meets,Male,33,10,1,11,17,0.0,4.7,3.4,0.0977,1,1,1,1,2.9,3.1,3.8
972,22,1,Middle East & Africa,R&D,Finance & Accounting,Meets,Female,36,19,0,12,39,4.6,3.3,4.0,0.0977,1,1,1,1,5.0,3.9,4.2
973,748,0,Middle East & Africa,HR,Communications,Meets,Male,35,11,0,10,17,2.6,4.6,3.3,0.0383,1,1,1,1,1.9,4.7,3.2
974,391,0,Middle East & Africa,Manufacturing,Sales,Below,Non-Binary/Other,38,9,1,12,14,0.0,4.1,2.3,0.0,1,1,1,1,3.5,2.8,2.6
975,668,0,Latin America,Digital,Finance & Accounting,Meets,Female,30,13,0,5,10,4.4,4.0,2.5,0.0853,1,1,1,1,3.6,2.6,1.0
976,313,0,Latin America,Commercial,Clinical Operations,Exceeds,Female,50,20,0,9,20,2.1,2.6,2.6,0.0743,1,1,1,1,4.2,2.5,3.2
977,75,0,Middle East & Africa,R&D,Supply Chain,Below,Non-Binary/Other,39,4,0,11,33,3.5,3.4,3.2,0.0,1,1,1,1,3.9,2.2,3.3
978,757,0,Europe,HR,Supply Chain,Below,Male,31,6,0,5,24,2.9,2.8,1.8,0.0,0,0,0,0,1.6,2.3,2.7
979,416,1,Asia Pacific,Manufacturing,Market Access,Far Exceeds,Female,31,10,0,12,28,1.5,3.4,2.4,0.1069,1,1,1,1,3.3,4.5,4.2
980,381,0,Asia Pacific,Manufacturing,Marketing,Far Below,Male,38,4,0,6,20,3.8,1.5,2.5,0.0,1,1,1,1,3.0,2.2,2.9
981,189,0,Asia Pacific,Commercial,Medical Affairs,Meets,Female,42,7,0,12,16,3.5,3.9,4.0,0.0422,1,1,1,1,4.0,4.6,3.8
982,126,0,Latin America,R&D,IT & Digital,Meets,Female,44,12,0,7,13,3.4,4.0,3.6,0.0977,0,0,0,0,4.8,3.0,3.1
983,258,0,Latin America,Commercial,Finance & Accounting,Meets,Male,38,10,0,6,16,2.3,3.3,2.2,0.0422,1,1,1,1,3.1,2.0,2.3
984,206,0,Europe,Commercial,Quality Assurance,Meets,Male,42,8,0,6,16,4.3,3.3,3.2,0.0422,1,1,1,1,3.1,3.6,2.6
985,952,0,Asia Pacific,Finance,IT & Digital,Exceeds,Female,40,18,0,11,21,3.6,3.4,3.4,0.0588,1,1,1,1,1.9,2.7,2.4
986,780,0,Asia Pacific,HR,Human Resources,Meets,Female,37,4,0,5,23,3.7,3.1,1.0,0.0383,1,1,1,1,3.5,3.5,1.2
987,414,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Meets,Female,36,23,1,9,17,0.0,4.4,2.1,0.0348,1,1,1,1,4.4,4.6,1.7
988,884,0,Latin America,Finance,Regulatory Affairs,Meets,Female,38,10,0,6,10,3.8,3.0,5.0,0.0331,1,1,1,1,4.0,4.6,3.3
989,526,0,Asia Pacific,Digital,Regulatory Affairs,Meets,Male,37,9,0,9,17,2.8,4.1,3.4,0.0853,1,1,1,1,3.1,3.8,2.7
990,446,0,Europe,Manufacturing,Data Science,Far Below,Female,38,5,1,9,15,0.0,3.3,4.3,0.0,0,0,0,0,2.1,5.0,3.5
991,398,0,Europe,Manufacturing,Marketing,Meets,Female,41,3,1,12,15,0.0,3.0,3.1,0.0348,1,0,0,0,2.2,3.8,2.4
992,714,0,Asia Pacific,HR,Clinical Operations,Meets,Male,48,10,0,6,25,3.4,5.0,2.9,0.0383,1,0,0,0,3.3,4.2,2.9
993,663,0,Latin America,Digital,Human Resources,Meets,Male,32,13,0,8,12,3.8,2.2,2.2,0.0853,1,1,1,1,3.7,3.5,3.8
994,172,0,Europe,R&D,Regulatory Affairs,Exceeds,Female,39,17,0,5,15,2.4,2.4,4.6,0.1648,1,1,1,1,3.5,1.3,3.2
995,547,0,Middle East & Africa,Digital,Market Access,Meets,Female,40,11,1,11,26,0.0,3.3,3.2,0.0853,1,1,1,1,2.2,3.2,3.3
996,68,0,Europe,R&D,Communications,Far Exceeds,Male,36,24,0,9,11,3.0,1.8,3.3,0.2644,1,1,1,1,3.5,1.5,1.9
997,618,0,North America,Digital,Regulatory Affairs,Meets,Non-Binary/Other,44,9,0,10,18,1.9,1.8,4.3,0.0853,1,1,1,1,3.3,3.5,3.3
998,243,0,North America,Commercial,Legal & Compliance,Exceeds,Female,35,5,0,6,18,3.0,4.0,2.3,0.0743,0,0,0,0,3.7,4.0,2.4
999,574,0,Latin America,Digital,IT & Digital,Meets,Non-Binary/Other,42,15,0,5,8,1.9,4.2,2.6,0.0853,1,1,1,1,1.0,2.8,2.4
1000,950,0,Asia Pacific,Finance,Clinical Operations,Far Exceeds,Male,46,2,1,8,25,0.0,2.5,3.7,0.1022,1,1,1,1,2.8,1.2,3.6
1001,941,0,Latin America,Finance,Data Science,Exceeds,Female,40,24,0,10,24,3.2,2.0,2.2,0.0588,0,0,0,0,2.8,3.1,3.7
1002,839,0,Latin America,HR,Market Access,Far Exceeds,Male,37,11,0,12,20,3.2,3.3,1.4,0.1168,1,1,1,1,3.7,2.0,1.5
1003,33,0,Latin America,R&D,Supply Chain,Far Exceeds,Female,41,22,0,10,13,3.8,2.9,3.3,0.2644,0,0,0,0,3.4,3.2,2.5
1004,398,0,Latin America,Manufacturing,Communications,Far Below,Male,36,6,0,7,17,4.3,1.9,3.3,0.0,1,1,1,1,3.7,4.3,3.7
1005,723,0,Middle East & Africa,HR,Finance & Accounting,Meets,Female,34,10,1,12,24,0.0,3.9,2.1,0.0383,1,1,1,1,1.8,4.1,1.9
1006,896,0,Middle East & Africa,Finance,Clinical Operations,Meets,Male,40,4,0,9,20,3.5,2.8,2.8,0.0331,1,1,1,1,4.3,2.0,1.7
1007,1037,0,Europe,Finance,Supply Chain,Meets,Female,42,9,1,5,9,0.0,3.6,2.8,0.0331,1,1,1,1,4.2,3.3,3.5
1008,84,0,North America,R&D,Sales,Far Exceeds,Female,39,7,0,10,13,2.1,2.9,2.4,0.2644,1,1,1,1,1.9,3.5,1.3
1009,914,0,Latin America,Finance,Pharmacovigilance,Far Below,Male,41,3,0,12,26,4.1,3.0,2.9,0.0,1,1,1,1,3.1,3.1,1.8
1010,885,0,Europe,Finance,Regulatory Affairs,Meets,Male,52,10,0,10,12,2.5,1.6,4.3,0.0331,1,1,1,0,2.4,2.9,4.4
1011,147,0,North America,R&D,Clinical Operations,Meets,Male,45,9,0,6,22,2.7,5.0,2.7,0.0977,1,1,1,1,2.9,4.2,2.1
1012,1027,0,Asia Pacific,Finance,Pharmacovigilance,Meets,Female,35,29,0,7,13,3.0,3.3,5.0,0.0331,1,1,1,1,4.6,3.2,2.6
1013,394,0,Middle East & Africa,Manufacturing,Quality Assurance,Meets,Male,39,8,0,8,18,2.4,3.2,2.8,0.0348,1,1,1,1,3.2,2.1,2.5
1014,299,0,North America,Commercial,Market Access,Below,Male,40,19,1,11,27,0.0,3.4,2.0,0.0,1,1,1,1,2.8,3.3,3.6
1015,787,0,Asia Pacific,HR,Marketing,Below,Male,33,10,0,12,41,3.7,1.4,4.8,0.0,1,1,1,1,3.5,2.7,5.0
1016,425,1,North America,Manufacturing,Communications,Meets,Female,42,1,1,8,17,0.0,3.2,1.8,0.0348,1,1,1,1,3.2,2.4,3.9
1017,506,0,Middle East & Africa,Manufacturing,Sales,Meets,Male,33,25,0,7,23,4.1,1.7,1.0,0.0348,0,0,0,0,4.6,3.1,3.6
1018,222,0,Middle East & Africa,Commercial,Quality Assurance,Far Below,Male,42,22,0,10,12,2.5,2.7,3.5,0.0,1,1,1,1,3.3,2.6,3.1
1019,741,0,Europe,HR,Quality Assurance,Far Exceeds,Female,50,16,0,8,15,4.0,2.7,5.0,0.1168,1,1,1,1,3.1,3.6,4.6
1020,483,0,Latin America,Manufacturing,Legal & Compliance,Meets,Female,37,11,1,12,14,0.0,3.6,2.3,0.0348,1,1,1,1,3.8,3.6,2.7
1021,891,0,North America,Finance,Sales,Meets,Female,41,10,0,11,13,2.4,2.9,2.8,0.0331,1,1,1,1,2.5,2.1,3.2
1022,313,0,North America,Commercial,IT & Digital,Meets,Male,40,7,0,12,18,2.5,2.0,1.9,0.0422,1,1,1,1,2.8,3.4,2.0
1023,799,0,Asia Pacific,HR,Supply Chain,Meets,Male,32,10,1,5,50,0.0,4.5,2.6,0.0383,1,1,1,1,3.5,3.1,3.6
1024,613,0,Middle East & Africa,Digital,Finance & Accounting,Meets,Female,34,4,0,8,11,4.2,2.0,1.9,0.0853,1,1,1,1,3.9,2.8,2.2
1025,89,0,North America,R&D,Finance & Accounting,Meets,Female,40,9,0,6,11,3.3,3.6,3.6,0.0977,1,1,1,1,3.3,4.5,4.0
1026,940,0,Middle East & Africa,Finance,Clinical Operations,Meets,Female,39,8,1,10,15,0.0,3.7,4.0,0.0331,1,1,1,1,4.2,3.4,3.0
1027,332,0,North America,Commercial,Medical Affairs,Below,Male,37,8,0,8,25,4.3,3.3,1.4,0.0,1,1,1,0,4.4,3.1,3.6
1028,68,0,Europe,R&D,Regulatory Affairs,Exceeds,Female,44,19,0,7,17,2.6,3.2,4.0,0.1648,1,1,1,1,2.5,2.8,2.1
1029,531,0,Latin America,Digital,Market Access,Meets,Female,41,2,0,12,16,4.4,3.7,1.8,0.0853,1,1,1,1,3.6,1.9,3.0
1030,446,0,North America,Manufacturing,Data Science,Meets,Female,51,15,0,10,24,3.9,2.8,3.1,0.0348,1,1,1,1,2.5,2.1,3.2
1031,453,0,Middle East & Africa,Manufacturing,IT & Digital,Far Exceeds,Female,32,8,0,11,15,2.6,4.0,3.6,0.1069,1,1,1,1,4.0,3.6,4.5
1032,822,0,Europe,HR,Clinical Operations,Meets,Male,36,17,0,9,16,2.8,2.8,2.5,0.0383,1,1,1,1,2.7,2.6,2.9
1033,332,0,North America,Commercial,Human Resources,Meets,Female,47,6,1,6,13,0.0,3.8,1.5,0.0422,1,1,0,0,4.9,4.2,1.0
1034,348,0,Asia Pacific,Commercial,Human Resources,Meets,Female,48,20,1,6,17,0.0,3.6,1.8,0.0422,0,0,0,0,4.4,2.9,1.3
1035,829,0,Latin America,HR,Regulatory Affairs,Below,Female,33,28,0,9,27,3.1,3.3,3.6,0.0,1,1,1,1,4.7,2.6,3.3
1036,34,1,North America,R&D,Finance & Accounting,Far Exceeds,Female,36,17,0,5,12,5.0,1.5,3.8,0.2644,1,1,1,1,5.0,3.1,3.7
1037,438,0,Europe,Manufacturing,Clinical Operations,Meets,Female,37,19,0,7,13,4.6,3.6,1.1,0.0348,1,1,0,0,5.0,3.5,1.0
1038,448,1,Asia Pacific,Manufacturing,Quality Assurance,Meets,Female,46,21,0,5,9,3.9,2.5,4.2,0.0348,1,0,0,0,4.7,2.6,4.1
1039,248,1,Europe,Commercial,Medical Affairs,Exceeds,Female,37,14,0,7,9,3.8,3.4,2.0,0.0743,1,1,1,1,4.0,1.5,3.4
1040,226,0,Europe,Commercial,Data Science,Meets,Male,37,13,0,10,17,3.8,3.8,2.2,0.0422,1,1,1,1,4.4,3.1,2.9
1041,829,0,Asia Pacific,HR,Clinical Operations,Meets,Female,36,8,1,12,15,0.0,2.8,3.2,0.0383,1,1,1,1,3.1,3.7,4.2
1042,607,0,Europe,Digital,Regulatory Affairs,Exceeds,Female,39,7,1,6,10,0.0,1.6,1.0,0.1452,1,1,1,1,3.6,1.8,1.8
1043,35,0,Asia Pacific,R&D,Data Science,Meets,Male,40,3,0,11,16,3.3,3.5,3.0,0.0977,1,1,1,1,2.7,3.8,2.7
1044,883,0,North America,Finance,Data Science,Below,Male,49,3,0,9,13,3.0,2.6,2.6,0.0,1,1,1,1,4.8,3.8,2.3
1045,534,0,Asia Pacific,Digital,Marketing,Below,Male,47,15,0,7,12,3.9,4.4,3.3,0.0,1,1,1,1,3.8,2.5,3.9
1046,570,0,Asia Pacific,Digital,Market Access,Exceeds,Male,32,14,1,11,12,0.0,1.7,2.6,0.1452,1,1,1,1,3.5,2.4,2.4
1047,225,0,Latin America,Commercial,Quality Assurance,Meets,Female,37,12,0,5,18,3.8,3.5,3.8,0.0422,1,1,1,1,3.4,3.0,4.6
1048,354,1,Asia Pacific,Commercial,Marketing,Meets,Male,38,14,0,5,17,3.1,3.0,1.9,0.0422,1,1,1,1,3.9,2.6,1.0
1049,218,1,Asia Pacific,Commercial,Regulatory Affairs,Meets,Female,35,17,0,8,10,4.4,3.0,3.3,0.0422,1,1,1,1,4.2,2.9,3.2
1050,543,0,North America,Digital,Regulatory Affairs,Meets,Male,44,12,0,8,26,3.5,4.0,2.4,0.0853,0,0,0,0,3.0,4.9,1.9
1051,54,0,Latin America,R&D,Legal & Compliance,Meets,Male,46,6,0,11,17,3.1,3.4,1.0,0.0977,1,1,1,1,2.9,2.3,1.5
1052,205,0,Middle East & Africa,Commercial,Supply Chain,Far Exceeds,Female,35,6,1,8,10,0.0,3.1,2.0,0.1275,0,0,0,0,2.8,2.7,3.7
1053,478,1,North America,Manufacturing,Clinical Operations,Meets,Female,38,5,0,9,13,4.0,2.7,2.8,0.0348,1,1,1,1,3.7,4.0,4.6
1054,55,0,North America,R&D,Clinical Operations,Meets,Male,43,8,0,6,14,3.4,3.1,2.6,0.0977,1,1,1,1,2.8,2.6,3.7
1055,364,0,Middle East & Africa,Manufacturing,Supply Chain,Meets,Non-Binary/Other,44,15,0,12,31,2.0,1.4,2.1,0.0348,1,1,1,1,3.8,2.6,2.4
1056,46,1,Asia Pacific,R&D,Pharmacovigilance,Meets,Female,35,30,0,8,20,4.1,2.8,1.9,0.0977,1,0,0,0,4.9,3.1,2.0
1057,233,0,Europe,Commercial,Sales,Exceeds,Male,41,4,0,10,18,2.0,2.6,2.7,0.0743,1,1,1,1,3.2,4.9,2.9
1058,885,0,Latin America,Finance,Human Resources,Meets,Female,34,8,0,7,31,2.2,3.1,4.2,0.0331,1,1,1,1,4.2,4.8,4.0
1059,740,0,Europe,HR,Clinical Operations,Meets,Male,44,14,0,12,17,3.4,3.2,2.6,0.0383,1,1,1,1,4.5,3.9,1.4
1060,353,0,Middle East & Africa,Commercial,Sales,Far Exceeds,Female,34,13,0,11,21,3.0,3.0,1.5,0.1275,1,1,1,1,4.0,3.3,1.6
1061,606,0,North America,Digital,Human Resources,Meets,Female,39,6,1,12,23,0.0,3.3,5.0,0.0853,1,1,1,1,2.4,3.1,5.0
1062,898,0,North America,Finance,Clinical Operations,Meets,Male,35,5,1,10,15,0.0,2.8,1.0,0.0331,1,1,1,1,5.0,1.6,1.6
1063,634,0,Latin America,Digital,Market Access,Below,Female,32,8,0,7,12,3.7,1.1,4.5,0.0,1,1,1,1,3.7,3.3,4.2
1064,131,0,North America,R&D,Communications,Far Exceeds,Male,35,27,0,10,18,2.7,1.0,2.9,0.2644,0,0,0,0,4.1,2.5,1.7
1065,556,0,North America,Digital,IT & Digital,Meets,Female,36,16,0,9,15,4.1,2.9,2.4,0.0853,1,1,1,1,4.6,4.6,2.0
1066,906,0,Latin America,Finance,Pharmacovigilance,Meets,Male,45,5,1,6,30,0.0,1.5,2.3,0.0331,1,1,1,1,3.1,4.3,2.9
1067,1032,0,Latin America,Finance,Medical Affairs,Exceeds,Female,35,5,1,6,9,0.0,5.0,2.5,0.0588,1,1,1,1,4.0,4.5,2.4
1068,256,0,Middle East & Africa,Commercial,Pharmacovigilance,Meets,Female,38,9,0,7,10,3.3,3.0,2.5,0.0422,1,1,1,1,2.9,2.7,3.4
1069,470,0,North America,Manufacturing,Regulatory Affairs,Meets,Male,34,22,0,12,43,2.8,5.0,4.5,0.0348,1,1,1,1,4.0,4.7,4.7
1070,289,0,North America,Commercial,Supply Chain,Meets,Female,44,10,1,9,19,0.0,1.8,1.6,0.0422,0,0,0,0,3.2,3.7,3.2
1071,2,0,Middle East & Africa,R&D,Communications,Meets,Female,44,8,1,11,25,0.0,3.9,2.5,0.0977,0,0,0,0,4.3,3.8,3.2
1072,576,0,Asia Pacific,Digital,IT & Digital,Meets,Female,43,7,0,12,15,3.6,2.9,2.6,0.0853,1,1,1,1,4.2,2.0,2.9
1073,492,0,Asia Pacific,Manufacturing,Finance & Accounting,Far Below,Female,36,10,0,11,30,3.4,1.6,2.7,0.0,1,1,1,1,3.2,2.4,3.7
1074,825,0,Asia Pacific,HR,Regulatory Affairs,Below,Male,34,7,0,6,15,4.1,3.1,4.5,0.0,1,0,0,0,4.5,3.5,3.9
1075,946,0,Middle East & Africa,Finance,IT & Digital,Meets,Male,32,3,0,8,30,2.5,2.2,2.5,0.0331,1,1,1,1,2.3,2.0,1.0
1076,380,0,North America,Manufacturing,Medical Affairs,Exceeds,Male,43,22,0,12,23,1.9,4.0,1.8,0.0616,1,1,1,1,2.1,4.2,2.6
1077,475,0,Middle East & Africa,Manufacturing,Marketing,Meets,Male,35,3,1,5,13,0.0,2.6,4.7,0.0348,1,1,1,1,3.1,1.5,5.0
1078,317,0,Middle East & Africa,Commercial,Legal & Compliance,Exceeds,Male,43,11,0,5,8,2.7,2.1,2.1,0.0743,1,1,1,1,2.8,3.1,1.5
1079,830,0,Asia Pacific,HR,Regulatory Affairs,Meets,Female,33,6,0,8,13,2.5,3.9,2.8,0.0383,0,0,0,0,3.1,3.1,2.6
1080,967,0,Europe,Finance,Regulatory Affairs,Exceeds,Male,37,12,0,10,23,3.5,4.8,2.0,0.0588,1,1,1,1,4.5,3.3,1.6
1081,26,0,North America,R&D,Regulatory Affairs,Below,Female,35,29,0,8,15,3.5,2.9,2.4,0.0,0,0,0,0,4.1,3.7,4.4
1082,81,1,Asia Pacific,R&D,Data Science,Meets,Male,34,8,0,8,11,4.3,3.1,3.4,0.0977,1,1,1,1,4.6,3.5,3.1
1083,439,0,Europe,Manufacturing,Sales,Meets,Male,28,10,0,7,14,3.4,2.8,2.9,0.0348,1,1,1,1,3.7,1.0,3.5
1084,443,0,Europe,Manufacturing,Pharmacovigilance,Meets,Male,30,12,0,7,27,3.4,2.2,2.2,0.0348,0,0,0,0,3.1,1.8,2.0
1085,659,0,Latin America,Digital,Marketing,Meets,Female,45,18,0,5,15,2.8,3.1,2.9,0.0853,1,1,1,1,3.6,4.4,2.2
1086,815,0,North America,HR,Communications,Exceeds,Female,33,18,0,11,13,4.6,3.3,4.2,0.0677,1,1,1,1,4.3,1.2,2.2
1087,976,0,Europe,Finance,Communications,Meets,Male,42,11,0,11,21,4.3,1.6,1.9,0.0331,1,1,1,1,3.8,3.3,2.3
1088,497,0,Asia Pacific,Manufacturing,IT & Digital,Exceeds,Female,38,32,0,8,39,1.8,1.6,3.4,0.0616,0,0,0,0,3.9,1.0,3.8
1089,564,0,Latin America,Digital,Legal & Compliance,Meets,Female,36,5,0,10,23,4.5,2.1,1.4,0.0853,1,1,1,1,4.8,1.3,3.3
1090,854,0,North America,HR,Pharmacovigilance,Meets,Non-Binary/Other,35,11,0,9,22,2.8,2.1,1.8,0.0383,1,1,1,1,3.9,2.5,1.0
1091,1026,0,Middle East & Africa,Finance,Market Access,Meets,Female,38,5,0,11,15,4.2,2.4,2.9,0.0331,1,1,1,1,4.5,3.3,3.8
1092,122,0,Asia Pacific,R&D,Communications,Meets,Male,42,6,0,6,35,3.7,4.9,2.3,0.0977,0,0,0,0,3.4,5.0,3.3
1093,615,0,Europe,Digital,Legal & Compliance,Meets,Male,31,7,0,7,9,4.1,3.5,4.3,0.0853,1,1,1,1,4.2,2.8,4.5
1094,701,1,Europe,HR,Finance & Accounting,Meets,Male,38,18,1,9,27,0.0,2.9,3.6,0.0383,1,1,1,1,4.2,3.2,1.9
1095,695,0,Asia Pacific,Digital,Sales,Exceeds,Female,40,21,0,12,22,3.7,3.2,3.6,0.1452,1,1,1,1,3.5,3.6,2.5
1096,509,0,Europe,Manufacturing,Human Resources,Meets,Female,42,2,0,6,19,3.9,3.1,4.7,0.0348,1,1,1,1,3.5,2.6,3.9
1097,231,0,Latin America,Commercial,Marketing,Meets,Female,44,25,0,12,15,2.6,2.8,1.9,0.0422,1,1,1,1,2.0,3.3,4.0
1098,168,0,North America,R&D,Market Access,Far Below,Male,37,23,1,5,18,0.0,3.0,1.8,0.0,1,1,1,1,2.8,2.8,2.0
1099,464,1,Latin America,Manufacturing,IT & Digital,Far Exceeds,Male,30,11,0,6,18,2.7,2.5,3.1,0.1069,1,1,1,1,5.0,3.8,2.0
1100,504,0,Europe,Manufacturing,Quality Assurance,Meets,Non-Binary/Other,40,6,0,9,19,3.7,2.7,2.8,0.0348,1,1,1,1,5.0,3.8,2.9
1101,829,0,Middle East & Africa,HR,Data Science,Exceeds,Non-Binary/Other,37,14,1,9,31,0.0,2.9,2.9,0.0677,1,0,0,0,4.5,3.2,3.0
1102,588,0,North America,Digital,Regulatory Affairs,Meets,Female,45,23,0,10,21,3.6,3.2,2.3,0.0853,1,1,1,1,2.8,2.8,3.5
1103,147,0,North America,R&D,Data Science,Meets,Male,39,17,0,5,19,2.4,3.0,1.9,0.0977,1,1,1,1,2.1,2.4,1.3
1104,473,0,Asia Pacific,Manufacturing,Legal & Compliance,Meets,Female,45,6,1,9,12,0.0,2.2,2.5,0.0348,1,1,1,1,3.7,3.9,1.3
1105,843,0,Asia Pacific,HR,Pharmacovigilance,Meets,Male,35,30,0,7,11,2.6,4.1,2.1,0.0383,1,1,1,1,3.0,4.4,1.9
1106,156,0,Middle East & Africa,R&D,Communications,Meets,Female,45,30,0,9,33,1.9,2.8,3.8,0.0977,1,1,1,1,1.8,3.4,3.5
1107,600,0,North America,Digital,Marketing,Meets,Male,39,7,1,8,23,0.0,2.2,2.7,0.0853,1,1,1,1,3.5,3.0,3.0
1108,461,0,Middle East & Africa,Manufacturing,Market Access,Meets,Female,41,11,0,12,16,4.8,5.0,3.8,0.0348,1,1,1,1,4.5,4.9,3.4
1109,1034,0,Asia Pacific,Finance,IT & Digital,Exceeds,Female,28,11,0,6,15,2.8,1.0,1.8,0.0588,1,1,1,1,2.5,1.6,4.0
1110,452,0,Asia Pacific,Manufacturing,Medical Affairs,Below,Female,45,10,0,11,25,3.7,3.2,2.8,0.0,1,1,1,1,4.5,5.0,3.1
1111,397,0,North America,Manufacturing,Market Access,Meets,Female,37,4,0,5,15,3.7,2.8,2.0,0.0348,1,1,1,1,3.5,4.5,1.4
1112,162,0,Latin America,R&D,Data Science,Below,Female,41,24,0,9,12,4.1,4.5,2.5,0.0,1,1,1,1,3.5,4.2,3.0
1113,57,0,Europe,R&D,Finance & Accounting,Below,Female,36,23,0,6,16,3.5,4.3,3.7,0.0,1,1,1,1,3.5,4.3,1.4
1114,115,0,Asia Pacific,R&D,Regulatory Affairs,Meets,Female,45,16,1,8,15,0.0,3.5,4.2,0.0977,1,1,1,1,2.7,3.5,4.2
1115,46,0,Asia Pacific,R&D,Communications,Below,Male,39,6,1,10,21,0.0,3.2,4.1,0.0,1,1,1,1,4.2,2.4,4.0
1116,845,1,Latin America,HR,Legal & Compliance,Meets,Male,39,4,1,12,18,0.0,2.1,1.8,0.0383,1,1,1,1,5.0,2.8,1.3
1117,215,0,Latin America,Commercial,Medical Affairs,Meets,Female,49,4,1,12,17,0.0,4.2,3.5,0.0422,1,1,1,1,2.1,4.0,4.0
1118,757,0,Middle East & Africa,HR,Pharmacovigilance,Meets,Female,28,12,1,5,18,0.0,2.8,1.9,0.0383,1,1,1,1,4.2,3.0,1.5
1119,455,0,Middle East & Africa,Manufacturing,Medical Affairs,Below,Male,36,11,1,9,22,0.0,4.3,3.5,0.0,1,1,1,1,2.9,2.9,3.8
1120,867,0,Europe,HR,Finance & Accounting,Meets,Male,37,36,0,12,20,2.9,3.3,1.6,0.0383,1,1,1,1,2.3,3.4,2.1
1121,681,0,Europe,Digital,IT & Digital,Exceeds,Male,33,10,0,6,14,3.3,2.6,3.0,0.1452,1,1,1,1,3.4,1.3,3.1
1122,990,0,North America,Finance,Sales,Meets,Female,40,14,0,5,21,4.8,3.7,1.8,0.0331,1,1,1,1,5.0,3.5,2.2
1123,42,1,Middle East & Africa,R&D,Communications,Exceeds,Male,30,17,0,7,25,3.2,2.9,3.7,0.1648,1,1,1,1,2.2,4.6,4.2
1124,574,0,Asia Pacific,Digital,Quality Assurance,Far Below,Male,30,13,0,7,10,4.1,2.8,1.7,0.0,1,1,1,1,3.4,3.4,1.0
1125,983,0,Middle East & Africa,Finance,Regulatory Affairs,Meets,Male,41,26,0,11,12,3.5,3.0,3.1,0.0331,1,1,1,1,5.0,2.7,1.8
1126,551,0,Asia Pacific,Digital,IT & Digital,Meets,Male,33,7,1,11,33,0.0,3.7,3.4,0.0853,1,1,1,1,3.4,3.8,4.8
1127,492,0,Latin America,Manufacturing,Human Resources,Meets,Female,41,36,0,11,37,3.2,3.5,2.1,0.0348,0,0,0,0,4.4,2.5,3.5
1128,114,0,Middle East & Africa,R&D,Legal & Compliance,Meets,Female,34,6,1,12,18,0.0,2.2,2.3,0.0977,0,0,0,0,2.9,2.1,2.0
1129,618,0,Latin America,Digital,Data Science,Meets,Male,33,16,1,12,13,0.0,4.3,3.0,0.0853,0,0,0,0,3.6,2.2,3.3
1130,430,0,Europe,Manufacturing,Marketing,Meets,Male,32,11,0,9,12,3.5,2.1,3.6,0.0348,1,1,1,1,3.3,2.1,1.0
1131,6,0,Europe,R&D,IT & Digital,Meets,Female,32,25,1,12,23,0.0,3.0,4.4,0.0977,1,1,1,1,3.1,3.3,4.8
1132,348,0,North America,Commercial,Supply Chain,Meets,Female,35,12,0,6,12,2.5,2.6,3.6,0.0422,1,1,1,1,2.3,2.8,3.0
1133,475,0,Middle East & Africa,Manufacturing,Medical Affairs,Meets,Male,33,15,1,11,50,0.0,3.7,3.8,0.0348,1,1,1,1,2.9,4.0,4.0
1134,783,0,Latin America,HR,Legal & Compliance,Meets,Male,37,6,0,8,15,3.2,2.6,3.2,0.0383,1,1,1,1,4.0,2.4,3.1
1135,125,0,Asia Pacific,R&D,Communications,Exceeds,Non-Binary/Other,28,14,0,11,14,1.9,4.2,2.5,0.1648,0,0,0,0,3.6,3.6,2.0
1136,530,1,Europe,Digital,Clinical Operations,Meets,Female,33,32,0,6,12,3.5,4.0,3.2,0.0853,1,1,1,1,3.6,3.2,2.1
1137,929,0,Europe,Finance,Supply Chain,Meets,Female,45,8,1,11,21,0.0,2.5,2.7,0.0331,1,1,1,1,3.7,2.2,4.0
1138,597,0,Asia Pacific,Digital,IT & Digital,Meets,Male,30,7,0,8,27,2.5,4.0,3.2,0.0853,1,1,1,1,4.5,2.9,3.9
1139,814,0,Latin America,HR,Pharmacovigilance,Meets,Female,34,11,0,11,22,4.2,4.4,1.0,0.0383,1,1,1,1,4.3,2.8,2.0
1140,743,0,Latin America,HR,Clinical Operations,Meets,Female,45,3,0,12,20,3.4,3.5,4.2,0.0383,1,1,1,1,4.3,4.4,3.9
1141,555,0,Middle East & Africa,Digital,Legal & Compliance,Far Below,Female,38,10,0,8,14,2.5,3.4,4.7,0.0,1,0,0,0,2.1,2.5,3.3
1142,1020,0,Middle East & Africa,Finance,Clinical Operations,Meets,Non-Binary/Other,28,7,0,6,16,4.0,3.2,1.4,0.0331,1,1,1,1,2.4,3.1,2.7
1143,95,0,North America,R&D,Clinical Operations,Meets,Male,42,13,0,9,13,1.7,3.6,3.7,0.0977,1,1,1,1,1.9,2.8,2.3
1144,448,0,Europe,Manufacturing,Market Access,Meets,Female,45,12,0,7,21,1.9,2.9,3.8,0.0348,1,1,1,1,2.2,3.4,3.2
1145,736,0,Middle East & Africa,HR,Supply Chain,Meets,Male,38,9,0,12,25,2.1,2.4,2.9,0.0383,1,1,1,1,3.3,2.5,3.0
1146,734,0,Latin America,HR,Human Resources,Meets,Female,35,20,0,5,15,3.5,3.9,1.0,0.0383,0,0,0,0,3.4,5.0,2.9
1147,765,0,Asia Pacific,HR,Pharmacovigilance,Exceeds,Female,28,3,0,7,21,3.8,3.8,2.4,0.0677,1,1,1,1,4.3,2.9,3.1
1148,971,0,Latin America,Finance,Data Science,Meets,Female,35,5,0,5,7,2.6,2.9,2.0,0.0331,1,1,1,1,3.3,2.9,2.2
1149,204,0,Europe,Commercial,Quality Assurance,Meets,Male,31,9,0,5,32,3.6,3.1,4.2,0.0422,1,1,1,1,3.5,2.4,3.9
1150,950,0,Latin America,Finance,Pharmacovigilance,Meets,Male,38,11,0,7,14,4.5,3.3,2.7,0.0331,1,1,1,1,4.5,4.8,2.3
1151,107,0,North America,R&D,Data Science,Below,Male,43,3,1,10,26,0.0,4.6,3.0,0.0,1,1,1,1,2.6,2.2,1.8
1152,165,0,Europe,R&D,IT & Digital,Far Exceeds,Male,32,30,0,6,19,2.1,2.0,3.5,0.2644,1,1,1,0,2.2,2.8,4.0
1153,111,0,Asia Pacific,R&D,IT & Digital,Meets,Male,42,7,0,7,22,5.0,3.4,2.5,0.0977,1,1,1,1,4.6,3.8,2.9
1154,89,0,North America,R&D,Data Science,Meets,Female,28,6,0,9,23,3.5,3.3,2.0,0.0977,0,0,0,0,4.1,3.5,2.8
1155,80,0,Europe,R&D,Communications,Meets,Female,37,21,0,5,11,2.3,4.0,3.6,0.0977,1,1,1,1,3.2,4.6,2.2
1156,690,0,Asia Pacific,Digital,Clinical Operations,Below,Female,28,12,0,11,24,2.9,2.7,3.0,0.0,1,1,1,1,3.5,3.9,1.9
1157,873,0,North America,HR,Regulatory Affairs,Exceeds,Female,39,1,1,9,10,0.0,2.9,2.5,0.0677,1,1,1,1,2.0,3.1,2.2
1158,917,0,North America,Finance,Supply Chain,Meets,Female,45,15,0,11,15,2.4,3.9,2.2,0.0331,1,1,1,1,4.2,3.6,3.0
1159,576,0,Europe,Digital,Data Science,Meets,Female,35,20,0,10,19,3.4,2.4,1.0,0.0853,1,1,1,1,2.7,2.7,3.5
1160,915,0,Middle East & Africa,Finance,Supply Chain,Far Below,Male,39,10,0,12,19,3.5,4.0,4.1,0.0,1,1,1,0,2.8,3.1,4.1
1161,266,0,North America,Commercial,Sales,Meets,Male,35,25,0,9,11,1.8,2.5,3.7,0.0422,1,1,1,1,2.5,3.6,1.8
1162,446,0,North America,Manufacturing,Market Access,Below,Male,40,17,0,7,16,3.7,2.5,4.7,0.0,1,1,1,1,3.4,2.4,5.0
1163,739,0,Asia Pacific,HR,Quality Assurance,Meets,Female,43,32,0,7,31,3.0,3.5,4.1,0.0383,1,1,1,1,1.9,3.8,2.4
1164,220,0,Latin America,Commercial,Sales,Meets,Female,38,12,0,5,15,3.6,2.9,3.7,0.0422,1,1,1,1,2.7,2.9,3.9
1165,658,0,Europe,Digital,Data Science,Below,Female,35,7,0,7,14,4.5,3.3,3.1,0.0,1,1,1,1,4.6,2.0,3.1
1166,367,0,Europe,Manufacturing,Pharmacovigilance,Meets,Female,40,4,0,10,14,4.0,3.8,2.0,0.0348,1,1,1,1,5.0,3.6,1.3
1167,227,0,Middle East & Africa,Commercial,Communications,Meets,Female,49,10,0,9,14,3.3,4.3,3.4,0.0422,0,0,0,0,3.5,3.7,4.6
1168,929,0,Middle East & Africa,Finance,Supply Chain,Exceeds,Non-Binary/Other,40,24,0,7,20,3.0,2.3,2.7,0.0588,1,1,1,1,2.7,2.2,3.9
1169,379,0,Europe,Manufacturing,Sales,Meets,Female,30,14,0,8,15,2.5,3.0,4.1,0.0348,1,1,1,1,3.6,2.9,4.4
1170,1020,0,Middle East & Africa,Finance,Supply Chain,Meets,Male,49,14,0,5,13,2.2,3.2,2.8,0.0331,1,1,1,1,3.0,2.5,2.3
1171,201,0,Asia Pacific,Commercial,Human Resources,Meets,Male,33,9,1,7,13,0.0,4.0,2.7,0.0422,1,1,1,1,2.6,3.0,3.8
1172,658,1,Europe,Digital,Market Access,Exceeds,Male,33,7,1,8,36,0.0,3.0,1.8,0.1452,1,1,1,1,5.0,1.9,1.3
1173,954,0,Middle East & Africa,Finance,Pharmacovigilance,Meets,Female,44,6,1,6,26,0.0,2.1,4.0,0.0331,1,1,1,1,3.2,2.1,2.9
1174,358,0,Europe,Manufacturing,Sales,Meets,Female,35,5,0,7,18,1.9,2.9,1.9,0.0348,1,0,0,0,3.6,3.6,1.7
1175,178,0,Latin America,Commercial,Supply Chain,Far Below,Male,41,12,1,6,9,0.0,2.3,3.4,0.0,1,1,1,1,4.9,3.1,1.8
1176,975,0,North America,Finance,Human Resources,Meets,Female,41,13,0,12,20,4.3,2.8,4.1,0.0331,1,1,1,1,4.5,4.2,2.8
1177,666,0,Europe,Digital,Pharmacovigilance,Exceeds,Male,41,14,0,11,23,3.0,2.6,2.8,0.1452,1,1,1,1,2.2,3.6,1.9
1178,749,0,North America,HR,Clinical Operations,Meets,Female,47,10,0,11,20,2.1,2.6,3.0,0.0383,1,1,1,1,2.6,2.7,2.3
1179,534,0,Middle East & Africa,Digital,Medical Affairs,Meets,Male,36,19,0,10,40,3.6,3.7,1.3,0.0853,1,1,1,1,3.0,3.7,2.5
1180,583,0,North America,Digital,Clinical Operations,Meets,Male,38,15,0,12,22,3.4,1.9,1.4,0.0853,1,1,1,1,3.4,3.1,1.0
1181,762,0,Europe,HR,Quality Assurance,Below,Male,32,24,0,10,19,2.7,3.7,1.5,0.0,0,0,0,0,3.6,5.0,1.0
1182,624,1,Latin America,Digital,Data Science,Far Exceeds,Male,42,15,1,12,16,0.0,4.4,3.6,0.2363,1,1,1,1,4.3,4.1,2.2
1183,813,0,Middle East & Africa,HR,Regulatory Affairs,Meets,Male,39,5,1,7,18,0.0,3.7,1.7,0.0383,1,1,1,1,4.1,4.3,2.1
1184,798,0,Europe,HR,Legal & Compliance,Meets,Female,46,20,0,11,30,3.3,2.9,3.6,0.0383,1,1,1,1,3.8,3.9,2.7
1185,1047,0,Middle East & Africa,Finance,Medical Affairs,Meets,Male,40,3,0,5,9,4.4,3.8,1.5,0.0331,0,0,0,0,4.2,5.0,1.9
1186,1032,0,Asia Pacific,Finance,Human Resources,Exceeds,Female,48,5,1,5,10,0.0,2.0,2.6,0.0588,1,1,1,1,2.4,3.1,3.3
1187,770,0,North America,HR,Data Science,Exceeds,Male,37,8,0,8,26,3.2,2.9,2.1,0.0677,1,1,1,1,4.5,1.6,1.6
1188,337,0,Asia Pacific,Commercial,Human Resources,Far Below,Male,39,17,0,11,21,3.4,2.5,2.4,0.0,1,1,1,1,2.8,3.0,2.6
1189,438,0,Europe,Manufacturing,Sales,Far Exceeds,Female,38,12,0,5,28,3.5,3.3,4.0,0.1069,1,1,1,1,3.9,3.4,3.0
1190,190,0,Latin America,Commercial,Communications,Exceeds,Male,34,6,0,10,12,3.7,2.7,1.0,0.0743,1,1,1,1,4.3,3.1,2.8
1191,783,0,Middle East & Africa,HR,Finance & Accounting,Meets,Female,28,15,0,6,9,3.2,2.1,4.2,0.0383,0,0,0,0,2.8,3.8,3.8
1192,433,0,North America,Manufacturing,Quality Assurance,Exceeds,Male,39,2,0,7,12,4.6,2.4,3.2,0.0616,1,1,1,1,3.5,1.4,3.4
1193,997,0,Middle East & Africa,Finance,Market Access,Meets,Male,28,27,0,11,16,2.4,2.1,1.5,0.0331,1,1,1,1,2.3,2.3,2.5
1194,366,0,Europe,Manufacturing,Quality Assurance,Meets,Male,41,2,0,10,19,4.0,2.0,3.5,0.0348,1,1,1,1,3.9,4.7,1.7
1195,742,0,Middle East & Africa,HR,Human Resources,Meets,Female,45,10,0,5,11,2.9,3.1,2.1,0.0383,1,1,1,1,2.7,3.0,3.5
1196,971,0,North America,Finance,Supply Chain,Meets,Male,38,19,0,10,27,3.3,3.8,2.5,0.0331,1,1,1,1,2.3,4.3,1.8
1197,390,0,Europe,Manufacturing,Quality Assurance,Far Below,Female,40,9,0,8,15,4.3,3.6,4.1,0.0,1,1,1,1,3.5,2.0,4.1
1198,382,0,Middle East & Africa,Manufacturing,Finance & Accounting,Exceeds,Female,40,14,0,12,13,3.8,2.0,1.4,0.0616,1,1,1,1,5.0,2.1,2.8
1199,225,0,Latin America,Commercial,Finance & Accounting,Far Exceeds,Male,44,11,1,5,24,0.0,2.3,2.6,0.1275,1,1,1,1,4.8,4.2,1.4
1200,473,0,Europe,Manufacturing,Sales,Meets,Female,37,15,0,11,20,3.2,2.2,3.5,0.0348,1,1,1,1,3.3,3.3,2.5
1201,739,0,Europe,HR,Market Access,Meets,Male,31,9,0,6,12,2.3,1.7,2.0,0.0383,0,0,0,0,3.8,3.0,1.0
1202,10,0,Latin America,R&D,Market Access,Meets,Female,28,4,1,8,25,0.0,1.0,1.0,0.0977,0,0,0,0,3.2,2.3,2.3
1203,39,0,Asia Pacific,R&D,Human Resources,Meets,Female,36,15,0,10,12,3.4,1.5,1.8,0.0977,1,1,1,1,4.9,2.5,4.1
1204,95,0,North America,R&D,IT & Digital,Meets,Male,28,3,0,7,14,3.7,3.4,3.2,0.0977,1,1,1,1,2.8,4.0,3.1
1205,698,0,Asia Pacific,HR,Human Resources,Meets,Female,38,12,1,6,12,0.0,2.9,1.0,0.0383,1,1,1,1,4.7,1.7,2.1
1206,123,0,Middle East & Africa,R&D,Finance & Accounting,Below,Male,40,10,0,7,9,3.0,3.3,1.0,0.0,1,0,0,0,2.9,3.8,2.8
1207,199,0,Latin America,Commercial,Marketing,Below,Male,35,5,0,7,17,2.3,3.2,3.1,0.0,1,1,1,1,1.8,2.3,3.2
1208,803,0,Asia Pacific,HR,Quality Assurance,Meets,Female,42,6,0,9,14,2.7,5.0,1.6,0.0383,0,0,0,0,2.0,4.2,2.0
1209,888,0,Europe,Finance,Communications,Meets,Non-Binary/Other,39,11,1,10,19,0.0,3.4,3.7,0.0331,1,1,1,1,2.7,3.0,3.9
1210,853,0,Middle East & Africa,HR,Finance & Accounting,Exceeds,Female,34,13,0,12,17,4.8,3.6,3.2,0.0677,1,1,1,1,3.9,3.3,2.4
1211,866,0,Middle East & Africa,HR,Clinical Operations,Meets,Male,35,12,0,9,10,2.9,4.5,2.3,0.0383,1,1,1,1,3.8,4.1,2.9
1212,361,0,Asia Pacific,Manufacturing,Marketing,Far Below,Female,46,10,0,7,10,1.7,3.4,3.5,0.0,1,1,1,1,2.5,2.8,3.0
1213,464,0,Asia Pacific,Manufacturing,Marketing,Meets,Male,28,28,0,11,24,2.1,4.9,2.8,0.0348,1,1,0,0,3.6,4.6,1.8
1214,400,0,Latin America,Manufacturing,Communications,Meets,Male,37,21,0,9,13,5.0,3.3,2.6,0.0348,1,1,1,1,5.0,2.2,2.5
1215,685,0,North America,Digital,Human Resources,Meets,Female,39,3,0,9,17,3.5,3.1,3.0,0.0853,1,1,1,0,3.2,3.5,1.9
1216,272,0,Asia Pacific,Commercial,Finance & Accounting,Meets,Male,34,5,0,8,10,4.1,4.3,2.4,0.0422,1,1,1,1,5.0,4.4,2.4
1217,774,0,Asia Pacific,HR,Sales,Meets,Female,34,2,0,6,11,2.2,3.0,3.0,0.0383,1,1,0,0,2.4,3.9,1.5
1218,831,0,Europe,HR,Medical Affairs,Meets,Female,45,22,0,11,23,4.2,1.6,1.4,0.0383,1,1,1,1,4.1,2.5,2.8
1219,518,0,Middle East & Africa,Manufacturing,Clinical Operations,Far Below,Female,50,14,0,7,25,2.2,3.7,4.9,0.0,0,0,0,0,2.8,4.4,4.0
1220,752,0,North America,HR,Human Resources,Meets,Female,36,14,1,6,23,0.0,1.9,3.8,0.0383,0,0,0,0,2.5,2.7,2.7
1221,936,0,Europe,Finance,Market Access,Meets,Male,38,20,0,7,13,3.6,2.1,3.1,0.0331,1,1,1,1,3.0,3.5,1.9
1222,854,0,Latin America,HR,Human Resources,Below,Non-Binary/Other,41,9,0,12,16,3.3,3.8,3.8,0.0,1,1,1,1,2.9,2.6,3.1
1223,17,0,Latin America,R&D,Quality Assurance,Meets,Male,32,5,0,11,12,3.5,4.3,3.9,0.0977,1,1,1,1,3.1,3.6,3.2
1224,1012,0,Asia Pacific,Finance,Marketing,Below,Female,38,12,0,5,27,2.6,2.3,2.7,0.0,1,1,1,1,4.4,2.6,2.6
1225,967,0,Asia Pacific,Finance,Data Science,Far Exceeds,Female,47,16,0,10,21,3.1,3.5,1.9,0.1022,1,1,1,1,3.6,3.1,2.6
1226,878,0,Latin America,HR,IT & Digital,Meets,Female,52,22,0,9,22,2.4,3.1,1.5,0.0383,1,1,1,1,5.0,2.2,2.1
1227,572,0,Asia Pacific,Digital,Data Science,Meets,Male,31,16,0,5,21,4.5,1.5,3.5,0.0853,1,1,1,1,4.0,1.9,4.2
1228,394,0,North America,Manufacturing,IT & Digital,Exceeds,Male,33,17,0,10,31,3.2,2.9,4.2,0.0616,1,0,0,0,2.4,2.0,2.2
1229,269,0,Asia Pacific,Commercial,Marketing,Meets,Female,35,4,0,10,11,2.4,4.1,2.2,0.0422,0,0,0,0,2.1,3.8,3.2
1230,316,0,Middle East & Africa,Commercial,IT & Digital,Meets,Male,36,19,0,9,17,4.8,2.8,3.1,0.0422,1,1,1,1,4.2,5.0,2.8
1231,48,0,Asia Pacific,R&D,Communications,Meets,Female,45,8,0,9,12,2.9,2.1,3.9,0.0977,1,1,1,1,4.1,1.7,3.2
1232,247,0,Europe,Commercial,Supply Chain,Meets,Male,38,8,1,6,13,0.0,4.4,3.5,0.0422,1,1,1,1,4.6,4.6,2.4
1233,299,0,North America,Commercial,Quality Assurance,Meets,Male,44,21,0,5,21,2.9,1.7,3.3,0.0422,0,0,0,0,2.6,1.6,4.9
1234,505,0,Europe,Manufacturing,Sales,Meets,Male,39,6,0,7,11,3.4,1.9,5.0,0.0348,1,1,1,1,2.9,3.3,5.0
1235,507,0,Europe,Manufacturing,Market Access,Exceeds,Male,37,3,0,8,14,3.9,3.4,2.3,0.0616,1,1,1,0,3.7,3.5,3.3
1236,535,0,Middle East & Africa,Digital,Marketing,Below,Female,41,11,0,9,9,3.1,3.5,2.6,0.0,1,1,1,1,4.3,3.4,1.3
1237,54,0,North America,R&D,IT & Digital,Below,Female,28,16,0,10,25,3.7,2.5,1.9,0.0,1,1,1,1,3.7,2.4,2.7
1238,246,0,North America,Commercial,Clinical Operations,Meets,Female,36,5,1,8,14,0.0,1.8,1.6,0.0422,1,1,1,1,4.4,3.8,1.8
1239,546,0,North America,Digital,Marketing,Meets,Male,36,12,0,6,15,2.5,3.9,2.9,0.0853,1,1,1,1,2.6,5.0,3.1
1240,126,0,North America,R&D,Pharmacovigilance,Meets,Male,30,8,0,12,17,1.8,2.2,1.5,0.0977,1,1,1,1,2.2,2.9,1.5
1241,1033,0,North America,Finance,Market Access,Exceeds,Male,46,19,0,7,21,2.9,1.9,1.0,0.0588,0,0,0,0,3.8,3.8,2.9
1242,223,0,Middle East & Africa,Commercial,Medical Affairs,Exceeds,Male,37,20,1,9,11,0.0,2.2,2.2,0.0743,1,1,1,1,2.7,2.9,3.2
1243,254,0,Asia Pacific,Commercial,Legal & Compliance,Meets,Female,40,5,1,12,21,0.0,3.1,2.4,0.0422,1,1,1,1,4.2,3.6,1.9
1244,363,0,Europe,Manufacturing,Legal & Compliance,Meets,Non-Binary/Other,43,7,1,7,14,0.0,2.9,3.9,0.0348,1,1,1,1,5.0,2.0,4.4
1245,855,0,North America,HR,Market Access,Far Exceeds,Female,33,11,0,7,15,3.8,2.5,1.1,0.1168,0,0,0,0,3.3,2.5,1.1
1246,55,0,Asia Pacific,R&D,Finance & Accounting,Meets,Female,40,20,0,5,16,3.9,2.9,1.4,0.0977,1,1,1,1,2.8,3.7,3.7
1247,330,0,Asia Pacific,Commercial,Clinical Operations,Below,Female,28,9,0,6,20,3.2,3.8,2.1,0.0,1,1,1,1,3.6,5.0,3.0
1248,10,0,Europe,R&D,Legal & Compliance,Meets,Female,41,4,1,8,19,0.0,3.6,2.3,0.0977,1,1,1,1,2.5,3.1,2.8
1249,557,0,Middle East & Africa,Digital,Human Resources,Meets,Female,35,5,1,5,17,0.0,4.5,1.4,0.0853,1,1,1,1,4.2,4.7,1.4
1250,642,0,Latin America,Digital,Pharmacovigilance,Below,Female,36,7,0,6,12,3.3,2.8,2.8,0.0,1,1,1,1,3.2,2.9,2.8
1251,774,0,Latin America,HR,Medical Affairs,Meets,Female,45,25,0,7,20,3.3,3.8,3.0,0.0383,1,0,0,0,3.7,3.4,4.0
1252,294,0,Asia Pacific,Commercial,Regulatory Affairs,Exceeds,Female,49,11,0,12,19,3.4,3.6,1.2,0.0743,1,1,1,1,3.3,2.4,1.8
1253,429,0,Europe,Manufacturing,Clinical Operations,Meets,Female,34,9,0,5,17,3.0,2.6,3.3,0.0348,1,1,1,1,3.6,4.7,3.0
1254,340,0,Latin America,Commercial,Data Science,Meets,Female,33,14,0,5,15,3.0,4.5,3.4,0.0422,1,1,1,1,2.8,4.9,2.6
1255,126,0,Asia Pacific,R&D,Supply Chain,Meets,Female,42,18,0,8,9,4.2,5.0,1.4,0.0977,1,1,1,0,4.4,3.7,2.5
1256,1000,0,Middle East & Africa,Finance,Human Resources,Meets,Female,42,12,0,11,14,2.5,3.0,4.0,0.0331,1,1,1,1,3.3,3.5,2.2
1257,542,0,Latin America,Digital,Market Access,Meets,Male,31,17,0,7,12,3.1,3.0,3.6,0.0853,1,1,1,1,2.4,2.7,4.2
1258,151,0,Asia Pacific,R&D,Regulatory Affairs,Meets,Female,38,11,0,7,11,4.6,3.7,2.1,0.0977,1,1,1,1,3.4,3.9,1.9
1259,760,0,Asia Pacific,HR,Communications,Meets,Male,38,8,0,9,29,3.2,2.4,1.9,0.0383,1,1,1,1,2.6,3.0,2.4
1260,626,0,North America,Digital,Pharmacovigilance,Exceeds,Female,38,6,1,9,21,0.0,3.8,1.1,0.1452,0,0,0,0,4.1,2.2,2.4
1261,472,0,Middle East & Africa,Manufacturing,IT & Digital,Far Exceeds,Male,42,13,0,9,15,2.8,4.7,1.3,0.1069,1,1,1,1,4.8,5.0,3.3
1262,533,0,North America,Digital,Finance & Accounting,Exceeds,Male,47,23,0,7,9,2.4,3.8,2.2,0.1452,1,1,1,1,2.2,3.5,3.1
1263,1044,0,Europe,Finance,Human Resources,Below,Female,37,9,0,10,19,4.8,2.6,2.5,0.0,1,1,1,1,3.7,3.7,1.6
1264,208,0,North America,Commercial,Regulatory Affairs,Far Below,Female,49,7,1,7,17,0.0,3.5,3.1,0.0,1,1,1,1,4.1,3.2,4.0
1265,1029,0,North America,Finance,Sales,Meets,Male,37,23,0,5,11,3.3,3.3,3.6,0.0331,1,1,1,1,4.1,3.0,1.0
1266,887,0,Latin America,Finance,Quality Assurance,Meets,Male,48,8,0,11,30,4.6,1.9,1.6,0.0331,1,1,1,1,5.0,1.7,1.9
1267,239,0,Asia Pacific,Commercial,Finance & Accounting,Far Exceeds,Female,41,5,1,5,8,0.0,3.9,2.7,0.1275,1,1,1,1,2.5,4.5,2.7
1268,631,1,Middle East & Africa,Digital,Finance & Accounting,Meets,Male,45,25,0,11,13,3.9,2.6,3.2,0.0853,1,1,1,1,5.0,3.5,2.3
1269,835,0,North America,HR,IT & Digital,Meets,Male,44,11,0,7,29,3.7,4.6,3.4,0.0383,1,1,1,1,5.0,3.3,1.8
1270,274,0,Middle East & Africa,Commercial,Market Access,Far Below,Female,33,1,0,11,22,3.3,4.4,2.1,0.0,1,1,1,1,4.1,4.0,3.2
1271,279,0,North America,Commercial,Quality Assurance,Exceeds,Female,40,13,1,12,19,0.0,4.5,3.2,0.0743,1,1,1,1,5.0,4.1,2.3
1272,500,0,Europe,Manufacturing,Data Science,Below,Female,33,20,0,5,13,3.5,3.4,3.2,0.0,1,0,0,0,2.1,3.8,2.3
1273,557,0,North America,Digital,Regulatory Affairs,Below,Female,37,14,0,8,18,3.4,3.8,4.2,0.0,1,1,1,1,5.0,4.7,3.4
1274,187,0,Latin America,Commercial,Pharmacovigilance,Exceeds,Female,31,7,1,7,24,0.0,4.0,2.6,0.0743,1,1,0,0,3.6,2.9,2.2
1275,698,0,Asia Pacific,HR,Data Science,Meets,Female,37,25,0,8,13,3.3,4.7,2.5,0.0383,1,1,1,1,3.8,4.6,2.6
1276,132,0,Europe,R&D,Quality Assurance,Below,Female,38,11,0,5,16,3.8,2.8,2.0,0.0,1,1,1,1,4.1,3.8,3.8
1277,671,0,North America,Digital,Regulatory Affairs,Meets,Male,33,18,0,11,13,4.0,2.5,1.7,0.0853,1,1,1,1,3.6,3.2,2.0
1278,424,0,Middle East & Africa,Manufacturing,Data Science,Below,Male,38,5,1,9,15,0.0,1.6,2.3,0.0,1,0,0,0,3.6,1.7,2.3
1279,1029,0,Europe,Finance,Clinical Operations,Meets,Female,43,19,0,8,15,1.9,2.8,1.4,0.0331,1,1,1,1,3.6,3.1,3.3
1280,353,0,Europe,Commercial,Legal & Compliance,Meets,Female,32,8,0,5,6,3.3,3.1,2.2,0.0422,1,1,1,1,4.7,1.4,2.5
1281,797,0,North America,HR,Human Resources,Exceeds,Male,43,17,0,8,48,2.6,1.9,1.4,0.0677,1,1,1,1,1.0,2.4,2.8
1282,689,0,Europe,Digital,Marketing,Meets,Female,44,15,0,5,11,2.1,3.5,1.4,0.0853,1,1,1,1,2.3,2.5,2.2
1283,726,0,Middle East & Africa,HR,Finance & Accounting,Meets,Female,32,9,0,11,29,2.8,4.1,1.8,0.0383,1,1,1,1,3.7,4.4,1.6
1284,800,0,Europe,HR,Supply Chain,Below,Male,28,17,0,8,12,2.9,2.3,3.1,0.0,1,1,1,1,3.7,3.2,1.6
1285,973,0,Middle East & Africa,Finance,Medical Affairs,Meets,Female,45,14,0,6,8,2.5,3.5,3.3,0.0331,1,1,1,1,2.4,2.5,3.1
1286,504,0,North America,Manufacturing,Clinical Operations,Meets,Female,37,9,0,11,19,3.3,2.9,2.6,0.0348,1,1,1,1,4.2,4.8,3.0
1287,653,0,Asia Pacific,Digital,Data Science,Meets,Male,38,13,0,6,23,3.9,3.3,2.8,0.0853,1,1,1,1,2.5,4.7,3.7
1288,234,0,Europe,Commercial,Pharmacovigilance,Meets,Female,50,10,0,10,14,3.7,3.7,3.3,0.0422,1,1,1,1,2.7,3.8,2.9
1289,510,0,Asia Pacific,Manufacturing,Sales,Meets,Male,41,10,0,6,26,2.9,2.7,2.3,0.0348,1,0,0,0,3.1,1.8,3.3
1290,241,0,Middle East & Africa,Commercial,Marketing,Exceeds,Female,41,5,0,7,14,4.0,2.7,2.9,0.0743,1,1,1,1,3.7,3.4,2.4
1291,1,0,Europe,R&D,Medical Affairs,Meets,Female,38,8,0,9,15,2.8,2.1,1.7,0.0977,0,0,0,0,3.5,2.8,1.5
1292,793,0,Latin America,HR,Clinical Operations,Below,Female,37,24,0,9,16,4.6,2.4,3.1,0.0,1,1,1,1,4.5,4.2,2.8
1293,164,0,Asia Pacific,R&D,Legal & Compliance,Meets,Male,38,16,0,9,12,3.5,3.5,2.5,0.0977,1,1,1,1,3.3,2.2,3.1
1294,810,0,Europe,HR,Sales,Meets,Male,37,12,0,5,11,4.0,3.2,3.0,0.0383,1,1,1,1,4.7,2.9,3.4
1295,907,0,Asia Pacific,Finance,Sales,Far Below,Female,28,29,0,11,19,2.9,2.0,2.4,0.0,1,1,1,1,2.8,3.8,3.7
1296,512,0,Europe,Manufacturing,Sales,Meets,Male,32,3,1,10,11,0.0,2.3,4.1,0.0348,1,1,1,1,3.9,3.5,3.8
1297,234,0,North America,Commercial,Communications,Meets,Male,38,2,1,12,20,0.0,3.3,4.0,0.0422,0,0,0,0,2.7,2.8,4.8
1298,999,0,Asia Pacific,Finance,Marketing,Far Exceeds,Male,50,6,1,7,27,0.0,4.6,4.0,0.1022,1,1,1,1,2.6,4.6,4.3
1299,270,0,Latin America,Commercial,Human Resources,Meets,Female,30,7,0,7,32,3.0,2.5,1.0,0.0422,1,1,1,1,3.2,2.7,1.0
1300,400,0,Latin America,Manufacturing,Regulatory Affairs,Below,Female,35,24,0,5,10,2.2,2.0,3.1,0.0,1,1,1,1,1.6,2.0,3.9
1301,616,0,Middle East & Africa,Digital,Clinical Operations,Meets,Non-Binary/Other,35,21,0,11,14,2.8,2.4,4.4,0.0853,1,1,1,1,2.9,3.6,4.6
1302,14,0,Europe,R&D,Communications,Meets,Male,42,9,0,10,11,2.4,3.0,2.8,0.0977,1,1,1,1,3.7,3.9,3.3
1303,125,0,Asia Pacific,R&D,Regulatory Affairs,Meets,Male,39,8,1,10,16,0.0,2.1,3.0,0.0977,1,1,1,1,2.1,2.5,3.2
1304,202,0,Middle East & Africa,Commercial,Finance & Accounting,Meets,Female,34,6,0,12,39,3.5,3.2,2.9,0.0422,0,0,0,0,3.7,2.5,3.0
1305,343,0,Asia Pacific,Commercial,Market Access,Exceeds,Female,45,15,0,8,10,2.6,3.7,4.9,0.0743,1,1,1,1,3.9,3.0,2.9
1306,258,0,Europe,Commercial,Marketing,Exceeds,Male,32,13,0,12,13,4.3,3.0,3.4,0.0743,1,1,1,1,4.2,3.4,1.8
1307,428,0,Latin America,Manufacturing,Sales,Below,Male,35,7,1,10,18,0.0,3.0,3.7,0.0,1,1,1,1,3.7,1.8,2.5
1308,645,0,North America,Digital,Communications,Meets,Male,31,9,0,8,28,2.6,3.9,2.6,0.0853,1,1,1,1,3.6,4.0,4.3
1309,18,0,Latin America,R&D,Sales,Meets,Female,44,6,0,10,25,4.2,3.9,3.3,0.0977,1,1,1,1,3.5,3.6,4.2
1310,931,0,Middle East & Africa,Finance,IT & Digital,Meets,Male,38,19,0,11,16,3.8,2.5,2.3,0.0331,1,1,1,1,3.5,3.0,2.8
1311,834,1,North America,HR,IT & Digital,Exceeds,Non-Binary/Other,34,10,1,7,32,0.0,2.9,4.5,0.0677,1,1,1,1,3.5,3.7,4.2
1312,506,0,Middle East & Africa,Manufacturing,Communications,Exceeds,Female,41,9,0,9,11,3.1,4.7,1.8,0.0616,1,1,1,1,4.0,2.7,3.4
1313,30,0,Europe,R&D,Marketing,Below,Male,47,17,0,9,14,1.9,3.4,1.5,0.0,1,1,1,1,1.0,2.8,2.2
1314,579,0,North America,Digital,Legal & Compliance,Below,Male,28,16,0,7,12,3.8,4.1,1.5,0.0,1,1,1,1,3.2,3.9,4.4
1315,427,0,Middle East & Africa,Manufacturing,Market Access,Meets,Male,42,12,0,8,12,4.1,2.5,3.1,0.0348,1,1,1,1,4.1,3.1,2.9
1316,907,0,Europe,Finance,Supply Chain,Meets,Female,48,6,1,5,11,0.0,2.2,4.6,0.0331,1,1,1,1,3.1,2.9,4.1
1317,65,0,Latin America,R&D,Pharmacovigilance,Exceeds,Female,47,12,0,6,17,4.7,2.6,2.8,0.1648,1,1,1,1,5.0,3.0,1.9
1318,443,0,Europe,Manufacturing,Supply Chain,Below,Male,37,9,0,8,21,3.8,2.8,5.0,0.0,1,1,0,0,4.3,2.2,3.0
1319,119,0,Asia Pacific,R&D,Regulatory Affairs,Meets,Female,39,25,0,10,20,3.3,3.4,4.1,0.0977,1,1,1,1,2.9,4.1,3.9
1320,170,0,Europe,R&D,Marketing,Meets,Female,39,5,0,7,15,3.8,3.7,3.3,0.0977,1,1,1,1,4.8,3.1,3.8
1321,666,0,Europe,Digital,Pharmacovigilance,Far Below,Male,36,9,0,12,18,2.6,2.7,1.6,0.0,1,1,1,1,3.0,2.8,1.4
1322,841,0,Asia Pacific,HR,Supply Chain,Meets,Male,44,20,0,6,20,3.4,2.0,3.5,0.0383,1,1,1,0,4.0,2.6,4.4
1323,556,0,Middle East & Africa,Digital,Regulatory Affairs,Exceeds,Male,28,8,1,10,15,0.0,3.2,5.0,0.1452,1,1,1,0,2.5,2.1,4.9
1324,127,0,Middle East & Africa,R&D,Data Science,Meets,Male,41,19,0,9,25,3.4,4.4,3.8,0.0977,0,0,0,0,4.0,5.0,1.8
1325,441,0,Europe,Manufacturing,Quality Assurance,Below,Female,38,10,0,5,8,3.5,4.8,3.8,0.0,0,0,0,0,4.4,3.1,4.4
1326,1034,0,Asia Pacific,Finance,Human Resources,Below,Male,44,21,0,11,15,3.5,1.2,1.9,0.0,1,1,1,1,4.5,2.5,2.3
1327,683,0,Asia Pacific,Digital,Pharmacovigilance,Meets,Male,45,24,0,12,16,3.2,3.7,3.1,0.0853,1,1,1,1,2.3,2.3,2.6
1328,785,0,Latin America,HR,Medical Affairs,Meets,Female,39,4,0,5,30,2.5,4.5,4.4,0.0383,1,1,1,1,2.8,3.0,3.1
1329,100,0,Middle East & Africa,R&D,Pharmacovigilance,Meets,Male,34,25,0,11,26,5.0,2.6,3.4,0.0977,1,1,1,1,4.5,3.9,3.4
1330,944,0,North America,Finance,Regulatory Affairs,Meets,Male,44,10,0,9,25,2.5,3.2,1.5,0.0331,0,0,0,0,2.3,2.6,1.7
1331,618,0,Middle East & Africa,Digital,Finance & Accounting,Meets,Female,30,9,0,11,18,2.3,3.8,3.1,0.0853,1,1,1,1,2.7,3.6,5.0
1332,623,0,Middle East & Africa,Digital,Human Resources,Meets,Male,32,3,1,8,27,0.0,3.9,2.8,0.0853,0,0,0,0,2.3,3.8,2.3
1333,692,0,Latin America,Digital,Sales,Below,Male,38,23,0,12,15,3.2,2.6,2.4,0.0,1,1,1,1,4.7,4.0,4.8
1334,692,0,North America,Digital,Human Resources,Meets,Male,35,9,1,12,19,0.0,4.4,3.3,0.0853,1,1,1,1,3.4,3.7,3.5
1335,987,0,Latin America,Finance,Regulatory Affairs,Meets,Female,37,12,0,6,28,3.9,3.1,2.2,0.0331,1,1,1,1,3.8,2.3,2.9
1336,398,0,North America,Manufacturing,Human Resources,Exceeds,Male,36,9,0,10,11,2.5,2.5,3.1,0.0616,0,0,0,0,2.7,1.0,3.8
1337,796,0,Europe,HR,Clinical Operations,Far Below,Female,38,18,0,12,13,4.4,2.1,2.3,0.0,1,1,1,1,3.3,1.0,2.5
1338,710,0,North America,HR,Finance & Accounting,Meets,Female,47,20,1,12,16,0.0,3.9,2.1,0.0383,1,1,1,1,4.2,4.7,3.0
1339,82,0,Latin America,R&D,Legal & Compliance,Below,Female,31,9,0,10,17,2.0,2.2,1.8,0.0,1,1,1,1,1.9,3.1,3.2
1340,230,0,Middle East & Africa,Commercial,Sales,Far Exceeds,Female,35,6,0,6,38,3.7,4.3,2.4,0.1275,1,1,1,1,4.3,5.0,4.4
1341,473,0,North America,Manufacturing,Regulatory Affairs,Meets,Male,43,13,0,11,17,3.2,4.0,3.0,0.0348,1,1,1,1,1.7,4.0,3.6
1342,117,0,North America,R&D,Legal & Compliance,Meets,Male,38,14,1,8,15,0.0,1.6,3.1,0.0977,1,1,1,1,2.3,2.7,3.3
1343,136,0,Asia Pacific,R&D,Finance & Accounting,Meets,Male,32,7,0,12,17,4.0,3.6,2.3,0.0977,1,0,0,0,4.0,2.2,2.4
1344,681,0,Middle East & Africa,Digital,Supply Chain,Exceeds,Male,37,13,0,12,19,4.4,1.6,3.5,0.1452,1,1,1,1,3.6,1.9,3.6
1345,329,0,Europe,Commercial,Quality Assurance,Exceeds,Non-Binary/Other,29,10,0,8,32,2.5,2.2,4.9,0.0743,1,1,1,1,4.5,4.1,4.7
1346,319,0,Latin America,Commercial,Regulatory Affairs,Exceeds,Female,44,3,0,10,18,1.3,4.8,3.9,0.0743,0,0,0,0,3.8,4.5,2.5
1347,492,0,Europe,Manufacturing,Supply Chain,Exceeds,Female,39,9,0,11,13,3.0,3.1,2.5,0.0616,1,1,1,1,3.6,2.4,3.0
1348,249,0,Middle East & Africa,Commercial,Medical Affairs,Exceeds,Female,51,9,0,5,9,2.8,2.5,2.7,0.0743,1,1,0,0,2.6,5.0,4.3
1349,89,0,North America,R&D,Clinical Operations,Meets,Non-Binary/Other,31,13,0,5,16,3.1,2.0,3.7,0.0977,1,1,1,1,3.7,3.3,2.9
1350,317,0,North America,Commercial,Human Resources,Far Below,Female,34,7,0,7,28,2.0,4.3,2.8,0.0,1,1,1,1,3.0,3.6,2.4
1351,209,0,Middle East & Africa,Commercial,Communications,Below,Female,39,10,0,10,18,3.0,4.2,3.4,0.0,1,1,1,1,3.5,4.3,2.6
1352,829,0,North America,HR,Data Science,Meets,Male,46,15,0,8,13,2.6,3.3,2.4,0.0383,1,1,1,1,1.5,2.6,2.1
1353,143,1,North America,R&D,Human Resources,Meets,Male,35,17,0,5,19,2.4,3.4,4.3,0.0977,1,1,1,1,5.0,2.9,4.3
1354,904,0,North America,Finance,IT & Digital,Meets,Male,34,12,0,6,14,1.8,3.4,2.8,0.0331,0,0,0,0,2.8,4.6,2.9
1355,249,0,Latin America,Commercial,Clinical Operations,Meets,Male,38,13,0,8,9,2.9,3.4,2.9,0.0422,1,1,1,1,3.5,2.6,1.7
1356,201,0,Latin America,Commercial,Sales,Meets,Male,34,5,0,8,23,4.3,3.9,3.8,0.0422,1,1,1,1,3.3,4.0,3.6
1357,671,0,Asia Pacific,Digital,Communications,Meets,Female,41,15,0,5,20,3.0,2.5,2.4,0.0853,1,0,0,0,2.6,2.3,3.8
1358,228,0,Europe,Commercial,Finance & Accounting,Meets,Female,38,7,1,9,17,0.0,1.6,2.6,0.0422,1,1,1,1,2.8,1.3,1.6
1359,269,0,Middle East & Africa,Commercial,Quality Assurance,Meets,Female,42,12,0,8,10,4.7,4.4,3.4,0.0422,1,1,0,0,3.5,2.8,1.3
1360,783,0,Middle East & Africa,HR,Clinical Operations,Below,Female,43,14,0,11,19,1.8,2.0,2.3,0.0,1,1,1,1,2.2,3.2,3.4
1361,43,0,Middle East & Africa,R&D,Legal & Compliance,Exceeds,Female,40,3,0,11,15,3.2,3.7,2.3,0.1648,1,1,1,1,3.4,4.3,1.6
1362,419,1,Asia Pacific,Manufacturing,Pharmacovigilance,Meets,Male,45,4,1,8,29,0.0,3.5,2.4,0.0348,1,1,1,1,3.3,4.3,4.7
1363,102,0,Latin America,R&D,Data Science,Exceeds,Female,36,9,0,8,24,2.8,2.9,2.6,0.1648,1,1,1,1,3.7,4.2,2.1
1364,659,0,Asia Pacific,Digital,Sales,Meets,Male,29,16,1,9,24,0.0,2.5,2.1,0.0853,1,1,1,1,3.6,1.8,1.4
1365,55,0,Middle East & Africa,R&D,Pharmacovigilance,Below,Female,32,17,0,10,18,3.8,3.3,2.4,0.0,1,1,1,1,3.4,3.5,1.6
1366,345,0,Europe,Commercial,Sales,Far Below,Male,37,5,0,7,17,3.2,4.3,3.4,0.0,0,0,0,0,2.4,4.2,1.6
1367,632,0,North America,Digital,Pharmacovigilance,Below,Female,41,18,0,12,44,4.0,1.9,4.5,0.0,1,1,1,1,5.0,1.3,3.7
1368,140,0,Latin America,R&D,Market Access,Below,Female,42,23,0,5,20,5.0,3.1,2.8,0.0,1,1,1,1,4.3,3.7,2.7
1369,653,0,Latin America,Digital,Quality Assurance,Below,Female,34,6,0,9,10,3.9,4.8,2.5,0.0,1,1,1,1,1.6,5.0,3.1
1370,431,0,Asia Pacific,Manufacturing,Supply Chain,Exceeds,Male,43,6,1,10,35,0.0,3.9,1.8,0.0616,1,1,1,1,3.0,5.0,1.7
1371,173,1,Latin America,R&D,Human Resources,Exceeds,Male,28,3,1,8,25,0.0,2.0,3.2,0.1648,1,1,1,1,3.8,1.5,2.6
1372,951,0,Middle East & Africa,Finance,Clinical Operations,Exceeds,Female,35,2,0,7,20,4.0,2.3,3.0,0.0588,1,1,1,1,4.4,3.7,3.1
1373,274,1,Middle East & Africa,Commercial,Medical Affairs,Far Exceeds,Male,41,20,0,8,11,3.5,4.0,1.8,0.1275,1,1,1,1,4.2,2.1,3.3
1374,572,0,Asia Pacific,Digital,Pharmacovigilance,Meets,Female,43,14,0,6,15,2.8,1.9,2.6,0.0853,1,1,1,0,2.3,2.2,2.1
1375,981,0,Middle East & Africa,Finance,Market Access,Meets,Female,43,16,0,5,12,3.3,2.8,2.4,0.0331,1,1,1,1,4.5,3.5,2.8
1376,1021,0,Europe,Finance,Quality Assurance,Below,Female,44,16,0,8,14,2.9,2.5,2.0,0.0,0,0,0,0,1.9,2.8,3.0
1377,817,0,Asia Pacific,HR,Medical Affairs,Below,Male,39,18,0,8,14,3.9,3.0,2.5,0.0,1,1,1,1,3.9,2.5,2.5
1378,556,0,Europe,Digital,IT & Digital,Meets,Female,37,5,1,10,17,0.0,4.0,3.5,0.0853,1,1,1,1,2.2,3.2,1.3
1379,998,0,North America,Finance,Clinical Operations,Exceeds,Male,28,19,0,12,17,3.2,3.0,1.0,0.0588,1,1,1,1,4.7,3.4,3.4
1380,707,0,Europe,HR,Market Access,Meets,Male,37,3,0,5,20,4.0,2.7,3.2,0.0383,1,1,1,1,4.9,2.3,3.2
1381,983,0,North America,Finance,Medical Affairs,Exceeds,Male,31,6,0,12,42,4.3,3.3,2.5,0.0588,1,1,0,0,4.7,4.7,3.9
1382,330,0,North America,Commercial,Communications,Meets,Male,42,5,1,8,18,0.0,3.1,3.6,0.0422,1,1,1,1,3.2,2.8,2.5
1383,508,0,Europe,Manufacturing,Data Science,Meets,Female,30,13,0,5,28,3.9,2.3,1.4,0.0348,1,1,1,1,4.0,3.8,2.4
1384,850,0,Asia Pacific,HR,Marketing,Meets,Male,37,8,0,12,23,4.2,2.7,1.0,0.0383,1,1,1,1,3.6,2.3,2.3
1385,414,0,Middle East & Africa,Manufacturing,Human Resources,Far Exceeds,Female,31,10,0,10,20,3.2,1.5,3.4,0.1069,1,1,1,1,3.1,2.4,2.9
1386,523,0,Middle East & Africa,Digital,Sales,Exceeds,Female,38,15,0,8,15,4.5,2.6,2.4,0.1452,1,1,1,1,3.5,3.0,4.2
1387,288,0,North America,Commercial,Sales,Meets,Female,37,7,1,5,22,0.0,4.4,2.0,0.0422,1,1,1,1,4.6,4.0,3.1
1388,748,0,North America,HR,Regulatory Affairs,Below,Male,28,8,0,6,10,2.2,3.7,2.2,0.0,1,1,1,1,3.4,4.0,3.0
1389,649,0,Asia Pacific,Digital,IT & Digital,Meets,Female,40,3,0,8,13,2.7,2.8,2.5,0.0853,1,1,1,1,2.4,1.9,2.4
1390,897,0,Latin America,Finance,Data Science,Meets,Female,36,17,0,6,16,3.2,3.9,1.9,0.0331,1,1,1,1,3.8,4.2,2.8
1391,37,0,Europe,R&D,Human Resources,Exceeds,Male,38,3,0,8,33,4.0,4.4,3.8,0.1648,1,1,1,1,3.6,4.4,2.8
1392,674,0,North America,Digital,Marketing,Below,Female,36,23,0,8,24,2.1,3.1,2.0,0.0,1,1,1,1,3.1,4.4,3.0
1393,368,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Meets,Male,34,8,0,12,16,3.3,2.4,3.0,0.0348,1,1,1,1,3.0,3.0,2.3
1394,299,0,Asia Pacific,Commercial,Communications,Meets,Male,43,10,1,7,12,0.0,2.8,4.2,0.0422,1,1,1,1,4.9,2.5,3.6
1395,219,0,Europe,Commercial,Medical Affairs,Exceeds,Non-Binary/Other,44,9,1,11,30,0.0,3.6,2.8,0.0743,1,1,1,1,3.4,2.7,3.1
1396,666,0,Asia Pacific,Digital,Regulatory Affairs,Meets,Male,44,17,0,9,13,3.7,4.1,2.6,0.0853,1,1,1,1,4.3,3.5,3.5
1397,958,0,Europe,Finance,Pharmacovigilance,Meets,Female,30,9,0,5,9,3.3,3.2,3.5,0.0331,1,1,1,1,3.1,2.9,4.2
1398,102,0,Europe,R&D,Data Science,Meets,Male,46,22,0,11,21,3.3,2.9,1.7,0.0977,1,1,1,1,2.5,2.0,1.0
1399,390,0,North America,Manufacturing,Market Access,Below,Female,41,4,0,10,14,2.4,4.0,2.9,0.0,0,0,0,0,2.4,3.3,2.4
1400,655,0,Asia Pacific,Digital,Market Access,Meets,Male,45,5,0,8,18,2.3,2.2,3.5,0.0853,1,1,1,1,3.3,3.4,3.9
1401,541,0,Asia Pacific,Digital,Marketing,Exceeds,Male,45,21,0,6,19,3.4,3.1,4.7,0.1452,1,1,1,1,2.6,3.5,4.0
1402,190,0,Middle East & Africa,Commercial,Communications,Exceeds,Female,40,8,0,5,13,3.8,4.2,5.0,0.0743,1,1,1,1,3.5,3.6,3.7
1403,425,0,Middle East & Africa,Manufacturing,Clinical Operations,Meets,Female,33,8,1,9,34,0.0,3.2,1.3,0.0348,1,1,1,1,3.4,3.0,2.6
1404,123,0,North America,R&D,Finance & Accounting,Meets,Female,33,13,0,11,24,3.9,2.9,1.7,0.0977,1,1,1,1,4.1,3.2,2.1
1405,327,0,North America,Commercial,Human Resources,Exceeds,Female,34,10,0,7,21,3.7,1.9,3.3,0.0743,1,1,1,1,2.9,1.3,3.3
1406,624,0,Latin America,Digital,Legal & Compliance,Meets,Male,37,31,0,12,19,3.1,2.7,2.5,0.0853,1,1,1,1,3.5,2.2,2.6
1407,317,0,Middle East & Africa,Commercial,Communications,Far Below,Male,32,5,0,12,16,2.7,3.2,2.0,0.0,1,1,1,1,3.3,3.4,4.5
1408,276,0,Europe,Commercial,Communications,Meets,Female,28,18,1,9,14,0.0,4.0,2.1,0.0422,1,1,1,1,3.2,4.3,3.4
1409,854,0,Asia Pacific,HR,Market Access,Meets,Female,28,18,1,11,20,0.0,1.8,4.1,0.0383,1,1,1,1,4.0,3.7,2.9
1410,258,0,North America,Commercial,Data Science,Meets,Male,38,7,0,7,16,3.3,2.5,3.6,0.0422,1,1,1,1,3.5,2.7,3.9
1411,979,0,Asia Pacific,Finance,Quality Assurance,Far Exceeds,Female,36,5,1,12,31,0.0,2.8,3.4,0.1022,1,1,1,1,2.2,4.3,3.6
1412,219,0,Asia Pacific,Commercial,Sales,Exceeds,Female,41,12,1,9,17,0.0,3.4,2.6,0.0743,1,1,1,1,4.5,3.9,1.7
1413,1035,0,Latin America,Finance,Quality Assurance,Below,Female,37,9,0,12,16,2.9,2.3,2.2,0.0,1,1,0,0,3.7,3.2,3.0
1414,424,0,Middle East & Africa,Manufacturing,Communications,Meets,Male,45,19,1,6,9,0.0,2.6,3.2,0.0348,1,1,1,1,2.9,3.3,1.8
1415,308,0,North America,Commercial,Regulatory Affairs,Meets,Male,34,10,0,8,18,4.5,4.5,2.8,0.0422,1,1,1,1,4.8,3.0,3.2
1416,103,0,Asia Pacific,R&D,Supply Chain,Meets,Male,40,8,0,10,19,3.3,3.3,1.5,0.0977,1,1,1,1,3.6,1.0,2.4
1417,921,0,North America,Finance,Pharmacovigilance,Meets,Male,41,5,0,9,34,3.3,2.7,3.2,0.0331,1,1,1,1,4.4,3.7,3.7
1418,1026,0,Europe,Finance,Supply Chain,Meets,Female,38,14,0,12,17,4.7,3.6,3.8,0.0331,1,1,1,1,3.3,2.8,2.4
1419,659,0,Latin America,Digital,Data Science,Exceeds,Male,44,2,1,8,15,0.0,1.7,1.0,0.1452,0,0,0,0,3.2,1.0,1.8
1420,503,0,Europe,Manufacturing,Supply Chain,Meets,Male,41,5,1,8,15,0.0,2.7,3.0,0.0348,0,0,0,0,3.7,3.9,2.4
1421,323,0,North America,Commercial,Communications,Exceeds,Male,43,9,1,6,10,0.0,2.4,4.0,0.0743,1,1,1,1,2.9,4.9,3.7
1422,73,1,North America,R&D,Quality Assurance,Meets,Male,34,7,1,12,14,0.0,2.5,3.0,0.0977,1,1,1,1,5.0,2.3,3.3
1423,607,0,Middle East & Africa,Digital,Legal & Compliance,Meets,Male,37,15,0,10,20,3.6,2.3,3.3,0.0853,1,1,0,0,3.1,3.0,3.8
1424,390,0,Asia Pacific,Manufacturing,Clinical Operations,Meets,Male,28,12,1,6,10,0.0,2.9,1.3,0.0348,1,1,1,1,3.9,4.4,2.5
1425,898,0,Asia Pacific,Finance,Finance & Accounting,Far Exceeds,Male,38,5,0,12,17,2.5,2.9,3.0,0.1022,1,1,1,0,2.1,4.3,2.3
1426,118,1,Europe,R&D,Finance & Accounting,Meets,Male,30,6,1,6,9,0.0,2.6,2.0,0.0977,0,0,0,0,4.6,3.1,3.6
1427,217,0,Latin America,Commercial,Data Science,Far Below,Female,52,4,0,6,19,5.0,1.5,3.7,0.0,1,1,1,1,4.3,3.5,3.2
1428,793,0,Asia Pacific,HR,Sales,Meets,Female,40,9,0,8,16,4.2,2.4,2.0,0.0383,1,1,1,1,3.7,2.9,2.3
1429,842,0,Middle East & Africa,HR,IT & Digital,Meets,Male,36,29,0,10,14,3.1,2.5,2.4,0.0383,1,1,1,1,4.3,1.4,2.5
1430,457,0,Europe,Manufacturing,Marketing,Exceeds,Female,43,24,0,11,12,3.8,1.8,2.6,0.0616,1,0,0,0,3.6,4.6,3.9
1431,49,0,Europe,R&D,Data Science,Meets,Male,30,14,0,7,9,2.8,4.4,2.1,0.0977,0,0,0,0,3.8,3.9,2.4
1432,544,0,Middle East & Africa,Digital,Communications,Far Exceeds,Female,35,16,0,11,13,3.4,1.6,2.4,0.2363,1,1,1,1,3.7,1.0,2.1
1433,91,0,Latin America,R&D,Medical Affairs,Meets,Male,36,10,0,9,22,2.6,4.6,1.9,0.0977,1,1,1,1,3.4,3.9,2.6
1434,1049,0,Middle East & Africa,Finance,Sales,Meets,Female,42,18,0,8,15,3.2,1.4,2.2,0.0331,1,1,1,1,5.0,4.4,1.6
1435,879,0,Latin America,HR,Communications,Meets,Male,32,7,1,11,32,0.0,1.9,3.6,0.0383,0,0,0,0,3.1,3.3,3.9
1436,429,0,Middle East & Africa,Manufacturing,Data Science,Meets,Male,34,15,0,6,14,4.8,2.8,3.7,0.0348,1,1,1,1,4.6,3.4,4.9
1437,210,0,Middle East & Africa,Commercial,Medical Affairs,Far Exceeds,Male,39,13,0,5,17,3.2,4.1,3.1,0.1275,1,1,1,1,2.1,5.0,3.3
1438,165,0,North America,R&D,Sales,Below,Female,42,14,0,11,20,2.7,2.4,4.3,0.0,1,1,1,1,1.8,2.5,4.0
1439,855,0,Europe,HR,Regulatory Affairs,Below,Male,39,15,0,7,15,2.5,5.0,3.1,0.0,1,1,1,1,2.9,4.5,1.4
1440,579,0,Middle East & Africa,Digital,Market Access,Below,Male,33,11,0,11,21,4.7,1.9,3.1,0.0,1,1,1,1,3.5,3.8,4.2
1441,404,0,Middle East & Africa,Manufacturing,Pharmacovigilance,Meets,Male,39,15,0,10,30,3.3,3.5,3.2,0.0348,1,1,1,1,2.8,4.7,3.3
1442,290,0,Asia Pacific,Commercial,Market Access,Below,Female,34,13,0,10,13,4.5,3.3,1.9,0.0,1,1,1,1,3.4,2.4,1.6
1443,128,0,Europe,R&D,Quality Assurance,Meets,Male,32,6,1,7,18,0.0,2.2,1.9,0.0977,1,1,1,1,4.9,3.0,2.0
1444,599,0,Asia Pacific,Digital,IT & Digital,Exceeds,Female,40,15,0,10,13,3.8,1.8,2.2,0.1452,1,1,1,1,4.0,3.5,2.1
1445,182,1,Europe,Commercial,Marketing,Meets,Male,41,6,0,9,18,3.5,3.2,2.2,0.0422,1,1,1,1,4.8,5.0,2.3
1446,918,0,Asia Pacific,Finance,Market Access,Meets,Female,38,7,0,8,17,2.3,3.2,3.0,0.0331,1,1,1,1,4.5,2.6,3.6
1447,844,0,Middle East & Africa,HR,Human Resources,Exceeds,Male,41,9,0,5,10,4.4,1.8,4.1,0.0677,1,1,1,1,3.4,4.0,3.2
1448,968,0,Middle East & Africa,Finance,Data Science,Meets,Male,43,29,0,11,16,3.6,3.6,2.3,0.0331,1,1,1,1,4.7,3.7,1.3
1449,730,0,North America,HR,Human Resources,Meets,Female,28,15,0,9,22,2.8,3.6,1.9,0.0383,1,1,1,1,2.0,4.7,1.0
1450,529,0,Asia Pacific,Digital,Regulatory Affairs,Meets,Female,40,6,1,8,17,0.0,3.9,1.6,0.0853,1,1,1,1,4.4,2.9,1.0
1451,1028,0,Latin America,Finance,Supply Chain,Meets,Non-Binary/Other,47,19,0,9,32,3.6,2.2,3.1,0.0331,1,1,1,1,3.3,1.5,3.0
1452,864,0,North America,HR,Quality Assurance,Below,Female,36,4,0,8,13,3.0,5.0,2.7,0.0,1,1,1,1,3.2,2.8,2.2
1453,480,0,Asia Pacific,Manufacturing,Market Access,Meets,Male,47,14,0,9,25,2.6,2.7,4.6,0.0348,1,1,1,1,4.1,3.3,2.6
1454,646,0,Asia Pacific,Digital,Clinical Operations,Far Exceeds,Female,40,6,0,7,14,2.4,2.9,2.1,0.2363,1,1,1,1,3.2,3.1,3.0
1455,784,0,North America,HR,Legal & Compliance,Meets,Female,38,22,0,6,10,3.1,2.1,4.0,0.0383,1,1,1,1,3.7,3.1,3.6
1456,37,0,Middle East & Africa,R&D,Communications,Meets,Male,40,11,1,9,17,0.0,3.1,1.0,0.0977,1,1,1,1,3.2,3.1,1.0
1457,702,0,Asia Pacific,HR,Marketing,Meets,Male,29,13,1,8,17,0.0,2.1,1.1,0.0383,1,1,1,1,3.4,5.0,1.0
1458,1030,0,Middle East & Africa,Finance,Supply Chain,Exceeds,Male,48,14,0,11,19,2.8,3.2,3.7,0.0588,1,1,1,1,3.1,4.8,3.5
1459,475,0,North America,Manufacturing,Communications,Exceeds,Male,35,8,0,12,17,3.1,1.2,2.7,0.0616,1,1,1,1,3.1,2.5,2.2
1460,231,0,Middle East & Africa,Commercial,Finance & Accounting,Meets,Male,31,11,1,12,16,0.0,3.7,2.5,0.0422,1,1,1,1,3.4,3.5,3.7
1461,246,0,Europe,Commercial,Pharmacovigilance,Meets,Female,35,13,0,11,16,3.5,1.6,2.2,0.0422,0,0,0,0,3.0,1.3,3.6
1462,825,0,Latin America,HR,IT & Digital,Meets,Female,38,15,0,7,14,3.2,3.5,3.5,0.0383,1,1,1,1,4.1,3.1,2.9
1463,299,0,Asia Pacific,Commercial,Data Science,Meets,Female,45,5,1,11,21,0.0,2.5,3.6,0.0422,1,1,1,1,3.6,2.6,3.8
1464,740,0,Latin America,HR,Regulatory Affairs,Below,Male,38,8,1,10,33,0.0,3.8,4.5,0.0,1,1,1,1,3.3,2.2,5.0
1465,506,0,Middle East & Africa,Manufacturing,Sales,Meets,Male,36,3,0,10,15,4.1,3.2,3.2,0.0348,1,1,1,1,3.1,3.0,1.6
1466,247,0,Asia Pacific,Commercial,Finance & Accounting,Meets,Female,36,25,0,12,21,3.9,3.2,3.6,0.0422,1,1,1,1,3.6,3.5,2.4
1467,1041,0,Middle East & Africa,Finance,Communications,Meets,Female,30,7,1,9,47,0.0,4.4,1.4,0.0331,1,1,1,1,2.8,4.9,3.0
1468,895,0,Europe,Finance,Market Access,Meets,Female,35,25,0,6,11,3.8,2.5,1.6,0.0331,0,0,0,0,4.7,4.5,2.6
1469,170,0,North America,R&D,Clinical Operations,Far Below,Female,34,2,0,8,15,3.3,2.0,3.2,0.0,1,1,1,1,3.4,2.5,4.0
1470,753,0,Asia Pacific,HR,Finance & Accounting,Meets,Male,40,3,1,12,17,0.0,3.8,3.6,0.0383,1,1,1,1,3.8,3.7,2.5
1471,257,0,Europe,Commercial,Marketing,Meets,Male,28,3,1,9,25,0.0,2.9,4.1,0.0422,1,1,1,1,2.8,2.2,2.3
1472,1004,0,Europe,Finance,Pharmacovigilance,Below,Male,35,15,0,11,13,3.6,3.9,1.2,0.0,1,1,1,1,3.2,3.8,1.5
1473,461,0,Asia Pacific,Manufacturing,Market Access,Exceeds,Male,46,9,1,8,13,0.0,2.2,2.2,0.0616,1,1,1,1,4.3,3.6,1.8
1474,476,0,Middle East & Africa,Manufacturing,Communications,Meets,Male,41,29,0,12,18,4.0,2.0,2.3,0.0348,1,1,1,1,2.5,1.9,2.9
1475,71,0,Europe,R&D,Pharmacovigilance,Far Below,Female,44,12,0,8,16,4.8,3.4,1.9,0.0,0,0,0,0,4.6,1.9,2.8
1476,413,0,Latin America,Manufacturing,Supply Chain,Meets,Non-Binary/Other,36,7,0,9,39,2.6,2.2,1.0,0.0348,0,0,0,0,3.3,2.6,2.5
1477,379,0,Europe,Manufacturing,Legal & Compliance,Meets,Female,48,15,0,10,24,2.2,2.2,3.2,0.0348,1,1,1,1,3.3,2.9,2.2
1478,285,0,Middle East & Africa,Commercial,Human Resources,Meets,Female,43,5,1,11,16,0.0,3.6,1.0,0.0422,0,0,0,0,2.8,2.1,2.2
1479,762,0,Middle East & Africa,HR,Supply Chain,Below,Non-Binary/Other,38,19,1,9,15,0.0,2.5,3.3,0.0,0,0,0,0,1.9,3.9,2.8
1480,689,0,Latin America,Digital,Communications,Meets,Female,42,20,0,6,18,3.0,3.4,3.5,0.0853,1,1,1,1,3.3,2.0,3.1
1481,515,0,Europe,Manufacturing,Quality Assurance,Meets,Female,31,22,0,9,15,3.4,1.3,3.6,0.0348,1,1,1,1,3.7,1.7,3.9
1482,468,0,Middle East & Africa,Manufacturing,Market Access,Meets,Male,30,13,0,6,11,3.2,1.8,3.1,0.0348,1,1,0,0,4.2,2.4,2.2
1483,684,0,Asia Pacific,Digital,Legal & Compliance,Meets,Male,43,7,0,7,11,4.1,3.2,3.1,0.0853,1,1,1,1,3.8,4.2,3.1
1484,467,0,North America,Manufacturing,Regulatory Affairs,Far Exceeds,Male,45,9,0,11,40,3.3,2.7,1.2,0.1069,1,1,1,1,2.7,3.3,2.5
1485,214,0,North America,Commercial,Legal & Compliance,Below,Male,32,7,1,11,13,0.0,2.7,1.7,0.0,1,1,1,1,3.6,2.2,2.5
1486,206,0,North America,Commercial,Marketing,Far Below,Female,43,10,1,11,26,0.0,1.9,2.4,0.0,0,0,0,0,2.5,1.9,2.3
1487,651,0,Europe,Digital,Sales,Far Exceeds,Female,41,17,0,10,23,4.1,3.2,1.2,0.2363,1,1,1,1,3.9,4.8,1.5
1488,885,0,Latin America,Finance,Sales,Meets,Male,33,11,0,5,20,2.8,4.7,1.4,0.0331,0,0,0,0,2.7,3.3,2.9
1489,491,0,Middle East & Africa,Manufacturing,Finance & Accounting,Meets,Male,32,23,0,12,24,3.8,3.2,2.1,0.0348,1,1,1,1,4.0,2.7,1.3
1490,950,0,Asia Pacific,Finance,Data Science,Below,Male,34,20,0,5,16,3.4,3.0,2.7,0.0,1,0,0,0,3.9,1.9,1.8
1491,389,0,Asia Pacific,Manufacturing,Data Science,Below,Male,35,19,0,5,17,4.0,3.6,3.4,0.0,1,1,1,0,3.6,3.3,2.9
1492,858,0,Europe,HR,Marketing,Below,Male,36,5,1,11,17,0.0,1.5,1.1,0.0,1,1,1,1,5.0,2.4,1.5
1493,459,0,North America,Manufacturing,IT & Digital,Meets,Male,28,18,0,6,7,2.7,3.8,3.1,0.0348,1,1,1,1,4.1,3.4,1.4
1494,286,0,Europe,Commercial,Market Access,Below,Male,35,8,0,5,20,4.3,5.0,1.9,0.0,1,1,1,1,4.3,2.9,2.5
1495,36,0,Latin America,R&D,Finance & Accounting,Meets,Female,40,15,0,8,16,2.5,2.2,2.8,0.0977,1,1,0,0,2.5,1.0,1.6
1496,133,0,Latin America,R&D,Market Access,Meets,Male,42,11,0,7,10,4.0,3.6,3.8,0.0977,1,1,1,1,4.4,3.6,2.5
1497,79,0,Middle East & Africa,R&D,Supply Chain,Far Below,Female,34,5,0,10,18,2.9,2.7,2.3,0.0,0,0,0,0,3.4,3.1,2.3
1498,165,0,Middle East & Africa,R&D,Legal & Compliance,Below,Male,47,6,0,7,17,1.5,3.9,3.2,0.0,1,1,1,1,2.1,3.3,2.5
1499,920,0,Latin America,Finance,Clinical Operations,Meets,Male,38,12,0,5,13,5.0,3.5,3.6,0.0331,0,0,0,0,5.0,4.0,3.3
1500,942,0,Latin America,Finance,Legal & Compliance,Below,Female,53,8,0,12,29,3.2,2.1,2.9,0.0,0,0,0,0,3.4,3.6,2.7
1501,395,0,Latin America,Manufacturing,Data Science,Below,Male,34,6,0,10,39,3.9,4.4,3.1,0.0,1,1,1,1,4.0,5.0,3.0
1502,987,0,Europe,Finance,IT & Digital,Meets,Male,40,19,0,8,9,3.1,3.4,1.0,0.0331,0,0,0,0,3.9,1.5,1.2
1503,413,0,Latin America,Manufacturing,Clinical Operations,Meets,Female,37,5,0,6,17,4.0,2.4,2.8,0.0348,1,1,1,1,3.4,3.2,2.3
1504,838,0,Asia Pacific,HR,Market Access,Meets,Female,34,3,1,10,18,0.0,2.1,1.2,0.0383,1,1,1,1,2.9,1.4,2.4
1505,448,0,North America,Manufacturing,Data Science,Below,Male,43,18,0,11,19,2.9,2.0,3.5,0.0,1,1,1,1,4.7,4.4,1.0
1506,30,0,Latin America,R&D,Sales,Meets,Female,43,6,0,6,15,3.8,3.1,2.7,0.0977,1,1,1,1,4.2,5.0,3.1
1507,650,1,North America,Digital,Pharmacovigilance,Exceeds,Female,36,4,0,5,17,3.2,3.3,1.5,0.1452,1,1,1,1,3.8,5.0,1.6
1508,582,1,Europe,Digital,Data Science,Meets,Male,40,14,1,7,13,0.0,1.4,3.2,0.0853,1,1,1,1,2.3,1.0,3.4
1509,272,0,North America,Commercial,Market Access,Far Below,Female,40,9,0,5,9,3.7,3.1,3.6,0.0,1,1,1,1,2.5,4.7,4.2
1510,227,0,Europe,Commercial,Legal & Compliance,Meets,Female,36,18,0,12,13,3.6,2.4,2.1,0.0422,1,1,1,1,4.0,1.9,2.0
1511,395,1,Asia Pacific,Manufacturing,Market Access,Meets,Male,33,24,0,11,18,3.2,2.4,3.2,0.0348,1,1,1,1,3.7,3.4,3.9
1512,668,0,Europe,Digital,Pharmacovigilance,Far Exceeds,Female,38,2,1,6,16,0.0,2.8,1.0,0.2363,1,1,1,1,3.5,2.2,4.4
1513,97,1,Europe,R&D,Clinical Operations,Far Exceeds,Male,37,8,0,12,17,3.2,4.1,2.9,0.2644,1,1,1,1,4.0,2.9,3.7
1514,986,0,Middle East & Africa,Finance,Marketing,Meets,Female,32,3,1,7,18,0.0,5.0,3.3,0.0331,0,0,0,0,4.4,4.2,2.6
1515,88,0,Latin America,R&D,Pharmacovigilance,Meets,Female,42,16,0,7,18,3.0,2.2,2.8,0.0977,0,0,0,0,3.7,5.0,2.4
1516,124,0,Latin America,R&D,IT & Digital,Exceeds,Male,38,7,0,5,6,1.9,3.1,3.9,0.1648,1,1,1,1,4.2,3.7,2.8
1517,389,0,Asia Pacific,Manufacturing,Sales,Exceeds,Female,37,4,1,10,13,0.0,2.5,1.3,0.0616,0,0,0,0,3.5,3.0,1.0
1518,479,0,Asia Pacific,Manufacturing,Human Resources,Meets,Female,29,8,0,11,22,3.3,3.6,3.3,0.0348,1,1,1,1,3.1,3.0,1.0
1519,817,0,Latin America,HR,Legal & Compliance,Meets,Female,40,20,0,10,16,3.5,2.6,3.3,0.0383,1,0,0,0,3.3,2.5,2.2
1520,37,0,Middle East & Africa,R&D,Market Access,Below,Male,29,5,1,5,14,0.0,3.7,1.9,0.0,1,1,1,1,3.4,3.8,3.3
1521,9,0,Latin America,R&D,Regulatory Affairs,Meets,Male,39,8,1,7,13,0.0,2.8,4.4,0.0977,1,1,1,1,3.1,5.0,1.7
1522,488,0,Middle East & Africa,Manufacturing,Sales,Meets,Female,43,4,0,6,9,3.2,2.3,4.6,0.0348,1,0,0,0,3.3,1.0,3.8
1523,363,0,Asia Pacific,Manufacturing,Clinical Operations,Far Exceeds,Male,48,19,0,7,14,3.2,3.7,3.9,0.1069,1,1,1,1,3.6,1.9,4.2
1524,862,0,North America,HR,Pharmacovigilance,Exceeds,Male,38,4,0,8,15,3.5,4.1,1.6,0.0677,1,1,1,1,3.4,4.8,2.9
1525,811,0,Asia Pacific,HR,Market Access,Meets,Female,49,21,0,7,13,1.8,3.5,3.4,0.0383,1,1,1,1,2.8,3.9,1.9
1526,194,1,Asia Pacific,Commercial,Finance & Accounting,Meets,Male,42,13,1,9,10,0.0,2.8,2.8,0.0422,1,1,1,1,1.8,3.2,3.3
1527,622,0,Europe,Digital,Market Access,Meets,Male,41,29,0,9,17,3.0,3.7,2.7,0.0853,0,0,0,0,3.4,1.3,1.1
1528,167,0,Europe,R&D,Pharmacovigilance,Meets,Male,45,4,0,9,22,3.1,4.0,2.9,0.0977,1,1,1,1,2.7,3.2,2.5
1529,26,0,Europe,R&D,Marketing,Meets,Male,46,13,0,8,14,2.3,3.5,2.2,0.0977,1,1,1,1,3.6,4.8,1.8
1530,739,0,Europe,HR,Human Resources,Meets,Male,43,2,0,8,26,3.4,2.8,2.1,0.0383,1,1,1,1,3.0,2.5,1.6
1531,788,0,Middle East & Africa,HR,Pharmacovigilance,Meets,Male,37,2,0,9,14,3.1,2.3,3.4,0.0383,1,1,1,1,4.2,2.4,1.8
1532,222,0,Latin America,Commercial,Legal & Compliance,Below,Male,35,14,0,11,16,2.1,2.8,1.8,0.0,1,1,1,1,2.1,3.2,1.6
1533,645,0,North America,Digital,Data Science,Below,Female,30,4,1,7,9,0.0,3.3,3.6,0.0,1,1,0,0,1.7,2.9,3.1
1534,214,0,Asia Pacific,Commercial,Communications,Exceeds,Male,39,7,0,10,27,3.4,3.6,3.0,0.0743,1,1,1,1,3.4,3.7,3.8
1535,686,0,Middle East & Africa,Digital,Medical Affairs,Far Below,Female,45,18,0,8,17,4.2,3.4,1.0,0.0,1,1,1,1,4.4,1.8,1.6
1536,1008,0,North America,Finance,Finance & Accounting,Below,Male,32,17,0,9,17,4.6,2.5,2.6,0.0,1,1,1,1,4.1,4.1,3.4
1537,153,1,Middle East & Africa,R&D,Marketing,Meets,Female,32,10,0,12,27,3.2,3.8,2.8,0.0977,1,1,1,1,5.0,4.3,3.1
1538,275,0,Middle East & Africa,Commercial,Medical Affairs,Exceeds,Non-Binary/Other,49,13,0,6,27,4.3,3.6,2.9,0.0743,0,0,0,0,3.2,3.2,2.9
1539,871,0,Asia Pacific,HR,Clinical Operations,Meets,Female,36,30,0,7,18,4.1,3.9,1.7,0.0383,1,1,1,1,4.4,2.0,2.8
1540,249,0,Latin America,Commercial,Supply Chain,Below,Female,28,12,1,10,30,0.0,3.9,1.7,0.0,1,1,1,1,4.5,2.2,3.3
1541,1050,0,Europe,Finance,Sales,Meets,Male,29,16,0,7,23,2.6,3.9,4.3,0.0331,0,0,0,0,3.6,3.5,4.1
1542,289,0,Latin America,Commercial,Legal & Compliance,Meets,Male,41,12,0,6,12,3.8,4.0,1.8,0.0422,1,1,1,1,3.0,3.9,1.9
1543,38,0,Asia Pacific,R&D,Communications,Meets,Female,35,5,1,7,14,0.0,3.0,2.0,0.0977,1,1,1,1,3.3,2.8,3.3
1544,1015,0,Asia Pacific,Finance,Quality Assurance,Meets,Female,41,5,0,7,21,4.0,5.0,3.1,0.0331,1,1,1,1,4.0,3.0,3.4
1545,874,0,Asia Pacific,HR,Pharmacovigilance,Meets,Female,37,8,1,10,20,0.0,2.9,1.0,0.0383,1,1,1,1,2.6,3.1,2.2
1546,778,0,North America,HR,Sales,Exceeds,Female,39,13,1,5,8,0.0,4.0,2.2,0.0677,1,1,1,1,2.4,4.8,1.6
1547,355,0,Latin America,Manufacturing,Quality Assurance,Meets,Male,49,28,0,9,18,3.8,4.7,3.1,0.0348,1,1,1,0,4.2,3.8,1.7
1548,942,0,Latin America,Finance,Finance & Accounting,Meets,Female,37,16,0,11,21,4.7,3.3,2.3,0.0331,1,1,1,1,4.6,2.4,2.5
1549,428,0,Middle East & Africa,Manufacturing,Clinical Operations,Meets,Male,45,4,0,5,15,3.7,3.2,1.0,0.0348,1,1,1,0,3.5,2.8,1.3
1550,377,0,Middle East & Africa,Manufacturing,Clinical Operations,Exceeds,Female,39,17,1,10,17,0.0,4.0,3.2,0.0616,1,1,1,1,4.6,5.0,3.5
1551,124,0,Middle East & Africa,R&D,Supply Chain,Meets,Male,31,14,0,7,17,2.6,1.2,2.1,0.0977,0,0,0,0,3.8,2.8,2.9
1552,177,0,Asia Pacific,Commercial,Communications,Below,Female,50,7,0,5,6,2.9,3.1,2.6,0.0,1,1,1,1,5.0,2.8,3.6
1553,750,0,Latin America,HR,Marketing,Meets,Female,51,9,0,9,24,3.1,3.5,2.3,0.0383,1,1,1,1,4.0,3.3,3.4
1554,850,0,Asia Pacific,HR,Sales,Meets,Male,37,2,0,10,32,2.9,4.1,1.7,0.0383,1,1,1,1,3.5,4.1,3.2
1555,298,0,North America,Commercial,Legal & Compliance,Meets,Female,39,24,0,11,14,4.0,2.5,2.8,0.0422,1,1,1,1,3.0,3.7,3.1
1556,765,0,Middle East & Africa,HR,Communications,Exceeds,Female,45,8,0,11,17,2.8,3.9,2.1,0.0677,1,1,1,1,2.6,3.5,1.6
1557,210,0,Asia Pacific,Commercial,Sales,Meets,Male,37,7,0,12,16,2.8,3.1,3.0,0.0422,1,1,1,1,2.2,2.7,4.3
1558,991,0,Asia Pacific,Finance,Legal & Compliance,Meets,Male,44,19,0,6,13,2.1,5.0,3.6,0.0331,1,1,1,1,2.9,4.4,3.7
1559,144,0,North America,R&D,Pharmacovigilance,Meets,Male,33,6,1,12,14,0.0,4.0,2.8,0.0977,1,1,1,1,3.0,3.5,3.2
1560,149,1,Europe,R&D,Clinical Operations,Meets,Male,49,12,0,5,11,4.3,5.0,3.0,0.0977,1,1,1,1,5.0,3.1,4.1
1561,2,0,Latin America,R&D,Quality Assurance,Far Exceeds,Female,40,12,0,6,21,3.8,2.7,1.5,0.2644,1,1,1,1,3.9,2.9,1.1
1562,257,0,Europe,Commercial,Regulatory Affairs,Meets,Male,43,8,1,12,20,0.0,2.2,2.2,0.0422,1,1,1,1,5.0,1.9,2.1
1563,270,0,Middle East & Africa,Commercial,Supply Chain,Below,Male,46,6,1,6,7,0.0,2.5,3.3,0.0,1,1,1,1,3.7,1.9,1.7
1564,556,0,Asia Pacific,Digital,Marketing,Below,Female,43,13,0,11,19,4.3,1.8,3.5,0.0,1,1,1,1,3.8,2.2,2.6
1565,712,0,North America,HR,Market Access,Meets,Non-Binary/Other,38,8,0,12,16,4.9,2.6,1.7,0.0383,0,0,0,0,4.6,3.6,1.7
1566,710,0,North America,HR,Regulatory Affairs,Meets,Female,48,15,0,12,17,3.8,3.8,2.4,0.0383,1,0,0,0,4.1,2.8,1.4
1567,599,1,Latin America,Digital,IT & Digital,Exceeds,Female,43,12,0,12,15,2.3,2.5,1.0,0.1452,1,0,0,0,1.0,5.0,2.1
1568,575,0,Europe,Digital,Finance & Accounting,Meets,Male,37,7,0,10,29,3.8,3.2,4.1,0.0853,1,0,0,0,2.4,4.0,5.0
1569,154,0,Latin America,R&D,Data Science,Meets,Male,29,20,0,11,34,3.7,3.0,2.3,0.0977,1,1,0,0,3.8,1.6,1.8
1570,599,0,Asia Pacific,Digital,Medical Affairs,Meets,Male,38,2,0,10,18,3.1,2.0,1.0,0.0853,1,1,1,1,2.9,1.5,2.7
1571,238,0,Latin America,Commercial,Supply Chain,Exceeds,Female,35,9,0,5,10,2.7,5.0,2.7,0.0743,1,1,1,1,2.0,4.8,2.4
1572,504,0,North America,Manufacturing,Quality Assurance,Meets,Male,38,3,0,10,15,3.9,2.8,2.6,0.0348,1,1,1,1,3.9,2.4,3.3
1573,349,0,North America,Commercial,Finance & Accounting,Meets,Male,34,20,0,6,17,3.1,4.0,4.5,0.0422,1,1,1,1,3.5,2.7,3.5
1574,627,0,Middle East & Africa,Digital,Human Resources,Below,Female,40,14,1,6,13,0.0,3.4,4.2,0.0,1,1,1,1,3.1,2.4,2.7
1575,773,0,Middle East & Africa,HR,Regulatory Affairs,Meets,Female,35,12,0,10,13,5.0,1.5,3.3,0.0383,1,1,1,1,4.2,1.8,3.8
1576,216,1,Asia Pacific,Commercial,Quality Assurance,Exceeds,Female,47,8,0,8,23,4.4,2.1,3.0,0.0743,1,1,1,1,3.8,2.7,2.9
1577,816,0,Europe,HR,Human Resources,Meets,Female,42,11,1,9,23,0.0,3.2,2.1,0.0383,1,1,1,1,2.6,3.4,2.4
1578,313,0,Latin America,Commercial,Pharmacovigilance,Meets,Male,35,8,0,5,15,5.0,2.6,3.4,0.0422,1,1,1,1,4.9,2.5,3.4
1579,870,0,Asia Pacific,HR,Supply Chain,Meets,Female,38,18,0,11,17,3.5,4.3,2.6,0.0383,1,1,0,0,2.9,2.5,1.7
1580,1027,0,Middle East & Africa,Finance,Clinical Operations,Meets,Male,41,9,0,12,19,4.0,1.2,3.0,0.0331,1,1,1,1,3.7,2.2,2.4
1581,298,0,Latin America,Commercial,Marketing,Below,Non-Binary/Other,29,4,1,6,25,0.0,4.1,3.2,0.0,1,1,1,1,3.4,5.0,3.4
1582,810,0,Middle East & Africa,HR,Quality Assurance,Exceeds,Male,41,2,0,9,43,4.4,2.7,3.3,0.0677,1,1,1,1,3.7,3.3,2.6
1583,366,0,Latin America,Manufacturing,Sales,Meets,Female,28,32,0,5,17,4.1,1.3,3.0,0.0348,1,1,0,0,2.7,2.5,1.2
1584,3,0,Europe,R&D,IT & Digital,Meets,Female,47,11,0,12,14,2.7,2.6,2.3,0.0977,1,1,1,1,3.2,2.1,3.7
1585,342,0,Asia Pacific,Commercial,Communications,Meets,Female,36,19,0,11,17,3.8,3.5,3.5,0.0422,1,1,1,1,3.8,3.1,2.2
1586,515,0,Latin America,Manufacturing,Regulatory Affairs,Far Exceeds,Female,44,14,0,8,9,4.2,2.7,3.5,0.1069,1,1,1,1,3.0,3.4,2.7
1587,155,0,North America,R&D,Communications,Meets,Female,31,17,0,6,14,4.4,3.5,3.1,0.0977,1,1,1,1,3.7,3.5,3.5
1588,285,0,North America,Commercial,Sales,Meets,Female,41,13,0,8,17,2.4,4.7,3.2,0.0422,1,1,1,1,2.9,4.8,4.8
1589,507,0,Latin America,Manufacturing,Quality Assurance,Meets,Female,31,15,0,8,10,4.0,5.0,3.9,0.0348,1,1,1,1,4.2,4.9,1.9
1590,378,0,Latin America,Manufacturing,Regulatory Affairs,Meets,Female,36,8,1,10,12,0.0,2.4,1.8,0.0348,1,1,1,1,3.5,3.4,2.4
1591,940,0,Latin America,Finance,Clinical Operations,Meets,Male,44,24,0,5,26,2.7,4.2,2.7,0.0331,1,1,1,1,2.6,2.3,3.1
1592,440,0,North America,Manufacturing,Communications,Far Exceeds,Female,42,12,1,6,23,0.0,2.9,3.6,0.1069,1,1,1,1,3.3,3.8,3.9
1593,951,0,North America,Finance,Medical Affairs,Exceeds,Female,41,14,0,7,22,3.1,1.7,1.1,0.0588,1,1,1,1,3.7,2.8,1.0
1594,624,0,Latin America,Digital,Medical Affairs,Meets,Female,36,10,1,7,19,0.0,1.7,4.2,0.0853,1,1,1,1,2.9,3.6,3.2
1595,726,0,Middle East & Africa,HR,Pharmacovigilance,Meets,Female,32,6,0,5,19,2.6,3.1,3.2,0.0383,0,0,0,0,2.6,4.2,4.1
1596,154,0,Middle East & Africa,R&D,Data Science,Below,Male,43,6,0,9,13,3.1,4.1,2.9,0.0,1,1,1,1,2.8,4.0,4.4
1597,847,0,Europe,HR,Medical Affairs,Exceeds,Male,32,19,0,7,25,4.0,2.5,3.7,0.0677,1,1,1,1,4.9,2.3,3.1
1598,752,0,Asia Pacific,HR,Data Science,Meets,Male,34,2,1,8,23,0.0,3.0,1.7,0.0383,1,1,1,1,2.9,2.8,1.4
1599,1016,0,Middle East & Africa,Finance,Regulatory Affairs,Meets,Female,47,14,0,10,22,2.3,3.3,4.6,0.0331,1,1,1,1,2.9,3.8,4.3
1600,811,0,North America,HR,Medical Affairs,Exceeds,Male,41,9,1,10,17,0.0,1.0,2.5,0.0677,1,1,1,1,3.3,2.1,2.0
1601,421,0,Middle East & Africa,Manufacturing,Legal & Compliance,Meets,Female,30,9,0,6,10,4.3,3.6,2.3,0.0348,1,1,1,1,4.3,3.1,1.0
1602,886,0,Europe,Finance,Quality Assurance,Exceeds,Male,38,16,0,11,18,3.2,3.9,2.1,0.0588,1,1,1,1,1.6,3.0,3.6
1603,806,0,Europe,HR,Clinical Operations,Meets,Male,37,8,1,8,11,0.0,4.0,5.0,0.0383,1,1,1,1,3.0,3.3,3.8
1604,991,0,Asia Pacific,Finance,Quality Assurance,Meets,Male,36,10,0,9,29,2.9,3.5,4.7,0.0331,1,1,1,1,2.8,4.4,3.9
1605,553,0,Middle East & Africa,Digital,Quality Assurance,Meets,Male,36,7,1,8,16,0.0,3.2,3.7,0.0853,1,1,1,1,2.7,2.9,4.1
1606,949,0,North America,Finance,Communications,Meets,Male,46,18,1,11,30,0.0,3.3,2.9,0.0331,1,1,1,1,1.9,3.1,3.3
1607,223,0,North America,Commercial,Data Science,Far Exceeds,Female,50,22,0,10,15,2.8,4.1,1.2,0.1275,1,1,1,1,4.0,2.6,3.1
1608,453,0,Latin America,Manufacturing,Legal & Compliance,Meets,Male,38,13,0,8,15,1.9,3.2,3.6,0.0348,1,1,1,0,3.6,3.3,3.4
1609,37,0,North America,R&D,Market Access,Meets,Male,39,5,1,5,21,0.0,3.9,1.0,0.0977,1,1,1,1,2.9,4.6,1.8
1610,349,0,Asia Pacific,Commercial,Market Access,Meets,Female,30,17,0,8,15,4.9,3.1,1.6,0.0422,1,1,1,1,4.7,2.3,2.2
1611,256,0,Asia Pacific,Commercial,IT & Digital,Far Below,Male,48,5,0,9,14,2.2,4.3,3.2,0.0,1,1,1,1,3.5,4.3,3.9
1612,278,1,North America,Commercial,IT & Digital,Meets,Female,34,8,0,10,21,4.0,2.9,2.6,0.0422,1,1,1,1,3.3,3.2,3.3
1613,708,0,North America,HR,Marketing,Meets,Non-Binary/Other,35,14,0,11,24,4.5,4.4,3.0,0.0383,1,1,1,1,4.4,3.9,4.7
1614,961,0,Latin America,Finance,Finance & Accounting,Exceeds,Female,43,2,1,5,11,0.0,1.8,1.9,0.0588,0,0,0,0,5.0,4.2,3.0
1615,944,0,North America,Finance,Finance & Accounting,Meets,Female,40,11,0,12,19,3.1,3.4,3.5,0.0331,1,1,1,1,4.1,3.7,4.2
1616,784,0,Latin America,HR,Medical Affairs,Meets,Male,41,17,0,5,9,2.2,4.3,1.9,0.0383,1,1,1,1,3.0,3.6,3.1
1617,391,0,Latin America,Manufacturing,Finance & Accounting,Meets,Male,42,8,0,10,33,2.2,3.6,1.0,0.0348,1,1,1,1,3.1,3.7,1.5
1618,827,1,North America,HR,Clinical Operations,Meets,Female,38,11,0,10,24,3.5,3.6,4.3,0.0383,1,1,1,1,4.0,3.1,1.7
1619,724,0,Europe,HR,Legal & Compliance,Exceeds,Male,43,6,0,7,10,5.0,3.7,1.2,0.0677,1,1,1,1,4.3,4.5,2.9
1620,775,0,Europe,HR,Clinical Operations,Meets,Male,28,12,1,10,20,0.0,3.2,3.2,0.0383,0,0,0,0,2.6,3.0,3.2
1621,459,0,Latin America,Manufacturing,Sales,Meets,Female,48,36,0,10,17,3.8,2.8,3.0,0.0348,1,1,1,1,4.7,3.2,3.4
1622,517,0,North America,Manufacturing,IT & Digital,Meets,Male,37,11,0,12,19,2.5,3.6,2.2,0.0348,1,1,1,1,3.3,3.8,2.4
1623,543,0,Europe,Digital,Quality Assurance,Far Below,Female,43,15,0,7,17,2.8,3.7,1.6,0.0,0,0,0,0,3.5,2.5,2.0
1624,541,0,North America,Digital,Clinical Operations,Meets,Female,41,10,0,7,26,2.4,2.4,3.5,0.0853,1,1,1,1,2.4,2.7,1.3
1625,629,0,North America,Digital,Regulatory Affairs,Meets,Male,28,21,0,6,28,2.7,3.8,3.8,0.0853,0,0,0,0,3.4,3.2,3.0
1626,607,0,North America,Digital,Supply Chain,Meets,Male,39,18,1,11,38,0.0,3.0,3.0,0.0853,1,1,1,1,4.3,4.3,2.8
1627,891,0,Middle East & Africa,Finance,Quality Assurance,Below,Male,28,22,0,7,23,1.9,2.3,3.3,0.0,1,1,1,1,1.8,2.6,2.5
1628,298,0,North America,Commercial,IT & Digital,Meets,Female,41,4,0,5,12,3.2,4.2,3.0,0.0422,1,1,1,1,3.7,4.3,2.8
1629,317,0,Middle East & Africa,Commercial,Legal & Compliance,Meets,Male,39,12,0,5,15,1.5,3.5,2.1,0.0422,1,1,1,1,2.1,3.9,2.9
1630,583,0,Latin America,Digital,Data Science,Far Below,Female,30,6,0,7,43,2.9,4.1,2.8,0.0,1,1,1,1,2.6,3.0,3.3
1631,693,0,Europe,Digital,Human Resources,Far Below,Female,39,28,0,11,13,2.2,2.6,2.2,0.0,1,1,1,1,2.9,2.7,2.6
1632,127,0,Europe,R&D,IT & Digital,Meets,Female,35,17,1,5,11,0.0,4.5,3.7,0.0977,1,1,1,1,3.1,3.4,2.2
1633,323,0,Europe,Commercial,Finance & Accounting,Meets,Male,37,11,0,8,16,3.5,3.1,3.2,0.0422,1,1,1,1,3.1,3.1,2.2
1634,163,0,Europe,R&D,Quality Assurance,Below,Female,28,17,1,6,13,0.0,3.8,4.4,0.0,0,0,0,0,3.0,4.2,4.4
1635,69,0,Europe,R&D,Clinical Operations,Below,Male,31,7,0,6,17,2.1,2.4,3.9,0.0,1,1,1,1,3.3,3.2,3.3
1636,856,0,Europe,HR,Pharmacovigilance,Exceeds,Male,33,9,1,6,29,0.0,3.7,2.5,0.0677,1,1,1,0,4.4,4.6,1.3
1637,1007,0,Europe,Finance,IT & Digital,Meets,Male,31,15,0,11,35,3.1,3.7,2.4,0.0331,1,1,1,1,4.0,2.0,3.5
1638,459,0,Latin America,Manufacturing,Regulatory Affairs,Meets,Female,35,15,1,8,22,0.0,2.9,1.0,0.0348,1,1,1,1,5.0,2.9,2.2
1639,290,0,North America,Commercial,Legal & Compliance,Exceeds,Non-Binary/Other,34,16,0,7,30,3.1,2.2,1.6,0.0743,0,0,0,0,4.1,2.7,3.5
1640,541,0,Asia Pacific,Digital,Finance & Accounting,Far Below,Male,40,6,1,11,18,0.0,3.7,3.4,0.0,1,1,1,0,2.9,4.0,5.0
1641,659,0,Middle East & Africa,Digital,Regulatory Affairs,Meets,Female,28,22,0,5,18,3.3,4.2,2.4,0.0853,1,1,1,1,1.8,3.5,2.6
1642,446,0,Asia Pacific,Manufacturing,Medical Affairs,Exceeds,Male,50,5,1,5,30,0.0,2.0,1.6,0.0616,1,1,1,1,3.4,4.4,1.8
1643,195,0,Asia Pacific,Commercial,IT & Digital,Meets,Female,34,13,0,6,9,1.0,3.2,2.5,0.0422,1,1,1,1,1.8,3.2,3.6
1644,632,1,North America,Digital,Market Access,Far Exceeds,Male,36,5,0,8,18,2.5,3.7,1.7,0.2363,1,1,1,1,3.1,3.2,2.7
1645,634,0,North America,Digital,Data Science,Exceeds,Female,42,7,1,10,20,0.0,2.2,2.7,0.1452,0,0,0,0,2.2,3.0,2.5
1646,780,0,North America,HR,Medical Affairs,Below,Female,48,16,0,5,16,4.3,4.6,1.2,0.0,1,1,1,1,2.4,4.5,2.6
1647,148,1,Europe,R&D,Marketing,Far Exceeds,Female,34,8,0,5,16,4.4,4.1,1.9,0.2644,1,1,1,1,4.6,3.7,2.3
1648,587,0,Latin America,Digital,Supply Chain,Exceeds,Male,42,14,1,7,9,0.0,3.8,3.8,0.1452,1,1,1,1,3.9,4.1,3.7
1649,994,0,Europe,Finance,Sales,Meets,Female,34,21,0,12,18,3.2,3.5,3.8,0.0331,1,0,0,0,3.5,4.0,4.1
1650,284,0,Latin America,Commercial,Regulatory Affairs,Far Exceeds,Male,44,10,0,10,27,2.4,2.5,3.2,0.1275,1,1,1,1,4.0,1.5,2.6
1651,1025,0,Latin America,Finance,Data Science,Far Below,Male,42,18,0,9,16,3.3,2.9,2.6,0.0,1,1,1,1,1.6,3.9,1.6
1652,421,0,Asia Pacific,Manufacturing,Market Access,Meets,Male,32,14,0,7,9,2.5,1.7,1.0,0.0348,1,1,1,1,4.0,2.1,1.4
1653,784,0,Asia Pacific,HR,Human Resources,Meets,Female,41,13,0,9,31,2.6,2.5,1.3,0.0383,0,0,0,0,3.5,1.9,1.4
1654,311,0,Latin America,Commercial,Data Science,Below,Female,29,4,0,12,24,2.6,3.5,3.3,0.0,1,1,1,1,2.6,3.0,2.8
1655,865,0,Latin America,HR,Legal & Compliance,Meets,Male,34,3,1,10,16,0.0,3.3,3.2,0.0383,1,1,1,1,3.6,3.6,1.9
1656,59,0,Europe,R&D,Sales,Meets,Female,30,16,0,11,18,3.0,2.6,3.7,0.0977,1,1,1,1,3.5,2.0,3.5
1657,595,0,Europe,Digital,IT & Digital,Meets,Female,38,5,0,10,12,1.1,3.3,1.6,0.0853,1,1,1,1,2.7,2.1,3.8
1658,312,0,Asia Pacific,Commercial,Human Resources,Meets,Female,44,24,1,10,14,0.0,3.7,2.4,0.0422,1,1,1,1,2.4,4.0,3.1
1659,461,0,North America,Manufacturing,IT & Digital,Meets,Female,31,8,0,5,16,3.2,2.3,2.8,0.0348,1,1,1,1,3.3,1.7,2.8
1660,61,0,Latin America,R&D,Sales,Below,Female,40,13,0,5,11,3.4,4.6,2.2,0.0,1,1,1,1,3.0,4.2,3.7
1661,166,0,Europe,R&D,Medical Affairs,Meets,Male,37,7,0,12,19,2.0,3.1,3.6,0.0977,1,1,1,1,2.7,2.8,3.3
1662,750,0,Asia Pacific,HR,Quality Assurance,Exceeds,Male,32,5,0,7,31,3.8,3.3,1.9,0.0677,1,1,1,1,3.0,4.7,3.2
1663,31,0,Europe,R&D,Marketing,Meets,Female,35,7,0,10,36,4.1,2.9,3.1,0.0977,1,1,1,1,3.9,2.5,2.9
1664,210,0,Latin America,Commercial,Marketing,Meets,Female,41,30,0,12,19,3.6,3.3,3.4,0.0422,0,0,0,0,3.1,4.7,4.4
1665,821,0,Latin America,HR,Clinical Operations,Meets,Male,44,29,0,8,21,3.3,1.3,2.7,0.0383,1,1,1,1,3.7,1.3,3.2
1666,48,0,Middle East & Africa,R&D,Marketing,Meets,Female,40,5,1,7,16,0.0,2.8,2.2,0.0977,1,1,1,1,2.5,2.9,2.9
1667,414,0,North America,Manufacturing,Data Science,Meets,Female,38,25,0,8,19,3.6,2.3,2.6,0.0348,1,1,1,1,2.8,2.9,4.0
1668,945,0,Middle East & Africa,Finance,Finance & Accounting,Far Exceeds,Male,38,10,0,7,17,2.5,3.4,3.9,0.1022,1,1,1,1,3.6,3.7,3.0
1669,280,0,Asia Pacific,Commercial,Marketing,Meets,Female,34,9,0,9,14,4.1,3.0,3.0,0.0422,0,0,0,0,4.4,2.0,2.2
1670,409,0,Europe,Manufacturing,Market Access,Meets,Male,39,5,0,10,20,4.2,2.2,1.7,0.0348,1,1,1,1,5.0,3.1,2.6
1671,430,0,Asia Pacific,Manufacturing,Finance & Accounting,Meets,Female,29,36,0,8,11,1.8,2.5,1.5,0.0348,1,1,1,1,2.1,3.3,2.3
1672,729,0,Latin America,HR,Human Resources,Meets,Female,37,8,0,9,30,2.0,2.7,3.7,0.0383,1,1,1,1,1.0,4.1,4.0
1673,689,0,Middle East & Africa,Digital,Finance & Accounting,Meets,Non-Binary/Other,48,9,0,6,11,3.5,3.4,3.3,0.0853,1,1,1,1,2.9,3.2,2.3
1674,702,0,Middle East & Africa,HR,Marketing,Meets,Female,35,8,1,7,49,0.0,3.7,1.9,0.0383,1,1,1,1,3.2,3.6,4.1
1675,226,0,Middle East & Africa,Commercial,Regulatory Affairs,Meets,Male,45,13,0,12,32,4.1,2.0,2.6,0.0422,1,1,1,1,4.6,2.6,4.3
1676,215,0,Asia Pacific,Commercial,Clinical Operations,Meets,Male,42,7,0,5,9,4.1,4.1,2.2,0.0422,1,1,0,0,4.1,3.6,2.8
1677,756,0,Latin America,HR,Human Resources,Meets,Female,47,22,0,5,22,3.7,3.5,4.3,0.0383,1,1,1,1,4.0,3.3,4.6
1678,688,1,Europe,Digital,Communications,Exceeds,Female,28,20,0,6,15,3.2,2.8,2.5,0.1452,0,0,0,0,2.2,2.7,2.6
1679,703,0,Europe,HR,Data Science,Meets,Female,39,14,0,6,20,2.5,2.7,3.1,0.0383,1,1,1,1,3.5,3.9,3.2
1680,221,0,Asia Pacific,Commercial,Sales,Far Exceeds,Male,42,13,0,6,9,4.1,3.4,4.5,0.1275,1,0,0,0,4.3,3.2,4.0
1681,578,0,Middle East & Africa,Digital,Communications,Below,Female,43,11,0,5,25,3.9,3.9,2.4,0.0,0,0,0,0,3.3,4.2,2.7
1682,285,0,North America,Commercial,Communications,Meets,Male,45,9,0,7,14,4.1,4.7,1.9,0.0422,1,1,1,1,3.0,4.8,2.0
1683,665,0,Asia Pacific,Digital,Medical Affairs,Meets,Male,42,6,0,5,9,2.2,3.3,2.0,0.0853,1,1,1,1,2.3,2.8,1.9
1684,614,0,Asia Pacific,Digital,Supply Chain,Meets,Male,39,16,0,8,19,4.3,4.4,1.9,0.0853,1,1,1,1,3.8,3.9,1.6
1685,759,0,Latin America,HR,Medical Affairs,Meets,Female,32,17,0,7,13,4.2,4.2,3.3,0.0383,1,1,1,1,4.4,3.8,3.5
1686,708,0,Europe,HR,Quality Assurance,Below,Female,28,28,0,11,16,2.5,4.0,2.4,0.0,1,0,0,0,3.1,3.9,2.5
1687,793,0,Asia Pacific,HR,Supply Chain,Meets,Non-Binary/Other,46,12,0,11,33,3.5,3.3,2.2,0.0383,1,1,1,1,3.8,2.1,2.6
1688,570,0,Asia Pacific,Digital,Market Access,Meets,Female,34,8,1,9,16,0.0,3.3,3.0,0.0853,1,1,1,1,2.4,2.4,4.2
1689,629,0,Middle East & Africa,Digital,Pharmacovigilance,Meets,Male,36,13,0,11,14,4.1,3.9,2.9,0.0853,1,1,1,1,4.9,3.3,2.4
1690,334,0,Middle East & Africa,Commercial,Clinical Operations,Meets,Female,43,10,0,10,18,3.2,2.8,3.9,0.0422,1,1,1,1,3.0,2.8,2.7
1691,465,1,North America,Manufacturing,Communications,Meets,Male,38,12,0,12,13,3.1,4.7,2.6,0.0348,1,1,1,1,3.5,3.3,1.9
1692,709,0,Latin America,HR,Sales,Meets,Female,31,5,0,10,29,3.3,3.9,2.4,0.0383,1,1,1,1,3.0,2.6,2.9
1693,961,0,North America,Finance,Finance & Accounting,Meets,Male,28,12,1,8,18,0.0,1.8,3.5,0.0331,1,1,1,1,3.1,1.6,2.6
1694,239,0,Middle East & Africa,Commercial,Medical Affairs,Below,Female,36,3,0,10,29,3.3,2.5,5.0,0.0,1,1,1,1,4.2,2.7,3.0
1695,231,0,Europe,Commercial,Marketing,Meets,Female,39,24,0,6,19,3.8,3.8,2.9,0.0422,1,1,1,1,3.4,4.6,2.5
1696,109,0,Middle East & Africa,R&D,Clinical Operations,Below,Male,43,8,0,8,39,3.8,4.5,2.5,0.0,1,1,1,1,3.5,5.0,2.7
1697,812,0,Latin America,HR,Marketing,Meets,Male,37,15,0,6,11,3.1,4.5,4.2,0.0383,1,1,1,1,4.0,3.1,3.4
1698,281,0,Middle East & Africa,Commercial,Clinical Operations,Exceeds,Male,38,17,0,8,13,3.9,3.2,1.9,0.0743,1,1,1,1,3.9,4.4,4.0
1699,136,0,Latin America,R&D,Legal & Compliance,Below,Non-Binary/Other,30,6,0,5,13,3.4,3.3,2.7,0.0,1,1,1,1,1.8,2.9,2.7
1700,916,0,Latin America,Finance,Legal & Compliance,Below,Male,44,3,0,6,14,3.3,3.4,1.8,0.0,1,1,1,1,2.9,3.3,1.0
1701,930,0,Latin America,Finance,Clinical Operations,Below,Female,55,26,0,5,17,5.0,4.3,2.7,0.0,1,1,1,1,4.9,5.0,3.0
1702,768,0,Latin America,HR,Quality Assurance,Exceeds,Male,46,7,0,10,14,3.5,2.2,3.5,0.0677,1,1,1,1,4.0,2.7,3.3
1703,612,0,Latin America,Digital,Regulatory Affairs,Below,Male,45,11,0,5,7,3.2,3.9,1.6,0.0,1,1,1,1,3.6,2.8,3.1
1704,121,0,Europe,R&D,Market Access,Far Exceeds,Female,40,7,0,8,16,3.4,4.8,4.2,0.2644,0,0,0,0,3.1,4.0,3.8
1705,594,0,North America,Digital,Finance & Accounting,Meets,Female,32,8,0,9,14,3.3,3.9,2.7,0.0853,1,1,1,1,3.8,3.4,3.0
1706,1021,0,Asia Pacific,Finance,Legal & Compliance,Meets,Female,33,8,0,7,10,3.1,2.8,1.8,0.0331,1,1,1,1,2.5,2.1,1.0
1707,1005,0,North America,Finance,Marketing,Below,Female,42,15,0,11,20,3.9,3.4,2.4,0.0,1,1,1,1,2.9,3.5,2.8
1708,361,0,Latin America,Manufacturing,Legal & Compliance,Meets,Female,43,9,0,11,21,3.4,4.1,2.2,0.0348,1,1,1,1,2.7,3.8,2.1
1709,371,0,Europe,Manufacturing,Marketing,Meets,Male,32,3,1,11,16,0.0,2.5,2.4,0.0348,1,1,1,1,1.7,3.9,2.1
1710,522,0,Middle East & Africa,Manufacturing,Marketing,Meets,Male,41,18,0,8,43,3.2,2.5,1.0,0.0348,1,0,0,0,3.9,3.4,2.2
1711,396,0,Europe,Manufacturing,Quality Assurance,Meets,Male,39,8,0,12,21,4.7,1.0,1.0,0.0348,1,1,1,1,3.7,2.6,1.5
1712,277,0,Latin America,Commercial,Medical Affairs,Meets,Male,41,10,0,5,37,3.3,4.5,1.8,0.0422,1,1,1,1,3.4,2.6,3.0
1713,498,0,Europe,Manufacturing,Data Science,Meets,Non-Binary/Other,40,35,0,7,11,3.3,3.8,2.3,0.0348,1,0,0,0,2.8,2.8,2.3
1714,212,0,Europe,Commercial,Marketing,Meets,Female,40,11,0,12,38,2.9,3.8,4.5,0.0422,1,1,1,1,4.1,3.3,4.5
1715,183,0,Latin America,Commercial,Medical Affairs,Meets,Male,28,11,0,9,50,3.6,2.7,2.4,0.0422,1,1,1,1,3.1,3.3,3.7
1716,770,0,Europe,HR,Regulatory Affairs,Meets,Female,49,23,0,7,14,5.0,1.8,2.4,0.0383,1,1,1,1,2.6,3.4,2.8
1717,224,0,Asia Pacific,Commercial,Marketing,Meets,Female,46,6,0,11,42,3.3,2.4,1.5,0.0422,0,0,0,0,2.4,2.6,2.1
1718,335,0,Asia Pacific,Commercial,Market Access,Meets,Male,38,31,0,11,14,4.0,2.2,2.9,0.0422,1,1,1,1,3.5,3.6,4.8
1719,360,0,Europe,Manufacturing,Sales,Meets,Female,31,3,0,5,19,3.1,4.4,2.0,0.0348,1,1,1,1,3.7,4.0,3.1
1720,200,0,Middle East & Africa,Commercial,Human Resources,Far Below,Male,41,18,0,12,18,1.2,1.1,4.1,0.0,1,1,1,1,3.9,2.7,5.0
1721,595,0,Latin America,Digital,Pharmacovigilance,Meets,Female,29,18,0,10,14,4.7,3.2,2.4,0.0853,0,0,0,0,5.0,2.2,2.4
1722,402,0,Asia Pacific,Manufacturing,Human Resources,Meets,Male,48,9,0,8,22,3.7,3.1,2.4,0.0348,1,1,1,0,4.0,3.6,3.3
1723,74,0,Middle East & Africa,R&D,Marketing,Below,Female,37,7,1,5,22,0.0,4.2,3.2,0.0,1,1,1,0,3.2,4.2,3.4
1724,470,0,Europe,Manufacturing,Legal & Compliance,Exceeds,Male,34,10,0,9,16,3.4,2.0,2.6,0.0616,1,1,1,1,3.5,3.3,3.6
1725,232,0,Middle East & Africa,Commercial,Data Science,Meets,Non-Binary/Other,42,5,0,12,19,3.1,1.4,1.0,0.0422,1,1,1,1,3.0,2.0,1.3
1726,533,0,North America,Digital,Human Resources,Meets,Male,35,6,1,8,17,0.0,5.0,2.7,0.0853,0,0,0,0,1.9,3.8,4.4
1727,434,0,Asia Pacific,Manufacturing,Sales,Exceeds,Male,36,6,0,10,38,3.9,3.5,3.2,0.0616,1,1,1,1,4.4,3.4,3.1
1728,602,0,Europe,Digital,Communications,Below,Female,33,7,1,7,15,0.0,2.0,2.7,0.0,1,1,1,1,3.2,2.0,2.7
1729,154,0,Latin America,R&D,Market Access,Exceeds,Female,42,8,0,9,13,2.9,3.7,3.1,0.1648,1,1,0,0,3.0,3.3,2.7
1730,1017,1,Europe,Finance,Quality Assurance,Meets,Female,40,18,0,9,18,2.7,1.6,3.5,0.0331,1,1,1,1,3.3,3.7,3.9
1731,20,0,Latin America,R&D,Pharmacovigilance,Meets,Female,44,8,0,7,35,3.3,3.2,2.9,0.0977,1,1,1,1,3.9,3.5,2.4
1732,991,0,Europe,Finance,Quality Assurance,Meets,Female,28,21,1,12,17,0.0,4.8,4.3,0.0331,0,0,0,0,3.5,3.9,3.4
1733,713,0,Middle East & Africa,HR,Communications,Exceeds,Male,31,12,0,9,14,3.6,2.0,3.6,0.0677,1,1,1,1,2.7,4.3,2.2
1734,939,0,Middle East & Africa,Finance,Data Science,Meets,Male,35,10,0,7,13,3.5,3.5,1.8,0.0331,1,1,1,1,4.4,2.8,2.4
1735,761,0,Middle East & Africa,HR,Pharmacovigilance,Meets,Male,45,3,1,5,13,0.0,2.8,3.4,0.0383,0,0,0,0,2.4,4.0,2.8
1736,449,0,North America,Manufacturing,Data Science,Meets,Female,29,11,0,8,23,2.4,2.1,2.5,0.0348,1,1,1,1,3.0,2.2,2.3
1737,717,1,Latin America,HR,Quality Assurance,Meets,Male,33,6,1,6,6,0.0,2.1,2.1,0.0383,1,1,1,1,5.0,2.8,2.4
1738,686,0,Middle East & Africa,Digital,Market Access,Meets,Male,47,9,1,11,13,0.0,2.9,3.5,0.0853,1,1,1,1,2.9,3.8,3.6
1739,731,0,North America,HR,Pharmacovigilance,Below,Female,41,17,1,5,12,0.0,3.8,2.6,0.0,1,1,1,1,2.4,2.8,2.8
1740,643,0,Latin America,Digital,Supply Chain,Meets,Male,44,8,1,11,17,0.0,2.9,2.1,0.0853,1,1,1,1,4.6,1.0,3.3
1741,1017,0,Europe,Finance,Medical Affairs,Meets,Male,37,14,0,6,23,3.1,2.1,3.1,0.0331,1,1,1,1,3.2,3.2,3.9
1742,1004,0,North America,Finance,Market Access,Exceeds,Female,49,12,0,6,9,2.5,3.0,4.0,0.0588,1,1,1,1,1.0,3.5,4.5
1743,974,0,Asia Pacific,Finance,Communications,Meets,Male,29,16,0,12,45,3.8,1.1,1.9,0.0331,1,1,1,1,3.9,1.0,2.3
1744,828,0,North America,HR,Pharmacovigilance,Meets,Female,37,5,1,9,16,0.0,1.6,4.7,0.0383,1,1,1,1,3.6,2.0,4.6
1745,1042,0,North America,Finance,Data Science,Below,Male,36,17,0,6,16,2.5,4.1,2.0,0.0,1,1,1,1,2.4,4.5,3.3
1746,760,0,Latin America,HR,Communications,Below,Male,36,9,0,12,17,2.5,2.1,2.5,0.0,1,1,1,1,4.0,1.3,3.4
1747,870,0,Europe,HR,Data Science,Meets,Female,30,36,0,7,12,3.6,4.1,3.3,0.0383,1,1,1,1,2.9,3.6,3.9
1748,267,0,Asia Pacific,Commercial,Regulatory Affairs,Meets,Male,41,6,1,6,20,0.0,5.0,2.2,0.0422,1,1,1,1,4.3,2.7,3.1
1749,204,0,Middle East & Africa,Commercial,Market Access,Meets,Male,31,5,0,12,35,3.9,3.3,3.9,0.0422,1,1,1,1,4.8,4.6,3.1
1750,759,0,Middle East & Africa,HR,Communications,Meets,Female,30,13,0,10,17,2.9,3.3,2.2,0.0383,1,1,1,1,3.6,3.0,2.1
1751,609,0,North America,Digital,Data Science,Meets,Male,28,4,0,7,16,4.5,3.8,2.9,0.0853,1,1,1,1,4.8,2.0,3.6
1752,379,0,Latin America,Manufacturing,Clinical Operations,Meets,Male,34,11,1,7,24,0.0,3.2,3.4,0.0348,1,1,0,0,5.0,4.0,4.2
1753,46,0,Latin America,R&D,Communications,Below,Male,39,19,0,9,13,4.3,4.2,2.8,0.0,1,1,1,1,3.8,5.0,2.5
1754,244,0,Middle East & Africa,Commercial,Medical Affairs,Meets,Female,40,14,0,9,14,4.4,3.6,2.6,0.0422,1,1,1,1,3.6,5.0,2.0
1755,848,0,Asia Pacific,HR,Quality Assurance,Below,Male,37,4,0,11,23,3.9,3.3,1.8,0.0,1,1,1,1,2.3,1.9,3.4
1756,160,0,Europe,R&D,Sales,Meets,Female,34,15,0,9,26,2.7,2.9,2.1,0.0977,1,1,1,1,3.0,1.0,3.1
1757,328,0,Asia Pacific,Commercial,Regulatory Affairs,Meets,Male,36,11,1,11,19,0.0,5.0,1.2,0.0422,1,1,1,1,3.8,2.2,2.9
1758,430,0,Europe,Manufacturing,Data Science,Meets,Male,34,11,0,9,21,5.0,1.7,1.0,0.0348,1,1,1,1,3.9,2.5,2.5
1759,533,0,Middle East & Africa,Digital,Clinical Operations,Meets,Female,50,7,0,5,8,4.3,4.9,4.2,0.0853,1,1,1,0,4.6,4.5,3.9
1760,818,0,Europe,HR,Regulatory Affairs,Meets,Male,31,6,1,11,34,0.0,3.5,2.5,0.0383,1,1,1,1,2.9,1.7,3.4
1761,392,0,Latin America,Manufacturing,Clinical Operations,Exceeds,Male,33,2,1,10,18,0.0,2.6,2.5,0.0616,1,1,1,0,2.7,4.0,2.0
1762,240,0,North America,Commercial,Regulatory Affairs,Meets,Female,38,11,1,11,24,0.0,2.3,4.4,0.0422,1,1,1,1,3.0,2.3,2.0
1763,846,0,North America,HR,Data Science,Far Below,Non-Binary/Other,31,5,1,12,14,0.0,2.9,1.9,0.0,0,0,0,0,2.6,2.8,2.5
1764,163,0,Middle East & Africa,R&D,Clinical Operations,Far Exceeds,Male,38,27,0,10,13,3.5,4.1,1.9,0.2644,1,1,1,1,3.8,3.9,2.5
1765,904,0,Latin America,Finance,Human Resources,Below,Male,28,13,0,6,10,3.3,3.8,2.9,0.0,1,1,1,1,2.4,4.5,3.4
1766,598,0,Asia Pacific,Digital,Pharmacovigilance,Meets,Male,39,9,1,5,9,0.0,3.0,2.1,0.0853,1,1,1,1,3.5,3.3,2.8
1767,212,0,Latin America,Commercial,Market Access,Meets,Female,35,17,0,9,16,4.1,2.2,1.1,0.0422,1,0,0,0,5.0,3.4,1.0
1768,577,0,North America,Digital,Sales,Meets,Female,34,8,1,11,32,0.0,1.6,2.1,0.0853,1,1,1,1,2.6,1.0,3.3
1769,814,0,North America,HR,Quality Assurance,Meets,Female,36,9,0,6,20,3.9,3.0,1.0,0.0383,1,1,1,1,3.0,3.7,1.0
1770,1041,0,Latin America,Finance,Sales,Below,Male,35,7,0,7,15,3.2,3.2,3.9,0.0,1,1,1,1,3.0,2.7,3.7
1771,433,0,Latin America,Manufacturing,Quality Assurance,Exceeds,Male,36,12,1,6,14,0.0,4.4,2.5,0.0616,0,0,0,0,3.6,3.8,2.1
1772,597,0,North America,Digital,Supply Chain,Meets,Male,43,23,0,7,22,3.2,1.3,1.0,0.0853,1,1,1,1,4.0,1.3,1.1
1773,153,0,Asia Pacific,R&D,IT & Digital,Meets,Male,49,15,1,11,16,0.0,4.0,2.9,0.0977,1,1,1,1,3.7,2.9,1.0
1774,250,0,Middle East & Africa,Commercial,Medical Affairs,Meets,Female,28,4,0,11,20,4.6,3.8,3.8,0.0422,1,1,1,1,4.3,1.6,3.3
1775,172,0,Middle East & Africa,R&D,Communications,Far Below,Male,37,13,0,10,19,1.5,2.5,3.5,0.0,1,1,1,1,3.6,2.4,3.8
1776,648,0,Latin America,Digital,Supply Chain,Meets,Female,30,36,0,12,15,4.5,1.6,3.7,0.0853,1,1,1,1,5.0,3.5,3.5
1777,894,0,Middle East & Africa,Finance,Marketing,Exceeds,Female,36,6,0,10,14,1.6,3.3,2.2,0.0588,1,1,0,0,2.7,3.5,2.0
1778,520,0,North America,Manufacturing,Data Science,Meets,Male,40,9,0,9,21,4.2,4.6,3.3,0.0348,1,1,1,1,4.1,3.3,1.8
1779,405,0,North America,Manufacturing,Pharmacovigilance,Meets,Female,52,9,0,12,20,3.2,1.1,2.5,0.0348,1,1,1,1,3.3,2.4,3.2
1780,62,0,Latin America,R&D,IT & Digital,Meets,Male,36,11,0,5,11,3.8,5.0,3.6,0.0977,1,1,1,1,5.0,3.7,2.1
1781,814,0,Latin America,HR,Market Access,Exceeds,Male,39,25,0,8,24,3.2,4.9,2.3,0.0677,1,1,1,1,3.1,3.6,1.0
1782,763,0,Latin America,HR,Communications,Below,Male,33,17,0,8,23,3.2,3.3,3.3,0.0,1,1,1,1,1.5,4.6,4.6
1783,926,0,Asia Pacific,Finance,Finance & Accounting,Meets,Male,32,13,0,8,10,3.4,1.9,2.4,0.0331,1,1,1,1,3.4,1.9,2.7
1784,419,0,Middle East & Africa,Manufacturing,Pharmacovigilance,Meets,Male,32,3,1,11,19,0.0,3.9,2.7,0.0348,1,1,1,1,3.9,3.4,3.6
1785,162,0,Latin America,R&D,Legal & Compliance,Exceeds,Female,34,25,0,12,12,2.7,1.3,2.5,0.1648,1,1,1,1,3.3,1.5,1.8
1786,164,1,Europe,R&D,Sales,Meets,Female,35,4,1,7,13,0.0,2.0,2.6,0.0977,1,1,1,1,2.7,2.6,2.6
1787,90,0,Europe,R&D,Quality Assurance,Exceeds,Male,47,4,1,5,10,0.0,3.8,2.1,0.1648,1,1,1,1,1.0,2.5,3.7
1788,563,0,North America,Digital,Supply Chain,Exceeds,Female,36,13,1,9,14,0.0,3.3,3.5,0.1452,1,1,1,1,3.4,3.4,2.9
1789,1042,0,Middle East & Africa,Finance,Pharmacovigilance,Meets,Female,41,9,0,6,8,5.0,2.2,2.5,0.0331,0,0,0,0,4.1,2.7,5.0
1790,875,0,Latin America,HR,Supply Chain,Far Below,Female,40,22,0,5,11,1.9,3.8,2.1,0.0,1,1,1,1,1.9,3.7,2.6
1791,740,0,Europe,HR,Medical Affairs,Meets,Male,44,7,0,12,15,4.7,3.5,3.5,0.0383,1,1,1,1,3.6,4.1,3.8
1792,607,0,Middle East & Africa,Digital,Medical Affairs,Meets,Male,28,3,1,9,36,0.0,2.6,2.3,0.0853,1,1,1,1,2.3,4.7,2.7
1793,240,0,North America,Commercial,Human Resources,Meets,Female,40,6,0,5,10,3.3,2.8,3.1,0.0422,0,0,0,0,3.0,2.5,2.3
1794,527,0,Asia Pacific,Digital,Quality Assurance,Meets,Female,39,15,1,6,22,0.0,2.9,1.6,0.0853,1,1,1,1,3.0,3.8,1.5
1795,922,0,Middle East & Africa,Finance,Marketing,Meets,Male,37,17,0,8,22,3.1,1.0,3.7,0.0331,1,1,1,0,2.8,1.4,2.3
1796,122,0,Middle East & Africa,R&D,Pharmacovigilance,Meets,Female,44,17,0,6,21,2.7,3.9,1.7,0.0977,1,1,1,1,3.8,5.0,1.5
1797,559,0,Asia Pacific,Digital,Legal & Compliance,Meets,Male,37,7,0,7,13,2.0,3.7,3.1,0.0853,1,1,1,1,4.3,3.3,2.8
1798,108,0,Middle East & Africa,R&D,Market Access,Meets,Female,43,16,0,7,8,3.3,2.7,3.4,0.0977,1,0,0,0,3.3,3.3,4.2
1799,994,0,North America,Finance,Legal & Compliance,Meets,Male,39,3,0,11,16,3.1,3.2,2.8,0.0331,1,1,1,1,2.2,1.6,1.5
1800,1049,0,North America,Finance,Supply Chain,Meets,Female,39,4,0,9,17,3.0,2.8,1.8,0.0331,1,1,1,1,3.1,3.1,2.9
1801,472,0,Asia Pacific,Manufacturing,Supply Chain,Meets,Female,40,23,0,11,23,4.1,4.2,1.5,0.0348,0,0,0,0,3.1,3.4,1.8
1802,63,0,Latin America,R&D,Medical Affairs,Exceeds,Male,37,22,0,11,36,3.0,2.4,2.6,0.1648,1,1,1,1,3.7,1.2,4.0
1803,832,0,Europe,HR,Data Science,Meets,Male,47,6,0,11,21,4.0,3.7,3.4,0.0383,1,1,1,1,3.6,3.1,3.5
1804,546,0,Latin America,Digital,Quality Assurance,Meets,Female,44,6,1,6,18,0.0,2.7,2.2,0.0853,1,1,1,1,2.8,2.7,1.0
1805,900,0,Middle East & Africa,Finance,Supply Chain,Meets,Female,38,7,0,12,16,4.1,3.7,1.2,0.0331,1,1,1,1,2.8,2.3,2.6
1806,144,0,Europe,R&D,Medical Affairs,Below,Female,39,17,0,10,16,4.4,2.7,3.9,0.0,1,1,1,1,4.1,3.2,3.1
1807,341,0,Asia Pacific,Commercial,Finance & Accounting,Below,Female,41,6,1,5,12,0.0,2.9,2.1,0.0,1,1,1,1,3.2,2.7,2.4
1808,445,1,Asia Pacific,Manufacturing,Medical Affairs,Meets,Female,43,21,0,12,25,3.3,2.0,2.0,0.0348,1,1,1,1,3.4,1.4,4.3
1809,182,0,Europe,Commercial,Clinical Operations,Below,Male,48,36,0,11,27,4.0,3.5,2.5,0.0,1,1,1,1,3.9,3.6,2.6
1810,939,0,North America,Finance,Human Resources,Meets,Female,43,5,0,8,14,3.8,2.7,3.6,0.0331,1,1,1,1,4.1,4.6,1.7
1811,345,0,Europe,Commercial,Supply Chain,Meets,Male,37,9,1,9,11,0.0,3.8,2.9,0.0422,1,1,1,1,2.9,5.0,3.4
1812,192,0,Middle East & Africa,Commercial,Clinical Operations,Meets,Male,33,10,0,11,33,3.4,4.4,2.7,0.0422,1,1,1,1,4.7,4.2,2.4
1813,364,0,North America,Manufacturing,Market Access,Meets,Female,44,22,0,9,12,5.0,3.2,3.6,0.0348,1,1,1,1,3.6,2.6,3.4
1814,455,0,Asia Pacific,Manufacturing,Market Access,Below,Non-Binary/Other,40,11,0,8,10,2.8,1.8,2.7,0.0,1,1,1,1,3.1,1.1,2.6
1815,374,0,Europe,Manufacturing,Medical Affairs,Meets,Male,32,14,0,8,26,3.8,2.4,2.6,0.0348,1,1,1,1,3.8,3.1,3.3
1816,488,0,Latin America,Manufacturing,Human Resources,Meets,Male,43,8,0,6,28,3.7,4.1,3.4,0.0348,1,1,1,1,2.3,3.5,1.9
1817,349,0,Latin America,Commercial,Legal & Compliance,Exceeds,Female,47,7,0,10,19,3.4,3.5,2.6,0.0743,1,1,1,1,3.1,5.0,2.7
1818,874,0,Middle East & Africa,HR,Data Science,Exceeds,Male,38,13,0,12,43,4.3,2.3,2.0,0.0677,1,1,1,1,4.6,2.8,3.1
1819,868,0,Latin America,HR,Human Resources,Meets,Non-Binary/Other,47,10,0,8,12,4.7,4.5,3.5,0.0383,1,1,1,1,4.1,3.8,3.5
1820,511,0,Europe,Manufacturing,Data Science,Meets,Female,43,5,0,6,29,4.6,4.1,3.8,0.0348,1,0,0,0,4.1,5.0,4.3
1821,557,0,Europe,Digital,IT & Digital,Below,Female,31,12,0,6,17,4.0,4.0,3.0,0.0,0,0,0,0,2.7,3.5,1.4
1822,83,0,Latin America,R&D,Clinical Operations,Below,Male,41,9,1,5,20,0.0,2.8,3.3,0.0,1,1,1,1,3.8,3.6,3.6
1823,908,0,Europe,Finance,Medical Affairs,Exceeds,Male,28,13,0,10,44,2.4,5.0,3.2,0.0588,1,1,1,1,2.1,3.6,3.7
1824,647,0,Middle East & Africa,Digital,Legal & Compliance,Meets,Female,40,14,0,9,14,1.9,3.1,1.0,0.0853,1,1,1,1,2.2,3.5,2.5
1825,962,0,North America,Finance,Clinical Operations,Meets,Male,32,13,0,10,27,1.1,3.7,2.5,0.0331,1,1,1,1,1.8,2.9,3.4
1826,537,0,Middle East & Africa,Digital,Legal & Compliance,Exceeds,Female,39,32,0,10,15,2.9,3.3,2.6,0.1452,1,1,1,1,4.5,5.0,3.4
1827,635,0,Middle East & Africa,Digital,Finance & Accounting,Meets,Male,42,8,1,11,19,0.0,1.1,2.4,0.0853,1,1,1,1,3.9,1.5,2.7
1828,767,0,Europe,HR,Finance & Accounting,Below,Male,34,11,1,8,18,0.0,2.6,3.8,0.0,1,1,0,0,3.7,3.3,4.6
1829,143,0,North America,R&D,Quality Assurance,Meets,Female,48,16,0,11,16,2.6,3.5,2.3,0.0977,1,1,1,1,2.8,3.7,3.0
1830,582,0,Europe,Digital,Communications,Far Below,Female,32,12,1,8,14,0.0,4.1,2.9,0.0,1,1,1,1,4.6,4.2,1.9
1831,515,0,Asia Pacific,Manufacturing,Communications,Meets,Male,28,22,0,6,8,2.6,1.2,1.6,0.0348,0,0,0,0,2.1,1.0,1.7
1832,958,0,Europe,Finance,Clinical Operations,Meets,Female,38,11,0,11,24,2.6,2.8,3.5,0.0331,1,1,1,1,2.3,3.7,4.5
1833,758,0,Europe,HR,IT & Digital,Exceeds,Female,46,22,0,11,22,2.8,4.2,1.9,0.0677,1,1,1,1,3.4,4.2,1.6
1834,1016,0,Europe,Finance,Legal & Compliance,Meets,Female,38,17,0,11,16,4.0,2.1,4.2,0.0331,1,1,1,1,3.3,1.5,2.7
1835,408,0,North America,Manufacturing,Marketing,Below,Male,34,10,0,9,18,2.2,3.2,4.2,0.0,1,1,1,1,3.4,1.6,4.0
1836,483,0,Europe,Manufacturing,Supply Chain,Below,Male,28,6,1,7,14,0.0,3.0,2.9,0.0,1,1,1,1,1.9,2.0,2.5
1837,530,0,North America,Digital,Communications,Meets,Female,35,10,0,5,19,2.3,3.0,3.3,0.0853,1,1,1,1,2.4,3.6,2.5
1838,459,0,Latin America,Manufacturing,Market Access,Exceeds,Male,31,7,0,6,11,3.7,2.1,2.4,0.0616,1,1,1,1,4.8,4.4,3.1
1839,7,0,Asia Pacific,R&D,Legal & Compliance,Meets,Male,39,6,1,12,22,0.0,3.7,2.4,0.0977,1,1,1,1,5.0,4.1,1.7
1840,499,0,North America,Manufacturing,IT & Digital,Exceeds,Male,40,9,0,6,29,2.8,2.6,1.4,0.0616,1,1,1,0,3.1,3.1,3.6
1841,614,0,Latin America,Digital,Regulatory Affairs,Meets,Male,32,11,1,6,14,0.0,2.8,1.2,0.0853,1,1,1,1,3.0,2.5,1.7
1842,949,0,North America,Finance,Medical Affairs,Meets,Female,36,8,0,11,13,1.5,4.4,1.7,0.0331,1,1,1,1,3.0,3.7,1.8
1843,450,0,North America,Manufacturing,Human Resources,Exceeds,Male,47,15,0,7,17,3.6,2.7,3.9,0.0616,1,1,1,1,3.7,3.9,3.1
1844,749,0,Asia Pacific,HR,Legal & Compliance,Far Below,Male,35,11,0,10,23,3.2,3.9,2.4,0.0,1,1,1,1,2.6,4.6,3.0
1845,832,0,Middle East & Africa,HR,Data Science,Meets,Female,35,14,0,7,15,2.4,2.1,3.7,0.0383,1,1,1,1,3.3,3.7,3.8
1846,709,0,Middle East & Africa,HR,Finance & Accounting,Far Below,Female,39,9,0,11,24,4.6,4.4,2.7,0.0,1,1,1,1,3.7,3.6,2.1
1847,950,0,North America,Finance,Finance & Accounting,Exceeds,Male,30,3,0,7,22,3.4,2.4,2.7,0.0588,1,1,1,1,3.8,4.2,2.5
1848,252,0,Europe,Commercial,Pharmacovigilance,Exceeds,Female,44,20,0,8,27,3.2,2.4,2.4,0.0743,0,0,0,0,4.2,2.4,1.3
1849,863,0,Latin America,HR,Legal & Compliance,Exceeds,Male,36,20,1,11,17,0.0,2.9,3.0,0.0677,1,1,1,1,3.5,3.3,2.8
1850,781,0,Europe,HR,Supply Chain,Below,Male,31,9,1,10,17,0.0,3.0,2.7,0.0,0,0,0,0,2.0,4.2,3.5
1851,282,0,Europe,Commercial,Regulatory Affairs,Below,Female,41,8,0,7,12,2.6,5.0,2.5,0.0,1,1,1,1,3.4,4.0,1.8
1852,1009,0,North America,Finance,Human Resources,Meets,Female,35,16,0,10,21,3.0,2.6,3.3,0.0331,1,1,1,1,4.2,2.9,3.5
1853,869,1,North America,HR,IT & Digital,Meets,Female,33,8,0,8,18,1.6,3.1,2.7,0.0383,1,0,0,0,3.8,4.3,2.6
1854,616,0,North America,Digital,Marketing,Meets,Female,38,13,0,12,18,3.0,2.9,2.2,0.0853,0,0,0,0,2.0,3.8,1.1
1855,942,0,North America,Finance,Pharmacovigilance,Meets,Female,44,36,0,10,19,1.6,3.0,2.1,0.0331,1,1,1,1,1.9,4.0,3.3
1856,730,0,Middle East & Africa,HR,IT & Digital,Below,Non-Binary/Other,36,14,1,8,15,0.0,4.7,3.3,0.0,1,1,1,1,3.1,4.8,2.9
1857,817,0,North America,HR,Data Science,Meets,Female,32,2,0,12,21,3.5,3.1,1.0,0.0383,1,1,1,1,3.2,3.4,1.2
1858,181,0,Middle East & Africa,Commercial,Legal & Compliance,Exceeds,Female,28,10,1,8,14,0.0,2.3,1.3,0.0743,1,1,1,1,3.9,2.5,2.2
1859,593,1,Middle East & Africa,Digital,Communications,Far Exceeds,Female,29,22,0,12,14,3.5,1.9,3.6,0.2363,1,1,1,1,3.6,3.3,4.6
1860,1049,0,North America,Finance,Human Resources,Meets,Male,35,5,1,7,13,0.0,5.0,3.4,0.0331,0,0,0,0,3.9,2.8,2.3
1861,501,0,Asia Pacific,Manufacturing,Marketing,Meets,Male,30,10,0,12,23,3.0,3.3,2.2,0.0348,1,1,1,1,2.7,4.3,2.7
1862,46,0,Latin America,R&D,Legal & Compliance,Below,Male,34,32,0,11,22,3.0,3.7,3.5,0.0,1,1,1,1,3.1,3.4,4.4
1863,640,0,Europe,Digital,Data Science,Below,Female,50,6,0,9,12,1.7,3.5,2.7,0.0,1,1,1,1,1.5,3.9,2.1
1864,474,0,Middle East & Africa,Manufacturing,Data Science,Meets,Female,45,15,0,12,19,3.9,2.8,2.3,0.0348,1,1,1,1,2.2,2.5,3.6
1865,578,0,Latin America,Digital,Medical Affairs,Far Exceeds,Female,33,6,0,10,23,4.5,2.9,2.9,0.2363,1,1,1,1,5.0,2.2,3.5
1866,460,0,Asia Pacific,Manufacturing,Pharmacovigilance,Below,Male,39,20,0,10,14,4.3,2.7,2.2,0.0,0,0,0,0,4.4,5.0,2.2
1867,401,1,Europe,Manufacturing,Human Resources,Meets,Male,32,5,0,8,19,1.8,2.3,2.2,0.0348,0,0,0,0,4.0,2.8,2.2
1868,652,0,Europe,Digital,Finance & Accounting,Below,Male,47,6,0,8,10,4.0,2.9,2.0,0.0,0,0,0,0,2.6,3.4,2.4
1869,317,0,Middle East & Africa,Commercial,Quality Assurance,Meets,Female,38,12,0,10,27,2.9,3.0,3.0,0.0422,1,1,1,1,3.5,2.2,3.6
1870,642,0,North America,Digital,Clinical Operations,Below,Female,44,6,0,6,12,4.8,1.0,2.8,0.0,1,1,1,1,5.0,3.8,3.5
1871,677,0,Asia Pacific,Digital,Finance & Accounting,Meets,Female,33,8,0,11,18,3.2,3.6,2.4,0.0853,1,1,1,1,3.5,3.2,2.8
1872,363,0,Middle East & Africa,Manufacturing,IT & Digital,Meets,Male,48,10,0,5,9,4.2,2.4,2.8,0.0348,1,1,1,1,4.7,3.0,3.5
1873,12,0,Asia Pacific,R&D,Human Resources,Below,Male,35,11,1,10,25,0.0,4.5,2.0,0.0,0,0,0,0,4.0,3.7,2.3
1874,492,0,North America,Manufacturing,Clinical Operations,Below,Male,28,9,1,8,20,0.0,4.3,2.3,0.0,1,1,1,1,3.1,4.3,1.6
1875,767,0,North America,HR,Supply Chain,Meets,Male,37,5,0,5,9,5.0,3.3,2.6,0.0383,1,1,1,1,4.8,3.7,1.3
1876,691,0,Middle East & Africa,Digital,Data Science,Meets,Female,34,22,0,7,13,2.1,1.0,3.8,0.0853,1,1,1,1,3.7,2.9,2.2
1877,1028,0,North America,Finance,Legal & Compliance,Below,Male,44,21,1,7,13,0.0,4.2,2.2,0.0,1,1,0,0,3.5,3.2,1.9
1878,569,0,Latin America,Digital,Human Resources,Exceeds,Female,34,13,0,6,12,3.9,3.3,2.6,0.1452,1,1,1,1,2.1,3.0,1.0
1879,287,0,Europe,Commercial,Supply Chain,Meets,Female,41,8,0,5,21,2.9,2.1,3.1,0.0422,1,1,1,1,3.7,1.4,3.6
1880,1048,0,Middle East & Africa,Finance,Pharmacovigilance,Meets,Male,34,7,1,12,31,0.0,4.2,3.0,0.0331,1,1,1,1,2.5,5.0,3.4
1881,471,0,Asia Pacific,Manufacturing,Data Science,Exceeds,Male,33,8,0,11,14,4.4,1.0,2.3,0.0616,0,0,0,0,3.9,1.0,3.5
1882,338,0,Latin America,Commercial,Data Science,Meets,Non-Binary/Other,38,12,0,10,38,3.6,2.8,1.9,0.0422,0,0,0,0,3.5,1.8,1.8
1883,551,0,Middle East & Africa,Digital,Regulatory Affairs,Exceeds,Male,41,26,0,9,16,4.9,4.7,3.0,0.1452,1,1,1,1,3.9,3.0,4.3
1884,464,0,North America,Manufacturing,Market Access,Exceeds,Female,29,5,0,9,24,3.0,3.8,3.9,0.0616,1,1,1,1,3.9,2.9,2.3
1885,504,0,North America,Manufacturing,Clinical Operations,Below,Male,44,21,0,10,14,3.6,3.3,3.1,0.0,1,1,1,0,3.4,3.4,3.0
1886,761,0,North America,HR,Pharmacovigilance,Exceeds,Female,44,8,1,7,21,0.0,3.1,1.0,0.0677,1,1,1,1,3.7,4.4,2.3
1887,737,0,North America,HR,Marketing,Below,Male,36,13,0,7,24,4.1,3.2,3.3,0.0,1,1,1,1,3.1,3.7,1.9
1888,40,0,Asia Pacific,R&D,Marketing,Meets,Female,37,14,0,11,13,2.6,4.7,3.4,0.0977,1,1,1,1,3.6,3.6,5.0
1889,830,0,Latin America,HR,Quality Assurance,Exceeds,Female,28,7,0,5,15,3.8,1.0,1.9,0.0677,1,1,1,1,2.9,1.9,1.9
1890,978,1,Europe,Finance,Human Resources,Exceeds,Male,49,4,1,5,21,0.0,3.6,3.9,0.0588,1,1,1,1,3.5,5.0,4.1
1891,499,0,Asia Pacific,Manufacturing,Sales,Meets,Male,36,27,0,11,12,3.3,3.0,2.3,0.0348,1,0,0,0,3.2,1.6,3.0
1892,763,0,Asia Pacific,HR,Pharmacovigilance,Below,Female,45,8,1,5,13,0.0,3.3,3.5,0.0,1,1,1,1,4.7,2.1,3.6
1893,157,0,Europe,R&D,Communications,Meets,Male,34,13,0,5,13,3.4,1.3,3.5,0.0977,1,1,1,1,2.5,1.7,3.3
1894,691,0,Europe,Digital,Human Resources,Meets,Female,38,8,0,11,14,3.4,3.4,3.0,0.0853,1,1,1,1,3.0,2.3,3.1
1895,1014,0,North America,Finance,Sales,Meets,Female,41,9,0,7,11,2.2,2.2,4.1,0.0331,1,0,0,0,3.1,3.1,4.6
1896,699,0,Asia Pacific,HR,Regulatory Affairs,Far Exceeds,Male,35,2,1,12,36,0.0,4.1,3.1,0.1168,1,1,1,1,3.5,3.9,3.2
1897,406,0,Middle East & Africa,Manufacturing,Marketing,Meets,Male,29,29,0,9,16,2.9,2.5,3.0,0.0348,1,1,1,1,3.8,3.5,2.6
1898,654,0,Europe,Digital,Communications,Meets,Male,37,8,0,9,23,3.7,1.3,1.7,0.0853,1,1,1,1,2.8,3.2,1.4
1899,427,0,Europe,Manufacturing,Pharmacovigilance,Below,Female,30,11,0,9,16,3.8,1.7,1.9,0.0,0,0,0,0,4.6,1.8,3.5
1900,598,0,Latin America,Digital,Data Science,Meets,Female,33,7,0,8,17,2.6,2.4,4.9,0.0853,1,1,1,1,2.7,3.4,5.0
1901,939,1,Middle East & Africa,Finance,Market Access,Meets,Female,34,2,1,12,16,0.0,4.1,1.0,0.0331,1,1,1,1,3.2,3.7,1.5
1902,423,0,Middle East & Africa,Manufacturing,Medical Affairs,Meets,Female,38,13,0,6,11,3.7,2.7,2.7,0.0348,1,1,1,1,3.6,3.4,3.4
1903,866,0,Europe,HR,Market Access,Meets,Female,34,3,1,6,12,0.0,3.8,2.3,0.0383,1,1,1,1,5.0,2.8,3.9
1904,776,0,North America,HR,Human Resources,Below,Male,31,8,1,5,16,0.0,2.1,3.3,0.0,1,1,1,1,3.2,1.7,3.6
1905,51,0,Latin America,R&D,Quality Assurance,Meets,Female,39,10,0,9,23,3.0,3.9,3.2,0.0977,1,1,1,1,3.4,3.4,2.6
1906,686,0,Middle East & Africa,Digital,Marketing,Meets,Male,42,9,0,10,16,3.0,3.8,2.1,0.0853,1,1,1,1,3.0,3.0,2.4
1907,102,0,Europe,R&D,Finance & Accounting,Below,Male,30,20,0,11,28,2.6,3.6,2.8,0.0,1,0,0,0,4.2,2.8,3.0
1908,241,0,Middle East & Africa,Commercial,Supply Chain,Meets,Female,38,14,0,11,28,3.4,2.8,1.0,0.0422,1,1,1,1,3.8,4.6,1.8
1909,770,1,Latin America,HR,Supply Chain,Meets,Female,43,6,0,6,20,2.8,2.8,4.2,0.0383,1,1,1,1,2.9,4.4,4.1
1910,662,0,Latin America,Digital,Medical Affairs,Meets,Male,39,2,0,5,12,1.7,2.4,2.4,0.0853,1,1,1,1,2.4,5.0,2.4
1911,971,0,Asia Pacific,Finance,Communications,Meets,Female,31,11,0,9,23,3.3,3.6,3.8,0.0331,1,1,1,1,3.9,2.5,2.2
1912,150,0,Europe,R&D,IT & Digital,Exceeds,Male,39,6,1,8,18,0.0,3.3,1.8,0.1648,1,1,1,1,3.0,3.4,3.3
1913,952,0,Latin America,Finance,Marketing,Far Exceeds,Female,38,5,1,8,16,0.0,4.1,3.3,0.1022,1,1,1,1,4.5,4.0,2.9
1914,1020,0,Asia Pacific,Finance,IT & Digital,Below,Male,39,12,0,7,13,2.5,1.5,2.5,0.0,1,1,1,1,2.0,3.4,2.2
1915,901,0,Asia Pacific,Finance,Pharmacovigilance,Meets,Male,38,15,0,5,25,3.3,3.2,3.1,0.0331,1,1,1,1,5.0,2.8,3.1
1916,8,0,Middle East & Africa,R&D,Data Science,Below,Female,28,5,0,12,16,4.2,3.8,2.1,0.0,1,1,1,1,4.8,1.8,2.3
1917,319,0,Middle East & Africa,Commercial,Quality Assurance,Far Below,Female,37,4,1,10,11,0.0,3.1,2.2,0.0,1,1,1,0,4.0,2.4,2.5
1918,100,0,Asia Pacific,R&D,Supply Chain,Meets,Female,44,2,1,10,31,0.0,2.5,3.0,0.0977,1,0,0,0,4.0,4.2,3.1
1919,437,0,Middle East & Africa,Manufacturing,Medical Affairs,Far Exceeds,Female,47,4,1,12,36,0.0,3.2,1.4,0.1069,1,1,1,1,2.9,3.0,1.6
1920,697,0,Latin America,HR,Market Access,Meets,Female,44,2,1,7,11,0.0,3.8,4.5,0.0383,1,1,1,1,3.2,4.4,3.9
1921,121,0,North America,R&D,Finance & Accounting,Meets,Female,38,7,0,9,20,3.3,3.6,2.5,0.0977,1,1,1,1,3.7,3.0,1.5
1922,167,0,Latin America,R&D,Data Science,Below,Female,42,25,0,12,22,3.6,3.9,2.8,0.0,1,1,1,1,3.3,3.0,2.2
1923,189,0,Asia Pacific,Commercial,Legal & Compliance,Exceeds,Female,41,7,1,9,10,0.0,2.6,4.2,0.0743,1,1,1,0,4.0,4.4,3.3
1924,508,0,Asia Pacific,Manufacturing,Supply Chain,Meets,Female,37,19,1,11,14,0.0,3.0,4.1,0.0348,1,1,1,1,2.1,2.9,3.3
1925,62,0,Latin America,R&D,Market Access,Meets,Male,45,9,0,6,16,2.1,4.4,3.2,0.0977,0,0,0,0,4.1,5.0,3.7
1926,822,0,Middle East & Africa,HR,Pharmacovigilance,Exceeds,Female,34,8,0,8,13,2.6,1.4,2.6,0.0677,1,1,1,1,3.4,2.3,2.6
1927,837,0,Middle East & Africa,HR,IT & Digital,Meets,Female,37,4,0,7,21,4.4,5.0,1.8,0.0383,1,0,0,0,3.5,5.0,3.0
1928,116,0,Asia Pacific,R&D,Market Access,Below,Male,43,7,0,7,18,4.1,1.9,5.0,0.0,1,1,1,1,4.3,3.0,4.0
1929,916,0,Europe,Finance,Data Science,Meets,Female,32,20,0,6,10,3.4,2.9,3.4,0.0331,1,1,1,1,3.7,4.5,3.8
1930,1007,0,Middle East & Africa,Finance,Communications,Exceeds,Male,30,7,0,10,14,3.4,2.3,1.0,0.0588,1,1,1,1,3.9,2.5,1.0
1931,365,0,Latin America,Manufacturing,Market Access,Exceeds,Male,32,21,0,7,9,3.7,3.4,3.3,0.0616,1,1,1,1,2.7,3.6,3.4
1932,739,0,Middle East & Africa,HR,Pharmacovigilance,Below,Female,41,15,0,9,19,3.7,3.3,2.2,0.0,1,1,1,1,3.3,3.1,2.8
1933,912,0,Latin America,Finance,Finance & Accounting,Meets,Male,51,13,0,11,23,2.8,3.6,1.0,0.0331,1,1,1,1,3.0,3.7,2.8
1934,864,0,Asia Pacific,HR,Quality Assurance,Below,Female,45,17,0,6,19,2.1,3.3,2.7,0.0,1,1,1,0,3.0,3.8,4.3
1935,411,0,Middle East & Africa,Manufacturing,IT & Digital,Meets,Male,43,2,0,9,20,2.6,2.6,2.0,0.0348,1,1,1,1,3.3,3.0,2.0
1936,413,0,Latin America,Manufacturing,Data Science,Meets,Female,47,8,1,9,16,0.0,3.3,3.1,0.0348,1,1,1,1,2.2,4.3,4.8
1937,970,0,Asia Pacific,Finance,Communications,Meets,Male,40,10,0,10,18,3.3,3.9,1.7,0.0331,1,1,1,1,4.6,3.6,1.4
1938,171,0,Europe,R&D,Quality Assurance,Meets,Male,34,12,0,11,15,2.8,2.7,2.5,0.0977,1,1,1,1,2.6,3.1,2.7
1939,608,0,Latin America,Digital,IT & Digital,Meets,Female,38,28,0,6,17,4.9,3.1,4.6,0.0853,1,1,1,1,3.3,3.4,4.3
1940,220,0,Europe,Commercial,Medical Affairs,Meets,Male,36,2,0,8,19,2.6,3.1,2.7,0.0422,1,1,0,0,3.3,2.3,2.8
1941,636,0,Europe,Digital,Marketing,Exceeds,Male,32,9,0,11,19,2.5,3.5,3.6,0.1452,1,1,1,0,3.5,2.6,3.1
1942,594,0,North America,Digital,IT & Digital,Meets,Male,37,9,0,10,23,3.2,3.1,2.6,0.0853,1,1,0,0,2.7,2.1,3.9
1943,769,0,Middle East & Africa,HR,Market Access,Meets,Male,29,18,0,6,8,2.4,4.0,1.7,0.0383,1,1,1,1,2.2,4.3,1.3
1944,497,0,Latin America,Manufacturing,Regulatory Affairs,Meets,Male,36,8,0,5,12,4.4,2.2,1.0,0.0348,1,1,1,1,4.1,3.4,2.1
1945,710,0,Europe,HR,Quality Assurance,Exceeds,Male,37,14,0,9,22,3.3,2.9,3.3,0.0677,1,1,1,1,4.2,2.1,2.1
1946,942,0,North America,Finance,Finance & Accounting,Below,Female,37,9,0,8,14,5.0,2.7,2.7,0.0,1,1,1,1,4.9,3.5,1.6
1947,180,0,Asia Pacific,Commercial,Pharmacovigilance,Exceeds,Female,48,13,0,8,21,4.6,4.0,3.6,0.0743,0,0,0,0,3.9,3.8,2.3
1948,896,0,Latin America,Finance,Supply Chain,Below,Female,39,8,0,6,20,3.1,3.3,2.8,0.0,1,1,1,1,3.5,2.1,3.9
1949,119,0,Europe,R&D,Quality Assurance,Far Below,Female,49,10,0,8,11,2.7,3.1,4.7,0.0,1,1,1,1,2.0,3.1,3.1
1950,197,0,Middle East & Africa,Commercial,Supply Chain,Below,Male,30,7,1,7,8,0.0,4.2,2.1,0.0,1,1,1,1,3.5,2.9,1.8
1951,756,1,North America,HR,Human Resources,Far Exceeds,Female,43,5,0,9,12,4.4,4.0,3.0,0.1168,1,1,1,1,5.0,4.0,4.2
1952,836,1,Europe,HR,Market Access,Meets,Male,39,27,0,8,16,2.4,2.2,2.8,0.0383,1,1,1,1,1.5,3.3,2.7
1953,919,0,Middle East & Africa,Finance,Medical Affairs,Far Below,Non-Binary/Other,37,12,0,5,11,1.6,2.3,3.3,0.0,1,1,1,1,3.1,2.2,2.7
1954,769,0,Europe,HR,Clinical Operations,Far Exceeds,Male,30,2,1,10,18,0.0,3.8,1.6,0.1168,1,1,1,1,2.2,3.2,4.2
1955,752,0,Latin America,HR,Data Science,Meets,Female,40,10,1,5,14,0.0,1.6,1.9,0.0383,1,1,1,1,2.2,2.8,1.8
1956,675,0,Latin America,Digital,Supply Chain,Exceeds,Female,52,18,0,10,19,4.1,3.3,1.8,0.1452,1,1,1,1,4.2,2.6,1.9
1957,134,0,Latin America,R&D,Human Resources,Meets,Male,41,10,0,5,13,2.4,3.5,3.6,0.0977,1,1,1,1,2.5,3.9,3.1
1958,556,0,North America,Digital,Human Resources,Below,Non-Binary/Other,38,3,1,10,13,0.0,4.0,4.8,0.0,1,1,1,1,4.6,4.4,5.0
1959,847,0,Latin America,HR,Supply Chain,Meets,Male,39,4,0,9,14,2.8,1.8,1.8,0.0383,1,1,1,1,1.6,2.7,1.9
1960,430,0,Middle East & Africa,Manufacturing,Human Resources,Meets,Female,42,6,0,5,16,2.6,2.9,2.9,0.0348,1,1,1,1,3.3,2.7,1.4
1961,555,1,Europe,Digital,Finance & Accounting,Meets,Female,47,14,1,9,11,0.0,2.1,2.9,0.0853,1,1,1,1,5.0,1.8,4.0
1962,837,0,Asia Pacific,HR,Data Science,Meets,Male,36,7,0,8,20,2.2,2.8,1.5,0.0383,1,0,0,0,3.7,3.2,1.2
1963,785,0,Middle East & Africa,HR,Clinical Operations,Meets,Male,39,8,1,12,21,0.0,3.5,3.6,0.0383,1,1,1,1,3.3,5.0,3.3
1964,66,0,Middle East & Africa,R&D,Market Access,Meets,Female,38,9,1,7,8,0.0,2.4,2.9,0.0977,1,1,1,1,2.6,2.6,1.9
1965,1032,0,Latin America,Finance,Pharmacovigilance,Meets,Female,35,8,0,5,8,2.6,3.2,1.5,0.0331,1,1,1,1,3.1,2.9,1.8
1966,181,0,North America,Commercial,IT & Digital,Meets,Female,39,18,0,8,32,5.0,2.9,2.5,0.0422,1,1,1,1,3.7,3.0,2.4
1967,646,0,Europe,Digital,Marketing,Below,Female,47,9,0,10,21,4.7,1.7,3.7,0.0,1,1,1,1,3.6,1.8,4.3
1968,536,0,North America,Digital,Finance & Accounting,Meets,Male,34,16,0,8,19,1.7,2.9,3.4,0.0853,1,1,1,1,1.9,1.8,1.7
1969,565,0,Europe,Digital,Finance & Accounting,Meets,Female,40,22,0,6,11,3.0,3.7,3.2,0.0853,1,1,1,1,3.2,3.9,2.9
1970,793,0,Europe,HR,IT & Digital,Exceeds,Non-Binary/Other,40,8,1,11,16,0.0,3.9,3.3,0.0677,1,1,1,1,3.9,3.7,3.9
1971,145,0,North America,R&D,Supply Chain,Meets,Male,38,6,0,6,14,2.6,5.0,1.2,0.0977,0,0,0,0,3.3,2.5,3.1
1972,876,0,Middle East & Africa,HR,Clinical Operations,Below,Male,41,16,1,12,14,0.0,3.0,3.3,0.0,1,1,1,1,3.0,2.3,3.0
1973,719,0,Europe,HR,Clinical Operations,Far Below,Male,40,5,1,5,10,0.0,2.0,4.6,0.0,1,1,1,1,3.7,2.0,2.8
1974,890,0,North America,Finance,Medical Affairs,Exceeds,Female,33,22,0,11,13,3.1,2.7,1.4,0.0588,1,1,1,1,1.9,4.4,3.9
1975,375,0,Europe,Manufacturing,Supply Chain,Meets,Male,38,11,0,11,47,3.1,2.3,3.2,0.0348,0,0,0,0,3.1,1.0,2.7
1976,56,0,Asia Pacific,R&D,Legal & Compliance,Far Exceeds,Female,38,12,1,9,20,0.0,2.9,3.4,0.2644,1,1,1,1,3.4,3.4,3.4
1977,583,0,Middle East & Africa,Digital,Human Resources,Exceeds,Non-Binary/Other,32,1,0,12,15,4.0,2.9,2.9,0.1452,1,1,1,1,3.1,2.5,2.9
1978,211,0,Latin America,Commercial,Communications,Meets,Male,38,7,1,12,17,0.0,4.4,3.8,0.0422,1,1,1,1,3.1,3.2,3.6
1979,696,0,Europe,Digital,Human Resources,Below,Female,38,16,0,8,20,2.6,1.7,4.0,0.0,1,1,1,1,3.3,1.2,3.4
1980,705,0,Asia Pacific,HR,Quality Assurance,Meets,Male,50,6,0,8,13,3.7,3.4,5.0,0.0383,1,1,1,1,3.4,3.3,3.6
1981,20,0,Latin America,R&D,Market Access,Far Below,Male,33,26,0,10,21,3.4,2.1,3.3,0.0,1,1,1,1,4.6,1.2,4.2
1982,4,0,Latin America,R&D,Pharmacovigilance,Below,Male,44,14,0,7,9,3.9,3.6,2.0,0.0,1,1,1,1,3.1,4.2,2.7
1983,83,0,Europe,R&D,Clinical Operations,Meets,Female,41,3,0,7,12,4.6,3.8,3.2,0.0977,1,1,1,1,3.3,4.7,4.0
1984,437,0,North America,Manufacturing,Medical Affairs,Meets,Female,44,12,0,9,33,3.2,4.1,2.0,0.0348,1,1,1,1,3.2,4.3,1.7
1985,588,1,Europe,Digital,Medical Affairs,Meets,Non-Binary/Other,33,8,0,11,24,2.2,2.2,3.2,0.0853,1,1,1,1,3.0,1.0,3.7
1986,378,0,Asia Pacific,Manufacturing,Data Science,Meets,Male,28,2,1,12,15,0.0,3.9,1.7,0.0348,1,1,0,0,5.0,3.9,1.8
1987,1032,0,Latin America,Finance,Supply Chain,Meets,Female,37,13,0,5,25,3.3,2.5,1.4,0.0331,1,1,1,1,4.1,3.5,3.1
1988,294,0,Europe,Commercial,Clinical Operations,Below,Female,43,3,0,11,15,2.5,3.5,2.9,0.0,1,1,1,1,3.8,2.9,3.3
1989,1034,0,North America,Finance,Pharmacovigilance,Meets,Male,36,25,0,10,18,3.0,2.4,1.0,0.0331,1,1,1,1,3.3,3.4,1.5
1990,859,0,Europe,HR,Finance & Accounting,Meets,Male,37,7,0,12,14,3.2,3.2,4.0,0.0383,1,1,1,1,3.4,4.9,3.5
1991,447,0,Middle East & Africa,Manufacturing,Quality Assurance,Meets,Female,50,36,0,12,17,2.4,3.3,2.9,0.0348,1,1,1,0,2.0,3.5,2.9
1992,470,0,North America,Manufacturing,Regulatory Affairs,Meets,Female,34,5,0,7,14,2.5,4.6,3.8,0.0348,1,1,1,1,2.7,2.5,3.9
1993,974,0,Asia Pacific,Finance,Regulatory Affairs,Meets,Male,44,14,1,12,16,0.0,1.4,3.6,0.0331,1,1,1,1,3.4,1.9,1.9
1994,832,0,Latin America,HR,Quality Assurance,Below,Female,32,7,1,8,30,0.0,4.6,3.5,0.0,1,1,1,1,3.3,3.1,1.4
1995,15,0,Europe,R&D,Human Resources,Meets,Non-Binary/Other,45,14,0,8,17,4.0,2.4,3.0,0.0977,1,1,1,1,2.9,4.1,1.7
1996,753,0,North America,HR,Legal & Compliance,Far Exceeds,Male,38,4,0,11,13,3.8,2.4,2.6,0.1168,1,1,1,1,4.3,3.7,3.9
1997,690,0,Middle East & Africa,Digital,Communications,Below,Male,41,26,0,11,26,2.4,2.3,3.2,0.0,1,1,1,1,3.8,1.2,3.7
1998,1016,0,North America,Finance,Clinical Operations,Meets,Female,34,7,0,8,15,3.3,5.0,1.8,0.0331,1,1,1,1,4.1,4.8,1.3
1999,835,0,Middle East & Africa,HR,Finance & Accounting,Exceeds,Male,39,14,1,11,29,0.0,3.2,2.6,0.0677,1,1,1,1,5.0,2.6,4.0
2000,164,0,Asia Pacific,R&D,Supply Chain,Meets,Female,39,8,1,11,16,0.0,2.7,2.4,0.0977,0,0,0,0,3.9,4.5,2.6
2001,838,0,Latin America,HR,Pharmacovigilance,Meets,Male,30,29,0,8,32,4.1,2.4,3.1,0.0383,1,1,1,1,3.4,3.6,3.1
2002,425,0,Asia Pacific,Manufacturing,IT & Digital,Exceeds,Female,35,6,1,6,8,0.0,3.0,3.0,0.0616,1,1,1,1,4.1,2.1,3.6
2003,337,0,Europe,Commercial,Communications,Meets,Female,40,25,1,8,13,0.0,1.4,2.6,0.0422,1,1,1,1,4.7,2.5,1.5
2004,356,0,North America,Manufacturing,Data Science,Meets,Male,33,18,1,7,13,0.0,3.0,4.3,0.0348,1,1,1,1,3.4,3.2,3.8
2005,288,0,Middle East & Africa,Commercial,Supply Chain,Meets,Male,39,8,0,5,18,4.5,3.5,4.0,0.0422,1,1,1,1,5.0,2.8,3.6
2006,802,0,Middle East & Africa,HR,Marketing,Meets,Female,37,10,1,6,21,0.0,2.8,4.5,0.0383,1,1,1,1,4.3,4.6,2.8
2007,580,0,North America,Digital,Communications,Far Exceeds,Male,42,12,1,10,17,0.0,4.1,1.4,0.2363,1,1,1,1,4.0,3.3,2.6
2008,855,0,North America,HR,Supply Chain,Exceeds,Female,37,11,0,11,34,3.4,2.5,3.3,0.0677,1,1,1,1,3.2,3.5,2.8
2009,94,0,Europe,R&D,Supply Chain,Meets,Male,52,14,0,6,23,3.3,2.8,2.3,0.0977,1,1,1,1,3.1,2.1,2.5
2010,877,0,Asia Pacific,HR,Market Access,Exceeds,Male,28,8,0,6,8,3.0,2.1,1.7,0.0677,1,1,1,1,4.6,3.5,1.6
2011,198,0,Middle East & Africa,Commercial,Clinical Operations,Exceeds,Male,33,13,0,5,20,2.4,4.1,3.5,0.0743,0,0,0,0,2.2,3.1,2.6
2012,444,0,Europe,Manufacturing,Legal & Compliance,Far Exceeds,Male,42,14,1,8,23,0.0,2.2,4.7,0.1069,1,1,1,1,3.2,3.1,4.3
2013,597,0,Asia Pacific,Digital,Data Science,Meets,Male,39,12,0,12,23,2.4,4.4,1.6,0.0853,1,1,1,1,2.0,4.6,2.0
2014,722,0,Europe,HR,Market Access,Below,Female,41,18,0,6,15,4.3,2.4,2.5,0.0,1,1,1,1,3.0,2.5,4.1
2015,720,0,Middle East & Africa,HR,Clinical Operations,Meets,Female,28,7,0,11,19,3.3,3.7,1.2,0.0383,1,1,1,1,4.3,5.0,2.7
2016,372,0,North America,Manufacturing,Sales,Below,Female,37,12,0,9,15,4.3,2.4,3.0,0.0,1,1,1,1,4.6,3.0,2.5
2017,657,0,North America,Digital,Data Science,Meets,Male,38,12,0,11,25,1.5,2.0,2.0,0.0853,1,0,0,0,2.2,2.0,2.6
2018,884,0,Asia Pacific,Finance,Clinical Operations,Below,Male,42,11,0,7,29,2.4,3.3,3.2,0.0,0,0,0,0,3.4,2.7,4.9
2019,789,0,Latin America,HR,Regulatory Affairs,Exceeds,Male,40,11,0,5,10,2.9,1.8,4.1,0.0677,0,0,0,0,2.7,3.0,3.7
2020,736,0,Asia Pacific,HR,Market Access,Meets,Male,38,15,0,8,9,4.1,5.0,3.6,0.0383,1,0,0,0,3.6,3.9,2.7
2021,1036,0,Latin America,Finance,Sales,Meets,Female,37,8,1,8,38,0.0,3.3,3.8,0.0331,1,1,0,0,2.5,4.1,2.9
2022,349,0,Europe,Commercial,Human Resources,Meets,Female,30,1,0,6,12,3.3,3.1,2.7,0.0422,1,1,1,0,2.8,4.1,1.0
2023,327,0,Europe,Commercial,Data Science,Below,Male,40,13,1,7,17,0.0,1.0,3.5,0.0,1,1,1,1,3.8,1.4,2.5
2024,10,0,Middle East & Africa,R&D,Marketing,Meets,Female,37,5,1,6,15,0.0,3.3,1.0,0.0977,1,1,1,1,3.6,3.9,1.4
2025,474,0,Latin America,Manufacturing,Pharmacovigilance,Meets,Male,35,11,0,10,12,3.3,3.8,3.4,0.0348,1,1,1,1,2.9,3.7,4.3
2026,695,0,Middle East & Africa,Digital,Marketing,Exceeds,Female,38,4,0,12,15,4.9,2.5,3.8,0.1452,1,1,1,1,3.8,2.1,3.4
2027,765,0,North America,HR,Regulatory Affairs,Below,Female,36,7,1,11,44,0.0,3.0,2.2,0.0,1,1,1,1,2.1,3.7,2.6
2028,760,0,Latin America,HR,Regulatory Affairs,Meets,Male,29,13,0,12,22,3.2,3.4,2.5,0.0383,1,1,1,1,3.0,3.5,2.2
2029,72,0,Asia Pacific,R&D,Communications,Meets,Female,42,10,0,7,14,2.3,4.6,3.2,0.0977,1,1,1,1,3.0,2.6,1.9
2030,800,0,North America,HR,Finance & Accounting,Far Below,Female,49,11,0,5,21,2.3,2.0,1.0,0.0,1,1,1,1,3.3,2.8,2.9
2031,488,0,North America,Manufacturing,Finance & Accounting,Meets,Male,40,14,0,8,10,2.7,4.2,1.7,0.0348,1,0,0,0,3.6,3.1,3.7
2032,28,0,Asia Pacific,R&D,Quality Assurance,Meets,Female,40,2,1,9,23,0.0,3.8,1.0,0.0977,1,1,1,1,4.7,1.6,1.5
2033,414,0,North America,Manufacturing,Human Resources,Meets,Female,47,11,1,8,22,0.0,1.8,3.2,0.0348,1,1,1,1,4.1,1.7,4.4
2034,74,0,Latin America,R&D,Quality Assurance,Meets,Female,49,4,0,5,21,3.1,1.3,3.9,0.0977,1,1,1,1,2.8,1.0,2.9
2035,840,0,Middle East & Africa,HR,Marketing,Meets,Female,37,12,1,12,21,0.0,2.2,2.4,0.0383,1,1,1,1,3.0,1.0,3.9
2036,122,0,North America,R&D,Market Access,Far Exceeds,Male,34,7,0,5,15,3.6,2.7,3.2,0.2644,1,1,1,1,3.7,4.5,3.2
2037,302,0,Latin America,Commercial,Supply Chain,Meets,Male,41,9,0,10,27,2.9,1.8,3.1,0.0422,1,1,1,1,3.5,2.8,3.0
2038,686,0,Europe,Digital,Clinical Operations,Meets,Male,39,8,0,12,40,3.5,3.4,3.3,0.0853,1,1,1,1,2.4,2.2,4.5
2039,747,0,Latin America,HR,Communications,Meets,Male,44,6,0,7,16,3.5,2.0,4.1,0.0383,1,0,0,0,3.4,3.4,3.0
2040,924,0,Middle East & Africa,Finance,IT & Digital,Meets,Female,38,3,1,7,16,0.0,3.6,3.3,0.0331,1,1,1,1,1.9,2.7,3.7
2041,643,0,Latin America,Digital,Pharmacovigilance,Far Below,Male,38,23,0,10,12,3.6,2.8,1.2,0.0,1,1,1,1,3.9,3.0,2.0
2042,757,0,Asia Pacific,HR,Sales,Meets,Female,32,2,1,5,18,0.0,2.9,3.4,0.0383,1,1,1,1,3.6,3.0,2.1
2043,597,0,Middle East & Africa,Digital,Pharmacovigilance,Meets,Female,44,13,0,12,27,3.1,4.2,4.5,0.0853,1,1,1,1,2.8,3.8,3.5
2044,220,0,Europe,Commercial,Regulatory Affairs,Meets,Female,34,3,1,6,20,0.0,4.1,1.4,0.0422,0,0,0,0,3.0,3.6,2.7
2045,681,0,Asia Pacific,Digital,Legal & Compliance,Exceeds,Male,31,7,1,8,23,0.0,3.8,2.0,0.1452,1,1,1,0,2.4,4.3,2.2
2046,52,0,Latin America,R&D,Quality Assurance,Exceeds,Male,28,26,1,5,12,0.0,1.9,1.5,0.1648,1,1,1,1,4.1,2.9,1.0
2047,565,0,Middle East & Africa,Digital,Supply Chain,Below,Male,37,5,1,6,13,0.0,2.0,2.0,0.0,1,1,1,1,3.5,1.6,3.0
2048,841,0,Europe,HR,Human Resources,Meets,Non-Binary/Other,34,9,1,12,16,0.0,2.5,5.0,0.0383,1,1,1,1,5.0,4.1,5.0
2049,974,0,Asia Pacific,Finance,Legal & Compliance,Far Below,Female,37,29,0,9,26,4.1,4.9,2.5,0.0,1,1,1,1,3.9,5.0,1.3
2050,1035,0,Europe,Finance,Medical Affairs,Meets,Male,35,23,0,7,13,2.7,1.9,1.2,0.0331,1,1,1,1,3.5,3.0,1.5
2051,505,0,Latin America,Manufacturing,Data Science,Below,Male,36,24,0,7,25,1.5,3.7,1.2,0.0,1,1,1,1,2.3,4.5,2.1
2052,529,0,Europe,Digital,Medical Affairs,Exceeds,Female,33,8,0,11,26,2.7,1.8,1.2,0.1452,1,1,1,1,2.9,2.4,1.0
2053,1046,0,North America,Finance,Medical Affairs,Exceeds,Male,34,16,0,11,15,3.7,3.7,3.2,0.0588,1,1,1,1,4.1,2.2,3.7
2054,590,0,Asia Pacific,Digital,Market Access,Far Below,Female,32,4,0,8,19,3.4,2.3,3.3,0.0,1,1,1,1,3.1,2.6,3.0
2055,1044,0,Europe,Finance,Market Access,Meets,Female,37,8,0,12,19,3.3,3.6,1.6,0.0331,0,0,0,0,3.9,4.7,2.9
2056,637,0,Latin America,Digital,Quality Assurance,Meets,Female,31,14,0,9,26,3.0,2.2,2.7,0.0853,1,1,1,1,3.3,1.0,3.5
2057,796,0,Latin America,HR,Finance & Accounting,Meets,Female,46,22,0,6,22,2.3,2.5,3.5,0.0383,1,1,1,1,3.2,2.4,3.0
2058,620,0,Europe,Digital,Finance & Accounting,Meets,Female,38,6,0,6,19,4.7,3.0,4.0,0.0853,1,1,1,1,3.8,3.5,4.8
2059,750,0,Latin America,HR,Medical Affairs,Meets,Male,29,14,0,7,15,3.8,2.4,2.0,0.0383,1,1,1,1,3.7,2.0,2.3
2060,808,0,Middle East & Africa,HR,Legal & Compliance,Exceeds,Female,39,17,0,8,19,3.7,2.1,4.0,0.0677,1,1,0,0,3.0,3.4,5.0
2061,448,0,Middle East & Africa,Manufacturing,Sales,Meets,Female,33,12,0,5,11,2.0,2.6,2.9,0.0348,1,1,1,1,3.4,2.7,4.3
2062,928,0,Middle East & Africa,Finance,Regulatory Affairs,Meets,Male,44,6,0,8,16,3.1,3.3,1.7,0.0331,1,1,1,1,3.0,1.7,1.0
2063,36,0,North America,R&D,Finance & Accounting,Exceeds,Male,34,10,0,12,28,3.8,1.0,4.1,0.1648,1,1,1,1,2.8,1.9,3.2
2064,824,1,Europe,HR,Medical Affairs,Far Exceeds,Male,46,5,1,6,9,0.0,3.3,2.5,0.1168,1,1,1,1,4.0,3.5,3.9
2065,1017,0,North America,Finance,Supply Chain,Meets,Female,44,12,0,12,31,4.2,1.5,2.3,0.0331,1,1,1,1,3.5,1.7,2.6
2066,347,0,Latin America,Commercial,Data Science,Below,Male,55,13,1,9,14,0.0,3.4,2.6,0.0,1,1,1,1,3.8,1.9,3.0
2067,580,0,North America,Digital,Legal & Compliance,Meets,Female,39,8,0,7,10,3.9,5.0,4.0,0.0853,1,1,1,1,4.4,4.1,3.5
2068,295,0,Latin America,Commercial,Legal & Compliance,Far Exceeds,Male,42,19,0,7,10,3.6,2.9,3.3,0.1275,1,1,1,1,3.5,3.1,1.9
2069,661,0,Latin America,Digital,Clinical Operations,Below,Female,38,13,0,7,8,4.0,3.3,3.6,0.0,1,1,1,1,2.3,3.8,5.0
2070,369,0,Asia Pacific,Manufacturing,Finance & Accounting,Meets,Female,39,24,0,6,11,3.0,2.0,2.1,0.0348,1,1,1,1,2.8,4.1,2.8
2071,842,0,Middle East & Africa,HR,Quality Assurance,Below,Male,45,20,0,11,16,3.4,2.9,1.0,0.0,1,1,1,1,3.2,2.0,2.1
2072,122,0,Latin America,R&D,Quality Assurance,Meets,Male,43,9,0,9,19,2.6,1.5,3.5,0.0977,1,1,1,1,1.7,1.0,3.4
2073,743,0,Asia Pacific,HR,Marketing,Exceeds,Male,37,13,0,9,18,3.0,4.2,3.0,0.0677,1,1,1,1,2.3,3.8,3.8
2074,626,1,Middle East & Africa,Digital,Supply Chain,Meets,Female,46,9,0,11,24,4.3,1.9,1.7,0.0853,1,1,1,1,4.6,2.2,2.5
2075,86,0,Latin America,R&D,Communications,Meets,Female,44,16,0,10,15,3.5,2.9,2.4,0.0977,1,1,1,1,4.1,5.0,2.5
2076,868,0,Latin America,HR,Market Access,Exceeds,Male,47,20,1,7,13,0.0,4.7,3.8,0.0677,1,0,0,0,3.3,2.2,2.2
2077,42,0,North America,R&D,Human Resources,Below,Female,45,22,0,10,28,2.9,2.9,2.1,0.0,1,1,1,1,4.1,2.6,1.9
2078,679,0,North America,Digital,Regulatory Affairs,Exceeds,Male,36,19,1,7,18,0.0,3.0,1.8,0.1452,1,1,1,1,4.3,2.5,2.5
2079,384,0,Middle East & Africa,Manufacturing,Sales,Meets,Female,35,14,0,12,16,1.8,3.4,2.9,0.0348,1,1,1,1,2.2,2.8,3.0
2080,500,0,Latin America,Manufacturing,IT & Digital,Meets,Male,35,13,0,11,23,3.9,4.5,2.1,0.0348,1,1,1,1,3.2,3.8,3.1
2081,827,0,Europe,HR,Supply Chain,Meets,Female,43,15,0,10,29,4.2,2.8,2.6,0.0383,1,1,1,1,4.1,2.8,2.7
2082,321,0,North America,Commercial,Communications,Meets,Female,46,4,1,10,15,0.0,4.7,4.0,0.0422,1,1,1,1,3.2,2.7,5.0
2083,567,1,Middle East & Africa,Digital,Pharmacovigilance,Exceeds,Female,44,4,0,12,20,2.8,3.5,1.7,0.1452,1,1,1,1,3.6,4.1,3.6
2084,829,1,Latin America,HR,Clinical Operations,Far Exceeds,Male,29,15,0,9,27,1.9,3.8,1.3,0.1168,1,1,1,1,4.2,3.6,2.3
2085,717,0,Latin America,HR,Communications,Exceeds,Male,34,6,1,5,8,0.0,3.9,1.7,0.0677,1,1,1,1,1.8,2.4,1.3
2086,498,0,Europe,Manufacturing,Data Science,Below,Female,42,18,0,7,24,4.6,3.3,3.6,0.0,1,1,1,1,2.0,1.6,3.5
2087,165,0,Middle East & Africa,R&D,Marketing,Meets,Male,45,23,0,12,22,3.2,2.8,2.2,0.0977,1,1,1,1,4.9,3.0,3.3
2088,680,0,Latin America,Digital,Legal & Compliance,Meets,Male,40,15,0,7,15,4.4,2.9,3.3,0.0853,1,1,1,1,3.8,2.9,2.0
2089,44,0,North America,R&D,Supply Chain,Exceeds,Female,47,7,0,8,12,3.0,2.3,1.9,0.1648,1,1,1,1,3.1,1.7,3.1
2090,1030,0,Europe,Finance,Marketing,Meets,Male,28,5,0,10,22,2.7,2.2,2.1,0.0331,1,1,1,1,2.0,1.8,2.0
2091,976,0,Middle East & Africa,Finance,Clinical Operations,Far Exceeds,Male,37,8,1,12,12,0.0,2.7,1.6,0.1022,1,1,1,1,1.9,2.9,2.0
2092,689,0,Europe,Digital,Medical Affairs,Far Exceeds,Female,47,10,1,12,30,0.0,2.8,3.2,0.2363,1,1,1,1,3.5,1.9,3.1
2093,295,0,North America,Commercial,Marketing,Meets,Female,40,7,0,12,17,3.8,2.5,4.6,0.0422,1,1,1,1,3.9,2.9,3.8
2094,978,0,Middle East & Africa,Finance,Quality Assurance,Exceeds,Male,33,9,0,7,17,2.4,2.1,3.3,0.0588,1,1,1,1,2.0,1.9,2.9
2095,433,0,Europe,Manufacturing,Market Access,Far Exceeds,Female,43,9,1,9,22,0.0,3.7,2.4,0.1069,1,1,1,1,2.1,3.2,3.5
2096,313,0,Asia Pacific,Commercial,Communications,Exceeds,Female,39,4,1,11,19,0.0,4.7,4.2,0.0743,1,1,1,1,2.0,3.5,3.6
2097,801,0,North America,HR,Legal & Compliance,Meets,Non-Binary/Other,35,6,0,9,29,4.4,5.0,2.6,0.0383,1,1,1,1,3.8,5.0,1.7
2098,1000,0,North America,Finance,Medical Affairs,Exceeds,Male,29,6,1,5,8,0.0,3.7,2.5,0.0588,1,1,1,1,2.6,2.4,3.2
2099,403,0,North America,Manufacturing,Supply Chain,Below,Non-Binary/Other,42,12,0,12,17,3.5,1.6,3.8,0.0,1,1,1,1,4.7,1.1,4.1
2100,727,0,Asia Pacific,HR,Human Resources,Meets,Male,31,16,1,9,19,0.0,4.8,3.3,0.0383,1,1,1,1,2.9,2.9,4.4
2101,337,0,Asia Pacific,Commercial,Data Science,Meets,Male,51,11,1,12,26,0.0,3.7,1.0,0.0422,1,1,1,1,3.5,2.2,1.6
2102,672,0,Latin America,Digital,Quality Assurance,Below,Male,28,12,0,12,19,2.7,4.0,2.9,0.0,1,1,1,0,3.9,4.6,2.7
2103,708,0,Europe,HR,Clinical Operations,Exceeds,Male,38,10,0,5,12,1.6,4.4,2.1,0.0677,0,0,0,0,3.6,3.2,2.5
2104,93,0,Latin America,R&D,Medical Affairs,Meets,Female,43,15,1,9,15,0.0,4.5,2.3,0.0977,1,1,0,0,2.5,2.7,2.5
2105,553,1,Europe,Digital,Quality Assurance,Meets,Female,32,10,0,12,14,5.0,3.2,3.0,0.0853,1,1,1,1,2.8,3.7,3.7
2106,536,0,Asia Pacific,Digital,Market Access,Meets,Male,34,11,0,11,18,2.5,2.3,3.7,0.0853,1,1,1,1,2.3,2.1,4.2
2107,312,0,Asia Pacific,Commercial,Medical Affairs,Far Exceeds,Male,43,30,0,12,17,1.8,4.3,1.9,0.1275,1,1,0,0,1.8,4.6,1.0
2108,247,0,Latin America,Commercial,Regulatory Affairs,Exceeds,Male,32,3,0,12,14,3.0,1.0,3.7,0.0743,1,1,1,1,1.8,2.1,2.8
2109,427,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Far Below,Male,50,7,0,6,17,3.6,2.2,1.1,0.0,1,1,1,1,3.9,1.6,2.9
2110,467,0,Latin America,Manufacturing,Medical Affairs,Far Exceeds,Male,38,11,0,10,15,2.4,4.8,1.2,0.1069,1,1,1,1,3.3,4.1,2.5
2111,113,0,Europe,R&D,Communications,Meets,Male,35,9,0,5,7,2.8,2.5,3.3,0.0977,1,1,1,1,1.5,4.4,2.6
2112,599,0,Latin America,Digital,Finance & Accounting,Meets,Male,48,3,1,5,15,0.0,4.7,2.7,0.0853,1,1,1,0,2.0,5.0,3.7
2113,131,0,North America,R&D,Medical Affairs,Meets,Male,32,12,0,11,14,3.3,2.4,4.3,0.0977,1,1,1,1,3.2,1.0,4.1
2114,142,0,Europe,R&D,Communications,Exceeds,Female,48,8,0,11,14,3.6,1.9,2.5,0.1648,1,1,1,1,4.2,2.8,2.8
2115,224,0,Europe,Commercial,Regulatory Affairs,Exceeds,Male,32,10,1,11,16,0.0,3.3,3.4,0.0743,1,1,1,1,3.1,3.6,2.0
2116,147,0,Middle East & Africa,R&D,Supply Chain,Meets,Male,46,6,0,6,11,2.5,3.9,4.7,0.0977,1,1,1,1,5.0,4.9,4.7
2117,92,0,Asia Pacific,R&D,Communications,Meets,Male,49,8,0,10,38,3.8,2.7,3.5,0.0977,1,1,1,1,3.2,5.0,2.1
2118,794,0,Europe,HR,Marketing,Meets,Male,37,15,0,5,15,3.9,3.5,2.1,0.0383,1,1,1,1,4.5,3.7,2.8
2119,443,0,Asia Pacific,Manufacturing,Human Resources,Meets,Female,37,10,0,5,16,3.1,3.4,4.3,0.0348,1,1,1,1,3.2,3.4,3.1
2120,420,0,Latin America,Manufacturing,Data Science,Meets,Female,36,11,0,6,19,3.6,3.4,4.5,0.0348,1,1,1,1,4.8,4.4,5.0
2121,545,0,North America,Digital,Quality Assurance,Meets,Female,33,9,0,6,18,4.0,5.0,2.6,0.0853,1,1,1,1,3.4,4.4,2.5
2122,442,0,Middle East & Africa,Manufacturing,Quality Assurance,Meets,Female,39,13,0,5,11,2.6,2.5,3.9,0.0348,1,1,1,1,3.0,3.6,2.2
2123,953,1,Asia Pacific,Finance,Clinical Operations,Meets,Male,43,4,0,6,11,2.1,3.5,4.2,0.0331,1,1,1,1,4.5,3.4,3.8
2124,681,0,Europe,Digital,Data Science,Meets,Male,42,9,0,8,15,4.0,2.5,3.1,0.0853,1,1,1,1,3.1,2.1,4.1
2125,759,0,Asia Pacific,HR,Sales,Meets,Female,41,27,0,9,21,5.0,2.1,2.6,0.0383,1,1,1,1,5.0,4.6,3.9
2126,438,0,Europe,Manufacturing,Regulatory Affairs,Meets,Female,34,3,1,11,15,0.0,3.0,2.6,0.0348,1,1,1,1,3.0,3.1,2.4
2127,731,0,Asia Pacific,HR,IT & Digital,Far Exceeds,Female,32,6,1,6,17,0.0,1.5,2.6,0.1168,1,1,1,1,4.4,1.8,3.6
2128,517,0,Europe,Manufacturing,IT & Digital,Below,Male,49,14,0,9,25,3.2,3.5,1.7,0.0,1,1,1,1,2.4,3.1,2.8
2129,396,0,Latin America,Manufacturing,Sales,Meets,Male,30,31,0,5,10,4.1,3.5,1.9,0.0348,1,1,1,1,3.0,2.9,1.0
2130,828,0,Europe,HR,Human Resources,Meets,Male,37,16,0,5,12,2.2,2.6,2.5,0.0383,1,1,1,1,3.2,4.8,2.0
2131,143,0,Europe,R&D,Market Access,Far Below,Male,43,13,0,5,34,2.8,2.9,3.7,0.0,1,1,1,1,3.9,2.2,2.3
2132,58,0,North America,R&D,Data Science,Meets,Female,47,12,0,6,11,4.1,4.3,4.5,0.0977,1,0,0,0,2.5,3.1,4.2
2133,176,0,Europe,R&D,Communications,Exceeds,Male,38,16,0,5,8,4.1,2.8,3.3,0.1648,1,1,1,1,2.9,3.3,2.5
2134,955,0,North America,Finance,Pharmacovigilance,Meets,Male,40,11,0,5,9,3.0,2.1,2.7,0.0331,1,1,1,1,3.1,2.3,3.0
2135,4,0,Middle East & Africa,R&D,Human Resources,Meets,Female,35,11,1,11,15,0.0,2.5,2.1,0.0977,1,1,1,1,4.5,3.7,3.6
2136,468,0,North America,Manufacturing,Clinical Operations,Meets,Male,48,9,1,8,12,0.0,4.1,1.3,0.0348,0,0,0,0,2.5,5.0,2.9
2137,304,0,Latin America,Commercial,Medical Affairs,Exceeds,Male,46,11,0,5,22,2.2,4.8,3.5,0.0743,1,1,1,1,1.8,4.5,3.9
2138,843,0,North America,HR,Market Access,Meets,Male,32,8,0,6,13,3.4,3.3,3.2,0.0383,1,1,1,1,3.6,3.2,3.5
2139,342,0,Middle East & Africa,Commercial,Marketing,Exceeds,Male,42,7,0,8,24,3.2,3.3,3.9,0.0743,1,1,1,1,4.1,3.2,4.2
2140,1021,0,Latin America,Finance,Communications,Meets,Male,37,22,0,5,10,3.0,2.9,2.8,0.0331,1,1,1,1,1.2,1.3,2.3
2141,279,0,Asia Pacific,Commercial,Pharmacovigilance,Meets,Female,40,9,0,10,21,2.2,2.9,2.4,0.0422,1,1,1,1,1.8,3.1,4.2
2142,557,0,Asia Pacific,Digital,Data Science,Below,Female,33,3,0,9,26,3.1,2.1,2.4,0.0,1,1,1,1,2.5,1.6,3.5
2143,151,0,North America,R&D,Communications,Exceeds,Female,28,10,0,10,15,3.5,3.1,2.0,0.1648,1,1,1,1,3.6,3.1,3.3
2144,953,0,North America,Finance,Data Science,Meets,Female,31,6,1,8,13,0.0,2.8,1.4,0.0331,0,0,0,0,2.6,1.0,2.8
2145,365,0,Middle East & Africa,Manufacturing,Communications,Meets,Female,35,3,1,9,21,0.0,1.7,3.6,0.0348,1,1,1,1,4.8,1.1,3.0
2146,171,0,Middle East & Africa,R&D,IT & Digital,Far Below,Male,35,7,0,9,19,2.0,3.3,2.8,0.0,0,0,0,0,1.6,2.8,3.4
2147,87,0,Europe,R&D,Sales,Meets,Female,28,6,0,10,11,3.1,2.0,4.3,0.0977,0,0,0,0,4.9,2.6,3.1
2148,278,0,Middle East & Africa,Commercial,Supply Chain,Meets,Male,40,5,1,6,16,0.0,1.0,3.1,0.0422,1,1,1,1,4.0,1.5,2.1
2149,561,0,Europe,Digital,Legal & Compliance,Meets,Male,30,3,0,7,31,2.8,3.0,1.1,0.0853,1,1,1,1,4.0,4.0,2.5
2150,76,1,Latin America,R&D,Sales,Exceeds,Male,38,23,1,12,24,0.0,2.5,2.6,0.1648,1,1,1,1,2.8,1.8,2.2
2151,859,0,North America,HR,Human Resources,Meets,Male,31,6,0,11,25,2.9,2.5,2.2,0.0383,1,1,1,1,3.5,4.1,2.7
2152,865,0,Latin America,HR,Quality Assurance,Meets,Female,28,10,0,10,13,2.8,3.8,1.9,0.0383,1,1,1,1,2.8,4.0,2.1
2153,3,1,Middle East & Africa,R&D,Sales,Far Exceeds,Male,38,8,1,12,17,0.0,1.5,1.0,0.2644,0,0,0,0,5.0,2.8,2.7
2154,321,0,Latin America,Commercial,Supply Chain,Exceeds,Male,37,13,1,10,38,0.0,4.5,1.4,0.0743,1,1,1,1,4.3,3.3,1.0
2155,228,0,Latin America,Commercial,Marketing,Meets,Female,39,12,0,7,19,4.9,3.5,4.6,0.0422,1,1,1,1,4.5,3.3,4.1
2156,367,0,Latin America,Manufacturing,Legal & Compliance,Meets,Male,48,1,1,12,16,0.0,4.1,1.7,0.0348,1,1,1,1,4.1,3.0,3.7
2157,950,0,Middle East & Africa,Finance,Market Access,Exceeds,Female,42,9,1,5,15,0.0,2.1,2.8,0.0588,1,1,1,1,4.2,4.3,5.0
2158,984,0,Latin America,Finance,Finance & Accounting,Meets,Female,50,10,0,12,20,5.0,5.0,2.0,0.0331,1,1,1,1,4.6,4.3,1.6
2159,980,0,Europe,Finance,Regulatory Affairs,Meets,Male,36,3,1,10,19,0.0,2.7,1.0,0.0331,1,1,1,1,3.4,2.7,1.5
2160,538,0,Middle East & Africa,Digital,Data Science,Meets,Male,34,24,0,5,11,4.1,2.8,2.4,0.0853,1,1,1,1,3.5,2.0,3.9
2161,230,0,Latin America,Commercial,Human Resources,Meets,Male,41,12,1,11,20,0.0,3.4,3.4,0.0422,1,1,1,1,1.8,4.2,3.5
2162,398,0,Middle East & Africa,Manufacturing,Human Resources,Exceeds,Male,49,21,0,10,28,3.9,3.2,2.2,0.0616,1,1,1,1,2.7,3.4,3.2
2163,706,0,Asia Pacific,HR,Medical Affairs,Meets,Male,31,9,0,8,16,2.5,3.6,5.0,0.0383,1,1,1,1,2.8,3.3,3.5
2164,993,0,Europe,Finance,Sales,Meets,Male,46,9,0,7,16,3.1,3.3,1.7,0.0331,1,1,1,1,3.6,3.5,3.3
2165,797,0,Latin America,HR,Pharmacovigilance,Below,Female,41,14,0,12,24,3.1,1.4,2.9,0.0,1,1,1,1,4.8,1.4,2.0
2166,842,0,Asia Pacific,HR,Marketing,Meets,Male,35,6,0,10,12,4.2,3.8,1.1,0.0383,1,1,1,1,4.5,2.7,2.8
2167,133,0,Asia Pacific,R&D,Clinical Operations,Meets,Male,47,5,0,12,21,3.8,3.6,3.0,0.0977,1,1,1,1,2.9,2.6,5.0
2168,554,0,Middle East & Africa,Digital,Data Science,Meets,Male,31,8,0,10,16,3.5,2.1,4.1,0.0853,1,1,1,1,4.2,2.6,5.0
2169,478,0,Asia Pacific,Manufacturing,Supply Chain,Meets,Female,42,14,0,5,12,2.3,1.9,3.3,0.0348,1,1,1,1,2.1,2.5,5.0
2170,633,0,Europe,Digital,Quality Assurance,Meets,Male,37,14,0,8,14,2.9,3.5,1.0,0.0853,1,1,1,1,4.0,2.5,1.0
2171,27,0,Europe,R&D,Supply Chain,Below,Male,45,3,0,10,19,2.8,3.4,3.3,0.0,1,1,1,1,2.7,3.2,2.8
2172,412,0,North America,Manufacturing,Sales,Meets,Male,40,27,0,9,11,5.0,4.2,2.0,0.0348,1,1,1,1,3.8,4.1,1.4
2173,406,0,Europe,Manufacturing,Communications,Meets,Male,45,20,1,5,12,0.0,4.2,1.8,0.0348,1,1,1,1,3.7,3.4,2.5
2174,182,0,Asia Pacific,Commercial,Market Access,Below,Male,38,3,0,9,27,2.6,4.9,3.3,0.0,1,1,1,1,3.0,4.0,2.4
2175,668,0,Europe,Digital,Quality Assurance,Far Below,Non-Binary/Other,35,20,0,12,15,3.4,2.6,3.5,0.0,0,0,0,0,4.1,2.8,3.3
2176,669,0,Middle East & Africa,Digital,Pharmacovigilance,Exceeds,Female,38,8,0,10,15,3.5,2.1,2.8,0.1452,1,1,1,1,2.2,2.0,2.2
2177,270,0,North America,Commercial,Supply Chain,Below,Female,39,17,0,5,11,3.2,1.7,2.9,0.0,1,1,1,1,3.2,3.7,2.2
2178,783,0,Asia Pacific,HR,Human Resources,Exceeds,Female,40,3,0,7,22,4.6,2.4,3.8,0.0677,1,0,0,0,3.8,3.2,3.7
2179,107,0,North America,R&D,Pharmacovigilance,Meets,Female,42,18,0,12,15,4.3,4.0,4.0,0.0977,1,1,1,1,2.2,4.0,3.3
2180,574,0,Asia Pacific,Digital,Clinical Operations,Meets,Female,38,12,0,5,13,2.7,1.6,2.8,0.0853,1,1,1,1,3.3,3.4,3.4
2181,273,0,Middle East & Africa,Commercial,Legal & Compliance,Below,Male,42,4,1,5,17,0.0,1.7,3.7,0.0,1,1,1,1,2.1,3.1,3.0
2182,398,0,North America,Manufacturing,Pharmacovigilance,Exceeds,Female,51,10,0,9,15,2.1,2.4,3.5,0.0616,1,1,1,1,3.2,3.9,3.2
2183,955,0,Latin America,Finance,Data Science,Below,Male,34,13,0,12,18,5.0,3.3,5.0,0.0,1,1,1,1,5.0,3.4,4.9
2184,254,0,Asia Pacific,Commercial,Marketing,Meets,Male,44,21,0,6,23,2.8,3.8,1.8,0.0422,1,1,1,1,3.0,1.3,2.2
2185,1002,0,Latin America,Finance,Quality Assurance,Meets,Male,34,9,0,8,17,3.3,3.1,4.3,0.0331,1,1,1,1,3.3,3.3,3.0
2186,871,0,North America,HR,Data Science,Exceeds,Female,32,5,0,12,18,2.9,2.3,2.5,0.0677,1,1,1,1,3.1,3.3,4.5
2187,119,0,Latin America,R&D,Medical Affairs,Exceeds,Male,47,7,0,11,20,2.2,3.9,5.0,0.1648,1,1,1,1,3.8,3.6,3.7
2188,905,0,Latin America,Finance,Supply Chain,Meets,Female,33,29,1,5,8,0.0,2.7,2.6,0.0331,1,1,1,1,3.6,2.2,1.7
2189,868,0,North America,HR,IT & Digital,Meets,Female,38,17,0,12,20,3.7,1.0,3.3,0.0383,1,1,1,1,3.8,2.7,3.0
2190,938,0,Middle East & Africa,Finance,Supply Chain,Meets,Male,33,13,0,9,20,3.1,3.8,2.9,0.0331,1,0,0,0,3.6,5.0,1.9
2191,455,0,Latin America,Manufacturing,Medical Affairs,Exceeds,Male,53,11,0,12,21,1.7,3.8,2.5,0.0616,1,1,1,1,2.2,3.1,1.8
2192,450,0,Latin America,Manufacturing,Pharmacovigilance,Meets,Male,38,15,0,6,10,3.2,4.1,1.5,0.0348,0,0,0,0,4.3,5.0,2.6
2193,364,1,Middle East & Africa,Manufacturing,Finance & Accounting,Exceeds,Male,31,15,0,8,13,3.7,2.2,2.7,0.0616,1,1,1,1,4.9,2.1,4.4
2194,471,0,Latin America,Manufacturing,Data Science,Meets,Female,33,21,1,7,20,0.0,3.4,2.6,0.0348,1,1,1,1,2.9,3.2,1.4
2195,288,0,Latin America,Commercial,IT & Digital,Below,Female,51,5,1,11,18,0.0,4.3,2.5,0.0,1,1,1,1,3.6,3.3,3.1
2196,486,0,Latin America,Manufacturing,Quality Assurance,Below,Male,37,4,1,10,19,0.0,4.3,1.9,0.0,1,1,1,1,4.7,4.5,3.4
2197,410,0,Europe,Manufacturing,Quality Assurance,Meets,Female,38,20,0,8,14,3.7,2.6,3.0,0.0348,0,0,0,0,3.1,1.6,1.8
2198,327,0,Middle East & Africa,Commercial,Finance & Accounting,Meets,Female,47,9,0,8,10,2.5,2.0,2.7,0.0422,1,1,1,1,1.8,2.6,3.1
2199,399,0,Latin America,Manufacturing,Medical Affairs,Below,Male,46,20,0,5,15,2.8,1.9,3.2,0.0,1,1,1,1,2.6,1.8,2.9
2200,858,0,Middle East & Africa,HR,Supply Chain,Meets,Female,33,8,1,6,26,0.0,1.0,3.3,0.0383,1,1,1,1,4.2,1.5,2.9
2201,842,0,Asia Pacific,HR,Medical Affairs,Meets,Male,33,4,0,12,18,4.3,3.1,2.8,0.0383,1,1,1,1,4.8,3.4,2.9
2202,612,0,Asia Pacific,Digital,Finance & Accounting,Below,Female,35,5,1,10,12,0.0,1.7,4.6,0.0,1,1,1,1,3.8,4.1,4.9
2203,816,0,Latin America,HR,IT & Digital,Far Below,Male,36,25,0,7,29,3.2,4.2,2.4,0.0,1,1,1,1,3.7,3.8,1.0
2204,86,1,Middle East & Africa,R&D,Clinical Operations,Exceeds,Female,43,9,0,6,11,2.7,1.7,2.0,0.1648,1,1,1,1,2.5,2.1,1.2
2205,16,0,Middle East & Africa,R&D,Clinical Operations,Meets,Male,37,9,1,9,15,0.0,3.2,3.2,0.0977,1,1,1,1,3.7,3.3,1.7
2206,11,0,Middle East & Africa,R&D,Legal & Compliance,Meets,Female,36,25,0,6,18,4.4,1.3,3.0,0.0977,0,0,0,0,4.4,1.0,3.1
2207,337,0,Europe,Commercial,Clinical Operations,Meets,Male,38,11,0,6,13,3.3,3.8,3.9,0.0422,1,1,1,1,4.1,3.6,3.0
2208,872,0,Asia Pacific,HR,Regulatory Affairs,Exceeds,Male,35,15,0,9,28,2.4,4.6,2.5,0.0677,1,1,1,1,3.6,4.1,4.2
2209,78,0,Middle East & Africa,R&D,Marketing,Meets,Female,47,4,0,8,29,2.1,4.0,2.1,0.0977,1,1,1,1,2.2,4.5,1.0
2210,640,0,Middle East & Africa,Digital,IT & Digital,Meets,Female,34,10,0,6,23,3.1,4.0,2.0,0.0853,1,1,1,1,4.3,3.9,3.1
2211,214,0,Europe,Commercial,Market Access,Exceeds,Female,38,10,0,11,13,4.6,3.9,3.3,0.0743,1,1,1,1,5.0,2.7,2.3
2212,626,0,Europe,Digital,Human Resources,Meets,Non-Binary/Other,42,12,0,7,38,2.4,4.2,3.0,0.0853,1,1,1,1,2.1,3.2,3.4
2213,816,0,Middle East & Africa,HR,Sales,Meets,Female,42,5,0,11,19,3.8,2.7,3.9,0.0383,1,1,1,1,4.4,3.1,4.2
2214,450,1,North America,Manufacturing,Human Resources,Meets,Female,36,31,0,6,15,3.9,1.0,3.5,0.0348,1,1,0,0,4.4,3.8,2.9
2215,659,0,Middle East & Africa,Digital,Regulatory Affairs,Meets,Male,45,6,0,11,19,2.2,3.3,2.1,0.0853,1,1,1,1,2.9,2.9,2.0
2216,444,0,Middle East & Africa,Manufacturing,Quality Assurance,Meets,Male,51,13,0,9,15,2.5,2.9,2.7,0.0348,1,1,1,1,3.5,1.9,2.8
2217,343,0,Europe,Commercial,Pharmacovigilance,Exceeds,Non-Binary/Other,49,18,0,8,25,2.8,3.8,1.7,0.0743,1,1,1,1,2.8,1.8,3.7
2218,671,1,Europe,Digital,Supply Chain,Meets,Female,28,15,0,6,8,3.8,4.1,2.4,0.0853,0,0,0,0,3.9,3.6,3.8
2219,624,0,Middle East & Africa,Digital,IT & Digital,Exceeds,Male,38,24,0,7,10,1.6,3.5,1.5,0.1452,1,1,1,1,3.2,3.2,2.1
2220,912,0,Middle East & Africa,Finance,Legal & Compliance,Meets,Female,34,11,1,11,18,0.0,1.0,1.4,0.0331,1,1,1,1,4.9,2.1,1.7
2221,215,0,Middle East & Africa,Commercial,Communications,Meets,Female,41,9,0,10,14,2.4,1.6,4.8,0.0422,1,1,1,1,1.7,2.1,4.2
2222,296,0,Europe,Commercial,Communications,Meets,Female,44,27,0,8,29,2.8,3.1,2.3,0.0422,0,0,0,0,2.4,2.5,2.0
2223,61,0,Middle East & Africa,R&D,IT & Digital,Below,Female,31,4,0,5,7,1.4,3.7,3.1,0.0,1,1,1,1,1.3,3.6,3.0
2224,726,0,Middle East & Africa,HR,Pharmacovigilance,Meets,Male,43,13,0,8,10,2.8,2.3,3.7,0.0383,1,1,1,1,2.5,3.8,3.3
2225,577,0,Latin America,Digital,Medical Affairs,Meets,Female,38,15,0,9,22,4.7,2.7,3.0,0.0853,1,1,1,1,3.6,4.0,3.9
2226,538,0,North America,Digital,Finance & Accounting,Meets,Male,36,5,0,10,15,2.5,4.0,1.6,0.0853,1,1,1,1,3.7,5.0,2.5
2227,314,0,Asia Pacific,Commercial,Supply Chain,Below,Female,41,9,0,12,22,4.5,3.0,4.9,0.0,1,1,1,1,3.7,3.7,3.2
2228,278,0,North America,Commercial,Sales,Meets,Male,37,8,0,5,17,1.9,4.4,2.3,0.0422,1,1,1,1,3.2,4.3,1.1
2229,805,0,Latin America,HR,Sales,Below,Female,45,5,0,8,9,2.5,3.0,2.9,0.0,0,0,0,0,2.7,2.9,1.8
2230,309,0,Asia Pacific,Commercial,Data Science,Exceeds,Female,36,4,1,6,18,0.0,2.7,2.6,0.0743,1,1,1,1,4.4,3.0,2.9
2231,356,0,Middle East & Africa,Manufacturing,Pharmacovigilance,Below,Female,46,21,0,10,16,3.5,1.8,2.9,0.0,0,0,0,0,2.6,1.8,3.6
2232,439,0,Latin America,Manufacturing,Finance & Accounting,Meets,Female,38,6,0,12,26,3.6,2.0,4.0,0.0348,1,1,1,1,3.5,4.0,3.8
2233,888,0,Middle East & Africa,Finance,Market Access,Meets,Female,28,10,1,11,29,0.0,2.4,2.4,0.0331,1,1,1,1,1.2,2.0,1.9
2234,367,0,Europe,Manufacturing,Sales,Meets,Male,33,15,0,9,18,4.6,4.9,2.3,0.0348,1,1,1,1,3.7,5.0,2.2
2235,417,0,Latin America,Manufacturing,Marketing,Meets,Female,37,23,0,11,25,3.2,5.0,3.5,0.0348,1,1,1,1,3.6,4.6,2.8
2236,713,0,Europe,HR,Data Science,Meets,Male,40,15,0,8,19,4.1,2.8,2.7,0.0383,1,1,1,1,5.0,3.3,2.0
2237,524,0,Latin America,Digital,Market Access,Exceeds,Female,37,6,1,8,13,0.0,4.3,3.3,0.1452,1,1,1,1,4.8,4.3,2.9
2238,418,0,Latin America,Manufacturing,Supply Chain,Meets,Male,34,8,0,5,8,3.6,3.8,3.3,0.0348,1,1,1,0,4.7,3.1,3.1
2239,952,0,Europe,Finance,Pharmacovigilance,Meets,Male,49,11,0,12,21,3.0,2.6,2.2,0.0331,1,1,1,1,3.0,3.2,2.8
2240,265,0,Asia Pacific,Commercial,Pharmacovigilance,Meets,Male,46,14,0,9,20,4.2,2.2,2.4,0.0422,1,1,1,1,2.8,2.5,2.4
2241,485,0,North America,Manufacturing,Legal & Compliance,Below,Female,31,18,0,9,22,3.8,3.5,3.1,0.0,1,1,1,1,3.2,2.6,3.4
2242,964,0,Middle East & Africa,Finance,Communications,Below,Male,33,19,0,9,32,3.6,1.8,3.3,0.0,1,1,1,1,4.5,1.6,3.5
2243,721,0,Latin America,HR,Finance & Accounting,Exceeds,Male,40,25,0,5,18,3.3,5.0,2.9,0.0677,1,1,1,1,2.6,3.8,3.3
2244,354,0,Middle East & Africa,Commercial,Market Access,Exceeds,Female,37,4,0,6,19,1.9,3.4,4.1,0.0743,1,1,1,1,2.8,3.1,3.1
2245,934,0,Europe,Finance,Legal & Compliance,Meets,Male,28,5,1,6,10,0.0,4.1,2.6,0.0331,0,0,0,0,4.2,2.7,2.1
2246,416,0,Middle East & Africa,Manufacturing,Market Access,Meets,Female,34,23,0,7,19,5.0,2.9,2.9,0.0348,0,0,0,0,4.8,4.3,3.2
2247,669,0,Europe,Digital,Sales,Meets,Female,42,6,0,10,15,3.5,4.5,2.4,0.0853,1,1,1,1,2.6,3.6,2.3
2248,276,0,Middle East & Africa,Commercial,Supply Chain,Meets,Female,39,4,0,8,17,2.7,4.3,2.8,0.0422,1,1,1,0,1.3,4.7,2.7
2249,326,0,North America,Commercial,Finance & Accounting,Meets,Male,32,6,1,7,20,0.0,3.5,2.0,0.0422,1,1,1,1,3.2,2.5,3.5
2250,549,0,North America,Digital,IT & Digital,Exceeds,Male,35,10,0,11,21,4.4,1.4,1.4,0.1452,1,1,1,0,2.9,2.0,1.6
2251,352,0,North America,Commercial,IT & Digital,Meets,Male,37,6,1,5,17,0.0,2.0,2.4,0.0422,1,1,1,1,2.5,4.0,3.0
2252,382,0,North America,Manufacturing,Finance & Accounting,Meets,Male,53,16,0,7,11,4.6,3.6,4.4,0.0348,0,0,0,0,3.6,2.9,3.1
2253,206,0,North America,Commercial,Data Science,Meets,Male,38,13,0,12,14,3.7,4.3,2.2,0.0422,1,1,1,1,4.5,5.0,1.4
2254,463,0,North America,Manufacturing,Marketing,Far Below,Female,34,13,0,11,18,2.5,3.8,2.8,0.0,0,0,0,0,2.2,2.1,2.8
2255,672,0,Europe,Digital,IT & Digital,Meets,Female,49,18,0,11,29,4.2,3.8,2.8,0.0853,1,1,1,1,3.8,2.7,2.0
2256,113,0,Latin America,R&D,Quality Assurance,Far Exceeds,Male,41,7,0,10,18,4.0,4.1,1.9,0.2644,1,1,0,0,2.9,3.1,2.6
2257,538,0,Middle East & Africa,Digital,Finance & Accounting,Exceeds,Male,33,9,0,5,7,2.7,3.5,2.2,0.1452,1,1,1,1,4.0,4.7,2.7
2258,492,0,North America,Manufacturing,Quality Assurance,Exceeds,Female,38,9,0,10,19,3.5,3.6,2.9,0.0616,1,1,1,1,3.1,5.0,3.4
2259,769,0,Europe,HR,Regulatory Affairs,Meets,Male,37,20,1,6,20,0.0,4.6,1.8,0.0383,1,1,1,1,1.7,3.9,3.6
2260,671,0,Europe,Digital,Marketing,Meets,Female,41,6,1,10,24,0.0,3.1,1.6,0.0853,1,1,1,1,2.3,2.7,3.0
2261,880,1,Europe,HR,Supply Chain,Far Exceeds,Male,30,29,0,6,16,3.8,4.6,2.1,0.1168,0,0,0,0,4.5,4.2,2.0
2262,704,0,Latin America,HR,IT & Digital,Meets,Female,31,17,0,10,19,2.8,1.1,2.1,0.0383,1,1,1,1,3.1,2.6,2.7
2263,476,0,Middle East & Africa,Manufacturing,Supply Chain,Exceeds,Female,36,16,1,10,20,0.0,2.9,1.5,0.0616,1,1,1,1,3.1,5.0,1.2
2264,509,0,Latin America,Manufacturing,Data Science,Meets,Female,33,8,0,7,9,3.2,2.7,3.6,0.0348,1,1,1,1,2.3,2.5,1.4
2265,41,0,Asia Pacific,R&D,Legal & Compliance,Meets,Male,44,5,1,12,26,0.0,3.9,4.3,0.0977,1,1,1,1,2.4,4.4,4.0
2266,889,0,Europe,Finance,Legal & Compliance,Meets,Male,32,4,0,10,14,4.9,2.3,2.1,0.0331,1,1,1,1,5.0,3.4,2.9
2267,211,0,Asia Pacific,Commercial,Pharmacovigilance,Meets,Female,52,3,1,7,10,0.0,2.4,3.7,0.0422,1,1,1,1,2.8,3.6,3.5
2268,529,0,North America,Digital,Regulatory Affairs,Below,Female,37,17,0,5,31,1.2,2.1,3.4,0.0,1,1,0,0,2.5,2.4,3.0
2269,501,0,North America,Manufacturing,Human Resources,Meets,Female,39,28,0,5,10,4.4,3.7,3.1,0.0348,0,0,0,0,3.8,3.8,2.5
2270,643,0,Latin America,Digital,Data Science,Exceeds,Female,40,10,1,7,11,0.0,3.5,3.2,0.1452,0,0,0,0,3.4,3.2,3.5
2271,907,0,Middle East & Africa,Finance,Communications,Meets,Male,38,11,0,12,26,3.6,3.8,3.7,0.0331,0,0,0,0,1.9,4.4,1.5
2272,1035,0,Asia Pacific,Finance,Human Resources,Meets,Male,45,17,0,12,47,2.9,2.7,1.0,0.0331,1,1,1,1,4.7,1.7,1.3
2273,837,0,Middle East & Africa,HR,Regulatory Affairs,Meets,Male,39,8,0,8,20,2.5,3.4,2.5,0.0383,1,1,1,1,3.7,3.3,2.6
2274,194,0,Latin America,Commercial,Human Resources,Meets,Female,35,15,0,8,13,4.6,2.4,1.6,0.0422,1,1,1,1,4.2,2.5,2.4
2275,83,0,North America,R&D,Pharmacovigilance,Meets,Male,30,8,0,6,6,3.1,3.4,2.7,0.0977,1,1,1,1,3.0,3.8,2.9
2276,545,0,Middle East & Africa,Digital,Medical Affairs,Meets,Male,40,10,0,11,14,2.9,4.4,2.7,0.0853,1,1,1,1,2.4,2.5,1.4
2277,332,0,Middle East & Africa,Commercial,Regulatory Affairs,Meets,Female,43,24,0,12,18,2.1,3.0,1.8,0.0422,1,1,1,1,3.6,3.4,3.1
2278,5,0,North America,R&D,Data Science,Meets,Female,30,12,0,5,19,3.8,2.7,4.7,0.0977,1,1,1,1,3.8,3.9,5.0
2279,595,0,Asia Pacific,Digital,Finance & Accounting,Below,Female,36,17,1,10,14,0.0,3.0,3.7,0.0,1,1,1,1,3.1,2.9,2.9
2280,292,1,North America,Commercial,Medical Affairs,Meets,Female,44,5,1,6,21,0.0,3.4,1.2,0.0422,1,1,1,1,3.0,3.4,1.8
2281,513,0,Middle East & Africa,Manufacturing,Communications,Meets,Non-Binary/Other,33,12,0,9,17,4.1,3.7,3.8,0.0348,1,0,0,0,2.9,3.1,4.3
2282,531,0,Asia Pacific,Digital,Legal & Compliance,Meets,Male,33,32,0,12,13,1.0,3.0,2.7,0.0853,1,1,1,1,1.0,2.6,3.3
2283,207,0,Asia Pacific,Commercial,Market Access,Meets,Male,37,6,0,5,18,2.2,3.0,1.5,0.0422,1,1,1,1,3.1,4.1,2.0
2284,979,0,North America,Finance,Finance & Accounting,Meets,Female,46,12,1,12,19,0.0,4.0,4.2,0.0331,1,0,0,0,4.5,2.5,4.1
2285,85,0,Middle East & Africa,R&D,Marketing,Exceeds,Male,44,8,0,9,11,4.2,2.8,2.7,0.1648,1,0,0,0,4.2,3.8,1.8
2286,298,0,Latin America,Commercial,Sales,Meets,Male,46,9,0,5,8,2.1,3.2,4.5,0.0422,1,1,1,1,1.9,3.0,3.9
2287,457,0,Middle East & Africa,Manufacturing,Data Science,Meets,Male,32,16,0,6,19,4.5,2.9,2.0,0.0348,1,1,1,1,3.7,3.6,2.9
2288,527,0,Europe,Digital,Market Access,Meets,Female,34,12,0,8,11,3.9,3.0,2.2,0.0853,1,1,1,1,2.7,2.2,1.6
2289,621,0,Latin America,Digital,Quality Assurance,Far Below,Male,37,6,0,6,9,2.6,3.4,2.5,0.0,1,1,1,1,2.9,3.7,1.8
2290,549,0,Asia Pacific,Digital,Quality Assurance,Meets,Male,36,6,1,11,20,0.0,3.4,4.3,0.0853,1,1,1,1,3.3,2.9,2.4
2291,369,0,Latin America,Manufacturing,Supply Chain,Exceeds,Male,33,10,1,11,15,0.0,2.7,2.4,0.0616,1,1,1,1,2.1,3.9,3.6
2292,94,0,Asia Pacific,R&D,Data Science,Meets,Male,41,36,0,7,8,3.1,3.8,3.1,0.0977,1,1,1,1,3.1,2.9,3.6
2293,533,0,Asia Pacific,Digital,Legal & Compliance,Meets,Female,28,14,0,6,7,3.8,2.8,4.9,0.0853,1,1,1,1,2.9,4.6,4.5
2294,94,0,Latin America,R&D,Communications,Meets,Non-Binary/Other,39,12,0,9,23,2.8,2.9,2.7,0.0977,1,1,1,1,3.3,1.6,3.6
2295,318,1,Asia Pacific,Commercial,Clinical Operations,Exceeds,Female,48,10,0,8,15,4.0,3.8,3.6,0.0743,1,1,1,1,5.0,2.9,2.6
2296,1033,0,Asia Pacific,Finance,Sales,Exceeds,Non-Binary/Other,38,7,0,6,15,2.8,3.7,1.5,0.0588,1,1,1,1,2.9,2.7,2.7
2297,913,0,Europe,Finance,Clinical Operations,Below,Male,33,3,1,9,23,0.0,3.2,1.1,0.0,1,1,1,1,3.8,3.6,2.4
2298,137,1,Middle East & Africa,R&D,Marketing,Meets,Female,30,7,0,8,22,2.7,3.2,1.8,0.0977,1,1,1,1,3.3,4.9,2.1
2299,4,0,Middle East & Africa,R&D,Human Resources,Below,Male,40,23,0,6,11,3.1,3.0,3.9,0.0,1,1,1,1,4.0,2.3,4.5
2300,960,0,Europe,Finance,Supply Chain,Meets,Female,48,8,0,9,31,2.4,3.0,1.4,0.0331,1,1,1,1,3.8,3.5,2.7
2301,593,0,Latin America,Digital,Communications,Below,Male,39,8,1,5,17,0.0,2.5,4.3,0.0,1,1,1,1,1.5,2.4,3.5
2302,730,0,North America,HR,Communications,Below,Female,36,6,0,8,25,4.3,5.0,1.2,0.0,1,1,1,1,3.3,4.4,1.1
2303,720,0,North America,HR,IT & Digital,Far Below,Male,33,10,0,9,20,4.1,3.8,3.1,0.0,1,1,1,1,4.2,2.8,1.1
2304,357,0,North America,Manufacturing,Sales,Exceeds,Male,29,30,0,12,15,4.5,2.7,2.9,0.0616,1,1,1,1,3.3,2.9,2.1
2305,962,0,Europe,Finance,Medical Affairs,Exceeds,Female,40,9,0,7,8,3.7,3.5,1.3,0.0588,1,1,1,1,3.3,3.1,1.8
2306,886,0,Europe,Finance,Regulatory Affairs,Below,Female,28,20,0,9,19,5.0,1.5,2.2,0.0,0,0,0,0,4.8,3.8,2.5
2307,489,0,Asia Pacific,Manufacturing,Sales,Meets,Female,43,30,0,10,12,2.6,2.7,2.4,0.0348,1,1,1,1,4.0,3.9,3.3
2308,829,0,North America,HR,Pharmacovigilance,Meets,Female,42,4,0,6,8,3.6,4.4,2.0,0.0383,1,1,1,1,3.2,4.1,1.7
2309,202,0,Latin America,Commercial,Medical Affairs,Meets,Male,37,11,0,5,19,1.4,5.0,1.2,0.0422,1,1,1,1,2.1,4.3,1.1
2310,539,0,Latin America,Digital,Legal & Compliance,Exceeds,Female,42,13,0,8,21,3.6,2.6,3.7,0.1452,1,1,1,1,4.5,3.3,3.4
2311,585,0,North America,Digital,Regulatory Affairs,Below,Male,39,19,0,7,15,2.4,3.6,1.1,0.0,1,1,1,1,2.9,3.0,2.7
2312,267,0,North America,Commercial,Finance & Accounting,Meets,Female,42,10,0,11,20,3.1,2.6,1.6,0.0422,0,0,0,0,4.4,3.6,1.5
2313,331,0,North America,Commercial,Communications,Meets,Female,43,4,1,12,13,0.0,4.1,2.2,0.0422,0,0,0,0,1.7,4.1,2.6
2314,810,0,Europe,HR,Marketing,Below,Female,36,18,0,6,10,2.6,1.7,2.9,0.0,1,1,1,1,3.2,3.1,3.7
2315,500,0,Europe,Manufacturing,Quality Assurance,Meets,Male,30,8,0,6,36,4.9,3.5,3.5,0.0348,1,1,1,1,4.1,2.7,1.8
2316,264,0,Europe,Commercial,Regulatory Affairs,Exceeds,Male,52,3,1,9,19,0.0,1.9,2.0,0.0743,1,1,1,1,4.0,1.0,2.7
2317,496,0,Middle East & Africa,Manufacturing,Pharmacovigilance,Meets,Male,37,10,1,10,13,0.0,3.0,1.6,0.0348,1,1,1,1,3.2,3.4,1.3
2318,106,0,Latin America,R&D,Supply Chain,Below,Male,35,8,0,12,28,3.3,2.9,1.7,0.0,1,1,1,1,3.4,3.8,2.3
2319,610,0,Latin America,Digital,Legal & Compliance,Exceeds,Male,41,1,1,7,16,0.0,3.2,2.9,0.1452,1,1,1,1,3.7,3.4,1.8
2320,739,0,Asia Pacific,HR,Finance & Accounting,Exceeds,Female,37,24,0,9,16,1.5,4.5,1.5,0.0677,0,0,0,0,2.9,2.6,1.0
2321,528,0,Europe,Digital,Regulatory Affairs,Meets,Male,30,21,0,7,9,4.2,3.7,2.3,0.0853,1,1,1,1,3.2,2.5,2.2
2322,743,0,Middle East & Africa,HR,Human Resources,Meets,Female,31,9,1,11,16,0.0,3.2,1.8,0.0383,1,0,0,0,3.9,2.5,3.7
2323,43,0,Middle East & Africa,R&D,Sales,Below,Male,33,19,0,5,13,5.0,3.2,1.0,0.0,1,1,1,1,3.9,1.7,1.4
2324,620,0,Latin America,Digital,Sales,Meets,Male,40,5,0,11,19,2.6,3.3,2.3,0.0853,1,1,1,1,2.9,1.9,1.8
2325,12,0,Europe,R&D,Supply Chain,Meets,Female,34,14,0,10,20,4.0,3.9,2.7,0.0977,1,1,1,1,3.7,2.6,1.4
2326,860,0,Asia Pacific,HR,Finance & Accounting,Meets,Female,44,14,0,10,44,1.6,3.5,3.3,0.0383,1,1,1,1,2.8,3.5,4.1
2327,293,0,Europe,Commercial,Communications,Far Below,Female,37,15,0,8,25,3.2,4.4,3.0,0.0,1,1,1,1,3.7,3.2,3.3
2328,664,0,North America,Digital,Sales,Meets,Male,38,8,0,5,15,3.1,2.2,2.1,0.0853,0,0,0,0,2.9,4.4,1.6
2329,39,0,Europe,R&D,Human Resources,Meets,Male,38,30,1,9,13,0.0,3.0,2.4,0.0977,1,1,1,0,2.6,2.0,2.2
2330,1025,0,North America,Finance,Legal & Compliance,Meets,Female,32,14,0,7,9,3.3,3.1,2.5,0.0331,0,0,0,0,2.6,5.0,1.3
2331,540,0,North America,Digital,Marketing,Meets,Female,46,12,0,11,19,3.8,2.9,3.6,0.0853,1,1,1,1,2.9,1.3,4.6
2332,545,0,Asia Pacific,Digital,Legal & Compliance,Below,Non-Binary/Other,40,7,0,10,19,4.7,3.1,3.6,0.0,1,1,1,1,4.1,2.2,3.2
2333,689,0,Latin America,Digital,Pharmacovigilance,Meets,Male,37,21,0,12,18,3.6,3.5,4.3,0.0853,0,0,0,0,2.5,2.4,3.4
2334,388,0,Europe,Manufacturing,Data Science,Meets,Female,35,5,1,6,7,0.0,2.2,2.7,0.0348,1,1,1,1,3.1,2.1,3.8
2335,176,0,North America,R&D,Data Science,Exceeds,Female,35,8,0,8,22,3.5,1.0,3.9,0.1648,1,0,0,0,2.7,2.2,3.8
2336,1,0,Europe,R&D,Quality Assurance,Meets,Female,31,8,1,11,12,0.0,3.5,2.5,0.0977,1,1,1,1,2.8,3.4,3.2
2337,675,0,Latin America,Digital,Market Access,Below,Male,30,9,1,10,44,0.0,2.4,2.8,0.0,1,0,0,0,3.6,3.2,2.6
2338,348,0,Latin America,Commercial,IT & Digital,Far Below,Female,30,22,1,5,10,0.0,2.0,2.1,0.0,1,1,1,1,3.2,3.2,2.5
2339,613,0,Middle East & Africa,Digital,Marketing,Meets,Female,44,14,0,8,23,3.0,2.9,3.1,0.0853,1,1,1,1,3.4,3.1,3.1
2340,518,0,Latin America,Manufacturing,IT & Digital,Below,Female,33,11,0,8,17,2.0,4.7,1.2,0.0,1,1,1,1,1.7,5.0,1.9
2341,768,0,Asia Pacific,HR,Market Access,Meets,Male,32,5,0,6,23,3.0,4.6,3.8,0.0383,1,1,1,1,3.7,3.7,4.8
2342,358,0,North America,Manufacturing,Data Science,Exceeds,Female,46,19,0,9,22,3.4,2.9,2.9,0.0616,1,0,0,0,1.8,3.6,3.3
2343,235,0,Middle East & Africa,Commercial,Regulatory Affairs,Meets,Non-Binary/Other,38,9,0,8,14,3.6,1.9,3.2,0.0422,1,1,1,1,3.5,2.7,4.8
2344,669,0,Asia Pacific,Digital,Finance & Accounting,Meets,Female,31,10,0,6,24,4.1,4.1,2.9,0.0853,0,0,0,0,3.2,2.9,4.1
2345,10,0,Europe,R&D,Regulatory Affairs,Meets,Female,41,12,0,6,12,4.5,5.0,3.9,0.0977,1,1,1,1,3.8,4.5,1.9
2346,925,0,North America,Finance,Regulatory Affairs,Meets,Female,47,5,1,11,13,0.0,4.8,3.1,0.0331,0,0,0,0,4.1,3.9,1.9
2347,640,0,Latin America,Digital,Communications,Below,Female,42,6,1,10,20,0.0,3.1,1.6,0.0,1,1,1,1,2.9,3.8,1.8
2348,295,0,North America,Commercial,Sales,Meets,Male,39,5,1,9,18,0.0,3.6,1.8,0.0422,1,1,1,1,4.6,3.6,2.2
2349,126,0,Europe,R&D,Communications,Exceeds,Male,41,5,1,10,17,0.0,3.6,2.6,0.1648,1,1,1,1,3.0,5.0,3.4
2350,411,0,Middle East & Africa,Manufacturing,IT & Digital,Exceeds,Female,45,13,0,9,17,2.7,3.3,1.8,0.0616,1,1,1,1,1.4,4.7,2.0
2351,718,0,Middle East & Africa,HR,Sales,Below,Male,48,13,0,7,14,3.6,2.5,1.7,0.0,1,1,1,1,2.5,2.6,1.6
2352,740,0,Middle East & Africa,HR,Clinical Operations,Meets,Female,32,4,1,11,14,0.0,2.2,2.0,0.0383,1,1,1,1,3.9,4.7,3.1
2353,600,0,Latin America,Digital,Regulatory Affairs,Meets,Female,38,30,0,12,15,2.0,4.0,2.8,0.0853,1,1,1,1,2.3,4.5,3.4
2354,489,0,Asia Pacific,Manufacturing,Regulatory Affairs,Meets,Female,42,5,1,8,22,0.0,3.3,3.9,0.0348,1,1,1,1,4.0,4.0,4.9
2355,1011,0,Asia Pacific,Finance,Communications,Meets,Female,39,2,0,5,21,3.9,3.6,3.9,0.0331,1,1,1,1,3.7,3.2,3.7
2356,965,0,North America,Finance,Medical Affairs,Meets,Male,41,15,0,11,21,3.8,2.7,3.3,0.0331,1,1,1,0,4.4,3.6,3.5
2357,280,0,Latin America,Commercial,Supply Chain,Far Exceeds,Male,51,12,0,12,19,3.6,2.5,2.4,0.1275,1,1,1,1,4.8,3.1,3.4
2358,752,1,Middle East & Africa,HR,Data Science,Meets,Male,36,10,0,5,19,2.5,1.5,2.6,0.0383,1,1,1,1,3.1,2.4,3.7
2359,459,0,Middle East & Africa,Manufacturing,Sales,Below,Female,30,8,0,8,9,3.2,1.4,2.8,0.0,1,1,1,1,2.9,1.0,4.7
2360,573,1,Europe,Digital,Human Resources,Meets,Non-Binary/Other,49,12,0,11,16,4.2,4.1,2.0,0.0853,1,1,1,1,3.5,4.5,1.6
2361,113,0,Europe,R&D,Pharmacovigilance,Below,Male,49,17,0,10,13,1.9,4.9,3.1,0.0,1,1,1,1,3.9,4.0,4.9
2362,537,1,Middle East & Africa,Digital,Sales,Meets,Male,41,10,0,10,19,4.2,3.2,3.4,0.0853,1,1,1,1,4.0,2.5,2.1
2363,559,0,Middle East & Africa,Digital,Pharmacovigilance,Meets,Male,35,11,0,11,16,2.1,3.2,2.2,0.0853,1,1,1,1,4.0,2.1,3.4
2364,400,1,Latin America,Manufacturing,Clinical Operations,Meets,Female,43,12,0,12,14,4.0,2.4,1.0,0.0348,0,0,0,0,4.4,3.1,1.7
2365,732,0,Asia Pacific,HR,Pharmacovigilance,Meets,Female,38,12,0,11,33,2.7,2.1,1.3,0.0383,1,1,1,1,3.9,3.4,1.4
2366,481,0,Europe,Manufacturing,Legal & Compliance,Meets,Female,36,5,0,10,13,2.9,2.5,3.4,0.0348,1,1,1,1,2.4,1.7,2.1
2367,14,0,Asia Pacific,R&D,Sales,Meets,Female,34,33,0,11,41,2.3,4.6,1.3,0.0977,1,1,1,1,1.6,4.6,2.9
2368,462,0,Latin America,Manufacturing,Quality Assurance,Meets,Female,38,4,0,9,10,5.0,5.0,3.0,0.0348,0,0,0,0,3.8,4.2,2.8
2369,231,0,Middle East & Africa,Commercial,Sales,Meets,Male,41,14,0,5,9,3.6,2.0,2.3,0.0422,0,0,0,0,3.8,1.0,1.9
2370,602,0,Asia Pacific,Digital,Legal & Compliance,Below,Male,39,31,0,10,17,4.4,3.8,3.9,0.0,1,1,1,1,4.2,3.2,3.8
2371,810,0,Middle East & Africa,HR,IT & Digital,Meets,Female,43,11,0,5,20,1.8,4.4,2.8,0.0383,0,0,0,0,2.4,3.4,4.0
2372,934,0,Middle East & Africa,Finance,Marketing,Meets,Female,37,19,0,9,35,4.1,2.7,1.0,0.0331,0,0,0,0,4.2,4.2,1.1
2373,51,0,North America,R&D,Quality Assurance,Meets,Male,35,5,1,10,20,0.0,3.3,2.6,0.0977,1,1,1,1,3.9,3.0,2.5
2374,888,0,Asia Pacific,Finance,Regulatory Affairs,Meets,Male,40,5,1,10,22,0.0,2.3,2.7,0.0331,1,1,1,1,3.4,1.8,2.9
2375,543,0,Asia Pacific,Digital,Data Science,Meets,Female,39,12,0,9,22,3.0,4.2,2.5,0.0853,1,1,1,1,3.8,3.2,1.8
2376,514,0,Middle East & Africa,Manufacturing,Human Resources,Far Exceeds,Male,47,10,0,10,20,2.5,3.8,1.8,0.1069,1,1,1,1,3.5,3.2,2.1
2377,1036,0,Latin America,Finance,Pharmacovigilance,Below,Female,36,11,0,9,18,3.8,1.8,3.0,0.0,1,1,1,1,4.4,1.5,3.2
2378,338,0,North America,Commercial,Sales,Meets,Female,35,18,0,10,18,2.5,2.9,2.4,0.0422,1,1,1,1,2.5,3.2,2.6
2379,493,0,Middle East & Africa,Manufacturing,Sales,Meets,Male,37,8,0,8,17,3.5,2.7,3.4,0.0348,1,1,1,1,4.1,2.8,3.9
2380,561,0,Europe,Digital,Pharmacovigilance,Meets,Female,36,5,0,7,9,4.2,4.5,2.6,0.0853,1,1,1,1,4.7,3.6,4.4
2381,1007,0,Europe,Finance,Market Access,Meets,Male,34,2,0,5,9,4.6,3.4,2.9,0.0331,1,1,1,1,3.5,4.4,1.9
2382,93,0,North America,R&D,Data Science,Exceeds,Male,28,8,0,11,24,3.7,2.9,2.3,0.1648,1,1,1,0,4.3,2.8,2.5
2383,973,0,Latin America,Finance,Legal & Compliance,Meets,Male,31,8,0,8,11,3.0,4.1,2.3,0.0331,0,0,0,0,2.6,4.0,3.2
2384,939,0,Middle East & Africa,Finance,Medical Affairs,Exceeds,Female,37,1,0,5,14,3.8,1.5,3.2,0.0588,1,1,1,1,4.3,3.4,3.5
2385,843,0,Asia Pacific,HR,Supply Chain,Below,Female,30,7,0,8,18,4.0,1.7,3.1,0.0,1,1,1,1,4.4,2.1,3.1
2386,930,0,North America,Finance,Regulatory Affairs,Meets,Male,41,25,0,5,11,2.0,4.6,2.4,0.0331,1,1,1,1,1.7,3.8,2.1
2387,553,0,Latin America,Digital,Quality Assurance,Meets,Female,40,14,1,7,9,0.0,2.7,2.2,0.0853,1,1,1,1,3.1,2.0,3.2
2388,26,0,Asia Pacific,R&D,Sales,Meets,Male,34,24,0,6,22,2.7,2.5,3.3,0.0977,1,1,0,0,1.8,2.6,2.4
2389,571,0,Europe,Digital,Communications,Meets,Female,38,11,0,8,19,3.9,2.8,1.6,0.0853,1,1,1,1,3.7,2.6,2.1
2390,345,0,Europe,Commercial,Clinical Operations,Meets,Female,37,3,0,9,18,1.3,5.0,2.5,0.0422,1,1,1,1,2.7,5.0,2.7
2391,480,0,Asia Pacific,Manufacturing,Data Science,Meets,Female,28,13,0,10,16,3.1,4.1,1.8,0.0348,1,1,1,1,3.8,4.4,2.4
2392,979,0,North America,Finance,Communications,Meets,Male,41,25,0,6,17,3.7,1.7,3.2,0.0331,1,1,1,1,2.9,3.3,2.6
2393,865,0,Europe,HR,Pharmacovigilance,Meets,Male,34,17,1,7,13,0.0,3.3,1.7,0.0383,1,1,1,1,3.7,2.3,2.3
2394,146,0,Middle East & Africa,R&D,Sales,Meets,Male,32,25,0,12,19,3.3,2.4,2.9,0.0977,1,1,1,1,5.0,2.8,2.1
2395,841,0,Asia Pacific,HR,Quality Assurance,Meets,Male,42,15,1,11,17,0.0,4.3,1.5,0.0383,1,1,1,1,3.2,3.3,2.6
2396,764,0,Asia Pacific,HR,Clinical Operations,Meets,Female,39,14,0,8,30,1.3,2.1,2.7,0.0383,1,1,1,1,3.5,1.3,3.0
2397,752,0,Europe,HR,Legal & Compliance,Meets,Male,43,9,0,6,16,3.3,3.5,2.5,0.0383,1,1,1,1,3.2,3.6,3.1
2398,996,0,North America,Finance,Supply Chain,Meets,Male,37,24,0,6,9,2.7,2.9,2.1,0.0331,1,1,1,1,4.4,4.7,2.1
2399,106,0,Middle East & Africa,R&D,Supply Chain,Meets,Male,39,18,0,10,12,2.5,3.1,2.5,0.0977,1,1,1,1,4.2,2.8,2.5
2400,98,0,North America,R&D,Quality Assurance,Meets,Female,43,11,0,5,20,4.1,3.4,1.7,0.0977,1,1,1,1,3.6,3.5,2.7
2401,713,0,Latin America,HR,Data Science,Meets,Female,48,6,0,11,27,5.0,4.2,2.3,0.0383,1,1,0,0,4.0,4.3,3.2
2402,473,0,Latin America,Manufacturing,Clinical Operations,Exceeds,Male,36,15,0,10,15,3.9,2.5,2.3,0.0616,1,1,1,1,3.9,3.7,3.7
2403,1047,0,Europe,Finance,Human Resources,Meets,Male,39,6,0,8,10,3.9,2.0,3.6,0.0331,1,1,1,0,3.5,3.0,3.8
2404,947,0,Europe,Finance,Communications,Below,Female,41,7,1,9,13,0.0,3.5,2.4,0.0,1,1,1,1,3.3,3.3,2.2
2405,599,0,Europe,Digital,Pharmacovigilance,Exceeds,Male,41,27,1,10,21,0.0,2.3,5.0,0.1452,1,1,1,1,3.3,3.1,3.8
2406,933,0,Latin America,Finance,Clinical Operations,Far Below,Female,35,5,0,6,13,3.5,3.5,1.5,0.0,1,1,1,1,2.7,3.1,1.4
2407,874,0,North America,HR,Human Resources,Meets,Female,37,4,1,9,18,0.0,3.0,3.1,0.0383,1,1,1,1,2.3,5.0,2.1
2408,333,0,North America,Commercial,Marketing,Exceeds,Male,41,9,1,11,13,0.0,2.2,1.1,0.0743,1,1,1,1,3.8,2.8,2.3
2409,817,0,Europe,HR,Pharmacovigilance,Exceeds,Male,39,14,0,11,16,3.2,2.1,1.9,0.0677,1,1,1,1,3.9,4.5,3.3
2410,121,0,Middle East & Africa,R&D,Legal & Compliance,Meets,Male,49,12,0,5,10,4.6,3.8,3.4,0.0977,1,1,1,1,4.0,4.8,3.0
2411,884,0,North America,Finance,Regulatory Affairs,Meets,Female,36,7,0,11,37,3.7,2.9,3.4,0.0331,1,1,1,1,3.0,5.0,2.3
2412,885,0,Latin America,Finance,Medical Affairs,Meets,Female,33,7,0,10,14,3.7,2.2,2.6,0.0331,0,0,0,0,4.8,2.9,1.2
2413,554,0,Asia Pacific,Digital,Regulatory Affairs,Exceeds,Male,41,4,1,9,20,0.0,3.0,1.8,0.1452,1,1,1,1,4.2,3.3,2.2
2414,310,0,Asia Pacific,Commercial,Medical Affairs,Meets,Male,32,9,0,5,20,4.9,2.3,3.5,0.0422,1,1,1,1,4.2,2.9,3.3
2415,896,0,Asia Pacific,Finance,Regulatory Affairs,Meets,Female,35,10,0,11,15,3.2,3.3,3.9,0.0331,1,1,1,1,2.5,2.7,4.0
2416,617,0,Middle East & Africa,Digital,IT & Digital,Meets,Male,38,8,0,11,13,2.4,3.5,1.8,0.0853,1,1,1,1,2.5,2.4,2.8
2417,525,0,Europe,Digital,Clinical Operations,Exceeds,Male,38,11,0,5,10,3.2,3.2,2.7,0.1452,1,1,1,1,1.8,2.5,3.1
2418,319,0,Latin America,Commercial,Human Resources,Exceeds,Female,38,8,1,10,13,0.0,2.7,3.3,0.0743,1,1,1,1,3.2,3.6,2.8
2419,812,0,Middle East & Africa,HR,Data Science,Meets,Female,35,11,0,6,21,2.5,2.0,2.7,0.0383,1,1,1,1,2.7,3.4,4.0
2420,766,0,Latin America,HR,Quality Assurance,Meets,Male,40,11,0,8,14,2.9,3.3,2.3,0.0383,1,1,1,1,3.6,2.9,2.6
2421,835,0,Latin America,HR,Sales,Far Below,Male,51,12,0,7,25,2.7,2.2,2.6,0.0,1,1,1,1,4.8,1.7,2.0
2422,451,0,Europe,Manufacturing,Medical Affairs,Meets,Female,43,15,0,10,14,1.0,2.5,1.9,0.0348,1,1,1,1,1.9,3.6,2.2
2423,780,0,Asia Pacific,HR,Sales,Meets,Male,28,15,0,9,16,3.3,3.1,1.0,0.0383,0,0,0,0,3.1,3.4,1.9
2424,251,0,Europe,Commercial,Marketing,Far Below,Female,36,19,0,8,14,3.9,3.5,1.8,0.0,1,1,1,1,4.2,4.1,2.7
2425,488,1,Middle East & Africa,Manufacturing,Marketing,Exceeds,Female,41,13,1,12,19,0.0,4.6,3.5,0.0616,1,1,1,1,3.3,3.1,3.5
2426,838,0,Middle East & Africa,HR,Sales,Exceeds,Male,29,2,0,9,26,4.8,2.4,1.5,0.0677,1,1,1,1,3.1,3.0,2.2
2427,410,0,Middle East & Africa,Manufacturing,IT & Digital,Meets,Female,28,7,0,9,17,3.8,2.6,3.0,0.0348,1,1,1,1,2.5,2.0,2.0
2428,354,0,Europe,Commercial,Human Resources,Exceeds,Male,34,10,0,12,22,3.9,1.3,3.1,0.0743,1,1,1,1,3.0,2.1,2.8
2429,716,0,Latin America,HR,IT & Digital,Meets,Female,33,23,0,6,18,2.0,3.2,5.0,0.0383,1,1,1,0,2.5,2.8,3.7
2430,141,0,Latin America,R&D,Marketing,Meets,Female,48,7,0,5,17,3.3,2.0,2.6,0.0977,1,1,1,1,3.6,3.3,4.0
2431,1035,0,North America,Finance,Pharmacovigilance,Exceeds,Female,40,10,0,8,26,4.0,3.9,3.8,0.0588,1,1,1,1,4.6,5.0,3.1
2432,183,0,Middle East & Africa,Commercial,Sales,Meets,Female,37,12,0,6,13,2.7,3.4,3.0,0.0422,1,1,1,1,3.1,3.9,2.9
2433,680,0,Latin America,Digital,Finance & Accounting,Meets,Male,36,10,0,12,19,5.0,2.0,1.0,0.0853,1,1,1,1,4.4,3.6,1.0
2434,631,0,North America,Digital,Marketing,Meets,Male,41,19,0,6,10,4.2,3.1,1.8,0.0853,1,1,1,1,4.6,2.6,3.3
2435,323,0,Latin America,Commercial,Medical Affairs,Meets,Male,39,5,0,8,9,3.9,3.1,2.8,0.0422,1,1,1,1,4.2,1.9,1.3
2436,677,0,Middle East & Africa,Digital,Finance & Accounting,Meets,Female,41,28,0,9,14,3.2,4.2,4.5,0.0853,1,1,1,1,3.2,4.6,2.3
2437,241,0,Asia Pacific,Commercial,Data Science,Below,Female,40,1,1,11,24,0.0,3.5,3.3,0.0,1,1,1,1,3.4,4.0,4.0
2438,41,0,Middle East & Africa,R&D,Finance & Accounting,Meets,Male,44,7,0,10,15,4.0,2.3,2.5,0.0977,1,1,1,1,3.0,2.7,2.4
2439,271,0,Europe,Commercial,IT & Digital,Meets,Female,38,14,0,5,32,2.8,4.8,3.0,0.0422,1,1,1,1,2.9,4.9,3.5
2440,866,0,Latin America,HR,Marketing,Below,Male,43,14,0,6,8,2.7,2.0,2.0,0.0,1,1,1,1,3.6,1.0,2.2
2441,792,0,Latin America,HR,Human Resources,Below,Female,40,14,0,12,15,3.0,4.7,2.6,0.0,1,1,1,1,4.3,2.6,2.1
2442,482,0,Europe,Manufacturing,Human Resources,Meets,Male,39,18,0,11,30,2.1,3.2,1.6,0.0348,1,1,1,1,2.8,3.6,2.0
2443,584,0,Europe,Digital,Sales,Exceeds,Female,36,9,0,6,9,2.4,1.9,2.8,0.1452,1,1,1,1,1.9,2.5,1.0
2444,1038,0,Asia Pacific,Finance,Medical Affairs,Exceeds,Male,38,21,0,5,20,3.9,2.4,3.6,0.0588,1,1,1,1,4.5,2.5,3.1
2445,649,0,Latin America,Digital,Sales,Exceeds,Male,38,11,0,7,27,3.8,3.6,4.2,0.1452,1,1,1,1,3.8,3.9,3.9
2446,331,0,Latin America,Commercial,Supply Chain,Exceeds,Male,44,7,0,10,17,3.5,4.3,5.0,0.0743,1,1,1,1,3.0,3.8,3.6
2447,939,0,Asia Pacific,Finance,Clinical Operations,Below,Male,39,12,0,6,11,1.9,2.3,4.9,0.0,1,1,1,1,2.7,1.6,3.6
2448,925,0,North America,Finance,Legal & Compliance,Meets,Male,33,18,0,6,9,4.4,2.6,1.6,0.0331,1,1,1,1,3.9,1.9,1.0
2449,533,1,Asia Pacific,Digital,Communications,Meets,Male,29,7,0,8,19,3.8,2.1,4.8,0.0853,1,1,1,1,4.1,2.1,4.6
2450,912,0,Middle East & Africa,Finance,Clinical Operations,Below,Male,31,36,0,10,30,1.9,2.5,3.6,0.0,0,0,0,0,2.2,4.9,4.1
2451,947,0,Latin America,Finance,Human Resources,Meets,Female,34,3,1,6,29,0.0,2.4,3.7,0.0331,1,1,1,1,3.4,4.1,2.1
2452,745,0,Europe,HR,Finance & Accounting,Meets,Female,41,17,0,12,26,2.9,2.5,4.0,0.0383,1,1,1,1,4.0,3.8,3.8
2453,54,1,Middle East & Africa,R&D,Clinical Operations,Exceeds,Female,34,5,0,10,12,3.8,3.3,1.8,0.1648,1,1,1,1,3.6,3.8,2.7
2454,214,0,Latin America,Commercial,Regulatory Affairs,Meets,Female,45,3,0,6,19,1.9,2.3,3.7,0.0422,1,1,1,1,3.3,2.2,3.0
2455,590,0,Asia Pacific,Digital,Pharmacovigilance,Far Exceeds,Male,31,4,0,10,16,2.8,3.1,1.0,0.2363,1,1,1,1,2.9,3.1,1.1
2456,746,0,Middle East & Africa,HR,Finance & Accounting,Below,Female,42,8,0,5,14,1.2,4.6,2.0,0.0,1,1,1,1,1.8,5.0,3.6
2457,408,0,Latin America,Manufacturing,Sales,Far Below,Male,28,9,0,11,16,3.2,1.9,1.7,0.0,1,1,1,1,3.0,2.7,3.0
2458,972,1,North America,Finance,Legal & Compliance,Far Exceeds,Male,31,4,1,8,17,0.0,3.8,4.3,0.1022,1,1,1,1,3.9,3.7,3.5
2459,912,0,North America,Finance,Pharmacovigilance,Below,Male,32,11,0,5,9,2.7,1.9,3.7,0.0,1,1,1,1,2.5,2.4,3.5
2460,565,0,Europe,Digital,Finance & Accounting,Meets,Male,32,11,0,5,6,3.5,2.9,2.4,0.0853,1,1,1,1,3.2,3.3,2.7
2461,93,0,Latin America,R&D,Sales,Meets,Male,34,11,0,6,16,2.2,3.4,2.8,0.0977,1,0,0,0,3.3,3.2,2.8
2462,110,0,North America,R&D,Communications,Exceeds,Male,43,14,0,12,13,3.2,3.2,3.6,0.1648,0,0,0,0,3.4,3.2,3.0
2463,673,1,Asia Pacific,Digital,Legal & Compliance,Meets,Male,42,5,0,5,13,4.5,3.7,3.4,0.0853,1,1,1,1,3.9,3.1,2.1
2464,660,0,Latin America,Digital,Supply Chain,Far Below,Male,32,16,0,7,32,3.1,2.2,3.7,0.0,1,1,1,1,2.2,2.8,2.5
2465,852,0,Asia Pacific,HR,Legal & Compliance,Meets,Female,37,7,1,11,13,0.0,3.1,1.0,0.0383,1,1,1,1,4.2,1.9,3.3
2466,607,0,Asia Pacific,Digital,Legal & Compliance,Meets,Female,41,12,0,11,20,3.9,2.2,2.1,0.0853,1,0,0,0,3.5,3.9,2.1
2467,408,0,North America,Manufacturing,Communications,Meets,Female,37,7,0,12,19,4.1,3.2,1.9,0.0348,1,1,1,1,3.8,4.7,1.3
2468,802,0,Latin America,HR,Marketing,Exceeds,Male,47,4,1,9,27,0.0,4.1,1.4,0.0677,1,1,1,1,3.9,3.8,1.7
2469,1036,0,Middle East & Africa,Finance,Regulatory Affairs,Meets,Male,40,30,0,7,32,4.0,4.3,2.2,0.0331,1,1,1,1,3.9,3.8,2.2
2470,933,0,North America,Finance,Data Science,Exceeds,Female,33,15,0,11,13,4.5,3.8,3.1,0.0588,1,1,0,0,3.6,3.1,4.5
2471,1014,0,North America,Finance,Sales,Below,Male,33,4,0,8,29,4.7,3.5,1.1,0.0,1,1,1,1,4.2,3.1,2.3
2472,1000,0,Latin America,Finance,Medical Affairs,Meets,Female,32,10,0,9,10,2.6,3.4,1.3,0.0331,1,1,1,1,2.6,3.9,3.2
2473,277,0,Latin America,Commercial,Legal & Compliance,Far Exceeds,Female,34,7,0,6,23,3.4,3.3,3.7,0.1275,1,1,1,1,4.2,3.4,1.3
2474,415,0,Asia Pacific,Manufacturing,Human Resources,Meets,Male,38,5,0,12,25,2.2,4.1,2.7,0.0348,1,1,1,1,3.2,3.7,3.3
2475,840,0,Latin America,HR,Marketing,Below,Male,37,7,0,5,15,2.9,1.2,1.9,0.0,1,1,1,1,2.9,2.4,2.9
2476,839,0,Asia Pacific,HR,Quality Assurance,Far Exceeds,Female,35,10,0,8,18,2.3,3.1,3.3,0.1168,1,1,1,1,3.5,3.4,3.3
2477,1018,0,North America,Finance,Quality Assurance,Meets,Male,41,12,0,5,14,4.2,3.3,2.2,0.0331,1,1,1,1,4.1,4.1,2.6
2478,39,0,Europe,R&D,Data Science,Exceeds,Male,40,15,1,8,9,0.0,2.1,3.3,0.1648,1,1,1,1,4.0,3.2,5.0
2479,811,0,Middle East & Africa,HR,Medical Affairs,Below,Female,29,6,0,5,8,3.8,1.0,2.3,0.0,1,1,1,1,3.6,2.3,3.3
2480,405,0,North America,Manufacturing,Clinical Operations,Meets,Female,30,7,0,5,15,3.5,2.4,2.9,0.0348,1,1,1,1,3.6,3.8,2.4
2481,554,0,Latin America,Digital,Regulatory Affairs,Exceeds,Female,32,13,0,11,16,3.5,4.4,3.5,0.1452,1,1,1,1,3.9,2.6,1.4
2482,502,0,Middle East & Africa,Manufacturing,Finance & Accounting,Meets,Male,33,14,0,12,24,3.2,5.0,2.8,0.0348,0,0,0,0,2.7,4.8,3.1
2483,921,0,Europe,Finance,Pharmacovigilance,Meets,Female,34,12,0,8,13,3.8,1.0,2.8,0.0331,0,0,0,0,4.7,1.7,2.6
2484,898,0,Europe,Finance,Communications,Below,Male,36,7,1,10,15,0.0,3.7,4.0,0.0,1,1,1,1,3.7,2.5,4.9
2485,200,0,Asia Pacific,Commercial,IT & Digital,Meets,Male,40,7,1,8,17,0.0,2.9,1.4,0.0422,1,1,1,1,3.4,2.9,1.6
2486,748,0,Middle East & Africa,HR,Market Access,Meets,Female,31,8,0,9,35,4.4,2.7,1.4,0.0383,1,1,1,1,3.5,2.9,2.4
2487,880,0,Asia Pacific,HR,Market Access,Meets,Male,33,9,0,6,27,5.0,2.0,4.6,0.0383,1,1,1,1,3.9,4.0,5.0
2488,758,0,North America,HR,Regulatory Affairs,Below,Female,28,8,0,9,14,3.9,3.2,2.5,0.0,1,1,1,1,4.3,3.8,2.9
2489,954,0,Middle East & Africa,Finance,IT & Digital,Below,Non-Binary/Other,32,11,0,6,21,2.4,1.0,4.3,0.0,1,1,1,1,2.9,3.0,4.1
2490,867,0,North America,HR,Marketing,Meets,Female,37,11,1,7,23,0.0,3.9,1.8,0.0383,1,1,1,1,2.7,2.1,3.0
2491,46,0,Asia Pacific,R&D,Legal & Compliance,Meets,Female,33,14,0,9,19,2.4,5.0,1.7,0.0977,1,1,1,1,3.4,3.5,2.4
2492,110,0,Middle East & Africa,R&D,Supply Chain,Meets,Female,32,22,0,9,18,3.1,2.6,3.1,0.0977,1,1,1,1,3.1,3.8,2.8
2493,562,0,Asia Pacific,Digital,Marketing,Meets,Female,35,12,0,5,7,3.2,1.6,2.0,0.0853,1,1,1,1,3.1,3.7,3.0
2494,802,0,Middle East & Africa,HR,Quality Assurance,Exceeds,Female,39,17,0,12,32,3.3,1.7,2.4,0.0677,1,1,1,1,2.5,3.2,3.7
2495,209,0,Asia Pacific,Commercial,Pharmacovigilance,Meets,Male,32,20,1,10,20,0.0,2.7,2.3,0.0422,1,1,1,1,2.9,3.2,2.8
2496,657,0,Europe,Digital,Quality Assurance,Meets,Female,44,23,0,12,23,3.6,1.8,1.0,0.0853,1,1,1,1,3.3,2.8,2.0
2497,1000,0,Asia Pacific,Finance,Sales,Meets,Male,33,11,1,12,37,0.0,3.0,2.4,0.0331,1,1,1,1,2.6,3.5,4.1
2498,766,0,Europe,HR,Quality Assurance,Far Below,Female,36,5,0,11,25,4.5,3.5,2.4,0.0,1,1,0,0,5.0,2.9,2.5
2499,39,0,Asia Pacific,R&D,Market Access,Meets,Female,45,4,1,9,19,0.0,2.7,2.9,0.0977,1,1,1,1,4.3,2.8,3.5
2500,249,0,Middle East & Africa,Commercial,Communications,Exceeds,Female,41,18,1,5,26,0.0,2.9,1.6,0.0743,1,1,1,1,3.1,3.0,2.4
2501,538,0,Middle East & Africa,Digital,Communications,Far Below,Female,37,15,0,6,10,3.5,3.7,2.7,0.0,1,1,1,1,4.1,4.7,4.0
2502,186,0,Middle East & Africa,Commercial,Market Access,Far Below,Female,40,36,0,11,15,4.8,2.7,3.3,0.0,1,1,1,1,3.8,2.2,3.1
2503,822,0,Latin America,HR,Pharmacovigilance,Meets,Female,30,18,0,9,18,2.8,4.4,2.0,0.0383,1,1,1,1,4.9,4.9,2.7
2504,393,0,North America,Manufacturing,Legal & Compliance,Meets,Female,49,10,0,6,20,2.5,3.8,2.8,0.0348,1,1,1,0,3.8,3.4,1.8
2505,178,0,Middle East & Africa,Commercial,Quality Assurance,Meets,Male,31,10,1,9,32,0.0,3.3,3.6,0.0422,1,1,1,1,3.8,2.9,3.4
2506,222,0,Europe,Commercial,Regulatory Affairs,Meets,Male,39,23,0,6,10,2.1,3.1,1.9,0.0422,1,1,1,1,3.4,3.4,2.1
2507,901,1,Middle East & Africa,Finance,Regulatory Affairs,Far Exceeds,Male,45,2,1,10,21,0.0,3.4,2.1,0.1022,1,1,1,1,2.4,2.7,2.2
2508,15,0,Latin America,R&D,IT & Digital,Meets,Female,40,25,0,9,19,1.9,4.1,4.3,0.0977,1,1,1,0,2.6,5.0,3.6
2509,788,0,Europe,HR,Data Science,Meets,Male,38,12,0,7,13,2.6,3.0,4.0,0.0383,1,1,1,1,1.7,2.9,4.7
2510,218,0,Latin America,Commercial,Supply Chain,Below,Male,45,30,0,10,14,4.6,3.8,3.4,0.0,1,1,1,1,4.4,4.7,2.7
2511,859,0,Europe,HR,Pharmacovigilance,Meets,Male,42,4,1,5,11,0.0,3.7,4.0,0.0383,1,1,1,1,2.8,2.8,4.1
2512,121,0,Asia Pacific,R&D,Quality Assurance,Meets,Male,35,26,0,10,13,3.2,1.7,3.7,0.0977,1,1,1,1,4.4,1.8,2.8
2513,951,0,North America,Finance,Pharmacovigilance,Far Exceeds,Male,47,6,1,7,12,0.0,4.4,3.7,0.1022,1,1,1,1,3.8,2.3,2.3
2514,764,0,North America,HR,Marketing,Meets,Male,34,8,0,10,19,3.4,2.9,2.8,0.0383,1,0,0,0,2.8,2.2,3.3
2515,138,0,Latin America,R&D,Clinical Operations,Meets,Male,48,23,0,5,21,3.2,2.0,2.5,0.0977,0,0,0,0,1.9,2.3,3.4
2516,53,0,North America,R&D,Legal & Compliance,Below,Female,42,7,1,9,15,0.0,4.0,2.7,0.0,1,1,1,1,3.4,4.4,3.6
2517,544,0,Latin America,Digital,IT & Digital,Meets,Male,36,2,0,10,16,3.5,3.0,1.5,0.0853,1,1,1,1,2.8,1.4,3.3
2518,1042,0,Latin America,Finance,Medical Affairs,Meets,Female,32,14,0,12,21,2.1,2.2,3.5,0.0331,1,1,1,1,2.6,3.4,3.7
2519,1031,0,Latin America,Finance,Finance & Accounting,Exceeds,Female,39,11,1,10,24,0.0,3.9,1.6,0.0588,1,1,1,1,2.9,2.6,1.9
2520,766,0,North America,HR,Marketing,Meets,Male,34,9,0,9,16,1.6,3.0,3.2,0.0383,1,1,1,1,3.3,3.0,1.6
2521,399,0,Latin America,Manufacturing,Communications,Meets,Male,39,14,1,9,13,0.0,3.0,2.4,0.0348,1,1,1,1,3.4,2.2,2.4
2522,666,0,North America,Digital,IT & Digital,Meets,Female,43,7,1,8,18,0.0,3.5,2.7,0.0853,1,1,1,1,3.3,3.6,4.2
2523,986,0,Latin America,Finance,Marketing,Below,Male,43,16,0,8,15,3.7,1.4,2.1,0.0,1,1,1,1,5.0,1.6,1.8
2524,85,0,Middle East & Africa,R&D,Communications,Meets,Female,46,11,1,9,18,0.0,3.5,1.4,0.0977,1,1,1,1,2.9,4.6,1.6
2525,987,0,Latin America,Finance,Quality Assurance,Below,Male,32,11,0,11,17,3.2,3.9,2.4,0.0,1,1,1,1,2.7,3.5,1.7
2526,359,0,Europe,Manufacturing,Communications,Meets,Female,39,18,0,12,33,4.1,3.2,2.5,0.0348,1,1,1,1,4.9,4.2,2.7
2527,354,0,Latin America,Commercial,Clinical Operations,Meets,Non-Binary/Other,30,7,1,10,22,0.0,3.2,2.4,0.0422,1,1,1,1,4.5,1.1,3.5
2528,222,0,Asia Pacific,Commercial,Finance & Accounting,Meets,Female,38,4,0,6,14,2.6,4.5,3.1,0.0422,1,1,1,1,3.1,3.9,5.0
2529,886,0,Latin America,Finance,Human Resources,Meets,Female,29,7,1,5,7,0.0,1.7,3.4,0.0331,1,0,0,0,3.9,3.3,1.5
2530,955,0,Europe,Finance,Regulatory Affairs,Far Below,Female,51,11,0,5,14,1.9,3.7,2.4,0.0,0,0,0,0,2.2,2.8,1.5
2531,550,0,Europe,Digital,Regulatory Affairs,Meets,Female,46,10,0,11,17,2.7,3.4,3.2,0.0853,1,1,1,1,2.8,3.1,4.5
2532,1002,0,North America,Finance,Finance & Accounting,Meets,Female,29,9,0,7,12,2.2,1.8,2.8,0.0331,0,0,0,0,3.2,1.9,2.8
2533,378,0,Middle East & Africa,Manufacturing,Marketing,Meets,Male,34,11,0,8,23,3.9,3.1,2.5,0.0348,1,1,1,1,3.7,3.0,2.4
2534,1018,0,Latin America,Finance,Legal & Compliance,Far Exceeds,Male,42,9,0,5,10,3.6,3.9,1.0,0.1022,1,1,1,1,2.9,5.0,1.0
2535,703,0,North America,HR,Legal & Compliance,Below,Male,39,9,0,12,18,2.3,3.7,3.9,0.0,1,1,1,1,3.0,4.9,4.1
2536,450,0,Middle East & Africa,Manufacturing,Human Resources,Meets,Non-Binary/Other,38,16,0,7,20,2.5,3.0,4.4,0.0348,1,0,0,0,3.1,4.0,3.4
2537,677,0,Latin America,Digital,Supply Chain,Meets,Male,40,29,0,8,23,3.0,2.5,3.7,0.0853,1,1,1,1,3.1,3.9,3.8
2538,818,0,Asia Pacific,HR,Regulatory Affairs,Meets,Male,43,5,0,7,14,2.8,3.2,2.4,0.0383,1,1,1,1,3.8,3.6,2.1
2539,851,0,Latin America,HR,Sales,Meets,Female,50,23,0,9,16,4.3,3.0,1.3,0.0383,1,1,1,1,5.0,3.3,1.6
2540,318,0,Europe,Commercial,Marketing,Below,Male,31,5,0,5,7,5.0,3.5,2.4,0.0,1,1,1,1,3.5,3.6,2.7
2541,495,0,Europe,Manufacturing,Medical Affairs,Meets,Female,37,25,0,9,14,2.4,2.5,3.2,0.0348,1,1,1,1,3.6,2.7,3.1
2542,752,0,Asia Pacific,HR,Clinical Operations,Below,Female,28,36,1,7,16,0.0,3.0,2.3,0.0,1,1,1,1,5.0,3.0,2.3
2543,658,0,North America,Digital,Data Science,Meets,Female,38,5,1,6,13,0.0,4.0,3.4,0.0853,1,1,1,1,2.0,4.6,3.2
2544,192,0,Middle East & Africa,Commercial,Legal & Compliance,Meets,Female,48,12,1,5,30,0.0,4.2,2.9,0.0422,0,0,0,0,4.0,3.7,3.7
2545,728,0,Latin America,HR,Market Access,Below,Female,41,12,1,9,14,0.0,2.2,3.8,0.0,1,1,1,0,3.8,4.8,1.9
2546,370,0,Europe,Manufacturing,Pharmacovigilance,Meets,Female,43,7,0,5,9,2.8,1.9,1.9,0.0348,1,1,0,0,3.1,3.2,1.6
2547,342,0,North America,Commercial,Finance & Accounting,Below,Male,39,10,0,10,19,2.6,1.1,3.9,0.0,1,1,1,1,2.2,2.8,3.4
2548,373,0,Asia Pacific,Manufacturing,Marketing,Meets,Male,34,32,0,11,18,2.8,2.7,2.3,0.0348,1,1,1,1,3.6,2.8,2.9
2549,421,0,Europe,Manufacturing,Regulatory Affairs,Meets,Male,29,9,0,7,28,3.5,4.8,2.2,0.0348,1,1,1,1,4.1,3.5,2.7
2550,370,0,Asia Pacific,Manufacturing,Pharmacovigilance,Meets,Female,47,10,0,12,19,3.6,3.6,2.7,0.0348,1,1,1,1,3.4,2.3,2.6
2551,336,0,Latin America,Commercial,Medical Affairs,Exceeds,Female,35,11,0,7,21,5.0,3.9,3.7,0.0743,1,1,1,1,4.3,1.5,3.3
2552,795,0,Middle East & Africa,HR,Human Resources,Meets,Male,37,6,0,12,17,3.2,3.2,3.3,0.0383,1,1,1,1,1.8,3.2,2.7
2553,892,0,Europe,Finance,Finance & Accounting,Meets,Female,28,9,1,11,18,0.0,3.7,1.4,0.0331,1,1,1,1,3.6,3.2,3.6
2554,36,1,Europe,R&D,Quality Assurance,Exceeds,Female,34,13,0,9,16,2.9,2.6,1.9,0.1648,0,0,0,0,3.1,2.6,3.3
2555,809,0,Latin America,HR,Market Access,Below,Male,39,15,0,11,11,3.0,3.3,5.0,0.0,1,1,1,1,3.1,3.2,2.8
2556,243,0,North America,Commercial,Supply Chain,Meets,Male,40,15,0,10,15,3.2,3.7,3.6,0.0422,1,1,1,1,2.6,4.1,3.3
2557,111,1,Middle East & Africa,R&D,IT & Digital,Exceeds,Female,48,12,1,8,16,0.0,4.3,2.9,0.1648,1,1,1,1,3.7,2.8,5.0
2558,58,0,Europe,R&D,Human Resources,Meets,Female,36,6,0,11,21,5.0,3.6,2.0,0.0977,1,1,1,1,4.9,4.4,1.9
2559,30,0,Middle East & Africa,R&D,Data Science,Below,Male,37,8,0,8,16,3.2,3.1,3.3,0.0,1,1,1,1,2.4,2.7,3.7
2560,1005,0,Europe,Finance,Communications,Below,Female,47,15,0,8,16,2.1,2.1,1.7,0.0,1,1,1,1,2.7,2.8,3.3
2561,647,0,Middle East & Africa,Digital,Quality Assurance,Meets,Male,45,22,1,6,15,0.0,2.8,3.5,0.0853,0,0,0,0,3.7,1.7,2.0
2562,271,0,Asia Pacific,Commercial,Medical Affairs,Meets,Female,30,8,0,6,20,3.7,3.5,3.5,0.0422,1,1,0,0,4.6,3.3,2.5
2563,886,0,Europe,Finance,Regulatory Affairs,Below,Male,47,12,1,6,8,0.0,2.9,3.5,0.0,1,1,1,1,2.6,4.3,3.1
2564,908,0,Middle East & Africa,Finance,Human Resources,Meets,Female,28,13,0,11,26,3.5,2.1,5.0,0.0331,1,1,1,0,2.5,3.3,4.2
2565,534,0,North America,Digital,Sales,Meets,Female,41,10,0,5,6,3.4,3.7,3.1,0.0853,1,1,1,1,3.5,2.7,2.6
2566,10,0,Asia Pacific,R&D,Clinical Operations,Exceeds,Female,43,4,0,11,32,4.0,3.1,2.1,0.1648,1,1,1,0,2.6,4.7,3.2
2567,686,0,Asia Pacific,Digital,Finance & Accounting,Exceeds,Female,39,9,1,8,29,0.0,2.4,1.1,0.1452,0,0,0,0,4.7,4.1,2.5
2568,588,0,North America,Digital,Quality Assurance,Exceeds,Male,36,6,1,11,16,0.0,1.0,4.4,0.1452,1,1,1,1,2.0,1.1,3.3
2569,1044,0,Middle East & Africa,Finance,Legal & Compliance,Meets,Female,35,10,0,6,14,3.0,3.1,2.4,0.0331,1,1,1,1,3.3,2.5,2.0
2570,343,0,Latin America,Commercial,Quality Assurance,Meets,Male,28,10,0,10,17,3.4,2.7,2.7,0.0422,1,1,1,1,4.1,2.5,2.2
2571,463,0,North America,Manufacturing,Data Science,Meets,Male,39,8,0,8,11,3.0,5.0,1.0,0.0348,1,1,1,1,2.7,3.9,2.7
2572,658,1,Middle East & Africa,Digital,Clinical Operations,Meets,Female,38,16,0,9,15,2.1,4.4,2.3,0.0853,1,1,1,1,4.4,2.6,3.0
2573,542,0,North America,Digital,Medical Affairs,Meets,Male,47,3,1,6,30,0.0,2.0,2.2,0.0853,1,1,1,1,3.7,2.4,1.0
2574,97,0,North America,R&D,Pharmacovigilance,Exceeds,Male,36,8,1,6,27,0.0,4.2,4.5,0.1648,1,1,1,1,1.1,3.1,3.5
2575,137,0,Europe,R&D,Pharmacovigilance,Below,Female,35,8,0,11,19,2.1,3.2,2.7,0.0,1,1,1,1,2.3,4.4,2.5
2576,1019,0,Middle East & Africa,Finance,Communications,Meets,Female,35,11,0,8,12,2.1,4.1,2.8,0.0331,1,1,1,1,3.8,5.0,2.0
2577,48,0,Latin America,R&D,Clinical Operations,Meets,Female,33,5,0,10,28,3.3,5.0,2.3,0.0977,1,1,1,1,3.5,4.4,3.8
2578,791,0,Europe,HR,Human Resources,Meets,Female,35,12,0,5,16,2.8,2.6,3.8,0.0383,1,1,1,1,1.0,1.9,2.4
2579,568,0,North America,Digital,Communications,Exceeds,Non-Binary/Other,32,10,0,11,20,4.0,2.7,1.0,0.1452,1,1,1,1,4.6,2.1,1.6
2580,85,0,North America,R&D,Supply Chain,Below,Female,42,12,0,12,20,4.3,2.2,2.4,0.0,1,1,1,1,3.8,4.8,2.6
2581,250,0,North America,Commercial,Marketing,Meets,Female,40,15,0,6,16,2.2,3.9,2.8,0.0422,1,1,1,1,3.0,5.0,2.5
2582,724,0,Middle East & Africa,HR,Legal & Compliance,Exceeds,Male,29,2,1,9,14,0.0,3.9,3.4,0.0677,1,1,1,1,2.0,2.2,5.0
2583,895,0,Middle East & Africa,Finance,Supply Chain,Meets,Female,39,7,0,10,19,2.0,4.8,2.8,0.0331,1,1,1,0,2.6,3.1,2.3
2584,406,0,Europe,Manufacturing,Supply Chain,Meets,Male,45,29,0,9,18,4.4,3.7,3.5,0.0348,0,0,0,0,3.5,4.0,3.9
2585,523,0,Latin America,Digital,Quality Assurance,Below,Female,44,9,0,9,28,3.4,1.8,2.5,0.0,1,1,1,1,3.6,2.0,3.0
2586,657,0,Europe,Digital,Quality Assurance,Meets,Female,32,32,0,10,20,2.6,4.5,2.8,0.0853,1,1,1,1,3.2,4.4,3.5
2587,300,0,Asia Pacific,Commercial,Market Access,Meets,Male,46,5,1,10,16,0.0,3.4,3.0,0.0422,1,1,1,1,4.7,2.5,3.1
2588,465,0,North America,Manufacturing,Legal & Compliance,Meets,Female,35,8,0,12,13,2.7,2.9,4.3,0.0348,1,1,1,1,3.6,3.2,2.8
2589,359,0,North America,Manufacturing,Human Resources,Meets,Female,38,21,0,10,23,3.6,2.2,2.8,0.0348,1,1,1,1,4.0,3.0,3.3
2590,929,0,North America,Finance,Regulatory Affairs,Meets,Female,36,7,0,8,17,2.9,4.0,3.2,0.0331,1,1,1,1,3.4,4.1,1.5
2591,1036,0,Europe,Finance,IT & Digital,Meets,Male,31,6,0,5,32,2.2,1.8,4.0,0.0331,1,1,0,0,3.0,3.2,3.6
2592,814,0,Europe,HR,IT & Digital,Meets,Female,33,21,0,9,17,4.0,4.8,3.5,0.0383,1,1,1,1,4.9,3.0,2.0
2593,584,0,North America,Digital,IT & Digital,Exceeds,Male,45,5,1,9,22,0.0,3.1,2.3,0.1452,1,1,1,1,3.1,2.9,3.7
2594,158,0,Europe,R&D,Medical Affairs,Exceeds,Female,46,5,1,5,17,0.0,1.0,1.8,0.1648,1,1,0,0,2.9,2.1,2.3
2595,954,0,Middle East & Africa,Finance,Medical Affairs,Below,Male,42,17,0,6,9,4.8,3.5,3.0,0.0,1,1,1,1,2.8,2.8,3.8
2596,253,0,Middle East & Africa,Commercial,Finance & Accounting,Exceeds,Male,37,15,1,6,25,0.0,3.3,4.4,0.0743,1,1,1,1,2.8,2.3,4.9
2597,198,0,Europe,Commercial,Communications,Below,Male,49,16,0,8,9,4.2,2.9,4.1,0.0,1,1,1,1,4.8,3.5,2.4
2598,241,0,North America,Commercial,Human Resources,Meets,Male,44,6,0,6,17,3.9,4.8,1.0,0.0422,1,1,1,1,3.6,4.3,2.4
2599,997,0,Europe,Finance,Market Access,Meets,Female,37,11,0,8,25,2.9,4.1,4.3,0.0331,0,0,0,0,3.5,2.8,3.8
2600,1024,0,Europe,Finance,IT & Digital,Below,Male,28,15,1,10,28,0.0,1.8,3.3,0.0,1,1,1,1,3.3,3.6,3.7
2601,283,0,Europe,Commercial,Finance & Accounting,Far Below,Female,43,13,1,12,22,0.0,3.7,1.4,0.0,1,1,1,1,3.4,4.3,2.2
2602,1027,0,Asia Pacific,Finance,Quality Assurance,Meets,Non-Binary/Other,45,1,1,11,12,0.0,4.0,1.5,0.0331,0,0,0,0,2.3,3.5,2.1
2603,138,0,Middle East & Africa,R&D,Legal & Compliance,Meets,Female,41,14,1,8,16,0.0,2.7,2.3,0.0977,1,1,1,1,3.5,3.6,4.2
2604,167,0,Latin America,R&D,Finance & Accounting,Meets,Male,28,26,0,7,7,3.9,2.8,2.0,0.0977,1,1,1,1,3.8,4.2,1.4
2605,855,0,Latin America,HR,Finance & Accounting,Meets,Female,39,9,0,11,14,2.8,3.1,4.7,0.0383,1,1,1,1,3.3,2.6,3.9
2606,589,0,Asia Pacific,Digital,Data Science,Exceeds,Male,51,17,0,6,22,1.9,1.7,3.8,0.1452,1,1,1,1,1.6,1.8,3.2
2607,66,0,Europe,R&D,IT & Digital,Meets,Male,37,11,0,10,21,4.7,2.8,3.0,0.0977,0,0,0,0,4.1,4.3,3.6
2608,842,0,Asia Pacific,HR,Finance & Accounting,Meets,Female,50,7,0,9,17,3.6,3.1,4.0,0.0383,1,1,1,1,2.8,3.3,4.4
2609,434,0,Asia Pacific,Manufacturing,Communications,Meets,Male,42,13,0,10,19,4.2,4.2,5.0,0.0348,1,1,1,1,3.0,3.3,5.0
2610,587,0,North America,Digital,Finance & Accounting,Far Below,Female,38,6,1,7,49,0.0,2.5,2.6,0.0,0,0,0,0,3.3,3.8,1.7
2611,42,0,Middle East & Africa,R&D,IT & Digital,Below,Male,46,13,0,10,22,3.2,3.2,1.6,0.0,1,1,1,1,2.4,3.5,1.3
2612,394,0,Latin America,Manufacturing,Data Science,Meets,Male,34,2,1,11,27,0.0,2.2,4.1,0.0348,1,1,1,1,2.0,3.3,3.2
2613,816,0,Europe,HR,Finance & Accounting,Meets,Male,31,6,0,11,24,4.7,2.4,3.6,0.0383,1,1,1,1,3.5,2.7,1.8
2614,129,0,Latin America,R&D,Regulatory Affairs,Far Exceeds,Female,31,36,0,5,8,5.0,2.4,2.9,0.2644,1,1,1,1,3.4,1.6,1.6
2615,135,0,Latin America,R&D,Clinical Operations,Below,Male,39,21,1,11,16,0.0,2.6,2.2,0.0,1,1,1,1,1.4,3.3,2.6
2616,955,0,Middle East & Africa,Finance,Quality Assurance,Below,Male,41,30,0,6,11,3.5,3.2,3.3,0.0,1,1,1,1,3.5,2.1,2.8
2617,498,0,Latin America,Manufacturing,Legal & Compliance,Below,Female,34,16,0,5,9,4.6,3.6,1.6,0.0,1,1,1,1,4.3,3.0,2.3
2618,82,0,Latin America,R&D,Pharmacovigilance,Below,Female,45,23,1,9,17,0.0,4.0,3.4,0.0,0,0,0,0,3.6,2.0,3.4
2619,224,0,Asia Pacific,Commercial,Pharmacovigilance,Meets,Female,39,7,1,11,16,0.0,1.9,1.1,0.0422,1,1,1,1,4.1,1.0,2.1
2620,1020,0,Middle East & Africa,Finance,Human Resources,Far Exceeds,Male,43,18,0,8,11,4.9,3.5,1.7,0.1022,1,1,1,1,4.0,4.0,2.4
2621,915,1,North America,Finance,Quality Assurance,Meets,Male,34,9,0,7,25,2.3,1.7,3.6,0.0331,1,1,1,1,3.6,3.3,3.6
2622,116,0,Europe,R&D,Sales,Meets,Female,37,9,0,11,15,2.4,1.0,1.0,0.0977,1,1,1,1,3.7,3.4,1.5
2623,1024,0,Latin America,Finance,Clinical Operations,Meets,Female,28,4,0,5,12,2.0,3.5,3.3,0.0331,1,1,1,1,3.8,5.0,2.2
2624,647,0,Europe,Digital,Pharmacovigilance,Below,Female,36,14,0,5,17,2.1,3.3,3.2,0.0,0,0,0,0,3.0,2.5,1.8
2625,367,0,North America,Manufacturing,Marketing,Exceeds,Female,39,8,0,12,32,3.8,4.1,1.5,0.0616,1,1,1,1,4.9,4.1,2.0
2626,548,0,Europe,Digital,IT & Digital,Meets,Male,35,4,1,8,18,0.0,2.1,3.2,0.0853,0,0,0,0,4.1,3.5,2.7
2627,793,0,North America,HR,Communications,Below,Male,38,13,0,5,8,3.6,2.7,2.4,0.0,0,0,0,0,3.1,3.2,5.0
2628,533,0,Asia Pacific,Digital,Supply Chain,Meets,Female,39,11,0,12,29,4.4,3.5,2.2,0.0853,1,1,1,1,1.8,3.9,3.8
2629,347,0,Latin America,Commercial,Quality Assurance,Meets,Male,35,26,0,7,15,4.1,2.8,2.4,0.0422,1,1,1,0,3.0,3.4,3.1
2630,897,0,North America,Finance,Finance & Accounting,Below,Non-Binary/Other,36,9,0,6,9,4.2,2.8,1.4,0.0,1,1,1,1,3.5,2.3,1.0
2631,1027,0,Europe,Finance,Sales,Meets,Male,34,9,1,8,23,0.0,3.4,3.5,0.0331,1,1,1,1,3.2,1.9,2.5
2632,318,0,Latin America,Commercial,Marketing,Meets,Female,32,20,0,12,27,4.3,4.1,2.3,0.0422,1,1,1,1,3.6,3.9,3.3
2633,996,0,Asia Pacific,Finance,IT & Digital,Meets,Male,45,12,0,9,16,3.3,4.4,1.1,0.0331,1,1,1,1,2.6,4.2,2.0
2634,586,0,Latin America,Digital,Finance & Accounting,Meets,Male,29,10,0,12,18,2.8,3.8,2.9,0.0853,1,1,0,0,3.6,2.5,3.8
2635,801,0,North America,HR,Supply Chain,Meets,Female,43,10,0,8,25,2.2,2.3,3.9,0.0383,1,1,1,1,2.3,5.0,3.4
2636,158,0,Asia Pacific,R&D,Supply Chain,Meets,Female,30,20,0,9,19,4.0,2.1,1.0,0.0977,1,1,1,1,3.6,1.4,2.2
2637,267,0,Europe,Commercial,Regulatory Affairs,Meets,Male,47,15,1,6,14,0.0,5.0,3.2,0.0422,1,1,1,1,3.8,4.4,2.7
2638,670,0,Asia Pacific,Digital,Legal & Compliance,Far Exceeds,Male,41,3,1,9,39,0.0,2.7,3.5,0.2363,1,1,1,1,3.4,2.4,2.4
2639,641,0,Asia Pacific,Digital,Human Resources,Meets,Female,36,18,1,8,19,0.0,2.8,1.9,0.0853,1,1,1,1,3.7,3.4,1.6
2640,667,0,Middle East & Africa,Digital,IT & Digital,Meets,Female,44,15,0,12,25,3.3,3.1,2.0,0.0853,1,1,1,1,3.9,2.6,1.6
2641,3,0,Asia Pacific,R&D,Legal & Compliance,Exceeds,Male,45,13,0,5,28,3.1,1.6,3.8,0.1648,1,1,1,1,3.8,3.2,2.5
2642,487,0,Asia Pacific,Manufacturing,Clinical Operations,Meets,Female,41,8,1,6,17,0.0,2.2,2.2,0.0348,1,1,1,1,4.5,3.3,2.5
2643,913,0,Latin America,Finance,Quality Assurance,Below,Male,41,26,1,9,15,0.0,3.6,3.7,0.0,1,1,1,1,4.1,4.0,2.9
2644,1002,0,Europe,Finance,Sales,Meets,Female,39,14,0,11,18,2.9,1.6,1.5,0.0331,1,1,1,1,3.3,1.8,2.6
2645,776,0,Latin America,HR,Market Access,Meets,Female,47,16,0,5,9,3.7,2.5,1.6,0.0383,1,1,1,1,3.6,2.5,1.9
2646,442,0,Latin America,Manufacturing,Communications,Meets,Male,38,7,1,6,14,0.0,2.0,3.9,0.0348,1,1,1,1,3.2,1.4,3.3
2647,1027,1,North America,Finance,Regulatory Affairs,Far Exceeds,Female,39,5,0,9,17,2.7,2.5,2.3,0.1022,1,1,1,1,3.4,2.2,2.3
2648,836,0,Latin America,HR,Data Science,Meets,Male,43,9,1,11,29,0.0,2.8,3.4,0.0383,0,0,0,0,2.7,3.6,4.3
2649,726,0,Middle East & Africa,HR,Marketing,Exceeds,Male,36,4,0,11,18,2.5,3.9,1.3,0.0677,1,1,1,1,2.3,3.6,2.9
2650,605,0,Middle East & Africa,Digital,Market Access,Below,Female,45,14,0,6,30,2.0,3.9,3.3,0.0,1,1,1,1,3.0,4.4,3.4
2651,329,0,North America,Commercial,Marketing,Meets,Male,43,9,1,9,22,0.0,3.1,2.2,0.0422,1,1,1,1,2.4,3.1,2.7
2652,619,0,Europe,Digital,Quality Assurance,Exceeds,Female,55,12,0,9,14,3.6,2.9,2.4,0.1452,1,1,1,1,3.2,2.5,2.8
2653,67,0,Europe,R&D,Sales,Meets,Male,37,26,0,11,16,3.8,1.7,1.2,0.0977,0,0,0,0,4.4,3.6,2.3
2654,1007,0,Latin America,Finance,Sales,Below,Female,42,6,1,10,15,0.0,1.6,3.6,0.0,0,0,0,0,3.3,1.5,3.6
2655,836,0,Latin America,HR,Supply Chain,Meets,Male,41,14,0,12,17,2.9,3.3,1.8,0.0383,1,1,1,1,2.9,4.2,4.1
2656,323,0,Latin America,Commercial,Market Access,Meets,Male,43,20,0,8,12,3.6,4.3,1.9,0.0422,1,1,1,1,3.8,4.7,2.8
2657,901,0,Europe,Finance,Finance & Accounting,Below,Female,38,11,0,5,6,2.5,3.3,3.0,0.0,1,1,1,1,3.7,2.3,2.9
2658,878,0,Asia Pacific,HR,Legal & Compliance,Meets,Male,41,9,1,6,27,0.0,3.2,3.2,0.0383,1,1,1,1,3.1,3.1,4.0
2659,838,0,Middle East & Africa,HR,Communications,Below,Non-Binary/Other,39,10,0,7,29,3.3,5.0,4.1,0.0,1,1,1,1,3.5,4.1,4.9
2660,603,0,Asia Pacific,Digital,Sales,Meets,Female,43,20,0,12,18,4.1,3.8,3.2,0.0853,1,1,1,1,2.3,4.7,2.3
2661,210,1,Asia Pacific,Commercial,Communications,Far Exceeds,Male,28,18,0,12,22,3.8,1.9,2.3,0.1275,1,1,1,1,4.7,3.9,1.5
2662,191,0,Europe,Commercial,Pharmacovigilance,Below,Female,37,11,1,12,14,0.0,1.9,1.0,0.0,1,1,1,1,3.2,3.5,1.9
2663,971,0,Asia Pacific,Finance,Marketing,Far Below,Male,51,10,0,7,10,3.4,2.6,1.1,0.0,1,1,1,1,4.4,3.1,1.0
2664,875,0,North America,HR,Supply Chain,Meets,Male,47,23,0,8,9,2.3,2.0,2.5,0.0383,1,1,1,1,3.8,2.5,3.5
2665,224,0,Latin America,Commercial,IT & Digital,Meets,Female,40,15,0,6,17,3.5,2.5,2.8,0.0422,1,1,1,1,3.4,4.2,2.6
2666,180,0,North America,Commercial,Quality Assurance,Meets,Female,42,7,0,8,23,2.6,3.1,3.2,0.0422,1,1,1,1,2.4,4.9,3.3
2667,999,0,Middle East & Africa,Finance,Finance & Accounting,Meets,Female,41,8,1,7,10,0.0,1.9,4.6,0.0331,1,1,1,1,3.2,3.1,3.7
2668,649,0,Latin America,Digital,Sales,Far Exceeds,Female,42,6,0,8,22,4.3,3.1,2.4,0.2363,1,0,0,0,4.0,2.6,2.2
2669,433,1,Asia Pacific,Manufacturing,Legal & Compliance,Meets,Female,33,3,1,12,22,0.0,3.3,1.0,0.0348,1,1,1,1,3.5,3.9,2.7
2670,56,1,Middle East & Africa,R&D,Human Resources,Meets,Female,34,10,0,11,27,4.3,5.0,2.6,0.0977,1,1,1,0,5.0,5.0,1.6
2671,388,0,Latin America,Manufacturing,Medical Affairs,Meets,Female,34,19,0,7,35,2.6,2.9,2.0,0.0348,1,1,1,1,4.3,2.2,2.2
2672,189,0,Asia Pacific,Commercial,Communications,Meets,Male,35,13,0,8,28,4.1,2.7,4.8,0.0422,1,1,1,1,4.2,4.4,3.8
2673,872,0,North America,HR,IT & Digital,Far Below,Male,47,23,0,12,27,2.6,4.9,3.4,0.0,1,1,1,1,3.3,2.1,1.6
2674,69,1,Latin America,R&D,Communications,Meets,Male,31,12,1,9,11,0.0,1.7,1.7,0.0977,1,0,0,0,5.0,2.3,2.1
2675,24,0,Asia Pacific,R&D,Quality Assurance,Far Exceeds,Female,50,20,0,6,20,3.5,5.0,1.3,0.2644,1,1,1,1,3.9,4.2,2.2
2676,856,1,North America,HR,IT & Digital,Meets,Female,40,22,0,8,20,3.7,3.4,1.7,0.0383,1,1,1,1,4.1,3.8,1.6
2677,3,0,Middle East & Africa,R&D,Market Access,Meets,Female,31,26,0,11,14,3.3,4.2,2.8,0.0977,1,1,1,1,3.2,3.5,4.3
2678,771,0,Middle East & Africa,HR,Pharmacovigilance,Far Below,Male,35,13,1,8,22,0.0,2.7,2.4,0.0,1,1,1,1,1.8,1.0,2.5
2679,30,0,Middle East & Africa,R&D,Clinical Operations,Meets,Male,41,13,1,9,15,0.0,1.8,2.7,0.0977,0,0,0,0,3.3,1.3,2.4
2680,1032,0,Middle East & Africa,Finance,Data Science,Meets,Female,30,15,1,7,12,0.0,1.9,1.6,0.0331,0,0,0,0,4.1,3.3,3.2
2681,940,0,Europe,Finance,IT & Digital,Meets,Male,36,13,0,10,26,4.9,3.5,2.0,0.0331,0,0,0,0,3.5,3.5,3.9
2682,495,0,Latin America,Manufacturing,Medical Affairs,Meets,Female,31,13,0,12,25,2.9,4.9,1.3,0.0348,1,1,1,1,2.7,3.6,3.9
2683,59,0,Latin America,R&D,Finance & Accounting,Below,Male,42,11,0,5,10,4.5,2.0,3.2,0.0,1,1,1,1,2.7,1.5,3.1
2684,650,0,Europe,Digital,Supply Chain,Meets,Female,31,4,1,9,11,0.0,3.3,3.1,0.0853,1,1,1,1,3.5,3.7,2.7
2685,736,0,Asia Pacific,HR,Marketing,Meets,Female,29,17,0,11,20,3.9,1.7,2.5,0.0383,1,1,1,1,4.3,3.5,3.2
2686,130,0,Asia Pacific,R&D,Market Access,Meets,Female,47,4,0,8,30,2.3,4.3,3.9,0.0977,1,1,1,1,3.1,3.8,5.0
2687,903,0,Middle East & Africa,Finance,Market Access,Exceeds,Male,36,4,1,8,19,0.0,3.4,3.3,0.0588,1,1,1,1,4.1,2.3,3.3
2688,992,0,North America,Finance,Human Resources,Far Below,Female,36,8,1,7,23,0.0,1.5,1.7,0.0,1,1,1,1,3.2,1.6,3.2
2689,832,0,Asia Pacific,HR,Clinical Operations,Meets,Female,41,5,0,9,26,3.3,3.3,2.8,0.0383,1,1,1,1,2.9,3.1,3.9
2690,693,1,North America,Digital,Medical Affairs,Meets,Female,38,18,0,10,14,3.6,3.5,1.3,0.0853,1,1,1,1,4.6,2.9,2.9
2691,118,0,Latin America,R&D,Marketing,Meets,Female,33,5,0,7,13,2.8,4.2,2.4,0.0977,1,1,1,1,3.0,3.7,4.0
2692,133,0,North America,R&D,Data Science,Meets,Male,34,7,1,6,29,0.0,3.5,3.4,0.0977,1,1,1,1,3.3,4.0,3.1
2693,636,0,Latin America,Digital,Communications,Meets,Female,42,6,0,6,24,4.2,1.0,2.2,0.0853,1,1,1,1,3.9,2.3,1.8
2694,604,0,Europe,Digital,Regulatory Affairs,Far Below,Female,32,19,0,9,11,1.6,1.0,2.5,0.0,1,1,1,1,1.7,1.1,2.5
2695,619,0,Europe,Digital,Regulatory Affairs,Meets,Female,38,2,0,7,19,3.4,3.5,3.0,0.0853,1,1,1,1,3.9,2.4,2.2
2696,920,0,Middle East & Africa,Finance,Market Access,Meets,Male,48,6,1,11,17,0.0,1.3,3.2,0.0331,1,1,1,1,2.5,1.9,2.7
2697,814,0,Asia Pacific,HR,IT & Digital,Meets,Male,36,28,0,5,21,2.7,5.0,2.6,0.0383,1,1,1,1,2.4,4.5,1.5
2698,539,0,Middle East & Africa,Digital,IT & Digital,Exceeds,Female,45,7,1,6,16,0.0,3.3,3.9,0.1452,1,1,1,1,1.9,3.7,1.7
2699,819,0,Latin America,HR,Medical Affairs,Exceeds,Female,32,9,1,5,12,0.0,3.6,3.1,0.0677,1,1,1,1,3.3,3.3,1.5
2700,519,0,Middle East & Africa,Manufacturing,Finance & Accounting,Meets,Male,39,14,0,8,13,2.9,2.6,1.8,0.0348,1,1,1,1,3.0,4.1,1.0
2701,41,0,North America,R&D,Clinical Operations,Meets,Male,45,14,0,11,30,5.0,3.3,5.0,0.0977,1,1,1,1,4.0,4.3,3.1
2702,83,0,Latin America,R&D,Communications,Far Below,Male,35,5,1,7,14,0.0,5.0,1.8,0.0,0,0,0,0,2.3,3.4,1.8
2703,270,0,Europe,Commercial,Market Access,Exceeds,Male,50,5,0,5,8,2.8,2.9,3.9,0.0743,1,1,1,1,3.3,3.2,4.1
2704,390,0,Asia Pacific,Manufacturing,Regulatory Affairs,Exceeds,Male,38,10,0,9,16,3.6,3.6,3.0,0.0616,1,1,1,1,4.0,4.3,3.3
2705,654,0,Latin America,Digital,Finance & Accounting,Far Below,Male,31,11,0,6,10,1.9,3.8,4.9,0.0,1,1,1,1,1.6,4.1,3.8
2706,580,0,Latin America,Digital,Market Access,Meets,Female,44,13,1,9,14,0.0,2.2,2.0,0.0853,1,1,1,1,3.3,2.3,3.4
2707,1016,0,North America,Finance,Communications,Exceeds,Male,48,7,1,11,14,0.0,3.2,3.1,0.0588,1,1,1,1,2.4,3.5,4.0
2708,466,0,Asia Pacific,Manufacturing,Regulatory Affairs,Below,Female,31,22,0,9,16,4.4,3.4,3.8,0.0,1,1,1,1,3.6,2.3,3.1
2709,617,1,Europe,Digital,Medical Affairs,Meets,Female,41,9,1,11,13,0.0,4.4,4.1,0.0853,1,1,1,1,2.3,3.9,3.7
2710,237,0,Latin America,Commercial,Medical Affairs,Meets,Female,34,11,1,7,33,0.0,2.7,2.5,0.0422,1,1,1,1,4.4,1.9,3.2
2711,842,0,Latin America,HR,Clinical Operations,Meets,Female,32,26,0,9,14,3.3,1.5,3.5,0.0383,1,1,1,1,2.3,2.5,3.3
2712,67,0,North America,R&D,Supply Chain,Far Below,Female,33,21,0,5,7,4.0,4.4,2.2,0.0,1,1,1,1,3.1,3.5,1.4
2713,386,0,Middle East & Africa,Manufacturing,Supply Chain,Meets,Female,39,8,1,9,12,0.0,3.2,2.4,0.0348,1,1,1,1,3.3,1.2,2.2
2714,65,0,Europe,R&D,Market Access,Meets,Female,46,20,0,9,15,3.7,3.8,1.9,0.0977,1,1,1,1,4.0,1.8,1.8
2715,752,0,Asia Pacific,HR,Human Resources,Exceeds,Male,38,10,0,12,14,4.1,3.7,1.5,0.0677,1,1,1,1,4.4,5.0,3.2
2716,522,0,Latin America,Manufacturing,Market Access,Meets,Male,41,9,0,9,42,3.6,4.9,2.1,0.0348,1,1,1,1,3.9,4.0,1.4
2717,741,0,Latin America,HR,Market Access,Meets,Female,35,27,0,9,36,2.7,3.4,2.9,0.0383,1,1,1,1,2.6,2.0,1.7
2718,621,1,Europe,Digital,Clinical Operations,Meets,Female,37,16,0,10,14,4.8,4.2,3.4,0.0853,1,1,1,1,3.1,4.2,4.3
2719,601,0,Middle East & Africa,Digital,Human Resources,Below,Female,33,19,1,6,20,0.0,3.6,1.8,0.0,1,1,1,1,2.2,3.8,3.0
2720,647,0,Latin America,Digital,Quality Assurance,Far Exceeds,Male,28,8,0,10,17,2.3,3.1,3.4,0.2363,1,1,1,1,1.8,2.0,2.2
2721,726,0,Europe,HR,Market Access,Exceeds,Male,35,19,0,12,24,3.0,4.9,4.5,0.0677,1,1,1,1,3.2,3.4,3.5
2722,699,0,North America,HR,Legal & Compliance,Meets,Male,45,29,0,5,13,2.7,4.3,3.7,0.0383,1,1,1,1,3.2,3.3,1.9
2723,802,0,Middle East & Africa,HR,Legal & Compliance,Meets,Male,28,2,0,12,23,3.3,2.4,3.7,0.0383,0,0,0,0,2.3,2.5,2.6
2724,61,0,Asia Pacific,R&D,Supply Chain,Meets,Female,45,1,1,8,12,0.0,3.4,2.9,0.0977,1,1,1,1,4.1,4.4,2.3
2725,700,0,Latin America,HR,Supply Chain,Meets,Female,40,3,1,8,15,0.0,3.2,1.2,0.0383,1,1,1,1,3.6,2.9,3.1
2726,587,0,Europe,Digital,Human Resources,Below,Female,37,12,0,5,20,3.7,3.0,3.7,0.0,1,1,1,1,3.5,3.6,4.1
2727,301,0,North America,Commercial,Marketing,Meets,Male,35,10,1,6,9,0.0,3.6,3.9,0.0422,1,1,1,1,3.1,3.7,2.7
2728,725,1,Asia Pacific,HR,IT & Digital,Far Exceeds,Female,41,20,0,10,18,3.7,3.4,1.0,0.1168,1,1,1,1,5.0,3.9,3.0
2729,223,0,Europe,Commercial,Medical Affairs,Below,Female,46,2,0,12,19,2.8,1.8,1.6,0.0,1,1,1,1,2.8,2.3,2.4
2730,597,0,Europe,Digital,Human Resources,Meets,Female,40,8,1,5,15,0.0,2.8,2.0,0.0853,1,1,1,1,4.1,3.1,1.2
2731,754,0,Asia Pacific,HR,Quality Assurance,Far Below,Female,37,23,0,5,9,2.3,2.9,1.3,0.0,1,1,1,1,2.8,5.0,1.0
2732,171,0,North America,R&D,Regulatory Affairs,Below,Female,54,16,0,6,22,5.0,2.5,1.6,0.0,1,1,1,1,3.2,3.5,1.8
2733,54,0,North America,R&D,Supply Chain,Meets,Male,39,14,0,10,23,2.8,2.1,4.4,0.0977,1,1,1,1,2.9,4.3,3.8
2734,344,0,Middle East & Africa,Commercial,Data Science,Meets,Female,28,3,0,8,21,4.7,2.7,3.3,0.0422,1,1,1,1,4.4,2.6,3.5
2735,967,0,Latin America,Finance,Legal & Compliance,Exceeds,Female,40,19,0,9,13,2.4,2.8,2.8,0.0588,1,1,1,1,2.6,3.5,2.6
2736,14,0,Asia Pacific,R&D,Data Science,Meets,Male,34,17,1,9,23,0.0,3.0,2.7,0.0977,1,1,1,1,5.0,4.6,2.4
2737,70,0,Asia Pacific,R&D,Legal & Compliance,Meets,Female,36,9,0,6,18,3.6,2.5,4.5,0.0977,1,1,1,0,4.3,2.4,4.7
2738,172,0,Asia Pacific,R&D,Supply Chain,Meets,Male,46,10,1,11,17,0.0,3.1,2.3,0.0977,1,1,1,1,4.3,2.4,1.2
2739,675,0,North America,Digital,IT & Digital,Meets,Male,43,11,0,11,21,2.9,1.1,1.7,0.0853,1,0,0,0,5.0,3.1,1.0
2740,43,0,Latin America,R&D,Data Science,Far Below,Female,28,13,1,12,18,0.0,2.7,3.8,0.0,1,1,0,0,3.3,1.6,4.0
2741,385,0,Middle East & Africa,Manufacturing,Communications,Meets,Male,28,9,1,8,19,0.0,4.4,1.7,0.0348,1,1,1,1,3.6,3.5,3.6
2742,872,0,Europe,HR,Communications,Meets,Male,39,7,1,5,20,0.0,3.0,1.0,0.0383,1,1,1,1,3.5,3.3,1.0
2743,84,0,Europe,R&D,Sales,Below,Male,44,5,1,10,20,0.0,2.8,2.7,0.0,0,0,0,0,3.9,3.1,2.2
2744,982,0,Asia Pacific,Finance,Quality Assurance,Exceeds,Male,28,8,0,7,20,3.6,3.1,1.4,0.0588,1,1,1,1,3.0,5.0,1.6
2745,913,0,Latin America,Finance,Legal & Compliance,Meets,Female,44,9,0,6,18,3.7,5.0,3.5,0.0331,1,1,1,1,3.3,3.5,3.5
2746,54,0,North America,R&D,Finance & Accounting,Below,Female,53,9,0,6,13,1.9,4.3,2.9,0.0,1,1,1,1,1.2,4.3,2.2
2747,110,0,Latin America,R&D,Medical Affairs,Meets,Male,45,6,0,9,10,3.9,3.2,2.8,0.0977,1,1,1,1,4.0,3.4,2.4
2748,449,0,Latin America,Manufacturing,Supply Chain,Below,Female,33,7,0,8,16,1.9,2.6,2.6,0.0,1,1,1,1,3.3,3.1,2.3
2749,166,0,North America,R&D,Supply Chain,Meets,Male,42,3,0,7,23,2.9,2.4,2.6,0.0977,1,1,1,0,4.5,3.7,2.1
2750,107,0,Asia Pacific,R&D,Regulatory Affairs,Meets,Female,39,12,0,12,28,2.8,3.7,2.5,0.0977,1,1,1,1,4.2,5.0,3.4
2751,708,0,Latin America,HR,Legal & Compliance,Below,Female,49,14,0,5,29,3.2,3.6,3.3,0.0,1,1,1,1,4.8,2.3,3.1
2752,1038,0,Europe,Finance,Quality Assurance,Exceeds,Female,45,8,0,9,29,3.1,2.9,1.5,0.0588,1,1,1,1,3.4,3.6,1.0
2753,460,1,North America,Manufacturing,Market Access,Meets,Non-Binary/Other,33,10,0,10,17,3.1,4.3,4.0,0.0348,1,1,0,0,4.0,3.2,4.2
2754,882,0,Middle East & Africa,Finance,IT & Digital,Meets,Female,42,25,0,9,11,3.2,2.8,2.7,0.0331,1,1,1,1,3.0,3.5,2.2
2755,385,0,Asia Pacific,Manufacturing,Market Access,Meets,Female,33,13,1,9,20,0.0,2.3,4.0,0.0348,1,1,1,1,3.8,1.8,2.5
2756,982,0,North America,Finance,Communications,Below,Male,44,6,0,11,39,5.0,3.2,3.6,0.0,1,1,1,1,4.5,3.9,2.8
2757,134,0,Middle East & Africa,R&D,Legal & Compliance,Meets,Female,36,4,0,7,14,1.7,1.4,2.1,0.0977,1,1,1,0,3.0,2.6,1.9
2758,962,0,Middle East & Africa,Finance,Pharmacovigilance,Exceeds,Female,38,6,0,8,16,2.6,3.5,3.6,0.0588,1,1,1,1,2.5,3.8,3.7
2759,975,0,Latin America,Finance,Marketing,Below,Female,39,2,0,8,16,3.3,2.1,1.8,0.0,1,1,1,1,3.6,3.4,3.3
2760,449,0,Latin America,Manufacturing,Legal & Compliance,Meets,Female,35,16,0,6,26,2.9,3.3,2.1,0.0348,1,1,1,1,2.3,4.0,2.2
2761,319,0,Latin America,Commercial,Sales,Meets,Female,39,17,0,6,12,3.1,4.7,1.0,0.0422,1,1,1,1,3.7,4.1,1.3
2762,369,0,North America,Manufacturing,Clinical Operations,Meets,Female,41,16,0,6,9,3.1,3.0,4.2,0.0348,1,1,1,1,3.8,4.4,2.4
2763,417,0,North America,Manufacturing,Clinical Operations,Meets,Male,36,5,1,12,13,0.0,3.6,3.9,0.0348,1,1,1,1,4.4,3.5,3.6
2764,518,0,Asia Pacific,Manufacturing,Pharmacovigilance,Below,Male,39,9,0,5,10,4.6,2.5,1.5,0.0,1,1,1,1,3.7,3.0,2.7
2765,529,0,Latin America,Digital,Legal & Compliance,Meets,Male,34,10,0,8,14,4.6,4.0,2.6,0.0853,0,0,0,0,5.0,2.6,1.6
2766,633,0,Middle East & Africa,Digital,Medical Affairs,Far Below,Male,31,3,1,11,12,0.0,3.3,3.2,0.0,1,1,1,1,1.9,1.2,3.5
2767,610,0,Europe,Digital,Clinical Operations,Meets,Male,38,21,0,6,16,2.5,2.7,3.0,0.0853,1,1,1,0,2.4,2.3,3.4
2768,437,0,Asia Pacific,Manufacturing,Human Resources,Meets,Male,44,19,0,9,21,2.3,1.4,1.8,0.0348,1,1,1,1,4.0,2.0,1.0
2769,220,0,North America,Commercial,Market Access,Exceeds,Male,44,7,0,8,16,2.1,3.3,3.4,0.0743,0,0,0,0,2.5,2.9,3.5
2770,473,0,Asia Pacific,Manufacturing,IT & Digital,Meets,Female,44,20,0,10,12,1.8,2.7,4.3,0.0348,0,0,0,0,3.3,3.1,3.8
2771,52,0,Asia Pacific,R&D,Data Science,Below,Male,44,9,0,7,12,4.5,4.6,4.3,0.0,1,1,1,1,4.2,4.8,3.9
2772,237,0,Asia Pacific,Commercial,Marketing,Meets,Male,39,26,0,9,12,4.0,1.2,3.0,0.0422,1,1,1,1,3.8,2.2,4.1
2773,567,0,Asia Pacific,Digital,Legal & Compliance,Meets,Female,35,10,0,10,20,2.8,4.0,3.0,0.0853,1,1,1,1,4.4,3.2,4.5
2774,898,0,Europe,Finance,Human Resources,Meets,Female,36,10,0,11,22,3.2,3.3,1.1,0.0331,1,1,1,0,2.3,3.6,1.7
2775,1022,0,Latin America,Finance,Finance & Accounting,Far Below,Male,37,27,0,11,32,2.6,2.8,1.7,0.0,1,1,1,1,3.5,1.6,2.8
2776,844,0,Middle East & Africa,HR,Finance & Accounting,Below,Male,34,10,1,5,7,0.0,4.7,2.2,0.0,1,1,1,1,2.6,3.1,2.3
2777,269,0,Asia Pacific,Commercial,Human Resources,Meets,Male,42,4,0,7,18,4.0,4.0,4.3,0.0422,1,1,1,1,3.9,2.9,2.6
2778,591,0,Asia Pacific,Digital,Quality Assurance,Exceeds,Male,34,15,0,12,22,3.6,2.3,2.8,0.1452,1,1,1,1,2.9,2.0,2.8
2779,252,0,Asia Pacific,Commercial,Finance & Accounting,Meets,Male,28,3,0,8,17,2.5,2.1,1.3,0.0422,1,1,1,1,3.0,2.6,1.3
2780,260,0,Latin America,Commercial,Market Access,Exceeds,Female,44,20,0,7,16,4.7,4.0,1.7,0.0743,0,0,0,0,4.6,4.6,1.9
2781,1047,0,North America,Finance,Regulatory Affairs,Meets,Female,41,9,0,6,14,4.5,4.1,3.9,0.0331,1,0,0,0,4.8,3.0,2.2
2782,444,0,North America,Manufacturing,Quality Assurance,Meets,Female,28,23,0,12,18,2.4,2.6,2.5,0.0348,1,1,1,1,2.8,3.9,2.5
2783,147,0,Europe,R&D,Legal & Compliance,Exceeds,Male,34,15,0,6,18,2.1,4.1,1.5,0.1648,1,1,1,1,2.3,3.4,2.2
2784,857,0,North America,HR,Finance & Accounting,Below,Male,37,19,0,7,9,3.6,4.6,2.4,0.0,1,1,1,1,3.0,3.5,3.0
2785,576,0,Asia Pacific,Digital,Clinical Operations,Far Below,Male,38,12,1,6,42,0.0,3.7,2.2,0.0,0,0,0,0,5.0,1.9,3.1
2786,204,0,Asia Pacific,Commercial,Human Resources,Meets,Male,51,20,0,6,10,2.5,3.7,2.0,0.0422,1,1,1,1,3.0,4.3,2.4
2787,857,0,Asia Pacific,HR,Regulatory Affairs,Meets,Female,32,4,1,5,8,0.0,4.7,4.3,0.0383,1,1,1,1,3.4,1.9,1.4
2788,276,0,Europe,Commercial,Quality Assurance,Meets,Female,32,12,0,7,33,2.9,3.1,4.7,0.0422,1,1,1,1,3.8,3.7,4.3
2789,919,0,Asia Pacific,Finance,Supply Chain,Meets,Male,46,9,1,9,18,0.0,3.7,1.7,0.0331,1,1,0,0,3.7,2.7,3.3
2790,172,0,North America,R&D,Sales,Exceeds,Female,37,15,0,11,25,1.5,2.9,1.7,0.1648,1,1,1,1,1.9,2.7,2.4
2791,960,0,Latin America,Finance,Communications,Meets,Female,45,16,0,7,15,2.6,2.9,1.0,0.0331,0,0,0,0,2.9,4.3,2.7
2792,847,0,Latin America,HR,Finance & Accounting,Meets,Male,36,10,0,8,11,3.5,3.4,2.9,0.0383,0,0,0,0,3.5,2.9,4.0
2793,578,0,Middle East & Africa,Digital,Market Access,Meets,Male,45,5,1,5,16,0.0,2.0,4.3,0.0853,1,1,1,1,1.8,4.1,3.9
2794,209,0,North America,Commercial,Regulatory Affairs,Meets,Male,36,23,0,6,16,1.6,4.2,3.2,0.0422,1,1,1,1,2.2,4.5,2.5
2795,25,0,Asia Pacific,R&D,Pharmacovigilance,Meets,Female,37,8,1,9,11,0.0,3.8,3.7,0.0977,1,1,1,1,2.1,4.1,2.8
2796,948,0,Latin America,Finance,Sales,Exceeds,Male,32,6,1,11,20,0.0,2.2,3.6,0.0588,1,1,1,1,3.6,1.9,3.2
2797,800,0,North America,HR,Quality Assurance,Meets,Male,48,6,1,11,20,0.0,1.7,2.6,0.0383,1,1,1,1,3.8,3.8,2.7
2798,914,0,Latin America,Finance,Finance & Accounting,Meets,Female,33,16,0,8,19,3.2,2.7,3.2,0.0331,1,1,1,1,3.3,2.9,2.6
2799,316,0,Asia Pacific,Commercial,Medical Affairs,Exceeds,Male,30,12,1,6,16,0.0,3.4,2.6,0.0743,1,1,1,1,4.8,2.7,4.1
2800,217,0,Latin America,Commercial,Legal & Compliance,Exceeds,Male,48,12,0,6,12,4.5,2.7,2.4,0.0743,1,1,1,1,4.5,3.9,1.0
2801,557,0,Middle East & Africa,Digital,Pharmacovigilance,Below,Female,42,10,1,7,23,0.0,3.8,3.4,0.0,1,1,1,1,2.1,3.0,1.9
2802,139,0,Middle East & Africa,R&D,Market Access,Below,Female,48,22,1,11,16,0.0,1.7,3.6,0.0,1,1,1,1,3.5,2.1,1.1
2803,482,0,Latin America,Manufacturing,Supply Chain,Meets,Male,34,9,0,11,16,4.1,2.9,2.6,0.0348,1,1,1,1,3.8,3.9,2.8
2804,881,1,North America,Finance,Regulatory Affairs,Far Exceeds,Male,42,8,0,5,20,3.0,3.5,2.7,0.1022,1,1,1,1,4.5,1.4,3.7
2805,201,0,North America,Commercial,Data Science,Meets,Female,46,8,0,5,10,2.9,2.5,3.1,0.0422,1,1,1,1,3.5,2.9,3.6
2806,712,0,North America,HR,Legal & Compliance,Meets,Female,31,6,1,8,12,0.0,2.5,3.1,0.0383,1,1,1,1,3.9,3.0,3.0
2807,999,0,Latin America,Finance,Regulatory Affairs,Meets,Non-Binary/Other,40,24,0,10,18,3.7,4.1,2.1,0.0331,1,1,1,1,4.1,4.0,2.8
2808,694,0,North America,Digital,Sales,Meets,Male,35,36,0,11,38,4.3,3.4,1.4,0.0853,1,1,1,1,2.1,3.4,2.3
2809,529,1,Asia Pacific,Digital,Regulatory Affairs,Far Exceeds,Female,36,16,0,7,25,3.7,3.7,1.5,0.2363,1,1,1,1,3.2,4.5,2.2
2810,304,0,Middle East & Africa,Commercial,Sales,Meets,Male,33,9,0,7,17,3.1,4.2,2.4,0.0422,1,1,1,1,4.1,3.1,2.4
2811,353,0,Asia Pacific,Commercial,Finance & Accounting,Exceeds,Female,41,18,1,11,21,0.0,3.2,3.3,0.0743,1,1,1,1,3.4,2.2,3.2
2812,235,0,North America,Commercial,Pharmacovigilance,Meets,Male,37,14,1,7,11,0.0,3.3,2.7,0.0422,1,1,1,1,2.5,1.3,1.8
2813,373,0,Asia Pacific,Manufacturing,Regulatory Affairs,Exceeds,Male,32,1,0,12,16,1.6,4.0,2.0,0.0616,1,1,1,1,2.6,5.0,2.6
2814,179,0,North America,Commercial,Pharmacovigilance,Meets,Male,47,8,0,12,17,4.0,4.7,2.7,0.0422,0,0,0,0,4.8,4.9,1.9
2815,975,0,Latin America,Finance,Supply Chain,Meets,Male,38,10,0,7,11,2.3,3.8,1.4,0.0331,0,0,0,0,2.8,4.0,1.4
2816,966,0,Asia Pacific,Finance,Supply Chain,Far Exceeds,Male,29,10,1,10,11,0.0,4.9,2.1,0.1022,0,0,0,0,4.2,4.7,2.3
2817,65,0,Latin America,R&D,Legal & Compliance,Meets,Male,34,9,1,9,18,0.0,4.7,4.0,0.0977,1,1,1,1,2.6,4.3,3.4
2818,829,1,Latin America,HR,Sales,Meets,Male,29,5,0,9,23,3.5,1.5,4.1,0.0383,1,1,1,1,4.5,2.6,3.6
2819,298,0,Europe,Commercial,Quality Assurance,Below,Male,34,10,1,7,12,0.0,4.0,4.9,0.0,1,1,1,1,1.9,3.2,5.0
2820,984,0,North America,Finance,Supply Chain,Meets,Female,40,6,0,7,22,2.0,2.4,3.1,0.0331,1,1,1,1,1.0,2.3,2.5
2821,1048,0,Middle East & Africa,Finance,Marketing,Exceeds,Male,42,17,0,12,23,3.3,4.3,2.6,0.0588,1,1,1,1,4.8,5.0,1.9
2822,969,1,North America,Finance,Regulatory Affairs,Meets,Female,43,4,1,11,15,0.0,4.3,2.5,0.0331,1,1,1,1,3.7,5.0,3.0
2823,441,0,Middle East & Africa,Manufacturing,Marketing,Meets,Female,34,36,0,9,30,3.6,3.9,2.6,0.0348,1,1,1,1,5.0,1.7,2.4
2824,787,0,North America,HR,Legal & Compliance,Meets,Male,36,15,0,8,23,2.7,1.7,1.9,0.0383,1,1,1,1,3.4,2.9,2.4
2825,618,0,Latin America,Digital,Regulatory Affairs,Meets,Male,41,11,1,7,11,0.0,3.4,2.7,0.0853,1,1,1,1,3.1,4.4,3.6
2826,1023,0,Asia Pacific,Finance,Clinical Operations,Meets,Female,43,12,1,8,47,0.0,4.3,2.8,0.0331,1,1,1,1,2.3,3.2,1.0
2827,266,0,Asia Pacific,Commercial,Pharmacovigilance,Meets,Male,37,21,0,8,32,4.9,3.4,1.9,0.0422,1,1,1,1,4.4,2.5,1.9
2828,928,0,Europe,Finance,Finance & Accounting,Below,Male,42,6,0,11,20,3.7,3.3,2.5,0.0,1,1,1,1,5.0,2.9,3.5
2829,751,0,Middle East & Africa,HR,Sales,Exceeds,Male,35,13,1,9,18,0.0,2.5,2.5,0.0677,1,1,1,1,4.2,1.5,2.3
2830,595,0,Middle East & Africa,Digital,Market Access,Meets,Male,28,13,0,12,28,1.8,3.4,2.0,0.0853,1,1,1,1,4.1,3.1,3.0
2831,521,0,Middle East & Africa,Manufacturing,Market Access,Meets,Male,43,10,0,7,11,4.0,2.4,3.4,0.0348,1,1,1,1,4.5,4.5,2.2
2832,97,0,Latin America,R&D,Medical Affairs,Meets,Non-Binary/Other,41,12,0,5,28,2.8,3.6,1.2,0.0977,0,0,0,0,3.4,3.2,1.8
2833,235,0,Middle East & Africa,Commercial,IT & Digital,Meets,Female,37,11,0,8,21,3.1,2.8,1.3,0.0422,1,1,1,1,1.4,3.2,2.1
2834,163,0,Asia Pacific,R&D,Human Resources,Meets,Female,39,2,0,10,18,4.4,1.6,1.0,0.0977,1,1,1,1,2.7,3.4,2.8
2835,517,0,Latin America,Manufacturing,Quality Assurance,Meets,Male,45,9,0,11,23,2.9,1.7,1.2,0.0348,1,1,1,1,3.1,2.1,2.4
2836,794,0,North America,HR,Communications,Meets,Non-Binary/Other,38,22,0,9,20,3.8,3.1,5.0,0.0383,1,1,1,1,4.5,4.4,2.8
2837,717,0,Middle East & Africa,HR,Sales,Exceeds,Female,28,17,0,8,18,3.0,2.6,4.6,0.0677,1,1,1,1,3.2,4.0,3.5
2838,493,0,Middle East & Africa,Manufacturing,Legal & Compliance,Below,Female,28,9,1,10,20,0.0,3.8,2.2,0.0,1,1,1,1,3.6,3.8,2.0
2839,956,0,North America,Finance,Supply Chain,Meets,Female,46,9,1,10,23,0.0,3.2,2.3,0.0331,1,1,1,1,2.6,2.3,2.6
2840,500,0,Middle East & Africa,Manufacturing,Data Science,Far Exceeds,Male,42,6,1,9,18,0.0,4.5,2.2,0.1069,1,1,1,1,4.1,3.7,3.6
2841,244,0,North America,Commercial,Communications,Far Below,Female,45,31,0,6,12,3.4,4.8,2.1,0.0,1,1,1,1,3.1,5.0,4.0
2842,693,0,Latin America,Digital,Quality Assurance,Exceeds,Female,47,16,0,5,15,3.6,3.9,4.1,0.1452,1,1,1,1,3.2,3.6,4.6
2843,16,0,Asia Pacific,R&D,Quality Assurance,Meets,Non-Binary/Other,47,3,0,7,18,4.5,3.7,3.2,0.0977,1,1,1,1,4.3,3.0,2.7
2844,26,0,North America,R&D,Data Science,Below,Male,30,13,0,5,12,3.3,1.9,1.9,0.0,1,1,1,1,1.4,2.4,2.8
2845,735,0,Europe,HR,Pharmacovigilance,Far Below,Non-Binary/Other,37,6,1,12,16,0.0,3.0,2.7,0.0,1,1,1,1,1.5,4.6,3.1
2846,965,0,North America,Finance,Legal & Compliance,Below,Male,33,12,1,11,14,0.0,2.9,5.0,0.0,1,1,1,1,5.0,4.1,4.2
2847,753,0,Middle East & Africa,HR,Quality Assurance,Below,Male,39,4,0,11,17,3.5,3.3,2.9,0.0,1,1,1,1,3.5,2.8,4.1
2848,248,0,Latin America,Commercial,Clinical Operations,Far Below,Female,30,7,0,8,19,2.5,3.1,4.4,0.0,1,1,1,1,4.2,3.2,2.8
2849,388,0,Latin America,Manufacturing,Quality Assurance,Meets,Female,38,13,0,8,16,4.1,3.2,3.2,0.0348,1,1,1,1,3.0,3.9,3.1
2850,160,0,North America,R&D,IT & Digital,Far Below,Female,28,28,0,5,18,2.2,3.2,3.6,0.0,1,1,1,1,1.9,4.5,2.9
2851,207,0,Asia Pacific,Commercial,Human Resources,Meets,Male,36,15,0,10,19,1.4,3.3,1.6,0.0422,1,1,1,1,2.5,4.3,1.0
2852,863,0,Europe,HR,Communications,Exceeds,Male,47,11,0,11,25,4.2,4.2,3.9,0.0677,1,1,1,1,3.3,2.1,4.1
2853,801,0,Latin America,HR,Medical Affairs,Exceeds,Female,34,17,0,10,13,4.3,3.7,1.7,0.0677,1,1,1,1,4.0,2.0,1.7
2854,82,0,Middle East & Africa,R&D,Marketing,Meets,Male,34,33,0,10,11,4.3,2.6,4.2,0.0977,1,1,1,1,4.5,1.3,3.7
2855,745,0,Middle East & Africa,HR,Legal & Compliance,Exceeds,Female,39,20,0,12,19,2.9,1.9,2.6,0.0677,1,1,1,1,4.7,2.9,1.9
2856,942,0,Asia Pacific,Finance,Finance & Accounting,Far Below,Male,39,4,0,10,24,3.0,2.0,1.0,0.0,1,1,1,1,3.1,3.2,2.9
2857,840,0,Latin America,HR,Market Access,Below,Male,40,6,0,5,15,2.9,2.8,2.7,0.0,1,1,1,0,3.9,2.2,3.6
2858,534,1,North America,Digital,Pharmacovigilance,Meets,Non-Binary/Other,33,13,0,6,10,2.1,4.6,4.1,0.0853,1,1,1,1,3.4,4.6,3.2
2859,431,0,Middle East & Africa,Manufacturing,Sales,Meets,Male,34,26,0,5,14,3.0,3.5,2.2,0.0348,1,1,1,1,3.0,3.4,4.6
2860,781,0,Asia Pacific,HR,Supply Chain,Exceeds,Female,38,18,1,11,22,0.0,3.9,4.7,0.0677,1,0,0,0,2.7,3.2,3.2
2861,656,0,Latin America,Digital,Finance & Accounting,Meets,Male,44,20,0,5,8,2.3,2.2,2.9,0.0853,1,0,0,0,3.1,1.6,2.2
2862,352,0,Latin America,Commercial,Communications,Meets,Male,34,6,1,5,24,0.0,2.7,5.0,0.0422,1,1,1,1,3.5,2.6,3.8
2863,702,0,Latin America,HR,Clinical Operations,Meets,Female,37,13,0,5,18,2.7,3.6,2.4,0.0383,1,1,1,1,3.0,3.2,2.0
2864,928,0,Latin America,Finance,Pharmacovigilance,Below,Male,28,14,0,7,14,4.6,3.1,3.0,0.0,1,1,1,1,4.2,3.2,3.3
2865,273,0,Latin America,Commercial,Legal & Compliance,Meets,Female,35,3,1,9,20,0.0,4.0,2.7,0.0422,1,1,1,1,2.0,3.5,4.2
2866,733,1,Middle East & Africa,HR,Marketing,Meets,Female,39,7,1,6,8,0.0,2.7,2.9,0.0383,1,1,1,1,3.1,3.0,2.6
2867,28,0,Asia Pacific,R&D,Human Resources,Below,Female,43,11,1,7,15,0.0,3.8,2.5,0.0,0,0,0,0,3.6,3.8,3.5
2868,630,0,Latin America,Digital,Medical Affairs,Far Below,Female,33,10,0,11,19,3.9,1.5,2.3,0.0,1,1,1,1,3.7,1.7,3.6
2869,637,0,Europe,Digital,Marketing,Meets,Female,39,9,1,10,14,0.0,3.7,2.7,0.0853,1,1,1,1,4.9,4.1,3.5
2870,90,0,Europe,R&D,Sales,Meets,Female,40,4,0,5,25,2.7,5.0,2.5,0.0977,1,1,1,1,2.3,3.6,2.2
2871,473,0,Asia Pacific,Manufacturing,Data Science,Meets,Male,28,13,1,11,20,0.0,3.5,2.0,0.0348,1,1,1,1,3.5,1.8,4.2
2872,984,0,North America,Finance,Supply Chain,Meets,Female,30,22,0,10,29,3.0,4.2,2.7,0.0331,1,1,1,1,2.0,2.8,3.2
2873,589,0,North America,Digital,Data Science,Far Exceeds,Female,41,9,1,10,19,0.0,2.4,3.8,0.2363,1,1,1,1,3.7,2.1,2.9
2874,326,0,North America,Commercial,Finance & Accounting,Meets,Male,38,8,0,9,46,3.4,4.2,2.9,0.0422,1,1,1,1,4.5,4.0,3.6
2875,1022,0,Europe,Finance,Legal & Compliance,Below,Male,39,6,1,11,26,0.0,2.2,3.4,0.0,1,1,1,1,3.0,1.3,3.8
2876,658,0,North America,Digital,Communications,Meets,Male,32,6,0,6,11,2.2,3.6,2.5,0.0853,1,1,1,1,1.1,4.6,2.5
2877,376,0,Middle East & Africa,Manufacturing,Finance & Accounting,Meets,Male,29,12,0,12,24,4.1,4.3,4.0,0.0348,1,1,1,1,5.0,2.9,4.0
2878,311,0,Latin America,Commercial,Regulatory Affairs,Far Below,Male,41,10,0,12,17,2.6,2.0,2.5,0.0,1,1,1,0,3.8,1.3,3.5
2879,922,0,Europe,Finance,Legal & Compliance,Meets,Female,39,9,0,8,17,2.8,2.3,2.5,0.0331,0,0,0,0,3.6,1.6,1.1
2880,351,0,Asia Pacific,Commercial,Medical Affairs,Meets,Male,28,13,1,10,21,0.0,1.9,3.0,0.0422,1,1,1,1,4.4,2.4,2.1
2881,21,0,Asia Pacific,R&D,Supply Chain,Meets,Female,37,10,0,11,19,2.3,1.1,2.3,0.0977,1,1,1,1,3.2,3.0,3.5
2882,827,0,Latin America,HR,Sales,Meets,Female,49,19,0,10,26,3.9,4.7,3.9,0.0383,1,1,1,1,3.4,4.3,3.2
2883,104,0,Europe,R&D,Legal & Compliance,Meets,Male,42,17,0,7,16,3.5,4.0,1.8,0.0977,1,1,1,1,2.6,4.0,1.6
2884,888,0,North America,Finance,Pharmacovigilance,Exceeds,Male,33,7,1,7,11,0.0,2.2,4.0,0.0588,1,1,1,1,4.4,1.9,4.8
2885,781,0,North America,HR,Market Access,Exceeds,Male,39,21,1,7,24,0.0,2.8,2.4,0.0677,1,1,1,1,3.5,4.1,2.3
2886,168,0,Middle East & Africa,R&D,Communications,Meets,Female,37,12,0,9,15,2.9,1.2,3.0,0.0977,1,1,1,1,2.2,1.8,3.0
2887,841,0,Middle East & Africa,HR,Supply Chain,Meets,Female,48,8,0,6,16,2.5,2.3,1.0,0.0383,1,1,1,1,2.6,2.9,1.4
2888,585,0,North America,Digital,IT & Digital,Exceeds,Male,31,6,0,10,22,1.1,4.4,2.2,0.1452,0,0,0,0,2.1,5.0,3.0
2889,276,0,Asia Pacific,Commercial,Legal & Compliance,Exceeds,Male,46,20,0,7,18,2.6,1.1,3.7,0.0743,1,1,1,1,3.4,2.3,3.6
2890,848,0,Asia Pacific,HR,Pharmacovigilance,Exceeds,Male,31,9,0,6,17,3.1,1.7,4.1,0.0677,1,0,0,0,3.5,1.7,2.8
2891,641,0,Middle East & Africa,Digital,Legal & Compliance,Below,Female,40,8,1,9,11,0.0,3.3,4.0,0.0,1,1,1,1,3.7,5.0,4.8
2892,490,0,Latin America,Manufacturing,Pharmacovigilance,Far Below,Male,42,5,0,12,18,3.6,3.8,4.0,0.0,1,1,1,1,2.5,3.7,2.3
2893,175,0,North America,R&D,IT & Digital,Far Exceeds,Female,45,11,0,10,12,2.2,2.2,1.9,0.2644,1,1,1,1,3.6,2.8,2.6
2894,445,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Far Exceeds,Female,43,11,1,6,10,0.0,2.1,5.0,0.1069,1,1,1,1,3.4,1.3,3.2
2895,899,0,Middle East & Africa,Finance,Communications,Meets,Male,29,6,0,11,15,3.8,2.6,3.4,0.0331,1,1,1,1,3.9,2.1,3.3
2896,678,0,North America,Digital,Clinical Operations,Far Exceeds,Female,38,4,0,9,9,4.1,2.7,1.9,0.2363,1,1,1,1,4.8,3.5,1.6
2897,434,0,North America,Manufacturing,Human Resources,Meets,Male,41,1,0,9,11,4.6,1.0,2.5,0.0348,1,1,1,1,3.7,2.1,2.1
2898,520,0,Asia Pacific,Manufacturing,Medical Affairs,Meets,Male,45,2,0,5,16,2.8,3.0,1.7,0.0348,1,0,0,0,3.5,3.3,2.9
2899,598,0,Latin America,Digital,Medical Affairs,Meets,Male,31,15,0,8,12,2.2,1.8,4.0,0.0853,1,1,1,1,3.4,2.1,3.5
2900,321,0,Latin America,Commercial,Finance & Accounting,Meets,Male,32,7,0,9,12,4.0,2.4,3.5,0.0422,1,1,1,1,1.7,2.9,2.4
2901,751,0,North America,HR,Regulatory Affairs,Meets,Male,29,6,1,5,26,0.0,3.6,2.9,0.0383,0,0,0,0,2.8,4.4,2.7
2902,895,0,Europe,Finance,Data Science,Far Exceeds,Female,38,6,1,8,13,0.0,2.4,3.1,0.1022,1,1,1,1,3.8,1.6,3.7
2903,1012,0,Middle East & Africa,Finance,Data Science,Meets,Female,40,26,0,5,20,2.4,2.8,3.8,0.0331,0,0,0,0,2.9,1.9,3.6
2904,87,0,Middle East & Africa,R&D,Sales,Exceeds,Female,40,10,0,10,22,2.4,2.8,2.8,0.1648,1,1,1,1,1.6,3.1,2.1
2905,761,0,North America,HR,Clinical Operations,Exceeds,Male,36,6,0,9,22,3.0,1.7,1.1,0.0677,1,1,1,1,2.9,1.9,2.1
2906,23,0,Europe,R&D,Pharmacovigilance,Below,Non-Binary/Other,37,18,0,5,22,5.0,3.1,4.0,0.0,1,1,1,1,4.9,3.7,3.2
2907,1048,0,Asia Pacific,Finance,Quality Assurance,Below,Male,37,14,0,10,23,3.3,3.8,1.0,0.0,1,1,1,1,3.6,4.2,2.0
2908,720,0,North America,HR,Quality Assurance,Meets,Male,37,12,0,12,21,4.0,3.8,3.6,0.0383,1,1,1,1,3.1,4.3,3.5
2909,407,0,North America,Manufacturing,Data Science,Meets,Male,28,4,1,5,5,0.0,2.6,3.6,0.0348,1,1,1,1,2.7,2.7,2.7
2910,181,0,Middle East & Africa,Commercial,Regulatory Affairs,Meets,Female,32,11,1,5,26,0.0,2.3,2.5,0.0422,1,1,1,1,1.2,3.1,3.0
2911,364,0,North America,Manufacturing,Clinical Operations,Below,Male,41,13,0,6,16,3.9,3.3,2.2,0.0,1,1,0,0,3.0,3.1,3.6
2912,200,0,North America,Commercial,IT & Digital,Meets,Female,35,14,0,5,22,2.4,5.0,1.5,0.0422,1,1,1,1,2.4,4.3,1.9
2913,600,0,North America,Digital,Marketing,Below,Male,35,12,1,7,12,0.0,3.6,2.3,0.0,1,1,1,1,4.3,3.7,2.6
2914,11,0,Middle East & Africa,R&D,Finance & Accounting,Meets,Female,46,8,1,10,22,0.0,3.1,1.0,0.0977,1,1,1,0,4.5,3.2,2.6
2915,79,0,Asia Pacific,R&D,Market Access,Below,Female,44,14,0,10,26,4.6,2.8,2.6,0.0,1,1,1,1,4.7,2.7,3.4
2916,660,0,Asia Pacific,Digital,Clinical Operations,Far Exceeds,Female,34,19,0,6,21,4.1,2.5,3.6,0.2363,1,1,1,1,4.2,1.0,3.6
2917,813,0,North America,HR,Legal & Compliance,Meets,Female,47,7,1,6,24,0.0,1.1,1.0,0.0383,1,1,1,1,1.9,3.7,3.3
2918,545,1,Middle East & Africa,Digital,Human Resources,Exceeds,Female,37,6,1,6,14,0.0,3.1,2.5,0.1452,1,1,1,1,2.6,2.3,3.2
2919,1009,0,Asia Pacific,Finance,Sales,Far Exceeds,Male,43,10,0,9,18,3.7,2.2,3.8,0.1022,1,1,1,1,4.3,3.2,3.4
2920,559,1,Asia Pacific,Digital,Pharmacovigilance,Exceeds,Female,38,9,0,11,15,3.8,2.9,4.1,0.1452,1,1,1,1,2.5,1.7,3.5
2921,202,0,Asia Pacific,Commercial,Human Resources,Meets,Male,34,18,0,10,14,3.0,3.4,2.9,0.0422,1,1,1,1,3.3,4.5,2.7
2922,1042,0,Middle East & Africa,Finance,Pharmacovigilance,Meets,Non-Binary/Other,43,6,0,12,15,3.7,4.6,1.0,0.0331,1,1,1,1,2.6,4.6,1.8
2923,624,0,Middle East & Africa,Digital,Finance & Accounting,Below,Female,33,11,1,7,24,0.0,1.9,1.5,0.0,1,1,1,1,3.9,2.7,3.7
2924,124,0,North America,R&D,IT & Digital,Below,Male,37,18,0,12,17,3.6,2.3,1.5,0.0,0,0,0,0,3.6,1.6,3.0
2925,479,0,Latin America,Manufacturing,Communications,Exceeds,Female,38,13,0,12,23,2.3,4.1,3.6,0.0616,0,0,0,0,3.3,3.4,3.8
2926,178,0,Asia Pacific,Commercial,Medical Affairs,Far Below,Male,36,33,0,8,13,3.3,2.3,3.5,0.0,1,1,0,0,2.5,2.2,3.9
2927,272,0,Latin America,Commercial,Supply Chain,Far Exceeds,Male,30,19,0,12,23,4.1,2.8,2.1,0.1275,1,1,1,1,3.6,3.5,2.2
2928,711,0,Middle East & Africa,HR,Legal & Compliance,Meets,Female,41,6,1,11,18,0.0,2.0,3.2,0.0383,1,1,1,1,1.7,3.5,3.4
2929,428,0,Middle East & Africa,Manufacturing,Human Resources,Meets,Male,44,9,0,8,47,4.3,4.4,1.4,0.0348,1,1,1,1,4.1,2.4,3.3
2930,331,0,Middle East & Africa,Commercial,Supply Chain,Below,Female,39,17,0,9,16,4.0,3.4,2.3,0.0,1,1,1,1,4.5,2.8,1.6
2931,534,0,Latin America,Digital,Medical Affairs,Meets,Male,33,7,0,6,21,3.6,2.2,2.5,0.0853,1,1,1,1,4.7,1.0,3.6
2932,184,0,Middle East & Africa,Commercial,Sales,Meets,Female,51,16,0,7,21,3.7,4.3,2.7,0.0422,1,1,1,1,1.9,3.7,2.2
2933,258,0,North America,Commercial,Human Resources,Meets,Female,37,4,1,6,7,0.0,4.6,1.4,0.0422,1,1,1,1,4.2,3.3,2.5
2934,190,0,Middle East & Africa,Commercial,Pharmacovigilance,Meets,Female,37,6,1,12,35,0.0,1.8,3.1,0.0422,0,0,0,0,4.3,3.9,3.3
2935,712,0,Europe,HR,Supply Chain,Below,Male,28,5,0,6,25,3.1,4.1,1.0,0.0,1,1,1,1,1.3,3.7,1.0
2936,245,0,Latin America,Commercial,Supply Chain,Meets,Male,31,11,1,9,16,0.0,3.3,1.4,0.0422,1,1,1,1,2.8,1.9,1.8
2937,305,0,Europe,Commercial,Market Access,Meets,Female,45,13,0,7,14,3.1,1.6,1.9,0.0422,1,1,1,1,2.5,2.0,1.1
2938,833,0,Middle East & Africa,HR,Supply Chain,Far Below,Female,55,13,0,5,8,3.6,3.0,3.6,0.0,1,1,1,1,3.2,3.0,4.9
2939,882,0,North America,Finance,Communications,Far Below,Male,46,10,0,12,25,3.6,3.3,3.2,0.0,1,1,1,1,4.5,3.8,3.5
2940,404,0,Asia Pacific,Manufacturing,Pharmacovigilance,Meets,Female,32,16,0,8,26,3.3,1.4,1.7,0.0348,1,1,1,1,2.1,2.5,2.4
2941,934,0,Middle East & Africa,Finance,Sales,Meets,Non-Binary/Other,41,8,1,11,20,0.0,5.0,2.9,0.0331,1,1,1,1,2.6,4.0,3.9
2942,19,0,North America,R&D,Marketing,Meets,Female,36,15,0,8,17,3.9,2.5,3.7,0.0977,1,1,1,1,3.0,2.9,4.7
2943,870,0,Latin America,HR,Data Science,Meets,Female,36,21,0,8,19,2.4,3.5,4.7,0.0383,1,1,1,1,4.7,2.4,4.0
2944,724,0,Europe,HR,Clinical Operations,Meets,Female,30,12,1,6,10,0.0,3.0,3.3,0.0383,1,1,1,1,3.1,3.4,3.2
2945,307,0,Europe,Commercial,Human Resources,Meets,Male,41,25,0,11,17,2.8,2.8,3.3,0.0422,0,0,0,0,3.0,3.4,2.2
2946,194,0,Europe,Commercial,IT & Digital,Meets,Female,30,9,0,5,9,3.6,2.5,1.6,0.0422,1,1,1,1,2.6,3.5,2.4
2947,69,0,Latin America,R&D,Regulatory Affairs,Meets,Female,28,14,0,5,9,3.1,3.2,3.0,0.0977,1,1,1,1,3.2,4.9,1.0
2948,341,0,North America,Commercial,Quality Assurance,Meets,Male,36,18,0,6,19,3.3,2.1,2.8,0.0422,1,0,0,0,3.1,1.4,3.2
2949,620,0,Latin America,Digital,Finance & Accounting,Below,Male,28,13,0,10,18,4.3,3.1,2.2,0.0,1,1,1,1,3.6,3.3,2.2
2950,231,0,Europe,Commercial,Clinical Operations,Meets,Male,33,15,1,6,11,0.0,1.6,1.2,0.0422,1,1,1,1,2.4,3.0,1.5
2951,241,0,Middle East & Africa,Commercial,Market Access,Meets,Female,42,15,0,7,28,3.6,4.0,1.8,0.0422,1,1,1,1,4.0,3.9,1.6
2952,632,1,Asia Pacific,Digital,Supply Chain,Meets,Female,45,9,1,8,16,0.0,2.5,1.9,0.0853,1,1,1,1,5.0,2.5,3.3
2953,16,0,Latin America,R&D,Sales,Exceeds,Female,42,9,0,8,25,4.0,2.9,3.7,0.1648,1,1,1,1,2.1,2.9,2.9
2954,563,0,Latin America,Digital,Finance & Accounting,Meets,Female,37,18,0,5,12,3.7,3.6,2.3,0.0853,1,1,0,0,2.9,3.8,2.9
2955,760,0,North America,HR,Marketing,Meets,Male,35,17,0,10,20,5.0,4.4,2.1,0.0383,1,1,1,1,4.7,5.0,2.2
2956,674,0,North America,Digital,Quality Assurance,Exceeds,Female,32,8,0,8,24,3.4,4.8,1.0,0.1452,1,1,1,1,3.9,3.9,2.0
2957,362,0,Latin America,Manufacturing,Medical Affairs,Meets,Female,47,12,0,11,19,4.2,4.0,3.0,0.0348,1,1,1,1,3.9,4.8,3.6
2958,702,0,Europe,HR,Marketing,Exceeds,Male,30,7,1,8,10,0.0,1.9,3.6,0.0677,1,1,1,1,5.0,2.7,2.7
2959,319,0,Asia Pacific,Commercial,Legal & Compliance,Below,Female,39,19,0,7,12,2.8,4.4,1.0,0.0,1,1,1,1,2.4,4.6,1.7
2960,739,0,North America,HR,Human Resources,Exceeds,Male,42,6,0,6,8,4.7,2.2,2.3,0.0677,0,0,0,0,4.1,3.1,2.7
2961,136,0,Europe,R&D,Data Science,Below,Male,28,9,1,6,10,0.0,2.1,2.9,0.0,1,1,1,1,3.8,3.1,2.4
2962,153,0,Middle East & Africa,R&D,Supply Chain,Meets,Male,28,18,0,9,14,4.8,2.7,4.3,0.0977,1,1,1,0,5.0,3.8,3.1
2963,569,0,North America,Digital,Regulatory Affairs,Meets,Female,42,12,0,5,10,3.5,3.5,2.0,0.0853,1,0,0,0,3.3,2.0,3.1
2964,743,0,Europe,HR,IT & Digital,Exceeds,Female,29,16,0,9,12,4.0,5.0,3.9,0.0677,1,1,1,1,2.9,4.6,3.6
2965,311,0,Europe,Commercial,Quality Assurance,Meets,Female,40,23,0,12,13,2.1,2.9,1.9,0.0422,0,0,0,0,2.4,1.5,2.4
2966,61,0,Asia Pacific,R&D,Finance & Accounting,Meets,Female,33,11,0,7,13,2.3,5.0,3.9,0.0977,1,1,1,1,3.1,5.0,3.3
2967,1024,0,Asia Pacific,Finance,Supply Chain,Meets,Male,40,4,0,11,18,3.8,3.9,2.0,0.0331,1,1,1,1,3.3,4.2,1.0
2968,239,0,Middle East & Africa,Commercial,IT & Digital,Below,Male,40,4,0,11,21,3.9,2.7,2.7,0.0,1,1,1,1,2.1,3.3,4.0
2969,970,0,Europe,Finance,IT & Digital,Meets,Male,44,4,1,6,10,0.0,4.0,3.3,0.0331,1,1,1,1,3.0,3.7,3.9
2970,362,0,Europe,Manufacturing,Quality Assurance,Meets,Male,41,21,0,7,16,3.9,2.1,1.0,0.0348,1,1,1,1,4.6,1.9,1.0
2971,917,0,Asia Pacific,Finance,Regulatory Affairs,Meets,Female,39,10,0,11,14,3.7,2.7,1.0,0.0331,1,1,1,1,3.9,1.3,1.7
2972,105,0,North America,R&D,Data Science,Meets,Female,48,8,0,11,26,3.8,2.4,3.6,0.0977,0,0,0,0,2.7,4.8,2.8
2973,568,0,North America,Digital,IT & Digital,Exceeds,Male,32,22,0,12,22,4.2,3.7,3.8,0.1452,1,1,1,1,3.5,4.4,4.5
2974,381,0,Latin America,Manufacturing,Medical Affairs,Meets,Male,38,7,1,6,7,0.0,4.2,4.1,0.0348,1,1,1,1,3.2,2.0,3.3
2975,799,1,Asia Pacific,HR,IT & Digital,Far Exceeds,Female,43,36,0,9,11,4.0,3.2,3.5,0.1168,1,1,1,1,3.8,3.3,4.1
2976,291,0,Latin America,Commercial,Pharmacovigilance,Below,Female,28,23,0,10,30,3.7,2.8,3.2,0.0,1,1,1,1,2.6,3.7,4.3
2977,112,0,Asia Pacific,R&D,IT & Digital,Far Below,Female,47,7,1,9,22,0.0,2.9,2.5,0.0,1,1,1,1,2.3,2.1,2.2
2978,471,0,Middle East & Africa,Manufacturing,IT & Digital,Exceeds,Male,37,6,0,12,25,2.3,1.4,2.5,0.0616,1,1,1,1,4.7,1.2,3.7
2979,448,1,Europe,Manufacturing,Sales,Exceeds,Female,41,17,0,5,16,2.9,2.7,3.0,0.0616,1,1,1,1,4.7,3.5,2.2
2980,45,0,Middle East & Africa,R&D,Marketing,Below,Male,35,10,0,12,19,3.0,3.2,1.0,0.0,1,1,1,1,3.6,3.2,1.4
2981,776,0,Asia Pacific,HR,Clinical Operations,Meets,Female,41,16,1,9,23,0.0,5.0,2.9,0.0383,1,1,1,1,3.0,4.6,4.0
2982,826,0,Europe,HR,Medical Affairs,Exceeds,Male,40,5,0,12,17,3.4,2.0,2.9,0.0677,1,1,1,1,2.6,2.9,3.2
2983,687,0,North America,Digital,Legal & Compliance,Below,Male,31,11,0,5,26,4.3,3.4,2.8,0.0,1,0,0,0,5.0,2.8,2.3
2984,892,0,North America,Finance,Medical Affairs,Meets,Female,35,26,0,7,8,3.6,1.8,1.0,0.0331,1,1,1,1,3.3,4.2,2.7
2985,798,0,Latin America,HR,Market Access,Meets,Male,41,9,0,8,25,2.4,3.5,3.1,0.0383,0,0,0,0,2.0,3.9,3.6
2986,672,1,Asia Pacific,Digital,Quality Assurance,Far Exceeds,Female,47,14,0,5,21,3.6,3.4,1.8,0.2363,1,1,1,1,4.1,3.1,1.8
2987,994,0,Asia Pacific,Finance,Quality Assurance,Meets,Male,36,19,0,9,18,3.0,4.2,3.1,0.0331,1,1,1,1,4.6,2.9,2.3
2988,433,0,North America,Manufacturing,Market Access,Meets,Male,30,8,0,8,14,3.0,3.2,4.3,0.0348,1,1,1,1,1.8,3.8,4.6
2989,6,0,Middle East & Africa,R&D,Marketing,Meets,Female,40,13,1,7,9,0.0,3.2,2.8,0.0977,0,0,0,0,2.1,3.4,2.6
2990,723,0,Europe,HR,Quality Assurance,Meets,Male,36,3,0,9,18,3.5,3.5,2.0,0.0383,0,0,0,0,2.0,2.7,3.9
2991,646,0,Middle East & Africa,Digital,Pharmacovigilance,Below,Male,43,3,1,7,11,0.0,2.9,1.2,0.0,1,0,0,0,2.9,4.6,1.1
2992,447,0,Middle East & Africa,Manufacturing,Sales,Far Exceeds,Male,34,14,0,10,20,2.8,3.3,3.0,0.1069,1,1,1,1,3.7,3.2,3.7
2993,774,0,North America,HR,Clinical Operations,Meets,Female,30,13,0,12,23,3.6,3.1,2.8,0.0383,1,1,1,1,2.7,3.3,1.2
2994,304,0,North America,Commercial,Clinical Operations,Meets,Female,47,13,0,9,27,3.2,2.2,2.4,0.0422,1,1,1,1,3.7,3.0,2.6
2995,473,0,North America,Manufacturing,Regulatory Affairs,Exceeds,Female,35,2,0,10,16,3.0,3.7,2.3,0.0616,1,1,0,0,3.8,3.0,2.3
2996,739,0,Latin America,HR,Regulatory Affairs,Far Below,Female,33,8,0,5,9,3.4,4.7,2.5,0.0,1,1,1,1,2.8,4.0,2.8
2997,507,0,Middle East & Africa,Manufacturing,Sales,Far Exceeds,Female,34,8,0,8,12,3.2,2.1,2.2,0.1069,1,1,1,1,4.2,3.3,1.5
2998,72,0,Asia Pacific,R&D,Supply Chain,Meets,Female,46,15,0,10,28,2.9,3.4,1.8,0.0977,1,1,1,1,2.8,1.9,1.5
2999,122,0,Europe,R&D,Supply Chain,Meets,Female,52,14,0,11,15,4.2,4.4,2.1,0.0977,0,0,0,0,4.3,3.6,3.3
3000,161,0,Latin America,R&D,Communications,Below,Male,33,10,0,9,12,4.2,3.0,3.5,0.0,1,1,1,1,3.1,2.4,1.9
3001,979,0,Asia Pacific,Finance,Medical Affairs,Exceeds,Female,37,5,1,9,21,0.0,4.7,1.4,0.0588,1,1,0,0,3.7,3.6,2.5
3002,270,0,Middle East & Africa,Commercial,Finance & Accounting,Exceeds,Female,40,17,0,9,12,3.6,4.0,3.2,0.0743,1,1,1,1,2.4,4.8,4.0
3003,143,0,North America,R&D,Medical Affairs,Far Below,Female,28,15,0,5,9,3.0,2.1,2.9,0.0,1,1,1,1,4.5,2.4,3.7
3004,229,0,Middle East & Africa,Commercial,Legal & Compliance,Below,Male,35,6,0,6,17,3.1,2.6,2.5,0.0,1,1,1,1,2.1,1.1,2.0
3005,34,0,Europe,R&D,Legal & Compliance,Exceeds,Female,49,13,0,9,25,2.8,4.0,2.6,0.1648,1,1,1,1,3.6,3.1,1.8
3006,905,0,Latin America,Finance,Human Resources,Below,Female,36,18,0,8,14,2.4,1.3,2.7,0.0,1,1,1,1,3.3,2.3,1.9
3007,435,0,Latin America,Manufacturing,Communications,Meets,Male,46,11,0,12,28,3.3,2.3,2.0,0.0348,1,1,1,1,4.7,1.3,1.7
3008,792,0,Europe,HR,Market Access,Meets,Non-Binary/Other,38,9,1,8,23,0.0,3.5,1.4,0.0383,1,1,1,1,3.8,2.7,2.3
3009,861,0,Asia Pacific,HR,Data Science,Exceeds,Female,28,11,1,9,27,0.0,2.6,3.4,0.0677,1,1,1,1,4.0,3.1,3.7
3010,19,0,Asia Pacific,R&D,Human Resources,Meets,Male,44,11,0,12,13,4.4,1.9,1.7,0.0977,0,0,0,0,3.2,1.9,1.8
3011,703,0,Latin America,HR,Regulatory Affairs,Meets,Female,36,20,0,8,10,3.6,3.1,3.3,0.0383,1,1,1,1,3.2,3.2,3.4
3012,56,0,Latin America,R&D,Data Science,Far Exceeds,Female,47,28,0,11,17,3.6,4.3,3.4,0.2644,1,1,1,1,5.0,3.7,3.9
3013,79,0,North America,R&D,Quality Assurance,Meets,Female,39,36,0,10,13,4.7,2.3,1.6,0.0977,1,1,1,0,3.7,1.0,2.9
3014,672,0,Asia Pacific,Digital,Communications,Meets,Female,38,22,0,11,17,3.7,2.5,3.5,0.0853,1,1,1,1,4.7,2.3,2.3
3015,576,0,Europe,Digital,Clinical Operations,Below,Male,41,1,0,9,19,5.0,2.9,1.0,0.0,1,1,1,1,4.0,3.0,2.4
3016,694,0,Asia Pacific,Digital,Medical Affairs,Far Exceeds,Male,40,26,0,12,19,3.0,4.9,3.7,0.2363,1,1,1,0,2.6,3.1,2.8
3017,294,0,North America,Commercial,Supply Chain,Meets,Male,28,9,0,10,18,3.3,2.1,2.2,0.0422,1,1,1,1,2.2,1.5,3.9
3018,669,0,Latin America,Digital,Sales,Far Below,Male,44,27,0,7,27,4.2,2.1,3.5,0.0,1,1,1,1,3.8,4.2,2.9
3019,99,1,Latin America,R&D,Regulatory Affairs,Meets,Female,38,5,1,10,20,0.0,3.5,3.1,0.0977,1,1,1,1,3.2,3.3,4.0
3020,1033,0,North America,Finance,Clinical Operations,Meets,Male,38,2,0,9,14,3.5,4.6,3.3,0.0331,0,0,0,0,3.2,3.9,2.6
3021,924,0,Europe,Finance,Marketing,Far Exceeds,Male,41,12,0,9,21,5.0,2.4,1.5,0.1022,1,1,1,1,4.0,2.4,1.0
3022,421,0,Latin America,Manufacturing,Finance & Accounting,Meets,Female,43,3,0,9,14,2.5,4.9,5.0,0.0348,1,1,1,1,4.1,3.3,3.5
3023,658,0,Middle East & Africa,Digital,Finance & Accounting,Meets,Male,44,8,1,6,17,0.0,1.6,3.6,0.0853,1,1,1,1,2.2,3.6,2.8
3024,964,0,Latin America,Finance,Sales,Meets,Male,42,18,0,6,22,3.2,1.8,3.7,0.0331,1,1,1,1,3.1,3.2,5.0
3025,529,0,Middle East & Africa,Digital,Data Science,Far Below,Female,28,4,1,11,18,0.0,2.4,3.7,0.0,1,1,1,1,4.4,1.0,2.1
3026,473,0,North America,Manufacturing,Human Resources,Exceeds,Male,38,5,0,9,16,2.7,3.1,3.1,0.0616,0,0,0,0,4.2,1.1,4.4
3027,909,0,North America,Finance,Human Resources,Below,Female,32,21,0,8,17,2.7,2.8,3.0,0.0,1,1,1,1,3.3,3.1,3.0
3028,151,0,Latin America,R&D,Communications,Meets,Female,39,12,0,6,8,2.5,2.3,3.5,0.0977,0,0,0,0,1.8,2.6,3.0
3029,197,0,Asia Pacific,Commercial,Human Resources,Meets,Female,37,5,0,12,31,3.5,1.0,2.5,0.0422,1,1,1,1,3.9,2.4,1.3
3030,670,0,Middle East & Africa,Digital,Pharmacovigilance,Meets,Male,50,21,0,9,15,3.0,3.1,1.9,0.0853,1,1,1,0,2.3,2.4,1.4
3031,936,0,Europe,Finance,Data Science,Below,Male,30,11,1,7,14,0.0,2.9,3.7,0.0,1,1,1,1,4.2,3.1,2.8
3032,898,0,Latin America,Finance,Regulatory Affairs,Far Exceeds,Female,38,19,0,8,15,3.6,3.1,2.3,0.1022,1,1,1,1,3.9,3.3,1.8
3033,489,0,Europe,Manufacturing,Sales,Meets,Male,39,3,0,8,22,3.9,2.1,2.3,0.0348,1,1,1,1,3.8,2.8,1.7
3034,28,0,Latin America,R&D,Pharmacovigilance,Meets,Male,35,24,0,5,29,1.6,2.8,1.0,0.0977,1,1,1,1,3.2,2.8,1.1
3035,704,0,Asia Pacific,HR,Quality Assurance,Meets,Male,38,26,0,9,24,4.1,3.0,3.3,0.0383,1,1,1,1,2.9,3.3,3.6
3036,933,1,Asia Pacific,Finance,Marketing,Exceeds,Female,51,7,0,10,22,2.3,2.6,2.6,0.0588,1,1,1,1,1.7,3.5,2.4
3037,262,0,Asia Pacific,Commercial,Data Science,Meets,Female,40,21,0,8,21,3.0,2.4,3.2,0.0422,1,1,1,1,4.1,3.3,2.9
3038,366,0,Asia Pacific,Manufacturing,Marketing,Meets,Non-Binary/Other,47,7,0,6,24,3.0,3.6,2.7,0.0348,0,0,0,0,3.6,4.3,1.6
3039,1044,0,North America,Finance,Sales,Exceeds,Female,35,3,1,9,30,0.0,1.8,3.6,0.0588,1,1,1,1,5.0,2.7,4.7
3040,1041,0,North America,Finance,Clinical Operations,Below,Male,43,3,1,7,13,0.0,3.0,3.0,0.0,1,1,1,1,3.0,3.2,3.5
3041,424,0,Middle East & Africa,Manufacturing,Sales,Far Below,Female,33,16,0,10,20,4.0,2.6,3.6,0.0,0,0,0,0,2.8,2.4,2.3
3042,362,0,Europe,Manufacturing,Legal & Compliance,Exceeds,Female,33,36,0,8,21,2.6,2.5,3.4,0.0616,1,1,1,1,1.9,3.5,3.8
3043,589,0,Latin America,Digital,Supply Chain,Meets,Female,28,13,0,10,13,4.2,3.9,3.0,0.0853,1,1,1,1,3.5,4.0,2.0
3044,919,0,Latin America,Finance,Pharmacovigilance,Below,Female,32,13,0,10,14,3.2,3.8,2.2,0.0,1,1,1,1,3.7,3.3,2.8
3045,821,0,North America,HR,IT & Digital,Meets,Non-Binary/Other,38,4,0,7,13,3.5,3.3,3.9,0.0383,1,1,1,1,4.3,2.7,3.4
3046,232,0,Latin America,Commercial,Communications,Below,Female,47,10,0,11,21,4.2,3.6,2.0,0.0,1,1,1,1,4.6,3.6,3.6
3047,142,0,North America,R&D,Clinical Operations,Far Below,Female,37,4,1,8,26,0.0,3.5,2.2,0.0,0,0,0,0,4.2,2.8,1.7
3048,7,0,Middle East & Africa,R&D,Data Science,Below,Female,39,15,0,7,11,5.0,2.3,2.1,0.0,1,1,1,1,4.5,3.3,1.0
3049,732,0,Europe,HR,Quality Assurance,Meets,Non-Binary/Other,45,11,0,9,20,3.1,3.0,4.0,0.0383,0,0,0,0,3.0,3.0,2.7
3050,487,0,Middle East & Africa,Manufacturing,Marketing,Meets,Female,36,13,0,7,21,3.5,2.3,1.7,0.0348,1,1,1,1,3.4,3.0,2.1
3051,442,0,Asia Pacific,Manufacturing,Finance & Accounting,Meets,Female,32,10,0,11,18,4.7,3.1,2.6,0.0348,1,1,1,1,5.0,1.5,2.7
3052,392,0,Asia Pacific,Manufacturing,Sales,Meets,Female,33,7,1,11,26,0.0,1.0,2.4,0.0348,1,1,0,0,3.3,1.9,3.2
3053,981,0,Asia Pacific,Finance,Finance & Accounting,Meets,Female,45,14,0,11,16,4.1,1.0,1.9,0.0331,1,1,1,1,4.7,1.4,1.4
3054,502,0,Middle East & Africa,Manufacturing,Market Access,Meets,Male,39,14,1,10,17,0.0,3.3,1.7,0.0348,1,1,1,1,3.9,3.6,1.5
3055,414,0,Latin America,Manufacturing,Regulatory Affairs,Meets,Male,39,9,1,6,11,0.0,4.4,3.6,0.0348,1,1,1,1,3.4,3.3,3.7
3056,916,0,Europe,Finance,Data Science,Exceeds,Male,33,14,0,5,14,2.8,3.0,3.4,0.0588,1,1,1,1,3.2,1.9,4.2
3057,894,0,Asia Pacific,Finance,IT & Digital,Meets,Male,46,1,1,5,20,0.0,2.2,2.6,0.0331,1,1,1,1,4.2,2.0,3.3
3058,767,1,Asia Pacific,HR,Regulatory Affairs,Meets,Female,49,13,0,11,21,2.7,2.6,2.5,0.0383,1,1,1,1,3.1,2.7,1.6
3059,632,0,Asia Pacific,Digital,Clinical Operations,Far Exceeds,Female,39,23,0,11,17,3.4,3.4,2.2,0.2363,0,0,0,0,2.8,4.2,3.0
3060,954,0,Europe,Finance,Supply Chain,Meets,Female,44,13,0,10,17,2.0,4.7,1.4,0.0331,1,1,1,1,1.0,5.0,2.3
3061,319,1,Asia Pacific,Commercial,Legal & Compliance,Meets,Non-Binary/Other,34,12,0,12,19,3.4,1.0,3.2,0.0422,1,1,1,1,2.3,1.6,4.9
3062,460,0,Europe,Manufacturing,Data Science,Meets,Male,46,18,1,11,16,0.0,3.8,1.9,0.0348,1,1,1,1,3.0,5.0,2.2
3063,561,0,Asia Pacific,Digital,Supply Chain,Meets,Female,41,2,1,6,14,0.0,2.5,1.0,0.0853,1,1,1,0,2.7,3.5,1.7
3064,156,0,Middle East & Africa,R&D,IT & Digital,Meets,Male,31,5,0,9,23,3.4,3.1,1.6,0.0977,1,1,1,1,5.0,3.2,2.7
3065,810,0,Middle East & Africa,HR,Supply Chain,Meets,Female,41,2,1,7,25,0.0,1.0,3.4,0.0383,0,0,0,0,3.0,1.9,2.4
3066,614,0,Europe,Digital,Quality Assurance,Meets,Female,41,13,0,7,15,3.0,2.4,3.1,0.0853,1,1,1,1,4.3,3.7,2.3
3067,978,0,Middle East & Africa,Finance,Clinical Operations,Far Below,Female,39,14,0,12,17,2.5,2.9,2.6,0.0,1,1,1,1,3.6,4.5,1.3
3068,359,0,Europe,Manufacturing,Sales,Far Exceeds,Female,41,8,0,6,13,2.4,3.4,3.6,0.1069,1,1,1,1,3.8,3.2,2.8
3069,392,0,Middle East & Africa,Manufacturing,Market Access,Meets,Male,38,3,0,5,6,4.6,1.4,1.8,0.0348,1,1,1,1,4.7,1.7,2.6
3070,402,0,Middle East & Africa,Manufacturing,Pharmacovigilance,Below,Male,37,1,0,5,12,3.9,3.8,3.1,0.0,1,1,1,1,2.7,4.1,3.9
3071,590,0,Europe,Digital,IT & Digital,Meets,Male,39,15,1,9,12,0.0,3.8,3.5,0.0853,1,1,1,1,3.0,2.3,3.3
3072,358,0,Latin America,Manufacturing,Human Resources,Meets,Male,36,4,1,7,21,0.0,4.3,1.5,0.0348,1,0,0,0,3.9,4.0,1.8
3073,1012,0,Middle East & Africa,Finance,Supply Chain,Below,Female,34,10,0,11,13,2.4,3.1,1.9,0.0,1,1,1,0,2.9,1.2,3.3
3074,542,0,Asia Pacific,Digital,Clinical Operations,Far Below,Female,45,7,0,10,28,3.2,2.6,4.8,0.0,0,0,0,0,3.1,2.7,3.7
3075,470,0,Latin America,Manufacturing,Quality Assurance,Meets,Female,35,8,1,6,15,0.0,5.0,2.0,0.0348,1,1,1,1,3.7,5.0,1.0
3076,17,0,Europe,R&D,Data Science,Meets,Female,37,21,0,7,9,3.7,1.7,2.5,0.0977,1,1,1,1,4.5,3.3,4.4
3077,156,0,Latin America,R&D,Finance & Accounting,Meets,Male,35,16,0,6,12,4.1,3.1,2.5,0.0977,1,1,1,1,2.8,3.6,3.6
3078,214,0,North America,Commercial,Medical Affairs,Below,Male,33,30,0,5,17,2.3,3.1,2.8,0.0,1,1,1,1,1.7,3.0,3.1
3079,521,0,North America,Manufacturing,Medical Affairs,Meets,Female,47,11,1,10,17,0.0,4.3,2.2,0.0348,1,1,1,1,3.7,2.5,1.6
3080,451,0,Middle East & Africa,Manufacturing,Communications,Meets,Male,29,9,0,9,19,3.5,2.7,2.0,0.0348,1,1,1,1,3.5,4.1,2.1
3081,638,0,Middle East & Africa,Digital,Market Access,Meets,Female,40,18,0,10,13,1.4,2.8,5.0,0.0853,0,0,0,0,2.5,4.5,3.9
3082,695,0,Asia Pacific,Digital,Legal & Compliance,Meets,Female,37,10,0,9,16,2.8,5.0,2.1,0.0853,1,1,1,0,5.0,2.7,2.9
3083,487,0,Latin America,Manufacturing,IT & Digital,Below,Female,41,21,0,5,17,2.6,4.3,3.0,0.0,1,0,0,0,3.5,3.2,1.4
3084,346,0,North America,Commercial,Quality Assurance,Meets,Female,37,10,0,5,25,4.4,3.4,2.2,0.0422,0,0,0,0,3.8,3.3,2.1
3085,415,0,Middle East & Africa,Manufacturing,Clinical Operations,Far Exceeds,Female,41,15,0,12,21,4.0,2.6,2.8,0.1069,1,1,0,0,4.0,2.3,3.5
3086,969,0,Latin America,Finance,Quality Assurance,Meets,Female,40,10,0,12,24,3.7,3.7,4.0,0.0331,1,1,1,1,3.6,4.2,3.5
3087,561,0,Middle East & Africa,Digital,Pharmacovigilance,Meets,Female,42,13,0,7,22,3.3,4.2,2.3,0.0853,1,1,1,1,3.9,3.6,2.3
3088,412,0,Middle East & Africa,Manufacturing,Pharmacovigilance,Meets,Female,48,4,0,8,20,3.8,2.3,1.8,0.0348,1,1,1,1,3.7,3.4,2.2
3089,686,0,North America,Digital,Sales,Meets,Male,28,26,0,9,19,3.1,1.9,2.8,0.0853,1,1,1,1,2.3,2.0,1.9
3090,495,0,North America,Manufacturing,Medical Affairs,Exceeds,Female,38,13,0,9,36,4.1,3.6,5.0,0.0616,1,1,1,1,3.4,3.9,3.8
3091,764,0,Middle East & Africa,HR,Medical Affairs,Meets,Male,32,5,1,8,10,0.0,3.9,1.0,0.0383,1,1,1,1,3.9,3.0,1.0
3092,633,0,Europe,Digital,Pharmacovigilance,Exceeds,Female,34,36,0,8,19,2.4,3.9,4.4,0.1452,1,1,1,1,3.3,3.2,3.9
3093,228,0,Middle East & Africa,Commercial,Communications,Below,Male,32,13,0,8,9,3.2,2.8,1.5,0.0,0,0,0,0,4.5,2.7,2.3
3094,801,0,Middle East & Africa,HR,Quality Assurance,Exceeds,Male,36,4,1,5,7,0.0,3.1,1.9,0.0677,1,1,1,1,1.7,4.0,2.4
3095,1006,0,Asia Pacific,Finance,Market Access,Below,Male,45,11,0,5,5,4.3,3.5,2.7,0.0,1,1,1,1,4.5,3.8,1.4
3096,496,0,Asia Pacific,Manufacturing,Communications,Far Below,Male,36,14,0,10,11,2.6,3.5,2.8,0.0,1,1,1,1,2.2,3.5,2.3
3097,966,0,Asia Pacific,Finance,Market Access,Below,Male,40,8,0,8,14,3.3,2.9,4.1,0.0,1,1,1,1,4.5,2.9,3.1
3098,594,0,Europe,Digital,IT & Digital,Below,Male,43,7,0,6,16,3.4,2.3,1.1,0.0,1,1,1,1,2.7,3.8,1.9
3099,716,0,Europe,HR,Supply Chain,Meets,Female,33,22,0,9,18,2.7,2.7,3.8,0.0383,1,1,1,1,3.0,2.8,3.3
3100,949,0,Middle East & Africa,Finance,IT & Digital,Meets,Female,33,8,0,8,21,3.8,4.7,3.0,0.0331,1,1,1,1,4.1,3.9,3.0
3101,295,0,Asia Pacific,Commercial,Data Science,Meets,Female,38,12,0,7,21,2.4,3.7,3.3,0.0422,1,1,1,1,4.0,4.0,2.8
3102,528,0,Europe,Digital,Medical Affairs,Below,Female,28,5,0,9,16,3.2,3.3,2.7,0.0,1,1,1,1,4.0,2.2,3.0
3103,698,0,North America,HR,Communications,Meets,Female,50,28,0,6,12,3.6,2.4,1.0,0.0383,1,1,1,1,2.8,2.9,3.4
3104,937,0,Middle East & Africa,Finance,Pharmacovigilance,Meets,Female,38,8,1,8,23,0.0,2.2,3.7,0.0331,1,1,1,1,2.7,3.3,4.1
3105,715,0,Latin America,HR,Legal & Compliance,Meets,Female,41,21,0,6,13,3.5,2.8,1.3,0.0383,1,1,1,1,3.0,2.6,2.6
3106,794,0,Middle East & Africa,HR,Finance & Accounting,Far Below,Female,37,8,1,11,28,0.0,1.8,2.2,0.0,1,1,1,1,3.3,4.0,1.0
3107,888,0,Latin America,Finance,Quality Assurance,Far Below,Female,42,9,0,9,18,4.2,3.9,3.8,0.0,1,1,1,1,3.9,3.3,1.9
3108,25,0,Asia Pacific,R&D,IT & Digital,Meets,Male,37,4,1,12,24,0.0,4.7,1.3,0.0977,0,0,0,0,5.0,4.6,2.5
3109,404,0,Latin America,Manufacturing,IT & Digital,Exceeds,Male,41,7,0,9,16,2.0,1.8,2.2,0.0616,1,1,1,1,2.7,2.6,1.7
3110,653,0,Asia Pacific,Digital,Clinical Operations,Meets,Female,46,13,1,8,28,0.0,2.2,4.2,0.0853,1,1,1,1,2.2,3.9,4.0
3111,532,0,North America,Digital,Data Science,Far Below,Male,28,7,0,6,20,2.1,3.4,2.6,0.0,1,1,1,1,2.2,2.9,1.7
3112,616,0,Latin America,Digital,Legal & Compliance,Below,Male,42,10,0,9,11,2.4,3.2,2.8,0.0,1,1,1,1,3.0,4.7,2.6
3113,740,0,Middle East & Africa,HR,IT & Digital,Meets,Male,35,19,0,5,12,3.1,3.2,2.3,0.0383,1,1,1,1,4.1,2.7,3.8
3114,1048,0,Asia Pacific,Finance,Market Access,Meets,Female,31,13,0,12,24,1.3,3.5,2.2,0.0331,1,1,1,1,1.7,4.0,1.4
3115,499,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Meets,Female,29,5,0,12,12,4.0,4.8,3.5,0.0348,1,1,1,1,3.6,4.2,3.6
3116,350,0,Europe,Commercial,Regulatory Affairs,Meets,Male,39,16,0,8,12,4.4,1.5,2.0,0.0422,1,0,0,0,3.7,2.8,2.7
3117,600,0,Asia Pacific,Digital,Finance & Accounting,Meets,Male,40,14,0,8,11,4.2,5.0,2.8,0.0853,1,1,1,1,4.1,5.0,3.7
3118,1006,0,Latin America,Finance,Finance & Accounting,Meets,Male,34,22,0,12,24,2.2,2.6,4.3,0.0331,1,1,1,1,1.1,2.2,5.0
3119,430,0,Asia Pacific,Manufacturing,Quality Assurance,Meets,Female,30,7,1,11,21,0.0,2.6,2.3,0.0348,1,1,1,1,3.6,2.7,4.3
3120,358,0,Middle East & Africa,Manufacturing,Marketing,Below,Male,39,9,0,12,19,4.2,3.1,1.5,0.0,1,1,1,1,4.2,1.8,3.7
3121,104,0,North America,R&D,IT & Digital,Meets,Male,38,6,1,5,21,0.0,2.4,3.8,0.0977,1,1,1,1,5.0,4.3,4.4
3122,910,0,Asia Pacific,Finance,IT & Digital,Meets,Male,42,15,0,10,27,2.2,5.0,3.8,0.0331,1,1,1,1,1.6,4.6,4.7
3123,680,0,Latin America,Digital,IT & Digital,Exceeds,Male,42,15,0,6,26,3.9,3.3,1.4,0.1452,1,1,1,1,3.7,2.3,3.0
3124,804,0,Europe,HR,Finance & Accounting,Meets,Male,45,16,0,9,10,3.0,3.9,3.7,0.0383,1,1,1,1,4.6,2.0,2.5
3125,355,0,North America,Manufacturing,Marketing,Below,Female,42,8,0,7,21,3.7,4.2,3.7,0.0,1,1,1,1,4.4,2.5,3.9
3126,466,0,Europe,Manufacturing,Medical Affairs,Below,Male,28,8,1,5,16,0.0,3.4,1.0,0.0,0,0,0,0,3.3,3.7,2.4
3127,328,0,Asia Pacific,Commercial,Clinical Operations,Meets,Female,38,17,0,5,8,3.6,2.3,2.8,0.0422,1,1,1,1,4.0,3.0,3.4
3128,81,0,Middle East & Africa,R&D,Human Resources,Meets,Male,44,22,0,5,11,5.0,3.6,3.0,0.0977,1,1,1,1,4.0,3.1,2.8
3129,418,0,Middle East & Africa,Manufacturing,Supply Chain,Exceeds,Male,43,11,0,11,15,2.6,2.5,3.1,0.0616,1,1,1,1,3.9,3.1,2.1
3130,489,0,Latin America,Manufacturing,Quality Assurance,Meets,Male,53,16,0,5,7,2.2,3.6,4.5,0.0348,1,1,1,1,3.5,3.0,3.2
3131,775,0,Middle East & Africa,HR,Regulatory Affairs,Exceeds,Female,43,10,0,7,8,2.7,2.2,3.7,0.0677,1,1,1,1,3.2,3.4,3.4
3132,751,0,North America,HR,Regulatory Affairs,Meets,Female,30,17,0,6,17,3.8,2.9,3.3,0.0383,1,1,0,0,3.8,3.5,2.8
3133,180,0,Middle East & Africa,Commercial,Clinical Operations,Exceeds,Female,29,10,1,11,36,0.0,2.6,2.6,0.0743,1,1,1,1,3.8,1.2,3.2
3134,1034,1,Latin America,Finance,Medical Affairs,Meets,Male,38,13,1,12,14,0.0,1.7,5.0,0.0331,1,1,1,1,2.8,2.5,5.0
3135,293,1,Asia Pacific,Commercial,Marketing,Meets,Male,39,12,0,11,29,3.1,2.1,3.2,0.0422,1,1,1,1,3.4,3.1,2.6
3136,263,1,Asia Pacific,Commercial,Legal & Compliance,Meets,Male,35,10,0,9,16,3.8,3.4,3.0,0.0422,1,1,1,1,4.7,3.8,2.7
3137,826,0,Middle East & Africa,HR,Sales,Exceeds,Male,43,21,0,8,26,3.6,1.3,1.3,0.0677,1,1,1,1,3.2,1.7,1.0
3138,954,0,Europe,Finance,Medical Affairs,Meets,Male,28,14,0,5,15,3.5,3.3,2.3,0.0331,1,1,1,1,3.3,3.0,3.1
3139,749,1,Asia Pacific,HR,Legal & Compliance,Exceeds,Male,35,12,1,9,12,0.0,3.2,2.4,0.0677,1,1,1,1,4.4,2.2,3.5
3140,116,0,Middle East & Africa,R&D,Medical Affairs,Meets,Male,28,8,0,10,14,3.1,4.2,3.9,0.0977,1,1,1,1,2.8,2.8,5.0
3141,613,1,Latin America,Digital,Market Access,Meets,Female,33,26,0,11,18,3.6,2.0,2.8,0.0853,1,1,1,1,3.8,1.7,3.1
3142,647,1,Middle East & Africa,Digital,Communications,Far Exceeds,Female,36,7,0,5,17,2.4,2.5,2.1,0.2363,1,1,1,1,2.8,3.2,2.6
3143,22,0,Asia Pacific,R&D,Supply Chain,Exceeds,Male,44,5,1,9,15,0.0,1.0,3.0,0.1648,0,0,0,0,4.9,2.0,3.3
3144,578,0,Latin America,Digital,Supply Chain,Meets,Male,31,9,0,6,16,2.3,3.7,4.1,0.0853,1,1,1,1,2.0,3.4,5.0
3145,973,0,Middle East & Africa,Finance,Regulatory Affairs,Meets,Female,37,18,0,7,24,2.8,4.2,4.3,0.0331,1,1,1,1,4.3,4.0,4.4
3146,739,0,North America,HR,Finance & Accounting,Far Exceeds,Male,35,16,1,7,12,0.0,4.6,3.0,0.1168,1,1,1,1,4.7,4.8,3.1
3147,662,0,Latin America,Digital,Supply Chain,Meets,Female,37,5,0,10,18,2.9,4.8,2.1,0.0853,1,1,1,1,4.6,4.5,2.4
3148,938,0,North America,Finance,Regulatory Affairs,Meets,Non-Binary/Other,36,11,0,10,27,3.7,2.9,2.0,0.0331,0,0,0,0,2.5,3.9,4.1
3149,780,0,Europe,HR,Medical Affairs,Exceeds,Female,36,8,1,8,13,0.0,3.0,2.6,0.0677,1,1,1,1,3.2,4.2,3.7
3150,881,0,Latin America,Finance,Communications,Below,Male,34,15,0,11,15,1.8,4.2,2.4,0.0,1,1,1,1,1.8,4.0,1.4
3151,165,0,North America,R&D,Clinical Operations,Below,Female,40,17,0,7,11,2.5,2.4,2.4,0.0,1,1,1,1,2.5,1.5,3.1
3152,199,0,Asia Pacific,Commercial,Sales,Meets,Female,45,15,0,6,18,4.3,3.4,3.5,0.0422,1,1,1,1,3.9,3.5,4.2
3153,79,0,Asia Pacific,R&D,Clinical Operations,Below,Male,38,18,0,12,23,1.7,3.5,3.4,0.0,1,1,0,0,2.5,2.7,3.1
3154,524,0,Europe,Digital,Medical Affairs,Meets,Female,50,12,0,8,11,3.7,4.2,2.7,0.0853,1,1,1,1,3.8,4.7,3.3
3155,750,0,Latin America,HR,Finance & Accounting,Meets,Male,38,19,1,5,12,0.0,2.8,1.8,0.0383,1,1,1,1,5.0,3.6,1.9
3156,940,0,Latin America,Finance,Pharmacovigilance,Below,Female,43,6,0,7,11,3.4,4.3,3.8,0.0,1,1,1,1,4.0,2.6,4.6
3157,545,0,Latin America,Digital,Finance & Accounting,Meets,Male,33,16,1,9,17,0.0,3.6,3.9,0.0853,1,1,1,1,1.8,3.5,3.9
3158,531,0,Europe,Digital,IT & Digital,Meets,Male,37,6,0,10,16,2.7,3.0,1.9,0.0853,1,1,1,1,3.3,3.6,2.0
3159,221,0,Latin America,Commercial,Quality Assurance,Below,Female,36,26,0,12,21,4.2,2.7,4.5,0.0,1,1,0,0,4.0,2.9,3.6
3160,535,0,Asia Pacific,Digital,Marketing,Far Below,Male,31,15,0,5,12,3.2,1.6,3.5,0.0,0,0,0,0,3.8,3.7,2.6
3161,186,0,North America,Commercial,Communications,Meets,Male,33,15,1,12,19,0.0,4.4,2.5,0.0422,1,1,1,1,2.7,3.5,1.8
3162,744,0,Asia Pacific,HR,Quality Assurance,Meets,Female,40,6,0,12,24,3.2,3.7,2.5,0.0383,1,1,1,1,4.8,3.4,1.5
3163,701,1,Asia Pacific,HR,Sales,Exceeds,Male,46,3,1,10,13,0.0,3.9,2.9,0.0677,1,1,1,1,5.0,3.1,4.7
3164,1028,0,North America,Finance,Supply Chain,Below,Female,41,9,0,5,12,3.4,2.0,3.6,0.0,1,1,1,1,3.3,3.3,3.9
3165,248,0,Asia Pacific,Commercial,Quality Assurance,Meets,Male,40,19,0,12,13,4.1,1.1,4.8,0.0422,1,1,1,1,3.1,2.5,5.0
3166,3,0,Europe,R&D,Supply Chain,Meets,Male,33,13,0,8,18,2.8,5.0,2.7,0.0977,1,1,0,0,2.2,5.0,2.7
3167,757,0,North America,HR,Legal & Compliance,Meets,Male,41,15,0,6,9,2.5,2.6,2.8,0.0383,1,1,1,1,3.4,2.3,1.9
3168,926,0,Asia Pacific,Finance,Medical Affairs,Exceeds,Male,34,9,0,7,17,3.3,2.1,4.1,0.0588,1,1,1,1,3.8,3.9,4.3
3169,86,0,Middle East & Africa,R&D,Sales,Meets,Female,31,11,1,8,12,0.0,2.4,3.5,0.0977,0,0,0,0,2.3,2.7,1.0
3170,866,0,Asia Pacific,HR,Finance & Accounting,Meets,Male,33,25,0,9,18,3.3,5.0,3.5,0.0383,1,1,1,1,2.6,4.0,2.8
3171,848,0,Europe,HR,Legal & Compliance,Meets,Female,37,15,0,9,19,5.0,2.7,4.1,0.0383,1,1,1,0,4.8,2.7,4.1
3172,990,0,Latin America,Finance,Market Access,Far Exceeds,Male,35,24,0,7,8,2.7,2.6,3.4,0.1022,1,1,1,1,2.0,2.8,1.2
3173,1003,0,Asia Pacific,Finance,Marketing,Meets,Male,40,10,0,11,43,4.0,5.0,3.6,0.0331,1,1,1,1,5.0,5.0,3.8
3174,387,0,Latin America,Manufacturing,Legal & Compliance,Meets,Female,36,7,0,7,23,3.0,3.5,1.8,0.0348,1,1,1,1,2.7,3.5,2.1
3175,558,0,Middle East & Africa,Digital,Legal & Compliance,Meets,Male,40,8,0,7,20,3.9,3.2,2.4,0.0853,1,1,1,1,4.5,2.4,3.0
3176,553,0,Asia Pacific,Digital,IT & Digital,Meets,Male,36,28,0,12,36,3.4,3.5,2.9,0.0853,1,1,1,1,3.7,2.0,2.7
3177,88,0,North America,R&D,Human Resources,Exceeds,Male,38,21,0,5,11,3.7,3.0,1.3,0.1648,1,0,0,0,2.9,2.3,1.0
3178,523,0,Latin America,Digital,Marketing,Far Below,Male,32,17,0,5,11,3.8,2.2,2.1,0.0,1,1,1,1,3.4,2.6,3.5
3179,66,0,Middle East & Africa,R&D,Finance & Accounting,Meets,Female,47,5,1,9,14,0.0,4.3,3.3,0.0977,1,1,1,1,3.0,4.7,2.5
3180,716,0,North America,HR,Pharmacovigilance,Meets,Female,28,25,0,5,29,1.3,2.8,1.4,0.0383,0,0,0,0,2.5,3.0,2.2
3181,504,0,North America,Manufacturing,Market Access,Below,Male,53,14,0,11,17,4.1,2.7,4.2,0.0,1,1,1,1,4.1,3.0,4.6
3182,498,0,North America,Manufacturing,Legal & Compliance,Below,Female,41,15,0,9,17,1.2,2.1,2.2,0.0,1,1,1,1,2.5,2.9,3.5
3183,809,0,North America,HR,Legal & Compliance,Meets,Non-Binary/Other,29,23,0,8,25,2.7,4.2,2.9,0.0383,1,1,1,1,3.1,4.0,1.7
3184,940,0,Asia Pacific,Finance,Regulatory Affairs,Meets,Female,39,5,0,9,11,2.4,3.1,2.6,0.0331,1,1,1,1,3.6,1.3,4.4
3185,178,0,Asia Pacific,Commercial,Marketing,Meets,Male,39,13,0,9,20,4.0,3.7,2.8,0.0422,1,1,1,1,3.5,4.0,1.7
3186,257,0,Asia Pacific,Commercial,Finance & Accounting,Below,Male,47,10,0,10,15,4.7,4.4,2.3,0.0,1,1,1,1,3.3,5.0,3.5
3187,542,0,Middle East & Africa,Digital,Data Science,Meets,Female,30,12,0,12,15,3.4,3.2,4.0,0.0853,1,1,1,1,4.1,4.4,4.1
3188,1049,1,Middle East & Africa,Finance,Legal & Compliance,Exceeds,Male,30,8,0,6,11,2.9,3.7,3.1,0.0588,1,1,1,1,4.1,3.1,4.5
3189,91,0,Middle East & Africa,R&D,Regulatory Affairs,Exceeds,Male,40,17,0,10,30,2.7,4.1,1.3,0.1648,1,1,1,1,3.8,1.8,3.4
3190,379,0,Europe,Manufacturing,Marketing,Meets,Male,39,5,1,10,15,0.0,3.2,3.6,0.0348,1,1,1,1,3.6,3.4,1.7
3191,540,0,Middle East & Africa,Digital,Medical Affairs,Meets,Male,47,11,0,5,10,2.1,3.6,2.6,0.0853,0,0,0,0,1.7,3.7,2.6
3192,709,0,Asia Pacific,HR,Sales,Meets,Female,32,6,0,6,14,1.8,3.0,3.8,0.0383,1,1,1,1,2.8,3.9,3.4
3193,883,0,Asia Pacific,Finance,Sales,Below,Female,32,8,0,5,20,2.6,4.0,3.2,0.0,1,1,1,1,2.9,4.0,2.8
3194,452,0,Europe,Manufacturing,Data Science,Exceeds,Male,49,16,0,12,15,2.9,2.4,2.7,0.0616,1,1,1,1,2.4,3.7,1.7
3195,5,0,Europe,R&D,IT & Digital,Meets,Female,38,27,0,5,18,1.5,3.8,2.1,0.0977,1,1,1,1,3.0,4.4,3.4
3196,118,0,Middle East & Africa,R&D,Medical Affairs,Meets,Female,34,8,0,9,14,4.7,2.7,1.8,0.0977,1,1,1,1,4.2,1.1,1.9
3197,297,0,Latin America,Commercial,Data Science,Meets,Female,42,17,0,9,23,2.7,4.0,2.2,0.0422,1,1,1,1,3.7,2.5,2.5
3198,535,0,Europe,Digital,Supply Chain,Exceeds,Non-Binary/Other,28,8,1,6,7,0.0,2.2,2.1,0.1452,1,1,1,1,2.9,2.9,1.4
3199,805,0,North America,HR,Communications,Exceeds,Non-Binary/Other,40,18,0,12,30,3.9,4.2,1.0,0.0677,1,1,1,1,4.4,3.6,1.9
3200,449,0,Asia Pacific,Manufacturing,Clinical Operations,Meets,Female,34,10,1,8,16,0.0,1.0,2.4,0.0348,1,1,1,1,3.2,3.6,1.8
3201,132,0,North America,R&D,Communications,Meets,Female,35,15,0,5,15,3.0,3.7,2.7,0.0977,1,1,1,1,3.6,4.1,3.1
3202,441,0,Asia Pacific,Manufacturing,Marketing,Meets,Male,46,12,0,9,20,3.5,1.6,3.4,0.0348,0,0,0,0,2.9,3.1,4.2
3203,831,0,Asia Pacific,HR,Medical Affairs,Below,Female,41,17,0,5,9,2.5,3.3,3.3,0.0,0,0,0,0,4.4,2.3,3.0
3204,492,0,Europe,Manufacturing,Clinical Operations,Exceeds,Female,31,12,0,11,16,3.2,2.0,1.9,0.0616,1,1,1,1,3.1,2.1,3.3
3205,625,0,Europe,Digital,Clinical Operations,Meets,Female,38,14,0,7,14,3.7,3.1,4.1,0.0853,1,1,1,1,2.4,2.1,4.8
3206,322,0,North America,Commercial,Sales,Meets,Male,39,8,1,8,20,0.0,3.8,3.3,0.0422,1,1,1,1,3.7,3.3,3.7
3207,522,0,Asia Pacific,Manufacturing,Legal & Compliance,Meets,Male,36,4,0,9,16,4.9,2.0,2.6,0.0348,1,1,1,1,4.0,2.4,3.3
3208,1015,0,North America,Finance,Sales,Meets,Male,32,4,0,10,23,3.1,2.8,3.6,0.0331,1,1,1,1,4.1,2.4,4.5
3209,265,0,Latin America,Commercial,Market Access,Below,Female,39,17,1,8,24,0.0,1.0,2.6,0.0,1,1,1,1,3.6,4.5,3.4
3210,768,1,North America,HR,Supply Chain,Far Exceeds,Non-Binary/Other,42,7,0,8,20,3.1,4.5,4.4,0.1168,1,1,1,1,3.9,4.4,4.7
3211,274,0,Middle East & Africa,Commercial,Finance & Accounting,Below,Male,41,8,1,8,28,0.0,5.0,4.0,0.0,1,1,1,1,3.0,5.0,2.5
3212,512,0,North America,Manufacturing,IT & Digital,Meets,Female,34,7,0,12,25,2.8,4.3,2.1,0.0348,1,1,1,1,2.2,4.2,2.5
3213,451,0,Middle East & Africa,Manufacturing,Medical Affairs,Meets,Male,37,8,1,12,29,0.0,2.9,3.6,0.0348,0,0,0,0,4.0,4.1,2.3
3214,996,0,Middle East & Africa,Finance,Legal & Compliance,Below,Female,28,7,0,11,17,4.5,4.3,1.8,0.0,1,1,1,1,3.6,4.1,2.2
3215,145,0,Middle East & Africa,R&D,Pharmacovigilance,Exceeds,Female,48,12,0,6,24,3.8,3.4,2.8,0.1648,1,1,1,1,3.3,2.7,3.8
3216,1036,1,Latin America,Finance,Medical Affairs,Meets,Male,34,5,0,5,23,3.3,4.4,3.5,0.0331,1,1,1,1,4.4,3.4,4.1
3217,461,0,North America,Manufacturing,Supply Chain,Meets,Male,35,13,0,12,22,2.9,3.0,2.8,0.0348,0,0,0,0,4.9,2.1,1.5
3218,309,0,North America,Commercial,Sales,Meets,Male,30,10,0,12,23,2.9,3.7,2.8,0.0422,1,1,1,1,4.9,3.6,2.4
3219,902,0,Latin America,Finance,Communications,Meets,Non-Binary/Other,43,13,0,7,14,5.0,2.6,4.0,0.0331,1,1,1,1,5.0,3.7,2.9
3220,984,0,Asia Pacific,Finance,Sales,Below,Male,44,11,1,6,9,0.0,1.3,4.1,0.0,1,1,1,1,3.9,2.3,2.9
3221,74,0,Europe,R&D,Marketing,Meets,Female,35,5,1,11,12,0.0,4.9,3.5,0.0977,1,1,1,1,3.1,4.8,2.0
3222,493,0,North America,Manufacturing,Quality Assurance,Meets,Male,31,5,1,12,23,0.0,4.7,1.5,0.0348,0,0,0,0,3.7,2.1,3.3
3223,479,0,Europe,Manufacturing,Communications,Below,Female,38,10,0,12,14,2.0,3.6,1.6,0.0,0,0,0,0,1.9,4.5,2.0
3224,804,0,Latin America,HR,Sales,Meets,Male,36,18,0,12,28,2.4,2.6,2.3,0.0383,1,1,1,1,3.6,3.7,2.9
3225,34,0,Asia Pacific,R&D,Communications,Meets,Male,42,8,0,8,12,3.2,2.8,3.2,0.0977,1,1,1,1,2.9,3.0,1.5
3226,715,0,Asia Pacific,HR,Data Science,Meets,Male,37,5,0,11,12,3.3,3.3,3.2,0.0383,1,0,0,0,4.3,3.7,2.3
3227,836,0,Asia Pacific,HR,Marketing,Below,Male,37,13,0,10,20,3.2,5.0,1.3,0.0,0,0,0,0,3.1,3.5,1.4
3228,701,0,Latin America,HR,Legal & Compliance,Meets,Male,42,17,0,10,19,3.4,3.0,1.7,0.0383,1,1,1,0,3.1,1.2,2.1
3229,628,0,Middle East & Africa,Digital,IT & Digital,Below,Female,29,21,1,7,20,0.0,2.5,2.4,0.0,1,1,0,0,4.5,1.4,2.6
3230,729,0,Middle East & Africa,HR,Legal & Compliance,Meets,Male,36,11,1,11,16,0.0,2.0,2.7,0.0383,1,1,1,1,3.5,2.3,1.7
3231,963,0,Europe,Finance,Regulatory Affairs,Exceeds,Female,39,10,0,5,16,3.0,1.6,3.1,0.0588,1,1,1,1,3.8,2.9,2.3
3232,306,0,Middle East & Africa,Commercial,IT & Digital,Far Below,Male,35,7,0,10,23,2.3,2.3,3.4,0.0,1,1,1,1,2.2,2.1,3.7
3233,1035,0,Middle East & Africa,Finance,IT & Digital,Meets,Male,40,8,0,8,12,4.0,4.4,3.7,0.0331,0,0,0,0,3.6,3.7,2.8
3234,1029,0,Asia Pacific,Finance,Quality Assurance,Meets,Male,39,10,0,12,13,2.8,1.4,2.1,0.0331,1,1,1,1,3.5,1.5,3.0
3235,384,0,Asia Pacific,Manufacturing,Quality Assurance,Far Below,Female,43,7,0,7,12,3.1,3.4,2.5,0.0,0,0,0,0,1.3,3.9,2.1
3236,663,0,Europe,Digital,Communications,Far Below,Male,36,3,0,10,31,4.5,3.1,2.2,0.0,1,1,1,1,3.8,2.0,3.8
3237,829,0,North America,HR,Data Science,Meets,Male,28,14,0,8,18,3.5,2.9,2.9,0.0383,0,0,0,0,2.9,4.8,3.5
3238,462,0,Europe,Manufacturing,IT & Digital,Meets,Female,29,14,0,6,37,2.6,2.2,2.0,0.0348,1,1,1,1,3.9,2.8,2.7
3239,130,0,Europe,R&D,Quality Assurance,Meets,Male,41,3,0,12,13,3.0,3.6,2.4,0.0977,1,1,1,1,3.6,4.3,2.5
3240,34,0,Latin America,R&D,Pharmacovigilance,Meets,Female,39,13,0,10,11,3.3,3.2,4.4,0.0977,1,1,1,1,2.8,3.3,3.6
3241,375,0,Latin America,Manufacturing,Sales,Meets,Male,37,18,0,12,22,3.8,3.8,3.4,0.0348,1,1,1,1,4.1,3.1,3.1
3242,216,0,Europe,Commercial,Sales,Exceeds,Male,37,16,0,12,17,3.3,3.5,3.3,0.0743,1,1,1,1,4.5,2.8,3.3
3243,360,0,Europe,Manufacturing,Marketing,Far Below,Female,34,13,0,11,14,2.5,2.0,2.6,0.0,1,1,1,1,1.4,1.2,3.1
3244,521,0,Europe,Manufacturing,Supply Chain,Meets,Male,34,20,0,12,22,4.3,2.8,3.8,0.0348,1,1,1,1,3.6,4.0,4.6
3245,634,0,Middle East & Africa,Digital,Data Science,Meets,Male,35,15,0,10,13,2.3,3.3,3.0,0.0853,1,1,1,1,2.4,5.0,3.5
3246,61,0,Latin America,R&D,Sales,Below,Female,36,20,0,10,20,3.8,1.6,3.2,0.0,1,1,1,1,4.4,4.4,3.1
3247,105,0,Europe,R&D,Clinical Operations,Meets,Male,39,19,0,9,20,3.5,4.0,4.2,0.0977,1,1,1,1,3.9,2.5,3.0
3248,759,0,Asia Pacific,HR,Human Resources,Meets,Female,38,3,0,6,11,3.2,4.5,2.4,0.0383,0,0,0,0,5.0,3.9,2.3
3249,973,0,Asia Pacific,Finance,Market Access,Meets,Female,36,3,1,8,9,0.0,3.3,1.5,0.0331,1,1,1,1,3.5,2.2,1.0
3250,414,0,Middle East & Africa,Manufacturing,Sales,Meets,Female,42,9,0,9,25,1.0,2.7,3.5,0.0348,1,1,1,1,3.0,3.4,4.3
3251,424,0,Middle East & Africa,Manufacturing,Medical Affairs,Meets,Male,43,20,0,9,22,1.9,1.7,2.2,0.0348,1,1,1,1,3.7,3.7,2.4
3252,346,0,North America,Commercial,Clinical Operations,Meets,Female,46,11,0,11,16,3.6,2.6,3.1,0.0422,1,1,1,1,3.2,2.1,2.0
3253,125,0,North America,R&D,Supply Chain,Meets,Male,37,12,0,9,21,3.7,3.7,3.0,0.0977,1,1,1,1,4.7,3.2,3.3
3254,193,0,North America,Commercial,Communications,Meets,Male,35,12,0,9,21,4.6,4.0,4.0,0.0422,1,1,1,1,3.1,3.9,3.3
3255,532,0,Middle East & Africa,Digital,Clinical Operations,Meets,Female,38,8,1,10,21,0.0,3.8,2.1,0.0853,1,0,0,0,3.5,3.8,2.8
3256,723,0,Middle East & Africa,HR,Finance & Accounting,Below,Male,35,5,0,5,16,3.3,1.0,3.2,0.0,1,1,1,1,2.6,3.9,1.4
3257,210,0,Middle East & Africa,Commercial,Quality Assurance,Meets,Male,38,10,0,8,29,2.7,2.1,3.1,0.0422,1,1,1,1,3.9,1.3,2.3
3258,44,0,Asia Pacific,R&D,Legal & Compliance,Far Below,Male,40,5,1,6,10,0.0,3.7,3.8,0.0,1,1,1,1,3.0,2.6,4.4
3259,562,0,Middle East & Africa,Digital,Market Access,Below,Non-Binary/Other,39,18,0,5,15,3.3,1.9,1.5,0.0,1,1,1,1,3.3,2.8,1.9
3260,492,0,Asia Pacific,Manufacturing,IT & Digital,Below,Male,37,6,1,9,18,0.0,2.5,3.6,0.0,1,1,1,1,3.7,2.2,3.9
3261,570,0,North America,Digital,Regulatory Affairs,Exceeds,Male,42,4,1,10,18,0.0,2.3,4.5,0.1452,1,1,1,0,4.7,3.9,3.5
3262,922,0,North America,Finance,Market Access,Far Below,Female,48,8,0,12,21,2.9,1.6,2.6,0.0,1,1,1,1,3.4,4.2,2.6
3263,259,0,North America,Commercial,Finance & Accounting,Meets,Female,34,4,1,7,10,0.0,3.7,3.2,0.0422,1,1,1,1,2.1,1.9,2.5
3264,128,0,Europe,R&D,IT & Digital,Far Below,Male,40,6,1,7,13,0.0,3.7,2.0,0.0,1,1,1,1,3.7,3.5,3.4
3265,274,0,Europe,Commercial,Sales,Meets,Female,37,24,0,10,21,2.2,3.1,2.5,0.0422,1,1,1,1,3.5,3.5,1.9
3266,464,1,Latin America,Manufacturing,Finance & Accounting,Exceeds,Male,33,14,1,12,15,0.0,4.5,4.3,0.0616,1,1,1,1,3.3,4.5,1.9
3267,493,0,Latin America,Manufacturing,Marketing,Meets,Male,34,36,0,9,13,3.3,3.6,4.3,0.0348,1,1,1,1,4.1,1.9,3.2
3268,150,0,Latin America,R&D,Pharmacovigilance,Exceeds,Male,36,7,0,6,9,2.6,3.3,3.4,0.1648,1,1,1,1,2.5,4.6,2.8
3269,947,0,Europe,Finance,Communications,Meets,Female,47,19,0,5,16,4.3,3.2,2.4,0.0331,1,1,1,1,4.1,3.4,2.7
3270,783,0,Europe,HR,Legal & Compliance,Meets,Male,44,13,0,6,8,4.0,3.9,2.6,0.0383,1,1,1,1,4.0,3.1,2.1
3271,588,0,Latin America,Digital,Supply Chain,Meets,Female,33,22,0,11,22,3.7,3.5,1.5,0.0853,0,0,0,0,3.2,3.9,3.2
3272,539,0,Latin America,Digital,Marketing,Meets,Non-Binary/Other,41,26,0,11,23,4.2,2.5,1.4,0.0853,1,1,1,1,4.1,3.2,2.8
3273,375,0,Middle East & Africa,Manufacturing,Sales,Meets,Male,32,13,1,8,10,0.0,3.5,3.1,0.0348,1,1,1,1,1.5,2.9,3.0
3274,232,0,Latin America,Commercial,Marketing,Far Exceeds,Non-Binary/Other,34,15,0,5,20,2.9,4.1,2.5,0.1275,1,1,1,1,2.9,5.0,2.8
3275,270,0,Middle East & Africa,Commercial,Communications,Meets,Male,46,10,1,9,13,0.0,4.5,4.0,0.0422,1,1,1,1,2.3,4.1,3.6
3276,985,0,Asia Pacific,Finance,Legal & Compliance,Far Exceeds,Male,50,5,0,5,16,3.2,5.0,1.0,0.1022,1,1,1,1,4.1,4.4,4.3
3277,864,0,Europe,HR,Human Resources,Meets,Female,28,6,1,5,6,0.0,4.4,3.3,0.0383,0,0,0,0,1.7,2.6,2.9
3278,240,0,Latin America,Commercial,Medical Affairs,Meets,Female,38,5,0,11,26,1.9,2.0,3.9,0.0422,1,0,0,0,1.3,1.8,3.8
3279,658,0,Europe,Digital,Clinical Operations,Meets,Female,40,16,1,5,9,0.0,3.5,3.1,0.0853,0,0,0,0,3.2,3.2,2.4
3280,286,0,Europe,Commercial,Communications,Exceeds,Male,36,9,0,6,11,3.3,4.1,1.4,0.0743,1,1,0,0,3.3,4.8,2.3
3281,804,0,Europe,HR,IT & Digital,Meets,Female,39,12,1,6,10,0.0,1.6,1.6,0.0383,1,1,1,1,4.0,2.6,3.4
3282,542,0,Asia Pacific,Digital,Pharmacovigilance,Far Below,Female,36,2,0,9,24,2.1,3.3,2.0,0.0,1,1,1,1,4.8,3.4,3.0
3283,246,0,North America,Commercial,Human Resources,Meets,Male,42,8,0,10,13,4.0,2.7,2.0,0.0422,1,1,1,1,3.3,3.3,4.4
3284,635,0,Latin America,Digital,Sales,Far Exceeds,Female,36,12,0,12,22,5.0,2.5,2.2,0.2363,1,1,1,1,4.4,2.9,3.1
3285,504,0,North America,Manufacturing,Quality Assurance,Meets,Non-Binary/Other,41,16,0,6,11,2.6,3.5,1.9,0.0348,0,0,0,0,2.2,4.2,2.8
3286,420,0,North America,Manufacturing,Supply Chain,Below,Male,44,6,0,8,19,2.8,2.2,2.5,0.0,0,0,0,0,3.2,2.6,2.7
3287,895,0,North America,Finance,Quality Assurance,Meets,Female,43,12,0,6,10,3.5,2.4,2.7,0.0331,0,0,0,0,3.2,2.7,2.4
3288,420,0,Europe,Manufacturing,Clinical Operations,Exceeds,Female,37,6,0,9,25,3.7,2.6,3.3,0.0616,1,1,1,1,1.7,3.9,4.1
3289,337,0,Middle East & Africa,Commercial,Pharmacovigilance,Far Below,Female,28,15,0,11,22,1.5,1.9,2.3,0.0,1,1,1,1,3.2,1.1,2.4
3290,817,0,Europe,HR,Clinical Operations,Meets,Male,41,10,0,7,17,4.0,2.6,1.1,0.0383,0,0,0,0,3.7,4.6,1.7
3291,645,0,Europe,Digital,Data Science,Below,Female,29,24,0,8,23,1.8,4.5,3.1,0.0,1,1,1,0,3.3,5.0,3.5
3292,71,1,North America,R&D,Quality Assurance,Meets,Non-Binary/Other,41,11,0,9,27,4.0,2.1,1.4,0.0977,1,0,0,0,3.4,1.7,2.0
3293,413,1,Europe,Manufacturing,IT & Digital,Meets,Male,40,30,0,9,15,1.7,3.2,2.5,0.0348,0,0,0,0,2.6,2.8,3.3
3294,454,0,North America,Manufacturing,Human Resources,Meets,Female,37,14,0,7,40,2.7,3.0,1.9,0.0348,1,1,1,1,2.3,2.8,4.5
3295,6,0,Middle East & Africa,R&D,Clinical Operations,Meets,Female,38,15,0,6,16,4.1,4.8,2.9,0.0977,1,1,1,1,3.3,4.3,3.1
3296,136,1,Latin America,R&D,Legal & Compliance,Meets,Male,47,14,1,11,20,0.0,3.9,2.2,0.0977,1,1,1,1,3.4,3.4,1.0
3297,263,0,North America,Commercial,Clinical Operations,Meets,Male,46,14,0,11,14,4.2,3.0,5.0,0.0422,1,1,1,1,2.9,4.2,5.0
3298,590,0,Middle East & Africa,Digital,Marketing,Meets,Female,36,35,0,5,9,3.3,4.6,3.3,0.0853,1,1,1,1,3.5,3.8,2.8
3299,398,0,Latin America,Manufacturing,Sales,Exceeds,Male,28,15,0,7,21,3.4,2.5,2.2,0.0616,1,1,1,1,3.0,2.5,2.1
3300,878,0,Asia Pacific,HR,Human Resources,Meets,Male,47,12,0,11,29,2.9,4.6,1.3,0.0383,1,1,1,1,2.1,2.8,1.4
3301,313,0,North America,Commercial,Marketing,Below,Female,29,11,0,6,15,2.5,4.4,3.5,0.0,1,0,0,0,2.9,4.2,3.7
3302,221,0,North America,Commercial,Data Science,Far Below,Female,39,18,0,12,17,4.8,3.3,1.9,0.0,1,1,1,1,4.2,3.5,1.6
3303,812,0,Asia Pacific,HR,Market Access,Meets,Male,38,12,0,11,42,3.4,2.5,1.0,0.0383,1,1,1,1,3.4,5.0,2.0
3304,778,0,Asia Pacific,HR,IT & Digital,Exceeds,Female,41,6,0,10,18,2.0,4.3,2.1,0.0677,1,1,0,0,5.0,2.0,4.1
3305,1006,0,North America,Finance,Market Access,Meets,Female,46,10,1,7,19,0.0,3.8,2.4,0.0331,1,1,1,1,2.8,4.2,2.3
3306,878,0,Asia Pacific,HR,Marketing,Meets,Male,38,20,0,8,20,2.0,3.8,2.6,0.0383,1,1,1,1,2.7,5.0,2.2
3307,7,0,Europe,R&D,Regulatory Affairs,Meets,Female,35,18,1,12,21,0.0,3.4,4.6,0.0977,1,1,1,1,3.9,2.6,3.5
3308,391,0,Latin America,Manufacturing,Quality Assurance,Meets,Female,40,7,1,11,23,0.0,2.8,3.0,0.0348,1,1,1,1,3.1,3.6,1.6
3309,951,0,Latin America,Finance,Communications,Meets,Male,30,3,1,6,17,0.0,3.7,2.9,0.0331,0,0,0,0,2.8,3.2,3.1
3310,1,0,Latin America,R&D,IT & Digital,Below,Female,34,16,0,11,17,3.4,2.3,3.0,0.0,1,1,1,1,2.8,4.9,3.9
3311,920,0,Europe,Finance,Marketing,Below,Female,37,23,0,8,15,3.5,2.4,2.5,0.0,1,1,1,1,2.6,4.4,2.1
3312,381,0,Asia Pacific,Manufacturing,Finance & Accounting,Meets,Male,41,5,0,10,15,2.2,4.5,2.7,0.0348,1,1,1,1,3.6,4.8,1.9
3313,992,0,Middle East & Africa,Finance,Finance & Accounting,Meets,Male,46,11,1,9,22,0.0,5.0,2.8,0.0331,1,1,1,1,3.0,1.5,2.9
3314,146,0,Asia Pacific,R&D,Medical Affairs,Far Exceeds,Male,44,13,0,9,11,1.8,2.9,2.3,0.2644,1,1,1,1,2.9,2.9,2.4
3315,574,0,North America,Digital,Medical Affairs,Far Below,Male,44,13,0,7,14,4.2,4.2,3.4,0.0,1,1,1,1,3.5,3.2,2.8
3316,505,0,Latin America,Manufacturing,Legal & Compliance,Meets,Male,45,12,1,8,23,0.0,3.4,2.8,0.0348,1,1,1,1,5.0,4.9,3.5
3317,320,0,Asia Pacific,Commercial,Human Resources,Meets,Male,42,8,0,6,13,3.3,3.0,3.2,0.0422,1,1,1,1,3.8,3.7,3.2
3318,396,0,Middle East & Africa,Manufacturing,Supply Chain,Meets,Female,38,5,0,5,26,2.6,2.9,1.8,0.0348,1,1,1,1,1.7,3.2,1.7
3319,454,0,North America,Manufacturing,Legal & Compliance,Exceeds,Male,32,10,0,10,15,2.6,4.5,2.8,0.0616,1,1,1,1,2.8,5.0,3.5
3320,467,0,Europe,Manufacturing,Data Science,Meets,Female,38,7,1,12,24,0.0,2.8,3.9,0.0348,1,1,1,1,5.0,3.5,2.6
3321,655,1,Europe,Digital,Human Resources,Far Exceeds,Female,28,8,0,6,20,3.6,2.6,2.8,0.2363,1,1,1,1,3.3,1.3,3.3
3322,152,0,Middle East & Africa,R&D,Data Science,Below,Female,35,15,0,8,12,4.1,4.2,4.6,0.0,1,1,1,1,5.0,2.5,5.0
3323,351,0,North America,Commercial,Marketing,Below,Female,38,6,0,8,12,2.7,4.6,3.7,0.0,1,1,1,1,2.5,5.0,3.0
3324,88,0,Latin America,R&D,Pharmacovigilance,Below,Female,38,17,0,11,20,3.1,3.9,3.0,0.0,1,1,1,1,3.3,3.7,4.3
3325,914,0,Asia Pacific,Finance,Clinical Operations,Meets,Female,34,9,0,9,18,3.6,1.5,2.9,0.0331,1,1,1,0,3.0,2.0,3.6
3326,925,0,North America,Finance,Sales,Meets,Female,28,6,0,12,22,3.1,2.9,2.1,0.0331,1,1,1,1,3.7,3.0,1.0
3327,967,1,Europe,Finance,Clinical Operations,Exceeds,Male,35,15,0,10,22,3.7,4.4,4.5,0.0588,0,0,0,0,5.0,4.2,3.9
3328,31,0,Middle East & Africa,R&D,Clinical Operations,Meets,Male,36,7,0,6,19,2.8,3.3,4.0,0.0977,1,1,1,1,2.2,3.8,2.3
3329,867,0,Middle East & Africa,HR,Data Science,Exceeds,Female,39,7,0,7,13,2.3,1.7,3.3,0.0677,1,1,1,1,2.4,2.6,4.0
3330,622,0,Asia Pacific,Digital,Data Science,Meets,Female,42,33,0,7,13,3.6,3.8,1.7,0.0853,1,1,1,1,3.1,4.2,2.7
3331,814,0,Middle East & Africa,HR,Medical Affairs,Meets,Male,36,8,0,12,17,2.1,2.8,2.8,0.0383,1,1,0,0,2.9,2.5,3.7
3332,933,0,Middle East & Africa,Finance,Data Science,Meets,Male,36,10,1,11,14,0.0,2.1,3.9,0.0331,1,1,1,1,4.4,3.4,4.9
3333,660,0,North America,Digital,Marketing,Below,Female,34,15,0,11,30,3.0,1.8,4.7,0.0,1,1,1,1,3.1,2.2,3.6
3334,93,0,Latin America,R&D,IT & Digital,Exceeds,Male,38,2,0,8,16,3.0,3.3,5.0,0.1648,1,1,1,1,2.5,2.8,3.6
3335,1048,0,Asia Pacific,Finance,Communications,Below,Female,44,4,1,5,6,0.0,3.8,2.7,0.0,1,1,1,1,3.7,3.0,2.9
3336,120,0,North America,R&D,Medical Affairs,Meets,Female,32,6,1,10,22,0.0,2.1,3.8,0.0977,1,1,1,1,1.9,3.1,2.3
3337,562,0,Latin America,Digital,Quality Assurance,Meets,Male,28,7,1,9,14,0.0,1.1,2.1,0.0853,1,1,1,1,3.1,1.0,2.7
3338,51,0,North America,R&D,Clinical Operations,Exceeds,Male,39,15,1,11,18,0.0,4.2,2.3,0.1648,1,1,1,1,2.7,3.9,2.5
3339,149,0,North America,R&D,Quality Assurance,Meets,Male,45,9,0,12,14,2.9,4.4,1.2,0.0977,1,1,1,1,3.2,4.5,3.7
3340,315,0,Middle East & Africa,Commercial,Human Resources,Meets,Male,40,2,1,9,14,0.0,2.3,3.2,0.0422,0,0,0,0,4.0,3.5,3.3
3341,879,0,Latin America,HR,Clinical Operations,Meets,Female,32,18,0,11,17,4.0,2.8,4.4,0.0383,1,1,1,1,4.5,3.0,3.5
3342,857,0,Asia Pacific,HR,Human Resources,Far Below,Female,37,13,0,10,20,2.9,4.8,2.7,0.0,0,0,0,0,2.2,3.2,3.8
3343,705,0,Asia Pacific,HR,Clinical Operations,Meets,Non-Binary/Other,38,3,0,10,12,2.9,2.3,1.6,0.0383,1,1,1,1,3.3,2.6,1.8
3344,421,0,Latin America,Manufacturing,Supply Chain,Below,Female,42,9,0,7,16,2.8,3.6,2.5,0.0,0,0,0,0,3.4,3.6,2.3
3345,198,1,Middle East & Africa,Commercial,Clinical Operations,Meets,Female,33,12,0,11,14,3.2,2.8,2.8,0.0422,1,1,1,1,3.8,3.6,3.9
3346,908,0,Europe,Finance,Pharmacovigilance,Below,Female,47,22,1,6,11,0.0,2.0,2.7,0.0,1,1,1,1,3.9,2.7,2.1
3347,1013,0,North America,Finance,Legal & Compliance,Far Exceeds,Female,36,7,0,6,23,3.9,2.5,3.9,0.1022,1,1,1,1,3.2,2.8,4.0
3348,989,1,Middle East & Africa,Finance,Communications,Meets,Female,34,6,0,8,25,3.4,1.7,5.0,0.0331,1,1,1,1,4.9,2.9,3.2
3349,778,0,Latin America,HR,Quality Assurance,Exceeds,Female,40,12,0,9,13,3.5,2.7,3.8,0.0677,1,1,1,1,3.1,1.0,4.1
3350,861,0,North America,HR,Finance & Accounting,Far Below,Female,30,2,0,6,23,3.2,2.3,2.1,0.0,1,0,0,0,4.1,3.3,3.7
3351,328,0,Asia Pacific,Commercial,Communications,Meets,Male,50,5,1,5,12,0.0,3.0,1.3,0.0422,1,1,1,1,3.8,2.6,2.3
3352,135,0,Europe,R&D,Clinical Operations,Meets,Male,41,14,0,6,13,3.0,4.6,1.7,0.0977,1,1,1,1,3.1,4.5,4.1
3353,723,0,Asia Pacific,HR,Regulatory Affairs,Meets,Female,36,18,0,12,15,4.9,2.7,4.3,0.0383,1,1,1,1,3.6,1.8,2.5
3354,1012,0,Latin America,Finance,Regulatory Affairs,Exceeds,Female,32,5,0,12,25,4.5,2.6,2.2,0.0588,1,1,1,1,4.6,3.1,1.4
3355,9,0,North America,R&D,Regulatory Affairs,Far Exceeds,Female,37,8,0,12,17,3.1,2.1,2.2,0.2644,1,1,1,1,3.0,1.9,1.0
3356,708,0,Latin America,HR,Marketing,Meets,Female,44,10,0,10,20,3.2,4.3,4.3,0.0383,1,1,1,1,5.0,2.9,3.8
3357,577,0,North America,Digital,Medical Affairs,Exceeds,Female,36,9,0,11,17,1.0,3.1,1.0,0.1452,1,1,1,1,1.0,3.0,1.9
3358,361,0,Middle East & Africa,Manufacturing,Quality Assurance,Meets,Male,33,11,0,10,22,2.2,4.6,2.4,0.0348,1,1,1,1,4.8,5.0,1.6
3359,708,0,Europe,HR,Clinical Operations,Far Exceeds,Male,42,17,0,9,17,2.9,2.7,2.9,0.1168,1,1,1,1,2.9,3.4,4.5
3360,681,0,Middle East & Africa,Digital,Communications,Meets,Male,32,16,0,10,13,2.9,3.5,4.8,0.0853,1,1,1,1,3.4,2.4,3.5
3361,221,1,Middle East & Africa,Commercial,Market Access,Far Exceeds,Male,39,17,0,6,41,3.7,1.9,4.2,0.1275,1,1,1,1,4.5,3.5,3.8
3362,602,0,Latin America,Digital,Legal & Compliance,Exceeds,Female,40,29,0,10,26,4.0,3.4,3.5,0.1452,1,1,1,1,5.0,4.4,2.4
3363,327,0,Europe,Commercial,Medical Affairs,Below,Male,40,12,0,10,23,1.9,4.4,3.8,0.0,1,1,1,1,2.2,3.9,3.1
3364,775,0,North America,HR,Market Access,Meets,Male,41,9,1,9,18,0.0,3.3,2.4,0.0383,1,1,1,1,3.7,4.9,1.0
3365,220,0,North America,Commercial,Human Resources,Meets,Male,32,5,1,11,20,0.0,2.6,2.8,0.0422,1,0,0,0,3.4,2.7,2.6
3366,563,0,Asia Pacific,Digital,Sales,Meets,Female,37,7,0,9,20,2.1,1.3,1.8,0.0853,1,1,1,1,3.1,1.4,2.8
3367,369,0,North America,Manufacturing,Pharmacovigilance,Exceeds,Male,36,15,0,9,17,3.3,3.6,2.4,0.0616,1,1,1,1,3.6,2.7,2.8
3368,23,0,Latin America,R&D,Sales,Meets,Female,39,12,0,8,16,4.1,4.3,2.5,0.0977,1,1,1,1,4.3,3.2,2.9
3369,76,0,Middle East & Africa,R&D,Finance & Accounting,Meets,Male,28,3,0,9,15,4.4,3.1,3.4,0.0977,1,1,1,1,4.3,3.9,3.0
3370,438,0,Middle East & Africa,Manufacturing,Human Resources,Meets,Male,30,12,0,10,20,4.3,2.4,2.3,0.0348,1,1,1,1,3.8,3.9,3.0
3371,899,0,Middle East & Africa,Finance,Data Science,Below,Female,51,8,0,7,10,1.7,1.7,3.5,0.0,1,0,0,0,2.6,2.3,2.5
3372,138,0,Europe,R&D,Human Resources,Meets,Female,42,14,0,8,29,2.9,3.1,3.8,0.0977,1,1,1,1,3.7,4.6,2.5
3373,722,0,North America,HR,Medical Affairs,Meets,Female,37,36,0,12,14,3.5,3.3,3.8,0.0383,1,1,1,1,3.5,4.7,3.3
3374,914,0,Latin America,Finance,Market Access,Below,Female,38,20,0,9,12,3.9,2.6,2.5,0.0,1,1,1,1,3.6,2.8,2.6
3375,712,0,Europe,HR,Supply Chain,Meets,Female,50,13,0,12,21,1.1,3.7,1.6,0.0383,1,1,1,1,1.9,3.1,2.3
3376,684,0,Asia Pacific,Digital,Clinical Operations,Meets,Female,28,26,0,9,13,2.6,3.3,3.0,0.0853,1,1,1,1,4.8,3.1,4.5
3377,574,0,Latin America,Digital,Human Resources,Below,Male,39,4,0,10,26,4.5,3.5,4.7,0.0,1,1,1,0,4.5,1.3,3.6
3378,1010,0,Latin America,Finance,Marketing,Meets,Female,36,29,0,8,9,3.2,4.2,2.7,0.0331,1,1,1,1,4.3,3.2,3.5
3379,979,0,Latin America,Finance,Quality Assurance,Below,Female,45,14,0,10,18,4.5,2.4,3.2,0.0,0,0,0,0,3.7,3.0,3.1
3380,976,0,Middle East & Africa,Finance,Clinical Operations,Far Exceeds,Female,41,18,1,8,13,0.0,2.8,2.8,0.1022,1,1,1,1,4.1,3.3,3.1
3381,1047,0,Latin America,Finance,Quality Assurance,Below,Female,51,14,0,11,19,2.8,3.9,2.8,0.0,1,1,1,1,3.7,4.6,1.3
3382,234,0,North America,Commercial,Supply Chain,Exceeds,Female,43,11,1,5,25,0.0,2.9,4.3,0.0743,1,1,1,1,3.7,4.3,3.6
3383,976,0,Latin America,Finance,Clinical Operations,Below,Male,35,9,1,11,21,0.0,4.3,2.9,0.0,1,0,0,0,3.7,4.4,4.4
3384,919,0,Middle East & Africa,Finance,Pharmacovigilance,Exceeds,Female,37,33,0,5,28,3.0,2.3,2.1,0.0588,1,1,1,1,1.8,2.3,2.4
3385,580,0,Latin America,Digital,Human Resources,Meets,Female,42,27,0,5,11,2.7,4.1,3.1,0.0853,1,1,1,1,3.2,3.9,2.0
3386,698,0,Asia Pacific,HR,Data Science,Exceeds,Female,47,14,0,9,18,2.4,3.8,3.6,0.0677,0,0,0,0,1.9,2.2,3.2
3387,624,0,Asia Pacific,Digital,Regulatory Affairs,Exceeds,Non-Binary/Other,34,13,0,12,15,4.0,3.5,3.6,0.1452,1,1,1,1,3.4,3.6,1.0
3388,142,0,Middle East & Africa,R&D,Supply Chain,Meets,Female,40,12,0,5,38,4.1,4.5,1.5,0.0977,1,1,1,1,3.7,4.6,2.1
3389,179,0,North America,Commercial,Human Resources,Exceeds,Non-Binary/Other,28,5,0,6,12,2.6,3.0,2.5,0.0743,1,1,1,1,3.7,2.3,2.5
3390,224,0,North America,Commercial,Data Science,Meets,Male,36,29,0,11,25,2.2,4.2,4.3,0.0422,1,1,1,1,2.7,2.8,2.7
3391,704,0,Europe,HR,Clinical Operations,Meets,Female,48,11,0,10,21,2.8,3.3,2.4,0.0383,1,1,1,1,3.5,3.1,3.4
3392,941,0,Middle East & Africa,Finance,Market Access,Meets,Male,47,26,0,11,22,3.1,4.2,2.4,0.0331,1,1,1,1,4.0,3.7,2.1
3393,604,0,Latin America,Digital,Finance & Accounting,Exceeds,Male,42,15,0,8,16,3.9,3.8,3.6,0.1452,1,0,0,0,3.6,2.9,1.9
3394,136,1,Middle East & Africa,R&D,Data Science,Exceeds,Female,49,2,1,12,32,0.0,3.3,1.6,0.1648,1,1,0,0,4.7,2.1,3.6
3395,681,0,Europe,Digital,Marketing,Below,Male,36,36,0,8,12,2.7,2.5,2.1,0.0,1,1,1,1,2.7,1.7,3.2
3396,1049,0,Middle East & Africa,Finance,Data Science,Meets,Female,38,10,0,5,19,4.7,2.6,1.4,0.0331,1,1,1,1,5.0,2.3,3.8
3397,1046,0,Middle East & Africa,Finance,Sales,Exceeds,Female,36,5,1,10,31,0.0,3.5,2.0,0.0588,1,1,1,1,2.4,3.1,1.3
3398,428,0,Europe,Manufacturing,Pharmacovigilance,Meets,Female,42,6,1,8,12,0.0,4.5,3.2,0.0348,1,1,1,1,4.7,3.9,3.5
3399,657,1,North America,Digital,Supply Chain,Far Exceeds,Male,55,11,1,6,9,0.0,3.0,1.0,0.2363,1,1,1,1,3.8,3.6,2.6
3400,741,0,Latin America,HR,Regulatory Affairs,Meets,Female,40,10,0,8,23,2.4,3.5,4.3,0.0383,1,1,1,1,3.5,3.5,4.1
3401,583,0,Europe,Digital,Clinical Operations,Meets,Female,31,11,0,7,11,2.4,3.1,3.1,0.0853,1,1,1,1,3.7,4.0,3.5
3402,213,0,Asia Pacific,Commercial,Supply Chain,Meets,Female,31,5,0,12,38,3.5,4.0,2.2,0.0422,1,1,1,1,2.9,2.8,3.5
3403,40,0,North America,R&D,Medical Affairs,Meets,Male,33,16,0,12,31,4.2,2.9,1.3,0.0977,1,1,1,1,4.1,2.7,2.1
3404,828,0,Asia Pacific,HR,Human Resources,Meets,Female,33,4,0,6,34,3.1,3.2,2.5,0.0383,1,1,1,1,3.3,3.7,3.1
3405,452,0,North America,Manufacturing,Supply Chain,Meets,Female,33,10,0,10,17,4.0,2.3,3.7,0.0348,1,1,1,1,4.0,4.4,4.1
3406,107,0,Latin America,R&D,Marketing,Below,Female,39,22,0,10,22,3.9,3.5,3.5,0.0,1,1,1,1,4.7,3.8,3.4
3407,68,0,Latin America,R&D,Supply Chain,Meets,Female,29,4,0,12,26,2.1,2.2,3.9,0.0977,1,1,1,1,3.6,4.0,3.4
3408,227,0,Middle East & Africa,Commercial,Medical Affairs,Below,Male,41,8,0,9,15,3.3,4.7,3.4,0.0,1,1,1,1,3.6,3.4,3.1
3409,315,0,Asia Pacific,Commercial,Data Science,Meets,Male,44,6,0,5,14,4.1,2.5,3.4,0.0422,1,1,1,1,3.3,3.6,3.0
3410,245,0,North America,Commercial,IT & Digital,Meets,Male,34,2,0,11,21,2.5,3.0,3.5,0.0422,1,1,1,1,3.2,3.5,2.8
3411,739,0,Latin America,HR,Sales,Meets,Female,40,14,0,11,21,2.7,1.0,2.8,0.0383,1,1,1,1,3.3,1.2,3.0
3412,654,0,Europe,Digital,Data Science,Meets,Female,42,13,1,8,10,0.0,2.6,3.2,0.0853,1,1,1,1,4.9,4.3,4.3
3413,165,0,Latin America,R&D,Legal & Compliance,Below,Female,43,11,0,5,9,3.2,2.7,1.4,0.0,0,0,0,0,4.1,3.7,1.4
3414,639,0,Europe,Digital,Data Science,Exceeds,Female,39,32,0,12,30,3.7,4.0,2.2,0.1452,1,1,1,1,2.0,4.9,1.4
3415,675,0,North America,Digital,Medical Affairs,Meets,Female,32,13,0,5,30,1.8,2.4,2.8,0.0853,1,1,1,0,1.7,2.1,2.7
3416,244,0,Latin America,Commercial,Quality Assurance,Exceeds,Male,39,8,1,5,11,0.0,3.3,3.4,0.0743,1,1,1,1,2.9,2.8,2.5
3417,678,0,Latin America,Digital,Regulatory Affairs,Meets,Male,37,8,0,8,12,2.7,4.5,3.3,0.0853,1,0,0,0,2.6,5.0,3.1
3418,164,0,North America,R&D,Medical Affairs,Exceeds,Female,39,1,1,8,20,0.0,3.6,2.0,0.1648,1,1,1,1,2.4,3.7,1.7
3419,137,1,Latin America,R&D,Human Resources,Meets,Female,32,10,1,5,13,0.0,2.6,3.1,0.0977,1,1,1,1,3.9,3.8,3.5
3420,1011,0,Europe,Finance,Data Science,Below,Female,29,14,0,11,21,4.0,4.3,1.9,0.0,0,0,0,0,3.7,3.8,3.1
3421,513,0,Latin America,Manufacturing,Supply Chain,Exceeds,Male,28,9,0,12,21,4.1,1.0,3.2,0.0616,0,0,0,0,3.9,3.9,2.9
3422,836,0,Asia Pacific,HR,Regulatory Affairs,Meets,Male,28,14,0,9,17,3.2,3.6,3.0,0.0383,1,1,1,1,3.4,3.8,2.6
3423,630,0,Middle East & Africa,Digital,Clinical Operations,Meets,Female,28,10,0,12,31,2.9,4.2,3.7,0.0853,1,1,1,1,2.3,3.6,3.2
3424,725,0,Europe,HR,Market Access,Meets,Female,44,16,0,5,9,2.0,2.2,3.8,0.0383,1,1,1,1,1.9,1.9,4.7
3425,714,0,Asia Pacific,HR,Clinical Operations,Meets,Female,40,26,0,5,13,3.8,1.0,5.0,0.0383,1,1,1,1,4.3,2.0,4.1
3426,715,0,North America,HR,Marketing,Exceeds,Male,38,36,0,12,15,3.2,2.1,1.0,0.0677,1,0,0,0,4.1,3.1,1.3
3427,996,0,Europe,Finance,Data Science,Far Exceeds,Female,36,6,1,5,25,0.0,2.9,1.9,0.1022,1,1,0,0,3.3,3.0,1.1
3428,796,1,Middle East & Africa,HR,Supply Chain,Meets,Male,28,10,0,8,24,3.0,2.3,2.7,0.0383,1,1,1,1,3.2,3.0,3.1
3429,1005,0,Middle East & Africa,Finance,Quality Assurance,Meets,Female,40,6,1,10,12,0.0,3.5,5.0,0.0331,1,1,1,1,3.6,4.7,4.2
3430,22,0,North America,R&D,Sales,Far Exceeds,Female,39,5,0,7,33,3.9,2.2,1.9,0.2644,0,0,0,0,4.4,3.9,2.4
3431,523,1,North America,Digital,Sales,Exceeds,Male,38,13,0,12,17,4.1,2.9,2.2,0.1452,1,1,1,1,3.2,2.6,2.5
3432,975,0,Europe,Finance,IT & Digital,Far Below,Male,33,5,0,12,15,3.9,3.9,2.5,0.0,1,1,1,1,2.1,3.3,2.8
3433,445,0,Latin America,Manufacturing,Regulatory Affairs,Meets,Male,34,12,1,9,31,0.0,3.3,2.3,0.0348,1,1,1,1,3.8,2.0,2.3
3434,716,0,North America,HR,Quality Assurance,Below,Non-Binary/Other,41,13,1,10,31,0.0,1.6,3.0,0.0,1,1,1,1,3.3,2.2,2.5
3435,398,0,Latin America,Manufacturing,Market Access,Far Exceeds,Female,33,7,0,8,11,3.2,4.6,2.9,0.1069,1,1,1,0,3.4,4.8,3.0
3436,127,0,Asia Pacific,R&D,Finance & Accounting,Below,Male,44,11,1,8,25,0.0,3.0,2.9,0.0,1,1,1,1,4.2,2.8,3.1
3437,68,0,Middle East & Africa,R&D,Clinical Operations,Meets,Male,48,8,0,11,29,3.9,3.4,2.9,0.0977,1,1,1,1,4.7,4.9,3.0
3438,256,0,Latin America,Commercial,Market Access,Meets,Non-Binary/Other,45,8,0,5,16,3.2,3.9,4.1,0.0422,1,1,1,1,2.3,3.5,3.6
3439,725,0,Middle East & Africa,HR,Pharmacovigilance,Exceeds,Female,39,7,0,9,14,3.2,2.2,2.9,0.0677,1,1,1,1,3.5,1.8,3.9
3440,234,0,Latin America,Commercial,Clinical Operations,Exceeds,Male,37,11,0,9,16,3.6,1.7,1.3,0.0743,0,0,0,0,4.5,2.1,2.8
3441,361,0,Asia Pacific,Manufacturing,Clinical Operations,Meets,Male,39,12,0,7,16,3.7,2.4,2.6,0.0348,1,1,0,0,5.0,1.8,2.5
3442,585,0,North America,Digital,Clinical Operations,Meets,Female,42,11,1,11,13,0.0,4.7,2.7,0.0853,0,0,0,0,2.6,3.9,3.3
3443,319,0,Asia Pacific,Commercial,Supply Chain,Far Exceeds,Male,47,11,1,10,32,0.0,2.9,3.9,0.1275,1,1,1,1,4.1,1.2,3.4
3444,155,0,North America,R&D,Medical Affairs,Meets,Male,41,25,0,6,22,2.5,3.8,3.5,0.0977,1,1,1,1,3.5,4.2,2.7
3445,716,0,North America,HR,IT & Digital,Meets,Non-Binary/Other,28,16,0,12,19,2.8,2.6,3.7,0.0383,1,1,1,1,1.6,4.1,4.5
3446,369,0,Middle East & Africa,Manufacturing,Supply Chain,Meets,Female,32,4,0,6,7,4.3,2.8,3.5,0.0348,1,1,1,1,4.8,3.4,2.4
3447,1023,0,Asia Pacific,Finance,Sales,Meets,Female,37,14,1,7,26,0.0,5.0,2.9,0.0331,1,1,1,1,2.6,4.2,4.3
3448,25,0,Latin America,R&D,IT & Digital,Meets,Male,44,10,0,10,19,3.8,2.9,1.9,0.0977,0,0,0,0,4.2,3.0,1.7
3449,955,0,Asia Pacific,Finance,Legal & Compliance,Meets,Male,52,23,0,5,23,3.9,2.3,2.7,0.0331,1,1,1,1,4.5,2.7,1.0
3450,532,1,Middle East & Africa,Digital,Supply Chain,Meets,Male,38,8,0,9,24,1.2,3.2,1.7,0.0853,1,1,1,1,1.4,2.9,2.8
3451,753,0,North America,HR,Market Access,Exceeds,Female,42,2,0,5,16,3.1,1.6,1.0,0.0677,0,0,0,0,3.8,1.7,2.4
3452,526,0,Middle East & Africa,Digital,Legal & Compliance,Far Below,Female,29,12,0,10,22,3.4,1.9,2.9,0.0,1,1,1,1,4.6,1.7,2.6
3453,628,0,Europe,Digital,Supply Chain,Meets,Female,34,9,0,6,21,2.5,4.2,3.7,0.0853,1,1,1,1,3.3,3.9,2.8
3454,858,0,Europe,HR,Medical Affairs,Meets,Female,40,16,0,5,25,2.0,3.4,1.8,0.0383,1,1,1,1,2.6,3.6,1.8
3455,794,0,Latin America,HR,Regulatory Affairs,Below,Female,28,20,0,7,15,3.1,3.3,1.3,0.0,1,1,1,1,2.4,2.5,1.0
3456,1039,0,Middle East & Africa,Finance,Quality Assurance,Exceeds,Male,39,17,0,10,16,3.8,2.9,3.6,0.0588,1,1,1,1,3.7,2.4,4.2
3457,560,0,Latin America,Digital,Regulatory Affairs,Meets,Male,36,7,0,11,19,4.1,1.9,3.9,0.0853,1,1,0,0,4.6,1.8,4.1
3458,394,0,Latin America,Manufacturing,Pharmacovigilance,Below,Male,38,11,0,9,11,2.1,4.0,2.3,0.0,1,1,1,1,2.8,2.7,3.1
3459,981,0,Europe,Finance,Sales,Meets,Male,34,7,0,5,12,3.6,4.7,1.4,0.0331,1,1,1,1,2.2,3.2,2.1
3460,717,0,Latin America,HR,Pharmacovigilance,Meets,Male,41,14,0,6,19,2.1,1.7,3.9,0.0383,1,1,0,0,3.0,1.7,2.1
3461,137,0,Europe,R&D,Communications,Below,Female,44,15,0,6,14,3.6,3.5,2.0,0.0,1,1,1,1,2.5,3.6,4.1
3462,1027,0,North America,Finance,Pharmacovigilance,Meets,Male,42,9,0,7,14,2.7,1.4,4.0,0.0331,1,1,1,1,3.7,2.8,5.0
3463,316,0,Middle East & Africa,Commercial,Legal & Compliance,Meets,Female,42,12,1,8,9,0.0,2.5,2.0,0.0422,1,1,1,1,3.6,1.0,2.6
3464,421,0,Latin America,Manufacturing,Quality Assurance,Meets,Female,41,1,0,9,12,3.5,5.0,3.4,0.0348,1,1,1,1,3.8,4.9,1.1
3465,943,0,Europe,Finance,Quality Assurance,Below,Male,38,5,0,8,14,4.7,4.1,2.8,0.0,1,1,1,0,4.9,2.9,1.9
3466,731,0,Asia Pacific,HR,Medical Affairs,Meets,Male,35,2,1,8,12,0.0,3.5,2.8,0.0383,1,1,0,0,2.9,1.2,2.2
3467,871,0,Latin America,HR,Legal & Compliance,Below,Male,44,11,0,10,15,3.7,1.4,2.9,0.0,1,1,1,1,3.0,3.2,2.2
3468,403,0,North America,Manufacturing,Medical Affairs,Below,Male,33,3,1,9,19,0.0,4.0,2.9,0.0,1,1,1,1,4.2,3.6,4.9
3469,179,0,North America,Commercial,Legal & Compliance,Exceeds,Female,41,19,0,8,21,2.9,3.4,3.1,0.0743,1,1,1,1,4.6,3.5,2.9
3470,883,0,Asia Pacific,Finance,Regulatory Affairs,Below,Female,41,14,0,9,17,4.2,2.8,2.3,0.0,1,0,0,0,2.4,3.3,2.2
3471,1000,0,Europe,Finance,Medical Affairs,Below,Female,32,28,0,10,26,5.0,2.1,4.7,0.0,1,1,1,1,3.8,3.3,2.6
3472,537,0,Latin America,Digital,Medical Affairs,Exceeds,Male,32,13,1,8,10,0.0,2.0,1.0,0.1452,0,0,0,0,3.7,2.6,3.0
3473,58,0,Europe,R&D,Marketing,Meets,Female,41,28,0,7,9,2.6,2.3,3.8,0.0977,1,1,1,1,3.5,3.3,2.8
3474,772,0,North America,HR,Data Science,Below,Female,39,6,0,10,26,1.3,3.7,2.9,0.0,1,1,1,1,2.6,4.4,2.2
3475,928,0,Europe,Finance,Regulatory Affairs,Far Exceeds,Male,40,10,1,11,15,0.0,3.0,1.2,0.1022,0,0,0,0,4.5,3.5,2.2
3476,974,0,North America,Finance,Communications,Below,Male,37,12,0,9,18,4.2,3.2,3.5,0.0,1,1,1,1,2.3,3.0,3.4
3477,1002,0,Europe,Finance,Quality Assurance,Meets,Female,47,6,0,8,9,3.5,4.3,3.3,0.0331,1,1,1,1,3.6,3.5,3.1
3478,280,0,Asia Pacific,Commercial,Regulatory Affairs,Far Below,Male,42,7,0,5,20,4.0,1.8,4.1,0.0,1,1,1,1,4.3,1.7,3.1
3479,26,0,Middle East & Africa,R&D,Quality Assurance,Meets,Female,46,11,0,11,43,2.3,1.2,1.5,0.0977,1,1,1,1,2.8,2.1,1.2
3480,881,0,Asia Pacific,Finance,Supply Chain,Meets,Male,36,7,0,10,37,4.4,3.8,4.0,0.0331,1,1,1,1,2.7,4.2,4.1
3481,491,0,Asia Pacific,Manufacturing,Data Science,Meets,Male,44,8,1,10,23,0.0,1.9,2.5,0.0348,1,1,1,1,3.3,1.6,1.7
3482,724,0,Middle East & Africa,HR,Marketing,Meets,Female,36,23,1,6,13,0.0,2.6,2.3,0.0383,1,1,1,1,1.9,3.4,3.4
3483,600,0,Middle East & Africa,Digital,Marketing,Meets,Female,36,14,0,11,16,3.4,2.8,2.8,0.0853,1,1,1,1,4.1,2.2,2.0
3484,444,0,Latin America,Manufacturing,Market Access,Meets,Female,31,17,0,7,25,2.6,3.0,4.2,0.0348,1,1,1,1,1.2,3.3,2.3
3485,701,1,Latin America,HR,Legal & Compliance,Exceeds,Male,41,11,0,6,12,2.6,1.2,3.5,0.0677,1,1,1,1,3.3,2.3,3.2
3486,297,0,Asia Pacific,Commercial,Sales,Meets,Female,32,13,1,12,35,0.0,3.0,2.7,0.0422,1,1,1,1,3.6,3.5,3.1
3487,152,0,Asia Pacific,R&D,Finance & Accounting,Meets,Male,34,4,1,8,21,0.0,4.8,5.0,0.0977,1,1,1,1,3.9,4.4,5.0
3488,155,0,North America,R&D,Quality Assurance,Meets,Male,30,5,0,5,9,3.4,2.8,4.0,0.0977,1,1,1,1,3.0,3.9,1.5
3489,738,0,North America,HR,Communications,Meets,Male,28,8,0,9,13,1.7,3.3,3.4,0.0383,1,1,1,1,3.2,2.7,2.3
3490,433,0,Latin America,Manufacturing,Human Resources,Meets,Female,38,12,0,12,14,2.0,4.0,2.8,0.0348,1,1,1,1,3.1,4.8,2.5
3491,673,0,Latin America,Digital,IT & Digital,Meets,Female,34,2,1,10,17,0.0,4.3,1.6,0.0853,0,0,0,0,4.1,2.0,3.1
3492,339,0,North America,Commercial,Sales,Meets,Male,40,7,0,12,24,3.9,4.3,4.7,0.0422,1,1,1,1,2.1,5.0,5.0
3493,712,0,North America,HR,Supply Chain,Far Exceeds,Female,38,9,1,11,14,0.0,2.7,5.0,0.1168,1,1,1,1,3.5,2.8,3.8
3494,221,0,Europe,Commercial,Marketing,Meets,Female,44,9,0,10,12,4.0,3.6,3.8,0.0422,1,1,1,1,3.7,5.0,2.8
3495,138,0,Europe,R&D,Human Resources,Meets,Female,50,8,0,6,15,1.9,4.7,2.4,0.0977,1,1,1,1,3.0,4.6,1.8
3496,1000,0,North America,Finance,Communications,Meets,Female,45,10,0,8,11,4.1,2.7,2.5,0.0331,0,0,0,0,4.1,3.9,1.3
3497,937,0,Europe,Finance,Supply Chain,Exceeds,Female,38,10,0,7,24,1.1,4.5,2.1,0.0588,1,1,1,1,1.8,4.0,2.5
3498,638,0,Middle East & Africa,Digital,Finance & Accounting,Exceeds,Male,42,8,1,7,29,0.0,2.7,3.5,0.1452,1,1,1,1,4.2,2.9,3.4
3499,292,0,Latin America,Commercial,Pharmacovigilance,Exceeds,Female,46,5,0,10,19,4.1,3.2,2.9,0.0743,0,0,0,0,1.7,3.8,4.0
3500,822,1,Latin America,HR,Data Science,Exceeds,Non-Binary/Other,35,15,1,10,29,0.0,5.0,1.8,0.0677,1,1,1,1,3.9,2.9,1.6
3501,621,0,North America,Digital,Market Access,Meets,Female,43,27,0,7,13,4.3,2.1,3.0,0.0853,1,1,1,1,3.8,2.8,1.7
3502,396,0,Asia Pacific,Manufacturing,Supply Chain,Meets,Male,46,20,1,8,21,0.0,1.0,1.6,0.0348,1,1,1,0,3.0,3.2,1.5
3503,936,0,North America,Finance,Finance & Accounting,Meets,Male,38,11,0,7,18,3.2,3.7,4.0,0.0331,1,1,1,1,2.3,2.8,5.0
3504,866,0,Europe,HR,Market Access,Meets,Non-Binary/Other,41,15,0,12,20,4.4,4.0,4.2,0.0383,1,1,1,1,3.9,4.7,2.5
3505,186,0,Asia Pacific,Commercial,Data Science,Meets,Male,50,12,0,12,19,4.2,2.7,4.6,0.0422,1,1,1,1,3.7,4.5,2.7
3506,683,0,Europe,Digital,Finance & Accounting,Exceeds,Female,34,7,0,9,14,3.0,2.9,3.1,0.1452,0,0,0,0,2.8,1.0,2.0
3507,704,0,Middle East & Africa,HR,Regulatory Affairs,Meets,Male,36,9,0,5,33,3.6,3.8,2.3,0.0383,1,1,1,0,2.9,2.7,1.0
3508,617,0,Europe,Digital,IT & Digital,Far Exceeds,Male,41,19,0,6,20,2.7,2.5,1.0,0.2363,1,1,1,1,3.6,3.1,1.0
3509,657,0,Middle East & Africa,Digital,Supply Chain,Far Exceeds,Female,33,10,0,5,16,4.4,2.7,3.5,0.2363,1,1,1,1,3.9,2.9,2.8
3510,570,0,Middle East & Africa,Digital,Medical Affairs,Meets,Male,38,6,1,11,16,0.0,3.9,2.9,0.0853,1,1,1,1,3.9,2.5,3.4
3511,303,0,Europe,Commercial,Clinical Operations,Exceeds,Male,31,24,0,6,16,3.6,4.0,5.0,0.0743,1,1,1,1,3.5,3.3,4.2
3512,873,0,Europe,HR,Marketing,Below,Male,28,19,1,10,18,0.0,3.1,3.7,0.0,1,1,1,1,2.8,4.1,4.7
3513,149,0,Middle East & Africa,R&D,Human Resources,Meets,Female,39,5,0,9,14,1.0,2.3,2.6,0.0977,1,1,1,1,2.2,4.0,2.6
3514,159,0,Asia Pacific,R&D,Marketing,Meets,Male,30,36,0,11,21,2.5,3.9,3.3,0.0977,1,1,1,1,2.6,4.6,1.4
3515,255,0,Middle East & Africa,Commercial,Marketing,Meets,Male,32,16,0,7,23,2.0,3.4,3.7,0.0422,1,1,1,1,1.8,2.5,2.4
3516,286,0,Latin America,Commercial,Regulatory Affairs,Exceeds,Female,44,22,0,9,18,3.6,2.2,4.8,0.0743,1,1,1,1,3.9,3.3,4.9
3517,1008,0,Middle East & Africa,Finance,Clinical Operations,Meets,Male,39,9,0,8,21,1.2,2.2,3.0,0.0331,1,1,1,1,2.4,3.6,2.2
3518,681,0,Asia Pacific,Digital,Data Science,Meets,Male,38,6,0,12,22,3.5,2.7,2.7,0.0853,1,1,1,1,4.4,3.5,2.1
3519,713,0,Latin America,HR,IT & Digital,Below,Female,36,18,1,5,12,0.0,4.4,1.1,0.0,1,1,1,1,2.7,4.6,1.7
3520,769,0,North America,HR,Legal & Compliance,Below,Female,47,12,0,11,21,3.6,2.2,3.0,0.0,1,1,1,1,2.7,3.2,3.1
3521,416,0,North America,Manufacturing,Regulatory Affairs,Meets,Male,51,12,0,9,16,3.3,4.9,2.8,0.0348,1,1,1,1,2.9,3.6,2.9
3522,441,0,Asia Pacific,Manufacturing,Marketing,Meets,Female,42,7,1,10,13,0.0,4.3,2.0,0.0348,0,0,0,0,4.1,3.1,3.5
3523,35,0,Middle East & Africa,R&D,Finance & Accounting,Meets,Female,28,16,0,7,18,4.2,3.7,1.9,0.0977,1,1,1,1,2.7,4.4,2.9
3524,384,0,Europe,Manufacturing,IT & Digital,Meets,Male,38,9,0,11,18,4.2,2.6,1.0,0.0348,1,1,1,1,2.9,2.5,3.2
3525,371,0,Asia Pacific,Manufacturing,Marketing,Meets,Female,32,27,0,9,22,4.4,5.0,1.5,0.0348,1,0,0,0,5.0,4.0,3.4
3526,109,0,Latin America,R&D,Finance & Accounting,Below,Male,35,10,0,6,9,2.7,3.1,1.6,0.0,1,1,1,1,2.3,3.9,1.4
3527,1016,0,Latin America,Finance,Sales,Meets,Male,41,13,0,7,25,2.3,2.5,1.7,0.0331,1,1,1,1,3.5,2.5,3.0
3528,8,1,North America,R&D,Market Access,Exceeds,Female,39,9,0,11,23,4.2,2.7,2.7,0.1648,1,1,1,1,4.6,3.7,4.7
3529,506,0,Latin America,Manufacturing,Market Access,Meets,Male,30,15,0,11,28,2.7,1.6,3.8,0.0348,1,1,1,1,2.5,2.5,3.9
3530,751,0,Asia Pacific,HR,Sales,Meets,Female,34,4,1,11,25,0.0,2.2,2.7,0.0383,1,1,1,1,2.8,3.9,1.7
3531,408,0,Latin America,Manufacturing,Pharmacovigilance,Meets,Male,45,4,1,9,19,0.0,2.4,1.2,0.0348,1,1,1,0,2.0,4.2,2.0
3532,594,1,Asia Pacific,Digital,Legal & Compliance,Meets,Male,48,4,0,10,11,3.4,3.0,2.3,0.0853,1,1,1,1,3.7,2.2,2.7
3533,589,0,Europe,Digital,Sales,Meets,Male,46,14,0,11,22,3.1,2.9,2.2,0.0853,1,1,1,1,3.2,2.5,1.9
3534,565,0,North America,Digital,Finance & Accounting,Far Exceeds,Male,30,7,0,10,15,4.2,1.7,4.3,0.2363,1,1,1,1,4.7,4.0,3.6
3535,931,0,Latin America,Finance,Market Access,Below,Female,36,10,0,12,13,2.1,2.7,2.5,0.0,1,1,0,0,2.7,2.8,4.5
3536,270,0,Asia Pacific,Commercial,Marketing,Far Exceeds,Female,34,6,0,8,14,2.0,2.8,3.2,0.1275,1,1,1,1,3.0,4.0,4.6
3537,658,0,Middle East & Africa,Digital,Human Resources,Far Exceeds,Female,42,9,1,11,15,0.0,2.7,4.0,0.2363,1,1,1,1,3.8,2.7,2.8
3538,701,0,North America,HR,Medical Affairs,Exceeds,Female,36,13,0,7,17,1.6,3.3,2.9,0.0677,1,1,1,1,1.0,2.6,2.4
3539,1021,0,Europe,Finance,Market Access,Meets,Female,32,17,0,11,20,2.9,3.4,3.4,0.0331,1,1,1,1,3.0,3.8,2.2
3540,321,0,Asia Pacific,Commercial,Legal & Compliance,Exceeds,Female,47,13,0,5,25,4.0,3.6,2.7,0.0743,0,0,0,0,3.9,3.1,3.0
3541,262,0,Europe,Commercial,Legal & Compliance,Meets,Male,35,16,0,11,25,5.0,1.8,2.3,0.0422,1,1,1,1,4.9,2.5,2.7
3542,613,0,Europe,Digital,Communications,Meets,Female,44,7,1,11,11,0.0,2.2,2.8,0.0853,1,1,1,1,3.2,2.5,2.6
3543,396,0,Latin America,Manufacturing,Clinical Operations,Below,Female,34,6,1,7,12,0.0,2.5,2.9,0.0,1,1,1,1,2.2,1.0,3.3
3544,163,0,Latin America,R&D,Medical Affairs,Exceeds,Female,43,10,1,10,12,0.0,3.8,2.0,0.1648,1,1,1,1,4.6,3.2,2.2
3545,492,0,Asia Pacific,Manufacturing,Regulatory Affairs,Meets,Female,36,19,1,6,12,0.0,3.3,3.0,0.0348,1,1,1,1,4.0,4.3,3.5
3546,445,0,Middle East & Africa,Manufacturing,Market Access,Below,Male,32,10,0,7,17,4.2,2.9,3.7,0.0,1,1,1,1,3.5,1.8,4.2
3547,180,0,Asia Pacific,Commercial,Data Science,Exceeds,Female,45,9,0,5,9,2.8,3.0,2.3,0.0743,1,1,1,1,3.3,4.3,1.8
3548,199,0,Middle East & Africa,Commercial,Supply Chain,Meets,Non-Binary/Other,34,17,0,8,26,4.2,4.3,1.0,0.0422,1,1,1,1,2.2,2.9,1.0
3549,1009,0,Europe,Finance,Supply Chain,Meets,Female,39,6,0,8,11,2.9,4.6,4.0,0.0331,0,0,0,0,2.2,4.3,5.0
3550,1022,0,North America,Finance,Clinical Operations,Meets,Female,30,18,0,10,12,4.7,2.9,2.7,0.0331,1,1,1,1,4.1,3.5,1.0
3551,300,0,Asia Pacific,Commercial,Quality Assurance,Exceeds,Male,30,6,0,5,12,4.1,2.5,2.9,0.0743,1,1,1,1,3.8,2.6,1.8
3552,726,0,Asia Pacific,HR,Supply Chain,Meets,Female,47,12,1,11,28,0.0,1.1,4.5,0.0383,1,1,1,1,2.8,1.2,3.4
3553,792,0,Middle East & Africa,HR,Clinical Operations,Meets,Female,39,11,0,10,17,3.4,3.5,2.3,0.0383,1,1,1,1,3.9,2.7,1.0
3554,97,0,Europe,R&D,Quality Assurance,Meets,Male,37,17,0,12,16,2.9,3.1,2.4,0.0977,1,1,1,1,3.1,2.0,1.7
3555,201,0,Europe,Commercial,Legal & Compliance,Meets,Female,35,15,0,9,11,3.8,4.0,2.3,0.0422,1,1,1,1,4.3,3.5,2.0
3556,678,0,Middle East & Africa,Digital,Legal & Compliance,Meets,Male,33,9,0,10,14,3.0,4.0,4.4,0.0853,1,1,1,1,3.4,3.8,4.4
3557,970,0,Europe,Finance,Regulatory Affairs,Meets,Male,41,12,0,6,8,2.7,3.0,2.2,0.0331,1,1,1,1,3.7,3.4,2.9
3558,203,0,Latin America,Commercial,Quality Assurance,Meets,Male,47,18,0,6,21,3.8,1.8,1.1,0.0422,1,1,1,1,3.7,1.8,1.3
3559,830,0,North America,HR,Data Science,Meets,Female,43,28,0,10,18,3.6,4.4,2.7,0.0383,0,0,0,0,4.1,3.1,2.4
3560,334,0,Asia Pacific,Commercial,Market Access,Exceeds,Female,42,15,0,5,11,2.2,2.4,3.7,0.0743,1,1,1,1,3.3,1.3,2.5
3561,792,0,North America,HR,Supply Chain,Meets,Female,36,28,0,12,26,4.5,4.4,1.9,0.0383,1,1,1,1,5.0,2.8,1.7
3562,340,0,Asia Pacific,Commercial,Finance & Accounting,Meets,Female,42,7,0,7,12,4.1,3.8,2.4,0.0422,1,1,1,1,5.0,3.9,2.1
3563,675,0,Latin America,Digital,Marketing,Meets,Female,50,11,0,8,11,4.0,1.3,4.0,0.0853,1,1,1,1,4.2,1.0,3.1
3564,159,0,Europe,R&D,Sales,Meets,Female,36,11,0,8,19,3.1,2.7,3.0,0.0977,1,1,1,1,2.5,3.2,3.7
3565,540,0,Middle East & Africa,Digital,Communications,Exceeds,Female,40,7,0,8,13,2.4,2.5,1.4,0.1452,1,1,1,1,3.7,3.0,2.4
3566,828,0,Latin America,HR,Human Resources,Far Below,Female,46,13,0,10,11,4.3,1.0,4.4,0.0,1,1,1,1,3.3,1.0,4.2
3567,1020,0,North America,Finance,Market Access,Meets,Male,50,22,0,11,21,2.7,1.8,1.5,0.0331,0,0,0,0,3.8,3.2,3.7
3568,959,0,Middle East & Africa,Finance,Legal & Compliance,Meets,Male,39,11,0,11,24,2.6,1.6,2.8,0.0331,1,1,1,1,3.0,1.7,2.7
3569,378,0,Europe,Manufacturing,Human Resources,Meets,Female,43,17,0,9,18,3.5,4.0,4.0,0.0348,1,1,1,1,3.7,4.0,2.3
3570,696,0,Latin America,Digital,Regulatory Affairs,Far Below,Male,36,8,0,8,10,1.8,2.5,2.4,0.0,1,1,1,1,2.0,4.4,1.6
3571,230,0,Middle East & Africa,Commercial,Regulatory Affairs,Exceeds,Male,40,10,1,9,26,0.0,2.9,3.5,0.0743,0,0,0,0,3.3,3.6,2.8
3572,139,0,Latin America,R&D,Finance & Accounting,Exceeds,Female,37,5,0,10,15,2.6,3.1,5.0,0.1648,1,1,1,1,2.1,4.1,3.7
3573,204,0,Latin America,Commercial,IT & Digital,Below,Non-Binary/Other,45,2,1,11,16,0.0,5.0,2.0,0.0,1,1,1,1,2.8,4.9,1.1
3574,288,0,Europe,Commercial,Communications,Meets,Female,48,8,1,5,12,0.0,3.1,2.9,0.0422,1,1,1,1,3.9,4.2,2.2
3575,683,0,Asia Pacific,Digital,Clinical Operations,Below,Male,31,13,1,7,26,0.0,2.5,4.5,0.0,1,1,1,1,4.3,2.5,3.9
3576,59,0,Middle East & Africa,R&D,Legal & Compliance,Meets,Female,37,17,0,12,20,4.2,2.5,3.3,0.0977,1,1,1,1,3.3,1.3,3.4
3577,452,0,Europe,Manufacturing,Pharmacovigilance,Meets,Female,35,19,0,8,11,4.5,2.7,3.6,0.0348,1,1,1,1,3.8,2.7,1.3
3578,244,0,Latin America,Commercial,Human Resources,Meets,Female,36,6,1,5,18,0.0,3.5,4.0,0.0422,1,1,1,1,4.7,3.2,1.9
3579,82,0,Europe,R&D,Quality Assurance,Below,Male,37,16,0,10,14,1.3,2.8,1.3,0.0,1,1,1,1,2.4,3.9,2.4
3580,385,0,Asia Pacific,Manufacturing,Quality Assurance,Exceeds,Female,33,21,0,10,17,3.1,2.2,3.8,0.0616,1,1,1,1,3.4,2.8,2.1
3581,352,0,Middle East & Africa,Commercial,Clinical Operations,Meets,Male,40,32,0,9,33,3.9,3.2,1.7,0.0422,1,0,0,0,4.7,2.8,3.1
3582,26,0,Asia Pacific,R&D,Sales,Far Below,Female,31,9,1,6,32,0.0,4.2,1.7,0.0,1,1,1,1,3.1,2.5,2.6
3583,629,0,North America,Digital,IT & Digital,Meets,Female,43,11,0,6,22,3.0,3.2,3.2,0.0853,0,0,0,0,3.4,2.8,3.0
3584,958,0,Middle East & Africa,Finance,Marketing,Exceeds,Female,40,18,0,9,16,2.3,2.5,2.0,0.0588,1,1,1,1,2.7,2.2,2.2
3585,954,0,Asia Pacific,Finance,Communications,Meets,Female,32,5,0,8,19,3.9,3.3,3.1,0.0331,1,1,1,1,3.3,3.0,2.1
3586,260,0,Latin America,Commercial,Regulatory Affairs,Meets,Non-Binary/Other,31,11,1,9,15,0.0,1.0,3.0,0.0422,1,0,0,0,4.0,1.0,3.6
3587,337,0,Middle East & Africa,Commercial,Market Access,Meets,Male,43,5,0,11,20,3.1,2.9,2.0,0.0422,1,1,1,1,4.5,4.6,4.7
3588,31,0,Middle East & Africa,R&D,Communications,Meets,Male,34,20,0,10,32,3.8,2.2,1.8,0.0977,1,1,1,1,4.2,2.5,2.6
3589,990,0,Europe,Finance,Sales,Meets,Male,47,14,1,9,14,0.0,1.3,2.2,0.0331,1,1,1,1,3.1,2.2,2.4
3590,339,0,Latin America,Commercial,Marketing,Far Exceeds,Female,28,14,1,8,14,0.0,4.4,3.2,0.1275,1,1,1,1,3.4,5.0,4.1
3591,520,0,North America,Manufacturing,Pharmacovigilance,Below,Female,32,8,1,5,12,0.0,2.6,5.0,0.0,1,1,1,1,2.5,2.5,4.0
3592,277,0,Asia Pacific,Commercial,Communications,Meets,Female,36,23,0,10,15,1.8,2.3,1.3,0.0422,1,1,1,0,1.0,2.6,1.6
3593,1000,0,Europe,Finance,Market Access,Below,Female,38,3,0,7,13,3.9,3.2,1.6,0.0,1,1,1,1,4.2,4.1,3.5
3594,854,0,Asia Pacific,HR,Clinical Operations,Meets,Male,42,7,1,6,8,0.0,1.7,3.6,0.0383,1,1,1,1,5.0,2.5,2.6
3595,942,0,North America,Finance,Finance & Accounting,Meets,Male,37,10,1,5,9,0.0,2.4,1.8,0.0331,1,1,1,1,3.5,2.9,2.6
3596,468,0,North America,Manufacturing,Market Access,Exceeds,Male,36,12,0,8,13,2.9,2.4,2.7,0.0616,1,1,1,1,3.3,2.6,2.9
3597,56,0,Middle East & Africa,R&D,Data Science,Below,Female,34,16,0,6,12,3.6,2.9,3.3,0.0,1,1,1,1,3.9,4.0,3.5
3598,435,0,North America,Manufacturing,IT & Digital,Far Exceeds,Female,33,12,0,5,8,3.1,5.0,3.7,0.1069,1,1,1,1,3.0,5.0,2.9
3599,859,0,Asia Pacific,HR,Pharmacovigilance,Meets,Female,34,11,0,6,20,2.0,4.7,2.3,0.0383,0,0,0,0,3.5,4.1,3.7
3600,778,0,Latin America,HR,Communications,Meets,Male,38,7,1,12,16,0.0,1.6,1.6,0.0383,1,1,1,1,2.8,1.8,1.9
3601,239,0,Latin America,Commercial,Legal & Compliance,Below,Male,28,7,0,8,45,3.8,3.1,3.5,0.0,1,1,1,1,3.5,2.7,2.3
3602,285,0,Middle East & Africa,Commercial,Clinical Operations,Meets,Female,41,9,1,11,27,0.0,2.4,3.7,0.0422,1,1,1,1,1.9,3.7,4.1
3603,920,0,Asia Pacific,Finance,Clinical Operations,Meets,Male,38,4,1,12,17,0.0,3.3,2.8,0.0331,1,1,1,1,2.0,3.3,3.1
3604,550,0,Asia Pacific,Digital,Clinical Operations,Meets,Male,37,11,1,10,18,0.0,1.7,1.5,0.0853,1,1,1,1,3.0,2.0,1.6
3605,381,0,North America,Manufacturing,Supply Chain,Meets,Male,45,20,0,9,20,2.9,5.0,4.2,0.0348,0,0,0,0,3.8,2.9,2.3
3606,1002,0,Asia Pacific,Finance,Finance & Accounting,Meets,Female,42,23,0,5,22,4.1,3.0,3.6,0.0331,1,1,1,1,3.0,3.5,1.1
3607,537,0,Europe,Digital,Sales,Meets,Male,39,13,0,11,24,3.4,2.5,2.5,0.0853,1,1,1,1,4.0,4.5,3.2
3608,989,0,North America,Finance,Marketing,Meets,Male,42,27,1,9,23,0.0,2.4,2.8,0.0331,1,1,1,1,2.6,2.4,3.6
3609,734,0,Europe,HR,Finance & Accounting,Exceeds,Female,34,20,1,7,15,0.0,3.3,4.6,0.0677,1,1,1,1,2.6,2.5,4.2
3610,260,0,Middle East & Africa,Commercial,Communications,Meets,Male,42,14,0,5,8,5.0,2.2,3.9,0.0422,1,1,1,1,5.0,2.4,3.9
3611,218,0,Latin America,Commercial,Legal & Compliance,Meets,Male,43,14,0,6,10,4.6,2.5,3.8,0.0422,1,1,1,1,3.3,3.2,2.6
3612,994,0,Middle East & Africa,Finance,Quality Assurance,Meets,Female,28,4,0,7,22,3.6,3.5,4.7,0.0331,1,0,0,0,2.6,3.1,4.4
3613,296,0,Latin America,Commercial,Legal & Compliance,Meets,Female,49,9,0,6,11,2.9,1.9,3.7,0.0422,1,1,1,1,3.6,2.7,4.0
3614,98,0,Middle East & Africa,R&D,Finance & Accounting,Below,Male,40,9,1,9,15,0.0,3.3,1.4,0.0,1,1,1,1,3.6,4.3,2.6
3615,952,0,Asia Pacific,Finance,Regulatory Affairs,Meets,Male,42,18,0,12,25,4.5,3.5,1.4,0.0331,1,1,1,1,5.0,3.1,2.3
3616,757,0,Europe,HR,Finance & Accounting,Meets,Male,44,8,1,7,20,0.0,1.7,2.4,0.0383,1,1,1,1,3.7,2.0,2.0
3617,923,0,Latin America,Finance,Regulatory Affairs,Meets,Female,37,8,1,5,10,0.0,3.2,2.6,0.0331,1,0,0,0,3.5,2.5,4.2
3618,1011,0,North America,Finance,Data Science,Meets,Female,36,22,0,12,13,2.3,3.2,2.4,0.0331,1,1,1,1,3.8,3.6,2.6
3619,295,0,Europe,Commercial,Finance & Accounting,Far Exceeds,Male,40,16,0,11,29,2.3,3.9,3.0,0.1275,1,0,0,0,2.8,3.6,2.4
3620,861,0,North America,HR,Data Science,Exceeds,Male,55,23,0,6,10,3.3,2.8,2.5,0.0677,0,0,0,0,2.7,3.3,1.4
3621,1043,0,Europe,Finance,Finance & Accounting,Exceeds,Male,37,11,0,5,16,3.8,2.1,1.8,0.0588,1,1,1,1,2.4,2.5,1.6
3622,331,0,Europe,Commercial,Data Science,Below,Male,34,4,0,9,16,1.6,2.0,1.0,0.0,1,0,0,0,4.4,2.2,2.6
3623,407,0,Middle East & Africa,Manufacturing,Medical Affairs,Exceeds,Male,46,5,0,8,11,4.2,1.8,2.6,0.0616,1,0,0,0,4.9,3.8,2.0
3624,803,0,Latin America,HR,Data Science,Meets,Female,28,9,1,6,22,0.0,3.0,4.6,0.0383,1,1,1,1,2.5,1.4,3.1
3625,678,0,Latin America,Digital,Regulatory Affairs,Meets,Female,37,16,1,5,35,0.0,2.2,4.0,0.0853,1,1,1,1,2.7,3.6,2.4
3626,109,0,Europe,R&D,Pharmacovigilance,Meets,Male,34,25,0,9,36,4.4,4.1,3.8,0.0977,1,1,1,1,4.0,3.2,3.5
3627,539,0,Asia Pacific,Digital,Marketing,Meets,Female,42,5,1,9,19,0.0,3.2,3.3,0.0853,1,0,0,0,3.5,2.9,4.4
3628,724,0,Asia Pacific,HR,Data Science,Exceeds,Male,39,7,1,7,12,0.0,3.4,2.3,0.0677,0,0,0,0,3.0,2.4,2.9
3629,1037,0,North America,Finance,Pharmacovigilance,Meets,Male,31,8,0,12,13,3.2,3.2,3.4,0.0331,1,1,1,1,3.5,3.7,3.5
3630,295,0,North America,Commercial,Communications,Meets,Female,42,17,1,9,14,0.0,2.9,2.7,0.0422,0,0,0,0,3.3,3.4,2.9
3631,710,0,Middle East & Africa,HR,Medical Affairs,Below,Male,33,7,0,7,15,3.2,4.3,2.9,0.0,1,1,1,1,3.0,4.6,2.3
3632,150,0,Europe,R&D,Medical Affairs,Meets,Female,38,9,0,6,16,4.0,1.4,3.4,0.0977,1,1,1,1,2.4,3.3,2.7
3633,725,0,North America,HR,Quality Assurance,Meets,Female,35,15,0,5,15,2.8,3.1,3.2,0.0383,1,1,1,1,2.8,4.6,2.7
3634,204,0,North America,Commercial,Supply Chain,Exceeds,Non-Binary/Other,43,14,0,12,27,2.8,1.7,2.4,0.0743,1,1,1,1,3.8,3.3,4.1
3635,532,0,Europe,Digital,Communications,Meets,Female,35,5,0,11,24,2.7,1.3,2.0,0.0853,1,1,1,0,2.0,2.6,2.2
3636,469,0,Middle East & Africa,Manufacturing,Supply Chain,Meets,Male,28,23,1,7,14,0.0,1.8,4.2,0.0348,1,1,1,1,2.9,3.7,2.7
3637,658,0,North America,Digital,Market Access,Meets,Female,31,3,0,7,11,3.7,4.9,2.4,0.0853,1,1,1,1,3.7,3.1,2.2
3638,336,0,Middle East & Africa,Commercial,Supply Chain,Meets,Male,38,13,0,12,35,3.6,2.7,4.9,0.0422,1,1,1,1,2.8,3.4,5.0
3639,274,0,Latin America,Commercial,Market Access,Meets,Female,34,5,0,5,39,4.9,3.2,3.2,0.0422,1,1,1,1,4.0,2.3,1.9
3640,157,0,Middle East & Africa,R&D,Human Resources,Below,Female,45,6,0,9,25,3.8,4.5,3.6,0.0,1,1,1,1,3.9,4.8,1.6
3641,717,0,Asia Pacific,HR,Sales,Meets,Female,32,12,0,8,23,5.0,2.0,2.4,0.0383,1,1,1,1,3.8,2.4,2.9
3642,842,0,Asia Pacific,HR,Communications,Below,Female,41,5,1,9,24,0.0,2.9,2.3,0.0,1,1,0,0,3.8,3.9,3.2
3643,572,0,Middle East & Africa,Digital,Supply Chain,Meets,Female,43,1,0,12,23,2.4,2.8,1.0,0.0853,1,1,1,1,3.7,2.7,1.5
3644,481,0,Asia Pacific,Manufacturing,Medical Affairs,Below,Female,39,8,1,6,13,0.0,3.9,4.1,0.0,1,1,1,1,3.7,4.4,5.0
3645,419,0,Latin America,Manufacturing,Quality Assurance,Far Exceeds,Female,40,6,0,6,11,4.5,4.3,2.4,0.1069,1,1,1,1,4.2,3.7,2.0
3646,73,0,Europe,R&D,Pharmacovigilance,Exceeds,Male,37,8,0,5,14,2.2,2.1,2.9,0.1648,1,1,1,1,2.5,3.2,3.6
3647,248,0,Asia Pacific,Commercial,Finance & Accounting,Meets,Female,40,6,1,10,19,0.0,2.3,2.6,0.0422,1,1,0,0,3.3,2.8,2.4
3648,96,0,Asia Pacific,R&D,IT & Digital,Meets,Female,35,4,1,10,21,0.0,4.3,3.4,0.0977,1,1,1,1,2.5,3.2,3.3
3649,764,0,Middle East & Africa,HR,Data Science,Meets,Female,39,20,0,9,21,3.6,2.4,2.3,0.0383,1,1,1,1,3.7,2.7,2.9
3650,906,0,Latin America,Finance,Supply Chain,Meets,Non-Binary/Other,36,16,0,6,21,4.3,2.8,2.6,0.0331,1,1,1,1,4.1,3.7,3.1
3651,1019,0,Europe,Finance,IT & Digital,Meets,Male,36,8,0,8,15,2.6,2.6,3.8,0.0331,1,1,1,1,3.7,1.5,3.1
3652,1040,0,Middle East & Africa,Finance,Market Access,Meets,Male,34,8,1,8,36,0.0,4.1,3.3,0.0331,1,1,1,1,2.8,4.4,4.4
3653,330,0,Middle East & Africa,Commercial,Pharmacovigilance,Far Below,Female,37,16,1,12,19,0.0,3.4,3.5,0.0,1,1,1,1,1.8,3.3,3.5
3654,142,0,Latin America,R&D,Clinical Operations,Below,Male,47,15,0,11,25,3.6,1.2,2.0,0.0,1,1,1,1,2.8,2.0,2.1
3655,564,0,Europe,Digital,Regulatory Affairs,Meets,Female,37,7,0,9,17,3.6,2.1,4.3,0.0853,1,1,1,1,2.8,1.4,3.3
3656,746,0,Latin America,HR,Supply Chain,Below,Female,44,16,0,6,24,3.4,2.7,3.0,0.0,1,1,1,0,4.0,3.2,2.8
3657,942,0,Europe,Finance,Communications,Meets,Male,41,15,0,9,18,2.7,3.0,1.1,0.0331,1,1,1,1,2.2,2.5,2.7
3658,415,0,Latin America,Manufacturing,Finance & Accounting,Below,Female,39,13,0,7,8,3.9,4.4,3.5,0.0,1,1,1,1,4.1,3.5,5.0
3659,87,1,Middle East & Africa,R&D,Regulatory Affairs,Exceeds,Non-Binary/Other,40,26,0,6,8,4.0,3.4,1.8,0.1648,1,1,0,0,4.5,4.0,2.0
3660,738,0,Middle East & Africa,HR,Supply Chain,Meets,Male,38,10,0,7,23,4.9,2.8,3.0,0.0383,0,0,0,0,2.6,2.7,2.2
3661,753,0,North America,HR,Clinical Operations,Meets,Female,35,17,0,5,18,5.0,3.4,1.5,0.0383,1,1,1,1,5.0,3.6,3.8
3662,484,0,Asia Pacific,Manufacturing,Communications,Meets,Male,48,18,0,7,17,2.4,3.0,3.0,0.0348,1,1,1,1,2.0,1.6,3.3
3663,424,0,Latin America,Manufacturing,Data Science,Meets,Female,44,10,0,6,23,2.7,2.4,2.8,0.0348,1,1,0,0,3.7,2.7,3.5
3664,424,0,North America,Manufacturing,Communications,Meets,Female,38,15,0,6,34,3.0,2.2,2.3,0.0348,1,1,1,1,3.5,3.9,2.5
3665,1021,0,Asia Pacific,Finance,Sales,Meets,Female,38,6,1,5,10,0.0,2.8,5.0,0.0331,1,1,1,1,4.2,4.0,3.5
3666,963,0,Latin America,Finance,Legal & Compliance,Far Below,Male,41,21,0,8,12,3.2,2.0,1.8,0.0,0,0,0,0,2.3,1.2,2.1
3667,12,0,Europe,R&D,IT & Digital,Meets,Female,32,5,1,5,10,0.0,3.2,2.5,0.0977,1,1,1,1,3.5,2.4,2.2
3668,357,0,Asia Pacific,Manufacturing,Legal & Compliance,Meets,Female,33,21,0,6,19,2.6,4.1,1.8,0.0348,1,1,1,1,2.8,3.9,2.4
3669,568,0,Middle East & Africa,Digital,Human Resources,Far Exceeds,Male,28,6,0,6,16,2.9,3.7,3.5,0.2363,1,1,1,1,4.3,4.8,4.0
3670,798,0,North America,HR,Marketing,Exceeds,Female,37,5,0,6,22,1.2,3.8,3.9,0.0677,1,1,1,1,1.9,4.8,1.9
3671,420,0,Asia Pacific,Manufacturing,Communications,Below,Female,45,8,0,10,19,3.5,2.3,3.4,0.0,1,1,1,1,4.1,3.0,3.9
3672,872,0,Asia Pacific,HR,Finance & Accounting,Meets,Female,36,6,1,7,12,0.0,1.9,3.3,0.0383,1,1,1,1,2.8,1.7,2.7
3673,208,0,Middle East & Africa,Commercial,Pharmacovigilance,Exceeds,Female,51,7,0,10,17,3.0,3.9,3.5,0.0743,1,1,1,1,2.9,3.9,3.8
3674,286,0,Latin America,Commercial,Pharmacovigilance,Far Below,Female,35,10,1,11,20,0.0,3.4,2.5,0.0,0,0,0,0,4.4,3.1,2.3
3675,506,0,Europe,Manufacturing,Data Science,Meets,Female,39,6,0,6,7,2.8,2.9,1.7,0.0348,1,1,1,1,4.2,2.7,3.1
3676,759,0,Middle East & Africa,HR,Legal & Compliance,Meets,Male,36,7,0,11,13,3.6,3.7,1.8,0.0383,1,1,1,1,3.7,2.2,2.6
3677,332,0,Europe,Commercial,Quality Assurance,Meets,Female,28,8,0,5,20,4.5,2.8,2.2,0.0422,1,1,0,0,4.9,2.4,1.8
3678,360,0,Latin America,Manufacturing,Finance & Accounting,Meets,Female,36,11,0,12,13,3.8,4.6,3.8,0.0348,1,0,0,0,2.5,3.5,4.7
3679,730,0,Asia Pacific,HR,Medical Affairs,Far Exceeds,Female,33,7,0,7,22,4.5,3.7,2.5,0.1168,1,1,1,0,5.0,3.5,2.7
3680,367,0,Europe,Manufacturing,Supply Chain,Meets,Male,39,23,0,5,29,4.8,3.1,3.0,0.0348,0,0,0,0,3.4,2.2,3.9
3681,1002,0,North America,Finance,Marketing,Meets,Male,46,11,1,8,22,0.0,1.7,4.0,0.0331,1,1,1,1,4.5,2.6,4.5
3682,813,0,North America,HR,Quality Assurance,Meets,Female,36,6,0,6,18,3.5,2.6,4.7,0.0383,1,1,1,1,2.9,2.7,5.0
3683,201,0,Middle East & Africa,Commercial,Marketing,Meets,Male,40,3,0,5,32,3.8,4.3,3.5,0.0422,1,1,1,1,3.6,4.6,2.3
3684,412,0,Latin America,Manufacturing,Medical Affairs,Far Exceeds,Male,37,13,0,8,18,2.2,3.7,2.5,0.1069,1,1,1,1,2.2,2.8,2.0
3685,353,0,Middle East & Africa,Commercial,Regulatory Affairs,Meets,Male,43,17,0,8,17,3.9,4.7,1.2,0.0422,1,1,1,1,3.4,4.6,1.0
3686,480,0,Middle East & Africa,Manufacturing,Supply Chain,Meets,Female,52,11,0,6,19,4.1,2.2,3.4,0.0348,1,1,1,1,3.2,2.8,2.9
3687,121,0,Middle East & Africa,R&D,Human Resources,Meets,Non-Binary/Other,47,34,0,9,15,1.9,1.4,3.2,0.0977,0,0,0,0,2.7,2.6,2.8
3688,201,0,North America,Commercial,Communications,Far Below,Female,34,17,0,10,20,2.7,3.9,2.9,0.0,1,1,1,1,2.9,4.1,2.1
3689,323,0,North America,Commercial,Finance & Accounting,Meets,Male,46,15,0,8,12,2.2,3.9,2.2,0.0422,1,1,1,1,1.1,3.8,2.2
3690,540,0,Middle East & Africa,Digital,Human Resources,Meets,Male,40,9,0,7,9,3.7,3.2,3.1,0.0853,1,1,1,1,2.4,2.6,4.5
3691,1009,0,North America,Finance,Medical Affairs,Meets,Female,45,27,0,6,23,2.7,4.0,3.2,0.0331,1,1,1,1,3.3,2.2,2.7
3692,296,0,Latin America,Commercial,Finance & Accounting,Meets,Female,32,8,0,10,14,4.5,4.5,2.2,0.0422,0,0,0,0,4.0,3.0,3.5
3693,803,0,Middle East & Africa,HR,Pharmacovigilance,Meets,Male,37,17,0,11,14,4.0,2.8,1.1,0.0383,1,1,1,1,2.6,3.5,1.8
3694,513,0,North America,Manufacturing,Pharmacovigilance,Meets,Female,39,18,0,7,50,4.7,4.4,2.8,0.0348,1,1,1,1,5.0,4.6,1.2
3695,118,0,Europe,R&D,Supply Chain,Far Below,Male,38,11,0,9,18,3.0,1.5,3.7,0.0,1,1,1,1,2.1,3.0,4.3
3696,756,0,Middle East & Africa,HR,Sales,Meets,Female,40,30,0,10,16,5.0,3.2,2.5,0.0383,1,1,1,1,4.7,1.8,2.8
3697,817,0,Middle East & Africa,HR,Data Science,Exceeds,Male,37,10,0,6,17,1.4,3.2,2.7,0.0677,1,1,1,1,1.0,4.1,1.2
3698,790,0,Latin America,HR,Data Science,Exceeds,Non-Binary/Other,36,5,1,12,18,0.0,3.4,3.0,0.0677,1,1,1,1,3.6,4.1,2.8
3699,811,0,Asia Pacific,HR,Pharmacovigilance,Meets,Female,35,12,1,7,12,0.0,3.8,3.9,0.0383,1,1,1,1,4.4,3.8,3.0
3700,27,0,Asia Pacific,R&D,Pharmacovigilance,Far Below,Male,33,18,0,11,23,4.2,4.0,1.6,0.0,1,1,1,1,5.0,4.1,3.6
3701,677,0,Latin America,Digital,IT & Digital,Meets,Female,40,6,0,6,15,3.0,2.6,2.3,0.0853,1,1,1,1,3.9,2.6,2.9
3702,980,0,Latin America,Finance,Finance & Accounting,Meets,Male,37,29,0,9,21,4.1,2.0,1.2,0.0331,1,1,1,1,4.6,2.3,2.4
3703,203,0,Latin America,Commercial,Human Resources,Meets,Male,35,11,1,8,15,0.0,4.0,2.2,0.0422,1,1,1,1,2.3,5.0,1.4
3704,782,0,Asia Pacific,HR,Medical Affairs,Meets,Male,29,16,0,8,18,2.9,2.2,1.0,0.0383,1,1,1,1,2.7,4.4,1.0
3705,289,0,Latin America,Commercial,Human Resources,Far Exceeds,Female,41,6,0,12,24,3.4,1.5,2.2,0.1275,1,1,1,1,3.8,2.0,1.7
3706,188,0,North America,Commercial,Clinical Operations,Meets,Male,42,23,0,9,14,3.9,3.4,4.0,0.0422,1,1,1,1,2.4,2.3,2.8
3707,860,0,Middle East & Africa,HR,Finance & Accounting,Meets,Female,32,29,1,5,14,0.0,2.8,2.5,0.0383,1,1,1,1,4.4,2.6,2.9
3708,603,0,Middle East & Africa,Digital,Market Access,Meets,Female,39,8,0,11,23,3.7,1.7,3.0,0.0853,1,1,1,1,3.3,1.7,2.5
3709,304,0,Europe,Commercial,Sales,Below,Female,35,20,1,10,22,0.0,1.7,1.8,0.0,1,1,1,1,1.4,2.0,1.6
3710,483,0,Europe,Manufacturing,Legal & Compliance,Below,Male,42,15,0,12,14,2.5,3.0,3.3,0.0,1,1,1,1,4.1,3.6,1.9
3711,328,0,Middle East & Africa,Commercial,Quality Assurance,Exceeds,Male,35,9,1,9,26,0.0,2.7,2.7,0.0743,1,0,0,0,3.4,2.1,1.7
3712,1032,0,North America,Finance,Market Access,Meets,Male,35,18,0,8,22,4.2,3.5,2.3,0.0331,1,1,1,1,5.0,3.4,2.7
3713,706,0,Asia Pacific,HR,Communications,Meets,Male,39,8,0,7,18,4.5,3.4,4.0,0.0383,1,1,1,1,5.0,2.3,4.2
3714,111,0,Asia Pacific,R&D,Communications,Meets,Female,35,30,0,6,7,2.5,3.4,2.3,0.0977,1,1,1,1,2.4,3.0,2.0
3715,303,0,North America,Commercial,Medical Affairs,Exceeds,Female,35,6,0,7,10,2.6,2.3,4.0,0.0743,1,1,1,1,2.7,1.0,4.5
3716,651,0,Asia Pacific,Digital,Market Access,Meets,Male,34,10,0,10,12,2.7,2.9,1.9,0.0853,1,1,1,1,3.7,2.2,1.0
3717,355,0,Latin America,Manufacturing,Market Access,Far Below,Female,35,18,0,9,11,3.6,3.5,3.7,0.0,0,0,0,0,2.8,3.9,2.0
3718,493,0,Middle East & Africa,Manufacturing,Medical Affairs,Meets,Male,36,11,0,11,44,4.6,2.9,4.0,0.0348,1,1,0,0,4.7,3.1,3.3
3719,36,0,Middle East & Africa,R&D,Finance & Accounting,Meets,Male,38,5,0,7,12,3.4,4.1,1.1,0.0977,1,1,1,1,5.0,3.1,1.0
3720,896,0,North America,Finance,IT & Digital,Meets,Female,37,5,0,11,27,1.7,2.6,1.0,0.0331,1,1,1,1,2.8,2.6,1.8
3721,53,0,Asia Pacific,R&D,Legal & Compliance,Meets,Female,41,1,1,8,10,0.0,3.6,3.6,0.0977,1,0,0,0,2.1,3.4,3.0
3722,948,0,Europe,Finance,Pharmacovigilance,Below,Female,31,3,0,6,18,3.3,3.2,2.7,0.0,1,1,1,1,3.4,2.1,4.4
3723,193,1,Europe,Commercial,Communications,Far Exceeds,Female,51,11,0,10,21,4.4,2.4,3.4,0.1275,1,1,1,1,4.2,1.0,3.0
3724,873,0,Asia Pacific,HR,Pharmacovigilance,Meets,Male,38,15,0,12,20,3.6,3.9,2.1,0.0383,1,1,1,1,5.0,4.0,1.9
3725,537,1,Europe,Digital,Supply Chain,Meets,Female,44,15,0,5,11,3.6,2.5,4.3,0.0853,1,1,1,1,3.6,4.3,3.2
3726,458,0,North America,Manufacturing,Market Access,Meets,Female,41,25,1,10,11,0.0,3.6,3.6,0.0348,1,1,1,1,2.9,4.7,4.0
3727,146,0,North America,R&D,Quality Assurance,Meets,Female,39,6,1,5,8,0.0,3.9,3.4,0.0977,1,1,1,1,3.4,1.7,1.3
3728,682,0,Asia Pacific,Digital,IT & Digital,Meets,Non-Binary/Other,41,5,0,8,26,3.3,3.9,2.2,0.0853,1,1,1,1,3.2,3.3,3.0
3729,920,0,Europe,Finance,IT & Digital,Far Below,Male,40,7,0,9,15,3.6,3.1,2.8,0.0,1,1,1,1,2.5,2.9,4.0
3730,716,0,North America,HR,Medical Affairs,Meets,Female,37,3,1,10,13,0.0,1.9,3.7,0.0383,1,1,1,1,2.9,4.4,2.7
3731,428,0,North America,Manufacturing,Quality Assurance,Meets,Male,52,7,0,10,19,1.7,3.4,2.7,0.0348,0,0,0,0,3.0,4.7,1.4
3732,425,1,Latin America,Manufacturing,Legal & Compliance,Exceeds,Female,45,33,0,8,19,4.1,4.7,2.9,0.0616,1,1,1,1,5.0,3.9,2.4
3733,945,0,Latin America,Finance,Marketing,Meets,Female,28,17,0,12,19,3.5,4.8,1.9,0.0331,1,1,1,1,1.9,3.0,5.0
3734,798,0,North America,HR,Finance & Accounting,Meets,Male,44,14,1,9,28,0.0,2.4,2.7,0.0383,1,1,1,1,4.7,2.6,2.4
3735,395,0,Asia Pacific,Manufacturing,Data Science,Meets,Non-Binary/Other,38,28,0,7,29,3.1,3.4,2.2,0.0348,1,1,1,1,3.4,3.5,2.0
3736,853,0,Middle East & Africa,HR,Supply Chain,Meets,Male,48,10,0,9,29,3.6,2.3,1.8,0.0383,1,1,1,1,2.7,3.0,2.6
3737,491,0,Middle East & Africa,Manufacturing,Data Science,Meets,Male,36,16,0,5,21,1.9,4.7,4.2,0.0348,1,1,1,1,2.3,3.1,4.4
3738,345,0,North America,Commercial,Human Resources,Meets,Female,28,14,1,7,24,0.0,3.8,3.3,0.0422,1,1,1,1,3.7,3.7,2.8
3739,949,0,North America,Finance,Supply Chain,Meets,Male,36,16,0,12,21,4.5,3.3,2.0,0.0331,1,1,1,1,3.6,1.7,3.3
3740,740,0,North America,HR,Sales,Exceeds,Male,28,14,1,9,12,0.0,3.7,3.8,0.0677,1,1,1,1,1.7,3.6,2.9
3741,609,0,Asia Pacific,Digital,Medical Affairs,Meets,Female,34,8,1,5,15,0.0,1.2,1.1,0.0853,1,1,1,1,3.1,1.8,2.1
3742,206,0,Latin America,Commercial,Data Science,Exceeds,Female,35,18,0,11,17,2.8,2.7,1.1,0.0743,1,1,1,1,2.9,3.5,2.9
3743,613,0,North America,Digital,Quality Assurance,Meets,Female,40,3,1,8,20,0.0,3.4,2.4,0.0853,1,1,0,0,5.0,3.4,2.5
3744,923,0,North America,Finance,Medical Affairs,Exceeds,Female,40,4,1,9,12,0.0,2.2,4.0,0.0588,1,1,1,1,3.5,2.1,3.0
3745,368,0,Europe,Manufacturing,Quality Assurance,Below,Female,42,19,0,10,11,3.8,2.8,3.6,0.0,1,1,0,0,3.4,3.5,2.8
3746,640,0,Asia Pacific,Digital,Market Access,Meets,Female,41,9,0,6,19,4.6,3.5,1.5,0.0853,1,1,1,1,4.3,3.4,2.1
3747,218,0,North America,Commercial,Data Science,Meets,Female,50,9,0,12,17,2.3,3.7,2.8,0.0422,1,1,1,1,2.9,4.3,4.0
3748,743,0,Europe,HR,Market Access,Meets,Male,38,6,1,5,20,0.0,2.8,4.3,0.0383,1,1,1,1,4.6,5.0,3.8
3749,167,0,Middle East & Africa,R&D,Finance & Accounting,Below,Female,41,14,0,9,13,3.6,3.1,2.7,0.0,1,1,1,1,2.8,3.1,2.5
3750,638,0,North America,Digital,Pharmacovigilance,Far Below,Male,43,8,1,6,17,0.0,2.2,3.4,0.0,1,1,0,0,5.0,2.2,4.4
3751,117,0,North America,R&D,Marketing,Meets,Male,34,9,0,6,20,3.5,2.5,3.6,0.0977,1,1,1,1,3.4,2.4,3.1
3752,1005,1,Europe,Finance,Communications,Meets,Female,30,5,0,10,21,4.4,3.8,3.7,0.0331,1,1,1,1,5.0,4.8,4.1
3753,532,0,Asia Pacific,Digital,Sales,Meets,Female,40,11,1,7,17,0.0,2.1,3.0,0.0853,1,1,1,1,2.8,3.1,2.7
3754,656,0,North America,Digital,Sales,Meets,Male,36,9,1,5,11,0.0,4.1,3.4,0.0853,1,1,1,1,2.8,3.9,3.0
3755,807,0,Middle East & Africa,HR,Finance & Accounting,Meets,Male,43,22,0,9,15,1.9,4.1,4.6,0.0383,1,1,1,1,1.8,3.2,5.0
3756,498,0,North America,Manufacturing,Data Science,Exceeds,Female,42,11,0,8,18,3.2,3.6,4.0,0.0616,1,1,1,1,3.6,3.1,3.4
3757,263,0,Middle East & Africa,Commercial,Regulatory Affairs,Meets,Male,44,5,0,7,26,4.2,3.6,2.3,0.0422,1,1,1,1,3.8,2.3,3.0
3758,339,0,Latin America,Commercial,Marketing,Meets,Male,33,14,0,7,12,3.4,1.9,1.9,0.0422,1,1,1,1,4.7,2.8,2.0
3759,352,0,Latin America,Commercial,Human Resources,Meets,Female,35,24,0,7,18,4.1,3.7,1.8,0.0422,1,1,1,1,5.0,2.9,3.0
3760,1039,0,Middle East & Africa,Finance,Clinical Operations,Exceeds,Male,39,15,0,7,26,3.2,2.1,3.0,0.0588,1,1,1,1,3.2,2.6,3.3
3761,371,0,Asia Pacific,Manufacturing,Communications,Exceeds,Male,37,8,0,12,33,1.8,1.4,1.0,0.0616,0,0,0,0,1.6,3.5,2.9
3762,109,0,North America,R&D,Communications,Far Below,Female,41,12,1,5,17,0.0,3.4,2.0,0.0,0,0,0,0,3.3,3.7,1.2
3763,271,0,North America,Commercial,Legal & Compliance,Exceeds,Female,46,7,1,8,21,0.0,4.8,3.0,0.0743,1,1,1,1,3.0,4.7,4.0
3764,172,0,Latin America,R&D,Supply Chain,Meets,Male,37,20,0,7,11,2.9,2.4,3.9,0.0977,1,0,0,0,4.1,2.2,1.6
3765,402,0,Middle East & Africa,Manufacturing,Communications,Meets,Female,30,13,0,11,33,2.0,3.6,4.2,0.0348,1,1,1,1,2.6,4.6,3.5
3766,986,0,North America,Finance,Sales,Meets,Male,28,8,0,11,23,4.0,3.5,2.2,0.0331,1,1,1,1,3.4,2.6,1.0
3767,429,0,North America,Manufacturing,Medical Affairs,Meets,Female,30,9,0,9,24,4.0,3.2,3.5,0.0348,1,1,1,1,1.7,2.9,2.5
3768,773,0,Asia Pacific,HR,Pharmacovigilance,Meets,Male,30,5,0,12,21,3.7,1.7,1.8,0.0383,1,1,1,1,3.5,2.8,1.2
3769,344,0,Europe,Commercial,Market Access,Meets,Female,42,17,0,5,22,2.5,3.3,3.7,0.0422,1,1,1,1,2.6,3.3,3.1
3770,1042,0,Latin America,Finance,Clinical Operations,Meets,Female,38,7,1,5,16,0.0,4.6,3.3,0.0331,1,1,1,1,3.9,5.0,3.9
3771,736,0,Latin America,HR,Human Resources,Meets,Female,38,27,1,6,10,0.0,4.0,4.1,0.0383,1,1,1,1,1.4,5.0,4.8
3772,237,0,Europe,Commercial,Communications,Meets,Male,42,17,0,9,21,1.9,1.3,4.5,0.0422,1,1,1,1,3.2,1.2,3.4
3773,461,0,North America,Manufacturing,Medical Affairs,Far Below,Female,46,11,0,9,19,3.5,4.2,1.6,0.0,1,1,1,1,3.9,3.1,1.0
3774,415,0,Asia Pacific,Manufacturing,Data Science,Far Below,Male,37,12,0,6,18,4.0,3.1,2.3,0.0,1,1,1,0,3.4,3.1,1.3
3775,556,0,Asia Pacific,Digital,Marketing,Meets,Male,42,19,0,8,22,3.7,4.3,3.2,0.0853,1,1,1,1,3.6,4.1,1.7
3776,601,0,Latin America,Digital,Sales,Exceeds,Male,40,2,0,7,12,2.4,1.7,2.1,0.1452,1,1,1,1,3.8,2.2,1.6
3777,517,0,Asia Pacific,Manufacturing,Supply Chain,Meets,Female,29,13,0,7,9,4.1,2.5,3.7,0.0348,1,1,1,1,3.8,2.2,2.2
3778,493,0,Europe,Manufacturing,Finance & Accounting,Meets,Male,29,2,1,11,18,0.0,3.2,2.7,0.0348,1,1,1,1,4.3,3.1,3.3
3779,4,0,North America,R&D,Clinical Operations,Meets,Non-Binary/Other,36,7,1,9,42,0.0,4.3,4.2,0.0977,1,1,1,1,3.3,2.3,3.3
3780,127,0,Europe,R&D,Finance & Accounting,Meets,Male,39,12,1,10,21,0.0,2.9,2.5,0.0977,1,1,1,1,2.9,2.1,4.3
3781,723,0,Middle East & Africa,HR,Sales,Far Exceeds,Female,41,11,0,9,31,2.8,2.6,2.9,0.1168,1,1,1,1,3.3,1.9,1.5
3782,684,0,Latin America,Digital,Legal & Compliance,Meets,Male,37,13,0,8,25,2.5,3.0,3.3,0.0853,1,1,1,0,1.1,3.3,2.9
3783,638,0,Asia Pacific,Digital,Regulatory Affairs,Meets,Male,28,4,1,8,12,0.0,4.9,1.0,0.0853,1,1,1,1,2.3,3.3,1.4
3784,434,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Meets,Male,36,12,0,7,27,3.7,2.2,3.3,0.0348,0,0,0,0,4.1,2.0,3.7
3785,478,0,Asia Pacific,Manufacturing,Human Resources,Exceeds,Non-Binary/Other,28,7,0,12,34,3.6,2.7,1.7,0.0616,0,0,0,0,4.8,2.4,2.9
3786,752,0,North America,HR,Communications,Below,Male,37,19,0,6,17,2.9,2.1,2.8,0.0,1,1,1,1,4.0,2.6,2.9
3787,899,0,North America,Finance,Human Resources,Meets,Female,41,13,0,6,10,3.3,3.6,1.9,0.0331,1,1,1,1,5.0,2.5,3.5
3788,1029,0,North America,Finance,Regulatory Affairs,Meets,Male,41,7,1,7,19,0.0,2.1,1.4,0.0331,1,1,1,1,2.1,4.0,1.0
3789,914,0,Asia Pacific,Finance,Pharmacovigilance,Meets,Female,35,23,0,5,7,3.1,3.2,2.3,0.0331,1,1,1,1,3.9,2.8,3.0
3790,570,0,Middle East & Africa,Digital,Market Access,Below,Male,40,16,0,10,16,3.1,2.4,3.2,0.0,1,1,1,1,2.2,3.4,1.9
3791,145,0,North America,R&D,Data Science,Meets,Male,31,15,0,6,35,2.7,3.5,3.4,0.0977,1,1,1,1,3.6,3.3,1.8
3792,921,0,Middle East & Africa,Finance,Medical Affairs,Meets,Female,34,15,0,7,19,3.5,3.3,1.8,0.0331,1,1,1,1,3.6,4.0,3.4
3793,322,0,Asia Pacific,Commercial,Communications,Exceeds,Male,28,10,0,5,22,3.3,3.9,1.2,0.0743,1,1,1,1,3.2,1.0,2.2
3794,822,0,Middle East & Africa,HR,Sales,Meets,Female,35,7,1,12,26,0.0,3.6,1.9,0.0383,1,1,1,1,3.5,2.4,2.5
3795,992,0,Asia Pacific,Finance,Legal & Compliance,Below,Male,33,4,1,10,17,0.0,4.3,2.0,0.0,1,1,1,0,3.3,3.3,3.4
3796,265,0,Asia Pacific,Commercial,Medical Affairs,Meets,Female,36,7,1,9,11,0.0,5.0,2.2,0.0422,1,0,0,0,3.2,5.0,3.4
3797,991,0,Latin America,Finance,Medical Affairs,Meets,Male,36,8,0,11,23,4.0,5.0,2.4,0.0331,1,1,1,1,4.7,4.2,3.1
3798,75,0,Asia Pacific,R&D,Sales,Meets,Male,39,6,1,12,15,0.0,3.5,4.0,0.0977,1,1,1,1,2.1,2.1,3.8
3799,41,0,Asia Pacific,R&D,Market Access,Meets,Female,28,3,1,8,16,0.0,3.3,1.6,0.0977,1,1,1,1,3.1,2.0,3.3
3800,912,0,Europe,Finance,Communications,Below,Male,33,19,0,9,15,3.8,2.8,3.6,0.0,1,1,1,1,3.1,3.7,3.3
3801,288,0,North America,Commercial,Pharmacovigilance,Meets,Female,44,30,0,6,10,5.0,2.9,1.7,0.0422,0,0,0,0,5.0,3.6,1.9
3802,843,0,Latin America,HR,IT & Digital,Meets,Female,44,5,0,7,17,2.6,3.4,2.0,0.0383,1,1,0,0,2.6,3.0,2.4
3803,323,0,Latin America,Commercial,Pharmacovigilance,Exceeds,Female,38,17,1,8,10,0.0,2.2,3.9,0.0743,1,1,1,1,2.9,1.0,3.0
3804,856,0,Latin America,HR,Legal & Compliance,Meets,Male,38,23,0,11,14,3.1,3.7,2.8,0.0383,1,1,1,1,3.6,4.2,2.7
3805,1030,0,Europe,Finance,Legal & Compliance,Below,Female,31,17,0,9,14,3.2,1.4,2.5,0.0,1,1,1,1,3.1,2.9,2.1
3806,841,0,Asia Pacific,HR,Marketing,Meets,Male,36,8,0,7,11,3.2,3.2,2.3,0.0383,1,1,0,0,3.1,3.6,3.1
3807,422,0,North America,Manufacturing,Human Resources,Exceeds,Male,43,16,0,7,17,3.6,2.3,2.0,0.0616,1,1,1,1,4.5,1.3,2.2
3808,623,0,Middle East & Africa,Digital,IT & Digital,Exceeds,Female,31,11,1,6,13,0.0,2.8,3.5,0.1452,1,1,1,1,3.8,4.0,2.8
3809,527,0,Asia Pacific,Digital,Legal & Compliance,Exceeds,Male,39,10,0,10,15,4.0,3.7,2.9,0.1452,1,1,1,1,3.8,3.6,3.5
3810,157,0,Europe,R&D,Data Science,Meets,Male,41,3,1,11,16,0.0,2.1,1.9,0.0977,1,1,1,1,2.6,2.9,1.1
3811,425,0,Asia Pacific,Manufacturing,Marketing,Meets,Female,38,6,0,8,23,1.6,2.5,3.6,0.0348,1,1,1,1,1.9,2.4,3.8
3812,602,0,Asia Pacific,Digital,Market Access,Meets,Male,37,27,0,6,9,4.6,2.0,2.3,0.0853,1,1,1,1,3.6,3.7,2.1
3813,1032,0,Europe,Finance,Medical Affairs,Below,Male,37,6,1,12,25,0.0,4.3,4.0,0.0,1,1,1,1,2.8,3.1,3.2
3814,732,0,Latin America,HR,Data Science,Far Below,Male,41,5,1,10,23,0.0,1.2,2.3,0.0,1,1,1,1,4.5,2.8,1.7
3815,796,0,Latin America,HR,Marketing,Meets,Male,39,3,1,7,19,0.0,2.7,1.9,0.0383,1,1,1,1,5.0,2.3,1.6
3816,268,0,North America,Commercial,Communications,Meets,Male,41,8,0,5,10,4.7,3.9,2.2,0.0422,1,1,1,1,3.8,3.0,1.1
3817,226,0,North America,Commercial,Human Resources,Exceeds,Male,36,9,0,5,14,4.7,4.2,3.8,0.0743,1,1,1,1,5.0,3.9,3.5
3818,866,0,Latin America,HR,Marketing,Below,Male,36,9,0,6,13,4.2,4.2,3.0,0.0,1,1,0,0,5.0,1.7,1.7
3819,944,0,Middle East & Africa,Finance,Regulatory Affairs,Exceeds,Female,41,8,0,9,27,4.7,3.8,2.6,0.0588,1,1,1,1,3.1,5.0,2.0
3820,785,0,Asia Pacific,HR,Pharmacovigilance,Meets,Male,33,7,1,10,18,0.0,2.3,2.0,0.0383,1,1,1,1,3.8,3.1,2.1
3821,237,0,Middle East & Africa,Commercial,Quality Assurance,Meets,Female,31,3,0,7,16,5.0,3.3,5.0,0.0422,1,1,1,0,5.0,4.1,3.2
3822,644,0,Asia Pacific,Digital,Marketing,Meets,Female,52,3,0,8,23,3.1,1.4,3.1,0.0853,1,1,1,1,3.6,1.0,3.4
3823,27,1,Latin America,R&D,Clinical Operations,Meets,Male,41,11,1,8,13,0.0,2.4,4.3,0.0977,1,1,1,1,2.6,1.9,4.3
3824,284,0,North America,Commercial,IT & Digital,Meets,Male,37,9,0,9,15,2.1,2.1,3.5,0.0422,1,1,1,1,2.0,1.5,2.4
3825,1001,0,North America,Finance,Regulatory Affairs,Meets,Female,34,16,0,8,15,3.0,2.6,1.8,0.0331,1,1,1,1,1.2,4.0,1.9
3826,533,0,Middle East & Africa,Digital,Communications,Meets,Male,32,10,0,6,17,1.3,3.0,3.6,0.0853,1,1,1,1,3.1,2.4,2.6
3827,649,0,North America,Digital,Medical Affairs,Exceeds,Female,38,11,0,8,9,3.1,1.9,2.7,0.1452,1,1,1,1,3.1,3.2,3.5
3828,601,0,Latin America,Digital,Supply Chain,Meets,Male,37,2,0,12,20,3.3,4.4,2.9,0.0853,1,1,1,1,3.1,3.9,4.5
3829,490,0,Middle East & Africa,Manufacturing,Pharmacovigilance,Meets,Male,41,12,0,7,12,3.8,1.9,3.7,0.0348,1,1,1,1,2.9,2.6,2.6
3830,437,0,Asia Pacific,Manufacturing,Market Access,Meets,Male,30,3,0,6,9,2.9,3.4,3.7,0.0348,1,1,1,1,3.5,4.4,2.6
3831,612,0,North America,Digital,Sales,Far Exceeds,Male,30,5,0,10,15,2.4,1.5,1.5,0.2363,1,1,1,1,3.4,1.9,1.5
3832,906,0,Europe,Finance,Market Access,Meets,Male,40,25,0,12,15,3.4,3.2,2.3,0.0331,1,1,1,1,2.9,3.2,2.6
3833,874,0,North America,HR,Regulatory Affairs,Far Exceeds,Male,40,5,1,11,19,0.0,1.9,4.0,0.1168,1,1,1,1,3.5,2.1,5.0
3834,961,0,Asia Pacific,Finance,Communications,Meets,Male,43,24,0,10,16,3.5,4.3,1.5,0.0331,1,1,1,1,2.3,3.1,1.3
3835,412,0,Middle East & Africa,Manufacturing,Finance & Accounting,Meets,Female,48,10,0,5,20,1.6,3.0,3.2,0.0348,1,1,1,1,2.8,3.1,3.8
3836,223,0,Asia Pacific,Commercial,Human Resources,Far Below,Male,36,20,0,11,17,3.9,2.6,2.7,0.0,1,1,1,1,3.5,2.1,2.1
3837,443,0,Europe,Manufacturing,Human Resources,Meets,Female,42,9,1,5,21,0.0,3.6,1.5,0.0348,1,1,0,0,4.0,4.5,2.5
3838,861,0,Latin America,HR,Human Resources,Meets,Male,32,3,1,8,30,0.0,3.0,2.0,0.0383,1,1,1,1,3.1,2.5,1.0
3839,82,0,North America,R&D,Clinical Operations,Far Below,Male,28,19,0,9,10,4.4,3.7,3.3,0.0,1,1,1,1,3.5,4.2,3.6
3840,495,0,Middle East & Africa,Manufacturing,Market Access,Meets,Male,32,8,0,11,19,4.2,4.0,2.2,0.0348,1,1,1,1,4.6,3.0,2.0
3841,961,0,Latin America,Finance,Legal & Compliance,Far Exceeds,Female,35,4,0,5,18,3.3,2.9,3.8,0.1022,1,1,1,1,4.1,2.8,2.7
3842,1007,0,Asia Pacific,Finance,Finance & Accounting,Meets,Female,51,13,0,5,12,3.1,3.0,2.2,0.0331,1,1,1,1,4.1,4.2,3.1
3843,603,0,Middle East & Africa,Digital,Legal & Compliance,Below,Male,28,14,0,7,22,3.8,1.9,3.4,0.0,1,1,1,1,3.9,3.1,2.1
3844,620,0,Latin America,Digital,Clinical Operations,Meets,Male,42,10,0,11,22,3.5,4.0,1.0,0.0853,1,1,1,1,2.2,3.6,1.0
3845,622,0,Middle East & Africa,Digital,Sales,Far Below,Non-Binary/Other,34,9,1,9,18,0.0,3.2,2.5,0.0,1,1,1,1,4.9,2.4,2.9
3846,154,0,Europe,R&D,Legal & Compliance,Meets,Female,41,15,0,10,19,2.8,3.7,2.3,0.0977,1,1,1,1,2.9,3.9,1.2
3847,761,0,Europe,HR,Supply Chain,Meets,Male,38,11,1,5,39,0.0,2.7,2.9,0.0383,1,1,1,1,4.5,2.1,3.5
3848,245,0,North America,Commercial,Pharmacovigilance,Meets,Female,33,7,0,6,9,3.7,1.4,4.3,0.0422,1,1,1,1,3.9,3.5,2.5
3849,969,0,North America,Finance,Pharmacovigilance,Meets,Male,44,13,0,12,21,3.6,2.3,3.2,0.0331,1,1,1,1,3.6,2.9,2.8
3850,952,0,Europe,Finance,Quality Assurance,Below,Male,41,29,0,12,24,1.8,1.0,2.1,0.0,0,0,0,0,2.0,4.2,3.2
3851,786,0,Middle East & Africa,HR,Clinical Operations,Exceeds,Female,38,10,0,7,22,4.6,2.8,2.0,0.0677,1,1,1,1,3.8,2.1,2.1
3852,157,0,Europe,R&D,Sales,Far Exceeds,Female,40,12,1,6,21,0.0,4.2,2.1,0.2644,1,1,1,1,3.8,3.1,3.4
3853,598,0,North America,Digital,Marketing,Far Below,Male,35,8,1,11,25,0.0,2.1,4.3,0.0,1,1,1,1,3.0,2.9,3.1
3854,843,0,Europe,HR,Marketing,Exceeds,Female,28,11,0,7,14,2.8,4.8,1.6,0.0677,0,0,0,0,4.2,3.9,1.9
3855,313,0,Europe,Commercial,Medical Affairs,Meets,Female,39,11,0,7,18,2.8,2.1,4.6,0.0422,1,1,1,0,2.3,3.7,3.3
3856,648,0,Middle East & Africa,Digital,Clinical Operations,Meets,Male,51,13,0,7,17,3.1,1.4,1.0,0.0853,1,1,1,1,3.6,1.9,1.2
3857,203,0,Latin America,Commercial,Data Science,Meets,Male,43,24,0,7,14,3.2,2.0,2.0,0.0422,1,1,1,1,4.4,4.4,2.6
3858,362,0,North America,Manufacturing,Market Access,Meets,Male,40,11,0,12,15,2.8,3.7,4.5,0.0348,1,1,1,1,3.1,2.5,5.0
3859,305,0,Middle East & Africa,Commercial,Communications,Far Exceeds,Male,40,7,0,12,26,5.0,2.9,4.2,0.1275,1,1,1,1,4.3,5.0,3.1
3860,680,0,Europe,Digital,Communications,Meets,Female,38,5,0,8,10,3.5,3.8,2.7,0.0853,1,1,1,1,3.1,2.8,2.6
3861,510,0,Europe,Manufacturing,Medical Affairs,Below,Male,28,7,0,7,16,4.0,4.2,4.4,0.0,1,1,1,1,2.8,4.0,3.8
3862,533,0,Latin America,Digital,Medical Affairs,Meets,Male,32,23,0,9,12,4.2,2.1,3.9,0.0853,1,1,1,1,3.5,3.8,4.7
3863,1050,0,North America,Finance,Finance & Accounting,Meets,Female,38,19,1,8,15,0.0,3.6,2.9,0.0331,1,1,1,1,4.5,4.0,4.1
3864,524,0,North America,Digital,Medical Affairs,Exceeds,Non-Binary/Other,44,3,0,9,12,3.9,1.7,2.7,0.1452,1,1,1,1,4.3,2.7,2.6
3865,484,0,Asia Pacific,Manufacturing,Legal & Compliance,Meets,Female,49,9,0,12,17,3.2,2.2,2.1,0.0348,1,1,1,1,3.9,2.2,3.5
3866,217,0,North America,Commercial,Sales,Meets,Female,32,18,0,8,22,3.3,3.5,3.1,0.0422,1,1,1,1,3.5,3.2,3.2
3867,934,0,Latin America,Finance,Finance & Accounting,Meets,Female,42,8,0,7,14,4.0,4.0,1.9,0.0331,1,1,1,1,3.8,3.3,2.3
3868,45,0,Asia Pacific,R&D,Communications,Meets,Female,28,9,0,6,9,4.2,2.7,2.5,0.0977,1,1,1,1,2.9,3.3,2.8
3869,165,0,Asia Pacific,R&D,Communications,Far Below,Male,36,15,0,7,41,2.0,3.5,3.6,0.0,1,1,1,1,3.3,3.2,2.9
3870,8,0,Europe,R&D,Human Resources,Meets,Male,38,12,1,8,21,0.0,2.7,1.3,0.0977,1,1,1,1,3.6,2.4,1.5
3871,67,0,Europe,R&D,Pharmacovigilance,Below,Female,48,9,0,12,23,5.0,5.0,4.1,0.0,1,1,1,1,4.3,3.3,3.8
3872,777,0,North America,HR,Medical Affairs,Exceeds,Male,33,3,1,7,24,0.0,3.2,3.2,0.0677,1,1,1,1,3.6,2.5,2.4
3873,59,0,Asia Pacific,R&D,Pharmacovigilance,Meets,Male,36,8,0,11,18,3.3,3.1,4.2,0.0977,1,1,0,0,3.5,3.1,3.1
3874,447,0,Europe,Manufacturing,Pharmacovigilance,Exceeds,Female,44,5,0,11,16,4.2,2.2,1.5,0.0616,1,1,1,1,4.8,4.0,2.5
3875,172,0,Latin America,R&D,Clinical Operations,Far Exceeds,Male,34,5,1,6,27,0.0,3.0,3.1,0.2644,0,0,0,0,4.0,1.6,2.9
3876,639,0,Europe,Digital,Sales,Exceeds,Male,35,6,0,8,25,3.7,3.4,2.4,0.1452,1,1,1,1,5.0,2.3,4.6
3877,50,0,Europe,R&D,Pharmacovigilance,Below,Male,29,6,1,7,16,0.0,2.9,1.6,0.0,1,1,1,1,4.3,2.0,1.2
3878,303,0,Asia Pacific,Commercial,Medical Affairs,Exceeds,Male,42,8,1,10,15,0.0,2.5,1.7,0.0743,1,1,1,1,3.0,1.4,1.6
3879,487,0,Asia Pacific,Manufacturing,Sales,Meets,Female,29,7,1,5,13,0.0,3.7,3.3,0.0348,1,1,1,1,2.7,3.1,4.0
3880,396,0,Middle East & Africa,Manufacturing,Medical Affairs,Meets,Female,44,14,1,12,24,0.0,2.6,2.1,0.0348,1,1,1,1,4.9,2.1,4.4
3881,987,0,Latin America,Finance,Finance & Accounting,Below,Female,31,23,0,9,15,3.7,4.0,3.6,0.0,1,1,1,1,4.3,4.9,3.8
3882,876,0,Asia Pacific,HR,Regulatory Affairs,Below,Female,33,4,0,5,11,3.5,2.5,2.6,0.0,1,1,1,1,4.2,2.5,2.1
3883,668,0,North America,Digital,Market Access,Far Exceeds,Female,31,5,1,6,7,0.0,2.5,4.1,0.2363,1,1,1,1,4.5,2.7,3.1
3884,453,0,Latin America,Manufacturing,Regulatory Affairs,Meets,Female,36,30,0,8,11,4.7,3.9,1.0,0.0348,1,1,1,1,4.0,3.9,1.0
3885,348,0,Latin America,Commercial,Regulatory Affairs,Below,Male,44,8,1,9,27,0.0,3.7,2.3,0.0,1,1,1,1,3.2,5.0,3.1
3886,167,0,Asia Pacific,R&D,Finance & Accounting,Meets,Female,34,11,0,9,21,2.9,4.5,3.5,0.0977,1,1,1,1,3.4,4.2,3.1
3887,411,0,Latin America,Manufacturing,Clinical Operations,Exceeds,Female,32,18,0,12,16,3.1,2.2,1.6,0.0616,1,0,0,0,2.6,2.5,1.0
3888,255,0,Asia Pacific,Commercial,Data Science,Meets,Female,38,12,0,8,18,3.7,3.2,2.4,0.0422,0,0,0,0,3.7,4.6,2.6
3889,92,1,Europe,R&D,Communications,Exceeds,Female,38,15,1,9,15,0.0,4.0,2.7,0.1648,1,1,1,1,2.2,4.0,3.1
3890,796,1,Middle East & Africa,HR,Legal & Compliance,Meets,Male,42,5,0,12,19,5.0,4.3,3.8,0.0383,1,1,1,1,4.2,3.3,2.5
3891,380,0,Europe,Manufacturing,Human Resources,Meets,Male,30,9,0,5,13,1.6,4.1,2.0,0.0348,1,1,1,1,3.0,4.8,2.0
3892,455,0,Asia Pacific,Manufacturing,Market Access,Meets,Female,39,16,1,12,13,0.0,3.0,3.7,0.0348,1,1,1,0,1.7,3.6,3.1
3893,196,0,Asia Pacific,Commercial,Clinical Operations,Meets,Male,45,12,0,6,12,2.9,3.6,1.6,0.0422,0,0,0,0,4.2,3.6,2.5
3894,884,1,Europe,Finance,Medical Affairs,Meets,Male,32,4,1,5,35,0.0,1.8,3.3,0.0331,1,1,1,1,4.8,1.3,3.0
3895,545,0,North America,Digital,Clinical Operations,Meets,Male,39,12,0,5,25,5.0,5.0,2.0,0.0853,1,1,1,1,3.8,3.5,2.9
3896,772,0,North America,HR,Medical Affairs,Meets,Male,32,7,1,7,10,0.0,3.5,2.6,0.0383,0,0,0,0,3.3,5.0,4.8
3897,652,0,North America,Digital,Data Science,Meets,Male,45,29,0,5,14,3.6,3.0,2.7,0.0853,1,1,1,1,3.7,4.1,3.6
3898,437,1,Asia Pacific,Manufacturing,Pharmacovigilance,Meets,Female,48,5,0,6,14,4.1,3.8,3.6,0.0348,1,1,1,1,4.7,2.8,3.1
3899,608,0,Latin America,Digital,Clinical Operations,Meets,Non-Binary/Other,31,14,0,9,19,3.4,3.1,4.6,0.0853,1,1,1,1,3.1,1.8,4.0
3900,99,0,Asia Pacific,R&D,Legal & Compliance,Below,Male,40,16,0,6,15,3.2,5.0,3.3,0.0,1,1,1,1,4.5,5.0,4.5
3901,716,0,Latin America,HR,Quality Assurance,Below,Male,40,9,1,5,23,0.0,5.0,2.8,0.0,1,1,1,1,2.6,4.2,3.8
3902,526,0,Europe,Digital,Human Resources,Meets,Female,39,2,1,6,9,0.0,2.5,3.5,0.0853,0,0,0,0,2.5,3.2,3.0
3903,82,1,Middle East & Africa,R&D,Pharmacovigilance,Exceeds,Male,37,17,0,8,17,4.5,3.2,2.4,0.1648,1,1,1,1,3.5,4.0,3.3
3904,204,0,Latin America,Commercial,IT & Digital,Meets,Female,35,11,0,8,11,3.1,3.1,3.2,0.0422,1,1,1,1,2.2,4.8,4.1
3905,581,0,North America,Digital,Supply Chain,Below,Male,29,8,0,11,15,3.2,1.3,5.0,0.0,1,1,1,1,3.8,4.2,4.4
3906,763,0,Asia Pacific,HR,Clinical Operations,Meets,Non-Binary/Other,37,2,0,10,19,2.9,3.7,3.0,0.0383,0,0,0,0,4.6,2.8,2.5
3907,108,0,Europe,R&D,Medical Affairs,Meets,Male,43,6,0,7,22,3.2,3.1,3.5,0.0977,1,1,1,1,3.2,2.3,3.9
3908,677,0,North America,Digital,Market Access,Meets,Female,45,11,1,12,16,0.0,3.8,1.0,0.0853,1,1,1,1,5.0,3.5,2.9
3909,347,0,Europe,Commercial,Clinical Operations,Meets,Female,39,17,0,11,17,2.4,1.9,3.1,0.0422,1,1,1,1,2.7,3.4,2.4
3910,556,1,Middle East & Africa,Digital,Medical Affairs,Meets,Female,32,7,0,5,15,3.9,4.3,2.3,0.0853,1,1,1,1,3.7,3.3,2.1
3911,139,0,Asia Pacific,R&D,Communications,Meets,Female,30,14,0,12,26,3.5,3.1,2.9,0.0977,1,1,1,1,3.8,2.4,3.0
3912,683,0,Asia Pacific,Digital,Data Science,Below,Female,34,26,0,8,10,3.9,1.6,2.3,0.0,0,0,0,0,3.4,2.0,3.4
3913,752,0,Middle East & Africa,HR,Regulatory Affairs,Below,Female,28,21,0,11,18,3.9,1.7,2.4,0.0,0,0,0,0,4.5,1.0,1.5
3914,452,0,Asia Pacific,Manufacturing,Clinical Operations,Meets,Female,28,6,0,5,25,2.6,3.1,1.8,0.0348,1,1,1,1,2.6,4.4,3.7
3915,9,0,Latin America,R&D,Marketing,Meets,Female,30,15,0,7,11,3.0,2.6,2.7,0.0977,1,1,1,1,4.2,3.3,1.6
3916,96,0,Europe,R&D,IT & Digital,Far Exceeds,Male,40,7,0,7,29,2.3,2.2,2.1,0.2644,1,1,0,0,3.2,2.0,2.1
3917,118,0,North America,R&D,Supply Chain,Meets,Male,28,11,0,9,27,2.8,3.4,3.6,0.0977,1,1,1,1,3.9,2.2,3.0
3918,116,0,Middle East & Africa,R&D,Marketing,Meets,Male,40,4,0,8,18,3.0,3.5,1.2,0.0977,1,0,0,0,3.4,3.7,1.1
3919,600,0,Latin America,Digital,Pharmacovigilance,Below,Male,33,14,1,12,16,0.0,3.3,3.8,0.0,1,1,1,1,3.8,4.6,3.0
3920,785,0,North America,HR,IT & Digital,Exceeds,Female,45,17,0,8,12,3.9,1.8,1.7,0.0677,0,0,0,0,3.4,3.4,1.9
3921,268,0,North America,Commercial,Pharmacovigilance,Meets,Male,34,5,1,7,17,0.0,3.0,4.1,0.0422,1,1,1,1,3.9,4.2,4.0
3922,827,0,Middle East & Africa,HR,Regulatory Affairs,Meets,Female,35,7,0,8,22,2.3,3.2,2.3,0.0383,0,0,0,0,2.3,3.5,4.4
3923,161,0,Latin America,R&D,Communications,Below,Female,33,22,0,11,14,5.0,1.9,1.0,0.0,1,1,1,1,3.7,1.5,1.4
3924,1005,0,North America,Finance,Communications,Far Below,Female,34,15,0,11,20,3.6,3.5,1.7,0.0,1,1,1,1,4.4,3.2,3.2
3925,675,0,North America,Digital,Regulatory Affairs,Meets,Female,39,8,1,7,13,0.0,3.3,2.2,0.0853,1,1,1,1,2.0,2.9,2.2
3926,940,0,Latin America,Finance,Pharmacovigilance,Below,Male,40,6,0,12,18,2.6,1.5,4.6,0.0,1,1,1,1,2.7,2.0,2.2
3927,590,0,Asia Pacific,Digital,Clinical Operations,Below,Non-Binary/Other,38,10,0,10,24,2.0,2.2,2.0,0.0,1,1,1,1,2.5,4.6,3.3
3928,96,0,North America,R&D,Sales,Below,Male,30,12,0,12,19,3.2,3.0,3.7,0.0,1,1,1,1,3.6,2.4,3.0
3929,586,0,Europe,Digital,Clinical Operations,Below,Female,40,12,0,8,12,3.4,3.8,2.1,0.0,0,0,0,0,2.5,3.6,2.8
3930,28,0,Latin America,R&D,Supply Chain,Meets,Male,31,12,0,8,28,4.4,1.0,2.2,0.0977,1,1,1,1,4.6,1.1,3.1
3931,835,0,North America,HR,Pharmacovigilance,Meets,Male,31,8,0,5,11,2.2,4.2,3.3,0.0383,1,1,1,1,3.0,3.4,3.4
3932,521,0,Middle East & Africa,Manufacturing,Marketing,Meets,Female,35,6,1,7,16,0.0,2.8,3.4,0.0348,1,1,1,1,3.9,2.4,3.2
3933,636,0,Europe,Digital,Legal & Compliance,Meets,Female,43,12,0,11,19,3.6,4.2,2.5,0.0853,1,1,1,1,3.3,5.0,3.1
3934,71,1,North America,R&D,Regulatory Affairs,Exceeds,Male,31,19,0,5,12,3.9,1.0,3.1,0.1648,1,1,1,1,4.5,1.5,3.6
3935,1026,0,Europe,Finance,Marketing,Exceeds,Female,40,4,0,8,12,4.3,2.2,1.3,0.0588,1,1,1,1,3.7,3.1,2.0
3936,120,0,Europe,R&D,Pharmacovigilance,Meets,Male,28,13,0,5,11,1.7,3.7,4.0,0.0977,1,1,1,1,3.4,3.7,3.6
3937,998,0,Asia Pacific,Finance,Data Science,Meets,Male,41,18,0,9,15,3.5,4.1,1.2,0.0331,1,1,1,1,3.2,2.8,2.1
3938,606,0,Europe,Digital,Pharmacovigilance,Meets,Female,44,2,1,6,13,0.0,4.4,2.3,0.0853,1,1,1,1,4.5,4.1,3.0
3939,181,0,Asia Pacific,Commercial,Quality Assurance,Meets,Female,42,36,0,10,12,4.0,4.0,2.9,0.0422,1,1,1,1,3.1,4.0,2.7
3940,889,0,Latin America,Finance,Communications,Meets,Female,38,10,0,11,22,3.3,3.1,3.7,0.0331,1,1,1,1,3.7,2.7,2.0
3941,162,0,Asia Pacific,R&D,Finance & Accounting,Meets,Female,34,7,1,12,13,0.0,3.7,1.8,0.0977,1,1,1,1,3.2,4.0,2.2
3942,692,0,Middle East & Africa,Digital,IT & Digital,Meets,Female,32,20,0,11,14,4.5,4.4,1.3,0.0853,1,0,0,0,3.3,4.7,1.7
3943,30,0,North America,R&D,Supply Chain,Meets,Male,33,10,0,6,15,3.2,4.1,3.7,0.0977,1,0,0,0,3.8,3.7,3.6
3944,346,0,Latin America,Commercial,Quality Assurance,Exceeds,Male,34,5,0,10,13,3.4,2.7,3.1,0.0743,1,1,1,1,2.2,2.7,2.5
3945,519,0,Latin America,Manufacturing,Market Access,Exceeds,Male,44,10,0,12,22,3.2,3.8,3.4,0.0616,1,1,1,1,3.3,3.2,3.7
3946,234,0,Middle East & Africa,Commercial,Marketing,Meets,Female,37,9,1,10,10,0.0,3.1,3.5,0.0422,1,1,1,1,3.2,1.4,5.0
3947,872,0,Asia Pacific,HR,Data Science,Meets,Male,43,9,0,12,26,2.2,4.4,3.3,0.0383,0,0,0,0,2.2,3.5,3.4
3948,533,0,North America,Digital,Supply Chain,Meets,Male,55,14,1,5,9,0.0,2.6,2.5,0.0853,1,1,1,1,3.3,2.8,1.8
3949,304,0,Asia Pacific,Commercial,Medical Affairs,Exceeds,Female,48,6,0,7,17,3.9,3.8,3.1,0.0743,1,1,1,1,1.9,3.0,3.9
3950,439,0,Europe,Manufacturing,Human Resources,Below,Male,38,33,0,7,11,3.8,4.1,1.6,0.0,1,1,1,1,3.1,3.6,1.5
3951,75,0,Asia Pacific,R&D,Market Access,Meets,Female,35,12,1,6,24,0.0,2.2,4.5,0.0977,1,1,1,1,4.0,3.6,2.4
3952,648,0,Latin America,Digital,Legal & Compliance,Meets,Male,43,13,0,12,28,3.3,2.6,2.0,0.0853,1,1,1,1,4.3,2.2,2.2
3953,884,0,North America,Finance,Sales,Meets,Female,43,17,0,11,20,1.8,4.9,2.1,0.0331,1,1,1,1,1.2,4.7,2.8
3954,258,0,Asia Pacific,Commercial,Quality Assurance,Meets,Male,41,23,0,9,25,4.2,3.8,2.7,0.0422,1,1,1,1,3.7,4.4,1.9
3955,383,1,North America,Manufacturing,Communications,Exceeds,Male,47,7,1,5,14,0.0,4.5,3.2,0.0616,1,1,1,1,3.9,3.8,3.4
3956,199,0,North America,Commercial,Supply Chain,Below,Female,32,6,0,8,12,2.2,2.5,2.4,0.0,1,1,1,0,1.9,1.8,2.5
3957,820,0,Europe,HR,Supply Chain,Meets,Female,40,5,0,9,25,3.3,2.3,4.4,0.0383,1,1,1,1,4.8,1.7,4.8
3958,636,1,Europe,Digital,Quality Assurance,Exceeds,Male,38,4,1,11,23,0.0,3.3,3.4,0.1452,1,1,1,1,3.9,2.7,3.2
3959,62,1,Latin America,R&D,Market Access,Exceeds,Male,42,25,0,7,10,4.6,2.6,1.9,0.1648,1,1,1,1,4.7,1.5,3.2
3960,363,1,Middle East & Africa,Manufacturing,Data Science,Meets,Male,35,11,0,6,10,4.1,1.0,3.8,0.0348,1,1,1,1,5.0,4.1,4.4
3961,261,0,North America,Commercial,Data Science,Meets,Male,40,7,0,9,12,3.9,4.4,2.5,0.0422,1,0,0,0,3.2,1.7,2.9
3962,660,0,Middle East & Africa,Digital,Regulatory Affairs,Far Exceeds,Female,28,12,0,8,9,3.7,4.7,2.6,0.2363,1,1,1,1,3.6,5.0,1.9
3963,196,0,Latin America,Commercial,Communications,Meets,Female,38,9,0,5,7,1.0,4.4,4.6,0.0422,1,1,1,1,2.5,4.9,3.9
3964,663,0,North America,Digital,Clinical Operations,Meets,Male,48,17,0,12,35,3.7,4.7,1.0,0.0853,1,1,1,1,3.8,2.8,2.3
3965,725,0,North America,HR,Market Access,Meets,Male,35,7,0,8,28,4.2,3.7,3.6,0.0383,1,1,1,1,3.6,3.9,2.0
3966,239,0,Middle East & Africa,Commercial,Marketing,Far Below,Female,37,22,0,12,20,2.0,2.8,2.0,0.0,1,1,1,1,2.2,3.8,1.6
3967,840,0,Asia Pacific,HR,Marketing,Meets,Male,44,9,0,9,24,3.5,5.0,3.0,0.0383,1,1,1,1,3.0,1.8,1.8
3968,1032,0,Europe,Finance,Finance & Accounting,Meets,Female,41,13,0,5,17,2.0,4.5,1.1,0.0331,1,1,1,1,2.6,3.2,1.0
3969,1006,0,Asia Pacific,Finance,Market Access,Meets,Female,28,8,0,12,31,4.0,3.9,3.5,0.0331,1,1,1,1,2.9,3.6,1.4
3970,378,0,Middle East & Africa,Manufacturing,IT & Digital,Far Below,Male,37,27,0,5,11,2.5,1.0,3.2,0.0,1,1,1,1,2.5,1.7,3.7
3971,697,0,Europe,HR,Quality Assurance,Exceeds,Male,40,7,0,7,13,5.0,3.3,3.8,0.0677,1,1,1,1,4.6,3.4,2.6
3972,604,0,Asia Pacific,Digital,Legal & Compliance,Meets,Male,46,11,0,7,18,4.0,2.8,4.1,0.0853,1,1,1,0,2.5,3.1,2.1
3973,407,0,Europe,Manufacturing,Marketing,Meets,Female,45,11,1,12,20,0.0,3.4,3.3,0.0348,1,1,1,1,3.1,2.6,2.3
3974,257,0,North America,Commercial,Marketing,Far Exceeds,Female,38,6,0,6,24,3.3,2.3,2.3,0.1275,1,1,1,1,3.0,3.3,3.1
3975,314,0,Asia Pacific,Commercial,Clinical Operations,Meets,Female,42,11,0,10,20,4.0,3.5,2.0,0.0422,1,1,1,1,3.7,5.0,2.9
3976,594,0,Europe,Digital,IT & Digital,Meets,Non-Binary/Other,38,2,1,8,18,0.0,2.4,1.0,0.0853,0,0,0,0,3.2,3.7,3.0
3977,59,0,Europe,R&D,Supply Chain,Meets,Female,35,15,0,5,7,3.6,3.8,2.8,0.0977,1,1,1,1,3.4,3.8,2.8
3978,155,0,Europe,R&D,Supply Chain,Meets,Female,45,15,0,8,19,2.3,2.1,2.4,0.0977,1,1,1,1,2.2,5.0,2.6
3979,179,0,Asia Pacific,Commercial,Market Access,Meets,Male,44,9,0,11,22,4.0,3.4,2.0,0.0422,1,1,1,1,3.5,2.4,2.7
3980,654,0,Latin America,Digital,Pharmacovigilance,Meets,Male,40,3,0,9,11,2.9,3.3,1.5,0.0853,1,1,0,0,2.6,2.3,2.7
3981,160,0,Asia Pacific,R&D,Legal & Compliance,Meets,Male,34,6,1,12,31,0.0,3.4,2.6,0.0977,0,0,0,0,3.1,3.5,2.1
3982,726,0,Middle East & Africa,HR,Communications,Meets,Female,38,4,0,12,19,3.2,2.8,2.1,0.0383,1,1,1,1,4.3,2.4,3.2
3983,323,0,Asia Pacific,Commercial,IT & Digital,Meets,Male,38,15,0,12,28,3.0,2.6,2.9,0.0422,1,1,1,1,4.5,2.3,3.7
3984,891,0,Europe,Finance,Supply Chain,Exceeds,Female,44,15,0,8,20,3.5,4.3,2.4,0.0588,1,1,1,1,2.3,2.7,3.1
3985,697,0,North America,HR,Quality Assurance,Meets,Female,36,1,1,9,20,0.0,3.2,3.5,0.0383,1,1,1,1,3.7,2.6,1.9
3986,644,0,Asia Pacific,Digital,Medical Affairs,Exceeds,Male,38,5,1,5,24,0.0,2.7,1.5,0.1452,1,1,1,1,3.1,4.2,2.8
3987,918,0,Asia Pacific,Finance,Pharmacovigilance,Meets,Female,39,9,0,5,24,3.7,2.8,2.1,0.0331,1,1,1,1,3.7,2.0,2.2
3988,879,0,Europe,HR,Communications,Meets,Male,36,11,0,5,13,3.8,3.6,4.0,0.0383,1,1,1,1,4.7,3.3,3.8
3989,52,0,North America,R&D,Legal & Compliance,Far Exceeds,Male,40,17,0,6,33,1.9,2.4,2.6,0.2644,1,1,1,1,2.1,1.2,1.8
3990,37,0,North America,R&D,Clinical Operations,Far Exceeds,Female,39,17,0,8,15,3.1,2.8,4.0,0.2644,1,1,1,1,3.7,2.9,3.5
3991,917,0,Middle East & Africa,Finance,Quality Assurance,Meets,Female,33,17,0,8,13,3.4,2.6,3.1,0.0331,1,1,1,1,2.4,3.8,4.0
3992,506,0,Asia Pacific,Manufacturing,Data Science,Exceeds,Male,35,6,1,7,15,0.0,4.6,2.8,0.0616,1,1,1,1,3.4,2.9,2.3
3993,212,0,North America,Commercial,Legal & Compliance,Meets,Male,30,6,0,9,16,3.7,2.8,3.0,0.0422,1,1,1,1,5.0,4.0,1.4
3994,919,0,North America,Finance,Clinical Operations,Below,Male,34,15,0,9,12,3.3,2.1,2.2,0.0,1,1,1,1,4.2,2.4,1.7
3995,671,0,Latin America,Digital,Regulatory Affairs,Meets,Male,47,19,0,11,14,3.2,1.9,1.8,0.0853,1,1,1,1,2.8,3.1,3.4
3996,294,0,Latin America,Commercial,Communications,Far Exceeds,Non-Binary/Other,42,5,1,6,9,0.0,2.6,3.8,0.1275,1,1,1,1,2.9,4.0,2.0
3997,880,0,North America,HR,Marketing,Far Exceeds,Male,33,15,1,10,20,0.0,2.8,3.4,0.1168,1,1,1,1,3.0,3.1,3.4
3998,534,0,Middle East & Africa,Digital,Sales,Below,Female,37,16,0,10,11,4.2,3.2,3.6,0.0,1,1,1,1,3.4,2.8,4.6
3999,581,0,North America,Digital,Legal & Compliance,Meets,Female,33,8,0,10,23,4.5,2.4,4.5,0.0853,1,1,1,1,2.3,3.8,4.1
4000,106,0,Europe,R&D,Data Science,Exceeds,Male,42,21,0,6,9,2.6,3.1,2.7,0.1648,1,1,1,1,2.2,4.2,4.0
4001,714,0,Asia Pacific,HR,Pharmacovigilance,Meets,Male,40,7,0,9,18,3.2,4.6,3.5,0.0383,1,1,1,1,2.6,4.5,3.6
4002,132,0,Middle East & Africa,R&D,Quality Assurance,Meets,Female,42,19,0,8,20,2.5,3.0,1.5,0.0977,1,1,1,1,3.3,4.9,1.5
4003,120,0,Europe,R&D,Finance & Accounting,Meets,Male,36,11,0,11,31,3.2,4.2,3.8,0.0977,1,1,1,1,3.0,4.2,4.2
4004,374,0,Middle East & Africa,Manufacturing,Data Science,Meets,Female,44,23,0,9,17,3.5,3.3,1.3,0.0348,1,1,1,1,3.8,4.4,2.0
4005,13,0,Europe,R&D,Regulatory Affairs,Meets,Male,31,29,0,6,32,3.4,2.4,2.1,0.0977,1,1,1,1,4.2,2.8,2.4
4006,308,0,Asia Pacific,Commercial,Quality Assurance,Meets,Male,34,11,0,11,22,1.1,2.5,2.1,0.0422,1,1,1,1,3.3,2.5,2.8
4007,542,0,Asia Pacific,Digital,Legal & Compliance,Meets,Male,36,11,0,9,29,4.3,3.5,3.3,0.0853,0,0,0,0,3.3,3.1,4.3
4008,94,0,Latin America,R&D,Communications,Below,Male,43,12,0,11,17,2.9,1.3,2.3,0.0,1,1,1,1,4.1,2.1,2.2
4009,988,0,Europe,Finance,Sales,Meets,Female,35,8,0,8,16,2.3,3.3,2.4,0.0331,1,1,1,1,1.5,3.4,3.6
4010,214,0,Latin America,Commercial,Communications,Meets,Non-Binary/Other,32,10,0,7,20,2.6,2.0,2.4,0.0422,1,1,0,0,2.4,1.2,2.6
4011,860,0,Europe,HR,Pharmacovigilance,Meets,Male,38,20,0,8,23,4.2,4.1,2.9,0.0383,1,1,1,1,5.0,2.3,3.5
4012,585,0,Latin America,Digital,Clinical Operations,Meets,Male,53,12,0,12,27,3.9,4.3,2.9,0.0853,1,1,1,1,3.9,2.3,2.6
4013,970,0,Asia Pacific,Finance,Market Access,Below,Male,32,24,1,10,18,0.0,2.8,2.1,0.0,0,0,0,0,3.7,3.5,2.8
4014,1018,0,Middle East & Africa,Finance,Data Science,Exceeds,Male,45,15,0,6,17,3.2,5.0,3.4,0.0588,1,1,1,1,4.1,5.0,2.5
4015,827,0,Latin America,HR,Sales,Meets,Female,38,25,0,9,12,2.2,2.4,2.5,0.0383,1,1,1,1,3.4,2.2,3.3
4016,1035,0,Europe,Finance,Regulatory Affairs,Meets,Female,38,11,0,9,19,4.2,2.2,2.7,0.0331,1,1,1,1,3.4,2.4,2.8
4017,195,0,Europe,Commercial,Data Science,Below,Male,34,18,0,7,12,4.1,2.8,3.8,0.0,1,1,1,1,4.2,1.9,3.3
4018,706,0,Asia Pacific,HR,Medical Affairs,Below,Female,42,8,0,10,19,4.4,1.0,2.8,0.0,1,1,1,1,4.1,2.6,3.7
4019,893,0,Europe,Finance,Medical Affairs,Exceeds,Female,44,16,0,8,13,3.5,3.0,1.9,0.0588,0,0,0,0,2.4,3.7,2.8
4020,866,0,North America,HR,Human Resources,Meets,Male,47,12,0,5,8,4.3,2.6,2.3,0.0383,1,1,1,1,4.6,1.7,2.4
4021,820,0,Middle East & Africa,HR,Pharmacovigilance,Meets,Female,40,5,1,9,13,0.0,5.0,4.0,0.0383,1,1,1,1,1.7,5.0,3.5
4022,99,0,Latin America,R&D,Clinical Operations,Below,Male,34,11,0,12,16,3.4,2.0,1.8,0.0,1,1,1,1,2.1,3.3,2.5
4023,124,0,Middle East & Africa,R&D,IT & Digital,Meets,Female,49,13,1,6,31,0.0,5.0,2.3,0.0977,1,1,1,1,3.6,5.0,1.5
4024,135,0,Asia Pacific,R&D,Pharmacovigilance,Exceeds,Female,35,26,0,11,45,3.9,4.2,3.8,0.1648,1,1,1,1,3.4,3.5,3.0
4025,883,0,Latin America,Finance,Communications,Meets,Male,33,30,0,11,17,4.7,1.6,2.5,0.0331,1,1,1,1,5.0,3.8,1.3
4026,562,0,Latin America,Digital,Pharmacovigilance,Meets,Female,40,3,0,6,15,2.8,3.3,3.1,0.0853,1,1,1,0,2.1,2.0,3.1
4027,314,1,North America,Commercial,Human Resources,Exceeds,Female,32,11,0,9,31,4.0,3.7,2.1,0.0743,1,1,1,1,3.9,4.5,2.6
4028,1023,0,Asia Pacific,Finance,Marketing,Meets,Female,35,7,0,11,14,2.3,3.0,2.7,0.0331,1,1,1,1,3.5,1.0,3.6
4029,173,0,Europe,R&D,Human Resources,Below,Male,42,28,0,7,18,1.8,1.8,1.7,0.0,1,1,1,1,1.9,2.5,2.6
4030,752,0,North America,HR,Clinical Operations,Meets,Female,55,15,0,11,12,3.6,2.1,3.0,0.0383,1,1,1,1,3.0,3.1,3.7
4031,1040,0,North America,Finance,Human Resources,Below,Male,41,22,0,6,19,4.8,2.5,3.2,0.0,0,0,0,0,4.8,2.5,3.1
4032,797,0,Middle East & Africa,HR,Finance & Accounting,Exceeds,Female,45,13,0,6,10,4.6,2.7,2.8,0.0677,1,1,1,1,5.0,2.7,2.1
4033,703,0,Middle East & Africa,HR,IT & Digital,Meets,Female,35,6,1,7,18,0.0,2.9,1.7,0.0383,0,0,0,0,4.5,1.8,2.4
4034,824,1,Middle East & Africa,HR,Marketing,Far Exceeds,Male,40,10,1,7,29,0.0,1.6,3.5,0.1168,1,1,1,1,2.9,1.4,5.0
4035,402,0,North America,Manufacturing,Quality Assurance,Far Below,Male,28,12,1,10,16,0.0,3.5,3.1,0.0,1,1,1,1,2.1,3.3,2.8
4036,533,0,Europe,Digital,Sales,Meets,Female,30,15,0,5,11,3.4,3.5,4.1,0.0853,1,1,1,0,2.1,3.9,4.3
4037,264,0,Latin America,Commercial,Sales,Below,Female,39,22,0,9,27,3.8,1.6,1.8,0.0,1,1,1,1,4.5,3.0,2.1
4038,318,0,Middle East & Africa,Commercial,Clinical Operations,Meets,Non-Binary/Other,40,12,0,5,12,3.0,3.6,1.5,0.0422,1,1,1,1,4.1,3.4,2.1
4039,159,0,Europe,R&D,Clinical Operations,Below,Male,43,11,0,11,43,3.5,1.0,2.2,0.0,1,1,1,1,2.8,2.8,1.9
4040,386,0,Asia Pacific,Manufacturing,Quality Assurance,Meets,Female,37,11,0,8,17,2.7,2.0,4.0,0.0348,1,1,1,1,3.8,1.2,5.0
4041,951,0,Middle East & Africa,Finance,Finance & Accounting,Exceeds,Female,47,5,1,6,13,0.0,2.0,5.0,0.0588,1,1,1,1,4.0,1.6,2.7
4042,973,0,Latin America,Finance,Sales,Below,Female,41,12,0,11,15,2.5,3.8,2.2,0.0,0,0,0,0,3.0,5.0,3.2
4043,184,0,Asia Pacific,Commercial,Quality Assurance,Meets,Female,28,11,0,11,24,2.6,2.2,4.4,0.0422,1,1,1,1,4.0,2.9,3.3
4044,575,0,Asia Pacific,Digital,Market Access,Exceeds,Male,28,14,0,6,21,4.8,2.4,2.2,0.1452,1,1,0,0,4.6,4.2,2.5
4045,721,0,Latin America,HR,Regulatory Affairs,Far Exceeds,Female,39,3,0,11,26,3.8,3.8,2.2,0.1168,1,1,1,1,3.3,3.2,2.4
4046,108,0,Middle East & Africa,R&D,Communications,Meets,Female,37,10,1,11,16,0.0,2.8,3.4,0.0977,1,1,1,1,2.4,4.4,2.9
4047,606,0,North America,Digital,Medical Affairs,Exceeds,Male,39,10,0,5,18,3.7,2.5,2.1,0.1452,1,1,1,1,2.5,1.8,1.0
4048,338,0,Latin America,Commercial,Finance & Accounting,Meets,Male,36,10,1,5,10,0.0,1.0,2.0,0.0422,1,1,1,1,4.8,1.0,1.7
4049,429,0,Latin America,Manufacturing,Human Resources,Meets,Female,34,12,0,6,17,4.9,3.6,2.9,0.0348,1,1,1,1,3.8,5.0,1.9
4050,82,0,Latin America,R&D,Legal & Compliance,Exceeds,Male,34,8,0,10,21,2.3,4.1,2.9,0.1648,1,1,1,1,3.7,4.1,2.8
4051,189,0,Asia Pacific,Commercial,Market Access,Meets,Male,38,18,0,10,14,3.8,3.1,4.6,0.0422,1,1,1,1,4.2,3.8,3.0
4052,948,0,Europe,Finance,Pharmacovigilance,Exceeds,Female,43,16,0,11,21,3.2,4.1,1.0,0.0588,0,0,0,0,2.7,2.2,2.2
4053,59,0,North America,R&D,Finance & Accounting,Exceeds,Male,32,14,0,9,15,3.5,3.3,3.4,0.1648,1,1,1,1,3.6,3.4,3.8
4054,297,0,Middle East & Africa,Commercial,Data Science,Meets,Male,37,11,0,10,12,3.9,2.4,2.7,0.0422,1,1,1,1,2.5,2.6,3.5
4055,999,0,Middle East & Africa,Finance,Marketing,Meets,Female,47,11,0,11,21,1.5,4.2,2.3,0.0331,1,1,1,1,3.0,5.0,2.5
4056,985,0,Europe,Finance,Human Resources,Meets,Male,28,3,1,7,24,0.0,4.1,4.4,0.0331,1,1,1,1,2.9,5.0,4.4
4057,880,0,Latin America,HR,Supply Chain,Meets,Female,42,3,1,7,21,0.0,2.9,3.8,0.0383,0,0,0,0,3.5,4.1,3.1
4058,502,0,North America,Manufacturing,Data Science,Below,Male,37,13,0,7,11,3.5,3.6,4.6,0.0,1,1,1,1,3.3,3.4,4.7
4059,750,0,Middle East & Africa,HR,Clinical Operations,Meets,Female,33,7,0,8,18,2.4,4.8,1.0,0.0383,1,1,1,1,1.9,3.0,2.0
4060,177,1,Middle East & Africa,Commercial,Regulatory Affairs,Exceeds,Male,35,5,0,12,30,3.2,2.7,1.0,0.0743,1,1,1,1,3.0,2.8,3.0
4061,534,0,Latin America,Digital,Human Resources,Exceeds,Male,44,24,0,11,22,4.5,3.9,3.4,0.1452,0,0,0,0,5.0,2.7,4.2
4062,860,0,Europe,HR,Legal & Compliance,Meets,Female,37,14,0,11,18,3.3,3.7,2.4,0.0383,1,1,1,1,4.7,4.5,1.5
4063,660,0,North America,Digital,Market Access,Meets,Male,32,7,0,10,21,4.0,3.3,4.0,0.0853,1,1,1,1,2.8,4.3,3.1
4064,957,0,Europe,Finance,Supply Chain,Meets,Female,33,10,0,12,15,3.7,3.0,2.1,0.0331,1,1,1,1,3.4,4.3,3.2
4065,340,1,Europe,Commercial,Supply Chain,Meets,Female,35,15,0,10,24,4.3,1.0,2.4,0.0422,1,1,1,1,4.2,2.2,1.6
4066,480,0,North America,Manufacturing,IT & Digital,Far Exceeds,Female,43,10,0,9,17,4.7,4.2,1.0,0.1069,1,1,1,1,3.8,5.0,1.6
4067,605,0,North America,Digital,Clinical Operations,Below,Male,35,16,0,7,12,1.5,2.1,2.7,0.0,1,1,1,1,3.1,4.0,3.3
4068,311,0,Middle East & Africa,Commercial,Market Access,Meets,Female,38,30,0,12,26,2.7,3.5,2.1,0.0422,0,0,0,0,4.0,3.3,1.8
4069,608,0,Middle East & Africa,Digital,Supply Chain,Exceeds,Female,34,9,0,10,23,3.3,2.6,2.3,0.1452,1,1,1,1,3.0,1.8,2.6
4070,867,0,North America,HR,Communications,Exceeds,Male,36,8,0,9,14,5.0,4.6,3.1,0.0677,1,1,1,0,4.7,3.4,2.9
4071,302,1,Asia Pacific,Commercial,Market Access,Meets,Male,37,7,1,7,13,0.0,2.3,3.1,0.0422,1,1,1,1,3.9,1.8,5.0
4072,711,0,Middle East & Africa,HR,Human Resources,Below,Female,32,13,0,6,13,3.8,2.6,4.0,0.0,1,1,1,1,4.6,1.6,2.2
4073,164,0,Asia Pacific,R&D,Marketing,Exceeds,Female,33,17,0,5,29,3.8,5.0,2.8,0.1648,1,1,1,1,4.2,3.9,3.8
4074,217,0,North America,Commercial,Human Resources,Meets,Male,35,7,0,12,25,2.5,3.8,1.0,0.0422,0,0,0,0,2.4,3.4,3.0
4075,658,0,Middle East & Africa,Digital,Marketing,Meets,Female,47,20,0,5,27,3.8,2.5,3.1,0.0853,1,1,1,1,3.7,2.5,2.0
4076,130,0,Europe,R&D,Supply Chain,Meets,Female,38,5,0,9,24,2.0,2.8,2.0,0.0977,1,1,1,1,2.1,2.8,3.4
4077,758,0,North America,HR,Supply Chain,Meets,Male,33,7,0,5,9,3.4,3.5,2.0,0.0383,0,0,0,0,4.3,4.5,2.1
4078,709,0,Latin America,HR,Clinical Operations,Far Below,Female,43,2,1,9,17,0.0,2.3,4.8,0.0,1,1,1,1,3.0,2.4,4.9
4079,565,0,Asia Pacific,Digital,Market Access,Meets,Male,43,25,0,6,23,4.1,2.6,2.0,0.0853,1,1,1,1,4.0,2.8,4.0
4080,107,0,North America,R&D,Sales,Below,Female,33,12,0,5,14,2.1,3.0,1.0,0.0,1,1,1,1,2.1,4.2,1.1
4081,891,0,North America,Finance,Communications,Below,Female,48,4,0,6,28,3.0,3.4,2.4,0.0,1,1,1,1,3.6,1.5,1.8
4082,384,0,Middle East & Africa,Manufacturing,Legal & Compliance,Meets,Male,40,11,1,6,10,0.0,3.7,3.0,0.0348,1,1,1,1,2.5,4.1,2.8
4083,616,0,Middle East & Africa,Digital,Legal & Compliance,Meets,Female,41,14,0,6,21,4.4,1.6,2.6,0.0853,1,1,1,1,3.1,1.0,4.6
4084,839,0,Middle East & Africa,HR,Quality Assurance,Meets,Male,40,7,0,11,27,4.8,2.6,2.8,0.0383,1,1,1,1,4.0,1.8,4.4
4085,230,0,Latin America,Commercial,Quality Assurance,Below,Female,40,13,0,5,7,4.1,3.2,3.1,0.0,1,1,1,1,4.2,3.5,3.6
4086,11,0,Middle East & Africa,R&D,Data Science,Exceeds,Male,37,7,0,8,12,2.3,4.3,1.8,0.1648,1,1,1,1,2.0,3.3,1.0
4087,887,0,North America,Finance,Data Science,Below,Female,42,19,0,6,27,3.3,3.2,2.5,0.0,1,1,1,1,2.7,2.2,2.2
4088,437,0,Middle East & Africa,Manufacturing,Supply Chain,Meets,Female,36,12,0,6,17,3.8,4.0,3.9,0.0348,1,1,1,1,4.1,4.4,4.7
4089,335,0,Europe,Commercial,Communications,Meets,Female,47,17,0,9,20,3.5,2.6,2.9,0.0422,1,1,1,1,3.7,3.8,4.8
4090,170,0,Middle East & Africa,R&D,Medical Affairs,Exceeds,Male,28,23,0,9,16,3.8,4.2,2.8,0.1648,1,1,1,1,4.9,4.3,2.8
4091,952,0,Latin America,Finance,Marketing,Meets,Female,33,4,0,11,14,3.5,2.9,1.0,0.0331,0,0,0,0,2.1,1.9,1.8
4092,614,0,Europe,Digital,Pharmacovigilance,Below,Male,40,15,1,8,17,0.0,4.0,4.3,0.0,1,1,1,1,3.6,2.7,4.1
4093,932,0,North America,Finance,Market Access,Far Below,Male,38,9,0,12,20,2.4,3.0,1.9,0.0,1,1,1,1,4.0,2.5,3.6
4094,628,0,North America,Digital,Regulatory Affairs,Meets,Male,35,7,0,8,24,4.0,3.9,3.5,0.0853,1,1,1,1,4.7,2.4,2.6
4095,126,0,Asia Pacific,R&D,Regulatory Affairs,Meets,Female,39,6,0,11,15,1.8,2.9,5.0,0.0977,1,1,1,1,3.3,2.3,4.6
4096,1042,0,Europe,Finance,Marketing,Meets,Female,31,6,1,9,15,0.0,3.4,3.2,0.0331,1,1,1,1,3.6,3.1,2.2
4097,515,0,Asia Pacific,Manufacturing,Data Science,Below,Female,32,14,1,11,19,0.0,3.1,1.3,0.0,1,1,1,1,2.8,2.9,2.1
4098,916,1,Europe,Finance,Clinical Operations,Meets,Female,37,12,1,8,18,0.0,3.2,4.6,0.0331,1,1,1,1,4.2,3.3,3.9
4099,116,0,Europe,R&D,Regulatory Affairs,Meets,Female,40,22,0,5,9,3.3,3.8,2.7,0.0977,1,1,1,1,1.9,2.7,2.7
4100,282,0,Latin America,Commercial,Legal & Compliance,Meets,Male,34,12,1,11,29,0.0,3.8,1.3,0.0422,1,1,1,1,2.7,3.8,1.4
4101,182,0,Asia Pacific,Commercial,Finance & Accounting,Below,Female,28,8,0,12,27,4.3,1.9,3.6,0.0,1,1,1,1,4.3,3.8,3.3
4102,903,0,Latin America,Finance,Supply Chain,Meets,Male,39,8,0,11,13,3.9,4.2,4.0,0.0331,1,1,1,1,4.3,4.5,3.2
4103,917,0,Europe,Finance,Medical Affairs,Meets,Female,41,23,0,9,24,2.9,1.8,3.3,0.0331,1,1,1,1,3.5,2.2,3.8
4104,629,0,North America,Digital,IT & Digital,Meets,Female,31,9,1,11,42,0.0,3.4,2.7,0.0853,0,0,0,0,3.3,3.6,2.8
4105,75,0,Europe,R&D,Regulatory Affairs,Meets,Female,36,16,0,9,16,3.3,2.0,4.9,0.0977,1,1,1,0,3.5,2.4,4.9
4106,684,0,Latin America,Digital,Human Resources,Exceeds,Female,43,9,0,12,12,3.3,4.2,2.4,0.1452,1,1,1,1,3.8,2.6,2.2
4107,512,1,Asia Pacific,Manufacturing,IT & Digital,Meets,Male,31,16,0,7,11,3.6,4.0,4.8,0.0348,1,1,1,1,2.9,4.1,3.4
4108,277,0,Asia Pacific,Commercial,IT & Digital,Meets,Male,38,19,0,8,11,3.6,3.3,3.9,0.0422,1,1,1,1,4.5,3.6,2.5
4109,855,0,Latin America,HR,Quality Assurance,Meets,Male,34,5,0,6,14,3.4,2.4,1.2,0.0383,1,0,0,0,4.0,3.3,2.2
4110,788,0,Asia Pacific,HR,Medical Affairs,Meets,Male,51,9,0,6,15,4.0,5.0,2.7,0.0383,1,1,1,1,3.7,4.1,3.0
4111,39,0,Middle East & Africa,R&D,Medical Affairs,Far Below,Female,31,5,1,11,17,0.0,2.8,1.0,0.0,1,1,1,1,3.1,2.5,1.0
4112,4,0,North America,R&D,Regulatory Affairs,Meets,Male,28,13,0,12,24,4.1,2.5,2.4,0.0977,1,1,1,1,2.8,2.2,2.6
4113,768,0,North America,HR,Legal & Compliance,Below,Female,42,11,0,12,17,2.5,1.0,2.7,0.0,1,1,1,1,3.4,1.0,2.8
4114,152,0,North America,R&D,Clinical Operations,Far Exceeds,Female,36,9,1,9,11,0.0,1.7,1.9,0.2644,1,1,1,1,3.0,3.9,3.6
4115,269,0,Asia Pacific,Commercial,Clinical Operations,Meets,Female,32,11,1,11,14,0.0,4.3,3.0,0.0422,1,1,1,0,3.3,3.6,3.9
4116,371,0,Asia Pacific,Manufacturing,Data Science,Below,Female,35,15,0,6,18,2.7,2.9,2.7,0.0,1,1,1,1,3.1,3.9,2.7
4117,507,0,Europe,Manufacturing,Marketing,Below,Male,47,21,0,8,12,3.1,2.6,3.7,0.0,1,1,1,1,1.0,3.6,2.1
4118,539,0,Europe,Digital,Supply Chain,Meets,Male,38,14,0,6,28,3.8,3.7,2.1,0.0853,0,0,0,0,4.1,3.2,1.6
4119,334,0,North America,Commercial,Finance & Accounting,Meets,Female,47,17,1,9,17,0.0,2.5,2.0,0.0422,1,1,1,1,4.6,3.7,1.0
4120,41,0,Middle East & Africa,R&D,Pharmacovigilance,Meets,Male,31,5,1,9,20,0.0,1.9,1.9,0.0977,1,1,1,1,4.2,3.7,3.5
4121,143,0,Europe,R&D,Sales,Meets,Male,45,18,0,9,31,3.8,3.5,3.0,0.0977,1,1,1,1,3.4,2.6,2.6
4122,590,0,Europe,Digital,Pharmacovigilance,Exceeds,Female,32,17,0,12,26,3.2,3.6,3.9,0.1452,1,1,1,1,4.3,3.2,4.6
4123,564,0,Asia Pacific,Digital,Quality Assurance,Meets,Female,45,7,1,9,14,0.0,3.7,2.7,0.0853,1,1,1,1,2.4,2.7,2.8
4124,90,0,Middle East & Africa,R&D,Clinical Operations,Meets,Female,45,14,0,8,11,2.6,1.4,2.6,0.0977,0,0,0,0,2.6,2.7,4.1
4125,27,0,North America,R&D,Human Resources,Exceeds,Male,32,9,1,5,6,0.0,3.8,3.3,0.1648,1,0,0,0,4.4,3.5,2.6
4126,198,0,Europe,Commercial,IT & Digital,Far Below,Female,41,11,0,12,18,3.0,3.6,1.7,0.0,1,1,1,1,1.4,3.9,3.8
4127,561,0,Middle East & Africa,Digital,Data Science,Below,Female,39,16,1,8,21,0.0,3.4,1.3,0.0,0,0,0,0,3.5,3.7,2.2
4128,250,0,Middle East & Africa,Commercial,Quality Assurance,Meets,Female,44,10,1,7,26,0.0,3.5,3.1,0.0422,1,1,1,1,2.7,2.9,3.0
4129,982,0,North America,Finance,Pharmacovigilance,Meets,Male,31,34,0,5,18,3.5,3.5,2.6,0.0331,1,1,1,1,4.2,4.1,4.5
4130,68,0,Middle East & Africa,R&D,Legal & Compliance,Meets,Female,36,27,0,7,19,2.8,2.3,2.1,0.0977,1,1,1,1,3.4,2.9,2.6
4131,728,0,Middle East & Africa,HR,Medical Affairs,Below,Female,38,7,0,11,14,2.1,2.0,2.7,0.0,1,1,1,1,3.2,2.1,2.1
4132,816,0,Middle East & Africa,HR,Legal & Compliance,Exceeds,Female,47,35,0,8,24,2.5,3.8,2.2,0.0677,1,1,1,1,4.0,4.6,2.1
4133,1002,0,Europe,Finance,Legal & Compliance,Meets,Male,38,18,0,6,17,4.2,2.9,1.4,0.0331,1,1,1,1,4.1,2.3,1.6
4134,146,0,North America,R&D,Legal & Compliance,Meets,Female,32,11,1,11,26,0.0,4.8,3.8,0.0977,1,1,1,1,4.2,4.7,3.5
4135,648,0,Middle East & Africa,Digital,IT & Digital,Exceeds,Female,40,22,0,12,16,2.1,2.7,2.2,0.1452,1,1,1,1,2.1,2.3,2.3
4136,753,0,Middle East & Africa,HR,Marketing,Meets,Female,32,24,0,10,22,1.4,3.1,2.3,0.0383,1,1,1,1,2.8,3.8,1.3
4137,607,0,Europe,Digital,Medical Affairs,Exceeds,Male,28,22,0,5,7,4.6,1.9,3.0,0.1452,1,1,1,0,3.6,1.0,3.7
4138,803,0,North America,HR,Finance & Accounting,Meets,Male,37,22,0,5,18,2.2,2.0,2.8,0.0383,1,1,1,1,3.2,3.3,1.3
4139,612,0,Asia Pacific,Digital,Communications,Exceeds,Male,40,10,0,8,9,2.9,2.5,2.4,0.1452,1,1,1,1,2.7,4.1,2.0
4140,761,0,Europe,HR,Pharmacovigilance,Meets,Female,39,11,0,12,31,3.3,2.0,1.5,0.0383,1,1,1,1,3.6,3.4,1.0
4141,580,0,North America,Digital,Regulatory Affairs,Exceeds,Female,38,7,0,6,12,1.9,4.0,2.4,0.1452,0,0,0,0,2.4,5.0,4.0
4142,979,0,Middle East & Africa,Finance,Marketing,Below,Male,49,22,0,12,27,3.6,4.0,2.3,0.0,1,1,1,0,3.4,3.4,3.3
4143,322,0,North America,Commercial,Human Resources,Meets,Female,47,19,0,10,16,2.2,1.0,2.7,0.0422,0,0,0,0,1.9,2.6,2.5
4144,683,0,North America,Digital,Finance & Accounting,Meets,Female,33,9,0,12,32,2.8,2.2,2.7,0.0853,1,1,1,1,3.5,3.6,2.8
4145,213,0,North America,Commercial,Data Science,Below,Male,44,13,1,9,12,0.0,2.6,3.6,0.0,1,1,1,1,4.7,2.4,2.4
4146,282,0,Asia Pacific,Commercial,Market Access,Below,Male,52,12,1,11,32,0.0,3.6,2.5,0.0,1,1,0,0,3.6,3.3,2.6
4147,169,0,North America,R&D,Medical Affairs,Meets,Male,49,11,0,8,10,3.2,2.7,3.2,0.0977,1,1,1,1,4.1,2.7,1.6
4148,1038,0,Asia Pacific,Finance,Regulatory Affairs,Meets,Female,44,24,0,8,28,2.2,1.0,4.2,0.0331,1,1,1,1,1.6,2.0,4.5
4149,189,0,Middle East & Africa,Commercial,Human Resources,Meets,Male,37,16,0,10,24,1.2,1.6,2.1,0.0422,1,1,1,1,1.4,3.1,2.9
4150,395,0,Asia Pacific,Manufacturing,Quality Assurance,Meets,Female,30,18,0,11,29,4.2,4.5,3.1,0.0348,1,1,1,1,3.7,3.1,3.4
4151,298,0,Middle East & Africa,Commercial,Market Access,Meets,Female,32,36,0,9,13,4.1,2.4,2.6,0.0422,1,1,1,1,2.9,4.2,3.5
4152,571,0,Middle East & Africa,Digital,Quality Assurance,Meets,Male,41,14,0,9,13,3.6,3.6,3.2,0.0853,1,1,1,1,3.7,2.9,1.0
4153,351,0,Asia Pacific,Commercial,Clinical Operations,Meets,Male,40,6,0,6,34,3.3,3.9,2.5,0.0422,1,1,1,1,3.7,3.4,2.8
4154,681,0,Europe,Digital,Market Access,Exceeds,Female,38,14,0,11,22,3.5,1.7,2.3,0.1452,1,1,1,1,2.6,3.5,2.4
4155,641,0,Latin America,Digital,Marketing,Meets,Male,43,12,0,11,15,4.6,3.0,5.0,0.0853,1,0,0,0,4.6,5.0,2.8
4156,507,0,North America,Manufacturing,Clinical Operations,Far Below,Female,45,8,0,12,18,4.0,4.7,2.8,0.0,0,0,0,0,4.3,5.0,3.3
4157,234,0,Latin America,Commercial,Marketing,Meets,Female,45,10,0,5,11,4.0,3.4,1.0,0.0422,1,1,1,1,3.6,3.9,2.9
4158,221,0,North America,Commercial,Supply Chain,Meets,Male,42,20,0,8,20,3.4,3.2,4.0,0.0422,1,1,1,1,3.3,3.3,2.7
4159,818,0,North America,HR,Communications,Below,Female,41,11,0,7,14,2.2,3.1,3.7,0.0,1,1,1,1,3.1,1.3,1.7
4160,854,0,Middle East & Africa,HR,Regulatory Affairs,Meets,Female,35,8,1,12,15,0.0,4.3,2.9,0.0383,1,1,1,1,4.4,3.3,3.0
4161,20,0,North America,R&D,Pharmacovigilance,Meets,Male,39,8,0,9,13,1.0,5.0,2.1,0.0977,1,1,1,1,2.8,4.0,2.5
4162,548,0,North America,Digital,Quality Assurance,Far Exceeds,Male,40,12,0,5,13,3.0,1.1,2.5,0.2363,1,0,0,0,3.2,2.8,2.1
4163,416,0,Asia Pacific,Manufacturing,Pharmacovigilance,Meets,Female,38,12,0,6,23,2.3,5.0,3.6,0.0348,1,1,1,1,2.9,3.7,3.8
4164,720,0,Latin America,HR,Communications,Meets,Male,28,16,0,12,18,5.0,3.6,3.5,0.0383,1,0,0,0,4.5,5.0,3.9
4165,347,0,Asia Pacific,Commercial,Market Access,Meets,Male,40,20,0,12,21,3.5,3.8,1.7,0.0422,0,0,0,0,3.4,3.8,1.6
4166,169,0,North America,R&D,Finance & Accounting,Meets,Female,38,22,0,10,18,4.9,2.8,4.8,0.0977,1,1,0,0,4.5,3.7,3.1
4167,518,0,Middle East & Africa,Manufacturing,Medical Affairs,Meets,Female,37,14,0,6,14,2.5,4.9,2.9,0.0348,1,1,1,1,3.6,4.3,3.3
4168,1004,0,Asia Pacific,Finance,Medical Affairs,Meets,Female,41,21,0,5,7,4.3,3.1,1.8,0.0331,1,1,1,1,5.0,4.0,1.7
4169,295,0,Asia Pacific,Commercial,IT & Digital,Meets,Male,41,13,0,7,9,3.7,3.2,1.0,0.0422,1,1,1,1,3.2,3.1,2.5
4170,329,1,Europe,Commercial,Quality Assurance,Exceeds,Male,45,12,0,9,15,4.2,2.3,2.9,0.0743,1,1,1,1,4.3,3.4,3.0
4171,905,0,North America,Finance,Clinical Operations,Below,Female,42,15,0,5,29,3.1,2.0,2.7,0.0,1,1,1,1,4.6,5.0,2.7
4172,605,0,Middle East & Africa,Digital,Quality Assurance,Below,Female,36,20,0,6,11,3.2,2.2,3.1,0.0,1,1,1,1,1.8,3.2,1.3
4173,652,0,Asia Pacific,Digital,Supply Chain,Meets,Female,46,9,0,8,11,3.8,4.1,2.9,0.0853,1,1,1,1,3.9,3.7,4.4
4174,733,0,Asia Pacific,HR,IT & Digital,Meets,Male,47,21,0,12,17,3.4,4.3,4.3,0.0383,1,1,1,1,2.9,4.5,3.9
4175,731,0,Middle East & Africa,HR,Supply Chain,Meets,Male,38,14,0,9,13,2.9,4.0,2.6,0.0383,1,1,1,1,4.1,3.4,2.4
4176,281,0,North America,Commercial,Pharmacovigilance,Meets,Female,45,4,0,9,12,2.1,3.0,2.6,0.0422,1,1,1,1,3.1,3.1,3.6
4177,216,0,Europe,Commercial,Communications,Meets,Female,39,16,0,6,9,4.6,4.0,3.4,0.0422,1,1,1,1,4.4,2.4,2.4
4178,807,0,Asia Pacific,HR,Finance & Accounting,Meets,Male,45,12,0,6,10,1.8,2.4,2.5,0.0383,1,1,1,1,4.7,4.0,3.0
4179,986,0,Europe,Finance,Market Access,Exceeds,Male,46,14,0,12,24,3.6,3.1,4.0,0.0588,1,1,1,0,3.0,2.3,3.9
4180,706,0,Latin America,HR,Supply Chain,Far Below,Female,34,22,1,8,35,0.0,2.6,2.6,0.0,1,1,1,1,3.4,3.0,2.2
4181,344,0,North America,Commercial,Communications,Exceeds,Non-Binary/Other,46,8,1,9,21,0.0,2.4,1.6,0.0743,1,1,1,1,2.8,2.4,1.4
4182,501,0,Latin America,Manufacturing,Regulatory Affairs,Meets,Male,38,19,0,9,22,3.5,3.3,3.8,0.0348,1,1,1,1,3.0,5.0,2.1
4183,298,0,Latin America,Commercial,Clinical Operations,Meets,Male,40,7,0,6,20,3.3,3.7,1.0,0.0422,1,0,0,0,3.8,4.4,1.2
4184,475,0,Latin America,Manufacturing,Clinical Operations,Meets,Male,45,7,1,7,29,0.0,2.8,2.9,0.0348,1,1,1,1,2.9,2.8,4.5
4185,440,0,North America,Manufacturing,Supply Chain,Meets,Male,36,20,0,6,13,3.7,3.7,3.3,0.0348,1,1,1,1,3.3,2.8,1.2
4186,350,0,North America,Commercial,Sales,Far Below,Male,44,19,0,8,22,2.0,3.1,2.6,0.0,1,1,1,1,3.3,2.6,3.5
4187,69,0,Middle East & Africa,R&D,Medical Affairs,Meets,Male,39,18,0,12,19,3.9,1.1,1.9,0.0977,1,1,1,1,3.6,2.0,2.2
4188,797,0,Europe,HR,Sales,Meets,Female,35,24,0,7,11,2.6,2.2,4.0,0.0383,1,0,0,0,3.1,2.0,4.8
4189,693,0,Europe,Digital,Market Access,Below,Female,42,10,0,11,28,2.9,3.5,2.5,0.0,1,0,0,0,4.1,3.8,3.2
4190,261,0,Middle East & Africa,Commercial,Market Access,Below,Female,46,7,0,7,18,3.2,3.5,1.0,0.0,1,1,0,0,3.7,3.6,1.7
4191,447,0,Middle East & Africa,Manufacturing,Marketing,Meets,Female,39,5,0,8,18,4.4,2.6,3.4,0.0348,1,1,1,1,4.1,3.5,5.0
4192,265,0,Latin America,Commercial,IT & Digital,Meets,Male,32,6,0,5,29,3.2,2.2,3.0,0.0422,1,1,1,1,3.9,3.5,2.7
4193,771,0,Middle East & Africa,HR,Communications,Meets,Male,36,16,0,12,15,2.5,4.4,2.2,0.0383,0,0,0,0,3.2,3.8,2.4
4194,959,0,Asia Pacific,Finance,Market Access,Meets,Female,34,8,0,12,17,4.4,3.8,2.0,0.0331,1,1,1,1,1.7,4.3,2.9
4195,377,0,Europe,Manufacturing,Marketing,Meets,Female,52,22,0,7,30,2.4,1.2,3.3,0.0348,1,1,1,1,1.8,3.3,3.4
4196,523,0,Middle East & Africa,Digital,Clinical Operations,Meets,Male,33,3,0,12,26,2.9,3.2,2.1,0.0853,1,1,1,1,3.5,2.3,3.4
4197,570,0,Asia Pacific,Digital,Regulatory Affairs,Meets,Male,28,12,0,11,30,4.4,3.2,2.9,0.0853,1,1,1,1,4.2,2.8,2.2
4198,691,0,Asia Pacific,Digital,Data Science,Meets,Female,36,16,0,10,27,3.8,2.4,4.0,0.0853,0,0,0,0,4.9,4.1,3.0
4199,1025,0,Asia Pacific,Finance,Medical Affairs,Exceeds,Male,39,11,0,8,19,2.7,2.9,5.0,0.0588,1,1,1,1,2.9,3.0,3.2
4200,22,1,Asia Pacific,R&D,Marketing,Meets,Male,38,8,1,6,16,0.0,1.9,3.1,0.0977,1,1,1,1,1.9,1.7,2.6
4201,431,0,Latin America,Manufacturing,IT & Digital,Meets,Female,39,25,0,8,16,3.8,3.9,1.9,0.0348,1,1,0,0,3.7,3.8,2.2
4202,949,0,Asia Pacific,Finance,IT & Digital,Meets,Female,30,12,0,5,31,2.2,4.5,2.5,0.0331,0,0,0,0,4.2,4.4,3.1
4203,495,1,Latin America,Manufacturing,Human Resources,Meets,Female,38,10,0,12,19,4.4,2.3,1.6,0.0348,0,0,0,0,3.9,2.4,3.9
4204,970,0,Latin America,Finance,Finance & Accounting,Meets,Male,32,5,0,12,18,3.5,2.9,3.3,0.0331,1,1,1,1,2.9,1.9,4.3
4205,903,0,Asia Pacific,Finance,Pharmacovigilance,Meets,Female,43,10,1,8,11,0.0,2.0,3.5,0.0331,0,0,0,0,2.7,2.7,3.6
4206,9,0,Europe,R&D,IT & Digital,Meets,Female,31,11,0,6,8,3.8,2.7,3.3,0.0977,1,1,1,1,4.0,2.1,1.9
4207,506,1,Asia Pacific,Manufacturing,Regulatory Affairs,Far Exceeds,Female,37,12,0,11,22,5.0,3.7,2.4,0.1069,1,1,1,1,4.5,2.9,2.7
4208,1015,0,Asia Pacific,Finance,Quality Assurance,Meets,Male,33,6,1,11,13,0.0,2.9,2.9,0.0331,1,1,1,1,2.5,3.6,3.1
4209,67,0,Asia Pacific,R&D,Pharmacovigilance,Below,Female,44,8,0,5,27,3.1,3.8,3.1,0.0,0,0,0,0,4.1,2.7,4.4
4210,345,1,Europe,Commercial,Regulatory Affairs,Meets,Male,35,21,0,10,10,3.8,5.0,2.4,0.0422,1,1,1,1,4.9,4.3,3.0
4211,755,0,North America,HR,Pharmacovigilance,Far Below,Male,32,9,0,9,15,4.9,2.5,3.0,0.0,1,1,1,1,4.5,1.5,3.8
4212,998,0,North America,Finance,Supply Chain,Meets,Male,44,5,0,5,15,4.3,3.3,3.2,0.0331,1,1,1,1,2.9,3.1,3.3
4213,576,1,Latin America,Digital,Pharmacovigilance,Meets,Female,28,8,0,8,14,3.2,2.7,2.6,0.0853,1,1,1,1,3.5,2.1,3.2
4214,32,0,Latin America,R&D,Marketing,Meets,Female,42,17,0,11,24,3.4,3.8,2.5,0.0977,1,1,1,1,4.1,3.5,3.5
4215,133,1,Europe,R&D,Regulatory Affairs,Far Exceeds,Female,40,13,0,6,26,3.8,3.2,1.8,0.2644,1,1,1,1,3.6,3.9,3.5
4216,955,1,Middle East & Africa,Finance,Quality Assurance,Far Exceeds,Male,53,4,0,12,33,3.3,3.3,2.8,0.1022,1,1,1,1,3.3,2.7,2.9
4217,70,0,North America,R&D,Market Access,Below,Female,42,8,0,9,14,2.8,3.1,3.2,0.0,1,1,1,1,2.3,3.2,1.7
4218,251,0,Latin America,Commercial,Communications,Meets,Male,41,12,0,7,19,4.2,3.0,2.5,0.0422,0,0,0,0,4.0,3.4,2.4
4219,61,1,North America,R&D,Pharmacovigilance,Exceeds,Male,33,11,0,12,42,3.7,3.5,2.6,0.1648,1,1,1,1,4.8,3.5,2.7
4220,819,0,Europe,HR,IT & Digital,Meets,Female,37,15,0,6,20,4.2,3.3,3.2,0.0383,1,1,1,1,4.0,3.1,2.4
4221,861,0,Europe,HR,Quality Assurance,Meets,Male,40,13,0,12,30,2.3,4.2,3.4,0.0383,0,0,0,0,2.7,2.4,2.4
4222,543,0,Middle East & Africa,Digital,Regulatory Affairs,Exceeds,Female,47,16,0,7,16,3.2,2.9,1.0,0.1452,1,1,1,1,3.3,4.6,1.9
4223,300,0,Middle East & Africa,Commercial,Communications,Meets,Male,33,9,1,10,19,0.0,4.7,3.2,0.0422,1,1,1,1,2.0,4.7,2.3
4224,763,0,Europe,HR,Quality Assurance,Meets,Male,28,9,0,11,16,2.9,3.3,3.2,0.0383,1,1,0,0,4.2,5.0,2.8
4225,928,0,Latin America,Finance,Data Science,Exceeds,Male,38,8,0,7,11,3.1,5.0,4.1,0.0588,0,0,0,0,3.8,5.0,4.3
4226,499,0,North America,Manufacturing,Data Science,Exceeds,Male,28,9,0,10,39,2.5,4.4,3.2,0.0616,0,0,0,0,2.8,3.2,2.9
4227,358,0,Asia Pacific,Manufacturing,Pharmacovigilance,Meets,Male,43,5,1,12,24,0.0,3.0,2.4,0.0348,1,1,1,1,3.3,2.7,3.5
4228,430,1,Middle East & Africa,Manufacturing,Finance & Accounting,Meets,Male,47,24,0,10,15,2.9,2.8,3.8,0.0348,1,1,1,1,3.1,2.5,4.5
4229,962,0,Asia Pacific,Finance,Pharmacovigilance,Meets,Female,44,8,1,6,8,0.0,1.9,2.8,0.0331,1,1,1,1,3.0,1.8,3.3
4230,129,0,Latin America,R&D,Communications,Meets,Male,35,13,0,5,36,3.4,4.5,2.6,0.0977,1,1,1,1,4.4,3.3,2.7
4231,932,0,Middle East & Africa,Finance,Pharmacovigilance,Meets,Female,48,10,0,6,14,4.2,5.0,2.6,0.0331,1,1,1,1,2.8,3.0,3.9
4232,41,0,Asia Pacific,R&D,Medical Affairs,Meets,Female,33,10,0,12,19,1.7,2.5,3.6,0.0977,1,1,1,1,2.1,4.2,3.3
4233,477,0,Latin America,Manufacturing,IT & Digital,Far Exceeds,Female,32,7,1,9,12,0.0,3.1,2.2,0.1069,1,1,1,1,3.0,4.0,1.7
4234,638,0,North America,Digital,Legal & Compliance,Exceeds,Female,47,7,0,12,18,2.5,3.4,3.0,0.1452,1,1,1,1,3.3,2.1,4.5
4235,609,1,Latin America,Digital,Supply Chain,Meets,Male,36,17,0,6,32,2.3,3.2,3.2,0.0853,1,1,1,1,3.2,3.2,2.3
4236,40,0,Middle East & Africa,R&D,Finance & Accounting,Meets,Male,39,10,0,7,10,2.7,2.2,1.5,0.0977,1,1,1,1,2.8,3.6,1.9
4237,438,0,Europe,Manufacturing,Quality Assurance,Meets,Female,44,6,1,5,12,0.0,4.2,5.0,0.0348,1,1,1,1,3.3,4.0,3.9
4238,968,0,North America,Finance,Communications,Exceeds,Female,31,8,0,10,17,3.6,3.2,3.0,0.0588,1,1,1,1,2.4,2.9,1.5
4239,689,1,Asia Pacific,Digital,Communications,Meets,Male,35,17,0,12,12,1.3,5.0,2.0,0.0853,1,1,1,1,2.5,4.3,2.7
4240,30,0,Middle East & Africa,R&D,Finance & Accounting,Exceeds,Female,34,8,0,9,13,2.5,2.9,2.9,0.1648,1,1,1,1,2.9,3.3,2.0
4241,921,0,Europe,Finance,Communications,Meets,Female,37,7,0,12,17,4.2,3.1,2.9,0.0331,1,1,1,1,2.2,2.2,2.3
4242,377,0,Latin America,Manufacturing,Finance & Accounting,Meets,Female,34,10,0,9,11,4.3,2.6,3.2,0.0348,1,1,1,1,4.5,1.9,3.0
4243,263,0,Europe,Commercial,Sales,Exceeds,Female,40,17,0,7,17,2.8,1.6,1.2,0.0743,1,1,1,1,3.4,3.4,2.8
4244,419,0,Middle East & Africa,Manufacturing,Finance & Accounting,Meets,Male,40,6,0,7,18,2.4,3.0,2.4,0.0348,1,1,1,1,2.8,2.7,2.2
4245,405,0,Middle East & Africa,Manufacturing,Communications,Far Below,Male,38,14,0,11,17,2.7,2.4,1.6,0.0,1,1,1,1,2.6,1.7,2.5
4246,883,0,Europe,Finance,Communications,Meets,Male,39,13,1,7,13,0.0,4.1,4.3,0.0331,1,1,1,1,4.9,3.7,4.3
4247,970,0,Latin America,Finance,Clinical Operations,Exceeds,Male,34,24,0,10,16,3.9,3.0,3.5,0.0588,1,1,1,1,4.5,1.9,3.4
4248,824,0,Europe,HR,Communications,Meets,Female,38,13,1,5,28,0.0,2.4,3.2,0.0383,1,0,0,0,2.3,2.2,1.7
4249,869,0,Middle East & Africa,HR,Pharmacovigilance,Meets,Male,28,7,0,9,20,3.6,1.6,1.9,0.0383,0,0,0,0,2.7,3.1,1.2
4250,948,0,Middle East & Africa,Finance,Marketing,Meets,Male,44,8,0,5,19,3.7,3.8,1.5,0.0331,0,0,0,0,1.9,2.9,2.5
4251,974,0,Asia Pacific,Finance,Data Science,Meets,Male,35,7,1,11,16,0.0,2.5,4.0,0.0331,1,1,1,1,3.0,4.3,3.6
4252,186,0,Asia Pacific,Commercial,Data Science,Meets,Female,35,14,0,8,14,3.6,3.5,1.8,0.0422,1,0,0,0,2.8,1.3,2.6
4253,342,0,North America,Commercial,Legal & Compliance,Below,Female,32,11,0,8,12,5.0,3.5,3.2,0.0,1,1,1,1,4.5,3.0,4.1
4254,407,0,Middle East & Africa,Manufacturing,Legal & Compliance,Far Exceeds,Female,39,8,0,5,29,2.8,3.8,4.0,0.1069,1,1,1,1,3.8,3.7,3.7
4255,672,0,Asia Pacific,Digital,Market Access,Meets,Female,35,16,0,10,27,2.1,2.1,1.1,0.0853,1,1,1,1,2.0,3.3,1.8
4256,235,0,Europe,Commercial,Clinical Operations,Meets,Male,42,14,0,8,17,4.9,3.8,2.4,0.0422,0,0,0,0,4.3,4.5,3.1
4257,466,0,Latin America,Manufacturing,Finance & Accounting,Meets,Male,32,36,0,5,12,4.8,2.7,3.1,0.0348,1,1,1,1,3.7,2.4,3.2
4258,53,0,Europe,R&D,Quality Assurance,Below,Female,39,6,1,11,20,0.0,3.4,2.9,0.0,1,1,1,1,5.0,2.8,3.6
4259,876,0,Latin America,HR,Regulatory Affairs,Meets,Female,41,23,1,8,19,0.0,2.9,3.0,0.0383,0,0,0,0,2.9,2.9,3.3
4260,683,0,Asia Pacific,Digital,IT & Digital,Meets,Male,43,5,1,10,21,0.0,4.3,3.6,0.0853,1,1,1,1,4.2,3.5,2.8
4261,477,0,North America,Manufacturing,Clinical Operations,Exceeds,Male,42,17,0,12,36,3.8,3.4,3.1,0.0616,1,1,1,1,3.6,3.3,3.5
4262,938,0,Europe,Finance,Supply Chain,Meets,Female,33,4,0,5,34,1.7,3.3,3.1,0.0331,1,1,1,1,3.2,3.5,2.8
4263,36,0,Europe,R&D,Legal & Compliance,Meets,Male,38,4,0,12,14,2.9,5.0,2.5,0.0977,1,1,1,1,2.8,4.0,1.7
4264,850,0,Europe,HR,Human Resources,Meets,Male,37,14,0,11,29,2.7,4.7,3.0,0.0383,1,1,1,1,2.9,4.0,2.3
4265,15,0,Latin America,R&D,Pharmacovigilance,Meets,Female,32,8,0,6,13,2.9,2.6,1.4,0.0977,1,1,1,1,2.8,3.0,1.5
4266,472,0,Asia Pacific,Manufacturing,Marketing,Meets,Male,38,8,0,9,15,4.0,2.6,4.3,0.0348,1,1,1,1,3.8,3.5,2.6
4267,270,1,Europe,Commercial,Quality Assurance,Far Exceeds,Female,30,34,0,5,9,2.6,2.9,2.5,0.1275,1,1,1,1,4.1,2.6,3.5
4268,756,0,Europe,HR,Quality Assurance,Meets,Male,39,6,0,6,23,3.1,3.2,3.3,0.0383,1,1,1,1,3.5,2.2,1.9
4269,5,0,North America,R&D,Pharmacovigilance,Far Below,Male,45,12,1,6,13,0.0,1.9,2.5,0.0,0,0,0,0,3.7,3.0,3.8
4270,262,0,North America,Commercial,Supply Chain,Meets,Female,44,13,0,6,27,2.5,4.0,2.9,0.0422,1,1,1,1,2.1,2.4,3.0
4271,593,0,Asia Pacific,Digital,Pharmacovigilance,Meets,Male,40,9,0,5,18,2.4,2.6,1.9,0.0853,1,1,1,1,2.4,3.8,2.3
4272,358,0,Asia Pacific,Manufacturing,Communications,Exceeds,Female,40,12,0,8,12,2.8,4.5,3.3,0.0616,1,1,1,1,2.7,3.5,2.1
4273,388,1,Middle East & Africa,Manufacturing,Pharmacovigilance,Meets,Male,37,16,0,12,14,3.3,3.8,2.0,0.0348,1,1,1,1,4.5,2.7,2.5
4274,707,0,North America,HR,IT & Digital,Meets,Male,51,16,1,5,10,0.0,2.2,3.0,0.0383,1,1,1,1,3.8,3.0,2.7
4275,132,0,Middle East & Africa,R&D,Human Resources,Below,Male,37,11,0,8,15,3.4,3.0,4.9,0.0,1,1,1,1,3.1,3.8,3.2
4276,656,0,Latin America,Digital,Clinical Operations,Meets,Female,30,4,0,7,8,1.2,1.6,3.2,0.0853,1,1,1,1,2.2,4.0,3.3
4277,994,0,Middle East & Africa,Finance,Marketing,Meets,Male,43,5,0,5,8,3.1,3.5,1.5,0.0331,1,1,1,1,3.2,3.8,2.7
4278,725,0,Europe,HR,IT & Digital,Meets,Male,41,8,1,12,17,0.0,2.1,2.9,0.0383,1,1,1,1,2.7,4.3,3.1
4279,928,0,Middle East & Africa,Finance,Quality Assurance,Below,Female,31,14,0,5,10,2.8,3.2,2.8,0.0,1,1,0,0,3.0,1.6,4.1
4280,803,0,Asia Pacific,HR,Market Access,Below,Female,36,14,0,11,11,3.2,2.6,1.8,0.0,1,1,1,1,3.3,2.8,1.7
4281,162,0,Latin America,R&D,Pharmacovigilance,Meets,Male,39,11,0,12,15,2.4,4.4,1.3,0.0977,1,1,1,1,2.2,2.3,1.5
4282,623,0,Europe,Digital,Communications,Meets,Female,35,3,1,12,14,0.0,3.0,4.6,0.0853,1,1,1,1,3.0,3.8,3.4
4283,12,1,Middle East & Africa,R&D,Medical Affairs,Exceeds,Female,44,18,0,12,19,2.6,5.0,2.2,0.1648,1,1,1,1,2.8,4.9,3.3
4284,409,0,Latin America,Manufacturing,Finance & Accounting,Far Below,Male,33,8,1,9,25,0.0,1.0,2.2,0.0,1,1,1,1,2.5,2.6,2.8
4285,899,0,Latin America,Finance,Regulatory Affairs,Meets,Male,36,3,0,12,16,2.7,2.5,3.4,0.0331,1,1,1,1,3.7,4.1,1.8
4286,252,0,Europe,Commercial,Human Resources,Meets,Female,35,25,0,12,17,4.0,5.0,1.1,0.0422,0,0,0,0,3.1,5.0,2.2
4287,366,0,Middle East & Africa,Manufacturing,Pharmacovigilance,Exceeds,Male,41,15,0,7,14,3.8,2.8,3.0,0.0616,1,1,1,1,4.2,4.4,1.7
4288,383,0,Latin America,Manufacturing,Pharmacovigilance,Meets,Female,42,25,0,7,14,4.1,3.8,3.4,0.0348,1,1,1,1,3.5,2.7,3.8
4289,964,0,Latin America,Finance,IT & Digital,Meets,Male,41,15,0,6,18,3.4,2.2,2.6,0.0331,1,1,1,1,4.0,3.7,3.5
4290,839,0,North America,HR,Quality Assurance,Meets,Female,28,11,1,9,14,0.0,5.0,2.6,0.0383,1,1,1,1,2.2,3.7,1.9
4291,514,0,Latin America,Manufacturing,Data Science,Meets,Female,39,12,0,9,18,3.1,2.8,3.7,0.0348,0,0,0,0,3.8,3.2,2.7
4292,643,0,North America,Digital,Sales,Meets,Male,41,12,1,10,34,0.0,1.9,3.4,0.0853,1,1,1,1,2.7,3.9,2.4
4293,436,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Far Below,Male,42,6,1,8,14,0.0,3.0,1.0,0.0,1,1,1,1,2.4,2.2,3.1
4294,560,0,Middle East & Africa,Digital,Legal & Compliance,Meets,Female,37,9,0,5,27,3.0,2.0,2.1,0.0853,1,1,1,1,2.6,2.8,1.8
4295,175,0,Middle East & Africa,R&D,Data Science,Meets,Female,38,4,1,11,16,0.0,1.9,3.0,0.0977,1,1,1,1,3.2,2.7,3.6
4296,748,0,Asia Pacific,HR,Clinical Operations,Meets,Male,35,7,1,9,10,0.0,1.5,2.3,0.0383,1,1,1,1,2.3,4.3,3.0
4297,547,0,Middle East & Africa,Digital,Medical Affairs,Meets,Female,46,5,0,8,11,3.8,2.3,2.4,0.0853,1,1,1,1,3.8,2.7,3.1
4298,442,0,Latin America,Manufacturing,Sales,Meets,Female,30,24,0,12,19,5.0,3.6,4.0,0.0348,1,1,1,1,3.8,3.7,3.0
4299,802,0,Europe,HR,IT & Digital,Meets,Non-Binary/Other,41,10,0,5,9,4.0,4.6,2.1,0.0383,1,1,1,1,3.6,4.1,1.1
4300,818,0,North America,HR,Regulatory Affairs,Below,Female,32,7,1,6,23,0.0,3.9,4.7,0.0,1,1,1,1,3.1,4.9,2.2
4301,629,0,Asia Pacific,Digital,Communications,Exceeds,Female,35,5,1,7,16,0.0,3.6,2.7,0.1452,1,1,1,1,2.8,3.8,2.5
4302,565,0,Middle East & Africa,Digital,Communications,Below,Female,38,18,0,8,21,1.7,3.1,1.0,0.0,1,1,1,1,4.1,3.1,1.0
4303,249,0,Middle East & Africa,Commercial,Data Science,Below,Male,28,35,0,11,14,3.3,3.1,2.1,0.0,1,1,1,1,4.1,3.3,1.6
4304,303,0,Europe,Commercial,IT & Digital,Exceeds,Female,30,2,0,7,11,3.1,2.1,3.0,0.0743,1,1,1,1,2.4,3.7,2.4
4305,753,0,Europe,HR,Marketing,Exceeds,Male,28,12,0,12,16,3.3,3.5,3.5,0.0677,1,1,1,1,3.7,5.0,3.0
4306,1022,0,Asia Pacific,Finance,Marketing,Below,Male,41,3,0,5,12,4.0,2.7,2.9,0.0,1,1,1,1,4.8,2.9,1.9
4307,1048,0,North America,Finance,Communications,Exceeds,Female,44,30,0,9,15,2.5,3.2,1.7,0.0588,1,1,1,1,2.0,4.4,2.6
4308,289,0,Middle East & Africa,Commercial,Supply Chain,Meets,Male,28,8,1,5,21,0.0,3.3,2.9,0.0422,1,1,1,1,5.0,4.4,2.5
4309,375,0,Asia Pacific,Manufacturing,IT & Digital,Meets,Female,37,34,0,7,10,3.9,3.5,1.6,0.0348,1,1,1,1,3.1,3.7,3.0
4310,164,0,Latin America,R&D,Pharmacovigilance,Below,Female,40,6,0,9,27,4.0,3.1,1.6,0.0,1,1,1,1,2.9,2.3,2.5
4311,790,0,Latin America,HR,Medical Affairs,Meets,Male,40,22,0,7,15,3.3,3.9,3.3,0.0383,1,1,1,1,4.3,2.9,3.7
4312,108,0,Asia Pacific,R&D,Sales,Meets,Male,50,14,0,9,14,3.1,2.3,2.3,0.0977,1,1,1,1,3.1,3.9,1.0
4313,354,0,Middle East & Africa,Commercial,Human Resources,Meets,Female,39,20,0,5,17,3.2,1.9,2.3,0.0422,1,1,1,1,2.0,3.5,3.5
4314,614,0,Asia Pacific,Digital,Regulatory Affairs,Meets,Female,32,13,0,8,17,3.1,1.7,2.3,0.0853,1,1,1,0,4.0,2.5,3.4
4315,770,0,Middle East & Africa,HR,Marketing,Meets,Female,42,13,0,12,13,3.3,3.4,3.0,0.0383,1,1,1,1,3.3,3.9,4.5
4316,194,0,Europe,Commercial,Medical Affairs,Far Exceeds,Male,48,17,0,9,26,3.6,3.3,2.2,0.1275,1,1,1,1,3.4,4.0,2.2
4317,492,0,Asia Pacific,Manufacturing,Sales,Below,Non-Binary/Other,30,8,0,12,20,4.4,3.0,3.4,0.0,1,1,1,1,4.2,3.5,3.0
4318,829,0,Middle East & Africa,HR,Supply Chain,Below,Male,41,5,1,11,26,0.0,3.5,3.2,0.0,1,1,1,1,3.3,5.0,2.8
4319,771,0,Asia Pacific,HR,Marketing,Meets,Male,38,8,0,10,20,3.4,4.4,1.5,0.0383,1,1,1,1,3.1,2.6,2.1
4320,994,0,Asia Pacific,Finance,Quality Assurance,Below,Male,32,4,0,8,23,2.2,1.1,3.1,0.0,1,1,1,1,2.8,2.5,4.4
4321,551,0,Middle East & Africa,Digital,Marketing,Meets,Male,34,21,0,10,21,3.6,2.6,3.4,0.0853,1,0,0,0,3.2,1.7,2.7
4322,747,0,Middle East & Africa,HR,Market Access,Meets,Female,48,7,1,8,10,0.0,2.4,1.2,0.0383,1,1,1,1,1.8,2.1,1.1
4323,578,0,North America,Digital,Legal & Compliance,Meets,Female,43,2,1,11,19,0.0,2.3,3.1,0.0853,1,1,1,1,3.3,3.1,2.2
4324,265,0,Asia Pacific,Commercial,Quality Assurance,Exceeds,Female,41,19,0,8,19,3.0,3.8,3.8,0.0743,1,0,0,0,3.0,2.3,4.5
4325,469,0,Latin America,Manufacturing,Finance & Accounting,Meets,Female,29,5,1,5,9,0.0,3.1,2.4,0.0348,1,1,1,1,2.5,3.4,4.1
4326,393,0,Asia Pacific,Manufacturing,Legal & Compliance,Meets,Male,42,5,1,7,16,0.0,2.7,2.1,0.0348,1,1,1,1,4.0,3.4,3.1
4327,877,0,Asia Pacific,HR,Legal & Compliance,Meets,Female,45,8,0,6,26,3.9,3.9,3.4,0.0383,1,1,1,1,3.3,3.8,2.6
4328,815,0,Middle East & Africa,HR,Medical Affairs,Below,Male,30,7,0,7,13,1.4,4.9,2.4,0.0,1,1,1,1,3.7,5.0,4.4
4329,347,0,Asia Pacific,Commercial,IT & Digital,Meets,Female,38,8,1,10,13,0.0,3.5,3.2,0.0422,1,0,0,0,3.5,4.7,2.4
4330,1012,0,Asia Pacific,Finance,Supply Chain,Meets,Male,44,17,0,8,12,4.0,2.4,3.4,0.0331,1,1,1,1,4.1,3.1,2.8
4331,931,0,Latin America,Finance,Data Science,Meets,Male,43,23,0,9,31,4.9,2.8,4.4,0.0331,1,1,1,1,2.5,4.0,3.2
4332,905,0,Middle East & Africa,Finance,Clinical Operations,Exceeds,Male,42,9,1,8,13,0.0,4.0,3.5,0.0588,1,1,0,0,4.0,3.9,3.3
4333,548,0,Asia Pacific,Digital,Finance & Accounting,Below,Female,38,13,1,9,17,0.0,2.7,2.0,0.0,0,0,0,0,3.4,2.4,3.9
4334,1004,0,Europe,Finance,Pharmacovigilance,Far Below,Female,45,14,0,10,20,4.4,3.3,2.3,0.0,1,1,1,1,5.0,3.3,3.8
4335,435,1,North America,Manufacturing,Pharmacovigilance,Far Exceeds,Female,39,17,1,12,20,0.0,3.1,1.6,0.1069,1,1,1,1,2.0,4.0,2.1
4336,667,0,Latin America,Digital,Marketing,Far Below,Male,41,8,0,6,10,3.6,4.6,2.4,0.0,1,1,1,1,4.5,4.5,2.3
4337,309,0,Asia Pacific,Commercial,Communications,Far Exceeds,Non-Binary/Other,40,19,0,9,12,4.3,2.4,3.2,0.1275,0,0,0,0,5.0,3.4,3.8
4338,508,0,Europe,Manufacturing,Regulatory Affairs,Exceeds,Male,32,12,0,11,16,4.3,1.7,1.0,0.0616,1,1,1,1,4.4,4.6,1.2
4339,471,1,Asia Pacific,Manufacturing,Quality Assurance,Exceeds,Female,32,18,0,10,27,3.2,2.6,1.1,0.0616,1,1,1,1,3.9,4.4,1.2
4340,11,0,Asia Pacific,R&D,Market Access,Meets,Male,29,2,1,5,15,0.0,2.7,3.9,0.0977,1,0,0,0,3.4,3.5,3.1
4341,304,0,Middle East & Africa,Commercial,Marketing,Below,Male,36,15,0,9,23,3.0,2.7,3.0,0.0,1,1,1,0,2.8,1.9,2.0
4342,278,0,Middle East & Africa,Commercial,Supply Chain,Meets,Female,43,5,0,12,21,3.3,2.5,3.4,0.0422,1,1,1,1,3.7,2.3,3.5
4343,136,0,Middle East & Africa,R&D,Finance & Accounting,Meets,Female,40,6,0,11,19,4.8,3.3,2.8,0.0977,1,1,1,1,4.1,4.1,3.7
4344,625,0,Europe,Digital,Clinical Operations,Below,Female,38,14,0,9,45,3.6,2.0,3.0,0.0,1,0,0,0,2.9,3.7,2.5
4345,927,0,Asia Pacific,Finance,Data Science,Meets,Male,46,1,0,12,16,1.7,4.8,3.6,0.0331,1,1,1,1,2.0,3.6,3.4
4346,986,1,North America,Finance,Communications,Meets,Female,36,36,0,7,16,3.1,2.9,1.0,0.0331,0,0,0,0,2.8,4.7,2.2
4347,1047,0,Latin America,Finance,Clinical Operations,Meets,Male,41,11,0,7,18,5.0,2.8,2.0,0.0331,1,1,1,1,3.1,3.6,3.4
4348,969,0,Middle East & Africa,Finance,Market Access,Exceeds,Male,36,11,0,5,10,3.6,3.3,3.9,0.0588,1,0,0,0,4.2,4.4,2.9
4349,979,0,Middle East & Africa,Finance,Clinical Operations,Below,Female,29,4,0,7,11,2.9,2.9,3.1,0.0,1,1,1,1,2.2,2.9,1.8
4350,137,0,Asia Pacific,R&D,IT & Digital,Meets,Female,33,8,0,9,13,1.6,2.8,3.7,0.0977,1,1,1,1,1.4,4.0,4.5
4351,194,0,Asia Pacific,Commercial,IT & Digital,Below,Non-Binary/Other,33,24,0,9,12,4.4,4.2,2.7,0.0,1,1,1,1,2.7,3.0,2.2
4352,690,0,Europe,Digital,Human Resources,Below,Male,29,5,0,11,19,5.0,3.4,3.4,0.0,1,1,1,1,3.2,2.8,3.9
4353,502,0,Europe,Manufacturing,Finance & Accounting,Below,Female,37,19,0,11,25,4.1,3.2,2.3,0.0,1,0,0,0,3.9,3.9,3.0
4354,937,0,Middle East & Africa,Finance,Clinical Operations,Meets,Female,34,6,0,12,21,3.3,2.3,1.4,0.0331,0,0,0,0,3.4,2.0,2.9
4355,146,0,Asia Pacific,R&D,Medical Affairs,Meets,Female,47,9,0,8,16,2.7,3.0,3.7,0.0977,1,1,1,1,3.1,2.1,3.2
4356,595,0,North America,Digital,Finance & Accounting,Exceeds,Male,37,11,0,10,43,3.3,1.7,2.2,0.1452,1,1,1,1,5.0,1.1,3.2
4357,575,0,Latin America,Digital,Supply Chain,Exceeds,Female,33,6,0,9,16,3.1,3.7,2.6,0.1452,1,1,1,1,4.1,2.5,3.2
4358,584,0,Asia Pacific,Digital,Supply Chain,Meets,Female,31,9,1,11,20,0.0,4.2,2.8,0.0853,1,0,0,0,3.7,2.7,2.2
4359,90,0,Asia Pacific,R&D,IT & Digital,Below,Male,31,14,0,12,16,3.9,3.8,2.9,0.0,1,1,1,1,3.4,2.2,3.8
4360,448,0,Europe,Manufacturing,Finance & Accounting,Meets,Female,43,16,0,6,18,3.6,2.6,3.1,0.0348,1,1,1,1,3.3,4.2,4.2
4361,967,0,Latin America,Finance,Sales,Meets,Male,44,11,1,8,12,0.0,1.4,2.8,0.0331,1,0,0,0,2.1,1.6,1.5
4362,655,0,Middle East & Africa,Digital,IT & Digital,Meets,Female,28,6,1,9,11,0.0,2.9,1.7,0.0853,1,1,0,0,2.2,2.8,2.4
4363,108,0,Asia Pacific,R&D,Marketing,Far Exceeds,Non-Binary/Other,51,8,0,9,16,4.7,4.2,2.0,0.2644,1,1,1,1,4.3,3.2,2.2
4364,295,0,Middle East & Africa,Commercial,Regulatory Affairs,Far Below,Male,38,11,0,7,9,2.5,3.4,1.9,0.0,0,0,0,0,2.8,4.2,3.8
4365,169,1,Asia Pacific,R&D,Sales,Meets,Female,44,16,0,8,14,2.8,3.1,3.9,0.0977,1,1,1,1,3.0,2.1,3.4
4366,47,0,Middle East & Africa,R&D,Supply Chain,Meets,Male,33,18,1,10,31,0.0,3.6,1.8,0.0977,1,1,1,1,4.7,2.8,3.0
4367,11,0,Latin America,R&D,Legal & Compliance,Exceeds,Female,32,11,0,8,13,3.0,2.8,1.8,0.1648,1,1,1,1,1.8,3.1,2.0
4368,564,0,Europe,Digital,Pharmacovigilance,Meets,Female,37,8,0,10,20,3.4,3.0,2.9,0.0853,1,1,1,1,3.2,1.9,2.3
4369,43,0,Latin America,R&D,Marketing,Meets,Male,40,14,0,5,6,3.2,3.8,2.4,0.0977,0,0,0,0,3.1,3.6,4.4
4370,217,0,North America,Commercial,IT & Digital,Meets,Male,39,5,1,12,18,0.0,2.5,2.7,0.0422,1,1,1,1,4.7,4.4,1.8
4371,525,1,Europe,Digital,Legal & Compliance,Exceeds,Female,45,5,0,8,39,2.4,2.7,2.5,0.1452,1,1,1,1,5.0,4.8,2.7
4372,212,0,Latin America,Commercial,Market Access,Meets,Female,28,26,0,11,26,3.9,4.2,3.6,0.0422,1,1,1,1,3.1,4.1,3.7
4373,832,0,North America,HR,Medical Affairs,Below,Male,43,8,1,5,6,0.0,2.4,1.5,0.0,1,1,1,1,3.5,3.0,2.2
4374,42,0,Asia Pacific,R&D,Data Science,Meets,Male,41,22,0,12,24,5.0,1.6,2.8,0.0977,1,1,1,0,5.0,1.0,1.6
4375,885,0,Asia Pacific,Finance,Pharmacovigilance,Meets,Male,40,17,0,7,15,2.7,1.9,3.0,0.0331,1,1,1,1,3.2,3.2,1.0
4376,1025,0,Middle East & Africa,Finance,Supply Chain,Meets,Male,30,16,0,11,14,3.2,3.4,1.6,0.0331,1,1,1,1,1.8,3.3,1.6
4377,531,0,Europe,Digital,Human Resources,Far Exceeds,Female,33,28,0,6,13,2.3,4.2,2.3,0.2363,1,1,1,1,2.1,3.2,3.9
4378,1020,1,Asia Pacific,Finance,Legal & Compliance,Meets,Male,42,14,0,10,24,2.7,5.0,2.2,0.0331,1,1,1,1,3.9,3.6,2.8
4379,600,1,Europe,Digital,Finance & Accounting,Meets,Female,28,17,0,10,25,1.7,2.5,1.0,0.0853,1,1,1,1,3.5,3.5,1.7
4380,128,1,Asia Pacific,R&D,Marketing,Meets,Male,28,8,0,9,21,2.6,1.4,2.7,0.0977,1,1,1,1,2.7,2.2,3.2
4381,443,0,Middle East & Africa,Manufacturing,Supply Chain,Exceeds,Male,41,14,0,6,8,2.9,5.0,3.5,0.0616,1,1,1,1,2.5,4.9,5.0
4382,507,0,Latin America,Manufacturing,Communications,Exceeds,Male,41,15,0,12,21,4.3,4.0,1.0,0.0616,1,1,1,1,2.8,5.0,2.4
4383,348,0,Middle East & Africa,Commercial,Quality Assurance,Meets,Female,34,30,0,12,13,4.3,2.9,2.5,0.0422,0,0,0,0,4.5,2.3,2.5
4384,135,0,North America,R&D,Sales,Meets,Male,34,11,0,5,7,3.7,2.7,3.4,0.0977,0,0,0,0,3.3,2.0,3.2
4385,947,0,Asia Pacific,Finance,Data Science,Meets,Non-Binary/Other,44,28,0,11,17,1.9,2.8,2.5,0.0331,0,0,0,0,1.0,4.3,3.7
4386,126,0,North America,R&D,Data Science,Meets,Male,43,14,0,9,9,3.3,2.8,3.7,0.0977,0,0,0,0,5.0,3.0,2.1
4387,825,0,North America,HR,Finance & Accounting,Meets,Male,36,15,1,12,16,0.0,3.3,1.0,0.0383,1,1,1,1,4.3,3.3,1.5
4388,506,0,Europe,Manufacturing,Regulatory Affairs,Meets,Male,31,8,0,11,40,2.3,3.5,2.4,0.0348,1,1,1,1,1.8,2.9,2.7
4389,993,0,Asia Pacific,Finance,Quality Assurance,Meets,Male,47,11,0,10,21,2.4,4.0,1.9,0.0331,1,1,1,1,1.7,3.5,2.2
4390,508,0,North America,Manufacturing,Clinical Operations,Meets,Female,30,6,0,8,14,3.3,2.7,1.4,0.0348,1,1,1,1,2.4,2.8,2.7
4391,128,0,Latin America,R&D,IT & Digital,Meets,Female,42,15,0,12,15,4.4,4.3,4.9,0.0977,1,1,1,1,2.6,3.3,4.8
4392,996,0,North America,Finance,Quality Assurance,Far Exceeds,Male,45,24,0,9,17,3.9,2.6,3.0,0.1022,1,1,1,1,4.1,3.1,3.9
4393,331,0,Latin America,Commercial,Data Science,Meets,Female,38,16,0,5,15,2.1,3.5,3.7,0.0422,1,1,1,1,1.3,3.1,3.8
4394,43,0,Europe,R&D,Pharmacovigilance,Meets,Female,34,20,0,8,20,3.6,1.3,3.0,0.0977,1,1,1,1,4.9,3.3,1.9
4395,246,0,North America,Commercial,IT & Digital,Meets,Non-Binary/Other,28,5,0,12,21,3.9,2.5,4.7,0.0422,0,0,0,0,4.4,2.9,3.1
4396,982,0,Middle East & Africa,Finance,Legal & Compliance,Meets,Male,38,21,0,5,11,3.1,3.4,3.5,0.0331,1,1,1,1,4.4,2.5,3.8
4397,507,0,Europe,Manufacturing,IT & Digital,Meets,Male,29,3,1,9,12,0.0,2.0,1.0,0.0348,1,1,1,1,3.5,3.3,1.6
4398,763,0,Latin America,HR,Human Resources,Meets,Female,40,25,0,12,17,3.0,2.3,3.7,0.0383,1,1,1,1,3.4,3.4,3.6
4399,684,0,Europe,Digital,Regulatory Affairs,Below,Male,28,26,0,5,17,4.4,3.8,3.7,0.0,1,1,1,1,4.0,2.8,2.6
4400,379,0,North America,Manufacturing,Market Access,Meets,Female,28,8,1,8,11,0.0,1.8,2.4,0.0348,1,0,0,0,4.2,3.8,3.3
4401,191,1,Asia Pacific,Commercial,Pharmacovigilance,Meets,Female,39,3,0,11,24,4.1,3.3,4.2,0.0422,1,1,1,1,3.1,1.3,2.9
4402,62,0,Asia Pacific,R&D,Marketing,Meets,Male,43,9,0,6,15,3.2,4.3,2.1,0.0977,1,1,1,1,3.2,3.1,4.6
4403,1033,1,Latin America,Finance,Clinical Operations,Meets,Female,36,9,0,9,14,3.9,4.1,1.2,0.0331,0,0,0,0,3.5,4.2,1.2
4404,376,0,Latin America,Manufacturing,Sales,Meets,Female,44,14,0,6,16,5.0,5.0,2.8,0.0348,1,1,1,1,4.4,4.3,4.0
4405,716,0,Asia Pacific,HR,Market Access,Meets,Female,35,6,1,10,17,0.0,3.1,2.8,0.0383,1,1,1,1,1.8,4.4,3.8
4406,899,0,Latin America,Finance,Pharmacovigilance,Exceeds,Female,51,3,0,12,15,2.9,3.6,2.1,0.0588,1,1,1,1,3.5,3.7,3.3
4407,200,0,Europe,Commercial,Finance & Accounting,Exceeds,Female,30,4,0,6,6,3.9,3.3,4.5,0.0743,1,1,1,1,4.2,1.4,3.0
4408,934,0,Middle East & Africa,Finance,Marketing,Meets,Male,34,17,0,10,22,2.1,3.5,1.8,0.0331,1,1,1,1,3.1,3.1,2.1
4409,968,0,Middle East & Africa,Finance,Supply Chain,Meets,Female,46,21,0,9,15,3.9,3.5,4.6,0.0331,1,1,1,1,4.2,3.3,4.3
4410,18,0,Europe,R&D,Medical Affairs,Meets,Male,36,14,0,7,9,4.3,1.9,2.1,0.0977,1,1,1,1,3.5,4.4,1.9
4411,592,0,Middle East & Africa,Digital,Clinical Operations,Below,Male,44,9,0,5,11,1.9,3.3,1.6,0.0,1,1,1,1,1.6,4.4,2.1
4412,242,0,North America,Commercial,Sales,Below,Male,30,6,0,5,17,4.4,4.8,1.9,0.0,1,1,1,1,4.6,3.8,1.7
4413,24,0,Europe,R&D,Regulatory Affairs,Below,Female,32,6,0,8,29,2.5,3.7,2.9,0.0,1,1,1,1,4.3,3.4,4.0
4414,666,0,Latin America,Digital,Quality Assurance,Meets,Male,42,3,1,12,17,0.0,2.6,1.8,0.0853,1,1,1,1,2.9,3.4,1.0
4415,7,0,Europe,R&D,Medical Affairs,Below,Female,29,9,1,11,19,0.0,3.9,4.4,0.0,1,1,1,1,3.7,3.4,4.7
4416,525,0,Asia Pacific,Digital,Clinical Operations,Meets,Female,31,13,1,12,17,0.0,1.4,5.0,0.0853,1,1,1,1,1.0,2.1,5.0
4417,687,0,Latin America,Digital,Market Access,Meets,Male,37,8,1,12,19,0.0,3.6,2.9,0.0853,1,1,1,1,2.9,4.0,3.0
4418,677,0,Asia Pacific,Digital,Supply Chain,Far Below,Male,46,6,0,10,12,2.4,1.0,2.7,0.0,1,1,1,1,3.2,1.6,1.3
4419,120,0,Latin America,R&D,IT & Digital,Below,Male,40,13,0,10,20,2.1,2.0,3.0,0.0,1,1,1,1,1.8,1.9,4.0
4420,1034,1,Middle East & Africa,Finance,Human Resources,Exceeds,Male,37,13,0,8,10,3.1,2.4,3.0,0.0588,1,1,1,1,4.9,3.6,4.0
4421,680,0,Europe,Digital,Regulatory Affairs,Meets,Male,39,10,0,9,15,3.1,2.2,1.9,0.0853,1,1,1,1,3.3,3.2,2.6
4422,1029,0,North America,Finance,Data Science,Meets,Male,28,15,1,7,24,0.0,3.8,1.1,0.0331,1,1,1,1,4.9,3.2,3.5
4423,213,0,Latin America,Commercial,Legal & Compliance,Far Below,Female,35,4,1,6,20,0.0,2.5,3.8,0.0,1,1,1,1,5.0,3.6,3.5
4424,813,0,Latin America,HR,Pharmacovigilance,Meets,Female,41,20,1,6,11,0.0,1.8,3.3,0.0383,1,1,1,1,2.8,2.0,2.7
4425,985,0,Asia Pacific,Finance,Communications,Meets,Female,39,30,0,12,16,3.6,2.6,2.9,0.0331,1,1,1,1,2.9,3.4,3.7
4426,750,0,Middle East & Africa,HR,Finance & Accounting,Far Exceeds,Male,42,10,0,6,25,4.0,2.8,3.1,0.1168,1,1,0,0,4.7,3.6,4.1
4427,586,0,Asia Pacific,Digital,Pharmacovigilance,Meets,Male,42,4,1,12,23,0.0,3.3,2.0,0.0853,1,1,1,0,3.2,4.9,2.1
4428,833,1,Asia Pacific,HR,Regulatory Affairs,Far Exceeds,Female,39,3,0,9,21,4.3,2.6,2.0,0.1168,1,1,1,1,2.8,3.3,1.0
4429,837,0,Middle East & Africa,HR,Data Science,Exceeds,Female,28,15,1,7,10,0.0,4.0,3.0,0.0677,1,1,1,1,2.4,3.4,2.3
4430,690,0,North America,Digital,Human Resources,Meets,Male,40,20,0,5,16,2.7,3.4,3.0,0.0853,1,1,0,0,3.8,4.9,3.3
4431,906,0,Asia Pacific,Finance,IT & Digital,Meets,Male,35,6,1,8,14,0.0,2.8,5.0,0.0331,1,1,1,1,4.3,3.9,4.3
4432,695,0,Asia Pacific,Digital,Pharmacovigilance,Exceeds,Female,36,6,0,10,18,1.5,4.0,1.4,0.1452,1,1,1,1,2.8,2.9,2.6
4433,274,0,Latin America,Commercial,Clinical Operations,Meets,Male,36,10,0,6,13,3.8,5.0,2.8,0.0422,1,1,1,1,4.0,3.8,3.7
4434,431,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Below,Male,40,12,0,9,30,3.7,3.1,4.2,0.0,1,1,1,1,2.6,5.0,3.5
4435,155,0,Europe,R&D,Human Resources,Meets,Male,29,17,1,9,10,0.0,1.3,1.0,0.0977,1,1,1,1,3.0,4.0,1.7
4436,663,0,North America,Digital,Regulatory Affairs,Below,Female,28,9,0,10,14,3.4,3.0,1.0,0.0,0,0,0,0,3.7,1.7,1.0
4437,682,0,North America,Digital,Market Access,Meets,Female,31,12,0,10,23,4.5,4.5,2.3,0.0853,1,1,1,1,4.5,3.8,3.0
4438,779,0,Middle East & Africa,HR,Legal & Compliance,Meets,Male,44,7,1,11,22,0.0,2.7,1.8,0.0383,1,1,1,1,4.3,4.0,1.5
4439,217,0,Latin America,Commercial,Data Science,Far Exceeds,Male,35,20,0,7,11,4.0,3.2,1.3,0.1275,1,1,1,1,3.9,4.4,1.9
4440,839,0,Latin America,HR,Market Access,Meets,Female,41,2,0,7,11,4.6,1.8,2.8,0.0383,1,1,1,1,3.5,2.3,2.9
4441,942,0,Middle East & Africa,Finance,Data Science,Exceeds,Male,41,13,1,5,10,0.0,3.6,2.8,0.0588,1,1,1,0,2.9,5.0,2.4
4442,535,0,Latin America,Digital,Market Access,Meets,Male,40,17,0,11,13,4.4,2.3,2.2,0.0853,1,1,1,1,4.7,2.5,2.8
4443,572,1,North America,Digital,Finance & Accounting,Meets,Male,41,26,0,12,13,2.8,4.2,4.4,0.0853,1,1,1,1,4.7,2.6,5.0
4444,714,0,North America,HR,Regulatory Affairs,Exceeds,Male,35,16,0,6,21,4.1,2.4,4.3,0.0677,1,1,1,1,2.5,3.0,3.9
4445,669,0,Europe,Digital,Quality Assurance,Meets,Female,42,4,0,7,11,3.6,1.5,1.6,0.0853,1,1,1,1,4.9,3.8,2.1
4446,998,0,Middle East & Africa,Finance,Quality Assurance,Meets,Female,40,19,0,5,7,3.1,3.4,3.4,0.0331,1,1,1,1,3.1,2.3,3.2
4447,436,0,Asia Pacific,Manufacturing,Quality Assurance,Meets,Female,28,13,0,9,17,4.0,2.6,1.0,0.0348,1,1,1,1,4.5,1.0,1.0
4448,66,0,Asia Pacific,R&D,Regulatory Affairs,Meets,Female,38,19,0,10,15,2.4,1.7,1.9,0.0977,1,1,1,1,2.5,2.8,3.0
4449,99,0,Europe,R&D,Communications,Exceeds,Non-Binary/Other,37,12,0,7,23,2.5,3.9,2.8,0.1648,1,1,1,1,3.0,4.2,2.9
4450,62,1,Europe,R&D,Finance & Accounting,Meets,Non-Binary/Other,41,3,0,8,16,3.0,2.9,1.6,0.0977,1,1,1,1,4.0,2.3,3.1
4451,368,0,Latin America,Manufacturing,Pharmacovigilance,Meets,Male,38,10,0,9,11,3.2,4.1,3.7,0.0348,1,1,1,1,2.8,3.2,4.3
4452,592,0,Europe,Digital,Human Resources,Meets,Male,37,8,1,11,40,0.0,2.6,1.0,0.0853,1,1,1,1,4.7,3.6,2.5
4453,770,0,Europe,HR,Supply Chain,Below,Female,47,4,0,7,9,4.2,2.8,1.5,0.0,0,0,0,0,3.8,4.0,2.6
4454,306,0,Asia Pacific,Commercial,IT & Digital,Meets,Female,42,7,1,9,15,0.0,3.6,2.2,0.0422,1,1,1,0,3.8,5.0,3.5
4455,667,0,Latin America,Digital,Sales,Below,Female,38,4,0,6,9,4.3,3.7,2.7,0.0,1,1,1,1,3.4,3.3,1.9
4456,438,0,Europe,Manufacturing,Supply Chain,Meets,Female,31,3,0,10,26,3.7,2.1,2.3,0.0348,1,1,1,1,4.5,1.8,2.8
4457,916,0,Europe,Finance,Quality Assurance,Meets,Male,39,7,1,8,20,0.0,3.0,2.3,0.0331,1,1,1,1,3.3,2.5,2.3
4458,360,0,Latin America,Manufacturing,Pharmacovigilance,Meets,Male,33,10,0,10,22,2.5,5.0,3.0,0.0348,1,1,1,1,3.0,3.7,3.1
4459,120,0,Middle East & Africa,R&D,Regulatory Affairs,Meets,Male,28,12,0,9,36,1.8,4.8,4.1,0.0977,1,1,1,1,1.8,3.4,4.0
4460,534,0,Latin America,Digital,Marketing,Exceeds,Female,36,36,0,6,11,3.4,3.5,3.5,0.1452,1,1,1,1,2.9,3.3,2.8
4461,35,0,Asia Pacific,R&D,Pharmacovigilance,Meets,Non-Binary/Other,36,25,0,9,16,1.7,5.0,3.7,0.0977,1,1,1,1,2.3,2.9,2.7
4462,310,0,Middle East & Africa,Commercial,Finance & Accounting,Far Exceeds,Male,44,7,0,5,28,4.7,3.4,2.8,0.1275,1,1,1,1,3.3,3.3,4.0
4463,898,0,North America,Finance,Marketing,Meets,Female,44,6,0,10,29,4.2,2.4,1.0,0.0331,1,1,1,1,3.3,3.2,1.9
4464,85,1,Latin America,R&D,Regulatory Affairs,Meets,Female,42,11,0,8,18,2.9,4.4,3.1,0.0977,1,1,1,1,5.0,3.0,3.7
4465,292,0,Asia Pacific,Commercial,Clinical Operations,Below,Male,37,11,0,6,9,2.5,1.7,2.2,0.0,1,1,1,1,2.3,2.4,3.0
4466,390,0,Middle East & Africa,Manufacturing,IT & Digital,Meets,Female,38,12,0,10,17,2.2,2.3,4.1,0.0348,1,1,1,1,3.1,4.4,4.5
4467,133,0,Latin America,R&D,Data Science,Below,Female,41,18,0,6,35,2.8,3.2,2.2,0.0,1,0,0,0,3.2,2.8,2.4
4468,153,0,Europe,R&D,Human Resources,Meets,Male,42,18,0,6,28,3.1,4.5,2.6,0.0977,1,1,1,1,3.4,4.7,3.6
4469,844,0,Latin America,HR,Sales,Meets,Male,40,20,0,5,36,1.8,4.3,3.9,0.0383,1,1,1,1,3.0,2.3,2.9
4470,969,0,North America,Finance,Supply Chain,Meets,Male,41,8,0,5,21,2.8,1.8,1.0,0.0331,1,1,1,1,3.5,2.4,2.0
4471,1042,0,Latin America,Finance,Market Access,Meets,Male,38,6,0,7,12,3.0,2.1,3.8,0.0331,1,1,1,1,1.7,2.8,4.0
4472,423,0,Middle East & Africa,Manufacturing,Market Access,Meets,Male,36,7,1,11,19,0.0,2.0,3.5,0.0348,1,1,1,1,3.7,3.4,3.2
4473,725,0,Middle East & Africa,HR,Data Science,Meets,Male,28,7,0,5,24,3.5,3.1,3.9,0.0383,0,0,0,0,3.7,4.6,2.7
4474,350,0,Latin America,Commercial,Pharmacovigilance,Below,Female,36,6,0,11,23,2.8,3.3,4.2,0.0,1,1,1,1,3.1,2.9,3.9
4475,293,0,Middle East & Africa,Commercial,Market Access,Meets,Female,34,9,0,9,19,2.8,2.8,2.5,0.0422,1,1,1,1,3.7,2.8,1.3
4476,493,0,Europe,Manufacturing,IT & Digital,Meets,Female,39,15,0,12,13,2.3,2.6,3.2,0.0348,0,0,0,0,3.2,1.3,1.5
4477,907,0,Latin America,Finance,Medical Affairs,Meets,Female,34,11,0,5,7,4.2,2.4,3.8,0.0331,1,1,1,1,3.6,4.2,4.9
4478,216,0,Europe,Commercial,Market Access,Below,Female,39,9,0,5,15,3.3,4.5,2.7,0.0,1,1,1,1,4.4,4.3,2.7
4479,424,0,Europe,Manufacturing,Regulatory Affairs,Meets,Female,28,5,1,10,24,0.0,2.3,2.4,0.0348,1,1,1,1,3.1,2.8,4.3
4480,237,0,Asia Pacific,Commercial,Data Science,Below,Male,32,4,0,7,21,2.8,1.7,3.6,0.0,0,0,0,0,4.8,1.8,2.9
4481,665,0,Latin America,Digital,Sales,Below,Male,34,10,0,7,10,2.4,5.0,2.5,0.0,1,1,1,1,1.7,3.5,3.0
4482,73,0,Middle East & Africa,R&D,Data Science,Below,Male,32,13,0,8,11,3.8,3.1,1.0,0.0,1,1,1,1,3.9,4.1,2.3
4483,920,0,Europe,Finance,Sales,Meets,Female,55,16,0,11,25,4.2,3.4,2.9,0.0331,1,1,0,0,5.0,4.0,4.2
4484,693,1,Asia Pacific,Digital,Medical Affairs,Meets,Female,28,9,0,5,17,2.7,2.4,3.6,0.0853,1,1,1,1,4.1,1.5,3.3
4485,509,0,Latin America,Manufacturing,Finance & Accounting,Exceeds,Female,42,14,0,7,13,1.9,3.3,1.0,0.0616,1,1,1,1,5.0,4.4,1.7
4486,428,0,Latin America,Manufacturing,Human Resources,Meets,Female,44,12,0,11,19,3.5,2.2,1.3,0.0348,1,1,1,0,4.2,3.0,2.3
4487,626,0,North America,Digital,Market Access,Meets,Female,35,9,0,6,20,2.1,2.1,3.3,0.0853,1,1,1,1,2.6,2.0,2.9
4488,166,0,North America,R&D,Finance & Accounting,Far Exceeds,Female,40,5,0,10,32,4.1,2.4,3.2,0.2644,1,1,1,1,4.0,4.0,2.4
4489,114,0,Europe,R&D,Data Science,Meets,Non-Binary/Other,42,14,0,11,16,2.4,2.2,2.4,0.0977,1,1,1,0,4.1,3.9,3.7
4490,821,0,North America,HR,IT & Digital,Meets,Female,39,7,1,11,21,0.0,4.2,3.7,0.0383,1,1,1,1,3.2,4.5,3.4
4491,191,0,Europe,Commercial,Marketing,Far Exceeds,Female,28,7,1,9,23,0.0,3.0,1.8,0.1275,1,1,1,1,2.8,3.1,2.5
4492,862,1,Middle East & Africa,HR,Quality Assurance,Far Exceeds,Female,40,34,0,5,25,4.2,4.2,4.2,0.1168,1,1,1,1,4.0,2.2,3.8
4493,34,0,Europe,R&D,Finance & Accounting,Meets,Male,44,17,0,11,39,2.3,3.6,1.9,0.0977,1,1,1,1,3.0,2.6,3.0
4494,594,0,North America,Digital,IT & Digital,Meets,Male,50,19,1,6,12,0.0,5.0,4.1,0.0853,1,1,1,1,1.4,5.0,3.8
4495,328,0,Middle East & Africa,Commercial,Medical Affairs,Meets,Male,30,7,0,12,18,3.4,2.6,3.6,0.0422,1,1,1,1,3.1,2.4,5.0
4496,615,0,North America,Digital,Pharmacovigilance,Meets,Male,37,9,0,10,30,4.3,2.5,1.2,0.0853,1,1,1,1,3.0,1.4,1.0
4497,841,0,Europe,HR,Marketing,Exceeds,Non-Binary/Other,38,12,0,11,17,3.7,3.7,1.4,0.0677,1,1,1,1,2.9,4.3,1.9
4498,497,0,Asia Pacific,Manufacturing,Sales,Meets,Male,37,12,0,11,34,3.2,3.6,3.3,0.0348,0,0,0,0,2.9,1.2,2.6
4499,655,0,Latin America,Digital,Data Science,Exceeds,Male,28,9,0,7,12,3.6,2.8,2.3,0.1452,1,0,0,0,2.2,3.4,2.9
4500,848,0,North America,HR,Sales,Meets,Female,45,6,1,7,22,0.0,3.7,4.7,0.0383,1,1,1,1,3.8,3.5,4.6
4501,806,0,Europe,HR,Sales,Meets,Female,44,8,1,10,17,0.0,2.0,3.8,0.0383,1,1,1,1,5.0,3.1,4.4
4502,731,0,Middle East & Africa,HR,Legal & Compliance,Meets,Female,40,8,1,5,16,0.0,3.5,3.0,0.0383,1,1,1,1,4.4,3.2,1.9
4503,507,0,North America,Manufacturing,Communications,Meets,Male,35,11,1,10,18,0.0,2.4,1.0,0.0348,1,1,1,1,2.3,1.9,2.3
4504,442,0,North America,Manufacturing,IT & Digital,Below,Female,37,17,0,9,11,2.0,2.8,1.6,0.0,1,1,1,1,4.1,2.6,2.4
4505,498,0,Latin America,Manufacturing,IT & Digital,Far Exceeds,Male,36,17,0,10,12,3.8,2.1,2.3,0.1069,1,1,1,1,2.4,1.4,4.4
4506,336,0,Europe,Commercial,Medical Affairs,Meets,Non-Binary/Other,30,6,0,7,8,2.6,2.5,1.3,0.0422,1,1,0,0,3.4,2.4,3.2
4507,496,0,Asia Pacific,Manufacturing,IT & Digital,Meets,Female,42,5,0,5,8,2.5,2.3,1.4,0.0348,1,1,1,1,3.8,1.8,1.0
4508,410,0,Middle East & Africa,Manufacturing,Marketing,Exceeds,Female,38,18,0,12,17,5.0,3.6,1.4,0.0616,1,1,1,1,4.6,3.1,3.5
4509,454,0,Europe,Manufacturing,Data Science,Far Exceeds,Male,42,5,1,6,10,0.0,4.8,1.9,0.1069,1,1,1,1,3.0,4.4,2.8
4510,597,0,Middle East & Africa,Digital,Market Access,Exceeds,Female,40,4,0,9,16,2.5,1.6,3.2,0.1452,1,1,1,1,2.5,2.1,3.1
4511,387,0,North America,Manufacturing,Clinical Operations,Meets,Female,32,8,1,12,14,0.0,3.8,2.7,0.0348,1,1,1,1,3.2,5.0,1.5
4512,208,0,Latin America,Commercial,Supply Chain,Meets,Male,32,24,0,8,9,3.3,4.0,2.8,0.0422,1,1,1,1,2.3,4.4,2.5
4513,763,0,Latin America,HR,Supply Chain,Meets,Male,46,16,0,6,11,4.3,2.9,2.1,0.0383,1,1,1,1,2.7,1.0,4.1
4514,574,0,Asia Pacific,Digital,IT & Digital,Meets,Non-Binary/Other,41,5,0,9,31,2.0,2.0,2.6,0.0853,0,0,0,0,3.2,2.8,2.8
4515,64,0,Latin America,R&D,Medical Affairs,Exceeds,Male,36,10,1,8,41,0.0,2.2,3.2,0.1648,0,0,0,0,2.8,2.8,3.0
4516,356,0,North America,Manufacturing,Pharmacovigilance,Meets,Female,41,10,0,11,15,2.8,3.7,1.7,0.0348,1,1,1,1,3.9,3.2,3.3
4517,855,0,Asia Pacific,HR,IT & Digital,Far Below,Female,33,10,1,6,10,0.0,2.5,2.8,0.0,1,1,1,1,1.8,3.4,1.4
4518,848,0,Europe,HR,Regulatory Affairs,Below,Male,45,17,0,5,10,4.6,2.9,1.0,0.0,1,1,1,1,5.0,3.5,1.5
4519,584,0,Latin America,Digital,Communications,Exceeds,Male,30,17,0,11,26,3.7,1.5,4.1,0.1452,1,1,1,1,4.1,2.1,3.9
4520,167,0,Asia Pacific,R&D,Finance & Accounting,Exceeds,Non-Binary/Other,39,14,1,6,14,0.0,3.5,2.7,0.1648,1,1,1,1,3.1,3.1,5.0
4521,1012,0,North America,Finance,Clinical Operations,Meets,Female,37,15,0,7,28,3.7,4.1,4.5,0.0331,1,1,1,1,3.4,4.0,4.5
4522,290,0,Middle East & Africa,Commercial,Communications,Meets,Male,38,3,1,8,16,0.0,2.2,2.9,0.0422,1,1,1,1,3.6,2.3,2.1
4523,888,0,Middle East & Africa,Finance,Data Science,Meets,Female,42,21,0,10,12,2.8,2.5,3.6,0.0331,1,1,1,1,3.7,4.8,3.5
4524,721,0,North America,HR,Supply Chain,Meets,Male,44,6,1,6,9,0.0,1.7,2.5,0.0383,1,1,1,1,3.1,4.7,2.6
4525,997,0,North America,Finance,Pharmacovigilance,Meets,Female,36,3,0,8,11,3.5,2.8,2.3,0.0331,0,0,0,0,3.3,3.6,2.4
4526,814,0,Middle East & Africa,HR,Regulatory Affairs,Meets,Male,28,11,1,10,23,0.0,3.2,3.2,0.0383,1,1,1,1,2.8,3.0,2.9
4527,1026,0,Asia Pacific,Finance,Marketing,Meets,Male,28,8,1,9,11,0.0,3.3,4.2,0.0331,1,1,1,1,2.6,5.0,3.6
4528,873,0,Middle East & Africa,HR,Data Science,Meets,Male,36,24,0,5,12,3.1,4.2,2.3,0.0383,1,1,1,1,2.9,4.2,1.5
4529,833,0,North America,HR,Sales,Meets,Male,38,9,0,6,12,4.7,4.2,3.4,0.0383,1,1,1,1,4.9,4.2,3.8
4530,683,0,Latin America,Digital,IT & Digital,Exceeds,Female,40,22,0,12,19,3.3,3.6,2.5,0.1452,1,1,1,1,2.4,2.9,2.5
4531,73,0,Europe,R&D,Pharmacovigilance,Exceeds,Female,39,12,0,12,15,1.8,1.6,3.7,0.1648,1,1,1,1,3.0,3.4,2.6
4532,787,0,Latin America,HR,Data Science,Exceeds,Female,43,24,0,10,16,2.2,3.6,3.5,0.0677,1,1,1,1,2.6,4.9,1.7
4533,352,1,Latin America,Commercial,Clinical Operations,Exceeds,Female,49,16,0,8,10,2.4,1.8,3.3,0.0743,1,1,1,1,2.5,1.5,3.1
4534,325,0,North America,Commercial,Sales,Meets,Male,39,5,0,11,28,5.0,3.0,1.0,0.0422,1,1,1,1,4.6,3.3,1.8
4535,484,0,Middle East & Africa,Manufacturing,Clinical Operations,Meets,Female,40,9,0,6,11,2.5,3.4,3.8,0.0348,1,1,1,1,2.6,4.5,4.5
4536,769,0,Asia Pacific,HR,Quality Assurance,Meets,Female,33,3,0,12,16,2.5,2.7,1.2,0.0383,1,1,1,1,2.3,3.5,2.5
4537,806,0,Latin America,HR,Supply Chain,Meets,Male,38,5,0,5,10,3.5,4.6,1.0,0.0383,1,1,1,1,3.7,4.3,1.8
4538,868,0,Middle East & Africa,HR,Communications,Meets,Male,39,2,0,9,16,4.6,2.8,4.7,0.0383,1,1,1,1,3.4,3.2,3.1
4539,965,0,Asia Pacific,Finance,Human Resources,Meets,Female,39,13,0,12,27,3.0,3.2,2.8,0.0331,1,1,1,1,3.6,4.0,2.2
4540,816,0,Latin America,HR,Regulatory Affairs,Meets,Male,33,3,1,7,14,0.0,4.4,4.1,0.0383,1,1,1,1,2.5,5.0,3.6
4541,864,0,Asia Pacific,HR,Legal & Compliance,Meets,Male,39,11,1,12,33,0.0,2.3,1.6,0.0383,1,1,1,1,3.4,2.0,1.5
4542,222,0,Middle East & Africa,Commercial,Human Resources,Below,Female,39,12,0,10,22,3.4,2.8,3.5,0.0,1,1,1,1,2.6,2.9,1.7
4543,86,0,Europe,R&D,Pharmacovigilance,Below,Female,40,11,0,11,13,3.5,4.2,1.0,0.0,0,0,0,0,3.9,3.9,2.1
4544,1,0,Middle East & Africa,R&D,Sales,Meets,Female,36,8,1,12,22,0.0,3.6,1.6,0.0977,1,1,1,1,2.4,1.9,2.4
4545,455,0,North America,Manufacturing,Supply Chain,Meets,Female,38,8,0,7,9,3.4,3.2,4.3,0.0348,1,1,1,1,3.9,3.9,4.2
4546,346,0,Asia Pacific,Commercial,Medical Affairs,Meets,Male,51,3,0,7,18,3.9,1.6,2.4,0.0422,1,1,1,1,4.2,3.9,2.7
4547,751,0,Europe,HR,IT & Digital,Below,Female,38,13,0,8,28,2.9,2.8,2.7,0.0,1,1,1,1,2.5,4.1,2.8
4548,146,0,Asia Pacific,R&D,Finance & Accounting,Meets,Female,44,7,0,8,26,2.8,2.0,4.0,0.0977,1,1,1,1,1.9,2.6,3.2
4549,613,0,Asia Pacific,Digital,Clinical Operations,Meets,Female,47,6,1,12,26,0.0,3.9,2.6,0.0853,1,1,0,0,2.5,4.3,4.1
4550,617,0,Latin America,Digital,Legal & Compliance,Meets,Male,29,4,0,9,21,4.1,3.1,1.6,0.0853,1,1,1,1,4.0,3.6,1.0
4551,564,0,North America,Digital,Quality Assurance,Below,Female,37,11,0,7,17,3.1,1.4,1.8,0.0,1,1,1,1,3.4,2.4,3.3
4552,766,0,Asia Pacific,HR,Finance & Accounting,Far Exceeds,Female,37,18,0,5,8,2.8,1.4,2.0,0.1168,1,1,1,1,3.0,1.7,1.7
4553,823,0,Middle East & Africa,HR,Clinical Operations,Meets,Female,50,13,0,9,14,4.8,2.4,3.8,0.0383,1,1,1,1,5.0,3.9,3.4
4554,496,0,Middle East & Africa,Manufacturing,Data Science,Meets,Male,49,27,0,7,35,3.8,1.8,3.9,0.0348,1,1,1,1,2.8,1.0,3.1
4555,503,0,Latin America,Manufacturing,Marketing,Meets,Male,29,5,1,7,12,0.0,2.6,2.3,0.0348,1,1,1,1,3.5,3.2,2.5
4556,394,0,North America,Manufacturing,Quality Assurance,Meets,Male,32,9,0,9,22,2.1,3.6,2.1,0.0348,1,1,1,1,2.2,4.7,2.9
4557,979,0,North America,Finance,Quality Assurance,Far Exceeds,Male,45,4,0,8,9,3.7,2.2,2.1,0.1022,1,1,1,1,3.3,3.1,3.6
4558,657,0,Middle East & Africa,Digital,Regulatory Affairs,Below,Female,35,5,0,7,11,2.3,3.8,2.3,0.0,1,1,1,1,2.7,2.8,2.5
4559,859,0,Europe,HR,Pharmacovigilance,Meets,Female,42,16,0,10,36,4.0,2.6,3.0,0.0383,1,1,1,1,2.2,2.2,2.4
4560,670,0,Latin America,Digital,Medical Affairs,Meets,Female,37,11,0,10,12,4.6,3.4,3.8,0.0853,1,1,1,1,2.1,2.9,3.6
4561,483,0,Latin America,Manufacturing,Medical Affairs,Meets,Female,32,9,1,6,27,0.0,1.6,3.0,0.0348,1,1,1,1,4.4,2.2,3.9
4562,811,0,Middle East & Africa,HR,Communications,Far Below,Male,46,12,0,12,26,4.4,4.0,2.3,0.0,1,1,1,1,4.0,3.8,1.6
4563,347,0,Middle East & Africa,Commercial,Legal & Compliance,Below,Female,34,5,1,5,10,0.0,4.3,1.5,0.0,1,1,1,1,2.8,2.8,4.2
4564,134,0,Europe,R&D,Regulatory Affairs,Meets,Male,37,2,0,7,13,4.1,2.8,1.5,0.0977,1,1,1,1,3.4,3.3,3.0
4565,57,0,Europe,R&D,Clinical Operations,Meets,Male,31,4,0,6,16,3.0,2.6,3.8,0.0977,1,1,1,1,1.5,2.3,3.3
4566,513,0,North America,Manufacturing,Market Access,Meets,Male,31,11,1,7,25,0.0,3.1,3.1,0.0348,1,1,1,1,4.0,3.6,3.7
4567,629,0,Latin America,Digital,Supply Chain,Meets,Female,38,7,1,8,13,0.0,2.9,2.9,0.0853,1,1,1,1,2.9,4.6,3.1
4568,284,0,Latin America,Commercial,Human Resources,Meets,Male,32,21,0,7,22,3.1,2.6,2.1,0.0422,0,0,0,0,2.6,3.4,3.1
4569,878,0,Middle East & Africa,HR,Market Access,Meets,Male,47,16,0,7,11,3.0,5.0,3.9,0.0383,1,1,1,1,2.3,3.4,4.0
4570,534,0,North America,Digital,Data Science,Exceeds,Female,42,9,0,10,29,3.7,4.0,2.7,0.1452,1,1,1,0,3.6,3.7,3.0
4571,454,0,Latin America,Manufacturing,Medical Affairs,Meets,Male,43,8,1,8,17,0.0,3.5,2.3,0.0348,1,1,1,1,2.7,3.7,2.8
4572,564,0,North America,Digital,Human Resources,Meets,Male,36,12,0,5,19,2.0,3.3,2.8,0.0853,1,1,1,1,1.6,1.7,2.7
4573,375,0,North America,Manufacturing,Pharmacovigilance,Meets,Female,36,6,0,5,46,4.2,1.5,1.0,0.0348,1,1,1,1,5.0,2.1,1.8
4574,948,0,Middle East & Africa,Finance,Marketing,Meets,Male,41,12,0,7,12,3.0,2.7,2.7,0.0331,1,1,1,0,3.4,4.0,1.8
4575,41,0,North America,R&D,Legal & Compliance,Meets,Female,28,18,0,5,15,4.5,2.6,2.4,0.0977,1,1,1,1,4.8,3.8,1.0
4576,141,0,Europe,R&D,Clinical Operations,Far Below,Female,35,35,0,12,19,4.2,4.1,4.4,0.0,1,1,1,1,3.0,2.2,3.5
4577,655,0,Europe,Digital,Pharmacovigilance,Below,Male,28,14,0,11,17,3.6,2.1,1.9,0.0,1,1,1,1,4.6,3.1,1.9
4578,206,0,Asia Pacific,Commercial,Pharmacovigilance,Exceeds,Male,39,3,1,12,17,0.0,3.5,3.5,0.0743,1,1,1,1,3.4,3.9,4.0
4579,861,0,Middle East & Africa,HR,Sales,Below,Female,31,5,0,5,9,2.9,2.3,2.1,0.0,1,1,1,1,2.0,1.6,2.6
4580,363,0,Asia Pacific,Manufacturing,Quality Assurance,Meets,Male,37,7,0,7,10,4.0,3.4,4.0,0.0348,1,1,1,1,4.5,5.0,4.4
4581,804,0,Europe,HR,Supply Chain,Below,Female,33,10,0,11,22,3.4,2.5,4.1,0.0,1,1,1,1,4.0,4.0,2.8
4582,151,0,Asia Pacific,R&D,Human Resources,Meets,Female,47,14,0,5,23,1.7,3.3,1.9,0.0977,1,1,1,1,1.9,2.9,2.1
4583,191,0,Middle East & Africa,Commercial,Quality Assurance,Meets,Female,52,4,0,5,8,3.0,3.2,2.4,0.0422,1,1,1,0,3.4,3.4,3.2
4584,195,0,Middle East & Africa,Commercial,Pharmacovigilance,Far Below,Female,44,9,0,12,22,2.6,3.5,2.2,0.0,1,1,1,1,2.6,4.5,4.3
4585,812,0,North America,HR,Legal & Compliance,Below,Female,44,10,0,8,14,2.8,4.1,4.7,0.0,1,1,0,0,4.0,4.4,4.2
4586,106,0,Latin America,R&D,Regulatory Affairs,Meets,Male,38,6,0,5,38,2.5,3.8,2.6,0.0977,1,0,0,0,2.8,4.0,1.3
4587,855,0,North America,HR,Market Access,Meets,Male,34,18,1,10,21,0.0,4.0,3.3,0.0383,1,1,1,1,1.8,4.5,3.4
4588,586,0,Middle East & Africa,Digital,Sales,Meets,Female,28,10,1,5,23,0.0,4.5,2.1,0.0853,1,1,1,1,4.4,5.0,2.2
4589,246,0,Europe,Commercial,Quality Assurance,Below,Male,39,11,0,7,30,2.8,3.0,3.1,0.0,1,1,1,1,3.3,2.5,3.0
4590,230,0,Europe,Commercial,Data Science,Exceeds,Female,36,5,0,6,19,3.2,3.1,2.4,0.0743,1,1,1,1,4.3,2.8,2.6
4591,660,0,North America,Digital,Human Resources,Far Exceeds,Female,39,23,0,11,18,3.9,2.0,2.8,0.2363,1,1,1,1,4.5,2.5,3.7
4592,130,0,Middle East & Africa,R&D,Communications,Far Below,Male,34,14,0,12,26,3.2,2.6,1.2,0.0,1,1,1,1,2.3,1.0,2.6
4593,204,1,Europe,Commercial,Human Resources,Far Exceeds,Male,29,2,1,10,13,0.0,1.2,2.2,0.1275,1,1,1,1,4.9,1.9,3.0
4594,993,0,Middle East & Africa,Finance,Marketing,Meets,Female,31,14,1,5,8,0.0,4.0,3.8,0.0331,1,1,1,1,3.6,4.7,3.1
4595,982,0,Europe,Finance,Marketing,Meets,Female,47,9,0,10,12,3.0,2.7,1.2,0.0331,0,0,0,0,3.2,4.4,3.2
4596,1029,0,Middle East & Africa,Finance,Supply Chain,Meets,Male,50,14,0,8,12,3.5,4.5,1.4,0.0331,1,1,1,1,2.4,4.0,2.4
4597,510,0,Asia Pacific,Manufacturing,Finance & Accounting,Meets,Female,29,8,0,7,15,3.9,3.3,2.0,0.0348,1,1,1,1,3.4,2.8,1.3
4598,438,0,Middle East & Africa,Manufacturing,Human Resources,Meets,Male,34,14,0,11,28,3.1,2.3,3.0,0.0348,1,1,1,1,3.2,3.8,2.7
4599,120,0,Middle East & Africa,R&D,Data Science,Meets,Male,28,8,1,11,32,0.0,1.6,4.5,0.0977,1,1,1,1,4.0,1.7,5.0
4600,584,0,North America,Digital,Quality Assurance,Meets,Male,38,19,0,10,16,4.0,1.1,1.3,0.0853,1,1,1,1,3.3,4.5,3.1
4601,771,0,Asia Pacific,HR,Quality Assurance,Meets,Male,39,3,1,9,18,0.0,1.9,4.2,0.0383,1,1,1,1,3.6,2.2,3.0
4602,138,0,Latin America,R&D,Pharmacovigilance,Meets,Female,37,7,0,6,22,3.9,3.6,1.8,0.0977,1,1,1,1,5.0,2.0,1.8
4603,840,0,North America,HR,Quality Assurance,Far Exceeds,Female,35,6,0,10,12,3.0,3.7,1.9,0.1168,1,1,1,1,2.0,4.8,2.6
4604,93,0,Latin America,R&D,Data Science,Exceeds,Non-Binary/Other,39,23,1,10,15,0.0,3.2,3.0,0.1648,1,1,1,1,3.7,5.0,2.1
4605,412,0,Europe,Manufacturing,Marketing,Far Exceeds,Male,42,5,0,6,24,2.4,3.3,1.9,0.1069,1,1,1,1,2.4,5.0,2.7
4606,968,0,Latin America,Finance,Pharmacovigilance,Exceeds,Female,42,8,0,10,15,3.5,1.8,2.4,0.0588,1,1,1,1,3.4,2.1,2.0
4607,579,0,Middle East & Africa,Digital,Clinical Operations,Meets,Female,45,13,0,9,16,3.5,2.1,2.1,0.0853,1,1,1,1,3.1,4.1,3.4
4608,490,0,Latin America,Manufacturing,Data Science,Meets,Male,36,6,1,7,28,0.0,2.4,2.9,0.0348,0,0,0,0,4.1,4.2,2.3
4609,528,0,North America,Digital,Regulatory Affairs,Meets,Male,34,15,1,9,13,0.0,3.5,3.8,0.0853,1,1,1,1,2.5,5.0,3.1
4610,819,0,North America,HR,IT & Digital,Far Exceeds,Female,44,29,0,12,16,3.1,1.9,1.1,0.1168,1,1,1,1,3.6,2.4,2.1
4611,47,0,Latin America,R&D,Quality Assurance,Below,Female,35,22,0,6,16,2.3,3.7,2.4,0.0,1,1,1,1,3.9,2.8,2.1
4612,298,0,North America,Commercial,Marketing,Meets,Female,37,10,1,10,30,0.0,1.9,3.2,0.0422,1,1,1,1,3.4,2.8,2.8
4613,297,0,North America,Commercial,Market Access,Below,Female,35,2,0,7,17,2.8,4.1,3.9,0.0,1,1,1,1,4.3,4.0,4.0
4614,692,0,Latin America,Digital,Human Resources,Meets,Male,48,11,0,9,33,4.1,2.2,1.0,0.0853,1,1,1,1,4.6,1.9,1.0
4615,969,0,Asia Pacific,Finance,Human Resources,Meets,Male,42,10,0,8,15,3.8,2.2,2.9,0.0331,0,0,0,0,3.3,2.5,3.1
4616,939,0,Asia Pacific,Finance,Quality Assurance,Meets,Male,31,8,0,5,14,1.7,3.8,1.6,0.0331,1,1,1,1,2.2,4.9,2.6
4617,545,0,Europe,Digital,Regulatory Affairs,Below,Male,38,5,1,6,10,0.0,3.1,1.9,0.0,1,1,1,1,5.0,3.9,2.5
4618,406,0,North America,Manufacturing,Human Resources,Meets,Female,40,7,1,12,13,0.0,3.2,4.0,0.0348,1,1,1,1,3.1,3.4,3.8
4619,272,0,Latin America,Commercial,Marketing,Exceeds,Female,31,5,1,9,12,0.0,3.7,4.3,0.0743,1,1,1,1,1.4,2.8,1.8
4620,468,0,North America,Manufacturing,Supply Chain,Meets,Male,40,8,0,7,11,3.8,3.1,2.2,0.0348,1,1,1,1,3.9,2.5,2.1
4621,719,0,Middle East & Africa,HR,Quality Assurance,Below,Female,37,12,0,11,28,2.4,4.1,1.7,0.0,1,1,1,1,2.5,2.6,1.0
4622,218,0,North America,Commercial,Pharmacovigilance,Exceeds,Male,31,18,0,6,8,2.6,2.6,1.0,0.0743,1,1,1,1,2.0,2.6,3.4
4623,810,0,North America,HR,Sales,Meets,Male,30,11,0,7,30,2.1,3.1,3.2,0.0383,1,1,1,1,1.9,2.3,2.6
4624,121,0,Asia Pacific,R&D,Human Resources,Far Below,Male,46,14,0,11,17,3.2,3.8,1.1,0.0,1,1,1,1,4.2,4.2,2.3
4625,486,0,Latin America,Manufacturing,Data Science,Meets,Male,33,6,0,10,18,4.2,4.4,4.5,0.0348,1,1,1,1,4.5,3.3,4.0
4626,589,0,North America,Digital,Regulatory Affairs,Meets,Male,44,20,0,8,13,3.7,2.2,3.0,0.0853,1,1,1,1,3.7,2.6,2.3
4627,320,0,Asia Pacific,Commercial,Quality Assurance,Meets,Male,42,4,0,6,13,3.4,2.7,2.0,0.0422,1,1,1,1,5.0,2.0,1.7
4628,494,0,Europe,Manufacturing,Clinical Operations,Far Below,Male,34,5,0,5,11,3.4,3.1,2.7,0.0,1,1,1,1,2.6,2.2,3.1
4629,555,0,Asia Pacific,Digital,Market Access,Meets,Male,41,17,0,11,13,4.9,3.1,2.8,0.0853,1,1,1,1,3.7,2.7,2.8
4630,51,0,Asia Pacific,R&D,Communications,Meets,Female,40,8,0,5,11,4.4,3.4,3.2,0.0977,1,1,1,1,2.9,4.3,3.2
4631,295,0,Asia Pacific,Commercial,Marketing,Meets,Male,43,7,1,11,16,0.0,4.0,2.3,0.0422,1,1,1,1,3.4,2.8,2.5
4632,823,0,North America,HR,Regulatory Affairs,Meets,Non-Binary/Other,39,9,0,9,18,2.2,3.4,1.9,0.0383,1,1,1,1,3.8,2.9,1.0
4633,98,0,North America,R&D,Data Science,Meets,Female,36,12,1,10,14,0.0,2.7,1.3,0.0977,1,1,1,1,1.8,4.0,1.0
4634,887,0,Europe,Finance,Quality Assurance,Meets,Female,46,8,0,10,19,3.0,3.8,3.3,0.0331,1,1,1,1,3.8,4.9,3.3
4635,596,0,Middle East & Africa,Digital,Clinical Operations,Meets,Female,42,2,0,6,15,4.1,5.0,1.4,0.0853,1,1,1,1,3.9,3.0,3.1
4636,292,0,Middle East & Africa,Commercial,Marketing,Meets,Female,34,10,0,8,18,2.7,2.7,1.0,0.0422,0,0,0,0,3.0,2.7,2.4
4637,217,0,Middle East & Africa,Commercial,Data Science,Exceeds,Male,37,4,0,11,39,4.3,2.5,1.9,0.0743,0,0,0,0,2.9,5.0,1.0
4638,134,1,Europe,R&D,Marketing,Meets,Female,46,9,0,8,11,3.6,2.1,2.5,0.0977,1,1,1,1,3.8,2.8,1.4
4639,342,0,Middle East & Africa,Commercial,Data Science,Meets,Male,47,13,0,10,21,2.6,4.4,2.3,0.0422,1,1,1,1,3.6,3.8,4.1
4640,695,0,Middle East & Africa,Digital,Human Resources,Meets,Male,37,7,1,6,19,0.0,2.1,3.8,0.0853,1,1,1,1,4.8,2.6,4.3
4641,94,0,Asia Pacific,R&D,Human Resources,Meets,Male,41,3,0,10,27,3.4,2.6,2.2,0.0977,0,0,0,0,3.8,2.9,1.4
4642,849,0,North America,HR,Quality Assurance,Exceeds,Male,40,12,0,9,14,2.9,3.7,2.1,0.0677,1,1,1,1,4.0,2.1,2.9
4643,175,0,North America,R&D,Sales,Meets,Male,31,17,0,6,33,4.0,2.1,3.6,0.0977,1,1,1,1,4.9,1.9,4.2
4644,50,0,Asia Pacific,R&D,Medical Affairs,Meets,Non-Binary/Other,41,12,0,10,14,3.2,3.7,2.6,0.0977,1,1,1,1,2.1,4.5,3.8
4645,701,0,Asia Pacific,HR,Pharmacovigilance,Far Exceeds,Male,28,9,0,12,27,1.0,3.1,4.1,0.1168,1,1,1,1,2.3,3.7,3.6
4646,1046,0,Asia Pacific,Finance,Communications,Meets,Female,43,14,0,9,22,3.3,1.0,2.3,0.0331,1,1,1,1,2.5,1.8,1.0
4647,615,0,North America,Digital,Sales,Below,Male,41,16,0,5,11,1.9,4.2,2.7,0.0,1,1,1,1,3.7,3.5,1.6
4648,910,0,Middle East & Africa,Finance,IT & Digital,Meets,Female,28,9,0,9,25,2.6,4.0,1.0,0.0331,1,1,1,1,3.1,3.4,1.0
4649,892,0,Asia Pacific,Finance,Legal & Compliance,Meets,Female,32,11,0,6,10,2.2,2.3,2.5,0.0331,1,1,1,0,2.9,1.0,4.0
4650,928,0,Europe,Finance,Medical Affairs,Meets,Female,28,25,0,9,20,3.1,2.4,2.4,0.0331,1,1,1,1,5.0,2.1,3.2
4651,356,0,Asia Pacific,Manufacturing,Quality Assurance,Far Below,Male,32,1,0,11,19,1.9,2.7,1.0,0.0,1,1,1,1,3.5,1.9,1.8
4652,889,0,Latin America,Finance,Quality Assurance,Meets,Female,39,5,0,8,11,2.2,3.8,2.2,0.0331,1,1,1,1,3.2,5.0,2.7
4653,412,0,Asia Pacific,Manufacturing,Quality Assurance,Meets,Male,48,11,0,8,15,4.4,3.6,2.9,0.0348,0,0,0,0,3.4,3.8,2.4
4654,771,0,North America,HR,Medical Affairs,Below,Female,41,16,0,11,24,3.4,3.4,1.1,0.0,0,0,0,0,2.0,1.4,3.2
4655,633,0,Asia Pacific,Digital,Finance & Accounting,Meets,Female,36,9,0,11,12,3.0,4.0,3.5,0.0853,1,1,1,1,3.0,4.7,3.7
4656,991,0,Latin America,Finance,Clinical Operations,Meets,Male,42,8,0,7,11,2.7,2.0,1.5,0.0331,1,1,1,1,3.8,3.0,1.0
4657,177,0,Europe,Commercial,Regulatory Affairs,Meets,Male,42,17,0,12,16,2.5,2.1,2.9,0.0422,1,1,1,1,3.8,3.3,3.5
4658,808,0,Middle East & Africa,HR,Medical Affairs,Meets,Male,47,17,0,6,22,4.9,4.5,4.5,0.0383,1,1,1,1,3.6,4.2,1.9
4659,521,0,Asia Pacific,Manufacturing,Market Access,Meets,Female,43,2,0,10,21,3.0,2.5,3.0,0.0348,1,1,1,1,2.3,3.6,1.7
4660,584,0,Latin America,Digital,Regulatory Affairs,Meets,Female,38,6,0,11,25,1.6,2.8,2.3,0.0853,1,1,1,1,3.4,3.2,2.1
4661,174,0,Latin America,R&D,Human Resources,Meets,Male,29,14,0,11,18,2.5,2.8,2.7,0.0977,1,0,0,0,2.8,1.1,3.3
4662,554,0,Europe,Digital,Market Access,Below,Male,46,11,0,11,18,4.2,2.7,3.9,0.0,1,1,1,1,4.4,3.4,2.2
4663,560,0,North America,Digital,Legal & Compliance,Meets,Male,37,20,0,10,14,4.5,3.1,2.5,0.0853,1,1,1,1,4.3,3.5,2.1
4664,968,0,Asia Pacific,Finance,Legal & Compliance,Exceeds,Male,33,17,0,11,25,1.7,2.8,1.3,0.0588,1,1,1,0,2.0,4.6,1.1
4665,949,0,Latin America,Finance,Data Science,Meets,Female,28,22,0,11,20,2.6,3.7,2.0,0.0331,1,1,1,1,3.3,4.4,2.5
4666,432,0,Europe,Manufacturing,Pharmacovigilance,Meets,Female,31,19,0,9,11,2.2,4.8,2.1,0.0348,0,0,0,0,4.4,3.7,3.2
4667,463,0,Middle East & Africa,Manufacturing,Communications,Meets,Female,40,12,0,8,24,1.9,2.9,2.4,0.0348,1,1,1,1,2.1,4.1,2.3
4668,986,0,Latin America,Finance,Pharmacovigilance,Far Below,Female,36,10,0,6,9,3.8,4.1,4.0,0.0,1,1,1,1,2.8,4.3,3.9
4669,903,0,Europe,Finance,Legal & Compliance,Meets,Female,44,11,0,11,18,3.5,3.1,2.2,0.0331,1,1,1,1,3.4,3.1,2.3
4670,280,0,North America,Commercial,Communications,Below,Female,48,11,0,10,11,3.1,2.7,4.7,0.0,1,1,1,1,3.2,3.2,5.0
4671,203,0,North America,Commercial,Human Resources,Exceeds,Female,28,14,0,6,24,2.9,2.0,2.1,0.0743,1,1,1,1,2.8,3.7,1.7
4672,836,0,Latin America,HR,Pharmacovigilance,Meets,Female,32,13,0,7,13,3.7,2.6,1.3,0.0383,1,1,1,1,4.0,1.5,1.2
4673,906,0,Latin America,Finance,Supply Chain,Meets,Female,39,7,0,7,15,3.7,1.0,1.9,0.0331,1,1,1,1,4.1,3.1,2.1
4674,43,0,Asia Pacific,R&D,Communications,Below,Female,47,25,1,7,13,0.0,3.6,2.6,0.0,1,1,1,1,3.6,3.2,3.2
4675,239,0,Europe,Commercial,Medical Affairs,Exceeds,Male,33,6,0,11,23,3.5,3.4,1.8,0.0743,1,1,1,1,4.1,2.3,2.1
4676,491,0,Latin America,Manufacturing,Clinical Operations,Far Exceeds,Female,39,8,0,7,11,5.0,3.0,4.3,0.1069,1,1,1,1,5.0,2.6,2.2
4677,558,0,Asia Pacific,Digital,Data Science,Below,Female,31,3,1,5,13,0.0,2.1,1.0,0.0,1,1,1,1,2.6,3.8,1.0
4678,823,0,Asia Pacific,HR,Communications,Meets,Male,37,24,0,6,17,2.4,3.1,1.5,0.0383,1,1,1,1,1.8,4.1,2.5
4679,190,0,Latin America,Commercial,Legal & Compliance,Far Below,Female,39,10,0,10,25,4.0,3.3,1.0,0.0,1,1,0,0,3.8,2.3,2.1
4680,652,0,North America,Digital,Quality Assurance,Meets,Male,36,12,1,12,31,0.0,3.1,2.3,0.0853,1,1,1,1,3.0,4.7,1.8
4681,639,0,Europe,Digital,Medical Affairs,Meets,Female,48,10,0,11,19,5.0,2.4,3.0,0.0853,1,1,1,1,5.0,4.0,3.2
4682,288,0,Europe,Commercial,Market Access,Meets,Female,45,8,0,7,18,2.7,3.1,1.6,0.0422,0,0,0,0,3.4,3.1,3.2
4683,16,0,North America,R&D,Market Access,Far Below,Male,36,15,0,8,11,3.9,1.8,2.4,0.0,1,1,1,1,3.5,2.1,2.4
4684,5,0,Latin America,R&D,Regulatory Affairs,Meets,Female,36,10,0,9,19,3.1,3.7,1.8,0.0977,1,1,1,1,4.1,3.8,2.4
4685,709,0,Europe,HR,Legal & Compliance,Meets,Female,43,15,0,7,10,3.9,3.5,2.6,0.0383,1,1,1,1,4.1,2.8,2.7
4686,84,0,Latin America,R&D,Quality Assurance,Meets,Female,38,2,0,8,9,1.5,4.7,3.3,0.0977,1,1,1,1,3.6,3.0,4.6
4687,815,0,Latin America,HR,Supply Chain,Meets,Male,38,10,0,11,25,3.2,2.0,2.6,0.0383,1,1,1,1,3.3,1.2,1.9
4688,490,0,Asia Pacific,Manufacturing,Human Resources,Below,Male,34,5,0,5,11,3.2,2.7,4.0,0.0,1,1,1,1,2.2,2.0,4.2
4689,254,0,North America,Commercial,Market Access,Meets,Female,42,12,0,7,20,2.5,2.9,1.5,0.0422,1,1,1,1,2.5,3.3,3.9
4690,558,0,Latin America,Digital,Pharmacovigilance,Meets,Male,34,5,0,7,18,3.6,2.1,3.9,0.0853,1,1,1,1,2.9,2.6,4.9
4691,848,0,Middle East & Africa,HR,Regulatory Affairs,Meets,Female,34,10,1,12,24,0.0,2.1,1.0,0.0383,1,1,1,1,3.5,2.6,1.0
4692,132,0,North America,R&D,Communications,Below,Female,40,13,0,6,22,3.3,2.8,3.3,0.0,1,1,1,1,3.2,2.5,4.3
4693,738,1,Europe,HR,Sales,Meets,Non-Binary/Other,39,6,0,8,12,3.0,1.8,1.4,0.0383,1,1,1,1,3.6,2.6,2.3
4694,923,0,Asia Pacific,Finance,Marketing,Far Exceeds,Male,38,4,1,5,12,0.0,3.9,1.0,0.1022,1,1,1,1,2.3,3.9,2.7
4695,719,1,Europe,HR,Finance & Accounting,Far Exceeds,Male,28,29,0,9,17,3.5,2.8,2.8,0.1168,1,1,1,1,5.0,3.7,3.5
4696,30,0,Europe,R&D,Regulatory Affairs,Meets,Female,39,9,0,8,19,3.7,3.4,2.7,0.0977,0,0,0,0,3.8,1.9,3.4
4697,925,0,North America,Finance,Communications,Meets,Male,28,15,0,7,18,2.8,3.3,1.0,0.0331,1,1,1,1,2.7,3.3,1.1
4698,1030,0,Europe,Finance,Regulatory Affairs,Meets,Female,44,18,0,5,17,2.6,3.3,2.0,0.0331,0,0,0,0,2.9,2.8,3.1
4699,161,0,Latin America,R&D,Finance & Accounting,Below,Female,35,10,0,11,17,3.2,3.6,2.6,0.0,1,1,1,1,2.3,3.4,2.6
4700,1016,0,Europe,Finance,Communications,Meets,Female,39,6,0,8,16,3.7,2.6,3.3,0.0331,1,1,1,1,3.1,1.5,2.3
4701,225,0,Asia Pacific,Commercial,Legal & Compliance,Below,Male,35,18,0,7,20,3.8,5.0,3.8,0.0,1,1,1,1,3.6,4.4,2.9
4702,610,0,Asia Pacific,Digital,Legal & Compliance,Meets,Male,40,5,0,12,22,2.9,3.0,2.4,0.0853,1,1,1,1,3.4,4.2,3.0
4703,330,0,Middle East & Africa,Commercial,Market Access,Exceeds,Male,31,24,0,5,12,2.4,2.3,2.8,0.0743,1,1,1,1,3.6,3.5,2.9
4704,302,0,Asia Pacific,Commercial,Legal & Compliance,Far Exceeds,Male,49,6,1,5,28,0.0,1.8,3.4,0.1275,1,1,1,1,3.6,2.6,3.9
4705,109,0,Europe,R&D,Medical Affairs,Exceeds,Female,34,16,0,8,22,3.3,1.7,3.4,0.1648,1,1,1,1,3.4,3.6,3.1
4706,153,0,Asia Pacific,R&D,Communications,Below,Male,43,10,0,5,8,1.5,5.0,3.2,0.0,0,0,0,0,2.4,4.9,2.5
4707,689,0,North America,Digital,Quality Assurance,Exceeds,Female,31,15,0,12,14,3.2,3.3,4.0,0.1452,1,1,1,1,3.2,1.7,3.0
4708,835,0,Asia Pacific,HR,Communications,Below,Female,36,12,0,11,15,2.3,2.4,3.8,0.0,1,1,0,0,2.6,3.2,1.7
4709,290,0,Latin America,Commercial,Legal & Compliance,Meets,Male,33,16,0,9,18,3.0,2.3,2.7,0.0422,1,1,1,1,3.5,1.5,1.4
4710,930,0,North America,Finance,Communications,Meets,Female,34,7,0,8,22,3.0,3.7,1.9,0.0331,0,0,0,0,3.4,5.0,3.7
4711,661,0,Middle East & Africa,Digital,Finance & Accounting,Meets,Female,41,12,0,9,15,2.7,2.3,2.9,0.0853,1,1,1,1,2.2,4.2,2.5
4712,226,0,Latin America,Commercial,Human Resources,Far Exceeds,Male,41,29,0,5,7,2.9,3.5,4.0,0.1275,1,1,0,0,2.9,3.2,4.1
4713,844,0,Europe,HR,Sales,Meets,Male,40,4,0,6,19,4.3,3.7,1.8,0.0383,1,1,1,1,4.8,3.1,3.9
4714,969,0,Europe,Finance,Pharmacovigilance,Meets,Female,33,16,0,6,17,3.0,3.3,4.0,0.0331,1,1,1,1,3.7,3.7,2.2
4715,346,0,Europe,Commercial,Medical Affairs,Below,Female,39,36,0,5,23,5.0,1.3,2.3,0.0,1,1,1,1,4.3,2.6,2.3
4716,425,0,Latin America,Manufacturing,Data Science,Exceeds,Female,33,29,0,9,24,2.8,4.4,1.0,0.0616,0,0,0,0,2.5,4.4,1.1
4717,623,0,Latin America,Digital,Market Access,Meets,Male,47,14,0,12,17,2.3,3.6,2.0,0.0853,1,1,1,1,2.0,1.3,1.9
4718,58,0,Latin America,R&D,Communications,Meets,Male,32,18,0,10,13,4.2,5.0,1.4,0.0977,1,1,1,1,3.8,3.9,2.1
4719,345,0,North America,Commercial,Quality Assurance,Meets,Male,35,31,0,11,18,2.4,3.7,1.6,0.0422,1,1,1,1,1.7,3.6,1.0
4720,969,0,North America,Finance,Clinical Operations,Meets,Male,38,19,0,9,13,2.9,2.4,5.0,0.0331,1,0,0,0,2.7,2.9,2.5
4721,988,0,Europe,Finance,Pharmacovigilance,Meets,Female,32,10,1,9,18,0.0,2.8,2.2,0.0331,1,1,1,1,1.8,3.9,2.9
4722,580,0,Asia Pacific,Digital,Medical Affairs,Meets,Female,42,10,0,6,19,3.1,3.0,2.9,0.0853,1,1,1,1,3.1,3.8,3.0
4723,696,0,Europe,Digital,Human Resources,Meets,Female,45,5,0,11,25,5.0,2.8,3.0,0.0853,1,1,1,1,5.0,2.4,3.3
4724,1000,0,Middle East & Africa,Finance,Pharmacovigilance,Far Exceeds,Male,33,18,1,6,12,0.0,2.5,2.5,0.1022,0,0,0,0,2.9,3.8,3.0
4725,896,0,North America,Finance,Quality Assurance,Exceeds,Male,34,36,0,9,12,3.2,3.3,1.3,0.0588,1,1,1,1,2.7,3.0,1.4
4726,926,0,Latin America,Finance,Data Science,Below,Female,45,13,0,7,13,2.8,2.5,1.6,0.0,1,1,1,1,2.9,2.3,1.8
4727,262,0,North America,Commercial,Data Science,Far Below,Female,39,9,0,7,9,2.1,4.5,1.9,0.0,1,1,1,1,1.7,3.1,1.2
4728,900,0,Latin America,Finance,Legal & Compliance,Meets,Female,37,11,0,8,16,5.0,1.7,1.9,0.0331,1,1,1,1,3.9,1.6,1.3
4729,100,0,Middle East & Africa,R&D,Pharmacovigilance,Meets,Male,33,9,0,11,16,1.5,2.9,3.0,0.0977,1,1,1,0,1.0,4.2,3.5
4730,1002,1,Middle East & Africa,Finance,Data Science,Meets,Female,36,4,1,6,21,0.0,2.2,2.6,0.0331,1,1,1,1,4.0,2.3,4.0
4731,64,0,North America,R&D,Medical Affairs,Meets,Female,37,5,0,8,23,3.2,2.9,2.3,0.0977,1,1,1,1,3.4,4.6,2.6
4732,289,0,Latin America,Commercial,Pharmacovigilance,Exceeds,Non-Binary/Other,42,6,1,6,16,0.0,3.9,2.7,0.0743,1,1,0,0,4.0,1.0,2.4
4733,609,0,Middle East & Africa,Digital,IT & Digital,Meets,Non-Binary/Other,38,8,0,11,17,4.7,3.6,1.6,0.0853,1,1,1,1,4.7,3.9,2.6
4734,142,0,Europe,R&D,Medical Affairs,Meets,Non-Binary/Other,33,18,0,11,36,2.3,4.6,1.5,0.0977,1,1,1,1,2.1,3.9,2.6
4735,310,0,Europe,Commercial,Human Resources,Exceeds,Female,35,11,0,5,12,3.7,1.9,2.9,0.0743,1,1,1,1,2.4,4.4,2.2
4736,1004,0,Latin America,Finance,Data Science,Meets,Female,31,3,1,12,20,0.0,1.6,2.0,0.0331,1,1,1,1,2.7,2.9,1.8
4737,229,0,North America,Commercial,Legal & Compliance,Meets,Male,37,18,0,11,18,5.0,2.1,3.0,0.0422,1,1,1,1,4.9,3.9,3.1
4738,907,0,Middle East & Africa,Finance,Supply Chain,Meets,Female,52,8,0,9,19,3.2,1.8,4.2,0.0331,1,1,1,1,3.4,2.9,2.0
4739,352,0,North America,Commercial,Marketing,Meets,Male,53,14,0,7,15,2.2,3.5,3.9,0.0422,1,1,1,1,1.3,4.5,3.8
4740,614,1,Europe,Digital,Clinical Operations,Meets,Male,40,25,0,9,14,3.1,3.9,2.9,0.0853,1,1,1,1,3.4,1.7,2.5
4741,9,0,Middle East & Africa,R&D,Legal & Compliance,Meets,Female,28,10,0,6,9,3.6,4.4,2.8,0.0977,1,1,1,1,3.4,4.0,3.5
4742,612,0,North America,Digital,Market Access,Meets,Female,44,20,0,5,14,4.8,1.6,3.8,0.0853,1,1,1,1,5.0,4.0,2.7
4743,498,0,Asia Pacific,Manufacturing,Quality Assurance,Meets,Female,42,18,0,11,18,3.0,2.4,4.2,0.0348,0,0,0,0,4.9,4.2,4.7
4744,1036,0,Latin America,Finance,Clinical Operations,Meets,Male,54,11,0,11,15,2.7,1.8,3.0,0.0331,1,1,1,1,3.2,2.4,4.3
4745,84,0,Latin America,R&D,Medical Affairs,Meets,Female,38,9,0,9,17,4.2,2.1,4.7,0.0977,1,1,1,1,3.9,1.8,3.5
4746,694,0,Asia Pacific,Digital,Marketing,Meets,Female,35,6,0,12,33,3.3,3.6,3.5,0.0853,1,0,0,0,3.6,2.2,3.0
4747,160,0,Europe,R&D,Marketing,Exceeds,Female,32,12,0,11,17,3.3,1.2,2.9,0.1648,1,1,1,1,4.0,1.6,2.5
4748,447,0,Middle East & Africa,Manufacturing,Supply Chain,Meets,Female,43,20,0,6,8,3.5,2.0,1.6,0.0348,1,1,1,1,2.8,3.2,2.7
4749,770,0,Latin America,HR,Legal & Compliance,Below,Female,37,8,0,6,30,1.6,3.0,3.8,0.0,1,1,1,1,2.2,3.0,4.5
4750,960,0,Asia Pacific,Finance,Human Resources,Meets,Female,36,19,0,9,24,3.2,1.3,2.2,0.0331,1,1,1,1,3.2,3.0,1.7
4751,992,0,Asia Pacific,Finance,IT & Digital,Meets,Male,35,17,0,12,25,2.8,4.2,3.0,0.0331,1,0,0,0,3.3,3.2,1.9
4752,270,0,Europe,Commercial,Legal & Compliance,Meets,Male,51,7,1,5,6,0.0,2.4,1.0,0.0422,1,1,1,1,3.2,5.0,2.6
4753,911,0,Europe,Finance,Sales,Below,Male,36,6,0,10,23,3.5,4.9,1.7,0.0,1,1,1,1,3.3,4.9,3.2
4754,905,0,North America,Finance,Sales,Below,Male,42,21,0,8,19,1.1,3.2,3.8,0.0,1,1,1,1,2.6,4.7,3.2
4755,549,0,Latin America,Digital,Medical Affairs,Meets,Male,41,18,0,7,9,2.4,2.7,1.2,0.0853,1,1,1,1,2.7,2.6,3.6
4756,978,0,North America,Finance,Marketing,Meets,Female,28,15,0,8,13,3.3,2.0,3.6,0.0331,1,1,1,1,3.5,1.3,3.7
4757,987,0,Asia Pacific,Finance,Supply Chain,Exceeds,Male,51,2,0,11,25,3.7,2.0,1.6,0.0588,1,1,1,1,4.3,3.5,1.8
4758,451,0,Middle East & Africa,Manufacturing,Market Access,Meets,Male,28,7,0,6,11,3.2,1.9,1.3,0.0348,1,1,1,1,2.9,2.1,2.0
4759,410,0,Middle East & Africa,Manufacturing,Communications,Meets,Male,33,12,0,9,12,2.1,3.5,2.4,0.0348,1,1,1,1,3.1,4.1,2.5
4760,46,1,Europe,R&D,Market Access,Exceeds,Female,35,6,0,7,11,2.9,4.2,1.0,0.1648,1,1,1,1,3.8,4.3,1.8
4761,168,0,Middle East & Africa,R&D,Clinical Operations,Below,Female,34,5,1,5,14,0.0,3.6,1.7,0.0,1,1,1,1,5.0,3.5,2.4
4762,1006,0,Middle East & Africa,Finance,Pharmacovigilance,Meets,Male,37,13,0,9,16,4.2,1.7,3.4,0.0331,1,0,0,0,4.2,2.7,1.3
4763,932,0,Middle East & Africa,Finance,Communications,Below,Male,33,14,0,5,10,2.8,3.1,3.9,0.0,1,1,1,1,2.9,4.5,3.0
4764,258,0,Asia Pacific,Commercial,Legal & Compliance,Meets,Female,46,14,0,12,17,2.2,2.9,2.4,0.0422,1,1,1,1,3.0,2.6,2.8
4765,92,0,Middle East & Africa,R&D,Quality Assurance,Below,Female,42,7,0,7,36,4.8,2.8,3.9,0.0,1,1,1,1,4.3,4.6,3.7
4766,540,0,Middle East & Africa,Digital,Supply Chain,Below,Female,34,17,1,12,23,0.0,1.1,1.9,0.0,1,1,1,1,4.9,3.4,2.0
4767,949,0,Middle East & Africa,Finance,Pharmacovigilance,Exceeds,Female,33,7,1,12,29,0.0,1.0,2.0,0.0588,1,1,1,1,5.0,2.0,2.9
4768,688,0,North America,Digital,Data Science,Meets,Female,35,10,0,7,20,3.2,2.5,1.4,0.0853,1,1,1,1,2.6,2.3,2.4
4769,958,0,Asia Pacific,Finance,Market Access,Exceeds,Female,33,19,0,11,23,2.2,2.3,1.4,0.0588,1,1,1,1,3.0,3.6,3.9
4770,619,0,Europe,Digital,Medical Affairs,Meets,Male,31,12,0,11,19,3.5,4.1,3.0,0.0853,1,1,1,1,3.0,5.0,3.8
4771,825,0,North America,HR,Supply Chain,Meets,Female,44,9,0,8,10,3.3,3.8,1.6,0.0383,1,1,1,1,3.8,2.7,2.6
4772,643,0,Latin America,Digital,Marketing,Far Below,Female,36,7,1,8,21,0.0,3.4,2.7,0.0,1,1,1,1,3.4,1.9,3.0
4773,43,0,Asia Pacific,R&D,Legal & Compliance,Meets,Male,40,10,0,12,19,2.6,2.4,1.9,0.0977,1,1,1,1,3.7,2.7,1.2
4774,961,0,Asia Pacific,Finance,Finance & Accounting,Meets,Male,38,10,0,9,50,2.7,4.4,3.9,0.0331,1,0,0,0,3.6,1.9,3.7
4775,176,0,Latin America,R&D,Regulatory Affairs,Far Below,Female,47,7,1,5,17,0.0,4.8,2.3,0.0,1,1,1,1,3.9,3.8,3.3
4776,624,0,Latin America,Digital,Regulatory Affairs,Meets,Male,43,9,0,8,17,3.7,3.7,3.0,0.0853,1,0,0,0,2.7,4.5,2.6
4777,368,0,Latin America,Manufacturing,Market Access,Meets,Female,40,8,1,10,15,0.0,2.6,1.2,0.0348,0,0,0,0,4.5,3.8,1.5
4778,435,0,Europe,Manufacturing,Supply Chain,Meets,Female,52,23,0,5,17,3.1,2.9,3.1,0.0348,1,1,1,1,2.7,2.3,3.1
4779,381,0,Middle East & Africa,Manufacturing,Pharmacovigilance,Meets,Male,34,4,0,11,26,3.5,5.0,2.1,0.0348,1,1,1,1,3.1,3.7,1.3
4780,996,0,Asia Pacific,Finance,Human Resources,Far Exceeds,Male,37,4,0,8,9,3.1,3.4,2.9,0.1022,1,1,0,0,3.0,2.5,1.9
4781,230,0,Middle East & Africa,Commercial,Communications,Below,Non-Binary/Other,42,7,0,11,26,2.2,4.3,2.6,0.0,1,1,1,1,3.3,3.9,2.1
4782,880,0,Middle East & Africa,HR,IT & Digital,Meets,Male,43,9,1,12,25,0.0,2.8,2.7,0.0383,1,1,1,1,3.6,1.9,1.0
4783,591,0,Latin America,Digital,Pharmacovigilance,Meets,Male,33,7,1,12,18,0.0,2.2,3.6,0.0853,1,0,0,0,3.6,2.2,3.9
4784,354,0,Europe,Commercial,Supply Chain,Below,Male,38,36,0,12,19,3.6,2.3,2.4,0.0,1,1,1,1,3.4,5.0,1.9
4785,430,0,North America,Manufacturing,Human Resources,Meets,Non-Binary/Other,38,11,0,10,21,1.9,1.0,4.2,0.0348,1,1,1,0,3.6,3.2,3.0
4786,613,0,Europe,Digital,Quality Assurance,Meets,Female,52,12,0,11,21,4.0,2.5,2.4,0.0853,1,1,1,1,4.3,2.3,1.9
4787,325,0,Middle East & Africa,Commercial,Market Access,Below,Female,42,8,1,10,21,0.0,4.9,2.2,0.0,1,1,1,1,3.8,5.0,1.2
4788,103,0,Europe,R&D,Data Science,Below,Male,44,7,0,7,20,2.5,3.3,3.8,0.0,1,1,1,1,2.9,3.4,3.5
4789,387,0,Latin America,Manufacturing,Clinical Operations,Exceeds,Male,36,9,1,10,26,0.0,2.7,1.7,0.0616,0,0,0,0,2.8,1.0,1.2
4790,261,0,North America,Commercial,Supply Chain,Below,Male,33,9,0,8,14,3.3,2.0,2.9,0.0,1,0,0,0,4.3,3.1,1.6
4791,995,0,Latin America,Finance,Quality Assurance,Meets,Female,35,12,0,6,7,5.0,3.6,4.2,0.0331,1,1,1,1,4.1,3.3,4.1
4792,86,0,North America,R&D,Regulatory Affairs,Below,Male,41,10,1,8,18,0.0,3.6,1.8,0.0,0,0,0,0,4.5,3.5,2.2
4793,410,0,Middle East & Africa,Manufacturing,Communications,Below,Female,47,6,0,9,35,3.4,3.6,1.0,0.0,0,0,0,0,5.0,4.1,1.0
4794,802,0,North America,HR,Pharmacovigilance,Meets,Female,29,20,0,7,12,2.2,2.5,4.2,0.0383,1,1,1,1,3.1,1.8,2.6
4795,478,0,North America,Manufacturing,Medical Affairs,Meets,Male,50,19,0,12,17,3.5,2.7,4.1,0.0348,1,1,1,1,2.1,1.0,3.3
4796,900,0,North America,Finance,Market Access,Meets,Non-Binary/Other,43,20,0,6,17,4.2,3.1,2.7,0.0331,1,1,1,0,4.5,5.0,2.6
4797,735,0,Europe,HR,Human Resources,Below,Male,44,24,0,9,14,4.2,1.8,1.4,0.0,1,1,1,1,4.7,1.4,2.7
4798,735,0,Europe,HR,Pharmacovigilance,Exceeds,Male,44,18,1,8,17,0.0,4.2,4.3,0.0677,1,1,1,1,4.5,3.5,2.6
4799,822,0,Middle East & Africa,HR,Finance & Accounting,Meets,Female,36,33,0,9,14,3.5,2.0,3.1,0.0383,1,1,1,1,3.2,2.0,3.4
4800,584,0,North America,Digital,Data Science,Below,Male,37,3,1,5,18,0.0,5.0,3.4,0.0,1,1,1,1,4.3,4.4,2.2
4801,590,0,Asia Pacific,Digital,Quality Assurance,Meets,Male,42,5,1,5,10,0.0,3.3,2.6,0.0853,1,1,1,1,3.2,1.9,2.4
4802,870,0,Middle East & Africa,HR,Human Resources,Below,Female,37,7,1,10,23,0.0,3.5,3.9,0.0,1,1,1,1,3.4,3.1,3.6
4803,18,0,North America,R&D,Regulatory Affairs,Meets,Male,39,2,1,10,13,0.0,1.8,3.6,0.0977,1,1,1,1,2.8,1.0,4.2
4804,844,0,North America,HR,Communications,Meets,Non-Binary/Other,34,23,0,12,22,3.9,3.3,3.8,0.0383,1,1,1,1,4.1,1.6,2.4
4805,289,0,Europe,Commercial,Legal & Compliance,Below,Male,43,5,1,12,14,0.0,4.0,3.0,0.0,0,0,0,0,3.7,3.7,2.8
4806,878,0,Middle East & Africa,HR,Data Science,Below,Male,37,15,0,10,16,3.1,3.4,2.4,0.0,1,1,1,1,4.4,3.0,2.9
4807,569,0,North America,Digital,Clinical Operations,Meets,Female,36,7,0,9,24,2.1,3.2,2.6,0.0853,1,1,1,1,2.9,3.5,2.3
4808,592,0,North America,Digital,Sales,Exceeds,Male,33,6,0,10,13,4.0,2.8,2.5,0.1452,0,0,0,0,4.5,2.8,1.2
4809,262,0,Middle East & Africa,Commercial,Medical Affairs,Below,Female,34,11,0,5,11,5.0,3.5,1.7,0.0,1,1,1,1,4.5,2.9,1.9
4810,273,0,Asia Pacific,Commercial,Finance & Accounting,Below,Male,30,12,1,7,14,0.0,2.7,1.6,0.0,1,1,1,1,4.2,2.9,2.3
4811,478,0,Middle East & Africa,Manufacturing,Clinical Operations,Meets,Male,41,16,0,7,20,2.8,3.4,1.0,0.0348,1,1,1,1,3.8,2.5,1.5
4812,131,0,Middle East & Africa,R&D,Market Access,Meets,Male,34,3,1,12,34,0.0,4.6,1.0,0.0977,1,1,1,1,3.2,4.0,1.0
4813,4,0,Asia Pacific,R&D,Pharmacovigilance,Below,Male,38,11,0,11,21,2.1,4.2,3.7,0.0,1,1,1,1,1.7,2.2,3.9
4814,37,0,Middle East & Africa,R&D,Marketing,Meets,Male,45,12,1,7,12,0.0,3.3,2.8,0.0977,1,1,1,1,3.4,3.6,2.0
4815,922,0,North America,Finance,Marketing,Meets,Male,37,12,0,6,15,3.7,2.0,3.4,0.0331,1,1,1,1,3.7,2.8,2.8
4816,624,0,Middle East & Africa,Digital,Legal & Compliance,Below,Female,37,34,0,9,33,4.1,2.9,1.7,0.0,1,1,1,1,5.0,2.9,2.3
4817,160,0,Asia Pacific,R&D,Human Resources,Meets,Male,38,7,1,9,23,0.0,3.5,2.6,0.0977,1,1,1,1,2.1,5.0,2.5
4818,495,0,Latin America,Manufacturing,Regulatory Affairs,Far Below,Male,40,20,1,5,15,0.0,3.6,2.5,0.0,1,1,1,1,3.7,4.2,2.8
4819,437,0,Middle East & Africa,Manufacturing,Communications,Meets,Male,35,16,0,5,11,3.3,4.2,3.3,0.0348,0,0,0,0,4.0,4.1,3.3
4820,44,0,Europe,R&D,Legal & Compliance,Far Exceeds,Female,43,6,0,10,38,2.8,2.0,2.0,0.2644,1,0,0,0,4.2,2.2,2.6
4821,305,0,North America,Commercial,Supply Chain,Meets,Male,39,10,0,5,19,3.7,4.1,3.3,0.0422,1,1,1,1,3.8,4.2,2.2
4822,421,0,North America,Manufacturing,IT & Digital,Meets,Male,35,12,0,8,17,4.1,3.8,3.0,0.0348,1,1,1,1,4.2,3.8,2.9
4823,354,0,Europe,Commercial,IT & Digital,Meets,Female,36,20,0,12,18,2.9,4.3,3.2,0.0422,1,1,1,1,2.9,4.2,1.0
4824,580,0,Europe,Digital,Communications,Meets,Male,45,25,0,12,29,3.5,1.9,3.8,0.0853,1,1,1,1,3.8,1.9,2.5
4825,1019,0,Middle East & Africa,Finance,Pharmacovigilance,Exceeds,Male,34,10,0,5,7,3.2,5.0,1.9,0.0588,1,1,1,1,2.7,3.7,3.1
4826,365,0,Europe,Manufacturing,Marketing,Meets,Male,41,21,1,9,26,0.0,2.2,1.7,0.0348,1,1,1,1,3.8,2.4,1.6
4827,247,0,Latin America,Commercial,Human Resources,Meets,Male,41,6,1,8,21,0.0,2.5,2.0,0.0422,1,1,1,1,3.3,2.7,2.4
4828,140,0,Asia Pacific,R&D,Quality Assurance,Meets,Female,32,14,0,8,24,3.8,2.4,2.1,0.0977,1,1,1,1,3.7,2.9,1.0
4829,558,0,Europe,Digital,IT & Digital,Meets,Male,29,14,0,8,12,4.2,3.7,4.4,0.0853,1,1,1,1,3.9,2.3,3.3
4830,868,0,Europe,HR,Sales,Meets,Male,36,7,0,5,17,3.7,3.4,1.0,0.0383,1,1,1,1,1.7,3.3,1.0
4831,848,0,Latin America,HR,Regulatory Affairs,Far Below,Male,43,4,0,12,22,3.6,2.9,3.0,0.0,1,1,1,1,4.4,1.5,2.6
4832,49,0,North America,R&D,Finance & Accounting,Meets,Non-Binary/Other,29,17,1,7,13,0.0,4.5,2.9,0.0977,1,1,1,1,3.1,5.0,2.2
4833,544,0,North America,Digital,Communications,Meets,Male,33,10,0,7,24,2.5,3.9,3.1,0.0853,0,0,0,0,3.2,2.6,1.4
4834,567,0,Middle East & Africa,Digital,Medical Affairs,Meets,Female,42,3,1,5,18,0.0,2.6,1.6,0.0853,1,1,1,1,4.3,2.4,1.0
4835,695,0,Latin America,Digital,IT & Digital,Exceeds,Male,32,9,0,7,14,3.2,2.1,3.5,0.1452,1,1,0,0,2.1,2.5,3.8
4836,681,0,Asia Pacific,Digital,Clinical Operations,Meets,Female,44,3,1,6,14,0.0,4.2,4.6,0.0853,1,1,1,1,3.1,4.3,4.3
4837,775,0,Asia Pacific,HR,Clinical Operations,Below,Female,54,11,0,9,13,4.0,2.2,2.1,0.0,1,1,1,1,1.8,3.5,1.5
4838,179,0,Latin America,Commercial,Marketing,Exceeds,Male,33,12,1,8,11,0.0,3.7,1.0,0.0743,1,1,0,0,3.1,2.7,1.6
4839,656,0,Asia Pacific,Digital,Communications,Exceeds,Male,47,11,0,6,23,3.2,1.0,1.3,0.1452,0,0,0,0,3.7,2.0,2.0
4840,193,0,North America,Commercial,Regulatory Affairs,Meets,Male,40,12,0,8,29,2.4,3.1,1.4,0.0422,1,0,0,0,2.9,4.1,3.1
4841,523,0,Asia Pacific,Digital,Marketing,Below,Male,33,5,1,6,23,0.0,4.6,2.4,0.0,1,1,1,1,2.3,3.3,3.2
4842,409,0,Asia Pacific,Manufacturing,Clinical Operations,Meets,Male,48,13,0,6,18,3.1,3.6,1.8,0.0348,1,1,1,1,2.9,2.0,1.7
4843,1040,0,Latin America,Finance,Human Resources,Below,Male,40,7,0,12,27,4.4,4.7,1.6,0.0,0,0,0,0,5.0,4.5,1.9
4844,448,0,Latin America,Manufacturing,Market Access,Exceeds,Male,45,20,0,10,37,2.4,2.6,2.7,0.0616,1,1,1,1,2.2,2.5,2.4
4845,975,0,Asia Pacific,Finance,Data Science,Meets,Male,52,2,0,5,10,2.4,3.3,3.3,0.0331,1,1,1,1,3.5,1.9,4.9
4846,448,0,Europe,Manufacturing,Legal & Compliance,Meets,Female,37,28,0,11,19,2.6,2.9,2.0,0.0348,0,0,0,0,3.8,4.3,1.0
4847,684,0,Latin America,Digital,Pharmacovigilance,Exceeds,Male,41,21,0,7,11,3.9,3.1,3.5,0.1452,0,0,0,0,2.7,1.6,3.5
4848,219,0,Middle East & Africa,Commercial,Regulatory Affairs,Meets,Male,31,13,1,11,13,0.0,2.2,4.4,0.0422,1,1,1,1,4.2,3.8,3.6
4849,915,1,Middle East & Africa,Finance,Quality Assurance,Far Exceeds,Female,35,5,0,8,14,2.6,3.1,1.4,0.1022,1,1,1,1,4.1,3.0,2.9
4850,819,0,North America,HR,Marketing,Far Exceeds,Female,38,18,0,5,8,3.9,2.9,2.1,0.1168,1,1,1,1,2.9,4.3,1.1
4851,109,0,Asia Pacific,R&D,IT & Digital,Far Below,Female,39,17,0,5,13,2.5,2.6,1.3,0.0,1,1,1,1,3.2,2.1,2.0
4852,920,0,Europe,Finance,Marketing,Below,Female,28,6,0,12,22,3.4,2.6,3.9,0.0,1,1,1,1,1.9,2.2,4.0
4853,1030,0,North America,Finance,Supply Chain,Meets,Female,47,7,0,5,19,2.2,2.7,2.6,0.0331,1,1,1,1,2.1,3.2,2.4
4854,782,1,Asia Pacific,HR,Sales,Far Exceeds,Male,42,28,0,6,29,4.5,4.0,3.2,0.1168,1,1,1,1,4.6,4.3,3.2
4855,599,0,Latin America,Digital,IT & Digital,Far Exceeds,Female,41,21,0,6,12,4.3,3.3,2.9,0.2363,1,1,1,1,3.8,3.1,2.8
4856,444,0,Middle East & Africa,Manufacturing,Human Resources,Meets,Female,50,9,0,7,15,3.3,2.9,2.7,0.0348,1,1,1,1,2.1,2.4,1.7
4857,460,0,Europe,Manufacturing,Medical Affairs,Below,Female,48,16,0,9,12,4.7,3.5,3.2,0.0,1,1,1,1,5.0,2.1,3.0
4858,192,0,Middle East & Africa,Commercial,Marketing,Below,Male,37,9,0,10,23,2.8,3.5,4.2,0.0,1,1,1,1,3.4,2.6,3.9
4859,565,0,Latin America,Digital,Quality Assurance,Meets,Female,35,23,1,6,21,0.0,2.9,1.0,0.0853,1,1,1,1,2.0,1.6,2.6
4860,759,0,Asia Pacific,HR,Medical Affairs,Meets,Female,42,6,0,7,22,4.6,2.0,3.3,0.0383,1,1,1,1,4.1,3.6,3.7
4861,652,0,Latin America,Digital,Sales,Meets,Male,47,17,0,12,32,2.5,1.0,2.2,0.0853,1,0,0,0,2.2,3.0,3.4
4862,604,0,Latin America,Digital,Supply Chain,Meets,Female,37,2,1,12,30,0.0,4.8,4.0,0.0853,1,1,1,1,3.9,3.6,2.7
4863,494,0,Middle East & Africa,Manufacturing,Marketing,Meets,Male,43,18,0,10,12,5.0,3.0,2.8,0.0348,1,1,1,1,2.9,2.5,4.4
4864,808,0,Europe,HR,Finance & Accounting,Exceeds,Female,48,7,1,9,12,0.0,2.3,3.8,0.0677,1,1,1,1,3.4,2.2,5.0
4865,40,0,Latin America,R&D,Medical Affairs,Meets,Female,44,19,0,12,22,3.3,2.3,3.2,0.0977,1,1,1,1,3.5,1.0,2.0
4866,936,0,Middle East & Africa,Finance,Finance & Accounting,Meets,Male,28,7,1,9,27,0.0,4.0,2.5,0.0331,1,1,1,1,2.6,3.4,2.4
4867,449,0,Europe,Manufacturing,Medical Affairs,Meets,Female,31,4,0,12,34,3.8,5.0,2.7,0.0348,1,1,1,0,4.5,3.7,2.5
4868,836,0,Asia Pacific,HR,Market Access,Exceeds,Female,50,27,0,8,17,2.2,4.1,2.7,0.0677,1,1,1,1,3.2,4.6,2.4
4869,231,0,Asia Pacific,Commercial,Medical Affairs,Meets,Male,39,8,0,5,15,4.1,2.3,4.8,0.0422,1,1,1,1,4.5,2.3,3.2
4870,919,0,North America,Finance,Clinical Operations,Meets,Male,40,8,0,5,21,3.0,4.7,1.2,0.0331,1,1,1,1,2.8,4.7,2.2
4871,995,0,Middle East & Africa,Finance,Sales,Meets,Female,41,8,1,8,18,0.0,4.8,3.6,0.0331,1,1,1,1,3.7,2.5,1.9
4872,484,0,Europe,Manufacturing,Quality Assurance,Meets,Male,47,14,0,5,14,2.0,1.2,1.9,0.0348,1,1,1,1,3.2,4.7,2.7
4873,292,0,Latin America,Commercial,Supply Chain,Below,Male,33,9,0,8,20,5.0,4.7,2.7,0.0,1,1,0,0,4.9,2.8,2.4
4874,467,1,Asia Pacific,Manufacturing,Sales,Meets,Female,36,13,0,6,16,3.0,2.2,1.8,0.0348,1,1,1,1,5.0,2.9,3.1
4875,627,0,Europe,Digital,Data Science,Meets,Non-Binary/Other,32,3,1,11,15,0.0,3.4,2.7,0.0853,0,0,0,0,2.6,1.8,3.8
4876,791,0,Middle East & Africa,HR,Communications,Meets,Male,28,20,0,12,17,2.5,4.8,1.0,0.0383,1,0,0,0,2.9,4.9,1.0
4877,227,0,North America,Commercial,Communications,Below,Male,40,15,0,11,22,1.8,2.3,3.3,0.0,1,1,1,1,3.9,2.6,2.7
4878,990,0,Asia Pacific,Finance,Human Resources,Below,Female,33,12,0,8,19,2.9,3.8,1.8,0.0,1,1,1,1,3.0,3.6,2.6
4879,427,0,Europe,Manufacturing,Clinical Operations,Meets,Female,44,9,1,7,12,0.0,4.0,3.1,0.0348,1,1,1,1,5.0,5.0,1.9
4880,1003,0,Europe,Finance,Finance & Accounting,Meets,Female,34,10,0,5,12,4.1,3.5,2.4,0.0331,1,1,1,1,4.0,3.1,2.2
4881,341,0,Europe,Commercial,Supply Chain,Meets,Male,30,36,0,9,28,2.7,2.0,4.9,0.0422,1,1,1,1,4.9,2.2,4.2
4882,962,0,Middle East & Africa,Finance,Finance & Accounting,Exceeds,Female,44,8,0,8,16,4.6,3.3,3.9,0.0588,1,1,1,1,4.6,1.9,5.0
4883,458,0,Middle East & Africa,Manufacturing,Communications,Below,Male,41,7,1,7,12,0.0,2.3,2.3,0.0,1,1,1,1,1.9,2.6,2.9
4884,391,0,Middle East & Africa,Manufacturing,Human Resources,Meets,Female,37,17,0,11,29,3.0,3.8,1.8,0.0348,1,1,1,1,1.9,1.5,3.0
4885,25,0,Latin America,R&D,Data Science,Meets,Male,37,7,0,10,24,3.7,4.4,3.0,0.0977,1,1,1,1,3.5,3.3,2.8
4886,1015,0,Europe,Finance,Medical Affairs,Exceeds,Female,42,10,0,12,18,2.4,4.5,5.0,0.0588,0,0,0,0,2.7,5.0,3.0
4887,121,0,Asia Pacific,R&D,Legal & Compliance,Meets,Female,48,12,0,11,13,1.0,4.3,3.9,0.0977,1,1,1,1,2.9,5.0,1.7
4888,121,0,Middle East & Africa,R&D,Sales,Meets,Female,40,9,0,5,24,4.0,1.4,3.2,0.0977,1,1,1,1,3.5,2.9,3.7
4889,958,0,Middle East & Africa,Finance,Finance & Accounting,Meets,Male,41,27,0,7,36,3.4,1.9,3.7,0.0331,1,1,1,1,3.4,1.0,3.0
4890,347,0,Europe,Commercial,Communications,Meets,Female,35,4,0,10,15,3.4,1.7,3.0,0.0422,1,1,1,1,3.2,2.7,2.4
4891,648,0,Middle East & Africa,Digital,IT & Digital,Meets,Female,37,30,0,12,29,2.4,2.8,3.8,0.0853,1,1,1,1,2.1,3.4,2.5
4892,385,0,Latin America,Manufacturing,Quality Assurance,Meets,Female,28,18,0,9,31,3.3,4.0,3.1,0.0348,1,1,1,1,2.8,3.6,2.5
4893,854,0,Latin America,HR,Finance & Accounting,Exceeds,Female,32,7,0,6,13,2.8,3.0,2.1,0.0677,1,1,1,1,3.2,2.5,3.6
4894,4,0,Middle East & Africa,R&D,Supply Chain,Meets,Male,32,11,0,5,11,2.6,2.6,1.3,0.0977,1,1,1,1,4.2,1.9,2.9
4895,283,0,Europe,Commercial,Pharmacovigilance,Far Exceeds,Male,31,10,1,9,20,0.0,1.5,4.0,0.1275,1,1,1,1,5.0,1.5,3.2
4896,902,0,Europe,Finance,Human Resources,Meets,Male,36,5,0,5,12,2.5,4.3,2.8,0.0331,1,1,1,1,3.1,2.9,4.0
4897,290,0,Europe,Commercial,Data Science,Exceeds,Male,36,23,0,6,12,3.2,3.7,2.8,0.0743,1,1,1,1,3.0,2.7,2.3
4898,331,0,North America,Commercial,Legal & Compliance,Meets,Male,32,10,0,12,27,3.4,3.5,2.6,0.0422,1,1,1,1,4.0,3.7,3.5
4899,909,0,Middle East & Africa,Finance,Human Resources,Meets,Female,46,12,0,5,33,2.7,2.5,4.4,0.0331,1,1,1,1,3.8,2.9,4.4
4900,700,0,Europe,HR,Market Access,Meets,Female,42,4,0,8,15,2.9,3.5,1.7,0.0383,1,1,1,1,2.9,5.0,1.6
4901,904,0,Latin America,Finance,Clinical Operations,Exceeds,Female,39,6,0,7,13,3.8,2.5,2.0,0.0588,0,0,0,0,3.5,2.8,1.0
4902,772,0,Asia Pacific,HR,Clinical Operations,Meets,Female,42,8,1,11,23,0.0,3.0,3.2,0.0383,0,0,0,0,5.0,4.0,2.6
4903,881,0,Asia Pacific,Finance,IT & Digital,Meets,Male,28,2,0,10,24,3.2,3.9,3.7,0.0331,1,1,1,1,3.9,3.6,3.6
4904,38,0,Europe,R&D,Market Access,Below,Female,28,15,0,12,17,3.7,2.0,1.5,0.0,1,1,1,1,2.5,2.5,2.5
4905,831,0,Asia Pacific,HR,Finance & Accounting,Far Exceeds,Male,45,29,0,11,17,2.8,3.2,3.2,0.1168,1,1,1,1,2.8,3.1,1.4
4906,119,0,Asia Pacific,R&D,Legal & Compliance,Meets,Male,52,6,1,11,15,0.0,4.4,3.0,0.0977,1,0,0,0,3.3,5.0,3.2
4907,707,0,North America,HR,Clinical Operations,Meets,Male,38,11,1,11,13,0.0,5.0,2.7,0.0383,1,1,1,1,2.9,2.7,1.7
4908,723,0,Latin America,HR,Regulatory Affairs,Exceeds,Female,52,7,0,12,15,3.6,2.0,4.6,0.0677,1,1,1,1,2.8,3.1,4.5
4909,989,0,Latin America,Finance,Regulatory Affairs,Exceeds,Non-Binary/Other,38,12,0,7,12,2.6,3.3,1.0,0.0588,1,0,0,0,4.5,2.4,1.8
4910,793,0,North America,HR,Supply Chain,Meets,Male,34,7,1,11,27,0.0,2.5,1.4,0.0383,1,1,1,1,3.3,2.6,3.2
4911,140,1,North America,R&D,Pharmacovigilance,Exceeds,Male,44,3,0,5,6,3.0,4.4,4.0,0.1648,1,1,1,1,2.9,3.6,3.5
4912,900,0,Asia Pacific,Finance,Quality Assurance,Meets,Female,28,20,0,7,22,2.1,2.0,2.6,0.0331,1,1,1,1,2.3,3.5,2.7
4913,395,0,Middle East & Africa,Manufacturing,Communications,Below,Female,34,18,0,6,21,2.6,3.8,4.3,0.0,1,1,1,1,2.5,1.8,2.3
4914,130,0,Asia Pacific,R&D,Medical Affairs,Exceeds,Female,33,22,0,10,18,3.5,1.2,4.8,0.1648,1,1,1,1,2.3,2.1,4.0
4915,418,0,North America,Manufacturing,Regulatory Affairs,Meets,Male,31,16,0,5,15,2.8,3.6,3.4,0.0348,1,1,1,1,3.0,2.2,4.2
4916,240,0,Latin America,Commercial,Data Science,Meets,Female,35,15,0,5,19,4.9,4.0,2.6,0.0422,1,1,1,1,3.8,4.9,4.4
4917,1035,0,Asia Pacific,Finance,Market Access,Below,Male,40,10,0,7,8,4.1,2.5,4.1,0.0,0,0,0,0,3.8,1.4,4.3
4918,349,0,Middle East & Africa,Commercial,Sales,Meets,Male,46,22,0,7,18,4.2,1.0,3.4,0.0422,1,1,1,1,4.5,1.0,2.9
4919,1035,0,Asia Pacific,Finance,Pharmacovigilance,Meets,Male,44,25,0,5,9,2.3,4.1,1.3,0.0331,1,1,1,1,2.1,3.9,1.1
4920,992,1,Europe,Finance,Quality Assurance,Far Exceeds,Female,28,5,0,6,11,2.7,1.3,3.4,0.1022,1,1,1,1,3.9,2.4,2.8
4921,47,0,Asia Pacific,R&D,Finance & Accounting,Meets,Male,52,9,0,6,16,2.9,1.3,5.0,0.0977,1,1,1,1,2.4,2.0,4.2
4922,388,0,North America,Manufacturing,IT & Digital,Exceeds,Female,45,9,1,10,26,0.0,3.5,3.1,0.0616,1,1,1,1,2.3,3.5,1.8
4923,980,0,Latin America,Finance,Legal & Compliance,Meets,Male,38,18,0,7,15,4.7,3.9,2.5,0.0331,1,1,1,1,4.8,3.6,3.3
4924,366,0,Latin America,Manufacturing,Data Science,Meets,Male,46,5,1,11,17,0.0,3.2,2.2,0.0348,1,1,1,1,2.1,3.2,2.9
4925,957,0,North America,Finance,Pharmacovigilance,Below,Non-Binary/Other,32,4,0,8,20,3.2,1.3,2.4,0.0,1,1,1,1,3.8,2.7,1.4
4926,364,0,Europe,Manufacturing,Market Access,Meets,Male,43,18,0,5,13,2.8,1.3,2.4,0.0348,1,1,1,1,3.8,2.3,3.1
4927,233,0,North America,Commercial,Data Science,Meets,Female,28,16,0,12,19,3.3,3.0,2.5,0.0422,1,1,1,1,3.2,3.6,3.3
4928,38,0,Asia Pacific,R&D,Market Access,Exceeds,Female,36,2,0,12,17,3.3,4.5,2.4,0.1648,1,1,1,1,3.8,3.8,3.8
4929,940,0,North America,Finance,IT & Digital,Meets,Female,46,11,0,11,34,2.8,4.4,3.8,0.0331,0,0,0,0,3.5,4.0,3.3
4930,619,0,North America,Digital,Legal & Compliance,Meets,Male,35,21,0,12,23,3.2,3.2,3.1,0.0853,1,1,1,1,3.5,2.5,2.4
4931,448,0,Europe,Manufacturing,Quality Assurance,Exceeds,Female,36,1,1,10,22,0.0,2.7,3.8,0.0616,1,1,1,1,3.4,3.3,2.6
4932,368,0,Asia Pacific,Manufacturing,Clinical Operations,Meets,Female,34,7,1,5,14,0.0,1.2,1.7,0.0348,1,1,1,1,3.1,2.2,2.3
4933,551,0,Middle East & Africa,Digital,Medical Affairs,Meets,Non-Binary/Other,37,36,1,5,17,0.0,2.7,2.6,0.0853,1,1,1,1,3.9,2.0,1.1
4934,61,0,Middle East & Africa,R&D,Medical Affairs,Meets,Female,32,24,0,6,20,3.2,2.3,2.8,0.0977,0,0,0,0,2.2,2.0,3.3
4935,467,0,Latin America,Manufacturing,Marketing,Exceeds,Male,47,5,0,8,45,4.8,4.3,2.2,0.0616,0,0,0,0,4.2,3.5,2.7
4936,100,0,North America,R&D,IT & Digital,Meets,Female,31,11,0,12,25,3.9,3.1,2.4,0.0977,1,1,1,1,4.0,3.4,1.4
4937,513,0,Latin America,Manufacturing,IT & Digital,Below,Female,40,7,1,11,19,0.0,2.6,1.3,0.0,1,1,1,1,4.4,2.8,3.0
4938,862,0,Europe,HR,Regulatory Affairs,Meets,Male,43,16,0,11,18,2.9,2.8,1.7,0.0383,1,1,1,1,2.8,1.7,2.7
4939,451,0,Middle East & Africa,Manufacturing,Supply Chain,Far Exceeds,Female,34,18,1,12,16,0.0,3.0,3.4,0.1069,1,1,1,1,3.1,1.4,2.7
4940,792,0,North America,HR,Sales,Below,Female,29,8,0,8,12,1.6,3.5,3.4,0.0,1,1,1,1,1.3,2.5,1.5
4941,895,0,Europe,Finance,Market Access,Meets,Female,35,24,0,11,25,2.0,4.5,1.4,0.0331,1,1,0,0,1.8,3.1,3.1
4942,80,0,Europe,R&D,Marketing,Meets,Female,36,17,0,11,31,2.6,2.2,2.4,0.0977,1,1,1,1,1.7,3.8,1.0
4943,455,0,North America,Manufacturing,Human Resources,Below,Male,44,23,0,5,8,2.1,1.4,1.7,0.0,1,1,1,1,1.6,2.0,2.2
4944,347,0,Europe,Commercial,Legal & Compliance,Meets,Male,37,7,0,9,32,3.3,2.0,1.9,0.0422,1,1,1,1,2.9,3.2,2.9
4945,317,0,North America,Commercial,Marketing,Exceeds,Male,38,14,0,5,7,3.3,2.9,1.0,0.0743,1,1,1,1,3.9,3.3,2.8
4946,680,0,North America,Digital,Legal & Compliance,Far Below,Male,30,10,0,10,19,4.8,2.6,1.5,0.0,0,0,0,0,4.4,4.2,2.5
4947,299,0,Asia Pacific,Commercial,Legal & Compliance,Meets,Male,37,8,0,12,15,3.6,2.0,1.8,0.0422,1,1,1,1,4.7,2.7,2.0
4948,701,0,Latin America,HR,IT & Digital,Exceeds,Female,47,14,0,10,23,3.4,5.0,2.9,0.0677,1,1,1,1,3.8,4.7,5.0
4949,206,0,Europe,Commercial,Legal & Compliance,Meets,Female,45,14,0,5,16,3.4,4.2,2.9,0.0422,1,1,1,1,2.0,3.2,3.6
4950,340,0,Europe,Commercial,Human Resources,Meets,Male,35,11,0,12,18,3.5,2.3,2.6,0.0422,1,1,1,1,3.6,4.0,2.7
4951,277,0,Asia Pacific,Commercial,Marketing,Exceeds,Male,43,9,1,6,15,0.0,3.1,3.5,0.0743,1,1,1,1,4.5,2.9,2.2
4952,405,0,Asia Pacific,Manufacturing,Market Access,Meets,Female,37,25,0,11,20,3.1,3.9,3.6,0.0348,1,1,1,1,2.4,2.9,4.8
4953,589,0,Asia Pacific,Digital,IT & Digital,Below,Male,41,5,0,10,32,2.6,3.6,3.1,0.0,1,1,1,1,3.3,3.6,2.2
4954,146,0,Middle East & Africa,R&D,Quality Assurance,Meets,Female,36,5,0,6,14,1.8,3.3,3.0,0.0977,1,1,1,1,2.4,3.6,2.1
4955,676,1,Middle East & Africa,Digital,Market Access,Meets,Male,32,6,0,9,15,2.9,2.3,1.3,0.0853,1,1,1,1,3.5,2.8,2.5
4956,748,0,Middle East & Africa,HR,Medical Affairs,Meets,Male,32,14,0,10,14,3.5,3.8,3.4,0.0383,0,0,0,0,4.3,2.8,2.1
4957,361,0,North America,Manufacturing,Market Access,Meets,Female,41,8,0,12,20,4.2,3.7,3.4,0.0348,1,1,1,1,3.9,3.1,4.5
4958,884,0,Europe,Finance,Quality Assurance,Far Exceeds,Female,28,3,1,9,23,0.0,3.1,2.8,0.1022,1,1,1,1,3.3,2.3,1.7
4959,436,0,Latin America,Manufacturing,Pharmacovigilance,Meets,Male,44,3,0,10,15,2.5,2.6,3.7,0.0348,1,1,1,1,2.8,4.2,4.0
4960,354,0,North America,Commercial,Finance & Accounting,Exceeds,Non-Binary/Other,37,11,1,8,49,0.0,3.1,1.9,0.0743,1,1,1,1,4.5,4.1,1.3
4961,286,1,Europe,Commercial,Finance & Accounting,Meets,Male,34,21,1,10,18,0.0,3.1,2.8,0.0422,1,1,1,0,3.3,3.4,2.9
4962,783,0,Europe,HR,Medical Affairs,Below,Male,44,16,0,7,10,2.1,1.0,2.6,0.0,1,1,1,1,2.8,2.3,4.9
4963,1034,0,Asia Pacific,Finance,Clinical Operations,Meets,Female,28,9,0,9,13,2.4,2.1,4.3,0.0331,1,1,0,0,2.6,1.6,4.9
4964,483,0,Asia Pacific,Manufacturing,Data Science,Meets,Female,41,13,0,11,19,3.5,2.5,2.3,0.0348,1,1,1,1,2.8,3.0,1.5
4965,1030,0,North America,Finance,Clinical Operations,Meets,Male,48,9,1,7,24,0.0,2.6,2.4,0.0331,1,1,1,1,4.2,2.1,2.0
4966,147,0,Asia Pacific,R&D,Supply Chain,Meets,Female,30,30,0,6,10,3.8,1.8,2.9,0.0977,1,1,1,1,4.4,3.0,3.7
4967,526,1,Europe,Digital,IT & Digital,Meets,Male,35,8,0,12,23,3.5,1.6,3.6,0.0853,1,1,1,1,4.1,3.3,3.0
4968,434,0,Asia Pacific,Manufacturing,Clinical Operations,Meets,Non-Binary/Other,41,8,0,9,12,4.3,3.1,1.3,0.0348,1,1,1,1,4.3,3.7,1.0
4969,963,0,Middle East & Africa,Finance,Human Resources,Far Exceeds,Female,29,12,1,9,15,0.0,4.0,3.3,0.1022,1,1,1,1,4.9,2.7,3.7
4970,135,0,Asia Pacific,R&D,Medical Affairs,Exceeds,Male,39,17,0,9,12,3.8,2.3,1.5,0.1648,1,1,1,1,3.4,1.0,1.9
4971,89,0,Europe,R&D,Finance & Accounting,Meets,Male,54,16,0,7,8,2.8,3.8,2.9,0.0977,1,1,1,1,3.0,3.0,3.5
4972,539,0,North America,Digital,Legal & Compliance,Meets,Female,40,13,0,10,16,3.6,2.8,1.2,0.0853,1,1,1,1,2.9,2.5,3.1
4973,18,0,Latin America,R&D,Clinical Operations,Far Below,Female,40,10,0,6,10,3.0,4.1,2.2,0.0,1,1,1,1,3.8,2.8,3.5
4974,850,0,Asia Pacific,HR,Finance & Accounting,Below,Female,31,7,0,10,20,3.5,3.4,3.1,0.0,1,1,1,1,3.3,3.9,3.7
4975,172,0,Europe,R&D,Finance & Accounting,Below,Female,46,8,1,12,27,0.0,2.7,2.2,0.0,1,1,1,1,3.4,2.8,2.6
4976,921,0,Latin America,Finance,Regulatory Affairs,Meets,Male,28,22,0,7,23,3.2,5.0,3.8,0.0331,0,0,0,0,3.7,4.2,3.7
4977,761,0,Latin America,HR,Human Resources,Below,Female,38,24,0,12,19,3.5,2.7,3.3,0.0,1,1,1,1,3.9,3.3,3.2
4978,23,0,Middle East & Africa,R&D,Communications,Meets,Female,43,15,0,5,10,4.9,3.2,2.3,0.0977,1,1,1,1,3.3,4.2,2.6
4979,301,0,Latin America,Commercial,Legal & Compliance,Meets,Male,28,12,0,10,15,3.8,3.9,3.8,0.0422,1,1,1,1,4.1,3.8,3.1
4980,84,0,Europe,R&D,Clinical Operations,Meets,Female,28,27,0,11,22,3.5,2.3,3.5,0.0977,1,1,1,1,5.0,3.0,2.6
4981,765,0,Europe,HR,Finance & Accounting,Exceeds,Male,29,26,0,12,16,3.3,1.9,3.6,0.0677,1,1,1,1,3.4,2.0,3.4
4982,176,0,Asia Pacific,R&D,Sales,Far Exceeds,Male,46,8,0,8,26,4.4,3.4,3.5,0.2644,1,1,1,1,5.0,2.7,3.8
4983,68,0,Asia Pacific,R&D,Supply Chain,Meets,Female,34,2,1,7,15,0.0,3.4,1.6,0.0977,1,1,1,1,1.8,4.0,1.0
4984,174,0,Asia Pacific,R&D,Data Science,Meets,Female,43,3,1,7,24,0.0,2.5,2.9,0.0977,1,1,1,1,3.8,3.6,1.7
4985,734,0,Latin America,HR,Legal & Compliance,Meets,Female,42,12,1,9,19,0.0,3.5,3.2,0.0383,1,1,1,1,2.7,3.7,3.0
4986,111,0,Latin America,R&D,Quality Assurance,Meets,Male,28,13,0,11,15,3.7,3.7,3.9,0.0977,1,1,1,1,4.4,4.7,3.4
4987,601,0,Middle East & Africa,Digital,Legal & Compliance,Meets,Male,36,7,1,8,15,0.0,2.2,1.7,0.0853,1,1,1,1,2.4,1.6,1.6
4988,916,0,Asia Pacific,Finance,Communications,Below,Male,37,7,0,10,12,2.5,4.0,4.0,0.0,1,1,1,1,2.7,4.4,5.0
4989,589,1,North America,Digital,Sales,Meets,Male,41,14,1,5,21,0.0,2.1,3.0,0.0853,1,1,1,1,3.0,2.6,3.7
4990,813,0,Middle East & Africa,HR,Sales,Meets,Non-Binary/Other,39,20,0,12,22,4.2,3.8,2.0,0.0383,1,1,1,0,4.7,2.8,1.0
4991,314,0,North America,Commercial,Finance & Accounting,Meets,Male,38,5,0,12,17,4.0,4.7,2.2,0.0422,1,1,1,1,4.6,3.1,2.0
4992,688,0,Latin America,Digital,Sales,Meets,Female,45,5,1,8,17,0.0,3.4,4.7,0.0853,1,0,0,0,2.6,2.5,3.6
4993,942,0,Middle East & Africa,Finance,Quality Assurance,Meets,Female,45,10,1,6,11,0.0,2.5,1.6,0.0331,1,1,1,1,3.8,2.0,3.1
4994,441,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Meets,Female,29,7,1,6,10,0.0,4.2,2.4,0.0348,1,1,1,1,3.1,3.8,2.4
4995,920,0,Europe,Finance,Regulatory Affairs,Far Below,Female,35,8,0,8,14,3.4,3.1,2.3,0.0,1,1,1,1,3.4,4.9,1.7
4996,565,0,Latin America,Digital,Communications,Meets,Female,38,23,0,7,11,2.8,3.3,3.2,0.0853,1,1,1,1,2.1,3.2,2.8
4997,449,0,Latin America,Manufacturing,Legal & Compliance,Meets,Female,39,4,1,11,20,0.0,4.2,2.1,0.0348,1,1,1,1,3.6,3.1,3.2
4998,754,0,Middle East & Africa,HR,IT & Digital,Below,Male,41,36,0,8,15,2.1,5.0,3.6,0.0,1,1,1,1,2.7,4.5,3.6
4999,943,0,Latin America,Finance,Quality Assurance,Below,Non-Binary/Other,40,28,0,7,33,3.5,3.9,4.2,0.0,1,1,1,1,4.2,4.6,3.8
5000,232,0,Middle East & Africa,Commercial,Pharmacovigilance,Exceeds,Female,42,22,0,10,32,3.0,3.6,1.0,0.0743,0,0,0,0,3.0,2.5,1.8
5001,359,0,Europe,Manufacturing,Human Resources,Meets,Male,42,5,1,8,36,0.0,2.4,1.1,0.0348,1,1,1,1,4.8,2.5,1.4
5002,430,0,Middle East & Africa,Manufacturing,IT & Digital,Exceeds,Female,36,3,0,8,11,3.7,3.2,4.0,0.0616,1,0,0,0,3.1,2.5,3.0
5003,1009,0,Latin America,Finance,Market Access,Exceeds,Female,36,14,0,7,20,2.7,4.0,2.8,0.0588,0,0,0,0,1.7,3.9,1.1
5004,680,0,Latin America,Digital,Market Access,Exceeds,Female,46,10,0,8,20,2.7,3.3,4.2,0.1452,1,1,1,1,2.0,2.9,4.2
5005,432,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Far Below,Male,35,3,0,12,16,3.3,4.7,3.3,0.0,1,1,1,1,2.9,4.5,3.1
5006,712,0,Middle East & Africa,HR,Medical Affairs,Below,Female,42,4,0,11,19,4.2,5.0,2.5,0.0,1,1,1,1,5.0,4.5,2.3
5007,980,0,Middle East & Africa,Finance,Quality Assurance,Meets,Male,33,11,0,6,8,2.8,4.6,1.0,0.0331,0,0,0,0,2.9,4.0,1.6
5008,833,0,Asia Pacific,HR,Regulatory Affairs,Below,Male,40,17,0,5,10,3.0,3.9,1.2,0.0,1,1,1,1,2.7,4.1,2.2
5009,1016,0,Latin America,Finance,Medical Affairs,Meets,Female,40,20,0,12,17,3.7,2.4,3.7,0.0331,1,1,1,1,3.9,3.8,1.2
5010,799,0,Latin America,HR,Market Access,Meets,Female,42,9,1,8,11,0.0,2.5,3.9,0.0383,1,1,1,1,5.0,3.1,2.9
5011,664,1,Asia Pacific,Digital,Finance & Accounting,Far Exceeds,Female,48,14,0,7,22,3.5,3.0,2.8,0.2363,1,1,1,1,4.3,4.6,3.6
5012,986,0,Middle East & Africa,Finance,Finance & Accounting,Exceeds,Female,32,13,0,6,24,1.6,2.1,1.2,0.0588,1,1,1,1,2.4,2.5,1.0
5013,332,0,Europe,Commercial,Clinical Operations,Meets,Female,39,11,1,10,27,0.0,3.1,4.4,0.0422,1,1,1,1,4.4,3.2,3.2
5014,523,0,Middle East & Africa,Digital,Regulatory Affairs,Meets,Female,42,13,1,6,12,0.0,2.6,4.8,0.0853,1,0,0,0,3.6,3.2,3.4
5015,865,0,Middle East & Africa,HR,Supply Chain,Meets,Male,42,6,1,11,24,0.0,3.5,3.9,0.0383,1,1,1,1,3.1,2.6,4.0
5016,887,0,Asia Pacific,Finance,Clinical Operations,Meets,Male,36,14,0,11,23,4.5,2.8,3.3,0.0331,1,1,1,1,5.0,4.8,2.2
5017,560,0,Latin America,Digital,IT & Digital,Exceeds,Female,40,15,0,11,15,3.4,3.8,3.3,0.1452,1,1,1,1,3.5,4.7,1.2
5018,804,0,Middle East & Africa,HR,Clinical Operations,Far Below,Male,38,8,1,8,18,0.0,2.1,1.0,0.0,1,1,1,0,3.7,3.4,1.0
5019,70,0,Latin America,R&D,Regulatory Affairs,Meets,Male,42,12,0,11,13,3.1,1.8,4.4,0.0977,1,1,1,1,2.8,2.6,2.9
5020,80,0,North America,R&D,Medical Affairs,Exceeds,Female,38,12,0,11,19,3.1,2.8,4.6,0.1648,0,0,0,0,2.6,1.9,4.8
5021,496,0,Latin America,Manufacturing,Supply Chain,Below,Female,38,6,0,9,19,2.8,4.0,4.1,0.0,1,1,1,0,3.1,2.7,4.7
5022,286,0,Europe,Commercial,Medical Affairs,Far Exceeds,Male,40,12,1,11,15,0.0,3.5,1.1,0.1275,1,1,1,1,2.6,2.3,1.7
5023,173,0,Europe,R&D,Sales,Far Below,Female,35,16,0,6,13,3.0,3.2,3.9,0.0,1,1,1,1,4.3,2.8,4.9
5024,788,0,Middle East & Africa,HR,Medical Affairs,Exceeds,Male,33,6,0,12,17,3.7,4.0,2.4,0.0677,1,1,1,1,3.8,2.8,2.4
5025,694,0,Latin America,Digital,Medical Affairs,Meets,Male,30,10,0,7,10,3.1,3.7,2.7,0.0853,1,1,1,0,3.1,4.6,3.6
5026,989,0,Middle East & Africa,Finance,Pharmacovigilance,Below,Male,37,10,1,10,16,0.0,4.6,1.2,0.0,0,0,0,0,3.5,3.6,4.2
5027,631,0,Asia Pacific,Digital,Communications,Below,Male,34,5,0,6,16,3.6,2.9,1.0,0.0,1,1,1,1,4.5,3.3,2.8
5028,409,0,Europe,Manufacturing,Marketing,Meets,Female,36,12,0,9,29,3.3,3.7,1.0,0.0348,1,0,0,0,3.4,3.0,2.6
5029,540,0,Middle East & Africa,Digital,IT & Digital,Exceeds,Male,45,9,0,7,16,5.0,4.1,2.3,0.1452,1,1,1,1,4.2,2.5,2.4
5030,164,0,Asia Pacific,R&D,Data Science,Meets,Female,36,12,0,10,28,2.8,2.6,1.0,0.0977,1,0,0,0,5.0,2.5,1.7
5031,570,0,Middle East & Africa,Digital,Marketing,Exceeds,Female,46,5,0,9,19,2.9,3.6,1.8,0.1452,1,1,1,1,2.6,2.9,1.3
5032,126,0,Latin America,R&D,Finance & Accounting,Exceeds,Male,40,3,0,6,17,2.4,4.2,2.6,0.1648,1,1,1,1,2.8,1.6,2.2
5033,127,0,Latin America,R&D,Supply Chain,Far Below,Male,36,8,1,12,15,0.0,3.5,2.5,0.0,1,1,1,1,2.3,2.6,1.4
5034,201,0,Latin America,Commercial,Supply Chain,Meets,Male,32,1,1,9,14,0.0,1.9,2.5,0.0422,1,1,1,1,4.6,2.1,1.9
5035,444,0,Latin America,Manufacturing,Quality Assurance,Meets,Female,37,6,1,12,26,0.0,3.9,2.4,0.0348,1,1,1,1,3.5,4.3,1.5
5036,859,0,North America,HR,Finance & Accounting,Meets,Male,36,16,0,5,13,5.0,3.9,2.4,0.0383,1,1,1,1,5.0,3.3,2.6
5037,126,0,Asia Pacific,R&D,Medical Affairs,Below,Female,45,15,0,8,23,2.9,1.6,2.1,0.0,1,1,1,1,3.8,2.1,1.9
5038,993,0,Asia Pacific,Finance,Clinical Operations,Meets,Male,50,6,0,12,36,2.2,3.4,2.5,0.0331,1,1,1,1,1.8,4.1,3.6
5039,428,0,Latin America,Manufacturing,Marketing,Meets,Female,44,18,0,10,20,3.1,3.8,3.1,0.0348,0,0,0,0,2.8,2.0,2.5
5040,744,0,North America,HR,Quality Assurance,Meets,Female,34,22,0,8,33,2.0,4.1,1.4,0.0383,1,1,1,1,1.5,2.5,4.4
5041,919,0,Latin America,Finance,Sales,Meets,Female,38,7,0,10,22,3.7,2.9,3.8,0.0331,1,1,1,1,2.9,2.6,3.5
5042,629,1,North America,Digital,Finance & Accounting,Exceeds,Female,37,3,0,5,17,2.1,3.3,2.2,0.1452,1,1,1,1,1.3,3.5,3.4
5043,417,0,Latin America,Manufacturing,Data Science,Far Below,Female,34,10,0,12,26,3.0,1.3,1.2,0.0,1,1,1,1,3.2,1.6,2.6
5044,1025,1,Europe,Finance,Medical Affairs,Meets,Female,37,27,0,9,20,2.6,4.1,3.0,0.0331,1,1,0,0,3.8,2.1,3.9
5045,440,0,Europe,Manufacturing,Quality Assurance,Meets,Female,37,12,0,11,34,3.1,2.5,3.9,0.0348,1,1,1,1,3.1,4.0,3.7
5046,425,0,Middle East & Africa,Manufacturing,Marketing,Far Below,Female,49,36,0,12,24,2.5,3.6,1.0,0.0,1,0,0,0,3.5,3.9,3.0
5047,634,1,Latin America,Digital,Finance & Accounting,Meets,Female,40,18,0,5,9,2.6,2.0,1.0,0.0853,1,1,1,1,2.9,3.0,1.3
5048,630,0,Asia Pacific,Digital,Communications,Meets,Male,43,5,0,11,13,3.4,3.6,4.1,0.0853,1,1,1,1,3.6,1.8,3.9
5049,397,0,Middle East & Africa,Manufacturing,Finance & Accounting,Meets,Male,44,10,0,7,12,3.8,3.3,1.3,0.0348,0,0,0,0,2.7,3.9,1.1
5050,922,0,Europe,Finance,Sales,Below,Male,43,13,0,12,26,2.1,2.9,1.3,0.0,1,1,1,1,2.9,2.7,2.0
5051,332,0,Latin America,Commercial,Finance & Accounting,Meets,Female,46,4,0,11,22,4.3,1.0,3.3,0.0422,1,1,1,1,4.2,1.7,3.2
5052,140,0,Middle East & Africa,R&D,Pharmacovigilance,Meets,Male,36,7,0,5,23,3.0,2.2,1.1,0.0977,1,1,1,1,3.3,3.9,1.8
5053,546,0,Latin America,Digital,Market Access,Meets,Female,44,25,0,6,27,3.2,3.3,3.2,0.0853,1,1,1,1,3.1,3.3,2.2
5054,354,0,Europe,Commercial,Data Science,Below,Male,50,15,0,7,10,3.5,2.0,3.1,0.0,1,1,1,1,4.3,2.7,4.7
5055,659,0,Middle East & Africa,Digital,Supply Chain,Exceeds,Male,34,2,1,11,18,0.0,3.0,1.0,0.1452,0,0,0,0,3.2,4.0,1.0
5056,459,0,Europe,Manufacturing,Pharmacovigilance,Exceeds,Male,36,19,0,5,17,4.5,2.5,1.0,0.0616,1,1,1,1,4.3,2.8,3.3
5057,352,0,North America,Commercial,Human Resources,Meets,Male,36,10,1,5,14,0.0,4.1,1.4,0.0422,1,1,1,1,3.9,2.5,2.0
5058,922,0,Europe,Finance,Finance & Accounting,Meets,Female,51,15,0,11,16,2.2,1.5,4.1,0.0331,1,1,1,1,3.6,1.5,3.2
5059,1011,0,Latin America,Finance,Human Resources,Below,Male,32,16,0,10,22,4.8,2.6,2.1,0.0,1,1,1,1,3.8,1.7,1.8
5060,878,0,Asia Pacific,HR,IT & Digital,Exceeds,Male,39,13,0,5,26,5.0,2.9,1.7,0.0677,1,1,1,1,5.0,3.8,1.8
5061,149,0,Europe,R&D,Medical Affairs,Below,Female,41,7,1,10,16,0.0,4.3,1.6,0.0,1,1,1,1,3.0,3.8,1.0
5062,50,0,Asia Pacific,R&D,Market Access,Far Below,Male,35,9,0,9,14,3.9,3.6,3.2,0.0,1,1,1,1,4.6,1.0,2.0
5063,528,0,North America,Digital,Market Access,Meets,Male,32,11,0,6,10,5.0,4.0,2.8,0.0853,1,1,1,0,4.6,3.2,2.7
5064,153,0,Middle East & Africa,R&D,Data Science,Meets,Female,33,7,0,11,11,3.5,2.7,2.0,0.0977,0,0,0,0,3.4,2.2,2.2
5065,812,0,Middle East & Africa,HR,Clinical Operations,Meets,Male,36,11,0,12,28,3.6,3.0,1.0,0.0383,1,1,1,1,3.3,3.5,2.8
5066,1050,0,Asia Pacific,Finance,Pharmacovigilance,Below,Male,35,8,0,5,30,4.3,3.0,3.0,0.0,1,1,1,1,3.0,4.8,2.7
5067,275,0,Middle East & Africa,Commercial,Finance & Accounting,Meets,Male,47,6,0,10,20,4.4,3.2,1.8,0.0422,0,0,0,0,4.0,3.1,3.6
5068,232,0,Europe,Commercial,Clinical Operations,Meets,Female,35,13,0,9,13,3.9,3.9,2.9,0.0422,1,1,1,1,2.5,4.9,2.8
5069,1009,0,Asia Pacific,Finance,Regulatory Affairs,Meets,Male,35,26,0,8,20,2.1,3.7,1.0,0.0331,0,0,0,0,2.4,4.0,1.7
5070,468,0,Latin America,Manufacturing,Pharmacovigilance,Meets,Male,40,9,0,6,22,2.3,4.8,4.1,0.0348,1,1,1,1,2.8,3.8,1.7
5071,1013,0,Europe,Finance,Sales,Meets,Male,40,8,0,9,12,3.1,4.0,2.3,0.0331,1,1,1,1,2.3,4.5,2.3
5072,320,0,Europe,Commercial,Medical Affairs,Meets,Male,28,16,0,6,16,4.5,3.2,3.2,0.0422,1,1,1,1,2.8,2.7,4.1
5073,662,0,Europe,Digital,Pharmacovigilance,Meets,Male,33,10,0,9,19,2.3,2.4,3.4,0.0853,1,1,1,1,2.8,4.3,5.0
5074,847,0,Latin America,HR,Pharmacovigilance,Meets,Male,35,9,1,12,16,0.0,3.7,1.0,0.0383,1,1,1,1,2.2,3.3,1.8
5075,935,0,North America,Finance,Regulatory Affairs,Meets,Female,32,13,0,10,28,4.2,1.4,1.4,0.0331,1,1,1,1,2.2,3.4,2.6
5076,412,0,Middle East & Africa,Manufacturing,Data Science,Meets,Male,44,17,0,10,24,2.6,2.4,2.7,0.0348,1,1,1,1,3.4,3.9,3.5
5077,608,0,Asia Pacific,Digital,IT & Digital,Far Below,Female,29,13,0,7,12,2.9,3.3,1.0,0.0,0,0,0,0,3.4,1.3,1.0
5078,1037,0,North America,Finance,Data Science,Meets,Female,44,17,0,11,14,2.0,4.2,1.2,0.0331,1,1,1,1,2.9,2.7,1.9
5079,531,0,Asia Pacific,Digital,Sales,Meets,Female,28,9,0,11,20,2.7,2.9,3.7,0.0853,1,1,1,1,3.1,3.5,3.3
5080,1003,0,Middle East & Africa,Finance,Finance & Accounting,Meets,Female,38,33,0,5,18,2.5,3.4,3.1,0.0331,1,1,1,1,3.3,4.5,4.0
5081,597,0,Latin America,Digital,Data Science,Below,Female,47,15,0,6,15,3.2,2.6,3.0,0.0,1,1,1,1,2.9,3.6,4.3
5082,5,1,Europe,R&D,Market Access,Exceeds,Female,34,11,0,7,17,2.4,5.0,3.8,0.1648,1,1,1,1,2.9,3.3,3.2
5083,533,1,Europe,Digital,Marketing,Meets,Male,38,9,0,12,28,4.2,4.0,4.1,0.0853,1,1,1,1,5.0,2.4,2.9
5084,36,0,Latin America,R&D,Regulatory Affairs,Meets,Male,44,9,1,5,18,0.0,3.3,4.0,0.0977,1,1,1,1,3.3,3.2,3.6
5085,339,0,North America,Commercial,Marketing,Far Below,Male,44,13,0,12,15,2.9,3.9,2.5,0.0,1,1,1,1,2.6,3.7,3.7
5086,5,0,North America,R&D,Marketing,Meets,Male,40,2,0,7,10,2.7,2.7,1.0,0.0977,1,1,1,1,3.7,4.3,2.8
5087,640,0,Asia Pacific,Digital,Regulatory Affairs,Meets,Female,37,6,1,12,14,0.0,2.7,1.6,0.0853,1,1,1,1,3.3,2.3,2.9
5088,775,0,Latin America,HR,Marketing,Exceeds,Female,37,11,1,8,17,0.0,4.0,2.2,0.0677,1,1,1,1,4.0,3.6,3.1
5089,777,0,North America,HR,Marketing,Meets,Male,30,10,1,10,14,0.0,3.8,3.3,0.0383,1,1,1,1,2.9,2.3,4.4
5090,235,0,Latin America,Commercial,Marketing,Meets,Female,32,4,0,7,36,3.8,3.7,1.0,0.0422,1,1,1,1,2.8,3.5,2.5
5091,626,0,Middle East & Africa,Digital,IT & Digital,Meets,Male,38,3,0,10,11,2.4,1.9,3.3,0.0853,1,1,1,1,2.7,2.7,3.3
5092,127,0,Europe,R&D,Finance & Accounting,Meets,Female,40,14,0,10,25,4.3,3.8,2.7,0.0977,1,1,1,1,4.0,3.9,4.3
5093,766,0,Europe,HR,Legal & Compliance,Exceeds,Female,53,17,0,11,15,3.5,4.0,2.4,0.0677,1,1,0,0,4.2,2.2,1.8
5094,902,0,Europe,Finance,Sales,Meets,Male,43,10,0,9,41,3.5,3.9,5.0,0.0331,1,1,1,1,2.8,4.2,3.8
5095,388,0,Latin America,Manufacturing,Supply Chain,Meets,Female,36,10,0,10,23,3.8,4.0,1.6,0.0348,1,1,1,1,4.1,3.1,2.6
5096,622,0,Latin America,Digital,Finance & Accounting,Below,Female,41,19,1,12,16,0.0,3.4,3.4,0.0,1,1,1,1,4.2,3.6,2.4
5097,1045,0,Asia Pacific,Finance,Communications,Meets,Female,28,12,0,7,25,4.7,4.6,2.0,0.0331,0,0,0,0,5.0,5.0,2.1
5098,1003,0,Europe,Finance,IT & Digital,Below,Male,39,3,1,10,14,0.0,4.3,3.6,0.0,1,1,1,1,4.0,4.1,2.4
5099,549,0,Asia Pacific,Digital,Sales,Meets,Female,42,15,0,9,18,2.4,3.3,1.0,0.0853,1,1,1,1,3.4,2.5,1.8
5100,360,0,Europe,Manufacturing,Human Resources,Meets,Female,42,4,1,5,12,0.0,2.1,2.3,0.0348,1,1,1,1,4.4,2.6,3.8
5101,858,0,Asia Pacific,HR,Clinical Operations,Far Below,Female,38,23,0,6,16,3.2,3.4,2.5,0.0,1,1,1,1,2.8,2.7,3.0
5102,460,1,Asia Pacific,Manufacturing,IT & Digital,Meets,Male,41,9,0,12,13,4.4,3.0,3.4,0.0348,1,1,1,1,3.9,4.0,1.4
5103,196,0,Middle East & Africa,Commercial,Pharmacovigilance,Meets,Male,36,27,0,7,18,1.5,4.2,2.2,0.0422,1,1,1,1,1.7,2.6,3.1
5104,81,0,Asia Pacific,R&D,Data Science,Meets,Female,40,5,0,6,27,3.5,2.4,3.3,0.0977,1,1,1,1,2.8,3.9,2.2
5105,96,0,Latin America,R&D,Regulatory Affairs,Far Below,Male,32,7,0,11,14,2.2,1.8,1.0,0.0,1,1,1,1,2.7,3.3,2.3
5106,1005,0,Asia Pacific,Finance,Market Access,Meets,Male,31,9,1,11,42,0.0,1.2,2.7,0.0331,1,0,0,0,3.8,1.7,2.2
5107,735,0,Europe,HR,Marketing,Meets,Male,46,4,1,6,20,0.0,4.3,2.4,0.0383,1,1,1,1,4.3,4.4,3.1
5108,520,0,Asia Pacific,Manufacturing,Quality Assurance,Meets,Male,37,25,0,10,14,2.4,4.4,3.3,0.0348,1,1,1,1,2.8,2.7,2.6
5109,977,1,North America,Finance,Regulatory Affairs,Meets,Male,41,4,0,5,17,1.7,5.0,4.3,0.0331,1,1,1,1,1.8,4.6,3.8
5110,629,0,Europe,Digital,Medical Affairs,Exceeds,Male,33,6,1,8,13,0.0,5.0,2.5,0.1452,1,1,1,1,3.9,3.3,2.3
5111,989,0,North America,Finance,Regulatory Affairs,Far Below,Male,31,9,0,10,12,3.5,4.7,3.0,0.0,1,1,1,1,4.3,5.0,2.9
5112,599,0,Europe,Digital,IT & Digital,Meets,Female,35,12,0,5,32,3.7,3.9,1.6,0.0853,1,1,1,0,3.3,3.0,2.7
5113,592,0,Latin America,Digital,IT & Digital,Meets,Female,41,16,0,10,19,3.1,2.7,1.5,0.0853,0,0,0,0,2.1,4.0,2.9
5114,200,0,Latin America,Commercial,Pharmacovigilance,Exceeds,Male,28,16,1,8,12,0.0,2.5,3.0,0.0743,1,1,1,1,3.2,2.8,2.8
5115,353,0,Latin America,Commercial,Market Access,Meets,Female,39,22,0,11,20,3.7,3.1,3.1,0.0422,1,1,1,1,3.3,2.9,3.6
5116,662,0,North America,Digital,Finance & Accounting,Meets,Male,42,29,0,6,10,5.0,4.1,1.4,0.0853,1,1,1,1,5.0,3.5,2.4
5117,852,0,Middle East & Africa,HR,Communications,Below,Male,33,16,0,9,12,3.6,2.2,2.1,0.0,1,1,1,1,5.0,3.9,2.8
5118,204,1,Europe,Commercial,Regulatory Affairs,Exceeds,Male,39,6,0,5,10,2.4,2.1,2.3,0.0743,1,1,1,1,3.6,2.3,2.3
5119,258,0,Latin America,Commercial,Market Access,Meets,Female,39,5,1,9,22,0.0,3.6,2.9,0.0422,1,1,1,1,3.2,4.1,1.9
5120,1,1,Europe,R&D,Regulatory Affairs,Meets,Female,33,20,0,8,21,3.1,2.1,3.6,0.0977,1,1,1,1,4.2,2.0,2.5
5121,980,0,North America,Finance,Legal & Compliance,Below,Male,37,17,0,12,23,3.9,1.6,2.0,0.0,1,1,1,1,3.9,1.7,2.9
5122,164,0,Middle East & Africa,R&D,Finance & Accounting,Exceeds,Female,38,5,0,9,46,2.6,3.0,1.8,0.1648,1,1,1,1,2.0,3.4,2.2
5123,851,0,North America,HR,Sales,Meets,Female,33,11,0,12,16,2.6,3.9,3.1,0.0383,1,1,1,1,2.4,5.0,4.1
5124,330,0,Europe,Commercial,IT & Digital,Below,Male,36,6,1,6,11,0.0,2.4,1.4,0.0,1,1,1,1,2.9,2.1,2.4
5125,254,0,Middle East & Africa,Commercial,Sales,Below,Female,38,7,0,5,14,2.4,1.9,3.0,0.0,1,1,1,1,2.8,4.0,3.8
5126,366,0,Middle East & Africa,Manufacturing,IT & Digital,Meets,Male,40,15,0,10,11,3.9,1.9,2.2,0.0348,1,1,1,1,3.9,1.5,3.5
5127,699,0,North America,HR,Supply Chain,Meets,Female,49,5,0,9,10,2.9,3.2,5.0,0.0383,1,1,1,1,2.9,1.0,3.8
5128,891,0,Latin America,Finance,Clinical Operations,Meets,Female,32,10,0,9,31,3.9,3.0,2.4,0.0331,1,1,1,1,2.5,1.5,1.6
5129,884,0,Europe,Finance,IT & Digital,Far Exceeds,Female,46,30,0,5,14,2.9,2.6,2.6,0.1022,1,1,1,1,3.3,2.9,1.6
5130,1040,0,Asia Pacific,Finance,Regulatory Affairs,Meets,Female,33,20,0,9,29,2.0,2.8,2.6,0.0331,1,1,1,0,4.0,3.4,1.3
5131,811,0,Asia Pacific,HR,Human Resources,Exceeds,Female,38,17,0,10,27,5.0,3.4,4.2,0.0677,1,1,1,1,3.8,5.0,2.8
5132,465,0,North America,Manufacturing,Human Resources,Meets,Male,44,18,0,12,18,2.9,3.1,3.5,0.0348,1,1,1,0,3.5,2.5,4.1
5133,377,0,Europe,Manufacturing,Marketing,Meets,Male,41,30,0,6,22,4.0,2.5,3.1,0.0348,1,1,1,1,5.0,3.2,3.8
5134,163,0,Europe,R&D,Regulatory Affairs,Meets,Female,28,14,0,11,25,3.2,4.2,3.2,0.0977,1,1,1,1,5.0,3.5,2.6
5135,804,0,North America,HR,Medical Affairs,Meets,Male,45,10,1,11,16,0.0,4.3,1.1,0.0383,1,1,1,1,3.6,2.9,2.9
5136,849,0,Europe,HR,Market Access,Meets,Male,40,8,1,6,9,0.0,2.3,2.9,0.0383,1,1,1,1,4.3,1.5,3.0
5137,410,0,Latin America,Manufacturing,Marketing,Meets,Male,35,20,0,9,20,4.9,1.9,3.4,0.0348,1,1,1,1,3.6,3.4,3.1
5138,558,0,North America,Digital,Finance & Accounting,Far Exceeds,Male,37,8,1,7,11,0.0,3.0,2.5,0.2363,1,1,1,1,3.6,3.5,4.2
5139,696,0,Latin America,Digital,IT & Digital,Meets,Male,41,15,0,8,17,2.7,3.5,3.7,0.0853,1,1,1,1,2.4,2.9,3.6
5140,9,0,Europe,R&D,Supply Chain,Exceeds,Female,42,15,0,8,15,2.8,3.1,3.0,0.1648,1,1,1,1,3.0,3.7,3.6
5141,581,0,North America,Digital,Market Access,Meets,Male,41,9,1,12,14,0.0,5.0,3.5,0.0853,1,0,0,0,5.0,5.0,3.8
5142,636,0,Europe,Digital,Sales,Meets,Female,34,9,0,8,12,2.2,3.3,3.1,0.0853,1,1,1,1,4.1,4.1,4.4
5143,642,0,North America,Digital,Quality Assurance,Meets,Male,38,13,0,5,13,2.9,3.3,4.0,0.0853,1,1,0,0,4.2,1.7,3.8
5144,225,0,Europe,Commercial,Marketing,Meets,Female,33,2,1,9,13,0.0,3.6,3.3,0.0422,1,1,1,1,3.1,4.3,3.1
5145,116,0,Latin America,R&D,Sales,Below,Male,43,16,0,6,9,2.4,3.3,1.0,0.0,0,0,0,0,3.6,2.8,1.9
5146,368,0,Latin America,Manufacturing,Medical Affairs,Meets,Female,37,6,1,7,16,0.0,3.3,3.6,0.0348,1,1,1,1,4.3,4.7,2.4
5147,597,0,Europe,Digital,Marketing,Exceeds,Male,41,7,0,6,18,4.7,1.7,3.9,0.1452,1,0,0,0,4.4,2.2,4.0
5148,1046,0,North America,Finance,Marketing,Meets,Female,35,16,0,10,12,3.6,2.8,2.3,0.0331,1,1,1,1,2.3,3.3,2.3
5149,224,0,Asia Pacific,Commercial,Marketing,Exceeds,Male,39,10,0,11,21,3.5,2.9,2.7,0.0743,1,1,1,1,3.2,3.2,3.2
5150,534,0,Latin America,Digital,Clinical Operations,Meets,Female,37,13,0,7,17,2.6,3.6,3.4,0.0853,0,0,0,0,2.4,3.4,4.0
5151,303,0,Latin America,Commercial,Marketing,Meets,Male,31,26,0,5,26,4.5,4.4,2.8,0.0422,1,1,1,1,3.6,4.6,3.8
5152,129,0,Asia Pacific,R&D,Clinical Operations,Meets,Male,45,22,0,11,17,1.8,3.3,2.9,0.0977,1,1,1,0,1.3,4.9,4.2
5153,1021,0,Europe,Finance,Sales,Below,Male,42,12,0,10,16,3.4,2.6,5.0,0.0,1,1,1,1,2.5,3.8,4.3
5154,972,0,North America,Finance,Supply Chain,Below,Female,30,14,0,6,17,3.5,1.7,2.7,0.0,1,1,0,0,2.2,2.5,4.0
5155,908,0,Europe,Finance,Clinical Operations,Meets,Male,33,18,1,9,25,0.0,4.8,2.7,0.0331,1,0,0,0,3.6,4.7,2.9
5156,592,0,Middle East & Africa,Digital,Finance & Accounting,Far Below,Female,34,6,0,12,19,4.1,2.7,2.5,0.0,1,1,1,1,5.0,5.0,3.9
5157,204,0,Latin America,Commercial,Clinical Operations,Below,Non-Binary/Other,46,27,0,12,17,3.6,4.0,2.9,0.0,1,1,1,1,2.4,2.8,1.3
5158,993,0,Middle East & Africa,Finance,Finance & Accounting,Below,Male,43,13,0,10,18,3.1,3.4,2.1,0.0,0,0,0,0,3.6,4.2,2.3
5159,749,0,Latin America,HR,Finance & Accounting,Far Below,Non-Binary/Other,39,6,0,12,22,3.4,4.3,3.5,0.0,1,1,1,1,2.9,4.6,3.0
5160,756,0,Latin America,HR,Communications,Below,Male,29,16,0,9,11,3.0,1.6,1.0,0.0,1,1,1,1,3.7,1.3,2.8
5161,303,0,Middle East & Africa,Commercial,Marketing,Meets,Female,41,1,1,9,16,0.0,2.0,3.1,0.0422,0,0,0,0,4.1,3.5,1.7
5162,542,0,Middle East & Africa,Digital,Communications,Exceeds,Non-Binary/Other,39,24,0,6,14,3.6,2.3,3.3,0.1452,1,1,1,1,3.3,4.8,4.8
5163,660,0,Europe,Digital,Supply Chain,Below,Non-Binary/Other,36,12,1,7,25,0.0,5.0,2.3,0.0,1,1,1,0,3.7,5.0,3.7
5164,158,0,Middle East & Africa,R&D,Marketing,Below,Male,46,16,0,12,22,2.6,2.1,1.7,0.0,1,1,1,1,2.4,2.1,3.1
5165,96,0,Europe,R&D,Sales,Meets,Female,37,21,0,7,21,3.2,2.6,3.4,0.0977,1,0,0,0,3.8,3.0,2.9
5166,890,0,Europe,Finance,Marketing,Far Below,Male,45,8,1,7,16,0.0,2.7,4.4,0.0,1,1,1,1,4.3,2.7,2.0
5167,360,0,Europe,Manufacturing,Finance & Accounting,Meets,Male,36,16,0,8,14,4.0,4.0,1.0,0.0348,0,0,0,0,5.0,4.3,2.6
5168,110,0,Latin America,R&D,Legal & Compliance,Below,Male,33,8,0,8,12,2.5,5.0,3.6,0.0,1,1,1,1,3.0,5.0,3.2
5169,581,0,Latin America,Digital,Data Science,Meets,Male,31,13,0,10,25,3.8,4.0,3.9,0.0853,1,1,1,1,4.3,4.9,1.9
5170,414,0,Middle East & Africa,Manufacturing,Pharmacovigilance,Below,Female,38,14,1,8,14,0.0,3.0,1.6,0.0,0,0,0,0,3.4,2.6,2.8
5171,129,0,Latin America,R&D,Communications,Meets,Male,38,11,0,11,20,3.2,1.5,4.2,0.0977,1,1,1,0,3.6,2.3,4.5
5172,247,0,Middle East & Africa,Commercial,Sales,Meets,Non-Binary/Other,32,4,0,6,9,2.5,3.9,2.7,0.0422,1,1,1,1,3.0,3.5,3.3
5173,822,0,Latin America,HR,Regulatory Affairs,Below,Female,33,7,1,7,8,0.0,3.4,1.1,0.0,1,1,1,1,3.4,3.4,1.0
5174,68,0,North America,R&D,Legal & Compliance,Far Exceeds,Female,45,18,0,9,13,2.7,3.4,3.1,0.2644,1,1,1,1,3.4,4.0,4.2
5175,128,0,North America,R&D,Legal & Compliance,Meets,Female,42,7,0,10,16,1.5,3.3,3.0,0.0977,1,1,1,1,2.9,2.4,1.8
5176,240,0,Middle East & Africa,Commercial,IT & Digital,Exceeds,Female,49,14,0,12,20,4.8,3.5,2.0,0.0743,1,1,1,1,4.7,4.1,3.0
5177,670,0,Latin America,Digital,Market Access,Below,Male,28,18,0,10,20,3.0,4.7,4.2,0.0,1,1,1,1,2.9,3.4,3.6
5178,1044,0,Latin America,Finance,Market Access,Below,Female,48,7,0,5,16,3.2,1.5,2.4,0.0,1,1,1,1,3.6,2.6,2.0
5179,290,0,Europe,Commercial,Supply Chain,Meets,Male,33,31,0,5,15,2.4,3.7,3.2,0.0422,1,1,1,1,2.8,4.5,2.1
5180,917,0,Asia Pacific,Finance,Data Science,Below,Male,30,17,0,10,34,3.0,3.5,2.2,0.0,1,1,1,1,3.4,5.0,2.0
5181,23,0,Middle East & Africa,R&D,Clinical Operations,Exceeds,Male,40,8,1,5,11,0.0,3.6,2.2,0.1648,1,0,0,0,2.3,4.9,1.7
5182,550,0,Asia Pacific,Digital,Data Science,Meets,Female,28,14,1,6,11,0.0,2.0,1.6,0.0853,1,1,1,1,3.1,2.7,2.7
5183,416,0,Asia Pacific,Manufacturing,Pharmacovigilance,Meets,Male,44,5,1,8,22,0.0,2.0,4.4,0.0348,1,1,1,1,1.3,2.7,2.7
5184,21,0,Middle East & Africa,R&D,Sales,Below,Male,39,19,0,8,10,1.8,2.9,3.2,0.0,1,1,1,0,3.7,1.9,4.7
5185,308,0,Latin America,Commercial,Supply Chain,Meets,Male,34,3,0,8,27,3.7,3.5,2.0,0.0422,1,1,1,1,3.3,2.9,3.3
5186,385,0,Middle East & Africa,Manufacturing,Data Science,Meets,Male,44,13,0,5,20,3.6,3.8,2.8,0.0348,1,1,1,1,4.7,4.0,2.3
5187,719,0,Asia Pacific,HR,Medical Affairs,Meets,Female,37,8,0,8,17,2.4,3.7,3.8,0.0383,0,0,0,0,3.0,4.7,3.8
5188,475,0,Latin America,Manufacturing,Clinical Operations,Meets,Female,38,6,0,8,18,3.6,4.5,2.6,0.0348,1,1,1,1,3.7,1.3,2.7
5189,266,1,North America,Commercial,Data Science,Exceeds,Non-Binary/Other,42,23,0,5,13,3.6,3.4,3.2,0.0743,1,1,1,1,5.0,2.7,3.7
5190,419,1,Middle East & Africa,Manufacturing,Supply Chain,Far Exceeds,Male,34,8,0,6,13,2.5,2.8,2.0,0.1069,1,1,1,1,4.4,2.7,2.4
5191,268,0,Middle East & Africa,Commercial,Medical Affairs,Exceeds,Male,32,5,0,5,8,4.1,5.0,2.7,0.0743,1,1,1,1,2.3,4.5,2.6
5192,82,0,Latin America,R&D,Communications,Meets,Male,37,13,0,11,12,2.5,3.4,1.0,0.0977,0,0,0,0,4.2,4.8,1.0
5193,532,0,North America,Digital,Regulatory Affairs,Meets,Female,30,10,0,8,26,5.0,3.4,2.6,0.0853,1,1,1,1,3.4,1.8,1.5
5194,797,0,North America,HR,Legal & Compliance,Below,Male,35,15,0,10,37,4.8,2.6,2.0,0.0,1,1,1,1,4.4,2.7,1.0
5195,554,0,Latin America,Digital,Sales,Exceeds,Male,32,7,1,8,34,0.0,3.0,4.0,0.1452,1,1,1,1,4.1,2.0,3.9
5196,558,0,Europe,Digital,Communications,Far Exceeds,Male,36,7,1,12,26,0.0,3.0,2.0,0.2363,1,1,1,1,3.8,2.6,2.1
5197,696,0,Middle East & Africa,Digital,Sales,Far Below,Male,33,10,0,10,27,3.3,4.1,1.8,0.0,1,1,1,1,2.6,5.0,2.8
5198,213,0,Middle East & Africa,Commercial,Communications,Meets,Male,36,7,0,11,22,3.2,3.4,3.5,0.0422,1,1,1,1,3.9,3.5,1.9
5199,258,0,Asia Pacific,Commercial,Regulatory Affairs,Exceeds,Female,44,11,0,6,10,2.8,3.6,1.9,0.0743,1,1,1,1,3.1,2.6,2.5
5200,709,0,Latin America,HR,Communications,Below,Female,34,3,0,10,21,3.2,2.1,2.7,0.0,1,1,1,1,4.6,2.3,4.1
5201,271,0,Asia Pacific,Commercial,Communications,Below,Male,40,21,0,8,12,3.3,2.9,2.6,0.0,1,1,1,1,3.8,2.3,3.0
5202,1028,0,Asia Pacific,Finance,Human Resources,Far Exceeds,Male,28,9,0,5,8,2.8,4.8,2.5,0.1022,1,1,1,0,3.6,4.0,2.7
5203,255,0,North America,Commercial,Marketing,Exceeds,Male,36,5,1,10,22,0.0,3.6,1.7,0.0743,1,1,1,1,3.7,2.8,4.3
5204,308,0,Middle East & Africa,Commercial,Market Access,Exceeds,Female,33,16,1,8,12,0.0,2.9,3.7,0.0743,1,1,1,1,3.9,4.4,3.7
5205,226,0,Asia Pacific,Commercial,Medical Affairs,Below,Female,38,7,0,11,28,4.8,3.0,2.0,0.0,1,1,1,1,4.1,2.8,2.2
5206,138,0,North America,R&D,Legal & Compliance,Meets,Female,35,8,0,9,12,4.5,1.4,3.2,0.0977,1,1,1,1,4.8,2.6,3.9
5207,877,0,Latin America,HR,Clinical Operations,Meets,Male,43,15,1,8,12,0.0,2.9,3.1,0.0383,1,1,1,1,5.0,3.2,4.4
5208,1037,0,Asia Pacific,Finance,Data Science,Meets,Female,36,13,0,6,11,3.0,4.2,3.3,0.0331,1,1,1,1,4.4,3.3,3.1
5209,321,0,Middle East & Africa,Commercial,Legal & Compliance,Meets,Non-Binary/Other,45,26,0,11,34,3.2,1.9,2.2,0.0422,1,1,1,1,3.8,2.0,2.4
5210,751,0,Asia Pacific,HR,Pharmacovigilance,Exceeds,Female,28,18,0,10,13,3.2,3.9,2.2,0.0677,1,1,1,1,3.4,4.0,2.3
5211,519,0,Latin America,Manufacturing,Market Access,Exceeds,Male,38,23,0,7,17,1.8,4.0,3.3,0.0616,1,1,1,1,2.5,3.7,2.9
5212,19,0,Asia Pacific,R&D,Supply Chain,Meets,Female,39,3,1,6,8,0.0,3.0,2.0,0.0977,1,1,1,1,2.4,3.7,1.4
5213,266,0,Middle East & Africa,Commercial,Finance & Accounting,Below,Female,32,12,0,6,18,2.4,3.3,2.2,0.0,1,1,1,1,3.7,1.0,3.0
5214,1040,0,North America,Finance,Marketing,Below,Male,38,7,0,7,13,3.0,4.4,2.3,0.0,1,1,1,1,3.1,2.3,2.7
5215,30,1,Middle East & Africa,R&D,Legal & Compliance,Meets,Male,41,18,0,6,14,2.8,1.8,2.6,0.0977,1,0,0,0,3.6,2.0,3.0
5216,1034,0,North America,Finance,Clinical Operations,Below,Female,45,16,0,8,10,4.4,3.8,2.3,0.0,1,1,1,1,2.5,2.7,3.6
5217,75,0,Europe,R&D,Pharmacovigilance,Meets,Female,36,27,0,7,9,3.6,2.1,2.6,0.0977,1,1,1,1,4.4,1.8,2.4
5218,494,0,Middle East & Africa,Manufacturing,Finance & Accounting,Meets,Non-Binary/Other,35,9,0,7,20,3.9,3.9,1.7,0.0348,1,1,1,1,4.2,2.9,1.4
5219,714,0,Middle East & Africa,HR,Pharmacovigilance,Exceeds,Male,34,28,0,6,15,4.2,2.1,2.7,0.0677,1,1,1,1,4.3,1.0,2.1
5220,126,0,Latin America,R&D,Clinical Operations,Meets,Female,38,5,0,5,13,4.1,4.3,3.6,0.0977,0,0,0,0,4.2,3.9,4.0
5221,687,0,Asia Pacific,Digital,Legal & Compliance,Meets,Male,32,10,0,11,14,3.8,2.7,1.9,0.0853,1,1,1,1,4.6,2.3,2.0
5222,517,0,North America,Manufacturing,Finance & Accounting,Meets,Non-Binary/Other,43,6,0,11,18,4.0,1.6,3.2,0.0348,1,0,0,0,2.9,2.1,2.7
5223,566,0,North America,Digital,Finance & Accounting,Meets,Male,28,5,0,10,33,2.7,2.9,4.7,0.0853,1,1,1,1,2.1,3.2,3.5
5224,439,0,Latin America,Manufacturing,Communications,Far Exceeds,Male,38,11,0,6,29,3.6,2.2,1.5,0.1069,1,1,1,1,3.5,3.9,1.1
5225,547,0,Latin America,Digital,Marketing,Meets,Male,30,25,0,11,18,4.8,4.1,2.6,0.0853,1,1,1,1,4.2,3.0,2.9
5226,619,1,Asia Pacific,Digital,Supply Chain,Exceeds,Female,38,17,0,9,16,4.8,4.5,2.9,0.1452,1,1,1,1,5.0,4.4,2.4
5227,937,0,Asia Pacific,Finance,Regulatory Affairs,Meets,Male,43,8,0,10,14,3.7,2.5,2.5,0.0331,1,1,0,0,3.4,2.6,1.7
5228,141,0,Middle East & Africa,R&D,Market Access,Meets,Female,39,10,1,8,19,0.0,3.5,1.5,0.0977,1,1,1,1,2.7,2.4,2.8
5229,29,0,Europe,R&D,Quality Assurance,Meets,Female,34,2,0,11,23,2.9,3.5,2.8,0.0977,1,1,1,1,3.5,3.7,4.5
5230,505,0,Asia Pacific,Manufacturing,Quality Assurance,Far Exceeds,Male,42,17,0,9,14,2.3,2.6,2.0,0.1069,1,1,1,1,3.3,3.2,1.0
5231,803,1,Latin America,HR,Marketing,Meets,Male,28,4,1,12,15,0.0,3.0,3.3,0.0383,1,1,1,1,4.1,3.2,3.0
5232,1000,0,Asia Pacific,Finance,Pharmacovigilance,Below,Male,38,17,0,11,14,4.9,2.6,4.8,0.0,1,1,1,1,4.0,2.8,4.0
5233,88,0,North America,R&D,Data Science,Meets,Male,33,7,1,8,13,0.0,2.6,2.8,0.0977,1,1,1,1,3.2,2.4,3.2
5234,144,0,Europe,R&D,Regulatory Affairs,Meets,Female,41,20,1,12,15,0.0,3.9,4.3,0.0977,1,1,1,1,1.5,3.7,4.3
5235,975,0,Middle East & Africa,Finance,Regulatory Affairs,Meets,Female,28,9,0,7,14,1.6,3.1,1.7,0.0331,1,1,1,1,2.6,3.1,1.6
5236,304,1,North America,Commercial,Marketing,Far Exceeds,Male,35,1,0,11,16,2.6,3.9,2.9,0.1275,1,1,0,0,4.9,3.4,3.1
5237,1020,0,North America,Finance,Supply Chain,Exceeds,Female,34,15,0,7,14,4.7,4.6,3.1,0.0588,1,1,1,1,4.6,3.9,3.0
5238,18,0,Europe,R&D,Marketing,Meets,Male,43,8,0,10,23,3.8,3.3,1.6,0.0977,1,1,1,1,3.0,1.6,2.9
5239,856,0,Middle East & Africa,HR,Human Resources,Below,Female,33,20,0,10,12,4.3,2.1,1.3,0.0,1,1,1,1,3.2,3.4,2.0
5240,265,0,Latin America,Commercial,Data Science,Meets,Non-Binary/Other,37,6,1,5,16,0.0,3.5,2.5,0.0422,1,1,0,0,4.4,2.8,1.4
5241,621,0,Middle East & Africa,Digital,Sales,Meets,Male,38,4,0,9,36,4.6,3.4,1.0,0.0853,1,1,1,1,4.9,3.7,1.0
5242,1011,0,Asia Pacific,Finance,Quality Assurance,Meets,Female,38,13,1,11,13,0.0,2.7,3.6,0.0331,1,1,1,1,2.5,2.4,2.1
5243,649,0,North America,Digital,Marketing,Meets,Female,38,17,0,7,16,2.7,3.8,2.1,0.0853,1,1,1,1,2.0,4.8,2.1
5244,351,0,Asia Pacific,Commercial,Regulatory Affairs,Meets,Male,38,36,0,9,16,4.6,2.7,3.1,0.0422,1,1,1,1,3.4,3.0,5.0
5245,340,0,Latin America,Commercial,Communications,Below,Female,38,30,0,7,23,4.9,2.8,3.3,0.0,1,1,1,1,5.0,3.3,3.1
5246,310,0,Asia Pacific,Commercial,Supply Chain,Meets,Male,52,6,0,9,43,3.4,2.5,2.7,0.0422,1,1,1,1,4.3,1.8,3.3
5247,407,0,Middle East & Africa,Manufacturing,Quality Assurance,Below,Male,28,23,0,5,19,3.3,3.3,1.3,0.0,1,1,1,1,2.8,2.2,1.6
5248,1023,0,Asia Pacific,Finance,Medical Affairs,Far Below,Female,33,10,0,10,27,2.5,3.3,1.3,0.0,1,1,0,0,4.1,4.0,2.5
5249,750,0,Latin America,HR,IT & Digital,Meets,Female,38,17,1,9,20,0.0,3.4,2.7,0.0383,1,1,1,1,3.1,3.8,3.0
5250,838,0,Latin America,HR,Clinical Operations,Meets,Female,45,13,0,7,18,2.3,3.8,1.3,0.0383,1,1,1,1,4.0,4.2,1.7
5251,644,0,Latin America,Digital,Regulatory Affairs,Meets,Female,44,10,0,5,19,3.3,3.3,1.8,0.0853,1,0,0,0,4.1,3.4,1.1
5252,659,0,Middle East & Africa,Digital,Medical Affairs,Meets,Male,44,17,0,7,13,2.8,2.5,2.1,0.0853,1,1,1,1,4.7,1.3,1.8
5253,657,0,Latin America,Digital,Supply Chain,Far Below,Female,38,5,0,7,10,3.9,3.1,1.2,0.0,1,1,1,1,2.7,3.1,1.8
5254,1047,0,North America,Finance,Regulatory Affairs,Meets,Female,45,7,1,11,16,0.0,2.1,3.2,0.0331,1,1,1,1,3.4,3.5,2.3
5255,63,0,Latin America,R&D,Marketing,Meets,Female,34,13,0,10,26,3.0,4.4,2.5,0.0977,1,1,1,1,2.4,4.7,4.2
5256,583,1,Asia Pacific,Digital,Regulatory Affairs,Meets,Female,43,7,0,6,12,2.9,1.6,3.9,0.0853,1,0,0,0,2.4,2.0,3.5
5257,189,0,Asia Pacific,Commercial,IT & Digital,Meets,Female,39,17,0,11,29,1.1,3.2,4.5,0.0422,1,1,1,1,2.4,2.3,4.7
5258,665,0,Asia Pacific,Digital,Supply Chain,Meets,Male,39,8,0,5,17,2.7,3.3,1.5,0.0853,1,1,0,0,2.6,2.1,2.8
5259,217,0,Middle East & Africa,Commercial,Regulatory Affairs,Meets,Male,30,10,0,12,20,2.5,4.1,1.0,0.0422,1,1,1,1,2.1,3.1,2.3
5260,413,0,Asia Pacific,Manufacturing,Data Science,Exceeds,Female,28,10,0,10,28,2.0,2.5,2.4,0.0616,1,1,1,1,3.3,2.9,2.7
5261,106,1,Middle East & Africa,R&D,Pharmacovigilance,Exceeds,Female,36,18,0,10,24,3.9,3.5,2.7,0.1648,1,1,1,1,3.8,4.2,2.4
5262,123,0,Middle East & Africa,R&D,Finance & Accounting,Exceeds,Female,37,14,0,9,16,1.2,1.4,1.1,0.1648,1,1,1,1,1.9,2.4,3.1
5263,952,0,Latin America,Finance,Communications,Meets,Male,31,9,0,6,11,1.0,3.7,3.0,0.0331,1,1,1,1,1.7,4.4,4.0
5264,902,0,North America,Finance,Medical Affairs,Meets,Male,44,6,1,11,19,0.0,3.3,2.3,0.0331,1,1,1,1,3.3,1.4,1.9
5265,799,0,Latin America,HR,Legal & Compliance,Meets,Male,33,13,1,12,17,0.0,2.4,4.2,0.0383,1,1,1,1,3.9,2.6,4.3
5266,416,0,Latin America,Manufacturing,Sales,Meets,Female,41,7,1,10,11,0.0,2.8,1.9,0.0348,1,1,1,1,4.8,1.5,1.8
5267,967,0,Middle East & Africa,Finance,Pharmacovigilance,Meets,Male,36,6,0,7,13,3.7,3.4,1.0,0.0331,1,1,1,1,2.9,3.2,2.0
5268,279,0,Middle East & Africa,Commercial,Supply Chain,Meets,Female,43,10,0,11,16,3.9,3.1,1.0,0.0422,0,0,0,0,3.9,2.2,1.2
5269,366,0,Asia Pacific,Manufacturing,Quality Assurance,Meets,Non-Binary/Other,31,33,0,8,19,4.1,3.3,1.5,0.0348,1,1,1,1,5.0,3.5,1.2
5270,130,0,Asia Pacific,R&D,Communications,Below,Male,28,12,0,8,12,2.2,3.1,3.6,0.0,1,1,1,1,2.6,2.8,3.5
5271,228,0,Latin America,Commercial,Human Resources,Meets,Male,41,23,0,9,21,3.5,3.2,3.0,0.0422,1,1,1,1,4.3,3.7,3.7
5272,522,0,Europe,Manufacturing,Data Science,Below,Male,43,1,0,11,13,3.0,4.2,2.6,0.0,1,1,1,1,3.3,2.2,2.7
5273,136,0,Europe,R&D,Human Resources,Far Below,Male,40,2,1,12,19,0.0,3.8,2.3,0.0,1,1,1,1,3.5,3.5,2.8
5274,881,0,Asia Pacific,Finance,Human Resources,Exceeds,Male,33,4,1,5,14,0.0,3.4,3.0,0.0588,1,1,1,1,3.8,3.0,1.8
5275,273,0,Europe,Commercial,Medical Affairs,Meets,Female,42,14,0,5,10,3.3,3.3,1.9,0.0422,0,0,0,0,2.9,3.8,1.7
5276,323,0,Asia Pacific,Commercial,Supply Chain,Meets,Female,41,11,0,12,18,3.6,2.9,4.0,0.0422,1,1,1,1,3.4,3.2,1.9
5277,110,0,Middle East & Africa,R&D,Medical Affairs,Meets,Male,31,1,0,10,21,3.5,4.6,1.3,0.0977,1,1,1,1,4.5,2.8,1.8
5278,313,0,Latin America,Commercial,Regulatory Affairs,Meets,Female,41,25,0,7,21,2.5,2.5,3.2,0.0422,1,1,1,1,2.9,2.1,2.7
5279,927,0,North America,Finance,Legal & Compliance,Below,Female,39,8,1,7,19,0.0,1.7,2.3,0.0,0,0,0,0,2.1,2.8,3.3
5280,968,1,Latin America,Finance,Market Access,Meets,Male,39,7,0,9,24,3.5,2.1,4.2,0.0331,1,1,1,1,4.2,3.2,3.8
5281,951,0,Asia Pacific,Finance,Marketing,Exceeds,Female,30,11,0,12,20,4.1,1.3,1.8,0.0588,1,1,1,1,3.1,1.3,3.2
5282,88,0,Asia Pacific,R&D,Pharmacovigilance,Exceeds,Male,43,5,1,9,20,0.0,3.9,2.4,0.1648,1,1,1,1,5.0,4.1,3.4
5283,587,0,Latin America,Digital,Regulatory Affairs,Below,Male,35,10,0,5,8,4.9,1.7,1.4,0.0,1,1,1,1,3.6,1.9,1.9
5284,536,0,Asia Pacific,Digital,Clinical Operations,Meets,Female,34,11,0,12,21,3.2,4.2,2.6,0.0853,1,1,1,1,2.8,3.8,4.5
5285,324,0,Europe,Commercial,Quality Assurance,Exceeds,Male,41,15,0,6,17,3.3,2.6,3.7,0.0743,1,1,1,1,3.2,3.7,2.8
5286,995,0,Europe,Finance,Clinical Operations,Below,Male,37,15,0,6,26,2.8,1.7,2.5,0.0,1,1,1,1,3.3,3.0,1.2
5287,283,0,Asia Pacific,Commercial,Clinical Operations,Below,Male,29,9,1,6,9,0.0,3.0,3.3,0.0,1,1,1,1,2.8,2.7,3.6
5288,68,0,Asia Pacific,R&D,Data Science,Exceeds,Female,47,5,0,11,25,3.1,4.7,1.4,0.1648,1,1,1,1,4.2,1.9,1.6
5289,265,0,Europe,Commercial,Sales,Meets,Male,39,8,0,5,11,3.7,2.7,4.8,0.0422,1,1,1,1,4.3,2.4,3.9
5290,790,0,Asia Pacific,HR,Finance & Accounting,Meets,Female,38,13,0,9,41,2.7,5.0,2.6,0.0383,1,1,1,1,2.9,3.5,3.2
5291,592,0,Asia Pacific,Digital,IT & Digital,Below,Female,38,13,1,12,22,0.0,1.7,1.6,0.0,1,1,1,1,2.6,3.3,1.7
5292,203,0,Latin America,Commercial,Pharmacovigilance,Meets,Male,38,13,0,10,22,1.8,3.3,1.5,0.0422,1,1,1,1,3.0,3.1,1.0
5293,211,0,North America,Commercial,Human Resources,Meets,Male,39,21,0,8,10,2.4,3.6,2.2,0.0422,1,1,1,1,2.2,3.0,1.7
5294,495,0,Europe,Manufacturing,Market Access,Meets,Male,45,6,1,9,13,0.0,3.9,1.0,0.0348,1,1,1,1,5.0,3.7,1.4
5295,343,0,Latin America,Commercial,Regulatory Affairs,Meets,Male,47,7,1,7,20,0.0,4.0,2.1,0.0422,1,1,1,1,3.7,3.8,2.7
5296,867,0,North America,HR,IT & Digital,Meets,Male,36,24,0,12,18,3.4,3.1,3.3,0.0383,1,1,1,1,4.6,3.1,2.9
5297,677,0,Asia Pacific,Digital,IT & Digital,Meets,Male,42,7,0,6,8,3.4,4.3,2.3,0.0853,1,1,1,1,4.1,4.9,1.7
5298,399,0,Asia Pacific,Manufacturing,Clinical Operations,Meets,Male,42,7,0,7,21,2.5,2.5,3.4,0.0348,1,1,1,1,3.5,2.3,5.0
5299,83,0,Latin America,R&D,Clinical Operations,Meets,Male,42,12,1,8,12,0.0,2.6,3.8,0.0977,1,1,1,1,3.2,2.6,3.6
5300,101,0,Asia Pacific,R&D,Quality Assurance,Below,Female,46,10,0,10,16,3.1,2.9,1.4,0.0,1,1,1,1,4.2,2.9,1.0
5301,676,0,Middle East & Africa,Digital,Market Access,Meets,Male,43,10,0,5,29,2.5,2.8,2.1,0.0853,1,1,1,0,3.8,2.3,3.2
5302,141,0,Latin America,R&D,Market Access,Below,Female,41,11,0,12,15,5.0,3.3,1.3,0.0,1,1,1,1,4.5,3.8,3.3
5303,836,0,North America,HR,Market Access,Meets,Male,34,34,0,8,15,4.6,3.7,3.5,0.0383,1,1,1,0,4.8,3.7,2.0
5304,212,1,Latin America,Commercial,Regulatory Affairs,Far Exceeds,Female,40,25,0,10,33,4.8,3.0,2.6,0.1275,1,1,1,1,4.3,4.0,2.7
5305,537,0,Europe,Digital,Finance & Accounting,Meets,Female,32,5,1,7,10,0.0,2.5,4.4,0.0853,1,1,1,1,1.9,2.6,3.5
5306,478,0,Latin America,Manufacturing,Pharmacovigilance,Below,Male,41,15,1,6,7,0.0,3.8,3.3,0.0,1,1,1,1,3.7,3.9,3.5
5307,201,0,Asia Pacific,Commercial,Pharmacovigilance,Meets,Female,40,6,0,10,17,4.9,3.6,2.6,0.0422,1,1,1,1,4.3,4.1,2.4
5308,79,0,Asia Pacific,R&D,Regulatory Affairs,Below,Male,29,5,0,8,17,2.1,2.4,3.8,0.0,1,1,1,1,1.6,2.4,4.0
5309,63,0,Middle East & Africa,R&D,Data Science,Below,Female,35,12,0,7,21,3.5,1.7,4.3,0.0,1,1,1,1,3.4,2.7,3.4
5310,456,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Meets,Female,34,29,0,12,14,2.6,3.9,2.5,0.0348,1,1,1,1,2.5,4.8,2.3
5311,740,0,Middle East & Africa,HR,Marketing,Meets,Male,42,7,0,7,13,3.4,3.4,2.3,0.0383,1,1,1,1,2.1,3.3,3.4
5312,381,0,North America,Manufacturing,Communications,Meets,Female,36,15,0,8,10,4.9,1.7,2.5,0.0348,1,1,1,1,3.8,2.4,2.0
5313,598,0,Middle East & Africa,Digital,Supply Chain,Below,Female,29,14,0,5,15,4.1,3.7,1.5,0.0,1,1,1,1,4.0,4.4,3.9
5314,370,0,North America,Manufacturing,IT & Digital,Meets,Male,41,19,0,8,23,3.3,3.2,3.0,0.0348,1,1,1,1,2.4,4.2,1.3
5315,38,0,Middle East & Africa,R&D,Marketing,Meets,Female,39,17,0,11,40,3.6,3.7,2.7,0.0977,1,0,0,0,2.9,3.7,2.8
5316,768,0,North America,HR,Data Science,Exceeds,Female,39,15,0,11,13,1.0,2.9,1.8,0.0677,1,1,1,1,2.7,5.0,2.5
5317,764,0,Latin America,HR,IT & Digital,Below,Male,31,6,0,12,19,3.1,2.4,4.1,0.0,1,1,0,0,3.4,2.2,3.8
5318,942,0,Latin America,Finance,Communications,Exceeds,Female,42,16,0,6,18,2.9,5.0,2.6,0.0588,0,0,0,0,4.2,4.4,3.3
5319,484,0,Asia Pacific,Manufacturing,Data Science,Meets,Male,37,11,0,11,29,3.1,4.1,4.2,0.0348,1,1,1,1,3.1,4.1,3.9
5320,668,0,North America,Digital,IT & Digital,Meets,Female,37,14,0,11,12,2.8,3.4,2.8,0.0853,1,1,1,1,3.4,4.3,1.2
5321,22,0,Europe,R&D,Regulatory Affairs,Meets,Male,30,18,1,11,20,0.0,2.8,2.3,0.0977,0,0,0,0,2.1,2.8,3.6
5322,340,0,Asia Pacific,Commercial,Regulatory Affairs,Meets,Female,31,15,1,6,16,0.0,4.5,2.4,0.0422,1,1,1,1,2.1,3.8,1.0
5323,798,0,Latin America,HR,Human Resources,Meets,Female,55,14,1,8,24,0.0,5.0,2.0,0.0383,1,1,1,1,3.6,4.3,2.8
5324,446,0,North America,Manufacturing,IT & Digital,Below,Female,31,14,0,8,10,3.4,2.4,3.6,0.0,1,1,1,1,4.9,3.1,3.4
5325,1009,0,Middle East & Africa,Finance,Sales,Exceeds,Non-Binary/Other,28,6,1,12,24,0.0,3.2,4.0,0.0588,1,1,1,1,4.9,3.6,2.4
5326,602,0,Europe,Digital,Human Resources,Below,Male,36,26,0,7,15,2.7,2.9,1.3,0.0,1,1,1,1,1.7,3.8,1.7
5327,562,0,Latin America,Digital,Human Resources,Meets,Male,37,11,0,11,15,2.5,3.2,2.8,0.0853,1,1,1,1,4.1,3.2,2.0
5328,119,0,Asia Pacific,R&D,Quality Assurance,Meets,Female,32,5,0,5,28,3.5,5.0,3.0,0.0977,1,1,1,1,2.4,2.6,1.9
5329,801,0,North America,HR,Marketing,Meets,Male,33,18,0,12,16,1.6,2.2,2.2,0.0383,1,1,1,1,3.5,2.1,3.2
5330,23,0,Europe,R&D,Pharmacovigilance,Exceeds,Male,37,10,1,11,34,0.0,3.0,2.3,0.1648,1,1,1,1,2.7,2.5,1.4
5331,975,0,North America,Finance,Human Resources,Far Exceeds,Female,40,16,0,10,21,3.5,1.7,3.5,0.1022,1,1,1,0,3.4,2.9,2.3
5332,271,0,Middle East & Africa,Commercial,Sales,Far Below,Female,30,13,1,12,17,0.0,4.1,1.7,0.0,1,1,1,1,3.8,2.9,2.3
5333,326,0,Asia Pacific,Commercial,Market Access,Meets,Male,36,5,0,9,16,3.5,2.1,1.0,0.0422,1,1,1,1,4.0,2.9,2.3
5334,289,0,North America,Commercial,Medical Affairs,Exceeds,Female,38,3,0,10,19,3.3,2.3,3.4,0.0743,1,1,1,1,3.9,2.9,2.2
5335,578,0,Latin America,Digital,Pharmacovigilance,Meets,Female,37,8,0,11,22,4.0,3.2,2.1,0.0853,1,1,1,1,4.1,1.8,3.9
5336,758,0,Asia Pacific,HR,IT & Digital,Meets,Female,34,10,0,6,19,3.5,2.1,4.0,0.0383,1,1,1,1,4.3,1.0,4.5
5337,122,0,Latin America,R&D,Market Access,Far Exceeds,Female,32,10,0,11,17,3.8,3.4,2.5,0.2644,1,1,1,1,3.5,3.4,1.2
5338,71,0,North America,R&D,Human Resources,Meets,Male,48,6,1,12,19,0.0,4.4,3.3,0.0977,1,1,1,1,4.7,4.9,3.6
5339,925,0,Asia Pacific,Finance,Legal & Compliance,Below,Female,28,12,1,9,45,0.0,4.5,3.3,0.0,1,1,1,1,2.5,3.0,4.2
5340,268,0,Latin America,Commercial,Sales,Exceeds,Male,44,8,0,5,16,3.4,3.9,2.5,0.0743,1,1,1,1,3.3,3.6,1.0
5341,874,0,Middle East & Africa,HR,Clinical Operations,Far Exceeds,Female,31,15,0,10,18,2.7,3.3,2.2,0.1168,1,0,0,0,4.1,3.9,2.2
5342,781,0,Middle East & Africa,HR,Sales,Meets,Female,39,20,0,5,24,3.9,3.6,1.8,0.0383,1,1,1,1,3.9,3.8,2.6
5343,1021,0,North America,Finance,Communications,Meets,Male,38,6,0,11,15,2.9,1.3,3.3,0.0331,1,1,1,1,3.9,3.4,2.9
5344,385,0,Asia Pacific,Manufacturing,Sales,Exceeds,Female,32,6,0,10,15,3.5,1.6,5.0,0.0616,0,0,0,0,3.8,2.5,3.3
5345,845,0,Europe,HR,Sales,Far Exceeds,Female,37,8,1,11,14,0.0,3.5,3.3,0.1168,1,1,1,1,3.1,4.3,2.2
5346,723,1,Asia Pacific,HR,Finance & Accounting,Exceeds,Female,36,7,1,12,27,0.0,1.8,3.2,0.0677,1,1,1,1,2.4,3.2,3.6
5347,14,0,Middle East & Africa,R&D,Regulatory Affairs,Meets,Male,38,12,0,7,16,2.1,1.9,1.8,0.0977,1,1,1,1,2.9,3.1,2.4
5348,964,0,Latin America,Finance,Finance & Accounting,Meets,Female,46,6,0,6,14,2.3,2.7,3.5,0.0331,1,1,1,1,3.6,3.0,3.7
5349,862,0,Europe,HR,Marketing,Meets,Female,47,29,0,5,10,4.9,4.1,4.0,0.0383,1,1,1,1,4.0,3.7,3.6
5350,876,0,North America,HR,Sales,Below,Female,33,8,1,12,16,0.0,1.7,2.5,0.0,0,0,0,0,2.7,3.7,3.5
5351,78,0,Europe,R&D,Regulatory Affairs,Meets,Female,40,24,0,5,14,4.4,4.5,2.2,0.0977,0,0,0,0,4.5,4.0,4.0
5352,833,0,North America,HR,IT & Digital,Meets,Female,44,10,1,9,36,0.0,2.2,2.4,0.0383,1,1,1,1,1.4,2.0,4.2
5353,64,0,Europe,R&D,Market Access,Exceeds,Female,35,10,0,7,13,3.3,2.2,2.0,0.1648,0,0,0,0,2.6,2.4,2.1
5354,480,0,North America,Manufacturing,Communications,Exceeds,Male,42,11,1,9,24,0.0,4.0,4.5,0.0616,1,1,1,1,3.5,3.2,1.8
5355,528,0,North America,Digital,Communications,Below,Female,52,9,1,10,21,0.0,2.5,4.7,0.0,1,0,0,0,5.0,1.4,4.8
5356,58,0,Europe,R&D,Legal & Compliance,Meets,Female,31,10,0,6,12,3.7,3.9,3.4,0.0977,0,0,0,0,4.0,3.9,2.6
5357,66,0,Europe,R&D,Quality Assurance,Meets,Female,41,10,0,12,25,3.2,1.8,3.2,0.0977,1,1,1,1,3.3,3.6,3.5
5358,820,1,North America,HR,Marketing,Exceeds,Male,32,4,0,12,20,2.0,3.3,1.9,0.0677,0,0,0,0,4.0,2.8,4.2
5359,58,0,Middle East & Africa,R&D,Human Resources,Far Below,Male,34,10,1,7,22,0.0,1.5,3.0,0.0,1,1,1,1,1.5,1.8,2.3
5360,941,0,Europe,Finance,Market Access,Meets,Male,35,19,0,8,18,3.5,1.7,2.0,0.0331,1,1,1,1,3.2,3.1,2.9
5361,228,0,Asia Pacific,Commercial,IT & Digital,Meets,Female,41,9,1,7,18,0.0,3.5,2.8,0.0422,1,1,1,1,3.4,4.4,3.4
5362,300,0,Latin America,Commercial,Human Resources,Exceeds,Male,50,16,0,9,16,4.1,4.1,4.6,0.0743,1,1,1,1,3.6,4.1,4.1
5363,360,0,North America,Manufacturing,Data Science,Meets,Male,34,16,0,11,30,2.1,3.3,2.2,0.0348,1,1,1,1,3.7,2.3,4.0
5364,173,1,North America,R&D,Pharmacovigilance,Meets,Female,44,9,0,8,19,2.2,3.6,2.7,0.0977,1,1,1,1,3.3,3.6,3.8
5365,894,0,Latin America,Finance,Finance & Accounting,Far Exceeds,Male,33,14,1,11,37,0.0,2.9,2.0,0.1022,1,1,1,1,4.3,3.8,2.3
5366,809,0,Middle East & Africa,HR,Human Resources,Meets,Female,35,7,0,7,16,2.8,2.7,2.4,0.0383,1,1,1,1,4.0,3.2,3.6
5367,836,0,Latin America,HR,Human Resources,Below,Female,46,6,0,8,11,3.0,2.8,2.8,0.0,1,1,1,1,4.0,2.7,2.9
5368,600,0,Europe,Digital,Legal & Compliance,Below,Non-Binary/Other,44,14,0,10,26,2.2,3.8,2.4,0.0,1,1,1,1,2.8,3.6,2.0
5369,430,0,Latin America,Manufacturing,Medical Affairs,Exceeds,Male,36,15,0,10,15,3.6,2.8,3.6,0.0616,1,1,1,1,3.8,3.7,2.4
5370,963,0,North America,Finance,Data Science,Meets,Male,34,21,0,5,9,3.1,2.8,2.0,0.0331,1,1,1,1,2.8,3.8,3.9
5371,934,0,Latin America,Finance,Supply Chain,Meets,Male,41,11,0,6,24,3.6,2.0,2.3,0.0331,0,0,0,0,4.3,2.8,3.7
5372,851,0,Asia Pacific,HR,IT & Digital,Meets,Female,34,9,0,8,15,4.0,4.2,2.7,0.0383,1,1,1,1,2.5,2.9,4.6
5373,528,0,Europe,Digital,Finance & Accounting,Far Exceeds,Male,35,4,0,7,22,2.2,3.5,3.0,0.2363,1,1,1,1,3.0,2.2,2.6
5374,760,0,Latin America,HR,Communications,Meets,Male,36,18,0,5,15,3.5,4.1,4.5,0.0383,1,1,1,1,2.2,2.5,5.0
5375,627,0,North America,Digital,Legal & Compliance,Meets,Female,37,6,0,9,18,2.5,2.8,4.1,0.0853,1,1,1,1,3.7,2.2,4.7
5376,292,0,Europe,Commercial,Quality Assurance,Far Below,Male,35,13,1,5,24,0.0,4.3,1.0,0.0,1,1,1,1,4.5,4.0,1.9
5377,995,0,North America,Finance,Supply Chain,Meets,Female,28,18,0,8,22,2.1,1.8,1.4,0.0331,1,1,1,1,3.8,1.7,1.5
5378,316,0,Middle East & Africa,Commercial,Clinical Operations,Below,Female,47,20,0,6,19,2.9,2.0,1.5,0.0,1,1,1,1,3.2,1.0,3.6
5379,769,0,Asia Pacific,HR,Clinical Operations,Exceeds,Male,43,12,1,12,18,0.0,2.8,2.9,0.0677,1,1,1,1,4.5,2.6,2.2
5380,378,0,Middle East & Africa,Manufacturing,Finance & Accounting,Exceeds,Female,37,16,0,8,14,2.3,2.8,2.6,0.0616,1,1,1,1,2.6,3.3,1.8
5381,123,0,Asia Pacific,R&D,Sales,Meets,Female,34,5,0,6,7,2.3,3.7,5.0,0.0977,1,1,1,1,1.6,3.6,3.0
5382,394,0,Latin America,Manufacturing,Communications,Meets,Male,45,4,1,10,22,0.0,3.5,3.1,0.0348,1,1,1,1,4.0,2.5,2.8
5383,500,0,Europe,Manufacturing,Legal & Compliance,Meets,Male,41,24,0,9,15,2.8,1.6,2.2,0.0348,0,0,0,0,3.6,1.9,1.3
5384,151,0,Latin America,R&D,Quality Assurance,Meets,Female,34,3,1,9,13,0.0,3.0,2.6,0.0977,1,0,0,0,4.5,4.3,3.2
5385,931,0,Asia Pacific,Finance,Legal & Compliance,Meets,Male,41,7,1,6,24,0.0,4.3,2.6,0.0331,1,1,1,1,3.3,2.5,3.6
5386,245,1,Asia Pacific,Commercial,Market Access,Far Exceeds,Female,38,6,1,5,11,0.0,3.0,2.5,0.1275,1,1,1,1,5.0,2.9,3.7
5387,293,0,Asia Pacific,Commercial,Human Resources,Exceeds,Female,39,11,0,12,28,4.7,2.2,1.4,0.0743,1,1,1,1,4.2,2.4,2.1
5388,997,0,North America,Finance,Data Science,Meets,Male,43,10,0,8,25,1.4,2.2,1.7,0.0331,1,1,1,1,3.0,2.2,2.4
5389,55,0,Europe,R&D,Quality Assurance,Meets,Female,41,18,0,10,12,2.6,2.9,3.5,0.0977,1,1,1,1,2.9,4.1,4.0
5390,545,0,Latin America,Digital,Data Science,Meets,Male,43,7,0,7,16,3.5,3.6,2.9,0.0853,0,0,0,0,3.8,1.0,3.4
5391,422,1,Latin America,Manufacturing,Medical Affairs,Exceeds,Male,49,12,1,12,23,0.0,5.0,1.5,0.0616,1,1,1,1,5.0,4.6,2.6
5392,853,0,Middle East & Africa,HR,Market Access,Meets,Female,42,16,0,5,12,3.5,2.2,3.1,0.0383,1,1,1,1,3.2,2.7,2.6
5393,200,0,Asia Pacific,Commercial,Supply Chain,Meets,Male,52,9,0,6,16,1.7,2.7,2.8,0.0422,1,1,1,1,1.8,1.6,2.2
5394,883,0,Asia Pacific,Finance,Data Science,Far Below,Female,45,10,0,5,10,3.8,4.5,3.9,0.0,0,0,0,0,4.4,3.7,3.8
5395,751,0,Asia Pacific,HR,Medical Affairs,Exceeds,Female,37,29,0,5,18,5.0,3.2,4.7,0.0677,1,1,1,1,4.2,1.4,4.0
5396,128,0,Latin America,R&D,Quality Assurance,Meets,Male,29,22,0,12,23,2.6,5.0,1.0,0.0977,1,1,1,1,3.0,3.9,2.1
5397,739,0,Middle East & Africa,HR,Medical Affairs,Meets,Male,45,2,0,9,20,4.0,3.1,2.5,0.0383,1,1,1,1,4.9,2.3,2.8
5398,782,0,North America,HR,Pharmacovigilance,Meets,Male,30,14,0,11,22,4.0,3.8,2.8,0.0383,1,1,1,1,3.7,3.9,3.9
5399,512,0,Europe,Manufacturing,Medical Affairs,Below,Female,39,6,1,5,12,0.0,2.4,2.8,0.0,1,1,1,1,3.7,3.1,2.4
5400,122,0,North America,R&D,Finance & Accounting,Exceeds,Male,42,9,0,10,17,4.7,1.0,5.0,0.1648,1,1,1,1,3.7,3.0,4.5
5401,825,0,Latin America,HR,Legal & Compliance,Meets,Male,32,6,0,6,8,4.4,3.1,1.0,0.0383,1,1,1,1,4.0,3.6,1.9
5402,279,0,Asia Pacific,Commercial,Medical Affairs,Meets,Female,34,4,1,6,27,0.0,2.1,2.7,0.0422,1,1,1,1,2.9,2.9,3.2
5403,85,0,Europe,R&D,Finance & Accounting,Below,Male,32,9,0,12,16,2.4,2.0,3.3,0.0,1,1,1,1,3.7,2.1,3.0
5404,219,0,Latin America,Commercial,Sales,Meets,Male,50,4,0,5,21,2.7,3.5,2.7,0.0422,1,1,1,1,3.8,3.2,3.5
5405,1022,0,Latin America,Finance,Clinical Operations,Meets,Female,42,8,0,9,25,3.4,3.0,2.8,0.0331,1,1,1,1,4.1,2.5,3.1
5406,966,0,Latin America,Finance,Supply Chain,Meets,Male,34,6,0,8,24,4.0,3.3,2.9,0.0331,1,1,1,1,3.9,3.4,3.2
5407,624,0,Europe,Digital,Pharmacovigilance,Meets,Male,29,13,0,12,37,3.1,1.5,3.1,0.0853,1,1,1,1,3.5,3.4,2.4
5408,993,0,Europe,Finance,IT & Digital,Meets,Male,33,11,0,5,18,4.6,2.6,3.0,0.0331,1,1,1,1,4.6,1.5,3.0
5409,805,0,Middle East & Africa,HR,Pharmacovigilance,Meets,Female,34,21,0,7,9,2.6,4.5,1.8,0.0383,1,1,1,1,2.8,4.1,1.1
5410,100,0,Middle East & Africa,R&D,Clinical Operations,Meets,Male,35,10,0,7,20,4.2,2.0,2.6,0.0977,1,1,1,1,4.6,3.3,2.0
5411,1001,0,North America,Finance,Communications,Exceeds,Male,43,4,1,8,16,0.0,2.2,3.1,0.0588,1,1,1,1,3.1,2.5,4.6
5412,213,0,Europe,Commercial,Marketing,Meets,Male,30,7,1,9,38,0.0,4.0,1.9,0.0422,1,0,0,0,2.8,2.8,1.4
5413,753,0,Europe,HR,Data Science,Meets,Non-Binary/Other,45,9,0,12,13,2.9,3.3,2.4,0.0383,1,1,1,1,3.3,2.7,3.8
5414,1050,0,Europe,Finance,Medical Affairs,Below,Male,28,15,0,9,15,3.8,3.1,1.0,0.0,1,1,1,1,3.9,2.4,2.9
5415,439,0,Middle East & Africa,Manufacturing,Quality Assurance,Meets,Male,38,14,0,9,13,3.5,3.3,2.8,0.0348,1,1,1,1,4.6,2.2,3.6
5416,210,0,Latin America,Commercial,Communications,Exceeds,Female,34,7,0,5,10,4.8,2.1,2.0,0.0743,1,1,1,1,5.0,3.2,2.0
5417,188,0,Asia Pacific,Commercial,Medical Affairs,Far Below,Male,44,12,0,9,24,1.5,1.9,3.3,0.0,1,1,0,0,4.3,2.9,2.0
5418,625,0,Middle East & Africa,Digital,Quality Assurance,Meets,Female,47,8,0,12,19,2.3,1.6,2.1,0.0853,1,1,1,1,2.3,2.1,2.7
5419,493,0,Europe,Manufacturing,Medical Affairs,Below,Female,43,7,0,10,11,3.7,4.5,4.2,0.0,1,1,1,1,3.3,3.7,3.5
5420,546,0,Middle East & Africa,Digital,Pharmacovigilance,Meets,Male,41,6,0,10,23,2.9,1.6,2.8,0.0853,1,1,1,0,3.9,2.9,2.5
5421,1028,0,North America,Finance,Marketing,Meets,Female,36,11,0,11,21,2.8,3.2,3.4,0.0331,1,1,1,1,2.7,3.2,3.6
5422,363,0,Europe,Manufacturing,Clinical Operations,Below,Male,46,5,0,5,8,3.1,2.6,2.4,0.0,1,1,1,0,3.5,3.0,3.2
5423,265,0,North America,Commercial,Finance & Accounting,Below,Male,32,11,0,6,29,1.2,4.2,3.2,0.0,1,1,1,1,1.9,3.3,2.6
5424,629,0,Europe,Digital,Market Access,Exceeds,Female,41,5,1,12,27,0.0,3.1,3.3,0.1452,1,1,1,1,3.1,2.3,3.8
5425,848,0,Middle East & Africa,HR,Regulatory Affairs,Meets,Male,45,8,0,9,31,3.2,1.9,1.6,0.0383,1,1,1,1,2.4,1.9,2.5
5426,405,0,Latin America,Manufacturing,Supply Chain,Meets,Male,43,10,0,6,25,3.0,3.4,1.4,0.0348,1,1,1,1,1.4,3.6,1.0
5427,272,0,Asia Pacific,Commercial,Market Access,Exceeds,Male,41,15,0,6,17,2.5,3.4,1.0,0.0743,1,1,1,1,3.4,3.4,2.0
5428,82,0,North America,R&D,Supply Chain,Meets,Female,41,4,0,8,20,4.9,2.3,3.6,0.0977,1,1,1,1,4.2,1.8,3.1
5429,375,0,Middle East & Africa,Manufacturing,Data Science,Exceeds,Female,43,5,1,12,28,0.0,2.8,1.9,0.0616,1,1,1,1,2.7,3.4,3.3
5430,394,0,Latin America,Manufacturing,Clinical Operations,Far Exceeds,Male,37,10,0,11,12,1.3,4.0,3.1,0.1069,1,1,1,1,1.0,2.8,2.2
5431,1035,0,Middle East & Africa,Finance,Quality Assurance,Meets,Male,47,4,1,9,19,0.0,4.4,2.8,0.0331,1,1,1,1,3.4,3.7,2.2
5432,875,0,North America,HR,Finance & Accounting,Meets,Non-Binary/Other,50,10,0,8,17,3.2,3.1,2.1,0.0383,1,1,1,1,3.9,2.8,2.8
5433,962,0,Asia Pacific,Finance,Finance & Accounting,Meets,Female,28,17,0,12,15,3.2,4.4,1.7,0.0331,1,1,1,1,2.9,2.7,3.1
5434,514,0,Middle East & Africa,Manufacturing,Market Access,Exceeds,Male,36,19,0,12,21,2.5,3.4,3.0,0.0616,1,1,1,1,3.7,2.4,3.5
5435,356,0,Europe,Manufacturing,Legal & Compliance,Meets,Female,31,4,0,5,18,2.1,2.8,2.4,0.0348,1,1,1,1,2.0,3.1,4.0
5436,812,0,Latin America,HR,Human Resources,Meets,Male,34,11,0,6,19,3.7,3.3,1.7,0.0383,1,0,0,0,3.9,3.4,3.1
5437,753,0,Middle East & Africa,HR,Communications,Far Exceeds,Female,39,19,0,7,19,2.0,2.3,2.1,0.1168,1,1,1,1,1.1,1.7,2.7
5438,606,0,Latin America,Digital,Human Resources,Exceeds,Female,41,13,0,5,15,2.9,2.6,1.0,0.1452,1,1,1,1,3.0,3.4,2.2
5439,262,0,Europe,Commercial,Market Access,Exceeds,Male,37,16,0,8,18,3.4,4.0,4.0,0.0743,1,1,1,1,3.6,4.1,3.0
5440,178,0,Asia Pacific,Commercial,Communications,Meets,Female,42,12,0,6,10,2.9,1.0,3.3,0.0422,1,1,1,1,2.8,1.6,1.7
5441,646,0,Asia Pacific,Digital,Supply Chain,Exceeds,Female,34,21,0,10,24,5.0,2.7,3.4,0.1452,1,1,1,1,4.1,2.8,4.7
5442,329,0,Europe,Commercial,Market Access,Below,Female,36,12,0,12,22,4.1,3.1,3.1,0.0,1,0,0,0,4.9,3.1,3.8
5443,379,0,Latin America,Manufacturing,Quality Assurance,Meets,Male,42,5,0,7,11,3.4,3.9,4.1,0.0348,1,1,1,1,2.7,4.8,2.0
5444,546,0,Middle East & Africa,Digital,Clinical Operations,Meets,Female,36,7,0,11,20,3.0,2.9,2.7,0.0853,1,1,1,1,1.7,3.3,3.6
5445,542,0,Europe,Digital,Legal & Compliance,Meets,Male,30,14,0,9,16,2.3,3.8,1.9,0.0853,1,1,1,0,3.5,1.9,3.8
5446,285,0,North America,Commercial,Data Science,Below,Male,51,17,0,7,10,5.0,3.3,2.0,0.0,1,1,1,1,3.1,1.8,1.8
5447,84,0,Latin America,R&D,Finance & Accounting,Meets,Male,44,5,0,10,19,2.9,1.9,3.5,0.0977,1,1,1,1,2.9,3.3,2.9
5448,313,0,Asia Pacific,Commercial,Regulatory Affairs,Below,Female,39,21,0,7,16,2.6,2.6,1.4,0.0,0,0,0,0,2.2,3.2,2.9
5449,1024,0,Europe,Finance,Clinical Operations,Meets,Male,43,20,0,6,8,3.6,3.0,3.8,0.0331,1,1,1,1,3.9,3.1,4.8
5450,116,0,Asia Pacific,R&D,Sales,Meets,Female,41,13,0,5,17,2.6,3.4,2.3,0.0977,1,1,1,1,3.8,4.5,2.7
5451,695,0,Latin America,Digital,Data Science,Far Exceeds,Male,28,16,0,10,23,3.9,2.7,3.6,0.2363,1,0,0,0,2.9,3.3,4.8
5452,85,0,Asia Pacific,R&D,Market Access,Meets,Female,39,7,0,6,9,3.6,2.4,2.8,0.0977,1,1,1,1,4.4,3.4,2.7
5453,444,0,Europe,Manufacturing,Communications,Exceeds,Male,34,12,1,11,37,0.0,3.6,2.1,0.0616,1,1,1,1,2.1,1.9,1.0
5454,796,0,Latin America,HR,Quality Assurance,Below,Male,39,7,1,12,22,0.0,2.8,4.2,0.0,1,1,1,0,4.1,2.4,3.3
5455,158,0,North America,R&D,Marketing,Meets,Female,40,22,0,9,14,4.1,3.4,2.7,0.0977,1,1,1,1,3.2,4.0,3.5
5456,895,0,Europe,Finance,Market Access,Meets,Female,44,12,1,8,18,0.0,3.6,1.5,0.0331,1,1,1,1,4.5,4.1,3.2
5457,742,0,Middle East & Africa,HR,Legal & Compliance,Meets,Male,32,16,0,9,20,3.1,4.4,1.7,0.0383,1,1,1,1,1.0,4.6,1.9
5458,492,0,Europe,Manufacturing,Pharmacovigilance,Exceeds,Female,32,16,0,10,17,1.6,3.5,2.9,0.0616,1,1,1,1,1.2,3.0,1.7
5459,1031,0,Latin America,Finance,Pharmacovigilance,Meets,Male,35,8,0,11,21,3.3,3.7,1.8,0.0331,1,1,1,1,3.2,2.4,1.4
5460,730,0,Europe,HR,Human Resources,Meets,Female,47,6,0,7,16,2.4,3.5,2.4,0.0383,0,0,0,0,1.9,3.9,3.3
5461,375,1,North America,Manufacturing,Marketing,Meets,Male,36,16,0,6,20,4.0,3.2,2.7,0.0348,1,1,1,1,5.0,4.4,2.1
5462,870,0,North America,HR,Regulatory Affairs,Meets,Male,41,13,0,11,36,4.3,2.0,2.3,0.0383,1,1,1,1,2.6,1.0,2.9
5463,808,0,Middle East & Africa,HR,Pharmacovigilance,Meets,Female,38,11,0,12,14,4.6,2.7,4.5,0.0383,1,0,0,0,3.7,3.2,4.1
5464,265,0,Asia Pacific,Commercial,Regulatory Affairs,Below,Male,36,6,0,5,8,4.0,1.9,3.7,0.0,1,0,0,0,5.0,2.2,2.1
5465,1024,0,Latin America,Finance,Data Science,Exceeds,Female,39,5,0,9,20,5.0,2.3,1.7,0.0588,1,1,1,1,4.9,1.0,3.2
5466,1019,0,Latin America,Finance,Marketing,Exceeds,Male,43,9,0,12,21,2.6,2.7,3.1,0.0588,1,1,1,1,1.5,1.8,3.0
5467,161,0,Asia Pacific,R&D,Regulatory Affairs,Meets,Male,42,5,1,9,16,0.0,3.8,3.9,0.0977,1,1,1,1,5.0,3.1,1.9
5468,999,0,North America,Finance,Sales,Exceeds,Female,31,6,0,9,11,3.6,2.7,1.9,0.0588,1,0,0,0,5.0,3.4,2.3
5469,966,0,North America,Finance,Regulatory Affairs,Meets,Male,40,16,1,5,11,0.0,2.3,1.3,0.0331,1,1,1,1,2.7,2.8,1.3
5470,733,0,Europe,HR,IT & Digital,Meets,Male,48,8,0,10,14,2.9,2.7,3.5,0.0383,0,0,0,0,3.5,1.7,4.1
5471,674,0,Middle East & Africa,Digital,Medical Affairs,Meets,Male,40,14,1,8,14,0.0,4.3,2.4,0.0853,0,0,0,0,2.9,2.7,2.9
5472,255,0,Middle East & Africa,Commercial,Communications,Far Exceeds,Male,45,5,0,12,18,2.3,1.9,2.1,0.1275,0,0,0,0,3.0,2.9,1.4
5473,40,0,Middle East & Africa,R&D,Human Resources,Meets,Male,48,11,0,8,13,4.1,3.6,3.3,0.0977,1,1,1,1,4.0,3.3,2.6
5474,322,0,Europe,Commercial,Human Resources,Meets,Female,39,8,0,6,10,3.6,3.6,2.6,0.0422,1,1,1,1,3.4,3.8,1.0
5475,162,0,Middle East & Africa,R&D,Data Science,Meets,Male,38,14,0,9,11,2.1,4.0,3.1,0.0977,1,1,1,1,3.1,2.9,5.0
5476,434,0,Asia Pacific,Manufacturing,Sales,Meets,Female,41,10,1,10,21,0.0,2.4,4.6,0.0348,1,1,1,1,4.4,2.7,2.9
5477,758,1,Europe,HR,Marketing,Meets,Male,46,19,1,11,16,0.0,2.2,4.2,0.0383,1,1,1,1,3.0,3.7,3.6
5478,887,0,Asia Pacific,Finance,Finance & Accounting,Meets,Female,37,11,0,7,38,3.2,2.2,3.9,0.0331,1,1,1,1,2.0,4.3,2.7
5479,931,0,Europe,Finance,Supply Chain,Meets,Male,31,15,0,9,11,3.3,3.5,4.2,0.0331,1,1,1,1,2.8,2.9,4.4
5480,603,0,Middle East & Africa,Digital,Market Access,Meets,Male,40,3,1,6,19,0.0,3.1,3.8,0.0853,0,0,0,0,3.2,4.0,2.2
5481,314,0,Asia Pacific,Commercial,Quality Assurance,Exceeds,Male,44,11,0,9,13,3.8,2.1,3.6,0.0743,1,1,1,1,3.3,2.7,3.3
5482,210,1,Asia Pacific,Commercial,Pharmacovigilance,Far Exceeds,Male,40,11,1,11,16,0.0,2.1,2.8,0.1275,1,1,1,1,3.8,2.1,2.9
5483,298,0,Asia Pacific,Commercial,Legal & Compliance,Meets,Female,41,5,1,5,24,0.0,2.4,2.4,0.0422,1,1,1,1,3.2,4.1,4.1
5484,925,0,Europe,Finance,Medical Affairs,Exceeds,Male,38,11,0,11,22,3.1,2.6,3.5,0.0588,1,1,1,1,2.6,3.2,1.8
5485,209,0,Latin America,Commercial,Medical Affairs,Exceeds,Female,37,15,0,9,12,2.1,2.4,1.3,0.0743,1,1,1,1,2.1,1.0,3.4
5486,697,0,Middle East & Africa,HR,Supply Chain,Meets,Female,46,10,1,11,27,0.0,3.1,2.3,0.0383,1,1,1,1,5.0,4.5,2.4
5487,162,0,Asia Pacific,R&D,IT & Digital,Exceeds,Male,28,19,0,11,14,3.0,3.0,2.4,0.1648,1,1,1,1,3.2,4.1,1.6
5488,975,0,Latin America,Finance,Communications,Below,Male,39,9,1,5,15,0.0,1.8,3.5,0.0,1,1,1,1,4.3,3.3,2.7
5489,749,0,Middle East & Africa,HR,Market Access,Meets,Female,32,28,0,11,17,3.0,2.6,2.6,0.0383,1,1,1,0,1.6,2.9,3.3
5490,431,0,Middle East & Africa,Manufacturing,Market Access,Meets,Male,38,23,0,7,10,3.2,4.0,3.7,0.0348,1,1,1,1,5.0,4.1,2.2
5491,856,0,Asia Pacific,HR,Human Resources,Meets,Female,40,11,1,8,17,0.0,3.5,2.7,0.0383,1,1,1,1,3.6,3.0,3.3
5492,807,0,Asia Pacific,HR,Pharmacovigilance,Meets,Female,41,9,0,6,21,3.9,2.3,1.0,0.0383,1,1,1,1,2.5,3.6,1.5
5493,466,0,Europe,Manufacturing,Human Resources,Meets,Female,39,13,0,10,13,2.8,3.7,3.6,0.0348,1,1,1,1,3.3,1.6,2.9
5494,821,0,Latin America,HR,Regulatory Affairs,Below,Female,46,14,0,11,23,3.8,4.1,2.1,0.0,1,1,1,1,5.0,4.1,1.0
5495,85,0,Latin America,R&D,Finance & Accounting,Far Exceeds,Female,39,9,0,7,23,4.5,3.0,1.4,0.2644,1,1,1,1,5.0,3.4,2.0
5496,1007,0,Asia Pacific,Finance,Human Resources,Meets,Female,32,5,0,5,12,4.1,4.3,3.4,0.0331,1,1,1,1,3.8,4.7,2.8
5497,569,0,Middle East & Africa,Digital,Marketing,Exceeds,Male,44,26,0,8,22,2.6,3.9,1.0,0.1452,1,1,1,1,3.0,4.2,1.0
5498,442,0,Asia Pacific,Manufacturing,Market Access,Meets,Male,40,16,0,9,15,3.0,3.6,2.7,0.0348,1,1,1,1,2.1,2.1,2.5
5499,957,0,Middle East & Africa,Finance,Market Access,Meets,Female,32,9,0,5,17,3.7,2.5,2.9,0.0331,1,1,1,1,5.0,2.5,2.0
5500,248,0,Middle East & Africa,Commercial,Quality Assurance,Meets,Female,42,11,1,12,18,0.0,1.5,3.6,0.0422,1,1,1,1,4.3,2.0,3.8
5501,67,0,Asia Pacific,R&D,Finance & Accounting,Meets,Female,35,14,0,6,15,5.0,1.9,1.2,0.0977,0,0,0,0,5.0,4.0,2.3
5502,555,0,North America,Digital,Sales,Below,Female,44,4,0,9,15,4.8,1.7,3.1,0.0,1,1,1,1,3.6,1.5,2.0
5503,97,0,Latin America,R&D,Sales,Meets,Male,30,30,0,5,15,2.7,3.8,3.9,0.0977,1,1,1,1,4.0,3.1,2.7
5504,122,0,Middle East & Africa,R&D,Quality Assurance,Below,Female,37,31,0,12,21,3.3,2.8,2.1,0.0,1,1,1,1,2.9,4.2,1.5
5505,326,0,Middle East & Africa,Commercial,Clinical Operations,Meets,Male,41,4,1,9,17,0.0,2.9,2.1,0.0422,1,1,1,1,4.7,3.7,1.1
5506,616,0,North America,Digital,Marketing,Far Exceeds,Female,32,18,0,9,17,4.6,4.6,3.5,0.2363,1,1,1,1,3.2,3.3,1.2
5507,104,0,Europe,R&D,Market Access,Far Below,Female,41,8,0,9,23,3.0,1.7,3.2,0.0,1,1,1,1,2.9,1.7,2.5
5508,324,0,North America,Commercial,Finance & Accounting,Meets,Male,44,10,0,8,15,4.0,3.6,2.1,0.0422,1,1,1,1,4.4,4.8,2.3
5509,401,0,North America,Manufacturing,Pharmacovigilance,Meets,Female,37,9,1,11,19,0.0,2.8,3.0,0.0348,1,1,1,1,2.2,2.4,3.5
5510,311,0,Middle East & Africa,Commercial,IT & Digital,Meets,Non-Binary/Other,40,6,0,10,17,3.9,1.3,3.9,0.0422,1,1,1,1,3.6,2.6,4.9
5511,716,0,Latin America,HR,Marketing,Meets,Female,33,23,0,10,19,4.1,3.3,1.6,0.0383,1,1,1,1,2.9,4.3,1.4
5512,947,0,North America,Finance,Communications,Meets,Male,55,2,0,6,9,4.5,2.0,2.4,0.0331,1,0,0,0,3.7,3.5,3.6
5513,316,0,Europe,Commercial,Supply Chain,Meets,Male,38,5,0,10,20,3.6,1.1,4.5,0.0422,0,0,0,0,2.8,1.2,4.0
5514,184,0,Asia Pacific,Commercial,Medical Affairs,Below,Female,40,13,0,8,27,3.7,1.1,2.1,0.0,1,1,1,1,3.9,2.5,1.8
5515,234,0,North America,Commercial,IT & Digital,Meets,Male,36,9,0,9,15,3.4,2.3,2.4,0.0422,1,1,1,1,4.1,3.0,3.2
5516,8,0,North America,R&D,Market Access,Meets,Male,34,12,0,8,36,3.5,2.5,3.8,0.0977,1,1,1,1,3.4,2.8,3.3
5517,676,0,Europe,Digital,Clinical Operations,Exceeds,Female,44,2,1,6,31,0.0,2.9,1.1,0.1452,0,0,0,0,5.0,3.5,3.1
5518,296,0,Latin America,Commercial,Pharmacovigilance,Exceeds,Female,28,16,1,7,12,0.0,1.0,2.2,0.0743,1,1,1,1,2.6,3.4,1.8
5519,324,0,North America,Commercial,IT & Digital,Meets,Male,28,35,0,10,14,3.0,2.4,3.3,0.0422,1,1,1,1,2.7,3.2,1.6
5520,725,0,North America,HR,Marketing,Meets,Male,40,8,0,7,16,2.6,3.5,1.7,0.0383,1,0,0,0,2.8,3.2,2.0
5521,750,0,Latin America,HR,Data Science,Meets,Female,36,17,0,12,27,2.7,3.4,3.0,0.0383,1,1,1,1,2.6,2.8,2.0
5522,430,1,Europe,Manufacturing,Medical Affairs,Meets,Female,43,6,1,5,10,0.0,2.0,2.2,0.0348,1,1,1,1,2.8,2.2,2.5
5523,490,0,North America,Manufacturing,Market Access,Meets,Male,35,15,0,7,11,2.4,4.4,1.2,0.0348,1,0,0,0,4.0,3.4,2.2
5524,795,0,Latin America,HR,IT & Digital,Meets,Male,28,19,0,12,16,3.4,1.7,1.0,0.0383,1,1,1,1,2.5,1.5,1.7
5525,621,0,North America,Digital,Marketing,Exceeds,Female,38,23,0,9,32,2.4,1.4,1.0,0.1452,1,1,1,1,2.8,1.0,1.0
5526,417,1,Asia Pacific,Manufacturing,Marketing,Meets,Male,36,6,1,11,23,0.0,3.2,3.0,0.0348,1,1,1,1,4.6,3.7,2.2
5527,893,0,Middle East & Africa,Finance,IT & Digital,Meets,Male,32,6,1,10,11,0.0,2.2,2.7,0.0331,1,1,1,1,3.3,3.6,4.9
5528,1024,0,Asia Pacific,Finance,Pharmacovigilance,Meets,Female,43,8,0,8,22,2.7,3.6,1.7,0.0331,1,1,1,1,3.2,4.1,2.0
5529,535,0,North America,Digital,Medical Affairs,Exceeds,Female,40,19,0,7,24,4.2,2.1,3.2,0.1452,1,1,1,1,3.5,3.9,4.0
5530,822,0,Europe,HR,Sales,Meets,Female,32,17,0,6,14,2.6,3.6,2.8,0.0383,1,1,1,1,4.0,2.4,3.0
5531,446,0,Middle East & Africa,Manufacturing,Sales,Meets,Female,29,13,0,9,18,2.7,4.5,3.4,0.0348,1,1,1,1,3.5,4.5,5.0
5532,239,0,Asia Pacific,Commercial,Data Science,Exceeds,Female,40,13,0,11,17,1.9,3.9,3.2,0.0743,1,1,1,1,1.5,4.1,2.6
5533,870,0,Latin America,HR,Regulatory Affairs,Below,Female,32,16,0,5,14,3.0,2.6,3.2,0.0,1,0,0,0,4.5,4.4,2.0
5534,426,0,Europe,Manufacturing,Quality Assurance,Meets,Female,32,5,0,6,17,2.2,2.5,4.0,0.0348,1,1,1,1,2.4,2.4,3.4
5535,611,0,Asia Pacific,Digital,Market Access,Exceeds,Female,37,11,0,12,15,4.0,2.5,2.9,0.1452,1,0,0,0,4.7,4.1,3.6
5536,887,0,Latin America,Finance,Communications,Exceeds,Male,38,6,0,8,14,4.9,3.5,2.8,0.0588,1,1,1,1,4.4,2.6,3.0
5537,548,0,North America,Digital,Pharmacovigilance,Far Below,Female,41,2,1,9,24,0.0,2.6,2.8,0.0,1,1,1,1,3.0,2.6,2.0
5538,427,0,Latin America,Manufacturing,Market Access,Meets,Female,44,13,0,9,13,4.5,2.2,3.9,0.0348,1,1,1,1,4.1,1.1,5.0
5539,553,0,Asia Pacific,Digital,Human Resources,Meets,Male,35,6,0,8,20,2.5,3.2,4.5,0.0853,1,1,1,1,3.5,3.9,2.8
5540,451,0,Asia Pacific,Manufacturing,Finance & Accounting,Meets,Female,42,3,0,10,46,3.2,4.1,1.9,0.0348,1,1,1,1,3.7,4.4,2.5
5541,396,0,North America,Manufacturing,Pharmacovigilance,Meets,Male,37,17,0,10,16,2.9,3.4,2.6,0.0348,1,1,1,1,3.8,3.8,3.3
5542,694,0,Latin America,Digital,Legal & Compliance,Far Exceeds,Male,45,4,1,7,14,0.0,4.3,5.0,0.2363,1,1,1,1,2.8,4.2,4.0
5543,39,0,Latin America,R&D,Sales,Meets,Male,33,5,0,9,12,3.1,2.9,2.3,0.0977,0,0,0,0,1.6,4.3,3.8
5544,180,0,North America,Commercial,Human Resources,Meets,Male,41,9,0,11,36,3.3,3.0,1.0,0.0422,1,1,1,1,2.6,3.0,3.2
5545,768,0,Latin America,HR,Pharmacovigilance,Meets,Male,33,2,0,10,29,3.0,3.3,1.4,0.0383,1,1,1,1,4.1,2.3,2.2
5546,990,0,North America,Finance,Medical Affairs,Below,Female,33,8,1,8,19,0.0,4.0,2.0,0.0,1,1,1,1,3.5,4.0,2.3
5547,308,0,Europe,Commercial,Regulatory Affairs,Meets,Female,35,11,0,10,14,3.1,3.2,1.4,0.0422,1,1,1,1,4.2,4.2,1.0
5548,856,0,Asia Pacific,HR,Data Science,Meets,Female,28,6,0,10,12,2.9,2.0,3.6,0.0383,1,0,0,0,3.2,3.9,3.6
5549,778,1,Europe,HR,Clinical Operations,Exceeds,Non-Binary/Other,44,4,1,8,21,0.0,5.0,3.8,0.0677,1,1,1,1,5.0,4.7,4.0
5550,914,0,Middle East & Africa,Finance,Sales,Meets,Female,33,18,0,7,18,4.0,4.5,1.9,0.0331,0,0,0,0,3.7,4.2,3.4
5551,255,0,Middle East & Africa,Commercial,Clinical Operations,Meets,Female,35,5,0,9,14,3.6,3.7,2.7,0.0422,0,0,0,0,3.9,2.7,4.5
5552,981,0,Middle East & Africa,Finance,IT & Digital,Meets,Female,32,14,0,5,16,3.2,2.4,1.2,0.0331,1,1,1,1,4.8,3.4,1.4
5553,392,0,North America,Manufacturing,Human Resources,Meets,Female,44,21,0,12,17,3.5,2.7,3.5,0.0348,1,1,1,0,2.6,1.6,2.4
5554,912,0,Latin America,Finance,Clinical Operations,Below,Male,40,12,0,8,11,5.0,3.7,3.4,0.0,1,1,1,1,4.5,2.4,4.1
5555,531,0,Europe,Digital,Legal & Compliance,Exceeds,Male,41,15,0,10,17,2.6,2.3,1.6,0.1452,1,1,1,1,2.5,3.2,1.4
5556,128,0,Europe,R&D,Human Resources,Exceeds,Female,39,7,0,9,12,3.5,2.8,3.8,0.1648,1,1,1,1,2.1,4.1,2.5
5557,8,0,Europe,R&D,Human Resources,Below,Male,39,11,0,11,24,3.8,2.4,2.2,0.0,1,1,1,1,3.9,3.8,3.3
5558,157,0,Europe,R&D,Finance & Accounting,Meets,Male,40,14,0,5,13,2.6,3.2,2.3,0.0977,1,1,1,1,3.7,4.7,3.6
5559,260,0,Middle East & Africa,Commercial,Supply Chain,Meets,Male,44,12,1,6,24,0.0,3.5,1.9,0.0422,1,1,1,1,2.6,1.8,3.6
5560,353,0,Europe,Commercial,Regulatory Affairs,Meets,Female,31,13,0,11,28,3.4,3.8,2.2,0.0422,1,1,1,1,5.0,4.4,3.4
5561,456,0,Latin America,Manufacturing,Communications,Meets,Male,35,6,0,10,18,2.3,2.0,1.4,0.0348,0,0,0,0,3.0,2.4,1.8
5562,26,0,Middle East & Africa,R&D,Quality Assurance,Meets,Female,32,6,0,8,16,3.0,2.5,1.0,0.0977,0,0,0,0,3.2,3.5,2.9
5563,413,0,Europe,Manufacturing,Marketing,Far Below,Male,42,15,1,7,11,0.0,2.4,3.2,0.0,0,0,0,0,2.6,4.8,2.4
5564,160,0,North America,R&D,Medical Affairs,Meets,Female,41,10,0,9,21,4.5,2.5,3.8,0.0977,1,1,1,1,4.0,2.2,4.3
5565,266,0,Asia Pacific,Commercial,Pharmacovigilance,Below,Female,42,10,1,11,21,0.0,3.2,2.1,0.0,1,1,1,1,4.9,2.8,3.9
5566,546,0,Asia Pacific,Digital,Communications,Far Below,Male,28,4,0,6,13,2.9,2.5,2.8,0.0,1,1,1,1,3.7,3.0,2.0
5567,617,1,Asia Pacific,Digital,Market Access,Meets,Female,35,7,0,7,19,1.6,2.0,1.4,0.0853,0,0,0,0,4.0,2.3,1.8
5568,537,0,Middle East & Africa,Digital,Quality Assurance,Meets,Female,28,21,0,12,21,4.8,3.3,1.6,0.0853,1,1,1,1,3.4,3.8,1.0
5569,923,0,Europe,Finance,Finance & Accounting,Meets,Male,50,15,0,8,12,4.6,1.0,2.9,0.0331,1,1,1,1,4.7,1.9,3.7
5570,651,0,Middle East & Africa,Digital,Market Access,Meets,Male,39,17,0,9,24,4.8,2.6,1.8,0.0853,1,1,1,1,4.8,4.3,2.5
5571,751,0,Latin America,HR,Data Science,Below,Male,33,13,0,5,18,3.1,4.1,3.3,0.0,1,1,1,1,3.3,2.7,3.2
5572,48,0,North America,R&D,Data Science,Meets,Female,37,20,0,6,17,4.4,4.4,1.9,0.0977,1,1,1,1,2.8,2.0,4.0
5573,676,0,North America,Digital,Medical Affairs,Exceeds,Male,38,4,0,10,28,2.9,3.7,4.3,0.1452,1,1,1,1,3.2,4.0,2.4
5574,846,0,Asia Pacific,HR,Legal & Compliance,Meets,Male,50,26,0,11,16,3.7,2.7,4.0,0.0383,0,0,0,0,2.7,2.3,4.0
5575,704,0,Asia Pacific,HR,Pharmacovigilance,Exceeds,Female,37,10,0,12,25,3.6,3.7,4.5,0.0677,1,1,1,1,3.8,2.8,2.6
5576,809,0,Asia Pacific,HR,Pharmacovigilance,Meets,Male,39,11,0,6,24,3.4,5.0,3.3,0.0383,1,1,1,1,3.0,3.6,3.1
5577,469,0,Europe,Manufacturing,Sales,Exceeds,Male,34,17,0,6,9,2.5,3.4,1.1,0.0616,1,1,1,1,4.5,4.1,1.0
5578,415,0,Latin America,Manufacturing,IT & Digital,Meets,Female,51,4,0,11,16,3.8,3.9,3.1,0.0348,1,1,1,1,2.8,4.0,3.1
5579,789,0,Latin America,HR,Pharmacovigilance,Below,Male,47,6,1,12,22,0.0,5.0,3.0,0.0,1,1,1,1,2.9,4.2,4.2
5580,930,0,Latin America,Finance,Marketing,Meets,Female,28,11,0,12,23,3.0,3.7,2.4,0.0331,1,1,1,1,2.3,3.6,3.5
5581,692,0,Latin America,Digital,Quality Assurance,Meets,Female,43,16,0,12,38,4.3,2.4,2.2,0.0853,1,1,1,1,5.0,2.8,1.4
5582,72,0,Asia Pacific,R&D,Human Resources,Meets,Male,41,10,0,12,29,2.3,1.4,2.3,0.0977,0,0,0,0,2.3,1.4,3.4
5583,981,0,North America,Finance,Quality Assurance,Meets,Female,33,2,0,11,18,2.4,3.8,1.6,0.0331,1,1,1,1,2.8,4.1,2.8
5584,292,0,Asia Pacific,Commercial,IT & Digital,Far Below,Female,32,13,0,8,20,2.6,2.3,2.6,0.0,1,1,1,1,2.7,2.4,2.3
5585,394,0,Latin America,Manufacturing,Market Access,Meets,Female,28,9,1,12,14,0.0,3.5,1.7,0.0348,1,1,0,0,3.7,4.6,2.8
5586,681,0,Asia Pacific,Digital,Communications,Exceeds,Male,42,5,1,7,8,0.0,2.0,1.4,0.1452,1,1,1,1,4.6,3.5,1.6
5587,542,0,Latin America,Digital,Supply Chain,Far Exceeds,Male,30,7,0,8,24,3.6,2.6,2.0,0.2363,1,1,1,1,4.6,3.0,1.9
5588,328,0,Middle East & Africa,Commercial,Medical Affairs,Meets,Female,40,36,0,6,19,2.6,3.9,2.1,0.0422,1,1,1,1,2.8,4.1,2.6
5589,334,0,North America,Commercial,Medical Affairs,Far Below,Male,31,12,0,8,20,3.8,1.2,2.7,0.0,1,1,1,1,2.3,1.0,1.4
5590,638,0,Middle East & Africa,Digital,Marketing,Below,Female,31,17,0,9,30,4.4,5.0,3.3,0.0,1,1,1,1,2.8,3.7,4.1
5591,281,0,Europe,Commercial,Legal & Compliance,Exceeds,Female,38,20,0,8,8,4.7,1.8,1.0,0.0743,1,1,1,1,4.3,1.0,2.0
5592,635,0,Asia Pacific,Digital,Pharmacovigilance,Exceeds,Male,46,8,0,10,14,1.9,2.6,3.7,0.1452,1,1,1,1,1.8,3.6,2.4
5593,945,0,Europe,Finance,Supply Chain,Exceeds,Female,33,4,0,10,13,4.0,2.8,4.9,0.0588,1,1,1,1,3.7,2.0,3.2
5594,228,0,Asia Pacific,Commercial,Sales,Meets,Female,38,15,0,12,19,3.6,2.8,5.0,0.0422,1,1,1,1,2.6,4.5,3.6
5595,924,0,Middle East & Africa,Finance,Sales,Exceeds,Male,39,6,1,11,33,0.0,2.3,1.5,0.0588,0,0,0,0,4.2,2.7,2.1
5596,953,0,Latin America,Finance,Quality Assurance,Exceeds,Female,38,36,0,11,24,3.1,4.7,2.4,0.0588,1,1,1,1,2.1,4.2,2.5
5597,190,0,Latin America,Commercial,Marketing,Meets,Male,40,13,0,8,18,3.2,2.5,2.1,0.0422,1,1,1,1,2.9,3.8,2.1
5598,623,0,Asia Pacific,Digital,Clinical Operations,Meets,Female,38,10,0,8,23,4.1,4.1,2.7,0.0853,1,1,1,1,2.4,3.4,3.2
5599,748,0,Latin America,HR,Clinical Operations,Below,Female,28,20,0,9,16,4.0,2.1,5.0,0.0,1,1,1,1,2.9,1.8,5.0
5600,563,1,Middle East & Africa,Digital,Pharmacovigilance,Meets,Female,46,5,0,7,10,4.3,1.7,2.1,0.0853,1,1,1,1,5.0,2.8,3.3
5601,150,0,Latin America,R&D,Quality Assurance,Far Exceeds,Male,40,16,0,11,20,2.7,3.8,1.4,0.2644,1,1,1,1,3.4,3.4,1.5
5602,224,0,Middle East & Africa,Commercial,Marketing,Below,Male,37,9,0,7,10,3.2,4.3,3.8,0.0,1,1,1,1,3.5,1.8,4.3
5603,453,0,Europe,Manufacturing,Finance & Accounting,Meets,Female,32,16,0,7,10,4.4,3.2,3.2,0.0348,1,1,1,1,3.2,2.9,2.8
5604,255,0,Middle East & Africa,Commercial,Clinical Operations,Meets,Male,36,4,0,9,15,3.3,5.0,2.5,0.0422,1,1,1,1,2.5,4.0,2.6
5605,176,0,North America,R&D,Legal & Compliance,Exceeds,Female,43,20,0,11,22,4.4,2.9,2.9,0.1648,0,0,0,0,2.9,4.0,3.0
5606,968,0,North America,Finance,Regulatory Affairs,Meets,Female,30,8,0,5,9,3.1,3.3,4.5,0.0331,0,0,0,0,3.8,2.8,3.9
5607,409,0,North America,Manufacturing,Market Access,Exceeds,Male,33,15,0,11,31,4.4,2.5,2.7,0.0616,1,1,1,1,4.0,1.7,3.2
5608,383,0,Asia Pacific,Manufacturing,Data Science,Meets,Male,37,2,1,10,42,0.0,2.6,2.6,0.0348,1,1,1,1,3.2,2.1,3.2
5609,638,0,Asia Pacific,Digital,Market Access,Meets,Female,28,4,1,12,20,0.0,4.2,1.6,0.0853,1,1,1,1,4.5,4.8,1.5
5610,768,0,Asia Pacific,HR,IT & Digital,Far Below,Female,32,22,0,11,15,3.7,4.6,2.8,0.0,0,0,0,0,2.7,3.5,3.0
5611,623,0,Middle East & Africa,Digital,Data Science,Meets,Male,36,12,1,7,11,0.0,4.1,1.9,0.0853,1,1,1,1,3.9,3.7,3.0
5612,470,0,Asia Pacific,Manufacturing,Regulatory Affairs,Meets,Female,28,7,0,11,25,1.4,2.3,2.2,0.0348,1,0,0,0,1.4,3.4,2.8
5613,443,0,Europe,Manufacturing,IT & Digital,Meets,Non-Binary/Other,37,18,0,7,15,2.9,2.7,2.9,0.0348,1,1,1,1,3.6,2.6,3.1
5614,741,0,North America,HR,Regulatory Affairs,Below,Male,30,12,0,11,31,4.0,1.6,3.2,0.0,1,1,1,1,5.0,2.7,3.7
5615,296,0,Middle East & Africa,Commercial,Marketing,Exceeds,Male,45,22,0,6,10,3.0,4.6,2.7,0.0743,0,0,0,0,3.3,3.1,2.9
5616,734,0,North America,HR,Supply Chain,Meets,Female,35,4,1,5,11,0.0,4.4,4.5,0.0383,1,1,1,1,5.0,3.5,3.3
5617,1000,0,Asia Pacific,Finance,Medical Affairs,Exceeds,Male,42,19,0,11,13,2.9,3.5,3.1,0.0588,1,1,1,1,2.3,2.1,3.4
5618,665,0,Middle East & Africa,Digital,Clinical Operations,Meets,Female,40,5,1,7,12,0.0,3.7,2.2,0.0853,1,1,1,1,3.4,3.1,1.4
5619,251,0,Latin America,Commercial,Marketing,Below,Female,33,4,0,11,16,2.0,3.7,3.6,0.0,1,1,1,1,3.6,5.0,3.8
5620,598,0,Europe,Digital,Supply Chain,Meets,Male,40,18,0,10,25,4.7,2.3,3.8,0.0853,1,1,0,0,4.8,3.3,4.4
5621,720,0,Asia Pacific,HR,Medical Affairs,Exceeds,Female,48,12,0,5,15,4.9,2.1,2.1,0.0677,1,1,0,0,4.7,2.7,1.0
5622,182,0,Asia Pacific,Commercial,Marketing,Meets,Male,38,6,0,9,15,4.6,3.3,3.7,0.0422,0,0,0,0,2.1,3.7,2.3
5623,825,0,Europe,HR,Pharmacovigilance,Meets,Male,36,15,0,6,17,3.7,3.8,2.5,0.0383,1,1,1,1,4.5,2.5,2.5
5624,921,1,Europe,Finance,Medical Affairs,Far Exceeds,Male,40,10,0,7,10,2.2,3.0,2.8,0.1022,1,1,1,1,4.3,3.6,3.2
5625,69,0,Latin America,R&D,IT & Digital,Meets,Female,41,18,0,8,20,3.3,3.5,1.9,0.0977,1,1,1,1,3.6,3.0,1.6
5626,413,0,Asia Pacific,Manufacturing,Communications,Meets,Male,36,3,1,9,14,0.0,3.9,1.0,0.0348,0,0,0,0,4.0,4.4,1.0
5627,219,0,Asia Pacific,Commercial,Legal & Compliance,Meets,Male,28,19,0,12,12,3.9,4.0,3.7,0.0422,1,1,1,1,3.0,4.2,3.8
5628,420,0,North America,Manufacturing,Market Access,Meets,Non-Binary/Other,33,20,0,6,10,2.7,2.1,2.0,0.0348,1,1,1,1,4.3,2.0,2.8
5629,142,0,Middle East & Africa,R&D,Medical Affairs,Meets,Non-Binary/Other,30,16,0,10,11,3.0,1.0,2.9,0.0977,1,1,1,1,2.9,3.1,2.5
5630,350,0,Middle East & Africa,Commercial,Market Access,Meets,Male,38,7,0,7,15,2.5,2.0,3.0,0.0422,1,1,1,1,3.0,2.4,3.4
5631,486,0,North America,Manufacturing,IT & Digital,Meets,Male,45,12,0,12,14,4.4,3.5,3.5,0.0348,1,1,1,1,3.4,4.9,3.9
5632,361,0,Middle East & Africa,Manufacturing,Sales,Below,Female,41,5,1,9,30,0.0,1.1,1.7,0.0,1,1,1,1,2.2,1.0,2.5
5633,251,1,Europe,Commercial,Data Science,Meets,Female,35,17,0,7,19,4.8,3.2,2.2,0.0422,1,1,1,1,4.3,2.1,3.4
5634,516,0,Middle East & Africa,Manufacturing,Market Access,Meets,Female,40,7,0,8,30,3.6,4.0,3.0,0.0348,1,1,1,1,3.2,4.1,1.7
5635,458,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Meets,Male,38,3,1,10,31,0.0,3.1,3.7,0.0348,1,1,1,1,4.3,4.8,4.0
5636,199,0,North America,Commercial,Communications,Exceeds,Male,41,11,0,9,12,4.0,3.7,3.4,0.0743,1,1,1,1,3.2,4.6,2.8
5637,368,0,Latin America,Manufacturing,Pharmacovigilance,Below,Female,41,6,1,8,19,0.0,2.6,1.7,0.0,1,1,1,1,3.9,2.7,2.4
5638,470,0,Middle East & Africa,Manufacturing,Finance & Accounting,Meets,Female,46,18,0,10,14,2.6,3.4,3.2,0.0348,0,0,0,0,3.2,2.8,1.0
5639,693,0,Middle East & Africa,Digital,Clinical Operations,Meets,Female,37,23,0,12,14,2.0,3.0,2.4,0.0853,1,1,1,1,3.5,3.5,3.6
5640,953,0,Latin America,Finance,Sales,Meets,Female,28,2,1,11,20,0.0,2.3,3.5,0.0331,0,0,0,0,4.0,3.8,2.6
5641,643,0,North America,Digital,Sales,Meets,Female,30,11,0,5,8,3.3,2.0,3.0,0.0853,1,1,1,1,3.7,2.1,2.3
5642,144,0,Latin America,R&D,Quality Assurance,Meets,Male,38,9,1,7,11,0.0,1.6,2.0,0.0977,1,1,0,0,3.2,1.7,3.8
5643,615,0,North America,Digital,Marketing,Meets,Female,36,36,0,8,14,3.8,4.0,4.2,0.0853,1,1,1,1,4.4,5.0,4.1
5644,614,0,Europe,Digital,Marketing,Meets,Male,42,8,0,5,19,4.0,3.5,3.2,0.0853,1,1,0,0,4.2,5.0,2.3
5645,156,0,North America,R&D,Marketing,Meets,Male,44,9,0,5,9,3.2,2.2,3.2,0.0977,1,1,1,1,3.9,1.7,4.3
5646,369,0,Europe,Manufacturing,Medical Affairs,Meets,Female,38,15,1,11,30,0.0,2.0,2.8,0.0348,1,1,1,1,2.4,2.5,3.0
5647,363,0,Europe,Manufacturing,Communications,Meets,Female,31,4,0,7,36,4.6,3.1,3.0,0.0348,1,0,0,0,3.2,3.0,2.8
5648,658,0,North America,Digital,Clinical Operations,Exceeds,Male,41,1,1,9,22,0.0,3.4,2.5,0.1452,1,1,1,0,4.2,2.4,3.3
5649,70,0,Asia Pacific,R&D,Data Science,Below,Male,40,8,0,8,26,4.2,2.6,4.7,0.0,1,1,1,1,3.4,3.5,4.5
5650,370,0,North America,Manufacturing,Finance & Accounting,Far Exceeds,Male,42,10,0,12,13,4.7,2.5,2.3,0.1069,0,0,0,0,5.0,3.3,1.0
5651,837,0,Middle East & Africa,HR,Finance & Accounting,Below,Male,34,2,1,6,31,0.0,3.0,2.5,0.0,1,1,1,1,3.1,2.6,1.0
5652,325,0,Middle East & Africa,Commercial,Communications,Meets,Female,55,9,0,5,11,2.4,3.0,2.5,0.0422,1,1,1,1,1.3,1.0,2.3
5653,271,0,Asia Pacific,Commercial,Market Access,Meets,Female,28,10,1,6,8,0.0,2.5,4.3,0.0422,1,1,1,1,3.1,3.7,4.2
5654,1040,0,Europe,Finance,IT & Digital,Below,Female,39,22,0,8,15,5.0,3.2,2.5,0.0,1,1,1,1,4.0,4.3,2.1
5655,309,0,Asia Pacific,Commercial,Human Resources,Exceeds,Male,42,7,0,11,12,3.8,1.0,3.9,0.0743,1,1,1,1,3.9,1.0,4.8
5656,682,0,Middle East & Africa,Digital,Marketing,Meets,Male,43,2,1,8,19,0.0,3.4,2.5,0.0853,0,0,0,0,3.2,3.0,3.2
5657,248,0,Asia Pacific,Commercial,Sales,Below,Male,38,19,0,12,21,3.1,3.8,3.3,0.0,1,1,1,1,3.4,4.5,2.3
5658,187,0,North America,Commercial,Market Access,Meets,Male,42,6,0,10,28,3.3,2.7,4.6,0.0422,1,1,0,0,3.9,2.1,5.0
5659,842,0,Asia Pacific,HR,Clinical Operations,Meets,Female,43,7,0,6,28,3.2,4.5,1.9,0.0383,1,1,1,1,4.5,3.9,2.9
5660,396,0,Europe,Manufacturing,Sales,Far Exceeds,Female,39,6,0,6,30,3.0,2.4,3.7,0.1069,1,1,0,0,2.8,2.9,3.3
5661,765,0,North America,HR,Regulatory Affairs,Meets,Non-Binary/Other,39,13,0,8,17,4.0,3.2,1.2,0.0383,1,1,1,1,4.4,2.7,2.8
5662,616,0,Latin America,Digital,Clinical Operations,Meets,Female,42,5,1,11,15,0.0,2.2,2.3,0.0853,1,1,1,1,3.4,1.9,2.7
5663,325,0,Middle East & Africa,Commercial,Medical Affairs,Below,Female,38,18,0,8,19,2.4,3.1,2.4,0.0,1,1,1,1,3.7,3.2,2.8
5664,402,0,Middle East & Africa,Manufacturing,Marketing,Meets,Male,46,19,0,12,18,4.8,2.9,2.6,0.0348,1,1,1,1,4.6,4.6,3.5
5665,895,0,Asia Pacific,Finance,Supply Chain,Meets,Male,44,11,0,9,17,4.6,1.9,2.2,0.0331,1,1,1,1,3.9,3.5,2.9
5666,931,0,North America,Finance,Pharmacovigilance,Far Exceeds,Female,36,16,0,6,11,3.4,3.5,3.1,0.1022,1,1,1,1,4.6,2.3,2.7
5667,258,0,Latin America,Commercial,Sales,Meets,Female,34,10,0,10,13,5.0,3.4,2.3,0.0422,1,1,1,1,2.1,4.8,3.2
5668,191,0,North America,Commercial,Quality Assurance,Exceeds,Female,43,36,0,5,15,2.5,2.9,2.4,0.0743,1,1,1,1,2.6,4.3,1.8
5669,1045,0,Middle East & Africa,Finance,Quality Assurance,Far Exceeds,Male,39,15,0,10,11,3.4,2.0,2.4,0.1022,1,1,1,1,1.8,1.4,3.1
5670,912,0,North America,Finance,Human Resources,Meets,Non-Binary/Other,34,10,0,11,19,4.6,3.8,2.3,0.0331,1,1,1,1,2.6,4.6,3.6
5671,529,0,Latin America,Digital,Pharmacovigilance,Below,Male,35,11,0,12,27,3.2,3.4,2.9,0.0,1,1,1,1,3.6,1.8,3.6
5672,348,0,Asia Pacific,Commercial,Data Science,Below,Male,42,25,0,12,24,2.6,4.9,2.7,0.0,1,1,1,1,2.2,4.2,1.4
5673,930,0,Europe,Finance,Data Science,Meets,Female,35,17,0,12,34,3.5,2.0,3.1,0.0331,1,1,1,1,4.2,3.4,2.8
5674,3,0,North America,R&D,Pharmacovigilance,Meets,Male,47,13,1,9,14,0.0,3.1,3.3,0.0977,1,1,1,1,4.6,4.0,2.1
5675,898,0,Europe,Finance,Supply Chain,Below,Female,32,17,0,10,15,3.4,5.0,2.7,0.0,1,1,1,1,4.1,4.6,2.2
5676,377,0,Middle East & Africa,Manufacturing,Communications,Meets,Male,35,15,0,12,14,4.4,3.9,2.0,0.0348,1,1,1,1,2.7,2.2,2.0
5677,516,0,Asia Pacific,Manufacturing,Medical Affairs,Meets,Female,32,16,1,6,23,0.0,3.3,2.0,0.0348,1,1,1,1,3.7,1.5,2.0
5678,42,0,Asia Pacific,R&D,Communications,Far Below,Male,31,16,1,9,15,0.0,2.1,2.4,0.0,1,1,1,1,2.5,3.1,2.5
5679,525,0,North America,Digital,Clinical Operations,Meets,Male,33,11,0,9,27,3.0,3.9,4.9,0.0853,1,1,1,1,3.4,2.9,4.2
5680,348,0,Asia Pacific,Commercial,Supply Chain,Below,Female,35,17,0,12,12,3.7,2.7,1.4,0.0,0,0,0,0,4.5,4.7,1.4
5681,299,0,North America,Commercial,Market Access,Meets,Male,35,5,1,11,20,0.0,2.7,2.3,0.0422,1,1,1,1,3.6,1.6,1.2
5682,990,0,North America,Finance,Marketing,Below,Male,28,12,0,7,14,2.6,4.7,2.1,0.0,1,1,0,0,1.8,3.0,2.0
5683,406,0,Europe,Manufacturing,Data Science,Exceeds,Female,31,11,0,6,12,3.8,4.3,1.5,0.0616,1,1,1,1,3.6,3.5,2.2
5684,640,0,Asia Pacific,Digital,Legal & Compliance,Below,Female,39,8,0,11,14,4.8,3.3,2.3,0.0,1,1,1,1,4.4,3.9,1.9
5685,536,1,North America,Digital,Sales,Exceeds,Male,34,6,0,11,44,3.7,2.8,2.8,0.1452,1,1,1,1,4.3,3.0,3.0
5686,647,0,Europe,Digital,Data Science,Meets,Male,44,6,0,11,19,3.8,1.4,4.1,0.0853,1,1,1,1,3.5,2.3,5.0
5687,943,0,Latin America,Finance,Quality Assurance,Meets,Female,37,2,0,10,19,3.4,3.5,2.1,0.0331,1,1,1,1,4.2,2.9,1.0
5688,218,0,Europe,Commercial,Sales,Meets,Female,42,21,0,8,13,3.8,3.1,4.5,0.0422,1,1,1,1,4.0,4.0,4.7
5689,696,0,Europe,Digital,Market Access,Meets,Non-Binary/Other,36,22,0,10,15,2.6,3.7,1.2,0.0853,0,0,0,0,2.6,4.7,2.2
5690,923,0,North America,Finance,Market Access,Below,Male,43,4,0,6,10,3.9,1.0,3.1,0.0,1,1,1,1,2.0,1.6,3.3
5691,920,0,Middle East & Africa,Finance,Marketing,Meets,Female,28,8,0,6,11,3.5,2.1,1.8,0.0331,1,1,0,0,3.6,1.9,1.8
5692,116,0,Middle East & Africa,R&D,Regulatory Affairs,Exceeds,Male,39,6,1,6,13,0.0,2.5,3.0,0.1648,1,1,1,1,3.7,3.2,3.1
5693,746,1,Middle East & Africa,HR,Quality Assurance,Far Exceeds,Male,47,3,0,8,20,4.1,3.2,5.0,0.1168,1,1,1,1,5.0,3.3,4.2
5694,690,0,Europe,Digital,Pharmacovigilance,Meets,Male,29,20,0,6,25,2.3,3.1,2.4,0.0853,1,1,1,1,1.8,3.3,1.8
5695,862,0,North America,HR,Data Science,Meets,Male,43,36,0,7,22,3.1,2.5,3.0,0.0383,1,1,1,1,2.3,1.7,3.0
5696,319,0,Asia Pacific,Commercial,Finance & Accounting,Meets,Female,40,14,0,8,16,3.7,3.2,3.1,0.0422,1,1,1,1,4.4,5.0,3.0
5697,1028,0,Europe,Finance,Communications,Meets,Male,29,15,0,11,13,3.7,4.6,2.6,0.0331,0,0,0,0,3.9,5.0,3.0
5698,531,0,Europe,Digital,Marketing,Exceeds,Female,40,9,0,5,10,2.2,3.3,5.0,0.1452,1,1,1,1,2.9,2.6,3.0
5699,358,0,North America,Manufacturing,Marketing,Meets,Female,40,14,1,7,31,0.0,3.7,2.8,0.0348,0,0,0,0,2.4,4.1,4.2
5700,347,1,Latin America,Commercial,Regulatory Affairs,Exceeds,Male,37,6,1,12,40,0.0,3.1,2.7,0.0743,1,0,0,0,4.1,1.8,2.2
5701,68,0,Europe,R&D,Market Access,Meets,Female,45,20,0,11,50,3.9,2.9,2.0,0.0977,1,1,1,1,4.9,3.3,3.8
5702,48,0,Latin America,R&D,Quality Assurance,Meets,Non-Binary/Other,44,8,1,6,15,0.0,2.8,1.7,0.0977,1,1,1,1,2.9,4.5,1.2
5703,862,1,Latin America,HR,Sales,Far Exceeds,Female,43,15,0,12,14,4.5,3.1,3.9,0.1168,1,1,1,1,3.6,1.0,5.0
5704,922,0,Middle East & Africa,Finance,Human Resources,Exceeds,Male,46,7,1,7,42,0.0,4.2,4.5,0.0588,1,1,1,1,1.6,3.8,3.4
5705,801,0,North America,HR,Human Resources,Meets,Male,33,10,0,9,30,5.0,4.2,4.4,0.0383,1,1,1,1,4.6,2.7,4.5
5706,438,0,Latin America,Manufacturing,Quality Assurance,Meets,Male,35,8,0,12,21,3.1,4.0,3.2,0.0348,1,1,1,1,3.1,2.8,3.2
5707,442,0,North America,Manufacturing,Legal & Compliance,Meets,Female,34,19,0,10,25,4.4,3.3,2.0,0.0348,1,1,1,1,3.4,4.5,2.3
5708,56,0,Middle East & Africa,R&D,Finance & Accounting,Below,Male,35,17,1,12,23,0.0,3.8,1.7,0.0,1,1,1,1,3.7,3.6,1.6
5709,690,1,North America,Digital,Legal & Compliance,Meets,Female,35,9,0,8,16,3.7,2.7,2.8,0.0853,1,1,1,1,4.2,3.4,3.8
5710,24,0,Europe,R&D,Quality Assurance,Meets,Male,37,10,0,5,21,3.4,4.2,3.3,0.0977,1,1,1,1,2.6,4.4,3.6
5711,110,0,Latin America,R&D,Communications,Meets,Male,36,16,0,5,9,3.2,4.2,2.6,0.0977,1,1,1,1,2.8,4.6,2.5
5712,439,0,North America,Manufacturing,IT & Digital,Meets,Male,31,30,0,10,19,3.2,3.0,1.7,0.0348,0,0,0,0,2.8,3.1,2.1
5713,777,0,Asia Pacific,HR,Data Science,Meets,Male,43,12,0,11,19,3.2,2.3,2.2,0.0383,1,1,1,1,2.0,4.1,5.0
5714,497,0,North America,Manufacturing,Sales,Meets,Male,33,5,0,6,10,3.6,2.6,3.4,0.0348,1,1,1,1,4.4,1.6,3.0
5715,929,0,Latin America,Finance,Supply Chain,Exceeds,Male,47,13,0,10,21,3.2,1.8,3.0,0.0588,1,1,1,1,3.6,3.1,3.8
5716,489,0,Middle East & Africa,Manufacturing,Sales,Far Below,Female,43,6,0,10,12,4.1,2.6,4.0,0.0,1,1,1,1,4.2,2.5,2.9
5717,467,0,Middle East & Africa,Manufacturing,Marketing,Exceeds,Female,31,10,0,11,14,2.2,1.7,4.2,0.0616,1,1,1,1,2.3,2.7,3.6
5718,85,0,Latin America,R&D,Regulatory Affairs,Meets,Male,38,28,0,5,14,3.6,2.2,5.0,0.0977,1,1,1,1,4.1,3.0,4.1
5719,665,0,Europe,Digital,Quality Assurance,Meets,Female,30,7,0,7,20,3.6,3.5,2.2,0.0853,1,1,1,1,4.4,5.0,1.3
5720,171,0,Europe,R&D,Sales,Exceeds,Female,46,2,0,5,14,3.2,2.5,3.6,0.1648,1,1,1,1,3.5,3.4,4.2
5721,281,0,Middle East & Africa,Commercial,Marketing,Meets,Male,38,9,0,11,28,3.7,2.0,1.7,0.0422,1,1,1,1,4.1,4.4,1.6
5722,479,0,Middle East & Africa,Manufacturing,Clinical Operations,Below,Male,38,23,0,7,22,1.9,3.1,3.1,0.0,1,1,1,1,1.9,3.7,2.0
5723,404,1,Latin America,Manufacturing,Market Access,Meets,Male,39,4,1,9,15,0.0,3.2,2.7,0.0348,1,1,1,1,5.0,3.9,2.3
5724,185,0,Europe,Commercial,Regulatory Affairs,Meets,Male,37,16,0,10,17,3.0,1.5,2.7,0.0422,1,1,1,1,3.8,2.2,1.3
5725,361,1,Middle East & Africa,Manufacturing,Human Resources,Meets,Male,34,20,0,5,39,4.0,3.5,3.1,0.0348,1,1,1,1,5.0,4.0,4.2
5726,362,0,Europe,Manufacturing,Medical Affairs,Below,Female,37,6,0,7,29,3.8,3.5,1.6,0.0,1,1,1,1,4.1,3.2,2.5
5727,887,0,Middle East & Africa,Finance,Human Resources,Below,Female,46,5,1,9,20,0.0,1.6,1.0,0.0,1,1,1,1,3.4,3.3,2.3
5728,445,0,North America,Manufacturing,Pharmacovigilance,Meets,Male,35,17,1,8,24,0.0,4.9,2.2,0.0348,1,1,1,1,3.4,3.9,2.6
5729,289,0,Asia Pacific,Commercial,Marketing,Meets,Male,46,15,1,6,9,0.0,4.9,2.5,0.0422,0,0,0,0,2.3,4.6,2.3
5730,54,0,North America,R&D,Quality Assurance,Meets,Male,35,12,1,11,42,0.0,4.4,2.8,0.0977,1,1,1,1,3.5,4.4,2.4
5731,519,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Meets,Female,39,13,0,8,10,4.4,2.2,2.1,0.0348,1,1,1,1,4.2,3.2,2.0
5732,646,0,Asia Pacific,Digital,Market Access,Meets,Male,50,5,1,6,21,0.0,1.4,2.0,0.0853,1,1,1,1,3.9,3.6,2.0
5733,234,0,Asia Pacific,Commercial,Communications,Below,Male,41,11,1,5,19,0.0,2.1,2.8,0.0,0,0,0,0,3.4,1.0,2.9
5734,726,0,Middle East & Africa,HR,Sales,Meets,Male,40,17,0,9,13,3.3,4.0,3.4,0.0383,1,1,1,1,2.2,3.1,3.4
5735,929,1,Middle East & Africa,Finance,IT & Digital,Exceeds,Female,42,16,0,8,13,3.2,3.1,2.5,0.0588,1,1,1,1,2.7,3.3,2.7
5736,337,0,Europe,Commercial,IT & Digital,Meets,Male,44,4,0,6,11,3.4,3.9,1.0,0.0422,1,1,1,1,3.5,2.4,1.1
5737,11,0,Middle East & Africa,R&D,Finance & Accounting,Meets,Female,33,11,0,11,21,3.0,3.7,1.8,0.0977,1,1,1,1,2.7,3.3,1.3
5738,353,0,Latin America,Commercial,Clinical Operations,Exceeds,Male,41,27,0,11,13,5.0,5.0,1.5,0.0743,1,1,1,1,5.0,4.6,2.1
5739,748,0,Middle East & Africa,HR,Medical Affairs,Exceeds,Male,40,6,0,11,18,3.2,4.8,3.0,0.0677,1,1,1,1,4.1,4.1,3.9
5740,1023,0,Latin America,Finance,Market Access,Meets,Male,28,9,0,9,26,4.0,3.1,4.3,0.0331,1,0,0,0,3.9,2.3,4.1
5741,544,0,Middle East & Africa,Digital,Clinical Operations,Meets,Female,39,14,0,7,13,3.2,3.6,2.1,0.0853,1,1,1,0,2.5,2.0,1.8
5742,812,0,Europe,HR,Human Resources,Meets,Male,32,3,0,11,49,3.2,2.0,2.6,0.0383,1,1,1,1,3.3,3.1,2.4
5743,284,0,Latin America,Commercial,Human Resources,Meets,Female,39,9,1,12,30,0.0,2.0,1.0,0.0422,0,0,0,0,3.5,3.3,3.3
5744,831,0,North America,HR,Pharmacovigilance,Meets,Male,44,21,0,9,16,3.5,4.8,4.5,0.0383,1,1,1,1,2.4,4.3,1.4
5745,221,0,Latin America,Commercial,Regulatory Affairs,Below,Male,32,13,0,9,21,3.4,2.5,3.1,0.0,1,1,1,1,4.5,3.6,2.1
5746,694,0,Europe,Digital,Supply Chain,Meets,Female,37,30,0,7,23,3.1,4.0,1.3,0.0853,1,1,0,0,3.0,1.8,2.1
5747,613,1,Latin America,Digital,Data Science,Meets,Male,35,10,1,12,27,0.0,1.9,5.0,0.0853,1,1,1,1,4.2,2.7,4.0
5748,80,0,Middle East & Africa,R&D,Legal & Compliance,Meets,Male,45,10,0,12,21,3.4,2.0,2.2,0.0977,1,1,1,1,2.8,2.8,1.0
5749,675,0,Middle East & Africa,Digital,Regulatory Affairs,Meets,Male,35,7,0,6,8,2.7,5.0,1.8,0.0853,0,0,0,0,3.7,4.5,1.7
5750,442,1,Europe,Manufacturing,Finance & Accounting,Far Exceeds,Male,39,19,1,5,9,0.0,3.1,3.5,0.1069,1,1,1,1,3.9,4.8,3.3
5751,808,0,Asia Pacific,HR,Medical Affairs,Far Exceeds,Male,42,7,1,10,21,0.0,3.0,2.5,0.1168,1,1,1,1,3.4,1.8,1.0
5752,701,0,Middle East & Africa,HR,Supply Chain,Meets,Male,43,11,0,12,16,4.2,4.7,3.2,0.0383,1,1,1,1,3.3,3.5,4.1
5753,205,0,North America,Commercial,Supply Chain,Far Exceeds,Male,32,22,0,11,14,3.6,3.0,4.7,0.1275,1,1,1,0,3.4,3.7,2.7
5754,682,0,Europe,Digital,Pharmacovigilance,Far Exceeds,Male,36,18,0,11,14,3.2,3.0,4.9,0.2363,1,1,1,1,2.7,3.4,4.4
5755,91,0,Latin America,R&D,IT & Digital,Exceeds,Female,48,24,0,7,14,2.4,3.3,2.8,0.1648,1,1,1,1,3.1,4.6,2.6
5756,27,0,Latin America,R&D,Finance & Accounting,Below,Male,38,13,0,9,21,2.9,3.2,2.3,0.0,1,1,1,1,3.6,4.3,2.0
5757,34,0,North America,R&D,Data Science,Meets,Female,44,8,0,11,35,3.7,3.1,1.2,0.0977,1,1,1,1,3.9,3.9,2.8
5758,897,0,Middle East & Africa,Finance,Supply Chain,Meets,Male,50,13,0,7,17,2.7,4.7,1.0,0.0331,0,0,0,0,2.2,5.0,2.4
5759,375,0,Europe,Manufacturing,Marketing,Below,Female,38,10,0,10,29,1.4,4.7,3.7,0.0,1,1,1,1,1.8,2.5,4.0
5760,689,0,North America,Digital,Market Access,Exceeds,Female,43,35,0,5,11,4.1,2.6,2.6,0.1452,1,1,1,1,4.2,3.0,3.7
5761,123,0,Middle East & Africa,R&D,Supply Chain,Below,Female,44,11,0,7,8,3.3,2.3,2.1,0.0,1,1,1,1,4.0,4.8,2.7
5762,356,0,Europe,Manufacturing,Supply Chain,Meets,Female,30,26,0,7,22,3.2,1.1,3.1,0.0348,1,1,1,1,3.0,2.5,1.6
5763,764,0,Latin America,HR,Market Access,Below,Male,40,14,1,12,22,0.0,2.6,2.2,0.0,1,1,1,1,3.0,2.5,2.7
5764,212,0,Europe,Commercial,Sales,Meets,Male,47,23,0,5,10,3.5,2.3,3.2,0.0422,1,0,0,0,3.3,3.2,1.2
5765,634,1,Asia Pacific,Digital,Pharmacovigilance,Meets,Female,29,7,0,9,11,3.3,4.3,2.7,0.0853,1,1,1,1,4.2,3.3,3.7
5766,576,0,Europe,Digital,Supply Chain,Meets,Male,37,5,0,10,22,2.9,3.5,1.3,0.0853,1,1,1,1,2.6,3.9,1.7
5767,895,0,Asia Pacific,Finance,Supply Chain,Meets,Male,39,8,1,8,11,0.0,3.9,1.9,0.0331,1,1,1,1,4.2,3.9,2.3
5768,777,0,Europe,HR,IT & Digital,Meets,Male,37,25,0,6,16,2.2,3.2,3.4,0.0383,1,1,1,1,3.0,1.8,2.2
5769,688,0,Asia Pacific,Digital,Legal & Compliance,Meets,Male,37,27,0,8,16,1.8,2.6,2.0,0.0853,1,1,1,1,2.5,2.9,2.4
5770,1030,0,Latin America,Finance,Data Science,Meets,Female,31,10,0,10,23,4.1,2.1,1.9,0.0331,1,1,1,1,4.0,1.0,2.1
5771,1032,0,Middle East & Africa,Finance,Clinical Operations,Meets,Male,40,13,1,10,14,0.0,2.1,4.3,0.0331,1,1,1,1,3.6,2.1,2.9
5772,896,0,Asia Pacific,Finance,Legal & Compliance,Below,Male,34,7,1,7,18,0.0,2.8,2.8,0.0,1,1,1,1,2.7,2.3,2.8
5773,639,0,Asia Pacific,Digital,Legal & Compliance,Far Below,Female,34,6,0,8,19,2.6,3.1,3.5,0.0,1,1,1,1,2.5,3.4,3.3
5774,605,0,Latin America,Digital,Sales,Meets,Male,28,11,0,9,18,3.3,4.0,3.9,0.0853,1,1,1,1,3.6,5.0,2.6
5775,684,0,Asia Pacific,Digital,Quality Assurance,Meets,Male,29,3,1,5,11,0.0,2.4,3.2,0.0853,0,0,0,0,3.5,3.5,3.0
5776,423,0,North America,Manufacturing,Sales,Below,Female,47,20,0,5,14,4.1,2.8,1.9,0.0,1,1,1,1,4.0,2.8,2.2
5777,993,0,Latin America,Finance,Market Access,Below,Male,38,30,0,8,13,3.8,4.1,3.2,0.0,1,1,1,1,3.3,3.6,3.3
5778,473,0,North America,Manufacturing,Data Science,Meets,Female,42,16,0,8,14,3.0,2.9,5.0,0.0348,1,1,1,1,3.4,3.5,4.0
5779,319,0,Latin America,Commercial,Pharmacovigilance,Meets,Male,33,7,0,9,18,3.3,3.5,2.2,0.0422,1,1,1,1,3.5,1.5,3.5
5780,559,0,Asia Pacific,Digital,Regulatory Affairs,Meets,Male,28,4,0,12,21,3.7,4.5,3.8,0.0853,1,1,1,1,4.7,4.0,4.2
5781,849,0,North America,HR,Communications,Meets,Male,34,20,1,5,13,0.0,3.8,3.7,0.0383,1,1,1,1,3.2,3.0,4.5
5782,48,0,Asia Pacific,R&D,Data Science,Below,Female,28,14,0,5,9,3.5,2.7,2.0,0.0,1,1,1,1,3.7,2.4,2.6
5783,269,0,Latin America,Commercial,IT & Digital,Meets,Female,34,22,0,12,34,3.5,3.5,1.0,0.0422,1,1,1,1,3.8,4.7,2.4
5784,57,0,Asia Pacific,R&D,Medical Affairs,Meets,Female,45,3,0,9,14,2.9,3.8,2.6,0.0977,1,1,1,1,4.2,5.0,2.0
5785,74,0,North America,R&D,Market Access,Meets,Female,37,9,1,10,11,0.0,3.2,1.4,0.0977,1,1,1,1,3.9,4.7,1.6
5786,561,0,North America,Digital,Clinical Operations,Exceeds,Male,47,15,0,10,17,3.6,4.1,1.0,0.1452,1,1,1,1,4.5,4.1,1.1
5787,765,0,Asia Pacific,HR,Human Resources,Meets,Female,41,2,0,7,9,3.3,4.3,2.0,0.0383,1,1,1,1,2.7,4.0,1.5
5788,25,0,Europe,R&D,Medical Affairs,Meets,Female,44,12,1,8,12,0.0,3.2,2.8,0.0977,1,1,1,1,3.9,3.2,3.3
5789,970,0,Latin America,Finance,Medical Affairs,Meets,Male,37,12,1,6,12,0.0,4.5,4.4,0.0331,1,1,1,1,3.9,3.9,3.9
5790,95,0,Latin America,R&D,Pharmacovigilance,Meets,Female,30,7,0,6,13,3.4,2.1,1.6,0.0977,1,1,1,1,2.9,2.6,3.4
5791,334,0,Asia Pacific,Commercial,Quality Assurance,Meets,Female,32,19,0,7,16,4.4,3.1,2.5,0.0422,1,1,1,1,3.8,2.8,2.6
5792,820,0,Europe,HR,Regulatory Affairs,Meets,Female,45,7,0,6,11,4.5,2.1,3.4,0.0383,1,1,1,1,4.7,2.4,2.5
5793,699,0,North America,HR,Finance & Accounting,Meets,Male,39,36,0,10,15,4.4,2.8,1.1,0.0383,1,1,1,1,3.6,3.2,1.8
5794,167,0,Middle East & Africa,R&D,Supply Chain,Meets,Non-Binary/Other,30,13,0,9,22,2.2,4.6,2.6,0.0977,1,1,1,1,3.2,5.0,2.5
5795,784,0,Middle East & Africa,HR,Marketing,Meets,Male,42,5,0,11,16,4.1,2.1,2.4,0.0383,1,1,1,1,3.7,2.5,3.2
5796,219,0,Asia Pacific,Commercial,Supply Chain,Far Exceeds,Female,29,10,0,10,22,4.0,2.4,1.0,0.1275,1,1,1,0,4.6,2.7,1.0
5797,259,0,Europe,Commercial,Human Resources,Below,Male,41,6,0,10,26,5.0,4.7,2.0,0.0,1,1,1,1,4.3,3.5,3.8
5798,248,0,Europe,Commercial,Medical Affairs,Below,Female,36,7,1,11,14,0.0,2.6,1.3,0.0,1,1,1,1,3.3,1.8,1.4
5799,911,0,Latin America,Finance,Legal & Compliance,Below,Male,42,14,0,7,12,3.6,4.6,3.0,0.0,1,1,1,1,4.0,4.4,2.9
5800,582,1,North America,Digital,Legal & Compliance,Meets,Female,36,7,0,5,12,3.5,2.8,2.5,0.0853,1,1,1,1,3.2,3.5,4.2
5801,136,0,Europe,R&D,Sales,Below,Male,42,11,0,9,14,5.0,3.7,2.7,0.0,1,0,0,0,3.8,2.0,2.1
5802,724,0,Middle East & Africa,HR,Marketing,Meets,Female,29,25,0,7,34,3.2,2.3,2.5,0.0383,1,1,1,1,3.0,2.1,1.1
5803,218,0,North America,Commercial,Pharmacovigilance,Meets,Female,40,5,0,5,9,4.3,3.3,2.2,0.0422,1,0,0,0,3.5,5.0,1.8
5804,85,0,North America,R&D,Regulatory Affairs,Meets,Female,35,5,1,7,31,0.0,1.0,2.8,0.0977,1,1,1,1,2.6,2.1,2.1
5805,78,0,Asia Pacific,R&D,Human Resources,Below,Male,40,13,1,6,24,0.0,3.1,2.9,0.0,1,1,1,1,4.0,2.6,3.3
5806,651,0,Europe,Digital,Pharmacovigilance,Meets,Male,36,10,1,9,23,0.0,2.3,2.0,0.0853,0,0,0,0,2.9,1.6,2.0
5807,970,0,Asia Pacific,Finance,Market Access,Below,Male,33,14,0,8,11,2.7,2.0,3.2,0.0,1,1,1,1,3.1,3.8,4.4
5808,804,0,Europe,HR,Clinical Operations,Below,Female,37,11,0,12,26,4.2,2.9,1.2,0.0,1,1,1,1,3.2,3.8,2.6
5809,928,0,Latin America,Finance,Medical Affairs,Meets,Female,45,18,0,12,24,4.5,1.2,3.1,0.0331,1,1,1,1,4.4,2.0,2.1
5810,871,0,Asia Pacific,HR,IT & Digital,Meets,Female,34,13,0,5,17,4.4,3.1,4.1,0.0383,1,1,1,1,3.9,4.3,4.5
5811,205,0,Asia Pacific,Commercial,Sales,Below,Male,39,16,0,6,26,3.5,4.3,2.8,0.0,1,1,1,1,3.6,3.5,1.7
5812,178,0,Middle East & Africa,Commercial,Pharmacovigilance,Meets,Male,34,18,0,6,21,4.5,2.2,1.2,0.0422,1,1,0,0,3.5,2.5,2.3
5813,73,0,Asia Pacific,R&D,Communications,Meets,Female,28,16,0,9,18,2.3,2.7,2.3,0.0977,1,1,1,1,3.1,4.3,2.3
5814,853,0,Europe,HR,Marketing,Meets,Male,38,8,0,10,21,4.5,2.8,2.6,0.0383,1,1,1,1,4.6,3.2,1.9
5815,871,0,Middle East & Africa,HR,Medical Affairs,Exceeds,Male,55,10,0,6,11,4.3,4.1,1.0,0.0677,1,1,1,1,3.0,2.6,1.0
5816,934,0,Asia Pacific,Finance,Regulatory Affairs,Exceeds,Male,30,10,1,10,23,0.0,3.3,3.2,0.0588,1,1,1,1,4.7,2.3,2.1
5817,187,0,Asia Pacific,Commercial,Sales,Meets,Male,44,13,0,6,11,3.8,2.7,3.9,0.0422,1,1,0,0,3.2,2.7,1.4
5818,506,0,Latin America,Manufacturing,Quality Assurance,Meets,Male,28,24,0,7,14,4.1,2.6,3.8,0.0348,1,1,1,1,2.6,2.4,4.5
5819,66,0,Asia Pacific,R&D,Quality Assurance,Meets,Female,38,6,0,11,17,3.5,3.3,1.4,0.0977,1,1,1,1,4.0,3.8,2.1
5820,774,0,North America,HR,Marketing,Below,Male,30,20,0,7,17,3.6,3.6,3.2,0.0,1,1,1,1,3.1,1.2,1.7
5821,680,1,Middle East & Africa,Digital,Human Resources,Meets,Female,41,12,0,11,13,3.2,3.6,4.5,0.0853,1,1,1,1,2.5,3.6,1.9
5822,661,0,North America,Digital,Clinical Operations,Exceeds,Female,35,9,0,12,35,3.2,4.0,2.1,0.1452,1,1,1,1,3.3,4.0,3.5
5823,448,0,Middle East & Africa,Manufacturing,Communications,Meets,Female,34,10,0,12,25,2.6,4.0,3.6,0.0348,1,1,1,1,2.9,4.3,2.9
5824,297,0,Latin America,Commercial,Quality Assurance,Meets,Male,31,10,0,5,16,2.1,2.5,1.9,0.0422,1,1,1,1,2.1,1.8,3.0
5825,187,0,Asia Pacific,Commercial,Medical Affairs,Meets,Male,28,10,0,5,12,5.0,4.8,3.5,0.0422,1,1,1,1,4.3,5.0,4.8
5826,197,0,Asia Pacific,Commercial,Communications,Below,Male,36,12,0,11,20,2.7,4.5,1.7,0.0,1,1,1,1,3.7,2.9,3.1
5827,1035,0,Asia Pacific,Finance,Legal & Compliance,Meets,Female,34,8,0,12,18,2.7,4.5,2.8,0.0331,1,1,1,1,2.9,4.8,3.7
5828,609,0,Middle East & Africa,Digital,Regulatory Affairs,Meets,Female,35,7,1,6,10,0.0,5.0,3.5,0.0853,1,1,1,1,5.0,2.1,3.3
5829,342,0,Asia Pacific,Commercial,Clinical Operations,Far Below,Female,36,8,0,9,15,5.0,3.9,3.1,0.0,1,1,1,1,3.8,4.0,3.0
5830,642,0,North America,Digital,Supply Chain,Below,Male,33,6,1,5,14,0.0,4.7,2.7,0.0,1,1,1,1,4.3,3.4,2.1
5831,405,0,Asia Pacific,Manufacturing,Regulatory Affairs,Meets,Male,39,4,0,7,10,3.8,2.2,3.0,0.0348,1,1,1,1,3.3,2.4,3.1
5832,7,0,Latin America,R&D,Finance & Accounting,Below,Male,37,10,0,12,27,2.6,3.6,3.2,0.0,1,1,1,1,3.4,2.7,3.0
5833,958,0,North America,Finance,Medical Affairs,Meets,Male,43,19,0,11,18,4.6,2.7,1.9,0.0331,1,1,1,1,4.1,3.4,1.7
5834,857,0,Asia Pacific,HR,Medical Affairs,Meets,Male,52,12,1,8,17,0.0,3.1,1.0,0.0383,0,0,0,0,3.9,3.5,1.0
5835,517,0,Asia Pacific,Manufacturing,Finance & Accounting,Far Below,Female,39,27,0,9,31,1.9,4.2,1.4,0.0,1,1,1,1,1.5,4.3,1.9
5836,620,0,Europe,Digital,Market Access,Meets,Male,45,7,1,6,21,0.0,1.0,2.6,0.0853,1,1,1,1,4.0,3.3,2.8
5837,437,0,Middle East & Africa,Manufacturing,Communications,Far Below,Female,39,8,0,9,16,4.2,3.0,4.3,0.0,1,1,1,1,4.0,3.8,4.3
5838,784,0,North America,HR,Clinical Operations,Meets,Male,41,9,0,6,19,2.7,2.4,1.0,0.0383,1,1,1,1,2.5,2.7,3.1
5839,1010,1,Europe,Finance,Regulatory Affairs,Meets,Male,36,8,1,7,13,0.0,3.5,1.4,0.0331,1,1,1,1,4.6,5.0,2.0
5840,110,0,Latin America,R&D,Clinical Operations,Meets,Female,37,9,1,5,15,0.0,1.4,4.4,0.0977,1,1,1,1,2.2,1.9,3.7
5841,803,0,Middle East & Africa,HR,Marketing,Meets,Male,33,10,0,6,18,2.6,2.1,2.7,0.0383,1,1,1,1,5.0,2.1,2.0
5842,982,0,North America,Finance,Finance & Accounting,Meets,Female,47,10,0,12,25,4.0,3.2,1.8,0.0331,1,1,1,1,3.3,4.0,3.2
5843,569,0,Asia Pacific,Digital,Data Science,Meets,Female,44,3,1,6,14,0.0,1.7,2.6,0.0853,1,1,1,1,3.2,1.8,1.7
5844,866,0,North America,HR,Clinical Operations,Meets,Female,40,3,0,7,13,4.0,4.3,2.1,0.0383,1,1,1,1,3.2,3.1,1.2
5845,432,0,Asia Pacific,Manufacturing,IT & Digital,Meets,Non-Binary/Other,32,3,1,12,21,0.0,2.5,2.3,0.0348,1,1,1,1,2.9,2.1,1.0
5846,287,0,Middle East & Africa,Commercial,Quality Assurance,Exceeds,Male,37,18,0,7,29,2.9,2.8,3.0,0.0743,0,0,0,0,3.5,2.5,3.1
5847,397,0,Asia Pacific,Manufacturing,Legal & Compliance,Meets,Male,44,14,1,5,15,0.0,5.0,2.5,0.0348,1,1,1,1,3.9,4.2,1.5
5848,582,0,Latin America,Digital,IT & Digital,Far Exceeds,Female,53,6,1,6,22,0.0,1.5,3.2,0.2363,1,1,1,1,4.0,3.2,3.6
5849,55,1,Asia Pacific,R&D,Legal & Compliance,Exceeds,Male,38,19,1,6,14,0.0,4.9,1.9,0.1648,1,1,1,1,5.0,5.0,2.0
5850,875,0,Latin America,HR,Medical Affairs,Meets,Male,45,17,0,9,11,3.2,3.6,3.3,0.0383,1,1,1,1,4.2,2.9,1.2
5851,75,0,Middle East & Africa,R&D,Market Access,Exceeds,Male,39,16,0,11,13,4.2,3.5,2.4,0.1648,1,1,1,1,4.8,3.3,3.1
5852,571,0,Middle East & Africa,Digital,Supply Chain,Meets,Male,46,13,0,8,16,3.3,2.7,4.2,0.0853,1,1,1,1,4.5,2.3,2.8
5853,873,0,North America,HR,Market Access,Exceeds,Female,28,2,0,11,26,4.2,4.4,3.8,0.0677,1,1,1,1,3.9,2.9,2.6
5854,990,0,Latin America,Finance,Regulatory Affairs,Meets,Male,33,4,1,6,11,0.0,3.0,3.5,0.0331,1,1,1,1,3.6,2.9,3.6
5855,998,0,Latin America,Finance,Communications,Meets,Male,40,17,0,7,17,5.0,4.1,2.7,0.0331,1,1,1,1,4.8,2.9,3.4
5856,508,0,Europe,Manufacturing,Marketing,Far Below,Male,31,5,0,9,16,4.0,3.4,2.2,0.0,1,1,1,1,3.9,4.3,2.4
5857,488,0,Europe,Manufacturing,Marketing,Meets,Male,41,9,0,5,10,2.9,1.2,1.9,0.0348,1,1,1,1,3.3,1.9,2.8
5858,529,0,Europe,Digital,Supply Chain,Meets,Female,38,9,1,7,20,0.0,4.0,2.0,0.0853,0,0,0,0,3.7,3.0,1.6
5859,1023,0,Asia Pacific,Finance,IT & Digital,Meets,Female,28,8,0,8,31,2.7,4.6,3.4,0.0331,1,1,1,1,3.5,3.9,2.8
5860,796,0,Europe,HR,Clinical Operations,Far Exceeds,Male,28,13,0,10,20,2.5,2.3,2.4,0.1168,1,1,1,1,2.9,2.7,1.5
5861,946,0,Latin America,Finance,Legal & Compliance,Below,Male,40,10,0,10,24,3.2,3.3,3.6,0.0,1,1,1,1,2.9,3.0,3.4
5862,454,0,Asia Pacific,Manufacturing,IT & Digital,Meets,Male,31,4,0,8,24,3.4,4.0,2.8,0.0348,1,1,1,1,3.9,4.2,3.3
5863,526,0,Middle East & Africa,Digital,Clinical Operations,Below,Male,35,6,0,5,18,3.0,4.1,2.2,0.0,1,1,1,1,2.7,5.0,2.5
5864,1030,0,North America,Finance,Communications,Far Below,Female,42,17,0,10,26,1.9,1.6,2.6,0.0,0,0,0,0,2.9,2.6,3.5
5865,668,0,Europe,Digital,Regulatory Affairs,Meets,Male,38,11,0,11,22,2.1,4.0,2.7,0.0853,1,1,1,1,1.4,2.4,2.5
5866,948,0,Middle East & Africa,Finance,Legal & Compliance,Below,Male,35,20,0,10,23,3.7,2.5,2.6,0.0,1,1,1,1,3.7,2.5,2.4
5867,158,1,Latin America,R&D,Human Resources,Far Exceeds,Female,29,6,1,5,22,0.0,2.7,1.5,0.2644,1,1,1,1,4.1,3.5,1.9
5868,1044,0,North America,Finance,Regulatory Affairs,Meets,Female,47,12,1,10,24,0.0,4.4,2.4,0.0331,1,1,1,1,3.6,4.4,1.3
5869,394,0,Middle East & Africa,Manufacturing,Sales,Below,Female,43,3,1,6,10,0.0,4.9,2.8,0.0,1,1,1,1,4.0,4.2,2.2
5870,738,0,North America,HR,Clinical Operations,Far Below,Female,34,5,0,5,16,2.9,3.3,2.1,0.0,1,1,0,0,2.1,4.1,2.7
5871,448,0,Europe,Manufacturing,Human Resources,Meets,Male,33,6,1,10,20,0.0,3.7,2.7,0.0348,0,0,0,0,4.0,3.6,1.5
5872,435,0,Latin America,Manufacturing,Regulatory Affairs,Far Below,Male,35,2,1,9,26,0.0,4.0,3.0,0.0,1,1,1,1,5.0,3.3,2.0
5873,443,0,North America,Manufacturing,Marketing,Meets,Female,32,9,0,12,18,3.1,3.0,3.3,0.0348,1,1,1,1,2.4,1.9,2.4
5874,642,0,Middle East & Africa,Digital,Data Science,Meets,Male,36,21,0,5,9,2.6,4.5,2.7,0.0853,1,1,1,1,2.7,3.0,4.2
5875,301,0,Europe,Commercial,Medical Affairs,Below,Male,45,31,0,6,7,3.0,3.9,1.8,0.0,1,1,1,1,2.8,3.7,2.1
5876,230,0,Europe,Commercial,Clinical Operations,Meets,Female,44,10,0,5,15,3.0,2.1,1.8,0.0422,1,1,1,1,3.4,2.5,3.1
5877,7,0,Middle East & Africa,R&D,Sales,Exceeds,Female,44,15,0,5,15,3.9,3.5,3.7,0.1648,1,1,1,1,3.6,5.0,3.4
5878,513,0,Middle East & Africa,Manufacturing,Medical Affairs,Meets,Male,30,7,1,12,32,0.0,3.4,3.3,0.0348,1,1,1,1,4.4,4.7,2.5
5879,344,0,North America,Commercial,Quality Assurance,Meets,Male,32,22,0,8,14,4.1,2.2,1.7,0.0422,1,1,1,1,4.3,3.1,2.7
5880,140,0,Asia Pacific,R&D,Data Science,Meets,Female,44,3,0,12,19,4.0,4.3,2.2,0.0977,1,1,1,1,4.1,3.6,3.2
5881,564,0,Europe,Digital,Market Access,Meets,Male,41,5,1,10,14,0.0,1.6,4.1,0.0853,1,1,1,1,3.2,1.1,2.8
5882,371,0,North America,Manufacturing,Clinical Operations,Meets,Male,35,12,0,5,14,4.2,3.8,1.9,0.0348,1,1,1,1,3.1,5.0,1.2
5883,699,0,Middle East & Africa,HR,Legal & Compliance,Exceeds,Female,42,19,0,7,31,1.5,5.0,5.0,0.0677,1,1,1,1,1.0,4.0,3.6
5884,676,0,North America,Digital,Finance & Accounting,Meets,Male,41,11,0,12,28,2.6,2.4,3.2,0.0853,1,1,1,1,2.5,3.7,2.9
5885,115,0,Middle East & Africa,R&D,Market Access,Below,Male,29,6,0,11,20,2.1,3.6,3.0,0.0,1,1,1,1,2.0,3.7,3.4
5886,674,0,Latin America,Digital,Sales,Meets,Female,28,6,1,10,12,0.0,3.4,3.6,0.0853,1,1,1,1,4.1,4.0,3.4
5887,852,0,Middle East & Africa,HR,Legal & Compliance,Exceeds,Female,38,12,0,7,12,3.7,3.5,2.1,0.0677,1,1,1,1,2.8,2.9,4.1
5888,559,0,Middle East & Africa,Digital,Communications,Below,Female,28,18,0,9,14,3.1,5.0,3.8,0.0,1,1,1,1,1.2,3.3,4.6
5889,119,0,Middle East & Africa,R&D,Clinical Operations,Meets,Female,45,25,0,10,12,4.0,2.5,3.4,0.0977,1,1,1,1,3.0,3.5,5.0
5890,786,0,Asia Pacific,HR,Human Resources,Meets,Male,41,6,0,5,11,3.3,1.7,3.1,0.0383,1,1,1,1,5.0,1.6,3.9
5891,825,0,Middle East & Africa,HR,Sales,Meets,Female,36,2,1,12,23,0.0,3.9,3.2,0.0383,1,1,1,1,5.0,4.1,2.0
5892,678,0,Europe,Digital,Pharmacovigilance,Meets,Female,31,7,0,5,16,4.3,2.3,4.6,0.0853,1,1,1,1,3.5,3.7,3.5
5893,843,0,Europe,HR,Sales,Meets,Male,32,4,0,7,8,4.6,2.6,3.8,0.0383,1,0,0,0,5.0,1.9,5.0
5894,649,0,North America,Digital,Regulatory Affairs,Below,Male,28,18,0,11,24,2.4,1.9,2.1,0.0,1,1,1,1,2.5,2.5,3.2
5895,517,0,Asia Pacific,Manufacturing,Finance & Accounting,Meets,Female,46,9,1,8,16,0.0,3.3,2.1,0.0348,0,0,0,0,3.9,3.2,1.9
5896,697,0,North America,HR,Communications,Far Below,Female,39,20,0,10,13,2.8,5.0,3.7,0.0,1,1,1,1,3.4,5.0,4.4
5897,615,0,Europe,Digital,Regulatory Affairs,Meets,Non-Binary/Other,37,6,0,5,13,1.9,3.6,2.8,0.0853,1,1,1,1,1.4,2.2,1.0
5898,474,0,Europe,Manufacturing,Market Access,Exceeds,Male,49,18,0,12,22,2.9,2.8,2.9,0.0616,1,1,1,1,5.0,3.5,2.8
5899,805,0,Latin America,HR,Pharmacovigilance,Meets,Female,32,8,1,7,12,0.0,2.7,2.5,0.0383,1,1,1,1,4.0,2.5,3.4
5900,443,0,Middle East & Africa,Manufacturing,IT & Digital,Meets,Female,37,5,0,9,13,3.2,2.8,2.3,0.0348,1,1,1,1,3.1,3.4,2.6
5901,903,0,Europe,Finance,Legal & Compliance,Meets,Male,34,15,1,9,12,0.0,2.6,3.3,0.0331,1,1,1,1,3.7,2.3,2.8
5902,697,0,North America,HR,Sales,Below,Non-Binary/Other,50,7,0,10,22,2.5,3.9,2.9,0.0,1,1,1,1,3.6,4.1,3.0
5903,1040,0,North America,Finance,Human Resources,Far Below,Female,36,4,1,11,17,0.0,3.4,1.5,0.0,1,1,1,1,3.5,1.6,2.7
5904,141,0,Middle East & Africa,R&D,Quality Assurance,Meets,Female,39,5,0,5,7,3.7,2.7,2.1,0.0977,1,1,1,1,3.9,2.0,3.3
5905,151,0,Middle East & Africa,R&D,Market Access,Meets,Female,48,4,0,7,13,3.3,2.8,3.7,0.0977,1,1,0,0,3.0,3.2,4.1
5906,694,0,Latin America,Digital,Medical Affairs,Far Exceeds,Female,45,8,0,12,19,3.2,2.6,2.4,0.2363,1,1,1,1,3.0,3.4,2.5
5907,187,0,Asia Pacific,Commercial,Regulatory Affairs,Meets,Male,28,17,0,6,12,3.3,2.4,2.6,0.0422,1,1,1,1,3.3,3.5,4.3
5908,926,0,North America,Finance,Medical Affairs,Meets,Female,36,8,0,9,13,3.3,1.7,3.9,0.0331,1,1,1,1,3.2,1.0,4.3
5909,1001,0,Middle East & Africa,Finance,IT & Digital,Meets,Non-Binary/Other,38,4,1,7,18,0.0,2.7,3.1,0.0331,1,1,1,1,4.4,3.2,2.6
5910,92,0,North America,R&D,Human Resources,Meets,Male,39,28,0,11,16,4.3,1.8,2.7,0.0977,1,1,1,1,3.5,1.0,3.2
5911,930,0,Middle East & Africa,Finance,Medical Affairs,Meets,Male,40,18,0,9,21,4.5,2.2,1.2,0.0331,1,1,1,1,3.8,2.4,1.4
5912,341,0,Europe,Commercial,Human Resources,Meets,Male,33,9,0,11,29,3.0,4.2,3.2,0.0422,0,0,0,0,3.9,4.5,3.4
5913,355,0,North America,Manufacturing,Pharmacovigilance,Meets,Female,47,6,1,12,19,0.0,3.2,1.7,0.0348,1,1,1,1,2.2,4.0,4.1
5914,378,0,Europe,Manufacturing,Market Access,Meets,Female,41,6,0,10,19,2.8,3.4,3.3,0.0348,1,1,1,1,2.0,4.5,2.6
5915,288,0,North America,Commercial,Human Resources,Meets,Non-Binary/Other,42,9,0,5,13,2.9,2.3,1.0,0.0422,0,0,0,0,2.8,2.9,1.0
5916,913,0,Asia Pacific,Finance,Marketing,Far Exceeds,Male,46,6,0,11,13,2.1,3.1,1.5,0.1022,1,1,1,1,1.6,3.3,3.2
5917,985,0,Latin America,Finance,Communications,Meets,Female,40,8,1,6,30,0.0,3.1,3.0,0.0331,1,1,1,1,2.5,3.6,3.6
5918,934,0,Europe,Finance,Market Access,Meets,Female,37,22,0,10,18,3.7,3.7,4.0,0.0331,1,1,1,1,3.3,2.5,3.3
5919,684,0,Middle East & Africa,Digital,Communications,Meets,Male,36,20,0,8,18,2.3,3.3,1.0,0.0853,1,0,0,0,2.7,2.7,1.4
5920,832,0,Asia Pacific,HR,Marketing,Exceeds,Female,37,19,0,12,25,2.2,3.1,3.0,0.0677,1,1,1,1,3.3,3.3,3.3
5921,331,0,North America,Commercial,Sales,Meets,Female,37,18,0,9,14,2.9,2.3,3.1,0.0422,1,1,1,1,4.0,2.9,2.2
5922,197,0,Europe,Commercial,Marketing,Meets,Female,28,12,1,8,15,0.0,2.4,3.8,0.0422,1,1,1,1,3.8,5.0,4.1
5923,330,0,North America,Commercial,Clinical Operations,Meets,Female,34,6,0,6,11,1.7,2.4,3.4,0.0422,1,1,1,1,2.5,2.6,4.1
5924,212,0,North America,Commercial,Finance & Accounting,Exceeds,Female,31,14,0,9,14,4.0,2.1,2.1,0.0743,1,1,1,1,3.0,2.6,2.4
5925,242,0,North America,Commercial,Sales,Meets,Male,28,9,0,9,20,3.5,3.5,1.6,0.0422,1,1,1,1,4.0,2.1,1.5
5926,892,0,Latin America,Finance,IT & Digital,Meets,Male,39,16,1,9,15,0.0,3.1,1.8,0.0331,1,1,1,1,1.6,1.9,4.2
5927,574,0,Latin America,Digital,Marketing,Exceeds,Female,41,18,0,5,11,2.9,2.8,1.0,0.1452,1,1,1,1,4.7,4.4,1.3
5928,21,0,Middle East & Africa,R&D,Quality Assurance,Exceeds,Male,33,7,0,7,18,2.7,3.2,1.6,0.1648,1,1,1,1,2.3,2.2,1.9
5929,929,0,Europe,Finance,Medical Affairs,Exceeds,Male,36,6,0,10,11,3.8,2.2,4.6,0.0588,1,1,1,1,3.1,3.1,5.0
5930,1005,0,Asia Pacific,Finance,Legal & Compliance,Below,Male,41,13,0,6,7,2.8,2.2,5.0,0.0,1,1,1,1,2.9,4.0,4.9
5931,717,0,Asia Pacific,HR,Sales,Meets,Male,36,6,1,5,21,0.0,2.2,1.8,0.0383,1,1,1,1,3.0,2.8,2.1
5932,27,0,Asia Pacific,R&D,Medical Affairs,Meets,Female,37,11,1,9,21,0.0,3.7,2.5,0.0977,1,1,1,1,2.9,2.5,2.8
5933,313,0,North America,Commercial,Supply Chain,Meets,Female,37,7,0,6,17,3.9,4.0,4.0,0.0422,1,1,1,1,4.0,4.4,3.3
5934,5,0,Latin America,R&D,Market Access,Exceeds,Female,42,12,0,7,12,2.0,2.8,2.1,0.1648,1,1,1,1,2.7,5.0,3.7
5935,571,0,Europe,Digital,Marketing,Exceeds,Female,38,36,0,11,18,2.9,4.3,4.9,0.1452,1,1,1,1,3.4,4.6,3.9
5936,434,0,North America,Manufacturing,Legal & Compliance,Meets,Male,36,12,0,7,28,2.8,3.4,4.0,0.0348,1,1,1,1,3.2,2.4,2.9
5937,1042,0,Latin America,Finance,Medical Affairs,Below,Male,35,17,1,5,14,0.0,2.7,2.9,0.0,1,1,1,1,3.4,2.8,3.2
5938,107,0,Latin America,R&D,Marketing,Far Below,Female,33,16,0,11,16,2.2,3.3,3.0,0.0,1,1,1,1,2.7,3.6,2.2
5939,785,0,Europe,HR,Finance & Accounting,Meets,Male,42,16,1,11,16,0.0,4.1,4.0,0.0383,1,1,1,1,2.9,3.9,4.7
5940,561,0,Europe,Digital,Medical Affairs,Far Below,Male,41,3,1,5,10,0.0,3.8,2.7,0.0,1,1,1,1,2.9,2.7,2.7
5941,447,0,Europe,Manufacturing,IT & Digital,Meets,Female,38,16,0,7,19,2.6,2.4,1.1,0.0348,1,1,1,1,3.4,4.4,1.9
5942,615,0,North America,Digital,Quality Assurance,Meets,Male,44,15,0,7,9,3.2,3.0,2.5,0.0853,1,1,1,1,4.3,3.3,3.1
5943,207,0,Middle East & Africa,Commercial,Human Resources,Exceeds,Male,38,8,1,8,29,0.0,2.8,4.1,0.0743,1,1,0,0,3.6,2.9,4.4
5944,358,0,Europe,Manufacturing,Communications,Below,Male,40,19,0,12,16,2.8,1.6,2.4,0.0,1,0,0,0,2.9,1.8,2.7
5945,825,0,Middle East & Africa,HR,Communications,Meets,Non-Binary/Other,35,9,0,10,29,2.4,2.1,3.3,0.0383,1,1,1,1,3.5,2.3,3.9
5946,363,0,North America,Manufacturing,Data Science,Exceeds,Male,45,5,0,6,22,2.6,3.8,2.5,0.0616,1,1,1,1,3.0,5.0,4.6
5947,703,0,Middle East & Africa,HR,Quality Assurance,Meets,Male,39,22,1,5,9,0.0,3.1,3.9,0.0383,1,1,1,1,3.3,2.3,4.2
5948,198,0,Asia Pacific,Commercial,Finance & Accounting,Below,Female,40,19,0,6,8,2.6,2.9,3.0,0.0,1,1,1,1,2.6,4.4,3.5
5949,848,0,Middle East & Africa,HR,Regulatory Affairs,Below,Female,38,12,0,10,15,2.9,3.3,3.9,0.0,1,1,1,1,3.7,5.0,3.2
5950,622,0,Europe,Digital,Marketing,Exceeds,Female,39,16,0,9,13,2.5,3.3,2.7,0.1452,1,1,1,1,2.7,2.4,4.0
5951,102,0,North America,R&D,Quality Assurance,Meets,Male,40,14,0,5,11,2.7,3.7,3.6,0.0977,1,1,1,1,2.2,3.6,2.2
5952,586,0,Europe,Digital,Clinical Operations,Exceeds,Male,28,14,1,7,9,0.0,4.0,2.1,0.1452,1,1,1,1,2.5,4.0,2.2
5953,997,0,Asia Pacific,Finance,Marketing,Below,Male,41,18,0,11,14,3.4,2.6,3.3,0.0,1,1,1,1,2.8,2.4,2.6
5954,527,0,Europe,Digital,Pharmacovigilance,Meets,Female,34,15,1,7,14,0.0,3.5,3.5,0.0853,1,1,1,1,3.0,4.2,3.8
5955,423,0,Europe,Manufacturing,Communications,Meets,Female,37,4,0,6,21,2.6,2.6,4.0,0.0348,1,1,1,1,3.1,1.8,2.8
5956,243,1,Europe,Commercial,Finance & Accounting,Meets,Male,34,7,0,6,16,3.5,1.7,2.5,0.0422,1,1,1,1,4.5,2.8,1.0
5957,1007,0,Latin America,Finance,Market Access,Far Exceeds,Female,43,20,0,11,18,4.1,3.7,2.6,0.1022,1,1,1,1,3.8,2.9,3.3
5958,1004,0,Asia Pacific,Finance,Market Access,Meets,Female,33,10,0,12,14,1.8,2.6,1.3,0.0331,1,1,1,1,2.5,2.5,1.5
5959,997,0,Europe,Finance,Regulatory Affairs,Exceeds,Female,36,8,1,8,29,0.0,2.8,3.8,0.0588,1,1,1,1,4.1,4.1,2.8
5960,46,0,Europe,R&D,Human Resources,Exceeds,Female,34,5,0,10,16,3.4,2.5,1.3,0.1648,1,1,1,1,3.4,3.9,1.6
5961,746,0,Europe,HR,Finance & Accounting,Meets,Female,34,17,1,9,17,0.0,3.0,1.0,0.0383,1,1,1,1,3.4,2.6,4.2
5962,364,0,North America,Manufacturing,Clinical Operations,Meets,Female,34,16,0,12,15,3.6,2.0,2.7,0.0348,1,1,1,1,4.0,3.6,2.5
5963,260,0,Latin America,Commercial,Regulatory Affairs,Meets,Male,31,11,1,11,19,0.0,3.9,2.1,0.0422,1,1,1,1,2.2,4.3,1.2
5964,28,0,North America,R&D,Sales,Meets,Male,35,5,1,7,18,0.0,3.8,3.7,0.0977,1,1,1,1,5.0,3.2,5.0
5965,695,0,Latin America,Digital,Marketing,Meets,Female,39,17,0,10,22,3.7,3.5,3.7,0.0853,1,1,1,1,5.0,2.4,4.5
5966,338,0,Europe,Commercial,Clinical Operations,Meets,Male,33,10,1,7,18,0.0,3.5,1.0,0.0422,1,1,1,1,3.4,4.3,1.7
5967,948,0,Asia Pacific,Finance,Supply Chain,Far Below,Male,39,23,0,9,21,2.8,3.3,3.6,0.0,1,1,1,1,3.2,3.1,2.8
5968,281,0,Middle East & Africa,Commercial,Human Resources,Meets,Female,41,7,1,12,29,0.0,2.3,1.6,0.0422,1,1,1,1,1.3,2.5,1.0
5969,327,0,Middle East & Africa,Commercial,Medical Affairs,Meets,Female,37,21,0,6,13,4.1,2.7,3.0,0.0422,1,1,0,0,3.5,2.1,2.7
5970,680,0,Europe,Digital,Pharmacovigilance,Meets,Female,31,5,0,6,9,2.7,4.1,4.7,0.0853,1,1,1,1,2.4,3.0,3.4
5971,750,0,North America,HR,Communications,Exceeds,Female,28,2,0,9,21,3.3,1.5,2.5,0.0677,1,1,1,1,4.2,2.4,2.0
5972,486,0,Asia Pacific,Manufacturing,Communications,Below,Male,43,32,0,11,22,2.8,3.0,3.4,0.0,1,1,1,1,2.5,3.6,2.6
5973,1046,0,Latin America,Finance,Communications,Meets,Female,47,17,0,11,20,3.4,3.3,3.0,0.0331,1,1,1,1,3.7,3.5,2.6
5974,783,0,Europe,HR,Marketing,Meets,Female,46,11,0,6,21,2.2,2.5,2.3,0.0383,1,1,1,1,4.3,2.5,2.9
5975,119,0,Asia Pacific,R&D,Pharmacovigilance,Meets,Female,40,13,0,11,13,2.6,3.4,2.5,0.0977,0,0,0,0,2.9,3.7,2.9
5976,951,0,Asia Pacific,Finance,Clinical Operations,Meets,Female,40,2,1,8,15,0.0,2.4,1.8,0.0331,1,1,1,1,3.9,2.9,3.7
5977,424,0,Latin America,Manufacturing,Medical Affairs,Meets,Female,37,9,0,9,16,3.0,2.6,2.4,0.0348,1,1,1,1,3.7,1.5,3.1
5978,171,0,Asia Pacific,R&D,Regulatory Affairs,Meets,Male,37,13,0,8,38,4.7,3.8,3.9,0.0977,1,1,1,1,3.9,3.7,2.3
5979,625,0,North America,Digital,Marketing,Meets,Male,34,7,0,7,12,4.1,3.1,3.3,0.0853,1,1,1,1,3.1,2.3,3.8
5980,830,0,North America,HR,Communications,Meets,Male,33,17,0,9,20,4.7,3.0,3.2,0.0383,1,1,1,1,4.5,2.1,2.9
5981,1045,0,North America,Finance,Medical Affairs,Meets,Female,28,7,0,12,21,3.3,3.9,4.5,0.0331,1,1,1,1,1.8,3.4,4.3
5982,276,0,Asia Pacific,Commercial,Pharmacovigilance,Meets,Female,42,9,1,6,22,0.0,2.9,4.1,0.0422,1,1,1,1,2.7,1.9,4.1
5983,497,0,North America,Manufacturing,Legal & Compliance,Meets,Female,41,8,0,8,26,1.6,4.2,2.8,0.0348,1,1,1,1,1.0,2.2,2.4
5984,1030,0,Latin America,Finance,Data Science,Below,Male,36,7,0,10,17,3.1,4.0,1.3,0.0,1,1,1,1,2.4,2.3,1.0
5985,323,0,Asia Pacific,Commercial,Clinical Operations,Below,Male,46,17,0,9,15,2.8,2.9,2.1,0.0,1,1,1,1,2.5,3.7,2.8
5986,1003,0,Middle East & Africa,Finance,Human Resources,Meets,Female,51,3,1,7,19,0.0,2.7,1.1,0.0331,1,1,1,1,3.1,2.6,2.3
5987,133,0,Asia Pacific,R&D,Finance & Accounting,Meets,Non-Binary/Other,29,9,0,12,22,2.5,3.6,2.5,0.0977,1,1,0,0,2.2,4.4,2.8
5988,265,0,Latin America,Commercial,Human Resources,Far Below,Female,41,19,0,11,24,1.8,4.1,4.3,0.0,1,1,1,1,2.0,3.4,1.0
5989,310,0,Middle East & Africa,Commercial,Clinical Operations,Meets,Female,38,7,1,6,13,0.0,2.8,1.5,0.0422,0,0,0,0,2.3,2.1,3.8
5990,944,0,Asia Pacific,Finance,IT & Digital,Below,Female,48,11,0,7,18,3.0,4.7,3.2,0.0,1,1,1,1,2.7,3.3,5.0
5991,576,1,North America,Digital,Pharmacovigilance,Far Exceeds,Female,35,15,1,12,19,0.0,3.5,1.9,0.2363,1,1,1,1,2.8,3.8,3.9
5992,593,0,Europe,Digital,Pharmacovigilance,Meets,Male,44,3,1,6,11,0.0,3.0,2.5,0.0853,1,1,1,1,2.8,2.2,3.6
5993,772,0,Europe,HR,Sales,Meets,Male,42,9,0,9,22,2.3,1.9,3.5,0.0383,1,1,1,1,2.6,3.7,4.2
5994,7,0,North America,R&D,Communications,Meets,Male,45,8,1,8,11,0.0,2.2,1.0,0.0977,1,1,1,1,2.5,2.4,1.6
5995,560,0,Europe,Digital,Regulatory Affairs,Exceeds,Male,34,13,0,6,32,3.3,3.1,3.4,0.1452,1,1,1,1,4.7,1.7,3.0
5996,1049,0,Europe,Finance,Pharmacovigilance,Below,Male,36,17,0,6,15,3.1,4.2,2.7,0.0,1,1,1,1,2.7,1.8,3.9
5997,583,0,North America,Digital,Finance & Accounting,Far Exceeds,Female,41,12,1,12,28,0.0,2.3,2.4,0.2363,1,1,1,1,1.4,3.9,1.9
5998,833,0,North America,HR,IT & Digital,Meets,Male,45,9,0,12,36,3.7,3.5,2.3,0.0383,1,1,1,1,3.2,2.8,3.1
5999,505,0,Asia Pacific,Manufacturing,Finance & Accounting,Below,Male,39,10,0,12,21,2.3,2.0,2.9,0.0,1,1,1,1,1.9,1.6,4.3
6000,706,0,Asia Pacific,HR,Quality Assurance,Meets,Female,28,12,0,12,30,4.9,4.3,3.6,0.0383,1,1,1,1,2.9,2.9,2.8
6001,316,0,North America,Commercial,Finance & Accounting,Meets,Male,45,28,0,11,16,4.7,1.6,2.5,0.0422,1,1,1,1,2.9,3.9,2.0
6002,192,0,Latin America,Commercial,Human Resources,Far Exceeds,Male,46,13,0,12,15,4.8,2.0,3.2,0.1275,1,1,1,1,3.4,1.6,1.9
6003,592,0,Europe,Digital,Market Access,Exceeds,Non-Binary/Other,35,12,0,6,30,3.5,3.5,4.1,0.1452,1,1,1,1,2.6,2.7,3.8
6004,659,0,Asia Pacific,Digital,Market Access,Meets,Male,43,6,0,5,12,3.0,3.1,2.6,0.0853,1,1,1,1,5.0,1.3,2.3
6005,821,0,Europe,HR,Marketing,Meets,Male,41,18,0,12,21,3.0,3.8,1.3,0.0383,0,0,0,0,4.2,3.2,2.2
6006,781,1,Middle East & Africa,HR,Supply Chain,Exceeds,Male,33,4,1,5,9,0.0,2.2,3.5,0.0677,1,1,1,1,2.6,3.5,2.7
6007,955,0,North America,Finance,IT & Digital,Meets,Female,43,7,0,6,23,3.6,2.8,4.6,0.0331,1,1,1,1,3.7,4.1,2.4
6008,98,0,Latin America,R&D,Marketing,Meets,Female,38,9,1,6,10,0.0,4.0,3.0,0.0977,0,0,0,0,2.0,3.3,2.1
6009,908,0,Middle East & Africa,Finance,Communications,Meets,Male,30,15,1,11,21,0.0,3.2,2.4,0.0331,1,0,0,0,3.2,4.6,2.2
6010,338,0,Middle East & Africa,Commercial,Communications,Meets,Female,43,7,1,5,12,0.0,2.1,2.3,0.0422,1,1,1,1,3.0,2.6,2.9
6011,990,0,Middle East & Africa,Finance,Sales,Exceeds,Male,51,23,0,5,27,3.9,3.1,2.1,0.0588,1,1,1,1,3.5,4.5,1.8
6012,721,0,North America,HR,Medical Affairs,Meets,Female,28,7,0,5,14,3.8,3.3,2.2,0.0383,1,1,1,1,2.5,4.4,1.7
6013,1008,0,Asia Pacific,Finance,Supply Chain,Meets,Female,40,24,0,5,14,3.1,3.1,2.1,0.0331,1,1,1,1,4.5,4.2,2.5
6014,361,0,North America,Manufacturing,Medical Affairs,Exceeds,Male,40,10,0,8,24,2.5,4.8,3.7,0.0616,1,1,1,1,3.2,3.7,1.9
6015,68,0,Asia Pacific,R&D,Market Access,Far Below,Female,31,15,0,7,37,2.0,3.5,3.1,0.0,1,1,1,1,3.4,5.0,4.0
6016,765,0,Middle East & Africa,HR,Market Access,Meets,Male,44,19,0,12,24,3.5,4.1,1.0,0.0383,1,1,1,1,3.8,4.8,2.4
6017,592,1,Middle East & Africa,Digital,Market Access,Exceeds,Female,31,1,0,6,22,2.5,4.3,3.2,0.1452,1,1,1,1,3.4,4.2,3.0
6018,899,0,Latin America,Finance,Pharmacovigilance,Meets,Non-Binary/Other,39,25,0,10,28,2.6,2.2,1.4,0.0331,1,1,1,1,2.9,2.0,3.7
6019,827,0,Asia Pacific,HR,Sales,Meets,Female,34,8,0,6,19,3.1,2.6,2.9,0.0383,1,1,1,1,4.1,2.9,4.2
6020,558,0,Middle East & Africa,Digital,Quality Assurance,Meets,Female,32,32,0,8,23,2.3,3.8,3.1,0.0853,1,1,0,0,3.4,2.3,2.7
6021,619,0,Europe,Digital,IT & Digital,Meets,Female,40,11,1,11,18,0.0,3.3,3.6,0.0853,1,1,1,1,4.3,2.0,3.4
6022,177,0,Latin America,Commercial,Finance & Accounting,Meets,Female,34,7,0,12,33,2.9,3.8,3.5,0.0422,1,1,1,1,5.0,3.6,1.8
6023,256,0,North America,Commercial,Communications,Far Below,Male,46,4,1,6,19,0.0,2.5,3.3,0.0,0,0,0,0,3.0,3.1,3.1
6024,841,0,Latin America,HR,IT & Digital,Below,Female,38,16,0,9,17,4.5,2.9,3.7,0.0,1,1,1,1,2.8,2.2,2.7
6025,830,0,Europe,HR,IT & Digital,Meets,Female,43,19,0,7,11,3.2,2.8,3.2,0.0383,1,1,1,1,3.6,5.0,2.1
6026,509,0,Asia Pacific,Manufacturing,Marketing,Meets,Female,43,16,0,9,15,2.9,3.0,2.7,0.0348,1,1,1,1,3.6,4.0,2.2
6027,59,0,North America,R&D,Medical Affairs,Meets,Male,45,8,1,5,25,0.0,2.6,2.0,0.0977,1,1,1,1,2.9,2.7,2.3
6028,10,0,North America,R&D,IT & Digital,Meets,Male,36,14,0,9,19,3.9,3.1,2.2,0.0977,1,1,1,1,3.4,1.7,3.0
6029,855,0,Asia Pacific,HR,Data Science,Meets,Female,37,8,0,5,13,2.4,4.9,2.1,0.0383,1,1,1,1,2.8,3.5,3.4
6030,350,0,Latin America,Commercial,Human Resources,Exceeds,Female,33,13,0,7,14,4.3,5.0,2.6,0.0743,1,1,1,1,3.3,3.4,2.7
6031,924,0,Middle East & Africa,Finance,Marketing,Far Below,Non-Binary/Other,39,16,0,8,12,2.6,4.2,3.9,0.0,1,1,1,1,3.8,3.0,4.0
6032,427,0,Latin America,Manufacturing,Clinical Operations,Below,Female,33,14,1,5,12,0.0,2.5,3.3,0.0,1,1,1,1,1.9,2.6,3.9
6033,43,0,Europe,R&D,Regulatory Affairs,Meets,Female,45,6,0,7,13,4.2,2.0,2.0,0.0977,1,1,1,1,4.0,2.4,2.7
6034,753,0,Middle East & Africa,HR,Supply Chain,Below,Male,33,14,0,6,21,4.2,5.0,3.0,0.0,1,1,1,1,2.4,4.9,2.5
6035,324,0,Latin America,Commercial,Communications,Meets,Male,35,7,0,8,13,3.0,1.8,3.4,0.0422,1,1,1,1,2.4,2.1,2.6
6036,281,1,Asia Pacific,Commercial,Medical Affairs,Far Exceeds,Female,41,8,1,10,23,0.0,3.0,2.5,0.1275,1,1,1,1,5.0,4.3,2.2
6037,274,0,Europe,Commercial,Sales,Exceeds,Female,41,3,0,8,19,2.6,4.2,3.1,0.0743,0,0,0,0,2.4,3.9,2.0
6038,1033,0,Europe,Finance,Communications,Meets,Female,31,7,0,5,7,3.6,2.7,1.8,0.0331,1,1,1,1,5.0,2.2,2.1
6039,651,1,Europe,Digital,Human Resources,Exceeds,Male,34,6,0,12,33,2.0,3.4,2.5,0.1452,1,1,1,1,2.8,2.4,2.6
6040,889,0,Middle East & Africa,Finance,Market Access,Below,Female,36,11,0,11,16,4.1,2.7,2.5,0.0,1,1,1,1,3.6,3.7,1.9
6041,283,0,North America,Commercial,Clinical Operations,Meets,Female,37,15,0,8,14,3.1,2.4,2.0,0.0422,1,1,1,1,2.2,4.9,2.0
6042,820,1,Middle East & Africa,HR,Regulatory Affairs,Meets,Female,39,19,0,10,16,2.3,4.1,3.8,0.0383,1,1,1,1,3.4,2.5,3.9
6043,436,0,Latin America,Manufacturing,Medical Affairs,Meets,Male,43,8,0,5,19,3.3,1.7,3.5,0.0348,1,1,1,1,2.8,3.2,2.9
6044,985,0,North America,Finance,Quality Assurance,Far Below,Male,37,16,0,9,26,2.1,2.6,3.0,0.0,1,1,1,1,4.2,1.5,1.3
6045,789,0,Latin America,HR,Market Access,Exceeds,Male,39,6,0,11,17,3.6,2.7,1.6,0.0677,1,1,1,1,2.8,2.0,2.5
6046,272,1,North America,Commercial,Medical Affairs,Meets,Male,33,6,0,8,9,3.4,4.2,4.1,0.0422,1,1,1,0,3.4,3.6,3.9
6047,411,0,Middle East & Africa,Manufacturing,Legal & Compliance,Meets,Non-Binary/Other,47,32,0,8,17,3.6,2.7,2.8,0.0348,1,1,1,1,2.9,3.6,2.6
6048,19,0,Europe,R&D,Data Science,Below,Male,40,17,0,8,34,2.9,2.4,2.7,0.0,1,1,1,1,2.4,3.1,3.3
6049,118,0,Asia Pacific,R&D,Data Science,Meets,Female,36,3,1,9,13,0.0,3.3,4.5,0.0977,1,1,1,1,3.8,3.8,2.8
6050,796,1,Europe,HR,IT & Digital,Exceeds,Female,45,9,0,9,21,2.8,2.1,3.2,0.0677,1,1,1,1,3.0,2.6,2.8
6051,443,0,Middle East & Africa,Manufacturing,Sales,Meets,Male,40,7,1,7,15,0.0,4.5,2.4,0.0348,1,0,0,0,3.0,4.2,1.0
6052,865,0,North America,HR,Data Science,Meets,Female,39,5,1,10,21,0.0,2.7,2.2,0.0383,0,0,0,0,3.1,2.5,1.9
6053,395,0,Europe,Manufacturing,Quality Assurance,Exceeds,Male,38,6,0,11,15,2.4,3.1,2.0,0.0616,1,1,1,1,2.7,4.0,3.3
6054,459,0,Middle East & Africa,Manufacturing,Sales,Meets,Female,44,16,0,7,27,1.8,3.4,3.0,0.0348,1,1,1,1,4.2,3.0,2.4
6055,818,0,Latin America,HR,IT & Digital,Meets,Male,48,5,1,5,13,0.0,3.2,4.7,0.0383,1,1,1,1,3.3,2.1,3.9
6056,421,0,Asia Pacific,Manufacturing,Legal & Compliance,Meets,Female,44,4,1,5,8,0.0,2.7,2.7,0.0348,1,1,1,1,4.9,2.0,1.5
6057,1002,0,Europe,Finance,IT & Digital,Meets,Female,38,16,0,6,33,3.0,1.8,1.7,0.0331,1,1,1,1,2.2,2.6,1.0
6058,240,0,North America,Commercial,Legal & Compliance,Meets,Female,46,14,0,6,11,3.5,3.5,2.0,0.0422,1,1,1,1,2.6,2.3,1.0
6059,510,0,Latin America,Manufacturing,Supply Chain,Meets,Female,36,9,1,8,18,0.0,2.9,2.2,0.0348,1,1,1,1,2.1,4.7,2.6
6060,905,0,Middle East & Africa,Finance,Human Resources,Meets,Female,33,2,0,5,17,3.3,3.0,3.5,0.0331,1,1,1,1,3.2,2.7,3.1
6061,365,0,Asia Pacific,Manufacturing,Quality Assurance,Meets,Male,43,10,0,10,33,1.7,3.2,3.2,0.0348,1,1,1,1,1.3,2.3,2.3
6062,988,0,North America,Finance,Sales,Below,Male,47,4,1,5,11,0.0,4.1,2.8,0.0,1,1,1,1,2.6,3.7,2.7
6063,713,0,Middle East & Africa,HR,Quality Assurance,Meets,Male,38,6,0,8,26,4.3,1.0,3.6,0.0383,1,1,1,1,4.5,3.1,2.8
6064,121,0,Middle East & Africa,R&D,IT & Digital,Meets,Female,48,9,0,9,50,3.0,2.3,3.7,0.0977,1,1,1,1,2.8,3.3,1.9
6065,582,0,Europe,Digital,Communications,Exceeds,Male,29,16,0,7,13,3.7,3.8,2.4,0.1452,1,1,1,1,4.8,3.3,1.9
6066,421,0,Europe,Manufacturing,Data Science,Meets,Non-Binary/Other,37,19,0,11,18,4.9,3.6,2.4,0.0348,1,1,1,1,3.2,3.1,1.0
6067,555,0,North America,Digital,Communications,Meets,Female,33,7,1,10,18,0.0,2.7,3.7,0.0853,1,1,1,1,3.6,3.5,3.3
6068,393,0,Middle East & Africa,Manufacturing,Legal & Compliance,Meets,Male,33,9,1,8,15,0.0,2.8,3.7,0.0348,1,1,1,1,3.0,4.5,2.7
6069,795,0,Europe,HR,IT & Digital,Meets,Male,38,6,0,8,21,2.3,1.7,2.5,0.0383,1,1,1,1,3.1,2.4,1.5
6070,767,0,Asia Pacific,HR,Supply Chain,Meets,Female,48,10,0,6,8,2.6,3.3,1.0,0.0383,0,0,0,0,3.3,3.3,1.9
6071,889,0,Asia Pacific,Finance,Quality Assurance,Exceeds,Male,46,8,1,12,17,0.0,4.9,3.7,0.0588,1,1,1,1,2.9,3.1,5.0
6072,441,0,Middle East & Africa,Manufacturing,Supply Chain,Meets,Male,46,7,0,6,26,2.9,3.1,2.5,0.0348,1,1,1,1,4.1,3.8,2.9
6073,876,0,Europe,HR,Legal & Compliance,Exceeds,Male,41,11,0,8,19,3.0,3.9,1.5,0.0677,1,1,1,0,3.4,1.7,2.7
6074,732,0,North America,HR,Regulatory Affairs,Below,Female,36,10,0,5,18,2.4,3.6,3.6,0.0,1,1,0,0,3.5,2.1,1.9
6075,379,0,North America,Manufacturing,Quality Assurance,Far Below,Female,40,7,0,10,20,2.8,2.7,3.8,0.0,1,0,0,0,2.1,3.0,2.3
6076,982,0,North America,Finance,Marketing,Meets,Male,30,8,0,7,13,2.9,2.5,3.4,0.0331,1,1,1,1,3.0,2.4,3.0
6077,971,0,Asia Pacific,Finance,Market Access,Meets,Male,47,7,0,10,17,3.6,3.7,3.5,0.0331,1,0,0,0,2.0,3.7,2.5
6078,935,0,Europe,Finance,Data Science,Meets,Male,28,14,0,9,14,3.3,2.4,3.7,0.0331,1,1,1,0,3.3,2.0,3.2
6079,962,0,Europe,Finance,Medical Affairs,Meets,Male,37,6,1,5,12,0.0,4.1,2.3,0.0331,1,1,1,1,3.6,2.8,3.2
6080,104,0,Asia Pacific,R&D,Supply Chain,Below,Female,38,12,1,10,11,0.0,3.5,3.8,0.0,1,1,0,0,5.0,3.7,3.2
6081,431,0,North America,Manufacturing,Data Science,Meets,Female,43,2,0,8,15,4.3,3.2,2.4,0.0348,1,1,1,1,4.9,2.1,4.2
6082,47,0,North America,R&D,Clinical Operations,Exceeds,Female,41,16,1,5,8,0.0,2.6,1.7,0.1648,1,1,1,1,1.8,2.6,1.1
6083,831,0,Middle East & Africa,HR,Marketing,Below,Male,41,7,0,10,13,4.8,3.2,3.2,0.0,1,1,1,1,4.3,3.7,2.9
6084,35,0,Latin America,R&D,Data Science,Exceeds,Female,28,9,0,10,23,3.2,3.3,2.0,0.1648,0,0,0,0,3.4,3.3,2.2
6085,902,0,Europe,Finance,Human Resources,Meets,Male,37,5,0,8,16,5.0,2.3,2.6,0.0331,1,1,1,1,4.3,3.5,2.9
6086,700,0,Europe,HR,Communications,Meets,Female,34,6,0,10,30,3.7,3.3,1.6,0.0383,1,1,1,1,4.1,1.3,2.3
6087,38,0,Europe,R&D,Market Access,Below,Female,39,8,0,5,8,3.6,4.2,2.1,0.0,1,1,1,0,4.2,4.3,1.6
6088,8,0,Latin America,R&D,Marketing,Meets,Male,37,6,1,8,14,0.0,2.8,3.3,0.0977,1,1,1,1,3.5,3.5,2.0
6089,408,0,Middle East & Africa,Manufacturing,Market Access,Below,Male,39,15,0,8,14,2.8,2.9,3.5,0.0,1,1,1,1,2.6,4.2,2.4
6090,119,0,Latin America,R&D,IT & Digital,Far Below,Female,31,4,1,8,14,0.0,2.4,2.8,0.0,1,1,1,1,4.2,1.9,1.9
6091,720,0,North America,HR,Data Science,Far Exceeds,Male,39,4,0,10,45,3.3,3.8,2.0,0.1168,1,1,1,1,2.5,3.5,2.9
6092,884,0,North America,Finance,Marketing,Meets,Female,48,18,0,7,9,4.2,2.2,3.5,0.0331,0,0,0,0,4.2,4.0,3.0
6093,510,0,Europe,Manufacturing,Human Resources,Meets,Female,51,19,1,11,14,0.0,1.3,4.1,0.0348,1,1,1,1,2.5,3.8,2.9
6094,147,0,Asia Pacific,R&D,Medical Affairs,Below,Male,46,4,1,11,25,0.0,2.8,1.7,0.0,1,1,1,1,3.4,1.7,3.9
6095,501,0,Europe,Manufacturing,Finance & Accounting,Exceeds,Female,28,9,0,6,23,1.0,2.6,2.4,0.0616,1,1,1,1,2.5,2.9,2.3
6096,584,0,Asia Pacific,Digital,Medical Affairs,Meets,Female,36,7,1,5,6,0.0,3.9,2.4,0.0853,1,1,1,1,3.4,2.7,1.5
6097,506,0,Latin America,Manufacturing,Market Access,Exceeds,Female,35,5,0,12,17,3.5,3.8,1.7,0.0616,1,1,1,1,2.8,2.7,3.7
6098,963,0,North America,Finance,Market Access,Far Below,Male,39,14,0,12,20,2.0,2.6,1.9,0.0,1,1,0,0,2.9,1.9,1.6
6099,685,0,Asia Pacific,Digital,Human Resources,Meets,Female,46,15,0,10,11,3.9,2.2,2.7,0.0853,1,1,1,1,2.9,1.2,4.3
6100,585,0,Latin America,Digital,Regulatory Affairs,Far Exceeds,Male,38,6,0,11,34,3.1,1.9,3.0,0.2363,1,1,1,1,2.3,2.8,1.9
6101,469,0,North America,Manufacturing,Legal & Compliance,Meets,Male,32,13,0,5,11,2.9,3.1,4.4,0.0348,1,1,1,1,2.9,2.0,3.5
6102,720,0,Asia Pacific,HR,Medical Affairs,Exceeds,Male,45,36,0,11,28,2.9,2.7,1.9,0.0677,1,1,1,1,3.6,2.3,2.3
6103,1013,0,Europe,Finance,Human Resources,Meets,Female,40,11,1,12,14,0.0,3.8,1.5,0.0331,1,1,1,1,3.3,4.1,1.4
6104,768,0,Europe,HR,IT & Digital,Meets,Male,43,11,0,5,14,4.3,3.5,1.0,0.0383,1,1,1,1,3.6,4.2,2.3
6105,897,0,Europe,Finance,Medical Affairs,Exceeds,Female,44,10,0,5,15,1.4,2.8,3.1,0.0588,0,0,0,0,1.5,4.1,3.7
6106,987,0,Latin America,Finance,Human Resources,Meets,Female,36,3,0,8,22,3.6,3.2,3.5,0.0331,1,1,1,1,5.0,2.3,2.7
6107,737,0,Europe,HR,Supply Chain,Meets,Female,31,5,1,12,33,0.0,5.0,2.3,0.0383,1,1,1,1,3.5,4.1,3.3
6108,214,0,Middle East & Africa,Commercial,Sales,Meets,Female,39,4,0,11,20,3.4,2.4,2.7,0.0422,1,1,1,1,2.9,2.1,2.1
6109,645,0,North America,Digital,Quality Assurance,Below,Female,36,7,0,9,18,3.3,2.5,1.8,0.0,1,1,1,1,3.1,1.9,3.5
6110,505,0,Latin America,Manufacturing,Supply Chain,Meets,Female,38,8,1,12,24,0.0,1.8,2.4,0.0348,1,0,0,0,4.1,3.0,1.4
6111,718,0,Europe,HR,Market Access,Meets,Female,47,7,1,7,27,0.0,2.7,3.0,0.0383,0,0,0,0,5.0,1.7,1.6
6112,732,1,North America,HR,Pharmacovigilance,Exceeds,Female,39,5,0,5,20,3.3,3.2,5.0,0.0677,0,0,0,0,3.3,1.9,4.2
6113,420,0,Asia Pacific,Manufacturing,Quality Assurance,Meets,Male,49,24,0,11,15,2.0,3.5,1.6,0.0348,0,0,0,0,2.8,3.2,1.9
6114,568,0,Europe,Digital,Communications,Meets,Female,40,14,0,11,13,3.3,2.5,1.5,0.0853,1,1,1,1,2.3,4.0,1.2
6115,478,0,North America,Manufacturing,Pharmacovigilance,Exceeds,Female,36,8,0,8,11,2.5,3.3,1.6,0.0616,1,1,1,1,3.2,3.6,1.3
6116,1040,0,Middle East & Africa,Finance,Clinical Operations,Meets,Female,30,7,0,7,14,2.4,1.0,2.4,0.0331,1,1,1,1,1.6,2.1,1.9
6117,306,0,Asia Pacific,Commercial,Market Access,Exceeds,Female,39,12,0,7,21,3.1,1.8,4.2,0.0743,1,1,1,1,2.5,3.6,3.4
6118,896,0,Middle East & Africa,Finance,Finance & Accounting,Far Exceeds,Female,33,1,0,10,14,3.2,3.5,2.5,0.1022,1,1,1,1,1.8,3.1,2.2
6119,235,0,North America,Commercial,IT & Digital,Far Below,Non-Binary/Other,41,20,0,5,21,2.7,3.6,3.0,0.0,1,1,1,1,3.8,1.0,2.8
6120,360,0,Middle East & Africa,Manufacturing,Data Science,Below,Male,37,15,0,7,9,4.5,4.6,1.2,0.0,1,1,1,1,4.8,2.5,1.3
6121,963,0,North America,Finance,Sales,Below,Male,37,30,0,9,18,3.2,2.5,1.4,0.0,1,1,1,1,3.4,2.5,2.4
6122,544,0,North America,Digital,Pharmacovigilance,Meets,Male,39,3,1,7,18,0.0,2.9,2.4,0.0853,1,1,1,1,4.2,2.7,3.0
6123,907,0,Middle East & Africa,Finance,Quality Assurance,Below,Non-Binary/Other,39,6,0,12,18,2.8,2.8,5.0,0.0,1,1,1,1,3.3,3.3,4.0
6124,872,0,North America,HR,Legal & Compliance,Meets,Male,38,17,0,6,10,4.7,3.6,1.1,0.0383,1,1,1,1,3.8,4.9,1.0
6125,250,0,Europe,Commercial,Market Access,Meets,Female,51,13,1,12,19,0.0,2.4,3.9,0.0422,1,1,1,1,4.1,4.3,3.9
6126,197,0,North America,Commercial,Supply Chain,Exceeds,Male,33,7,1,7,18,0.0,3.4,2.4,0.0743,1,1,1,1,5.0,2.8,2.2
6127,570,0,Latin America,Digital,Regulatory Affairs,Exceeds,Male,44,19,0,12,32,4.6,4.0,1.3,0.1452,1,1,1,1,4.9,3.1,2.0
6128,262,0,North America,Commercial,Communications,Far Exceeds,Female,46,15,0,6,7,3.2,4.0,1.4,0.1275,1,1,1,1,4.6,4.1,2.0
6129,267,0,Latin America,Commercial,Human Resources,Meets,Female,31,6,1,8,10,0.0,4.7,4.3,0.0422,1,1,1,1,4.2,4.6,5.0
6130,694,0,North America,Digital,Marketing,Meets,Male,38,15,0,8,15,3.5,1.8,2.3,0.0853,1,1,1,1,4.6,1.0,1.6
6131,1011,0,North America,Finance,Medical Affairs,Far Below,Male,40,8,1,11,17,0.0,3.5,2.7,0.0,1,1,1,1,4.3,2.8,2.6
6132,464,0,Middle East & Africa,Manufacturing,Sales,Meets,Male,39,6,0,12,22,2.7,2.2,3.9,0.0348,1,1,1,0,3.7,3.2,3.4
6133,945,0,Europe,Finance,Legal & Compliance,Meets,Female,39,14,0,5,20,2.9,1.5,2.8,0.0331,1,1,1,1,4.5,2.8,3.3
6134,699,0,Europe,HR,Sales,Far Exceeds,Male,42,4,0,7,27,4.3,1.5,3.6,0.1168,1,1,1,1,4.0,1.8,3.8
6135,776,0,Asia Pacific,HR,Finance & Accounting,Exceeds,Female,28,8,1,5,18,0.0,3.7,2.6,0.0677,1,1,1,1,1.6,3.8,1.0
6136,289,0,Middle East & Africa,Commercial,Medical Affairs,Below,Male,37,7,1,12,12,0.0,2.6,2.1,0.0,1,0,0,0,5.0,2.3,2.9
6137,820,0,Middle East & Africa,HR,Medical Affairs,Meets,Female,35,16,0,10,12,2.4,2.3,2.1,0.0383,1,1,1,1,2.8,2.6,3.8
6138,403,0,Europe,Manufacturing,Communications,Below,Male,34,2,0,12,17,4.0,4.1,3.9,0.0,1,1,1,1,3.6,3.1,2.5
6139,344,0,Middle East & Africa,Commercial,Medical Affairs,Below,Male,43,9,0,9,25,4.6,2.7,3.1,0.0,0,0,0,0,2.8,4.3,2.4
6140,767,1,Europe,HR,Human Resources,Exceeds,Male,44,7,0,11,13,2.7,3.3,2.8,0.0677,1,1,1,1,3.8,3.6,3.2
6141,16,0,Middle East & Africa,R&D,Regulatory Affairs,Far Exceeds,Female,45,10,0,7,13,3.9,1.5,1.0,0.2644,1,1,1,1,4.5,2.1,1.0
6142,55,0,North America,R&D,Clinical Operations,Below,Female,43,14,0,7,19,3.2,3.4,3.5,0.0,1,1,1,1,4.2,5.0,2.5
6143,92,0,Europe,R&D,IT & Digital,Exceeds,Female,31,13,1,11,19,0.0,3.2,4.9,0.1648,1,1,1,1,3.4,2.9,4.2
6144,17,0,Europe,R&D,Regulatory Affairs,Exceeds,Female,39,10,0,8,50,3.5,3.7,3.2,0.1648,1,1,1,1,3.4,3.4,2.8
6145,1021,0,Latin America,Finance,Supply Chain,Below,Female,45,13,0,6,11,2.9,2.6,2.3,0.0,1,1,1,1,2.6,2.4,4.7
6146,22,0,Middle East & Africa,R&D,IT & Digital,Meets,Female,28,4,0,9,13,3.9,3.5,3.3,0.0977,1,1,1,1,4.0,3.6,1.6
6147,348,0,Middle East & Africa,Commercial,Clinical Operations,Meets,Female,48,4,1,6,11,0.0,2.3,4.0,0.0422,1,1,1,1,3.5,1.6,2.9
6148,537,1,Europe,Digital,Marketing,Exceeds,Female,30,17,0,10,20,4.7,3.2,1.2,0.1452,1,1,1,1,4.4,2.9,3.6
6149,982,0,North America,Finance,Medical Affairs,Meets,Female,33,14,1,11,15,0.0,4.7,1.6,0.0331,1,1,1,1,4.9,5.0,3.2
6150,664,0,North America,Digital,Regulatory Affairs,Below,Male,43,3,1,6,15,0.0,2.2,2.1,0.0,1,1,1,1,3.5,1.5,2.7
6151,336,0,North America,Commercial,Communications,Meets,Male,50,8,0,6,14,3.8,2.7,3.1,0.0422,1,1,1,1,3.7,3.8,1.0
6152,215,0,Middle East & Africa,Commercial,Communications,Meets,Female,32,9,1,12,24,0.0,3.4,1.8,0.0422,1,1,1,1,4.4,4.4,3.0
6153,462,0,Latin America,Manufacturing,Data Science,Meets,Female,33,11,1,12,29,0.0,2.7,2.8,0.0348,1,1,1,1,3.8,3.7,4.9
6154,990,0,Europe,Finance,Supply Chain,Below,Male,46,8,0,6,11,3.0,3.2,1.0,0.0,1,1,1,1,2.2,1.8,3.1
6155,596,0,Asia Pacific,Digital,Marketing,Exceeds,Male,39,9,1,9,36,0.0,2.5,2.7,0.1452,1,1,1,1,3.5,3.5,2.6
6156,45,0,Latin America,R&D,Communications,Meets,Male,37,8,0,8,23,2.1,3.1,3.6,0.0977,1,1,1,1,3.5,3.0,3.7
6157,183,0,Asia Pacific,Commercial,Communications,Exceeds,Non-Binary/Other,39,22,0,9,13,2.8,2.7,2.9,0.0743,1,1,1,1,1.2,3.2,2.1
6158,82,0,Latin America,R&D,Marketing,Exceeds,Male,51,8,0,6,33,1.6,3.5,4.0,0.1648,1,1,1,0,2.5,4.1,3.8
6159,690,0,North America,Digital,Quality Assurance,Exceeds,Female,43,11,0,9,24,3.8,2.2,2.6,0.1452,1,1,0,0,4.6,3.1,3.2
6160,915,0,Middle East & Africa,Finance,Quality Assurance,Far Exceeds,Non-Binary/Other,40,3,1,7,10,0.0,2.4,3.3,0.1022,1,1,1,1,3.2,4.3,2.1
6161,848,0,Asia Pacific,HR,Marketing,Far Exceeds,Male,41,2,0,6,8,3.1,1.9,2.7,0.1168,1,1,1,1,3.4,2.7,3.6
6162,722,0,Latin America,HR,Clinical Operations,Meets,Female,40,10,0,11,23,2.7,3.6,4.5,0.0383,1,1,1,1,3.2,2.4,3.9
6163,257,0,Middle East & Africa,Commercial,Market Access,Meets,Female,43,4,1,5,13,0.0,4.4,2.5,0.0422,1,1,1,1,4.5,4.4,2.1
6164,473,0,Asia Pacific,Manufacturing,Finance & Accounting,Meets,Male,34,18,0,9,21,4.1,4.0,1.0,0.0348,1,1,1,1,5.0,2.1,1.0
6165,72,0,Europe,R&D,Supply Chain,Meets,Male,38,10,1,9,13,0.0,4.1,1.7,0.0977,1,1,1,1,2.6,4.2,2.3
6166,207,0,Latin America,Commercial,Quality Assurance,Far Below,Male,38,14,0,7,10,2.6,3.3,3.5,0.0,0,0,0,0,2.6,3.1,2.6
6167,485,0,Europe,Manufacturing,Sales,Meets,Male,32,10,0,6,18,1.0,3.4,3.6,0.0348,1,1,1,1,1.8,3.0,2.4
6168,45,0,North America,R&D,Finance & Accounting,Below,Female,31,16,0,11,14,3.2,2.9,2.3,0.0,1,1,1,1,3.1,2.9,3.2
6169,654,0,Europe,Digital,Human Resources,Meets,Male,46,9,0,7,22,3.6,3.2,1.3,0.0853,1,1,1,1,4.0,2.3,2.5
6170,726,0,Europe,HR,Medical Affairs,Below,Female,42,11,0,5,7,2.7,3.2,3.1,0.0,1,1,1,1,3.2,3.9,4.6
6171,478,0,Latin America,Manufacturing,Supply Chain,Exceeds,Male,49,8,0,10,22,3.9,2.1,2.1,0.0616,1,1,1,1,3.4,3.2,2.5
6172,52,0,North America,R&D,IT & Digital,Meets,Non-Binary/Other,41,8,0,8,17,3.3,3.2,2.9,0.0977,1,1,1,1,4.9,2.4,2.4
6173,184,0,Europe,Commercial,IT & Digital,Below,Male,40,18,0,8,10,4.3,1.1,2.6,0.0,1,1,1,1,4.0,2.6,1.5
6174,33,0,Middle East & Africa,R&D,Human Resources,Meets,Female,37,10,0,11,16,3.9,2.2,2.6,0.0977,1,1,1,1,4.0,2.8,2.9
6175,230,0,Asia Pacific,Commercial,Finance & Accounting,Below,Male,44,20,0,10,11,3.3,4.2,3.3,0.0,1,1,1,0,2.4,2.8,4.5
6176,744,0,Europe,HR,Marketing,Exceeds,Male,30,11,0,6,10,3.2,2.9,1.0,0.0677,1,1,1,1,4.2,2.8,3.3
6177,863,0,North America,HR,IT & Digital,Meets,Male,40,20,0,5,8,1.7,4.1,3.0,0.0383,1,0,0,0,2.4,3.8,2.2
6178,145,0,Europe,R&D,Marketing,Meets,Male,44,14,0,9,11,1.9,3.2,2.7,0.0977,1,1,1,1,1.0,2.8,4.0
6179,33,0,Asia Pacific,R&D,Legal & Compliance,Exceeds,Male,37,3,1,6,14,0.0,1.1,3.6,0.1648,1,0,0,0,3.0,1.1,3.6
6180,181,0,North America,Commercial,Data Science,Meets,Female,41,16,0,11,21,3.6,4.2,2.6,0.0422,0,0,0,0,2.3,5.0,2.1
6181,204,0,Latin America,Commercial,Human Resources,Exceeds,Male,48,8,0,6,10,3.8,3.1,3.1,0.0743,1,1,1,1,3.8,3.8,4.2
6182,388,1,North America,Manufacturing,Market Access,Meets,Female,37,16,0,6,10,2.9,3.2,2.9,0.0348,1,1,1,1,4.2,1.1,3.3
6183,443,0,Latin America,Manufacturing,Communications,Meets,Female,41,11,1,12,26,0.0,1.8,2.1,0.0348,1,1,1,1,1.9,3.4,2.5
6184,417,0,North America,Manufacturing,Medical Affairs,Meets,Female,44,12,0,10,23,4.7,3.6,2.4,0.0348,1,1,1,1,3.4,2.7,2.8
6185,34,0,Asia Pacific,R&D,Sales,Below,Female,36,14,0,5,12,3.9,4.1,3.6,0.0,1,1,1,1,4.1,3.4,3.0
6186,891,0,Asia Pacific,Finance,Pharmacovigilance,Below,Female,32,21,1,10,12,0.0,4.2,1.8,0.0,1,1,1,1,3.4,5.0,1.8
6187,1036,0,North America,Finance,Quality Assurance,Meets,Male,42,9,1,8,15,0.0,3.3,3.0,0.0331,1,1,1,1,3.3,2.6,3.0
6188,953,0,Europe,Finance,Data Science,Exceeds,Male,39,16,0,5,12,2.2,4.8,2.3,0.0588,1,1,1,1,5.0,3.7,2.8
6189,1039,0,Asia Pacific,Finance,Marketing,Meets,Female,38,4,0,9,39,2.5,2.7,2.7,0.0331,1,1,1,1,2.3,4.7,2.6
6190,475,0,Latin America,Manufacturing,Market Access,Below,Female,39,28,0,11,25,4.6,1.8,2.9,0.0,1,1,1,1,2.3,2.8,2.8
6191,80,1,Latin America,R&D,Clinical Operations,Meets,Male,31,16,0,8,24,3.2,4.2,1.5,0.0977,1,1,1,1,3.6,2.8,4.0
6192,945,0,Middle East & Africa,Finance,Data Science,Exceeds,Female,37,3,0,7,25,4.3,3.4,4.2,0.0588,1,1,1,1,2.5,2.9,4.6
6193,773,0,Latin America,HR,Market Access,Below,Male,42,4,0,10,17,1.4,1.0,3.1,0.0,1,1,1,1,2.4,1.6,4.0
6194,608,0,Middle East & Africa,Digital,Legal & Compliance,Meets,Male,38,14,0,8,25,2.6,4.6,2.6,0.0853,1,1,1,0,2.6,3.6,2.5
6195,806,0,North America,HR,IT & Digital,Meets,Female,35,4,0,8,8,2.4,2.7,2.2,0.0383,1,1,1,1,2.2,2.0,3.2
6196,134,0,North America,R&D,Supply Chain,Meets,Male,34,21,0,6,21,3.1,4.5,4.1,0.0977,1,1,1,1,4.5,5.0,4.5
6197,128,0,North America,R&D,Supply Chain,Meets,Male,40,8,0,12,18,4.1,3.1,5.0,0.0977,1,1,1,1,3.1,2.4,3.8
6198,674,0,Europe,Digital,Regulatory Affairs,Exceeds,Male,43,19,0,10,12,4.4,2.6,1.8,0.1452,1,1,1,1,2.5,2.7,3.1
6199,205,0,Europe,Commercial,Data Science,Meets,Male,44,12,0,11,18,2.9,3.0,2.7,0.0422,1,1,1,1,3.6,2.5,3.9
6200,306,0,Middle East & Africa,Commercial,Communications,Meets,Male,35,8,1,10,16,0.0,3.5,2.9,0.0422,1,1,1,1,3.7,3.8,3.3
6201,276,0,Latin America,Commercial,Supply Chain,Meets,Male,48,14,0,7,29,3.3,3.7,2.6,0.0422,1,1,1,1,2.8,3.7,2.6
6202,452,0,Latin America,Manufacturing,IT & Digital,Meets,Male,39,7,1,12,27,0.0,2.6,3.2,0.0348,1,1,1,1,3.6,3.9,3.0
6203,298,0,North America,Commercial,Marketing,Below,Male,28,16,0,12,17,3.9,2.1,2.1,0.0,1,1,1,1,4.1,3.0,3.5
6204,522,0,Asia Pacific,Manufacturing,Finance & Accounting,Exceeds,Male,39,14,0,12,23,2.8,3.1,3.1,0.0616,1,1,1,1,1.9,2.4,4.1
6205,487,0,Europe,Manufacturing,Supply Chain,Below,Male,32,12,0,7,22,3.4,2.4,2.0,0.0,1,1,1,1,5.0,2.7,4.2
6206,344,0,Europe,Commercial,Market Access,Exceeds,Male,40,10,0,9,24,2.4,1.9,2.2,0.0743,1,1,1,1,3.9,3.7,1.7
6207,344,0,North America,Commercial,Pharmacovigilance,Meets,Female,40,19,0,7,13,2.0,2.9,2.0,0.0422,1,0,0,0,3.3,3.9,2.4
6208,523,1,Europe,Digital,Quality Assurance,Meets,Female,29,18,1,11,18,0.0,2.6,2.9,0.0853,1,1,1,1,4.4,2.2,2.8
6209,1002,0,North America,Finance,Marketing,Below,Female,47,17,0,6,14,2.6,2.4,3.9,0.0,1,1,1,0,3.8,1.2,3.8
6210,565,0,Middle East & Africa,Digital,IT & Digital,Meets,Female,34,21,1,12,16,0.0,2.2,1.8,0.0853,1,1,1,1,3.8,4.1,1.7
6211,401,0,Latin America,Manufacturing,Legal & Compliance,Meets,Male,28,18,0,9,36,4.4,4.2,2.3,0.0348,1,1,1,0,3.9,2.8,2.8
6212,679,0,Asia Pacific,Digital,Medical Affairs,Exceeds,Non-Binary/Other,46,24,0,9,11,2.4,1.7,1.9,0.1452,1,1,1,1,2.0,1.9,1.0
6213,406,1,Latin America,Manufacturing,Legal & Compliance,Meets,Male,42,9,0,5,21,3.2,3.5,5.0,0.0348,1,1,1,1,3.8,4.2,3.2
6214,29,1,Latin America,R&D,Finance & Accounting,Meets,Male,36,13,1,10,14,0.0,3.5,3.4,0.0977,1,1,1,1,3.2,2.6,3.2
6215,480,0,Middle East & Africa,Manufacturing,Market Access,Far Below,Male,38,26,0,10,16,3.6,3.8,1.4,0.0,1,1,1,1,1.8,3.2,2.0
6216,470,0,Europe,Manufacturing,Pharmacovigilance,Exceeds,Female,37,17,0,6,23,3.2,3.5,3.3,0.0616,1,1,1,1,3.9,2.8,3.6
6217,533,0,Asia Pacific,Digital,Supply Chain,Exceeds,Female,28,8,1,11,13,0.0,2.4,4.6,0.1452,1,1,1,1,3.2,1.8,3.9
6218,1019,0,Europe,Finance,Sales,Meets,Female,30,12,1,8,19,0.0,3.8,1.5,0.0331,1,1,1,1,3.2,2.9,1.7
6219,134,0,Latin America,R&D,Regulatory Affairs,Far Below,Male,44,16,0,7,11,3.8,1.6,3.5,0.0,1,0,0,0,3.7,2.5,3.0
6220,877,1,North America,HR,Pharmacovigilance,Meets,Female,40,16,0,9,11,3.2,4.3,2.2,0.0383,1,1,1,1,4.5,3.7,1.4
6221,737,0,Latin America,HR,Legal & Compliance,Meets,Male,43,10,0,12,23,4.6,3.8,2.1,0.0383,1,1,1,1,4.9,3.7,3.6
6222,1039,0,Europe,Finance,Supply Chain,Meets,Female,45,24,0,5,13,4.0,1.0,2.7,0.0331,1,1,1,1,3.3,2.6,4.2
6223,743,0,Latin America,HR,Pharmacovigilance,Meets,Female,28,21,0,12,16,4.3,3.2,3.5,0.0383,0,0,0,0,4.9,3.0,3.3
6224,37,0,North America,R&D,Human Resources,Exceeds,Female,36,8,0,10,19,3.7,2.9,1.7,0.1648,1,1,1,1,3.8,1.5,3.0
6225,297,0,Middle East & Africa,Commercial,Pharmacovigilance,Below,Male,31,8,0,10,22,3.4,3.5,3.7,0.0,1,0,0,0,3.9,3.6,2.6
6226,100,0,Europe,R&D,Market Access,Meets,Female,37,9,1,10,19,0.0,2.1,3.4,0.0977,1,1,1,0,4.1,3.1,2.4
6227,615,0,Latin America,Digital,Sales,Far Below,Male,28,14,0,11,19,4.0,2.0,3.1,0.0,1,1,1,1,3.1,2.7,1.6
6228,373,0,Europe,Manufacturing,Supply Chain,Below,Male,42,17,0,5,19,2.8,3.5,3.5,0.0,1,1,1,1,1.7,3.0,2.4
6229,496,0,Middle East & Africa,Manufacturing,Sales,Exceeds,Female,42,21,1,7,9,0.0,4.1,2.9,0.0616,1,1,1,1,2.2,4.1,2.2
6230,592,0,Latin America,Digital,Communications,Meets,Male,52,16,0,12,27,2.9,2.6,4.3,0.0853,1,1,1,1,3.4,3.2,3.3
6231,549,0,Latin America,Digital,Data Science,Exceeds,Male,37,28,0,12,15,4.6,2.6,1.3,0.1452,1,1,1,1,3.6,2.1,2.8
6232,480,0,Europe,Manufacturing,Market Access,Meets,Female,42,9,0,11,18,4.5,2.9,2.0,0.0348,1,1,1,1,4.6,1.9,1.9
6233,914,1,Europe,Finance,Quality Assurance,Exceeds,Female,44,21,0,11,15,3.8,2.2,2.2,0.0588,1,1,1,1,2.6,3.5,2.4
6234,187,0,North America,Commercial,Quality Assurance,Meets,Male,48,11,0,9,10,5.0,1.0,2.5,0.0422,1,0,0,0,4.0,3.5,2.1
6235,178,0,Middle East & Africa,Commercial,Pharmacovigilance,Far Below,Male,31,2,1,11,23,0.0,2.8,1.5,0.0,1,1,1,1,3.8,5.0,2.7
6236,214,0,North America,Commercial,Human Resources,Exceeds,Female,43,15,0,7,26,3.8,4.6,2.5,0.0743,1,1,1,1,3.8,4.4,2.3
6237,636,0,Latin America,Digital,Legal & Compliance,Below,Male,40,10,0,9,14,2.5,1.7,3.0,0.0,1,1,1,1,1.9,2.8,4.6
6238,419,0,Europe,Manufacturing,IT & Digital,Meets,Female,28,9,0,8,17,2.4,1.0,2.6,0.0348,1,0,0,0,2.9,2.4,3.4
6239,988,0,Latin America,Finance,Marketing,Meets,Female,41,6,0,11,22,2.3,4.7,1.8,0.0331,1,1,1,1,3.0,3.0,2.1
6240,389,0,Latin America,Manufacturing,Regulatory Affairs,Far Below,Female,42,3,1,10,14,0.0,4.5,2.3,0.0,1,1,1,1,2.4,3.9,3.2
6241,389,0,Asia Pacific,Manufacturing,Data Science,Below,Male,28,18,1,9,12,0.0,3.1,2.3,0.0,1,1,1,1,3.3,5.0,3.4
6242,999,0,Asia Pacific,Finance,Finance & Accounting,Meets,Male,38,8,1,10,23,0.0,3.7,2.9,0.0331,1,1,1,1,3.4,4.3,2.8
6243,86,0,Latin America,R&D,Human Resources,Meets,Female,38,4,0,5,10,4.4,3.1,3.4,0.0977,1,1,1,1,3.9,4.0,2.6
6244,988,0,Europe,Finance,IT & Digital,Meets,Female,38,10,0,11,29,3.3,1.3,1.2,0.0331,0,0,0,0,2.8,2.0,2.4
6245,19,0,Latin America,R&D,Market Access,Meets,Female,42,15,0,9,13,3.3,3.7,2.8,0.0977,1,1,1,1,3.3,3.7,3.1
6246,820,0,Asia Pacific,HR,Human Resources,Meets,Male,34,4,1,5,12,0.0,3.9,1.6,0.0383,1,1,1,1,4.5,3.4,2.2
6247,75,0,Europe,R&D,Communications,Meets,Male,31,2,0,12,21,4.2,3.4,2.8,0.0977,1,1,1,1,4.1,3.2,2.5
6248,237,0,Latin America,Commercial,Marketing,Exceeds,Male,41,14,0,9,27,3.3,1.5,5.0,0.0743,1,1,1,1,2.6,1.4,2.9
6249,281,0,Middle East & Africa,Commercial,Clinical Operations,Below,Female,47,4,1,6,15,0.0,1.0,1.9,0.0,1,1,1,0,3.8,1.0,4.2
6250,1025,0,Middle East & Africa,Finance,Legal & Compliance,Meets,Female,47,17,1,7,17,0.0,2.1,2.1,0.0331,1,1,1,1,3.7,2.6,2.1
6251,340,0,Latin America,Commercial,Regulatory Affairs,Meets,Male,52,3,0,7,9,3.1,1.5,3.0,0.0422,1,1,0,0,2.1,1.0,4.9
6252,215,0,Europe,Commercial,Quality Assurance,Meets,Female,36,5,0,6,9,4.8,1.9,3.7,0.0422,1,1,1,1,4.9,1.9,4.2
6253,868,1,Latin America,HR,Human Resources,Meets,Female,37,12,1,12,19,0.0,2.9,3.4,0.0383,1,1,1,1,4.1,3.8,2.5
6254,213,0,Latin America,Commercial,Quality Assurance,Meets,Female,28,21,1,11,19,0.0,5.0,4.1,0.0422,1,1,1,1,2.8,5.0,3.2
6255,667,0,Asia Pacific,Digital,Marketing,Below,Male,34,5,0,12,15,2.0,2.8,1.6,0.0,1,1,1,1,3.4,4.3,1.4
6256,539,0,Middle East & Africa,Digital,Data Science,Meets,Female,29,13,0,10,28,3.1,2.2,2.3,0.0853,1,1,0,0,2.3,2.5,1.5
6257,626,0,Asia Pacific,Digital,Legal & Compliance,Below,Male,36,14,0,8,11,3.6,3.2,2.4,0.0,1,1,1,1,5.0,3.4,2.8
6258,73,0,Asia Pacific,R&D,Regulatory Affairs,Below,Female,46,11,1,10,22,0.0,3.1,3.1,0.0,1,1,1,1,3.7,4.1,4.1
6259,1018,1,Latin America,Finance,Finance & Accounting,Far Exceeds,Female,44,18,1,12,28,0.0,4.3,1.9,0.1022,1,1,1,1,5.0,3.5,3.9
6260,984,0,Asia Pacific,Finance,Marketing,Meets,Female,36,7,0,8,35,2.7,1.3,3.7,0.0331,1,1,1,1,3.7,3.2,3.5
6261,394,0,Middle East & Africa,Manufacturing,Clinical Operations,Meets,Male,35,17,0,5,9,3.1,1.9,2.7,0.0348,1,0,0,0,2.9,3.4,3.9
6262,765,0,Asia Pacific,HR,Legal & Compliance,Meets,Female,33,6,0,10,11,4.0,4.0,2.7,0.0383,1,1,1,1,4.4,3.7,2.1
6263,582,0,Middle East & Africa,Digital,Market Access,Exceeds,Male,43,17,1,9,16,0.0,4.4,1.8,0.1452,1,1,1,1,3.1,3.4,2.7
6264,691,0,Asia Pacific,Digital,Marketing,Meets,Female,36,19,0,7,9,2.5,3.7,3.7,0.0853,1,1,1,1,3.4,2.9,2.5
6265,199,0,Middle East & Africa,Commercial,Pharmacovigilance,Meets,Male,40,6,0,7,39,2.7,3.0,3.0,0.0422,1,1,1,1,3.3,2.6,3.3
6266,564,0,Asia Pacific,Digital,Supply Chain,Meets,Male,42,3,0,8,17,4.6,5.0,1.4,0.0853,1,1,1,1,3.9,4.3,3.4
6267,232,0,Asia Pacific,Commercial,Pharmacovigilance,Exceeds,Male,42,7,1,5,18,0.0,4.2,2.9,0.0743,1,1,1,1,2.9,2.9,2.4
6268,236,0,Europe,Commercial,Regulatory Affairs,Exceeds,Male,28,7,0,7,14,2.4,3.7,2.9,0.0743,1,1,1,1,3.8,1.9,2.5
6269,362,0,Middle East & Africa,Manufacturing,Human Resources,Meets,Male,41,7,0,7,17,3.6,4.4,3.7,0.0348,1,1,1,1,3.7,3.9,2.8
6270,50,0,Middle East & Africa,R&D,Legal & Compliance,Exceeds,Male,39,22,0,7,27,3.5,2.7,2.8,0.1648,1,1,1,1,3.4,2.6,1.7
6271,207,0,Middle East & Africa,Commercial,Sales,Meets,Male,28,5,0,7,23,1.8,3.6,3.2,0.0422,1,1,1,1,4.1,5.0,3.8
6272,271,0,North America,Commercial,Pharmacovigilance,Far Exceeds,Male,46,5,0,9,18,3.9,2.0,2.4,0.1275,1,1,1,1,3.2,1.1,1.2
6273,950,0,Asia Pacific,Finance,Supply Chain,Exceeds,Female,39,18,0,9,20,3.1,4.3,1.6,0.0588,0,0,0,0,4.6,4.0,1.8
6274,440,0,Middle East & Africa,Manufacturing,Pharmacovigilance,Meets,Male,29,12,0,10,25,4.7,3.3,2.3,0.0348,1,1,1,1,4.1,4.0,1.1
6275,267,0,North America,Commercial,Legal & Compliance,Meets,Female,35,14,0,11,27,2.8,3.1,3.8,0.0422,1,1,1,1,3.6,3.4,2.6
6276,762,0,Europe,HR,Human Resources,Meets,Female,37,25,0,11,20,3.5,4.5,3.8,0.0383,1,1,1,1,3.2,4.2,3.2
6277,17,0,Middle East & Africa,R&D,Marketing,Meets,Male,54,1,0,10,17,4.0,3.0,1.6,0.0977,0,0,0,0,3.0,3.5,2.9
6278,775,0,Middle East & Africa,HR,Communications,Below,Male,33,8,1,7,14,0.0,3.5,1.1,0.0,1,1,1,1,2.6,4.0,1.9
6279,555,0,North America,Digital,Supply Chain,Far Below,Male,34,17,1,7,19,0.0,2.8,2.1,0.0,0,0,0,0,4.5,2.6,3.0
6280,147,0,Asia Pacific,R&D,Market Access,Far Below,Female,39,28,0,11,19,2.4,2.9,1.3,0.0,0,0,0,0,4.5,4.0,1.6
6281,586,0,Europe,Digital,Sales,Far Exceeds,Female,51,7,0,8,21,3.7,2.3,5.0,0.2363,1,1,1,1,2.9,3.4,2.3
6282,889,0,Middle East & Africa,Finance,Marketing,Below,Male,37,9,0,7,14,3.2,4.1,3.2,0.0,1,1,1,1,3.3,3.5,3.7
6283,244,0,Asia Pacific,Commercial,Clinical Operations,Far Below,Male,35,26,0,10,17,4.3,3.9,3.6,0.0,1,1,1,1,4.0,4.2,2.4
6284,379,0,Europe,Manufacturing,Clinical Operations,Meets,Female,39,11,0,8,12,3.6,3.9,3.7,0.0348,1,1,1,1,3.7,4.1,4.0
6285,829,0,Latin America,HR,Regulatory Affairs,Meets,Male,36,2,0,11,27,3.8,1.6,2.1,0.0383,1,1,1,1,3.2,3.3,2.5
6286,614,0,Latin America,Digital,Human Resources,Exceeds,Female,36,10,0,12,17,2.5,2.8,1.0,0.1452,1,1,1,1,3.4,3.7,2.7
6287,186,0,Europe,Commercial,Legal & Compliance,Meets,Male,44,3,1,11,17,0.0,2.1,3.7,0.0422,0,0,0,0,3.5,2.9,3.6
6288,789,0,North America,HR,Medical Affairs,Meets,Male,35,7,0,6,15,4.3,2.2,2.2,0.0383,1,1,1,1,4.0,3.6,2.0
6289,737,0,Europe,HR,Human Resources,Exceeds,Male,36,9,1,12,19,0.0,3.1,3.9,0.0677,1,1,1,1,4.3,4.8,3.6
6290,908,0,Europe,Finance,Pharmacovigilance,Far Below,Female,44,29,0,9,11,3.1,3.9,1.0,0.0,1,1,1,1,2.8,5.0,1.3
6291,888,0,North America,Finance,Supply Chain,Far Exceeds,Male,29,25,0,12,21,3.5,3.0,2.1,0.1022,1,1,1,1,3.5,4.5,3.8
6292,583,0,North America,Digital,Marketing,Below,Male,36,30,0,12,20,2.5,1.5,2.5,0.0,1,1,1,1,4.3,2.2,2.5
6293,304,0,Asia Pacific,Commercial,Communications,Meets,Male,28,7,1,11,29,0.0,3.9,3.0,0.0422,1,1,1,1,1.3,4.1,2.4
6294,490,0,Asia Pacific,Manufacturing,Clinical Operations,Far Below,Male,35,9,0,6,9,1.0,3.2,2.3,0.0,1,1,1,1,3.2,2.4,3.4
6295,600,0,North America,Digital,Sales,Exceeds,Female,36,14,0,5,13,2.2,1.8,2.9,0.1452,1,1,1,1,2.6,3.2,2.6
6296,876,0,Latin America,HR,Human Resources,Below,Male,36,21,0,11,16,3.0,2.8,2.3,0.0,1,1,1,1,3.3,3.8,1.5
6297,812,0,Latin America,HR,IT & Digital,Below,Female,36,14,0,7,28,4.5,3.0,4.7,0.0,1,1,1,1,4.0,2.0,4.1
6298,105,0,Europe,R&D,Finance & Accounting,Exceeds,Male,40,10,0,10,24,3.3,3.7,3.3,0.1648,1,1,1,1,3.9,4.3,3.0
6299,185,0,Middle East & Africa,Commercial,Medical Affairs,Below,Female,31,11,0,9,19,3.8,3.7,4.6,0.0,1,1,1,1,2.8,3.5,3.2
6300,48,0,Europe,R&D,Sales,Meets,Female,40,13,0,11,23,3.2,4.1,3.1,0.0977,1,1,1,1,3.8,2.7,4.4
6301,894,0,Europe,Finance,Human Resources,Meets,Female,35,18,0,6,21,2.7,2.4,3.3,0.0331,0,0,0,0,3.5,4.4,3.4
6302,406,0,Middle East & Africa,Manufacturing,Pharmacovigilance,Meets,Female,43,4,1,8,19,0.0,3.2,1.7,0.0348,1,1,1,1,4.3,5.0,1.9
6303,547,0,North America,Digital,IT & Digital,Meets,Male,38,5,0,6,14,2.7,3.2,3.3,0.0853,0,0,0,0,3.6,3.2,3.3
6304,809,0,Latin America,HR,Data Science,Exceeds,Non-Binary/Other,34,19,0,5,20,2.4,4.8,2.5,0.0677,1,1,1,1,1.7,1.5,2.4
6305,301,0,Europe,Commercial,Medical Affairs,Exceeds,Male,30,4,0,12,23,3.9,2.7,4.8,0.0743,1,1,1,1,4.4,2.4,4.2
6306,740,0,Middle East & Africa,HR,Quality Assurance,Meets,Male,40,15,0,10,22,3.1,3.3,2.5,0.0383,1,0,0,0,5.0,1.3,2.2
6307,1029,0,Asia Pacific,Finance,Data Science,Meets,Male,37,6,0,10,12,2.5,3.7,4.2,0.0331,1,1,1,1,2.7,4.5,3.6
6308,108,0,Europe,R&D,Finance & Accounting,Meets,Male,47,14,0,12,25,3.5,2.6,1.0,0.0977,1,1,1,1,3.7,2.7,2.1
6309,141,0,Latin America,R&D,Data Science,Meets,Female,47,8,0,11,33,4.1,2.9,2.6,0.0977,1,1,1,1,4.3,2.4,2.1
6310,556,0,North America,Digital,Finance & Accounting,Meets,Male,35,7,0,9,22,2.6,3.1,2.7,0.0853,1,1,1,1,1.7,3.0,2.6
6311,239,0,Europe,Commercial,Pharmacovigilance,Exceeds,Female,28,17,1,10,27,0.0,2.1,2.9,0.0743,1,1,1,1,2.7,2.3,4.9
6312,939,0,Europe,Finance,Sales,Meets,Male,43,11,0,12,17,3.4,2.0,2.7,0.0331,1,1,1,1,4.2,2.8,4.0
6313,309,0,Middle East & Africa,Commercial,Market Access,Meets,Female,35,10,0,7,25,4.1,3.5,4.4,0.0422,0,0,0,0,2.6,2.6,4.2
6314,663,0,Asia Pacific,Digital,Clinical Operations,Meets,Female,36,3,0,8,14,4.4,3.0,3.4,0.0853,1,1,1,1,4.4,3.4,4.0
6315,939,0,Asia Pacific,Finance,Supply Chain,Meets,Female,45,9,0,5,12,2.2,3.0,2.8,0.0331,1,1,0,0,3.0,3.7,3.6
6316,952,0,North America,Finance,Supply Chain,Meets,Male,40,10,0,6,20,2.0,3.8,3.4,0.0331,1,1,1,1,4.4,1.0,3.9
6317,76,0,Latin America,R&D,Communications,Meets,Non-Binary/Other,43,8,0,10,23,2.7,1.4,2.0,0.0977,1,1,1,1,3.2,1.7,1.6
6318,62,0,North America,R&D,Marketing,Meets,Female,44,17,0,12,19,3.0,3.7,2.4,0.0977,1,1,1,1,2.6,3.0,2.5
6319,164,0,Europe,R&D,Marketing,Far Below,Non-Binary/Other,37,10,0,6,14,3.5,3.4,2.6,0.0,1,1,1,1,3.9,4.4,4.1
6320,797,1,Europe,HR,Data Science,Meets,Female,42,23,0,11,17,3.6,1.8,3.2,0.0383,1,1,1,1,3.2,2.8,3.0
6321,493,0,Asia Pacific,Manufacturing,Data Science,Meets,Female,39,9,0,12,20,5.0,3.6,1.0,0.0348,1,1,1,1,4.8,1.7,1.9
6322,107,0,Latin America,R&D,Market Access,Below,Female,41,13,0,8,15,1.5,3.6,3.1,0.0,1,1,1,1,3.2,4.7,3.1
6323,388,0,Middle East & Africa,Manufacturing,Human Resources,Meets,Female,39,8,0,7,19,3.5,3.4,2.1,0.0348,1,1,1,1,3.2,3.2,3.4
6324,420,0,Latin America,Manufacturing,Pharmacovigilance,Meets,Female,46,15,0,11,13,4.1,3.7,3.6,0.0348,1,1,1,1,4.2,3.8,4.5
6325,252,0,Europe,Commercial,Clinical Operations,Exceeds,Female,30,8,0,8,27,2.4,2.4,3.6,0.0743,0,0,0,0,3.6,4.1,3.4
6326,692,0,Middle East & Africa,Digital,Supply Chain,Meets,Female,35,7,1,8,21,0.0,2.5,2.7,0.0853,1,1,1,1,2.9,1.8,1.0
6327,859,0,Latin America,HR,Finance & Accounting,Meets,Non-Binary/Other,37,7,0,12,20,4.3,4.0,1.0,0.0383,0,0,0,0,3.5,4.1,2.4
6328,410,0,Latin America,Manufacturing,IT & Digital,Exceeds,Male,39,10,0,11,13,2.0,1.0,2.5,0.0616,1,1,1,1,1.8,1.4,2.7
6329,811,0,Middle East & Africa,HR,Human Resources,Meets,Female,30,10,0,12,21,3.7,3.1,1.4,0.0383,1,1,1,1,4.3,3.6,2.1
6330,280,0,Europe,Commercial,Market Access,Exceeds,Male,34,8,1,7,13,0.0,3.2,2.6,0.0743,1,1,1,1,3.3,2.8,3.3
6331,115,0,Latin America,R&D,Supply Chain,Meets,Male,38,17,0,7,25,1.5,1.5,2.9,0.0977,1,1,1,1,2.1,3.3,2.8
6332,1020,0,Middle East & Africa,Finance,Quality Assurance,Exceeds,Male,35,3,0,8,14,2.8,2.7,2.6,0.0588,0,0,0,0,2.4,2.4,3.5
6333,359,0,Europe,Manufacturing,Marketing,Meets,Male,28,8,0,12,24,4.7,3.1,2.4,0.0348,1,1,1,1,3.9,2.1,3.8
6334,614,0,Middle East & Africa,Digital,Quality Assurance,Below,Non-Binary/Other,36,9,1,6,7,0.0,2.5,2.7,0.0,1,1,1,1,3.8,3.5,4.2
6335,914,0,Middle East & Africa,Finance,Clinical Operations,Meets,Male,31,25,0,12,21,3.5,3.4,2.4,0.0331,1,1,1,0,3.3,4.7,2.5
6336,185,0,Latin America,Commercial,Clinical Operations,Meets,Female,42,14,0,10,29,4.1,3.3,4.1,0.0422,1,1,1,1,1.8,3.6,3.8
6337,832,0,Europe,HR,Pharmacovigilance,Meets,Male,40,9,1,5,18,0.0,3.1,3.6,0.0383,1,1,1,1,2.7,4.3,4.2
6338,73,1,Latin America,R&D,IT & Digital,Meets,Female,43,5,1,8,19,0.0,2.2,2.0,0.0977,1,1,1,1,4.0,1.9,3.4
6339,754,0,North America,HR,Medical Affairs,Far Below,Female,39,8,1,6,9,0.0,1.0,1.2,0.0,1,1,1,1,3.3,1.1,1.7
6340,565,0,North America,Digital,Data Science,Meets,Male,32,12,0,9,16,3.5,4.3,4.2,0.0853,1,1,1,1,2.7,3.1,3.2
6341,430,0,Europe,Manufacturing,Marketing,Meets,Male,28,11,0,9,27,2.9,1.0,3.1,0.0348,1,1,1,1,3.5,2.1,2.2
6342,600,0,Middle East & Africa,Digital,Market Access,Below,Male,45,12,1,6,33,0.0,1.5,1.8,0.0,1,1,1,1,3.0,1.6,1.0
6343,810,0,Latin America,HR,IT & Digital,Meets,Male,35,23,0,9,24,3.7,2.0,1.0,0.0383,0,0,0,0,3.1,1.8,2.0
6344,779,0,Latin America,HR,Finance & Accounting,Far Below,Male,28,9,0,9,20,2.6,3.3,2.5,0.0,1,1,1,0,3.9,3.5,1.8
6345,897,0,Europe,Finance,IT & Digital,Meets,Non-Binary/Other,47,2,0,5,15,3.5,2.8,2.7,0.0331,1,1,1,1,2.3,2.9,1.9
6346,691,0,Europe,Digital,Pharmacovigilance,Exceeds,Female,41,5,0,10,24,3.3,3.6,3.1,0.1452,1,1,0,0,2.8,3.6,4.8
6347,602,0,North America,Digital,Market Access,Meets,Male,47,4,0,7,34,2.7,4.6,3.7,0.0853,1,1,1,1,3.0,4.2,3.9
6348,529,0,Asia Pacific,Digital,Human Resources,Far Below,Non-Binary/Other,41,25,0,12,22,2.6,3.2,2.5,0.0,1,1,1,1,3.2,3.1,2.0
6349,127,0,Europe,R&D,Medical Affairs,Meets,Male,42,4,0,11,40,5.0,1.9,2.0,0.0977,1,1,1,1,4.1,1.7,2.8
6350,709,1,Asia Pacific,HR,Pharmacovigilance,Meets,Male,35,19,0,11,18,4.7,3.8,3.5,0.0383,1,1,1,1,3.7,5.0,2.6
6351,348,0,Europe,Commercial,Communications,Meets,Female,42,26,0,11,29,3.3,4.0,2.3,0.0422,0,0,0,0,3.3,5.0,2.6
6352,3,0,Middle East & Africa,R&D,Sales,Meets,Male,50,10,0,5,21,4.1,2.5,3.2,0.0977,1,1,1,0,5.0,3.0,3.5
6353,98,0,Middle East & Africa,R&D,Finance & Accounting,Exceeds,Male,43,8,0,11,16,3.8,3.3,2.3,0.1648,1,1,1,1,4.0,4.8,2.7
6354,120,0,North America,R&D,Supply Chain,Exceeds,Male,36,11,1,9,18,0.0,2.6,3.1,0.1648,1,0,0,0,3.8,2.3,2.3
6355,933,0,North America,Finance,Data Science,Below,Female,30,2,1,11,20,0.0,3.3,1.9,0.0,1,1,1,1,1.8,2.3,2.4
6356,268,0,Asia Pacific,Commercial,Data Science,Below,Female,45,10,0,11,27,4.0,2.6,3.3,0.0,1,1,1,1,3.5,2.4,3.2
6357,609,0,Europe,Digital,IT & Digital,Meets,Female,38,5,0,12,28,4.2,3.2,3.5,0.0853,1,1,1,1,4.5,2.5,2.4
6358,968,0,Latin America,Finance,Data Science,Meets,Female,39,13,0,12,24,4.1,2.8,3.4,0.0331,1,1,1,1,3.7,2.6,2.8
6359,875,0,North America,HR,Quality Assurance,Meets,Female,28,10,0,5,7,1.7,4.9,2.7,0.0383,1,1,1,1,2.8,3.4,2.3
6360,373,1,Latin America,Manufacturing,Legal & Compliance,Meets,Male,28,6,1,5,16,0.0,1.3,2.9,0.0348,1,1,1,1,5.0,2.0,3.3
6361,905,0,Latin America,Finance,Marketing,Below,Female,39,5,0,7,20,4.9,2.7,2.6,0.0,0,0,0,0,4.1,3.8,2.7
6362,356,0,Europe,Manufacturing,Pharmacovigilance,Exceeds,Female,33,16,1,12,38,0.0,4.8,2.4,0.0616,1,1,1,1,2.9,4.3,1.7
6363,770,0,Asia Pacific,HR,Pharmacovigilance,Meets,Male,39,10,0,11,28,2.4,4.5,1.1,0.0383,1,1,1,1,1.9,3.2,1.5
6364,283,0,Europe,Commercial,Quality Assurance,Far Exceeds,Male,44,9,1,7,23,0.0,3.0,1.0,0.1275,0,0,0,0,2.6,2.2,1.0
6365,449,0,North America,Manufacturing,Clinical Operations,Meets,Non-Binary/Other,35,8,0,5,15,3.4,1.9,2.4,0.0348,1,1,1,1,5.0,1.5,3.4
6366,1,1,Latin America,R&D,Marketing,Meets,Male,39,36,0,8,15,1.5,3.3,1.9,0.0977,0,0,0,0,2.9,2.3,2.6
6367,969,0,Europe,Finance,Medical Affairs,Below,Female,37,6,0,12,14,3.6,2.8,1.3,0.0,1,1,1,1,2.0,3.0,1.0
6368,450,0,Europe,Manufacturing,Medical Affairs,Meets,Male,55,8,0,12,39,3.3,3.5,2.6,0.0348,0,0,0,0,2.7,3.1,3.2
6369,800,0,Europe,HR,Data Science,Below,Female,35,6,0,9,12,2.7,3.4,4.6,0.0,1,1,1,1,2.1,3.0,3.9
6370,151,0,North America,R&D,IT & Digital,Meets,Male,34,15,0,12,20,4.4,3.2,1.6,0.0977,1,1,1,1,4.1,4.0,3.2
6371,432,0,Asia Pacific,Manufacturing,Pharmacovigilance,Below,Female,35,20,0,12,27,3.1,2.8,4.3,0.0,1,1,1,1,4.3,4.6,3.8
6372,734,0,Europe,HR,Regulatory Affairs,Below,Female,45,11,1,8,11,0.0,2.8,2.1,0.0,1,1,1,1,1.7,1.9,1.9
6373,197,0,North America,Commercial,Clinical Operations,Below,Male,35,6,0,12,15,4.3,3.9,3.4,0.0,1,1,1,1,3.4,4.0,3.4
6374,861,0,Latin America,HR,Legal & Compliance,Below,Male,42,8,1,12,21,0.0,2.0,1.5,0.0,0,0,0,0,4.0,3.8,1.7
6375,215,0,Middle East & Africa,Commercial,Communications,Meets,Male,38,2,0,5,17,2.9,3.8,4.0,0.0422,1,1,1,1,3.6,3.2,3.5
6376,113,0,North America,R&D,Market Access,Far Exceeds,Female,38,27,0,5,7,2.1,3.1,2.5,0.2644,1,1,1,1,3.5,3.7,5.0
6377,869,0,Middle East & Africa,HR,Data Science,Meets,Female,48,1,1,11,28,0.0,2.3,3.9,0.0383,1,1,1,1,3.6,1.5,4.4
6378,530,0,Europe,Digital,Finance & Accounting,Meets,Female,28,10,0,5,11,2.5,4.3,2.7,0.0853,0,0,0,0,4.4,3.6,4.0
6379,1029,0,Europe,Finance,Communications,Below,Male,39,17,0,12,15,3.9,1.5,2.0,0.0,1,1,1,1,3.5,1.0,1.8
6380,647,0,North America,Digital,Medical Affairs,Meets,Female,42,7,1,12,22,0.0,2.8,1.1,0.0853,1,1,1,1,3.4,2.7,2.9
6381,636,0,Middle East & Africa,Digital,Medical Affairs,Below,Non-Binary/Other,40,6,1,5,15,0.0,4.1,3.7,0.0,1,1,1,1,3.2,4.9,3.1
6382,617,0,Europe,Digital,Marketing,Below,Female,29,17,0,5,16,4.3,2.9,2.8,0.0,1,1,1,1,4.4,2.4,3.9
6383,1005,0,Latin America,Finance,Clinical Operations,Below,Male,31,11,0,12,27,3.2,3.4,2.5,0.0,1,1,1,1,3.8,4.2,3.9
6384,648,0,Asia Pacific,Digital,Clinical Operations,Meets,Female,40,27,0,6,14,4.0,3.7,1.3,0.0853,1,1,1,1,3.8,1.9,1.0
6385,194,0,Asia Pacific,Commercial,Regulatory Affairs,Below,Female,28,6,0,6,13,4.2,4.3,2.9,0.0,1,1,1,1,4.0,3.2,2.4
6386,709,0,Europe,HR,Medical Affairs,Exceeds,Female,35,7,1,7,10,0.0,1.0,2.9,0.0677,1,1,1,1,4.0,1.6,2.0
6387,17,0,Middle East & Africa,R&D,Supply Chain,Meets,Male,31,12,1,11,19,0.0,3.9,1.4,0.0977,1,1,1,1,2.6,3.0,2.8
6388,623,0,Europe,Digital,Marketing,Exceeds,Male,39,5,1,11,24,0.0,3.3,3.8,0.1452,1,1,1,1,5.0,2.2,2.6
6389,553,1,Middle East & Africa,Digital,Communications,Far Exceeds,Female,37,7,1,8,11,0.0,3.7,1.6,0.2363,1,0,0,0,3.8,3.9,2.7
6390,118,0,Latin America,R&D,Human Resources,Meets,Male,40,6,0,8,37,4.2,3.8,2.3,0.0977,1,1,1,1,4.1,2.4,2.3
6391,84,0,Middle East & Africa,R&D,Pharmacovigilance,Exceeds,Male,33,24,0,11,14,3.8,1.1,1.0,0.1648,1,1,1,1,2.4,1.5,3.6
6392,593,0,Europe,Digital,Supply Chain,Below,Female,40,6,0,11,13,4.2,4.1,2.6,0.0,1,1,1,1,4.6,4.0,2.7
6393,284,0,Latin America,Commercial,IT & Digital,Exceeds,Female,38,13,0,6,16,3.9,3.2,2.0,0.0743,1,1,1,1,3.0,2.8,2.7
6394,107,0,North America,R&D,Sales,Meets,Non-Binary/Other,33,3,1,12,28,0.0,3.0,3.8,0.0977,1,1,1,1,3.5,2.3,3.6
6395,845,0,Asia Pacific,HR,Marketing,Meets,Male,45,11,1,10,31,0.0,2.6,1.9,0.0383,1,1,1,1,3.9,4.2,1.7
6396,848,0,Europe,HR,Market Access,Meets,Female,42,7,1,12,17,0.0,2.0,2.3,0.0383,1,1,1,1,3.2,2.2,1.8
6397,322,0,Europe,Commercial,Pharmacovigilance,Exceeds,Male,34,16,0,7,13,3.1,3.1,4.2,0.0743,1,1,1,1,3.7,4.4,3.5
6398,907,0,Europe,Finance,Clinical Operations,Exceeds,Male,33,20,0,6,19,2.9,3.3,3.1,0.0588,1,1,1,1,2.9,2.9,2.7
6399,360,0,Latin America,Manufacturing,Human Resources,Below,Male,44,10,1,11,17,0.0,3.1,2.3,0.0,1,1,1,1,3.7,3.8,4.0
6400,277,0,North America,Commercial,Pharmacovigilance,Meets,Female,28,15,0,9,30,4.1,4.4,1.3,0.0422,1,1,1,1,5.0,4.4,3.2
6401,586,0,Middle East & Africa,Digital,Marketing,Meets,Female,30,5,0,11,14,3.2,3.4,2.7,0.0853,1,1,1,1,3.7,1.5,4.0
6402,395,0,North America,Manufacturing,IT & Digital,Meets,Male,41,18,0,7,12,3.5,2.8,2.0,0.0348,1,1,1,1,2.7,3.4,2.2
6403,672,0,Latin America,Digital,Medical Affairs,Far Below,Male,49,3,0,5,18,1.6,3.7,2.4,0.0,1,1,1,1,1.2,4.0,3.8
6404,878,0,Europe,HR,IT & Digital,Meets,Female,34,16,0,9,23,3.5,2.6,2.7,0.0383,1,1,1,1,2.9,2.3,4.0
6405,163,0,Asia Pacific,R&D,Sales,Exceeds,Male,35,13,0,5,23,3.5,1.0,4.6,0.1648,1,1,1,1,3.5,2.8,2.5
6406,547,0,Europe,Digital,Finance & Accounting,Meets,Male,37,23,0,8,21,3.5,3.9,1.9,0.0853,1,1,1,1,2.1,4.8,2.1
6407,757,0,Middle East & Africa,HR,Clinical Operations,Meets,Female,35,7,0,12,17,1.8,1.5,2.8,0.0383,1,1,1,1,3.7,1.9,3.5
6408,339,0,Asia Pacific,Commercial,Supply Chain,Meets,Male,35,4,1,11,14,0.0,4.6,1.6,0.0422,1,1,1,1,2.5,3.8,2.2
6409,670,0,Europe,Digital,Finance & Accounting,Meets,Male,34,9,0,7,9,2.0,2.5,3.7,0.0853,1,1,1,1,3.4,3.1,3.1
6410,763,0,Asia Pacific,HR,Communications,Exceeds,Female,39,7,0,8,13,2.8,1.8,2.4,0.0677,1,1,1,1,3.5,2.7,1.8
6411,115,0,North America,R&D,Communications,Meets,Male,42,9,0,9,22,3.2,3.0,1.5,0.0977,1,1,1,1,1.9,3.8,2.0
6412,647,0,Latin America,Digital,Finance & Accounting,Meets,Female,39,13,0,11,20,3.4,3.2,2.3,0.0853,1,1,1,1,3.1,3.6,3.6
6413,1049,0,Europe,Finance,Quality Assurance,Exceeds,Female,37,7,1,6,12,0.0,4.5,3.7,0.0588,1,1,1,1,2.9,2.9,3.5
6414,870,0,Middle East & Africa,HR,Human Resources,Far Below,Male,34,9,0,8,11,3.1,3.9,1.3,0.0,1,1,1,1,4.6,2.6,2.6
6415,687,0,North America,Digital,Sales,Exceeds,Female,31,13,0,6,16,3.1,3.6,3.7,0.1452,1,1,1,1,2.8,3.5,5.0
6416,172,0,Europe,R&D,Regulatory Affairs,Meets,Male,30,11,0,12,13,2.2,2.6,1.9,0.0977,0,0,0,0,4.2,3.5,2.6
6417,671,0,North America,Digital,Quality Assurance,Exceeds,Female,29,10,0,7,13,2.7,4.5,2.9,0.1452,1,1,1,1,4.2,2.7,3.6
6418,620,0,Middle East & Africa,Digital,Market Access,Meets,Female,42,9,0,6,14,4.0,5.0,4.0,0.0853,1,1,1,1,3.6,4.0,3.9
6419,921,0,Europe,Finance,Supply Chain,Meets,Female,35,17,0,5,30,4.4,2.5,3.0,0.0331,1,1,1,1,4.3,3.0,3.9
6420,790,0,Middle East & Africa,HR,Market Access,Exceeds,Non-Binary/Other,40,9,0,6,10,3.2,2.4,2.9,0.0677,1,1,1,1,3.0,3.1,3.4
6421,439,0,Asia Pacific,Manufacturing,Pharmacovigilance,Meets,Female,34,3,0,8,21,3.7,4.4,2.5,0.0348,1,1,1,1,2.3,3.8,1.9
6422,657,0,Middle East & Africa,Digital,Medical Affairs,Meets,Female,38,19,0,7,26,3.0,3.3,1.3,0.0853,1,1,1,1,4.0,2.2,2.5
6423,466,0,Asia Pacific,Manufacturing,Human Resources,Meets,Male,36,4,1,7,16,0.0,3.9,2.9,0.0348,1,1,1,1,3.1,3.4,3.3
6424,256,0,Europe,Commercial,Pharmacovigilance,Meets,Female,47,13,0,7,14,2.8,4.8,3.0,0.0422,1,1,1,1,3.0,3.9,2.1
6425,565,0,Asia Pacific,Digital,Medical Affairs,Meets,Male,35,16,0,9,10,5.0,4.9,2.5,0.0853,1,1,1,1,5.0,3.6,2.6
6426,454,0,Europe,Manufacturing,Data Science,Meets,Female,43,12,0,8,15,2.5,3.8,1.0,0.0348,1,1,1,1,3.0,3.5,1.6
6427,299,0,Europe,Commercial,Communications,Meets,Male,30,7,1,8,23,0.0,4.0,2.5,0.0422,1,1,1,1,4.8,4.1,2.1
6428,995,0,Latin America,Finance,Human Resources,Exceeds,Male,46,20,1,8,10,0.0,3.5,2.1,0.0588,1,1,1,1,2.8,2.2,1.5
6429,858,0,Europe,HR,Data Science,Meets,Male,43,4,0,7,9,5.0,4.8,1.2,0.0383,1,1,1,1,4.3,4.5,3.2
6430,667,0,Asia Pacific,Digital,Market Access,Far Below,Male,34,6,1,7,21,0.0,3.7,2.6,0.0,0,0,0,0,4.7,4.0,3.0
6431,826,0,Latin America,HR,Regulatory Affairs,Far Below,Male,34,36,0,12,23,3.5,3.3,1.7,0.0,0,0,0,0,3.0,4.9,2.6
6432,248,0,Latin America,Commercial,Market Access,Meets,Male,45,14,1,9,31,0.0,4.2,2.6,0.0422,1,1,1,1,4.6,5.0,2.9
6433,743,0,Europe,HR,Data Science,Meets,Male,44,7,1,12,16,0.0,1.5,2.4,0.0383,1,1,0,0,3.6,3.8,3.7
6434,756,0,Middle East & Africa,HR,Legal & Compliance,Meets,Male,37,6,0,11,21,4.0,2.2,2.1,0.0383,1,1,1,1,3.7,3.1,2.3
6435,40,0,Middle East & Africa,R&D,Quality Assurance,Meets,Male,33,15,1,6,11,0.0,2.8,1.4,0.0977,1,1,1,1,4.8,4.0,2.7
6436,290,0,Latin America,Commercial,Human Resources,Meets,Female,44,16,1,12,14,0.0,1.6,4.2,0.0422,1,1,1,1,4.0,2.9,5.0
6437,805,0,Europe,HR,Quality Assurance,Far Exceeds,Female,35,19,0,5,36,3.3,2.0,3.7,0.1168,1,1,1,1,3.4,3.8,3.0
6438,380,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Exceeds,Female,40,4,0,5,15,3.4,3.0,1.8,0.0616,0,0,0,0,3.3,3.4,2.8
6439,235,0,Europe,Commercial,Human Resources,Far Below,Male,35,7,1,6,12,0.0,2.1,2.8,0.0,1,1,1,1,3.7,1.9,3.1
6440,16,0,Europe,R&D,Regulatory Affairs,Exceeds,Male,37,23,0,7,11,3.0,2.9,3.1,0.1648,1,1,1,1,3.7,3.6,3.5
6441,563,0,Latin America,Digital,Regulatory Affairs,Meets,Male,49,2,0,6,12,2.9,3.0,3.2,0.0853,1,1,1,1,2.8,2.0,1.8
6442,973,0,Latin America,Finance,Market Access,Meets,Female,38,36,0,11,16,4.1,4.2,3.0,0.0331,1,1,1,1,3.9,4.0,3.3
6443,769,0,North America,HR,Supply Chain,Meets,Male,47,5,0,11,23,2.3,2.0,2.9,0.0383,0,0,0,0,3.8,4.6,2.7
6444,481,0,Middle East & Africa,Manufacturing,Communications,Exceeds,Female,29,20,1,6,11,0.0,3.1,3.6,0.0616,1,1,1,1,3.9,2.1,2.4
6445,14,0,Middle East & Africa,R&D,Marketing,Far Exceeds,Male,28,15,0,9,26,3.6,3.0,1.0,0.2644,1,1,1,1,3.1,3.3,3.7
6446,279,1,Middle East & Africa,Commercial,IT & Digital,Meets,Male,41,9,0,9,17,2.1,3.8,2.4,0.0422,1,1,1,1,3.0,3.3,4.1
6447,967,0,Asia Pacific,Finance,Human Resources,Below,Female,33,15,0,10,31,3.9,2.0,4.2,0.0,1,1,1,1,4.5,4.1,4.5
6448,916,0,Europe,Finance,Clinical Operations,Meets,Male,38,3,0,7,15,3.9,3.2,1.5,0.0331,1,1,1,1,3.6,3.1,1.9
6449,783,0,Latin America,HR,Regulatory Affairs,Below,Male,28,15,1,8,14,0.0,4.4,2.8,0.0,1,1,1,1,2.4,2.5,2.2
6450,59,0,Middle East & Africa,R&D,Legal & Compliance,Meets,Female,28,13,0,7,22,3.3,3.6,1.2,0.0977,1,1,1,1,4.3,3.0,1.7
6451,103,0,North America,R&D,Clinical Operations,Exceeds,Male,38,20,0,9,13,2.5,3.4,2.7,0.1648,1,1,1,1,3.3,4.0,2.6
6452,494,0,Middle East & Africa,Manufacturing,Communications,Meets,Female,35,11,1,9,30,0.0,1.6,1.2,0.0348,1,1,1,1,4.4,3.8,2.4
6453,557,0,Europe,Digital,IT & Digital,Below,Male,36,9,0,12,16,3.2,4.0,2.1,0.0,1,1,1,1,4.0,2.9,2.8
6454,692,0,Europe,Digital,Human Resources,Meets,Non-Binary/Other,48,13,0,7,9,3.3,3.4,2.1,0.0853,0,0,0,0,2.2,3.2,3.0
6455,543,1,Latin America,Digital,Supply Chain,Meets,Female,41,12,0,6,14,3.5,2.0,3.5,0.0853,1,1,1,1,5.0,2.8,3.8
6456,933,0,Asia Pacific,Finance,Marketing,Meets,Male,51,7,0,12,36,3.7,2.7,2.1,0.0331,1,1,1,1,3.3,2.7,3.2
6457,909,0,Latin America,Finance,Regulatory Affairs,Meets,Female,38,10,0,9,16,3.7,3.5,2.8,0.0331,1,1,1,1,2.7,3.1,2.8
6458,285,0,Middle East & Africa,Commercial,Regulatory Affairs,Far Exceeds,Male,47,16,0,12,43,3.4,3.2,2.4,0.1275,1,1,1,1,5.0,3.7,4.7
6459,956,0,North America,Finance,Regulatory Affairs,Meets,Male,44,14,0,5,15,3.0,3.0,4.3,0.0331,1,1,1,1,3.3,4.4,4.5
6460,967,0,Latin America,Finance,Quality Assurance,Meets,Female,35,4,0,8,38,3.6,4.5,1.2,0.0331,1,1,1,1,4.5,4.0,2.5
6461,74,0,Asia Pacific,R&D,Legal & Compliance,Meets,Female,37,7,0,12,19,3.8,2.0,1.0,0.0977,1,1,1,1,2.7,2.8,1.0
6462,213,0,Latin America,Commercial,Supply Chain,Below,Female,36,7,0,8,18,3.9,2.7,2.1,0.0,1,1,1,1,4.4,1.3,2.7
6463,121,0,Europe,R&D,Clinical Operations,Exceeds,Female,44,13,1,11,29,0.0,2.6,4.4,0.1648,1,1,1,1,1.8,4.1,2.2
6464,374,0,Middle East & Africa,Manufacturing,Medical Affairs,Meets,Female,40,13,0,5,8,3.5,3.7,1.8,0.0348,0,0,0,0,3.5,4.2,1.2
6465,405,0,Middle East & Africa,Manufacturing,Human Resources,Far Exceeds,Non-Binary/Other,32,9,1,9,16,0.0,3.1,3.7,0.1069,1,1,1,1,4.7,1.8,4.4
6466,226,0,Middle East & Africa,Commercial,Medical Affairs,Far Exceeds,Female,30,7,1,11,14,0.0,2.5,2.7,0.1275,1,1,1,1,2.9,2.6,3.3
6467,310,0,Middle East & Africa,Commercial,Supply Chain,Meets,Female,30,11,0,5,25,2.1,2.9,3.3,0.0422,1,1,1,1,3.2,1.5,4.0
6468,892,1,Middle East & Africa,Finance,Regulatory Affairs,Far Exceeds,Male,33,4,1,10,22,0.0,3.4,4.4,0.1022,1,1,1,1,2.7,4.3,4.1
6469,450,0,Middle East & Africa,Manufacturing,Medical Affairs,Far Exceeds,Female,32,24,0,9,24,3.6,3.3,3.4,0.1069,1,0,0,0,3.6,2.7,3.0
6470,815,0,North America,HR,Clinical Operations,Meets,Female,31,10,0,7,10,5.0,2.5,4.2,0.0383,1,1,1,1,3.0,2.6,3.4
6471,557,0,Asia Pacific,Digital,Finance & Accounting,Meets,Non-Binary/Other,45,19,0,12,17,4.3,1.1,4.7,0.0853,1,1,1,1,3.0,1.4,3.5
6472,1004,0,Middle East & Africa,Finance,Communications,Meets,Male,29,14,0,8,12,3.1,2.3,2.7,0.0331,1,1,1,1,3.1,2.6,1.8
6473,662,0,Asia Pacific,Digital,Finance & Accounting,Meets,Female,40,15,0,5,24,3.4,3.5,2.6,0.0853,1,1,1,1,3.6,1.4,3.4
6474,460,0,Middle East & Africa,Manufacturing,Human Resources,Meets,Non-Binary/Other,52,21,0,12,22,2.6,4.1,3.7,0.0348,0,0,0,0,1.5,4.9,3.1
6475,618,0,Latin America,Digital,Human Resources,Far Below,Male,39,13,0,7,12,4.4,3.3,1.7,0.0,1,1,1,1,4.9,4.6,1.6
6476,737,0,Middle East & Africa,HR,Medical Affairs,Meets,Female,39,19,0,12,20,3.4,2.5,2.5,0.0383,0,0,0,0,3.5,2.5,2.0
6477,800,1,Europe,HR,Human Resources,Far Exceeds,Non-Binary/Other,39,16,0,9,31,3.0,3.4,3.8,0.1168,1,1,1,1,3.4,1.5,3.3
6478,46,1,North America,R&D,Communications,Meets,Female,29,9,0,11,29,2.9,4.1,4.4,0.0977,1,1,1,1,4.8,2.8,3.4
6479,235,0,Latin America,Commercial,Legal & Compliance,Meets,Female,41,8,0,10,22,3.6,3.7,3.9,0.0422,1,1,1,1,3.6,2.7,3.7
6480,566,1,Latin America,Digital,Clinical Operations,Meets,Male,40,12,1,7,20,0.0,4.4,2.7,0.0853,1,1,1,1,3.6,3.7,3.9
6481,706,0,Europe,HR,Regulatory Affairs,Meets,Female,38,10,1,8,13,0.0,2.5,3.4,0.0383,1,1,1,1,3.0,2.2,4.5
6482,256,1,Middle East & Africa,Commercial,Regulatory Affairs,Meets,Male,28,8,0,8,23,4.1,2.2,2.1,0.0422,0,0,0,0,3.2,1.7,2.1
6483,326,0,North America,Commercial,IT & Digital,Below,Male,49,9,0,11,12,1.5,4.3,3.3,0.0,1,1,1,1,2.0,3.1,4.3
6484,98,0,Latin America,R&D,Market Access,Meets,Female,39,10,1,6,14,0.0,3.8,1.5,0.0977,1,1,1,1,3.1,3.4,1.4
6485,236,0,North America,Commercial,IT & Digital,Exceeds,Male,31,8,0,6,17,4.2,4.4,5.0,0.0743,1,1,1,1,4.0,1.8,5.0
6486,343,0,Latin America,Commercial,Data Science,Meets,Female,32,19,0,5,10,4.3,3.5,4.0,0.0422,1,1,1,1,3.0,4.3,4.2
6487,981,0,Middle East & Africa,Finance,Quality Assurance,Meets,Female,33,3,0,8,11,4.3,1.3,3.1,0.0331,1,1,1,1,4.0,3.4,3.8
6488,474,0,Latin America,Manufacturing,Human Resources,Meets,Female,48,16,0,9,17,3.3,2.5,2.3,0.0348,1,1,1,1,3.1,3.6,2.3
6489,116,0,Latin America,R&D,Marketing,Meets,Male,37,21,0,8,13,3.5,3.0,3.9,0.0977,1,1,1,1,5.0,3.7,3.2
6490,23,0,Asia Pacific,R&D,Marketing,Exceeds,Male,37,34,0,12,20,4.0,2.3,1.2,0.1648,1,1,1,1,4.1,1.3,2.2
6491,635,0,Middle East & Africa,Digital,Pharmacovigilance,Meets,Male,35,18,0,12,23,2.9,3.5,1.5,0.0853,0,0,0,0,3.0,2.8,3.3
6492,349,0,Europe,Commercial,Quality Assurance,Meets,Male,44,6,0,10,21,3.1,2.6,1.6,0.0422,1,1,1,1,4.0,2.6,1.1
6493,586,0,Europe,Digital,Regulatory Affairs,Below,Female,44,7,0,7,13,2.2,1.8,4.8,0.0,1,1,1,1,2.8,2.2,3.4
6494,1036,0,Middle East & Africa,Finance,Communications,Meets,Female,29,18,0,11,15,2.5,4.0,1.4,0.0331,1,1,1,1,2.7,4.0,3.4
6495,868,1,Europe,HR,Marketing,Meets,Female,37,14,0,11,34,3.6,3.6,1.5,0.0383,1,1,1,1,2.9,3.4,2.3
6496,218,0,Middle East & Africa,Commercial,Clinical Operations,Meets,Female,37,9,0,8,13,3.2,2.5,4.3,0.0422,0,0,0,0,2.9,3.4,3.9
6497,867,0,Europe,HR,Finance & Accounting,Meets,Female,32,8,1,12,19,0.0,2.7,1.8,0.0383,1,1,1,1,3.1,5.0,4.2
6498,379,0,Asia Pacific,Manufacturing,Legal & Compliance,Meets,Female,35,16,0,12,21,4.4,2.6,2.5,0.0348,1,1,1,1,3.8,2.9,2.8
6499,971,0,Europe,Finance,Pharmacovigilance,Meets,Male,36,2,0,11,21,2.6,3.9,3.7,0.0331,1,1,1,1,4.5,3.6,3.7
6500,210,0,Latin America,Commercial,Medical Affairs,Meets,Female,32,7,0,12,15,2.9,3.8,1.7,0.0422,1,1,1,1,3.8,3.9,2.6
6501,632,1,Middle East & Africa,Digital,Medical Affairs,Far Exceeds,Male,40,9,1,7,12,0.0,2.5,3.5,0.2363,1,1,1,1,4.8,1.9,2.8
6502,639,0,North America,Digital,Pharmacovigilance,Far Exceeds,Female,40,21,0,9,30,3.2,2.8,2.5,0.2363,1,1,1,1,3.7,4.4,3.3
6503,238,0,North America,Commercial,Data Science,Meets,Male,41,10,0,12,32,3.1,4.3,1.0,0.0422,1,1,1,1,3.4,5.0,2.1
6504,673,0,Middle East & Africa,Digital,Sales,Meets,Female,35,4,0,10,16,2.3,3.5,2.5,0.0853,0,0,0,0,3.2,2.7,4.0
6505,349,0,Asia Pacific,Commercial,Clinical Operations,Meets,Male,28,10,0,11,20,3.7,3.6,4.6,0.0422,1,1,1,1,3.4,2.5,4.2
6506,131,0,Europe,R&D,Marketing,Below,Male,34,4,1,8,14,0.0,4.6,1.2,0.0,1,1,1,1,3.3,2.8,2.3
6507,613,0,Asia Pacific,Digital,Data Science,Meets,Female,32,5,1,8,35,0.0,3.4,4.8,0.0853,1,0,0,0,4.8,3.5,4.2
6508,227,0,North America,Commercial,Clinical Operations,Meets,Male,37,18,0,10,24,3.4,2.8,2.8,0.0422,1,1,1,1,2.9,3.7,2.0
6509,246,0,Middle East & Africa,Commercial,Market Access,Below,Male,41,5,0,8,8,4.9,2.8,2.0,0.0,1,1,1,1,3.6,2.5,2.3
6510,602,0,Middle East & Africa,Digital,Marketing,Meets,Male,49,8,0,6,7,4.2,2.7,2.4,0.0853,1,1,1,1,3.8,3.6,2.0
6511,40,0,Asia Pacific,R&D,Legal & Compliance,Exceeds,Male,33,16,0,10,24,2.4,4.0,4.6,0.1648,1,1,1,1,2.2,2.3,3.3
6512,544,0,Asia Pacific,Digital,IT & Digital,Exceeds,Female,39,15,1,6,23,0.0,3.8,1.4,0.1452,1,1,1,1,4.6,4.0,3.7
6513,270,0,Europe,Commercial,Market Access,Meets,Female,39,18,0,9,11,3.0,3.6,2.9,0.0422,1,1,1,1,3.5,3.5,2.7
6514,22,0,Latin America,R&D,Regulatory Affairs,Meets,Female,47,9,0,11,19,2.8,3.3,2.2,0.0977,1,1,1,1,4.2,1.5,2.6
6515,789,0,Latin America,HR,Quality Assurance,Below,Male,39,10,0,8,32,2.9,3.8,2.9,0.0,1,1,1,1,3.8,5.0,2.7
6516,444,0,Europe,Manufacturing,Legal & Compliance,Meets,Male,36,19,0,7,10,2.9,2.0,3.1,0.0348,1,1,1,1,3.2,1.7,3.0
6517,680,0,Latin America,Digital,Finance & Accounting,Exceeds,Female,38,22,0,12,29,2.8,3.1,2.5,0.1452,1,1,1,1,3.2,2.7,1.7
6518,913,1,North America,Finance,Communications,Exceeds,Male,40,8,0,7,10,3.7,2.9,3.0,0.0588,1,1,1,1,4.6,3.0,3.4
6519,209,0,Latin America,Commercial,Human Resources,Meets,Male,42,12,0,9,17,3.8,1.8,2.4,0.0422,1,1,1,1,3.2,2.3,4.1
6520,16,0,Europe,R&D,IT & Digital,Far Below,Female,48,12,0,5,42,3.2,3.8,2.3,0.0,0,0,0,0,2.2,3.0,3.6
6521,151,0,Latin America,R&D,Regulatory Affairs,Meets,Female,48,9,1,10,20,0.0,3.2,2.8,0.0977,1,1,1,1,2.7,4.5,2.8
6522,850,0,Middle East & Africa,HR,Medical Affairs,Meets,Male,33,15,0,11,13,3.4,3.4,2.7,0.0383,1,1,1,1,2.3,2.5,2.9
6523,523,0,Asia Pacific,Digital,Legal & Compliance,Exceeds,Male,29,21,0,12,17,3.2,3.2,2.6,0.1452,1,1,1,1,2.9,1.9,3.0
6524,1008,0,North America,Finance,Data Science,Below,Female,31,18,0,11,14,1.9,2.3,3.4,0.0,1,1,1,1,1.3,3.3,3.6
6525,89,0,Middle East & Africa,R&D,Pharmacovigilance,Meets,Male,39,2,1,8,18,0.0,1.9,3.6,0.0977,1,1,1,1,3.0,1.5,3.8
6526,783,0,Middle East & Africa,HR,Regulatory Affairs,Below,Female,45,9,0,12,27,3.1,1.5,3.7,0.0,1,1,1,1,3.8,1.0,3.0
6527,261,0,Europe,Commercial,Data Science,Meets,Female,37,6,0,10,18,4.2,2.5,1.7,0.0422,1,1,1,1,3.5,3.9,1.4
6528,778,0,Asia Pacific,HR,Supply Chain,Meets,Female,32,6,1,12,16,0.0,3.3,2.7,0.0383,1,1,1,1,3.9,3.2,2.9
6529,673,0,Asia Pacific,Digital,Medical Affairs,Meets,Male,29,3,0,7,16,3.4,4.5,1.0,0.0853,1,0,0,0,3.4,3.8,1.7
6530,760,0,North America,HR,Marketing,Meets,Male,48,10,0,5,12,4.0,1.2,2.3,0.0383,0,0,0,0,4.2,3.5,2.9
6531,85,0,Europe,R&D,Data Science,Meets,Female,35,3,1,11,23,0.0,1.1,2.4,0.0977,1,1,1,1,5.0,2.4,3.4
6532,29,0,North America,R&D,Clinical Operations,Below,Male,29,7,0,10,14,3.1,2.6,2.8,0.0,0,0,0,0,2.3,4.1,3.9
6533,375,0,Latin America,Manufacturing,Human Resources,Meets,Male,38,15,0,12,39,2.1,3.8,3.0,0.0348,1,1,1,1,1.7,3.6,2.9
6534,730,1,Middle East & Africa,HR,Marketing,Far Exceeds,Male,38,15,1,10,19,0.0,3.6,2.3,0.1168,1,1,1,1,3.4,4.2,2.2
6535,266,0,North America,Commercial,Medical Affairs,Meets,Male,43,12,0,6,19,2.6,2.9,2.4,0.0422,1,1,1,1,2.0,1.8,1.9
6536,961,0,Middle East & Africa,Finance,Regulatory Affairs,Below,Female,31,23,0,6,14,2.7,1.2,2.0,0.0,1,1,1,1,3.4,3.1,2.8
6537,994,0,Europe,Finance,Supply Chain,Meets,Female,45,28,0,6,14,2.5,1.6,1.3,0.0331,0,0,0,0,2.2,2.0,2.2
6538,596,0,Latin America,Digital,Communications,Meets,Female,46,10,0,7,11,4.4,4.2,3.1,0.0853,1,1,1,0,4.1,3.8,1.0
6539,392,0,Europe,Manufacturing,Market Access,Meets,Female,39,36,0,9,11,2.9,3.4,3.5,0.0348,1,1,1,1,3.1,3.4,2.9
6540,797,0,Latin America,HR,Finance & Accounting,Meets,Male,42,21,0,11,25,3.4,4.0,1.3,0.0383,0,0,0,0,4.7,4.6,1.7
6541,245,0,Latin America,Commercial,IT & Digital,Far Exceeds,Female,43,7,0,7,19,2.4,3.9,1.6,0.1275,1,1,1,1,2.6,2.4,2.2
6542,409,0,Middle East & Africa,Manufacturing,Communications,Meets,Male,34,17,0,12,22,4.1,5.0,2.3,0.0348,1,1,1,1,3.2,3.5,3.5
6543,101,0,Europe,R&D,Finance & Accounting,Far Below,Male,30,7,0,12,17,3.4,2.7,2.4,0.0,1,0,0,0,4.0,2.1,1.0
6544,623,0,Europe,Digital,Sales,Meets,Male,34,25,0,6,11,4.4,2.8,2.6,0.0853,1,1,1,1,4.9,1.8,1.8
6545,795,0,North America,HR,Marketing,Exceeds,Female,28,18,0,5,13,2.6,3.4,3.8,0.0677,1,0,0,0,4.3,5.0,3.1
6546,978,0,Europe,Finance,Marketing,Exceeds,Male,41,16,1,11,19,0.0,4.2,1.7,0.0588,1,1,1,1,3.9,3.6,1.9
6547,183,0,North America,Commercial,Legal & Compliance,Meets,Non-Binary/Other,48,7,0,10,38,2.8,1.5,4.0,0.0422,1,1,1,1,3.9,2.6,3.6
6548,112,0,Asia Pacific,R&D,Pharmacovigilance,Meets,Non-Binary/Other,33,5,1,9,29,0.0,2.6,1.1,0.0977,1,1,1,1,3.5,1.8,3.0
6549,376,0,Asia Pacific,Manufacturing,IT & Digital,Exceeds,Male,35,4,1,8,13,0.0,3.0,2.5,0.0616,1,0,0,0,3.9,4.6,1.7
6550,686,0,Asia Pacific,Digital,Regulatory Affairs,Meets,Male,36,14,0,9,13,3.4,3.2,2.5,0.0853,1,1,1,0,4.6,2.7,2.8
6551,484,0,Europe,Manufacturing,IT & Digital,Meets,Female,50,11,1,11,13,0.0,3.8,4.1,0.0348,1,1,1,1,4.4,3.2,4.5
6552,965,0,Europe,Finance,Marketing,Below,Female,35,6,1,12,17,0.0,4.4,2.1,0.0,1,1,1,1,2.4,3.2,1.5
6553,397,0,North America,Manufacturing,Pharmacovigilance,Meets,Female,45,18,0,5,11,3.3,3.9,2.4,0.0348,1,1,1,0,3.2,5.0,2.6
6554,248,0,Latin America,Commercial,IT & Digital,Below,Male,38,15,0,11,27,3.0,3.2,4.3,0.0,1,0,0,0,3.9,3.7,4.4
6555,18,0,North America,R&D,Medical Affairs,Below,Male,28,11,0,12,17,4.3,3.3,3.3,0.0,1,1,0,0,4.3,3.8,2.4
6556,743,0,Asia Pacific,HR,Finance & Accounting,Meets,Male,35,15,0,7,18,4.3,3.2,2.1,0.0383,1,1,1,1,5.0,1.8,1.9
6557,303,0,North America,Commercial,IT & Digital,Meets,Male,43,15,0,6,16,3.7,4.9,3.9,0.0422,1,1,1,1,3.9,3.6,3.2
6558,977,0,Latin America,Finance,Finance & Accounting,Meets,Male,35,10,0,10,15,3.8,3.9,2.1,0.0331,0,0,0,0,4.1,4.8,3.3
6559,692,0,Europe,Digital,Finance & Accounting,Meets,Female,41,8,0,9,11,2.8,2.1,1.7,0.0853,0,0,0,0,1.9,2.4,3.5
6560,895,0,North America,Finance,Human Resources,Far Below,Male,48,15,0,11,12,3.6,3.0,3.7,0.0,1,1,1,1,3.2,3.2,2.6
6561,993,0,Asia Pacific,Finance,Marketing,Below,Female,41,15,0,9,17,4.0,2.4,2.0,0.0,1,0,0,0,4.4,1.8,3.6
6562,423,0,Asia Pacific,Manufacturing,Supply Chain,Below,Male,34,7,0,6,10,3.1,4.2,2.2,0.0,1,1,1,1,2.9,2.9,2.6
6563,679,0,Europe,Digital,Clinical Operations,Meets,Male,42,24,0,9,42,4.0,1.5,3.5,0.0853,1,1,1,1,4.2,3.3,4.4
6564,179,0,North America,Commercial,Sales,Meets,Male,41,14,0,5,18,3.1,2.6,3.7,0.0422,1,1,1,1,2.6,2.6,4.4
6565,981,0,Latin America,Finance,Medical Affairs,Meets,Male,44,8,1,6,10,0.0,2.7,1.6,0.0331,1,1,1,1,3.3,4.4,1.0
6566,284,0,Europe,Commercial,Finance & Accounting,Meets,Female,37,8,1,10,24,0.0,2.7,3.7,0.0422,1,1,1,1,5.0,3.1,3.1
6567,754,0,North America,HR,Finance & Accounting,Meets,Male,33,6,1,5,33,0.0,2.3,1.9,0.0383,1,1,1,1,2.4,2.5,4.1
6568,376,0,Middle East & Africa,Manufacturing,Finance & Accounting,Meets,Female,41,12,0,11,18,2.9,2.8,1.2,0.0348,0,0,0,0,3.0,2.1,2.8
6569,316,0,Asia Pacific,Commercial,Market Access,Exceeds,Non-Binary/Other,41,6,1,11,19,0.0,4.1,2.6,0.0743,1,1,1,1,5.0,4.1,1.9
6570,681,0,Latin America,Digital,Communications,Meets,Female,35,10,0,9,28,2.0,3.4,2.1,0.0853,1,1,1,1,2.0,4.8,1.1
6571,1050,0,Latin America,Finance,Communications,Exceeds,Female,29,14,0,5,14,4.2,3.5,3.0,0.0588,1,1,1,1,4.7,3.4,1.8
6572,788,0,Latin America,HR,Regulatory Affairs,Meets,Female,35,9,0,6,27,2.7,4.0,3.4,0.0383,1,1,1,1,4.0,3.8,3.6
6573,591,0,Asia Pacific,Digital,Regulatory Affairs,Exceeds,Male,31,12,0,12,21,2.5,3.8,2.7,0.1452,1,1,1,1,4.1,3.4,3.2
6574,411,0,North America,Manufacturing,Regulatory Affairs,Meets,Female,36,13,0,7,12,2.9,1.4,2.0,0.0348,1,1,1,1,3.8,2.9,1.2
6575,810,0,Europe,HR,Supply Chain,Meets,Female,43,8,0,7,12,2.0,3.1,3.0,0.0383,1,1,1,1,1.8,3.8,3.2
6576,800,0,North America,HR,Human Resources,Meets,Male,28,16,0,9,23,2.6,3.1,2.0,0.0383,0,0,0,0,4.8,3.2,1.5
6577,761,1,Europe,HR,Finance & Accounting,Exceeds,Female,40,16,0,10,20,4.3,1.8,3.2,0.0677,1,1,1,1,5.0,1.5,3.8
6578,979,0,Latin America,Finance,Human Resources,Meets,Female,40,13,1,11,12,0.0,4.5,4.0,0.0331,1,1,1,0,5.0,4.8,2.6
6579,24,0,North America,R&D,Medical Affairs,Exceeds,Non-Binary/Other,32,18,0,12,13,2.5,2.0,3.2,0.1648,1,1,1,1,1.0,2.2,2.6
6580,698,1,Latin America,HR,Communications,Meets,Male,40,4,0,6,9,3.1,2.6,1.7,0.0383,0,0,0,0,3.2,4.1,3.4
6581,573,0,Middle East & Africa,Digital,Marketing,Meets,Male,45,8,0,10,11,3.6,2.9,3.9,0.0853,1,1,1,1,4.6,2.1,3.6
6582,689,0,Latin America,Digital,Supply Chain,Exceeds,Male,41,8,0,5,16,3.9,3.9,1.0,0.1452,1,1,0,0,3.3,4.9,3.3
6583,485,0,Latin America,Manufacturing,Pharmacovigilance,Far Exceeds,Female,50,28,0,8,13,4.5,2.8,1.3,0.1069,0,0,0,0,4.2,2.8,2.0
6584,254,0,Europe,Commercial,Human Resources,Meets,Male,38,10,0,9,20,3.0,2.3,2.5,0.0422,1,1,1,1,3.1,2.4,2.7
6585,297,0,Middle East & Africa,Commercial,Regulatory Affairs,Meets,Male,44,4,0,7,22,3.3,4.5,2.9,0.0422,1,1,1,1,5.0,3.1,3.9
6586,132,0,Latin America,R&D,Market Access,Meets,Male,50,20,0,12,22,2.2,3.4,2.9,0.0977,1,1,1,1,2.5,3.5,3.3
6587,943,1,Latin America,Finance,IT & Digital,Meets,Male,41,3,0,6,15,2.9,1.8,4.2,0.0331,1,1,1,1,5.0,1.7,3.7
6588,944,0,Middle East & Africa,Finance,Finance & Accounting,Below,Male,49,3,0,12,18,2.9,3.2,2.5,0.0,1,1,1,1,3.9,4.3,3.1
6589,811,0,Middle East & Africa,HR,Pharmacovigilance,Below,Female,41,29,0,12,39,2.7,3.8,2.8,0.0,1,1,1,1,3.5,3.0,3.3
6590,97,0,North America,R&D,Human Resources,Meets,Female,47,9,0,7,22,3.7,3.4,1.6,0.0977,1,1,1,1,3.0,4.0,1.9
6591,457,0,Europe,Manufacturing,Sales,Exceeds,Male,31,15,0,9,20,5.0,3.7,3.4,0.0616,1,1,1,1,3.1,2.1,3.2
6592,486,0,Middle East & Africa,Manufacturing,Finance & Accounting,Far Below,Female,38,24,1,6,13,0.0,3.4,1.3,0.0,0,0,0,0,2.2,4.9,2.9
6593,342,0,Middle East & Africa,Commercial,Marketing,Meets,Female,53,12,1,12,23,0.0,2.5,1.0,0.0422,1,1,1,1,2.8,3.2,2.4
6594,402,0,Asia Pacific,Manufacturing,Marketing,Meets,Male,28,27,0,12,14,3.2,1.6,2.7,0.0348,1,1,1,1,3.6,2.9,2.6
6595,837,0,Middle East & Africa,HR,Human Resources,Exceeds,Female,33,15,0,7,13,4.6,4.3,3.3,0.0677,1,1,1,1,4.1,4.0,4.0
6596,543,0,Europe,Digital,Data Science,Below,Male,51,9,1,12,20,0.0,3.0,4.2,0.0,1,1,1,1,2.8,4.6,3.7
6597,393,0,Latin America,Manufacturing,Human Resources,Meets,Female,37,18,0,6,10,3.4,3.4,2.2,0.0348,1,1,1,1,3.8,4.0,3.0
6598,34,1,Latin America,R&D,Human Resources,Far Exceeds,Female,37,2,0,11,26,3.3,2.9,3.7,0.2644,1,1,1,1,4.1,3.2,3.7
6599,702,0,Latin America,HR,Market Access,Meets,Female,43,8,0,7,10,4.1,2.8,2.5,0.0383,1,1,1,1,3.0,3.2,2.5
6600,404,0,Latin America,Manufacturing,Supply Chain,Meets,Male,46,7,0,10,26,4.2,4.0,3.8,0.0348,1,1,1,1,4.9,2.2,2.1
6601,1003,0,Asia Pacific,Finance,Communications,Exceeds,Female,36,10,0,6,20,2.9,3.0,2.8,0.0588,1,1,1,1,2.3,4.3,3.8
6602,380,0,Middle East & Africa,Manufacturing,Finance & Accounting,Below,Female,28,11,0,10,23,2.8,3.8,3.9,0.0,1,1,1,1,2.0,3.0,3.0
6603,1045,0,Latin America,Finance,Supply Chain,Far Exceeds,Female,32,8,1,12,14,0.0,1.6,4.0,0.1022,1,1,1,1,4.6,2.6,2.6
6604,797,0,North America,HR,Quality Assurance,Exceeds,Female,35,13,0,8,16,4.4,1.8,2.5,0.0677,1,1,1,1,5.0,5.0,2.2
6605,400,0,Latin America,Manufacturing,Sales,Below,Female,31,4,1,5,11,0.0,2.4,5.0,0.0,1,1,1,1,3.8,1.0,4.5
6606,1017,0,Middle East & Africa,Finance,Regulatory Affairs,Meets,Male,33,17,0,11,17,3.0,1.0,3.9,0.0331,1,1,1,1,4.1,3.0,2.5
6607,653,0,Latin America,Digital,Communications,Meets,Male,38,8,0,11,14,3.3,3.2,2.2,0.0853,1,1,1,1,3.9,3.2,2.6
6608,347,0,Asia Pacific,Commercial,Finance & Accounting,Exceeds,Female,33,24,0,6,28,1.6,2.0,2.0,0.0743,0,0,0,0,2.8,1.5,2.9
6609,809,0,Europe,HR,Data Science,Below,Female,49,4,0,5,19,2.8,2.8,3.0,0.0,1,1,1,1,3.9,2.8,3.4
6610,951,0,Europe,Finance,Pharmacovigilance,Meets,Male,36,6,1,9,29,0.0,2.7,2.4,0.0331,1,1,1,1,4.1,2.4,1.7
6611,43,0,Middle East & Africa,R&D,Communications,Meets,Male,29,4,1,7,11,0.0,2.5,2.8,0.0977,1,1,1,1,2.8,2.3,2.4
6612,415,0,Europe,Manufacturing,Marketing,Exceeds,Male,45,8,0,11,19,2.1,1.7,2.4,0.0616,1,1,1,1,2.2,2.9,3.5
6613,884,0,Europe,Finance,Quality Assurance,Meets,Female,55,5,0,11,32,3.5,3.6,2.3,0.0331,1,1,1,1,3.8,3.0,2.4
6614,1039,0,North America,Finance,Quality Assurance,Meets,Female,36,30,0,7,15,3.6,3.7,2.7,0.0331,1,1,1,1,3.3,3.5,3.6
6615,988,0,Middle East & Africa,Finance,Legal & Compliance,Meets,Female,40,13,0,11,16,2.7,3.6,3.3,0.0331,1,1,1,1,3.2,3.5,2.9
6616,307,0,Middle East & Africa,Commercial,Sales,Exceeds,Male,46,5,1,9,21,0.0,2.8,2.5,0.0743,1,1,1,1,3.0,2.0,2.8
6617,154,0,Europe,R&D,Clinical Operations,Meets,Male,36,9,0,7,8,1.3,3.0,3.4,0.0977,1,1,1,1,2.7,2.8,3.3
6618,23,0,Europe,R&D,Marketing,Meets,Female,49,8,0,8,22,3.7,1.9,1.5,0.0977,1,1,1,1,2.6,2.6,4.0
6619,563,0,Europe,Digital,Supply Chain,Below,Male,28,7,0,8,42,4.5,2.9,3.5,0.0,1,1,1,1,3.9,3.3,3.3
6620,296,0,Asia Pacific,Commercial,Pharmacovigilance,Meets,Male,37,16,0,12,16,4.4,2.8,2.1,0.0422,1,1,1,1,5.0,3.3,2.0
6621,1048,0,Latin America,Finance,Regulatory Affairs,Meets,Female,33,15,0,12,14,3.3,3.3,2.9,0.0331,1,1,1,1,4.4,3.7,2.0
6622,776,0,Asia Pacific,HR,IT & Digital,Meets,Female,31,6,1,12,20,0.0,2.3,1.5,0.0383,1,1,1,1,3.6,3.1,1.1
6623,299,0,Middle East & Africa,Commercial,Finance & Accounting,Meets,Male,33,21,0,8,21,3.2,3.1,1.1,0.0422,1,1,1,1,2.8,3.7,1.8
6624,279,0,North America,Commercial,Regulatory Affairs,Meets,Female,41,14,0,10,19,4.1,2.8,2.6,0.0422,0,0,0,0,4.2,2.9,2.7
6625,143,0,Latin America,R&D,Market Access,Exceeds,Male,44,4,0,10,16,2.4,3.7,1.0,0.1648,1,0,0,0,2.5,2.3,2.1
6626,546,0,North America,Digital,Clinical Operations,Below,Male,42,12,1,11,16,0.0,4.5,2.7,0.0,1,1,0,0,4.9,3.5,2.0
6627,594,0,Middle East & Africa,Digital,Sales,Below,Male,29,8,1,10,16,0.0,3.8,4.8,0.0,1,1,1,1,4.1,3.1,3.6
6628,206,0,Middle East & Africa,Commercial,Regulatory Affairs,Exceeds,Female,41,21,0,11,20,3.6,3.0,4.7,0.0743,1,0,0,0,2.7,2.3,3.2
6629,322,0,North America,Commercial,Data Science,Exceeds,Male,37,12,0,9,12,4.0,2.8,2.1,0.0743,1,1,1,1,4.1,2.7,2.1
6630,403,0,North America,Manufacturing,Regulatory Affairs,Meets,Female,35,17,1,5,14,0.0,3.5,2.5,0.0348,1,1,1,1,4.2,2.9,4.0
6631,915,0,North America,Finance,Human Resources,Far Exceeds,Male,37,20,0,11,15,3.1,1.4,3.9,0.1022,1,1,0,0,2.4,2.2,5.0
6632,111,0,Middle East & Africa,R&D,Medical Affairs,Meets,Male,48,15,0,9,11,4.4,2.6,3.8,0.0977,1,1,1,1,3.9,2.4,3.6
6633,889,0,Europe,Finance,Human Resources,Far Exceeds,Male,36,3,0,5,8,2.6,3.4,2.6,0.1022,1,1,1,1,2.6,2.5,4.0
6634,804,0,North America,HR,Data Science,Meets,Female,43,10,0,9,21,2.7,2.1,2.7,0.0383,1,1,1,1,2.3,1.6,4.1
6635,851,0,Latin America,HR,Pharmacovigilance,Meets,Female,44,33,0,7,9,3.6,3.0,2.6,0.0383,1,1,1,1,3.8,3.6,1.3
6636,584,0,Middle East & Africa,Digital,Market Access,Meets,Female,43,13,0,9,19,4.8,3.7,2.6,0.0853,1,1,1,1,5.0,4.1,4.1
6637,95,0,Asia Pacific,R&D,IT & Digital,Far Exceeds,Female,35,10,0,8,24,1.8,3.7,2.5,0.2644,1,1,1,1,2.7,4.0,3.1
6638,943,0,Asia Pacific,Finance,Regulatory Affairs,Meets,Female,36,7,0,11,20,2.3,1.9,3.1,0.0331,1,1,1,1,3.7,3.9,4.1
6639,543,0,Latin America,Digital,Supply Chain,Far Exceeds,Female,40,25,0,8,12,3.4,2.0,1.1,0.2363,1,1,1,1,3.8,1.4,1.8
6640,816,0,Europe,HR,Communications,Meets,Non-Binary/Other,35,2,0,8,16,3.7,2.6,1.8,0.0383,1,1,1,1,4.0,3.7,3.4
6641,333,0,North America,Commercial,Human Resources,Meets,Female,33,8,0,12,28,3.6,4.0,2.6,0.0422,0,0,0,0,3.5,3.8,2.6
6642,43,1,Middle East & Africa,R&D,Legal & Compliance,Meets,Female,39,2,1,11,25,0.0,2.6,4.6,0.0977,1,1,1,1,4.2,2.0,3.4
6643,161,0,North America,R&D,Data Science,Meets,Female,33,22,0,7,18,2.8,3.1,3.0,0.0977,1,1,1,1,3.5,3.2,3.1
6644,934,0,Middle East & Africa,Finance,Market Access,Meets,Female,35,17,0,11,17,3.1,3.1,2.9,0.0331,1,1,1,1,1.2,3.2,3.1
6645,409,0,Asia Pacific,Manufacturing,Quality Assurance,Below,Male,36,16,0,8,18,3.4,3.2,3.7,0.0,1,1,1,1,3.2,3.3,3.4
6646,902,0,North America,Finance,Medical Affairs,Exceeds,Female,35,15,0,8,19,4.7,3.3,3.0,0.0588,1,1,1,1,4.3,3.6,2.3
6647,198,0,Latin America,Commercial,Legal & Compliance,Meets,Male,36,19,0,11,40,4.4,4.1,2.1,0.0422,1,1,1,0,1.8,3.2,2.0
6648,224,0,Europe,Commercial,Medical Affairs,Exceeds,Male,35,12,0,12,30,5.0,3.0,3.2,0.0743,1,1,1,1,3.0,3.6,2.3
6649,594,0,Latin America,Digital,Pharmacovigilance,Meets,Female,50,15,0,11,21,3.4,2.4,3.4,0.0853,1,1,1,1,4.3,2.9,3.2
6650,32,0,Europe,R&D,Human Resources,Meets,Male,49,11,0,12,22,2.6,3.4,2.7,0.0977,1,1,1,1,1.5,5.0,3.4
6651,574,0,North America,Digital,Data Science,Meets,Female,35,12,0,12,32,2.6,1.0,3.8,0.0853,1,1,1,1,3.0,3.6,2.6
6652,282,0,North America,Commercial,Supply Chain,Exceeds,Female,35,10,0,8,20,3.5,2.9,4.7,0.0743,1,1,1,1,3.0,2.8,4.3
6653,409,0,Europe,Manufacturing,Clinical Operations,Meets,Female,37,7,0,12,25,3.8,1.7,2.5,0.0348,0,0,0,0,2.1,2.1,1.5
6654,98,0,Asia Pacific,R&D,Supply Chain,Far Exceeds,Male,39,8,0,8,14,4.7,2.8,2.4,0.2644,0,0,0,0,5.0,2.3,4.1
6655,321,0,Middle East & Africa,Commercial,Market Access,Meets,Female,37,27,0,8,24,2.5,4.0,3.1,0.0422,1,1,1,1,2.2,3.1,2.9
6656,355,0,Latin America,Manufacturing,Human Resources,Far Exceeds,Male,38,8,0,11,14,2.6,1.3,4.2,0.1069,1,0,0,0,4.5,1.5,3.3
6657,990,0,Latin America,Finance,Regulatory Affairs,Exceeds,Male,43,12,0,12,19,4.2,2.2,2.3,0.0588,1,1,1,1,3.6,2.2,2.5
6658,741,0,Latin America,HR,IT & Digital,Meets,Female,33,7,1,11,25,0.0,3.2,2.5,0.0383,1,1,1,1,2.5,1.4,2.8
6659,353,0,North America,Commercial,Legal & Compliance,Meets,Male,34,24,0,5,7,3.3,3.7,2.6,0.0422,1,1,1,1,3.7,4.0,2.1
6660,713,0,Latin America,HR,Legal & Compliance,Meets,Female,29,4,0,7,24,4.7,4.0,3.1,0.0383,1,1,1,1,2.1,1.6,2.8
6661,612,0,Middle East & Africa,Digital,Marketing,Exceeds,Female,36,5,1,9,15,0.0,2.8,2.6,0.1452,1,1,1,1,3.4,2.1,2.0
6662,837,0,Middle East & Africa,HR,Communications,Meets,Female,38,13,0,7,33,3.4,2.2,3.9,0.0383,1,1,1,1,3.0,2.7,2.0
6663,239,0,Europe,Commercial,Finance & Accounting,Meets,Female,38,9,0,7,9,3.7,3.1,3.3,0.0422,1,1,1,1,3.0,3.2,4.1
6664,820,0,North America,HR,Pharmacovigilance,Meets,Female,46,32,0,11,14,1.6,2.9,2.8,0.0383,1,1,1,1,1.4,4.4,3.7
6665,23,0,Middle East & Africa,R&D,Marketing,Meets,Female,33,7,0,5,32,4.7,3.8,1.8,0.0977,1,1,1,1,3.9,4.5,2.1
6666,284,0,Asia Pacific,Commercial,Data Science,Meets,Female,28,28,0,11,22,1.8,3.7,2.4,0.0422,1,1,1,1,2.4,4.4,2.8
6667,377,0,North America,Manufacturing,Clinical Operations,Below,Female,39,8,0,8,12,2.9,3.2,3.0,0.0,1,1,1,1,2.7,4.0,3.2
6668,792,0,North America,HR,IT & Digital,Meets,Female,37,19,0,10,29,2.7,2.3,2.7,0.0383,1,1,1,1,2.8,2.4,1.2
6669,164,0,Middle East & Africa,R&D,IT & Digital,Exceeds,Female,43,10,0,7,13,3.4,2.6,2.6,0.1648,1,0,0,0,3.1,4.6,1.4
6670,632,0,Asia Pacific,Digital,Communications,Exceeds,Male,38,4,0,10,15,2.8,3.2,3.2,0.1452,1,1,1,0,2.8,3.4,5.0
6671,625,0,Europe,Digital,Medical Affairs,Far Below,Male,46,19,0,10,29,2.6,4.2,2.9,0.0,1,1,1,1,3.7,2.2,3.7
6672,726,0,Middle East & Africa,HR,Medical Affairs,Exceeds,Female,37,21,0,9,34,2.6,2.5,1.0,0.0677,1,1,1,1,3.0,1.2,1.0
6673,620,0,Asia Pacific,Digital,Finance & Accounting,Far Below,Male,35,23,0,9,19,5.0,3.4,4.3,0.0,1,1,1,1,3.6,3.4,2.5
6674,365,0,North America,Manufacturing,Quality Assurance,Meets,Female,42,6,0,6,16,3.1,3.7,2.1,0.0348,1,1,1,1,3.8,3.2,2.4
6675,220,0,Asia Pacific,Commercial,Market Access,Below,Female,41,21,1,11,20,0.0,4.8,2.7,0.0,1,1,1,1,2.6,1.9,2.5
6676,54,1,North America,R&D,Market Access,Far Exceeds,Male,34,17,0,8,25,4.0,4.0,3.2,0.2644,1,1,1,1,4.6,4.4,4.0
6677,898,0,Middle East & Africa,Finance,Legal & Compliance,Far Exceeds,Male,41,12,0,7,12,3.4,2.7,3.9,0.1022,1,1,1,1,2.8,3.7,5.0
6678,826,0,Middle East & Africa,HR,Finance & Accounting,Meets,Female,41,5,0,9,19,2.3,1.0,3.0,0.0383,1,1,1,1,3.4,2.7,4.0
6679,607,0,Latin America,Digital,Supply Chain,Meets,Female,38,21,0,8,20,4.0,2.1,1.0,0.0853,1,1,1,1,2.0,2.2,1.0
6680,184,0,Latin America,Commercial,Market Access,Meets,Female,45,4,1,6,20,0.0,2.6,3.7,0.0422,1,1,1,1,4.1,4.0,3.7
6681,961,0,Latin America,Finance,Supply Chain,Meets,Male,47,5,0,11,15,2.7,2.4,3.4,0.0331,1,1,1,1,2.8,3.8,2.5
6682,458,0,Middle East & Africa,Manufacturing,Supply Chain,Meets,Female,35,4,0,5,8,2.4,2.5,4.5,0.0348,1,1,1,1,1.9,1.5,3.9
6683,625,0,Europe,Digital,IT & Digital,Meets,Female,41,8,0,10,23,3.2,1.6,2.9,0.0853,1,1,1,1,2.4,2.9,2.8
6684,636,1,Middle East & Africa,Digital,Regulatory Affairs,Meets,Female,38,13,0,6,29,5.0,3.4,2.8,0.0853,1,1,1,1,2.9,4.5,3.5
6685,76,0,Asia Pacific,R&D,Pharmacovigilance,Meets,Male,35,3,0,6,11,3.1,3.1,3.7,0.0977,1,1,1,1,2.6,2.5,3.4
6686,380,0,Middle East & Africa,Manufacturing,Marketing,Far Below,Male,37,4,1,6,15,0.0,1.4,3.5,0.0,1,0,0,0,2.9,2.8,2.6
6687,362,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Meets,Male,28,11,0,12,30,3.2,5.0,2.3,0.0348,1,1,1,1,2.3,5.0,2.9
6688,757,0,North America,HR,Clinical Operations,Meets,Male,44,14,1,6,19,0.0,4.3,1.1,0.0383,1,1,1,1,3.6,4.3,3.1
6689,995,0,North America,Finance,Human Resources,Far Exceeds,Male,43,5,1,10,35,0.0,3.8,3.6,0.1022,1,1,1,1,3.0,3.5,3.9
6690,29,0,North America,R&D,Clinical Operations,Far Below,Female,28,10,1,7,15,0.0,3.0,2.4,0.0,1,1,0,0,2.6,3.6,1.9
6691,880,0,Middle East & Africa,HR,Clinical Operations,Meets,Female,37,27,1,12,20,0.0,2.9,3.8,0.0383,1,1,1,1,3.3,4.4,4.1
6692,65,0,Europe,R&D,Medical Affairs,Meets,Female,40,6,0,5,7,5.0,3.5,2.6,0.0977,1,1,0,0,4.7,3.0,1.4
6693,477,0,Asia Pacific,Manufacturing,Medical Affairs,Meets,Male,43,7,1,8,35,0.0,3.6,3.6,0.0348,1,1,1,1,3.4,4.2,3.1
6694,91,0,Asia Pacific,R&D,Legal & Compliance,Meets,Male,36,12,0,9,27,2.1,2.0,1.9,0.0977,1,1,1,1,3.3,3.3,2.5
6695,89,0,Europe,R&D,IT & Digital,Below,Female,37,12,0,8,39,3.3,3.6,4.0,0.0,1,1,1,1,3.8,3.5,3.4
6696,100,0,Europe,R&D,Pharmacovigilance,Meets,Non-Binary/Other,40,19,0,12,34,3.1,3.1,4.6,0.0977,1,0,0,0,3.2,2.5,2.4
6697,314,0,Asia Pacific,Commercial,Finance & Accounting,Meets,Male,34,12,1,12,31,0.0,3.9,3.0,0.0422,1,1,1,0,3.8,3.1,1.0
6698,342,0,Latin America,Commercial,IT & Digital,Meets,Male,48,10,1,9,16,0.0,4.4,2.2,0.0422,1,1,1,1,2.9,4.9,3.0
6699,955,0,North America,Finance,IT & Digital,Far Exceeds,Male,39,8,0,10,25,2.9,1.8,2.3,0.1022,1,1,1,1,3.0,3.6,1.7
6700,903,0,North America,Finance,Clinical Operations,Meets,Female,39,21,0,7,11,2.0,3.6,2.5,0.0331,0,0,0,0,4.0,3.0,1.8
6701,489,0,Asia Pacific,Manufacturing,Data Science,Meets,Non-Binary/Other,46,4,1,7,26,0.0,3.3,2.0,0.0348,1,1,1,1,4.1,3.1,2.1
6702,143,0,Europe,R&D,Data Science,Meets,Female,38,17,0,9,10,3.6,4.1,1.8,0.0977,1,1,0,0,4.3,3.2,1.7
6703,484,0,Latin America,Manufacturing,Quality Assurance,Meets,Female,46,3,1,9,37,0.0,3.3,2.9,0.0348,1,1,1,1,4.2,3.4,3.3
6704,215,0,Asia Pacific,Commercial,Regulatory Affairs,Exceeds,Male,28,9,0,8,19,2.4,2.9,3.1,0.0743,1,1,1,1,2.7,2.6,4.9
6705,174,0,North America,R&D,Marketing,Meets,Male,45,13,0,6,8,4.5,3.0,2.2,0.0977,1,1,1,1,3.6,2.8,2.1
6706,811,0,Middle East & Africa,HR,Human Resources,Meets,Female,44,7,0,7,9,4.7,1.8,1.9,0.0383,1,1,1,1,3.4,4.0,1.3
6707,213,0,Europe,Commercial,Medical Affairs,Meets,Male,28,3,0,10,23,2.1,2.8,2.6,0.0422,1,1,1,1,2.2,3.1,1.7
6708,268,0,Middle East & Africa,Commercial,Finance & Accounting,Far Exceeds,Male,36,12,0,10,22,2.7,3.7,2.3,0.1275,1,1,1,1,4.3,1.9,3.9
6709,235,0,Asia Pacific,Commercial,Market Access,Below,Non-Binary/Other,40,8,1,7,10,0.0,3.7,1.0,0.0,1,1,1,1,2.9,1.6,1.2
6710,105,0,North America,R&D,Marketing,Meets,Male,43,5,0,11,27,2.9,2.9,3.5,0.0977,1,1,1,1,2.3,3.8,3.2
6711,949,0,Latin America,Finance,Finance & Accounting,Meets,Male,46,17,0,12,21,3.5,4.5,1.6,0.0331,1,1,1,1,4.0,4.7,2.7
6712,558,0,Middle East & Africa,Digital,Sales,Exceeds,Male,29,22,0,7,15,3.6,3.0,3.3,0.1452,1,1,1,1,3.3,4.7,3.2
6713,859,0,Latin America,HR,IT & Digital,Below,Female,38,6,0,9,21,3.5,4.0,3.4,0.0,1,0,0,0,4.7,4.1,2.3
6714,727,0,North America,HR,Pharmacovigilance,Meets,Male,32,12,1,6,25,0.0,1.8,1.2,0.0383,1,1,1,1,4.2,1.3,2.5
6715,446,0,Middle East & Africa,Manufacturing,Pharmacovigilance,Meets,Male,34,5,1,7,26,0.0,3.5,5.0,0.0348,1,1,1,1,3.8,2.3,5.0
6716,39,0,Latin America,R&D,Clinical Operations,Meets,Female,43,5,0,9,18,2.5,3.2,1.0,0.0977,1,0,0,0,2.7,4.4,1.4
6717,940,0,Latin America,Finance,Data Science,Exceeds,Female,33,6,0,7,22,4.0,2.8,2.8,0.0588,1,1,1,1,2.6,4.0,3.6
6718,275,0,Middle East & Africa,Commercial,Clinical Operations,Meets,Male,38,5,0,6,16,3.8,3.6,4.7,0.0422,1,1,1,1,3.9,3.0,3.7
6719,674,0,North America,Digital,Marketing,Meets,Female,35,9,1,8,36,0.0,3.3,1.9,0.0853,1,1,1,1,3.5,3.5,1.3
6720,93,1,Latin America,R&D,IT & Digital,Far Exceeds,Female,44,19,0,5,12,3.2,3.5,4.4,0.2644,1,1,1,1,2.4,2.5,4.0
6721,139,0,Asia Pacific,R&D,Data Science,Meets,Male,28,10,0,8,15,1.9,3.6,3.3,0.0977,1,1,1,1,3.1,2.4,2.9
6722,1023,0,Middle East & Africa,Finance,Legal & Compliance,Meets,Male,45,24,0,12,27,4.1,2.5,2.7,0.0331,1,1,1,1,3.5,1.7,3.9
6723,680,0,Europe,Digital,Clinical Operations,Meets,Female,47,19,0,9,24,4.3,4.8,2.3,0.0853,0,0,0,0,3.4,3.9,1.8
6724,334,0,Europe,Commercial,Marketing,Meets,Female,42,6,0,8,17,2.4,4.5,3.7,0.0422,1,1,1,1,2.6,3.7,2.9
6725,23,0,North America,R&D,Sales,Meets,Male,39,3,1,7,10,0.0,3.0,3.3,0.0977,1,1,1,1,2.8,2.9,2.8
6726,825,0,Asia Pacific,HR,IT & Digital,Meets,Male,28,17,1,9,22,0.0,3.6,2.4,0.0383,1,1,1,1,3.5,3.7,3.8
6727,875,0,Latin America,HR,IT & Digital,Meets,Male,42,4,1,10,15,0.0,2.4,2.0,0.0383,1,1,1,1,1.5,2.0,2.7
6728,558,0,Europe,Digital,Quality Assurance,Meets,Female,44,10,0,7,15,3.3,1.9,1.0,0.0853,1,1,1,1,2.4,3.1,1.0
6729,267,0,North America,Commercial,Legal & Compliance,Exceeds,Female,39,15,0,12,22,3.8,3.7,4.0,0.0743,1,1,1,1,5.0,3.8,2.8
6730,696,1,Asia Pacific,Digital,Regulatory Affairs,Exceeds,Female,34,13,0,8,13,2.9,4.5,1.6,0.1452,1,1,1,1,3.7,4.4,1.6
6731,96,0,Asia Pacific,R&D,Quality Assurance,Meets,Female,47,10,0,12,26,2.9,2.8,2.3,0.0977,1,1,1,1,3.0,3.3,2.5
6732,812,0,North America,HR,IT & Digital,Exceeds,Female,33,14,0,5,15,3.8,3.4,2.0,0.0677,1,1,1,1,3.5,2.5,2.5
6733,388,0,North America,Manufacturing,Sales,Below,Non-Binary/Other,45,9,0,5,7,3.1,2.3,1.8,0.0,1,1,1,1,3.9,2.6,2.5
6734,692,0,Latin America,Digital,Quality Assurance,Exceeds,Female,41,18,0,8,18,3.3,1.6,2.1,0.1452,1,1,1,1,3.8,3.6,2.5
6735,381,0,North America,Manufacturing,IT & Digital,Meets,Female,37,15,0,11,31,4.5,2.6,4.3,0.0348,1,1,1,1,5.0,3.3,4.1
6736,421,0,Latin America,Manufacturing,Market Access,Meets,Male,53,12,0,8,12,3.3,3.0,1.3,0.0348,0,0,0,0,4.3,2.9,3.0
6737,891,0,Latin America,Finance,Medical Affairs,Meets,Male,41,18,0,10,12,3.8,4.0,3.0,0.0331,0,0,0,0,3.6,4.1,2.0
6738,705,0,Middle East & Africa,HR,Communications,Below,Female,42,30,0,9,19,3.3,1.9,3.8,0.0,1,1,1,1,4.0,2.5,3.8
6739,556,0,Asia Pacific,Digital,Medical Affairs,Far Below,Non-Binary/Other,41,15,0,10,15,3.5,2.1,5.0,0.0,1,1,1,1,4.3,2.1,3.5
6740,437,0,Asia Pacific,Manufacturing,Market Access,Meets,Male,40,20,0,9,23,1.9,2.1,1.5,0.0348,1,1,0,0,1.0,1.9,2.1
6741,149,0,Asia Pacific,R&D,Communications,Exceeds,Female,37,12,0,5,12,1.1,4.4,2.0,0.1648,1,1,1,1,1.9,3.6,2.8
6742,892,0,Middle East & Africa,Finance,Communications,Meets,Non-Binary/Other,43,15,0,11,13,2.9,4.7,1.0,0.0331,1,1,1,1,3.9,2.9,1.0
6743,209,0,Latin America,Commercial,Medical Affairs,Meets,Female,39,7,0,12,16,4.2,4.9,2.0,0.0422,1,1,1,0,3.7,1.8,2.3
6744,1012,0,Latin America,Finance,Legal & Compliance,Exceeds,Female,28,13,0,5,16,3.6,4.4,3.1,0.0588,1,1,1,1,3.2,3.0,2.7
6745,229,0,North America,Commercial,Human Resources,Meets,Male,33,13,1,10,14,0.0,3.4,2.5,0.0422,1,1,1,1,3.8,3.7,3.7
6746,828,0,Middle East & Africa,HR,Communications,Exceeds,Male,45,24,0,5,14,3.7,3.1,4.4,0.0677,1,1,1,1,4.4,2.3,2.5
6747,590,0,North America,Digital,Marketing,Meets,Male,43,17,0,11,31,2.9,3.8,3.7,0.0853,0,0,0,0,3.3,2.9,2.8
6748,623,0,Middle East & Africa,Digital,Medical Affairs,Meets,Female,32,22,0,9,17,3.7,2.9,2.3,0.0853,0,0,0,0,3.3,1.3,2.6
6749,344,0,North America,Commercial,Pharmacovigilance,Meets,Male,35,4,0,9,17,2.6,4.5,1.4,0.0422,1,1,1,1,3.1,4.1,2.5
6750,54,0,Europe,R&D,Pharmacovigilance,Exceeds,Male,34,8,1,12,15,0.0,3.6,3.0,0.1648,1,1,1,1,2.7,4.0,2.7
6751,342,0,Asia Pacific,Commercial,Data Science,Below,Female,47,1,1,8,27,0.0,2.8,2.6,0.0,1,1,1,1,3.9,3.6,3.8
6752,329,0,Asia Pacific,Commercial,Supply Chain,Below,Female,29,11,1,9,11,0.0,2.5,3.5,0.0,1,1,1,1,3.3,3.1,2.4
6753,621,0,Latin America,Digital,IT & Digital,Meets,Female,34,23,0,11,20,2.9,3.3,2.6,0.0853,0,0,0,0,2.2,3.1,2.8
6754,376,0,Europe,Manufacturing,Sales,Exceeds,Non-Binary/Other,38,5,1,8,16,0.0,3.0,3.2,0.0616,1,1,1,1,2.7,3.3,1.3
6755,110,0,Asia Pacific,R&D,Communications,Below,Male,29,10,1,10,17,0.0,3.8,2.7,0.0,1,1,1,1,3.0,2.6,2.7
6756,564,0,Latin America,Digital,IT & Digital,Meets,Female,38,19,0,11,25,3.2,3.4,3.4,0.0853,1,1,1,1,2.0,4.8,2.3
6757,941,0,Europe,Finance,Pharmacovigilance,Meets,Female,32,6,0,10,18,4.5,3.2,4.4,0.0331,1,1,1,1,4.3,4.6,3.3
6758,200,0,Asia Pacific,Commercial,Regulatory Affairs,Meets,Male,33,20,0,6,7,2.4,5.0,2.0,0.0422,1,1,1,1,3.0,5.0,1.8
6759,521,1,North America,Manufacturing,Data Science,Meets,Female,35,17,0,8,10,2.6,3.9,3.0,0.0348,1,1,1,1,3.2,3.6,3.5
6760,91,1,Middle East & Africa,R&D,Market Access,Meets,Female,37,8,1,6,20,0.0,3.6,1.2,0.0977,1,1,1,1,3.3,2.4,2.4
6761,757,0,Europe,HR,Sales,Meets,Female,35,6,0,9,27,3.5,2.5,3.6,0.0383,1,1,1,1,3.8,3.1,3.7
6762,137,0,Latin America,R&D,IT & Digital,Meets,Male,39,3,1,11,26,0.0,1.4,2.2,0.0977,1,1,1,1,5.0,3.4,3.5
6763,117,0,Europe,R&D,Sales,Below,Female,45,18,1,5,10,0.0,5.0,4.1,0.0,1,1,1,1,4.2,4.0,5.0
6764,318,0,Latin America,Commercial,Market Access,Meets,Female,43,9,0,8,19,3.2,2.9,2.4,0.0422,1,1,1,1,3.5,3.3,2.3
6765,203,1,Europe,Commercial,IT & Digital,Meets,Male,47,4,0,7,48,2.4,1.9,3.6,0.0422,1,1,1,1,5.0,1.6,1.0
6766,725,0,Latin America,HR,Communications,Meets,Male,38,12,1,10,13,0.0,3.0,2.7,0.0383,1,1,1,1,3.3,3.5,3.1
6767,871,0,Asia Pacific,HR,Legal & Compliance,Meets,Female,38,2,0,8,25,2.9,3.6,1.0,0.0383,1,1,1,1,3.4,4.3,2.5
6768,788,0,North America,HR,Legal & Compliance,Exceeds,Male,39,11,0,9,14,4.4,3.6,2.0,0.0677,1,0,0,0,4.7,3.6,2.0
6769,640,0,Asia Pacific,Digital,Supply Chain,Meets,Female,29,21,0,7,17,4.0,1.8,2.6,0.0853,1,1,1,1,3.8,1.3,1.4
6770,602,0,North America,Digital,Finance & Accounting,Meets,Male,44,3,0,5,17,3.6,1.0,2.1,0.0853,1,1,0,0,5.0,2.0,2.1
6771,235,0,Asia Pacific,Commercial,Legal & Compliance,Below,Female,36,5,0,8,15,2.1,4.3,4.1,0.0,1,1,1,1,3.4,3.8,2.8
6772,304,0,Asia Pacific,Commercial,Quality Assurance,Meets,Male,38,13,0,7,11,3.9,4.6,4.5,0.0422,1,1,1,1,2.6,5.0,3.4
6773,716,0,Europe,HR,Quality Assurance,Meets,Non-Binary/Other,41,14,0,11,16,1.4,4.4,2.3,0.0383,1,1,1,1,2.0,4.4,3.7
6774,621,0,Middle East & Africa,Digital,Legal & Compliance,Meets,Male,33,12,0,8,10,2.5,3.0,2.8,0.0853,1,1,1,1,2.5,1.4,3.8
6775,517,0,Latin America,Manufacturing,Clinical Operations,Meets,Male,34,16,0,11,18,2.9,2.1,1.2,0.0348,1,1,1,1,4.2,4.4,1.2
6776,679,0,Latin America,Digital,Legal & Compliance,Exceeds,Male,40,4,0,10,28,4.1,3.8,2.6,0.1452,0,0,0,0,3.0,3.0,2.6
6777,290,0,Latin America,Commercial,Clinical Operations,Exceeds,Female,41,3,0,7,23,4.1,3.2,3.9,0.0743,1,1,1,1,3.5,3.3,4.6
6778,593,0,North America,Digital,Data Science,Far Below,Female,52,5,1,11,38,0.0,3.6,2.1,0.0,1,1,1,1,2.4,2.4,2.7
6779,340,0,Latin America,Commercial,Clinical Operations,Meets,Female,39,13,0,11,18,2.7,3.2,2.4,0.0422,1,1,1,1,2.9,3.0,4.5
6780,796,0,Latin America,HR,Clinical Operations,Far Below,Male,41,4,1,7,22,0.0,2.3,1.0,0.0,1,1,1,1,2.8,3.4,1.0
6781,824,0,Europe,HR,Market Access,Meets,Male,52,13,0,7,19,2.9,3.6,2.2,0.0383,1,0,0,0,4.4,3.8,2.5
6782,871,0,Asia Pacific,HR,Quality Assurance,Meets,Female,40,12,0,7,11,3.3,3.2,1.0,0.0383,1,1,1,1,3.3,3.0,3.5
6783,365,0,Latin America,Manufacturing,Clinical Operations,Meets,Female,41,17,0,5,10,3.0,2.4,1.1,0.0348,1,1,1,1,4.5,4.6,2.1
6784,503,0,Middle East & Africa,Manufacturing,Pharmacovigilance,Meets,Male,28,9,1,6,21,0.0,3.0,4.7,0.0348,1,1,1,1,3.4,3.1,3.0
6785,303,0,Latin America,Commercial,Regulatory Affairs,Exceeds,Male,36,3,1,6,14,0.0,3.5,2.1,0.0743,1,1,1,1,3.6,2.7,2.7
6786,153,0,North America,R&D,Pharmacovigilance,Meets,Male,39,28,0,9,26,2.9,2.6,3.8,0.0977,1,1,1,1,1.8,2.9,4.2
6787,993,0,North America,Finance,Legal & Compliance,Meets,Male,33,7,1,11,23,0.0,4.6,2.2,0.0331,1,1,1,1,2.7,4.0,3.7
6788,461,0,North America,Manufacturing,Supply Chain,Meets,Female,39,17,1,9,14,0.0,1.9,2.1,0.0348,1,1,1,1,1.7,2.1,3.7
6789,213,0,Latin America,Commercial,Pharmacovigilance,Meets,Male,42,12,1,11,29,0.0,1.2,3.4,0.0422,1,1,1,1,2.7,3.3,2.7
6790,657,0,Europe,Digital,Data Science,Below,Female,44,13,0,12,42,3.2,3.5,3.2,0.0,1,0,0,0,3.6,3.6,3.2
6791,828,0,Middle East & Africa,HR,Clinical Operations,Meets,Female,37,10,1,6,10,0.0,2.0,1.7,0.0383,1,1,1,1,3.1,3.1,2.2
6792,870,0,Latin America,HR,Clinical Operations,Meets,Female,29,12,0,9,22,3.2,3.5,1.8,0.0383,1,0,0,0,3.5,3.0,3.9
6793,778,0,Europe,HR,Human Resources,Meets,Female,39,7,0,8,23,3.2,3.9,1.7,0.0383,0,0,0,0,3.8,3.5,3.1
6794,318,0,Europe,Commercial,Communications,Below,Female,35,10,1,10,14,0.0,2.6,3.7,0.0,1,1,1,1,2.6,3.2,2.7
6795,777,0,Latin America,HR,Market Access,Below,Female,33,25,0,8,19,3.5,4.2,4.1,0.0,1,1,1,1,2.3,3.3,4.1
6796,363,0,Latin America,Manufacturing,Marketing,Meets,Female,36,31,1,9,14,0.0,2.0,3.5,0.0348,1,1,1,0,3.5,2.9,3.1
6797,604,0,Europe,Digital,Supply Chain,Meets,Female,36,19,0,7,14,4.2,3.6,2.8,0.0853,1,1,1,1,4.8,4.0,3.3
6798,852,0,Europe,HR,Pharmacovigilance,Meets,Male,37,13,0,12,25,2.4,1.0,2.4,0.0383,1,1,1,1,2.3,1.6,1.3
6799,264,0,Europe,Commercial,Marketing,Meets,Male,35,7,0,8,12,5.0,2.9,3.1,0.0422,1,1,1,1,2.7,2.4,2.0
6800,610,0,Latin America,Digital,Sales,Meets,Male,47,17,0,11,33,3.0,3.0,3.1,0.0853,1,1,1,1,4.1,1.6,4.6
6801,831,0,Europe,HR,Legal & Compliance,Meets,Male,40,7,0,7,11,2.9,3.3,2.2,0.0383,0,0,0,0,3.2,1.9,1.5
6802,96,0,North America,R&D,Regulatory Affairs,Meets,Female,40,11,0,8,19,2.3,3.3,2.1,0.0977,0,0,0,0,3.5,2.7,2.3
6803,806,0,Latin America,HR,Regulatory Affairs,Meets,Female,40,13,0,12,24,2.4,5.0,2.9,0.0383,0,0,0,0,2.2,3.4,2.8
6804,916,0,North America,Finance,Quality Assurance,Far Exceeds,Female,30,6,1,11,15,0.0,4.5,3.4,0.1022,1,1,1,1,1.5,4.1,1.2
6805,482,0,Asia Pacific,Manufacturing,Communications,Meets,Male,44,26,0,12,23,3.9,1.9,1.8,0.0348,1,1,1,1,3.6,3.4,1.0
6806,667,0,Latin America,Digital,Clinical Operations,Exceeds,Female,55,15,0,6,12,4.2,3.5,3.6,0.1452,1,1,1,1,3.2,1.9,1.4
6807,390,0,Asia Pacific,Manufacturing,Quality Assurance,Meets,Male,32,11,0,11,16,3.7,2.5,2.6,0.0348,1,1,1,1,1.4,2.0,2.8
6808,146,0,Europe,R&D,Human Resources,Exceeds,Male,34,18,1,9,15,0.0,4.5,2.3,0.1648,1,1,1,1,2.7,2.6,2.6
6809,60,1,Europe,R&D,Market Access,Far Exceeds,Female,35,13,0,7,21,2.8,3.5,3.2,0.2644,1,1,1,1,2.9,2.2,1.7
6810,931,0,Middle East & Africa,Finance,Human Resources,Far Below,Male,40,7,0,11,23,3.4,3.0,2.9,0.0,1,1,1,1,1.8,2.8,3.1
6811,392,0,Europe,Manufacturing,Supply Chain,Below,Male,37,20,1,7,10,0.0,4.7,1.0,0.0,1,1,1,1,3.0,5.0,1.5
6812,695,0,Asia Pacific,Digital,Supply Chain,Meets,Male,35,21,0,7,10,4.2,4.1,4.2,0.0853,0,0,0,0,2.8,4.1,4.2
6813,13,0,Europe,R&D,Sales,Meets,Male,42,4,1,12,21,0.0,2.9,2.3,0.0977,1,1,1,1,3.0,3.5,3.5
6814,96,0,Latin America,R&D,Data Science,Exceeds,Male,40,8,1,8,20,0.0,2.9,2.8,0.1648,1,1,1,1,2.6,2.3,2.2
6815,789,0,Europe,HR,Supply Chain,Far Below,Male,45,21,0,10,24,3.6,3.9,3.2,0.0,1,1,0,0,3.3,4.8,3.9
6816,892,0,Middle East & Africa,Finance,Supply Chain,Exceeds,Male,39,14,0,6,12,2.9,3.0,2.6,0.0588,1,1,1,1,2.2,3.2,2.5
6817,189,0,Europe,Commercial,Supply Chain,Below,Male,38,11,0,9,29,4.0,2.1,1.7,0.0,0,0,0,0,4.2,1.0,2.0
6818,11,0,Asia Pacific,R&D,IT & Digital,Meets,Female,35,13,0,5,28,3.4,2.7,3.3,0.0977,1,1,1,1,3.4,3.0,3.5
6819,692,0,Asia Pacific,Digital,Communications,Far Exceeds,Male,39,11,1,12,15,0.0,3.4,2.8,0.2363,1,1,1,1,3.6,3.7,2.4
6820,549,0,Europe,Digital,Communications,Below,Female,32,12,0,9,15,3.5,3.4,4.0,0.0,1,1,1,1,3.1,2.8,3.6
6821,699,0,Asia Pacific,HR,Human Resources,Meets,Male,45,7,0,7,12,4.8,1.6,1.5,0.0383,1,1,1,1,4.7,2.3,2.0
6822,667,0,Asia Pacific,Digital,Regulatory Affairs,Below,Female,42,3,0,8,14,3.3,2.8,2.7,0.0,1,1,1,1,4.4,3.5,2.7
6823,737,0,Middle East & Africa,HR,Data Science,Exceeds,Female,39,11,0,10,30,4.0,2.3,2.5,0.0677,1,1,1,1,3.1,5.0,5.0
6824,166,1,Latin America,R&D,Data Science,Meets,Male,36,4,0,7,20,3.2,4.5,5.0,0.0977,1,1,1,1,4.3,2.8,4.1
6825,86,0,Middle East & Africa,R&D,Medical Affairs,Exceeds,Male,48,21,0,10,32,2.7,3.2,1.8,0.1648,1,1,1,1,2.4,1.0,1.6
6826,131,0,North America,R&D,IT & Digital,Meets,Male,35,8,0,6,18,2.4,3.6,2.5,0.0977,1,1,1,1,3.2,2.9,1.0
6827,103,1,Middle East & Africa,R&D,Pharmacovigilance,Meets,Female,33,17,0,5,15,3.6,2.4,2.9,0.0977,1,1,1,1,3.5,1.8,3.5
6828,195,0,Europe,Commercial,Market Access,Far Below,Male,36,11,0,7,27,3.8,3.8,3.2,0.0,1,1,1,1,1.9,3.0,1.8
6829,1041,0,Latin America,Finance,Communications,Meets,Male,43,22,0,11,12,2.6,2.5,1.0,0.0331,1,1,1,1,3.6,2.9,1.3
6830,915,0,Europe,Finance,Clinical Operations,Meets,Female,47,11,0,12,16,2.6,3.0,2.8,0.0331,1,1,1,1,3.6,3.6,2.6
6831,291,0,North America,Commercial,Communications,Meets,Male,44,15,0,10,26,4.5,2.0,2.6,0.0422,0,0,0,0,4.4,1.5,3.2
6832,78,0,Latin America,R&D,Communications,Meets,Female,30,6,1,8,11,0.0,3.4,2.7,0.0977,1,1,1,1,4.1,3.1,2.2
6833,667,0,Asia Pacific,Digital,IT & Digital,Below,Female,38,17,0,5,20,3.9,1.0,4.0,0.0,0,0,0,0,4.7,2.9,2.8
6834,860,0,Middle East & Africa,HR,Supply Chain,Meets,Female,35,28,0,5,7,3.8,5.0,2.3,0.0383,0,0,0,0,5.0,3.7,2.0
6835,903,0,Europe,Finance,Supply Chain,Meets,Female,40,11,0,7,18,4.2,4.0,3.0,0.0331,1,1,1,1,3.4,3.2,3.9
6836,457,0,North America,Manufacturing,Human Resources,Below,Female,36,6,0,7,11,4.5,2.8,2.2,0.0,1,1,1,1,4.5,2.5,2.7
6837,838,0,Asia Pacific,HR,Medical Affairs,Below,Female,43,4,0,6,36,3.8,4.3,2.6,0.0,1,1,1,1,4.1,4.2,4.0
6838,405,0,Middle East & Africa,Manufacturing,Finance & Accounting,Far Below,Female,35,7,0,11,16,4.3,3.7,2.8,0.0,1,1,1,0,5.0,3.7,3.4
6839,418,0,Asia Pacific,Manufacturing,Human Resources,Exceeds,Male,33,3,1,6,20,0.0,2.5,3.3,0.0616,1,1,1,1,2.9,3.4,4.4
6840,143,0,Middle East & Africa,R&D,Clinical Operations,Meets,Male,46,13,0,8,28,2.7,2.7,1.0,0.0977,1,1,1,1,2.0,4.6,1.6
6841,410,0,Latin America,Manufacturing,Data Science,Exceeds,Male,38,20,0,6,9,4.1,1.7,4.8,0.0616,1,1,1,1,3.4,1.0,4.2
6842,21,0,Asia Pacific,R&D,Sales,Meets,Female,43,13,0,10,25,2.5,2.9,2.5,0.0977,1,1,1,1,3.5,4.6,4.5
6843,179,0,Asia Pacific,Commercial,IT & Digital,Meets,Male,31,3,1,10,17,0.0,2.6,1.0,0.0422,1,1,1,1,3.6,2.4,2.7
6844,654,0,Asia Pacific,Digital,Regulatory Affairs,Below,Male,32,3,0,7,21,2.6,2.7,4.6,0.0,1,1,1,1,1.9,2.7,3.3
6845,437,0,Latin America,Manufacturing,Supply Chain,Meets,Male,30,10,1,10,22,0.0,2.3,2.9,0.0348,1,1,1,1,4.4,2.5,5.0
6846,581,0,North America,Digital,Legal & Compliance,Meets,Female,33,12,0,8,22,3.4,3.3,3.0,0.0853,1,1,1,1,2.3,3.1,3.1
6847,87,0,Middle East & Africa,R&D,Market Access,Below,Female,34,15,0,12,21,2.7,2.6,1.5,0.0,1,1,1,1,2.7,4.3,1.9
6848,508,0,Asia Pacific,Manufacturing,Market Access,Exceeds,Male,33,13,0,7,11,3.3,2.1,1.0,0.0616,1,1,1,1,2.9,2.4,2.1
6849,716,0,Latin America,HR,Supply Chain,Meets,Female,38,7,0,11,32,3.3,3.5,3.8,0.0383,1,1,1,0,3.5,4.0,4.9
6850,190,0,North America,Commercial,IT & Digital,Meets,Male,32,9,0,10,27,3.6,3.3,3.4,0.0422,1,1,1,1,3.4,4.0,2.8
6851,1018,0,Middle East & Africa,Finance,Market Access,Meets,Male,33,3,0,8,17,2.4,1.7,3.1,0.0331,1,0,0,0,3.4,2.4,1.9
6852,270,0,Latin America,Commercial,Sales,Meets,Female,39,7,1,10,15,0.0,3.1,1.6,0.0422,1,1,1,1,4.3,3.4,1.2
6853,362,0,Middle East & Africa,Manufacturing,Communications,Meets,Female,50,21,1,5,16,0.0,3.7,2.1,0.0348,1,1,1,1,3.6,1.7,4.9
6854,297,0,Asia Pacific,Commercial,IT & Digital,Meets,Male,41,10,0,7,14,4.4,2.1,4.7,0.0422,1,1,1,1,4.1,1.8,2.7
6855,952,0,North America,Finance,Market Access,Far Below,Non-Binary/Other,40,11,0,7,13,2.1,3.0,1.4,0.0,1,1,1,1,4.0,2.4,1.4
6856,738,0,Latin America,HR,Communications,Below,Male,36,11,0,5,16,3.8,1.8,1.2,0.0,1,1,1,1,3.3,2.1,1.4
6857,663,1,North America,Digital,Marketing,Meets,Female,28,11,0,10,33,2.9,5.0,3.0,0.0853,1,1,0,0,3.8,2.7,2.2
6858,791,0,Asia Pacific,HR,Clinical Operations,Meets,Female,37,10,0,10,14,4.4,4.3,3.0,0.0383,1,1,1,1,3.1,4.6,4.5
6859,197,0,North America,Commercial,Medical Affairs,Meets,Male,32,10,0,9,21,3.0,2.3,2.5,0.0422,1,0,0,0,3.9,3.2,1.9
6860,1048,0,North America,Finance,Medical Affairs,Meets,Female,44,11,0,9,20,3.2,3.6,2.7,0.0331,1,1,1,1,3.3,3.6,2.4
6861,604,0,Europe,Digital,Human Resources,Meets,Male,47,2,0,11,22,4.2,2.8,1.9,0.0853,1,1,1,0,5.0,3.5,2.5
6862,967,0,North America,Finance,Quality Assurance,Meets,Male,33,22,0,5,14,2.8,3.1,1.0,0.0331,1,1,1,1,3.5,2.6,2.3
6863,778,0,Middle East & Africa,HR,Communications,Exceeds,Male,38,2,0,12,19,2.2,4.1,2.2,0.0677,1,1,1,1,2.1,5.0,3.0
6864,9,0,Latin America,R&D,Regulatory Affairs,Below,Female,30,10,0,9,16,1.0,4.0,1.8,0.0,1,0,0,0,2.1,3.1,1.7
6865,21,0,Europe,R&D,Clinical Operations,Meets,Female,43,2,0,9,19,3.3,2.7,4.4,0.0977,1,1,1,1,4.6,3.9,4.0
6866,663,0,Latin America,Digital,Supply Chain,Exceeds,Female,45,23,0,6,20,1.4,2.3,3.6,0.1452,1,0,0,0,4.9,4.5,4.0
6867,598,0,Latin America,Digital,Marketing,Meets,Female,41,5,0,9,12,2.0,4.0,2.7,0.0853,1,1,1,1,3.4,4.2,2.1
6868,540,0,Asia Pacific,Digital,Sales,Meets,Male,40,7,1,10,26,0.0,2.5,1.3,0.0853,1,1,1,1,1.3,2.7,1.4
6869,45,0,Asia Pacific,R&D,IT & Digital,Below,Male,38,11,0,10,27,3.8,4.8,1.0,0.0,1,1,1,1,4.2,4.1,1.0
6870,850,0,Europe,HR,Finance & Accounting,Exceeds,Male,41,12,0,12,21,3.0,5.0,3.0,0.0677,1,1,1,1,4.6,4.5,2.2
6871,620,0,Asia Pacific,Digital,Finance & Accounting,Meets,Non-Binary/Other,36,16,0,6,15,2.2,3.3,2.9,0.0853,1,1,1,1,3.2,2.7,3.4
6872,96,0,Asia Pacific,R&D,Finance & Accounting,Meets,Female,36,21,0,9,17,2.9,2.5,2.6,0.0977,1,1,1,1,5.0,3.5,1.4
6873,557,0,Asia Pacific,Digital,Quality Assurance,Below,Female,46,10,0,10,15,1.4,1.0,4.1,0.0,1,1,1,1,2.2,3.4,2.7
6874,633,0,Latin America,Digital,Human Resources,Far Below,Male,43,4,0,11,23,3.5,2.7,1.6,0.0,1,1,1,1,3.8,1.6,1.8
6875,1007,0,Europe,Finance,Communications,Meets,Female,35,8,1,11,15,0.0,1.7,3.6,0.0331,1,1,1,1,2.3,1.6,2.6
6876,593,0,Latin America,Digital,Finance & Accounting,Meets,Female,49,6,1,11,20,0.0,2.9,2.7,0.0853,1,1,1,1,3.9,3.2,2.5
6877,60,0,Middle East & Africa,R&D,Regulatory Affairs,Exceeds,Female,34,23,0,6,17,2.3,3.8,2.3,0.1648,1,1,0,0,2.2,3.9,3.2
6878,760,0,Latin America,HR,Regulatory Affairs,Exceeds,Female,50,8,1,11,45,0.0,3.1,2.5,0.0677,1,1,1,1,2.5,2.6,3.4
6879,152,0,Middle East & Africa,R&D,Pharmacovigilance,Meets,Male,30,13,0,5,7,2.2,3.4,2.8,0.0977,1,1,1,1,3.9,4.1,1.8
6880,131,0,North America,R&D,Clinical Operations,Far Below,Female,37,19,0,6,12,2.2,2.6,2.7,0.0,1,1,1,1,3.2,2.5,3.1
6881,630,0,North America,Digital,Marketing,Meets,Female,41,7,0,9,19,2.4,2.0,2.0,0.0853,0,0,0,0,3.3,2.4,2.2
6882,978,0,Middle East & Africa,Finance,Finance & Accounting,Meets,Male,40,14,0,11,13,2.5,4.2,3.8,0.0331,1,1,1,1,3.1,1.9,3.9
6883,410,0,Middle East & Africa,Manufacturing,Finance & Accounting,Below,Female,39,11,1,10,17,0.0,2.2,4.0,0.0,1,1,1,1,3.6,2.4,4.7
6884,399,0,Latin America,Manufacturing,Data Science,Meets,Female,46,19,0,8,10,4.1,1.7,2.2,0.0348,1,1,1,1,4.3,3.8,1.2
6885,437,0,Middle East & Africa,Manufacturing,Communications,Far Below,Female,41,10,0,8,17,2.4,3.3,2.5,0.0,1,1,1,1,2.9,3.8,2.0
6886,40,1,Europe,R&D,Finance & Accounting,Meets,Female,41,11,0,7,16,2.0,2.2,1.6,0.0977,1,1,1,1,3.9,3.0,1.4
6887,618,0,North America,Digital,Sales,Exceeds,Female,34,28,0,12,15,4.0,3.4,4.8,0.1452,1,1,1,1,3.6,3.8,4.5
6888,420,0,North America,Manufacturing,Quality Assurance,Meets,Male,43,4,1,8,29,0.0,3.5,3.7,0.0348,1,1,1,1,4.3,3.3,3.1
6889,210,0,Middle East & Africa,Commercial,Supply Chain,Exceeds,Female,35,10,1,9,19,0.0,3.6,2.0,0.0743,0,0,0,0,4.0,3.1,1.0
6890,276,0,Asia Pacific,Commercial,Finance & Accounting,Meets,Male,45,4,0,8,11,2.7,2.7,4.4,0.0422,1,1,1,1,3.2,3.1,2.7
6891,347,0,Asia Pacific,Commercial,IT & Digital,Meets,Non-Binary/Other,47,24,0,10,30,2.3,3.0,1.3,0.0422,1,1,1,1,1.6,3.8,1.0
6892,715,0,Middle East & Africa,HR,Medical Affairs,Meets,Male,38,3,0,8,12,4.0,2.4,2.4,0.0383,1,1,1,1,2.2,4.7,1.8
6893,618,0,Europe,Digital,Quality Assurance,Meets,Male,41,14,0,11,24,4.6,3.8,2.5,0.0853,1,1,1,1,4.6,4.2,1.0
6894,68,0,Asia Pacific,R&D,Human Resources,Exceeds,Female,40,4,0,12,19,3.4,2.7,2.3,0.1648,1,1,1,1,3.6,3.9,2.2
6895,73,0,Middle East & Africa,R&D,Human Resources,Meets,Male,38,15,0,7,11,4.5,1.6,1.7,0.0977,1,1,1,1,3.8,1.5,1.7
6896,637,0,Europe,Digital,Market Access,Meets,Male,37,13,1,9,10,0.0,2.7,3.3,0.0853,1,1,1,1,2.5,2.5,2.8
6897,995,0,Europe,Finance,Human Resources,Meets,Female,31,12,0,8,30,3.0,3.2,4.3,0.0331,1,1,1,1,3.7,4.0,3.9
6898,999,0,Latin America,Finance,Legal & Compliance,Below,Male,34,10,0,11,22,4.5,2.6,2.2,0.0,1,1,1,1,3.3,2.8,1.7
6899,760,0,Europe,HR,Regulatory Affairs,Far Exceeds,Male,39,25,0,7,24,3.4,2.5,1.0,0.1168,1,1,0,0,3.0,3.3,1.7
6900,549,0,Asia Pacific,Digital,Supply Chain,Below,Male,47,3,1,8,12,0.0,3.5,1.5,0.0,1,1,1,1,3.1,3.8,2.8
6901,974,0,Asia Pacific,Finance,Sales,Exceeds,Female,40,22,0,5,44,2.5,3.7,3.0,0.0588,0,0,0,0,2.0,3.6,2.8
6902,706,0,Middle East & Africa,HR,Human Resources,Meets,Male,45,6,0,12,18,2.9,1.6,1.8,0.0383,1,1,1,1,3.8,3.8,2.8
6903,510,0,Middle East & Africa,Manufacturing,Marketing,Meets,Female,28,14,0,7,17,2.0,4.3,1.7,0.0348,0,0,0,0,2.6,2.4,2.6
6904,522,0,Europe,Manufacturing,Data Science,Meets,Male,46,10,0,12,23,3.3,2.5,2.6,0.0348,1,1,1,1,3.4,4.4,3.8
6905,841,0,North America,HR,Human Resources,Exceeds,Male,42,5,0,5,12,2.7,3.2,2.6,0.0677,1,1,1,1,1.1,2.9,1.6
6906,578,0,Latin America,Digital,Market Access,Exceeds,Male,44,6,1,9,15,0.0,3.5,1.2,0.1452,0,0,0,0,3.9,3.2,1.0
6907,372,0,North America,Manufacturing,Supply Chain,Exceeds,Non-Binary/Other,28,29,0,9,22,3.0,3.8,3.0,0.0616,1,1,1,1,3.0,4.6,2.2
6908,643,0,Europe,Digital,Supply Chain,Meets,Female,36,14,0,11,17,4.9,2.4,2.3,0.0853,1,1,1,1,4.3,2.7,1.5
6909,902,0,Europe,Finance,Regulatory Affairs,Far Below,Male,32,3,1,6,29,0.0,3.2,2.8,0.0,0,0,0,0,2.7,4.9,3.7
6910,452,0,North America,Manufacturing,Clinical Operations,Meets,Male,42,21,0,8,25,3.4,2.5,3.1,0.0348,1,1,1,1,4.2,3.8,2.8
6911,1017,0,Latin America,Finance,Market Access,Meets,Male,41,11,0,11,15,2.7,2.7,1.5,0.0331,1,1,1,1,3.2,3.3,2.7
6912,670,0,North America,Digital,Regulatory Affairs,Meets,Female,44,13,0,11,13,3.3,3.4,1.1,0.0853,1,1,1,0,3.4,4.3,2.1
6913,652,0,Middle East & Africa,Digital,IT & Digital,Meets,Male,36,15,0,5,10,3.9,2.2,3.3,0.0853,1,1,1,1,4.3,3.1,1.7
6914,279,0,Asia Pacific,Commercial,Quality Assurance,Meets,Male,43,6,1,10,32,0.0,3.6,1.6,0.0422,1,1,1,1,1.7,3.4,1.5
6915,869,0,Middle East & Africa,HR,Human Resources,Meets,Female,38,23,0,12,23,4.2,2.7,3.1,0.0383,0,0,0,0,5.0,1.7,3.2
6916,113,0,Asia Pacific,R&D,Market Access,Exceeds,Male,45,20,0,7,9,4.0,3.0,2.1,0.1648,0,0,0,0,3.7,3.4,1.8
6917,707,0,Europe,HR,Data Science,Exceeds,Male,42,12,0,7,11,3.5,3.0,3.4,0.0677,1,1,1,1,2.4,3.0,2.8
6918,594,0,Latin America,Digital,Human Resources,Meets,Male,34,15,0,11,29,4.3,2.4,3.4,0.0853,1,1,1,1,2.4,3.6,2.8
6919,641,0,North America,Digital,Medical Affairs,Meets,Male,40,8,0,8,20,2.7,3.3,2.7,0.0853,1,1,1,1,3.6,3.7,2.3
6920,756,0,Latin America,HR,Quality Assurance,Meets,Male,30,12,1,6,19,0.0,5.0,4.2,0.0383,1,1,0,0,3.4,4.1,3.7
6921,658,0,North America,Digital,Data Science,Far Below,Male,45,20,0,7,35,3.7,4.5,3.2,0.0,1,1,1,1,4.4,3.8,2.9
6922,939,0,Middle East & Africa,Finance,Marketing,Below,Female,42,10,0,6,11,1.9,2.5,2.0,0.0,1,1,1,1,2.5,3.7,1.9
6923,363,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Below,Female,42,7,0,10,20,2.3,1.0,4.1,0.0,1,1,1,1,1.7,1.7,3.3
6924,632,0,North America,Digital,Data Science,Below,Female,44,5,0,7,16,2.4,1.2,2.4,0.0,1,1,1,1,3.1,1.9,1.5
6925,769,0,Latin America,HR,Clinical Operations,Far Below,Female,39,16,0,12,13,3.2,1.1,2.0,0.0,1,1,1,1,4.1,3.9,2.5
6926,831,1,North America,HR,Pharmacovigilance,Exceeds,Female,29,11,0,7,8,3.0,2.4,2.6,0.0677,1,1,1,1,3.1,3.7,2.4
6927,793,0,Europe,HR,Medical Affairs,Meets,Male,44,3,0,12,18,2.4,2.6,2.2,0.0383,1,1,1,1,2.3,4.5,4.1
6928,315,0,Middle East & Africa,Commercial,Marketing,Meets,Male,34,14,1,10,33,0.0,2.4,1.1,0.0422,1,1,1,1,5.0,3.1,2.5
6929,969,0,Europe,Finance,Communications,Meets,Male,33,16,0,8,13,4.2,1.0,3.2,0.0331,1,1,1,1,3.8,1.9,3.1
6930,982,0,Middle East & Africa,Finance,Supply Chain,Meets,Female,43,22,0,5,21,3.4,2.8,3.4,0.0331,1,1,1,1,3.0,3.1,2.6
6931,334,0,Middle East & Africa,Commercial,Regulatory Affairs,Below,Female,35,8,0,7,15,4.0,4.1,2.7,0.0,1,1,1,1,3.4,3.7,2.9
6932,1014,0,Asia Pacific,Finance,Quality Assurance,Meets,Male,39,7,0,12,26,3.2,4.6,3.5,0.0331,1,1,1,1,3.0,3.2,3.7
6933,276,0,Europe,Commercial,IT & Digital,Exceeds,Male,42,8,0,6,7,4.8,3.6,3.5,0.0743,1,1,1,1,4.0,2.9,3.7
6934,1023,0,Europe,Finance,Pharmacovigilance,Meets,Female,42,22,0,11,29,5.0,2.9,3.6,0.0331,1,0,0,0,4.2,3.2,3.0
6935,209,0,Asia Pacific,Commercial,Legal & Compliance,Meets,Male,45,4,1,5,13,0.0,1.8,2.0,0.0422,1,0,0,0,4.5,4.5,3.2
6936,202,0,Latin America,Commercial,Market Access,Meets,Female,35,12,0,7,12,1.6,3.7,3.0,0.0422,1,1,1,1,2.7,3.5,3.2
6937,1023,0,Europe,Finance,Human Resources,Meets,Female,36,19,0,9,48,3.5,1.2,2.1,0.0331,1,1,1,1,4.2,3.9,1.2
6938,216,0,North America,Commercial,Regulatory Affairs,Meets,Male,40,8,1,8,11,0.0,2.2,1.4,0.0422,1,1,1,1,2.8,1.5,2.6
6939,992,0,Asia Pacific,Finance,Sales,Meets,Male,30,8,0,7,29,3.5,1.8,1.0,0.0331,1,1,1,1,4.0,1.9,3.9
6940,241,0,Europe,Commercial,Regulatory Affairs,Meets,Male,33,21,0,12,29,4.3,3.6,4.3,0.0422,1,1,1,1,3.9,2.9,3.6
6941,840,0,Latin America,HR,Human Resources,Below,Male,33,4,1,8,15,0.0,3.7,2.6,0.0,1,1,1,1,2.6,3.9,4.2
6942,74,0,Europe,R&D,Sales,Exceeds,Female,28,3,0,5,25,3.2,2.3,1.6,0.1648,1,1,1,1,2.6,1.7,2.1
6943,986,0,Middle East & Africa,Finance,Supply Chain,Meets,Male,35,8,0,8,28,3.4,2.9,1.5,0.0331,1,1,1,1,3.8,3.4,2.5
6944,233,0,North America,Commercial,Marketing,Meets,Male,38,6,1,9,16,0.0,4.0,1.0,0.0422,1,1,1,1,3.5,4.3,1.8
6945,701,0,Asia Pacific,HR,Medical Affairs,Meets,Female,39,5,0,6,18,3.9,2.2,2.9,0.0383,1,1,1,1,3.2,1.9,2.0
6946,15,0,Middle East & Africa,R&D,Legal & Compliance,Meets,Female,35,13,0,6,17,2.4,2.4,4.7,0.0977,1,1,1,1,2.9,2.5,3.1
6947,211,0,Latin America,Commercial,Regulatory Affairs,Meets,Male,33,10,0,6,24,3.7,4.2,2.0,0.0422,1,1,1,1,2.8,4.1,2.0
6948,20,0,Middle East & Africa,R&D,Supply Chain,Below,Male,37,8,0,5,15,4.1,3.1,2.0,0.0,1,1,1,1,4.1,1.9,1.0
6949,957,0,Middle East & Africa,Finance,IT & Digital,Meets,Male,35,10,0,9,17,4.0,3.8,1.2,0.0331,1,1,1,1,4.6,3.8,2.8
6950,59,0,Latin America,R&D,Market Access,Meets,Female,28,19,1,10,11,0.0,3.2,3.3,0.0977,1,1,1,1,2.5,3.3,3.4
6951,504,0,Middle East & Africa,Manufacturing,Pharmacovigilance,Below,Male,33,14,1,11,41,0.0,4.1,2.9,0.0,1,1,1,1,3.4,4.3,1.8
6952,554,0,Asia Pacific,Digital,Clinical Operations,Below,Male,40,6,1,10,29,0.0,3.4,2.6,0.0,1,1,1,1,4.4,3.0,2.0
6953,463,0,Europe,Manufacturing,Data Science,Meets,Non-Binary/Other,38,7,1,5,14,0.0,2.6,3.1,0.0348,1,1,1,1,3.7,2.7,3.5
6954,995,0,Middle East & Africa,Finance,Supply Chain,Below,Male,39,12,1,7,26,0.0,3.2,1.2,0.0,1,1,1,1,5.0,2.9,2.2
6955,994,0,Asia Pacific,Finance,Communications,Below,Male,42,12,0,8,35,4.5,4.2,1.0,0.0,1,1,1,1,5.0,3.4,2.7
6956,91,0,Europe,R&D,Legal & Compliance,Meets,Female,40,11,0,5,33,3.8,2.8,1.4,0.0977,1,1,1,1,2.9,3.4,2.1
6957,880,0,Europe,HR,Pharmacovigilance,Exceeds,Male,39,35,0,12,28,4.1,4.1,1.6,0.0677,1,1,1,1,3.1,4.2,1.5
6958,237,0,Middle East & Africa,Commercial,Finance & Accounting,Meets,Male,36,21,0,7,25,3.5,2.8,2.8,0.0422,1,1,1,1,3.2,2.6,3.0
6959,680,0,Asia Pacific,Digital,Sales,Exceeds,Male,34,7,0,7,14,3.3,2.7,1.9,0.1452,1,1,1,1,1.8,2.8,2.1
6960,203,0,Middle East & Africa,Commercial,Supply Chain,Meets,Female,38,6,1,7,29,0.0,3.8,4.1,0.0422,1,1,1,1,4.2,3.2,2.8
6961,777,0,Latin America,HR,Communications,Meets,Non-Binary/Other,32,4,1,9,12,0.0,2.3,4.3,0.0383,1,1,1,1,2.4,3.8,2.4
6962,1030,0,Europe,Finance,Market Access,Meets,Female,42,6,0,9,15,4.4,4.4,2.2,0.0331,1,1,1,1,4.1,3.4,1.6
6963,623,0,Middle East & Africa,Digital,Supply Chain,Meets,Male,32,17,0,8,12,3.3,4.2,2.5,0.0853,1,1,1,1,3.7,4.4,1.6
6964,370,0,Europe,Manufacturing,Medical Affairs,Below,Male,46,17,0,5,11,3.4,2.0,1.8,0.0,1,1,1,1,4.5,1.5,1.5
6965,960,0,Asia Pacific,Finance,Sales,Meets,Female,38,11,0,7,10,4.4,4.0,3.0,0.0331,1,1,1,1,4.9,3.5,3.0
6966,1043,0,North America,Finance,Regulatory Affairs,Meets,Female,45,1,0,10,17,2.8,3.9,3.6,0.0331,1,1,1,1,2.5,4.6,2.8
6967,168,1,Middle East & Africa,R&D,Quality Assurance,Meets,Female,32,21,0,11,12,3.4,3.0,3.5,0.0977,1,1,1,1,4.3,2.2,4.2
6968,734,0,Middle East & Africa,HR,IT & Digital,Meets,Female,48,8,0,6,24,4.2,3.2,2.4,0.0383,0,0,0,0,3.0,4.5,3.3
6969,119,0,Europe,R&D,Communications,Below,Non-Binary/Other,31,5,1,5,7,0.0,1.7,2.2,0.0,1,1,1,0,2.7,2.9,3.7
6970,28,1,Asia Pacific,R&D,Communications,Exceeds,Male,38,8,1,6,21,0.0,4.2,2.0,0.1648,1,1,1,1,3.2,2.9,3.4
6971,262,0,Latin America,Commercial,Clinical Operations,Meets,Male,30,8,0,12,14,1.7,2.4,4.2,0.0422,1,1,1,1,1.0,2.3,4.9
6972,926,0,Asia Pacific,Finance,Regulatory Affairs,Meets,Female,38,16,0,5,17,2.9,1.2,2.2,0.0331,0,0,0,0,3.8,2.3,2.0
6973,745,0,Middle East & Africa,HR,IT & Digital,Exceeds,Male,37,6,0,5,8,2.6,2.6,3.6,0.0677,1,1,1,1,3.2,3.7,3.1
6974,9,0,Latin America,R&D,Data Science,Below,Male,28,10,0,6,12,2.8,2.3,2.4,0.0,1,1,1,1,3.3,1.0,2.4
6975,479,0,Asia Pacific,Manufacturing,Supply Chain,Meets,Female,39,8,0,7,31,4.6,3.3,1.0,0.0348,1,1,1,1,5.0,3.7,1.9
6976,592,0,North America,Digital,Marketing,Meets,Male,41,19,0,8,14,1.6,4.5,2.6,0.0853,1,1,1,1,1.4,4.3,2.1
6977,786,0,Europe,HR,Legal & Compliance,Meets,Male,33,9,0,9,16,4.0,3.4,1.2,0.0383,1,1,1,1,5.0,3.3,2.7
6978,305,0,Asia Pacific,Commercial,Supply Chain,Exceeds,Female,36,8,1,5,13,0.0,3.8,2.1,0.0743,1,1,1,1,2.0,4.0,2.8
6979,880,0,Asia Pacific,HR,Human Resources,Meets,Male,37,5,0,6,10,3.6,5.0,1.8,0.0383,1,1,1,0,3.0,4.8,3.8
6980,1023,0,North America,Finance,Sales,Far Below,Male,48,10,0,11,17,2.6,2.8,2.8,0.0,1,1,1,1,4.3,4.5,2.3
6981,262,0,Middle East & Africa,Commercial,Legal & Compliance,Far Below,Male,39,7,0,10,23,4.1,1.2,2.2,0.0,1,1,0,0,4.9,1.9,2.9
6982,686,0,Europe,Digital,Medical Affairs,Meets,Female,35,11,0,8,9,2.9,2.2,1.8,0.0853,1,1,1,1,2.5,2.7,3.0
6983,361,0,Asia Pacific,Manufacturing,Communications,Meets,Male,31,35,0,8,14,2.2,3.4,3.4,0.0348,1,1,1,1,2.0,3.5,2.2
6984,21,0,Latin America,R&D,Communications,Meets,Female,28,21,1,10,13,0.0,2.2,2.2,0.0977,1,1,1,1,2.0,2.6,2.9
6985,704,0,Asia Pacific,HR,Supply Chain,Meets,Male,37,7,0,12,23,3.1,3.9,2.8,0.0383,1,1,1,1,3.1,4.1,4.0
6986,270,0,Europe,Commercial,Data Science,Meets,Male,39,9,0,11,23,2.7,2.0,2.8,0.0422,1,1,1,1,4.4,2.7,2.6
6987,599,0,Asia Pacific,Digital,Finance & Accounting,Below,Female,31,17,0,9,13,3.3,2.0,1.9,0.0,1,1,1,1,4.5,2.7,2.4
6988,107,0,North America,R&D,Market Access,Exceeds,Male,29,16,0,5,15,2.5,1.8,2.6,0.1648,1,1,1,1,3.7,2.1,2.6
6989,618,0,Asia Pacific,Digital,Supply Chain,Meets,Male,41,15,0,12,21,2.9,5.0,2.0,0.0853,1,1,1,1,2.3,2.0,2.3
6990,356,0,Asia Pacific,Manufacturing,Regulatory Affairs,Below,Female,44,5,1,7,16,0.0,2.9,2.5,0.0,1,1,1,1,2.7,3.4,2.9
6991,161,0,Latin America,R&D,IT & Digital,Below,Male,36,3,1,10,16,0.0,2.8,2.2,0.0,1,1,1,1,2.9,2.9,3.2
6992,122,1,North America,R&D,IT & Digital,Far Exceeds,Female,41,18,0,9,19,3.3,3.9,3.0,0.2644,1,1,1,1,2.9,4.1,1.5
6993,148,0,North America,R&D,Quality Assurance,Meets,Male,37,3,1,5,12,0.0,3.7,3.2,0.0977,1,1,1,1,4.0,4.1,3.3
6994,296,0,Asia Pacific,Commercial,IT & Digital,Meets,Female,54,6,0,10,23,4.5,4.5,1.0,0.0422,1,1,1,1,4.4,3.2,2.6
6995,77,0,Latin America,R&D,Marketing,Meets,Female,38,4,1,5,7,0.0,4.9,1.7,0.0977,1,1,1,1,3.7,5.0,1.6
6996,675,0,Asia Pacific,Digital,IT & Digital,Meets,Male,46,8,0,6,17,3.3,4.2,1.8,0.0853,0,0,0,0,3.5,5.0,3.0
6997,273,0,Asia Pacific,Commercial,Communications,Meets,Male,41,7,0,11,25,1.3,3.6,2.4,0.0422,1,1,1,1,1.0,3.6,1.5
6998,135,0,Europe,R&D,Data Science,Meets,Male,35,6,1,11,14,0.0,2.7,4.1,0.0977,1,1,1,1,2.5,3.9,5.0
6999,525,0,Europe,Digital,Data Science,Meets,Non-Binary/Other,42,10,0,7,12,3.1,4.0,1.0,0.0853,1,1,1,1,4.8,4.0,1.0
7000,572,0,Latin America,Digital,Sales,Below,Female,38,3,0,7,15,2.9,4.3,3.2,0.0,1,1,1,1,3.5,3.0,1.8
7001,748,0,Middle East & Africa,HR,Data Science,Meets,Male,32,24,0,8,11,3.0,2.8,3.6,0.0383,1,1,1,1,4.0,4.3,3.2
7002,553,0,Europe,Digital,Marketing,Below,Male,39,17,0,5,16,4.5,2.9,2.1,0.0,1,1,1,1,4.5,2.9,2.9
7003,978,0,Middle East & Africa,Finance,Regulatory Affairs,Exceeds,Male,35,8,1,6,12,0.0,4.2,2.9,0.0588,1,1,1,1,3.3,4.0,2.7
7004,416,0,North America,Manufacturing,Quality Assurance,Far Below,Female,38,9,0,7,18,3.5,1.0,3.3,0.0,1,1,1,1,4.3,1.7,2.0
7005,109,0,Europe,R&D,Finance & Accounting,Meets,Female,38,11,0,7,26,3.0,3.7,2.0,0.0977,0,0,0,0,2.4,1.3,1.0
7006,55,0,Europe,R&D,Human Resources,Meets,Male,37,12,0,9,17,4.4,2.4,1.7,0.0977,1,1,1,0,4.5,2.8,2.0
7007,165,0,Latin America,R&D,IT & Digital,Exceeds,Female,32,12,1,9,37,0.0,2.4,4.8,0.1648,1,1,1,1,3.4,3.2,2.3
7008,669,0,Middle East & Africa,Digital,Human Resources,Below,Male,45,13,0,12,15,4.8,2.4,1.9,0.0,1,1,1,1,5.0,1.0,1.7
7009,545,1,Europe,Digital,Pharmacovigilance,Far Exceeds,Female,38,8,0,8,32,3.4,1.5,2.8,0.2363,1,1,1,1,3.1,2.6,3.3
7010,77,0,Europe,R&D,Finance & Accounting,Below,Male,39,12,0,12,22,4.4,2.8,1.6,0.0,1,1,1,1,4.0,1.6,1.0
7011,905,0,Latin America,Finance,Communications,Meets,Female,37,33,0,7,9,2.6,3.9,3.6,0.0331,1,1,1,1,2.9,5.0,3.0
7012,259,0,Latin America,Commercial,Supply Chain,Meets,Female,36,14,0,6,37,3.1,2.3,1.0,0.0422,1,1,1,0,4.2,4.4,2.7
7013,205,0,Middle East & Africa,Commercial,Legal & Compliance,Meets,Female,39,11,1,12,18,0.0,3.2,2.5,0.0422,1,1,1,1,4.1,1.2,3.0
7014,375,0,North America,Manufacturing,Data Science,Meets,Female,46,12,0,12,18,4.7,2.0,2.3,0.0348,1,1,1,1,5.0,2.3,2.5
7015,876,0,North America,HR,Human Resources,Exceeds,Male,29,18,0,7,19,4.5,1.3,2.5,0.0677,1,1,1,1,4.7,3.3,3.9
7016,515,0,Asia Pacific,Manufacturing,Legal & Compliance,Below,Non-Binary/Other,31,10,0,11,21,3.5,1.0,4.4,0.0,1,1,1,1,3.9,3.1,3.8
7017,171,0,Europe,R&D,Market Access,Meets,Female,36,11,0,5,9,4.3,3.3,2.8,0.0977,1,1,1,1,3.5,3.2,2.4
7018,74,0,Middle East & Africa,R&D,Medical Affairs,Meets,Male,33,15,0,6,8,5.0,4.0,1.0,0.0977,1,1,1,1,3.2,4.4,3.0
7019,174,1,Europe,R&D,IT & Digital,Far Exceeds,Male,50,19,1,6,18,0.0,3.5,2.1,0.2644,1,1,1,1,4.3,3.7,2.3
7020,792,0,Middle East & Africa,HR,Market Access,Meets,Female,36,3,0,10,26,3.3,1.8,2.2,0.0383,1,1,1,1,3.1,2.2,1.0
7021,662,0,Middle East & Africa,Digital,Regulatory Affairs,Below,Male,41,5,1,10,11,0.0,4.6,4.2,0.0,1,1,1,1,3.8,3.0,4.1
7022,842,1,Middle East & Africa,HR,Pharmacovigilance,Meets,Male,36,10,1,9,17,0.0,3.8,2.3,0.0383,1,1,1,1,3.2,3.6,2.3
7023,522,0,Europe,Manufacturing,Legal & Compliance,Below,Female,28,16,0,9,27,2.1,4.1,2.3,0.0,1,1,1,1,2.7,3.9,1.6
7024,594,0,Latin America,Digital,Sales,Meets,Male,36,10,1,12,23,0.0,4.1,3.3,0.0853,1,1,1,1,1.9,4.8,3.3
7025,671,0,Europe,Digital,IT & Digital,Meets,Female,31,11,0,7,21,3.2,3.7,5.0,0.0853,1,1,0,0,3.7,4.9,4.5
7026,506,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Exceeds,Male,40,5,1,6,13,0.0,2.8,1.0,0.0616,0,0,0,0,3.8,2.3,2.1
7027,528,1,Asia Pacific,Digital,Market Access,Exceeds,Male,36,17,0,11,20,3.7,2.3,2.1,0.1452,1,1,1,1,3.6,3.3,1.0
7028,327,0,North America,Commercial,Marketing,Far Below,Female,33,8,0,8,17,2.5,3.6,1.7,0.0,1,1,1,1,2.9,3.1,1.6
7029,417,0,Middle East & Africa,Manufacturing,Supply Chain,Meets,Female,37,11,0,11,16,2.3,2.5,2.1,0.0348,1,1,1,1,4.0,3.1,4.1
7030,426,0,Asia Pacific,Manufacturing,Finance & Accounting,Meets,Female,35,23,0,8,25,3.5,3.3,2.7,0.0348,1,1,1,1,4.1,4.0,3.0
7031,189,0,Latin America,Commercial,Regulatory Affairs,Meets,Female,44,18,0,6,16,1.6,3.1,4.7,0.0422,1,1,1,1,2.5,2.5,3.2
7032,840,0,Middle East & Africa,HR,Communications,Far Below,Male,41,9,1,6,10,0.0,2.6,4.0,0.0,1,1,1,1,4.2,1.0,4.1
7033,711,0,Asia Pacific,HR,Clinical Operations,Meets,Female,48,14,0,11,23,3.2,3.3,2.1,0.0383,1,1,1,0,2.6,3.8,2.1
7034,861,1,Middle East & Africa,HR,Finance & Accounting,Far Exceeds,Female,42,16,0,8,12,2.2,3.5,4.0,0.1168,1,1,1,1,2.6,3.5,4.4
7035,611,0,Europe,Digital,Supply Chain,Meets,Female,41,20,0,6,12,3.3,2.9,3.4,0.0853,1,1,1,1,3.3,3.1,4.3
7036,336,0,Asia Pacific,Commercial,Clinical Operations,Meets,Female,42,8,0,6,10,3.8,1.0,4.0,0.0422,1,0,0,0,4.9,3.1,3.5
7037,501,0,Europe,Manufacturing,Data Science,Meets,Female,42,7,0,7,17,3.6,3.0,4.2,0.0348,1,1,1,1,3.8,2.8,4.3
7038,408,0,Europe,Manufacturing,Medical Affairs,Exceeds,Male,28,16,0,11,14,4.5,2.6,1.1,0.0616,1,1,1,1,5.0,4.1,2.0
7039,482,0,Asia Pacific,Manufacturing,Regulatory Affairs,Far Below,Female,41,21,0,6,9,3.8,1.9,2.1,0.0,1,1,1,1,3.2,3.4,1.7
7040,544,0,North America,Digital,Supply Chain,Meets,Female,28,3,1,8,17,0.0,4.9,3.0,0.0853,1,1,1,1,3.5,3.7,2.6
7041,687,0,Asia Pacific,Digital,Sales,Exceeds,Male,28,2,0,8,12,3.1,2.3,2.5,0.1452,1,1,1,1,2.2,4.2,3.8
7042,1039,0,North America,Finance,Clinical Operations,Below,Female,31,5,0,8,27,2.7,4.3,3.3,0.0,1,1,1,1,1.5,4.7,3.4
7043,709,0,Middle East & Africa,HR,IT & Digital,Meets,Female,40,5,1,5,13,0.0,3.1,1.6,0.0383,0,0,0,0,2.1,2.3,2.0
7044,981,0,Middle East & Africa,Finance,IT & Digital,Below,Male,30,14,0,8,9,4.4,3.0,3.1,0.0,1,1,1,1,4.6,3.5,2.3
7045,932,0,Asia Pacific,Finance,Quality Assurance,Exceeds,Female,41,7,0,10,15,2.8,3.6,2.4,0.0588,1,1,1,1,3.8,3.4,2.0
7046,672,0,Middle East & Africa,Digital,Market Access,Meets,Male,48,2,1,7,12,0.0,4.8,2.8,0.0853,1,1,1,1,4.5,3.6,2.4
7047,843,0,Latin America,HR,Supply Chain,Far Exceeds,Female,36,22,0,10,14,2.6,3.1,4.6,0.1168,1,1,1,1,3.1,1.6,4.2
7048,860,0,Europe,HR,Medical Affairs,Exceeds,Male,39,6,1,7,11,0.0,2.6,2.7,0.0677,1,1,1,1,4.2,2.7,3.4
7049,432,1,Europe,Manufacturing,Regulatory Affairs,Meets,Male,34,3,1,10,17,0.0,3.7,3.3,0.0348,1,1,1,1,3.4,2.9,1.8
7050,566,0,North America,Digital,Communications,Meets,Male,31,9,0,11,29,2.0,4.1,2.4,0.0853,1,1,1,1,2.8,2.0,1.9
7051,850,0,Middle East & Africa,HR,Supply Chain,Meets,Female,37,9,1,7,9,0.0,3.6,1.0,0.0383,1,1,1,1,3.9,2.8,2.3
7052,917,0,North America,Finance,Human Resources,Below,Male,33,10,0,7,11,3.0,3.9,2.7,0.0,1,1,1,1,4.1,2.3,2.5
7053,234,0,Europe,Commercial,Regulatory Affairs,Meets,Female,35,15,0,7,14,2.0,4.1,3.3,0.0422,0,0,0,0,2.1,4.1,4.4
7054,303,0,Europe,Commercial,Marketing,Far Below,Male,34,9,0,5,7,2.0,4.1,3.4,0.0,1,1,1,1,2.9,2.3,3.4
7055,554,0,Middle East & Africa,Digital,Clinical Operations,Meets,Female,30,12,0,9,16,4.1,3.1,2.2,0.0853,1,1,1,1,3.0,3.9,3.2
7056,443,0,Latin America,Manufacturing,Legal & Compliance,Exceeds,Female,37,17,0,12,20,4.5,4.4,2.0,0.0616,1,1,1,1,4.6,2.9,1.9
7057,382,0,Latin America,Manufacturing,Supply Chain,Exceeds,Female,28,11,0,10,22,3.3,2.8,4.5,0.0616,1,1,1,1,4.0,2.2,2.6
7058,766,0,Middle East & Africa,HR,Supply Chain,Meets,Male,41,4,0,8,30,4.8,4.4,4.9,0.0383,1,1,1,1,4.6,3.2,3.4
7059,696,0,Middle East & Africa,Digital,IT & Digital,Meets,Male,28,5,1,6,16,0.0,4.6,1.0,0.0853,1,1,1,1,2.7,3.5,2.9
7060,239,0,North America,Commercial,Medical Affairs,Exceeds,Female,34,25,0,9,11,3.5,3.9,2.9,0.0743,1,1,1,1,3.2,3.3,2.8
7061,1036,0,Middle East & Africa,Finance,Medical Affairs,Exceeds,Female,45,3,1,6,15,0.0,4.1,3.2,0.0588,1,1,1,1,5.0,3.2,3.3
7062,839,0,Latin America,HR,Communications,Meets,Male,42,4,0,7,15,3.9,4.1,3.1,0.0383,1,1,1,1,4.7,2.8,3.8
7063,1049,0,Middle East & Africa,Finance,Market Access,Below,Male,38,16,0,11,25,1.8,3.2,3.5,0.0,1,1,1,1,2.9,2.3,2.9
7064,786,1,North America,HR,Sales,Meets,Male,51,5,1,11,20,0.0,3.7,3.1,0.0383,1,1,1,1,3.6,2.6,3.7
7065,97,0,North America,R&D,Regulatory Affairs,Meets,Male,39,21,1,7,8,0.0,4.6,1.2,0.0977,1,1,1,1,3.5,3.2,2.0
7066,1038,0,North America,Finance,Pharmacovigilance,Meets,Male,44,12,1,10,13,0.0,2.2,2.6,0.0331,1,1,0,0,4.4,2.4,2.2
7067,678,1,North America,Digital,Market Access,Far Exceeds,Female,34,9,0,7,14,2.3,4.3,3.0,0.2363,1,1,1,1,4.0,3.2,2.3
7068,895,0,Asia Pacific,Finance,Medical Affairs,Exceeds,Female,28,8,0,8,28,4.5,1.0,1.3,0.0588,0,0,0,0,3.8,2.3,1.7
7069,903,0,Middle East & Africa,Finance,Human Resources,Meets,Non-Binary/Other,39,19,0,11,35,3.7,2.6,1.6,0.0331,1,1,1,1,3.1,3.8,3.2
7070,802,0,Europe,HR,Pharmacovigilance,Below,Male,41,15,0,9,18,3.6,3.2,1.5,0.0,1,1,1,1,3.4,3.4,2.0
7071,226,0,Middle East & Africa,Commercial,Legal & Compliance,Meets,Female,40,6,1,6,19,0.0,3.0,1.0,0.0422,1,1,1,1,3.2,3.6,1.0
7072,170,0,Asia Pacific,R&D,Data Science,Below,Male,29,18,1,11,15,0.0,4.1,3.1,0.0,1,1,1,1,2.8,1.4,1.8
7073,943,0,North America,Finance,Pharmacovigilance,Meets,Male,55,1,1,10,16,0.0,1.6,1.7,0.0331,1,1,1,1,3.9,2.7,2.4
7074,191,0,Asia Pacific,Commercial,Clinical Operations,Exceeds,Female,31,11,0,10,16,3.6,3.7,2.9,0.0743,1,1,1,1,4.6,3.5,2.0
7075,370,0,Latin America,Manufacturing,Supply Chain,Meets,Female,39,5,0,12,21,3.5,2.3,2.0,0.0348,1,1,1,1,3.9,3.8,3.1
7076,45,0,Latin America,R&D,Medical Affairs,Meets,Non-Binary/Other,40,19,0,8,16,3.0,4.0,4.3,0.0977,1,1,1,1,4.2,5.0,4.1
7077,130,0,Middle East & Africa,R&D,Supply Chain,Below,Female,43,3,1,10,43,0.0,2.0,2.3,0.0,1,1,1,1,4.0,3.4,2.8
7078,865,0,Middle East & Africa,HR,Legal & Compliance,Meets,Male,34,12,0,5,23,3.2,3.5,2.5,0.0383,1,1,1,1,3.1,4.3,3.3
7079,904,0,Europe,Finance,Market Access,Exceeds,Male,41,25,1,10,24,0.0,4.4,2.4,0.0588,1,0,0,0,3.5,4.1,2.8
7080,498,1,Europe,Manufacturing,Communications,Meets,Female,48,20,1,11,13,0.0,2.4,2.1,0.0348,0,0,0,0,4.0,4.3,4.0
7081,736,0,Latin America,HR,Marketing,Below,Female,35,22,0,5,14,1.3,3.1,1.3,0.0,1,1,1,1,2.5,3.3,2.6
7082,616,0,North America,Digital,Medical Affairs,Exceeds,Male,35,7,0,6,12,4.0,3.0,3.2,0.1452,0,0,0,0,5.0,2.9,4.9
7083,286,0,Asia Pacific,Commercial,Medical Affairs,Meets,Male,32,19,0,5,21,1.9,2.8,3.2,0.0422,1,1,1,1,3.9,3.3,2.3
7084,197,0,Europe,Commercial,Quality Assurance,Meets,Female,39,9,1,11,25,0.0,3.0,1.6,0.0422,1,1,1,1,3.8,2.3,2.3
7085,817,0,Europe,HR,Supply Chain,Below,Female,33,9,0,10,14,4.1,1.6,2.6,0.0,1,1,1,1,3.6,1.0,1.8
7086,251,0,North America,Commercial,Medical Affairs,Meets,Male,42,5,0,7,19,2.9,3.6,4.2,0.0422,1,1,1,1,4.4,2.6,3.9
7087,932,0,North America,Finance,Human Resources,Far Below,Non-Binary/Other,35,7,0,9,14,2.9,2.9,3.4,0.0,1,1,1,1,3.3,4.2,3.5
7088,330,0,Middle East & Africa,Commercial,Marketing,Meets,Female,37,6,0,8,36,2.9,3.0,3.2,0.0422,1,0,0,0,3.3,3.5,3.0
7089,978,0,Asia Pacific,Finance,Marketing,Meets,Male,32,20,0,5,14,3.5,4.0,1.9,0.0331,1,1,1,0,2.7,4.7,2.6
7090,613,0,North America,Digital,Clinical Operations,Meets,Male,51,5,1,6,9,0.0,2.5,3.1,0.0853,1,1,1,1,2.6,2.9,1.6
7091,464,0,Europe,Manufacturing,Finance & Accounting,Exceeds,Female,39,5,0,9,18,3.8,3.2,1.9,0.0616,1,1,1,1,2.6,2.4,1.0
7092,4,0,Europe,R&D,Regulatory Affairs,Far Below,Male,31,9,1,9,23,0.0,1.0,3.9,0.0,1,1,1,1,3.7,2.4,3.8
7093,747,0,Latin America,HR,Medical Affairs,Exceeds,Female,40,26,0,10,18,4.9,5.0,2.6,0.0677,1,1,1,1,4.6,3.5,3.9
7094,788,0,North America,HR,Marketing,Meets,Female,28,12,0,6,16,3.0,4.3,4.0,0.0383,1,1,1,1,2.3,3.3,2.1
7095,971,0,Middle East & Africa,Finance,Marketing,Meets,Male,34,7,0,6,20,4.5,2.8,2.8,0.0331,1,1,1,1,4.4,4.2,3.5
7096,587,0,Asia Pacific,Digital,Clinical Operations,Meets,Female,41,7,0,5,15,3.3,4.9,1.4,0.0853,1,0,0,0,2.9,5.0,2.7
7097,657,0,Middle East & Africa,Digital,Quality Assurance,Below,Female,41,5,0,6,12,3.0,3.5,2.3,0.0,1,1,1,1,3.2,3.0,3.5
7098,138,0,Europe,R&D,Regulatory Affairs,Meets,Male,43,12,0,11,14,3.4,1.0,1.2,0.0977,0,0,0,0,4.6,2.3,1.9
7099,395,0,Middle East & Africa,Manufacturing,Finance & Accounting,Meets,Female,46,6,0,12,17,3.4,2.3,1.4,0.0348,1,1,1,1,3.7,3.1,1.2
7100,704,1,Europe,HR,Sales,Exceeds,Female,37,14,0,7,24,3.6,3.6,1.7,0.0677,1,1,1,1,2.9,3.9,3.1
7101,1037,0,Europe,Finance,Medical Affairs,Far Exceeds,Female,43,1,1,9,16,0.0,2.6,1.9,0.1022,1,1,1,1,2.6,3.5,2.2
7102,673,0,Europe,Digital,Sales,Far Below,Male,43,16,0,6,14,3.4,2.6,3.0,0.0,1,1,1,1,2.3,3.3,1.9
7103,871,0,Europe,HR,Sales,Meets,Female,43,19,0,5,14,2.8,3.5,2.6,0.0383,1,1,1,1,3.5,4.3,2.8
7104,962,0,Europe,Finance,Communications,Meets,Male,29,6,0,7,11,4.9,4.0,1.6,0.0331,1,1,1,1,4.5,3.9,1.0
7105,256,0,Latin America,Commercial,Market Access,Meets,Female,40,13,0,7,20,2.6,2.4,2.7,0.0422,1,1,1,1,3.5,1.8,4.3
7106,722,0,Middle East & Africa,HR,Quality Assurance,Exceeds,Male,36,7,0,9,16,2.8,4.9,2.0,0.0677,1,1,1,1,1.8,5.0,2.1
7107,395,0,Latin America,Manufacturing,Market Access,Far Below,Female,46,7,0,6,17,2.8,3.0,1.5,0.0,0,0,0,0,4.5,2.5,1.3
7108,962,0,Latin America,Finance,Supply Chain,Meets,Male,39,6,1,6,22,0.0,3.1,3.3,0.0331,1,1,1,1,3.7,2.4,3.2
7109,487,0,North America,Manufacturing,IT & Digital,Meets,Male,36,27,1,6,16,0.0,3.0,1.9,0.0348,0,0,0,0,4.3,3.5,1.6
7110,870,0,North America,HR,Legal & Compliance,Meets,Male,36,10,0,5,12,2.7,1.9,3.3,0.0383,1,1,1,1,4.0,2.8,3.5
7111,353,0,North America,Commercial,Pharmacovigilance,Meets,Female,36,20,1,9,11,0.0,2.4,3.3,0.0422,1,1,1,1,4.5,4.0,4.2
7112,362,0,Asia Pacific,Manufacturing,IT & Digital,Below,Male,39,13,0,5,16,2.5,1.7,2.7,0.0,1,1,0,0,3.2,1.5,2.7
7113,631,0,North America,Digital,Human Resources,Meets,Female,40,3,0,10,17,4.1,1.8,5.0,0.0853,1,1,1,1,3.0,3.2,5.0
7114,968,0,Middle East & Africa,Finance,Finance & Accounting,Meets,Male,37,24,0,12,13,4.3,2.1,2.6,0.0331,1,1,1,1,3.0,1.5,3.1
7115,723,0,Latin America,HR,Communications,Meets,Female,36,12,0,6,19,2.1,2.7,2.4,0.0383,1,1,1,1,1.5,3.6,2.2
7116,279,0,Middle East & Africa,Commercial,Clinical Operations,Below,Female,32,13,0,6,12,2.9,2.3,1.5,0.0,1,1,1,1,3.3,1.1,3.3
7117,690,0,North America,Digital,Marketing,Far Exceeds,Male,47,17,0,12,23,4.0,2.6,4.1,0.2363,1,1,1,1,3.8,5.0,2.7
7118,775,0,Asia Pacific,HR,Marketing,Exceeds,Male,36,10,0,11,16,2.6,3.2,3.4,0.0677,1,1,1,1,2.9,2.9,3.6
7119,228,0,Asia Pacific,Commercial,Regulatory Affairs,Exceeds,Male,39,3,1,7,19,0.0,2.4,3.4,0.0743,1,1,1,1,3.8,3.1,3.4
7120,588,0,Latin America,Digital,Human Resources,Far Exceeds,Female,40,25,0,11,14,2.7,3.1,1.8,0.2363,0,0,0,0,2.8,3.3,2.1
7121,406,0,Middle East & Africa,Manufacturing,Quality Assurance,Below,Male,40,16,0,8,27,3.9,4.6,3.2,0.0,1,1,1,1,3.3,3.0,4.3
7122,845,0,Europe,HR,Marketing,Below,Female,35,14,0,8,12,3.6,2.6,2.5,0.0,1,1,1,1,3.6,3.1,2.5
7123,875,0,Middle East & Africa,HR,Human Resources,Far Below,Male,42,21,0,6,8,4.1,2.8,3.2,0.0,1,1,1,1,3.9,2.9,3.0
7124,503,0,North America,Manufacturing,Finance & Accounting,Exceeds,Male,47,2,0,10,25,3.6,3.4,2.7,0.0616,1,1,1,1,4.1,2.9,2.8
7125,104,0,Europe,R&D,Market Access,Meets,Female,42,18,1,8,26,0.0,4.0,2.7,0.0977,1,1,1,1,4.4,4.3,3.1
7126,609,0,Asia Pacific,Digital,Pharmacovigilance,Meets,Male,41,13,0,8,21,3.6,2.7,2.2,0.0853,1,1,1,1,3.7,1.6,1.8
7127,387,0,Latin America,Manufacturing,Market Access,Exceeds,Female,42,13,1,5,15,0.0,2.3,1.9,0.0616,1,1,1,1,3.3,4.0,3.0
7128,777,0,Latin America,HR,Sales,Meets,Female,38,8,0,10,23,5.0,3.8,2.1,0.0383,1,1,1,1,2.9,3.4,3.3
7129,596,0,Asia Pacific,Digital,Supply Chain,Below,Male,36,5,1,11,20,0.0,3.8,3.6,0.0,1,1,1,1,3.3,2.8,3.5
7130,608,0,North America,Digital,Marketing,Below,Female,49,11,0,8,20,3.3,2.5,4.3,0.0,1,1,1,1,3.6,4.0,3.8
7131,59,0,Asia Pacific,R&D,Human Resources,Below,Male,47,13,1,10,31,0.0,3.4,3.5,0.0,1,1,1,1,3.5,4.3,2.2
7132,863,0,North America,HR,Communications,Meets,Female,35,2,1,7,19,0.0,4.3,3.8,0.0383,1,1,1,1,4.0,2.7,3.9
7133,216,0,Europe,Commercial,Sales,Meets,Male,45,17,0,12,32,3.1,4.6,1.4,0.0422,1,1,1,1,2.6,4.1,1.0
7134,159,0,Asia Pacific,R&D,Marketing,Meets,Female,41,12,0,10,12,3.5,4.2,3.1,0.0977,1,0,0,0,3.8,3.3,3.8
7135,87,0,North America,R&D,Medical Affairs,Below,Male,39,12,0,5,15,3.2,3.5,1.7,0.0,1,1,1,1,1.9,4.2,1.9
7136,310,0,Europe,Commercial,Data Science,Meets,Female,47,9,1,11,16,0.0,2.7,2.5,0.0422,1,1,1,1,3.3,2.2,1.7
7137,342,0,Asia Pacific,Commercial,Finance & Accounting,Meets,Female,39,13,0,10,26,3.2,2.8,2.8,0.0422,1,1,1,1,4.6,2.3,3.5
7138,10,0,Latin America,R&D,Clinical Operations,Far Exceeds,Male,40,16,0,9,23,3.9,3.0,2.4,0.2644,1,1,1,1,3.4,2.9,2.5
7139,624,0,Asia Pacific,Digital,Clinical Operations,Meets,Male,41,25,0,10,24,4.0,3.2,4.1,0.0853,1,1,1,1,4.0,3.2,2.8
7140,518,0,Middle East & Africa,Manufacturing,Marketing,Far Exceeds,Female,31,28,0,7,12,3.2,3.8,1.3,0.1069,1,1,1,1,3.0,4.3,1.9
7141,482,0,Asia Pacific,Manufacturing,Legal & Compliance,Meets,Male,40,22,0,12,18,1.9,2.8,1.0,0.0348,1,1,1,1,2.7,1.7,3.1
7142,77,0,Middle East & Africa,R&D,Pharmacovigilance,Below,Female,30,10,0,12,24,3.7,2.8,1.5,0.0,1,0,0,0,3.4,1.9,1.0
7143,672,0,Europe,Digital,Quality Assurance,Meets,Female,42,3,1,6,20,0.0,3.8,2.4,0.0853,0,0,0,0,2.6,3.6,3.2
7144,234,0,Asia Pacific,Commercial,IT & Digital,Below,Female,41,12,0,10,32,2.8,1.9,3.3,0.0,1,1,1,1,3.5,3.4,4.0
7145,927,0,Europe,Finance,Regulatory Affairs,Meets,Female,45,9,0,9,12,2.5,3.5,2.9,0.0331,1,1,1,1,2.1,3.8,2.9
7146,120,0,Europe,R&D,Pharmacovigilance,Meets,Male,42,12,0,8,10,3.1,3.2,3.8,0.0977,1,1,1,1,3.3,4.4,4.1
7147,715,0,North America,HR,Quality Assurance,Meets,Female,53,8,0,6,7,3.1,3.0,1.0,0.0383,1,0,0,0,4.5,3.5,2.0
7148,578,0,Europe,Digital,Legal & Compliance,Exceeds,Male,30,10,0,11,17,3.3,2.3,3.4,0.1452,1,1,1,1,3.4,2.8,4.0
7149,736,0,Europe,HR,Legal & Compliance,Meets,Male,38,6,1,6,34,0.0,2.7,3.0,0.0383,1,1,1,1,3.3,3.3,4.0
7150,780,0,Asia Pacific,HR,IT & Digital,Far Exceeds,Male,44,6,0,8,24,3.3,3.6,2.6,0.1168,0,0,0,0,2.2,3.8,2.6
7151,154,0,Asia Pacific,R&D,Pharmacovigilance,Meets,Female,45,8,0,6,12,1.4,3.1,2.6,0.0977,1,0,0,0,3.5,1.6,3.0
7152,684,0,Latin America,Digital,Medical Affairs,Meets,Male,35,11,0,9,18,4.2,3.9,3.4,0.0853,0,0,0,0,4.0,3.3,2.8
7153,788,0,North America,HR,Pharmacovigilance,Meets,Female,45,6,0,6,15,2.4,3.9,3.6,0.0383,1,1,1,1,4.7,4.4,3.7
7154,645,0,Europe,Digital,Regulatory Affairs,Exceeds,Male,29,2,0,6,21,2.9,2.0,2.4,0.1452,1,1,1,1,1.9,2.8,2.1
7155,405,0,North America,Manufacturing,Finance & Accounting,Meets,Male,33,5,0,12,26,2.3,1.0,3.3,0.0348,1,1,0,0,2.8,1.0,3.9
7156,999,0,Middle East & Africa,Finance,Clinical Operations,Meets,Female,40,9,1,5,33,0.0,3.2,1.6,0.0331,1,1,1,1,4.3,4.1,2.2
7157,873,0,Europe,HR,Finance & Accounting,Meets,Male,40,12,0,12,21,3.6,2.8,4.1,0.0383,1,1,1,0,4.0,1.0,4.4
7158,849,0,North America,HR,Pharmacovigilance,Far Below,Male,46,10,0,9,12,3.1,2.9,3.0,0.0,1,1,1,1,2.8,2.2,3.2
7159,531,0,Latin America,Digital,Market Access,Below,Female,43,12,1,8,8,0.0,3.1,2.3,0.0,1,1,1,1,1.9,3.1,2.1
7160,953,0,Latin America,Finance,Quality Assurance,Meets,Male,35,9,1,11,25,0.0,2.3,4.2,0.0331,1,1,1,1,3.8,2.6,4.9
7161,521,0,Europe,Manufacturing,Supply Chain,Far Exceeds,Male,46,7,1,7,19,0.0,3.3,3.6,0.1069,1,1,1,1,3.1,3.0,3.1
7162,708,0,Middle East & Africa,HR,Legal & Compliance,Exceeds,Male,41,10,1,7,11,0.0,3.4,3.1,0.0677,1,1,1,1,4.5,2.7,3.4
7163,22,0,Latin America,R&D,Finance & Accounting,Meets,Female,43,9,1,10,19,0.0,2.6,1.7,0.0977,1,1,0,0,4.2,2.7,1.6
7164,669,0,Latin America,Digital,Quality Assurance,Meets,Female,43,11,0,10,13,2.0,3.4,1.6,0.0853,1,1,1,1,2.9,1.6,1.5
7165,642,0,Middle East & Africa,Digital,IT & Digital,Meets,Male,37,15,0,11,19,4.0,2.0,1.9,0.0853,1,1,1,1,3.8,1.4,3.6
7166,751,0,North America,HR,Clinical Operations,Far Below,Male,44,10,1,6,10,0.0,2.8,2.6,0.0,1,1,1,1,3.5,2.8,2.6
7167,398,0,Latin America,Manufacturing,Legal & Compliance,Meets,Male,40,28,0,9,23,3.9,2.8,2.7,0.0348,1,1,1,1,4.6,4.8,1.9
7168,774,0,Asia Pacific,HR,Pharmacovigilance,Meets,Male,43,6,0,11,22,3.7,4.4,3.9,0.0383,1,1,1,1,3.1,3.8,4.6
7169,250,0,Latin America,Commercial,IT & Digital,Meets,Female,47,10,0,6,14,1.3,3.3,1.0,0.0422,1,1,1,1,2.5,4.7,2.8
7170,739,0,North America,HR,Market Access,Meets,Male,37,20,0,8,15,3.4,4.1,2.2,0.0383,0,0,0,0,2.7,3.9,1.0
7171,906,0,North America,Finance,Human Resources,Exceeds,Female,44,16,0,6,13,2.5,3.1,3.3,0.0588,1,1,1,1,3.6,3.8,3.4
7172,1010,0,Europe,Finance,Pharmacovigilance,Meets,Female,36,17,1,6,9,0.0,2.5,2.5,0.0331,1,1,1,1,3.9,2.3,2.2
7173,284,0,Asia Pacific,Commercial,Communications,Meets,Female,35,2,1,5,10,0.0,3.0,3.2,0.0422,1,1,1,1,3.5,3.7,2.4
7174,886,0,North America,Finance,IT & Digital,Meets,Male,38,16,0,9,20,2.3,2.2,1.4,0.0331,1,1,1,1,2.9,3.7,2.6
7175,1013,0,Middle East & Africa,Finance,Human Resources,Meets,Female,38,9,1,9,20,0.0,2.9,2.8,0.0331,1,1,1,1,1.9,4.4,3.3
7176,153,1,Asia Pacific,R&D,Pharmacovigilance,Meets,Female,41,3,1,5,12,0.0,4.4,1.6,0.0977,1,0,0,0,3.6,3.5,3.9
7177,546,0,Asia Pacific,Digital,Finance & Accounting,Meets,Male,31,5,0,8,9,3.0,3.7,3.1,0.0853,1,1,1,1,3.2,1.8,3.0
7178,902,0,Middle East & Africa,Finance,Legal & Compliance,Meets,Female,41,4,1,11,25,0.0,3.7,2.7,0.0331,1,1,1,1,4.1,4.0,3.7
7179,591,1,Latin America,Digital,Marketing,Meets,Female,37,6,0,7,18,4.6,3.9,1.8,0.0853,1,1,1,1,5.0,5.0,1.9
7180,458,0,Middle East & Africa,Manufacturing,Medical Affairs,Meets,Male,28,13,1,11,23,0.0,3.0,1.8,0.0348,1,0,0,0,3.5,2.7,1.7
7181,732,0,Middle East & Africa,HR,Finance & Accounting,Below,Female,40,10,0,12,15,3.2,3.1,3.3,0.0,1,1,1,1,2.1,2.9,4.2
7182,37,0,Latin America,R&D,Regulatory Affairs,Meets,Male,46,5,0,6,24,2.5,3.0,2.6,0.0977,1,1,1,1,2.2,2.9,2.3
7183,233,0,Latin America,Commercial,Human Resources,Meets,Male,44,7,0,8,22,2.4,3.8,3.8,0.0422,1,1,1,1,2.9,2.6,3.1
7184,504,0,Latin America,Manufacturing,Medical Affairs,Meets,Female,38,19,0,7,18,4.3,2.9,2.6,0.0348,1,1,0,0,4.7,1.4,2.8
7185,99,0,Latin America,R&D,Supply Chain,Meets,Non-Binary/Other,35,20,0,6,18,2.8,2.1,2.9,0.0977,1,1,1,1,4.2,4.4,2.8
7186,153,0,Latin America,R&D,Clinical Operations,Meets,Female,43,19,0,8,27,3.0,2.6,3.2,0.0977,1,1,1,1,2.7,3.2,4.2
7187,302,0,Middle East & Africa,Commercial,Legal & Compliance,Meets,Male,35,21,0,10,26,3.7,5.0,4.1,0.0422,1,1,1,1,3.4,3.4,4.3
7188,288,0,Europe,Commercial,Pharmacovigilance,Exceeds,Female,38,12,0,11,15,4.2,4.0,3.2,0.0743,1,1,1,1,2.4,4.5,3.2
7189,615,0,Europe,Digital,Data Science,Exceeds,Female,53,3,0,12,24,3.1,2.6,3.1,0.1452,1,1,1,1,2.0,2.3,2.2
7190,849,0,North America,HR,Finance & Accounting,Meets,Female,47,8,0,11,18,2.6,1.3,2.4,0.0383,1,1,1,1,1.7,2.9,2.3
7191,495,0,Europe,Manufacturing,Finance & Accounting,Meets,Female,37,6,0,10,15,1.9,3.6,3.2,0.0348,1,1,1,1,2.5,3.6,3.3
7192,706,0,Europe,HR,Medical Affairs,Meets,Female,42,8,0,11,19,5.0,3.8,2.7,0.0383,1,1,1,1,4.4,3.6,3.6
7193,482,0,Middle East & Africa,Manufacturing,IT & Digital,Far Below,Male,48,14,0,11,13,4.0,4.4,3.8,0.0,1,1,1,1,4.6,2.8,3.2
7194,50,0,Latin America,R&D,Sales,Meets,Male,41,14,0,11,17,3.9,3.2,3.0,0.0977,1,1,1,1,4.5,3.2,2.4
7195,910,0,Latin America,Finance,IT & Digital,Meets,Male,31,15,1,7,19,0.0,2.9,2.8,0.0331,1,1,1,1,2.7,3.7,1.8
7196,903,0,Middle East & Africa,Finance,Finance & Accounting,Meets,Female,40,13,0,10,22,2.9,4.0,2.4,0.0331,1,1,1,1,2.7,4.4,2.6
7197,286,0,Europe,Commercial,Data Science,Below,Male,37,10,0,9,22,3.5,3.8,3.1,0.0,1,1,0,0,3.1,3.1,1.6
7198,206,1,Middle East & Africa,Commercial,Medical Affairs,Far Exceeds,Female,37,9,0,9,17,2.9,3.9,3.5,0.1275,1,1,1,1,3.3,3.7,2.6
7199,90,0,North America,R&D,Sales,Meets,Male,34,15,0,11,22,2.5,1.9,3.2,0.0977,1,1,1,1,2.8,2.2,3.1
7200,25,0,Latin America,R&D,IT & Digital,Meets,Non-Binary/Other,31,18,0,10,23,2.3,4.3,1.8,0.0977,0,0,0,0,3.0,3.1,3.6
7201,365,0,Asia Pacific,Manufacturing,Clinical Operations,Below,Male,35,6,0,9,14,3.3,3.3,2.6,0.0,1,1,1,1,3.7,2.9,2.1
7202,161,1,North America,R&D,Legal & Compliance,Meets,Male,43,5,1,11,22,0.0,3.0,3.8,0.0977,1,1,0,0,4.0,3.3,4.1
7203,481,0,North America,Manufacturing,Pharmacovigilance,Below,Male,44,13,0,10,34,2.9,2.6,1.8,0.0,1,1,1,1,2.7,3.9,2.6
7204,748,0,Middle East & Africa,HR,Market Access,Meets,Male,51,5,0,5,22,2.9,4.3,4.1,0.0383,1,1,1,1,4.5,4.2,4.0
7205,250,0,Europe,Commercial,Finance & Accounting,Meets,Female,35,12,0,7,17,3.6,1.9,3.2,0.0422,1,1,1,1,2.7,1.3,2.9
7206,201,0,Latin America,Commercial,Market Access,Exceeds,Female,33,24,0,7,16,2.1,1.4,2.4,0.0743,1,1,1,1,1.0,2.3,2.0
7207,910,0,Asia Pacific,Finance,Finance & Accounting,Meets,Female,43,4,1,11,13,0.0,1.8,3.4,0.0331,1,1,1,1,5.0,3.4,2.9
7208,1018,0,North America,Finance,Legal & Compliance,Meets,Female,29,20,0,12,15,2.3,4.2,2.1,0.0331,1,1,1,1,3.9,2.8,2.7
7209,290,0,Asia Pacific,Commercial,Medical Affairs,Below,Male,28,13,0,10,18,3.8,2.7,3.0,0.0,1,1,1,0,5.0,1.0,2.5
7210,773,0,Europe,HR,Finance & Accounting,Meets,Female,43,19,0,7,17,1.2,1.0,2.5,0.0383,1,1,1,1,3.5,2.5,2.3
7211,815,0,Europe,HR,Pharmacovigilance,Exceeds,Female,33,27,0,6,11,3.4,2.7,2.8,0.0677,1,1,1,1,5.0,4.0,2.6
7212,590,0,Asia Pacific,Digital,Medical Affairs,Meets,Female,34,16,0,8,15,3.0,4.2,2.4,0.0853,1,1,1,1,2.9,4.2,2.7
7213,514,1,Latin America,Manufacturing,Legal & Compliance,Meets,Male,42,8,0,6,12,4.1,2.0,1.1,0.0348,1,1,1,1,3.8,4.1,1.1
7214,954,0,Europe,Finance,Clinical Operations,Meets,Male,38,21,0,5,15,2.9,3.3,2.5,0.0331,1,1,1,1,2.8,3.6,2.8
7215,371,0,Asia Pacific,Manufacturing,IT & Digital,Meets,Male,36,5,0,6,10,3.7,2.2,2.9,0.0348,1,1,1,1,3.0,2.2,3.3
7216,951,0,North America,Finance,Sales,Below,Male,30,16,0,7,19,3.3,5.0,3.0,0.0,1,1,1,1,2.9,3.7,2.5
7217,673,0,Asia Pacific,Digital,Finance & Accounting,Meets,Male,35,10,0,8,16,2.6,2.5,4.2,0.0853,1,1,1,1,2.2,2.7,4.2
7218,226,0,Asia Pacific,Commercial,Pharmacovigilance,Below,Male,35,7,1,7,13,0.0,1.8,4.8,0.0,1,1,1,1,2.9,3.0,2.5
7219,395,0,Middle East & Africa,Manufacturing,Data Science,Meets,Male,36,7,1,10,16,0.0,3.2,2.1,0.0348,0,0,0,0,5.0,2.3,1.9
7220,894,0,Europe,Finance,Sales,Below,Male,42,8,0,9,19,4.3,2.7,2.4,0.0,1,1,1,1,2.8,2.4,2.2
7221,410,0,Latin America,Manufacturing,Data Science,Below,Female,40,9,0,11,20,3.7,2.4,3.1,0.0,1,1,1,1,4.6,3.9,1.9
7222,242,0,Latin America,Commercial,IT & Digital,Meets,Female,37,8,1,6,25,0.0,3.7,5.0,0.0422,1,1,1,0,3.0,1.7,4.1
7223,87,0,Middle East & Africa,R&D,Data Science,Exceeds,Male,39,13,0,8,15,3.3,3.0,4.8,0.1648,1,1,1,1,2.9,1.9,3.7
7224,1011,0,Latin America,Finance,Clinical Operations,Far Exceeds,Female,49,26,0,8,12,2.1,2.5,3.0,0.1022,1,1,1,1,2.5,1.0,2.7
7225,156,0,Asia Pacific,R&D,Regulatory Affairs,Exceeds,Female,40,10,0,10,12,2.7,2.4,1.8,0.1648,1,1,1,1,1.6,1.0,1.0
7226,620,0,Middle East & Africa,Digital,Regulatory Affairs,Meets,Male,47,15,0,8,14,3.3,2.2,1.3,0.0853,0,0,0,0,4.6,4.1,2.7
7227,823,0,North America,HR,Pharmacovigilance,Meets,Male,35,8,1,5,31,0.0,3.0,1.3,0.0383,1,1,1,1,2.6,2.4,2.5
7228,396,0,Europe,Manufacturing,Supply Chain,Exceeds,Male,37,9,1,10,14,0.0,2.9,3.4,0.0616,1,1,1,1,2.3,3.6,3.6
7229,986,0,Europe,Finance,Quality Assurance,Exceeds,Female,36,18,0,12,29,4.5,2.6,3.1,0.0588,1,1,0,0,4.2,3.9,4.1
7230,518,0,Europe,Manufacturing,Regulatory Affairs,Meets,Male,40,9,0,6,11,2.6,2.9,3.6,0.0348,1,1,1,1,3.7,4.2,1.8
7231,694,1,Asia Pacific,Digital,Pharmacovigilance,Meets,Female,41,10,0,5,13,4.3,2.1,3.8,0.0853,1,1,1,1,4.4,2.6,2.2
7232,569,0,North America,Digital,Finance & Accounting,Meets,Female,41,28,0,12,31,2.5,3.3,3.5,0.0853,1,0,0,0,3.4,3.8,3.8
7233,481,0,Middle East & Africa,Manufacturing,Data Science,Exceeds,Female,28,5,0,6,29,1.7,2.2,3.3,0.0616,1,1,1,1,1.6,2.8,5.0
7234,946,0,Middle East & Africa,Finance,Market Access,Meets,Male,33,6,1,10,21,0.0,5.0,3.5,0.0331,1,1,1,1,3.4,4.0,3.1
7235,338,0,Europe,Commercial,Finance & Accounting,Meets,Male,40,5,1,8,12,0.0,2.9,1.6,0.0422,1,1,1,1,1.6,2.5,4.6
7236,203,0,North America,Commercial,Regulatory Affairs,Far Exceeds,Male,49,8,0,5,24,3.4,2.8,3.9,0.1275,1,1,1,1,3.5,3.5,3.0
7237,714,0,North America,HR,IT & Digital,Meets,Male,35,12,0,5,16,2.7,3.8,2.7,0.0383,1,1,1,1,3.2,4.8,2.6
7238,412,0,North America,Manufacturing,Clinical Operations,Meets,Female,51,27,0,6,18,4.5,3.6,3.6,0.0348,1,1,1,1,3.5,3.5,2.2
7239,387,0,Latin America,Manufacturing,Pharmacovigilance,Meets,Female,30,7,0,9,13,4.1,1.6,3.1,0.0348,1,1,1,1,5.0,3.9,3.4
7240,909,0,Latin America,Finance,Quality Assurance,Below,Female,39,12,0,5,20,3.8,3.9,3.9,0.0,1,1,1,1,3.4,5.0,4.8
7241,408,0,Europe,Manufacturing,Finance & Accounting,Meets,Male,37,12,0,6,12,3.4,2.2,3.8,0.0348,1,1,1,1,3.8,2.9,4.1
7242,923,1,North America,Finance,Communications,Meets,Male,35,16,0,6,9,3.7,2.7,3.3,0.0331,1,1,1,1,5.0,3.8,4.4
7243,471,0,North America,Manufacturing,IT & Digital,Meets,Female,43,1,1,10,33,0.0,2.5,3.6,0.0348,1,1,0,0,3.2,2.7,1.7
7244,649,1,Middle East & Africa,Digital,Human Resources,Meets,Female,38,12,0,12,16,2.3,2.9,4.7,0.0853,1,1,1,1,4.0,3.6,3.7
7245,44,0,Middle East & Africa,R&D,Medical Affairs,Far Below,Male,29,10,1,6,10,0.0,4.1,3.2,0.0,1,1,1,1,3.4,2.8,2.7
7246,393,0,Europe,Manufacturing,Supply Chain,Far Exceeds,Female,28,12,0,12,26,3.4,2.2,1.2,0.1069,1,1,1,1,3.6,3.2,1.0
7247,103,1,North America,R&D,IT & Digital,Exceeds,Male,32,8,0,5,17,3.4,2.5,3.5,0.1648,1,1,1,1,4.7,2.9,3.8
7248,225,0,Europe,Commercial,Legal & Compliance,Meets,Male,42,28,0,5,30,4.7,3.0,2.3,0.0422,0,0,0,0,3.5,2.2,2.8
7249,778,0,Middle East & Africa,HR,Data Science,Exceeds,Female,37,5,1,6,7,0.0,3.5,3.8,0.0677,1,1,1,1,4.4,4.0,3.0
7250,233,0,Middle East & Africa,Commercial,Data Science,Meets,Female,44,7,1,9,12,0.0,3.4,3.1,0.0422,1,1,1,1,3.3,3.6,3.3
7251,415,0,Latin America,Manufacturing,Medical Affairs,Meets,Male,37,3,0,12,15,3.1,3.0,2.2,0.0348,1,1,1,1,3.9,1.2,1.6
7252,1018,0,Europe,Finance,Regulatory Affairs,Meets,Female,40,17,0,8,16,3.4,2.3,3.4,0.0331,1,1,1,1,3.2,2.9,4.5
7253,241,0,Europe,Commercial,Legal & Compliance,Meets,Female,47,13,0,11,28,1.7,3.2,4.2,0.0422,1,1,1,1,2.1,4.2,3.8
7254,688,0,North America,Digital,Market Access,Below,Female,37,9,0,5,19,3.0,5.0,2.5,0.0,1,1,1,1,2.4,3.1,2.4
7255,59,0,North America,R&D,Medical Affairs,Meets,Female,50,14,0,5,11,2.7,2.4,1.4,0.0977,1,1,1,1,3.0,2.8,3.4
7256,1013,0,Latin America,Finance,Market Access,Exceeds,Male,42,13,0,10,19,2.6,4.2,3.2,0.0588,1,1,1,1,2.7,2.2,1.3
7257,941,0,Asia Pacific,Finance,Data Science,Far Below,Male,32,30,0,5,7,2.2,3.3,2.7,0.0,1,1,1,1,2.2,2.6,3.1
7258,480,0,Asia Pacific,Manufacturing,Quality Assurance,Below,Female,31,20,0,10,16,3.1,3.5,2.1,0.0,1,1,1,1,4.4,3.9,2.2
7259,675,0,Asia Pacific,Digital,Human Resources,Meets,Female,29,9,0,6,12,5.0,2.8,1.5,0.0853,1,1,1,1,4.9,4.3,2.4
7260,87,1,Europe,R&D,Regulatory Affairs,Meets,Male,38,16,0,7,10,2.1,1.4,1.5,0.0977,1,1,1,1,4.3,1.7,1.2
7261,552,0,Europe,Digital,Human Resources,Below,Female,28,9,0,6,12,2.6,3.8,3.3,0.0,1,1,1,1,2.4,3.1,4.0
7262,281,0,Middle East & Africa,Commercial,Pharmacovigilance,Meets,Female,49,3,1,5,9,0.0,1.7,2.5,0.0422,1,1,1,1,4.4,2.5,1.8
7263,453,0,Europe,Manufacturing,Data Science,Meets,Female,51,5,0,8,16,4.3,3.3,1.4,0.0348,1,1,1,0,3.4,3.3,2.3
7264,1015,0,Europe,Finance,Medical Affairs,Below,Female,28,8,0,8,31,1.8,2.1,4.7,0.0,1,1,1,1,2.2,2.7,3.4
7265,1033,0,Europe,Finance,Finance & Accounting,Exceeds,Female,40,18,0,8,19,2.9,4.3,2.9,0.0588,1,1,1,1,3.4,3.8,2.9
7266,349,0,Latin America,Commercial,Market Access,Meets,Male,28,16,0,6,10,3.6,2.5,3.2,0.0422,1,1,1,1,4.0,2.2,1.5
7267,1008,0,Europe,Finance,Legal & Compliance,Meets,Male,42,8,0,10,19,3.6,3.3,3.1,0.0331,0,0,0,0,3.0,2.8,3.7
7268,785,0,North America,HR,Communications,Meets,Male,44,22,0,8,19,3.0,1.5,2.8,0.0383,1,1,1,1,3.1,3.1,3.4
7269,440,0,North America,Manufacturing,Market Access,Meets,Female,38,11,0,7,41,4.2,1.8,1.0,0.0348,1,1,1,1,3.0,3.4,1.0
7270,201,0,Middle East & Africa,Commercial,Communications,Meets,Female,40,2,1,8,11,0.0,2.3,2.6,0.0422,1,0,0,0,3.9,2.6,3.4
7271,421,0,Latin America,Manufacturing,Communications,Below,Male,34,11,1,11,30,0.0,3.3,3.8,0.0,1,1,1,1,2.0,3.5,4.3
7272,7,1,North America,R&D,Data Science,Exceeds,Male,38,12,1,11,16,0.0,3.8,2.5,0.1648,1,1,1,1,3.7,4.1,3.6
7273,470,0,Latin America,Manufacturing,Data Science,Meets,Male,42,24,0,9,23,4.3,2.8,1.6,0.0348,1,1,1,1,4.5,3.5,2.1
7274,392,0,Latin America,Manufacturing,Quality Assurance,Exceeds,Female,37,15,0,12,17,5.0,1.8,2.5,0.0616,0,0,0,0,3.7,3.1,2.8
7275,141,0,Middle East & Africa,R&D,Quality Assurance,Below,Male,45,14,0,8,20,2.8,2.6,4.3,0.0,1,1,1,1,2.9,1.6,3.6
7276,285,0,Latin America,Commercial,Finance & Accounting,Below,Male,34,3,1,6,16,0.0,3.3,2.9,0.0,0,0,0,0,3.9,1.9,2.4
7277,469,0,Europe,Manufacturing,Finance & Accounting,Meets,Female,36,24,0,9,11,3.5,3.9,1.0,0.0348,1,1,1,1,4.0,3.9,2.8
7278,586,0,Latin America,Digital,Marketing,Below,Male,28,14,0,12,14,3.5,3.7,1.7,0.0,1,1,1,1,2.4,2.2,1.7
7279,377,0,Middle East & Africa,Manufacturing,Medical Affairs,Below,Male,52,8,0,6,12,5.0,3.0,1.0,0.0,0,0,0,0,3.1,5.0,2.1
7280,184,0,Middle East & Africa,Commercial,Clinical Operations,Below,Female,28,10,1,6,47,0.0,4.1,2.4,0.0,1,1,1,1,3.7,4.0,3.2
7281,1043,0,Middle East & Africa,Finance,Medical Affairs,Meets,Female,45,13,0,8,15,2.4,4.3,4.9,0.0331,1,1,1,1,5.0,4.4,3.6
7282,162,0,North America,R&D,Quality Assurance,Far Below,Male,41,8,0,6,12,3.5,3.7,2.7,0.0,0,0,0,0,4.1,3.5,3.3
7283,941,0,Europe,Finance,Marketing,Below,Female,38,20,0,6,13,4.1,1.3,1.7,0.0,1,1,1,1,4.6,1.2,2.6
7284,250,0,North America,Commercial,Regulatory Affairs,Exceeds,Female,33,13,0,7,12,2.8,1.0,3.6,0.0743,1,1,1,1,2.7,3.5,2.4
7285,820,0,Asia Pacific,HR,Data Science,Below,Female,35,11,1,11,14,0.0,2.4,1.3,0.0,1,1,1,1,3.8,3.7,1.8
7286,951,0,Europe,Finance,IT & Digital,Meets,Female,36,24,0,7,17,2.2,1.8,3.0,0.0331,1,1,1,1,3.0,2.2,3.0
7287,478,0,Latin America,Manufacturing,Supply Chain,Meets,Female,35,19,0,11,16,3.1,4.8,1.4,0.0348,1,1,1,1,5.0,5.0,3.9
7288,359,0,Middle East & Africa,Manufacturing,Human Resources,Far Exceeds,Female,28,15,0,6,24,4.7,3.3,4.1,0.1069,1,1,1,1,4.2,2.4,3.2
7289,36,0,Asia Pacific,R&D,Human Resources,Exceeds,Male,41,14,0,8,16,3.7,2.4,2.5,0.1648,1,0,0,0,4.1,4.9,3.7
7290,456,0,Europe,Manufacturing,Medical Affairs,Meets,Female,42,4,1,12,25,0.0,3.6,2.0,0.0348,1,1,1,1,3.8,4.0,1.9
7291,555,0,North America,Digital,Medical Affairs,Exceeds,Male,36,5,0,10,18,3.4,1.6,2.4,0.1452,0,0,0,0,3.1,3.8,3.1
7292,604,0,Middle East & Africa,Digital,Communications,Meets,Female,38,5,0,7,19,3.1,4.2,2.6,0.0853,1,1,1,1,4.1,4.1,2.2
7293,936,0,North America,Finance,Communications,Meets,Non-Binary/Other,41,8,0,8,18,4.2,4.3,1.9,0.0331,0,0,0,0,3.2,2.8,2.5
7294,183,0,Europe,Commercial,Sales,Meets,Male,30,12,0,10,21,4.9,2.6,1.0,0.0422,1,1,0,0,4.4,3.1,1.9
7295,143,0,Europe,R&D,Quality Assurance,Meets,Male,28,7,1,7,29,0.0,3.0,3.0,0.0977,1,1,1,1,4.3,2.9,1.3
7296,808,0,Asia Pacific,HR,Legal & Compliance,Meets,Male,38,12,0,12,15,3.1,2.6,3.3,0.0383,1,1,1,1,2.4,3.0,2.8
7297,1020,0,Latin America,Finance,Legal & Compliance,Meets,Male,36,27,0,8,15,4.8,3.4,3.8,0.0331,1,1,1,1,5.0,3.7,1.7
7298,230,0,North America,Commercial,Supply Chain,Meets,Female,35,6,0,7,29,4.0,2.7,4.7,0.0422,1,1,1,1,4.9,2.5,5.0
7299,73,0,Asia Pacific,R&D,Pharmacovigilance,Below,Female,42,10,0,9,22,2.5,3.2,3.9,0.0,1,1,1,1,3.0,3.1,3.6
7300,50,0,Middle East & Africa,R&D,Communications,Meets,Female,36,20,0,7,43,3.4,3.3,3.3,0.0977,1,1,1,1,4.0,3.1,4.4
7301,890,0,Latin America,Finance,Sales,Meets,Female,41,4,1,10,17,0.0,1.9,4.1,0.0331,1,1,0,0,4.0,2.5,2.5
7302,260,0,Asia Pacific,Commercial,Clinical Operations,Below,Male,49,13,0,12,21,3.7,4.7,2.2,0.0,1,1,1,1,2.9,4.1,2.0
7303,278,0,North America,Commercial,Medical Affairs,Meets,Female,51,4,1,6,12,0.0,4.0,1.3,0.0422,1,1,1,1,4.2,4.3,1.5
7304,498,0,Europe,Manufacturing,Marketing,Meets,Female,43,7,0,5,14,2.9,3.0,3.2,0.0348,1,1,1,1,2.9,3.2,2.1
7305,759,1,Middle East & Africa,HR,Marketing,Exceeds,Male,28,16,0,12,16,3.4,2.2,1.3,0.0677,1,1,1,1,3.8,2.0,1.6
7306,630,0,North America,Digital,Pharmacovigilance,Below,Male,42,8,1,6,16,0.0,3.3,2.6,0.0,1,1,1,1,3.3,3.3,4.0
7307,439,0,Latin America,Manufacturing,Market Access,Meets,Male,47,6,0,12,50,3.0,4.3,2.3,0.0348,0,0,0,0,3.6,5.0,3.8
7308,121,0,Latin America,R&D,Finance & Accounting,Below,Male,40,7,1,9,27,0.0,1.4,2.8,0.0,1,1,0,0,3.7,1.4,2.6
7309,785,0,Europe,HR,Sales,Meets,Female,34,4,1,10,12,0.0,2.4,2.9,0.0383,1,1,1,1,3.0,3.7,3.3
7310,746,0,Europe,HR,Sales,Below,Male,36,3,1,12,42,0.0,3.1,2.8,0.0,1,1,1,1,4.3,2.3,2.1
7311,189,0,Middle East & Africa,Commercial,Marketing,Meets,Female,45,25,0,10,20,3.9,4.5,1.8,0.0422,1,1,1,1,2.8,4.3,3.5
7312,771,0,Middle East & Africa,HR,Human Resources,Meets,Female,35,19,0,9,10,2.7,3.1,1.7,0.0383,1,1,1,1,3.7,3.6,1.0
7313,920,1,Europe,Finance,Marketing,Meets,Male,32,20,0,10,23,2.9,2.9,2.4,0.0331,1,1,1,1,4.6,3.1,3.4
7314,765,0,Europe,HR,Data Science,Meets,Male,34,10,1,12,21,0.0,3.4,2.9,0.0383,0,0,0,0,3.4,2.5,3.7
7315,7,0,Latin America,R&D,Marketing,Meets,Female,38,27,0,5,14,3.8,4.1,2.9,0.0977,1,1,1,1,4.1,4.5,3.8
7316,955,0,Europe,Finance,Quality Assurance,Meets,Female,37,9,1,9,11,0.0,3.2,1.3,0.0331,1,1,1,1,3.4,3.7,1.3
7317,1039,0,Asia Pacific,Finance,IT & Digital,Meets,Male,28,23,0,7,13,4.1,2.4,2.7,0.0331,1,1,1,1,4.3,3.7,3.3
7318,490,0,North America,Manufacturing,Marketing,Meets,Female,35,9,0,12,17,4.1,3.9,2.2,0.0348,1,1,1,1,5.0,2.9,3.3
7319,814,0,Europe,HR,IT & Digital,Meets,Female,49,11,1,7,25,0.0,3.9,2.6,0.0383,1,1,1,1,2.1,3.6,2.4
7320,247,0,Middle East & Africa,Commercial,Human Resources,Meets,Male,39,2,0,10,25,2.9,4.6,3.3,0.0422,1,1,1,1,2.4,3.0,3.9
7321,500,0,Asia Pacific,Manufacturing,Sales,Meets,Female,42,4,1,9,21,0.0,3.4,3.0,0.0348,1,1,1,1,2.8,3.6,1.9
7322,205,0,Middle East & Africa,Commercial,Data Science,Exceeds,Male,29,9,0,11,24,3.2,2.8,2.6,0.0743,1,1,1,1,2.5,2.8,4.2
7323,833,0,Asia Pacific,HR,Clinical Operations,Meets,Male,42,6,0,9,31,3.7,2.6,2.5,0.0383,1,1,1,1,3.7,3.2,3.7
7324,495,0,Europe,Manufacturing,Sales,Below,Female,47,15,0,9,28,4.7,2.5,1.0,0.0,1,1,1,1,4.1,2.1,2.0
7325,840,1,North America,HR,Marketing,Exceeds,Male,40,4,1,10,13,0.0,2.0,3.1,0.0677,1,1,1,1,4.2,1.7,3.6
7326,77,0,Middle East & Africa,R&D,Legal & Compliance,Meets,Male,31,19,0,6,19,2.8,3.3,2.8,0.0977,0,0,0,0,1.7,3.0,3.2
7327,366,0,Asia Pacific,Manufacturing,Marketing,Meets,Male,42,12,0,8,15,2.1,5.0,1.4,0.0348,1,1,0,0,2.4,5.0,3.0
7328,304,0,Latin America,Commercial,Legal & Compliance,Exceeds,Male,43,18,0,7,9,3.5,5.0,3.4,0.0743,0,0,0,0,4.6,3.7,2.6
7329,103,0,Europe,R&D,Marketing,Meets,Male,34,11,1,6,10,0.0,1.9,2.7,0.0977,1,1,1,1,3.6,3.5,2.5
7330,567,0,North America,Digital,Data Science,Meets,Female,44,15,1,6,20,0.0,3.5,3.0,0.0853,1,1,1,1,3.2,3.8,2.6
7331,180,0,Europe,Commercial,Communications,Exceeds,Male,41,13,0,11,15,2.0,3.0,4.2,0.0743,1,1,1,1,3.2,2.9,3.7
7332,847,0,Latin America,HR,Medical Affairs,Meets,Male,28,14,0,7,9,3.3,2.8,3.4,0.0383,1,1,1,1,3.2,3.6,3.9
7333,317,0,North America,Commercial,Communications,Meets,Male,34,8,0,9,24,2.7,3.4,3.2,0.0422,1,1,1,1,2.6,4.1,3.9
7334,673,0,Latin America,Digital,Data Science,Meets,Male,36,14,0,6,9,4.6,4.7,1.9,0.0853,1,1,1,1,4.0,3.5,3.7
7335,307,0,Europe,Commercial,Regulatory Affairs,Far Below,Male,38,18,0,11,18,2.8,3.8,2.3,0.0,0,0,0,0,3.6,3.0,2.6
7336,77,1,Asia Pacific,R&D,Quality Assurance,Meets,Female,38,20,0,7,10,2.6,3.8,2.2,0.0977,1,1,1,1,3.9,3.4,2.5
7337,1041,0,Europe,Finance,Supply Chain,Exceeds,Female,43,7,0,9,24,3.3,1.9,3.2,0.0588,1,1,1,1,3.9,3.1,3.0
7338,264,0,Europe,Commercial,Human Resources,Below,Non-Binary/Other,43,8,0,12,17,2.9,3.5,3.5,0.0,0,0,0,0,2.6,2.3,3.7
7339,460,0,Europe,Manufacturing,Quality Assurance,Meets,Male,48,3,0,6,20,2.5,3.1,2.4,0.0348,0,0,0,0,3.2,4.2,2.6
7340,651,0,Middle East & Africa,Digital,Finance & Accounting,Meets,Female,40,18,0,11,25,3.9,4.3,2.1,0.0853,1,1,1,1,4.2,2.5,3.4
7341,197,0,Latin America,Commercial,Marketing,Meets,Female,47,6,0,11,12,3.9,2.0,3.0,0.0422,0,0,0,0,3.6,1.8,3.0
7342,539,1,Latin America,Digital,Human Resources,Meets,Female,44,17,0,10,17,3.9,1.8,2.1,0.0853,1,1,1,1,3.5,3.0,3.6
7343,929,0,Latin America,Finance,Communications,Far Exceeds,Male,45,12,1,9,23,0.0,3.8,2.2,0.1022,1,1,1,1,4.5,4.0,2.1
7344,27,0,Middle East & Africa,R&D,IT & Digital,Meets,Male,48,13,0,10,30,4.8,4.0,3.9,0.0977,1,1,1,1,3.4,4.3,3.4
7345,377,0,Asia Pacific,Manufacturing,Communications,Meets,Female,36,9,0,9,11,2.2,3.5,1.6,0.0348,1,1,1,1,3.9,3.5,2.8
7346,704,0,Europe,HR,Legal & Compliance,Meets,Female,38,21,0,8,12,3.0,4.9,2.7,0.0383,1,1,0,0,3.2,4.4,2.5
7347,236,0,Asia Pacific,Commercial,Supply Chain,Meets,Female,28,9,0,10,19,2.9,2.3,4.4,0.0422,1,1,1,1,2.5,3.2,4.3
7348,132,0,Middle East & Africa,R&D,Clinical Operations,Below,Male,45,36,0,9,31,3.4,2.8,1.0,0.0,0,0,0,0,3.2,3.3,1.6
7349,523,0,Latin America,Digital,Market Access,Meets,Male,44,8,0,5,22,1.6,1.4,2.2,0.0853,0,0,0,0,1.7,2.6,3.1
7350,888,0,Europe,Finance,Sales,Far Exceeds,Non-Binary/Other,39,17,0,6,20,3.5,2.6,2.9,0.1022,1,1,1,1,1.9,4.3,1.9
7351,637,0,North America,Digital,Medical Affairs,Meets,Male,43,5,0,7,25,3.1,2.5,4.6,0.0853,1,1,1,1,2.1,4.6,3.1
7352,993,0,North America,Finance,Market Access,Meets,Female,44,11,0,12,14,3.9,3.4,1.6,0.0331,0,0,0,0,2.9,4.7,3.5
7353,1031,0,Asia Pacific,Finance,Data Science,Far Exceeds,Male,38,18,0,6,40,5.0,3.7,2.5,0.1022,1,1,1,1,5.0,3.7,3.4
7354,50,0,Latin America,R&D,Regulatory Affairs,Meets,Female,41,14,0,8,19,3.3,2.8,2.0,0.0977,0,0,0,0,3.7,3.9,2.0
7355,322,0,North America,Commercial,Legal & Compliance,Meets,Male,38,17,0,11,23,3.0,4.2,4.6,0.0422,1,1,1,1,2.7,3.4,3.8
7356,790,0,Asia Pacific,HR,Legal & Compliance,Far Exceeds,Male,37,19,0,8,15,3.3,3.1,2.4,0.1168,0,0,0,0,4.8,5.0,3.2
7357,321,0,Middle East & Africa,Commercial,Pharmacovigilance,Below,Male,34,12,0,5,17,3.4,5.0,2.0,0.0,1,1,1,1,2.5,3.8,1.0
7358,405,0,Asia Pacific,Manufacturing,Quality Assurance,Meets,Female,30,9,1,8,14,0.0,2.9,2.7,0.0348,1,1,1,1,3.8,3.1,2.6
7359,260,0,Asia Pacific,Commercial,Market Access,Meets,Male,30,13,1,7,27,0.0,4.0,3.3,0.0422,1,1,1,1,3.2,4.8,1.7
7360,914,0,Asia Pacific,Finance,Communications,Meets,Female,38,16,1,6,13,0.0,1.5,4.2,0.0331,1,1,1,1,3.7,2.0,4.2
7361,1048,0,Europe,Finance,Regulatory Affairs,Meets,Female,31,20,0,12,21,4.1,4.7,1.7,0.0331,1,1,1,1,3.7,3.7,3.7
7362,442,0,Asia Pacific,Manufacturing,Marketing,Far Below,Female,32,10,0,5,15,3.2,2.8,3.7,0.0,1,1,1,1,3.2,3.1,3.3
7363,560,0,Asia Pacific,Digital,Data Science,Meets,Male,33,12,1,10,14,0.0,4.8,3.0,0.0853,1,1,1,1,2.5,4.1,3.2
7364,930,0,Europe,Finance,Data Science,Below,Male,36,5,1,7,22,0.0,2.8,3.3,0.0,1,1,1,1,4.5,4.3,2.6
7365,481,0,Europe,Manufacturing,Sales,Below,Female,45,12,0,12,24,4.0,2.7,1.5,0.0,1,1,1,1,3.0,3.6,2.0
7366,909,0,Middle East & Africa,Finance,Supply Chain,Meets,Female,28,12,1,11,19,0.0,3.6,2.0,0.0331,1,1,1,1,3.7,3.1,3.9
7367,728,0,Latin America,HR,Supply Chain,Exceeds,Female,38,15,0,6,19,4.9,3.3,1.9,0.0677,1,1,1,1,3.9,3.5,2.5
7368,970,0,North America,Finance,Human Resources,Meets,Male,32,13,1,11,21,0.0,1.6,2.1,0.0331,1,1,1,1,4.5,2.7,2.6
7369,105,0,North America,R&D,Market Access,Meets,Female,38,6,0,11,23,5.0,1.1,3.6,0.0977,1,1,1,1,3.2,1.4,4.0
7370,408,0,Asia Pacific,Manufacturing,Clinical Operations,Meets,Female,34,9,0,9,15,3.3,3.9,3.2,0.0348,1,1,1,1,3.7,2.8,2.4
7371,296,0,Middle East & Africa,Commercial,Human Resources,Meets,Female,37,31,0,10,15,3.8,3.5,2.2,0.0422,1,1,1,1,2.9,4.3,2.4
7372,376,0,Asia Pacific,Manufacturing,Supply Chain,Exceeds,Female,29,28,0,9,16,3.2,3.7,1.0,0.0616,1,1,1,1,2.5,3.1,2.6
7373,629,0,North America,Digital,Supply Chain,Exceeds,Female,40,11,1,10,19,0.0,3.9,2.3,0.1452,1,1,1,1,1.9,3.9,3.7
7374,1038,0,Europe,Finance,Marketing,Meets,Male,38,6,1,8,11,0.0,2.4,1.7,0.0331,1,1,1,1,4.8,2.5,3.0
7375,419,0,Latin America,Manufacturing,Marketing,Far Exceeds,Female,39,7,0,11,17,3.0,2.6,4.3,0.1069,1,1,0,0,3.2,1.7,5.0
7376,838,0,Middle East & Africa,HR,Finance & Accounting,Meets,Female,44,8,0,6,19,4.0,1.8,1.8,0.0383,1,1,1,1,4.6,1.0,3.2
7377,521,0,Europe,Manufacturing,Finance & Accounting,Meets,Female,30,7,0,8,16,3.0,2.8,3.4,0.0348,1,1,1,1,3.4,3.0,2.8
7378,862,0,Latin America,HR,Regulatory Affairs,Meets,Female,31,10,1,9,16,0.0,3.9,3.7,0.0383,1,1,1,1,2.9,3.8,2.5
7379,888,0,Middle East & Africa,Finance,Data Science,Meets,Male,48,6,0,5,6,3.1,2.7,2.9,0.0331,1,1,1,1,3.4,3.9,4.2
7380,337,0,Middle East & Africa,Commercial,Data Science,Meets,Female,41,10,0,12,15,4.0,3.1,1.9,0.0422,1,1,1,1,3.4,2.8,1.6
7381,944,0,North America,Finance,Finance & Accounting,Meets,Female,28,5,1,12,20,0.0,3.6,2.1,0.0331,0,0,0,0,4.6,4.8,3.8
7382,630,0,Europe,Digital,Data Science,Meets,Male,37,24,0,6,21,3.6,2.2,4.1,0.0853,1,1,0,0,4.1,1.9,2.5
7383,110,0,Middle East & Africa,R&D,Regulatory Affairs,Far Exceeds,Female,44,17,0,8,10,2.4,2.6,3.5,0.2644,1,1,1,1,3.0,3.8,4.3
7384,318,0,Middle East & Africa,Commercial,Pharmacovigilance,Exceeds,Non-Binary/Other,50,5,0,12,22,2.5,3.9,4.9,0.0743,0,0,0,0,3.0,4.0,4.5
7385,349,0,Latin America,Commercial,Marketing,Meets,Male,47,14,0,7,13,4.3,1.7,1.7,0.0422,1,1,1,0,4.9,1.9,2.3
7386,15,0,North America,R&D,Regulatory Affairs,Far Below,Male,35,13,1,8,15,0.0,3.1,3.2,0.0,1,1,1,1,2.3,2.9,3.9
7387,447,0,Asia Pacific,Manufacturing,Data Science,Meets,Male,37,6,1,5,24,0.0,3.7,3.3,0.0348,1,1,1,1,5.0,3.9,2.8
7388,945,0,North America,Finance,Market Access,Meets,Male,28,9,0,11,12,3.0,3.5,2.8,0.0331,1,1,1,1,3.4,3.9,4.1
7389,377,0,Asia Pacific,Manufacturing,Marketing,Exceeds,Male,39,11,1,9,28,0.0,3.6,3.4,0.0616,1,1,1,1,4.9,4.6,2.5
7390,376,0,Europe,Manufacturing,Medical Affairs,Exceeds,Female,39,12,0,9,18,4.1,2.7,3.2,0.0616,1,1,1,1,5.0,4.2,3.0
7391,886,0,Europe,Finance,Supply Chain,Exceeds,Male,43,13,0,7,10,5.0,2.3,3.2,0.0588,0,0,0,0,4.3,4.0,3.8
7392,563,0,Middle East & Africa,Digital,Marketing,Meets,Female,28,9,1,5,15,0.0,3.6,2.1,0.0853,1,1,1,1,2.7,2.9,2.7
7393,242,1,Europe,Commercial,Communications,Exceeds,Male,32,7,0,11,17,5.0,3.5,1.6,0.0743,1,1,1,1,4.5,2.6,3.4
7394,763,0,Middle East & Africa,HR,Marketing,Far Below,Female,37,11,0,5,7,3.1,3.7,1.0,0.0,1,1,1,1,2.1,2.8,2.5
7395,140,0,North America,R&D,IT & Digital,Meets,Male,43,7,1,12,24,0.0,1.9,1.6,0.0977,1,1,1,1,3.3,2.5,2.4
7396,352,0,Europe,Commercial,Data Science,Below,Female,36,17,0,10,17,5.0,2.0,5.0,0.0,1,1,1,1,4.6,2.0,4.7
7397,455,0,North America,Manufacturing,Human Resources,Exceeds,Male,52,10,1,10,22,0.0,2.6,2.2,0.0616,1,1,1,1,3.8,2.2,1.9
7398,170,0,North America,R&D,Quality Assurance,Exceeds,Male,32,5,0,12,25,3.3,2.8,4.1,0.1648,1,1,1,1,3.5,2.2,1.8
7399,863,0,Europe,HR,Pharmacovigilance,Meets,Male,35,19,0,6,13,3.9,3.4,2.6,0.0383,1,1,1,1,4.9,4.2,3.4
7400,215,0,North America,Commercial,Marketing,Meets,Female,31,6,0,6,22,3.5,2.2,2.3,0.0422,1,1,1,1,2.3,3.2,2.6
7401,226,0,Europe,Commercial,Regulatory Affairs,Far Exceeds,Male,37,4,0,6,16,3.8,3.0,3.8,0.1275,0,0,0,0,3.8,3.1,2.9
7402,561,1,Europe,Digital,Clinical Operations,Meets,Female,41,24,0,8,15,3.1,3.8,2.6,0.0853,1,1,1,1,4.7,2.4,2.7
7403,245,0,Europe,Commercial,Data Science,Meets,Male,39,13,0,9,11,3.2,3.0,2.4,0.0422,1,1,1,1,4.3,4.1,2.7
7404,303,0,Asia Pacific,Commercial,Data Science,Meets,Male,33,24,0,5,20,3.5,4.0,2.7,0.0422,1,1,1,1,5.0,2.5,2.1
7405,825,0,North America,HR,Quality Assurance,Meets,Male,45,11,0,9,23,2.8,3.0,2.2,0.0383,1,1,1,1,3.6,3.8,3.2
7406,855,0,Latin America,HR,Sales,Far Exceeds,Female,46,15,0,10,20,4.8,3.7,4.1,0.1168,1,1,1,1,3.8,3.1,1.9
7407,83,0,Europe,R&D,Clinical Operations,Meets,Male,34,6,1,8,31,0.0,5.0,2.1,0.0977,1,1,1,1,4.0,2.9,1.4
7408,471,0,North America,Manufacturing,Human Resources,Below,Male,55,10,1,8,24,0.0,4.4,3.2,0.0,0,0,0,0,2.8,3.5,3.3
7409,835,0,Middle East & Africa,HR,Medical Affairs,Below,Female,31,8,0,12,26,4.2,1.4,4.3,0.0,1,1,1,1,3.7,1.5,3.6
7410,151,0,Europe,R&D,Supply Chain,Far Below,Male,38,23,0,10,20,3.7,4.0,3.3,0.0,1,1,1,1,3.4,3.5,3.8
7411,238,0,Europe,Commercial,Sales,Meets,Female,38,33,0,11,14,2.3,4.1,3.0,0.0422,1,1,1,1,2.9,4.7,2.5
7412,130,0,Latin America,R&D,Market Access,Exceeds,Male,31,13,0,7,23,4.2,4.1,1.9,0.1648,1,1,1,1,3.2,3.1,1.1
7413,15,0,Asia Pacific,R&D,Communications,Meets,Female,39,11,0,10,27,3.6,1.9,2.1,0.0977,1,1,1,1,4.0,2.0,2.8
7414,21,0,Asia Pacific,R&D,Finance & Accounting,Far Exceeds,Non-Binary/Other,37,12,1,6,14,0.0,3.5,3.7,0.2644,1,1,1,1,2.9,3.7,3.7
7415,930,0,Europe,Finance,Marketing,Exceeds,Male,41,14,1,11,21,0.0,2.5,1.1,0.0588,0,0,0,0,3.9,1.0,2.7
7416,110,1,North America,R&D,Legal & Compliance,Meets,Male,38,10,1,8,15,0.0,2.9,4.7,0.0977,1,1,1,1,3.8,3.9,5.0
7417,769,0,Middle East & Africa,HR,Market Access,Meets,Female,43,36,0,8,11,2.4,3.6,2.5,0.0383,1,1,1,1,3.4,3.8,3.5
7418,958,0,Middle East & Africa,Finance,Medical Affairs,Meets,Female,42,8,0,7,11,2.1,2.1,4.7,0.0331,1,1,1,1,4.3,3.3,4.0
7419,408,0,North America,Manufacturing,Regulatory Affairs,Below,Female,32,5,0,7,18,3.4,3.5,2.0,0.0,1,1,1,1,3.6,2.7,3.0
7420,54,0,Europe,R&D,Pharmacovigilance,Meets,Female,36,12,0,10,25,3.6,2.2,2.6,0.0977,1,1,1,1,4.9,1.8,3.0
7421,663,0,Middle East & Africa,Digital,Communications,Meets,Male,33,11,1,8,20,0.0,1.0,1.9,0.0853,1,1,1,1,3.2,3.7,3.2
7422,228,0,Asia Pacific,Commercial,Regulatory Affairs,Meets,Female,48,5,0,7,8,2.9,4.2,1.4,0.0422,1,1,0,0,4.3,4.2,1.3
7423,304,0,North America,Commercial,Regulatory Affairs,Meets,Female,44,8,0,5,22,4.3,2.7,3.6,0.0422,1,1,1,1,4.9,2.4,2.7
7424,1003,0,Latin America,Finance,Finance & Accounting,Meets,Female,40,5,0,9,21,4.3,3.0,2.6,0.0331,1,1,1,1,4.0,3.1,3.7
7425,326,0,Europe,Commercial,IT & Digital,Meets,Female,41,11,1,9,29,0.0,5.0,4.2,0.0422,1,1,1,1,3.5,2.7,2.4
7426,205,0,North America,Commercial,Regulatory Affairs,Meets,Female,37,13,0,8,19,4.1,3.8,3.1,0.0422,1,1,1,0,3.7,5.0,3.3
7427,932,0,Middle East & Africa,Finance,Clinical Operations,Below,Female,39,14,0,10,21,4.1,4.0,1.6,0.0,1,0,0,0,3.6,3.1,2.8
7428,294,0,Europe,Commercial,Finance & Accounting,Meets,Non-Binary/Other,34,5,0,5,14,2.4,3.1,2.6,0.0422,1,1,1,1,2.2,1.9,1.4
7429,152,0,Asia Pacific,R&D,IT & Digital,Meets,Male,34,6,0,8,28,3.4,2.2,1.7,0.0977,1,1,1,1,3.8,3.3,3.7
7430,391,0,Europe,Manufacturing,IT & Digital,Exceeds,Male,42,9,0,7,26,3.2,3.6,3.1,0.0616,1,1,1,1,2.2,4.2,3.6
7431,920,0,Europe,Finance,Data Science,Below,Male,32,10,0,7,9,3.6,4.2,1.9,0.0,1,1,1,1,4.5,4.7,2.7
7432,552,0,Asia Pacific,Digital,Marketing,Meets,Non-Binary/Other,34,9,0,6,40,1.6,3.7,2.4,0.0853,1,1,1,1,3.1,2.9,1.7
7433,896,0,Asia Pacific,Finance,Supply Chain,Meets,Female,37,14,0,10,19,3.4,4.7,2.8,0.0331,1,1,1,1,3.8,4.0,2.8
7434,826,0,Europe,HR,Clinical Operations,Below,Male,29,17,0,12,18,3.9,3.1,1.5,0.0,1,1,1,1,4.0,2.7,2.5
7435,569,0,Asia Pacific,Digital,Legal & Compliance,Meets,Male,44,4,0,9,16,2.8,3.8,2.4,0.0853,1,1,1,1,1.6,4.1,1.7
7436,728,0,North America,HR,Sales,Meets,Male,42,20,0,9,15,3.5,4.1,4.1,0.0383,1,1,1,1,3.3,3.6,3.0
7437,988,0,Asia Pacific,Finance,Sales,Meets,Male,41,13,0,5,14,4.4,3.3,3.3,0.0331,1,1,1,1,4.3,4.8,2.5
7438,775,0,Asia Pacific,HR,Clinical Operations,Below,Female,36,3,0,12,18,2.0,2.0,3.8,0.0,1,1,1,1,4.4,2.8,3.0
7439,643,0,Europe,Digital,Medical Affairs,Meets,Female,45,7,0,11,16,3.0,5.0,1.5,0.0853,0,0,0,0,4.1,4.8,2.3
7440,23,1,North America,R&D,Market Access,Meets,Female,40,19,0,10,13,3.3,3.0,2.4,0.0977,1,1,1,0,3.8,3.5,4.2
7441,908,0,Latin America,Finance,Clinical Operations,Meets,Male,44,22,0,6,13,1.9,3.2,1.8,0.0331,1,1,1,1,1.2,1.9,2.9
7442,938,1,Latin America,Finance,Finance & Accounting,Exceeds,Female,44,7,1,6,13,0.0,2.8,3.2,0.0588,1,1,1,1,4.6,2.6,4.6
7443,238,0,Middle East & Africa,Commercial,Legal & Compliance,Below,Female,35,12,0,9,17,2.6,2.8,1.1,0.0,0,0,0,0,3.1,2.3,1.1
7444,983,0,Asia Pacific,Finance,Communications,Meets,Female,33,11,0,8,12,1.8,3.8,3.2,0.0331,1,1,1,1,3.1,3.5,2.3
7445,1008,0,Asia Pacific,Finance,Clinical Operations,Meets,Non-Binary/Other,32,7,1,9,18,0.0,1.9,3.8,0.0331,1,1,1,1,4.2,2.8,2.8
7446,134,0,North America,R&D,IT & Digital,Meets,Female,38,3,0,7,16,5.0,1.6,3.1,0.0977,0,0,0,0,4.8,3.4,1.9
7447,211,0,Latin America,Commercial,Communications,Meets,Female,28,11,0,11,19,2.4,3.3,2.3,0.0422,1,1,1,1,2.9,1.8,3.2
7448,450,0,Middle East & Africa,Manufacturing,Supply Chain,Meets,Male,32,9,1,7,9,0.0,3.5,4.0,0.0348,1,0,0,0,4.7,4.8,3.6
7449,725,0,North America,HR,Supply Chain,Far Below,Female,34,16,0,11,18,3.0,2.3,2.2,0.0,1,1,1,1,2.2,2.7,2.6
7450,569,0,Asia Pacific,Digital,Data Science,Below,Male,34,11,0,5,21,4.4,2.3,2.8,0.0,0,0,0,0,3.5,3.8,3.5
7451,375,0,Latin America,Manufacturing,Supply Chain,Meets,Male,42,13,0,6,11,3.3,2.6,3.1,0.0348,1,1,1,1,4.1,2.4,3.1
7452,217,0,Middle East & Africa,Commercial,Data Science,Meets,Male,29,19,0,11,18,1.9,4.7,1.6,0.0422,1,1,1,1,2.9,3.2,2.8
7453,146,0,Europe,R&D,Regulatory Affairs,Below,Male,28,13,0,6,15,4.7,3.6,4.3,0.0,1,0,0,0,2.0,3.6,3.8
7454,608,1,Latin America,Digital,Market Access,Meets,Female,28,13,0,12,17,3.5,2.0,3.0,0.0853,0,0,0,0,2.2,1.2,4.8
7455,880,0,Middle East & Africa,HR,Communications,Below,Male,41,16,0,5,32,2.8,2.8,3.4,0.0,1,1,1,1,3.3,4.5,1.3
7456,881,0,North America,Finance,Medical Affairs,Below,Male,35,7,1,8,13,0.0,2.3,2.3,0.0,1,1,1,1,2.7,4.3,2.1
7457,929,0,Europe,Finance,Legal & Compliance,Meets,Male,34,4,1,12,14,0.0,1.0,2.8,0.0331,1,1,1,1,3.3,1.1,2.8
7458,385,0,Middle East & Africa,Manufacturing,Market Access,Below,Female,48,16,0,12,26,3.4,3.2,2.9,0.0,1,1,1,1,3.3,3.9,2.5
7459,721,0,Middle East & Africa,HR,Data Science,Meets,Female,41,5,0,10,24,1.6,4.1,2.7,0.0383,1,1,1,1,1.5,2.5,2.7
7460,300,0,Asia Pacific,Commercial,IT & Digital,Below,Male,34,4,1,12,16,0.0,3.2,3.3,0.0,1,1,1,1,2.3,3.4,2.8
7461,746,0,Latin America,HR,Supply Chain,Meets,Female,30,6,0,12,17,3.6,1.8,2.6,0.0383,1,1,0,0,3.1,2.8,2.2
7462,110,0,Asia Pacific,R&D,IT & Digital,Meets,Female,49,8,0,11,27,2.9,4.3,1.8,0.0977,0,0,0,0,3.0,5.0,2.0
7463,371,0,Europe,Manufacturing,IT & Digital,Meets,Female,39,17,0,5,10,4.3,2.1,2.1,0.0348,1,1,1,1,3.0,3.3,1.4
7464,516,0,Middle East & Africa,Manufacturing,Clinical Operations,Below,Female,35,2,0,5,11,2.0,3.2,1.7,0.0,1,1,0,0,1.6,2.9,1.1
7465,87,0,Asia Pacific,R&D,Marketing,Exceeds,Female,39,5,0,10,14,2.9,1.8,2.8,0.1648,0,0,0,0,4.6,1.9,3.7
7466,797,0,Latin America,HR,Communications,Meets,Male,35,9,0,12,24,3.3,5.0,4.8,0.0383,1,1,1,1,3.6,4.3,4.8
7467,134,0,Europe,R&D,Legal & Compliance,Below,Female,41,18,0,11,24,3.4,3.3,2.8,0.0,1,1,1,1,3.9,3.0,2.8
7468,691,1,North America,Digital,Regulatory Affairs,Meets,Female,28,11,0,7,14,4.0,2.1,1.5,0.0853,0,0,0,0,3.0,1.9,2.7
7469,101,0,Asia Pacific,R&D,Quality Assurance,Meets,Male,36,7,1,11,21,0.0,3.3,2.5,0.0977,0,0,0,0,2.8,4.3,3.3
7470,857,0,Europe,HR,Legal & Compliance,Exceeds,Female,32,15,0,12,15,3.2,2.8,2.9,0.0677,0,0,0,0,2.6,3.5,3.1
7471,173,0,North America,R&D,Sales,Meets,Female,38,6,0,12,15,2.9,4.9,4.1,0.0977,1,1,1,1,2.2,4.8,5.0
7472,195,0,Asia Pacific,Commercial,Data Science,Meets,Male,32,13,0,11,31,2.8,2.7,4.2,0.0422,1,1,1,1,2.1,4.7,3.0
7473,917,0,Europe,Finance,Market Access,Meets,Female,34,10,0,7,26,4.2,1.9,3.0,0.0331,1,1,1,1,3.2,1.8,3.7
7474,1,0,Europe,R&D,Supply Chain,Meets,Male,35,3,1,5,18,0.0,2.3,4.1,0.0977,1,1,1,1,3.7,2.5,4.0
7475,925,0,Asia Pacific,Finance,Legal & Compliance,Meets,Male,40,16,0,5,17,2.5,1.1,1.5,0.0331,1,1,1,1,2.3,2.4,2.7
7476,173,0,Europe,R&D,Human Resources,Meets,Female,36,11,1,7,12,0.0,3.1,2.6,0.0977,1,1,1,1,4.7,3.8,3.1
7477,817,0,Middle East & Africa,HR,Communications,Far Below,Female,32,7,0,9,26,3.3,2.7,4.1,0.0,1,1,1,1,3.1,3.8,4.6
7478,623,0,Asia Pacific,Digital,Communications,Far Below,Male,40,12,0,11,21,3.3,3.3,2.1,0.0,1,1,1,1,3.6,3.7,1.6
7479,600,0,Europe,Digital,Regulatory Affairs,Meets,Female,51,12,0,9,15,4.1,3.4,1.1,0.0853,1,1,1,1,4.4,2.8,1.0
7480,1044,0,North America,Finance,Sales,Meets,Female,36,23,0,5,6,3.0,2.1,1.9,0.0331,1,0,0,0,3.3,3.0,3.1
7481,870,0,North America,HR,Human Resources,Meets,Female,46,9,0,10,14,4.2,2.5,3.4,0.0383,0,0,0,0,5.0,3.6,2.0
7482,793,0,Middle East & Africa,HR,Quality Assurance,Exceeds,Male,29,3,1,5,10,0.0,5.0,1.9,0.0677,1,1,1,1,2.6,4.0,3.5
7483,715,0,Asia Pacific,HR,Finance & Accounting,Meets,Female,33,21,0,5,11,3.0,2.0,1.4,0.0383,1,1,1,1,3.2,3.1,1.3
7484,259,0,Europe,Commercial,Human Resources,Meets,Female,46,11,0,5,13,3.0,4.6,1.4,0.0422,1,1,1,1,3.4,4.8,2.6
7485,483,0,Europe,Manufacturing,Clinical Operations,Meets,Non-Binary/Other,39,12,0,11,20,3.1,3.8,3.4,0.0348,1,1,1,1,1.5,3.6,3.0
7486,145,1,North America,R&D,Communications,Meets,Female,34,17,1,6,7,0.0,5.0,5.0,0.0977,1,1,1,1,3.7,4.2,3.6
7487,860,0,Middle East & Africa,HR,Clinical Operations,Exceeds,Male,43,16,0,5,15,4.1,4.0,2.6,0.0677,1,1,1,1,2.7,3.3,1.9
7488,758,0,North America,HR,Data Science,Far Below,Male,32,6,0,8,20,4.3,3.2,2.5,0.0,0,0,0,0,4.4,4.3,3.2
7489,841,0,North America,HR,Data Science,Below,Male,38,11,1,9,27,0.0,3.6,2.7,0.0,1,1,1,1,1.4,3.9,2.7
7490,560,0,Middle East & Africa,Digital,Finance & Accounting,Meets,Female,44,17,0,12,19,2.6,3.6,1.0,0.0853,1,1,1,1,4.1,3.6,1.9
7491,732,0,Asia Pacific,HR,Supply Chain,Meets,Female,40,5,1,5,16,0.0,4.0,2.7,0.0383,1,1,1,1,2.6,3.3,1.9
7492,57,0,Europe,R&D,Marketing,Far Below,Female,53,4,0,5,18,3.8,2.6,3.4,0.0,1,1,1,1,3.5,3.6,4.6
7493,782,0,Asia Pacific,HR,Supply Chain,Meets,Female,35,12,0,7,12,4.0,1.8,2.9,0.0383,1,1,1,1,1.8,3.1,2.8
7494,152,0,Latin America,R&D,Medical Affairs,Meets,Male,42,4,1,12,27,0.0,1.6,3.2,0.0977,1,0,0,0,3.5,2.7,2.0
7495,287,0,Latin America,Commercial,Human Resources,Meets,Male,43,10,1,11,18,0.0,2.0,2.5,0.0422,1,1,1,1,4.7,3.6,1.6
7496,510,0,Latin America,Manufacturing,Regulatory Affairs,Meets,Male,37,17,1,12,26,0.0,4.3,1.0,0.0348,1,1,1,1,2.4,3.8,2.5
7497,656,0,Middle East & Africa,Digital,Regulatory Affairs,Far Below,Female,32,11,0,6,31,2.7,2.9,2.1,0.0,1,1,1,1,3.0,3.6,1.0
7498,130,0,North America,R&D,Market Access,Below,Female,45,12,0,12,23,3.3,4.5,3.3,0.0,1,1,1,1,5.0,3.4,3.5
7499,995,0,Asia Pacific,Finance,Clinical Operations,Meets,Female,35,4,0,8,21,2.5,1.9,3.1,0.0331,1,1,1,1,2.3,3.1,1.8
7500,213,0,Europe,Commercial,Legal & Compliance,Meets,Male,42,7,1,7,21,0.0,3.7,3.1,0.0422,1,0,0,0,2.9,2.2,3.0
7501,451,0,Latin America,Manufacturing,Finance & Accounting,Exceeds,Female,41,11,1,11,23,0.0,2.3,3.3,0.0616,1,1,1,1,4.5,1.2,2.3
7502,442,0,Asia Pacific,Manufacturing,Legal & Compliance,Below,Male,39,6,1,8,14,0.0,4.3,3.1,0.0,1,0,0,0,4.4,3.0,3.9
7503,361,0,Latin America,Manufacturing,Pharmacovigilance,Exceeds,Female,46,4,0,5,6,3.1,2.7,3.6,0.0616,0,0,0,0,2.2,2.8,2.8
7504,6,0,Latin America,R&D,Legal & Compliance,Meets,Male,40,13,0,10,16,2.3,4.0,3.4,0.0977,1,1,1,1,4.0,4.1,3.8
7505,204,0,Europe,Commercial,Legal & Compliance,Meets,Male,42,32,0,11,23,4.0,2.4,4.1,0.0422,1,1,1,1,1.8,2.8,2.8
7506,796,0,Middle East & Africa,HR,Supply Chain,Meets,Female,40,10,0,12,25,3.9,2.4,3.5,0.0383,1,1,1,1,3.3,3.3,4.0
7507,921,0,North America,Finance,Market Access,Meets,Female,38,11,1,10,26,0.0,5.0,2.6,0.0331,1,1,1,1,3.6,4.1,2.7
7508,345,0,Middle East & Africa,Commercial,Data Science,Meets,Male,36,8,0,7,10,2.1,4.7,3.9,0.0422,1,1,0,0,2.8,3.2,4.8
7509,255,0,Asia Pacific,Commercial,Regulatory Affairs,Meets,Male,38,11,1,8,25,0.0,1.8,3.9,0.0422,1,1,1,1,2.6,4.1,3.1
7510,227,0,Middle East & Africa,Commercial,Legal & Compliance,Meets,Male,42,3,0,5,9,3.5,2.2,3.1,0.0422,1,1,1,1,2.9,2.2,2.3
7511,136,0,Asia Pacific,R&D,Data Science,Meets,Male,41,9,0,12,16,3.7,2.3,3.7,0.0977,1,1,1,1,3.6,2.6,3.8
7512,978,0,Asia Pacific,Finance,Supply Chain,Meets,Female,42,12,0,11,17,2.1,1.4,2.6,0.0331,1,1,1,1,2.4,3.6,2.7
7513,170,0,North America,R&D,Sales,Meets,Female,55,7,0,11,25,3.4,1.1,1.8,0.0977,1,1,1,1,4.5,2.2,1.0
7514,900,0,Europe,Finance,IT & Digital,Meets,Male,35,9,0,11,32,3.3,4.8,4.1,0.0331,1,1,1,1,3.2,5.0,3.1
7515,965,0,North America,Finance,Data Science,Exceeds,Male,28,6,0,12,17,2.1,4.2,4.1,0.0588,1,1,1,1,3.6,4.6,4.0
7516,113,0,Middle East & Africa,R&D,Pharmacovigilance,Meets,Male,36,6,0,9,14,2.7,1.5,1.0,0.0977,1,1,1,1,2.7,1.3,1.0
7517,939,1,Asia Pacific,Finance,Regulatory Affairs,Far Exceeds,Male,36,12,0,5,14,4.6,1.2,2.1,0.1022,1,1,1,1,5.0,2.9,3.3
7518,194,0,Latin America,Commercial,Supply Chain,Below,Female,41,12,1,5,15,0.0,4.5,3.6,0.0,0,0,0,0,2.7,4.1,4.1
7519,9,0,Latin America,R&D,Communications,Exceeds,Non-Binary/Other,36,19,0,8,11,3.2,3.9,1.0,0.1648,1,1,1,1,2.8,3.5,1.1
7520,903,0,Asia Pacific,Finance,Market Access,Exceeds,Male,42,12,0,9,14,2.8,3.7,4.4,0.0588,1,1,1,1,3.5,1.7,2.0
7521,491,0,North America,Manufacturing,Marketing,Meets,Male,33,7,0,5,27,3.7,4.1,4.6,0.0348,1,1,1,1,3.2,4.1,1.7
7522,93,1,Europe,R&D,Marketing,Meets,Male,41,15,0,10,14,4.0,3.3,1.3,0.0977,1,1,1,1,3.1,3.3,3.7
7523,604,0,North America,Digital,Legal & Compliance,Far Exceeds,Male,29,15,0,10,21,4.0,2.8,3.4,0.2363,1,1,1,1,4.4,2.8,3.4
7524,163,0,Asia Pacific,R&D,Supply Chain,Far Exceeds,Male,38,11,0,9,12,3.4,1.0,2.2,0.2644,1,1,1,1,3.6,2.2,1.3
7525,32,0,Asia Pacific,R&D,Marketing,Meets,Female,33,5,0,12,20,4.3,2.7,2.5,0.0977,1,1,1,1,4.0,2.9,2.8
7526,57,0,Europe,R&D,Regulatory Affairs,Meets,Female,36,6,0,8,14,2.6,2.9,1.2,0.0977,0,0,0,0,3.7,2.8,2.5
7527,905,0,Middle East & Africa,Finance,Human Resources,Exceeds,Male,28,12,0,9,14,3.1,3.2,3.1,0.0588,1,1,1,1,3.3,3.4,3.1
7528,22,0,Middle East & Africa,R&D,Sales,Below,Male,43,27,0,9,15,3.1,3.3,3.1,0.0,1,1,1,1,1.6,3.3,1.2
7529,599,0,Europe,Digital,Data Science,Meets,Male,36,7,1,7,8,0.0,4.9,2.3,0.0853,1,1,1,1,4.6,3.9,2.6
7530,710,0,Middle East & Africa,HR,Pharmacovigilance,Far Exceeds,Male,37,7,0,7,11,1.6,4.8,4.2,0.1168,1,1,1,1,4.3,2.8,3.1
7531,100,1,Latin America,R&D,Quality Assurance,Exceeds,Female,41,7,0,9,17,2.0,2.3,4.8,0.1648,1,1,1,1,3.2,3.3,3.1
7532,378,0,Middle East & Africa,Manufacturing,Market Access,Exceeds,Female,34,7,0,6,11,2.0,2.3,2.5,0.0616,1,1,1,1,1.3,2.1,3.1
7533,660,0,Middle East & Africa,Digital,Human Resources,Meets,Male,35,18,0,5,22,3.2,2.9,1.5,0.0853,1,0,0,0,4.3,2.9,3.6
7534,877,0,Middle East & Africa,HR,Regulatory Affairs,Meets,Female,28,8,0,6,20,3.0,5.0,1.0,0.0383,1,1,1,1,3.0,5.0,1.0
7535,887,0,Latin America,Finance,Communications,Far Exceeds,Female,36,22,0,6,14,1.8,2.7,4.5,0.1022,1,1,1,1,3.5,3.1,3.9
7536,122,0,Middle East & Africa,R&D,Clinical Operations,Meets,Male,47,9,0,11,20,3.9,1.9,2.4,0.0977,1,1,0,0,3.5,3.3,2.1
7537,870,0,Latin America,HR,Communications,Meets,Male,40,25,0,5,24,4.0,3.8,2.7,0.0383,1,1,0,0,3.5,2.5,2.5
7538,486,0,Europe,Manufacturing,Medical Affairs,Meets,Male,29,16,0,6,16,3.4,2.8,2.1,0.0348,1,1,1,1,2.1,2.4,1.7
7539,563,0,North America,Digital,Medical Affairs,Meets,Female,41,15,0,11,27,2.2,3.3,2.1,0.0853,1,1,1,1,2.4,5.0,2.2
7540,614,0,Europe,Digital,IT & Digital,Far Below,Female,46,10,0,10,11,5.0,2.6,3.3,0.0,1,1,1,1,3.1,4.7,4.0
7541,1032,0,North America,Finance,Market Access,Meets,Female,32,12,0,12,18,4.0,3.0,2.5,0.0331,1,1,1,1,3.4,1.0,2.1
7542,897,0,Europe,Finance,Human Resources,Meets,Female,37,17,0,11,16,4.3,3.9,1.0,0.0331,1,1,1,1,4.4,3.3,1.6
7543,947,0,North America,Finance,Regulatory Affairs,Below,Female,37,11,0,8,30,2.5,3.1,3.0,0.0,1,1,1,1,2.4,2.8,3.5
7544,718,0,North America,HR,Supply Chain,Meets,Female,39,13,0,10,23,2.5,3.2,1.8,0.0383,0,0,0,0,2.2,2.8,2.2
7545,105,0,Asia Pacific,R&D,Finance & Accounting,Meets,Female,39,7,0,11,23,2.3,3.0,3.4,0.0977,1,1,1,1,2.7,2.2,2.3
7546,243,0,North America,Commercial,Communications,Meets,Female,42,11,0,11,20,2.9,2.2,2.2,0.0422,1,0,0,0,3.2,2.9,2.9
7547,659,0,North America,Digital,Data Science,Below,Male,37,6,0,10,16,3.0,3.1,1.9,0.0,1,1,1,1,2.4,4.3,1.0
7548,329,0,Asia Pacific,Commercial,Supply Chain,Meets,Male,45,5,1,9,16,0.0,2.8,2.1,0.0422,1,1,1,1,1.8,4.2,2.7
7549,686,0,Middle East & Africa,Digital,Supply Chain,Below,Male,28,7,0,7,22,4.1,4.5,1.0,0.0,1,1,0,0,2.9,3.4,3.9
7550,971,0,Middle East & Africa,Finance,Clinical Operations,Far Below,Female,31,6,1,7,27,0.0,5.0,3.3,0.0,1,1,1,1,4.2,2.6,1.5
7551,4,0,Asia Pacific,R&D,Marketing,Below,Female,47,13,1,9,15,0.0,2.7,4.4,0.0,1,1,1,1,4.0,3.3,4.1
7552,64,0,Latin America,R&D,Medical Affairs,Meets,Male,35,16,0,9,20,4.4,2.8,3.4,0.0977,1,1,1,1,4.8,2.1,2.8
7553,597,0,North America,Digital,Human Resources,Below,Female,41,16,0,9,15,3.5,4.2,2.7,0.0,1,1,1,1,5.0,4.4,5.0
7554,830,0,North America,HR,Quality Assurance,Far Below,Male,37,7,1,5,34,0.0,2.5,2.6,0.0,1,1,1,1,5.0,4.0,2.1
7555,921,0,Asia Pacific,Finance,Quality Assurance,Below,Female,44,28,0,11,16,3.4,3.6,2.3,0.0,1,1,1,1,3.0,3.2,2.5
7556,72,1,Asia Pacific,R&D,Data Science,Exceeds,Female,40,8,1,10,23,0.0,3.1,1.6,0.1648,1,1,1,1,4.0,1.8,1.8
7557,160,1,Latin America,R&D,Medical Affairs,Exceeds,Non-Binary/Other,54,10,0,5,14,2.5,2.5,3.9,0.1648,1,1,1,1,3.9,2.3,4.0
7558,468,0,Middle East & Africa,Manufacturing,Communications,Below,Male,38,2,0,8,20,2.6,4.3,2.2,0.0,1,1,1,1,2.6,3.9,1.0
7559,146,0,Europe,R&D,Clinical Operations,Meets,Female,35,5,1,11,16,0.0,2.6,2.7,0.0977,1,1,1,0,3.5,3.4,2.5
7560,504,0,Middle East & Africa,Manufacturing,Market Access,Exceeds,Male,46,12,0,11,14,3.2,2.6,4.5,0.0616,1,1,1,1,2.5,3.2,3.9
7561,40,0,North America,R&D,Regulatory Affairs,Below,Female,42,6,1,6,23,0.0,1.0,2.4,0.0,1,1,1,1,4.4,1.0,3.2
7562,75,0,Asia Pacific,R&D,Supply Chain,Below,Male,33,25,0,6,17,2.4,3.5,3.0,0.0,1,1,1,1,2.9,3.4,3.2
7563,803,0,Latin America,HR,Communications,Below,Female,43,5,0,10,18,2.2,2.6,5.0,0.0,1,1,1,1,2.5,3.9,3.8
7564,860,0,Middle East & Africa,HR,Legal & Compliance,Far Exceeds,Non-Binary/Other,39,14,0,7,21,3.6,2.2,2.2,0.1168,0,0,0,0,4.2,1.9,1.0
7565,911,0,Latin America,Finance,Human Resources,Meets,Female,39,5,0,10,12,2.9,1.4,3.7,0.0331,1,1,1,1,1.8,1.6,4.7
7566,126,0,Middle East & Africa,R&D,IT & Digital,Meets,Female,41,24,0,6,20,3.3,3.4,2.3,0.0977,1,1,1,1,3.5,1.8,2.1
7567,1041,0,North America,Finance,Communications,Far Below,Male,43,3,0,7,12,3.6,3.5,3.8,0.0,1,1,1,1,3.7,1.3,2.5
7568,983,0,Europe,Finance,Supply Chain,Far Exceeds,Male,39,12,0,9,18,3.6,1.9,3.3,0.1022,1,1,1,1,2.9,2.5,3.0
7569,922,0,Latin America,Finance,Finance & Accounting,Meets,Male,36,13,0,11,29,2.9,3.3,5.0,0.0331,1,1,1,1,1.8,2.8,3.5
7570,948,0,Latin America,Finance,Pharmacovigilance,Meets,Male,51,14,0,9,34,2.9,1.2,1.1,0.0331,1,1,1,1,3.0,1.8,1.4
7571,620,0,Europe,Digital,Market Access,Meets,Female,38,11,0,12,28,4.1,4.8,2.1,0.0853,1,1,1,1,4.1,4.6,1.6
7572,692,0,Latin America,Digital,Pharmacovigilance,Meets,Female,46,12,0,7,17,3.3,2.8,1.7,0.0853,1,1,1,1,3.8,2.9,2.0
7573,166,0,Latin America,R&D,Pharmacovigilance,Below,Female,35,12,0,5,11,3.7,3.5,2.6,0.0,1,1,1,1,3.3,5.0,3.5
7574,584,0,Middle East & Africa,Digital,Marketing,Meets,Male,33,22,0,10,13,3.2,3.4,3.6,0.0853,1,1,1,1,4.5,4.3,3.5
7575,53,0,Middle East & Africa,R&D,Quality Assurance,Meets,Female,44,3,1,5,11,0.0,4.4,1.0,0.0977,1,1,1,1,5.0,5.0,2.1
7576,741,0,Europe,HR,Pharmacovigilance,Below,Female,36,27,0,7,23,2.7,3.0,3.2,0.0,1,1,1,1,4.5,4.2,3.4
7577,185,0,North America,Commercial,IT & Digital,Meets,Female,28,13,0,5,18,3.8,2.1,2.8,0.0422,1,1,1,1,3.0,3.9,2.8
7578,433,0,Latin America,Manufacturing,Legal & Compliance,Exceeds,Male,37,11,1,12,17,0.0,3.5,2.6,0.0616,1,1,1,1,2.5,3.1,3.8
7579,612,0,North America,Digital,Supply Chain,Meets,Female,41,6,0,11,50,2.5,4.4,2.5,0.0853,1,1,1,1,2.7,2.6,2.4
7580,616,0,Europe,Digital,Medical Affairs,Far Below,Male,34,36,0,11,19,4.0,4.2,1.5,0.0,1,0,0,0,3.9,3.9,3.3
7581,755,0,Europe,HR,Legal & Compliance,Meets,Male,33,4,1,8,35,0.0,2.2,5.0,0.0383,0,0,0,0,2.2,2.7,3.4
7582,671,0,Middle East & Africa,Digital,Medical Affairs,Meets,Female,39,7,0,6,30,4.2,2.5,1.0,0.0853,1,1,1,1,3.0,4.2,2.2
7583,18,1,Latin America,R&D,Marketing,Meets,Non-Binary/Other,31,1,0,8,12,2.7,3.3,2.7,0.0977,1,1,1,1,5.0,3.7,3.3
7584,3,0,Asia Pacific,R&D,Legal & Compliance,Meets,Female,40,21,1,9,31,0.0,3.8,3.0,0.0977,1,1,1,1,4.8,4.2,2.3
7585,252,0,Europe,Commercial,Human Resources,Below,Male,44,4,1,10,18,0.0,1.4,3.1,0.0,1,1,1,1,3.6,2.0,4.0
7586,185,0,Latin America,Commercial,Medical Affairs,Meets,Male,46,2,1,8,25,0.0,3.3,3.8,0.0422,1,1,1,1,4.6,2.4,3.6
7587,317,0,North America,Commercial,Human Resources,Meets,Male,34,9,0,5,31,3.0,3.6,2.9,0.0422,1,1,1,0,2.7,2.7,4.1
7588,109,0,Middle East & Africa,R&D,Supply Chain,Exceeds,Non-Binary/Other,49,8,0,12,20,4.5,2.6,4.4,0.1648,1,1,1,1,4.4,2.2,3.2
7589,974,0,North America,Finance,Quality Assurance,Meets,Male,42,26,0,11,18,4.0,3.4,1.8,0.0331,1,1,1,1,4.3,2.7,1.8
7590,904,0,Europe,Finance,Quality Assurance,Meets,Female,34,4,0,5,9,4.4,4.6,3.7,0.0331,1,1,1,1,4.4,4.2,2.8
7591,199,0,Europe,Commercial,Legal & Compliance,Meets,Female,35,9,0,6,8,2.6,3.6,2.1,0.0422,1,1,1,1,3.1,3.0,2.1
7592,243,0,North America,Commercial,Quality Assurance,Meets,Female,34,7,0,12,18,2.7,2.5,1.9,0.0422,1,1,1,1,2.9,3.7,3.3
7593,57,0,Europe,R&D,Regulatory Affairs,Meets,Male,28,15,0,7,20,3.1,3.7,3.5,0.0977,1,1,1,1,3.0,4.3,2.4
7594,782,0,Latin America,HR,Legal & Compliance,Meets,Male,47,4,0,5,18,3.3,2.2,2.1,0.0383,1,1,1,1,3.1,2.7,2.4
7595,688,0,Europe,Digital,Market Access,Exceeds,Female,39,22,0,12,15,2.6,4.2,1.0,0.1452,1,1,1,1,4.2,5.0,2.0
7596,377,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Meets,Female,42,26,0,8,10,3.3,3.6,3.3,0.0348,1,1,1,1,3.1,3.0,2.4
7597,890,0,Latin America,Finance,Regulatory Affairs,Meets,Non-Binary/Other,39,14,0,6,23,3.6,5.0,2.5,0.0331,1,1,1,1,3.6,4.1,2.8
7598,1014,0,Asia Pacific,Finance,Regulatory Affairs,Below,Male,29,5,0,11,18,4.3,3.9,4.4,0.0,1,1,1,1,3.9,4.6,4.8
7599,128,0,Europe,R&D,Medical Affairs,Meets,Female,40,20,0,5,21,3.4,4.2,3.2,0.0977,1,1,1,1,3.6,3.6,3.2
7600,151,0,Europe,R&D,Sales,Far Below,Female,44,8,0,5,23,3.6,2.9,3.0,0.0,1,1,1,1,4.1,3.7,3.7
7601,480,0,Middle East & Africa,Manufacturing,Medical Affairs,Meets,Male,44,9,1,7,26,0.0,2.7,3.6,0.0348,1,1,1,1,3.7,2.2,5.0
7602,372,0,Middle East & Africa,Manufacturing,Communications,Meets,Female,45,12,0,9,15,1.9,2.8,2.2,0.0348,1,1,1,1,3.7,2.3,1.6
7603,230,0,North America,Commercial,Sales,Meets,Female,38,14,0,11,13,4.3,2.6,4.5,0.0422,1,1,1,1,3.8,3.9,4.8
7604,387,0,North America,Manufacturing,Medical Affairs,Meets,Male,28,28,0,11,19,3.4,5.0,2.7,0.0348,1,1,1,1,3.1,4.6,2.3
7605,606,0,North America,Digital,Supply Chain,Meets,Male,42,11,0,8,17,4.1,2.1,2.3,0.0853,1,1,1,1,3.7,1.0,2.7
7606,561,0,Middle East & Africa,Digital,Market Access,Far Exceeds,Female,38,10,0,10,26,3.0,3.3,3.5,0.2363,1,1,1,1,4.2,3.4,2.5
7607,1029,0,North America,Finance,Clinical Operations,Meets,Male,50,6,1,5,7,0.0,2.3,3.2,0.0331,1,1,1,1,1.5,1.3,2.6
7608,560,1,North America,Digital,Legal & Compliance,Meets,Male,49,25,0,11,18,2.1,3.3,2.2,0.0853,1,1,1,1,3.4,1.6,2.5
7609,586,0,Asia Pacific,Digital,Finance & Accounting,Meets,Male,45,9,1,7,9,0.0,2.9,3.5,0.0853,0,0,0,0,2.8,2.9,3.4
7610,640,0,North America,Digital,Clinical Operations,Meets,Female,30,11,0,11,19,2.5,2.7,2.1,0.0853,1,1,1,1,2.6,2.7,1.7
7611,293,0,Europe,Commercial,Regulatory Affairs,Far Below,Female,31,17,1,9,30,0.0,3.7,3.2,0.0,1,1,1,1,2.9,4.7,4.3
7612,937,0,Middle East & Africa,Finance,Finance & Accounting,Meets,Female,41,12,0,6,12,3.2,4.2,1.1,0.0331,1,1,1,1,2.2,3.3,3.6
7613,120,0,Latin America,R&D,Clinical Operations,Meets,Male,31,7,1,7,22,0.0,4.1,2.8,0.0977,0,0,0,0,4.3,3.6,2.3
7614,1002,0,Asia Pacific,Finance,IT & Digital,Meets,Male,43,26,0,7,11,3.1,3.2,1.9,0.0331,1,1,1,1,3.9,4.3,2.0
7615,910,0,Middle East & Africa,Finance,Communications,Meets,Female,44,11,0,10,14,4.5,2.3,1.7,0.0331,1,1,1,1,3.9,2.9,3.3
7616,1021,0,Middle East & Africa,Finance,Market Access,Meets,Male,47,9,0,11,24,3.8,2.3,1.6,0.0331,0,0,0,0,2.5,3.0,2.5
7617,383,0,Europe,Manufacturing,IT & Digital,Meets,Female,45,19,0,8,12,3.3,2.4,1.4,0.0348,1,1,1,1,4.0,2.8,1.2
7618,152,0,North America,R&D,IT & Digital,Meets,Male,36,6,0,6,17,2.7,3.3,3.0,0.0977,1,1,1,1,3.8,1.6,2.4
7619,509,0,Europe,Manufacturing,Market Access,Exceeds,Male,38,15,1,11,23,0.0,3.5,3.3,0.0616,1,1,1,1,5.0,5.0,3.1
7620,288,0,North America,Commercial,Finance & Accounting,Meets,Female,33,5,0,6,10,2.9,3.4,3.2,0.0422,1,1,1,1,3.5,1.6,3.4
7621,229,0,North America,Commercial,Legal & Compliance,Meets,Female,40,3,0,11,18,3.9,3.2,1.9,0.0422,0,0,0,0,4.2,3.3,1.1
7622,757,0,Middle East & Africa,HR,Human Resources,Meets,Non-Binary/Other,28,2,1,5,9,0.0,3.2,2.7,0.0383,1,1,1,1,2.4,4.1,1.8
7623,768,0,North America,HR,Data Science,Meets,Female,36,6,0,9,25,4.4,2.4,3.1,0.0383,1,1,1,1,4.1,3.5,3.5
7624,330,0,Asia Pacific,Commercial,Marketing,Meets,Female,42,1,1,8,9,0.0,1.3,4.0,0.0422,1,1,1,1,2.6,3.6,3.7
7625,189,0,Asia Pacific,Commercial,Market Access,Exceeds,Male,42,17,0,8,12,5.0,3.0,5.0,0.0743,1,1,1,1,2.6,4.2,4.4
7626,475,0,Asia Pacific,Manufacturing,Human Resources,Meets,Male,43,7,0,6,15,4.9,4.4,2.0,0.0348,1,1,1,1,4.1,4.1,1.6
7627,291,0,Middle East & Africa,Commercial,Marketing,Exceeds,Female,32,19,0,5,13,3.8,3.5,3.5,0.0743,1,1,1,1,3.2,3.4,3.5
7628,95,0,Europe,R&D,Clinical Operations,Below,Male,30,18,0,9,15,2.1,1.9,1.9,0.0,1,1,1,1,2.3,3.7,3.5
7629,358,0,Latin America,Manufacturing,Marketing,Meets,Female,42,23,1,8,18,0.0,3.3,1.4,0.0348,1,1,1,1,5.0,1.5,1.9
7630,309,0,North America,Commercial,Sales,Meets,Female,32,20,0,11,13,4.0,1.8,1.7,0.0422,1,1,1,1,2.8,1.7,3.0
7631,501,0,Latin America,Manufacturing,Supply Chain,Meets,Female,31,11,0,11,19,2.2,3.4,2.9,0.0348,1,1,1,1,2.3,3.7,2.1
7632,406,0,Europe,Manufacturing,Marketing,Exceeds,Female,39,7,0,10,23,3.2,3.2,2.6,0.0616,1,1,1,1,3.2,3.1,1.8
7633,595,0,Europe,Digital,IT & Digital,Meets,Male,38,18,0,11,13,4.3,2.0,3.3,0.0853,1,1,1,1,3.6,2.5,1.2
7634,729,0,Middle East & Africa,HR,IT & Digital,Far Exceeds,Female,52,9,1,5,12,0.0,2.9,1.0,0.1168,0,0,0,0,1.2,2.4,3.3
7635,371,0,Asia Pacific,Manufacturing,Supply Chain,Below,Female,40,13,0,5,9,3.6,2.3,2.8,0.0,1,1,1,1,4.0,1.7,2.4
7636,888,0,Asia Pacific,Finance,Regulatory Affairs,Meets,Female,39,5,1,9,22,0.0,4.1,1.8,0.0331,1,1,1,1,3.0,3.5,3.6
7637,460,0,Europe,Manufacturing,IT & Digital,Meets,Female,35,26,0,12,18,2.4,4.8,1.0,0.0348,1,1,1,1,4.2,3.3,1.3
7638,1001,0,Middle East & Africa,Finance,Clinical Operations,Far Below,Male,43,9,0,7,15,3.8,1.6,2.1,0.0,1,1,1,1,2.3,2.7,2.5
7639,548,0,Middle East & Africa,Digital,Legal & Compliance,Below,Female,38,10,0,9,18,3.3,3.0,2.3,0.0,1,1,1,1,2.9,3.4,3.2
7640,321,0,North America,Commercial,Supply Chain,Far Below,Male,35,6,0,8,29,3.3,2.2,4.6,0.0,1,1,1,1,2.8,2.1,4.8
7641,396,0,Asia Pacific,Manufacturing,Pharmacovigilance,Far Exceeds,Female,37,6,1,9,28,0.0,2.4,2.0,0.1069,1,1,1,1,4.5,4.1,2.9
7642,547,0,Europe,Digital,Regulatory Affairs,Meets,Female,36,16,0,11,35,3.2,4.1,1.9,0.0853,1,1,1,1,4.2,2.3,1.9
7643,176,0,Latin America,R&D,IT & Digital,Meets,Male,38,8,0,8,22,3.1,3.2,2.4,0.0977,1,1,1,1,2.8,3.8,1.6
7644,670,0,Asia Pacific,Digital,Supply Chain,Below,Non-Binary/Other,52,15,0,9,32,3.0,3.5,5.0,0.0,0,0,0,0,2.4,2.0,4.7
7645,747,0,North America,HR,Data Science,Below,Non-Binary/Other,42,8,1,5,8,0.0,3.5,5.0,0.0,1,1,1,1,3.5,2.1,3.5
7646,709,0,Middle East & Africa,HR,Marketing,Meets,Female,37,7,0,9,15,2.7,2.9,2.2,0.0383,1,1,1,1,3.3,3.2,2.3
7647,225,0,Europe,Commercial,Data Science,Far Exceeds,Female,38,21,0,6,11,5.0,1.4,1.7,0.1275,1,0,0,0,4.7,3.8,2.2
7648,896,0,Asia Pacific,Finance,Finance & Accounting,Meets,Female,30,7,0,11,13,2.5,3.7,3.0,0.0331,1,1,1,1,2.6,2.4,1.9
7649,322,0,Latin America,Commercial,Market Access,Meets,Male,28,8,0,9,20,3.8,1.0,2.1,0.0422,1,1,1,1,3.2,1.9,1.2
7650,911,0,North America,Finance,Finance & Accounting,Meets,Female,42,5,1,10,19,0.0,1.5,4.5,0.0331,1,1,1,1,3.3,2.3,3.8
7651,891,0,North America,Finance,Human Resources,Far Exceeds,Female,42,16,0,7,18,5.0,1.0,4.4,0.1022,1,1,1,1,5.0,2.8,4.6
7652,947,0,Asia Pacific,Finance,Human Resources,Meets,Female,40,12,1,12,18,0.0,1.8,1.8,0.0331,1,1,1,1,4.1,1.6,1.9
7653,968,0,Latin America,Finance,Human Resources,Far Exceeds,Female,47,9,0,11,22,4.9,2.5,2.6,0.1022,0,0,0,0,3.9,1.7,2.4
7654,724,0,North America,HR,Sales,Far Below,Female,39,12,1,9,23,0.0,3.3,2.6,0.0,0,0,0,0,2.4,3.9,4.1
7655,714,1,Europe,HR,Communications,Meets,Female,43,5,0,7,9,4.0,3.2,2.3,0.0383,1,1,1,1,2.8,2.8,3.6
7656,437,0,North America,Manufacturing,Regulatory Affairs,Meets,Female,38,13,0,10,50,3.3,2.8,2.8,0.0348,0,0,0,0,3.1,4.0,3.2
7657,877,0,Latin America,HR,Quality Assurance,Meets,Male,28,23,0,11,16,3.6,2.4,2.0,0.0383,0,0,0,0,3.2,3.9,2.4
7658,220,0,Middle East & Africa,Commercial,Legal & Compliance,Meets,Female,45,9,1,9,25,0.0,1.5,3.7,0.0422,1,1,1,1,3.7,1.2,2.3
7659,771,0,Middle East & Africa,HR,Quality Assurance,Far Below,Female,32,14,0,10,20,3.9,2.8,4.2,0.0,1,1,1,1,3.3,3.1,1.0
7660,311,0,Asia Pacific,Commercial,Supply Chain,Below,Male,40,7,0,12,25,3.8,3.3,3.7,0.0,1,1,1,1,2.9,4.3,3.8
7661,8,1,Latin America,R&D,Marketing,Exceeds,Male,34,22,0,11,26,3.2,3.8,1.8,0.1648,1,1,1,1,3.3,3.4,3.1
7662,856,0,North America,HR,Clinical Operations,Meets,Male,40,14,0,10,17,3.4,4.0,2.7,0.0383,1,1,1,1,4.0,3.8,1.7
7663,274,0,North America,Commercial,Quality Assurance,Far Exceeds,Male,48,12,0,7,18,3.4,4.6,2.8,0.1275,1,1,1,1,2.0,5.0,1.5
7664,1045,0,Middle East & Africa,Finance,Clinical Operations,Meets,Male,42,8,0,9,22,3.3,3.1,3.3,0.0331,1,1,1,1,3.4,3.0,3.2
7665,628,0,Middle East & Africa,Digital,Quality Assurance,Meets,Female,43,9,0,6,15,3.2,4.5,1.9,0.0853,1,1,1,1,3.9,5.0,2.9
7666,1010,0,Europe,Finance,Human Resources,Exceeds,Female,37,6,0,6,18,3.7,2.6,2.0,0.0588,1,1,1,1,2.6,3.2,2.4
7667,413,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Meets,Male,36,3,0,11,18,3.0,1.2,2.5,0.0348,1,1,1,1,3.5,3.6,2.9
7668,327,0,Europe,Commercial,Quality Assurance,Meets,Male,36,9,0,5,9,4.1,4.0,2.1,0.0422,1,1,1,1,4.7,4.3,2.0
7669,976,0,North America,Finance,Market Access,Below,Female,43,15,0,8,25,4.4,3.2,4.2,0.0,1,1,1,1,3.3,1.9,4.2
7670,878,0,Europe,HR,IT & Digital,Exceeds,Female,38,13,1,7,23,0.0,3.0,4.4,0.0677,1,1,1,1,3.2,4.1,3.8
7671,834,0,Europe,HR,Medical Affairs,Meets,Male,42,15,0,10,17,3.8,3.2,3.5,0.0383,0,0,0,0,3.2,4.2,2.8
7672,133,0,Asia Pacific,R&D,Supply Chain,Meets,Male,37,10,0,9,17,3.0,2.0,3.1,0.0977,1,1,1,1,3.2,3.2,4.8
7673,639,0,Middle East & Africa,Digital,Sales,Meets,Male,44,22,0,5,13,2.7,2.0,3.8,0.0853,1,1,1,1,2.1,3.0,3.5
7674,180,0,Europe,Commercial,Quality Assurance,Meets,Female,42,13,0,6,10,2.8,3.0,2.7,0.0422,1,1,1,1,2.4,3.6,2.6
7675,886,0,North America,Finance,IT & Digital,Exceeds,Female,39,4,0,12,23,2.7,3.7,3.4,0.0588,1,1,1,1,3.9,2.7,3.2
7676,595,0,Latin America,Digital,Communications,Far Below,Male,42,11,0,12,15,2.0,2.9,1.0,0.0,0,0,0,0,2.2,2.8,1.6
7677,6,0,Europe,R&D,Marketing,Meets,Male,44,9,0,12,26,5.0,1.0,3.0,0.0977,1,1,1,1,4.1,3.1,3.6
7678,426,0,Middle East & Africa,Manufacturing,Legal & Compliance,Far Below,Non-Binary/Other,49,22,0,7,12,3.3,1.4,3.0,0.0,1,1,1,1,3.0,1.3,2.6
7679,647,0,Asia Pacific,Digital,Communications,Below,Female,34,7,0,10,21,3.6,2.5,1.8,0.0,1,1,1,1,4.9,2.6,2.2
7680,2,0,North America,R&D,Sales,Meets,Male,43,36,0,7,18,2.8,3.3,3.7,0.0977,1,1,1,1,1.7,3.9,1.8
7681,220,0,Asia Pacific,Commercial,Clinical Operations,Far Below,Female,42,10,1,8,18,0.0,3.0,1.7,0.0,1,1,1,1,3.5,3.2,3.7
7682,428,0,Latin America,Manufacturing,Data Science,Below,Male,44,7,1,8,18,0.0,2.7,1.2,0.0,1,1,1,1,2.1,3.5,1.3
7683,873,0,Europe,HR,Market Access,Meets,Female,35,11,0,9,16,4.0,1.9,3.5,0.0383,1,1,1,1,3.5,2.2,2.4
7684,166,0,Europe,R&D,Pharmacovigilance,Meets,Male,39,11,1,6,23,0.0,3.5,3.0,0.0977,1,1,1,1,3.3,3.0,3.2
7685,758,0,Middle East & Africa,HR,Communications,Meets,Male,35,12,0,10,15,4.9,4.8,2.7,0.0383,1,1,1,1,3.9,3.6,3.7
7686,425,0,Europe,Manufacturing,Legal & Compliance,Meets,Female,40,9,0,8,20,2.9,5.0,2.5,0.0348,1,1,1,1,3.2,5.0,3.8
7687,166,0,North America,R&D,Pharmacovigilance,Meets,Male,33,17,0,7,12,3.7,2.6,3.7,0.0977,1,1,1,1,3.1,4.0,2.5
7688,71,0,Latin America,R&D,Sales,Meets,Male,46,7,0,9,21,2.4,2.0,1.7,0.0977,1,1,1,1,1.6,3.0,3.1
7689,433,0,Asia Pacific,Manufacturing,Data Science,Meets,Female,39,11,1,10,24,0.0,2.5,3.3,0.0348,1,1,1,1,3.2,4.3,3.5
7690,240,0,Latin America,Commercial,Marketing,Far Exceeds,Male,48,6,0,12,18,1.8,1.6,1.5,0.1275,1,1,1,1,2.6,1.6,2.9
7691,35,0,Europe,R&D,Sales,Far Below,Female,34,8,0,7,18,2.4,2.7,2.4,0.0,1,1,1,1,2.0,2.8,3.7
7692,460,0,Asia Pacific,Manufacturing,Communications,Meets,Male,39,31,0,12,33,4.4,3.1,3.2,0.0348,1,1,1,1,3.5,4.6,3.4
7693,528,0,Middle East & Africa,Digital,Clinical Operations,Meets,Female,39,13,0,12,27,4.6,2.4,2.5,0.0853,1,1,1,1,4.1,2.7,4.8
7694,835,0,Latin America,HR,Regulatory Affairs,Meets,Non-Binary/Other,42,12,1,10,18,0.0,1.8,3.0,0.0383,1,1,1,1,3.3,2.8,2.7
7695,61,0,Asia Pacific,R&D,IT & Digital,Exceeds,Male,43,14,0,6,10,3.4,3.0,3.5,0.1648,0,0,0,0,4.0,3.6,2.3
7696,616,0,Asia Pacific,Digital,Sales,Far Below,Female,30,19,0,11,24,4.1,4.3,3.0,0.0,1,1,1,1,3.3,4.3,2.4
7697,104,0,Asia Pacific,R&D,Legal & Compliance,Meets,Female,45,4,0,12,14,3.5,3.4,2.2,0.0977,1,1,1,1,4.4,4.2,2.6
7698,343,0,North America,Commercial,Pharmacovigilance,Meets,Male,43,4,1,5,13,0.0,2.8,1.6,0.0422,1,1,1,1,2.6,3.6,2.1
7699,495,0,Latin America,Manufacturing,IT & Digital,Meets,Female,29,14,0,8,10,4.0,3.9,2.3,0.0348,0,0,0,0,3.7,3.2,4.1
7700,112,0,Asia Pacific,R&D,Medical Affairs,Below,Female,47,14,0,9,13,3.8,3.1,4.7,0.0,1,1,1,1,2.6,2.5,3.8
7701,513,0,Latin America,Manufacturing,Pharmacovigilance,Meets,Male,30,10,0,9,22,4.5,1.8,1.7,0.0348,1,1,1,1,3.4,3.2,2.8
7702,1004,0,Asia Pacific,Finance,Data Science,Meets,Female,40,10,0,9,14,4.3,4.0,1.8,0.0331,1,1,1,0,3.4,4.3,1.5
7703,153,0,Middle East & Africa,R&D,Clinical Operations,Far Below,Male,36,11,0,7,40,1.8,3.0,1.0,0.0,1,1,1,1,3.2,3.2,1.8
7704,229,0,Middle East & Africa,Commercial,Marketing,Meets,Female,37,7,0,11,16,2.5,1.8,2.3,0.0422,1,1,1,1,1.7,3.2,3.2
7705,196,0,Middle East & Africa,Commercial,Communications,Far Below,Male,36,2,0,7,13,5.0,3.2,2.5,0.0,1,1,1,1,5.0,3.5,2.6
7706,635,0,Europe,Digital,Market Access,Meets,Male,41,11,1,11,41,0.0,1.4,1.7,0.0853,1,1,1,1,3.5,3.1,1.0
7707,203,0,Asia Pacific,Commercial,Legal & Compliance,Meets,Male,33,14,0,10,19,3.3,2.5,1.5,0.0422,0,0,0,0,3.5,2.4,2.0
7708,422,0,Europe,Manufacturing,Supply Chain,Meets,Male,44,13,0,12,18,3.2,3.7,1.9,0.0348,1,1,1,1,2.4,3.9,1.0
7709,1004,0,Latin America,Finance,Medical Affairs,Exceeds,Female,41,4,0,12,21,3.0,1.8,1.6,0.0588,1,1,1,1,5.0,2.1,1.0
7710,291,0,Europe,Commercial,Market Access,Meets,Male,37,15,1,6,15,0.0,2.4,1.9,0.0422,1,1,1,1,4.7,3.8,2.4
7711,118,0,Latin America,R&D,Sales,Meets,Male,43,21,0,6,13,3.4,3.4,2.8,0.0977,1,1,1,1,5.0,3.8,1.2
7712,209,0,Latin America,Commercial,Medical Affairs,Far Exceeds,Male,35,10,0,7,14,2.5,3.0,2.6,0.1275,1,1,1,1,3.2,3.0,1.3
7713,1011,0,Latin America,Finance,Data Science,Exceeds,Male,38,32,0,5,28,3.1,4.8,1.9,0.0588,1,1,1,1,3.0,5.0,2.7
7714,486,0,Europe,Manufacturing,Clinical Operations,Meets,Female,29,4,0,7,27,4.2,4.7,1.7,0.0348,1,1,1,1,4.6,3.7,2.6
7715,171,0,Asia Pacific,R&D,Finance & Accounting,Meets,Male,35,21,0,10,20,2.7,3.3,3.4,0.0977,1,1,1,1,1.3,4.0,3.3
7716,650,0,Europe,Digital,Marketing,Meets,Female,33,8,0,8,16,3.9,5.0,1.0,0.0853,1,1,1,1,2.8,5.0,1.7
7717,650,0,Asia Pacific,Digital,Market Access,Exceeds,Female,28,5,0,5,26,2.8,1.7,3.6,0.1452,1,1,1,1,2.1,2.2,3.0
7718,627,0,Asia Pacific,Digital,Sales,Far Below,Female,37,6,0,7,20,3.2,2.1,4.5,0.0,1,1,1,1,4.4,2.2,4.7
7719,112,0,Latin America,R&D,Human Resources,Meets,Male,37,10,0,11,24,4.5,3.1,2.3,0.0977,1,1,1,1,2.4,4.1,2.3
7720,664,0,Europe,Digital,Clinical Operations,Exceeds,Female,40,26,0,10,14,4.0,4.2,1.9,0.1452,1,1,1,0,4.0,2.5,1.8
7721,259,0,Asia Pacific,Commercial,Sales,Meets,Male,41,14,0,8,30,3.8,2.9,5.0,0.0422,1,1,1,1,4.6,3.3,5.0
7722,159,0,Middle East & Africa,R&D,Marketing,Meets,Male,37,10,0,7,18,2.5,2.7,3.3,0.0977,1,1,1,1,3.6,2.9,4.8
7723,93,0,Asia Pacific,R&D,Market Access,Meets,Female,41,5,0,7,15,4.3,1.4,1.1,0.0977,1,1,1,1,5.0,1.9,1.0
7724,45,0,Middle East & Africa,R&D,Sales,Meets,Female,43,14,0,5,21,2.5,2.5,2.5,0.0977,0,0,0,0,2.8,3.0,3.3
7725,786,0,Europe,HR,Clinical Operations,Meets,Male,45,20,0,11,22,3.2,2.6,1.6,0.0383,1,1,1,1,4.3,2.7,1.8
7726,423,0,Europe,Manufacturing,Legal & Compliance,Meets,Female,41,9,0,11,13,3.5,3.5,2.3,0.0348,0,0,0,0,4.1,4.6,3.3
7727,756,0,Europe,HR,Sales,Meets,Female,41,5,1,8,22,0.0,2.4,1.9,0.0383,0,0,0,0,2.6,2.3,1.0
7728,732,0,Asia Pacific,HR,Market Access,Exceeds,Male,32,29,0,6,18,3.6,3.1,3.9,0.0677,1,1,1,1,2.8,4.0,3.3
7729,871,0,North America,HR,Clinical Operations,Meets,Male,43,6,0,6,7,3.6,3.0,3.3,0.0383,1,1,1,1,1.7,2.2,2.7
7730,463,0,Asia Pacific,Manufacturing,Human Resources,Far Below,Male,32,18,0,10,16,2.7,1.4,3.4,0.0,1,1,1,1,1.0,2.4,2.6
7731,756,0,Asia Pacific,HR,Data Science,Meets,Male,40,18,0,9,10,4.3,2.7,1.4,0.0383,0,0,0,0,4.3,4.0,2.4
7732,577,0,Latin America,Digital,IT & Digital,Meets,Male,42,7,1,11,27,0.0,3.7,2.1,0.0853,1,1,1,1,2.9,1.8,1.8
7733,13,1,Latin America,R&D,Finance & Accounting,Meets,Male,41,5,0,8,10,1.9,1.8,1.1,0.0977,0,0,0,0,2.1,2.0,2.9
7734,47,0,Asia Pacific,R&D,Regulatory Affairs,Meets,Male,28,17,0,9,14,5.0,3.1,1.4,0.0977,1,1,1,1,4.2,2.5,1.9
7735,274,0,Middle East & Africa,Commercial,Finance & Accounting,Meets,Male,43,14,1,10,44,0.0,4.3,3.2,0.0422,1,1,1,1,3.5,4.9,3.8
7736,1034,0,Latin America,Finance,Clinical Operations,Meets,Male,47,22,1,12,18,0.0,4.1,2.4,0.0331,1,1,1,1,4.4,4.3,3.1
7737,676,1,Asia Pacific,Digital,Medical Affairs,Meets,Male,28,2,0,5,17,3.0,4.0,2.4,0.0853,1,1,1,1,4.0,4.7,4.1
7738,365,0,North America,Manufacturing,Regulatory Affairs,Exceeds,Male,39,14,0,7,14,4.4,3.3,3.8,0.0616,1,1,1,1,5.0,3.0,1.9
7739,984,0,Middle East & Africa,Finance,Sales,Below,Female,37,18,0,5,22,5.0,3.5,3.7,0.0,1,1,1,1,4.4,3.2,1.7
7740,142,0,Europe,R&D,Market Access,Meets,Male,38,13,0,12,19,3.5,2.3,3.5,0.0977,1,1,1,1,3.1,2.0,2.8
7741,828,0,Asia Pacific,HR,Clinical Operations,Meets,Female,46,22,0,6,19,3.9,2.5,2.5,0.0383,0,0,0,0,3.6,3.2,3.1
7742,287,0,Asia Pacific,Commercial,IT & Digital,Far Exceeds,Non-Binary/Other,39,10,0,8,18,3.0,3.3,2.4,0.1275,0,0,0,0,3.7,4.6,3.1
7743,354,0,Middle East & Africa,Commercial,Market Access,Below,Male,32,6,0,9,14,4.6,3.4,2.5,0.0,1,1,1,1,2.0,2.3,3.3
7744,49,0,Latin America,R&D,Clinical Operations,Meets,Male,34,18,1,8,27,0.0,3.6,2.3,0.0977,1,1,1,1,3.3,3.2,2.0
7745,535,0,Latin America,Digital,Human Resources,Exceeds,Female,33,20,0,6,27,4.1,3.2,2.0,0.1452,1,1,1,0,3.9,2.0,2.1
7746,1035,0,Latin America,Finance,Market Access,Exceeds,Male,28,34,0,11,26,5.0,4.2,1.0,0.0588,1,1,1,1,4.8,2.8,2.1
7747,320,0,Europe,Commercial,Medical Affairs,Exceeds,Male,35,10,0,9,16,4.3,4.5,2.7,0.0743,1,1,1,1,5.0,5.0,3.1
7748,66,0,Middle East & Africa,R&D,Supply Chain,Meets,Male,42,7,0,12,26,3.6,3.4,4.5,0.0977,1,0,0,0,3.0,2.9,3.0
7749,644,0,Middle East & Africa,Digital,Legal & Compliance,Exceeds,Male,40,17,0,9,18,2.8,3.5,1.9,0.1452,0,0,0,0,2.8,3.5,1.0
7750,34,0,Latin America,R&D,Legal & Compliance,Meets,Male,39,4,1,11,17,0.0,3.1,2.6,0.0977,1,1,1,1,3.4,1.5,3.2
7751,99,0,Latin America,R&D,Regulatory Affairs,Meets,Non-Binary/Other,36,4,1,12,17,0.0,1.3,2.8,0.0977,1,1,1,1,2.6,2.5,2.9
7752,657,0,North America,Digital,Regulatory Affairs,Meets,Male,38,4,0,6,22,3.7,2.0,4.1,0.0853,1,1,1,1,4.1,2.8,1.7
7753,618,0,North America,Digital,Clinical Operations,Meets,Female,41,2,1,6,13,0.0,3.8,3.7,0.0853,1,1,1,1,2.8,4.2,1.1
7754,577,0,Asia Pacific,Digital,Sales,Meets,Female,43,9,0,10,25,2.3,4.4,2.3,0.0853,1,1,1,1,3.4,2.7,3.1
7755,6,0,Asia Pacific,R&D,Marketing,Meets,Male,40,34,0,7,11,3.6,3.8,1.6,0.0977,1,1,1,1,3.0,2.8,2.5
7756,191,0,Middle East & Africa,Commercial,Finance & Accounting,Meets,Male,31,3,0,9,18,3.2,2.2,3.8,0.0422,1,1,1,1,3.9,3.0,4.1
7757,448,0,Middle East & Africa,Manufacturing,Marketing,Meets,Female,35,3,0,10,17,2.3,2.2,3.9,0.0348,1,1,1,1,4.4,2.1,3.0
7758,442,0,Europe,Manufacturing,Regulatory Affairs,Meets,Male,41,21,0,9,17,2.8,3.8,2.7,0.0348,1,1,1,1,3.4,3.5,2.3
7759,3,0,Europe,R&D,IT & Digital,Meets,Male,34,15,0,10,13,2.4,4.2,2.7,0.0977,0,0,0,0,3.0,4.3,4.3
7760,153,0,North America,R&D,IT & Digital,Meets,Male,34,15,0,11,23,3.1,3.5,3.8,0.0977,1,1,1,1,3.5,2.4,3.2
7761,328,0,Asia Pacific,Commercial,Supply Chain,Meets,Male,42,8,0,5,20,3.4,4.0,1.9,0.0422,1,1,1,1,2.2,1.9,3.4
7762,615,0,North America,Digital,Marketing,Meets,Male,43,11,0,11,17,2.6,4.6,2.9,0.0853,1,1,1,1,2.2,4.4,2.9
7763,15,0,North America,R&D,Quality Assurance,Meets,Female,32,28,0,6,19,1.9,3.8,1.1,0.0977,1,1,1,1,2.9,3.3,2.0
7764,738,0,Asia Pacific,HR,Marketing,Meets,Male,30,4,1,12,16,0.0,3.4,2.6,0.0383,1,1,1,1,4.1,3.2,3.9
7765,552,0,Europe,Digital,Pharmacovigilance,Meets,Male,31,4,1,6,18,0.0,3.6,2.6,0.0853,1,1,1,1,2.1,3.9,3.5
7766,36,0,Asia Pacific,R&D,Market Access,Meets,Female,42,14,0,8,15,3.9,3.2,1.8,0.0977,1,1,1,1,3.9,3.5,3.0
7767,874,0,Latin America,HR,Regulatory Affairs,Far Below,Female,33,18,1,11,36,0.0,2.9,1.7,0.0,1,1,1,1,3.4,3.9,2.8
7768,1008,0,Latin America,Finance,Supply Chain,Meets,Female,35,16,0,12,24,3.8,2.6,2.0,0.0331,1,1,1,1,3.5,3.0,3.0
7769,312,0,Latin America,Commercial,Sales,Meets,Female,31,8,0,12,28,3.1,3.1,1.1,0.0422,0,0,0,0,2.2,4.3,1.8
7770,880,0,Middle East & Africa,HR,Clinical Operations,Far Exceeds,Male,38,17,0,8,28,4.4,3.2,1.3,0.1168,1,1,1,1,3.9,3.1,2.3
7771,114,0,Europe,R&D,Data Science,Far Below,Female,37,14,1,7,13,0.0,5.0,3.1,0.0,1,1,1,1,5.0,3.2,3.3
7772,416,0,Europe,Manufacturing,Medical Affairs,Meets,Female,41,5,1,12,18,0.0,3.5,3.2,0.0348,0,0,0,0,3.0,5.0,3.2
7773,150,0,Middle East & Africa,R&D,IT & Digital,Exceeds,Female,40,9,1,9,33,0.0,3.2,3.4,0.1648,1,1,1,1,3.2,3.3,3.4
7774,406,0,North America,Manufacturing,Regulatory Affairs,Exceeds,Female,28,5,1,6,22,0.0,3.3,4.9,0.0616,1,1,1,1,4.7,3.0,3.6
7775,184,0,Latin America,Commercial,Supply Chain,Far Below,Female,40,18,0,12,26,2.8,3.2,3.2,0.0,1,0,0,0,4.0,3.5,2.4
7776,279,0,Latin America,Commercial,Clinical Operations,Meets,Female,37,8,0,8,11,1.0,3.4,2.4,0.0422,1,1,1,1,1.8,3.3,2.6
7777,588,0,North America,Digital,Data Science,Far Below,Female,45,8,1,9,16,0.0,2.7,3.7,0.0,1,1,1,1,1.6,5.0,3.0
7778,557,0,Asia Pacific,Digital,IT & Digital,Meets,Female,33,7,0,10,19,4.4,3.4,2.3,0.0853,1,1,1,1,2.5,2.2,2.0
7779,467,0,Asia Pacific,Manufacturing,Pharmacovigilance,Meets,Female,41,8,0,11,15,4.2,3.9,4.4,0.0348,1,1,1,1,4.4,3.7,4.3
7780,420,0,Europe,Manufacturing,Human Resources,Meets,Male,39,12,1,7,17,0.0,4.5,3.4,0.0348,0,0,0,0,3.5,3.6,4.6
7781,350,0,Middle East & Africa,Commercial,Legal & Compliance,Exceeds,Male,33,17,0,10,14,4.9,3.3,5.0,0.0743,1,1,1,1,5.0,2.7,4.6
7782,864,0,Europe,HR,Regulatory Affairs,Far Exceeds,Female,44,13,0,5,16,2.6,3.4,1.7,0.1168,1,1,1,1,3.4,2.4,2.2
7783,502,0,Asia Pacific,Manufacturing,Sales,Exceeds,Female,40,14,0,6,14,5.0,4.1,2.4,0.0616,1,1,1,1,4.9,2.7,2.2
7784,358,0,North America,Manufacturing,Medical Affairs,Meets,Male,36,5,1,11,12,0.0,2.5,3.1,0.0348,1,1,1,1,4.1,2.9,3.7
7785,769,0,Europe,HR,IT & Digital,Below,Female,33,8,0,11,21,3.0,4.5,4.0,0.0,1,1,1,1,2.8,3.9,3.6
7786,538,0,Latin America,Digital,Data Science,Meets,Male,45,22,0,7,32,1.7,2.0,1.7,0.0853,0,0,0,0,1.6,3.0,2.7
7787,572,0,Latin America,Digital,Sales,Meets,Female,43,23,0,10,14,3.0,2.5,3.4,0.0853,1,1,1,1,3.1,3.5,2.5
7788,490,0,North America,Manufacturing,Marketing,Far Below,Female,38,13,1,9,13,0.0,4.2,3.2,0.0,1,1,1,1,4.3,3.5,3.4
7789,582,0,Asia Pacific,Digital,Clinical Operations,Meets,Female,38,1,0,9,15,3.1,3.5,2.3,0.0853,1,1,1,1,4.6,2.6,1.2
7790,677,0,Latin America,Digital,Regulatory Affairs,Exceeds,Female,31,13,0,5,10,1.9,2.1,1.0,0.1452,1,1,1,1,3.9,4.2,2.4
7791,997,0,Latin America,Finance,Clinical Operations,Exceeds,Male,46,6,0,5,19,3.5,4.6,4.7,0.0588,1,1,0,0,5.0,4.3,3.1
7792,536,0,Middle East & Africa,Digital,Data Science,Meets,Male,31,18,0,5,9,3.3,4.5,2.5,0.0853,1,1,1,1,4.0,4.8,3.1
7793,325,1,Europe,Commercial,Quality Assurance,Meets,Male,43,2,0,11,19,3.4,1.7,1.8,0.0422,1,1,1,1,3.8,3.0,2.1
7794,109,0,Asia Pacific,R&D,Quality Assurance,Meets,Female,50,4,1,12,14,0.0,3.8,2.1,0.0977,1,1,1,1,4.7,3.7,3.2
7795,444,1,Europe,Manufacturing,Medical Affairs,Exceeds,Female,33,8,1,9,17,0.0,2.1,3.0,0.0616,1,1,0,0,4.3,2.3,3.8
7796,361,0,Asia Pacific,Manufacturing,Marketing,Meets,Male,35,21,0,9,15,3.4,4.3,2.8,0.0348,1,1,1,1,3.0,2.5,3.7
7797,266,0,Latin America,Commercial,IT & Digital,Far Exceeds,Male,33,6,1,9,24,0.0,4.6,2.2,0.1275,1,1,1,1,4.6,4.2,3.5
7798,81,0,Middle East & Africa,R&D,Pharmacovigilance,Meets,Female,45,15,0,11,16,2.8,3.5,3.3,0.0977,1,1,1,1,3.7,2.7,2.8
7799,32,0,Europe,R&D,Legal & Compliance,Far Exceeds,Female,39,11,1,11,16,0.0,3.0,2.4,0.2644,0,0,0,0,3.7,1.9,3.7
7800,257,0,Latin America,Commercial,Supply Chain,Meets,Female,29,14,0,10,26,3.4,2.4,1.1,0.0422,1,1,1,1,4.0,2.8,1.3
7801,775,0,Asia Pacific,HR,Regulatory Affairs,Exceeds,Female,32,8,1,10,19,0.0,3.3,3.5,0.0677,1,1,1,1,2.8,3.8,3.9
7802,790,0,Europe,HR,Human Resources,Exceeds,Male,42,8,0,12,25,4.5,2.3,1.9,0.0677,1,1,1,1,5.0,2.1,1.0
7803,81,0,Europe,R&D,Regulatory Affairs,Meets,Male,34,6,1,5,10,0.0,4.2,2.3,0.0977,0,0,0,0,3.7,4.2,1.2
7804,787,0,Latin America,HR,Data Science,Meets,Female,28,3,0,7,35,3.8,2.0,2.0,0.0383,1,1,1,1,4.7,3.3,4.2
7805,727,0,Europe,HR,Quality Assurance,Exceeds,Male,41,8,0,8,26,2.4,2.4,2.6,0.0677,0,0,0,0,4.1,2.7,3.0
7806,823,0,Middle East & Africa,HR,Market Access,Below,Male,40,5,1,12,18,0.0,3.5,1.7,0.0,1,1,1,1,2.3,3.3,1.1
7807,88,0,Middle East & Africa,R&D,Communications,Meets,Male,33,17,0,10,12,4.1,3.2,2.5,0.0977,1,1,1,1,4.2,3.0,3.8
7808,867,0,Latin America,HR,Pharmacovigilance,Exceeds,Male,36,9,0,5,8,1.5,3.7,3.8,0.0677,1,1,1,1,3.5,4.0,4.0
7809,496,0,Asia Pacific,Manufacturing,Finance & Accounting,Exceeds,Male,36,11,0,8,12,2.1,3.3,4.0,0.0616,1,1,1,1,3.3,1.9,2.6
7810,1016,0,Latin America,Finance,Legal & Compliance,Below,Female,37,8,0,8,19,4.5,4.9,1.7,0.0,0,0,0,0,3.8,3.4,2.6
7811,43,0,Middle East & Africa,R&D,Data Science,Meets,Non-Binary/Other,46,9,0,5,8,5.0,3.6,3.1,0.0977,1,1,1,1,4.0,2.9,3.5
7812,242,0,North America,Commercial,Pharmacovigilance,Meets,Male,42,6,0,12,38,4.4,4.2,3.4,0.0422,0,0,0,0,2.8,4.2,2.6
7813,770,0,North America,HR,IT & Digital,Meets,Female,41,8,0,9,15,2.3,2.9,2.7,0.0383,1,1,1,1,3.8,3.3,2.2
7814,527,0,Europe,Digital,IT & Digital,Exceeds,Male,37,7,0,5,9,3.7,2.4,2.2,0.1452,1,1,1,0,3.1,2.0,1.0
7815,175,0,Europe,R&D,Market Access,Meets,Male,33,22,0,11,31,2.1,2.9,1.4,0.0977,1,1,1,1,4.6,2.6,1.7
7816,277,1,North America,Commercial,IT & Digital,Far Exceeds,Female,47,17,1,5,16,0.0,3.0,3.5,0.1275,1,1,1,1,2.2,3.9,2.5
7817,884,0,Middle East & Africa,Finance,Quality Assurance,Below,Non-Binary/Other,38,3,0,5,14,2.7,3.0,3.5,0.0,1,0,0,0,1.6,3.3,2.7
7818,461,0,Europe,Manufacturing,Sales,Meets,Female,32,9,0,11,21,4.5,2.4,2.5,0.0348,1,1,1,1,3.3,3.7,3.3
7819,212,0,Latin America,Commercial,Human Resources,Exceeds,Male,55,13,1,8,12,0.0,2.0,2.1,0.0743,1,1,1,1,2.0,4.1,3.5
7820,876,0,Latin America,HR,Market Access,Meets,Male,39,17,1,11,14,0.0,2.5,1.9,0.0383,1,1,1,1,2.4,2.7,3.1
7821,667,0,Middle East & Africa,Digital,Data Science,Meets,Female,31,15,0,12,25,3.7,3.8,1.0,0.0853,1,1,1,1,3.5,2.5,2.2
7822,707,0,Europe,HR,Human Resources,Far Exceeds,Male,43,9,0,10,19,3.0,3.4,1.6,0.1168,1,1,1,1,3.8,4.5,1.7
7823,178,0,Latin America,Commercial,Supply Chain,Exceeds,Female,44,6,0,5,18,2.9,3.0,2.8,0.0743,1,1,1,1,1.8,3.2,2.4
7824,142,0,Europe,R&D,Pharmacovigilance,Meets,Male,36,13,0,6,10,4.5,3.8,2.4,0.0977,1,1,1,1,3.3,3.8,3.4
7825,551,0,Europe,Digital,IT & Digital,Meets,Female,33,8,1,8,12,0.0,1.4,1.0,0.0853,1,1,1,1,5.0,2.6,2.0
7826,546,0,Latin America,Digital,Marketing,Far Below,Female,36,11,0,9,19,2.1,4.1,4.1,0.0,1,1,1,1,3.0,3.9,2.2
7827,269,0,North America,Commercial,Data Science,Far Exceeds,Male,42,2,0,7,11,2.9,4.4,1.4,0.1275,1,1,1,1,4.2,4.0,1.5
7828,957,0,Latin America,Finance,Sales,Exceeds,Female,43,4,0,7,36,2.8,2.7,3.0,0.0588,1,1,1,1,4.1,2.9,2.0
7829,977,0,Middle East & Africa,Finance,Supply Chain,Far Below,Male,34,7,1,6,24,0.0,2.7,4.6,0.0,1,1,1,1,3.2,2.2,3.9
7830,781,0,Asia Pacific,HR,Quality Assurance,Below,Male,46,17,0,6,20,2.6,2.6,2.5,0.0,1,1,1,1,3.4,1.3,2.2
7831,276,0,Latin America,Commercial,Finance & Accounting,Exceeds,Male,29,10,0,9,15,3.3,1.7,3.3,0.0743,1,1,1,1,4.4,1.2,3.9
7832,559,0,Europe,Digital,Legal & Compliance,Below,Male,34,16,0,10,18,3.7,3.2,3.5,0.0,1,1,1,1,4.5,2.9,3.2
7833,326,0,Europe,Commercial,IT & Digital,Exceeds,Male,37,21,0,9,15,3.8,1.2,1.4,0.0743,1,1,1,1,2.4,1.1,2.1
7834,597,1,Latin America,Digital,Medical Affairs,Far Exceeds,Male,36,16,0,11,13,3.5,3.2,3.0,0.2363,1,1,1,1,2.9,3.6,3.8
7835,798,0,Asia Pacific,HR,Regulatory Affairs,Exceeds,Male,35,6,1,6,21,0.0,3.1,1.5,0.0677,1,1,1,1,2.9,2.8,2.7
7836,55,0,Latin America,R&D,Market Access,Meets,Non-Binary/Other,46,10,0,8,14,3.7,3.8,1.9,0.0977,1,1,1,1,3.7,3.9,3.0
7837,101,0,Asia Pacific,R&D,Regulatory Affairs,Meets,Male,37,6,1,10,20,0.0,2.6,2.3,0.0977,1,1,1,1,4.2,3.3,2.6
7838,269,0,Asia Pacific,Commercial,IT & Digital,Below,Female,40,11,0,10,23,1.8,3.8,1.7,0.0,1,1,1,1,2.6,2.1,2.3
7839,530,0,Middle East & Africa,Digital,Data Science,Meets,Female,40,12,0,9,17,2.9,2.9,2.1,0.0853,1,1,1,1,3.4,3.5,2.0
7840,87,0,Europe,R&D,Quality Assurance,Meets,Female,40,8,0,8,33,3.5,3.9,2.2,0.0977,1,1,1,1,4.0,4.6,2.1
7841,630,0,Europe,Digital,Clinical Operations,Meets,Female,37,10,0,5,18,3.1,3.4,2.8,0.0853,1,1,1,1,4.3,3.0,2.9
7842,706,0,Asia Pacific,HR,Legal & Compliance,Meets,Male,28,10,0,5,13,2.6,3.9,3.0,0.0383,0,0,0,0,3.3,3.9,4.2
7843,219,0,Europe,Commercial,Supply Chain,Meets,Male,43,5,0,9,20,1.5,3.4,3.9,0.0422,1,1,1,1,2.2,3.1,2.5
7844,560,0,North America,Digital,Marketing,Meets,Male,38,19,0,7,16,4.1,2.8,2.5,0.0853,1,1,1,1,3.3,2.4,1.5
7845,290,0,Asia Pacific,Commercial,Legal & Compliance,Exceeds,Female,35,11,0,7,12,3.9,3.6,2.9,0.0743,0,0,0,0,3.1,4.5,1.7
7846,647,0,Europe,Digital,Regulatory Affairs,Meets,Female,35,15,1,12,14,0.0,3.4,4.7,0.0853,1,1,1,1,2.7,2.3,3.8
7847,956,0,North America,Finance,Pharmacovigilance,Meets,Female,40,5,0,8,17,4.9,3.4,2.4,0.0331,1,1,1,1,4.8,2.5,2.5
7848,907,0,Middle East & Africa,Finance,Finance & Accounting,Meets,Male,35,7,0,12,35,3.4,2.1,4.6,0.0331,1,1,1,1,3.1,3.3,2.6
7849,677,0,Europe,Digital,IT & Digital,Far Below,Female,37,15,0,10,29,2.8,3.9,3.7,0.0,1,1,1,1,4.0,2.9,2.2
7850,817,0,North America,HR,Sales,Exceeds,Female,42,6,1,7,11,0.0,3.3,2.6,0.0677,1,1,1,1,2.4,4.0,3.0
7851,315,0,Latin America,Commercial,Regulatory Affairs,Meets,Male,39,13,0,7,12,2.7,2.3,1.2,0.0422,1,1,1,1,2.7,4.0,1.6
7852,371,0,Latin America,Manufacturing,Data Science,Below,Male,33,3,1,10,24,0.0,3.3,2.4,0.0,1,1,1,1,1.8,2.6,4.2
7853,670,0,North America,Digital,Supply Chain,Meets,Female,41,23,0,8,8,3.3,3.2,1.0,0.0853,1,1,1,1,2.5,3.4,2.0
7854,612,1,Asia Pacific,Digital,Supply Chain,Far Exceeds,Female,36,15,0,11,27,3.5,4.6,2.8,0.2363,1,1,1,1,3.3,4.1,2.6
7855,903,0,Asia Pacific,Finance,Market Access,Meets,Male,43,9,1,10,22,0.0,2.4,5.0,0.0331,1,1,1,1,2.5,2.2,3.8
7856,4,1,Europe,R&D,Clinical Operations,Meets,Male,36,8,1,10,12,0.0,3.3,2.4,0.0977,1,1,1,1,4.4,2.7,2.7
7857,943,0,Latin America,Finance,Communications,Meets,Male,39,14,0,11,21,2.9,3.4,3.4,0.0331,1,1,1,1,3.2,3.7,2.5
7858,333,0,Asia Pacific,Commercial,Market Access,Meets,Female,42,10,1,7,9,0.0,1.7,2.5,0.0422,1,1,1,1,2.9,2.6,1.0
7859,918,0,Asia Pacific,Finance,Legal & Compliance,Far Below,Female,33,4,0,12,18,2.6,2.6,3.9,0.0,1,1,1,1,2.3,1.5,3.7
7860,445,0,Latin America,Manufacturing,Human Resources,Exceeds,Male,42,14,0,7,12,3.5,3.1,1.6,0.0616,1,1,1,1,3.9,3.1,2.9
7861,819,0,Middle East & Africa,HR,Human Resources,Meets,Female,48,6,1,10,11,0.0,1.0,2.7,0.0383,1,1,1,1,3.4,2.1,4.6
7862,407,0,Asia Pacific,Manufacturing,IT & Digital,Exceeds,Female,41,11,1,8,14,0.0,3.8,1.4,0.0616,1,1,1,1,3.6,3.2,1.5
7863,764,0,North America,HR,Medical Affairs,Meets,Female,39,12,1,11,22,0.0,3.1,4.1,0.0383,1,1,1,1,2.8,3.6,3.7
7864,402,0,Europe,Manufacturing,Marketing,Below,Male,43,16,0,5,12,2.4,3.5,2.7,0.0,1,1,1,1,3.8,3.1,2.6
7865,925,0,Asia Pacific,Finance,Quality Assurance,Exceeds,Male,43,15,0,8,9,3.1,3.8,3.2,0.0588,1,1,1,1,2.8,4.3,3.6
7866,407,0,Asia Pacific,Manufacturing,Data Science,Meets,Male,39,11,0,8,14,3.0,2.6,3.2,0.0348,0,0,0,0,2.9,2.0,3.3
7867,888,0,Middle East & Africa,Finance,Legal & Compliance,Meets,Male,32,15,1,6,10,0.0,1.4,1.2,0.0331,1,1,1,1,2.4,1.9,3.1
7868,962,1,North America,Finance,Data Science,Exceeds,Female,34,17,0,8,29,2.6,1.0,1.4,0.0588,1,1,1,1,4.4,1.4,1.4
7869,200,0,Europe,Commercial,Quality Assurance,Far Exceeds,Male,36,25,0,7,16,2.5,4.0,3.3,0.1275,1,1,1,1,3.8,1.7,2.4
7870,1045,0,Asia Pacific,Finance,Quality Assurance,Below,Female,30,9,0,9,13,2.4,4.1,3.1,0.0,0,0,0,0,3.2,3.4,3.0
7871,61,0,Europe,R&D,Quality Assurance,Far Below,Female,46,15,1,9,23,0.0,2.9,3.1,0.0,1,1,1,1,3.2,2.8,3.3
7872,355,0,Latin America,Manufacturing,Clinical Operations,Meets,Male,32,10,1,10,11,0.0,4.1,3.5,0.0348,1,1,1,1,3.1,2.4,4.2
7873,587,0,Asia Pacific,Digital,Quality Assurance,Meets,Female,38,8,1,10,28,0.0,3.9,2.5,0.0853,1,1,1,1,2.0,2.3,2.0
7874,583,0,Asia Pacific,Digital,Quality Assurance,Meets,Male,33,5,1,5,9,0.0,3.9,2.2,0.0853,1,1,1,1,3.6,3.5,1.0
7875,612,0,Latin America,Digital,Regulatory Affairs,Below,Male,42,8,0,9,27,4.9,3.7,1.2,0.0,1,1,1,1,5.0,2.4,3.1
7876,87,0,Middle East & Africa,R&D,IT & Digital,Meets,Female,44,17,0,8,16,1.9,2.3,4.1,0.0977,1,1,1,1,2.6,2.6,3.2
7877,988,0,Asia Pacific,Finance,Pharmacovigilance,Below,Female,30,9,1,11,18,0.0,5.0,2.8,0.0,1,1,1,1,2.1,4.1,2.3
7878,441,0,Europe,Manufacturing,Supply Chain,Exceeds,Male,42,14,1,6,22,0.0,2.4,1.1,0.0616,0,0,0,0,5.0,2.1,1.8
7879,869,0,North America,HR,Quality Assurance,Meets,Female,31,8,0,12,19,3.1,3.8,1.6,0.0383,1,1,1,1,3.9,3.2,2.6
7880,775,0,Europe,HR,Regulatory Affairs,Below,Male,36,12,0,12,21,4.3,2.6,2.6,0.0,1,1,1,1,3.6,3.4,2.9
7881,196,0,Middle East & Africa,Commercial,Medical Affairs,Exceeds,Male,54,11,0,6,13,1.0,4.1,2.9,0.0743,1,1,0,0,1.7,3.3,2.6
7882,48,0,North America,R&D,Supply Chain,Meets,Male,40,2,0,11,27,3.1,2.8,3.9,0.0977,1,1,1,1,3.3,3.6,2.8
7883,381,0,Europe,Manufacturing,Marketing,Meets,Male,43,14,0,9,15,1.5,4.5,3.3,0.0348,1,1,1,1,1.4,4.4,3.9
7884,1043,0,Europe,Finance,Supply Chain,Below,Male,40,3,0,10,14,3.4,3.8,1.4,0.0,0,0,0,0,3.9,2.8,1.7
7885,569,1,Latin America,Digital,Clinical Operations,Exceeds,Female,37,13,0,10,15,3.4,5.0,2.8,0.1452,1,1,1,1,3.5,3.5,3.4
7886,157,0,Middle East & Africa,R&D,Quality Assurance,Meets,Non-Binary/Other,34,10,0,7,15,2.3,1.4,2.4,0.0977,1,1,1,1,3.8,3.4,3.8
7887,92,0,Latin America,R&D,Finance & Accounting,Far Below,Female,47,11,0,5,18,3.3,3.4,2.6,0.0,1,1,1,1,3.6,1.7,3.9
7888,369,0,North America,Manufacturing,Supply Chain,Far Exceeds,Female,50,4,1,9,19,0.0,3.7,3.7,0.1069,1,1,0,0,2.4,3.8,2.3
7889,1049,1,Latin America,Finance,Finance & Accounting,Meets,Female,38,7,1,10,20,0.0,2.0,4.0,0.0331,1,1,1,1,3.3,2.9,4.1
7890,307,0,Middle East & Africa,Commercial,Medical Affairs,Exceeds,Female,45,8,0,12,38,4.0,4.4,4.0,0.0743,1,1,1,1,2.9,3.9,2.0
7891,1038,0,Asia Pacific,Finance,Clinical Operations,Meets,Male,43,2,1,6,9,0.0,1.8,2.9,0.0331,1,1,1,1,2.0,2.0,3.0
7892,240,0,Asia Pacific,Commercial,Communications,Exceeds,Female,37,24,0,11,13,4.3,2.5,3.4,0.0743,0,0,0,0,3.3,2.8,4.0
7893,329,0,North America,Commercial,Quality Assurance,Meets,Non-Binary/Other,38,13,1,7,9,0.0,3.7,2.9,0.0422,1,1,1,1,3.8,3.8,2.6
7894,694,0,Asia Pacific,Digital,Market Access,Exceeds,Male,35,5,0,7,13,3.3,1.0,2.2,0.1452,1,1,1,1,4.1,2.7,1.8
7895,542,1,Latin America,Digital,Supply Chain,Far Exceeds,Male,50,25,0,12,24,3.6,2.6,1.5,0.2363,1,1,1,1,4.0,2.2,1.7
7896,407,0,North America,Manufacturing,Quality Assurance,Exceeds,Male,43,16,0,10,15,2.9,4.1,1.5,0.0616,1,1,1,1,4.3,2.5,1.0
7897,974,0,Middle East & Africa,Finance,Market Access,Meets,Male,38,23,0,8,11,2.8,2.2,3.2,0.0331,1,1,1,1,2.7,2.7,2.7
7898,222,0,North America,Commercial,Clinical Operations,Exceeds,Female,35,12,0,11,17,3.9,4.0,3.1,0.0743,1,1,1,1,3.0,4.6,2.9
7899,468,0,North America,Manufacturing,Sales,Meets,Female,41,7,1,9,19,0.0,3.8,3.2,0.0348,1,1,1,1,1.6,4.6,5.0
7900,284,0,Europe,Commercial,Pharmacovigilance,Below,Male,30,7,1,11,17,0.0,1.9,3.5,0.0,1,1,1,1,4.8,3.9,3.7
7901,71,1,Europe,R&D,Sales,Exceeds,Male,33,10,0,8,28,4.3,1.8,4.2,0.1648,1,1,1,1,3.7,3.1,4.2
7902,867,0,North America,HR,Finance & Accounting,Meets,Female,37,10,1,6,30,0.0,3.0,3.1,0.0383,1,1,1,1,2.6,4.1,1.0
7903,715,0,Asia Pacific,HR,Legal & Compliance,Below,Female,35,17,0,5,20,3.5,3.1,2.4,0.0,1,1,1,1,4.0,1.6,3.5
7904,227,0,Europe,Commercial,Legal & Compliance,Meets,Female,37,11,0,9,11,3.8,3.5,1.3,0.0422,1,1,1,1,3.6,3.0,2.4
7905,511,0,Middle East & Africa,Manufacturing,Market Access,Meets,Male,42,20,0,8,20,4.1,2.1,3.1,0.0348,1,1,1,1,2.3,1.8,5.0
7906,557,0,Latin America,Digital,IT & Digital,Meets,Male,50,14,0,10,20,2.9,3.5,2.0,0.0853,0,0,0,0,3.7,3.4,1.6
7907,964,0,Europe,Finance,Data Science,Meets,Male,42,28,0,5,10,3.4,4.0,2.0,0.0331,1,1,1,1,3.2,3.8,1.0
7908,197,0,North America,Commercial,Pharmacovigilance,Meets,Male,37,6,1,5,30,0.0,2.9,2.3,0.0422,1,1,1,1,3.7,1.5,2.9
7909,193,0,Asia Pacific,Commercial,Finance & Accounting,Meets,Male,44,7,1,6,27,0.0,5.0,3.1,0.0422,1,1,1,1,2.4,3.1,3.9
7910,946,0,Latin America,Finance,Pharmacovigilance,Exceeds,Male,38,20,1,10,19,0.0,2.4,2.9,0.0588,1,1,1,1,2.8,2.1,4.1
7911,604,0,Europe,Digital,Medical Affairs,Meets,Female,28,13,0,12,21,3.1,3.3,4.2,0.0853,1,1,1,1,2.6,1.1,4.3
7912,342,0,Asia Pacific,Commercial,Medical Affairs,Meets,Male,45,10,0,5,15,3.5,2.9,2.3,0.0422,1,1,1,1,3.5,2.2,2.6
7913,85,0,Asia Pacific,R&D,Human Resources,Meets,Female,31,6,0,12,20,2.3,2.3,1.3,0.0977,0,0,0,0,2.4,2.4,2.3
7914,570,0,Asia Pacific,Digital,Quality Assurance,Far Below,Male,39,4,0,8,12,4.1,5.0,1.5,0.0,1,1,1,1,3.6,4.1,1.7
7915,9,0,North America,R&D,Supply Chain,Meets,Male,33,28,0,10,22,2.7,3.0,1.0,0.0977,1,1,1,1,3.1,2.1,4.0
7916,722,0,Middle East & Africa,HR,Human Resources,Far Below,Male,31,30,0,11,20,2.6,2.5,3.4,0.0,1,0,0,0,2.6,3.3,4.3
7917,1037,0,Asia Pacific,Finance,Sales,Meets,Female,35,5,1,8,16,0.0,2.1,3.5,0.0331,1,1,1,1,3.6,2.5,2.2
7918,587,0,Latin America,Digital,Marketing,Meets,Male,28,15,0,12,42,3.8,4.1,2.0,0.0853,0,0,0,0,3.7,3.4,3.1
7919,581,0,Europe,Digital,Communications,Meets,Male,34,18,0,7,9,4.3,4.4,2.1,0.0853,1,1,1,1,3.1,4.4,4.0
7920,489,0,Latin America,Manufacturing,Data Science,Meets,Male,41,5,0,11,21,3.1,4.2,3.0,0.0348,0,0,0,0,3.5,4.2,2.9
7921,516,0,North America,Manufacturing,Legal & Compliance,Exceeds,Female,40,27,0,12,22,2.0,2.9,1.5,0.0616,1,1,1,1,2.9,2.6,2.2
7922,949,0,North America,Finance,Communications,Far Below,Female,28,12,0,6,14,2.3,3.0,1.8,0.0,1,1,1,1,3.2,1.9,1.2
7923,639,1,Latin America,Digital,Marketing,Meets,Male,44,10,0,11,33,3.0,3.3,2.9,0.0853,1,1,1,0,4.8,2.8,2.6
7924,866,0,Middle East & Africa,HR,Finance & Accounting,Exceeds,Female,52,20,0,5,12,2.8,1.9,3.5,0.0677,1,1,1,1,3.1,3.0,2.8
7925,234,0,North America,Commercial,Quality Assurance,Exceeds,Male,48,12,0,5,11,2.0,2.2,2.3,0.0743,1,1,1,1,3.3,3.7,2.9
7926,929,0,North America,Finance,Market Access,Meets,Male,35,24,0,8,11,3.5,5.0,1.1,0.0331,0,0,0,0,2.7,3.1,2.6
7927,1037,0,Latin America,Finance,Legal & Compliance,Meets,Female,34,28,0,5,18,3.0,4.2,2.6,0.0331,0,0,0,0,3.8,3.1,2.6
7928,390,0,North America,Manufacturing,Finance & Accounting,Below,Non-Binary/Other,33,6,0,12,22,3.9,2.6,2.4,0.0,1,1,1,1,2.4,4.0,2.7
7929,772,0,Middle East & Africa,HR,Human Resources,Below,Female,49,19,0,5,9,3.5,2.3,2.1,0.0,1,1,1,1,2.1,1.7,3.1
7930,1016,0,Middle East & Africa,Finance,Pharmacovigilance,Meets,Male,35,9,1,12,26,0.0,3.8,3.1,0.0331,0,0,0,0,2.2,3.4,2.9
7931,727,0,Middle East & Africa,HR,Data Science,Far Below,Male,34,9,0,11,26,3.1,5.0,2.9,0.0,1,1,1,1,1.9,2.5,2.9
7932,977,1,Europe,Finance,Quality Assurance,Exceeds,Female,43,15,0,11,15,3.3,3.0,1.1,0.0588,0,0,0,0,5.0,2.4,2.6
7933,488,0,Middle East & Africa,Manufacturing,IT & Digital,Meets,Male,45,13,0,12,24,4.6,3.1,1.6,0.0348,1,1,1,0,4.0,3.6,2.7
7934,320,0,Middle East & Africa,Commercial,Data Science,Far Below,Female,44,7,1,6,11,0.0,4.5,3.0,0.0,1,1,1,1,1.7,3.1,4.4
7935,417,0,Europe,Manufacturing,Regulatory Affairs,Meets,Female,32,14,0,10,32,3.5,2.7,2.9,0.0348,1,1,1,1,3.1,1.9,1.1
7936,1001,0,Asia Pacific,Finance,Sales,Meets,Female,41,15,1,5,40,0.0,3.3,2.9,0.0331,1,1,1,1,4.4,3.5,3.1
7937,705,0,North America,HR,Legal & Compliance,Far Below,Male,47,11,0,11,12,2.6,3.2,2.7,0.0,1,1,1,1,3.0,3.9,1.0
7938,150,1,Middle East & Africa,R&D,Medical Affairs,Meets,Male,38,5,0,10,14,3.8,1.9,2.9,0.0977,1,1,1,1,4.6,2.9,3.2
7939,411,0,North America,Manufacturing,Finance & Accounting,Exceeds,Female,40,6,0,8,16,2.9,3.7,2.4,0.0616,1,0,0,0,2.7,2.2,2.3
7940,863,0,Latin America,HR,Sales,Far Exceeds,Non-Binary/Other,39,12,0,8,14,2.1,1.8,3.1,0.1168,1,1,1,1,1.2,3.3,1.2
7941,494,0,North America,Manufacturing,Marketing,Meets,Male,36,10,0,11,21,2.5,2.8,1.6,0.0348,1,1,1,1,2.9,3.7,3.1
7942,918,0,Europe,Finance,Communications,Exceeds,Female,41,12,0,9,13,3.7,1.0,2.1,0.0588,1,1,1,1,3.5,3.5,2.9
7943,717,0,North America,HR,Data Science,Meets,Female,43,12,0,11,20,3.5,3.0,3.0,0.0383,1,1,1,1,4.8,4.2,4.0
7944,266,0,North America,Commercial,Clinical Operations,Meets,Female,46,9,0,12,23,2.0,4.3,4.3,0.0422,1,1,1,1,1.7,3.1,1.7
7945,701,0,North America,HR,Communications,Meets,Female,38,9,0,7,14,1.8,3.3,1.9,0.0383,0,0,0,0,2.7,2.9,1.9
7946,687,0,Asia Pacific,Digital,Medical Affairs,Meets,Female,38,9,0,11,22,3.0,1.8,1.2,0.0853,1,1,1,1,3.7,1.6,2.8
7947,82,0,Asia Pacific,R&D,Marketing,Below,Female,35,20,0,12,48,1.0,4.4,2.3,0.0,1,1,1,1,2.5,2.9,2.0
7948,1019,0,Latin America,Finance,Regulatory Affairs,Meets,Male,47,10,0,6,19,4.6,2.0,2.6,0.0331,1,1,1,1,3.9,2.2,1.7
7949,700,0,Europe,HR,Regulatory Affairs,Far Exceeds,Female,35,12,0,12,32,3.1,2.5,2.2,0.1168,1,1,1,1,3.0,3.5,2.8
7950,1024,0,North America,Finance,Clinical Operations,Meets,Female,37,7,0,8,11,4.0,4.4,3.9,0.0331,1,1,1,1,3.6,3.2,3.8
7951,460,0,North America,Manufacturing,Pharmacovigilance,Meets,Female,38,5,0,6,27,4.0,3.2,2.4,0.0348,1,1,1,1,3.2,3.7,1.5
7952,465,0,North America,Manufacturing,Data Science,Meets,Male,39,9,0,12,15,2.5,4.2,2.4,0.0348,1,1,1,1,2.6,2.7,2.9
7953,796,1,North America,HR,Regulatory Affairs,Meets,Female,29,12,0,7,12,3.5,3.1,3.5,0.0383,1,1,1,0,4.0,2.9,2.7
7954,603,0,Asia Pacific,Digital,Medical Affairs,Meets,Male,41,9,0,8,10,3.4,4.1,3.3,0.0853,1,1,1,1,4.0,3.4,4.6
7955,829,0,Latin America,HR,Marketing,Exceeds,Male,41,21,0,7,20,3.2,3.1,4.4,0.0677,1,1,1,1,1.9,1.3,2.6
7956,269,0,Middle East & Africa,Commercial,Clinical Operations,Meets,Male,39,18,0,10,17,2.3,3.0,2.2,0.0422,1,1,1,1,3.4,3.3,1.4
7957,655,0,Europe,Digital,Pharmacovigilance,Below,Female,40,6,0,5,16,4.0,4.7,3.1,0.0,1,1,1,0,3.8,2.6,3.8
7958,959,0,North America,Finance,Pharmacovigilance,Meets,Female,38,15,0,11,24,2.8,3.7,3.1,0.0331,1,1,1,1,3.2,2.7,2.5
7959,732,0,Latin America,HR,Quality Assurance,Meets,Female,29,4,0,12,32,2.5,2.5,3.9,0.0383,1,1,1,1,1.3,1.4,4.8
7960,1009,0,Middle East & Africa,Finance,Marketing,Meets,Male,45,9,1,8,16,0.0,2.3,2.3,0.0331,1,1,1,1,4.6,4.0,5.0
7961,120,0,Latin America,R&D,Medical Affairs,Meets,Female,29,28,0,9,17,2.8,4.7,4.2,0.0977,1,1,1,1,3.5,3.6,4.3
7962,694,0,Asia Pacific,Digital,Regulatory Affairs,Meets,Female,33,11,0,5,20,3.1,2.5,3.6,0.0853,1,1,1,1,3.4,1.5,3.1
7963,807,0,Middle East & Africa,HR,Quality Assurance,Below,Male,45,8,0,8,16,3.7,3.5,3.8,0.0,1,1,1,1,3.2,4.3,3.2
7964,174,0,Latin America,R&D,Supply Chain,Far Below,Male,30,14,0,12,13,3.5,3.9,2.1,0.0,1,1,1,1,2.2,3.0,2.0
7965,802,0,Asia Pacific,HR,IT & Digital,Meets,Female,37,9,0,5,25,2.2,2.2,2.7,0.0383,1,1,1,0,3.1,3.5,2.9
7966,253,1,Latin America,Commercial,Legal & Compliance,Meets,Male,49,9,0,9,13,2.0,2.4,2.5,0.0422,1,1,1,1,3.0,1.9,4.4
7967,452,0,Latin America,Manufacturing,Medical Affairs,Meets,Non-Binary/Other,38,14,0,8,24,3.6,3.3,1.6,0.0348,1,0,0,0,2.9,4.1,2.4
7968,943,0,Middle East & Africa,Finance,Data Science,Meets,Male,30,15,0,6,24,3.4,2.8,3.0,0.0331,1,1,1,1,4.0,3.8,4.1
7969,807,0,Asia Pacific,HR,Communications,Far Exceeds,Male,43,10,1,5,16,0.0,4.5,2.9,0.1168,1,1,1,1,4.1,3.7,2.8
7970,626,0,North America,Digital,Marketing,Meets,Female,41,8,0,9,12,2.1,3.4,2.9,0.0853,1,1,1,1,2.6,2.0,3.9
7971,834,0,Europe,HR,Communications,Exceeds,Male,39,6,1,10,27,0.0,1.3,2.7,0.0677,1,1,1,1,2.5,2.2,3.4
7972,823,0,Middle East & Africa,HR,Communications,Exceeds,Male,28,29,0,12,19,3.5,3.4,2.7,0.0677,1,1,1,1,4.0,4.2,3.2
7973,854,1,Asia Pacific,HR,Clinical Operations,Exceeds,Male,46,7,0,6,14,1.0,3.3,2.8,0.0677,1,1,0,0,2.0,4.1,5.0
7974,785,0,Latin America,HR,Regulatory Affairs,Exceeds,Female,49,21,0,9,16,2.9,4.2,2.7,0.0677,0,0,0,0,2.4,2.9,3.6
7975,617,0,Asia Pacific,Digital,Supply Chain,Meets,Male,38,21,0,9,20,3.4,2.1,2.0,0.0853,1,1,1,1,3.7,2.2,2.1
7976,609,0,Europe,Digital,Human Resources,Meets,Female,34,3,0,6,10,3.4,5.0,2.7,0.0853,1,1,1,1,3.9,4.7,2.3
7977,751,0,Europe,HR,Data Science,Meets,Male,41,21,1,9,19,0.0,2.6,2.8,0.0383,1,1,1,1,5.0,3.1,3.3
7978,356,0,North America,Manufacturing,Legal & Compliance,Meets,Female,41,7,1,8,16,0.0,4.0,1.4,0.0348,0,0,0,0,3.2,2.2,1.6
7979,762,1,North America,HR,Finance & Accounting,Meets,Male,42,10,0,10,22,3.6,3.6,1.7,0.0383,1,1,1,1,4.5,3.8,1.9
7980,943,0,Europe,Finance,Clinical Operations,Meets,Male,38,7,0,11,22,4.1,4.5,1.3,0.0331,1,1,1,1,3.7,5.0,3.3
7981,1004,0,Middle East & Africa,Finance,Regulatory Affairs,Meets,Female,41,7,1,5,10,0.0,2.3,2.4,0.0331,1,1,1,1,2.5,2.4,2.7
7982,671,0,Middle East & Africa,Digital,Market Access,Meets,Male,42,17,0,9,14,3.8,3.2,2.5,0.0853,1,1,1,1,3.7,1.9,1.9
7983,900,0,Latin America,Finance,Market Access,Far Exceeds,Female,53,1,1,11,20,0.0,3.1,1.7,0.1022,0,0,0,0,3.7,3.2,1.0
7984,928,0,North America,Finance,Legal & Compliance,Exceeds,Male,41,23,0,10,33,1.9,2.8,4.1,0.0588,1,1,0,0,1.7,4.0,5.0
7985,345,0,Latin America,Commercial,Pharmacovigilance,Meets,Female,39,10,0,7,15,4.9,1.4,1.0,0.0422,1,1,1,1,4.6,3.4,1.5
7986,825,0,North America,HR,Supply Chain,Below,Female,29,7,0,8,31,3.1,4.2,2.8,0.0,1,1,1,1,3.6,3.3,2.6
7987,764,0,Europe,HR,Supply Chain,Meets,Female,29,3,1,10,33,0.0,3.2,1.1,0.0383,1,1,1,1,4.8,5.0,1.6
7988,762,0,Middle East & Africa,HR,Legal & Compliance,Meets,Non-Binary/Other,39,18,0,5,15,3.7,4.6,2.0,0.0383,1,1,1,1,3.5,3.8,2.1
7989,835,0,Middle East & Africa,HR,Market Access,Exceeds,Male,38,5,0,8,10,3.6,1.1,2.5,0.0677,1,1,1,1,2.6,1.8,2.8
7990,25,0,Europe,R&D,Quality Assurance,Meets,Female,32,3,1,10,17,0.0,2.8,1.5,0.0977,1,1,0,0,5.0,3.7,3.5
7991,706,0,Latin America,HR,Communications,Meets,Male,32,9,1,9,22,0.0,2.8,2.6,0.0383,1,1,1,1,4.6,3.1,2.8
7992,566,0,Latin America,Digital,IT & Digital,Meets,Male,42,18,0,6,15,4.2,2.6,1.2,0.0853,1,1,1,1,3.3,5.0,1.4
7993,621,0,Asia Pacific,Digital,IT & Digital,Below,Male,35,5,0,10,15,3.6,3.0,2.5,0.0,1,1,0,0,2.6,4.1,1.6
7994,167,0,North America,R&D,Quality Assurance,Meets,Female,33,12,0,10,24,2.5,3.3,1.9,0.0977,1,1,1,1,2.8,3.9,1.2
7995,756,0,Latin America,HR,Pharmacovigilance,Meets,Female,32,14,0,10,16,2.4,2.7,4.3,0.0383,1,1,1,1,2.4,3.2,2.8
7996,411,0,Europe,Manufacturing,Regulatory Affairs,Far Exceeds,Male,33,14,0,11,13,3.7,3.3,3.6,0.1069,1,1,1,1,2.7,4.0,4.5
7997,790,0,Latin America,HR,Legal & Compliance,Below,Female,36,5,0,5,22,2.7,2.6,3.5,0.0,1,1,1,1,1.8,2.8,3.8
7998,655,0,Middle East & Africa,Digital,Quality Assurance,Meets,Female,38,27,0,12,26,3.8,4.3,4.2,0.0853,1,1,1,1,2.6,3.2,4.3
7999,242,0,North America,Commercial,Quality Assurance,Meets,Female,39,2,0,6,6,2.5,3.3,1.6,0.0422,1,1,1,1,1.0,3.4,3.8
8000,1046,0,Asia Pacific,Finance,Finance & Accounting,Meets,Male,35,11,1,12,22,0.0,3.5,2.0,0.0331,1,1,1,1,3.5,2.7,1.6
8001,186,0,North America,Commercial,Sales,Exceeds,Male,28,21,0,11,16,4.6,1.8,3.8,0.0743,1,1,1,1,3.7,2.5,2.9
8002,450,0,Middle East & Africa,Manufacturing,Sales,Below,Male,31,2,1,9,10,0.0,3.7,2.5,0.0,1,1,0,0,4.1,3.0,2.1
8003,714,0,Middle East & Africa,HR,Medical Affairs,Far Exceeds,Male,35,9,0,9,11,3.2,3.9,2.9,0.1168,0,0,0,0,2.9,2.5,2.5
8004,147,0,Middle East & Africa,R&D,Legal & Compliance,Exceeds,Male,44,23,1,9,17,0.0,4.0,2.6,0.1648,1,1,1,1,3.3,3.7,2.6
8005,844,0,Middle East & Africa,HR,Sales,Exceeds,Male,37,9,0,5,17,3.6,1.6,3.8,0.0677,1,1,1,1,3.1,3.0,3.2
8006,396,0,Europe,Manufacturing,Regulatory Affairs,Below,Non-Binary/Other,41,4,0,11,15,4.9,3.8,2.8,0.0,1,1,1,1,4.2,4.0,4.2
8007,438,0,Asia Pacific,Manufacturing,Regulatory Affairs,Meets,Female,46,4,1,11,19,0.0,3.6,2.3,0.0348,1,1,1,1,4.1,5.0,2.5
8008,1014,0,Middle East & Africa,Finance,Sales,Exceeds,Female,37,6,0,10,16,4.1,3.1,3.7,0.0588,1,1,1,1,3.8,3.9,2.2
8009,455,0,Middle East & Africa,Manufacturing,Human Resources,Exceeds,Female,38,9,0,6,25,2.6,3.2,1.6,0.0616,0,0,0,0,2.5,3.1,2.1
8010,351,0,Latin America,Commercial,Finance & Accounting,Meets,Female,38,18,0,9,16,3.3,3.1,2.1,0.0422,1,1,1,1,3.5,1.1,2.2
8011,939,0,Asia Pacific,Finance,Data Science,Meets,Male,38,11,0,12,23,4.6,2.6,1.3,0.0331,1,1,1,1,3.7,2.4,2.2
8012,752,0,North America,HR,Clinical Operations,Meets,Female,32,9,0,8,12,4.8,2.0,2.6,0.0383,1,1,1,1,4.0,3.4,2.8
8013,875,0,Asia Pacific,HR,Pharmacovigilance,Far Exceeds,Male,41,8,0,6,7,2.4,2.1,3.2,0.1168,1,1,1,1,2.5,2.0,3.7
8014,79,0,Asia Pacific,R&D,Regulatory Affairs,Below,Male,39,14,1,12,16,0.0,2.9,2.4,0.0,1,1,1,1,4.0,1.9,2.0
8015,420,0,Asia Pacific,Manufacturing,Legal & Compliance,Far Below,Male,33,10,1,12,23,0.0,3.2,2.0,0.0,1,1,1,1,5.0,3.8,2.7
8016,521,0,Middle East & Africa,Manufacturing,IT & Digital,Far Below,Male,37,2,0,7,14,4.3,5.0,1.6,0.0,0,0,0,0,3.5,3.4,1.9
8017,527,1,Middle East & Africa,Digital,Legal & Compliance,Meets,Female,28,23,0,5,10,3.2,3.7,3.1,0.0853,1,0,0,0,3.6,5.0,4.9
8018,984,0,Europe,Finance,Market Access,Below,Female,29,28,0,10,35,3.3,3.1,2.9,0.0,1,1,1,1,3.5,3.4,2.5
8019,615,0,North America,Digital,Regulatory Affairs,Meets,Male,43,1,1,6,11,0.0,2.9,3.2,0.0853,0,0,0,0,3.7,4.4,4.0
8020,900,0,Latin America,Finance,Legal & Compliance,Meets,Male,37,7,0,5,19,2.0,2.8,2.2,0.0331,1,1,1,1,3.0,3.1,2.7
8021,276,0,Asia Pacific,Commercial,Medical Affairs,Below,Male,46,13,1,6,11,0.0,3.4,4.6,0.0,1,1,1,1,3.7,3.2,2.5
8022,928,0,North America,Finance,Regulatory Affairs,Meets,Female,38,22,0,8,21,3.7,2.5,2.1,0.0331,1,1,1,1,4.2,2.2,1.8
8023,771,0,North America,HR,Supply Chain,Below,Male,39,10,1,9,31,0.0,3.3,3.3,0.0,1,1,1,1,2.6,4.2,3.6
8024,129,0,Europe,R&D,Communications,Meets,Non-Binary/Other,38,20,0,5,9,5.0,1.5,2.9,0.0977,1,1,1,1,4.6,1.6,2.7
8025,1038,0,Latin America,Finance,IT & Digital,Meets,Male,32,7,0,5,8,3.3,3.2,2.7,0.0331,1,1,1,1,3.5,2.2,2.6
8026,982,0,Asia Pacific,Finance,Market Access,Meets,Non-Binary/Other,40,8,0,9,16,4.8,2.1,2.0,0.0331,1,1,1,1,3.8,1.8,2.2
8027,1023,0,Latin America,Finance,Communications,Meets,Male,34,8,0,12,16,3.8,1.7,1.1,0.0331,1,0,0,0,4.4,3.2,1.0
8028,54,0,Europe,R&D,Clinical Operations,Exceeds,Male,40,9,0,6,14,4.4,3.6,1.6,0.1648,1,1,1,1,3.8,2.9,1.0
8029,431,0,Middle East & Africa,Manufacturing,Human Resources,Exceeds,Male,33,16,0,10,17,2.3,2.8,2.4,0.0616,1,1,1,1,2.3,3.4,3.5
8030,141,0,North America,R&D,Regulatory Affairs,Meets,Female,42,16,1,11,25,0.0,2.9,4.3,0.0977,1,1,1,1,4.2,4.6,2.6
8031,439,0,Asia Pacific,Manufacturing,Human Resources,Meets,Male,41,16,0,8,26,2.8,2.0,2.8,0.0348,0,0,0,0,3.6,2.8,2.8
8032,742,0,Middle East & Africa,HR,Sales,Meets,Female,45,17,0,10,22,3.4,3.2,2.4,0.0383,1,0,0,0,3.4,4.2,3.1
8033,138,0,Europe,R&D,Communications,Exceeds,Male,42,2,0,8,23,3.9,3.4,3.0,0.1648,0,0,0,0,3.3,4.7,3.0
8034,468,0,Latin America,Manufacturing,Regulatory Affairs,Meets,Female,38,3,1,5,17,0.0,4.4,2.4,0.0348,0,0,0,0,2.3,3.3,3.7
8035,745,0,North America,HR,Pharmacovigilance,Below,Male,47,9,0,11,20,3.0,3.9,3.5,0.0,1,1,1,1,2.7,3.9,1.5
8036,801,0,Asia Pacific,HR,Medical Affairs,Exceeds,Male,40,3,0,12,14,3.4,3.3,4.9,0.0677,1,1,1,1,3.5,4.5,4.4
8037,413,0,Middle East & Africa,Manufacturing,Pharmacovigilance,Meets,Male,28,20,0,8,11,4.0,3.3,1.3,0.0348,1,1,1,1,3.0,3.4,2.5
8038,447,0,Middle East & Africa,Manufacturing,Human Resources,Meets,Non-Binary/Other,34,1,0,12,30,3.1,4.1,2.9,0.0348,1,1,1,1,5.0,2.3,3.6
8039,266,1,North America,Commercial,IT & Digital,Meets,Male,37,17,0,9,18,3.6,2.7,2.5,0.0422,1,0,0,0,3.8,2.7,2.9
8040,767,0,Latin America,HR,Clinical Operations,Below,Male,46,17,1,8,18,0.0,2.7,2.6,0.0,1,1,1,1,2.3,3.2,1.7
8041,434,0,Europe,Manufacturing,Clinical Operations,Far Exceeds,Male,35,15,0,7,40,2.3,1.9,4.2,0.1069,1,1,1,1,3.3,3.2,4.8
8042,719,0,Latin America,HR,Clinical Operations,Meets,Female,34,8,0,8,15,4.6,2.0,2.7,0.0383,1,1,1,1,5.0,1.1,3.5
8043,36,0,Latin America,R&D,Legal & Compliance,Below,Male,28,14,0,9,14,4.0,3.8,1.0,0.0,1,1,1,1,4.7,3.7,2.3
8044,557,0,Latin America,Digital,Medical Affairs,Meets,Female,46,4,1,8,14,0.0,3.3,4.0,0.0853,1,1,1,1,3.8,2.9,4.5
8045,540,0,North America,Digital,Pharmacovigilance,Meets,Male,47,13,0,11,16,2.5,1.0,3.7,0.0853,1,1,1,1,3.8,1.2,4.2
8046,971,0,North America,Finance,Quality Assurance,Below,Male,31,17,0,5,29,2.8,3.8,2.3,0.0,1,1,1,1,2.4,3.8,3.3
8047,403,0,Europe,Manufacturing,Supply Chain,Meets,Male,29,11,0,9,15,3.8,2.4,2.6,0.0348,1,1,1,1,5.0,1.9,2.6
8048,494,0,Latin America,Manufacturing,Communications,Meets,Female,44,9,0,6,21,3.4,3.4,1.7,0.0348,1,1,1,1,3.5,3.2,2.7
8049,783,0,North America,HR,Clinical Operations,Meets,Male,46,4,0,12,44,4.1,3.3,3.9,0.0383,1,1,1,1,3.8,3.1,3.0
8050,973,0,Europe,Finance,Data Science,Meets,Male,34,10,0,9,17,2.4,3.9,2.5,0.0331,1,1,1,1,3.1,4.5,1.4
8051,434,0,Europe,Manufacturing,Pharmacovigilance,Below,Male,37,7,0,12,23,3.5,1.9,3.7,0.0,1,0,0,0,3.4,1.9,4.1
8052,706,0,Latin America,HR,Communications,Meets,Female,41,28,0,12,23,3.2,2.1,2.2,0.0383,1,1,1,1,4.2,3.1,4.1
8053,474,0,Asia Pacific,Manufacturing,Pharmacovigilance,Meets,Male,32,10,0,6,10,2.8,4.6,3.9,0.0348,1,1,1,1,3.2,3.5,2.4
8054,731,0,Latin America,HR,Sales,Below,Male,33,17,0,8,17,4.6,4.7,4.0,0.0,1,1,1,1,3.4,5.0,1.6
8055,426,0,Asia Pacific,Manufacturing,IT & Digital,Meets,Female,36,17,0,6,10,3.0,3.7,2.1,0.0348,1,1,1,1,1.5,3.4,1.4
8056,218,0,Europe,Commercial,Finance & Accounting,Meets,Male,32,33,0,12,14,3.3,2.0,1.0,0.0422,0,0,0,0,2.4,1.5,2.4
8057,709,0,North America,HR,Marketing,Meets,Male,55,15,0,12,35,1.7,2.6,3.0,0.0383,1,1,1,1,2.8,2.9,3.1
8058,214,0,Middle East & Africa,Commercial,Human Resources,Meets,Female,45,36,0,5,17,4.5,2.6,3.1,0.0422,1,1,1,1,4.0,2.7,3.6
8059,194,0,Europe,Commercial,Finance & Accounting,Meets,Male,36,7,0,8,23,2.5,2.4,3.8,0.0422,1,1,1,1,3.0,2.5,3.2
8060,199,0,North America,Commercial,Marketing,Meets,Male,39,6,1,7,17,0.0,2.7,3.9,0.0422,1,1,1,1,2.9,2.5,4.8
8061,238,0,Europe,Commercial,Market Access,Meets,Male,28,19,0,12,15,4.1,3.5,3.3,0.0422,1,1,0,0,3.9,1.0,3.0
8062,127,0,Latin America,R&D,Medical Affairs,Meets,Male,40,8,0,12,18,4.2,4.9,1.3,0.0977,1,1,1,1,5.0,5.0,2.8
8063,1024,0,Asia Pacific,Finance,Clinical Operations,Below,Non-Binary/Other,42,8,0,5,12,3.9,2.3,3.4,0.0,1,1,1,1,2.9,2.6,2.9
8064,655,0,Europe,Digital,Sales,Far Exceeds,Male,34,5,1,7,10,0.0,3.1,2.9,0.2363,0,0,0,0,3.1,3.5,1.7
8065,176,0,North America,R&D,Finance & Accounting,Exceeds,Female,35,5,1,8,25,0.0,4.2,2.9,0.1648,1,1,1,1,5.0,4.6,3.0
8066,457,0,Latin America,Manufacturing,Clinical Operations,Meets,Female,33,7,1,8,11,0.0,3.2,1.9,0.0348,1,1,1,1,2.5,2.8,1.0
8067,386,0,Middle East & Africa,Manufacturing,Clinical Operations,Exceeds,Female,46,10,1,8,19,0.0,5.0,1.4,0.0616,0,0,0,0,3.0,4.5,1.8
8068,1040,0,Latin America,Finance,Human Resources,Meets,Female,46,18,1,8,22,0.0,3.8,2.3,0.0331,1,1,1,1,4.7,2.5,2.0
8069,657,0,Asia Pacific,Digital,Sales,Far Below,Male,40,4,0,7,17,4.2,3.8,4.4,0.0,1,1,1,1,4.7,3.5,2.9
8070,577,1,Latin America,Digital,Sales,Meets,Male,39,6,0,5,8,3.6,3.8,1.3,0.0853,1,1,1,1,4.1,3.8,2.2
8071,643,0,Middle East & Africa,Digital,Supply Chain,Exceeds,Female,31,12,1,7,13,0.0,3.9,3.5,0.1452,1,1,1,1,3.0,3.6,3.5
8072,290,0,North America,Commercial,Regulatory Affairs,Below,Female,34,13,0,12,13,2.8,3.6,3.4,0.0,1,1,1,1,3.0,3.0,2.7
8073,157,0,Europe,R&D,Communications,Meets,Male,36,5,1,11,18,0.0,3.6,4.3,0.0977,1,1,1,1,3.6,3.0,3.0
8074,457,0,Asia Pacific,Manufacturing,Marketing,Exceeds,Male,34,15,0,8,11,3.3,3.0,1.1,0.0616,1,1,1,1,3.7,2.8,2.2
8075,32,0,Middle East & Africa,R&D,Regulatory Affairs,Exceeds,Male,41,2,0,12,21,3.0,4.2,3.1,0.1648,1,1,1,1,3.2,4.8,2.4
8076,149,0,Asia Pacific,R&D,Communications,Meets,Female,28,21,1,7,22,0.0,3.7,4.2,0.0977,1,1,1,1,4.2,2.7,2.4
8077,166,0,Latin America,R&D,Finance & Accounting,Below,Female,30,5,1,11,42,0.0,2.9,2.0,0.0,1,1,1,1,3.7,2.5,2.5
8078,692,0,Asia Pacific,Digital,Market Access,Meets,Female,34,3,0,8,15,4.2,4.1,3.9,0.0853,1,1,1,1,3.1,4.5,5.0
8079,955,0,Middle East & Africa,Finance,Sales,Meets,Male,29,11,0,11,36,3.5,2.9,2.4,0.0331,1,1,1,1,2.7,5.0,1.8
8080,1015,0,Europe,Finance,Medical Affairs,Exceeds,Male,44,10,1,6,24,0.0,1.5,3.5,0.0588,0,0,0,0,3.8,2.4,4.6
8081,563,0,Europe,Digital,Human Resources,Meets,Male,45,7,0,10,20,3.0,3.4,2.0,0.0853,1,1,1,1,4.1,4.1,1.4
8082,468,0,Asia Pacific,Manufacturing,Market Access,Exceeds,Male,28,6,0,12,27,3.5,3.4,2.1,0.0616,1,1,1,1,2.7,2.9,2.0
8083,430,0,North America,Manufacturing,Sales,Meets,Male,40,26,0,6,14,4.9,2.5,3.2,0.0348,1,1,1,1,4.2,5.0,2.8
8084,464,0,Asia Pacific,Manufacturing,Regulatory Affairs,Meets,Male,36,6,1,5,18,0.0,3.5,2.9,0.0348,1,1,1,1,3.3,4.3,2.2
8085,894,0,Latin America,Finance,Quality Assurance,Far Below,Male,38,19,0,8,16,3.2,1.7,1.9,0.0,1,1,1,1,4.5,2.4,1.7
8086,992,0,Europe,Finance,Quality Assurance,Meets,Female,41,12,0,10,15,4.3,4.6,3.9,0.0331,1,1,1,1,3.2,4.6,3.0
8087,6,0,Europe,R&D,Marketing,Below,Male,28,19,0,9,18,5.0,2.1,3.8,0.0,1,1,1,1,4.2,2.1,2.6
8088,683,1,Europe,Digital,Data Science,Meets,Male,44,15,1,8,20,0.0,4.4,1.0,0.0853,1,1,1,1,2.9,2.3,1.7
8089,179,0,North America,Commercial,Medical Affairs,Below,Female,41,17,0,6,35,2.5,4.6,2.0,0.0,1,1,1,1,2.6,5.0,3.7
8090,22,0,North America,R&D,Clinical Operations,Below,Male,45,14,0,10,15,2.5,5.0,4.4,0.0,1,1,1,1,3.0,3.4,4.1
8091,839,0,Middle East & Africa,HR,Pharmacovigilance,Meets,Male,28,6,0,8,18,1.6,3.3,2.0,0.0383,1,1,1,1,3.9,4.0,2.9
8092,881,0,Asia Pacific,Finance,Market Access,Meets,Female,38,5,1,6,13,0.0,2.2,1.0,0.0331,1,1,1,1,4.0,1.9,2.5
8093,99,0,Asia Pacific,R&D,Sales,Meets,Female,41,10,0,8,20,4.8,3.7,4.3,0.0977,1,1,0,0,2.8,3.2,4.6
8094,586,0,Latin America,Digital,Legal & Compliance,Meets,Female,41,4,0,11,17,4.1,2.9,1.5,0.0853,1,1,1,1,3.6,3.1,1.3
8095,776,0,Europe,HR,Quality Assurance,Meets,Male,43,3,1,10,16,0.0,3.1,1.0,0.0383,1,1,0,0,3.2,2.0,2.2
8096,19,1,North America,R&D,Data Science,Meets,Non-Binary/Other,41,9,0,12,24,4.3,4.5,1.0,0.0977,1,1,1,1,5.0,3.3,1.9
8097,545,0,Latin America,Digital,Medical Affairs,Meets,Male,28,7,0,11,20,5.0,3.2,2.4,0.0853,1,1,1,0,3.9,2.9,1.3
8098,620,0,Latin America,Digital,Medical Affairs,Meets,Non-Binary/Other,45,12,0,7,11,3.3,2.9,3.9,0.0853,0,0,0,0,3.0,2.0,5.0
8099,1015,0,North America,Finance,Quality Assurance,Exceeds,Female,35,13,0,5,12,3.3,2.7,2.9,0.0588,1,1,1,1,2.8,2.8,1.8
8100,354,0,Asia Pacific,Commercial,Communications,Meets,Female,39,10,1,9,17,0.0,3.2,3.8,0.0422,1,1,1,1,4.0,3.6,2.7
8101,63,1,Europe,R&D,IT & Digital,Meets,Female,47,11,0,11,22,4.0,2.6,2.5,0.0977,1,1,1,1,4.0,1.6,2.2
8102,538,0,Asia Pacific,Digital,Pharmacovigilance,Below,Female,38,17,0,7,14,4.6,2.9,1.1,0.0,1,1,1,1,5.0,2.3,2.3
8103,410,0,Latin America,Manufacturing,Data Science,Meets,Male,36,5,0,6,16,4.2,3.6,3.4,0.0348,0,0,0,0,4.7,2.9,2.6
8104,528,0,Europe,Digital,Supply Chain,Meets,Female,31,7,1,5,19,0.0,1.9,3.7,0.0853,1,1,1,1,2.5,1.9,3.1
8105,312,0,Middle East & Africa,Commercial,Pharmacovigilance,Meets,Female,30,6,0,7,12,4.0,2.6,4.0,0.0422,1,1,1,1,3.0,1.9,3.0
8106,613,0,Latin America,Digital,Regulatory Affairs,Below,Male,31,17,0,12,19,2.6,3.1,1.5,0.0,1,1,1,1,2.3,2.2,2.9
8107,904,0,Asia Pacific,Finance,Medical Affairs,Meets,Female,38,10,1,5,31,0.0,4.7,1.9,0.0331,1,1,1,1,2.8,3.8,2.4
8108,37,0,Asia Pacific,R&D,Data Science,Meets,Female,51,13,0,11,16,3.3,3.5,3.1,0.0977,1,1,1,0,4.1,3.2,3.4
8109,968,0,Asia Pacific,Finance,Quality Assurance,Meets,Female,36,20,0,5,9,4.3,3.9,1.0,0.0331,0,0,0,0,4.5,2.9,1.6
8110,107,0,North America,R&D,Medical Affairs,Meets,Male,38,14,0,6,10,2.8,3.1,1.8,0.0977,1,1,1,1,3.1,4.4,2.4
8111,815,0,Latin America,HR,Pharmacovigilance,Exceeds,Male,42,18,0,12,49,2.8,3.5,2.6,0.0677,1,1,1,1,1.8,3.6,2.9
8112,12,0,Europe,R&D,Clinical Operations,Meets,Female,34,4,1,6,8,0.0,3.1,3.0,0.0977,0,0,0,0,3.1,4.9,2.5
8113,760,0,Asia Pacific,HR,Clinical Operations,Meets,Male,46,16,0,11,13,3.4,3.2,1.2,0.0383,1,1,1,1,3.7,3.2,2.7
8114,1049,0,Asia Pacific,Finance,Medical Affairs,Exceeds,Female,35,19,0,10,34,3.2,1.7,2.9,0.0588,1,1,1,1,2.3,2.9,3.9
8115,483,0,North America,Manufacturing,Data Science,Below,Female,45,9,1,8,24,0.0,2.7,3.3,0.0,1,1,1,1,2.9,3.8,3.2
8116,326,0,Europe,Commercial,Data Science,Meets,Male,42,14,1,12,31,0.0,3.5,4.3,0.0422,1,1,1,1,4.3,3.8,3.9
8117,522,0,Latin America,Manufacturing,Market Access,Below,Female,39,7,0,7,20,3.1,4.1,3.5,0.0,1,1,1,1,3.2,2.7,2.4
8118,871,0,Middle East & Africa,HR,IT & Digital,Exceeds,Male,34,15,0,10,38,2.9,3.6,1.0,0.0677,0,0,0,0,3.1,4.3,1.0
8119,540,0,North America,Digital,Regulatory Affairs,Far Below,Female,44,14,0,8,23,3.6,2.2,3.7,0.0,1,1,1,1,4.4,2.9,4.8
8120,558,0,Latin America,Digital,Legal & Compliance,Below,Male,37,13,0,7,11,2.2,3.5,2.2,0.0,1,1,1,1,1.8,2.4,2.7
8121,436,0,Middle East & Africa,Manufacturing,Market Access,Exceeds,Female,35,7,1,6,9,0.0,3.5,3.9,0.0616,1,1,1,1,3.5,3.8,2.9
8122,526,0,Asia Pacific,Digital,Market Access,Meets,Female,48,21,0,5,15,3.6,3.6,4.1,0.0853,1,1,1,1,4.0,4.2,4.3
8123,851,0,Asia Pacific,HR,Regulatory Affairs,Meets,Male,28,10,1,7,17,0.0,3.3,2.4,0.0383,1,1,1,1,2.8,4.2,2.1
8124,955,0,Europe,Finance,Quality Assurance,Far Below,Male,47,15,0,6,22,3.6,1.3,2.2,0.0,1,1,1,1,4.3,2.0,2.0
8125,324,0,Middle East & Africa,Commercial,Clinical Operations,Meets,Male,50,13,0,12,28,2.3,1.7,2.3,0.0422,1,1,1,1,2.6,2.8,1.7
8126,71,1,Asia Pacific,R&D,Legal & Compliance,Far Exceeds,Male,33,19,0,10,15,1.9,2.3,3.5,0.2644,1,1,1,1,3.6,3.1,3.7
8127,838,0,Asia Pacific,HR,Communications,Meets,Female,34,14,0,5,6,3.1,2.2,2.8,0.0383,0,0,0,0,3.6,3.5,2.6
8128,863,0,Europe,HR,Quality Assurance,Exceeds,Female,31,2,1,6,21,0.0,3.6,2.4,0.0677,1,1,1,0,3.6,3.1,2.5
8129,30,0,Latin America,R&D,Market Access,Far Exceeds,Non-Binary/Other,43,4,1,7,12,0.0,1.2,2.4,0.2644,1,1,1,1,4.0,2.2,2.7
8130,55,0,Asia Pacific,R&D,Data Science,Meets,Male,34,9,0,12,16,1.8,4.6,2.0,0.0977,1,1,1,1,3.6,4.5,2.5
8131,199,0,North America,Commercial,Regulatory Affairs,Meets,Female,37,3,0,9,16,3.7,4.8,4.2,0.0422,1,0,0,0,2.6,5.0,1.1
8132,183,0,North America,Commercial,Pharmacovigilance,Meets,Female,42,6,1,12,21,0.0,3.5,2.3,0.0422,1,1,1,1,3.9,3.0,3.9
8133,299,0,Latin America,Commercial,Sales,Below,Non-Binary/Other,28,6,1,7,8,0.0,3.0,2.8,0.0,1,1,1,1,3.7,5.0,3.7
8134,557,0,Middle East & Africa,Digital,Communications,Meets,Male,29,11,0,5,12,3.7,2.1,2.1,0.0853,1,1,1,0,4.1,4.0,2.2
8135,727,1,Europe,HR,Legal & Compliance,Exceeds,Female,40,8,0,6,14,4.3,2.4,3.5,0.0677,1,1,1,1,4.2,3.2,2.7
8136,1036,0,North America,Finance,Sales,Meets,Female,36,13,0,12,16,2.7,3.4,4.6,0.0331,1,1,1,1,3.5,3.9,2.0
8137,25,0,North America,R&D,Finance & Accounting,Exceeds,Female,32,5,1,7,12,0.0,3.3,3.0,0.1648,1,1,1,1,3.6,4.2,2.7
8138,802,0,Latin America,HR,Marketing,Exceeds,Female,38,19,0,12,18,2.5,4.2,2.7,0.0677,1,1,1,1,3.3,2.3,3.1
8139,712,0,Middle East & Africa,HR,Medical Affairs,Far Exceeds,Male,37,14,0,5,18,2.1,2.7,3.6,0.1168,1,1,1,1,2.4,1.6,4.1
8140,181,0,Middle East & Africa,Commercial,Supply Chain,Exceeds,Female,33,5,0,10,20,3.2,2.6,3.4,0.0743,1,1,1,1,3.7,4.2,5.0
8141,267,0,Latin America,Commercial,Supply Chain,Meets,Male,39,21,0,7,9,2.2,4.5,1.7,0.0422,1,1,1,1,3.1,2.8,1.2
8142,793,0,North America,HR,Human Resources,Exceeds,Male,32,12,0,12,17,3.2,2.5,2.2,0.0677,1,1,1,1,3.2,4.5,2.9
8143,296,0,Europe,Commercial,Pharmacovigilance,Meets,Male,42,10,1,7,10,0.0,2.8,1.6,0.0422,1,1,1,1,1.4,1.9,2.9
8144,648,0,North America,Digital,Marketing,Meets,Male,37,20,0,7,18,4.6,4.0,2.7,0.0853,1,1,1,1,4.3,3.8,2.4
8145,19,0,Middle East & Africa,R&D,Finance & Accounting,Meets,Male,49,3,0,8,19,2.9,4.3,1.6,0.0977,1,1,1,1,2.6,4.9,3.1
8146,731,0,North America,HR,Clinical Operations,Meets,Male,30,14,0,7,14,3.6,2.9,4.0,0.0383,1,1,1,1,3.8,2.7,2.7
8147,83,0,Europe,R&D,Pharmacovigilance,Meets,Male,34,17,1,5,15,0.0,1.6,2.4,0.0977,1,1,1,1,4.8,2.4,2.9
8148,575,0,Asia Pacific,Digital,IT & Digital,Meets,Male,44,5,0,8,21,3.5,5.0,3.9,0.0853,1,1,1,1,4.8,5.0,3.1
8149,331,0,North America,Commercial,Finance & Accounting,Meets,Male,32,27,0,8,22,2.8,2.2,4.4,0.0422,1,1,1,1,3.1,1.5,2.6
8150,383,0,Latin America,Manufacturing,Market Access,Below,Female,38,21,1,12,30,0.0,3.5,3.3,0.0,1,1,1,1,4.4,3.0,2.6
8151,676,0,Asia Pacific,Digital,Pharmacovigilance,Meets,Female,28,6,0,7,11,4.3,3.8,3.4,0.0853,0,0,0,0,4.3,4.1,2.9
8152,469,1,Latin America,Manufacturing,Sales,Exceeds,Female,32,8,0,11,14,3.9,2.9,2.1,0.0616,1,1,1,0,4.9,2.0,2.1
8153,83,0,Latin America,R&D,Supply Chain,Meets,Male,32,4,0,9,17,4.2,2.3,1.5,0.0977,1,1,1,1,3.1,1.4,1.6
8154,824,0,Latin America,HR,Clinical Operations,Below,Female,37,5,0,11,14,2.7,2.1,3.8,0.0,1,1,1,1,3.5,3.4,3.0
8155,348,0,North America,Commercial,Medical Affairs,Exceeds,Female,44,6,1,6,28,0.0,3.9,2.9,0.0743,1,1,1,1,3.6,4.4,3.8
8156,570,0,Middle East & Africa,Digital,IT & Digital,Exceeds,Male,36,4,1,9,20,0.0,1.5,4.6,0.1452,1,1,1,1,3.9,2.2,3.3
8157,344,0,Asia Pacific,Commercial,Market Access,Exceeds,Male,36,19,0,5,19,4.2,3.2,3.0,0.0743,1,1,1,1,4.8,2.7,2.7
8158,472,0,Europe,Manufacturing,Medical Affairs,Meets,Female,33,19,0,9,36,4.4,3.0,1.9,0.0348,1,1,1,1,3.1,3.4,2.8
8159,423,0,Middle East & Africa,Manufacturing,Sales,Below,Female,31,7,1,11,26,0.0,3.5,2.5,0.0,1,1,1,0,2.1,3.8,2.9
8160,983,0,North America,Finance,Marketing,Meets,Male,44,15,0,5,21,3.4,2.9,1.5,0.0331,1,1,1,1,3.4,3.5,2.5
8161,774,0,Latin America,HR,Medical Affairs,Meets,Female,39,3,0,7,15,2.3,3.9,2.5,0.0383,1,1,1,1,3.7,4.5,3.0
8162,355,0,Europe,Manufacturing,Marketing,Below,Male,36,15,0,8,19,3.1,3.1,1.3,0.0,1,1,1,1,3.0,3.7,1.0
8163,816,0,Asia Pacific,HR,Market Access,Below,Female,48,10,0,7,20,4.3,3.0,1.7,0.0,1,1,1,1,4.0,3.8,3.6
8164,904,0,Middle East & Africa,Finance,Supply Chain,Exceeds,Male,28,10,0,5,11,2.2,1.6,3.5,0.0588,1,1,1,1,1.9,2.4,3.3
8165,662,0,Middle East & Africa,Digital,Data Science,Meets,Male,44,13,0,6,9,3.4,3.4,1.6,0.0853,1,1,1,1,3.6,4.8,2.3
8166,919,0,Europe,Finance,Pharmacovigilance,Meets,Male,29,14,0,8,9,3.7,3.5,3.3,0.0331,1,1,1,1,2.4,4.9,3.8
8167,754,1,North America,HR,Quality Assurance,Meets,Male,39,11,0,8,15,4.7,3.1,1.7,0.0383,1,1,1,1,4.7,4.1,1.0
8168,408,0,Asia Pacific,Manufacturing,Clinical Operations,Meets,Non-Binary/Other,44,2,1,12,17,0.0,3.4,2.8,0.0348,1,1,1,1,3.8,2.4,3.7
8169,104,0,Europe,R&D,Finance & Accounting,Below,Female,28,8,1,7,13,0.0,2.7,2.5,0.0,1,1,1,1,4.8,2.2,1.5
8170,856,0,Latin America,HR,Regulatory Affairs,Meets,Female,45,14,0,5,19,3.1,1.1,3.0,0.0383,1,1,1,1,2.5,4.0,2.4
8171,312,0,Asia Pacific,Commercial,Regulatory Affairs,Below,Female,37,20,0,12,16,3.8,2.8,2.7,0.0,1,1,1,1,3.3,2.9,3.3
8172,146,0,Middle East & Africa,R&D,Market Access,Exceeds,Male,33,17,0,12,14,3.2,2.4,2.0,0.1648,1,1,1,1,3.1,3.1,3.1
8173,817,0,Europe,HR,Pharmacovigilance,Exceeds,Male,39,10,1,10,14,0.0,3.4,3.9,0.0677,1,1,1,1,3.7,5.0,3.8
8174,224,0,Middle East & Africa,Commercial,IT & Digital,Meets,Female,41,12,0,12,29,3.4,2.1,1.3,0.0422,1,1,1,1,3.9,3.4,1.0
8175,921,0,Middle East & Africa,Finance,Pharmacovigilance,Meets,Female,52,20,0,11,17,4.1,4.1,1.8,0.0331,1,1,1,1,5.0,3.8,2.1
8176,70,0,Middle East & Africa,R&D,Pharmacovigilance,Below,Female,37,11,0,6,8,4.2,3.5,1.2,0.0,1,1,1,1,4.4,3.2,1.1
8177,767,0,North America,HR,Clinical Operations,Meets,Male,43,6,1,6,38,0.0,3.8,1.8,0.0383,1,1,1,1,3.3,2.5,2.7
8178,616,0,Middle East & Africa,Digital,Supply Chain,Meets,Female,39,23,0,9,13,2.0,2.9,2.5,0.0853,1,1,0,0,4.0,3.1,3.2
8179,975,0,Latin America,Finance,Communications,Meets,Female,40,20,0,7,11,3.6,3.3,1.0,0.0331,0,0,0,0,2.9,2.6,1.3
8180,318,0,Latin America,Commercial,IT & Digital,Below,Female,36,13,0,7,14,3.0,3.5,3.3,0.0,1,1,1,1,3.0,3.5,3.3
8181,580,0,Asia Pacific,Digital,Human Resources,Meets,Non-Binary/Other,33,12,1,5,7,0.0,2.4,3.9,0.0853,1,1,1,1,4.7,3.1,3.5
8182,393,0,Middle East & Africa,Manufacturing,Finance & Accounting,Meets,Female,40,5,1,8,16,0.0,3.5,3.9,0.0348,1,1,1,1,2.5,3.2,4.5
8183,921,0,Middle East & Africa,Finance,Data Science,Meets,Female,32,25,0,5,13,5.0,2.0,1.0,0.0331,0,0,0,0,4.4,2.7,1.0
8184,953,0,Europe,Finance,Human Resources,Meets,Male,28,11,1,6,44,0.0,4.5,2.4,0.0331,1,1,1,1,3.2,4.6,2.8
8185,815,0,North America,HR,Pharmacovigilance,Meets,Male,39,13,0,11,42,2.9,2.7,3.1,0.0383,1,1,1,1,3.7,3.1,4.1
8186,868,0,Asia Pacific,HR,Quality Assurance,Meets,Female,33,7,0,11,15,2.5,3.3,3.6,0.0383,1,1,1,1,1.7,2.2,3.2
8187,199,0,Middle East & Africa,Commercial,Data Science,Below,Male,36,4,0,6,12,2.9,2.5,2.7,0.0,1,1,1,1,1.8,3.1,2.4
8188,998,0,Europe,Finance,Clinical Operations,Exceeds,Female,28,6,0,7,11,1.0,2.0,1.9,0.0588,1,1,1,1,2.6,2.2,1.4
8189,799,0,North America,HR,Pharmacovigilance,Meets,Female,44,18,0,6,13,3.5,4.3,3.3,0.0383,1,1,1,1,3.8,5.0,4.0
8190,376,0,Asia Pacific,Manufacturing,Finance & Accounting,Far Below,Female,28,9,1,11,17,0.0,3.4,3.3,0.0,1,1,1,1,1.9,3.3,3.1
8191,803,0,Asia Pacific,HR,Market Access,Meets,Male,41,14,1,7,18,0.0,1.0,3.3,0.0383,1,0,0,0,4.4,2.9,3.0
8192,1037,0,Middle East & Africa,Finance,Clinical Operations,Meets,Female,41,9,1,10,19,0.0,1.6,3.3,0.0331,1,0,0,0,5.0,1.6,2.6
8193,41,0,Asia Pacific,R&D,Communications,Meets,Female,39,23,0,8,24,2.6,3.0,4.2,0.0977,1,1,1,1,2.5,2.9,4.5
8194,564,0,Europe,Digital,Data Science,Meets,Female,44,8,0,9,15,4.4,3.7,2.6,0.0853,1,1,1,1,4.7,4.1,1.9
8195,1008,0,Asia Pacific,Finance,Finance & Accounting,Exceeds,Male,31,12,0,5,11,3.1,3.1,1.7,0.0588,1,0,0,0,3.6,2.3,2.5
8196,514,0,Latin America,Manufacturing,Marketing,Meets,Female,50,7,0,12,19,2.6,3.4,2.7,0.0348,1,1,1,1,3.0,4.4,1.6
8197,1033,0,Europe,Finance,Marketing,Meets,Female,33,14,0,5,7,3.3,2.0,1.8,0.0331,1,1,1,1,3.5,1.3,1.0
8198,471,0,North America,Manufacturing,Legal & Compliance,Below,Male,42,4,0,7,14,5.0,4.9,3.3,0.0,1,1,1,1,3.1,3.4,2.2
8199,1042,0,North America,Finance,Human Resources,Exceeds,Male,49,6,0,7,14,2.8,2.9,3.9,0.0588,1,1,1,1,3.8,3.2,3.2
8200,543,1,Middle East & Africa,Digital,Market Access,Meets,Female,37,9,0,7,10,2.0,3.4,3.4,0.0853,1,1,1,1,3.0,2.8,3.6
8201,579,0,Middle East & Africa,Digital,Medical Affairs,Below,Male,34,16,0,6,30,3.4,2.0,1.4,0.0,1,1,1,1,5.0,3.2,2.4
8202,451,0,Latin America,Manufacturing,Regulatory Affairs,Meets,Male,43,2,1,5,11,0.0,3.0,3.3,0.0348,1,1,1,1,1.9,3.2,4.9
8203,1020,0,North America,Finance,Finance & Accounting,Far Below,Male,35,18,0,8,18,3.8,4.4,5.0,0.0,1,1,1,1,4.0,2.5,5.0
8204,587,0,North America,Digital,Market Access,Meets,Female,33,5,0,7,33,1.4,3.5,2.2,0.0853,1,1,1,1,1.6,3.5,2.0
8205,249,0,North America,Commercial,Marketing,Below,Female,42,8,1,9,14,0.0,1.9,2.6,0.0,1,1,1,1,4.0,1.3,3.3
8206,1002,0,North America,Finance,Market Access,Below,Male,43,5,1,12,18,0.0,4.0,2.7,0.0,1,1,1,1,2.2,4.1,1.0
8207,595,0,Asia Pacific,Digital,Sales,Below,Male,38,9,0,5,48,5.0,2.2,3.0,0.0,1,1,1,1,3.8,2.0,2.3
8208,72,0,Europe,R&D,Finance & Accounting,Exceeds,Female,38,7,0,11,27,2.5,1.0,2.0,0.1648,1,1,1,1,2.7,1.1,1.0
8209,1,0,Europe,R&D,Marketing,Exceeds,Male,39,10,1,10,12,0.0,3.1,3.9,0.1648,1,1,1,1,3.1,3.1,4.3
8210,264,0,Latin America,Commercial,Supply Chain,Meets,Male,37,3,0,7,19,3.8,1.3,4.6,0.0422,1,1,1,1,4.0,1.7,4.1
8211,595,0,Asia Pacific,Digital,Human Resources,Meets,Male,36,12,0,11,28,2.7,3.3,1.5,0.0853,1,1,0,0,2.5,4.0,1.9
8212,55,0,North America,R&D,Pharmacovigilance,Meets,Male,30,23,0,12,13,3.8,1.0,2.7,0.0977,1,1,1,1,3.6,2.3,4.0
8213,997,0,North America,Finance,IT & Digital,Meets,Female,34,29,0,9,26,4.0,2.5,2.6,0.0331,1,1,0,0,4.8,2.5,2.9
8214,714,0,Middle East & Africa,HR,IT & Digital,Meets,Female,38,14,0,7,23,2.0,4.4,1.8,0.0383,1,1,1,1,2.9,2.9,3.2
8215,675,0,Middle East & Africa,Digital,Legal & Compliance,Meets,Female,51,9,0,12,14,3.1,3.9,4.3,0.0853,1,1,1,1,4.2,2.8,2.6
8216,212,0,Latin America,Commercial,Supply Chain,Meets,Male,31,17,0,9,11,3.8,3.8,2.9,0.0422,1,1,1,1,4.5,2.4,1.9
8217,648,0,North America,Digital,Medical Affairs,Meets,Male,35,10,1,8,31,0.0,3.7,2.5,0.0853,1,1,1,1,3.8,4.1,2.0
8218,441,0,Latin America,Manufacturing,Market Access,Meets,Male,30,13,1,12,17,0.0,4.3,1.6,0.0348,1,1,1,1,2.3,5.0,1.0
8219,516,1,Asia Pacific,Manufacturing,Sales,Meets,Male,28,5,1,5,19,0.0,1.6,2.8,0.0348,1,0,0,0,4.4,1.8,3.8
8220,86,0,Europe,R&D,Communications,Exceeds,Male,46,5,1,6,14,0.0,5.0,2.7,0.1648,1,1,1,1,3.5,5.0,4.3
8221,511,0,North America,Manufacturing,Finance & Accounting,Meets,Female,41,6,1,7,18,0.0,3.2,3.7,0.0348,1,1,1,1,2.8,3.2,2.1
8222,256,0,Asia Pacific,Commercial,Marketing,Far Exceeds,Male,46,36,0,6,15,2.9,2.0,3.2,0.1275,1,1,1,1,3.1,2.4,2.2
8223,141,0,North America,R&D,Finance & Accounting,Meets,Female,28,6,1,5,17,0.0,2.6,3.7,0.0977,1,1,1,1,2.0,3.0,3.8
8224,312,0,Middle East & Africa,Commercial,Pharmacovigilance,Below,Female,42,14,0,5,20,2.8,2.4,2.8,0.0,1,1,1,1,5.0,4.1,2.1
8225,1043,0,Latin America,Finance,Sales,Meets,Male,51,11,1,11,46,0.0,4.5,3.9,0.0331,1,1,1,1,3.5,3.2,4.1
8226,337,0,Middle East & Africa,Commercial,Sales,Meets,Male,44,5,0,12,28,4.1,4.0,3.2,0.0422,1,1,1,1,3.8,3.1,3.2
8227,456,0,Europe,Manufacturing,Supply Chain,Meets,Female,41,29,0,6,18,2.5,4.1,4.3,0.0348,1,1,1,1,2.1,1.7,3.6
8228,1037,0,Middle East & Africa,Finance,Regulatory Affairs,Meets,Female,33,4,0,9,16,5.0,4.2,1.6,0.0331,1,1,1,1,3.2,3.2,3.4
8229,385,0,North America,Manufacturing,Data Science,Below,Female,47,9,0,8,24,4.1,4.1,3.2,0.0,1,1,1,1,4.2,3.0,1.5
8230,217,0,Middle East & Africa,Commercial,IT & Digital,Far Exceeds,Male,34,16,0,10,19,3.0,3.1,2.1,0.1275,1,1,1,1,2.6,3.2,4.0
8231,366,0,North America,Manufacturing,Regulatory Affairs,Exceeds,Female,41,27,0,9,15,2.7,3.8,2.7,0.0616,1,1,1,1,3.8,3.1,3.0
8232,501,0,Europe,Manufacturing,Market Access,Meets,Male,32,2,1,7,12,0.0,4.2,3.5,0.0348,1,1,1,1,4.6,2.8,4.3
8233,505,0,Middle East & Africa,Manufacturing,Market Access,Below,Female,37,12,0,8,28,3.2,3.8,2.3,0.0,1,1,1,1,3.1,3.7,4.2
8234,617,0,Latin America,Digital,IT & Digital,Exceeds,Female,44,17,0,10,18,2.8,3.1,2.1,0.1452,1,1,1,1,3.4,2.8,1.5
8235,887,0,Latin America,Finance,Legal & Compliance,Meets,Female,43,12,0,11,24,2.5,3.4,4.1,0.0331,1,1,1,1,3.1,1.5,3.0
8236,988,0,Latin America,Finance,Regulatory Affairs,Meets,Male,38,13,0,7,11,2.9,3.7,2.6,0.0331,1,1,1,1,4.4,3.4,2.2
8237,956,0,Middle East & Africa,Finance,Data Science,Meets,Female,51,5,0,7,20,4.2,1.7,3.3,0.0331,1,1,0,0,3.3,2.8,2.2
8238,230,0,Middle East & Africa,Commercial,Marketing,Meets,Female,37,11,1,9,12,0.0,2.3,3.2,0.0422,1,1,1,1,2.4,3.1,2.9
8239,744,0,Middle East & Africa,HR,Sales,Below,Male,45,15,1,12,22,0.0,3.0,3.0,0.0,0,0,0,0,4.1,1.5,2.9
8240,297,0,North America,Commercial,Human Resources,Meets,Female,35,6,1,5,9,0.0,4.8,2.5,0.0422,1,1,1,1,3.9,3.9,3.0
8241,885,0,Europe,Finance,Communications,Meets,Male,31,13,0,8,22,3.8,2.6,4.4,0.0331,1,1,1,1,3.4,4.9,4.5
8242,166,0,Latin America,R&D,Legal & Compliance,Meets,Male,37,11,0,12,32,3.9,5.0,3.6,0.0977,1,1,1,1,3.9,5.0,3.9
8243,438,0,North America,Manufacturing,Finance & Accounting,Meets,Male,28,13,1,8,29,0.0,1.8,2.4,0.0348,1,1,1,1,2.4,1.1,3.6
8244,505,0,Latin America,Manufacturing,Sales,Below,Male,40,7,0,12,22,3.6,3.2,1.6,0.0,1,1,1,1,3.3,1.5,2.4
8245,840,0,North America,HR,Regulatory Affairs,Below,Male,39,14,1,9,18,0.0,4.9,1.5,0.0,1,1,1,1,3.5,4.4,4.0
8246,64,0,Middle East & Africa,R&D,Regulatory Affairs,Far Below,Male,42,7,1,10,29,0.0,3.4,3.2,0.0,1,1,1,1,3.6,1.7,2.7
8247,626,0,Latin America,Digital,IT & Digital,Meets,Female,38,8,0,11,19,2.6,2.5,4.2,0.0853,1,1,1,1,4.2,2.2,4.1
8248,215,0,Middle East & Africa,Commercial,Clinical Operations,Meets,Male,36,12,0,12,20,3.2,3.7,1.2,0.0422,1,1,1,1,1.9,4.5,2.4
8249,537,0,Latin America,Digital,Data Science,Meets,Non-Binary/Other,38,7,1,11,18,0.0,2.3,1.0,0.0853,1,1,1,1,2.8,2.7,2.1
8250,20,0,Asia Pacific,R&D,IT & Digital,Meets,Male,45,25,0,10,18,3.0,3.4,1.2,0.0977,1,1,1,1,3.7,1.3,1.5
8251,729,0,North America,HR,IT & Digital,Meets,Female,44,12,1,7,25,0.0,1.3,4.7,0.0383,1,1,1,1,4.2,2.6,5.0
8252,16,0,Asia Pacific,R&D,Human Resources,Meets,Male,46,12,0,9,21,3.0,3.0,3.3,0.0977,1,1,1,1,3.9,2.9,3.1
8253,721,0,North America,HR,Legal & Compliance,Meets,Male,28,8,0,7,13,2.5,2.8,2.4,0.0383,1,1,1,1,3.6,3.7,3.4
8254,667,0,Europe,Digital,Supply Chain,Meets,Female,44,23,0,8,37,2.5,3.1,1.3,0.0853,1,1,1,1,2.4,2.8,3.3
8255,667,0,Latin America,Digital,Human Resources,Far Below,Female,42,25,0,11,23,3.0,3.9,2.7,0.0,1,1,1,1,3.3,5.0,2.7
8256,156,0,Europe,R&D,Sales,Meets,Female,50,11,1,11,25,0.0,3.6,2.2,0.0977,1,1,1,1,3.0,3.3,3.4
8257,174,0,Europe,R&D,Supply Chain,Meets,Female,35,10,0,7,27,3.4,2.8,1.9,0.0977,1,1,1,1,2.8,3.6,1.3
8258,505,0,North America,Manufacturing,Pharmacovigilance,Meets,Female,36,27,0,6,8,3.9,3.6,3.0,0.0348,1,1,1,1,4.4,4.3,2.5
8259,838,0,Asia Pacific,HR,Marketing,Exceeds,Male,40,20,0,5,11,2.6,5.0,1.0,0.0677,1,1,1,1,1.5,5.0,3.0
8260,355,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Meets,Female,28,12,1,9,15,0.0,1.7,3.7,0.0348,1,1,1,1,3.1,1.2,1.7
8261,284,0,North America,Commercial,Clinical Operations,Meets,Male,28,15,1,7,14,0.0,2.6,1.4,0.0422,1,1,1,1,3.4,4.3,3.1
8262,233,0,Middle East & Africa,Commercial,Clinical Operations,Meets,Male,40,5,0,5,15,3.4,4.7,4.0,0.0422,1,1,1,1,2.7,3.6,4.7
8263,139,0,Europe,R&D,Market Access,Meets,Male,31,8,1,9,19,0.0,2.1,1.0,0.0977,1,1,1,1,3.5,3.1,2.4
8264,571,0,Middle East & Africa,Digital,Pharmacovigilance,Below,Male,30,26,0,9,17,4.6,1.8,2.4,0.0,0,0,0,0,3.4,1.0,3.1
8265,317,0,Asia Pacific,Commercial,Legal & Compliance,Meets,Male,41,1,0,5,9,3.5,1.9,2.5,0.0422,1,1,1,1,3.7,1.0,2.7
8266,325,0,North America,Commercial,Marketing,Meets,Female,28,15,0,11,43,4.1,2.5,3.8,0.0422,1,1,1,1,3.1,3.1,3.9
8267,522,0,Asia Pacific,Manufacturing,Marketing,Exceeds,Female,42,13,0,10,17,3.9,3.2,3.6,0.0616,0,0,0,0,3.2,4.4,1.5
8268,429,0,Asia Pacific,Manufacturing,Medical Affairs,Meets,Male,33,7,1,6,48,0.0,1.6,3.8,0.0348,1,1,1,1,4.5,1.3,4.6
8269,218,0,North America,Commercial,IT & Digital,Meets,Female,33,22,0,7,12,3.2,3.9,2.6,0.0422,1,1,0,0,2.9,2.0,1.2
8270,27,0,Asia Pacific,R&D,Legal & Compliance,Below,Male,40,17,1,10,19,0.0,4.3,3.8,0.0,1,1,1,1,2.6,3.8,1.1
8271,379,1,Latin America,Manufacturing,Regulatory Affairs,Meets,Male,31,3,1,7,16,0.0,3.1,1.8,0.0348,1,1,0,0,4.7,2.4,2.8
8272,201,0,Latin America,Commercial,Market Access,Meets,Female,48,3,1,12,23,0.0,2.5,1.1,0.0422,1,1,1,1,1.2,3.5,2.8
8273,555,0,Latin America,Digital,Data Science,Meets,Female,37,18,0,8,18,3.4,4.0,4.6,0.0853,1,1,1,1,3.9,2.8,2.7
8274,434,0,Middle East & Africa,Manufacturing,Data Science,Meets,Female,38,17,0,10,19,4.4,3.0,3.3,0.0348,1,1,1,1,3.8,3.0,4.3
8275,245,0,Asia Pacific,Commercial,Quality Assurance,Meets,Female,42,12,0,7,13,3.0,2.6,1.6,0.0422,1,1,1,1,3.9,4.3,1.1
8276,799,0,North America,HR,Marketing,Meets,Female,44,19,0,5,10,2.7,2.9,3.2,0.0383,1,1,1,1,2.0,4.0,2.3
8277,438,0,North America,Manufacturing,Supply Chain,Meets,Female,35,9,0,10,32,2.8,2.2,1.9,0.0348,1,1,1,1,3.8,1.3,2.4
8278,728,0,Middle East & Africa,HR,Pharmacovigilance,Meets,Female,42,20,0,8,19,2.3,2.6,3.5,0.0383,1,1,1,1,1.2,3.0,4.1
8279,453,0,North America,Manufacturing,Clinical Operations,Exceeds,Female,43,28,0,12,18,2.9,4.0,2.3,0.0616,1,1,1,1,3.3,3.5,2.1
8280,450,0,Latin America,Manufacturing,Regulatory Affairs,Meets,Male,47,10,0,11,13,2.4,3.9,2.5,0.0348,1,1,1,1,1.9,2.6,2.9
8281,881,0,Asia Pacific,Finance,Communications,Meets,Female,35,8,0,7,8,3.6,3.5,2.7,0.0331,1,1,1,1,2.7,4.1,2.9
8282,907,0,North America,Finance,Pharmacovigilance,Meets,Male,43,19,0,9,11,3.8,4.2,4.0,0.0331,0,0,0,0,3.7,4.2,1.1
8283,755,0,North America,HR,Sales,Meets,Female,41,7,0,5,15,4.7,3.8,4.2,0.0383,1,1,1,1,2.8,4.6,3.3
8284,117,0,Europe,R&D,Medical Affairs,Far Exceeds,Male,41,10,0,10,14,3.7,4.2,2.4,0.2644,1,1,0,0,3.9,3.3,2.3
8285,302,0,Europe,Commercial,Clinical Operations,Meets,Male,28,18,0,9,28,3.0,2.9,1.2,0.0422,1,1,1,1,3.4,3.1,1.0
8286,144,0,Europe,R&D,Pharmacovigilance,Meets,Female,46,5,0,6,17,2.4,4.3,2.0,0.0977,0,0,0,0,2.9,5.0,2.3
8287,169,0,Asia Pacific,R&D,Human Resources,Meets,Male,44,6,1,8,11,0.0,4.2,3.3,0.0977,1,1,0,0,2.3,4.9,3.2
8288,935,0,Latin America,Finance,Finance & Accounting,Meets,Female,42,6,0,11,14,2.5,4.0,1.5,0.0331,1,1,1,1,3.3,3.4,1.0
8289,296,0,Latin America,Commercial,Pharmacovigilance,Below,Male,34,10,0,10,23,4.3,2.9,4.8,0.0,1,1,1,1,5.0,3.2,4.9
8290,1004,0,Latin America,Finance,Medical Affairs,Meets,Male,48,23,0,8,19,2.9,2.1,1.1,0.0331,1,1,1,1,3.7,1.6,2.4
8291,1013,0,Asia Pacific,Finance,Pharmacovigilance,Below,Female,38,12,1,5,15,0.0,2.8,1.7,0.0,1,1,1,1,5.0,4.4,2.6
8292,940,0,Asia Pacific,Finance,Market Access,Below,Male,41,13,0,10,11,3.5,2.3,1.1,0.0,1,1,1,1,4.8,3.9,1.8
8293,675,0,Europe,Digital,Finance & Accounting,Far Below,Female,31,18,0,7,13,2.7,1.5,3.0,0.0,1,1,1,1,1.0,2.8,2.5
8294,79,0,North America,R&D,Clinical Operations,Meets,Male,36,12,0,6,11,3.6,2.8,1.9,0.0977,0,0,0,0,3.6,4.0,3.4
8295,51,0,Middle East & Africa,R&D,Communications,Meets,Female,38,11,1,11,25,0.0,3.3,3.0,0.0977,1,1,1,1,2.5,1.6,3.2
8296,58,1,Middle East & Africa,R&D,Sales,Exceeds,Female,33,7,1,8,12,0.0,3.3,3.1,0.1648,1,1,1,1,4.4,4.0,3.8
8297,569,0,North America,Digital,Clinical Operations,Meets,Female,34,12,0,7,39,4.2,5.0,3.2,0.0853,1,1,1,1,2.2,4.9,2.8
8298,501,0,Europe,Manufacturing,Medical Affairs,Exceeds,Female,41,9,0,11,19,3.3,2.2,1.5,0.0616,1,1,1,1,4.6,2.8,1.0
8299,712,0,North America,HR,IT & Digital,Meets,Male,44,16,0,7,10,2.9,1.6,2.4,0.0383,0,0,0,0,2.1,2.2,2.0
8300,876,0,North America,HR,Sales,Below,Female,29,15,0,11,17,4.5,3.9,4.3,0.0,1,1,1,1,4.4,3.1,4.3
8301,691,0,Middle East & Africa,Digital,Legal & Compliance,Meets,Female,52,6,1,5,11,0.0,4.6,1.7,0.0853,1,1,1,1,4.4,4.4,3.5
8302,36,0,Europe,R&D,Human Resources,Meets,Male,33,27,0,8,17,2.5,3.7,2.0,0.0977,1,1,1,1,3.0,3.4,4.1
8303,840,0,Asia Pacific,HR,Data Science,Meets,Female,32,8,0,11,22,3.0,3.4,2.5,0.0383,1,1,1,1,2.4,4.1,2.1
8304,643,0,Middle East & Africa,Digital,Regulatory Affairs,Exceeds,Female,47,19,0,5,20,2.8,3.4,3.0,0.1452,1,1,1,1,3.2,3.6,1.0
8305,897,0,Asia Pacific,Finance,Marketing,Meets,Female,42,25,0,11,13,5.0,2.0,2.0,0.0331,1,1,1,1,5.0,3.0,3.1
8306,237,0,Europe,Commercial,Human Resources,Meets,Male,44,8,0,12,30,3.3,4.2,2.9,0.0422,1,1,1,0,3.6,3.3,2.6
8307,705,0,North America,HR,Finance & Accounting,Exceeds,Male,33,15,1,7,20,0.0,3.5,3.0,0.0677,0,0,0,0,4.6,4.7,2.1
8308,335,0,Latin America,Commercial,Data Science,Meets,Male,41,7,0,12,24,2.9,2.2,3.5,0.0422,1,1,1,1,3.8,3.4,3.4
8309,115,0,Latin America,R&D,Market Access,Below,Male,53,23,0,7,22,2.4,1.9,3.5,0.0,1,1,1,1,3.5,2.3,2.5
8310,838,1,Europe,HR,Clinical Operations,Meets,Male,33,8,1,6,9,0.0,3.5,1.0,0.0383,1,1,1,1,3.9,3.8,1.4
8311,600,0,Latin America,Digital,Human Resources,Meets,Female,42,18,0,11,15,3.4,2.3,3.0,0.0853,1,1,1,1,3.0,3.1,3.5
8312,411,0,Asia Pacific,Manufacturing,Finance & Accounting,Meets,Male,33,14,0,6,35,4.5,3.1,2.2,0.0348,1,1,1,1,5.0,3.7,3.0
8313,827,0,Latin America,HR,Sales,Exceeds,Female,32,22,0,8,18,3.2,3.5,1.3,0.0677,1,1,1,1,3.3,3.5,1.6
8314,797,0,Europe,HR,Regulatory Affairs,Below,Female,37,12,0,10,22,3.0,2.3,3.9,0.0,1,1,1,1,3.5,4.0,4.0
8315,737,0,Europe,HR,Communications,Meets,Male,38,18,0,7,29,2.4,3.6,1.4,0.0383,1,1,1,1,4.3,3.2,2.2
8316,719,0,Asia Pacific,HR,Regulatory Affairs,Exceeds,Male,37,7,0,7,10,2.9,3.2,1.1,0.0677,1,1,1,1,4.2,3.8,1.0
8317,623,0,Latin America,Digital,Communications,Meets,Female,38,11,0,10,17,3.3,3.3,2.1,0.0853,1,1,1,1,3.8,3.1,1.8
8318,589,0,Latin America,Digital,Medical Affairs,Meets,Female,51,5,0,10,16,3.9,2.5,2.5,0.0853,1,1,1,1,3.7,2.7,2.6
8319,416,0,North America,Manufacturing,Medical Affairs,Meets,Female,48,8,1,8,12,0.0,2.7,2.2,0.0348,1,1,1,1,4.5,2.9,1.5
8320,573,0,Middle East & Africa,Digital,Medical Affairs,Meets,Female,39,36,0,12,22,3.5,4.9,5.0,0.0853,1,1,1,1,3.9,4.0,3.9
8321,628,0,Europe,Digital,Supply Chain,Meets,Male,39,9,0,6,28,3.2,4.5,2.3,0.0853,1,1,1,1,2.7,3.4,2.6
8322,124,0,North America,R&D,Clinical Operations,Exceeds,Female,47,4,1,6,18,0.0,1.8,1.5,0.1648,1,1,1,1,3.3,2.9,1.3
8323,66,0,Europe,R&D,Finance & Accounting,Below,Female,42,2,1,9,15,0.0,3.8,3.3,0.0,1,1,1,1,3.2,2.6,4.2
8324,247,0,North America,Commercial,Quality Assurance,Meets,Male,40,5,1,10,16,0.0,2.3,1.0,0.0422,1,1,1,1,3.8,3.7,1.7
8325,492,0,Middle East & Africa,Manufacturing,IT & Digital,Below,Male,51,9,0,7,10,3.7,2.9,1.1,0.0,1,1,1,1,4.8,4.3,2.9
8326,144,1,North America,R&D,Finance & Accounting,Meets,Male,33,6,0,9,21,5.0,1.9,3.9,0.0977,1,1,1,1,3.6,1.0,3.8
8327,449,0,Europe,Manufacturing,Market Access,Meets,Female,38,16,0,8,18,2.9,2.8,4.0,0.0348,1,1,1,1,2.2,3.0,3.7
8328,391,0,Latin America,Manufacturing,Pharmacovigilance,Below,Female,37,11,0,10,15,3.5,2.8,1.5,0.0,1,1,1,1,3.1,3.2,2.8
8329,859,0,Europe,HR,Market Access,Meets,Female,41,5,1,8,10,0.0,2.1,5.0,0.0383,1,1,1,1,5.0,2.9,1.8
8330,989,0,Asia Pacific,Finance,Finance & Accounting,Below,Male,32,13,1,12,19,0.0,2.3,2.2,0.0,1,1,1,1,1.9,3.3,1.6
8331,1024,0,Asia Pacific,Finance,Legal & Compliance,Meets,Female,41,12,0,10,25,4.6,2.8,1.3,0.0331,1,0,0,0,3.8,3.1,1.0
8332,881,1,Asia Pacific,Finance,Communications,Meets,Non-Binary/Other,36,5,1,6,14,0.0,3.6,3.1,0.0331,1,1,1,1,5.0,3.1,3.5
8333,456,0,Asia Pacific,Manufacturing,Marketing,Meets,Female,44,16,0,12,26,3.2,2.7,2.2,0.0348,1,1,0,0,3.8,2.4,3.1
8334,852,0,Middle East & Africa,HR,Medical Affairs,Below,Female,36,6,0,5,6,3.2,3.5,2.0,0.0,1,1,1,1,4.0,3.9,2.8
8335,354,0,Latin America,Commercial,Marketing,Meets,Male,35,18,0,9,20,3.2,1.3,1.8,0.0422,1,1,0,0,3.0,2.8,2.2
8336,215,0,Latin America,Commercial,Market Access,Meets,Female,42,7,0,11,22,4.2,2.5,1.8,0.0422,1,1,1,1,4.4,3.9,2.4
8337,937,0,Europe,Finance,Supply Chain,Below,Male,39,15,0,6,7,4.0,2.6,3.3,0.0,1,1,1,1,3.4,3.6,3.6
8338,225,0,North America,Commercial,Marketing,Meets,Male,36,15,1,9,11,0.0,3.2,3.4,0.0422,1,1,1,1,2.6,2.9,1.3
8339,705,0,Europe,HR,Human Resources,Meets,Male,37,5,0,5,22,3.5,3.5,2.7,0.0383,1,1,1,1,3.3,3.9,1.6
8340,1048,0,Europe,Finance,Clinical Operations,Meets,Male,35,12,0,5,19,4.2,2.3,4.1,0.0331,1,1,1,1,2.7,2.9,5.0
8341,770,1,Europe,HR,Sales,Meets,Female,50,6,1,7,13,0.0,3.8,2.4,0.0383,1,1,1,1,3.9,2.4,2.8
8342,205,0,Europe,Commercial,Quality Assurance,Below,Female,41,6,0,8,10,3.4,3.8,3.3,0.0,1,1,1,1,3.7,4.6,3.4
8343,953,0,Latin America,Finance,Communications,Below,Female,43,18,0,10,17,3.5,3.6,3.8,0.0,1,1,1,1,2.7,4.3,2.8
8344,734,0,North America,HR,Quality Assurance,Meets,Male,41,9,0,8,11,4.1,2.6,4.0,0.0383,1,1,1,1,3.7,3.0,3.6
8345,611,0,Europe,Digital,IT & Digital,Far Below,Female,40,9,1,8,22,0.0,1.9,2.0,0.0,0,0,0,0,2.8,2.0,1.0
8346,665,0,Latin America,Digital,Market Access,Below,Female,35,8,0,6,13,3.5,3.8,2.6,0.0,1,1,1,1,3.5,2.9,2.5
8347,817,0,Europe,HR,Pharmacovigilance,Meets,Female,34,6,0,10,12,3.0,3.3,2.9,0.0383,1,1,1,1,3.7,3.2,2.0
8348,737,0,Asia Pacific,HR,Medical Affairs,Meets,Male,35,7,1,5,11,0.0,3.2,5.0,0.0383,0,0,0,0,3.1,3.7,3.0
8349,142,0,Europe,R&D,Market Access,Meets,Male,42,21,0,10,15,3.6,2.7,2.7,0.0977,0,0,0,0,3.5,2.9,2.1
8350,51,0,Europe,R&D,Marketing,Meets,Female,35,9,0,5,10,4.7,2.9,1.1,0.0977,1,1,1,1,3.0,2.9,1.7
8351,477,0,Middle East & Africa,Manufacturing,Supply Chain,Meets,Female,46,5,0,6,15,2.6,2.1,4.5,0.0348,0,0,0,0,4.0,1.2,3.9
8352,987,0,Asia Pacific,Finance,Sales,Meets,Female,48,10,1,8,25,0.0,4.5,2.0,0.0331,1,1,1,1,3.8,2.3,1.8
8353,519,0,North America,Manufacturing,Communications,Meets,Male,28,13,0,10,19,2.8,3.3,2.8,0.0348,1,1,1,1,2.5,1.0,2.5
8354,373,0,Europe,Manufacturing,Human Resources,Exceeds,Female,48,10,0,5,9,3.0,3.4,1.3,0.0616,1,1,1,0,4.1,3.9,1.5
8355,284,0,North America,Commercial,Quality Assurance,Meets,Male,31,11,0,9,23,3.5,1.0,2.9,0.0422,1,1,1,1,4.2,2.9,3.0
8356,610,0,Asia Pacific,Digital,Data Science,Meets,Male,36,10,0,7,28,4.2,2.4,3.6,0.0853,1,1,1,1,3.4,3.2,1.8
8357,188,0,Europe,Commercial,Quality Assurance,Far Below,Female,39,4,1,6,18,0.0,3.3,1.7,0.0,1,1,1,1,3.9,4.6,1.3
8358,948,0,Middle East & Africa,Finance,Communications,Below,Female,28,4,0,12,22,2.8,2.9,3.8,0.0,1,1,1,1,3.9,2.5,3.9
8359,737,0,Latin America,HR,Legal & Compliance,Below,Female,34,7,0,7,11,2.2,2.6,4.0,0.0,1,1,1,1,4.4,3.2,3.6
8360,84,0,Middle East & Africa,R&D,Sales,Meets,Male,39,7,0,8,19,3.3,3.1,3.4,0.0977,0,0,0,0,2.8,2.1,2.6
8361,937,0,Middle East & Africa,Finance,Clinical Operations,Meets,Male,31,14,1,6,14,0.0,2.4,2.2,0.0331,1,1,1,1,3.1,3.4,1.6
8362,715,0,Latin America,HR,Finance & Accounting,Far Below,Male,30,8,0,9,13,3.0,3.0,2.6,0.0,1,1,1,1,3.4,3.5,3.3
8363,955,0,Latin America,Finance,Marketing,Meets,Male,49,20,0,12,17,3.3,2.5,2.0,0.0331,1,1,1,1,2.2,3.0,2.4
8364,704,0,Latin America,HR,Regulatory Affairs,Meets,Female,39,14,0,6,19,4.2,4.1,1.9,0.0383,1,1,1,1,3.3,3.4,2.3
8365,71,0,Europe,R&D,Communications,Far Exceeds,Female,44,28,0,7,23,2.0,2.6,3.5,0.2644,1,1,1,0,3.5,3.0,3.8
8366,733,0,North America,HR,Supply Chain,Meets,Female,50,6,0,6,26,3.2,2.9,3.5,0.0383,1,1,1,1,3.3,2.7,3.1
8367,495,0,North America,Manufacturing,Communications,Meets,Female,43,13,0,9,10,3.7,2.7,2.7,0.0348,1,1,1,1,3.6,3.1,2.5
8368,890,0,Latin America,Finance,Communications,Exceeds,Female,35,7,0,5,6,3.0,3.1,3.5,0.0588,1,1,1,1,4.1,2.4,4.0
8369,137,0,Middle East & Africa,R&D,Pharmacovigilance,Exceeds,Female,34,8,0,8,14,3.4,5.0,2.7,0.1648,1,1,1,1,3.3,4.1,2.3
8370,782,0,Asia Pacific,HR,Data Science,Meets,Male,41,8,0,12,20,3.6,5.0,2.2,0.0383,1,1,1,1,3.2,5.0,1.4
8371,355,0,Latin America,Manufacturing,Legal & Compliance,Meets,Male,42,6,1,9,22,0.0,4.1,1.4,0.0348,1,1,1,1,3.0,2.9,2.0
8372,503,0,Middle East & Africa,Manufacturing,Market Access,Meets,Male,40,5,0,8,23,4.6,3.7,1.9,0.0348,1,1,1,1,2.7,4.0,4.5
8373,640,0,Middle East & Africa,Digital,Legal & Compliance,Meets,Female,43,8,1,8,22,0.0,2.8,2.9,0.0853,1,1,1,1,4.8,4.5,2.0
8374,409,0,Europe,Manufacturing,Medical Affairs,Meets,Female,37,7,0,9,20,3.6,3.3,2.5,0.0348,1,1,1,1,2.7,3.6,2.3
8375,282,0,Europe,Commercial,Medical Affairs,Meets,Female,38,34,0,6,12,3.3,3.2,1.6,0.0422,1,1,1,1,2.7,3.8,1.9
8376,40,0,North America,R&D,Medical Affairs,Meets,Female,35,6,1,11,20,0.0,3.5,3.3,0.0977,1,1,1,1,5.0,4.3,2.7
8377,41,0,North America,R&D,Data Science,Meets,Female,33,16,0,6,19,3.5,2.3,3.5,0.0977,1,1,1,1,2.8,2.4,3.7
8378,126,0,Asia Pacific,R&D,Sales,Below,Male,33,12,1,10,16,0.0,2.4,2.4,0.0,1,1,1,1,3.7,1.2,1.9
8379,723,0,Asia Pacific,HR,Pharmacovigilance,Meets,Male,36,11,0,10,33,3.8,2.5,3.8,0.0383,1,1,1,1,4.1,2.9,3.1
8380,981,0,Asia Pacific,Finance,Communications,Meets,Male,42,9,0,11,21,2.8,2.3,1.0,0.0331,1,1,1,1,2.5,2.3,1.8
8381,822,0,Asia Pacific,HR,Human Resources,Meets,Non-Binary/Other,38,7,0,9,10,3.7,2.6,3.4,0.0383,1,1,1,1,3.7,4.2,4.0
8382,330,0,Middle East & Africa,Commercial,Quality Assurance,Meets,Male,35,4,0,12,25,4.2,3.7,5.0,0.0422,1,1,1,1,4.8,2.6,3.0
8383,881,0,Middle East & Africa,Finance,Market Access,Meets,Female,36,5,0,11,23,1.3,3.1,3.4,0.0331,1,1,1,1,3.6,4.1,3.8
8384,392,0,North America,Manufacturing,Regulatory Affairs,Far Exceeds,Female,28,11,0,7,11,2.6,3.2,1.3,0.1069,1,1,1,1,3.1,3.1,2.1
8385,779,0,Europe,HR,IT & Digital,Below,Male,35,12,0,6,11,4.6,3.9,2.8,0.0,1,1,1,1,3.8,4.1,3.4
8386,988,0,Europe,Finance,Pharmacovigilance,Exceeds,Female,43,7,1,7,11,0.0,2.3,3.9,0.0588,1,1,1,1,3.1,2.0,3.4
8387,364,0,Latin America,Manufacturing,IT & Digital,Meets,Female,31,10,0,8,29,4.6,3.7,1.2,0.0348,1,1,1,1,3.5,2.2,2.2
8388,893,0,Middle East & Africa,Finance,Market Access,Exceeds,Female,29,29,0,9,28,2.9,4.5,1.2,0.0588,1,1,1,1,3.8,4.0,2.5
8389,384,0,Asia Pacific,Manufacturing,Regulatory Affairs,Meets,Female,31,33,0,12,23,3.5,3.4,4.8,0.0348,0,0,0,0,4.3,3.3,3.6
8390,907,0,Asia Pacific,Finance,Supply Chain,Meets,Male,35,11,0,12,27,4.0,2.1,2.6,0.0331,1,0,0,0,4.5,2.4,3.7
8391,824,0,Latin America,HR,Sales,Below,Female,38,18,1,8,11,0.0,2.5,2.0,0.0,1,1,1,1,3.6,3.9,1.6
8392,712,0,Europe,HR,Communications,Meets,Male,39,14,0,10,15,3.3,2.1,1.3,0.0383,1,1,1,1,3.1,3.3,1.6
8393,328,0,Asia Pacific,Commercial,Finance & Accounting,Meets,Male,42,1,1,6,13,0.0,2.2,3.0,0.0422,1,1,1,1,4.5,3.2,1.7
8394,604,0,Europe,Digital,Supply Chain,Meets,Female,37,23,0,10,31,2.9,2.9,2.7,0.0853,0,0,0,0,3.2,2.3,3.4
8395,109,0,Latin America,R&D,Sales,Meets,Male,42,13,0,6,26,2.0,3.0,2.4,0.0977,1,1,1,1,3.5,3.2,2.5
8396,832,0,Europe,HR,IT & Digital,Exceeds,Female,31,15,0,6,32,4.0,1.9,4.2,0.0677,1,1,1,1,3.6,1.4,5.0
8397,704,0,Europe,HR,Marketing,Meets,Male,45,2,0,11,23,3.9,3.1,1.7,0.0383,1,1,1,1,3.2,4.3,1.6
8398,358,0,Europe,Manufacturing,Quality Assurance,Meets,Female,40,8,1,8,15,0.0,3.1,2.8,0.0348,1,1,1,1,2.5,3.7,3.5
8399,577,0,Asia Pacific,Digital,Clinical Operations,Below,Male,28,30,0,8,11,3.1,3.1,1.6,0.0,1,1,1,1,3.6,2.2,2.7
8400,874,0,North America,HR,Finance & Accounting,Meets,Female,39,7,0,6,8,2.0,4.3,2.9,0.0383,0,0,0,0,3.8,1.5,2.7
8401,893,0,Middle East & Africa,Finance,Human Resources,Below,Male,52,6,1,9,23,0.0,2.5,3.0,0.0,1,1,1,1,3.8,3.4,2.1
8402,553,0,Europe,Digital,Finance & Accounting,Exceeds,Male,50,30,0,6,8,3.0,1.5,2.6,0.1452,0,0,0,0,3.2,1.8,2.4
8403,103,0,Europe,R&D,IT & Digital,Meets,Female,38,23,0,5,21,2.7,3.1,1.0,0.0977,0,0,0,0,3.0,3.0,2.0
8404,1035,0,Europe,Finance,Clinical Operations,Meets,Female,42,23,0,12,22,4.0,4.0,2.8,0.0331,1,1,1,1,3.7,4.0,2.1
8405,512,0,North America,Manufacturing,Sales,Meets,Female,31,8,0,9,22,3.4,1.3,4.6,0.0348,1,1,1,1,5.0,1.5,3.0
8406,188,0,Latin America,Commercial,Communications,Meets,Male,30,14,1,11,17,0.0,3.0,1.0,0.0422,1,1,1,1,5.0,3.2,2.6
8407,972,0,Asia Pacific,Finance,Clinical Operations,Meets,Female,37,8,1,11,16,0.0,3.1,2.7,0.0331,1,1,1,1,2.8,2.8,2.5
8408,86,0,North America,R&D,Data Science,Meets,Female,35,9,1,6,15,0.0,2.4,4.4,0.0977,1,1,1,1,2.1,2.4,5.0
8409,921,0,Europe,Finance,Market Access,Far Below,Female,39,13,0,5,9,2.7,1.6,1.8,0.0,1,1,1,1,3.5,2.7,2.8
8410,575,0,North America,Digital,Communications,Far Exceeds,Female,42,8,1,12,26,0.0,4.7,1.9,0.2363,0,0,0,0,3.6,3.8,2.6
8411,656,1,North America,Digital,Pharmacovigilance,Meets,Male,42,24,0,7,14,3.3,2.9,4.1,0.0853,1,1,1,1,3.3,5.0,4.5
8412,133,0,North America,R&D,Legal & Compliance,Meets,Female,44,10,0,5,7,2.7,2.2,2.5,0.0977,1,0,0,0,4.2,2.8,4.4
8413,592,0,Latin America,Digital,Finance & Accounting,Meets,Female,41,16,1,10,12,0.0,4.2,3.2,0.0853,1,1,1,1,3.5,2.9,2.3
8414,954,0,Middle East & Africa,Finance,Supply Chain,Meets,Female,45,10,0,12,24,4.1,1.8,2.6,0.0331,1,0,0,0,4.1,2.0,2.7
8415,346,0,Asia Pacific,Commercial,IT & Digital,Below,Female,44,13,0,9,11,3.1,2.4,2.9,0.0,1,1,1,1,3.1,1.4,4.7
8416,992,0,Latin America,Finance,Marketing,Meets,Female,37,13,0,12,23,5.0,1.6,5.0,0.0331,1,1,1,1,5.0,2.1,3.8
8417,306,0,Latin America,Commercial,Quality Assurance,Meets,Male,28,11,0,9,21,3.0,2.1,1.0,0.0422,1,1,1,1,2.0,2.7,2.2
8418,588,1,Middle East & Africa,Digital,Quality Assurance,Meets,Female,31,6,0,5,26,3.4,2.3,3.1,0.0853,1,1,1,1,3.8,3.7,4.2
8419,943,0,Latin America,Finance,Marketing,Far Exceeds,Female,42,12,0,10,18,3.8,3.5,4.9,0.1022,1,1,1,1,2.6,4.6,4.5
8420,636,0,North America,Digital,Medical Affairs,Below,Male,39,4,1,7,15,0.0,4.0,2.8,0.0,1,1,1,1,2.7,3.3,2.1
8421,250,0,North America,Commercial,Medical Affairs,Meets,Female,50,5,0,5,8,1.4,4.0,3.6,0.0422,1,1,1,1,1.0,3.2,3.7
8422,665,0,Europe,Digital,Medical Affairs,Meets,Female,29,12,0,12,17,4.5,2.7,3.5,0.0853,1,1,1,1,2.4,2.9,4.0
8423,791,0,Latin America,HR,Marketing,Meets,Female,43,6,0,12,20,3.2,4.2,2.9,0.0383,1,1,1,1,3.6,3.3,3.5
8424,447,0,Europe,Manufacturing,Clinical Operations,Meets,Male,38,6,1,7,12,0.0,1.9,4.3,0.0348,1,1,1,1,3.4,2.7,4.4
8425,989,0,Asia Pacific,Finance,IT & Digital,Meets,Female,33,3,0,9,24,3.2,4.4,2.3,0.0331,1,1,1,1,4.5,5.0,1.8
8426,836,0,North America,HR,Regulatory Affairs,Meets,Female,49,5,0,12,13,4.0,3.0,1.7,0.0383,1,1,1,1,4.4,2.1,3.7
8427,674,0,Asia Pacific,Digital,Marketing,Meets,Male,31,14,0,9,17,3.7,4.0,1.1,0.0853,1,1,1,1,2.3,5.0,2.7
8428,632,0,Middle East & Africa,Digital,Legal & Compliance,Meets,Female,40,11,1,8,34,0.0,3.5,1.8,0.0853,1,1,1,1,3.7,1.4,3.4
8429,462,0,North America,Manufacturing,Legal & Compliance,Far Below,Non-Binary/Other,45,11,0,7,23,3.3,3.2,3.6,0.0,0,0,0,0,4.2,3.9,2.3
8430,549,1,Asia Pacific,Digital,Human Resources,Meets,Female,33,27,0,5,20,3.3,4.0,2.9,0.0853,1,1,1,1,3.3,3.7,3.6
8431,515,0,Middle East & Africa,Manufacturing,Clinical Operations,Meets,Non-Binary/Other,28,15,0,7,17,2.6,2.7,3.9,0.0348,1,1,1,1,5.0,3.5,2.9
8432,932,0,Asia Pacific,Finance,Pharmacovigilance,Meets,Female,42,11,0,5,8,2.3,4.0,3.7,0.0331,0,0,0,0,3.4,3.7,3.9
8433,314,0,Middle East & Africa,Commercial,IT & Digital,Below,Male,45,24,0,9,13,2.5,2.8,1.5,0.0,1,1,1,1,2.8,4.1,2.6
8434,372,0,Middle East & Africa,Manufacturing,Marketing,Exceeds,Male,35,23,0,9,25,2.8,5.0,2.7,0.0616,1,1,1,1,3.7,3.3,3.6
8435,521,0,North America,Manufacturing,Supply Chain,Below,Female,29,17,0,10,13,2.6,1.9,3.6,0.0,1,1,1,1,4.3,3.7,3.2
8436,772,0,Europe,HR,Legal & Compliance,Meets,Male,39,5,0,6,28,3.9,3.6,3.8,0.0383,1,1,1,1,3.8,5.0,2.7
8437,566,0,Middle East & Africa,Digital,IT & Digital,Below,Female,36,10,1,9,18,0.0,3.4,2.3,0.0,1,1,1,1,4.3,4.4,2.8
8438,911,0,Middle East & Africa,Finance,Clinical Operations,Meets,Male,28,22,1,11,32,0.0,3.9,3.0,0.0331,1,1,1,1,2.7,2.7,2.7
8439,259,0,North America,Commercial,Quality Assurance,Meets,Non-Binary/Other,41,16,0,9,35,3.1,2.3,4.2,0.0422,1,1,1,1,3.5,2.5,4.3
8440,12,0,Europe,R&D,IT & Digital,Meets,Male,34,4,0,9,19,2.3,2.7,2.3,0.0977,1,1,1,1,3.6,3.8,3.0
8441,518,0,Latin America,Manufacturing,IT & Digital,Below,Female,42,6,1,5,18,0.0,2.2,2.7,0.0,1,1,1,1,3.3,1.0,2.4
8442,143,0,Latin America,R&D,IT & Digital,Far Below,Female,52,5,0,5,10,3.7,3.5,2.0,0.0,1,1,1,1,3.2,3.7,2.5
8443,567,0,Europe,Digital,IT & Digital,Meets,Female,38,7,0,6,15,4.3,4.4,2.0,0.0853,1,1,1,1,3.8,3.8,3.1
8444,393,0,Asia Pacific,Manufacturing,IT & Digital,Exceeds,Male,39,4,1,6,14,0.0,3.0,2.3,0.0616,1,1,1,1,3.0,2.4,1.6
8445,31,0,North America,R&D,Sales,Exceeds,Female,39,12,0,11,40,4.2,3.9,1.6,0.1648,1,1,1,1,4.4,3.2,3.8
8446,721,0,Europe,HR,Sales,Meets,Female,37,4,1,12,21,0.0,5.0,2.2,0.0383,1,1,1,1,2.6,3.9,2.9
8447,2,0,Latin America,R&D,Legal & Compliance,Meets,Male,31,5,1,7,13,0.0,3.1,2.2,0.0977,1,1,1,1,4.7,3.1,3.3
8448,832,0,Middle East & Africa,HR,Marketing,Exceeds,Female,40,7,1,7,21,0.0,1.0,2.2,0.0677,1,1,1,1,2.7,2.7,2.0
8449,235,0,Latin America,Commercial,Supply Chain,Meets,Female,35,7,0,11,14,3.9,3.3,2.3,0.0422,1,1,1,1,2.9,4.2,2.6
8450,590,0,Middle East & Africa,Digital,Supply Chain,Exceeds,Female,35,4,0,12,18,2.7,4.1,2.0,0.1452,1,1,1,1,1.6,1.9,1.0
8451,1014,0,North America,Finance,Sales,Meets,Female,34,17,0,7,10,5.0,2.2,2.9,0.0331,0,0,0,0,2.9,2.6,3.1
8452,154,0,Middle East & Africa,R&D,Clinical Operations,Meets,Male,41,22,0,8,26,3.6,2.4,4.1,0.0977,1,1,1,1,4.1,2.9,3.9
8453,355,0,Europe,Manufacturing,Human Resources,Meets,Male,33,13,0,7,21,2.3,2.2,1.6,0.0348,1,1,1,1,2.4,2.8,2.9
8454,683,0,Middle East & Africa,Digital,Pharmacovigilance,Meets,Male,40,19,0,6,10,3.3,3.6,1.6,0.0853,1,1,1,1,3.0,4.0,3.2
8455,103,0,Asia Pacific,R&D,Communications,Meets,Female,41,11,0,11,13,3.6,2.5,1.4,0.0977,1,1,1,1,3.7,2.4,2.4
8456,485,0,Europe,Manufacturing,Marketing,Below,Female,38,19,0,8,15,3.1,4.6,3.4,0.0,1,1,1,1,1.9,4.0,3.4
8457,409,0,North America,Manufacturing,Finance & Accounting,Meets,Male,30,6,1,7,9,0.0,3.9,3.4,0.0348,1,1,1,1,2.3,3.3,4.4
8458,942,1,Europe,Finance,Pharmacovigilance,Meets,Male,34,3,1,6,18,0.0,4.9,1.9,0.0331,1,1,1,1,3.6,4.3,1.1
8459,952,0,Asia Pacific,Finance,Human Resources,Meets,Male,37,16,0,6,30,3.1,3.5,3.9,0.0331,1,1,1,1,3.7,3.3,2.4
8460,402,0,North America,Manufacturing,Medical Affairs,Meets,Female,30,10,0,6,15,2.0,4.0,3.8,0.0348,1,1,1,1,2.8,3.4,4.7
8461,988,0,Latin America,Finance,Regulatory Affairs,Meets,Male,40,22,0,8,26,3.1,3.9,2.8,0.0331,1,1,1,1,3.8,2.2,2.7
8462,364,0,Asia Pacific,Manufacturing,Finance & Accounting,Meets,Female,47,8,0,12,28,5.0,2.4,1.1,0.0348,1,1,1,1,5.0,2.8,1.0
8463,102,1,North America,R&D,Finance & Accounting,Far Exceeds,Male,41,10,0,9,27,3.5,4.0,2.2,0.2644,1,1,1,1,5.0,3.5,3.3
8464,309,0,Middle East & Africa,Commercial,Data Science,Meets,Female,31,15,0,12,34,2.3,3.9,2.8,0.0422,1,1,1,1,3.2,2.7,3.4
8465,999,0,Europe,Finance,IT & Digital,Meets,Male,53,11,1,11,15,0.0,2.2,2.3,0.0331,0,0,0,0,2.5,2.4,3.9
8466,786,0,North America,HR,Medical Affairs,Meets,Male,35,7,0,7,28,2.9,1.3,3.4,0.0383,0,0,0,0,2.9,1.0,4.4
8467,705,0,Europe,HR,Market Access,Meets,Female,40,22,0,9,20,4.8,3.2,1.8,0.0383,0,0,0,0,3.6,2.2,3.4
8468,737,0,Middle East & Africa,HR,IT & Digital,Exceeds,Female,34,18,0,10,22,2.4,3.3,2.5,0.0677,1,1,1,1,3.4,4.8,2.0
8469,323,0,North America,Commercial,Quality Assurance,Meets,Female,39,27,0,10,15,3.0,2.1,1.9,0.0422,1,1,1,1,2.2,2.6,2.1
8470,431,0,Latin America,Manufacturing,Data Science,Meets,Male,46,2,0,6,8,2.4,3.5,1.5,0.0348,0,0,0,0,1.7,3.1,3.1
8471,508,0,Asia Pacific,Manufacturing,Quality Assurance,Meets,Female,32,8,1,11,24,0.0,3.4,1.8,0.0348,0,0,0,0,5.0,2.9,3.7
8472,552,0,North America,Digital,Marketing,Below,Male,35,1,0,12,17,1.8,3.5,3.0,0.0,1,1,1,1,1.6,3.2,3.9
8473,864,0,Middle East & Africa,HR,Medical Affairs,Below,Female,39,12,0,11,21,2.4,2.4,1.5,0.0,1,1,1,1,1.7,1.0,2.7
8474,732,0,North America,HR,Legal & Compliance,Meets,Male,28,13,0,12,16,3.5,3.4,4.0,0.0383,1,1,1,1,4.2,4.5,4.1
8475,376,0,Europe,Manufacturing,Supply Chain,Meets,Male,43,10,1,12,15,0.0,3.7,3.4,0.0348,1,1,1,1,3.1,3.4,2.8
8476,802,1,North America,HR,Communications,Meets,Male,34,18,0,5,15,4.2,4.3,2.1,0.0383,1,1,1,1,4.5,5.0,2.4
8477,496,0,Latin America,Manufacturing,Legal & Compliance,Meets,Male,38,8,0,5,13,4.0,1.5,2.4,0.0348,1,1,1,1,3.4,2.9,1.4
8478,465,0,North America,Manufacturing,Human Resources,Far Below,Female,31,24,0,8,12,3.5,5.0,3.4,0.0,1,1,1,1,3.5,2.7,3.3
8479,982,0,Asia Pacific,Finance,Finance & Accounting,Meets,Female,31,13,0,11,24,3.4,4.5,1.1,0.0331,1,1,1,1,3.7,4.2,2.5
8480,388,0,North America,Manufacturing,Sales,Meets,Male,38,6,0,11,30,4.4,3.4,1.0,0.0348,1,1,1,1,3.0,4.7,1.6
8481,57,0,Europe,R&D,Sales,Meets,Male,47,8,1,9,32,0.0,3.5,2.1,0.0977,1,1,1,1,4.4,1.5,2.6
8482,161,0,North America,R&D,Pharmacovigilance,Meets,Male,32,19,0,9,35,3.0,1.6,1.5,0.0977,1,1,1,1,4.5,2.2,1.0
8483,97,1,Latin America,R&D,Finance & Accounting,Exceeds,Male,43,5,1,10,23,0.0,2.9,2.0,0.1648,1,1,1,1,3.4,3.1,2.2
8484,140,0,Middle East & Africa,R&D,Data Science,Meets,Male,46,6,0,10,45,2.1,4.0,1.0,0.0977,1,1,1,1,3.0,4.3,2.9
8485,275,0,North America,Commercial,Market Access,Meets,Male,44,13,0,5,25,3.5,2.8,1.0,0.0422,1,1,1,1,2.7,2.8,3.6
8486,630,0,North America,Digital,Communications,Far Below,Male,37,4,1,5,8,0.0,2.6,3.0,0.0,1,1,1,1,3.7,1.4,2.4
8487,611,1,Asia Pacific,Digital,Medical Affairs,Far Exceeds,Female,39,7,1,9,12,0.0,3.1,3.4,0.2363,1,1,1,1,3.4,4.0,3.9
8488,486,0,Latin America,Manufacturing,Sales,Meets,Female,47,15,0,5,18,3.8,3.4,1.3,0.0348,0,0,0,0,3.7,2.1,1.3
8489,816,0,Middle East & Africa,HR,Clinical Operations,Meets,Female,44,3,1,9,16,0.0,2.5,3.5,0.0383,1,1,1,1,3.1,3.4,1.2
8490,72,0,Europe,R&D,Supply Chain,Exceeds,Female,38,10,1,10,34,0.0,3.3,3.5,0.1648,1,1,1,1,2.9,4.2,3.4
8491,651,0,North America,Digital,Quality Assurance,Meets,Non-Binary/Other,31,9,0,6,15,4.2,3.5,2.3,0.0853,1,1,1,1,4.5,2.3,2.2
8492,661,0,Middle East & Africa,Digital,Communications,Meets,Male,49,9,0,7,14,4.4,2.4,1.4,0.0853,1,1,1,1,3.7,3.5,2.2
8493,117,0,Europe,R&D,Marketing,Meets,Male,39,7,0,5,9,2.4,2.1,3.0,0.0977,1,1,1,1,3.5,1.9,3.5
8494,291,0,Latin America,Commercial,Pharmacovigilance,Meets,Non-Binary/Other,35,19,0,10,14,2.8,3.2,2.5,0.0422,1,1,1,1,3.1,2.8,2.2
8495,331,0,Latin America,Commercial,Data Science,Meets,Female,41,8,0,8,20,4.1,3.1,2.8,0.0422,1,1,1,1,3.6,2.3,2.3
8496,619,0,Middle East & Africa,Digital,Regulatory Affairs,Meets,Female,28,12,1,7,11,0.0,2.5,2.8,0.0853,1,1,1,1,4.0,3.0,3.1
8497,328,0,Europe,Commercial,Sales,Meets,Female,42,36,0,7,23,3.9,3.3,3.7,0.0422,1,1,1,1,3.1,2.6,4.2
8498,918,0,Latin America,Finance,Finance & Accounting,Exceeds,Female,42,7,0,11,14,1.0,3.6,2.7,0.0588,1,1,1,1,2.4,2.6,2.9
8499,143,0,Middle East & Africa,R&D,Pharmacovigilance,Meets,Female,40,27,0,7,11,2.3,2.3,1.7,0.0977,1,1,1,1,1.9,3.7,2.5
8500,662,1,Latin America,Digital,Human Resources,Meets,Female,44,7,1,9,15,0.0,2.8,4.3,0.0853,1,0,0,0,4.2,2.5,3.9
8501,116,0,Latin America,R&D,Clinical Operations,Meets,Male,40,11,0,8,14,4.6,3.2,3.0,0.0977,1,1,1,1,3.3,4.4,3.6
8502,348,0,Latin America,Commercial,Clinical Operations,Meets,Female,42,31,0,10,11,2.8,4.3,1.1,0.0422,1,1,1,1,4.2,1.6,2.2
8503,50,0,Asia Pacific,R&D,Market Access,Meets,Female,42,36,0,10,34,3.3,3.4,4.3,0.0977,1,1,1,1,4.9,3.4,3.8
8504,314,0,Europe,Commercial,Data Science,Meets,Female,44,20,0,9,11,2.4,3.7,2.8,0.0422,1,1,1,1,3.0,5.0,1.7
8505,195,0,Middle East & Africa,Commercial,Market Access,Far Below,Male,36,8,0,11,18,4.6,2.2,2.6,0.0,0,0,0,0,3.9,2.8,3.7
8506,151,1,Middle East & Africa,R&D,Data Science,Meets,Female,41,16,0,7,15,2.4,4.8,1.7,0.0977,1,1,1,1,3.7,5.0,3.3
8507,253,0,Europe,Commercial,Sales,Far Exceeds,Male,35,4,1,10,16,0.0,2.2,2.0,0.1275,1,1,1,1,3.9,2.9,3.4
8508,1010,0,Europe,Finance,Medical Affairs,Below,Non-Binary/Other,40,23,0,11,13,2.5,3.8,3.0,0.0,1,1,1,1,2.0,4.9,2.5
8509,359,0,Europe,Manufacturing,Marketing,Meets,Female,38,36,0,8,19,1.3,3.2,1.0,0.0348,0,0,0,0,1.2,3.3,2.1
8510,112,0,Europe,R&D,IT & Digital,Meets,Male,33,9,1,5,18,0.0,2.7,3.1,0.0977,1,1,1,1,2.5,2.7,1.0
8511,469,1,North America,Manufacturing,Quality Assurance,Exceeds,Female,41,11,0,5,29,3.2,2.6,3.0,0.0616,1,1,1,1,2.6,1.2,3.0
8512,170,0,Middle East & Africa,R&D,Quality Assurance,Meets,Female,28,7,1,8,34,0.0,3.6,1.4,0.0977,1,1,1,1,2.7,2.5,1.8
8513,183,0,North America,Commercial,Communications,Exceeds,Male,31,22,0,9,14,3.5,2.3,2.8,0.0743,1,1,1,0,3.0,2.6,4.0
8514,195,0,Latin America,Commercial,Human Resources,Meets,Male,42,17,0,11,15,2.4,2.8,2.6,0.0422,1,1,0,0,3.2,2.1,2.7
8515,529,0,Latin America,Digital,Medical Affairs,Exceeds,Female,34,18,0,11,12,3.1,1.9,2.5,0.1452,1,1,1,1,3.7,1.4,2.1
8516,988,0,Middle East & Africa,Finance,Clinical Operations,Meets,Female,41,5,0,8,19,4.3,2.8,2.7,0.0331,1,1,1,1,4.0,3.7,2.9
8517,535,0,Latin America,Digital,Finance & Accounting,Meets,Male,52,2,0,7,18,3.9,3.7,2.4,0.0853,1,0,0,0,2.3,2.6,2.7
8518,428,1,Europe,Manufacturing,Legal & Compliance,Exceeds,Female,28,20,0,9,28,3.8,3.2,2.9,0.0616,0,0,0,0,4.5,3.2,1.3
8519,323,0,North America,Commercial,Legal & Compliance,Meets,Male,40,10,1,12,18,0.0,2.0,2.5,0.0422,1,1,1,1,3.5,2.6,1.8
8520,590,0,Europe,Digital,Supply Chain,Exceeds,Male,49,7,0,9,20,3.8,3.1,4.2,0.1452,1,1,1,0,4.1,4.5,5.0
8521,302,1,Latin America,Commercial,Marketing,Meets,Male,39,10,1,5,31,0.0,5.0,1.4,0.0422,1,0,0,0,3.8,2.6,2.3
8522,50,0,North America,R&D,Sales,Meets,Male,38,4,0,8,30,2.0,1.8,1.0,0.0977,1,1,1,0,3.3,3.3,1.4
8523,673,1,Europe,Digital,Medical Affairs,Meets,Female,36,31,0,8,16,4.1,3.3,1.1,0.0853,0,0,0,0,4.7,1.1,3.1
8524,433,0,Middle East & Africa,Manufacturing,Marketing,Meets,Non-Binary/Other,33,10,0,12,19,3.6,4.0,1.0,0.0348,1,1,0,0,3.1,3.5,1.4
8525,636,0,Europe,Digital,Quality Assurance,Below,Male,28,19,0,12,14,3.9,1.9,2.5,0.0,1,1,1,1,3.8,2.7,2.6
8526,298,0,Latin America,Commercial,Marketing,Far Below,Male,35,21,0,7,15,3.5,2.6,1.9,0.0,1,1,1,1,2.8,4.8,2.8
8527,778,0,North America,HR,Data Science,Exceeds,Non-Binary/Other,38,17,0,11,17,4.0,4.2,3.5,0.0677,1,1,1,1,3.6,3.1,2.8
8528,815,0,Middle East & Africa,HR,Pharmacovigilance,Exceeds,Male,39,15,0,6,14,3.5,2.2,2.7,0.0677,0,0,0,0,4.2,3.3,3.7
8529,947,0,North America,Finance,Data Science,Below,Male,44,17,1,6,12,0.0,3.7,2.3,0.0,1,1,1,1,3.3,2.8,3.2
8530,321,0,Middle East & Africa,Commercial,Medical Affairs,Meets,Male,43,6,0,8,14,4.8,3.8,3.0,0.0422,1,1,1,1,3.5,3.4,2.6
8531,3,0,North America,R&D,Finance & Accounting,Meets,Female,39,5,1,11,19,0.0,2.4,2.2,0.0977,1,1,1,1,2.2,1.8,2.1
8532,567,0,Latin America,Digital,Sales,Meets,Male,40,10,0,5,21,4.7,3.1,3.5,0.0853,1,1,1,1,3.5,2.4,4.0
8533,819,0,Middle East & Africa,HR,Human Resources,Meets,Female,38,17,0,12,25,3.8,5.0,1.0,0.0383,1,1,1,1,4.3,5.0,1.7
8534,69,1,Asia Pacific,R&D,Regulatory Affairs,Meets,Female,33,14,1,11,17,0.0,2.6,1.8,0.0977,1,1,1,1,3.4,3.5,1.7
8535,248,0,North America,Commercial,Human Resources,Meets,Male,44,9,1,11,15,0.0,4.4,2.6,0.0422,1,1,1,1,3.3,3.9,3.7
8536,32,0,North America,R&D,Market Access,Meets,Male,37,13,0,10,10,2.8,3.7,2.9,0.0977,1,1,1,1,3.1,4.8,2.4
8537,263,0,Europe,Commercial,Communications,Meets,Female,40,11,0,10,24,2.8,3.2,3.1,0.0422,1,1,1,1,3.0,3.2,2.7
8538,1015,0,Middle East & Africa,Finance,Human Resources,Meets,Female,54,3,0,6,13,3.1,3.4,4.0,0.0331,1,1,1,1,2.7,4.5,4.9
8539,654,0,Asia Pacific,Digital,Market Access,Meets,Female,43,10,0,7,10,1.6,4.0,2.9,0.0853,1,1,1,1,2.6,4.5,1.4
8540,149,0,Latin America,R&D,Regulatory Affairs,Meets,Male,37,12,0,7,16,2.5,2.5,3.5,0.0977,1,1,1,1,2.9,2.9,3.8
8541,693,0,Europe,Digital,Marketing,Meets,Male,29,5,0,10,18,4.2,3.1,5.0,0.0853,1,0,0,0,5.0,3.4,3.3
8542,27,0,Asia Pacific,R&D,Communications,Meets,Female,45,11,0,5,15,4.1,1.0,3.8,0.0977,1,1,1,1,3.2,3.7,3.5
8543,324,0,Middle East & Africa,Commercial,Legal & Compliance,Meets,Male,28,16,1,7,11,0.0,5.0,2.9,0.0422,1,1,1,1,3.8,2.4,2.4
8544,285,0,Asia Pacific,Commercial,Regulatory Affairs,Meets,Female,35,6,0,10,16,5.0,3.0,1.5,0.0422,1,1,1,1,3.4,2.6,1.0
8545,145,0,North America,R&D,Market Access,Meets,Male,28,10,0,7,30,2.7,3.8,4.1,0.0977,1,1,1,1,3.7,3.4,3.8
8546,1037,0,North America,Finance,Clinical Operations,Meets,Female,35,5,0,12,43,3.7,3.8,4.3,0.0331,1,1,0,0,4.1,2.9,3.6
8547,302,0,Europe,Commercial,Quality Assurance,Meets,Male,35,17,0,6,18,3.9,3.3,3.6,0.0422,1,1,1,1,3.5,3.3,3.6
8548,423,0,Middle East & Africa,Manufacturing,Market Access,Meets,Female,39,9,1,11,19,0.0,2.6,4.7,0.0348,1,1,1,1,2.4,2.2,2.9
8549,426,0,Middle East & Africa,Manufacturing,Legal & Compliance,Meets,Female,37,14,1,6,9,0.0,2.0,2.7,0.0348,0,0,0,0,3.3,2.7,2.3
8550,542,0,Asia Pacific,Digital,Market Access,Meets,Male,44,4,0,11,15,3.3,1.8,2.9,0.0853,1,1,1,1,3.9,2.1,3.4
8551,441,0,Europe,Manufacturing,Finance & Accounting,Meets,Male,42,8,1,6,7,0.0,2.3,3.7,0.0348,1,1,1,1,3.5,3.6,2.9
8552,421,0,Middle East & Africa,Manufacturing,Clinical Operations,Far Below,Female,43,8,0,7,10,5.0,3.5,2.9,0.0,1,1,1,1,4.2,4.4,2.7
8553,1039,0,North America,Finance,Market Access,Meets,Female,30,20,0,7,13,3.2,3.9,5.0,0.0331,1,1,1,1,2.9,4.7,2.9
8554,891,0,Asia Pacific,Finance,Legal & Compliance,Below,Female,37,10,0,12,30,3.7,2.8,4.7,0.0,1,1,1,1,4.2,3.0,3.7
8555,742,0,Latin America,HR,Marketing,Meets,Male,42,18,0,5,26,3.0,3.2,2.8,0.0383,1,1,1,1,2.8,1.5,1.2
8556,766,0,North America,HR,IT & Digital,Meets,Female,39,8,0,11,22,5.0,3.1,1.5,0.0383,1,1,1,0,3.2,3.3,1.8
8557,931,0,Europe,Finance,Legal & Compliance,Meets,Male,34,11,1,9,18,0.0,2.4,3.5,0.0331,1,1,1,1,4.2,1.4,2.5
8558,698,0,Middle East & Africa,HR,Clinical Operations,Meets,Male,33,5,1,5,34,0.0,3.7,3.3,0.0383,1,1,1,1,1.9,4.4,3.3
8559,1047,0,North America,Finance,Quality Assurance,Meets,Male,49,9,0,7,13,2.6,3.9,3.4,0.0331,1,1,1,1,3.5,3.8,2.8
8560,815,0,Latin America,HR,Legal & Compliance,Meets,Male,41,7,1,9,26,0.0,1.0,2.9,0.0383,1,1,1,1,3.0,2.0,3.7
8561,197,0,Latin America,Commercial,Sales,Meets,Male,28,6,1,12,14,0.0,4.3,3.0,0.0422,1,1,1,1,3.4,3.4,5.0
8562,977,0,Europe,Finance,Data Science,Below,Female,30,9,0,12,21,4.1,2.5,2.1,0.0,1,1,1,1,4.8,3.5,2.2
8563,598,0,North America,Digital,Sales,Meets,Male,28,12,0,11,24,4.2,4.1,3.6,0.0853,1,1,1,1,4.2,2.9,3.5
8564,601,0,Asia Pacific,Digital,Communications,Below,Male,30,10,0,5,13,3.1,3.5,1.0,0.0,1,1,1,1,4.1,3.2,2.9
8565,999,0,North America,Finance,Finance & Accounting,Below,Male,31,6,1,11,12,0.0,3.3,3.0,0.0,1,1,1,1,3.8,2.3,2.9
8566,431,0,Latin America,Manufacturing,Clinical Operations,Below,Female,45,6,1,6,30,0.0,2.7,3.9,0.0,1,1,1,1,2.3,3.3,3.7
8567,551,0,Europe,Digital,Clinical Operations,Meets,Male,41,8,0,7,25,3.7,1.9,1.9,0.0853,1,1,1,1,3.3,2.7,2.4
8568,378,0,Europe,Manufacturing,IT & Digital,Exceeds,Male,33,14,0,11,13,2.1,1.8,3.5,0.0616,1,1,1,1,2.6,2.2,2.2
8569,601,0,Asia Pacific,Digital,Legal & Compliance,Meets,Male,33,7,1,5,19,0.0,1.2,2.6,0.0853,1,1,1,1,4.3,1.3,3.3
8570,84,0,Europe,R&D,Medical Affairs,Meets,Male,34,7,0,6,19,3.0,3.2,1.4,0.0977,0,0,0,0,4.7,3.5,2.1
8571,95,0,Europe,R&D,Pharmacovigilance,Far Exceeds,Male,33,5,0,7,36,3.4,2.9,1.0,0.2644,1,1,1,1,3.6,4.5,1.0
8572,951,0,Europe,Finance,Legal & Compliance,Meets,Female,36,36,0,8,21,3.0,4.0,1.0,0.0331,1,1,1,1,2.7,4.1,3.0
8573,552,1,Europe,Digital,Pharmacovigilance,Meets,Male,33,7,1,10,21,0.0,3.4,2.8,0.0853,1,1,1,1,3.4,3.3,3.2
8574,311,0,Europe,Commercial,Clinical Operations,Exceeds,Male,37,13,0,6,14,4.4,3.1,4.6,0.0743,1,1,1,1,5.0,4.0,3.9
8575,370,0,Latin America,Manufacturing,Data Science,Exceeds,Male,30,12,0,9,24,4.5,2.4,1.9,0.0616,1,1,1,1,4.3,2.3,1.8
8576,649,0,North America,Digital,Finance & Accounting,Below,Female,38,29,0,12,26,3.0,3.7,1.2,0.0,1,1,1,1,2.8,2.7,2.0
8577,1005,0,Middle East & Africa,Finance,IT & Digital,Meets,Female,39,14,0,6,26,4.2,2.1,3.9,0.0331,1,1,1,1,4.2,1.8,3.7
8578,515,0,Europe,Manufacturing,Medical Affairs,Meets,Female,32,13,0,12,24,1.3,3.0,1.6,0.0348,1,1,1,1,3.6,2.5,1.4
8579,731,1,Middle East & Africa,HR,Regulatory Affairs,Meets,Non-Binary/Other,34,9,0,5,18,3.8,4.5,1.3,0.0383,0,0,0,0,3.7,3.8,3.5
8580,975,0,Middle East & Africa,Finance,Supply Chain,Meets,Female,37,9,0,6,16,2.2,3.6,2.3,0.0331,0,0,0,0,1.9,5.0,2.3
8581,679,0,Latin America,Digital,Data Science,Meets,Male,43,9,0,9,14,4.2,1.9,4.3,0.0853,1,1,1,1,3.2,4.3,3.7
8582,237,0,Europe,Commercial,Clinical Operations,Below,Male,45,22,0,10,13,4.4,2.8,2.1,0.0,0,0,0,0,4.1,3.5,3.8
8583,779,0,Middle East & Africa,HR,Clinical Operations,Below,Female,37,4,0,8,12,3.9,2.2,1.0,0.0,1,1,1,1,3.1,3.0,1.0
8584,957,0,Europe,Finance,Data Science,Below,Male,40,5,0,6,38,3.0,3.6,4.5,0.0,1,1,1,1,2.8,4.0,3.1
8585,572,0,Asia Pacific,Digital,Marketing,Meets,Female,37,8,1,9,14,0.0,3.2,2.8,0.0853,1,1,1,1,2.0,3.9,3.1
8586,66,0,Asia Pacific,R&D,Medical Affairs,Below,Female,45,19,0,11,18,3.4,4.2,3.7,0.0,1,1,1,1,2.0,3.0,2.3
8587,564,1,Asia Pacific,Digital,Clinical Operations,Exceeds,Female,48,4,0,6,10,3.2,4.5,1.9,0.1452,1,1,1,1,3.4,2.8,2.1
8588,37,0,Middle East & Africa,R&D,Supply Chain,Meets,Male,43,27,0,8,21,3.3,2.4,2.3,0.0977,1,1,1,1,4.6,2.7,1.5
8589,45,0,Asia Pacific,R&D,Regulatory Affairs,Below,Female,41,3,1,9,17,0.0,3.6,2.3,0.0,0,0,0,0,1.7,2.6,1.3
8590,965,0,Latin America,Finance,IT & Digital,Meets,Male,41,2,0,9,10,4.3,2.3,1.0,0.0331,0,0,0,0,4.2,3.2,1.8
8591,536,0,Latin America,Digital,Sales,Meets,Female,39,18,0,10,15,2.7,3.9,3.1,0.0853,1,1,1,1,2.2,1.0,3.1
8592,582,0,Middle East & Africa,Digital,Quality Assurance,Meets,Male,33,6,1,12,15,0.0,3.6,2.4,0.0853,1,1,1,1,1.0,3.5,3.1
8593,100,0,Europe,R&D,Supply Chain,Meets,Male,35,8,0,10,18,3.3,3.4,2.4,0.0977,1,1,1,1,4.2,4.3,2.5
8594,387,0,North America,Manufacturing,Human Resources,Below,Female,40,15,0,11,16,3.3,2.8,3.0,0.0,1,1,1,1,3.0,1.7,4.9
8595,866,0,Europe,HR,IT & Digital,Meets,Male,35,3,0,7,17,3.4,3.1,3.2,0.0383,1,1,1,1,2.3,1.7,3.2
8596,305,0,Europe,Commercial,Quality Assurance,Meets,Male,30,19,0,7,16,3.6,1.5,3.1,0.0422,1,1,1,1,3.5,2.5,2.8
8597,538,0,Europe,Digital,Finance & Accounting,Meets,Male,37,12,0,10,26,3.4,4.1,2.3,0.0853,1,1,1,1,4.0,3.7,1.8
8598,710,0,Europe,HR,Market Access,Far Exceeds,Female,28,7,0,10,17,2.6,1.0,1.7,0.1168,1,0,0,0,2.7,2.4,1.0
8599,820,0,North America,HR,Legal & Compliance,Exceeds,Female,49,4,1,10,15,0.0,4.4,3.6,0.0677,1,0,0,0,3.0,3.4,5.0
8600,408,0,Asia Pacific,Manufacturing,Human Resources,Exceeds,Male,35,17,0,10,17,4.6,1.9,1.2,0.0616,1,1,1,1,4.4,2.0,1.7
8601,754,0,Europe,HR,Marketing,Below,Male,38,10,0,9,13,3.3,4.2,2.9,0.0,1,1,1,0,5.0,3.9,3.2
8602,629,0,Latin America,Digital,Supply Chain,Meets,Female,45,18,0,12,23,3.5,2.7,2.9,0.0853,1,0,0,0,2.5,2.0,4.3
8603,893,0,Middle East & Africa,Finance,Pharmacovigilance,Exceeds,Male,53,11,0,10,18,4.4,3.0,1.6,0.0588,0,0,0,0,5.0,2.7,1.1
8604,1032,0,Middle East & Africa,Finance,Marketing,Meets,Female,37,6,1,7,14,0.0,2.8,2.1,0.0331,1,1,1,1,2.7,2.1,2.5
8605,754,0,Latin America,HR,Pharmacovigilance,Below,Male,33,9,0,5,8,3.2,2.1,3.5,0.0,1,1,1,1,3.6,2.0,4.4
8606,593,0,Europe,Digital,Communications,Meets,Male,42,10,0,5,9,4.3,2.3,1.8,0.0853,1,1,1,1,5.0,1.0,2.1
8607,574,0,North America,Digital,Finance & Accounting,Far Below,Male,38,10,1,10,23,0.0,5.0,3.1,0.0,1,1,1,1,3.5,4.3,3.1
8608,94,0,Asia Pacific,R&D,IT & Digital,Meets,Male,37,16,0,7,17,4.0,2.0,1.6,0.0977,0,0,0,0,2.4,4.0,1.9
8609,459,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Exceeds,Female,39,16,0,10,44,1.4,3.6,2.4,0.0616,1,1,1,1,1.5,4.8,2.8
8610,181,0,Asia Pacific,Commercial,Finance & Accounting,Meets,Male,41,7,0,5,15,2.7,2.4,2.2,0.0422,1,1,1,1,2.7,2.4,1.7
8611,40,0,North America,R&D,Regulatory Affairs,Meets,Female,50,12,1,10,18,0.0,4.0,3.1,0.0977,1,1,1,1,2.8,3.6,2.7
8612,331,0,Middle East & Africa,Commercial,Legal & Compliance,Meets,Female,30,14,0,11,15,4.5,3.1,2.2,0.0422,1,1,1,1,4.6,3.6,2.4
8613,622,0,Asia Pacific,Digital,Regulatory Affairs,Exceeds,Male,50,16,0,7,20,3.8,3.8,3.0,0.1452,0,0,0,0,4.3,3.1,1.8
8614,953,0,North America,Finance,Marketing,Meets,Female,37,8,0,7,18,3.3,3.5,1.3,0.0331,1,1,1,1,3.3,2.2,2.9
8615,9,0,Asia Pacific,R&D,Regulatory Affairs,Meets,Male,43,9,1,7,14,0.0,2.4,2.9,0.0977,1,1,1,1,3.2,3.1,2.3
8616,834,0,Europe,HR,Data Science,Meets,Female,39,20,0,7,17,3.0,2.7,2.5,0.0383,0,0,0,0,3.8,2.5,2.9
8617,738,0,North America,HR,Finance & Accounting,Meets,Male,38,8,0,11,25,5.0,2.9,1.6,0.0383,1,1,1,1,4.8,3.4,1.8
8618,336,1,Asia Pacific,Commercial,Quality Assurance,Meets,Male,39,12,0,9,13,3.3,2.7,1.8,0.0422,1,1,1,1,3.5,3.4,1.0
8619,620,0,Europe,Digital,Quality Assurance,Meets,Female,33,2,1,7,15,0.0,2.2,2.6,0.0853,1,1,1,1,4.1,1.9,3.1
8620,993,0,Europe,Finance,Human Resources,Far Exceeds,Non-Binary/Other,48,18,0,9,19,2.3,4.3,1.9,0.1022,1,1,0,0,3.4,4.3,3.3
8621,217,0,North America,Commercial,IT & Digital,Far Below,Female,41,16,1,8,12,0.0,3.6,1.8,0.0,1,1,1,1,5.0,2.5,3.2
8622,934,0,Latin America,Finance,Medical Affairs,Far Below,Male,40,7,0,11,25,3.3,2.7,4.2,0.0,1,1,1,1,2.0,3.9,4.2
8623,422,0,Middle East & Africa,Manufacturing,Pharmacovigilance,Meets,Female,36,23,0,6,13,3.0,2.1,2.7,0.0348,0,0,0,0,3.1,2.3,2.7
8624,994,0,North America,Finance,Quality Assurance,Meets,Female,30,27,0,7,12,2.2,2.9,3.8,0.0331,1,1,1,1,3.0,2.9,5.0
8625,781,0,Europe,HR,Clinical Operations,Meets,Male,42,9,0,10,20,2.5,1.7,2.0,0.0383,1,1,1,1,3.2,1.7,2.5
8626,118,0,Europe,R&D,Quality Assurance,Far Exceeds,Male,42,6,0,6,22,4.3,3.5,2.5,0.2644,1,1,1,1,2.3,3.3,3.1
8627,8,0,North America,R&D,Clinical Operations,Below,Female,42,16,1,8,15,0.0,2.7,1.4,0.0,1,1,1,1,1.8,2.3,3.3
8628,103,0,Latin America,R&D,Communications,Far Below,Female,39,13,0,11,19,2.3,2.6,4.1,0.0,1,1,1,1,2.1,2.4,3.3
8629,1000,0,Middle East & Africa,Finance,Medical Affairs,Below,Female,37,28,0,10,14,3.0,4.2,1.9,0.0,1,1,1,1,4.5,3.2,2.2
8630,805,0,Asia Pacific,HR,Market Access,Exceeds,Male,45,12,0,8,19,3.7,2.6,3.2,0.0677,1,1,1,1,3.7,3.9,2.8
8631,931,0,North America,Finance,Marketing,Below,Female,41,5,0,6,12,3.4,4.7,2.7,0.0,1,1,1,1,2.3,5.0,2.4
8632,606,0,Middle East & Africa,Digital,Supply Chain,Meets,Male,40,12,1,12,12,0.0,2.2,4.4,0.0853,1,1,1,1,2.6,3.3,4.4
8633,704,0,Middle East & Africa,HR,Market Access,Meets,Female,29,15,0,8,22,2.8,2.2,3.5,0.0383,1,1,1,1,2.1,2.1,2.8
8634,788,0,Europe,HR,Finance & Accounting,Meets,Female,28,12,0,12,19,2.8,2.8,2.7,0.0383,1,1,0,0,4.0,3.2,2.0
8635,958,0,Asia Pacific,Finance,Medical Affairs,Below,Male,52,12,0,11,19,3.2,3.1,2.2,0.0,1,1,1,1,3.8,3.6,2.2
8636,953,0,North America,Finance,Quality Assurance,Meets,Female,43,11,0,5,8,2.6,2.3,3.9,0.0331,1,1,1,1,3.0,2.3,3.7
8637,152,0,Europe,R&D,Quality Assurance,Meets,Male,46,12,1,10,18,0.0,4.5,1.0,0.0977,1,1,1,1,3.0,5.0,1.0
8638,766,0,Europe,HR,Legal & Compliance,Exceeds,Male,28,17,0,5,5,4.4,3.4,2.2,0.0677,1,1,1,1,3.7,2.9,1.5
8639,98,1,Latin America,R&D,Legal & Compliance,Exceeds,Male,44,14,0,11,20,4.2,2.2,3.6,0.1648,1,1,1,1,4.6,1.1,2.1
8640,543,0,Middle East & Africa,Digital,Legal & Compliance,Meets,Female,36,9,1,8,27,0.0,2.6,2.2,0.0853,1,1,1,1,3.2,3.0,2.3
8641,510,0,North America,Manufacturing,Pharmacovigilance,Far Exceeds,Male,39,6,0,12,17,2.5,3.4,2.3,0.1069,1,1,1,1,5.0,4.3,1.0
8642,65,0,North America,R&D,Legal & Compliance,Below,Male,41,9,1,9,15,0.0,2.9,3.8,0.0,1,1,1,1,4.5,3.8,5.0
8643,949,0,North America,Finance,Marketing,Meets,Male,39,8,0,11,20,3.5,2.3,5.0,0.0331,1,1,1,1,3.4,2.1,5.0
8644,274,0,Europe,Commercial,Medical Affairs,Meets,Female,39,9,0,5,41,3.5,4.0,2.3,0.0422,0,0,0,0,2.3,5.0,1.7
8645,379,0,Latin America,Manufacturing,Regulatory Affairs,Meets,Male,33,10,0,11,13,4.6,4.8,1.5,0.0348,1,1,1,1,4.3,2.2,2.4
8646,579,0,Asia Pacific,Digital,Communications,Below,Female,42,6,1,10,12,0.0,3.0,2.7,0.0,1,1,1,1,4.7,2.3,2.8
8647,895,0,Europe,Finance,Supply Chain,Meets,Female,33,18,0,9,22,4.0,3.5,3.0,0.0331,1,1,1,1,3.5,2.8,3.2
8648,367,0,Asia Pacific,Manufacturing,Market Access,Below,Female,33,6,1,6,20,0.0,4.3,2.6,0.0,1,1,1,1,3.6,3.4,4.8
8649,911,0,Latin America,Finance,Data Science,Meets,Female,39,16,0,9,24,3.2,2.4,2.1,0.0331,1,1,1,1,3.3,2.9,2.6
8650,162,0,Middle East & Africa,R&D,Human Resources,Meets,Male,30,15,0,9,16,4.5,4.8,2.9,0.0977,1,1,1,1,3.6,2.6,3.0
8651,960,0,North America,Finance,Finance & Accounting,Meets,Male,45,9,1,9,13,0.0,2.0,2.2,0.0331,1,1,1,1,5.0,2.4,1.0
8652,591,0,Asia Pacific,Digital,IT & Digital,Meets,Male,45,16,0,5,17,3.1,3.5,1.6,0.0853,1,1,1,1,3.2,3.9,2.1
8653,285,0,Europe,Commercial,Data Science,Meets,Female,35,11,0,12,16,3.8,2.4,2.4,0.0422,1,1,1,1,4.2,3.0,3.2
8654,105,0,Asia Pacific,R&D,Data Science,Meets,Female,36,4,0,6,23,3.9,2.0,3.0,0.0977,1,1,1,1,3.2,2.7,1.8
8655,25,0,Middle East & Africa,R&D,Medical Affairs,Below,Female,38,11,1,8,16,0.0,2.5,3.8,0.0,1,1,1,1,3.3,3.7,3.4
8656,527,0,North America,Digital,Regulatory Affairs,Far Below,Female,28,6,0,9,14,4.3,2.7,4.2,0.0,1,1,1,1,3.3,2.4,2.8
8657,529,0,Asia Pacific,Digital,Finance & Accounting,Meets,Non-Binary/Other,29,28,0,5,7,1.1,2.5,2.6,0.0853,1,1,1,1,3.5,2.9,2.9
8658,485,0,Middle East & Africa,Manufacturing,Finance & Accounting,Exceeds,Male,42,7,0,7,14,3.9,4.0,2.0,0.0616,1,1,1,1,2.2,3.8,3.9
8659,184,0,Europe,Commercial,Sales,Meets,Male,40,8,0,6,16,3.2,3.1,2.8,0.0422,1,1,1,1,5.0,1.5,1.5
8660,946,0,Latin America,Finance,Data Science,Meets,Male,36,10,0,7,21,3.5,3.7,3.2,0.0331,1,1,1,1,2.7,1.3,3.0
8661,486,0,Europe,Manufacturing,Market Access,Exceeds,Female,35,5,1,10,19,0.0,3.7,1.1,0.0616,1,1,1,1,1.9,4.6,2.3
8662,966,0,North America,Finance,Sales,Exceeds,Male,42,9,0,11,14,2.6,3.0,2.4,0.0588,1,1,1,1,2.1,4.1,2.8
8663,958,0,Europe,Finance,IT & Digital,Meets,Female,28,6,1,11,25,0.0,1.9,2.3,0.0331,1,1,1,1,3.9,2.9,1.6
8664,890,0,Europe,Finance,Finance & Accounting,Meets,Female,49,5,1,11,24,0.0,3.9,3.4,0.0331,1,1,1,1,3.7,2.6,4.2
8665,478,0,Europe,Manufacturing,Supply Chain,Exceeds,Female,44,22,0,12,16,2.1,2.3,2.9,0.0616,0,0,0,0,2.4,3.9,1.6
8666,7,0,Europe,R&D,Pharmacovigilance,Exceeds,Male,36,10,0,10,14,3.4,4.6,2.8,0.1648,1,1,1,1,2.6,2.4,1.7
8667,530,1,North America,Digital,Regulatory Affairs,Meets,Male,40,14,1,10,21,0.0,4.1,4.4,0.0853,1,1,1,1,4.8,4.2,2.9
8668,176,1,Middle East & Africa,R&D,Pharmacovigilance,Meets,Male,46,6,1,8,13,0.0,3.1,2.1,0.0977,1,1,1,1,4.4,3.0,4.4
8669,193,0,Asia Pacific,Commercial,Market Access,Meets,Non-Binary/Other,32,7,0,7,10,3.4,1.0,2.1,0.0422,1,1,1,1,2.2,1.7,2.6
8670,486,0,Latin America,Manufacturing,Marketing,Meets,Male,46,8,0,7,26,3.0,3.4,3.1,0.0348,1,1,1,0,3.1,2.6,4.9
8671,311,0,Asia Pacific,Commercial,IT & Digital,Exceeds,Female,38,8,1,9,24,0.0,5.0,1.9,0.0743,1,1,1,1,2.6,4.1,4.0
8672,604,0,Asia Pacific,Digital,Marketing,Meets,Non-Binary/Other,42,12,1,10,16,0.0,2.9,2.8,0.0853,1,0,0,0,4.4,1.6,4.4
8673,686,0,Latin America,Digital,Human Resources,Meets,Male,43,10,0,9,13,3.9,2.5,4.5,0.0853,1,1,1,1,3.5,3.5,5.0
8674,699,0,North America,HR,Data Science,Meets,Male,39,32,0,9,21,3.1,3.1,3.9,0.0383,1,1,1,1,3.6,3.7,3.5
8675,302,0,Latin America,Commercial,Legal & Compliance,Exceeds,Female,45,12,0,12,13,2.7,3.6,1.7,0.0743,1,1,1,1,3.1,3.4,2.1
8676,46,0,North America,R&D,Market Access,Meets,Female,35,8,1,5,25,0.0,4.0,1.0,0.0977,1,1,1,1,2.3,4.2,2.6
8677,219,0,Asia Pacific,Commercial,Finance & Accounting,Meets,Female,38,8,1,11,18,0.0,2.9,1.0,0.0422,1,1,1,1,3.5,3.2,3.2
8678,455,0,North America,Manufacturing,Pharmacovigilance,Below,Male,33,14,0,12,16,4.3,2.3,3.0,0.0,1,1,1,1,2.8,2.4,3.1
8679,573,0,Middle East & Africa,Digital,Medical Affairs,Meets,Male,34,14,0,8,13,2.7,4.9,1.9,0.0853,1,1,1,1,4.2,3.5,3.6
8680,653,0,Latin America,Digital,Sales,Below,Male,39,35,0,11,17,2.9,1.5,2.4,0.0,1,1,1,1,2.5,2.0,4.4
8681,341,0,Middle East & Africa,Commercial,Data Science,Meets,Female,43,6,0,10,25,3.2,4.0,2.2,0.0422,1,1,1,1,4.4,3.7,2.7
8682,262,0,Asia Pacific,Commercial,Sales,Meets,Male,30,16,0,12,21,2.6,3.7,2.6,0.0422,1,1,1,1,4.0,3.7,3.6
8683,1007,0,Latin America,Finance,Quality Assurance,Meets,Female,40,17,0,6,12,5.0,3.9,1.9,0.0331,1,1,1,1,3.3,3.2,1.4
8684,180,0,Asia Pacific,Commercial,Quality Assurance,Exceeds,Female,45,6,0,11,27,3.8,2.4,2.0,0.0743,1,1,1,1,3.5,3.8,2.3
8685,1009,0,Middle East & Africa,Finance,Legal & Compliance,Far Below,Female,46,8,1,6,13,0.0,2.1,5.0,0.0,1,1,1,1,3.7,3.5,3.1
8686,424,0,Asia Pacific,Manufacturing,Quality Assurance,Meets,Male,37,8,0,9,16,2.3,3.2,2.5,0.0348,1,1,0,0,3.1,4.6,1.7
8687,512,0,Latin America,Manufacturing,Marketing,Below,Male,32,11,0,9,24,3.1,2.3,2.8,0.0,1,1,1,0,2.3,4.8,3.9
8688,141,0,Latin America,R&D,Communications,Below,Female,42,22,0,10,17,4.0,2.2,2.5,0.0,1,0,0,0,3.1,2.4,1.4
8689,334,0,Asia Pacific,Commercial,Communications,Below,Male,41,19,0,5,11,3.6,2.6,3.3,0.0,1,1,1,1,4.6,3.0,1.4
8690,92,1,Latin America,R&D,Clinical Operations,Meets,Male,38,12,1,12,15,0.0,3.1,4.0,0.0977,1,1,1,0,3.3,2.5,5.0
8691,879,0,Latin America,HR,Human Resources,Meets,Female,36,17,0,5,24,3.9,3.8,1.0,0.0383,0,0,0,0,3.1,4.7,1.6
8692,476,0,Asia Pacific,Manufacturing,Market Access,Exceeds,Female,40,27,0,6,16,2.8,2.1,1.8,0.0616,1,1,1,1,2.3,3.0,3.0
8693,610,0,Middle East & Africa,Digital,IT & Digital,Far Below,Male,41,23,0,12,18,3.3,4.8,3.0,0.0,1,1,1,1,3.4,4.1,2.7
8694,1006,0,Latin America,Finance,Marketing,Meets,Female,36,12,0,10,17,3.7,1.0,3.9,0.0331,1,1,1,1,3.5,1.7,3.5
8695,709,0,Latin America,HR,IT & Digital,Far Exceeds,Male,37,10,1,8,11,0.0,3.8,1.0,0.1168,1,1,1,1,4.6,2.8,1.0
8696,632,0,Latin America,Digital,Human Resources,Below,Male,30,15,0,9,10,1.2,4.1,2.0,0.0,1,1,1,1,3.6,5.0,2.9
8697,729,0,Latin America,HR,Market Access,Meets,Male,40,7,0,8,22,2.6,4.3,2.7,0.0383,1,1,1,1,3.1,3.3,2.4
8698,172,0,Asia Pacific,R&D,Supply Chain,Meets,Female,40,1,0,11,14,3.6,2.9,2.1,0.0977,0,0,0,0,4.1,3.5,2.4
8699,105,0,Middle East & Africa,R&D,Legal & Compliance,Meets,Female,31,13,0,5,16,1.3,2.7,4.1,0.0977,1,1,1,1,1.0,1.3,4.3
8700,986,0,Middle East & Africa,Finance,Pharmacovigilance,Meets,Male,37,9,1,12,26,0.0,4.9,3.4,0.0331,1,1,1,1,3.9,2.7,2.7
8701,385,0,North America,Manufacturing,IT & Digital,Meets,Male,35,6,0,12,16,3.4,1.3,4.3,0.0348,1,1,1,1,2.9,3.3,3.5
8702,1022,0,Latin America,Finance,Quality Assurance,Meets,Male,45,10,0,7,22,3.2,2.5,3.0,0.0331,1,1,1,1,2.9,3.2,3.9
8703,598,0,Latin America,Digital,Human Resources,Meets,Male,30,8,0,12,15,2.1,2.1,5.0,0.0853,1,1,1,1,1.7,2.5,4.1
8704,769,0,North America,HR,IT & Digital,Below,Female,45,9,1,10,20,0.0,4.0,3.2,0.0,1,1,1,1,3.6,4.3,2.8
8705,930,0,Middle East & Africa,Finance,Quality Assurance,Far Exceeds,Male,46,6,0,11,24,2.2,3.1,2.7,0.1022,1,1,1,1,2.9,3.9,3.6
8706,334,0,Europe,Commercial,Communications,Meets,Male,28,12,0,11,12,4.3,1.6,4.3,0.0422,1,0,0,0,3.8,1.7,2.0
8707,330,0,Europe,Commercial,Supply Chain,Meets,Male,42,11,0,8,16,5.0,2.3,2.6,0.0422,1,1,1,1,3.6,3.3,3.4
8708,364,0,Middle East & Africa,Manufacturing,Regulatory Affairs,Exceeds,Male,41,22,0,6,15,4.8,2.7,2.1,0.0616,1,1,1,1,5.0,3.6,2.7
8709,954,0,Latin America,Finance,Clinical Operations,Meets,Male,29,10,1,9,11,0.0,3.6,1.9,0.0331,1,1,1,1,4.3,4.6,2.9
8710,662,0,Europe,Digital,Communications,Below,Female,36,9,1,8,12,0.0,1.7,2.3,0.0,1,1,1,1,3.8,2.4,1.7
8711,297,0,Asia Pacific,Commercial,Regulatory Affairs,Meets,Male,35,27,0,6,31,4.1,4.8,1.7,0.0422,1,1,1,1,3.5,4.7,2.2
8712,398,0,Asia Pacific,Manufacturing,Communications,Meets,Male,32,15,1,8,14,0.0,3.4,2.5,0.0348,1,1,1,1,3.1,3.0,2.0
8713,1016,0,North America,Finance,Marketing,Meets,Male,34,7,1,9,14,0.0,3.7,3.0,0.0331,1,1,1,1,2.3,4.5,2.5
8714,487,0,Middle East & Africa,Manufacturing,Finance & Accounting,Far Exceeds,Female,43,12,0,8,11,2.3,3.4,3.2,0.1069,1,0,0,0,3.3,2.1,2.8
8715,527,0,Middle East & Africa,Digital,Regulatory Affairs,Far Below,Male,39,11,0,9,12,4.1,3.8,2.4,0.0,1,1,1,1,3.9,4.4,3.6
8716,261,0,Europe,Commercial,Market Access,Meets,Male,34,6,1,6,12,0.0,1.2,1.0,0.0422,1,1,1,1,3.3,1.2,1.3
8717,234,0,Latin America,Commercial,Medical Affairs,Meets,Male,31,10,1,9,11,0.0,4.5,3.1,0.0422,1,1,1,1,4.6,5.0,4.3
8718,182,0,Middle East & Africa,Commercial,Communications,Meets,Male,43,13,0,12,24,2.2,4.3,2.8,0.0422,1,1,1,1,3.4,3.2,2.7
8719,114,0,Europe,R&D,Market Access,Meets,Male,48,3,1,5,16,0.0,3.6,1.4,0.0977,1,1,1,1,3.5,2.6,2.4
8720,180,0,Europe,Commercial,Data Science,Exceeds,Male,37,14,0,9,12,3.1,4.9,2.1,0.0743,0,0,0,0,2.2,5.0,3.1
8721,880,0,Middle East & Africa,HR,Marketing,Below,Male,37,5,1,11,12,0.0,2.2,3.2,0.0,1,1,1,1,3.6,3.6,2.5
8722,45,0,Europe,R&D,IT & Digital,Far Below,Male,53,16,1,12,19,0.0,2.2,3.4,0.0,1,1,1,1,3.3,1.4,3.9
8723,954,0,North America,Finance,IT & Digital,Far Exceeds,Male,43,5,0,11,15,3.4,3.0,1.0,0.1022,1,1,1,1,3.0,2.8,1.3
8724,57,0,North America,R&D,Finance & Accounting,Meets,Female,45,5,0,8,12,2.8,2.4,3.9,0.0977,1,1,1,1,3.7,3.3,3.7
8725,174,0,Middle East & Africa,R&D,Legal & Compliance,Far Exceeds,Female,35,8,0,6,9,2.7,3.2,3.5,0.2644,0,0,0,0,3.9,2.2,2.0
8726,165,0,Latin America,R&D,Quality Assurance,Meets,Male,33,4,1,8,17,0.0,4.2,3.0,0.0977,1,1,1,1,3.0,3.6,2.4
8727,363,0,North America,Manufacturing,Human Resources,Below,Female,46,3,0,9,16,4.1,3.4,2.0,0.0,1,1,1,1,5.0,2.9,2.2
8728,722,0,North America,HR,Marketing,Meets,Female,41,26,0,9,19,4.4,3.4,3.9,0.0383,1,1,1,1,3.6,4.1,3.5
8729,670,0,Middle East & Africa,Digital,Regulatory Affairs,Exceeds,Non-Binary/Other,39,10,0,10,17,2.8,2.0,1.7,0.1452,0,0,0,0,3.3,2.1,1.2
8730,300,1,Asia Pacific,Commercial,Sales,Meets,Female,41,13,0,12,21,3.5,3.0,2.9,0.0422,1,1,1,1,2.8,2.4,3.6
8731,125,0,Europe,R&D,Human Resources,Below,Female,48,23,0,8,24,3.6,3.0,1.7,0.0,0,0,0,0,3.7,2.4,1.6
8732,642,0,North America,Digital,Finance & Accounting,Meets,Female,34,15,0,6,8,4.5,2.8,1.7,0.0853,1,1,0,0,3.8,2.1,1.5
8733,384,0,Asia Pacific,Manufacturing,Marketing,Below,Male,39,9,1,5,19,0.0,4.2,1.0,0.0,1,0,0,0,4.3,3.4,1.5
8734,554,0,Latin America,Digital,Pharmacovigilance,Exceeds,Male,34,7,1,10,23,0.0,3.5,3.0,0.1452,1,1,1,1,2.5,3.0,2.7
8735,21,0,Asia Pacific,R&D,Marketing,Meets,Male,40,13,0,8,11,1.7,2.1,2.0,0.0977,1,1,1,1,3.5,1.5,2.0
8736,964,0,Middle East & Africa,Finance,Market Access,Exceeds,Male,43,10,0,6,33,3.2,3.1,2.1,0.0588,1,1,1,1,4.0,3.9,2.2
8737,755,0,Latin America,HR,Sales,Meets,Male,40,8,1,11,14,0.0,4.0,3.1,0.0383,1,1,1,1,2.9,4.8,5.0
8738,534,0,Latin America,Digital,Clinical Operations,Meets,Male,48,4,0,8,33,2.6,3.4,4.2,0.0853,1,1,1,1,2.4,3.2,2.4
8739,152,0,Asia Pacific,R&D,Market Access,Meets,Male,35,7,0,10,15,2.1,3.4,2.7,0.0977,1,1,1,1,2.2,3.2,3.3
8740,172,0,Middle East & Africa,R&D,Sales,Far Below,Non-Binary/Other,41,7,0,9,12,3.6,2.3,2.5,0.0,1,1,1,1,3.4,2.3,1.0
8741,295,0,North America,Commercial,Sales,Exceeds,Male,46,32,0,10,12,3.0,4.0,2.6,0.0743,1,1,1,1,2.3,2.8,3.9
8742,1006,0,Asia Pacific,Finance,Marketing,Below,Female,36,25,0,8,12,4.3,2.0,2.9,0.0,1,1,1,1,3.5,3.6,2.2
8743,230,0,North America,Commercial,Supply Chain,Meets,Female,35,9,0,8,12,3.1,3.0,3.0,0.0422,1,1,1,1,3.6,2.9,3.7
8744,1004,0,Asia Pacific,Finance,Finance & Accounting,Meets,Female,37,21,0,7,14,3.4,3.3,3.8,0.0331,1,1,1,1,3.2,3.5,3.6
8745,715,0,North America,HR,Finance & Accounting,Exceeds,Female,29,4,0,7,14,4.7,3.7,1.8,0.0677,1,1,0,0,3.0,3.1,1.5
8746,211,0,Asia Pacific,Commercial,Medical Affairs,Far Below,Female,45,13,0,10,20,3.5,3.1,1.2,0.0,1,1,1,1,2.6,3.5,2.5
8747,805,0,Latin America,HR,Supply Chain,Meets,Male,39,13,0,11,13,3.4,3.0,2.0,0.0383,0,0,0,0,3.7,3.9,1.8
8748,520,0,Europe,Manufacturing,Sales,Meets,Male,28,9,0,11,19,2.3,1.8,2.3,0.0348,0,0,0,0,3.0,4.8,3.2
8749,507,0,Latin America,Manufacturing,Marketing,Meets,Female,35,12,0,9,12,3.4,2.8,1.3,0.0348,1,1,1,1,4.3,4.2,3.5
8750,902,0,North America,Finance,Medical Affairs,Meets,Male,46,14,0,6,8,2.8,4.0,3.8,0.0331,1,1,1,1,1.7,2.6,2.1
8751,950,0,Middle East & Africa,Finance,IT & Digital,Meets,Female,36,28,0,7,21,3.4,3.7,3.3,0.0331,1,1,1,1,4.5,3.7,2.2
8752,259,0,Latin America,Commercial,Quality Assurance,Below,Male,47,18,0,12,17,2.0,3.0,2.0,0.0,1,1,1,1,3.3,3.7,2.6
8753,390,0,Europe,Manufacturing,Pharmacovigilance,Meets,Female,36,12,1,12,17,0.0,3.9,2.2,0.0348,1,1,1,0,2.7,3.8,1.8
8754,589,0,North America,Digital,Regulatory Affairs,Meets,Male,29,17,0,10,12,2.3,3.6,1.1,0.0853,1,1,1,1,3.6,2.9,2.2
8755,573,0,Latin America,Digital,IT & Digital,Exceeds,Non-Binary/Other,28,10,0,12,16,4.7,5.0,1.0,0.1452,1,1,1,1,4.1,3.9,1.8
8756,596,0,Asia Pacific,Digital,Human Resources,Meets,Male,51,11,0,10,27,4.1,2.7,2.0,0.0853,1,1,1,1,3.2,3.5,3.1
8757,510,0,Middle East & Africa,Manufacturing,Medical Affairs,Meets,Female,33,15,0,11,14,3.3,2.9,2.0,0.0348,1,1,0,0,2.9,2.9,1.8
8758,602,0,North America,Digital,Human Resources,Far Below,Male,34,4,0,5,12,3.4,2.7,1.5,0.0,1,1,1,1,4.9,3.9,3.1
8759,750,0,Latin America,HR,Quality Assurance,Meets,Female,37,7,1,11,15,0.0,3.2,3.8,0.0383,1,1,0,0,3.5,1.8,2.9
8760,30,0,North America,R&D,Quality Assurance,Far Exceeds,Female,39,2,1,9,15,0.0,2.5,2.4,0.2644,1,1,1,1,2.8,2.0,3.3
8761,900,0,Asia Pacific,Finance,Communications,Meets,Male,32,13,1,11,14,0.0,3.2,2.0,0.0331,1,1,1,1,3.2,2.1,4.1
8762,245,0,Europe,Commercial,Pharmacovigilance,Meets,Female,46,17,0,12,20,5.0,3.8,2.1,0.0422,1,1,0,0,5.0,4.2,2.0
8763,755,0,Latin America,HR,Data Science,Meets,Male,40,16,1,5,7,0.0,4.6,2.7,0.0383,1,1,0,0,3.0,3.9,3.4
8764,570,0,North America,Digital,Clinical Operations,Meets,Male,45,8,0,7,7,1.9,3.6,1.3,0.0853,1,1,1,1,2.8,2.5,2.6
8765,11,0,North America,R&D,Pharmacovigilance,Meets,Female,28,2,1,8,33,0.0,4.7,3.2,0.0977,1,1,1,1,3.7,2.2,3.3
8766,191,0,North America,Commercial,Clinical Operations,Below,Female,41,17,0,9,17,3.4,2.4,2.2,0.0,1,1,1,1,4.2,2.8,1.9
8767,841,0,Europe,HR,Data Science,Meets,Female,40,7,0,9,35,2.9,4.4,3.1,0.0383,1,1,1,1,3.3,4.7,1.5
8768,340,0,North America,Commercial,Data Science,Meets,Female,38,13,0,9,13,2.5,3.0,2.1,0.0422,1,1,1,1,3.5,3.5,1.1
8769,959,0,Middle East & Africa,Finance,Pharmacovigilance,Meets,Female,35,26,0,8,31,1.9,1.1,3.3,0.0331,0,0,0,0,3.8,1.6,2.2
8770,431,0,Middle East & Africa,Manufacturing,Communications,Meets,Female,29,3,1,8,19,0.0,1.1,3.7,0.0348,1,1,1,1,2.7,2.9,4.1
8771,613,1,North America,Digital,Clinical Operations,Exceeds,Non-Binary/Other,30,14,0,10,15,3.7,3.2,3.0,0.1452,1,1,1,1,4.9,3.9,2.6
8772,793,0,Middle East & Africa,HR,Supply Chain,Below,Female,46,16,0,8,32,4.1,1.7,1.6,0.0,0,0,0,0,4.7,1.2,2.4
8773,818,0,Latin America,HR,Regulatory Affairs,Meets,Male,40,13,0,6,17,4.9,3.1,1.0,0.0383,1,0,0,0,3.3,3.4,1.0
8774,163,0,Middle East & Africa,R&D,Supply Chain,Meets,Male,37,8,0,5,13,4.9,3.3,1.0,0.0977,0,0,0,0,3.6,2.6,2.2
8775,46,0,North America,R&D,Communications,Below,Male,36,18,0,10,16,2.3,3.2,3.0,0.0,1,1,1,1,4.5,2.7,2.3
8776,16,0,Asia Pacific,R&D,Communications,Meets,Female,44,4,0,9,24,2.2,2.6,1.0,0.0977,1,1,1,1,3.0,4.7,1.6
8777,269,0,Latin America,Commercial,Clinical Operations,Meets,Non-Binary/Other,44,10,0,6,14,2.6,5.0,2.7,0.0422,0,0,0,0,3.1,2.3,2.2
8778,543,1,Europe,Digital,Finance & Accounting,Meets,Female,33,4,0,8,15,3.5,3.4,2.6,0.0853,1,1,1,0,3.5,3.1,2.7
8779,303,0,North America,Commercial,Market Access,Below,Female,29,23,0,5,15,2.6,3.8,2.5,0.0,1,1,1,1,2.9,4.5,1.9
8780,619,0,Europe,Digital,Market Access,Meets,Male,40,10,0,12,32,3.2,3.9,1.9,0.0853,0,0,0,0,3.3,1.2,1.4
8781,813,0,Asia Pacific,HR,Quality Assurance,Exceeds,Female,45,14,0,9,24,3.1,1.7,1.7,0.0677,1,1,1,1,3.4,3.9,1.5
8782,322,0,Europe,Commercial,Market Access,Far Below,Female,42,9,1,6,29,0.0,3.9,3.5,0.0,1,1,1,1,2.1,4.2,3.2
8783,295,0,North America,Commercial,Finance & Accounting,Exceeds,Female,48,17,0,6,10,3.3,3.8,2.4,0.0743,1,1,1,1,3.0,2.5,1.6
8784,241,0,North America,Commercial,Market Access,Meets,Female,37,10,0,5,8,4.0,2.6,3.6,0.0422,1,1,1,1,2.8,2.6,3.7
8785,488,0,Asia Pacific,Manufacturing,Regulatory Affairs,Meets,Male,40,7,0,5,7,3.1,3.6,2.9,0.0348,1,1,1,1,2.7,4.0,2.5
8786,947,0,North America,Finance,Data Science,Meets,Female,38,8,0,11,26,4.1,3.5,2.5,0.0331,1,0,0,0,4.8,2.3,3.5
8787,536,0,Asia Pacific,Digital,Legal & Compliance,Exceeds,Female,43,23,0,10,16,1.7,3.8,2.2,0.1452,1,1,1,1,2.1,2.3,2.9
8788,687,0,Asia Pacific,Digital,Quality Assurance,Meets,Female,34,19,0,5,50,3.0,4.4,2.1,0.0853,1,1,1,1,4.6,3.2,2.1
8789,258,1,North America,Commercial,Data Science,Far Exceeds,Female,39,14,0,11,19,3.7,3.7,2.5,0.1275,1,1,1,1,3.5,4.8,3.7
8790,390,0,Middle East & Africa,Manufacturing,Clinical Operations,Meets,Male,48,11,0,9,17,3.2,2.5,2.5,0.0348,1,1,1,1,4.3,4.7,2.6
8791,327,0,Asia Pacific,Commercial,Pharmacovigilance,Meets,Male,34,7,0,10,13,1.8,2.7,3.1,0.0422,0,0,0,0,3.7,3.2,2.8
8792,550,0,North America,Digital,Quality Assurance,Far Exceeds,Male,28,11,0,10,17,2.3,3.0,2.5,0.2363,1,1,1,1,3.5,3.2,3.3
8793,976,1,Middle East & Africa,Finance,Communications,Far Exceeds,Male,41,8,0,5,11,2.6,2.4,4.2,0.1022,1,1,1,1,4.2,3.6,3.7
8794,1042,0,Asia Pacific,Finance,Medical Affairs,Below,Female,51,16,0,10,14,2.4,2.2,3.9,0.0,1,1,1,1,1.7,2.8,3.9
8795,702,0,Middle East & Africa,HR,Quality Assurance,Exceeds,Male,34,11,0,10,14,3.3,3.1,2.5,0.0677,1,1,1,1,3.0,2.3,2.6
8796,465,0,Latin America,Manufacturing,Legal & Compliance,Meets,Female,46,16,0,7,9,2.3,1.7,2.4,0.0348,1,1,1,1,1.3,1.4,2.5
8797,924,0,Latin America,Finance,Sales,Exceeds,Male,38,17,0,6,18,4.2,2.5,2.6,0.0588,1,1,1,1,4.2,2.8,4.1
8798,475,0,Middle East & Africa,Manufacturing,Data Science,Exceeds,Male,32,4,1,11,17,0.0,3.3,1.1,0.0616,1,1,1,1,2.7,2.3,3.1
8799,247,0,Asia Pacific,Commercial,Clinical Operations,Exceeds,Male,42,36,0,9,16,2.4,4.0,2.8,0.0743,1,1,1,1,1.6,2.5,2.6
8800,855,0,North America,HR,Finance & Accounting,Exceeds,Male,29,9,0,12,15,4.1,3.0,1.4,0.0677,1,1,1,1,2.6,4.3,2.0
8801,553,0,Europe,Digital,Market Access,Below,Male,47,13,1,12,21,0.0,1.9,1.3,0.0,1,1,1,1,3.3,2.4,3.0
8802,970,0,North America,Finance,Sales,Below,Male,39,10,0,11,20,2.5,3.0,2.8,0.0,1,1,1,1,2.6,4.2,1.3
8803,1031,0,Europe,Finance,Human Resources,Below,Male,28,22,0,5,12,3.8,2.6,3.4,0.0,0,0,0,0,3.9,2.7,3.0
8804,171,0,Europe,R&D,Marketing,Below,Male,49,9,1,6,15,0.0,3.1,2.5,0.0,0,0,0,0,2.6,1.8,2.1
8805,537,0,Asia Pacific,Digital,Medical Affairs,Meets,Male,43,4,0,5,9,3.7,4.0,5.0,0.0853,1,1,1,0,4.0,3.1,1.4
8806,974,0,Middle East & Africa,Finance,Supply Chain,Meets,Male,40,15,0,12,21,3.0,3.0,3.0,0.0331,1,1,1,1,2.4,2.8,3.9
8807,976,0,North America,Finance,Data Science,Meets,Male,43,20,0,10,38,1.6,3.3,2.9,0.0331,0,0,0,0,2.7,3.2,4.4
8808,540,0,Middle East & Africa,Digital,Supply Chain,Meets,Male,28,7,1,5,17,0.0,3.8,2.6,0.0853,1,1,1,1,3.9,3.3,3.0
8809,801,0,Latin America,HR,Legal & Compliance,Exceeds,Female,34,15,0,6,10,5.0,4.0,2.3,0.0677,1,1,1,1,5.0,3.6,3.3
8810,400,0,Asia Pacific,Manufacturing,Clinical Operations,Meets,Male,53,13,1,7,15,0.0,2.5,2.6,0.0348,1,1,0,0,5.0,3.1,2.4
8811,561,0,Asia Pacific,Digital,Supply Chain,Meets,Female,39,15,0,9,21,4.0,3.6,3.9,0.0853,1,1,1,0,3.6,4.6,2.9
8812,415,0,Latin America,Manufacturing,Clinical Operations,Meets,Male,34,22,1,6,7,0.0,3.0,2.3,0.0348,1,1,1,1,3.0,3.8,2.1
8813,701,0,North America,HR,Finance & Accounting,Below,Non-Binary/Other,39,20,0,10,14,3.3,2.7,2.0,0.0,1,1,1,1,2.7,4.0,2.6
8814,801,0,Latin America,HR,Human Resources,Meets,Male,31,11,0,9,13,3.7,1.1,1.0,0.0383,1,1,1,1,3.2,1.3,2.5
8815,287,0,North America,Commercial,Clinical Operations,Meets,Female,47,11,1,8,23,0.0,4.4,3.6,0.0422,1,1,1,1,2.0,3.5,2.7
8816,81,0,Europe,R&D,Regulatory Affairs,Meets,Male,35,18,0,12,20,2.6,5.0,4.1,0.0977,1,1,1,1,1.8,4.8,3.2
8817,817,0,Asia Pacific,HR,Regulatory Affairs,Meets,Female,29,14,0,6,9,2.5,2.5,4.4,0.0383,1,1,1,1,2.6,2.7,1.7
8818,713,0,North America,HR,Medical Affairs,Meets,Female,39,13,1,12,15,0.0,3.6,2.6,0.0383,1,0,0,0,3.1,2.8,3.1
8819,499,0,Middle East & Africa,Manufacturing,Finance & Accounting,Below,Male,44,10,1,7,20,0.0,2.7,2.3,0.0,1,1,1,1,3.7,4.0,3.8
8820,864,0,Middle East & Africa,HR,Clinical Operations,Meets,Male,42,13,1,6,15,0.0,3.8,3.7,0.0383,1,1,1,1,2.3,1.8,2.4
8821,644,0,Asia Pacific,Digital,Medical Affairs,Meets,Non-Binary/Other,30,14,0,5,7,4.0,3.2,2.6,0.0853,0,0,0,0,4.0,3.2,2.6
8822,228,0,Latin America,Commercial,Regulatory Affairs,Meets,Female,32,6,0,11,20,4.8,4.5,1.7,0.0422,0,0,0,0,3.3,3.7,5.0
8823,268,0,Latin America,Commercial,Medical Affairs,Exceeds,Female,28,13,0,9,13,4.1,3.4,3.5,0.0743,1,1,1,1,3.9,3.5,3.5
8824,631,0,North America,Digital,Medical Affairs,Below,Female,42,14,0,10,26,2.6,1.2,1.0,0.0,1,1,1,1,3.4,4.3,2.7
8825,928,0,Latin America,Finance,Pharmacovigilance,Meets,Male,41,6,1,11,21,0.0,1.0,4.4,0.0331,1,1,1,1,2.5,3.4,3.2
8826,840,0,Asia Pacific,HR,Pharmacovigilance,Meets,Female,41,7,1,10,28,0.0,2.8,1.3,0.0383,1,1,1,1,4.1,3.3,2.2
8827,139,0,North America,R&D,Clinical Operations,Meets,Male,35,20,0,9,18,3.3,1.0,3.6,0.0977,1,1,1,1,3.4,2.3,4.3
8828,827,0,Europe,HR,Sales,Below,Female,28,8,1,8,16,0.0,3.2,1.0,0.0,1,1,1,1,3.7,2.5,2.4
8829,322,0,Latin America,Commercial,Supply Chain,Exceeds,Female,33,14,0,8,23,2.3,3.2,2.8,0.0743,1,1,1,1,2.9,4.4,3.4
8830,129,0,Latin America,R&D,Medical Affairs,Below,Male,45,21,0,6,16,3.1,2.1,1.2,0.0,1,1,1,1,3.8,2.1,2.4
8831,1040,0,North America,Finance,IT & Digital,Meets,Female,40,9,1,12,31,0.0,3.7,2.3,0.0331,1,0,0,0,2.9,3.4,2.3
8832,444,0,Middle East & Africa,Manufacturing,Sales,Meets,Male,28,3,0,5,23,2.9,3.4,2.9,0.0348,1,1,1,1,3.9,2.8,3.3
8833,446,0,Latin America,Manufacturing,Regulatory Affairs,Meets,Male,36,21,0,6,25,3.4,3.3,2.0,0.0348,1,1,1,1,3.4,2.9,1.4
8834,867,0,Asia Pacific,HR,Data Science,Meets,Female,41,5,1,12,15,0.0,4.1,2.9,0.0383,1,1,0,0,1.6,5.0,2.8
8835,834,0,Latin America,HR,Supply Chain,Below,Female,37,4,1,6,10,0.0,3.4,3.7,0.0,1,1,1,1,4.1,3.4,3.5
8836,173,0,Europe,R&D,Market Access,Meets,Male,29,5,0,8,16,2.7,2.1,2.2,0.0977,1,1,0,0,3.9,2.5,4.0
8837,145,0,Latin America,R&D,Finance & Accounting,Far Below,Female,35,17,0,7,11,2.1,2.8,2.7,0.0,1,1,1,1,1.0,2.7,3.0
8838,916,0,Middle East & Africa,Finance,Communications,Exceeds,Male,34,31,0,8,12,5.0,2.4,4.4,0.0588,1,1,1,1,3.7,2.5,5.0
8839,878,0,Latin America,HR,Supply Chain,Below,Male,38,9,0,9,13,3.1,1.0,2.6,0.0,0,0,0,0,2.6,1.6,2.9
8840,324,1,North America,Commercial,Medical Affairs,Exceeds,Female,40,9,0,5,7,4.2,4.0,3.2,0.0743,1,1,1,1,3.5,4.5,2.3
8841,389,0,Latin America,Manufacturing,IT & Digital,Exceeds,Male,34,15,0,5,16,2.4,4.3,2.1,0.0616,1,1,1,1,2.7,4.0,1.6
8842,915,0,Middle East & Africa,Finance,Clinical Operations,Meets,Male,42,6,0,10,25,2.5,3.6,4.3,0.0331,1,1,0,0,3.7,1.8,2.5
8843,86,0,North America,R&D,Clinical Operations,Meets,Male,48,18,0,7,32,2.2,2.4,2.6,0.0977,1,1,1,1,2.2,2.1,3.2
8844,353,0,Asia Pacific,Commercial,Medical Affairs,Meets,Male,55,6,1,12,16,0.0,2.4,2.3,0.0422,1,1,1,1,3.9,2.0,1.8
8845,815,0,North America,HR,Medical Affairs,Far Exceeds,Male,32,14,0,11,19,2.6,3.5,2.3,0.1168,1,1,1,1,3.8,3.2,3.2
8846,679,0,Europe,Digital,Marketing,Meets,Female,38,7,0,12,22,3.4,2.6,1.5,0.0853,1,1,1,1,4.2,3.4,3.2
8847,2,0,North America,R&D,Supply Chain,Far Exceeds,Male,28,7,0,6,24,3.3,4.1,1.0,0.2644,1,1,1,1,4.0,3.3,2.5
8848,936,0,Asia Pacific,Finance,Pharmacovigilance,Meets,Male,35,11,0,9,14,3.7,5.0,1.1,0.0331,1,1,1,1,3.7,3.4,3.2
8849,567,0,Latin America,Digital,Pharmacovigilance,Exceeds,Male,46,3,0,9,12,2.7,2.8,2.4,0.1452,1,1,1,1,1.7,1.7,3.2
8850,282,0,North America,Commercial,Market Access,Meets,Male,28,14,0,7,15,2.9,4.6,1.7,0.0422,1,1,1,0,4.5,5.0,2.7
8851,510,1,North America,Manufacturing,IT & Digital,Exceeds,Male,35,19,0,12,16,5.0,4.1,3.3,0.0616,1,1,1,1,3.9,2.7,4.0
8852,311,0,North America,Commercial,Communications,Below,Male,38,20,0,7,15,2.2,2.8,3.0,0.0,1,1,1,1,2.1,3.3,1.7
8853,521,0,North America,Manufacturing,IT & Digital,Meets,Male,29,24,0,11,18,3.4,2.5,1.0,0.0348,1,1,1,1,3.6,2.2,3.0
8854,188,0,Asia Pacific,Commercial,Sales,Meets,Male,40,33,0,5,9,3.4,3.6,3.5,0.0422,1,1,1,1,2.9,3.3,3.1
8855,118,0,Middle East & Africa,R&D,Market Access,Meets,Male,40,6,0,10,17,2.9,3.0,3.1,0.0977,1,1,1,1,1.7,4.6,4.5
8856,95,0,Middle East & Africa,R&D,Human Resources,Meets,Female,34,5,0,7,10,2.0,3.3,2.6,0.0977,1,1,1,1,3.5,4.7,2.7
8857,912,0,North America,Finance,Data Science,Meets,Male,42,8,0,7,24,2.5,4.7,4.4,0.0331,1,1,1,1,1.2,4.7,4.0
8858,568,0,Asia Pacific,Digital,Data Science,Meets,Male,33,8,0,5,22,2.9,2.4,3.1,0.0853,1,1,1,1,3.2,2.2,3.3
8859,273,0,Asia Pacific,Commercial,Communications,Meets,Female,41,10,0,9,12,2.9,2.3,3.2,0.0422,1,1,1,1,2.8,3.3,1.9
8860,256,0,North America,Commercial,Marketing,Meets,Non-Binary/Other,38,11,0,12,14,2.4,3.3,2.2,0.0422,1,0,0,0,3.8,2.8,3.0
8861,611,0,Europe,Digital,Clinical Operations,Meets,Female,39,7,0,11,11,3.0,2.9,3.0,0.0853,1,0,0,0,3.4,2.2,3.8
8862,717,0,North America,HR,Supply Chain,Meets,Female,37,23,0,12,34,3.5,3.2,1.9,0.0383,1,1,1,1,2.9,3.5,2.4
8863,934,0,Europe,Finance,Data Science,Below,Female,30,14,0,12,31,2.1,3.1,3.2,0.0,1,1,1,1,3.1,3.2,2.4
8864,341,0,North America,Commercial,Sales,Below,Female,30,4,0,12,23,3.2,2.2,3.0,0.0,1,1,1,0,4.0,1.9,1.9
8865,993,0,Europe,Finance,Supply Chain,Meets,Female,33,26,0,11,21,3.2,2.5,3.5,0.0331,1,1,1,1,3.3,2.5,3.1
8866,350,0,Europe,Commercial,Supply Chain,Exceeds,Female,35,21,0,10,13,3.1,2.9,2.5,0.0743,1,1,1,1,2.4,3.9,2.0
8867,274,0,North America,Commercial,Pharmacovigilance,Meets,Male,40,5,0,8,30,4.2,2.7,2.7,0.0422,0,0,0,0,4.6,2.0,2.1
8868,758,0,Europe,HR,Clinical Operations,Exceeds,Male,38,22,0,11,14,4.2,2.9,2.4,0.0677,1,1,1,1,3.6,3.7,3.1
8869,16,0,Latin America,R&D,Data Science,Meets,Female,35,8,0,6,28,3.7,3.3,2.0,0.0977,0,0,0,0,2.8,3.1,1.7
8870,957,0,Middle East & Africa,Finance,Pharmacovigilance,Meets,Female,28,7,0,6,10,4.0,3.0,3.6,0.0331,1,1,1,0,3.9,2.1,3.2
8871,672,0,Asia Pacific,Digital,Quality Assurance,Meets,Male,34,14,1,5,15,0.0,2.1,2.1,0.0853,1,1,1,0,2.6,2.6,1.4
8872,903,1,Europe,Finance,Regulatory Affairs,Exceeds,Male,31,11,0,11,32,3.6,3.0,3.6,0.0588,1,1,1,1,3.6,3.2,3.2
8873,757,0,Europe,HR,Quality Assurance,Meets,Female,48,22,0,8,12,2.4,4.3,2.8,0.0383,1,1,1,1,3.4,3.0,3.0
8874,456,0,Asia Pacific,Manufacturing,Quality Assurance,Meets,Female,38,8,0,7,27,3.2,5.0,3.5,0.0348,1,1,1,1,2.4,4.3,3.5
8875,423,0,Europe,Manufacturing,Regulatory Affairs,Below,Female,47,7,1,12,31,0.0,4.4,1.2,0.0,1,1,1,1,3.6,4.7,3.2
8876,749,0,Asia Pacific,HR,Quality Assurance,Exceeds,Non-Binary/Other,38,17,0,7,16,3.0,1.6,2.9,0.0677,1,1,1,1,2.9,4.2,2.7
8877,845,0,North America,HR,Data Science,Meets,Male,49,6,1,11,13,0.0,2.0,4.3,0.0383,0,0,0,0,3.8,3.6,3.6
8878,166,0,Latin America,R&D,Supply Chain,Exceeds,Male,40,12,0,11,13,4.2,1.7,1.7,0.1648,1,1,1,1,5.0,3.1,3.0
8879,948,0,Latin America,Finance,Finance & Accounting,Meets,Male,40,22,0,6,10,3.2,4.3,2.2,0.0331,1,1,1,1,3.2,4.0,3.1
8880,908,0,Middle East & Africa,Finance,Pharmacovigilance,Below,Female,50,11,0,6,6,3.2,4.2,2.4,0.0,1,1,1,1,3.2,4.4,3.8
8881,376,0,Europe,Manufacturing,Medical Affairs,Meets,Male,34,11,0,6,7,3.3,3.4,3.0,0.0348,1,1,1,1,3.7,5.0,3.6
8882,548,0,Middle East & Africa,Digital,Communications,Meets,Male,34,13,0,12,15,3.0,5.0,2.2,0.0853,1,0,0,0,3.7,4.0,2.0
8883,925,0,North America,Finance,Human Resources,Exceeds,Male,39,10,1,11,42,0.0,2.8,3.1,0.0588,1,1,0,0,4.1,2.7,3.3
8884,281,0,Latin America,Commercial,Marketing,Meets,Male,55,11,0,12,14,2.9,3.3,3.7,0.0422,1,1,1,1,1.9,3.2,4.3
8885,253,0,North America,Commercial,Pharmacovigilance,Meets,Male,36,11,0,11,50,2.8,3.4,3.8,0.0422,1,1,1,1,3.1,2.9,4.4
8886,24,0,North America,R&D,Human Resources,Meets,Female,40,3,1,7,16,0.0,1.8,2.3,0.0977,1,1,1,1,2.8,3.3,4.0
8887,161,0,Europe,R&D,Human Resources,Meets,Female,43,19,0,12,21,2.6,2.0,2.6,0.0977,1,1,1,1,2.8,2.9,1.4
8888,504,0,North America,Manufacturing,Sales,Meets,Female,48,10,1,11,19,0.0,2.9,4.1,0.0348,1,1,1,1,3.7,4.3,2.4
8889,661,0,Latin America,Digital,IT & Digital,Far Exceeds,Male,43,25,0,9,24,1.9,1.4,1.0,0.2363,1,1,1,1,2.8,2.3,2.4
8890,659,0,Middle East & Africa,Digital,Clinical Operations,Below,Female,47,7,0,5,32,1.5,2.4,2.3,0.0,1,1,1,1,2.8,1.6,3.6
8891,781,0,Latin America,HR,Data Science,Meets,Female,43,29,0,11,27,3.0,4.3,3.0,0.0383,1,1,1,1,2.4,3.8,4.2
8892,88,0,Europe,R&D,Human Resources,Meets,Male,39,8,0,9,13,3.5,2.8,1.4,0.0977,1,1,1,1,3.1,3.3,1.0
8893,930,0,Latin America,Finance,Communications,Meets,Male,32,12,0,12,49,2.0,4.4,2.3,0.0331,1,1,1,1,4.4,4.1,2.0
8894,279,0,Asia Pacific,Commercial,Pharmacovigilance,Meets,Female,35,4,1,7,15,0.0,3.8,3.1,0.0422,0,0,0,0,3.1,4.2,2.3
8895,947,0,Middle East & Africa,Finance,Data Science,Meets,Female,36,13,0,8,23,3.3,3.6,2.4,0.0331,0,0,0,0,2.8,3.6,4.0
8896,320,0,Asia Pacific,Commercial,Human Resources,Meets,Male,40,6,1,5,10,0.0,4.7,3.8,0.0422,1,1,1,1,3.1,3.4,4.0
8897,360,0,Asia Pacific,Manufacturing,Human Resources,Meets,Male,41,3,1,6,22,0.0,2.9,2.4,0.0348,1,1,1,1,2.6,3.5,4.1
8898,324,0,Europe,Commercial,Market Access,Below,Male,49,10,0,6,25,3.2,2.9,2.2,0.0,1,1,1,1,3.0,2.9,1.6
8899,958,0,North America,Finance,Regulatory Affairs,Exceeds,Male,28,7,0,10,16,3.6,2.7,2.5,0.0588,1,0,0,0,2.5,2.1,2.8
8900,1044,0,Asia Pacific,Finance,Medical Affairs,Meets,Male,38,11,0,11,12,3.6,2.8,2.9,0.0331,1,1,1,1,4.0,2.7,1.4
8901,544,0,Latin America,Digital,Sales,Meets,Male,49,4,1,5,18,0.0,1.2,1.0,0.0853,1,1,1,1,3.4,1.3,1.6
8902,550,0,North America,Digital,Supply Chain,Meets,Male,30,8,1,12,25,0.0,2.7,3.1,0.0853,1,1,1,1,3.3,3.7,2.9
8903,85,0,Latin America,R&D,Supply Chain,Below,Female,34,5,0,10,24,3.6,5.0,1.3,0.0,1,1,1,1,2.9,3.7,1.5
8904,962,0,Latin America,Finance,Pharmacovigilance,Meets,Non-Binary/Other,41,18,0,10,37,4.2,2.6,2.6,0.0331,1,0,0,0,4.1,2.6,1.8
8905,372,1,North America,Manufacturing,Finance & Accounting,Exceeds,Male,43,12,1,7,14,0.0,3.7,1.0,0.0616,1,1,0,0,2.8,3.4,2.0
8906,292,0,North America,Commercial,Quality Assurance,Exceeds,Male,30,8,0,8,15,2.4,2.8,3.6,0.0743,1,1,1,1,4.4,3.8,2.4
8907,42,0,Latin America,R&D,Finance & Accounting,Meets,Male,47,23,0,7,18,2.7,2.2,1.1,0.0977,1,1,1,0,2.4,4.0,1.0
8908,697,0,Europe,HR,Communications,Meets,Female,41,10,0,12,21,3.9,3.6,3.7,0.0383,1,1,1,1,3.9,3.9,2.0
8909,850,0,Middle East & Africa,HR,Regulatory Affairs,Meets,Female,30,5,0,5,17,3.5,1.7,3.1,0.0383,1,1,1,1,3.9,2.9,3.1
8910,194,0,Middle East & Africa,Commercial,IT & Digital,Meets,Female,45,15,0,11,20,2.4,4.6,2.9,0.0422,1,0,0,0,3.7,2.6,3.4
8911,327,0,Europe,Commercial,Quality Assurance,Exceeds,Female,44,4,1,8,16,0.0,3.6,4.0,0.0743,1,1,1,1,3.8,2.5,4.2
8912,229,0,North America,Commercial,Quality Assurance,Far Below,Female,38,13,0,9,23,2.8,2.7,1.4,0.0,1,1,1,1,2.0,3.8,2.1
8913,641,0,Latin America,Digital,Sales,Far Below,Non-Binary/Other,35,15,0,7,11,2.9,3.4,2.2,0.0,1,1,1,0,1.8,3.2,3.9
8914,325,0,Middle East & Africa,Commercial,Communications,Meets,Male,31,10,0,9,30,2.7,2.5,3.5,0.0422,1,0,0,0,4.3,3.4,2.6
8915,778,0,Latin America,HR,Finance & Accounting,Below,Non-Binary/Other,36,16,0,9,20,2.6,2.9,4.9,0.0,1,1,1,1,3.0,4.3,2.4
8916,238,0,Europe,Commercial,Data Science,Exceeds,Female,44,11,0,6,8,2.0,4.1,3.2,0.0743,1,1,1,1,2.7,4.7,3.3
8917,922,0,Latin America,Finance,Pharmacovigilance,Meets,Female,28,18,0,6,21,3.8,3.7,2.0,0.0331,1,1,1,1,4.4,2.8,1.7
8918,413,0,Europe,Manufacturing,IT & Digital,Exceeds,Female,33,4,0,9,28,5.0,4.4,2.6,0.0616,1,1,1,1,5.0,4.1,2.9
8919,734,0,North America,HR,Supply Chain,Below,Female,40,19,0,9,17,3.2,3.8,4.0,0.0,1,1,1,1,3.9,2.5,4.7
8920,399,0,Europe,Manufacturing,Clinical Operations,Meets,Female,42,14,0,9,37,3.6,3.5,3.7,0.0348,1,1,1,1,1.5,3.7,4.3
8921,841,0,Europe,HR,Quality Assurance,Meets,Male,42,13,0,11,25,3.5,1.8,1.0,0.0383,1,1,1,1,2.7,2.7,1.7
8922,167,0,Middle East & Africa,R&D,Market Access,Meets,Female,33,2,0,10,20,3.7,2.4,2.8,0.0977,1,0,0,0,3.4,4.1,1.0
8923,909,0,Latin America,Finance,Finance & Accounting,Meets,Female,37,15,0,10,21,2.4,2.8,3.4,0.0331,1,1,1,1,3.0,2.6,2.5
8924,745,0,Middle East & Africa,HR,Sales,Meets,Male,35,15,0,9,21,3.1,1.0,2.6,0.0383,1,1,1,1,2.8,1.9,3.6
8925,897,0,Asia Pacific,Finance,Marketing,Exceeds,Male,40,3,0,12,16,2.9,2.8,1.7,0.0588,0,0,0,0,3.6,3.2,3.5
8926,733,0,Europe,HR,Pharmacovigilance,Below,Male,41,4,0,8,21,3.8,3.2,4.6,0.0,1,1,0,0,2.8,2.8,4.1
8927,411,0,Asia Pacific,Manufacturing,Market Access,Exceeds,Female,37,15,0,12,17,3.4,3.6,2.3,0.0616,0,0,0,0,2.9,2.5,2.0
8928,378,0,Middle East & Africa,Manufacturing,Communications,Far Exceeds,Female,39,8,0,12,15,4.1,1.6,4.0,0.1069,1,1,1,1,4.3,3.7,3.7
8929,743,0,Latin America,HR,Legal & Compliance,Meets,Male,38,16,0,9,17,3.5,2.3,2.1,0.0383,1,1,0,0,3.3,5.0,3.9
8930,736,0,Middle East & Africa,HR,Quality Assurance,Meets,Female,29,2,0,12,23,4.3,2.9,2.6,0.0383,1,1,1,1,3.7,3.9,2.5
8931,688,0,Latin America,Digital,Legal & Compliance,Meets,Female,46,11,0,6,10,4.0,4.9,2.6,0.0853,1,1,0,0,3.0,4.4,1.9
8932,1048,0,Latin America,Finance,Human Resources,Meets,Male,44,15,0,9,13,3.2,4.3,3.5,0.0331,1,1,1,1,3.3,3.8,5.0
8933,976,0,North America,Finance,Legal & Compliance,Meets,Male,28,10,0,9,34,2.0,2.6,2.3,0.0331,1,1,0,0,2.3,3.3,3.5
8934,996,0,Europe,Finance,Legal & Compliance,Meets,Female,51,15,0,8,14,3.8,3.8,2.7,0.0331,1,1,1,1,3.8,4.9,4.2
8935,918,0,Middle East & Africa,Finance,Data Science,Meets,Female,40,20,1,8,15,0.0,2.1,1.0,0.0331,1,0,0,0,2.3,3.1,2.6
8936,171,0,Latin America,R&D,Finance & Accounting,Exceeds,Male,41,8,0,7,11,3.3,1.7,2.3,0.1648,1,1,1,1,3.2,3.3,4.2
8937,36,0,Middle East & Africa,R&D,Sales,Meets,Female,35,6,0,12,27,3.2,2.5,1.0,0.0977,1,1,1,1,2.5,2.2,2.2
8938,243,0,Middle East & Africa,Commercial,Medical Affairs,Far Exceeds,Female,39,19,0,12,18,3.1,3.1,2.4,0.1275,0,0,0,0,2.8,3.5,4.4
8939,835,0,Latin America,HR,Legal & Compliance,Meets,Male,41,6,1,9,12,0.0,3.2,2.3,0.0383,1,1,1,1,4.4,2.3,1.9
8940,790,0,Asia Pacific,HR,Clinical Operations,Meets,Female,49,15,0,6,15,3.3,4.6,3.2,0.0383,1,0,0,0,3.3,3.8,4.0
8941,762,0,Europe,HR,Sales,Meets,Male,31,9,0,12,18,4.1,1.7,2.7,0.0383,1,1,1,1,4.0,2.8,3.0
8942,742,0,Europe,HR,Market Access,Meets,Female,45,10,0,8,19,3.0,4.3,4.5,0.0383,1,1,1,1,2.8,4.9,3.1
8943,1003,0,North America,Finance,Supply Chain,Far Below,Male,35,6,0,12,29,3.7,4.8,4.0,0.0,1,1,1,1,3.5,3.6,4.6
8944,924,0,North America,Finance,Clinical Operations,Below,Female,47,8,0,9,28,3.7,4.5,4.1,0.0,1,1,1,1,3.7,4.7,4.2
8945,130,0,North America,R&D,Medical Affairs,Meets,Male,29,11,0,10,20,3.5,4.7,4.0,0.0977,1,1,1,1,2.9,4.0,4.1
8946,487,0,Europe,Manufacturing,Marketing,Exceeds,Male,38,19,0,6,11,4.3,2.6,2.7,0.0616,1,1,1,1,4.0,3.7,2.4
8947,633,0,Asia Pacific,Digital,Human Resources,Meets,Male,28,18,0,11,29,2.2,4.0,2.0,0.0853,1,1,1,1,2.9,2.9,3.0
8948,1011,0,Europe,Finance,IT & Digital,Meets,Male,34,8,0,7,13,2.1,4.5,3.2,0.0331,1,1,1,1,3.8,3.8,1.5
8949,1030,0,Europe,Finance,Pharmacovigilance,Meets,Female,35,3,0,8,27,2.6,3.4,1.2,0.0331,1,1,1,1,2.4,4.1,1.0
8950,1036,1,Europe,Finance,Human Resources,Meets,Male,41,18,0,8,17,2.9,2.9,4.6,0.0331,1,1,1,1,4.8,3.8,5.0
8951,423,0,Europe,Manufacturing,Quality Assurance,Meets,Female,29,3,0,12,38,3.7,1.8,1.0,0.0348,1,1,1,0,3.4,4.4,2.2
8952,432,0,Asia Pacific,Manufacturing,Regulatory Affairs,Far Exceeds,Female,48,4,1,6,15,0.0,5.0,2.9,0.1069,1,1,1,1,3.7,5.0,2.4
8953,53,0,North America,R&D,Human Resources,Meets,Female,49,5,1,11,32,0.0,2.1,2.7,0.0977,1,1,1,1,3.0,3.7,2.9
8954,1020,0,Middle East & Africa,Finance,Data Science,Meets,Male,39,23,0,6,16,4.5,4.4,3.3,0.0331,1,1,1,1,4.0,3.1,3.9
8955,677,0,North America,Digital,Market Access,Meets,Female,30,2,1,9,23,0.0,2.4,3.3,0.0853,1,1,1,1,4.8,2.1,4.4
8956,764,0,North America,HR,Finance & Accounting,Meets,Female,29,32,0,7,18,3.5,4.1,3.1,0.0383,1,1,1,1,4.9,2.7,3.6
8957,959,0,Middle East & Africa,Finance,Sales,Meets,Male,39,7,1,5,13,0.0,2.3,3.3,0.0331,1,0,0,0,4.7,2.4,3.2
8958,76,0,Europe,R&D,Human Resources,Meets,Male,33,16,0,5,8,4.8,3.2,3.3,0.0977,1,1,1,1,5.0,2.9,1.6
8959,168,0,Asia Pacific,R&D,Supply Chain,Meets,Female,46,7,1,6,17,0.0,3.6,1.0,0.0977,1,1,1,1,4.0,4.2,1.0
8960,652,0,Asia Pacific,Digital,Data Science,Meets,Female,36,36,0,9,10,3.9,3.6,3.3,0.0853,1,1,0,0,3.5,2.5,2.6
8961,315,0,North America,Commercial,IT & Digital,Below,Female,41,24,1,7,17,0.0,1.7,2.0,0.0,1,1,1,1,4.4,2.8,1.6
8962,137,0,Middle East & Africa,R&D,Supply Chain,Meets,Male,38,16,0,8,36,4.6,2.3,2.2,0.0977,1,1,1,1,5.0,4.2,2.4
8963,482,0,Latin America,Manufacturing,Sales,Below,Female,35,12,0,5,13,3.9,2.6,3.8,0.0,1,1,1,1,2.2,5.0,5.0
8964,367,0,Europe,Manufacturing,Market Access,Exceeds,Male,33,12,0,5,23,2.5,3.7,1.6,0.0616,1,1,1,1,3.3,5.0,1.4
8965,765,0,North America,HR,Marketing,Below,Male,31,12,0,10,24,3.4,4.2,3.6,0.0,1,1,1,1,2.5,3.7,3.2
8966,41,0,Asia Pacific,R&D,Marketing,Meets,Female,36,9,0,9,21,4.7,2.3,1.0,0.0977,1,0,0,0,3.7,4.0,1.0
8967,761,0,Middle East & Africa,HR,Human Resources,Meets,Male,38,8,0,6,32,4.5,2.8,2.0,0.0383,1,1,1,1,4.9,4.1,1.7
8968,88,0,Middle East & Africa,R&D,Human Resources,Meets,Male,39,17,0,7,13,1.4,1.0,2.4,0.0977,1,1,1,1,3.6,3.2,2.1
8969,585,0,North America,Digital,Legal & Compliance,Meets,Female,38,21,0,10,12,3.1,2.7,3.3,0.0853,1,1,1,1,2.1,3.0,3.3
8970,1016,0,Latin America,Finance,IT & Digital,Meets,Male,37,15,0,11,25,3.2,4.1,2.9,0.0331,1,1,1,1,2.4,3.4,2.9
8971,80,0,Asia Pacific,R&D,Medical Affairs,Meets,Female,28,20,0,12,18,3.2,3.5,3.3,0.0977,1,1,1,1,3.1,4.0,4.5
8972,280,0,North America,Commercial,IT & Digital,Meets,Female,45,10,0,8,32,2.3,2.2,5.0,0.0422,1,1,1,1,3.1,2.4,3.9
8973,386,0,Latin America,Manufacturing,Quality Assurance,Meets,Male,29,12,0,11,14,3.4,3.4,2.7,0.0348,1,1,1,1,2.8,2.4,4.0
8974,598,0,Middle East & Africa,Digital,Pharmacovigilance,Exceeds,Female,41,14,0,6,11,2.7,2.1,3.1,0.1452,1,1,1,1,4.1,2.5,3.8
8975,956,0,Europe,Finance,Regulatory Affairs,Exceeds,Female,45,23,0,12,21,4.4,2.4,3.8,0.0588,1,1,1,1,3.6,3.4,3.1
8976,969,0,Asia Pacific,Finance,Pharmacovigilance,Meets,Female,45,8,1,9,12,0.0,4.5,3.0,0.0331,1,1,1,1,3.6,2.5,2.5
8977,415,0,Asia Pacific,Manufacturing,Human Resources,Exceeds,Male,43,13,0,6,9,1.8,3.1,1.3,0.0616,1,1,1,1,2.8,2.6,1.5
8978,983,0,Latin America,Finance,IT & Digital,Far Exceeds,Non-Binary/Other,38,1,0,8,11,4.3,3.0,1.5,0.1022,0,0,0,0,3.0,2.6,1.9
8979,827,0,North America,HR,Medical Affairs,Meets,Female,33,7,0,5,22,2.4,3.6,3.4,0.0383,0,0,0,0,3.1,2.1,3.6
8980,581,0,Middle East & Africa,Digital,Marketing,Meets,Female,30,16,0,10,18,4.1,3.6,3.2,0.0853,1,1,1,1,4.1,3.9,3.4
8981,256,0,Latin America,Commercial,Legal & Compliance,Meets,Female,38,33,0,5,9,2.0,3.4,3.0,0.0422,1,1,1,1,2.6,2.2,2.5
8982,476,0,Europe,Manufacturing,Supply Chain,Exceeds,Male,34,7,0,5,27,2.2,3.9,3.6,0.0616,1,1,1,1,2.7,4.4,4.1
8983,5,0,Europe,R&D,Medical Affairs,Meets,Female,35,30,0,9,19,1.8,1.0,2.3,0.0977,1,1,1,1,1.2,1.0,2.5
8984,70,0,Europe,R&D,Quality Assurance,Exceeds,Female,42,26,0,8,16,3.4,3.4,1.0,0.1648,1,1,1,1,4.2,4.1,2.6
8985,109,0,Latin America,R&D,Finance & Accounting,Below,Male,37,17,0,11,14,4.6,4.1,3.5,0.0,1,1,1,0,3.9,3.9,1.7
8986,674,0,Middle East & Africa,Digital,Legal & Compliance,Below,Female,33,7,0,8,11,1.9,3.5,2.1,0.0,1,1,1,1,2.4,4.4,3.2
8987,231,0,Asia Pacific,Commercial,Market Access,Meets,Male,55,11,0,7,12,2.5,1.9,4.3,0.0422,1,1,1,1,1.0,2.9,3.1
8988,1037,0,North America,Finance,Quality Assurance,Below,Female,36,7,0,7,14,4.3,3.3,4.2,0.0,1,1,1,1,3.8,2.6,2.5
8989,284,0,Asia Pacific,Commercial,Clinical Operations,Exceeds,Female,43,9,1,7,24,0.0,3.6,2.7,0.0743,1,1,1,1,3.6,3.9,1.8
8990,314,0,Middle East & Africa,Commercial,Quality Assurance,Meets,Male,42,4,0,8,15,3.5,2.9,3.8,0.0422,1,1,1,1,4.4,4.1,5.0
8991,385,0,Asia Pacific,Manufacturing,Market Access,Meets,Male,35,3,1,10,22,0.0,4.0,2.6,0.0348,1,1,1,1,2.9,4.9,3.5
8992,535,0,Latin America,Digital,Legal & Compliance,Below,Male,34,16,0,10,17,3.7,2.3,1.8,0.0,1,1,1,1,3.5,2.6,2.7
8993,49,0,Europe,R&D,IT & Digital,Below,Female,28,17,0,9,35,3.3,3.0,2.9,0.0,1,1,1,1,3.6,3.6,2.5
8994,453,0,Middle East & Africa,Manufacturing,Data Science,Meets,Female,39,7,0,10,15,3.9,4.2,2.7,0.0348,1,1,1,1,4.3,3.0,3.1
8995,1011,0,Middle East & Africa,Finance,Sales,Far Exceeds,Female,38,4,0,10,17,3.3,2.6,3.1,0.1022,0,0,0,0,3.4,1.8,3.6
8996,205,0,Asia Pacific,Commercial,Legal & Compliance,Meets,Male,31,4,0,6,18,2.8,2.7,2.4,0.0422,0,0,0,0,1.6,2.3,1.9
8997,122,0,Latin America,R&D,Market Access,Meets,Female,46,10,0,6,8,2.4,2.2,2.1,0.0977,1,1,1,0,2.7,2.5,2.0
8998,686,0,Asia Pacific,Digital,Quality Assurance,Exceeds,Male,42,9,0,12,24,2.6,2.6,1.4,0.1452,1,1,1,1,3.2,2.3,4.6
8999,846,1,Asia Pacific,HR,Human Resources,Far Exceeds,Male,38,26,0,8,13,3.5,2.7,3.7,0.1168,1,1,1,1,3.2,3.8,4.8
9000,315,0,Middle East & Africa,Commercial,Marketing,Meets,Male,36,11,0,11,22,2.4,3.0,1.0,0.0422,1,0,0,0,2.4,3.1,3.6
